PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Younan, ND; Nadal, RC; Davies, P; Brown, DR; Viles, JH				Younan, Nadine D.; Nadal, Rebecca C.; Davies, Paul; Brown, David R.; Viles, John H.			Methionine Oxidation Perturbs the Structural Core of the Prion Protein and Suggests a Generic Misfolding Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE CHANGES; COPPER-CATALYZED OXIDATION; SULFOXIDE REDUCTASES; SPONGIFORM ENCEPHALOPATHIES; ANTIOXIDANT DEFENSE; DOMAIN PRP(121-231); HYDROGEN-PEROXIDE; HYDROXYL RADICALS; CELLULAR-RESPONSE; TERMINAL DOMAIN	Oxidative stress and misfolding of the prion protein (PrPC) are fundamental to prion diseases. We have therefore probed the effect of oxidation on the structure and stability of PrPC. Urea unfolding studies indicate that H2O2 oxidation reduces the thermodynamic stability of PrPC by as much as 9 kJ/mol.H-1-N-15 NMR studies indicate methionine oxidation perturbs key hydrophobic residues on one face of helix-C as follows: Met-205, Val-209, and Met-212 together with residues Val-160 and Tyr-156. These hydrophobic residues pack together and form the structured core of the protein, stabilizing its ternary structure. Copper-catalyzed oxidation of PrPC causes a more significant alteration of the structure, generating a monomeric molten globule species that retains its native helical content. Further copper-catalyzed oxidation promotes extended beta-strand structures that lack a cooperative fold. This transition from the helical molten globule to beta-conformation has striking similarities to a misfolding intermediate generated at low pH. PrP may therefore share a generic misfolding pathway to amyloid fibers, irrespective of the conditions promoting misfolding. Our observations support the hypothesis that oxidation of PrP destabilizes the native fold of PrPC, facilitating the transition to PrPSc. This study gives a structural and thermodynamic explanation for the high levels of oxidized methionine in scrapie isolates.	[Younan, Nadine D.; Nadal, Rebecca C.; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Davies, Paul; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of London; University of Bath	Viles, JH (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk		Davies, Paul/0000-0001-8022-2719; Nadal, Rebecca/0000-0002-5526-3508	Wellcome Trust [093241/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BBD0050271]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/D005027/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005027/1] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Project Grant 093241/Z/10/Z, Biotechnology and Biological Sciences Research Council Project Grant BBD0050271, and Biotechnology and Biological Sciences Research Council Quota studentships.	Abdelraheim SR, 2006, INT J BIOCHEM CELL B, V38, P1429, DOI 10.1016/j.biocel.2006.02.007; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; Binger KJ, 2010, BIOCHEMISTRY-US, V49, P2981, DOI 10.1021/bi902203m; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Brazier MW, 2008, FREE RADICAL BIO MED, V45, P184, DOI 10.1016/j.freeradbiomed.2008.04.006; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Brown DR, 2005, FOLIA NEUROPATHOL, V43, P229; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Crowhurst KA, 2002, J MOL BIOL, V322, P163, DOI 10.1016/S0022-2836(02)00741-6; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fernaeus S, 2005, NEUROSCI LETT, V389, P133, DOI 10.1016/j.neulet.2005.07.032; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Gerber R, 2008, PROTEIN SCI, V17, P537, DOI 10.1110/ps.073163308; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Jones CE, 2005, J MOL BIOL, V346, P1393, DOI 10.1016/j.jmb.2004.12.043; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JI, 2001, ANN NY ACAD SCI, V928, P182, DOI 10.1111/j.1749-6632.2001.tb05648.x; Klamt F, 2001, FREE RADICAL BIO MED, V30, P1137; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Klewpatinond M, 2007, FEBS LETT, V581, P1430, DOI 10.1016/j.febslet.2007.02.068; Klewpatinond M, 2007, BIOCHEM J, V404, P393, DOI 10.1042/BJ20061893; Lee DW, 1999, FREE RADICAL RES, V30, P499, DOI 10.1080/10715769900300541; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liu L, 2011, J AM CHEM SOC, V133, P12229, DOI 10.1021/ja2045259; Martin SF, 2007, FREE RADICAL BIO MED, V42, P1723, DOI 10.1016/j.freeradbiomed.2007.03.005; Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Millhauser GL, 2004, ACCOUNTS CHEM RES, V37, P79, DOI 10.1021/ar0301678; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Nadal RC, 2008, BIOCHEMISTRY-US, V47, P11653, DOI 10.1021/bi8011093; Nadal RC, 2007, FREE RADICAL BIO MED, V42, P79, DOI 10.1016/j.freeradbiomed.2006.09.019; Nadal RC, 2009, BIOCHEMISTRY-US, V48, P8929, DOI 10.1021/bi9011397; O'Sullivan DBD, 2007, BIOCHEM J, V401, P533, DOI 10.1042/BJ20060668; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; Pamplona R, 2008, FREE RADICAL BIO MED, V45, P1159, DOI 10.1016/j.freeradbiomed.2008.07.009; Petropoulos I, 2005, BBA-PROTEINS PROTEOM, V1703, P261, DOI 10.1016/j.bbapap.2004.08.018; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Redecke L, 2007, J STRUCT BIOL, V157, P308, DOI 10.1016/j.jsb.2006.06.013; Requena JR, 2004, ARCH BIOCHEM BIOPHYS, V432, P188, DOI 10.1016/j.abb.2004.09.012; Requena JR, 2001, P NATL ACAD SCI USA, V98, P7170, DOI 10.1073/pnas.121190898; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Schenck HL, 1996, J AM CHEM SOC, V118, P12487, DOI 10.1021/ja962026p; Shiraishi N, 2005, BIOCHEM J, V387, P247, DOI 10.1042/BJ20041561; Sideri TC, 2011, J BIOL CHEM, V286, P38924, DOI 10.1074/jbc.M111.272419; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Viles J. H., 2012, COORDINAT C IN PRESS; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Viles JH, 2008, BIOCHEM SOC T, V36, P1288, DOI 10.1042/BST0361288; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Wildegger G, 1999, NAT STRUCT BIOL, V6, P550, DOI 10.1038/9323; Wolschner C, 2009, P NATL ACAD SCI USA, V106, P7756, DOI 10.1073/pnas.0902688106; Wong BS, 2000, BIOCHEM BIOPH RES CO, V275, P249, DOI 10.1006/bbrc.2000.3158; Wong BS, 1999, BIOCHEM BIOPH RES CO, V259, P352, DOI 10.1006/bbrc.1999.0802; Wong BS, 2001, J NEUROCHEM, V76, P565, DOI 10.1046/j.1471-4159.2001.00028.x; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamin G, 2003, J BIOL CHEM, V278, P27630, DOI 10.1074/jbc.M303302200; Younan ND, 2011, J MOL BIOL, V410, P369, DOI 10.1016/j.jmb.2011.05.013; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025	84	36	37	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28263	28275		10.1074/jbc.M112.354779	http://dx.doi.org/10.1074/jbc.M112.354779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22654104	Green Published, hybrid			2022-12-28	WOS:000308074600005
J	Oh, E; Kalwat, MA; Kim, MJ; Verhage, M; Thurmond, DC				Oh, Eunjin; Kalwat, Michael A.; Kim, Min-Jung; Verhage, Matthijs; Thurmond, Debbie C.			Munc18-1 Regulates First-phase Insulin Release by Promoting Granule Docking to Multiple Syntaxin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; MEMBRANE-FUSION; SNARE COMPLEX; N-PEPTIDE; TYROSINE PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; SEC1/MUNC18 PROTEINS; SECRETORY GRANULES; NEGATIVE REGULATOR; PLASMA-MEMBRANE	Attenuated levels of the Sec1/Munc18 (SM) protein Munc18-1 in human islet beta-cells is coincident with type 2 diabetes, although how Munc18-1 facilitates insulin secretion remains enigmatic. Herein, using conventional Munc18-1(-/-) and beta-cell specific Munc18-1(-/-) knock-out mice, we establish that Munc18-1 is required for the first phase of insulin secretion. Conversely, human islets expressing elevated levels of Munc18-1 elicited significant potentiation of only first-phase insulin release. Insulin secretory changes positively correlated with insulin granule number at the plasma membrane: Munc18-1-deficient cells lacked 35% of the normal component of pre-docked insulin secretory granules, whereas cells with elevated levels of Munc18-1 exhibited a similar to 20% increase in pre-docked granule number. Pre-docked syntaxin 1-based SNARE complexes bound by Munc18-1 were detected in beta-cell lysates but, surprisingly, were reduced by elevation of Munc18-1 levels. Paradoxically, elevated Munc18-1 levels coincided with increased binding of syntaxin 4 to VAMP2 at the plasma membrane. Accordingly, syntaxin 4 was a requisite for Munc18-1 potentiation of insulin release. Munc18c, the cognate SM isoform for syntaxin 4, failed to bind SNARE complexes. Given that Munc18-1 does not pair with syntaxin 4, these data suggest a novel indirect role for Munc18-1 in facilitating syntaxin 4-mediated granule pre-docking to support first-phase insulin exocytosis.	[Oh, Eunjin; Thurmond, Debbie C.] Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr, Indianapolis, IN 46202 USA; [Kalwat, Michael A.; Thurmond, Debbie C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kim, Min-Jung] Korea Food & Drug Adm, Recombinant Prot Prod Div, Biopharmaceut & Herbal Med Bur, Chungcheongbuk Do 363700, South Korea; [Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogen & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam, Dept Clin Genet, Ctr Neurogen & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, NL-1081 HV Amsterdam, Netherlands	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Thurmond, DC (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu	Kalwat, Michael/GRJ-4422-2022; Kalwat, Michael A/H-3184-2013	Kalwat, Michael A/0000-0002-8349-9470; verhage, matthijs/0000-0002-6085-7503	National Institutes of Health [DK067912, DK076614]; Showalter Trust of Indiana University School of Medicine; American Heart Association [10PRE3040010]; Korean Government Overseas Research fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076614, R01DK067912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Trust of Indiana University School of Medicine; American Heart Association(American Heart Association); Korean Government Overseas Research fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK067912 and DK076614 (to D. C. T.). This work was also supported by the Showalter Trust of Indiana University School of Medicine (to E. O.), American Heart Association Grant 10PRE3040010 (to M. A. K.), and the Korean Government Overseas Research fellowship (to M. J. K.).	Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; Betz A, 1997, J BIOL CHEM, V272, P2520; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Gladycheva SE, 2004, J PHYSIOL-LONDON, V558, P857, DOI 10.1113/jphysiol.2004.067249; Groffen AJA, 2004, J BIOL CHEM, V279, P23740, DOI 10.1074/jbc.M400731200; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Jewell JL, 2008, J BIOL CHEM, V283, P21734, DOI 10.1074/jbc.M710445200; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Kalwat MA, 2012, MOL ENDOCRINOL, V26, P128, DOI 10.1210/me.2011-1112; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Mandic SA, 2011, J BIOL CHEM, V286, P28026, DOI 10.1074/jbc.M111.235366; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Mistry AC, 2009, AM J PHYSIOL-RENAL, V297, pF292, DOI 10.1152/ajprenal.00196.2009; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Shi L, 2011, MOL BIOL CELL, V22, P4150, DOI 10.1091/mbc.E11-02-0150; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Straub SG, 2004, DIABETES, V53, P3179, DOI 10.2337/diabetes.53.12.3179; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wiseman DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214031; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zhang HJ, 2005, GENESIS, V42, P210, DOI 10.1002/gene.20137; Zhang W, 2000, J BIOL CHEM, V275, P41521, DOI 10.1074/jbc.M005479200	62	48	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25821	25833		10.1074/jbc.M112.361501	http://dx.doi.org/10.1074/jbc.M112.361501			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685295	Green Published, hybrid			2022-12-28	WOS:000306916300012
J	Goncharova, V; Serobyan, N; Iizuka, S; Schraufstatter, I; de Ridder, A; Povaliy, T; Wacker, V; Itano, N; Kimata, K; Orlovskaja, IA; Yamaguchi, Y; Khaldoyanidi, S				Goncharova, Valentina; Serobyan, Naira; Iizuka, Shinji; Schraufstatter, Ingrid; de Ridder, Audrey; Povaliy, Tatiana; Wacker, Valentina; Itano, Naoki; Kimata, Koji; Orlovskaja, Irina A.; Yamaguchi, Yu; Khaldoyanidi, Sophia			Hyaluronan Expressed by the Hematopoietic Microenvironment Is Required for Bone Marrow Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR CELLS; STEM-CELLS; GROWTH-FACTOR; STEM/PROGENITOR CELLS; EXTRACELLULAR-MATRIX; CHEMOKINE FAMILY; LUNG INJURY; IN-VITRO; ACID; PROLIFERATION	The contribution of hyaluronan (HA) to the regulatory network of the hematopoietic microenvironment was studied using knock-out mice of three hyaluronan synthase genes (Has1, Has2, and Has3). The number of hematopoietic progenitors was decreased in bone marrow and increased in extramedullary sites of Prx1-Cre;Has2(flox/flox); Has1(-/-); Has3(-/-) triple knock-out (tKO) mice as compared with wild type (WT) and Has1(-/-); Has3(-/-) double knock-out (dKO) mice. In line with this observation, decreased hematopoietic activity was observed in long term bone marrow cultures (LTBMC) from tKO mice, whereas the formation of the adherent layer and generation of hematopoietic cells in WT and dKO cultures was not different. 4-Methylumbelliferone (4MU) was used to pharmacologically inhibit the production of HA in LTBMC. Treatment with 4MU inhibited HA synthesis, decreased expression of HAS2 and HAS3, and eliminated hematopoiesis in LTBMC, and this effect was alleviated by the addition of exogenous HA. Exogenous HA also augmented the cell motility in LTBMC, which correlated with the HA-stimulated production of chemokines and growth factors. Conditioned media from HA-induced LTBMC enhanced the chemotaxis of hematopoietic stem/progenitor cells (HSPC) in response to SDF-1. Exposure of endothelial cells to 4MU decreased their ability to support HSPC rolling and adhesion. In addition, migration of transplanted HSPC into the marrow of 4MU-pretreated mice was lower than in untreated mice. Collectively, the results suggest that HA depletion reduces the ability of the microenvironment to support HSPC, and confirm a role for HA as a necessary regulatory element in the structure of the hematopoietic microenvironment.	[Goncharova, Valentina; Schraufstatter, Ingrid; de Ridder, Audrey; Povaliy, Tatiana; Wacker, Valentina; Khaldoyanidi, Sophia] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Serobyan, Naira] La Jolla Inst Mol Med, San Diego, CA 92121 USA; [Iizuka, Shinji; Yamaguchi, Yu] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [de Ridder, Audrey] Univ Namur, B-5000 Namur, Belgium; [Itano, Naoki] Kyoto Sangyo Univ, Kyoto 6038555, Japan; [Kimata, Koji] Aichi Med Univ, Nagakute, Aichi 4801095, Japan; [Orlovskaja, Irina A.] Inst Clin Immunol, Novosibirsk 630099, Russia	Torrey Pines Institute for Molecular Studies, California; Sanford Burnham Prebys Medical Discovery Institute; University of Namur; Kyoto Sangyo University; Aichi Medical University; Russian Academy of Medical Sciences	Khaldoyanidi, S (corresponding author), 3550 Gen Atom Ct, San Diego, CA 92121 USA.	skhaldoyanidi@tpims.org			National Institutes of Health Grants [R41CA126004, R43AI082759, R21NS062428]; University of California TRDRP Grant [16RT-0134]; NATIONAL CANCER INSTITUTE [R41CA126004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI082759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062428] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California TRDRP Grant(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R41CA126004, R43AI082759, and R21NS062428 and University of California TRDRP Grant 16RT-0134 (to S. K. K.).	Andreutti D, 1999, J SUBMICR CYTOL PATH, V31, P173; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; BROXMEYER HE, 1993, J IMMUNOL, V150, P3448; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; Broxmeyer HE, 1996, ANN HEMATOL, V73, P1, DOI 10.1007/s002770050192; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cashman JD, 1998, BLOOD, V92, P2338, DOI 10.1182/blood.V92.7.2338.2338_2338_2344; Chang H, 2000, EXP HEMATOL, V28, P743, DOI 10.1016/S0301-472X(00)00184-3; Choong ML, 2004, CYTOKINE, V25, P239, DOI 10.1016/j.cyto.2003.11.002; Christophis C, 2011, BIOPHYS J, V101, P585, DOI 10.1016/j.bpj.2011.05.045; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fukuda S, 2007, BLOOD, V110, P860, DOI 10.1182/blood-2006-06-031401; GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0; HAMANN KJ, 1995, J IMMUNOL, V154, P4073; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Imai K, 1999, BLOOD, V93, P149, DOI 10.1182/blood.V93.1.149.401a02_149_156; JACOBSEN SEW, 1993, J EXP MED, V178, P413, DOI 10.1084/jem.178.2.413; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Khaldoyanidi S, 1999, BLOOD, V94, P940, DOI 10.1182/blood.V94.3.940.415k27_940_949; Khaldoyanidi S, 2002, BLOOD, V99, P3955, DOI 10.1182/blood.V99.11.3955; Khaldoyanidi S, 1996, J LEUKOCYTE BIOL, V60, P579, DOI 10.1002/jlb.60.5.579; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kollet O, 2002, BLOOD, V100, P2778, DOI 10.1182/blood-2002-02-0564; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Liesveld JL, 2001, J HEMATOTH STEM CELL, V10, P643, DOI 10.1089/152581601753193850; Liu LQ, 2003, ONCOL RES, V13, P359; LU L, 1993, EXP HEMATOL, V21, P1442; Matrosova VY, 2004, STEM CELLS, V22, P544, DOI 10.1634/stemcells.22-4-544; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; MATSUMOTO T, 1994, BONE, V15, P97, DOI 10.1016/8756-3282(94)90898-2; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Moll J, 1998, J CLIN INVEST, V102, P1024, DOI 10.1172/JCI2494; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; NOORDEGRAAF EM, 1981, EXP HEMATOL, V9, P326; Oertli B, 1998, J IMMUNOL, V161, P3431; Park D, 2012, FRONT BIOSCI-LANDMRK, V17, P30, DOI 10.2741/3913; PILARSKI LM, 1994, LEUKEMIA LYMPHOMA, V14, P363, DOI 10.3109/10428199409049691; Pilarski LM, 1999, BLOOD, V93, P2918; PYE DA, 1994, BBA-MOL CELL RES, V1220, P266, DOI 10.1016/0167-4889(94)90148-1; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; REHAKOVA M, 1994, INT J BIOL MACROMOL, V16, P121, DOI 10.1016/0141-8130(94)90037-X; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Schraufstatter IU, 2012, FRONT BIOSCI, V17, P2271; Shin DY, 2007, J CHROMATOGR A, V1160, P270, DOI 10.1016/j.chroma.2007.05.047; Siegelman MH, 2000, J CLIN INVEST, V105, P683, DOI 10.1172/JCI8692; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 2002, GLYCOCONJUGATE J, V19, P341, DOI 10.1023/A:1025321105691; Srinivas A, 2007, TISSUE ENG, V13, P447, DOI 10.1089/ten.2006.0196; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sudhoff T, 2002, J HEMATOTH STEM CELL, V11, P147, DOI 10.1089/152581602753448612; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; VERFAILLIE CM, 1993, BLOOD, V82, P2045; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; WEGROWSKI J, 1992, INT J RADIAT BIOL, V61, P685, DOI 10.1080/09553009214551501; Weidt Corinna, 2007, Curr Stem Cell Res Ther, V2, P89, DOI 10.2174/157488807779317008; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Xu Y. X., 1999, Hematology, V4, P345; YODER MC, 1995, EXP HEMATOL, V23, P961; Yoshihara S, 2005, FEBS LETT, V579, P2722, DOI 10.1016/j.febslet.2005.03.079	71	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25419	25433		10.1074/jbc.M112.376699	http://dx.doi.org/10.1074/jbc.M112.376699			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654110	Green Published, hybrid			2022-12-28	WOS:000306651700049
J	Lim, JC; Gruschus, JM; Kim, G; Berlett, BS; Tjandra, N; Levine, RL				Lim, Jung Chae; Gruschus, James M.; Kim, Geumsoo; Berlett, Barbara S.; Tjandra, Nico; Levine, Rodney L.			A Low pK(a) Cysteine at the Active Site of Mouse Methionine Sulfoxide Reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; ANTIOXIDANT DEFENSE; CATALYTIC MECHANISM; OXIDATIVE STRESS; PROTEIN; ENZYME; MSRA; ACID	Methionine sulfoxide reductase A is an essential enzyme in the antioxidant system which scavenges reactive oxygen species through cyclic oxidation and reduction of methionine and methionine sulfoxide. Recently it has also been shown to catalyze the reverse reaction, oxidizing methionine residues to methionine sulfoxide. A cysteine at the active site of the enzyme is essential for both reductase and oxidase activities. This cysteine has been reported to have a pK(a) of 9.5 in the absence of substrate, decreasing to 5.7 upon binding of substrate. Using three independent methods, we show that the pK(a) of the active site cysteine of mouse methionine sulfoxide reductase is 7.2 even in the absence of substrate. The primary mechanism by which the pK(a) is lowered is hydrogen bonding of the active site Cys-72 to protonated Glu-115. The low pK(a) renders the active site cysteine susceptible to oxidation to sulfenic acid by micromolar concentrations of hydrogen peroxide. This characteristic supports a role for methionine sulfoxide reductase in redox signaling.	[Lim, Jung Chae; Kim, Geumsoo; Berlett, Barbara S.; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Gruschus, James M.; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 50,Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov	Levine, Rodney L/D-9885-2011		Intramural Research Program of the NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048, ZIAHL000225] Funding Source: NIH RePORTER	Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the NHLBI, National Institutes of Health.	Antoine M, 2006, J BIOL CHEM, V281, P39062, DOI 10.1074/jbc.M608844200; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Barton J.P., 1973, J CHEM SOC P2, V1, P1547; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Brot N, 2006, J BIOL CHEM, V281, P32668, DOI 10.1074/jbc.M604971200; DONOVAN JW, 1964, BIOCHEMISTRY-US, V3, P67, DOI 10.1021/bi00889a012; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Lim JC, 2012, J BIOL CHEM, V287, P25589, DOI 10.1074/jbc.M112.368936; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Onufriev A, 2001, BIOCHEMISTRY-US, V40, P3413, DOI 10.1021/bi002740q; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; POLGAR L, 1975, EUR J BIOCHEM, V51, P63, DOI 10.1111/j.1432-1033.1975.tb03907.x; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Ranaivoson FM, 2006, J MOL BIOL, V358, P443, DOI 10.1016/j.jmb.2006.02.025; Regino CAS, 2007, INORG CHIM ACTA, V360, P3971, DOI 10.1016/j.ica.2007.05.020; Richardson DE, 2003, FREE RADICAL BIO MED, V35, P1538, DOI 10.1016/j.freeradbiomed.2003.08.019; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100	38	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25596	25601		10.1074/jbc.M112.369116	http://dx.doi.org/10.1074/jbc.M112.369116			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661719	Green Published, hybrid			2022-12-28	WOS:000306651700067
J	Waldetoft, KW; Svensson, L; Morgelin, M; Olin, AI; Nitsche-Schmitz, DP; Bjorck, L; Frick, IM				Waldetoft, Kristofer Wollein; Svensson, Lisbeth; Morgelin, Matthias; Olin, Anders I.; Nitsche-Schmitz, D. Patric; Bjorck, Lars; Frick, Inga-Maria			Streptococcal Surface Proteins Activate the Contact System and Control Its Antibacterial Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; VIRULENCE MECHANISM; C STREPTOCOCCUS; INNATE IMMUNITY; HUMAN-PLASMA; COMPLEMENT; IGG; IDENTIFICATION; FOG; PATHOGENESIS	Group G streptococci (GGS) are important bacterial pathogens in humans. Here, we investigated the interactions between GGS and the contact system, a procoagulant and proinflammatory proteolytic cascade that, upon activation, also generates antibacterial peptides. Two surface proteins of GGS, protein FOG and protein G (PG), were found to bind contact system proteins. Experiments utilizing contact protein-deficient human plasma and isogenic GGS mutant strains lacking FOG or PG showed that FOG and PG both activate the procoagulant branch of the contact system. In contrast, only FOG induced cleavage of high molecular weight kininogen, generating the proinflammatory bradykinin peptide and additional high molecular weight kininogen fragments containing the antimicrobial peptide NAT-26. On the other hand, PG protected the bacteria against the antibacterial effect of NAT-26. These findings underline the significance of the contact system in innate immunity and demonstrate that GGS have evolved surface proteins to exploit and modulate its effects.	[Waldetoft, Kristofer Wollein; Svensson, Lisbeth; Morgelin, Matthias; Olin, Anders I.; Bjorck, Lars; Frick, Inga-Maria] Lund Univ, Div Infect Med, Dept Clin Sci, SE-22184 Lund, Sweden; [Nitsche-Schmitz, D. Patric] Helmholtz Ctr Infect Res HZI, Microbial Pathogenesis Res Grp, D-38124 Braunschweig, Germany	Lund University; Helmholtz Association; Helmholtz-Center for Infection Research	Waldetoft, KW (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, BMC B14, SE-22184 Lund, Sweden.	kristofer.wollein_waldetoft@med.lu.se			Swedish Research Council [7480]; Swedish Government Funds for Clinical Research (ALF); Kock Foundation; Osterlund Foundation; Knut and Alice Wallenberg Foundation; Royal Physiographic Society; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Funds for Clinical Research (ALF); Kock Foundation; Osterlund Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Royal Physiographic Society; Hansa Medical AB	This work was supported by Swedish Research Council Project 7480, the Swedish Government Funds for Clinical Research (ALF), the Kock Foundation, the Osterlund Foundation, the Knut and Alice Wallenberg Foundation, the Royal Physiographic Society, and Hansa Medical AB.	Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Akesson P, 2010, MICROBIOL-SGM, V156, P3660, DOI 10.1099/mic.0.039578-0; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BJORCK L, 1984, J IMMUNOL, V133, P969; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bramhachari PV, 2010, J MED MICROBIOL, V59, P220, DOI 10.1099/jmm.0.015644-0; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cohen-Poradosu R, 2004, EMERG INFECT DIS, V10, P1455, DOI 10.3201/eid1008.030840; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; della Vergiliana JFV, 2010, BIOL CHEM, V391, P1067, DOI 10.1515/BC.2010.102; Dinkla K, 2007, J BIOL CHEM, V282, P18686, DOI 10.1074/jbc.M701047200; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Frick IM, 2007, THROMB HAEMOSTASIS, V98, P497, DOI 10.1160/TH07-01-0051; Frick IM, 2011, J BIOL CHEM, V286, P1331, DOI 10.1074/jbc.M110.178350; GHEBREHIWET B, 1983, J CLIN INVEST, V71, P1450, DOI 10.1172/JCI110898; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; HERWALD H, 1995, J BIOL CHEM, V270, P14634; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Holm K, 2011, INFECT IMMUN, V79, P3284, DOI 10.1128/IAI.05264-11; Johansson HM, 2004, MICROBIOL-SGM, V150, P4211, DOI 10.1099/mic.0.27269-0; Joseph K, 2005, ADV IMMUNOL, V86, P159, DOI 10.1016/S0065-2776(04)86005-X; Linge HM, 2007, MICROBIOL-SGM, V153, P3800, DOI 10.1099/mic.0.2007/009647-0; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Murphy EC, 2011, MICROBIOL-SGM, V157, P2094, DOI 10.1099/mic.0.046862-0; NESBITT SA, 1992, ANAL BIOCHEM, V206, P267, DOI 10.1016/0003-2697(92)90365-E; Nitsche-Schmitz DP, 2007, J BIOL CHEM, V282, P17530, DOI 10.1074/jbc.M702612200; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; REIS KJ, 1984, J IMMUNOL, V132, P3091; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; SMITHERICHSEN N, 1982, CIRC SHOCK, V9, P491; Sylvetsky N, 2002, AM J MED, V112, P622, DOI 10.1016/S0002-9343(02)01117-8; Takahashi T, 2011, J INFECT CHEMOTHER, V17, P1, DOI 10.1007/s10156-010-0084-2; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898	40	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25010	25018		10.1074/jbc.M112.373217	http://dx.doi.org/10.1074/jbc.M112.373217			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22648411	Green Published, hybrid			2022-12-28	WOS:000306651700014
J	Chucair-Elliott, AJ; Elliott, MH; Wang, JG; Moiseyev, GP; Ma, JX; Politi, LE; Rotstein, NP; Akira, S; Uematsu, S; Ash, JD				Chucair-Elliott, Ana J.; Elliott, Michael H.; Wang, Jiangang; Moiseyev, Gennadiy P.; Ma, Jian-Xing; Politi, Luis E.; Rotstein, Nora P.; Akira, Shizuo; Uematsu, Satoshi; Ash, John D.			Leukemia Inhibitory Factor Coordinates the Down-regulation of the Visual Cycle in the Retina and Retinal-pigmented Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-INDUCED DEGENERATION; PRECONDITIONING-INDUCED PROTECTION; FIBROBLAST-GROWTH-FACTOR; MACULAR DEGENERATION; PHOTOTRANSDUCTION MACHINERY; DARK-ADAPTATION; OUTER SEGMENTS; GENE LEADS; RAT RETINA; RPE65	Leukemia inhibitory factor (LIF), an interleukin-6 family neurocytokine, is up-regulated in response to different types of retinal stress and has neuroprotective activity through activation of the gp130 receptor/STAT3 pathway. We observed that LIF induces rapid, robust, and sustained activation of STAT3 in both the retina and retinal pigmented epithelium (RPE). Here, we tested whether LIF-induced STAT3 activation within the RPE can down-regulate RPE65, the central enzyme in the visual cycle that provides the 11-cis-retinal chromophore to photoreceptors in vivo. We generated conditional knock-out mice to specifically delete STAT3 or gp130 in RPE, retina, or both RPE and retina. After intravitreal injection of LIF, we analyzed the expression levels of visual cycle genes and proteins, isomerase activity of RPE65, levels of rhodopsin protein, and the rates of dark adaptation and rhodopsin regeneration. We found that RPE65 protein levels and isomerase activity were reduced and recovery of bleachable rhodopsin was delayed in LIF-injected eyes. In mice with functional gp130/STAT3 signaling in the retina, rhodopsin protein was also reduced by LIF. However, the LIF-induced down-regulation of RPE65 required a functional gp130/STAT3 cascade intrinsic to RPE. Our data demonstrate that a single cytokine, LIF, can simultaneously and independently affect both RPE and photoreceptors through the same signaling cascade to reduce the generation and utilization of 11-cis-retinal.	[Wang, Jiangang; Ash, John D.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Chucair-Elliott, Ana J.; Elliott, Michael H.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy P.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy P.; Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Chucair-Elliott, Ana J.; Politi, Luis E.; Rotstein, Nora P.] Univ Nacl Sur, Dept Biol Bioquim & Farm, Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Akira, Shizuo; Uematsu, Satoshi] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	State University System of Florida; University of Florida; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; National University of the South; Osaka University	Ash, JD (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA.	jash@ufl.edu	Akira, Shizuo/C-3134-2009; wang, jian/GVS-0711-2022	Chucair-Elliott, Ana/0000-0002-0172-1876; Ash, John/0000-0002-8330-7301	National Institutes of Health [R01EY16459, R01EY012231, R01EY018659, R01EY019309, R01EY019494, EY012190, RR024215, RR017703]; Foundation Fighting Blindness; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215, P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019494, R01EY012231, R01EY016459, P30EY012190, R01EY018659, R01EY019309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY16459 (to J. D. A.), R01EY012231 (to J. X. M.), R01EY018659 (to J. X. M.), R01EY019309 (to J. X. M.), R01EY019494 (to M. H. E.), EY012190 (NEI core grant), and Grants RR024215 and RR017703 (Center of Biomedical Research Excellence). This work was also supported by Foundation Fighting Blindness and an unrestricted grant from Research to Prevent Blindness, Inc.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; BOK D, 1993, J CELL SCI, P189; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Burgi S, 2009, MOL VIS, V15, P1631; CHAITIN MH, 1983, INVEST OPHTH VIS SCI, V24, P812; Chollangi S, 2009, NEUROBIOL DIS, V34, P535, DOI 10.1016/j.nbd.2009.03.012; Do Rhee K, 2007, INVEST OPHTH VIS SCI, V48, P1389, DOI 10.1167/iovs.06-0677; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Farjo KM, 2009, INVEST OPHTH VIS SCI, V50, P5089, DOI 10.1167/iovs.09-3797; Fasler-Kan E, 2005, OPHTHALMOLOGICA, V219, P214, DOI 10.1159/000085730; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; GAO H, 1995, DEV BIOL, V169, P168, DOI 10.1006/dbio.1995.1135; Gao H, 1996, EXP EYE RES, V62, P181, DOI 10.1006/exer.1996.0022; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Kubota R, 2012, RETINA-J RET VIT DIS, V32, P183, DOI 10.1097/IAE.0b013e318217369e; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LAVAIL MM, 1976, EXP EYE RES, V23, P277, DOI 10.1016/0014-4835(76)90209-8; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Li R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023148; Liu CD, 1998, J NEUROSCI, V18, P1337; LOPEZ PF, 1992, AUST NZ J OPHTHALMOL, V20, P163, DOI 10.1111/j.1442-9071.1992.tb00935.x; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; Marmorstein AD, 2001, TRAFFIC, V2, P867, DOI 10.1034/j.1600-0854.2001.21202.x; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Moiseyev G, 2008, J BIOL CHEM, V283, P8110, DOI 10.1074/jbc.M703654200; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Rattner A, 2008, J NEUROSCI, V28, P9880, DOI 10.1523/JNEUROSCI.2401-08.2008; Redmond TM, 2007, MOL VIS, V13, P1813; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Samardzija M, 2006, EUR J NEUROSCI, V23, P1028, DOI 10.1111/j.1460-9568.2006.04639.x; SHICHI H, 1969, J BIOL CHEM, V244, P529; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strick DJ, 2009, INVEST OPHTH VIS SCI, V50, P2427, DOI 10.1167/iovs.08-3058; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Ueki Y, 2010, ADV EXP MED BIOL, V664, P655, DOI 10.1007/978-1-4419-1399-9_75; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; WEN R, 1995, J NEUROSCI, V15, P7377; Wen R, 2008, ADV EXP MED BIOL, V613, P407, DOI 10.1007/978-0-387-74904-4_48; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2003, INVEST OPHTH VIS SCI, V44, P2798, DOI 10.1167/iovs.02-1134; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845; Zarbin MA, 1998, EUR J OPHTHALMOL, V8, P199, DOI 10.1177/112067219800800401; Zhang SSM, 2003, EXP EYE RES, V76, P421, DOI 10.1016/S0014-4835(03)00002-2	60	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24092	24102		10.1074/jbc.M112.378240	http://dx.doi.org/10.1074/jbc.M112.378240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645143	Green Published, hybrid			2022-12-28	WOS:000306651100004
J	Jian, XY; Gruschus, JM; Sztul, E; Randazzo, PA				Jian, Xiaoying; Gruschus, James M.; Sztul, Elizabeth; Randazzo, Paul A.			The Pleckstrin Homology (PH) Domain of the Arf Exchange Factor Brag2 Is an Allosteric Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; GUANINE-NUCLEOTIDE-EXCHANGE; AMINO-TERMINUS; ACTIN CYTOSKELETON; MYRISTOYLATED ARF1; KINETIC MECHANISM; STRUCTURAL BASIS; CELL-ADHESION; FACTOR ARNO; G-PROTEINS	Brag2, a Sec7 domain (sec7d)-containing guanine nucleotide exchange factor, regulates cell adhesion and tumor cell invasion. Brag2 catalyzes nucleotide exchange, converting Arf.GDP to Arf.GTP. Brag2 contains a pleckstrin homology (PH) domain, and its nucleotide exchange activity is stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2). Here we determined kinetic parameters for Brag2 and examined the basis for regulation by phosphoinositides. Using myristoylated Arf1.GDP as a substrate, the k(cat) was 1.8 +/- 0.1/s as determined by single turnover kinetics, and the K-m was 0.20 +/- 0.07 mu M as determined by substrate saturation kinetics. PIP2 decreased the K-m and increased the k(cat) of the reaction. The effect of PIP2 required the PH domain of Brag2 and the N terminus of Arf and was largely independent of Arf myristoylation. Structural analysis indicated that the linker between the sec7d and the PH domain in Brag2 may directly contact Arf. In support, we found that a Brag2 fragment containing the sec7d and the linker was more active than sec7d alone. We conclude that Brag2 is allosterically regulated by PIP2 binding to the PH domain and that activity depends on the interdomain linker. Thus, the PH domain and the interdomain linker of Brag2 may be targets for selectively regulating the activity of Brag2.	[Jian, Xiaoying; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Gruschus, James M.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Alabama System; University of Alabama Birmingham	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov			National Institutes of Health Intramural Program of the NCI [BC 007365]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program of the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program of the NCI (Project BC 007365).	Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; CHANG CH, 1983, BIOCHEMISTRY-US, V22, P600, DOI 10.1021/bi00272a012; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Lee DY, 2006, BIOCHEMISTRY-US, V45, P15301, DOI 10.1021/bi061824h; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Lowery J, 2011, J BIOL CHEM, V286, P36898, DOI 10.1074/jbc.M111.230631; Luo RB, 2005, CURR BIOL, V15, P2164, DOI 10.1016/j.cub.2005.10.065; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; RANDAZZO PA, 1994, J BIOL CHEM, V269, P29490; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; TERUI T, 1994, J BIOL CHEM, V269, P28130; WEISS O, 1989, J BIOL CHEM, V264, P21066; Wu XW, 2003, J STRUCT BIOL, V141, P63, DOI 10.1016/S1047-8477(02)00570-1; Yoon HY, 2004, CELL SIGNAL, V16, P1033, DOI 10.1016/j.cellsig.2004.02.008	39	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24273	24283		10.1074/jbc.M112.368084	http://dx.doi.org/10.1074/jbc.M112.368084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613714	Green Published, hybrid			2022-12-28	WOS:000306651100021
J	Noguchi, TQP; Komori, T; Umeki, N; Demizu, N; Ito, K; Iwane, AH; Tokuraku, K; Yanagida, T; Uyeda, TQP				Noguchi, Taro Q. P.; Komori, Tomotaka; Umeki, Nobuhisa; Demizu, Noriyuki; Ito, Kohji; Iwane, Atsuko Hikikoshi; Tokuraku, Kiyotaka; Yanagida, Toshio; Uyeda, Taro Q. P.			G146V Mutation at the Hinge Region of Actin Reveals a Myosin Class-specific Requirement of Actin Conformations for Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; F-ACTIN; SLIDING MOVEMENT; ATP HYDROLYSIS; CROSS-LINKING; MOTOR DOMAIN; FILAMENTS; PHOSPHATE; BINDING; DICTYOSTELIUM	The G146V mutation in actin is dominant lethal in yeast. G146V actin filaments bind cofilin only minimally, presumably because cofilin binding requires the large and small actin domains to twist with respect to one another around the hinge region containing Gly-146, and the mutation inhibits that twisting motion. A number of studies have suggested that force generation by myosin also requires actin filaments to undergo conformational changes. This prompted us to examine the effects of the G146V mutation on myosin motility. When compared with wild-type actin filaments, G146V filaments showed a 78% slower gliding velocity and a 70% smaller stall force on surfaces coated with skeletal heavy meromyosin. In contrast, the G146V mutation had no effect on either gliding velocity or stall force on myosin V surfaces. Kinetic analyses of actin-myosin binding and ATPase activity indicated that the weaker affinity of actin filaments for myosin heads carrying ADP, as well as reduced actin-activated ATPase activity, are the cause of the diminished motility seen with skeletal myosin. Interestingly, the G146V mutation disrupted cooperative binding of myosin II heads to actin filaments. These data suggest that myosin-induced conformational changes in the actin filaments, presumably around the hinge region, are involved in mediating the motility of skeletal myosin but not myosin V and that the specific structural requirements for the actin subunits, and thus the mechanism of motility, differ among myosin classes.	[Demizu, Noriyuki; Tokuraku, Kiyotaka] Miyakonojo Natl Coll Technol, Dept Chem Sci & Engn, Miyazaki 8858567, Japan; [Noguchi, Taro Q. P.; Umeki, Nobuhisa; Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Noguchi, Taro Q. P.; Uyeda, Taro Q. P.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058573, Japan; [Komori, Tomotaka; Iwane, Atsuko Hikikoshi; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Nanobiol Labs, Suita, Osaka 5650871, Japan; [Ito, Kohji] Chiba Univ, Fac Sci, Dept Biol, Chiba 2638522, Japan; [Yanagida, Toshio] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka 5650874, Japan; [Yanagida, Toshio] Ctr Informat & Neural Networks CiNet, Suita, Osaka 5650871, Japan; [Yanagida, Toshio] Osaka Univ, World Premier Int Res Ctr WPI, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Osaka University; Chiba University; RIKEN; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST)	Noguchi, TQP (corresponding author), Miyakonojo Natl Coll Technol, Dept Chem Sci & Engn, Yoshio Cho, Miyazaki 8858567, Japan.	t-noguchi@cc.miyakonojo-nct.ac.jp	Ito, Kohji/K-8441-2017; Tokuraku, Kiyotaka/D-4542-2014	Ito, Kohji/0000-0001-9573-432X; Tokuraku, Kiyotaka/0000-0002-7747-4808; Iwane, Atsuko/0000-0003-2641-2268	Ministry of Science, Culture, Sports and Technology; Grants-in-Aid for Scientific Research [23370072] Funding Source: KAKEN	Ministry of Science, Culture, Sports and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for scientific research from the Ministry of Science, Culture, Sports and Technology (to T. Q. P. U. and T. Q. P. N.).	Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Hachikubo Y, 2003, J BIOCHEM, V134, P165, DOI 10.1093/jb/mvg125; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim E, 2002, BIOCHEMISTRY-US, V41, P86, DOI 10.1021/bi0113824; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Komori T, 2009, BIOPHYS J, V96, pL4, DOI 10.1016/j.bpj.2008.09.031; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kubota H, 2009, J BIOL CHEM, V284, P35251, DOI 10.1074/jbc.M109.013565; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P3670, DOI 10.1021/bi952645v; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Noguchi TQP, 2010, BIOCHEM BIOPH RES CO, V396, P1006, DOI 10.1016/j.bbrc.2010.05.047; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; Oosawa F., 1972, COLD SPRING HARB SYM, V37, P277; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; Orlova A, 2001, J MOL BIOL, V312, P95, DOI 10.1006/jmbi.2001.4945; Prochniewicz E, 2001, BIOCHEMISTRY-US, V40, P13933, DOI 10.1021/bi010893n; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Tokuraku K, 2009, J MOL BIOL, V386, P149, DOI 10.1016/j.jmb.2008.12.008; Uyeda TQP, 2002, BIOCHEMISTRY-US, V41, P9525, DOI 10.1021/bi026177i; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Volkmann N, 2003, P NATL ACAD SCI USA, V100, P3227, DOI 10.1073/pnas.0536510100; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0	41	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24339	24345		10.1074/jbc.M111.321752	http://dx.doi.org/10.1074/jbc.M111.321752			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637580	Green Published, hybrid			2022-12-28	WOS:000306651100028
J	Wang, B; Means, CK; Yang, YM; Mamonova, T; Bisello, A; Altschuler, DL; Scott, JD; Friedman, PA				Wang, Bin; Means, Chris K.; Yang, Yanmei; Mamonova, Tatyana; Bisello, Alessandro; Altschuler, Daniel L.; Scott, John D.; Friedman, Peter A.			Ezrin-anchored Protein Kinase A Coordinates Phosphorylation-dependent Disassembly of a NHERF1 Ternary Complex to Regulate Hormone-sensitive Phosphate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; OPOSSUM KIDNEY-CELLS; PARATHYROID-HORMONE; PDZ DOMAIN; I COTRANSPORTER; DOWN-REGULATION; ERM PROTEINS; NAPI-IIA; MUTATIONS; ASSOCIATION	Congenital defects in the Na/H exchanger regulatory factor-1 (NHERF1) are linked to disordered phosphate homeostasis and skeletal abnormalities in humans. In the kidney, these mutations interrupt parathyroid hormone (PTH)-responsive sequestration of the renal phosphate transporter, Npt2a, with ensuing urinary phosphate wasting. We now report that NHERF1, a modular PDZ domain scaffolding protein, coordinates the assembly of an obligate ternary complex with Npt2a and the PKA-anchoring protein ezrin to facilitate PTH-responsive cAMP signaling events. Activation of ezrin-anchored PKA initiates NHERF1 phosphorylation to disassemble the ternary complex, release Npt2a, and thereby inhibit phosphate transport. Loss-of-function mutations stabilize an inactive NHERF1 conformation that we show is refractory to PKA phosphorylation and impairs assembly of the ternary complex. Compensatory mutations introduced in mutant NHERF1 re-establish the integrity of the ternary complex to permit phosphorylation of NHERF1 and rescue PTH action. These findings offer new insights into a novel macromolecular mechanism for the physiological action of a critical ternary complex, where anchored PKA coordinates the assembly and turnover of the Npt2a-NHERF1-ezrin complex.	[Wang, Bin; Yang, Yanmei; Mamonova, Tatyana; Bisello, Alessandro; Altschuler, Daniel L.; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Prot Coupled Receptor Biol G, Pittsburgh, PA 15261 USA; [Means, Chris K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Prot Coupled Receptor Biol G, W1340 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	paf10@pitt.edu		Wang, Bin/0000-0002-5396-6111	National Institutes of Health [DK069998, DK071158, DK063069, GM048231]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071158, R01DK063069, R01DK069998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK069998 (to P. A. F.), DK071158 (to A. B.), DK063069 (to D. L. A.), GM048231 (to J. D. S.). This work was also supported by the Howard Hughes Medical Institute (to J. D. S.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alarcon-Riquelme ME, 2003, NAT GENET, V35, P299, DOI 10.1038/ng1203-299; Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Arola AM, 2007, MOL GENET METAB, V90, P435, DOI 10.1016/j.ymgme.2006.12.008; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; BIBER J, 1990, METHOD ENZYMOL, V191, P494; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; Charizopoulou N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1200; Cheng H, 2009, STRUCTURE, V17, P660, DOI 10.1016/j.str.2009.03.009; COLE JA, 1987, AM J PHYSIOL, V253, pE221, DOI 10.1152/ajpendo.1987.253.2.E221; Courbebaisse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034764; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Dai JL, 2004, ONCOGENE, V23, P8681, DOI 10.1038/sj.onc.1207962; de Azevedo WF, 2008, CURR DRUG TARGETS, V9, P1071, DOI 10.2174/138945008786949441; de Paula FJA, 2010, HORM METAB RES, V42, P299, DOI 10.1055/s-0030-1248255; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferrara AM, 2009, J ENDOCRINOL INVEST, V32, P238, DOI 10.1007/BF03346459; Forster IC, 1999, J PHYSIOL-LONDON, V517, P327, DOI 10.1111/j.1469-7793.1999.0327t.x; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Aparisi MJ, 2010, MOL VIS, V16, P2948; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Khundmiri SJ, 2003, J BIOL CHEM, V278, P10134, DOI 10.1074/jbc.M211775200; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Levi M, 2008, NEW ENGL J MED, V359, P1171, DOI 10.1056/NEJMe0805943; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Murer H, 2010, J NEPHROL, V23, pS145; Nagai S, 2011, J BIOL CHEM, V286, P1618, DOI 10.1074/jbc.M110.198416; Nashiki K, 2005, KIDNEY INT, V68, P1137, DOI 10.1111/j.1523-1755.2005.00505.x; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Stokka AJ, 2010, BIOCHEM J, V425, P381, DOI 10.1042/BJ20091136; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Tanimura A, 2011, J MED INVESTIG, V58, P140, DOI 10.2152/jmi.58.140; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2011, AM J PHYSIOL-RENAL, V300, pF231, DOI 10.1152/ajprenal.00532.2010; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Weinman EJ, 2010, J BIOL CHEM, V285, P13454, DOI 10.1074/jbc.M109.094359; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wozniak M, 1996, J BIOL CHEM, V271, P5017	73	32	33	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24148	24163		10.1074/jbc.M112.369405	http://dx.doi.org/10.1074/jbc.M112.369405			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22628548	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000306651100010
J	Eren, E; van den Berg, B				Eren, Elif; van den Berg, Bert			Structural Basis for Activation of an Integral Membrane Protease by Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA-PESTIS; ESCHERICHIA-COLI; PLASMINOGEN ACTIVATION; SURFACE PROTEASE; ACTIVE-SITE; OMPT; PLAGUE; FAMILY	Omptins constitute a unique family of outer membrane proteases that are widespread in Enterobacteriaceae. The plasminogen activator (Pla) of Yersinia pestis is an omptin family member that is very important for development of both bubonic and pneumonic plague. The physiological function of Pla is to cleave (activate) human plasminogen to form the plasma protease plasmin. Uniquely, lipopolysaccharide (LPS) is essential for the catalytic activity of all omptins, including Pla. Why omptins require LPS for enzymatic activity is unknown. Here, we report the co-crystal structure of LPS-free Pla in complex with the activation loop peptide of human plasminogen, its natural substrate. The structure shows that in the absence of LPS, the peptide substrate binds deep within the active site groove and displaces the nucleophilic water molecule, providing an explanation for the dependence of omptins on LPS for enzymatic activity.	[Eren, Elif; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	van den Berg, B (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804; Eren, Elif/0000-0002-7942-4943				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baaden M, 2004, BIOPHYS J, V87, P2942, DOI 10.1529/biophysj.104.046987; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eren E, 2010, STRUCTURE, V18, P809, DOI 10.1016/j.str.2010.03.013; Haiko J, 2009, INNATE IMMUN-LONDON, V15, P67, DOI 10.1177/1753425909102559; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hritonenko V, 2007, MOL MEMBR BIOL, V24, P395, DOI 10.1080/09687680701443822; Kramer RA, 2002, EUR J BIOCHEM, V269, P1746, DOI 10.1046/j.1432-1327.2002.02820.x; Kramer RA, 2001, FEBS LETT, V505, P426, DOI 10.1016/S0014-5793(01)02863-0; Kukkonen M, 2004, INT J MED MICROBIOL, V294, P7, DOI 10.1016/j.ijmm.2004.01.003; Kukkonen M, 2004, MOL MICROBIOL, V51, P215, DOI 10.1046/j.1365-2958.2003.03817.x; Kukkonen M, 2001, MOL MICROBIOL, V40, P1097, DOI 10.1046/j.1365-2958.2001.02451.x; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plow Edward F., 1999, Thrombosis and Haemostasis, V82, P4; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033	23	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23971	23976		10.1074/jbc.M112.376418	http://dx.doi.org/10.1074/jbc.M112.376418			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645135	Green Published, hybrid			2022-12-28	WOS:000306511300066
J	Lang, C; Rastew, E; Hermes, B; Siegbrecht, E; Ahrends, R; Banerji, S; Flieger, A				Lang, Christina; Rastew, Elena; Hermes, Bjoern; Siegbrecht, Enrico; Ahrends, Robert; Banerji, Sangeeta; Flieger, Antje			Zinc Metalloproteinase ProA Directly Activates Legionella pneumophila PlaC Glycerophospholipid:cholesterol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROBIAL LIPASE ACYLTRANSFERASE; FURIN-INDUCED CLEAVAGE; PHOSPHOLIPASE-A; CHOLESTEROL ACYLTRANSFERASE; LEGIONNAIRES-DISEASE; LYSOPHOSPHOLIPASE-A; LIPOLYTIC ENZYMES; SECRETION SYSTEM; BACTERIAL; FAMILY	Enzymes secreted by Legionella pneumophila, such as phospholipases A (PLAs) and glycerophospholipid: cholesterol acyltransferases (GCATs), may target host cell lipids and therefore contribute to the establishment of Legionnaires disease. L. pneumophila possesses three proteins, PlaA, PlaC, and PlaD, belonging to the GDSL family of lipases/acyltransferases. We have shown previously that PlaC is the major GCAT secreted by L. pneumophila and that the zinc metalloproteinase ProA is essential for GCAT activity. Here we characterized the mode of PlaC GCAT activation and determined that ProA directly processes PlaC. We further found that not only cholesterol but also ergosterol present in protozoa was palmitoylated by PlaC. Such ester formations were not induced by either PlaA or PlaD. PlaD was shown here to possess lysophospholipase A activity, and interestingly, all three GDSL enzymes transferred short chain fatty acids to sterols. The three single putative catalytic amino acids (Ser-37, Asp-398, and His-401) proved essential for all PlaC-associated PLA, lysophospholipase A, and GCAT activities. A further four cysteine residues are important for the PLA/GCAT activities as well as their oxidized state, and we therefore conclude that PlaC likely forms at least one disulfide loop. Analysis of cleavage site and loop deletion mutants suggested that for GCAT activation deletion of several amino acids within the loop is necessary rather than cleavage at a single site. Our data therefore suggest a novel enzyme inhibition/activation mechanism where a disulfide loop inhibits PlaC GCAT activity until the protein is exported to the external space where it is ProA-activated.	[Lang, Christina; Rastew, Elena; Hermes, Bjoern; Siegbrecht, Enrico; Banerji, Sangeeta; Flieger, Antje] Robert Koch Inst, Div Bacterial Infect, D-38855 Wernigerode, Germany; [Ahrends, Robert] Humboldt Univ, Inst Analyt & Environm Chem, D-12489 Berlin Adlershof, Germany	Robert Koch Institute; Humboldt University of Berlin	Flieger, A (corresponding author), Robert Koch Inst, Div Bacterial Infect, Burgstr 37, D-38855 Wernigerode, Germany.	fliegera@rki.de		Ahrends, Robert/0000-0003-0232-3375; Banerji, Sangeeta/0000-0003-1433-5250; Flieger, Antje/0000-0003-3819-2979	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG FL 359/6-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grant DFG FL 359/6-1.	Ahrends R, 2009, ANAL CHEM, V81, P2176, DOI 10.1021/ac802310c; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Banerji S, 2005, INFECT IMMUN, V73, P2899, DOI 10.1128/IAI.73.5.2899-2909.2005; Banerji S, 2004, MICROBIOL-SGM, V150, P522, DOI 10.1099/mic.0.26957-0; Banerji S, 2008, INT J MED MICROBIOL, V298, P169, DOI 10.1016/j.ijmm.2007.11.004; Bender J, 2009, J BIOL CHEM, V284, P27185, DOI 10.1074/jbc.M109.026021; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BLACK WJ, 1990, J BACTERIOL, V172, P2608, DOI 10.1128/jb.172.5.2608-2613.1990; Brick DJ, 1995, FEBS LETT, V377, P475, DOI 10.1016/0014-5793(95)01405-5; Broich M, 2006, J BACTERIOL, V188, P1218, DOI 10.1128/JB.188.4.1218-1226.2006; Brumlik MJ, 1996, J BACTERIOL, V178, P2060, DOI 10.1128/jb.178.7.2060-2064.1996; BUCKLEY JT, 1981, CAN J BIOCHEM CELL B, V59, P430, DOI 10.1139/o81-059; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Christen M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000430; CONLAN JW, 1986, J GEN MICROBIOL, V132, P1565; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; DUCKWORTH WC, 1979, P NATL ACAD SCI USA, V76, P635, DOI 10.1073/pnas.76.2.635; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; EGGSET G, 1994, J FISH DIS, V17, P17, DOI 10.1111/j.1365-2761.1994.tb00342.x; FASMAN GD, 1966, J MOL BIOL, V19, P240, DOI 10.1016/S0022-2836(66)80002-5; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Flieger A, 2000, FEMS MICROBIOL LETT, V188, P129; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; Flieger A, 2001, J BACTERIOL, V183, P2121, DOI 10.1128/JB.183.6.2121-2124.2001; GARRED O, 1995, J BIOL CHEM, V270, P10817; Geiger O., 2010, HDB HYDROCARBON LIPI, P3195; Giannelli V, 1997, INFECT IMMUN, V65, P331, DOI 10.1128/IAI.65.1.331-334.1997; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; GOLDFINE H, 1982, CURR TOP MEMBR TRANS, V17, P1; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Hales LM, 1999, INFECT IMMUN, V67, P3662, DOI 10.1128/IAI.67.7.3662-3666.1999; Hilbi H, 2010, MOL MICROBIOL, V76, P1, DOI 10.1111/j.1365-2958.2010.07086.x; HILTON S, 1991, BIOCHEMISTRY-US, V30, P6070, DOI 10.1021/bi00238a034; HILTON S, 1990, BIOCHEMISTRY-US, V29, P9072, DOI 10.1021/bi00490a026; HILTON S, 1991, J BIOL CHEM, V266, P997; Holk A, 2002, PLANT PHYSIOL, V130, P90, DOI 10.1104/pp.006288; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; KEEN MG, 1989, INFECT IMMUN, V57, P732, DOI 10.1128/IAI.57.3.732-738.1989; KORN ED, 1973, J BIOL CHEM, V248, P439; Kurmanova A, 2007, BIOCHEM BIOPH RES CO, V357, P144, DOI 10.1016/j.bbrc.2007.03.110; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; Lossi NS, 2008, MICROBIOL-SGM, V154, P2680, DOI 10.1099/mic.0.2008/019075-0; MOFFAT JF, 1994, INFECT IMMUN, V62, P751, DOI 10.1128/IAI.62.2.751-753.1994; MOFFAT JF, 1994, MOL MICROBIOL, V12, P693, DOI 10.1111/j.1365-2958.1994.tb01057.x; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; NEU HC, 1965, J BIOL CHEM, V240, P3685; OGATA M, 1992, J BIOL CHEM, V267, P25396; Okamoto T, 2004, BIOL CHEM, V385, P997, DOI 10.1515/BC.2004.130; PRESTIDGE L, 1971, J BACTERIOL, V107, P815, DOI 10.1128/JB.107.3.815-823.1971; QUINN FD, 1989, MOL MICROBIOL, V3, P797, DOI 10.1111/j.1365-2958.1989.tb00228.x; RAEDERSTORFF D, 1985, BIOCHEM J, V231, P609, DOI 10.1042/bj2310609; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Rossier O, 2008, APPL ENVIRON MICROB, V74, P753, DOI 10.1128/AEM.01944-07; Ruggiero A, 2010, STRUCTURE, V18, P1184, DOI 10.1016/j.str.2010.06.007; SMITH FR, 1968, J LIPID RES, V9, P405; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; THORPE TC, 1981, INFECT IMMUN, V33, P632, DOI 10.1128/IAI.33.2.632-635.1981; TSUNEOKA M, 1993, J BIOL CHEM, V268, P26461; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Winiecka-Krusnell J, 1999, SCAND J INFECT DIS, V31, P383, DOI 10.1080/00365549950163833; WINN WC, 1981, HUM PATHOL, V12, P401, DOI 10.1016/S0046-8177(81)80021-4	73	17	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23464	23478		10.1074/jbc.M112.346387	http://dx.doi.org/10.1074/jbc.M112.346387			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22582391	hybrid, Green Published			2022-12-28	WOS:000306511300019
J	Theodoraki, MA; Nillegoda, NB; Saini, J; Caplan, AJ				Theodoraki, Maria A.; Nillegoda, Nadinath B.; Saini, Jagdeep; Caplan, Avrom J.			A Network of Ubiquitin Ligases Is Important for the Dynamics of Misfolded Protein Aggregates in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 CLIENT PROTEINS; RETICULUM-ASSOCIATED DEGRADATION; HEAT-SHOCK FACTOR; END RULE PATHWAY; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; CYTOSOLIC PROTEINS; E3	Quality control ubiquitin ligases promote degradation of misfolded proteins by the proteasome. If the capacity of the ubiquitin/proteasome system is exceeded, then misfolded proteins accumulate in aggregates that are cleared by the autophagic system. To identify components of the ubiquitin/proteasome system that protect against aggregation, we analyzed a GFP-tagged protein kinase, Ste11 Delta N-K444R-GFP, in yeast strains deleted for 14 different ubiquitin ligases. We show that deletion of almost all of these ligases affected the proteostatic balance in untreated cells such that Ste11 Delta N-K444R-GFP aggregation was changed significantly compared with the levels found in wild type cells. By contrast, aggregation was increased significantly in only six E3 deletion strains when Ste11 Delta N-K444R-GFP folding was impaired due to inhibition of the molecular chaperone Hsp90 with geldanamycin. The increase in aggregation of Ste11 Delta N-K444R-GFP due to deletion of UBR1 and UFD4 was partially suppressed by deletion of UBR2 due to up-regulation of Rpn4, which controls proteasome activity. Deletion of UBR1 in combination with LTN1, UFD4, or DOA10 led to a marked hypersensitivity to azetidine 2-carboxylic acid, suggesting some redundancy in the networks of quality control ubiquitin ligases. Finally, we show that Ubr1 promotes clearance of protein aggregates when the autophagic system is inactivated. These results provide insight into the mechanics by which ubiquitin ligases cooperate and provide feedback regulation in the clearance of misfolded proteins.	[Theodoraki, Maria A.; Nillegoda, Nadinath B.; Saini, Jagdeep; Caplan, Avrom J.] CUNY City Coll, Dept Biol, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Caplan, AJ (corresponding author), CUNY City Coll, Dept Biol, Convent Ave & 138th St, New York, NY 10031 USA.	acaplan@sci.ccny.cuny.edu	Caplan, Avrom/GPT-0824-2022	Theodoraki, Maria/0000-0002-0775-8928; Nillegoda, Nadinath/0000-0002-9980-3991	National Institutes of Health [U54CA132378, NCRR 5G12-RR03060]; NATIONAL CANCER INSTITUTE [U54CA132378] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants U54CA132378 and NCRR 5G12-RR03060 (to City College of New York).	Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brachmann CB, 1998, YEAST, V14, P115; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaiser C., 1994, METHODS YEAST GENETI; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mandel AK, 2011, METHODS MOL BIOL, V787, P75, DOI 10.1007/978-1-61779-295-3_6; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SEUFERT W, 1991, ACTA BIOL HUNG, V42, P27; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stein KC, 2011, PRION, V5, P291, DOI [10.4161/pri.5.4.18213, 10.4161/pri.18213]; Sultana R, 2012, EXP CELL RES, V318, P53, DOI 10.1016/j.yexcr.2011.09.010; Theodoraki MA, 2007, EXP CELL RES, V313, P3851, DOI 10.1016/j.yexcr.2007.06.022; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang Y, 2011, CANCER RES, V71, P371, DOI 10.1158/0008-5472.CAN-10-3221; Wolfe KJ, 2011, SEMIN CELL DEV BIOL, V22, P476, DOI 10.1016/j.semcdb.2011.03.011; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065	50	50	50	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23911	23922		10.1074/jbc.M112.341164	http://dx.doi.org/10.1074/jbc.M112.341164			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593585	Green Published, hybrid			2022-12-28	WOS:000306511300061
J	Blaich, A; Pahlavan, S; Tian, QH; Oberhofer, M; Poomvanicha, M; Lenhardt, P; Domes, K; Wegener, JW; Moosmang, S; Ruppenthal, S; Scholz, A; Lipp, P; Hofmann, F				Blaich, Anne; Pahlavan, Sara; Tian, Qinghai; Oberhofer, Martin; Poomvanicha, Montatip; Lenhardt, Peter; Domes, Katrin; Wegener, Joerg W.; Moosmang, Sven; Ruppenthal, Sandra; Scholz, Anke; Lipp, Peter; Hofmann, Franz			Mutation of the Calmodulin Binding Motif IQ of the L-type Ca(v)1.2 Ca2+ Channel to EQ Induces Dilated Cardiomyopathy and Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; KINASE-II; CA2+-DEPENDENT INACTIVATION; HEART-FAILURE; FACILITATION; PHOSPHORYLATION; MECHANISMS; MYOCYTES; GENE; HYPERTROPHY	Cardiac excitation-contraction coupling (EC coupling) links the electrical excitation of the cell membrane to the mechanical contractile machinery of the heart. Calcium channels are major players of EC coupling and are regulated by voltage and Ca2+ / calmodulin (CaM). CaM binds to the IQ motif located in the C terminus of the Ca(v)1.2 channel and induces Ca2+-dependent inactivation (CDI) and facilitation (CDF). Mutation of Ile to Glu (Ile1624Glu) in the IQ motif abolished regulation of the channel by CDI and CDF. Here, we addressed the physiological consequences of such a mutation in the heart. Murine hearts expressing the Ca(v)1.2(I1624E) mutation were generated in adult heterozygous mice through inactivation of the floxed WT Ca(v)1.2(L2) allele by tamoxifen-induced cardiac-specific activation of the MerCreMer Cre recombinase. Within 10 days after the first tamoxifen injection these mice developed dilated cardiomyopathy (DCM) accompanied by apoptosis of cardiac myocytes (CM) and fibrosis. In Ca(v)1.2(I1624E) hearts, the activity of phospho-CaM kinase II and phospho-MAPK was increased. CMs expressed reduced levels of Ca(v)1.2(I1624E) channel protein and I-Ca. The Cav1.2(I1624E) channel showed "CDI" kinetics. Despite a lower sarcoplasmic reticulum Ca2+ content, cellular contractility and global Ca2+ transients remained unchanged because the EC coupling gain was up-regulated by an increased neuroendocrine activity. Treatment of mice with metoprolol and captopril reducedDCMin Cav1.2(I1624E) hearts at day 10. Weconclude that mutation of the IQ motif to IE leads to dilated cardiomyopathy and death.	[Blaich, Anne; Poomvanicha, Montatip; Lenhardt, Peter; Domes, Katrin; Wegener, Joerg W.; Moosmang, Sven; Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, Forschergrp, D-80802 Munich, Germany; [Pahlavan, Sara; Tian, Qinghai; Oberhofer, Martin; Ruppenthal, Sandra; Scholz, Anke; Lipp, Peter] Univ Saarland, Inst Mol Cell Biol, Res Ctr Mol Imaging & Screening, Fac Med, D-66424 Homburg, Germany	Technical University of Munich; Saarland University	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, Forschergrp, FOR923,Biedersteiner Str 29, D-80802 Munich, Germany.	franz.hofmann@mytum.de		Wegener, Jorg/0000-0002-8129-1537; Pahlavan, Sara/0000-0002-8854-2626	Deutsche Forschungsgemeinschaft [GraKO1326, KFO196]; Fond der Chemischen Industrie; Medical Faculty (HOMFOR) of the Saarland University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie); Medical Faculty (HOMFOR) of the Saarland University	This work was supported by grants from the Deutsche Forschungsgemeinschaft and Fond der Chemischen Industrie (to F. H.).; Supported by Deutsche Forschungsgemeinschaft Grants GraKO1326 and KFO196 and by the Medical Faculty (HOMFOR) of the Saarland University.	Acsai K, 2011, J PHYSIOL-LONDON, V589, P2569, DOI 10.1113/jphysiol.2010.202663; Altamirano J, 2007, CIRC RES, V101, P590, DOI 10.1161/CIRCRESAHA.107.152322; ANDERSON ME, 1994, CIRC RES, V75, P854, DOI 10.1161/01.RES.75.5.854; Anderson ME, 2001, J MOL CELL CARDIOL, V33, P639, DOI 10.1006/jmcc.2000.1354; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2002, J MOL CELL CARDIOL, V34, P369, DOI 10.1006/jmcc.2002.1530; Bers DM, 2006, J PHARMACOL SCI, V100, P315, DOI 10.1254/jphs.CPJ06001X; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blaich A, 2010, P NATL ACAD SCI USA, V107, P10285, DOI 10.1073/pnas.0914287107; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Currie S, 2009, FRONT BIOSCI-LANDMRK, V14, P5134, DOI 10.2741/3591; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Hall ME, 2011, AM J PHYSIOL-HEART C, V301, pH253, DOI 10.1152/ajpheart.00786.2010; Halling D Brent, 2006, Sci STKE, V2006, per1; Hammer K, 2010, J MOL CELL CARDIOL, V49, P427, DOI 10.1016/j.yjmcc.2010.05.010; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hougen K, 2010, AM J PHYSIOL-HEART C, V299, pH1671, DOI 10.1152/ajpheart.01155.2009; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Lipp P, 2002, J PHYSIOL-LONDON, V542, P383, DOI 10.1113/jphysiol.2001.013382; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Poomvanicha M, 2011, J BIOL CHEM, V286, P26702, DOI 10.1074/jbc.M111.247841; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; ROSS J, 1995, CIRCULATION, V92, P2327, DOI 10.1161/01.CIR.92.8.2327; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; YUAN WL, 1994, AM J PHYSIOL, V267, pH982, DOI 10.1152/ajpheart.1994.267.3.H982; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	45	22	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22616	22625		10.1074/jbc.M112.357921	http://dx.doi.org/10.1074/jbc.M112.357921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589547	Green Published, hybrid			2022-12-28	WOS:000306495000018
J	Irving, M; Zoete, V; Hebeisen, M; Schmid, D; Baumgartner, P; Guillaume, P; Romero, P; Speiser, D; Luescher, I; Rufer, N; Michielin, O				Irving, Melita; Zoete, Vincent; Hebeisen, Michael; Schmid, Daphne; Baumgartner, Petra; Guillaume, Philippe; Romero, Pedro; Speiser, Daniel; Luescher, Immanuel; Rufer, Nathalie; Michielin, Olivier			Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8(+) T Cell Responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY DECOMPOSITION; HIGH-AFFINITY; DWELL-TIME; MM-GBSA; TCR; ANTIGEN; MHC; ACTIVATION; LIGANDS; IMPACT	Through a rational design approach, we generated a panel of HLA-A*0201/NY-ESO-1(157-165)-specific T cell receptors (TCR) with increasing affinities of up to 150-fold from the wild-type TCR. Using these TCR variants which extend just beyond the natural affinity range, along with an extreme supraphysiologic one having 1400-fold enhanced affinity, and a low-binding one, we sought to determine the effect of TCR binding properties along with cognate peptide concentration on CD8(+) T cell responsiveness. Major histocompatibility complexes (MHC) expressed on the surface of various antigen presenting cells were peptide-pulsed and used to stimulate human CD8(+) T cells expressing the different TCR via lentiviral transduction. At intermediate peptide concentration we measured maximum cytokine/chemokine secretion, cytotoxicity, and Ca2+ flux for CD8(+) T cells expressing TCR within a dissociation constant (K-D) range of similar to 1-5 mu M. Under these same conditions there was a gradual attenuation in activity for supraphysiologic affinity TCR with K-D < similar to 1 mu M, irrespective of CD8 co-engagement and of half-life (t(1/2) = ln 2/k(off)) values. With increased peptide concentration, however, the activity levels of CD8(+) T cells expressing supraphysiologic affinity TCR were gradually restored. Together our data support the productive hit rate model of T cell activation arguing that it is not the absolute number of TCR/pMHC complexes formed at equilibrium, but rather their productive turnover, that controls levels of biological activity. Our findings have important implications for various immunotherapies under development such as adoptive cell transfer of TCR-engineered CD8(+) T cells, as well as for peptide vaccination strategies.	[Irving, Melita; Schmid, Daphne; Rufer, Nathalie; Michielin, Olivier] Multidisciplinary Oncol Ctr CePO, Div Expt Oncol, Lausanne, Switzerland; [Michielin, Olivier] Quartier UNIL Sorge, Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Hebeisen, Michael] Univ Hosp Ctr, Dept Res, CH-1011 Lausanne, Switzerland; [Hebeisen, Michael] Univ Lausanne, Lausanne, Switzerland; [Baumgartner, Petra; Guillaume, Philippe; Romero, Pedro; Speiser, Daniel; Luescher, Immanuel; Rufer, Nathalie; Michielin, Olivier] Univ Lausanne LICR UNIL, Ludwig Ctr Canc Res, Lausanne, Switzerland	Swiss Institute of Bioinformatics; University of Lausanne	Luescher, I (corresponding author), Univ Lausanne, Ludwig Ctr Canc Res, Chemin Boveresses 155, CH-1044 Epalinges, Switzerland.	Immanuel.Luescher@unil.ch; Nathalie.Rufer@unil.ch; Olivier.Michielin@unil.ch	Romero, Pedro/S-6015-2017; Speiser, Daniel E./F-2173-2013; Michielin, Olivier/ABE-7924-2020	Romero, Pedro/0000-0002-9688-2882; 	Swiss National Center of Competence in Research; Swiss National Science foundation [3200B0-103173, 3200B0-118123]; OncoSuisse [OCS 01381-08-2003, 02555-02-2010]	Swiss National Center of Competence in Research(Swiss National Science Foundation (SNSF)); Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); OncoSuisse	This work was supported by the Swiss National Center of Competence in Research and the Swiss National Science foundation Grants 3200B0-103173 (to O. M.) and 3200B0-118123 (to N. R.) and by OncoSuisse Grants OCS 01381-08-2003 (to O. M.) and 02555-02-2010 (to O. M. and V. Z.).	Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barde I., 2010, CURRENT PROTOCOLS NE, P21; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Carreno LJ, 2010, P NATL ACAD SCI USA, V107, P210, DOI 10.1073/pnas.0911258107; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chen JL, 2000, J IMMUNOL, V165, P948, DOI 10.4049/jimmunol.165.2.948; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Corse E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000481; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Dushek O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001430; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; Molloy PE, 2005, CURR OPIN PHARMACOL, V5, P438, DOI 10.1016/j.coph.2005.02.004; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Nicholson LB, 1998, P NATL ACAD SCI USA, V95, P264, DOI 10.1073/pnas.95.1.264; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; SMITH SD, 1984, CANCER RES, V44, P5657; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Thomas S, 2011, BLOOD, V118, P319, DOI 10.1182/blood-2010-12-326736; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; Udyavar A, 2009, J IMMUNOL, V182, P4439, DOI 10.4049/jimmunol.0804377; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	54	86	88	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23068	23078		10.1074/jbc.M112.357673	http://dx.doi.org/10.1074/jbc.M112.357673			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549784	Green Published, hybrid			2022-12-28	WOS:000306495000063
J	McPherson, AJ; Snell, LM; Mak, TW; Watts, TH				McPherson, Ann J.; Snell, Laura M.; Mak, Tak W.; Watts, Tania H.			Opposing Roles for TRAF1 in the Alternative versus Classical NF-kappa B Pathway in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED FACTOR-1; ALPHA-DEPENDENT APOPTOSIS; NF-KAPPA-B2 P100; HODGKINS-LYMPHOMA; IMMUNE-RESPONSE; DOWN-REGULATION; IN-VIVO; ACTIVATION; KINASE; 4-1BB	T cells lacking TRAF1 hyperproliferate in response to T cell receptor signaling but have impaired signaling downstream of specific TNFR family members such as 4-1BB. Here we resolve this paradox by showing that while TRAF1 is required for maximal activation of the classical NF-kappa B pathway downstream of 4-1BB in primary T cells, TRAF1 also restricts the constitutive activation of NIK in anti-CD3-activated T cells. Activation of the alternative NF-kappa B pathway is restricted in unstimulated cells by a cIAP1/2:TRAF2:TRAF3:NIK complex. Using knockdown of NIK by siRNA we show that in activated CD8 T cells TRAF1 is also involved in this process and that constitutive activation of the alternative NF-kappa B pathway is responsible for costimulation independent hyperproliferation and excess cytokine production in TRAF1-deficient CD8 T cells compared with WT CD8 T cells. The T cell costimulatory molecule 4-1BB critically regulates the survival of activated and memory CD8 T cells. We demonstrate that stimulation through 4-1BB induces cIAP1-dependent TRAF3 degradation and activation of the alternative NF-kappa B pathway. We also show that while both TRAF1 and cIAP1 have non-redundant roles in suppressing the alternative NF-kappa B pathway in T cells activated in the absence of costimulation, activation of the classical NF-kappa B pathway downstream of 4-1BB requires TRAF1, whereas cIAP1 plays a redundant role with cIAP2. Collectively these results demonstrate that TRAF1 plays a critical role in regulating T cell activation both through restricting the costimulation independent activation of NIK in activated T cells and by promoting the 4-1BB-induced classical NF-kappa B pathway.	[McPherson, Ann J.; Snell, Laura M.; Mak, Tak W.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Mak, Tak W.] Univ Toronto, Princess Margaret Hosp, Campbell Family Canc Res Inst, Toronto, ON M5S 1A8, Canada; [Mak, Tak W.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Watts, TH (corresponding author), Univ Toronto, Dept Immunol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	tania.watts@utoronto.ca		Snell, Laura/0000-0001-9890-6588	Canadian Cancer Society [018119]	Canadian Cancer Society(Canadian Cancer Society (CCS))	This research was funded by Grant No. 018119 from the Canadian Cancer Society (to T. H. W.).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Cannons JL, 2000, J IMMUNOL, V165, P6193, DOI 10.4049/jimmunol.165.11.6193; Cannons JL, 1999, J IMMUNOL, V163, P2990; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Guo F, 2009, MOL IMMUNOL, V46, P2441, DOI 10.1016/j.molimm.2009.05.178; Ha H., 2009, CURRENT PROTOCOLS IM; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hendriks J, 2005, J IMMUNOL, V175, P1665, DOI 10.4049/jimmunol.175.3.1665; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Horie R, 2003, INT J HEMATOL, V77, P37, DOI 10.1007/BF02982601; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; Lavorgna A, 2009, MOL IMMUNOL, V46, P3278, DOI 10.1016/j.molimm.2009.07.029; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Matsumoto M, 2002, J IMMUNOL, V169, P1151, DOI 10.4049/jimmunol.169.3.1151; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Nocentini G, 2009, ADV EXP MED BIOL, V647, P156, DOI 10.1007/978-0-387-89520-8_11; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Sabbagh L, 2006, P NATL ACAD SCI USA, V103, P18703, DOI 10.1073/pnas.0602919103; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wallach D, 2008, NAT IMMUNOL, V9, P1325, DOI 10.1038/ni1208-1325; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	63	63	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23010	23019		10.1074/jbc.M112.350538	http://dx.doi.org/10.1074/jbc.M112.350538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570473	hybrid, Green Published			2022-12-28	WOS:000306495000057
J	Koch, B; Mitterer, V; Niederhauser, J; Stanborough, T; Murat, G; Rechberger, G; Bergler, H; Kressler, D; Pertschy, B				Koch, Barbara; Mitterer, Valentin; Niederhauser, Johannes; Stanborough, Tamsyn; Murat, Guillaume; Rechberger, Gerald; Bergler, Helmut; Kressler, Dieter; Pertschy, Brigitte			Yar1 Protects the Ribosomal Protein Rps3 from Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; ANKYRIN REPEAT; DUAL FUNCTION; YEAST; RNA; BIOGENESIS; SUBUNIT; PATHWAY; COMPLEX	2000 ribosomes have to be synthesized in yeast every minute. Therefore the fast production of ribosomal proteins, their efficient delivery to the nucleus and correct incorporation into ribosomal subunits are prerequisites for optimal growth rates. Here, we report that the ankyrin repeat protein Yar1 directly interacts with the small ribosomal subunit protein Rps3 and accompanies newly synthesized Rps3 from the cytoplasm into the nucleus where Rps3 is assembled into pre-ribosomal subunits. A yar1 deletion strain displays a similar phenotype as an rps3 mutant strain, showing an accumulation of 20S pre-rRNA and a 40S export defect. The combination of an rps3 mutation with a yar1 deletion leads to an enhancement of these phenotypes, while increased expression of RPS3 suppresses the defects of a yar1 deletion strain. We further show that Yar1 protects Rps3 from aggregation in vitro and increases its solubility in vivo. Our data suggest that Yar1 is a specific chaperone for Rps3, which serves to keep Rps3 soluble until its incorporation into the pre-ribosome.	[Koch, Barbara; Mitterer, Valentin; Niederhauser, Johannes; Stanborough, Tamsyn; Rechberger, Gerald; Bergler, Helmut; Pertschy, Brigitte] Graz Univ, Inst Mol Biowissensch, A-8010 Graz, Austria; [Murat, Guillaume; Kressler, Dieter] Univ Fribourg, Dept Biol, Biochem Unit, CH-1700 Fribourg, Switzerland	University of Graz; University of Fribourg	Pertschy, B (corresponding author), Graz Univ, Inst Mol Biowissensch, Humboldtstr 50, A-8010 Graz, Austria.	brigitte.pertschy@uni-graz.at	Mitterer, Valentin/AAV-3722-2020; Kressler, Dieter/C-2218-2012; Mitterer, Valentin/ABE-3970-2020	Mitterer, Valentin/0000-0003-1587-1194; Mitterer, Valentin/0000-0003-1587-1194; Bergler, Helmut/0000-0002-7724-309X; Rechberger, Gerald N./0000-0002-0071-317X; Pertschy, Brigitte/0000-0003-3558-0191; Kressler, Dieter/0000-0003-4855-3563; Murat, Guillaume/0000-0003-1288-984X	Austrian Science Fund (FWF) [T404-B12, P21991]; Swiss National Science Foundation [PP00P3_123341]; Austrian Science Fund (FWF) [P 21991, P 23682] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research was funded by Grant T404-B12 from the Austrian Science Fund (FWF) (to B. P.), Grant PP00P3_123341 from the Swiss National Science Foundation (to D. K.), and Grant P21991 from the FWF (to H. B.).	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Birner-Gruenberger R, 2008, PROTEOMICS, V8, P3645, DOI 10.1002/pmic.200800191; Demoinet E, 2007, RNA, V13, P1570, DOI 10.1261/rna.585007; Eisinger DP, 1997, MOL CELL BIOL, V17, P5146, DOI 10.1128/MCB.17.9.5146; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Grosshans H, 2000, GENE DEV, V14, P830; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Iouk TL, 2001, MOL CELL BIOL, V21, P1260, DOI 10.1128/MCB.21.4.1260-1271.2001; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Karbstein K, 2010, J CELL BIOL, V189, P11, DOI 10.1083/jcb.201002102; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lycan DE, 1996, GENE, V171, P33, DOI 10.1016/0378-1119(96)00023-6; Meyer AE, 2007, P NATL ACAD SCI USA, V104, P1558, DOI 10.1073/pnas.0610704104; Meyer AE, 2010, J BIOL CHEM, V285, P961, DOI 10.1074/jbc.M109.038349; Neville M, 1999, EMBO J, V18, P3746, DOI 10.1093/emboj/18.13.3746; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schaper S, 2001, CURR BIOL, V11, P1885, DOI 10.1016/S0960-9822(01)00584-X; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	36	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21806	21815		10.1074/jbc.M112.365791	http://dx.doi.org/10.1074/jbc.M112.365791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570489	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-28	WOS:000306418600022
J	Rajabi, M; Ericksen, B; Wu, XJ; de Leeuw, E; Zhao, L; Pazgier, M; Lu, WY				Rajabi, Mohsen; Ericksen, Bryan; Wu, Xueji; de Leeuw, Erik; Zhao, Le; Pazgier, Marzena; Lu, Wuyuan			Functional Determinants of Human Enteric alpha-Defensin HD5 CRUCIAL ROLE FOR HYDROPHOBICITY AT DIMER INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR LIPID II; CAVITY-CREATING MUTATIONS; CONSERVED SALT BRIDGE; ANTHRAX LETHAL TOXIN; ANTIMICROBIAL PEPTIDES; MAMMALIAN DEFENSINS; MOUSE CRYPTDIN-4; INNATE IMMUNITY; PANETH CELLS; ANTIBACTERIAL ACTIVITY	Human alpha-defensins are cationic peptides that self-associate into dimers and higher-order oligomers. They bind protein toxins, such as anthrax lethal factor (LF), and kill bacteria, including Escherichia coli and Staphylococcus aureus, among other functions. There are six members of the human alpha-defensin family: four human neutrophil peptides, including HNP1, and two enteric human defensins, including HD5. We subjected HD5 to comprehensive alanine scanning mutagenesis. We then assayed LF binding by surface plasmon resonance, LF activity by enzyme kinetic inhibition, and antibacterial activity by the virtual colony count assay. Most mutations could be tolerated, resulting in activity comparable with that of wild type HD5. However, the L29A mutation decimated LF binding and bactericidal activity against Escherichia coli and Staphylococcus aureus. A series of unnatural aliphatic and aromatic substitutions at position 29, including aminobutyric acid (Abu) and norleucine (Nle) correlated hydrophobicity with HD5 function. The crystal structure of L29Abu-HD5 depicted decreased hydrophobic contacts at the dimer interface, whereas the Nle-29-HD5 crystal structure depicted a novel mode of dimerization with parallel beta strands. The effect of mutating Leu(29) is similar to that of a C-terminal hydrophobic residue of HNP1, Trp(26). In addition, in order to further clarify the role of dimerization in HD5 function, an obligate monomer was generated by N-methylation of the Glu(21) residue, decreasing LF binding and antibacterial activity against S. aureus. These results further characterize the dimer interface of the alpha-defensins, revealing a crucial role of hydrophobicity-mediated dimerization.	[Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Inst Human Virol, Sch Med, Baltimore, MD 21201 USA; [Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Pazgier, M (corresponding author), Univ Maryland, Inst Human Virol, Sch Med, 725 W Lombard St, Baltimore, MD 21201 USA.	mpazgier@ihv.umaryland.edu; wlu@ihv.umaryland.edu	Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017	Lu, Wuyuan/0000-0003-1318-9968; Ericksen, Bryan/0000-0002-8016-8289	Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS; National Institutes of Health [AI072732, AI061482]; Xian Jiaotong University School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, R01AI061482] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xian Jiaotong University School of Medicine(Xi'an Jiaotong University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Changyou Zhan, Gang Wei, and Guozhang Zou and Weirong Yuan for technical assistance and useful discussions. We thank the X-ray Crystallography Core Facility of the University of Maryland at Baltimore for providing crystallographic equipment and resources. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States. Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (Grant P41RR001209), and NIGMS, National Institutes of Health.This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.).A Guanghua Scholar supported by Xian Jiaotong University School of Medicine.	Andersson H. S., 2012, AMINO ACIDS IN PRESS; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Chapnik N, 2012, APPL BIOCHEM BIOTECH, V166, P1703, DOI 10.1007/s12010-012-9571-5; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; de Leeuw E, 2009, FEBS LETT, V583, P2507, DOI 10.1016/j.febslet.2009.06.051; Ding JA, 2011, J INNATE IMMUN, V3, P208, DOI 10.1159/000322355; Ding J, 2009, J INNATE IMMUN, V1, P413, DOI 10.1159/000226256; Durr E, 2000, BIOCHEMISTRY-US, V39, P4472, DOI 10.1021/bi992948f; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Penberthy WT, 2011, CELL MOL LIFE SCI, V68, P2231, DOI 10.1007/s00018-011-0715-5; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wang W, 2006, J BIOL CHEM, V281, P32755, DOI 10.1074/jbc.M603614200; Wanniarachchi YA, 2011, BIOCHEMISTRY-US, V50, P8005, DOI 10.1021/bi201043j; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WILDE CG, 1989, J BIOL CHEM, V264, P11200; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao L., 2012, J BIOL CHEM IN PRESS; Zou GZ, 2008, J MOL BIOL, V381, P1281, DOI 10.1016/j.jmb.2008.06.066; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	88	53	54	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21615	21627		10.1074/jbc.M112.367995	http://dx.doi.org/10.1074/jbc.M112.367995			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573326	Green Published, hybrid			2022-12-28	WOS:000306418600005
J	Tiaden, AN; Klawitter, M; Lux, V; Mirsaidi, A; Bahrenberg, G; Glanz, S; Quero, L; Liebscher, T; Wuertz, K; Ehrmann, M; Richards, PJ				Tiaden, Andre N.; Klawitter, Marina; Lux, Vanda; Mirsaidi, Ali; Bahrenberg, Gregor; Glanz, Stephan; Quero, Lilian; Liebscher, Thomas; Wuertz, Karin; Ehrmann, Michael; Richards, Peter J.			Detrimental Role for Human High Temperature Requirement Serine Protease A1 (HTRA1) in the Pathogenesis of Intervertebral Disc (IVD) Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; FIBRONECTIN; CELLS; CARTILAGE; MOUSE; LOCALIZATION; FRAGMENTS; MATRIX; TISSUE; PAIN	Human HTRA1 is a highly conserved secreted serine protease that degrades numerous extracellular matrix proteins. We have previously identified HTRA1 as being up-regulated in osteoarthritic patients and as having the potential to regulate matrix metalloproteinase (MMP) expression in synovial fibroblasts through the generation of fibronectin fragments. In the present report, we have extended these studies and investigated the role of HTRA1 in the pathogenesis of intervertebral disc (IVD) degeneration. HTRA1 mRNA expression was significantly elevated in degenerated disc tissue and was associated with increased protein levels. However, these increases did not correlate with the appearance of rs11200638 single nucleotide polymorphism in the promoter region of the HTRA1 gene, as has previously been suggested. Recombinant HTRA1 induced MMP production in IVD cell cultures through a mechanism critically dependent on MEK but independent of IL-1 beta signaling. The use of a catalytically inactive mutant confirmed these effects to be primarily due to HTRA1 serine protease activity. HTRA1-induced fibronectin proteolysis resulted in the generation of various sized fragments, which when added to IVD cells in culture, caused a significant increase in MMP expression. Furthermore, one of these fragments was identified as being the amino-terminal fibrin-and heparin-binding domain and was also found to be increased within HTRA1-treated IVD cell cultures as well as in disc tissue from patients with IVD degeneration. Our results therefore support a scenario in which HTRA1 promotes IVD degeneration through the proteolytic cleavage of fibronectin and subsequent activation of resident disc cells.	[Tiaden, Andre N.; Klawitter, Marina; Mirsaidi, Ali; Bahrenberg, Gregor; Glanz, Stephan; Richards, Peter J.] Univ Zurich, Ctr Appl Biotechnol & Mol Med, Bone & Stem Cell Res Grp, CH-8057 Zurich, Switzerland; [Klawitter, Marina; Quero, Lilian; Wuertz, Karin] Univ Zurich, Ctr Appl Biotechnol & Mol Med, Spine Res Grp, CH-8057 Zurich, Switzerland; [Lux, Vanda; Ehrmann, Michael] Univ Duisburg Essen, Fac Biol & Geog, Ctr Med Biotechnol, D-45117 Essen, Germany; [Mirsaidi, Ali; Bahrenberg, Gregor; Glanz, Stephan; Wuertz, Karin; Richards, Peter J.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Mirsaidi, Ali; Bahrenberg, Gregor; Glanz, Stephan; Wuertz, Karin; Richards, Peter J.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8057 Zurich, Switzerland; [Liebscher, Thomas] SRH Klinikum Karlsbad Langensteinbach, Dept Spinal Surg, D-76307 Karlsbad, Germany; [Wuertz, Karin] AOSpine Res Network, CH-8600 Dubendorf, Switzerland	University of Zurich; University of Zurich; University of Duisburg Essen; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Richards, PJ (corresponding author), Univ Zurich, Ctr Appl Biotechnol & Mol Med, Bone & Stem Cell Res Grp, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	peter.richards@cabmm.uzh.ch	Ehrmann, Michael/A-7307-2012; Wuertz-Kozak, Karin/G-3144-2012	Ehrmann, Michael/0000-0002-1927-260X; Wuertz-Kozak, Karin/0000-0002-3281-4629; Lux, Vanda/0000-0002-0184-8076; Liebscher, Thomas/0000-0002-6025-6564	Center for Applied Biotechnology and Molecular Medicine Start-up Grant/Maxi Foundation; Swiss National Science Foundation; Stiftung Osteoporose Schweiz and Forschungskredit UZH, University of Zurich; AOSpine	Center for Applied Biotechnology and Molecular Medicine Start-up Grant/Maxi Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung Osteoporose Schweiz and Forschungskredit UZH, University of Zurich; AOSpine	This work was supported by a grant from the Center for Applied Biotechnology and Molecular Medicine Start-up Grant/Maxi Foundation.; Supported by grants from the Swiss National Science Foundation.; Supported by grants from the Stiftung Osteoporose Schweiz and Forschungskredit UZH, University of Zurich.; Supported by grants from AOSpine. We thank Dr. Jurgen Klasen (University Hospital Balgrist, University of Zurich, Zurich, Switzerland) for providing fresh human disc biopsies used for all cell culture experiments.	Anderson DG, 2010, SPINE, V35, P1581, DOI 10.1097/BRS.0b013e3181c6ef1a; Anderson DG, 2005, SPINE, V30, P1242, DOI 10.1097/01.brs.0000164097.47091.4c; Anderson DG, 2003, SPINE, V28, P2338, DOI 10.1097/01.BRS.0000096943.27853.BC; Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Freemont AJ, 2002, J PATHOL, V196, P374, DOI 10.1002/path.1050; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Gruber HE, 2011, EXP MOL PATHOL, V91, P534, DOI 10.1016/j.yexmp.2011.06.001; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Le Maitre CL, 2006, BIOTECH HISTOCHEM, V81, P125, DOI 10.1080/10520290601005298; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Nerlich AG, 2005, EUR SPINE J, V14, P17, DOI 10.1007/s00586-004-0745-x; Nie GY, 2005, DEV DYNAM, V233, P1102, DOI 10.1002/dvdy.20399; Oegema TR, 2000, SPINE, V25, P2742, DOI 10.1097/00007632-200011010-00005; Peterson CK, 2000, SPINE, V25, P218, DOI 10.1097/00007632-200001150-00013; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Shridhar V, 2002, CANCER RES, V62, P262; Su SL, 2005, OSTEOARTHR CARTILAGE, V13, P879, DOI 10.1016/j.joca.2005.04.017; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Urano T, 2010, J BONE MINER METAB, V28, P220, DOI 10.1007/s00774-009-0124-0; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Wuertz K, 2007, J ORTHOP RES, V25, P1513, DOI 10.1002/jor.20436; Xia MS, 2011, J ORTHOP RES, V29, P556, DOI 10.1002/jor.21273; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yasuda T, 2002, ARTHRITIS RHEUM, V46, P138, DOI 10.1002/1529-0131(200201)46:1<138::AID-ART10051>3.0.CO;2-K	37	52	57	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21335	21345		10.1074/jbc.M112.341032	http://dx.doi.org/10.1074/jbc.M112.341032			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556410	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000306416800052
J	Ebert, SM; Dyle, MC; Kunkel, SD; Bullard, SA; Bongers, KS; Fox, DK; Dierdorff, JM; Foster, ED; Adams, CM				Ebert, Scott M.; Dyle, Michael C.; Kunkel, Steven D.; Bullard, Steven A.; Bongers, Kale S.; Fox, Daniel K.; Dierdorff, Jason M.; Foster, Eric D.; Adams, Christopher M.			Stress-induced Skeletal Muscle Gadd45a Expression Reprograms Myonuclei and Causes Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; GENE-EXPRESSION; UBIQUITIN LIGASES; PATHWAY; PROTEIN; COACTIVATORS; DEGRADATION; PGC-1-ALPHA; ACTIVATION; GENERATION	Diverse stresses including starvation and muscle disuse cause skeletal muscle atrophy. However, the molecular mechanisms of muscle atrophy are complex and not well understood. Here, we demonstrate that growth arrest and DNA damage-inducible 45a protein (Gadd45a) is a critical mediator of muscle atrophy. We identified Gadd45a through an unbiased search for potential downstream mediators of the stress-inducible, pro-atrophy transcription factor ATF4. We show that Gadd45a is required for skeletal muscle atrophy induced by three distinct skeletal muscle stresses: fasting, muscle immobilization, and muscle denervation. Conversely, forced expression of Gadd45a in muscle or cultured myotubes induces atrophy in the absence of upstream stress. We show that muscle-specific ATF4 knock-out mice have a reduced capacity to induce Gadd45a mRNA in response to stress, and as a result, they undergo less atrophy in response to fasting or muscle immobilization. Interestingly, Gadd45a is a myonuclear protein that induces myonuclear remodeling and a comprehensive program for muscle atrophy. Gadd45a represses genes involved in anabolic signaling and energy production, and it induces pro-atrophy genes. As a result, Gadd45a reduces multiple barriers to muscle atrophy (including PGC-1 alpha, Akt activity, and protein synthesis) and stimulates pro-atrophy mechanisms (including autophagy and caspase-mediated proteolysis). These results elucidate a critical stress-induced pathway that reprograms muscle gene expression to cause atrophy.	[Ebert, Scott M.; Dyle, Michael C.; Kunkel, Steven D.; Bullard, Steven A.; Bongers, Kale S.; Fox, Daniel K.; Dierdorff, Jason M.; Foster, Eric D.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol, Iowa City, IA 52242 USA; [Ebert, Scott M.; Dyle, Michael C.; Kunkel, Steven D.; Bullard, Steven A.; Bongers, Kale S.; Fox, Daniel K.; Dierdorff, Jason M.; Foster, Eric D.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biophys, Iowa City, IA 52242 USA; [Ebert, Scott M.; Dyle, Michael C.; Kunkel, Steven D.; Bullard, Steven A.; Bongers, Kale S.; Fox, Daniel K.; Dierdorff, Jason M.; Foster, Eric D.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Kunkel, Steven D.; Bullard, Steven A.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Adams, CM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Bongers, Kale/0000-0002-9297-9185; Adams, Christopher/0000-0002-5795-7212	National Institutes of Health [NIAMS 1R01AR059115-01, T32 GM07361]; Cardiovascular Interdisciplinary Research Fellowship [HL007121]; Doris Duke Charitable Foundation; American Diabetes Association; Department of Veterans Affairs; Fraternal Order of Eagles Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular Interdisciplinary Research Fellowship; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Diabetes Association(American Diabetes Association); Department of Veterans Affairs(US Department of Veterans Affairs); Fraternal Order of Eagles Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants NIAMS 1R01AR059115-01 and T32 GM07361, and Cardiovascular Interdisciplinary Research Fellowship HL007121, the Doris Duke Charitable Foundation, the American Diabetes Association, the Department of Veterans Affairs, and the Fraternal Order of Eagles Diabetes Research Center.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Banduseela VC, 2009, PHYSIOL GENOMICS, V39, P141, DOI 10.1152/physiolgenomics.00026.2009; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Dedkov EI, 2003, J GERONTOL A-BIOL, V58, P984; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Easwaran HP, 2010, COLD SH Q B, V75, P507, DOI 10.1101/sqb.2010.75.031; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gundersen K, 2008, J PHYSIOL-LONDON, V586, P2675, DOI 10.1113/jphysiol.2008.154369; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Korenyi-Both A. L., 1983, MUSCLE PATHOLOGY NEU; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Kutner M. H., 2004, APPL LINEAR REGRESSI; Laure L, 2009, FEBS J, V276, P669, DOI 10.1111/j.1742-4658.2008.06814.x; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Malmberg SE, 2008, J BIOL CHEM, V283, P19229, DOI 10.1074/jbc.M801331200; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8; Plant PJ, 2009, J APPL PHYSIOL, V107, P224, DOI 10.1152/japplphysiol.90932.2008; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sytnikova YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014500; Tian JM, 2011, J CLIN INVEST, V121, P4491, DOI 10.1172/JCI38760; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Verhees KJP, 2011, AM J PHYSIOL-CELL PH, V301, pC995, DOI 10.1152/ajpcell.00520.2010; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	58	132	139	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27290	27301		10.1074/jbc.M112.374777	http://dx.doi.org/10.1074/jbc.M112.374777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22692209	Green Published, hybrid			2022-12-28	WOS:000307840700002
J	Teichmann, A; Rutz, C; Kreuchwig, A; Krause, G; Wiesner, B; Schulein, R				Teichmann, Anke; Rutz, Claudia; Kreuchwig, Annika; Krause, Gerd; Wiesner, Burkhard; Schuelein, Ralf			The Pseudo Signal Peptide of the Corticotropin-releasing Factor Receptor Type 2A Prevents Receptor Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; DELTA-OPIOID RECEPTORS; HORMONE-RECEPTOR; TRANSMEMBRANE DOMAIN; PROTEIN; DIMERIZATION; EXPRESSION; VARIANT; STRESS; CELL	N-terminal signal peptides mediate the interaction of native proteins with the translocon complex of the endoplasmic reticulum membrane and are cleaved off during early protein biogenesis. The corticotropin-releasing factor receptor type 2a (CRF2(a)R) possesses an N-terminal pseudo signal peptide, which represents a so far unique domain within the large protein family of G protein-coupled receptors (GPCRs). In contrast to a conventional signal peptide, the pseudo signal peptide remains uncleaved and consequently forms a hydrophobic extension at the N terminus of the receptor. The functional consequence of the presence of the pseudo signal peptide is not understood. Here, we have analyzed the significance of this domain for receptor dimerization/oligomerization in detail. To this end, we took the CRF2(a)R and the homologous corticotropin-releasing factor receptor type 1 (CRF1R) possessing a conventional cleaved signal peptide and conducted signal peptide exchange experiments. Using single cell and single molecule imaging methods (fluorescence resonance energy transfer and fluorescence cross-correlation spectroscopy, respectively) as well as biochemical experiments, we obtained two novel findings; we could show that (i) the CRF2(a)R is expressed exclusively as a monomer, and (ii) the presence of the pseudo signal peptide prevents its oligomerization. Thus, we have identified a novel functional domain within the GPCR protein family, which plays a role in receptor oligomerization and which may be useful to study the functional significance of this process in general.	[Teichmann, Anke; Rutz, Claudia; Kreuchwig, Annika; Krause, Gerd; Wiesner, Burkhard; Schuelein, Ralf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wiesner, B (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	wiesner@fmp-berlin.de; schuelein@fmp-berlin.de			Deutsche Forschungsgemeinschaft [SCHU 1116/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU 1116/2-1.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Charles AC, 2003, MOL PHARMACOL, V63, P89, DOI 10.1124/mol.63.1.89; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x; Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x; Evans RT, 2009, ENDOCRINOLOGY, V150, P4191, DOI 10.1210/en.2009-0285; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hauger RL, 2003, PHARMACOL REV, V55, P21, DOI 10.1124/pr.55.1.3; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Heinze KG, 2000, P NATL ACAD SCI USA, V97, P10377, DOI 10.1073/pnas.180317197; Khelashvili G, 2010, BIOINFORMATICS, V26, P1804, DOI 10.1093/bioinformatics/btq264; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kraetke O, 2005, J RECEPT SIG TRANSD, V25, P251, DOI 10.1080/10799890500468838; Kreuchwig A, 2011, MOL ENDOCRINOL, V25, P707, DOI 10.1210/me.2010-0510; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Li HW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3484751; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Maurice P, 2010, EMBO J, V29, P3646, DOI 10.1038/emboj.2010.236; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sambrook J., 2001, MOL CLONING LAB MANU; Schulz K, 2010, J BIOL CHEM, V285, P32878, DOI 10.1074/jbc.M110.129627; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; Skrabanek L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-177; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Vrecl M, 2006, J RECEPT SIG TRANSD, V26, P505, DOI 10.1080/10799890600932253; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200	47	28	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27265	27274		10.1074/jbc.M112.360594	http://dx.doi.org/10.1074/jbc.M112.360594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689579	Green Published, hybrid			2022-12-28	WOS:000307386000078
J	Belyi, Y; Tartakovskaya, D; Tais, A; Fitzke, E; Tzivelekidis, T; Jank, T; Rospert, S; Aktories, K				Belyi, Yury; Tartakovskaya, Dina; Tais, Arlette; Fitzke, Edith; Tzivelekidis, Tina; Jank, Thomas; Rospert, Sabine; Aktories, Klaus			Elongation Factor 1A Is the Target of Growth Inhibition in Yeast Caused by Legionella pneumophila Glucosyltransferase Lgt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; SACCHAROMYCES-CEREVISIAE; LEGIONNAIRES DISEASE; SHUTTLE VECTORS; PROTEIN IMPORT; TRANSLATION; MUTATIONS; COMPLEX; PHOSPHORYLATION; EEF1A	Legionella is a pathogenic Gram-negative bacterium that can multiply inside of eukaryotic cells. It translocates numerous bacterial effector proteins into target cells to transform host phagocytes into a niche for replication. One effector of Legionella pneumophila is the glucosyltransferase Lgt1, which modifies serine 53 in mammalian elongation factor 1A (eEF1A), resulting in inhibition of protein synthesis and cell death. Here, we demonstrate that similar to mammalian cells, Lgt1 was severely toxic when produced in yeast and effectively inhibited in vitro protein synthesis. Saccharomyces cerevisiae strains, which were deleted of endogenous eEF1A but harbored a mutant eEF1A not glucosylated by Lgt1, were resistant toward the bacterial effector. In contrast, deletion of Hbs1, which is also an in vitro substrate of the glucosyltransferase, did not influence the toxic effects of Lgt1. Serial mutagenesis in yeast showed that Phe(54), Tyr(56) and Trp(58), located immediately downstream of serine 53 of eEF1A, are essential for the function of the elongation factor. Replacement of serine 53 by glutamic acid, mimicking phosphorylation, produced a non-functional eEF1A, which failed to support growth of S. cerevisiae. Our data indicate that Lgt1-induced lethal effect in yeast depends solely on eEF1A. The region of eEF1A encompassing serine 53 plays a critical role in functioning of the elongation factor.	[Tzivelekidis, Tina; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Belyi, Yury; Tartakovskaya, Dina] NF Gamalei Inst Epidemiol & Microbiol, Moscow 123098, Russia; [Tais, Arlette; Fitzke, Edith; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mikrobiol, Zentrum Biochem & Mol Zellforsch, D-79102 Freiburg, Germany	University of Freiburg; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Belyi, Yury/AAU-8092-2020; Aktories, Klaus/CAJ-5682-2022; Jank, Thomas/R-9627-2017	Aktories, Klaus/0000-0002-5397-0436; Rospert, Sabine/0000-0002-3089-9614	Deutsche Forschungsgemeinschaft; Center for Biological Signaling Studies (BIOSS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biological Signaling Studies (BIOSS)	This work was supported by the Deutsche Forschungsgemeinschaft and the Center for Biological Signaling Studies (BIOSS).	Belyi I, 2003, INFECT IMMUN, V71, P181, DOI 10.1128/IAI.71.1.181-186.2003; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00076; Belyi Y, 2009, J BIOL CHEM, V284, P20167, DOI 10.1074/jbc.M109.008441; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRENNER DJ, 1979, ANN INTERN MED, V90, P656, DOI 10.7326/0003-4819-90-4-656; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; Chen LM, 2010, NAT STRUCT MOL BIOL, V17, P1233, DOI 10.1038/nsmb.1922; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Conz C, 2007, J BIOL CHEM, V282, P33977, DOI 10.1074/jbc.M706737200; Dinman JD, 1997, RNA, V3, P870; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; GARCIA PD, 1991, METHOD ENZYMOL, V194, P675; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Hurtado-Guerrero R, 2010, BIOCHEM J, V426, P281, DOI 10.1042/BJ20091351; Jules M, 2007, FEBS LETT, V581, P2829, DOI 10.1016/j.febslet.2007.05.026; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu W, 2010, J MOL BIOL, V396, P321, DOI 10.1016/j.jmb.2009.11.044; Magazinnik T, 2005, NUCLEIC ACIDS RES, V33, P4584, DOI 10.1093/nar/gki765; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; Piazzi M, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.003152; Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tzivelekidis T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029525; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685	41	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26029	26037		10.1074/jbc.M112.372672	http://dx.doi.org/10.1074/jbc.M112.372672			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685293	hybrid, Green Published			2022-12-28	WOS:000306916300030
J	Glembotski, CC; Thuerauf, DJ; Huang, CQ; Vekich, JA; Gottlieb, RA; Doroudgar, S				Glembotski, Christopher C.; Thuerauf, Donna J.; Huang, Chengqun; Vekich, John A.; Gottlieb, Roberta A.; Doroudgar, Shirin			Mesencephalic Astrocyte-derived Neurotrophic Factor Protects the Heart from Ischemic Damage and Is Selectively Secreted upon Sarco/endoplasmic Reticulum Calcium Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; ENDOPLASMIC-RETICULUM; ER STRESS; SARCOPLASMIC-RETICULUM; MYOCARDIAL-INFARCTION; MOLECULAR CHAPERONES; CA2+ RELEASE; HELA-CELLS; PROTEINS; ATF6	The endoplasmic reticulum (ER) stress protein mesencephalic astrocyte-derived neurotrophic factor (MANF) has been reported to protect cells from stress-induced cell death before and after its secretion; however, the conditions under which it is secreted are not known. Accordingly, we examined the mechanism of MANF release from cultured ventricular myocytes and HeLa cells, both of which secrete proteins via the constitutive pathway. Although the secretion of proteins via the constitutive pathway is not known to increase upon changes in intracellular calcium, MANF secretion was increased within 30 min of treating cells with compounds that deplete sarcoplasmic reticulum (SR)/ER calcium. In contrast, secretion of atrial natriuretic factor from ventricular myocytes was not increased by SR/ER calcium depletion, suggesting that not all secreted proteins exhibit the same characteristics as MANF. We postulated that SR/ER calcium depletion triggered MANF secretion by decreasing its retention. Consistent with this were co-immunoprecipitation and live cell, zero distance, photo affinity cross-linking, demonstrating that, in part, MANF was retained in the SR/ER via its calcium-dependent interaction with the SR/ER-resident protein, GRP78 (glucose-regulated protein 78 kDa). This unusual mechanism of regulating secretion from the constitutive secretory pathway provides a potentially missing link in the mechanism by which extracellular MANF protects cells from stresses that deplete SR/ER calcium. Consistent with this was our finding that administration of recombinant MANF to mice decreased tissue damage in an in vivo model of myocardial infarction, a condition during which ER calcium is known to be dysregulated, and MANF expression is induced.	[Glembotski, Christopher C.] San Diego State Univ, SDSU Heart Inst, San Diego, CA 92182 USA; [Glembotski, Christopher C.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Glembotski, CC (corresponding author), San Diego State Univ, SDSU Heart Inst, 5500 Campanile Dr, San Diego, CA 92182 USA.	cglembotski@sciences.sdsu.edu			National Institutes of Health [PO1 HL085577, RO1 HL75573, RO1 HL104535, RO3 EB011698, R01HL060590, RO1AG033283]; Rees-Stealy Research Foundation; San Diego Chapter of the Achievement Rewards for College Scientists Foundation; American Heart Association [10PRE3410005]; Inamori Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104535, P01HL085577, R01HL060590, R01HL075573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB011698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rees-Stealy Research Foundation; San Diego Chapter of the Achievement Rewards for College Scientists Foundation; American Heart Association(American Heart Association); Inamori Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL085577, RO1 HL75573, RO1 HL104535, and RO3 EB011698 (to C. C. G.), and R01HL060590, and RO1AG033283 (to R. A. G.). This work was also supported by grants and fellowships from the Rees-Stealy Research Foundation, the San Diego Chapter of the Achievement Rewards for College Scientists Foundation, the American Heart Association (Predoctoral Fellowship 10PRE3410005), and the Inamori Foundation (to S. D.).	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Bhogal MS, 1998, P NATL ACAD SCI USA, V95, P1484, DOI 10.1073/pnas.95.4.1484; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Castellano J, 2011, J MOL CELL CARDIOL, V50, P894, DOI 10.1016/j.yjmcc.2011.02.002; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; DEYOUNG MB, 1994, CIRC RES, V74, P33, DOI 10.1161/01.RES.74.1.33; DiJeso B, 1997, BIOCHEM BIOPH RES CO, V234, P133, DOI 10.1006/bbrc.1997.6601; DORNER AJ, 1994, BIOLOGICALS, V22, P103, DOI 10.1006/biol.1994.1016; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Doroudgar S, 2011, TRENDS MOL MED, V17, P207, DOI 10.1016/j.molmed.2010.12.003; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Eaddy AC, 2011, BIOCHEM BIOPH RES CO, V404, P424, DOI 10.1016/j.bbrc.2010.11.137; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; HALBAN PA, 1994, BIOCHEM J, V299, P1; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; KIM NN, 1995, AM J PHYSIOL-ENDOC M, V269, pE426, DOI 10.1152/ajpendo.1995.269.3.E426; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kuznetsov G, 1997, J BIOL CHEM, V272, P3057, DOI 10.1074/jbc.272.5.3057; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; LODISH HF, 1990, J BIOL CHEM, V265, P10893; LODISH HF, 1992, J BIOL CHEM, V267, P12753; Louch WE, 2006, J PHYSIOL-LONDON, V574, P519, DOI 10.1113/jphysiol.2006.107227; Lu FH, 2010, BASIC CLIN PHARMACOL, V106, P396, DOI 10.1111/j.1742-7843.2009.00502.x; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Missiaen L, 2004, CELL CALCIUM, V36, P479, DOI 10.1016/j.ceca.2004.04.007; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Molinari A, 2005, CURR TOP MICROBIOL, V300, P1; Montero M, 1997, FASEB J, V11, P881, DOI 10.1096/fasebj.11.11.9285486; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Paula S, 2009, BIOORGAN MED CHEM, V17, P6613, DOI 10.1016/j.bmc.2009.07.075; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Pelham HRB, 1999, PHILOS T ROY SOC B, V354, P1471, DOI 10.1098/rstb.1999.0491; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santhamma KR, 2000, J BIOL CHEM, V275, P23253, DOI 10.1074/jbc.M000593200; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Temsah RM, 2002, AM J PHYSIOL-CELL PH, V283, pC1306, DOI 10.1152/ajpcell.00138.2002; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Treiman M, 2002, TRENDS CARDIOVAS MED, V12, P57, DOI 10.1016/S1050-1738(01)00147-5; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu XL, 2008, PHARMACOLOGY, V81, P325, DOI 10.1159/000121335; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zhou CY, 2006, NEUROREPORT, V17, P293, DOI 10.1097/01.wnr.0000201504.23255.bc	71	132	139	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25893	25904		10.1074/jbc.M112.356345	http://dx.doi.org/10.1074/jbc.M112.356345			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22637475	hybrid, Green Published			2022-12-28	WOS:000306916300018
J	Peng, C; Zhu, F; Wen, WH; Yao, K; Li, SQ; Zykova, T; Liu, KD; Li, X; Ma, WY; Bode, AM; Dong, ZG				Peng, Cong; Zhu, Feng; Wen, Weihong; Yao, Ke; Li, Shengqing; Zykova, Tatyana; Liu, Kangdong; Li, Xiang; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang			Tumor Necrosis Factor Receptor-associated Factor Family Protein 2 Is a Key Mediator of the Epidermal Growth Factor-induced Ribosomal S6 Kinase 2/cAMP-responsive Element-binding Protein/Fos Protein Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; ACTIVATION; RSK2; PHOSPHORYLATION; TRAF2; UBIQUITINATION; TRANSFORMATION; REGULATOR; APOPTOSIS; CELLS	TRAF2 has an important function in mediating the TNF-R signaling pathway toward activation of NF-kappa B and JNKs. Here we reveal a novel function of TRAF2 in the epidermal growth factor (EGF) signaling pathway. Knockdown of TRAF2 blocked EGF-induced AP-1 activity and anchorage-independent cell transformation. Notably, we showed that EGF induces ribosomal S6 kinase 2 (RSK2) ubiquitination, and knocking down TRAF2 suppresses ubiquitination of RSK2 induced by EGF. We also found that TRAF2 affects RSK2 activity through RSK2 ubiquitination. RSK2 plays a critical role in AP-1 activity mediated through CREB and c-Fos, which regulates anchorage-independent cell transformation. In addition, TRAF2 is overexpressed in colon cancer and required for colon cancer development, suggesting that TRAF2 might be a potential molecular target for cancer prevention and treatment.	[Peng, Cong; Zhu, Feng; Wen, Weihong; Yao, Ke; Li, Shengqing; Zykova, Tatyana; Liu, Kangdong; Li, Xiang; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	温, 家琦/GYV-3177-2022; ZHU, Feng/C-1303-2010	Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA007646, CA111536, CA120388, R37CA081064, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA120388, F32CA007646, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA007646, CA111536, CA120388, R37CA081064, and ES016548. This work was also supported by The Hormel Foundation.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bekes M, 2009, CELL, V137, P604, DOI 10.1016/j.cell.2009.04.052; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Kako K, 1996, NEUROSCI LETT, V216, P159, DOI 10.1016/S0304-3940(96)13018-4; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; Lee ZH, 2000, MOL PHARMACOL, V58, P1536, DOI 10.1124/mol.58.6.1536; Liu KD, 2011, J BIOL CHEM, V286, P2057, DOI 10.1074/jbc.M110.147306; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Peng C, 2011, J BIOL CHEM, V286, P6946, DOI 10.1074/jbc.M110.172338; Peng C, 2010, FASEB J, V24, P3490, DOI 10.1096/fj.09-151290; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Swanson KD, 1999, J BIOL CHEM, V274, P3385, DOI 10.1074/jbc.274.6.3385; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Trauzold A, 2005, FASEB J, V19, P620, DOI 10.1096/fj.04-2984fje; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	37	13	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25881	25892		10.1074/jbc.M112.359521	http://dx.doi.org/10.1074/jbc.M112.359521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685297	Green Published, hybrid			2022-12-28	WOS:000306916300017
J	Wu, QX; Song, R; Ortogero, N; Zheng, HL; Evanoff, R; Small, CL; Griswold, MD; Namekawa, SH; Royo, H; Turner, JM; Yan, W				Wu, Qiuxia; Song, Rui; Ortogero, Nicole; Zheng, Huili; Evanoff, Ryan; Small, Chris L.; Griswold, Michael D.; Namekawa, Satoshi H.; Royo, Helene; Turner, James M.; Yan, Wei			The RNase III Enzyme DROSHA Is Essential for MicroRNA Production and Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-CHROMOSOME INACTIVATION; MALE GERM-CELLS; GENE-EXPRESSION; MIRNA BIOGENESIS; BINDING PROTEINS; CONDITIONAL LOSS; CRE RECOMBINASE; DICER; DIFFERENTIATION; CYCLE	DROSHA is a nuclear RNase III enzyme responsible for cleaving primary microRNAs (miRNAs) into precursor miRNAs and thus is essential for the biogenesis of canonical miRNAs. DICER is a cytoplasmic RNase III enzyme that not only cleaves precursor miRNAs to produce mature miRNAs but also dissects naturally formed/synthetic double-stranded RNAs to generate small interfering RNAs (siRNAs). To investigate the role of canonical miRNA and/or endogenous siRNA production in spermatogenesis, we generated Drosha or Dicer conditional knock-out (cKO) mouse lines by inactivating Drosha or Dicer exclusively in spermatogenic cells in postnatal testes using the Cre-loxp strategy. Both Drosha and Dicer cKO males were infertile due to disrupted spermatogenesis characterized by depletion of spermatocytes and spermatids leading to oligoteratozoospermia or azoospermia. The developmental course of spermatogenic disruptions was similar at morphological levels between Drosha and Dicer cKO males, but Drosha cKO testes appeared to be more severe in spermatogenic disruptions than Dicer cKO testes. Microarray analyses revealed transcriptomic differences between Drosha- and Dicer-null pachytene spermatocytes or round spermatids. Although levels of sex-linked mRNAs were mildly elevated, meiotic sex chromosome inactivation appeared to have occurred normally. Our data demonstrate that unlike DICER, which is required for the biogenesis of several small RNA species, DROSHA is essential mainly for the canonical miRNA production, and DROSHA-mediated miRNA production is essential for normal spermatogenesis and male fertility.	[Wu, Qiuxia; Song, Rui; Ortogero, Nicole; Zheng, Huili; Yan, Wei] Univ Nevada, Dept Physiol & Cell Biol, Sch Med, Reno, NV 89557 USA; [Evanoff, Ryan; Small, Chris L.; Griswold, Michael D.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Namekawa, Satoshi H.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Reprod Sci, Cincinnati, OH 45229 USA; [Namekawa, Satoshi H.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Royo, Helene; Turner, James M.] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England	Nevada System of Higher Education (NSHE); University of Nevada Reno; Washington State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; MRC National Institute for Medical Research	Yan, W (corresponding author), Univ Nevada, Dept Physiol & Cell Biol, Sch Med, CMMBldg,Rm 202,1664 N Virginia St,MS0575, Reno, NV 89557 USA.	wyan@unr.edu	Yan, Wei/AAH-7943-2019		National Institutes of Health Grants [HD050281, HD060858]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098605] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD050281 and HD060858 (to W.Y.).	Aoki Koji, 2008, V468, P307, DOI 10.1007/978-1-59745-249-6_24; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Frezzetti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027648; Georgi SA, 2011, DEV NEUROBIOL, V71, P1153, DOI 10.1002/dneu.20899; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Ho JJD, 2008, J AM SOC NEPHROL, V19, P2043, DOI 10.1681/ASN.2008090986; Hogarth CA, 2011, BIOL REPROD, V84, P34, DOI 10.1095/biolreprod.110.086215; Huang CCJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-66; Huang TC, 2012, J PROTEOME RES, V11, P2193, DOI 10.1021/pr2009884; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Idler RK, 2012, J ANDROL, V33, P309, DOI 10.2164/jandrol.111.014167; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Meng D. M., 2011, ACTA DIABET IN PRESS; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nakahara K, 2004, CURR OPIN CELL BIOL, V16, P127, DOI 10.1016/j.ceb.2004.02.006; Nakamura M, 2007, GENES CELLS, V12, P997, DOI 10.1111/j.1365-2443.2007.01111.x; Namekawa SH, 2007, P NATL ACAD SCI USA, V104, P9730, DOI 10.1073/pnas.0700323104; Namekawa SH, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.195; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Pan YQ, 2011, BIOCHEM BIOPH RES CO, V408, P369, DOI 10.1016/j.bbrc.2011.02.119; Paronetto MP, 2010, INT J ANDROL, V33, P2, DOI 10.1111/j.1365-2605.2009.00959.x; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964; Shukla Kamla Kant, 2012, Front Biosci (Elite Ed), V4, P746; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tang KF, 2007, BBA-GEN SUBJECTS, V1770, P820, DOI 10.1016/j.bbagen.2007.01.004; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang Xin, 2009, Methods Mol Biol, V561, P265, DOI 10.1007/978-1-60327-019-9_17; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yu Yiling, 2009, V493, P87, DOI 10.1007/978-1-59745-523-7_6; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104	87	136	148	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25173	25190		10.1074/jbc.M112.362053	http://dx.doi.org/10.1074/jbc.M112.362053			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665486	Green Published, hybrid			2022-12-28	WOS:000306651700028
J	Gonzalez-Paez, GE; Wolan, DW				Gonzalez-Paez, Gonzalo E.; Wolan, Dennis W.			Ultrahigh and High Resolution Structures and Mutational Analysis of Monomeric Streptococcus pyogenes SpeB Reveal a Functional Role for the Glycine-rich C-terminal Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; PROTEINASE; ZYMOGEN; PAPAIN; INHIBITORS; MECHANISM; SEQUENCE; FIBRONECTIN	Cysteine protease SpeB is secreted from Streptococcus pyogenes and has been studied as a potential virulence factor since its identification almost 70 years ago. Here, we report the crystal structures of apo mature SpeB to 1.06 angstrom resolution as well as complexes with the general cysteine protease inhibitor trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane and a novel substrate mimetic peptide inhibitor. These structures uncover conformational changes associated with maturation of SpeB from the inactive zymogen to its active form and identify the residues required for substrate binding. With the use of a newly developed fluorogenic tripeptide substrate to measure SpeB activity, we determined IC50 values for trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane and our new peptide inhibitor and the effects of mutations within the C-terminal active site loop. The structures and mutational analysis suggest that the conformational movements of the glycine-rich C-terminal loop are important for the recognition and recruitment of biological substrates and release of hydrolyzed products.	[Wolan, Dennis W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wolan, DW (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM L43,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wolan@scripps.edu		Wolan, Dennis/0000-0001-9879-8353; Gonzalez-Paez, Gonzalo/0000-0003-4708-5753				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albericio F, 2004, CURR OPIN CHEM BIOL, V8, P211, DOI 10.1016/j.cbpa.2004.03.002; Alphey MS, 2006, ACTA CRYSTALLOGR F, V62, P504, DOI 10.1107/S1744309106014849; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brak K, 2010, J MED CHEM, V53, P1763, DOI 10.1021/jm901633v; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2003, INFECT IMMUN, V71, P2983, DOI 10.1128/IAI.71.6.2983-2992.2003; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Dardenne LE, 2003, PROTEINS, V52, P236, DOI 10.1002/prot.10368; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Doran JD, 1996, BIOCHEMISTRY-US, V35, P12495, DOI 10.1021/bi960649+; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; GERWIN BI, 1966, J BIOL CHEM, V241, P3331; Ghosh R, 2008, FEBS J, V275, P421, DOI 10.1111/j.1742-4658.2007.06211.x; Gubba S, 1998, INFECT IMMUN, V66, P765, DOI 10.1128/IAI.66.2.765-770.1998; Guncar G, 2000, STRUCTURE, V8, P305, DOI 10.1016/S0969-2126(00)00108-8; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Hoffman B., 1993, ACTA CRYSTALLOGR S, P102; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Imamura T, 2005, J EXP MED, V201, P1669, DOI 10.1084/jem.20042041; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIU TY, 1965, NATURE, V206, P33, DOI 10.1038/206033a0; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Musser JM, 1996, INFECT IMMUN, V64, P1913, DOI 10.1128/IAI.64.6.1913-1917.1996; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P4868, DOI 10.1021/bi982632s; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Olsen JG, 2009, J MOL BIOL, V393, P693, DOI 10.1016/j.jmb.2009.08.046; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potempa J, 2005, MOL MICROBIOL, V57, P605, DOI 10.1111/j.1365-2958.2005.04714.x; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RODRIGUEZ M, 1991, TETRAHEDRON LETT, V32, P923, DOI 10.1016/S0040-4039(00)92121-X; Vedadi M, 2010, J STRUCT BIOL, V172, P107, DOI 10.1016/j.jsb.2010.05.005; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wang CC, 2009, J BIOL CHEM, V284, P10957, DOI 10.1074/jbc.M807624200; YU CE, 1991, INFECT IMMUN, V59, P211, DOI 10.1128/IAI.59.1.211-215.1991	56	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24412	24426		10.1074/jbc.M112.361576	http://dx.doi.org/10.1074/jbc.M112.361576			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645124	Green Published, hybrid			2022-12-28	WOS:000306651100035
J	Recktenwald, CV; Leisz, S; Steven, A; Mimura, K; Muller, A; Wulfanger, J; Kiessling, R; Seliger, B				Recktenwald, Christian V.; Leisz, Sandra; Steven, Andre; Mimura, Kousaku; Mueller, Anja; Wulfaenger, Jens; Kiessling, Rolf; Seliger, Barbara			HER-2/neu-mediated Down-regulation of Biglycan Associated with Altered Growth Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCAN; MATRIX PROTEOGLYCANS; MESENCHYMAL TRANSITION; CANCER CELLS; DECORIN; EXPRESSION; PROTEIN; LUMICAN; TRANSFORMATION; INHIBITOR	The extracellular matrix protein biglycan (Bgn) is a leucine-rich proteoglycan that is involved in the matrix assembly, cellular migration and adhesion, cell growth, and apoptosis. Although a distinct expression of Bgn was found in a number of human tumors, the role of this protein in the initiation and/or maintenance of neoplastic transformation has not been studied in detail. Using an in vitro model of oncogenic transformation, a down-regulation of Bgn expression as well as an altered secretion of different Bgn isoforms was found both in murine and human HER-2/neu oncogene-transformed cells when compared with HER-2/neu(-) cells. This was associated with a reduced growth, wound closure, and migration capacity. Vice versa, silencing of Bgn in HER-2/neu(-) fibroblasts increased the growth rate and migration capacity of these cells. Bgn expression was neither modulated in HER-2/neu(-) cells by transforming growth factor-beta(1) nor by inhibition of the phosphoinositol 3-kinase and MAP kinase pathways. In contrast, inhibition of the protein kinase C (PKC) pathway led to the reconstitution of Bgn expression. In particular, the PKC target protein cAMP response element binding protein (CREB) is a major regulator of Bgn expression as the silencing of CREB by RNA interference was accompanied by similar to 5000-fold increase in Bgn-mRNA expression in HER-2/neu(+) cells. Thus, Bgn inhibits the major properties of HER-2/neu(-) transformed cells, which is inversely modulated by the PKC signaling cascade.	[Recktenwald, Christian V.; Leisz, Sandra; Steven, Andre; Mueller, Anja; Wulfaenger, Jens; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, D-06112 Halle, Germany; [Mimura, Kousaku; Kiessling, Rolf] Karolinska Inst, S-17177 Stockholm, Sweden	Martin Luther University Halle Wittenberg; Karolinska Institutet	Seliger, B (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Magdeburger Str 2, D-06112 Halle, Germany.	Barbara.Seliger@uk-halle.de		Seliger, Barbara/0000-0002-5544-4958; Leisz, Sandra/0000-0003-4581-5185; Recktenwald, Christian Viktor/0000-0003-1710-1863; Steven, Andre/0000-0003-4860-3399	Bundesministerium fur Bildung und Forschung [Colonet 0315417E]; Mildred Scheel Foundation [109247]; intramural Roux program	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Mildred Scheel Foundation(Deutsche Krebshilfe); intramural Roux program	The work was sponsored by grants of the Bundesministerium fur Bildung und Forschung (Colonet 0315417E), Mildred Scheel Foundation Grant 109247, and the intramural Roux program.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Benayahu D, 2002, J CELL BIOCHEM, V84, P108, DOI 10.1002/jcb.1270; Brezillon S, 2007, CLIN EXP DERMATOL, V32, P405, DOI 10.1111/j.1365-2230.2007.02437.x; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Datsis GA, 2011, FEBS J, V278, P3782, DOI 10.1111/j.1742-4658.2011.08300.x; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Gu XH, 2012, CLIN EXP MED, V12, P195, DOI 10.1007/s10238-011-0155-4; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Hocking AM, 1998, MATRIX BIOL, V17, P1; HUNZELMANN N, 1995, J INVEST DERMATOL, V104, P509, DOI 10.1111/1523-1747.ep12605979; Iacob S, 2010, CONNECT TISSUE RES, V51, P347, DOI 10.3109/03008200903427695; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Markou T, 2004, J MOL CELL CARDIOL, V37, P1001, DOI 10.1016/j.yjmcc.2004.08.002; Mathias RA, 2010, J PROTEOME RES, V9, P1007, DOI 10.1021/pr900907g; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Meyer-Kirchrath J, 2009, CARDIOVASC RES, V81, P310, DOI 10.1093/cvr/cvn312; Mimura K, 2011, INT J CANCER, V128, P390, DOI 10.1002/ijc.25613; Nannuru Kalyan C, 2010, Curr Osteoporos Rep, V8, P105, DOI 10.1007/s11914-010-0011-6; Nash MA, 1999, CANCER RES, V59, P6192; Recktenwald CV, 2007, PROTEOMICS, V7, P385, DOI 10.1002/pmic.200600506; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Rodriguez Luis G., 2004, V294, P23; Roughley PJ, 1996, BIOCHEM J, V318, P779, DOI 10.1042/bj3180779; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Schaefer L, 2001, FASEB J, V15, P559; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Skandalis SS, 2004, BBA-MOL BASIS DIS, V1689, P152, DOI 10.1016/j.bbadis.2004.03.006; Tchernitsa OI, 2004, ONCOGENE, V23, P4536, DOI 10.1038/sj.onc.1207585; Tiede K, 2010, BASIC RES CARDIOL, V105, P99, DOI 10.1007/s00395-009-0049-8; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tufvesson E, 2002, EUR J BIOCHEM, V269, P3688, DOI 10.1046/j.1432-1033.2002.03058.x; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; Wang B, 2011, EXP BIOL MED, V236, P1247, DOI 10.1258/ebm.2011.011124; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; Wulfaenger J, 2008, MOL MEMBR BIOL, V25, P72, DOI 10.1080/09687680701551855; Yoshioka N, 2000, J VIROL, V74, P1008, DOI 10.1128/JVI.74.2.1008-1013.2000	47	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24320	24329		10.1074/jbc.M111.334425	http://dx.doi.org/10.1074/jbc.M111.334425			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22582394	Green Published, hybrid			2022-12-28	WOS:000306651100026
J	Deiss, K; Kisker, C; Lohse, MJ; Lorenz, K				Deiss, Katharina; Kisker, Caroline; Lohse, Martin J.; Lorenz, Kristina			Raf Kinase Inhibitor Protein (RKIP) Dimer Formation Controls Its Target Switch from Raf1 to G Protein-coupled Receptor Kinase (GRK) 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; METASTASIS SUPPRESSOR; HEART-FAILURE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; BOVINE BRAIN; PHOSPHORYLATION; MECHANISM; ACTIVATION; REGULATOR	Proteins controlling cellular networks have evolved distinct mechanisms to ensure specificity in protein-protein interactions. Raf kinase inhibitor protein (RKIP) is a multifaceted kinase modulator, but it is not well understood how this small protein (21 kDa) can coordinate its diverse signaling functions. Raf1 and G protein-coupled receptor kinase (GRK) 2 are direct interaction partners of RKIP and thus provide the possibility to untangle the mechanism of its target specificity. Here, we identify RKIP dimer formation as an important mechanistic feature in the target switch from Raf1 to GRK2. Co-immunoprecipitation and cross-linking experiments revealed RKIP dimerization upon phosphorylation of RKIP at serine 153 utilizing purified proteins as well as in cells overexpressing RKIP. A functional phosphomimetic RKIP mutant had a high propensity for dimerization and reproduced the switch from Raf1 to GRK2. RKIP dimerization and GRK2 binding, but not Raf1 interaction, were prevented by a peptide comprising amino acids 127-146 of RKIP, which suggests that this region is critical for dimer formation. Furthermore, a dimeric RKIP mutant displayed a higher affinity to GRK2, but a lower affinity to Raf1. Functional analyses of phosphomimetic as well as dimeric RKIP demonstrated that enhanced dimerization of RKIP translates into decreased Raf1 and increased GRK2 inhibition. The detection of RKIP dimers in a complex with GRK2 in murine hearts implies their physiological relevance. These findings represent a novel mechanistic feature how RKIP can discriminate between its different interaction partners and thus advances our understanding how specific inhibition of kinases can be achieved.	[Deiss, Katharina; Lohse, Martin J.; Lorenz, Kristina] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Lohse, Martin J.; Lorenz, Kristina] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97078 Wurzburg, Germany; [Kisker, Caroline; Lohse, Martin J.] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Lohse, MJ (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	lohse@toxi.uni-wuerzburg.de; lorenz@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Kisker, Caroline/T-1724-2019; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Kisker, Caroline/0000-0002-0216-6026; Lorenz, Kristina/0000-0002-5747-2207	Deutsche Forschungsgemeinschaft; Bundesministerium fuer Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung	This work was supported by the Deutsche Forschungsgemeinschaft and the Bundesministerium fuer Bildung und Forschung.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Al-Mulla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029532; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; Anderson E, 2010, BIOCHEMISTRY-US, V49, P1217, DOI 10.1021/bi901873p; Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Banfield MJ, 2000, J MOL BIOL, V297, P1159, DOI 10.1006/jmbi.2000.3619; Belmonte SL, 2011, CIRC RES, V109, P309, DOI 10.1161/CIRCRESAHA.110.231233; BERNIER I, 1986, BIOCHIM BIOPHYS ACTA, V871, P19, DOI 10.1016/0167-4838(86)90128-7; BOLLENGIER F, 1989, J NEUROCHEM, V52, P1123, DOI 10.1111/j.1471-4159.1989.tb01856.x; COHEN C, 1986, TRENDS BIOCHEM SCI, V11, P245, DOI 10.1016/0968-0004(86)90186-6; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Crasto CJ, 2001, PROTEINS, V42, P399, DOI 10.1002/1097-0134(20010215)42:3<399::AID-PROT100>3.0.CO;2-E; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; Eichmann T, 2003, J BIOL CHEM, V278, P8052, DOI 10.1074/jbc.M204795200; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Granovsky AE, 2008, CELL RES, V18, P452, DOI 10.1038/cr.2008.43; Granovsky AE, 2009, MOL CELL BIOL, V29, P1306, DOI 10.1128/MCB.01271-08; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; Hellmann J, 2010, DEV NEUROSCI-BASEL, V32, P33, DOI 10.1159/000236595; Huang JA, 2007, AM J PHYSIOL-GASTR L, V292, pG867, DOI 10.1152/ajpgi.00326.2006; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Keller ET, 2004, BIOCHEM PHARMACOL, V68, P1049, DOI 10.1016/j.bcp.2004.04.024; Keller ET, 2005, J CELL BIOCHEM, V94, P273, DOI 10.1002/jcb.20169; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kroslak T, 2001, J BIOL CHEM, V276, P39772, DOI 10.1074/jbc.M106991200; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Lorenz K, 2009, INT J BIOCHEM CELL B, V41, P2351, DOI 10.1016/j.biocel.2009.08.002; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Rath O, 2008, CELL SIGNAL, V20, P935, DOI 10.1016/j.cellsig.2008.01.012; Rengo G, 2011, J MOL CELL CARDIOL, V50, P785, DOI 10.1016/j.yjmcc.2010.08.014; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Serre L, 1998, STRUCTURE, V6, P1255, DOI 10.1016/S0969-2126(98)00126-9; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; Shemon AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010479; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Vallee BS, 2001, EUR J BIOCHEM, V268, P5831, DOI 10.1046/j.0014-2956.2001.02528.x; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]	53	47	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23407	23417		10.1074/jbc.M112.363812	http://dx.doi.org/10.1074/jbc.M112.363812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610096	Green Published, hybrid			2022-12-28	WOS:000306511300013
J	Syberg, F; Suveyzdis, Y; Kotting, C; Gerwert, K; Hofmann, E				Syberg, Falk; Suveyzdis, Yan; Koetting, Carsten; Gerwert, Klaus; Hofmann, Eckhard			Time-resolved Fourier Transform Infrared Spectroscopy of the Nucleotide-binding Domain from the ATP-binding Cassette Transporter MsbA ATP HYDROLYSIS IS THE RATE-LIMITING STEP IN THE CATALYTIC CYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MSBA; ABC TRANSPORTER; P-GLYCOPROTEIN; FUNCTIONAL-CHARACTERIZATION; CONFORMATIONAL CYCLE; ALTERNATING ACCESS; FTIR SPECTROSCOPY; LIPID FLIPPASE; MECHANISM; PHOSPHATE	MsbA is an essential Escherichia coli ATP-binding cassette (ABC) transporter involved in the flipping of lipid A across the cytoplasmic membrane. It is a close homologue of human P-glycoprotein involved in multidrug resistance, and it similarly accepts a variety of small hydrophobic xenobiotics as transport substrates. X-ray structures of three full-length ABC multidrug exporters (including MsbA) have been published recently and reveal large conformational changes during the transport cycle. However, how ATP hydrolysis couples to these conformational changes and finally the transport is still an open question. We employed time-resolved FTIR spectroscopy, a powerful method to elucidate molecular reaction mechanisms of soluble and membrane proteins, to address this question with high spatio-temporal resolution. Here, we monitored the hydrolysis reaction in the nucleotide-binding domain of MsbA at the atomic level. The isolated MsbA nucleotide-binding domain hydrolyzed ATP with V-max = 45 nmol mg(-1) min(-1), similar to the full-length transporter. A Hill coefficient of 1.49 demonstrates positive cooperativity between the two catalytic sites formed upon dimerization. Global fit analysis of time-resolved FTIR data revealed two apparent rate constants of similar to 1 and 0.01 s(-1), which were assigned to formation of the catalytic site and hydrolysis, respectively. Using isotopically labeled ATP, we identified specific marker bands for protein-bound ATP (1245 cm(-1)), ADP (1101 and 1205 cm(-1)), and free phosphate (1078 cm(-1)). Cleavage of the beta-phosphate-gamma-phosphate bond was found to be the rate-limiting step; no protein-bound phosphate intermediate was resolved.	[Syberg, Falk; Suveyzdis, Yan; Koetting, Carsten; Gerwert, Klaus; Hofmann, Eckhard] Ruhr Univ Bochum, Dept Biophys, Fac Biol & Biotechnol, D-44780 Bochum, Germany	Ruhr University Bochum	Gerwert, K (corresponding author), LS Biophys, Gebaude ND04-396, D-44780 Bochum, Germany.	klaus.gerwert@bph.rub.de; eckhard.hofmann@bph.rub.de	Hofmann, Eckhard/GPF-5024-2022; Gerwert, Klaus/G-7311-2015; Kötting, Carsten/A-8266-2008	Kötting, Carsten/0000-0002-3599-9657; Hofmann, Eckhard/0000-0003-4874-372X	Protein Research Department of Ruhr-Universitat Bochum and Collaborative Research Center of the Deutsche Forschungsgemeinschaft [SFB 642];  [A22]	Protein Research Department of Ruhr-Universitat Bochum and Collaborative Research Center of the Deutsche Forschungsgemeinschaft; 	This work was supported by the Protein Research Department of Ruhr-Universitat Bochum and Collaborative Research Center SFB 642 of the Deutsche Forschungsgemeinschaft (Teilprojekt A1 (to K.G. and C.K.) and A22 (to E.H.)).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Barth A, 2008, SPECTROSC-INT J, V22, P63, DOI 10.1155/2008/489739; Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Brucker S, 2010, J MOL BIOL, V401, P1, DOI 10.1016/j.jmb.2010.05.068; Cepus V, 1998, Methods Enzymol, V291, P223; Chakrabarti PP, 2007, J MOL BIOL, V367, P983, DOI 10.1016/j.jmb.2006.11.022; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Du XL, 2000, J BIOL CHEM, V275, P8492, DOI 10.1074/jbc.275.12.8492; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2010, BIOCHEM J, V429, P195, DOI 10.1042/BJ20100144; Gerwert K, 1999, BIOL CHEM, V380, P931, DOI 10.1515/BC.1999.115; GERWERT K, 1990, P NATL ACAD SCI USA, V87, P9774, DOI 10.1073/pnas.87.24.9774; GOODY RS, 1982, ANAL BIOCHEM, V119, P322, DOI 10.1016/0003-2697(82)90592-9; Grimard V, 2001, BIOCHEMISTRY-US, V40, P11876, DOI 10.1021/bi010017+; Gustot A, 2010, J BIOL CHEM, V285, P14144, DOI 10.1074/jbc.M109.079673; HESSLING B, 1993, BIOPHYS J, V65, P1929, DOI 10.1016/S0006-3495(93)81264-5; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; HOARD DE, 1965, J AM CHEM SOC, V87, P1785, DOI 10.1021/ja01086a031; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jun B, 2010, J BIOL CHEM, V285, P11073, DOI 10.1074/jbc.C110.103762; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Kerr ID, 2003, EUR BIOPHYS J BIOPHY, V32, P644, DOI 10.1007/s00249-003-0327-6; Klahn M, 2004, J PHYS CHEM A, V108, P6186, DOI 10.1021/jp048617g; Kotting C, 2008, P NATL ACAD SCI USA, V105, P6260, DOI 10.1073/pnas.0712095105; Licht A, 2011, CENT EUR J BIOL, V6, P785, DOI 10.2478/s11535-011-0054-4; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Park CH, 1997, J AM CHEM SOC, V119, P2453, DOI 10.1021/ja9635589; Rammelsberg R, 1999, VIB SPECTROSC, V19, P143, DOI 10.1016/S0924-2031(99)00013-2; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P3599, DOI 10.1021/bi101666p; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P2594, DOI 10.1021/bi1018418; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Stolz M, 2009, BIOPHYS J, V96, P3433, DOI 10.1016/j.bpj.2009.01.010; TAKEUCHI H, 1988, J AM CHEM SOC, V110, P392, DOI 10.1021/ja00210a013; Troullier A, 1996, BIOPHYS J, V71, P2970, DOI 10.1016/S0006-3495(96)79537-1; van der Does C, 2006, J BIOL CHEM, V281, P5694, DOI 10.1074/jbc.M511730200; Vollmecke C, 2009, FEBS J, V276, P6172, DOI 10.1111/j.1742-4658.2009.07320.x; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Westfahl KM, 2008, BIOCHEMISTRY-US, V47, P13878, DOI 10.1021/bi801745u; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	61	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23923	23931		10.1074/jbc.M112.359208	http://dx.doi.org/10.1074/jbc.M112.359208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593573	hybrid, Green Published			2022-12-28	WOS:000306511300062
J	Hsu, CC; Lee, YC; Yeh, SH; Chen, CH; Wu, CC; Wang, TY; Chen, YN; Hung, LY; Liu, YW; Chen, HK; Hsiao, YT; Wang, WS; Tsou, JH; Tsou, YH; Wu, MH; Chang, WC; Lin, DY				Hsu, Che-Chia; Lee, Yi-Chao; Yeh, Shiu-Hwa; Chen, Chang-Han; Wu, Chih-Ching; Wang, Tsui-Ying; Chen, Yu-Nong; Hung, Liang-Yi; Liu, Yao-Wen; Chen, Han-Ku; Hsiao, Yi-Ting; Wang, Wei-Sheng; Tsou, Jen-Hui; Tsou, Yi-Huan; Wu, Mei-Hsiang; Chang, Wen-Chang; Lin, Ding-Yen			58-kDa Microspherule Protein (MSP58) Is Novel Brahma-related Gene 1 (BRG1)-associated Protein That Modulates p53/p21 Senescence Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; CHROMATIN REMODELING COMPLEXES; DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; CELLULAR SENESCENCE; TRANSCRIPTIONAL ACTIVITY; RETINOBLASTOMA PROTEIN; HUMAN TUMORIGENESIS; TUMOR SUPPRESSION; DOWN-REGULATION	The nucleolar 58-kDa microspherule protein (MSP58) protein is a candidate oncogene implicated in modulating cellular proliferation and malignant transformation. In this study, we show that knocking down MSP58 expression caused aneuploidy and led to apoptosis, whereas ectopic expression of MSP58 regulated cell proliferation in a context-dependent manner. Specifically, ectopic expression of MSP58 in normal human IMR90 and Hs68 diploid fibroblasts, the H184B5F5/M10 mammary epithelial cell line, HT1080 fibrosarcoma cells, primary mouse embryonic fibroblasts, and immortalized NIH3T3 fibroblasts resulted in induction of premature senescence, an enlarged and flattened cellular morphology, and increased senescence-associated beta-galactosidase activity. MSP58-driven senescence was strictly dependent on the presence of functional p53 as revealed by the fact that normal cells with p53 knockdown by specific shRNA or cells with a mutated or functionally impaired p53 pathway were effective in bypassing MSP58-induced senescence. At least two senescence mechanisms are induced by MSP58. First, MSP58 activates the DNA damage response and p53/p21 signaling pathways. Second, MSP58, p53, and the SWI/SNF chromatinremodeling subunit Brahma-related gene 1 (BRG1) form a ternary complex on the p21 promoter and collaborate to activate p21. Additionally, MSP58 protein levels increased in cells undergoing replicative senescence and stress-induced senescence. Notably, the results of analyzing expression levels of MSP58 between tumors and matched normal tissues showed significant changes (both up-and down-regulation) in its expression in various types of tumors. Our findings highlight new aspects of MSP58 in modulating cellular senescence and suggest that MSP58 has both oncogenic and tumor-suppressive properties.	[Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan; [Hsu, Che-Chia; Hung, Liang-Yi; Tsou, Jen-Hui; Wu, Mei-Hsiang; Lin, Ding-Yen] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Wang, Tsui-Ying; Chen, Yu-Nong; Tsou, Yi-Huan; Chang, Wen-Chang; Lin, Ding-Yen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Chang, Wen-Chang; Lin, Ding-Yen] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan; [Chang, Wen-Chang; Lin, Ding-Yen] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Lee, Yi-Chao] Taipei Med Univ, Coll Med Sci & Technol, Program Neural Regenerat Med, Taipei 11031, Taiwan; [Yeh, Shiu-Hwa; Hsiao, Yi-Ting] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli 35053, Taiwan; [Chen, Chang-Han] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung 833, Taiwan; [Wang, Wei-Sheng] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung 833, Taiwan; [Wu, Chih-Ching] Chang Gung Univ, Albany Med Coll, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan; [Liu, Yao-Wen] Kuo Gen Hosp, Dept Pathol, Tainan 700, Taiwan; [Chen, Han-Ku] Fooyin Univ Hosp, Dept Pathol, Pingtung 928, Taiwan	Taipei Medical University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, WC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan.	wcchang@mail.ncku.edu.tw; lindy@mail.ncku.edu.tw	Yeh, Shiu-Hwa/D-2088-2010; Hung, Liang-Yi/AAG-4174-2019	Wu, Chih-Ching/0000-0002-7264-9672; Lee, Yi-Chao/0000-0003-3451-183X; , Liang-Yi/0000-0002-7284-2608	National Science Council of Taiwan [NSC96-2320-B-006-011, NSC96-2320-B-006-049-MY2, NSC98-2320-B-006-035-MY3]; National Cheng Kung University Landmark [C015]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Landmark	This work was supported by National Science Council of Taiwan Grants NSC96-2320-B-006-011, NSC96-2320-B-006-049-MY2, and NSC98-2320-B-006-035-MY3) and National Cheng Kung University Landmark Grant C015 (to D.-Y. L.).	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Andersen DS, 2010, MOL CELL BIOL, V30, P4744, DOI 10.1128/MCB.01586-09; Bader AG, 2001, ONCOGENE, V20, P7524, DOI 10.1038/sj.onc.1204938; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Campisi J, 2000, IN VIVO, V14, P183; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Chen QM, 2000, ANN NY ACAD SCI, V908, P111; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Du XL, 2006, EXP MOL PATHOL, V81, P184, DOI 10.1016/j.yexmp.2006.07.008; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARPER JW, 1993, CELL, V75, P805; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hirohashi Y, 2006, ONCOGENE, V25, P4937, DOI 10.1038/sj.onc.1209500; HUNTER T, 1993, CELL, V75, P839, DOI 10.1016/0092-8674(93)90528-X; Ivanova AV, 2005, CELL MOL LIFE SCI, V62, P471, DOI 10.1007/s00018-004-4423-2; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kim S, 2002, ONCOGENE, V21, P503, DOI 10.1038/sj.onc.1205077; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lin DY, 2002, J BIOL CHEM, V277, P25446, DOI 10.1074/jbc.M200633200; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lin W, 2009, J CELL MOL MED, V13, P4608, DOI 10.1111/j.1582-4934.2008.00499.x; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Ren Y, 1998, EUR J BIOCHEM, V253, P734, DOI 10.1046/j.1432-1327.1998.2530734.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sharma SV, 2010, BIOCHEM PHARMACOL, V80, P666, DOI 10.1016/j.bcp.2010.03.001; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shi H, 2009, CANCER SCI, V100, P1585, DOI 10.1111/j.1349-7006.2009.01223.x; Shimono K, 2005, J BIOL CHEM, V280, P39436, DOI 10.1074/jbc.M507356200; Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com; Song H, 2004, BIOCHEM BIOPH RES CO, V316, P1116, DOI 10.1016/j.bbrc.2004.02.166; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Wu RC, 1997, J BIOL CHEM, V272, P29091, DOI 10.1074/jbc.272.46.29091; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06	58	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22533	22548		10.1074/jbc.M111.335331	http://dx.doi.org/10.1074/jbc.M111.335331			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22563078	Green Published, hybrid			2022-12-28	WOS:000306495000011
J	Ryu, MJ; Liu, YG; Zhong, XF; Du, J; Peterson, N; Kong, GY; Li, HD; Wang, JY; Salamat, S; Chang, Q; Zhang, J				Ryu, Myung-Jeom; Liu, Yangang; Zhong, Xiaofen; Du, Juan; Peterson, Nicholas; Kong, Guangyao; Li, Hongda; Wang, Jinyong; Salamat, Shahriar; Chang, Qiang; Zhang, Jing			Oncogenic Kras Expression in Postmitotic Neurons Leads to S100A8-S100A9 Protein Overexpression and Gliosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC-CELLS; K-RAS; MYELOPROLIFERATIVE DISORDER; TYPE-1 NEUROFIBROMATOSIS; PILOCYTIC ASTROCYTOMA; GENE-EXPRESSION; ACTIVATION; NF1; GLIOMA; GROWTH	Previous studies suggest that up-regulation of Ras signaling in neurons promotes gliosis and astrocytoma formation in a cell nonautonomous manner. However, the underlying mechanisms remain unknown. To address this question, we generated compound mice (LSL Kras G12D/+;CamKII-Cre) that express oncogenic Kras from its endogenous locus in postmitotic neurons after birth. These mice developed progressive gliosis, which is associated with hyperactivation of Ras signaling pathways. Microarray analysis identified S100A8 and S100A9 as two secreted molecules that are significantly overexpressed in mutant cortices. In contrast to their usual predominant expression in myeloid cells, we found that overexpression of S100A8 and S100A9 in the mutant cortex is primarily in neurons. This neuronal expression pattern is associated with increased infiltration of microglia in mutant cortex. Moreover, purified S100A8-S100A9 but not S100A8 or S100A9 alone promotes growth of primary astrocytes in vitro through both TLR4 and receptor of advanced glycation end product receptors. In summary, our results identify overexpression of S100A8-S100A9 in neurons as an early step in oncogenic Kras-induced gliosis. These molecules expressed in nonhematopoietic cells may be involved in tumorigenesis at a stage much earlier than what has been reported previously.	[Ryu, Myung-Jeom; Liu, Yangang; Du, Juan; Kong, Guangyao; Wang, Jinyong; Zhang, Jing] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Zhong, Xiaofen; Li, Hongda; Chang, Qiang] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Peterson, Nicholas] Univ Wisconsin, Dept Biochem, Sch Letters & Sci, Madison, WI 53705 USA; [Salamat, Shahriar] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53792 USA; [Li, Hongda; Chang, Qiang] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Li, Hongda; Chang, Qiang] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, J (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	zhang@oncology.wisc.edu	Li, Hongda/F-3034-2017; Kong, Guangyao/L-2162-2013	Li, Hongda/0000-0001-6754-5150; 	National Institutes of Health [R01 CA152108, P30 CA014520]; Greater Milwaukee Foundation; V Foundation for Cancer Research; University of Wisconsin Carbone Comprehensive Cancer Center; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA152108, P30CA014520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greater Milwaukee Foundation; V Foundation for Cancer Research; University of Wisconsin Carbone Comprehensive Cancer Center; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA152108 and P30 CA014520-UW Comprehensive Cancer Center Support from the NCI. This work was also supported by a Howard Temin Award, a Shaw Scientist Award from the Greater Milwaukee Foundation, a V Scholar Award from the V Foundation for Cancer Research, an Investigator Initiated Grant from University of Wisconsin Carbone Comprehensive Cancer Center (to J. Z.), and a Postdoctoral Fellowship from the American Heart Association (to M. J.).	Abel TW, 2009, MOL CANCER RES, V7, P645, DOI 10.1158/1541-7786.MCR-08-0477; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bajenaru ML, 2003, CANCER RES, V63, P8573; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Dasgupta B, 2005, CANCER RES, V65, P236; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DEVERY JM, 1994, J IMMUNOL, V152, P1888; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Gutmann DH, 2008, J CHILD NEUROL, V23, P1186, DOI 10.1177/0883073808321061; Gutmann DH, 2000, NEUROPATH APPL NEURO, V26, P361, DOI 10.1046/j.1365-2990.2000.00258.x; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hiatt KK, 2001, J BIOL CHEM, V276, P7240, DOI 10.1074/jbc.M009202200; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Janzarik WG, 2007, NEUROPEDIATRICS, V38, P61, DOI 10.1055/s-2007-984451; KRAIG RP, 1991, J NEUROSCI, V11, P2187; LACKMANN M, 1993, J IMMUNOL, V150, P2981; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Lau N, 2000, J NEUROPATH EXP NEUR, V59, P759, DOI 10.1093/jnen/59.9.759; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Mathias RA, 2010, J PROTEOME RES, V9, P1007, DOI 10.1021/pr900907g; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; NORDLUND ML, 1995, J NEUROPATH EXP NEUR, V54, P588, DOI 10.1097/00005072-199507000-00013; Pino Paula A, 2011, J Vis Exp, DOI 10.3791/2348; Riccardi V. M., 1999, NEUROFIBROMATOSIS PH, P1; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Roth J, 2003, J IMMUNOL, V171, P5651, DOI 10.4049/jimmunol.171.11.5651; Ryu MJ, 2007, J NEUROCHEM, V102, P646, DOI 10.1111/j.1471-4159.2007.04504.x; Sharma MK, 2005, NEUROLOGY, V65, P1335, DOI 10.1212/01.wnl.0000180409.78098.d7; Sherman LS, 2000, J BIOL CHEM, V275, P30740, DOI 10.1074/jbc.M001702200; STEWARD O, 1991, P NATL ACAD SCI USA, V88, P6819, DOI 10.1073/pnas.88.15.6819; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	52	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22948	22958		10.1074/jbc.M112.357772	http://dx.doi.org/10.1074/jbc.M112.357772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577135	Green Published, hybrid			2022-12-28	WOS:000306495000052
J	Wu, LF; Pan, Y; Chen, GQ; Matsunami, H; Zhuang, HY				Wu, Lifang; Pan, Yi; Chen, Guo-Qiang; Matsunami, Hiroaki; Zhuang, Hanyi			Receptor-transporting Protein 1 Short (RTP1S) Mediates Translocation and Activation of Odorant Receptors by Acting through Multiple Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; OLFACTORY RECEPTOR; TRAFFICKING; RETENTION; MEMBERS; FAMILY; RIC-8B; RAFTS	Odorant receptor (OR) proteins are retained in the endoplasmic reticulum when heterologously expressed in cultured cells of non-olfactory origins. RTP1S is an accessory protein to mammalian ORs and facilitates their trafficking to the cell-surface membrane and ligand-induced responses in heterologous cells. The mechanism by which RTP1S promotes the functional expression of ORs remains poorly understood. To obtain a better understanding of the role(s) of RTP1S, we performed a series of structure-function analyses of RTP1S in HEK293T cells. By constructing RTP1S deletion and chimera series and subsequently introducing single-site mutations into the protein, we found the N terminus of RTP1S is important for the endoplasmic reticulum exit of ORs and that a middle region of RTP1S is important for OR trafficking from the Golgi to the membrane. Using sucrose gradient centrifugation, we found that the localization of RTP1S to the lipid raft microdomain is critical to the activation of ORs. Finally, in a protein-protein interaction analysis, we determined that the C terminus of RTP1S may be interacting with ORs. These findings provide new insights into the distinct roles of RTP1S in OR translocation and activation.	[Zhuang, Hanyi] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang; Zhuang, Hanyi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Wu, Lifang; Pan, Yi; Chen, Guo-Qiang; Zhuang, Hanyi] Shanghai Jiao Tong Univ, Dept Pathophysiol, Shanghai Univ E Inst Chem Biol,Key Lab Cell Diffe, Natl Minist Educ,Sch Med, Shanghai 200025, Peoples R China; [Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet, Durham, NC 27710 USA; [Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Matsunami, Hiroaki] Duke Univ, Med Ctr, Duke Inst Brain Sci, Durham, NC 27710 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Duke University; Duke University; Duke University	Zhuang, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Bldg 1,Rm 205,225 S Chongqing Rd, Shanghai 200025, Peoples R China.	hanyizhuang@sjtu.edu.cn	Pan, Yi/AAJ-2341-2021; Wu, Lifang/R-3630-2016	chen, guo qiang/0000-0003-4936-2363; Wu, Lifang/0000-0003-3334-2923	National Institutes of Health from NIDCD [DC005782]; National Natural Science Foundation of China [30970981, 31070972]; 973 Program [2012CB910401]; Shanghai Pujiang Program [09PJ1406900]; Shanghai Municipal Education Commission [2009CG15, J50201]; Shanghai Education Development Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010857, R01DC005782] Funding Source: NIH RePORTER	National Institutes of Health from NIDCD; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by a National Institutes of Health Grant DC005782 from NIDCD (to H. M.). This work was also supported by National Natural Science Foundation of China Grants 30970981 and 31070972, 973 Program Grant 2012CB910401, Shanghai Pujiang Program Grant 09PJ1406900, the Program for Innovative Research Team of the Shanghai Municipal Education Commission, Chen Guang Project Grant 2009CG15 funded by the Shanghai Municipal Education Commission and the Shanghai Education Development Foundation, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, and Leading Academic Discipline Project Grant J50201 from the Shanghai Municipal Education Commission (to H. Z.).	Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Mast TG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-61; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mombaerts P, 1999, CURR OPIN GENET DEV, V9, P315, DOI 10.1016/S0959-437X(99)80047-1; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wang TY, 2001, BIOCHEMISTRY-US, V40, P13031, DOI 10.1021/bi0112311; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	28	29	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22287	22294		10.1074/jbc.M112.345884	http://dx.doi.org/10.1074/jbc.M112.345884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570474	Green Published, hybrid			2022-12-28	WOS:000306418600066
J	Bergfeld, AK; Pearce, OMT; Diaz, SL; Pham, T; Varki, A				Bergfeld, Anne K.; Pearce, Oliver M. T.; Diaz, Sandra L.; Tho Pham; Varki, Ajit			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups ELUCIDATING THE INTRACELLULAR FATE OF THE NON-HUMAN SIALIC ACID N-GLYCOLYLNEURAMINIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HANGANUTZIU-DEICHER ANTIGEN; SIALATE PYRUVATE-LYASE; ACETYLNEURAMINIC ACID; MOUSE-LIVER; ACETYLGLUCOSAMINE KINASE; GLYCOLOYLNEURAMINIC ACID; GLCNAC 2-EPIMERASE; MOLECULAR-CLONING; CELL LINE; CANCER	The two major mammalian sialic acids are N-acetylneuraminic acid and N-glycolylneuraminic acid (Neu5Gc). The only known biosynthetic pathway generating Neu5Gc is the conversion of CMP-N-acetylneuraminic acid into CMP-Neu5Gc, which is catalyzed by the CMP-Neu5Ac hydroxylase enzyme. Given the irreversible nature of this reaction, there must be pathways for elimination or degradation of Neu5Gc, which would allow animal cells to adjust Neu5Gc levels to their needs. Although humans are incapable of synthesizing Neu5Gc due to an inactivated CMAH gene, exogenous Neu5Gc from dietary sources can be metabolically incorporated into tissues in the face of an anti-Neu5Gc antibody response. However, the metabolic turnover of Neu5Gc, which apparently prevents human cells from continued accumulation of this immunoreactive sialic acid, has not yet been elucidated. In this study, we show that pre-loaded Neu5Gc is eliminated from human cells over time, and we propose a conceivable Neu5Gc-degrading pathway based on the well studied metabolism of N-acetylhexosamines. We demonstrate that murine tissue cytosolic extracts harbor the enzymatic machinery to sequentially convert Neu5Gc into N-glycolylmannosamine, N-glycolylglucosamine, and N-glycolylglucosamine 6-phosphate, whereupon irreversible de-N-glycolylation of the latter results in the ubiquitous metabolites glycolate and glucosamine 6-phosphate. We substantiate this finding by demonstrating activity of recombinant human enzymes in vitro and by studying the fate of radiolabeled pathway intermediates in cultured human cells, suggesting that this pathway likely occurs in vivo. Finally, we demonstrate that the proposed degradative pathway is partially reversible, showing that N-glycolylmannosamine and N-glycolylglucosamine (but not glycolate) can serve as precursors for biosynthesis of endogenous Neu5Gc.	[Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu		Pearce, Oliver/0000-0003-3953-1629	National Institutes of Health [R01GM32373, R01CA38701]; Deutsche Forschungsgemeinschaft [BE 4643/1-1]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32373 and R01CA38701 (to A. V.). This work was also supported by Deutsche Forschungsgemeinschaft Research Fellowship BE 4643/1-1 (to A. K. B.) and a Cancer Research Institute/Samuel and Ruth Engelberg Fellowship (to O. M. T. P.). A. V. is a co-founder of and consultant for Sialix Inc., a biotech startup company interested in the practical implications of Neu5Gc uptake in humans.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bergfeld AK, 2012, J BIOL CHEM, V287, P28898, DOI 10.1074/jbc.M112.363499; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; BRUNETTI P, 1962, J BIOL CHEM, V237, P2447; Bulai T, 2002, BIOCHIMIE, V84, P655, DOI 10.1016/S0300-9084(02)01436-0; CAMPBELL P, 1987, ANAL BIOCHEM, V166, P134, DOI 10.1016/0003-2697(87)90555-0; Choo A, 2006, J BIOTECHNOL, V122, P130, DOI 10.1016/j.jbiotec.2005.09.008; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; DEVINE PL, 1991, CANCER RES, V51, P5826; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Fujita A, 2007, BIOCHEM BIOPH RES CO, V355, P174, DOI 10.1016/j.bbrc.2007.01.139; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; GHOSH S, 1965, J BIOL CHEM, V240, P1531; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; HIGA HH, 1985, J BIOL CHEM, V260, P8838; HIGASHI H, 1985, CANCER RES, V45, P3796; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P614; Inoue S, 2010, GLYCOBIOLOGY, V20, P752, DOI 10.1093/glycob/cwq030; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; JOURDIAN GW, 1962, J BIOL CHEM, V237, P2442; KAWACHI S, 1988, INT ARCH ALLER A IMM, V85, P381, DOI 10.1159/000234536; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KAWANO T, 1993, GLYCOCONJUGATE J, V10, P109, DOI 10.1007/BF00731194; KEAN EL, 1966, J BIOL CHEM, V241, P5643; KENT PW, 1968, BIOCHEM J, V106, P645, DOI 10.1042/bj1060645; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Koda Tetsuzo, 2003, Int J Clin Oncol, V8, P317, DOI 10.1007/s10147-003-0346-4; KOZUTSUMI Y, 1990, J BIOCHEM, V108, P704, DOI 10.1093/oxfordjournals.jbchem.a123268; Li YH, 2008, APPL MICROBIOL BIOT, V79, P963, DOI 10.1007/s00253-008-1506-2; Luchansky SJ, 2003, J BIOL CHEM, V278, P8035, DOI 10.1074/jbc.M212127200; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Matuszek M, 2001, Med Sci Monit, V7, P377; MENEZES J, 1975, BIOMEDICINE, V22, P276; MIYOSHI I, 1986, MOL IMMUNOL, V23, P631, DOI 10.1016/0161-5890(86)90100-8; Munster-Kuhnel AK, 2004, GLYCOBIOLOGY, V14, p43R, DOI 10.1093/glycob/cwh113; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; PALADINI AC, 1952, BIOCHEM J, V51, P426, DOI 10.1042/bj0510426; Pearce OMT, 2010, CARBOHYD RES, V345, P1225, DOI 10.1016/j.carres.2010.04.003; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Sampathkumar SG, 2006, NAT CHEM BIOL, V2, P149, DOI 10.1038/nchembio770; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Schauer R, 1978, Methods Enzymol, V50, P64; Schauer R, 1999, BIOSCIENCE REP, V19, P373, DOI 10.1023/A:1020256004616; Schauer R, 1996, BIOL CHEM H-S, V377, P293, DOI 10.1515/bchm3.1996.377.5.293; Schlenzka W, 1996, FEBS LETT, V385, P197, DOI 10.1016/0014-5793(96)00384-5; SHAW L, 1992, EUR J BIOCHEM, V206, P269, DOI 10.1111/j.1432-1033.1992.tb16925.x; SHAW L, 1994, EUR J BIOCHEM, V219, P1001, DOI 10.1111/j.1432-1033.1994.tb18583.x; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; SINAY P, 1971, CARBOHYD RES, V16, P113, DOI 10.1016/S0008-6215(00)86104-2; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; Sommer U, 1999, GLYCOCONJUGATE J, V16, P425, DOI 10.1023/A:1007030627948; Takahashi S, 1999, J BIOCHEM-TOKYO, V125, P348, DOI 10.1093/oxfordjournals.jbchem.a022293; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; TAKEMATSU H, 1994, J BIOCHEM-TOKYO, V115, P381, DOI 10.1093/oxfordjournals.jbchem.a124347; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; TREVELYAN WE, 1950, NATURE, V166, P444, DOI 10.1038/166444b0; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; VAMECQ J, 1992, J BIOCHEM, V111, P579, DOI 10.1093/oxfordjournals.jbchem.a123800; VAMECQ J, 1990, BIOCHEM CELL BIOL, V68, P846, DOI 10.1139/o90-125; Varki A, 2001, BIOCHIMIE, V83, P615, DOI 10.1016/S0300-9084(01)01309-8; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Watanabe M, 2006, HISTOL HISTOPATHOL, V21, P1135, DOI 10.14670/HH-21.1135; WAZER DE, 1995, P NATL ACAD SCI USA, V92, P3687, DOI 10.1073/pnas.92.9.3687; Weidanz JA, 1996, BRIT J HAEMATOL, V95, P645, DOI 10.1046/j.1365-2141.1996.d01-1955.x; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; Willett W C, 2000, Oncologist, V5, P393, DOI 10.1634/theoncologist.5-5-393; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Yamada-Okabe T, 2001, EUR J BIOCHEM, V268, P2498, DOI 10.1046/j.1432-1327.2001.02135.x; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; Zhang JJ, 2005, NUTR CANCER, V53, P65, DOI 10.1207/s15327914nc5301_8	90	52	67	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28865	28881		10.1074/jbc.M112.363549	http://dx.doi.org/10.1074/jbc.M112.363549			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692205	Green Published, hybrid			2022-12-28	WOS:000308074600058
J	Lo, YH; Ho, PC; Wang, SC				Lo, Yuan-Hung; Ho, Po-Chun; Wang, Shao-Chun			Epidermal Growth Factor Receptor Protects Proliferating Cell Nuclear Antigen from Cullin 4A Protein-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUL4-DDB1 UBIQUITIN LIGASE; DNA-DAMAGE; CDT1 DEGRADATION; TYROSINE PHOSPHORYLATION; MAMMALIAN-CELLS; S-PHASE; PCNA; REPLICATION; DESTRUCTION; COMPLEX	Proliferating cell nuclear antigen (PCNA) is an essential component for DNA synthesis upon growth stimulation. It has been shown that phosphorylation of PCNA at Tyr-211 by the EGF receptor (EGFR) protects PCNA from polyubiquitylation and degradation, whereas blocking phosphorylation induces ubiquitylation-mediated degradation of the chromatin-bound, but not the -unbound, PCNA, and suppresses cell proliferation. However, the ubiquitin E3 ligase linking growth signaling to the proteolysis of PCNA and the underlying regulatory mechanism remain to be identified. Here we show that, in the absence of Tyr-211 phosphorylation, PCNA is subject to polyubiquitylation at Lys-164 by the CUL4A E3 ligase, resulting in the degradation of PCNA. Mutation of Lys-164 to arginine prevents PCNA ubiquitylation and rescues the degradation of the K164R/Y211F PCNA double mutant. Activation of EGFR inhibits the interaction of PCNA with CUL4A, whereas inhibition of EGFR leads to increased CUL4A-PCNA interaction and CUL4A-dependent ubiquitin-mediated degradation of PCNA. Substitution of endogenous PCNA with the Y211F mutant PCNA conveys enhanced sensitization to EGFR inhibition. Our findings identify CUL4A as the ubiquitin ligase linking the down-regulation of cell surface receptor tyrosine kinase to the nuclear DNA replication machinery in cancer cells.	[Lo, Yuan-Hung; Ho, Po-Chun; Wang, Shao-Chun] Univ Cincinnati, Dept Canc & Cell Biol, Coll Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Wang, SC (corresponding author), Univ Cincinnati, Dept Canc & Cell Biol, Coll Med, 3125 Eden Ave, Cincinnati, OH 45267 USA.	shao-chun.wang@uc.edu	Wang, Shao-Chun/P-9904-2019	Wang, Shao-Chun/0000-0002-5477-1682	Susan G. Komen Research Award [KG080540]; Department of Defense Prostate Cancer Research Award [PC073951]; Marlene Harris-Ride Cincinnati pilot grant; University of Cincinnati; Cincinnati Children's Hospital Medical Center for Clinical and Translational Science and Training (CCTST) Junior Investigator pilot grant; Public Health Service Grant [P30 DK078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Susan G. Komen Research Award(Susan G. Komen Breast Cancer Foundation); Department of Defense Prostate Cancer Research Award(United States Department of Defense); Marlene Harris-Ride Cincinnati pilot grant; University of Cincinnati; Cincinnati Children's Hospital Medical Center for Clinical and Translational Science and Training (CCTST) Junior Investigator pilot grant; Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Susan G. Komen Research Award KG080540, the Department of Defense Prostate Cancer Research Award PC073951, the Marlene Harris-Ride Cincinnati pilot grant, the University of Cincinnati and Cincinnati Children's Hospital Medical Center for Clinical and Translational Science and Training (CCTST) Junior Investigator pilot grant (to S.-C. W.), and Public Health Service Grant P30 DK078392.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Dai QA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-14; Das-Bradoo S, 2010, NAT CELL BIOL, V12, P74, DOI 10.1038/ncb2007; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Martineau M, 2008, GLIA, V56, P1271, DOI 10.1002/glia.20696; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Sugasawa K, 2009, MOL CELL, V34, P403, DOI 10.1016/j.molcel.2009.05.009; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	42	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27148	27157		10.1074/jbc.M112.388843	http://dx.doi.org/10.1074/jbc.M112.388843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22692198	Green Published, hybrid			2022-12-28	WOS:000307386000067
J	Takeo, K; Watanabe, N; Tomita, T; Iwatsubo, T				Takeo, Koji; Watanabe, Naoto; Tomita, Taisuke; Iwatsubo, Takeshi			Contribution of the gamma-Secretase Subunits to the Formation of Catalytic Pore of Presenilin 1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN 1; C-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PAL MOTIF; COMPLEX; ACTIVATION; BINDING; ENDOPROTEOLYSIS	gamma-Secretase is an intramembrane-cleaving protease related to the etiology of Alzheimer disease. gamma-Secretase is a membrane protein complex composed of presenilin (PS) and three indispensable subunits: nicastrin, Aph-1, and Pen-2. PS functions as a protease subunit forming a hydrophilic catalytic pore structure within the lipid bilayer. However, it remains unclear how other subunits are involved in the pore formation. Here, we show that the hydrophilic pore adopted with an open conformation has already been formed by PS within the immature gamma-secretase complex. The binding of the subunits induces the close proximity between transmembrane domains facing the catalytic pore. We propose a model in which the gamma-secretase subunits restrict the arrangement of the transmembrane domains of PS during the formation of the functional structure of the catalytic pore.	[Tomita, Taisuke] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo 1130033, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Tomita, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	Japan Society for the Promotion of Science (JSPS); Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST); Core Research for Evolutional Science and Technology of JST; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24659028, 24111511] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST); Core Research for Evolutional Science and Technology of JST; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for young scientists (S) (to T. T.) from the Japan Society for the Promotion of Science (JSPS), by the Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST) (to T. T. and T. I.), by Core Research for Evolutional Science and Technology of JST (to T. T. and T. I.), and by the Strategic Research Program for Brain Sciences "Analysis of the molecular basis of brain aging and degeneration due to failure in metabolic homeostasis and environmental stress" by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Wang KW, 2008, NEUROCHEM RES, V33, P1964, DOI 10.1007/s11064-008-9705-x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Watanabe N, 2010, J BIOL CHEM, V285, P19738, DOI 10.1074/jbc.M110.101287	51	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25834	25843		10.1074/jbc.M111.336347	http://dx.doi.org/10.1074/jbc.M111.336347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689582	hybrid, Green Published			2022-12-28	WOS:000306916300013
J	Hyodo, T; Ito, S; Hasegawa, H; Asano, E; Maeda, M; Urano, T; Takahashi, M; Hamaguchi, M; Senga, T				Hyodo, Toshinori; Ito, Satoko; Hasegawa, Hitoki; Asano, Eri; Maeda, Masao; Urano, Takeshi; Takahashi, Masahide; Hamaguchi, Michinari; Senga, Takeshi			Misshapen-like kinase 1 (MINK1) Is a Novel Component of Striatin-interacting Phosphatase and Kinase (STRIPAK) and Is Required for the Completion of Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20 KINASE; PROTEIN PHOSPHATASES; DENDRITIC SPINES; EPITHELIAL-CELLS; MITOTIC EXIT; FAMILY; PHOSPHORYLATION; DROSOPHILA; 2A; ABSCISSION	Cytokinesis is initiated by constriction of the cleavage furrow and terminated by abscission of the intercellular bridge that connects two separating daughter cells. The complicated processes of cytokinesis are coordinated by phosphorylation and dephosphorylation mediated by protein kinases and phosphatases. Mammalian Misshapen-like kinase 1 (MINK1) is a member of the germinal center kinases and is known to regulate cytoskeletal organization and oncogene-induced cell senescence. To search for novel regulators of cytokinesis, we performed a screen using a library of siRNAs and found that MINK1 was essential for cytokinesis. Time-lapse analysis revealed that MINK1-depleted cells were able to initiate furrowing but that abscission was disrupted. STRN4 (Zinedin) is a regulatory subunit of protein phosphatase 2A (PP2A) and was recently shown to be a component of a novel protein complex called striatin-interacting phosphatase and kinase (STRIPAK). Mass spectrometry analysis showed that MINK1 was a component of STRIPAK and that MINK1 directly interacted with STRN4. Similar to MINK1 depletion, STRN4-knockdown induced multinucleated cells and inhibited the completion of abscission. In addition, STRN4 reduced MINK1 activity in the presence of catalytic and structural subunits of PP2A. Our study identifies a novel regulatory network of protein kinases and phosphatases that regulate the completion of abscission.	[Hyodo, Toshinori; Ito, Satoko; Hasegawa, Hitoki; Asano, Eri; Maeda, Masao; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Div Canc Biol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Takahashi, Masahide] Nagoya Univ, Dept Pathol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Urano, Takeshi] Shimane Univ, Dept Biochem, Sch Med, Matsue, Shimane 6938501, Japan	Nagoya University; Nagoya University; Shimane University	Senga, T (corresponding author), 65 Tsurumai Cho,Showa Ku, Nagoya, Aichi 4668550, Japan.	tsenga@med.nagoya-u.ac.jp	TAKAHASHI, Masahide/I-7244-2014; Takahashi, Masahide/AAN-4770-2020; MAEDA, Masao/P-2709-2015	Takahashi, Masahide/0000-0002-2803-2683; Maeda, Masao/0000-0001-5936-5790; Hyodo, Toshinori/0000-0003-3046-5338	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22570182] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; Cobreros-Reguera L, 2010, EMBO REP, V11, P943, DOI 10.1038/embor.2010.156; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Daulat AM, 2012, MOL CELL BIOL, V32, P173, DOI 10.1128/MCB.06320-11; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gaillard S, 2006, TRAFFIC, V7, P74, DOI 10.1111/j.1600-0854.2005.00363.x; Gaillard S, 2001, FEBS LETT, V508, P49, DOI 10.1016/S0014-5793(01)03020-4; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kaneko S, 2011, P NATL ACAD SCI USA, V108, P11127, DOI 10.1073/pnas.1104128108; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Nonaka H, 2008, BIOCHEM BIOPH RES CO, V377, P573, DOI 10.1016/j.bbrc.2008.10.038; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Ruan WJ, 2002, NEURON, V36, P831, DOI 10.1016/S0896-6273(02)01027-9; Salaun P, 2008, ADV EXP MED BIOL, V617, P41; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Su YC, 2000, MOL CELL BIOL, V20, P4736, DOI 10.1128/MCB.20.13.4736-4744.2000; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149	43	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25019	25029		10.1074/jbc.M112.372342	http://dx.doi.org/10.1074/jbc.M112.372342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665485	Green Published, hybrid			2022-12-28	WOS:000306651700015
J	Chichili, GR; Cail, RC; Rodgers, W				Chichili, Gurunadh R.; Cail, Robert C.; Rodgers, William			Cytoskeletal Modulation of Lipid Interactions Regulates Lck Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CELL ANTIGEN RECEPTOR; ENRICHED MEMBRANE DOMAINS; TYROSINE PROTEIN-KINASE; GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN CYTOSKELETON; LIVE CELLS; 2-PHOTON MICROSCOPY	The actin cytoskeleton promotes clustering of proteins associated with cholesterol-dependent rafts, but its effect on lipid interactions that form and maintain rafts is not understood. We addressed this question by determining the effect of disrupting the cytoskeleton on co-clustering of dihexadecyl-(C-16)-anchored DiO and DiI, which co-enrich in ordered lipid environments such as rafts. Co-clustering was assayed by fluorescence resonance energy transfer (FRET) in labeled T cells, where rafts function in the phosphoregulation of the Src family kinase Lck. Our results show that probe co-clustering was sensitive to depolymerization of actin filaments with latrunculin B (Lat B), inhibition of myosin II with blebbistatin, and treatment with neomycin to sequester phosphatidylinositol 4,5-bisphosphate. Cytoskeletal effects on lipid interactions were not restricted to order-preferring label because co-clustering of C-16-anchored DiO with didodecyl (C-12)-anchored DiI, which favors disordered lipids, was also reduced by Lat B and blebbistatin. Furthermore, conditions that disrupted probe co-clustering resulted in activation of Lck. These data show that the cytoskeleton globally modulates lipid interactions in the plasma membrane, and this property maintains rafts that function in Lck regulation.	[Chichili, Gurunadh R.; Cail, Robert C.; Rodgers, William] Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Dept Microbiol & Immunol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rodgers, W (corresponding author), Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, Cardiovasc Biol Res Program, 825 NE 13th St,MS 45, Oklahoma City, OK 73104 USA.	william-rodgers@omrf.org			Oklahoma Center for the Advancement of Science and Technology [HR08-084, HR11-42]	Oklahoma Center for the Advancement of Science and Technology	This work was supported by Oklahoma Center for the Advancement of Science and Technology Grants HR08-084 and HR11-42 (to W. R.).	Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Chichili GR, 2010, J BIOL CHEM, V285, P14737, DOI 10.1074/jbc.M109.097311; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gordy C, 2004, J IMMUNOL, V172, P2030, DOI 10.4049/jimmunol.172.4.2030; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Johnson CM, 2008, J BIOL CHEM, V283, P29920, DOI 10.1074/jbc.M805921200; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KLAUSNER RD, 1980, BIOCHEMISTRY-US, V19, P6199, DOI 10.1021/bi00567a039; KORETZKY GA, 1992, J IMMUNOL, V149, P1138; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; MCCONNELL HM, 1984, P NATL ACAD SCI USA, V81, P3249, DOI 10.1073/pnas.81.10.3249; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; Sengupta P, 2007, BIOPHYS J, V92, P3564, DOI 10.1529/biophysj.106.094730; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Trichet L, 2007, BIOPHYS J, V92, P1081, DOI 10.1529/biophysj.106.091884; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Veatch Sarah L., 2007, V398, P59, DOI 10.1007/978-1-59745-513-8_6; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	54	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24186	24194		10.1074/jbc.M111.320747	http://dx.doi.org/10.1074/jbc.M111.320747			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613726	hybrid, Green Published			2022-12-28	WOS:000306651100013
J	Montserrat, N; Ramirez-Bajo, MJ; Xia, Y; Sancho-Martinez, I; Moya-Rull, D; Miquel-Serra, L; Yang, SL; Nivet, E; Cortina, C; Gonzalez, F; Belmonte, JCI; Campistol, JM				Montserrat, Nuria; Jose Ramirez-Bajo, Maria; Xia, Yun; Sancho-Martinez, Ignacio; Moya-Rull, Daniel; Miquel-Serra, Laia; Yang, Shenglian; Nivet, Emmanuel; Cortina, Carme; Gonzalez, Federico; Izpisua Belmonte, Juan Carlos; Campistol, Josep M.			Generation of Induced Pluripotent Stem Cells from Human Renal Proximal Tubular Cells with Only Two Transcription Factors, Oct4 and Sox2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; EPIGENETIC MEMORY; DISTAL TUBULE; EFFICIENT; MOUSE; DIFFERENTIATION	The tubular epithelium of the kidney is susceptible to injury from a number of different causes, including inflammatory and immune disorders, oxidative stress, and nephrotoxins, among others. Primary renal epithelial cells remain one of the few tools for studying the biochemical and physiological characteristics of the renal tubular system. Nevertheless, differentiated primary cells are not suitable for recapitulation of disease properties that might arise during embryonic kidney formation and further maturation. Thus, cellular systems resembling kidney characteristics are in urgent need to model disease as well as to establish reliable drug-testing platforms. Induced pluripotent stem cells (iPSCs) bear the capacity to differentiate into every cell lineage comprising the adult organism. Thus, iPSCs bring the possibility for recapitulating embryonic development by directed differentiation into specific lineages. iPSC differentiation ultimately allows for both disease modeling in vitro and the production of cellular products with potential for regenerative medicine. Here, we describe the rapid, reproducible, and highly efficient generation of iPSCs derived from endogenous kidney tubular renal epithelial cells with only two transcriptional factors, OCT4 and SOX2. Kidney-derived iPSCs may provide a reliable cellular platform for the development of kidney differentiation protocols allowing drug discovery studies and the study of kidney pathology.	[Xia, Yun; Sancho-Martinez, Ignacio; Yang, Shenglian; Nivet, Emmanuel; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Montserrat, Nuria; Miquel-Serra, Laia; Cortina, Carme; Gonzalez, Federico; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Jose Ramirez-Bajo, Maria; Moya-Rull, Daniel; Campistol, Josep M.] Hosp Clin Barcelona, Dept Nephrol & Renal Transplantat, E-08036 Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu; jmcampis@clinic.ub.es	Montserrat, Nuria/F-3136-2016; Cortina Duran, Carme/K-7203-2017; Xia, Yun/K-4128-2015; Nivet, Emmanuel/C-2729-2014	Montserrat, Nuria/0000-0002-1603-1755; Cortina Duran, Carme/0000-0003-3477-4322; Xia, Yun/0000-0003-2184-4870; Nivet, Emmanuel/0000-0001-7903-4059; ramirez-bajo, maria jose/0000-0003-0119-1331; Miquel Serra, Laia/0000-0001-8382-3341; Gonzalez Grassi, Federico/0000-0002-7147-2246; Josep M, Campistol/0000-0001-6244-0253; Sancho-Martinez, Ignacio/0000-0003-4348-1038; Moya Rull, Daniel/0000-0002-3555-6477	Ministerio de Economia y Competitividad; Fondo de Investigaciones Sanitarias [TERCEL, PI052847]; Fundacion Cellex; Sanofi; Leona M. and Harry B. Helmsley Charitable Trust; Harold and Leila Y. Mathers Charitable Foundation; Ministerio de Ciencia e Innovacion; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Cellex(Foundation CELLEX); Sanofi; Leona M. and Harry B. Helmsley Charitable Trust; Harold and Leila Y. Mathers Charitable Foundation; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from Ministerio de Economia y Competitividad, Fondo de Investigaciones Sanitarias Grants TERCEL and PI052847, Fundacion Cellex, Sanofi, The Leona M. and Harry B. Helmsley Charitable Trust, and the G. Harold and Leila Y. Mathers Charitable Foundation (to the J. C. I. B. laboratory).; Supported in part by "Juan de la Cierva Project" from Ministerio de Ciencia e Innovacion.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Baer PC, 2008, NEPHROLOGY, V13, P316, DOI 10.1111/j.1440-1797.2008.00927.x; Baer PC, 1997, KIDNEY INT, V52, P1321, DOI 10.1038/ki.1997.457; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Sullivan GJ, 2010, MOL HUM REPROD, V16, P880, DOI 10.1093/molehr/gaq091; Sun N, 2010, CELL CYCLE, V9, P880, DOI 10.4161/cc.9.5.10827; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	28	45	47	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24131	24138		10.1074/jbc.M112.350413	http://dx.doi.org/10.1074/jbc.M112.350413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613719	Green Published, hybrid			2022-12-28	WOS:000306651100008
J	van der Veen, JN; Lingrell, S; Vance, DE				van der Veen, Jelske N.; Lingrell, Susanne; Vance, Dennis E.			The Membrane Lipid Phosphatidylcholine Is an Unexpected Source of Triacylglycerol in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PLASMA HIGH-DENSITY; REVERSE CHOLESTEROL TRANSPORT; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; B TYPE-I; TANGIER-DISEASE; DEFICIENT MICE; HEART-DISEASE; HEPATIC CTP	The increased prevalence of obesity and diabetes in human populations can induce the deposition of fat (triacylglycerol) in the liver (steatosis). The current view is that most hepatic triacylglycerols are derived from fatty acids released from adipose tissue. In this study, we show that phosphatidylcholine (PC), an important structural component of cell membranes and plasma lipoproteins, can be a precursor of similar to 65% of the triacylglycerols in liver. Mice were injected with [H-3]PC-labeled high density lipoproteins (HDLs). Hepatic uptake of HDL-PC was similar to 10 mu mol/day, similar to the rate of hepatic de novo PC synthesis. Consistent with this finding, measurement of the specific radioactivity of PC in plasma and liver indicated that 50% of hepatic PC is derived from the circulation. Moreover, one-third of HDL-derived PC was converted into triacylglycerols. Importantly, similar to 65% of the total hepatic pool of triacylglycerol appears to be derived from hepatic PC, half of which is derived from HDL. Thus, lipoprotein-associated PC should be considered a quantitatively significant source of triacylglycerol for the etiology of hepatic steatosis.	[Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca			Canadian Institutes of Health Research [MOP 89793]; Alberta Innovates-Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions	This work was supported in part by Canadian Institutes of Health Research Grant MOP 89793.; Supported by a postdoctoral fellowship from Alberta Innovates-Health Solutions.	Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; FIELDING CJ, 1995, J LIPID RES, V36, P211; Glomset J A, 1980, Adv Intern Med, V25, P91; Jacobs RL, 2008, J BIOL CHEM, V283, P2147, DOI 10.1074/jbc.M706628200; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Mardones P, 2001, J LIPID RES, V42, P170; Minahk C, 2008, J BIOL CHEM, V283, P6449, DOI 10.1074/jbc.M706995200; Nofer JR, 2002, ATHEROSCLEROSIS, V161, P1, DOI 10.1016/S0021-9150(01)00651-7; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Oram JF, 1996, J LIPID RES, V37, P2473; PORTAL I, 1993, AM J PHYSIOL, V264, pG1052, DOI 10.1152/ajpgi.1993.264.6.G1052; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Robichaud JC, 2009, BBA-GEN SUBJECTS, V1790, P538, DOI 10.1016/j.bbagen.2009.02.010; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2006, CIRCULATION, V114, P1301, DOI 10.1161/CIRCULATIONAHA.106.621433; Singaraja RR, 2006, ARTERIOSCL THROM VAS, V26, P1821, DOI 10.1161/01.ATV.0000229219.13757.a2; Tang W, 1997, J BIOL CHEM, V272, P13146, DOI 10.1074/jbc.272.20.13146; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Trigatti B, 2004, BIOCHEM SOC T, V32, P116, DOI 10.1042/BST0320116; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wiersma H, 2010, J LIPID RES, V51, P544, DOI 10.1194/jlr.M000844; Wiggins D, 1996, BIOCHEM J, V320, P673, DOI 10.1042/bj3200673; YAO ZM, 1988, J BIOL CHEM, V263, P2998; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; ZHOU X, 1992, J LIPID RES, V33, P1233	41	43	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23418	23426		10.1074/jbc.M112.381723	http://dx.doi.org/10.1074/jbc.M112.381723			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610093	hybrid, Green Published			2022-12-28	WOS:000306511300014
J	Amici, SA; McKay, SB; Wells, GB; Robson, JI; Nasir, M; Ponath, G; Anand, R				Amici, Stephanie A.; McKay, Susan B.; Wells, Gregg B.; Robson, Jordan I.; Nasir, Muhammad; Ponath, Gerald; Anand, Rene			A Highly Conserved Cytoplasmic Cysteine Residue in the alpha 4 Nicotinic Acetylcholine Receptor Is Palmitoylated and Regulates Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC-TRANSMISSION; TRAFFICKING; SUBUNIT; INHIBITION; ACTIVATION; PSD-95; SITES	Nicotinic acetylcholine receptor (nAChR) cell surface expression levels are modulated during nicotine dependence and multiple disorders of the nervous system, but the mechanisms underlying nAChR trafficking remain unclear. To determine the role of cysteine residues, including their palmitoylation, on neuronal alpha 4 nAChR subunit maturation and cell surface trafficking, the cysteines in the two intracellular regions of the receptor were replaced with serines using site-directed mutagenesis. Palmitoylation is a post-translational modification that regulates membrane receptor trafficking and function. Metabolic labeling with [H-3] palmitate determined that the cysteine in the cytoplasmic loop between transmembrane domains 1 and 2 (M1-M2) is palmitoylated. When this cysteine is mutated to a serine, producing a depalmitoylated alpha 4 nAChR, total protein expression decreases, but surface expression increases compared with wild-type alpha 4 levels, as determined by Western blotting and enzyme-linked immunoassays, respectively. The cysteines in the M3-M4 cytoplasmic loop do not appear to be palmitoylated, but replacing all of the cysteines in the loop with serines increases total and cell surface expression. When all of the intracellular cysteines in both loops are mutated to serines, there is no change in total expression, but there is an increase in surface expression. Calcium accumulation assays and high affinity binding for [3H] epibatidine determined that all mutants retain functional activity. Thus, our results identify a novel palmitoylation site on cysteine 273 in the M1-M2 loop of the alpha 4 nAChR and determine that cysteines in both intracellular loops are regulatory factors in total and cell surface protein expression of the alpha 4 beta 2 nAChR.	[Amici, Stephanie A.; McKay, Susan B.; Robson, Jordan I.; Nasir, Muhammad; Ponath, Gerald; Anand, Rene] Ohio State Univ, Dept Pharmacol, Coll Med, Columbus, OH 43210 USA; [Anand, Rene] Ohio State Univ, Dept Neurosci, Coll Med, Columbus, OH 43210 USA; [Wells, Gregg B.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Anand, R (corresponding author), Ohio State Univ, Dept Pharmacol, Coll Med, 460 W 12th Ave,Rm 796, Columbus, OH 43210 USA.	Rene.Anand@osumc.edu	Wells, Gregg/AAU-7798-2021		National Institutes of Health from the National Institute on Drug Abuse [RO1 DA019675]; Ohio State University College of Medicine; National Institute on Drug Abuse [F32 DA026240]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019675, F32DA026240] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Drug Abuse; Ohio State University College of Medicine(Ohio State University); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grant RO1 DA019675 (to R. A.) from the National Institute on Drug Abuse and the Ohio State University College of Medicine Medical Research Fund.; Recipient of Ruth Kirschstein National Research Service Award F32 DA026240 from the National Institute on Drug Abuse.	Alexander JK, 2010, J MOL NEUROSCI, V40, P12, DOI 10.1007/s12031-009-9246-z; Buisson B, 2000, NEUROPHARMACOLOGY, V39, P2561, DOI 10.1016/S0028-3908(00)00158-1; Campanucci V, 2010, NEURON, V66, P827, DOI 10.1016/j.neuron.2010.06.010; Campanucci VA, 2008, J NEUROSCI, V28, P1733, DOI 10.1523/JNEUROSCI.5130-07.2008; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; HESS DT, 1992, J NEUROSCI, V12, P4634; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Krishnaswamy A, 2012, J PHYSIOL-LONDON, V590, P39, DOI 10.1113/jphysiol.2011.214007; Marks MJ, 1998, J PHARMACOL EXP THER, V285, P377; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; OLSON EN, 1984, J BIOL CHEM, V259, P5364; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006	27	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23119	23127		10.1074/jbc.M111.328294	http://dx.doi.org/10.1074/jbc.M111.328294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593584	Green Published, hybrid			2022-12-28	WOS:000306495000067
J	Camara, D; Bisanz, C; Barette, C; Van Daele, J; Human, E; Barnard, B; Van Der Straeten, D; Stove, CP; Lambert, WE; Douce, R; Marechal, E; Birkholtz, LM; Cesbron-Delauw, MF; Dumas, R; Rebeille, F				Camara, Djeneb; Bisanz, Cordelia; Barette, Caroline; Van Daele, Jeroen; Human, Esmare; Barnard, Bernice; Van Der Straeten, Dominique; Stove, Christophe P.; Lambert, Willy E.; Douce, Roland; Marechal, Eric; Birkholtz, Lyn-Marie; Cesbron-Delauw, Marie-France; Dumas, Renaud; Rebeille, Fabrice			Inhibition of p-Aminobenzoate and Folate Syntheses in Plants and Apicomplexan Parasites by Natural Product Rubreserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO SYNTHESIS; ANTHRANILATE SYNTHASE; TOXOPLASMA-GONDII; 4-AMINO-4-DEOXYCHORISMATE SYNTHASE; AMINODEOXYCHORISMATE SYNTHASE; ISOCHORISMATE SYNTHASE; PLASMODIUM-FALCIPARUM; GLUCOSE ESTER; METABOLISM; BIOSYNTHESIS	Glutamine amidotransferase/aminodeoxychorismate synthase (GAT-ADCS) is a bifunctional enzyme involved in the synthesis of p-aminobenzoate, a central component part of folate cofactors. GAT-ADCS is found in eukaryotic organisms autonomous for folate biosynthesis, such as plants or parasites of the phylum Apicomplexa. Based on an automated screening to search for new inhibitors of folate biosynthesis, we found that rubreserine was able to inhibit the glutamine amidotransferase activity of the plant GAT-ADCS with an apparent IC50 of about 8 mu M. The growth rates of Arabidopsis thaliana, Toxoplasma gondii, and Plasmodium falciparum were inhibited by rubreserine with respective IC50 values of 65, 20, and 1 mu M. The correlation between folate biosynthesis and growth inhibition was studied with Arabidopsis and Toxoplasma. In both organisms, the folate content was decreased by 40-50% in the presence of rubreserine. In both organisms, the addition of p-aminobenzoate or 5-formyltetrahydrofolate in the external medium restored the growth for inhibitor concentrations up to the IC50 value, indicating that, within this range of concentrations, rubreserine was specific for folate biosynthesis. Rubreserine appeared to be more efficient than sulfonamides, antifolate drugs known to inhibit the invasion and proliferation of T. gondii in human fibroblasts. Altogether, these results validate the use of the bifunctional GAT-ADCS as an efficient drug target in eukaryotic cells and indicate that the chemical structure of rubreserine presents interesting anti-parasitic (toxoplasmosis, malaria) potential.	[Rebeille, Fabrice] Univ Grenoble 1, PCV iRTSV,Inst Rech Technol & Sci Vivant, CEA Grenoble,CNRS UMR5168,INRA USC1200, Lab Physiol Cellulaire Vegetale,Commissariat Ener, F-38054 Grenoble, France; [Bisanz, Cordelia; Cesbron-Delauw, Marie-France] Univ Grenoble 1, CNRS UMR 5163, Lab Adaptat & Pathogenie Microorganismes, Inst Jean Roget, F-38042 Grenoble, France; [Barette, Caroline] Commissariat Energie Atom Grenoble, Inst Rech Technol & Sci Vivant, Ctr Criblage Mol Bioact, F-38054 Grenoble, France; [Van Daele, Jeroen; Stove, Christophe P.; Lambert, Willy E.] Univ Ghent, Toxicol Lab, B-9000 Ghent, Belgium; [Human, Esmare; Barnard, Bernice; Birkholtz, Lyn-Marie] Univ Pretoria, Dept Biochem, Malaria Res Grp, ZA-0028 Pretoria, South Africa; [Van Der Straeten, Dominique] Univ Ghent, Lab Funct Plant Biol, Dept Physiol, B-9000 Ghent, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Ghent University; University of Pretoria; Ghent University	Rebeille, F (corresponding author), Univ Grenoble 1, PCV iRTSV,Inst Rech Technol & Sci Vivant, CEA Grenoble,CNRS UMR5168,INRA USC1200, Lab Physiol Cellulaire Vegetale,Commissariat Ener, 17 Ave Martyrs, F-38054 Grenoble, France.	frebeille@cea.fr	Stove, Christophe/B-6057-2008; Bisanz, Cordelia/M-6063-2014; Birkholtz, Lyn-Marie/AAF-8481-2019; Dumas, Renaud/E-1835-2011; Van Der Straeten, Dominique/E-7385-2016; Birkholtz, Lyn-Marie/E-2939-2010; cesbron delauw, marie france/M-6076-2014	Stove, Christophe/0000-0001-7126-348X; Birkholtz, Lyn-Marie/0000-0001-5888-2905; Van Der Straeten, Dominique/0000-0002-7755-1420; Birkholtz, Lyn-Marie/0000-0001-5888-2905; BARETTE, Caroline/0000-0003-0999-7751	Region Rhone-Alpes; Ghent University [BOF09-GOA-004]; Agence Nationale de la Recherche PlasmoExpress grant	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Ghent University(Ghent University); Agence Nationale de la Recherche PlasmoExpress grant(French National Research Agency (ANR))	This work was supported in part the Region Rhone-Alpes (Cluster 9, "Plantacter").; Supported by Ghent University Grant BOF09-GOA-004.; Supported by an Agence Nationale de la Recherche PlasmoExpress grant.	Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Basset GJC, 2004, P NATL ACAD SCI USA, V101, P1496, DOI 10.1073/pnas.0308331100; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Bertino JR, 2009, BEST PRACT RES CL HA, V22, P577, DOI 10.1016/j.beha.2009.09.004; Bhat JY, 2008, BIOCHEM J, V409, P263, DOI 10.1042/BJ20070996; Bisanz C, 2006, BIOCHEM J, V394, P197, DOI 10.1042/BJ20050609; Blancquaert D, 2010, CRIT REV PLANT SCI, V29, P14, DOI 10.1080/07352680903436283; Bulloch EMM, 2004, J AM CHEM SOC, V126, P9912, DOI 10.1021/ja048312f; Camara D, 2011, ARCH BIOCHEM BIOPHYS, V505, P83, DOI 10.1016/j.abb.2010.09.010; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; De Brouwer V, 2010, J CHROMATOGR B, V878, P509, DOI 10.1016/j.jchromb.2009.12.032; de La Garza RID, 2007, P NATL ACAD SCI USA, V104, P4218, DOI 10.1073/pnas.0700409104; Dixon S, 2006, J MED CHEM, V49, P7413, DOI 10.1021/jm0609869; Ellis S, 1943, J PHARMACOL EXP THER, V79, P309; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Hyde JE, 2005, ACTA TROP, V94, P191, DOI 10.1016/j.actatropica.2005.04.002; Kaur K, 2009, BIOORGAN MED CHEM, V17, P3229, DOI 10.1016/j.bmc.2009.02.050; Keller S, 2007, ANGEW CHEM INT EDIT, V46, P8284, DOI 10.1002/anie.200701836; Kerbarh O, 2005, BIOCHEM SOC T, V33, P763, DOI 10.1042/BST0330763; KOZLOWSKI MC, 1995, J AM CHEM SOC, V117, P2128, DOI 10.1021/ja00113a002; Loizeau K, 2008, PLANT PHYSIOL, V148, P2083, DOI 10.1104/pp.108.130336; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Meneceur P, 2008, ANTIMICROB AGENTS CH, V52, P1269, DOI 10.1128/AAC.01203-07; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAMURA J, 1995, J BIOL CHEM, V270, P23450, DOI 10.1074/jbc.270.40.23450; Nzila A, 2005, TRENDS PARASITOL, V21, P334, DOI 10.1016/j.pt.2005.05.008; Nzila A, 2006, DRUG DISCOV TODAY, V11, P939, DOI 10.1016/j.drudis.2006.08.003; Orsomando G, 2006, PLANT J, V46, P426, DOI 10.1111/j.1365-313X.2006.02685.x; Payne RJ, 2010, ORG BIOMOL CHEM, V8, P3534, DOI 10.1039/c004062b; Payne RJ, 2009, ORG BIOMOL CHEM, V7, P2421, DOI 10.1039/b901694e; Poobrasert O, 1996, J NAT PROD, V59, P1087, DOI 10.1021/np960518+; Quinlivan EP, 2003, J BIOL CHEM, V278, P20731, DOI 10.1074/jbc.M302894200; Rattanachuen W, 2009, MOL BIOCHEM PARASIT, V168, P135, DOI 10.1016/j.molbiopara.2009.07.005; Ravanel S, 2011, ADV BOT RES, V59, P67, DOI 10.1016/B978-0-12-385853-5.00004-0; Rebeille F, 2006, PHYSIOL PLANTARUM, V126, P330, DOI 10.1111/j.1399-3054.2006.00587.x; Rebeille F, 2007, PHOTOSYNTH RES, V92, P149, DOI 10.1007/s11120-007-9167-z; Riedlinger J, 2004, J ANTIBIOT, V57, P271, DOI 10.7164/antibiotics.57.271; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; ROBINSON B, 1965, J PHARM PHARMACOL, V17, P89, DOI 10.1111/j.2042-7158.1965.tb07619.x; ROUX B, 1992, BIOCHEMISTRY-US, V31, P6904, DOI 10.1021/bi00145a006; Sahr T, 2006, BIOCHEM J, V396, P157, DOI 10.1042/BJ20051851; Salcedo-Sora JE, 2011, J BIOL CHEM, V286, P44659, DOI 10.1074/jbc.M111.286054; Schroder M, 2005, PLANT PHYSIOL, V138, P1926, DOI 10.1104/pp.105.063693; Segel I.H., 1975, ENZYME KINETICS; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; Siehl DL, 1999, BOOK SOIL P, P171; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Storozhenko S, 2007, NAT BIOTECHNOL, V25, P1277, DOI 10.1038/nbt1351; Wang P, 2004, MOL MICROBIOL, V51, P1425, DOI 10.1111/j.1365-2958.2003.03915.x; Wang P, 2010, MOL BIOCHEM PARASIT, V172, P41, DOI 10.1016/j.molbiopara.2010.03.012; YANG ST, 1987, J PHARMACEUT BIOMED, V5, P383, DOI 10.1016/0731-7085(87)80045-6; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203; Zhang GF, 2005, RAPID COMMUN MASS SP, V19, P963, DOI 10.1002/rcm.1878; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XH, 2001, PLANT PHYSIOL, V127, P131, DOI 10.1104/pp.127.1.131; Ziebart KT, 2010, J MED CHEM, V53, P3718, DOI 10.1021/jm100158v; Ziebart KT, 2010, BIOCHEMISTRY-US, V49, P2851, DOI 10.1021/bi100021x	58	17	17	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22367	22376		10.1074/jbc.M112.365833	http://dx.doi.org/10.1074/jbc.M112.365833			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577137	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000306418600073
J	Cerna, D; Li, HY; Flaherty, S; Takebe, N; Coleman, CN; Yoo, SS				Cerna, David; Li, Hongyun; Flaherty, Siobhan; Takebe, Naoko; Coleman, C. Norman; Yoo, Stephen S.			Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity by Small Molecule GMX1778 Regulates Reactive Oxygen Species (ROS)-mediated Cytotoxicity in a p53-and Nicotinic Acid Phosphoribosyltransferase1 (NAPRT1)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; OXIDATIVE STRESS; TUMOR-CELLS; P53; APOPTOSIS; ROS; ANTIOXIDANT; SURVIVAL; DAMAGE; ACTIVATION	Cancer cells undergo mitosis more frequently than normal cells and thus have increased metabolic needs, which in turn lead to higher than normal reactive oxygen species (ROS) production. Higher ROS production increases cancer cell dependence on ROS scavenging systems to balance the increased ROS. Selectively modulating intracellular ROS in cancers by exploiting cancer dependence on ROS scavenging systems provides a useful therapeutic approach. Essential to developing these therapeutic strategies is to maintain physiologically low ROS levels in normal tissues while inducing ROS in cancer cells. GMX1778 is a specific inhibitor of nicotinamide phosphoribosyltransferase, a rate-limiting enzyme required for the regeneration of NAD(+) from nicotinamide. We show that GMX1778 increases intracellular ROS in cancer cells by elevating the superoxide level while decreasing the intracellular NAD(+) level. Notably, GMX1778 treatment does not induce ROS in normal cells. GMX1778-induced ROS can be diminished by adding nicotinic acid (NA) in a NA phosphoribosyltransferase 1 (NAPRT1)-dependent manner, but NAPRT1 is lost in a high frequency of glioblastomas, neuroblastomas, and sarcomas. In NAPRT1-deficient cancer cells, ROS induced by GMX1778 was not susceptible to treatment with NA. GMX1778-mediated ROS induction is p53-dependent, suggesting that the status of both p53 and NAPRT1 might affect tumor apoptosis, as determined by annexin-V staining. However, as determined by colony formation, GMX1778 long term cytotoxicity in cancer cells was only prevented by the addition of NA to NAPRT1-expressing cells. Exposure to GMX1778 may be a novel way including ROS selectively in NAPRT1-negative tumors without inducing cytotoxic ROS in normal tissue.	[Cerna, David; Li, Hongyun; Flaherty, Siobhan; Yoo, Stephen S.] NIH, Mol Radiat Therapeut Branch Support, SAIC Frederick, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Takebe, Naoko] NCI, Mol Radiat Therapeut Branch, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA; [Coleman, C. Norman] NCI, Mol Radiat Therapeut Branch, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yoo, SS (corresponding author), NCI, Mol Radiat Therapeut Branch, Div Canc Treatment & Diag, 6130 Execut Blvd,Rm 6012, Rockville, MD USA.	yoosu@mail.nih.gov			National Institutes of Health Grant from NCI [HHSN261200800001E]	National Institutes of Health Grant from NCI	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN261200800001E from NCI.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Beauparlant P, 2009, ANTI-CANCER DRUG, V20, P346, DOI 10.1097/CAD.0b013e3283287c20; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Camhi S L, 1995, New Horiz, V3, P170; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chen Y, 2007, MOL INTERV, V7, P147, DOI 10.1124/mi.7.3.6; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fuchs D, 2010, INT J CANCER, V126, P2773, DOI 10.1002/ijc.25206; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; He X, 2011, HUM MOL GENET, V20, P80, DOI 10.1093/hmg/ddq434; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Kato H, 2010, CLIN CANCER RES, V16, P898, DOI 10.1158/1078-0432.CCR-09-1945; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Kuo PL, 2007, CANCER RES, V67, P7406, DOI 10.1158/0008-5472.CAN-07-1089; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meng LH, 2007, ACTA PHARMACOL SIN, V28, P1460, DOI 10.1111/j.1745-7254.2007.00698.x; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sen N, 2011, MOL CELL, V44, P621, DOI 10.1016/j.molcel.2011.08.044; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]	40	57	61	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22408	22417		10.1074/jbc.M112.357301	http://dx.doi.org/10.1074/jbc.M112.357301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570471	Green Published, hybrid			2022-12-28	WOS:000306418600077
J	Choi, JH; Choi, DK; Sohn, KC; Kwak, SS; Suk, J; Lim, JS; Shin, I; Kim, SW; Lee, JH; Joe, CO				Choi, Ji Hye; Choi, Dae-Kyoung; Sohn, Kyung-Cheol; Kwak, Sang Su; Suk, Jinkyu; Lim, Jong-Soon; Shin, Incheol; Kim, Sung-Woo; Lee, Jeung-Hoon; Joe, Cheol O.			Absence of a Human DnaJ Protein hTid-1(S) Correlates with Aberrant Actin Cytoskeleton Organization in Lesional Psoriatic Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; HYPOXIA-INDUCIBLE FACTORS; HEAT-SHOCK PROTEIN-27; NF-KAPPA-B; CELL-MIGRATION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HUMAN HOMOLOG; PHOSPHORYLATION; ACTIVATION	The biochemical mechanism by which the human tumorous imaginal disc1(S) (hTid-1(S)) interferes with actin cytoskeleton organization in keratinocytes of human skin epidermis was investigated. We found that hTid-1, specifically hTid-1(S), interacts with MK5, a p38-regulated/activated protein kinase, and inhibits the protein kinase activity of MK5 that phosphorylates heat shock protein HSP27 in cultured HeLa cells. Thus, hTid-1(S) expression inhibits the phosphorylation of HSP27 known to play important roles in F-actin polymerization and actin cytoskeleton organization. The interplay between MK5/HSP27 signaling and hTid-1(S) expression was supported by the inhibition of HSP27 phosphorylation and MK5 activity in HeLa cells in response to hypoxia during which hTid-1(S) expression was down-regulated. We also found that overexpression of hTid-1(S) results in the inhibition of HSP27 phosphorylation, F-actin polymerization, and actin cytoskeleton organization in transduced HaCaT keratinocytes. This study further proposes that the loss of hTid-1(S) expression in the basal layer of skin epidermis correlates with the enhanced HSP27 phosphorylation, keratinocyte hyperproliferation, and excess actin cytoskeleton organization in lesional psoriatic skin.	[Choi, Ji Hye; Kwak, Sang Su; Suk, Jinkyu; Joe, Cheol O.] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Choi, Dae-Kyoung; Sohn, Kyung-Cheol; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon 305764, South Korea; [Lim, Jong-Soon] Daejeon Univ, Inst Tradit Med & Biosci, Taejon 300716, South Korea; [Shin, Incheol] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Kim, Sung-Woo] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Daejeon University; Hanyang University; University of Calgary	Joe, CO (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	cojoe@kaist.ac.kr	Joe, Cheol O/C-1917-2011		National Research Foundation of Korea [2010-0011268, 2009-0085835]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants 2010-0011268 and 2009-0085835 (to C. O. J.).	Bae MK, 2005, CANCER RES, V65, P2520, DOI 10.1158/0008-5472.CAN-03-2735; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; Ferns G, 2006, INT J EXP PATHOL, V87, P253, DOI 10.1111/j.1365-2613.2006.00484.x; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Green H, 1980, Harvey Lect, V74, P101; Guay J, 1997, J CELL SCI, V110, P357; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; HUOT J, 1995, EUR J BIOCHEM, V227, P416, DOI 10.1111/j.1432-1033.1995.tb20404.x; Huot J, 1996, CANCER RES, V56, P273; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Johansen C, 2005, J INVEST DERMATOL, V124, P1284, DOI 10.1111/j.0022-202X.2005.23749.x; Johansen C, 2005, BRIT J DERMATOL, V152, P37, DOI 10.1111/J.1365-2133.2004.06304.X; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Kostenko S, 2009, CELL SIGNAL, V21, P712, DOI 10.1016/j.cellsig.2009.01.009; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; KUBLER MD, 1993, J INVEST DERMATOL, V100, P785, DOI 10.1111/1523-1747.ep12476492; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Perander M, 2008, FRONT BIOSCI-LANDMRK, V13, P4617; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Plavina T, 2008, CLIN CHEM, V54, P1805, DOI 10.1373/clinchem.2008.103770; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Tak H, 2007, CELL SIGNAL, V19, P2379, DOI 10.1016/j.cellsig.2007.07.016; Valdimarsson H, 2009, TRENDS IMMUNOL, V30, P494, DOI 10.1016/j.it.2009.07.008; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANGER L, 1978, ACTA DERM-VENEREOL, V58, P73; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001	51	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25954	25963		10.1074/jbc.M111.313809	http://dx.doi.org/10.1074/jbc.M111.313809			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692211	hybrid, Green Published			2022-12-28	WOS:000306916300023
J	Finger, JN; Lich, JD; Dare, LC; Cook, MN; Brown, KK; Duraiswami, C; Bertin, JJ; Gough, PJ				Finger, Joshua N.; Lich, John D.; Dare, Lauren C.; Cook, Michael N.; Brown, Kristin K.; Duraiswami, Chaya; Bertin, John J.; Gough, Peter J.			Autolytic Proteolysis within the Function to Find Domain (FIIND) Is Required for NLRP1 Inflammasome Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHRAX LETHAL TOXIN; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; PROTEIN ASC; FAMILY; PYRIN; GENE; ACTIVATION; APOPTOSIS; CASPASE-1	Nucleotide-binding domain leucine-rich repeat proteins (NLRs) play a key role in immunity and disease through their ability to modulate inflammation in response to pathogen-derived and endogenous danger signals. Here, we identify the requirements for activation of NLRP1, an NLR protein associated with a number of human pathologies, including vitiligo, rheumatoid arthritis, and Crohn disease. We demonstrate that NLRP1 activity is dependent upon ASC, which associates with the C-terminal CARD domain of NLRP1. In addition, we show that NLRP1 activity is dependent upon autolytic cleavage at Ser(1213) within the FIIND. Importantly, this post translational event is dependent upon the highly conserved distal residue His(1186). A disease-associated single nucleotide polymorphism near His(1186) and a naturally occurring mRNA splice variant lacking exon 14 differentially affect this autolytic processing and subsequent NLRP1 activity. These results describe key molecular pathways that regulate NLRP1 activity and offer insight on how small sequence variations in NLR genes may influence human disease pathogenesis.	[Finger, Joshua N.; Lich, John D.; Dare, Lauren C.; Cook, Michael N.; Bertin, John J.; Gough, Peter J.] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, Collegeville, PA 19426 USA; [Brown, Kristin K.; Duraiswami, Chaya] GlaxoSmithKline, Computat Chem, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline	Gough, PJ (corresponding author), GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, 1250 S Collegeville Rd, Collegeville, PA 19426 USA.	peter.j.gough@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This work was supported by GlaxoSmithKline.	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Davenport EA, 2009, METHODS MOL BIOL, V552, P199, DOI 10.1007/978-1-60327-317-6_14; Dieude P, 2011, ANN RHEUM DIS, V70, P668, DOI 10.1136/ard.2010.131243; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Hedrich CM, 2008, SCAND J RHEUMATOL, V37, P385, DOI 10.1080/03009740801978889; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Jin Y, 2010, J INVEST DERMATOL, V130, P774, DOI 10.1038/jid.2009.273; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Sui JD, 2012, ARTHRITIS RHEUM-US, V64, P647, DOI 10.1002/art.33370; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Verma D., 2012, PIGMENT CEL IN PRESS; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Zurawek M, 2010, HUM IMMUNOL, V71, P530, DOI 10.1016/j.humimm.2010.02.004	33	152	160	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25030	25037		10.1074/jbc.M112.378323	http://dx.doi.org/10.1074/jbc.M112.378323			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665479	Green Published, hybrid			2022-12-28	WOS:000306651700016
J	Fleetwood, MR; Ho, YG; Cooke, NE; Liebhaber, SA				Fleetwood, Margaret R.; Ho, Yugong; Cooke, Nancy E.; Liebhaber, Stephen A.			DNase I Hypersensitive Site II of the Human Growth Hormone Locus Control Region Mediates an Essential and Distinct Long-range Enhancer Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN LOCUS; TRANS-ACTING FACTOR; RNA-POLYMERASE-II; GENE-EXPRESSION; HGH-N; TETRACYCLINE RESISTANCE; ARTIFICIAL CHROMOSOME; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; ESCHERICHIA-COLI	Locus control regions (LCRs) comprise sets of DNA elements capable of establishing autonomous chromatin domains that support robust and physiologically appropriate expression of target genes, often working over extensive distances. Human growth hormone (hGH-N) expression in the pituitary is under the regulation of a well characterized LCR containing four DNase I hypersensitive sites (HSs). The two pituitary-specific HS, HSI and HSII, are located 14.5 and 15.5 kb 5' to the hGH-N promoter. HSI is essential for activation of hGH-N during pituitary development and for sustaining robust activity in the adult. To determine whether the closely linked HSII has a role in hGH-N expression, it was deleted from a previously validated hGH/P1 transgene. Analysis of three independent hGH/P1(Delta HSII) transgenic mouse lines revealed that this deletion had no adverse effect on the formation of HSI, yet resulted in a substantial loss (70%) in hGH-N mRNA expression. This loss of expression was accompanied by a corresponding reduction in recruitment of the pituitary-specific transcription factor Pit-1 to the hGH-N promoter and a selective decrease in promoter occupancy of the elongation-linked isoform of RNA polymerase II. Sufficiency of HSI and HSII in LCR activity was explored by establishing two additional sets of mouse transgenic lines in which DNA segments containing these HS were positioned within the lambda phage genome. In this "neutral" DNA context, HSII was required for the recruitment of HAT activity. These data establish HSII as a nonredundant component of the hGH LCR essential for establishment of robust levels of hGH-N gene expression.	Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Cooke, NE (corresponding author), Univ Penn, Sch Med, Dept Med, 547A Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	necooke@mail.med.upenn.edu		Ho, Yugong/0000-0002-7642-7700	National Institutes of Health Grants [R01HD/DK25147, R01HD/DK046737]; NIH Genetics Training Grant [T32-GM008216]; National Institutes of Health Center Grants [P30DK050306, P30DK019525, P30CA016520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD025147] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, P30DK019525, R43DK046737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Genetics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HD/DK25147 and R01HD/DK046737 (to N.E.C. and S.A.L).; Supported by NIH Genetics Training Grant T32-GM008216.; We thank Dr. Brian Shewchuk (East Carolina University, Department of Biochemistry and Molecular Biology) for the lambda phage construct. We are grateful to the Transgenic and Chimeric Mouse Core of the University of Pennsylvania for generation of all transgenic lines (supported by National Institutes of Health Center Grants P30DK050306, P30DK019525, and P30CA016520).	Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; Bennani-Baiti IM, 1998, GENOMICS, V48, P258, DOI 10.1006/geno.1997.5171; Bennani-Baiti IM, 1998, P NATL ACAD SCI USA, V95, P10655, DOI 10.1073/pnas.95.18.10655; BENNANIBAITI IM, 1995, GENOMICS, V29, P647, DOI 10.1006/geno.1995.9954; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; BODNER M, 1987, CELL, V50, P267, DOI 10.1016/0092-8674(87)90222-4; Bresnick EH, 2006, PROG NUCLEIC ACID RE, V81, P435, DOI 10.1016/S0079-6603(06)81011-1; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; CAMPBELL KS, 1991, P NATL ACAD SCI USA, V88, P3982, DOI 10.1073/pnas.88.9.3982; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CURTIN P, 1985, J CLIN INVEST, V76, P1554, DOI 10.1172/JCI112136; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Fang XD, 2007, J MOL BIOL, V365, P31, DOI 10.1016/j.jmb.2006.09.072; Fedosyuk H, 2007, BLOOD CELL MOL DIS, V39, P44, DOI 10.1016/j.bcmd.2007.02.006; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; Ho YG, 2002, MOL CELL, V9, P291, DOI 10.1016/S1097-2765(02)00447-1; Ho YG, 2008, EMBO REP, V9, P891, DOI 10.1038/embor.2008.126; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Ho YG, 2011, MOL ENDOCRINOL, V25, P877, DOI 10.1210/me.2010-0411; Hunsaker TL, 2012, J MOL BIOL, V415, P29, DOI 10.1016/j.jmb.2011.11.001; Jin Y, 2011, DNA CELL BIOL, V30, P995, DOI 10.1089/dna.2011.1268; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kimura AP, 2004, MOL ENDOCRINOL, V18, P1018, DOI 10.1210/me.2003-0468; KIOUSSIS D, 1983, NATURE, V306, P662, DOI 10.1038/306662a0; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; MAYO KE, 1988, MOL ENDOCRINOL, V2, P606, DOI 10.1210/mend-2-7-606; MCCLATCHEY AI, 1992, HUM MOL GENET, V1, P521; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; Papachatzopoulou A, 2007, AM J HEMATOL, V82, P1005, DOI 10.1002/ajh.20979; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Shewchuk BM, 1999, J BIOL CHEM, V274, P35725, DOI 10.1074/jbc.274.50.35725; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yang XY, 2010, J MOL ENDOCRINOL, V45, P19, DOI 10.1677/JME-10-0017; Yoo EJ, 2006, MOL CELL BIOL, V26, P5569, DOI 10.1128/MCB.00405-06	47	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25454	25465		10.1074/jbc.M112.365825	http://dx.doi.org/10.1074/jbc.M112.365825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669946	Green Published, hybrid			2022-12-28	WOS:000306651700052
J	Xu, YC; Brown, KM; Wang, ZA; van der Wel, H; Teygong, C; Zhang, DM; Blader, IJ; West, CM				Xu, Yuechi; Brown, Kevin M.; Wang, Zhuo A.; van der Wel, Hanke; Teygong, Crystal; Zhang, Dongmei; Blader, Ira J.; West, Christopher M.			The Skp1 Protein from Toxoplasma Is Modified by a Cytoplasmic Prolyl 4-Hydroxylase Associated with Oxygen Sensing in the Social Amoeba Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; HYDROXYLASE DOMAIN; GONDII; HIF; GLYCOSYLATION; CYCLE; HYDROXYPROLINE; STABILIZATION; BRADYZOITES; INHIBITION	In diverse types of organisms, cellular hypoxic responses are mediated by prolyl 4-hydroxylases that use O-2 and alpha-ketoglutarate as substrates to hydroxylate conserved proline residues in target proteins. Whereas in metazoans these enzymes control the stability of the HIF alpha family of transcription factor subunits, the Dictyostelium enzyme (DdPhyA) contributes to O-2 regulation of development by a divergent mechanism involving hydroxylation and subsequent glycosylation of DdSkp1, an adaptor subunit in E3(SCF) ubiquitin ligases. Sequences related to DdPhyA, DdSkp1, and the glycosyltransferases that cap Skp1 hydroxyproline occur also in the genomes of Toxoplasma and other protists, suggesting that this O-2 sensing mechanism may be widespread. Here we show by disruption of the TgphyA locus that this enzyme is required for Skp1 glycosylation in Toxoplasma and that disrupted parasites grow slowly at physiological O-2 levels. Conservation of cellular function was tested by expression of TgPhyA in DdphyA-null cells. Simple gene replacement did not rescue Skp1 glycosylation, whereas overexpression not only corrected Skp1 modification but also restored the O-2 requirement to a level comparable to that of overexpressed DdPhyA. Bacterially expressed TgPhyA protein can prolyl hydroxylate both Toxoplasma and Dictyostelium Skp1s. Kinetic analyses showed that TgPhyA has similar properties to DdPhyA, including a superimposable dependence on the concentration of its co-substrate alpha-ketoglutarate. Remarkably, however, TgPhyA had a significantly higher apparent affinity for O-2. The findings suggest that Skp1 hydroxylation by PhyA is a conserved process among protists and that this biochemical pathway may indirectly sense O-2 by detecting the levels of O-2-regulated metabolites such as alpha-ketoglutarate.	[Xu, Yuechi; Wang, Zhuo A.; van der Wel, Hanke; Zhang, Dongmei; West, Christopher M.] OUHSC, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Brown, Kevin M.; Teygong, Crystal; Blader, Ira J.] OUHSC, Dept Microbiol & Immunol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Blader, Ira J.] OUHSC, Dept Ophthalmol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	West, CM (corresponding author), OUHSC, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, 975 NE 10th St,BRC 417, Oklahoma City, OK 73104 USA.	Cwest2@ouhsc.edu	zhang, dongmei/B-8011-2013; Wang, Zhuo/L-6912-2019; xu, yuechi/G-5353-2012	Wang, Zhuo/0000-0002-4707-036X; Xu, yuechi/0000-0003-0030-4111	National Institutes of Health [R01-GM084383, R01-GM037539, R01-AI069986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084383, R01GM037539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM084383, R01-GM037539, and R01-AI069986.	Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Asif MH, 2009, FUNCT INTEGR GENOMIC, V9, P525, DOI 10.1007/s10142-009-0118-y; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Culpepper MA, 2010, BIOCHEMISTRY-US, V49, P124, DOI 10.1021/bi901771z; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Kimmel Alan R., 2006, V346, P187; Knauer SH, 2012, FEBS J, V279, P816, DOI 10.1111/j.1742-4658.2012.08473.x; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; KOZAROV E, 1995, J BIOL CHEM, V270, P3022, DOI 10.1074/jbc.270.7.3022; Leite RB, 2008, PROTIST, V159, P355, DOI 10.1016/j.protis.2008.03.002; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; van der Wel H, 2005, J BIOL CHEM, V280, P14645, DOI 10.1074/jbc.M500600200; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2002, J BIOL CHEM, V277, P46328, DOI 10.1074/jbc.M208024200; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Wang ZA, 2011, DEV BIOL, V349, P283, DOI 10.1016/j.ydbio.2010.10.013; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; West CM, 2006, METHOD ENZYMOL, V417, P389, DOI 10.1016/S0076-6879(06)17023-8; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Zhang DM, 2012, J BIOL CHEM, V287, P2006, DOI 10.1074/jbc.M111.314021	43	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25098	25110		10.1074/jbc.M112.355446	http://dx.doi.org/10.1074/jbc.M112.355446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22648409	hybrid, Green Published			2022-12-28	WOS:000306651700022
J	Al-Owais, MMA; Scragg, JL; Dallas, ML; Boycott, HE; Warburton, P; Chakrabarty, A; Boyle, JP; Peers, C				Al-Owais, Moza M. A.; Scragg, Jason L.; Dallas, Mark L.; Boycott, Hannah E.; Warburton, Philip; Chakrabarty, Aruna; Boyle, John P.; Peers, Chris			Carbon Monoxide Mediates the Anti-apoptotic Effects of Heme Oxygenase-1 in Medulloblastoma DAOY Cells via K+ Channel Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; TUMOR-CELLS; HYPOXIA; TARGET; PROLIFERATION; HOMEOSTASIS; DEATH	Tumor cell survival and proliferation is attributable in part to suppression of apoptotic pathways, yet the mechanisms by which cancer cells resist apoptosis are not fully understood. Many cancer cells constitutively express heme oxygenase-1 (HO-1), which catabolizes heme to generate biliverdin, Fe2+, and carbon monoxide (CO). These breakdown products may play a role in the ability of cancer cells to suppress apoptotic signals. K+ channels also play a crucial role in apoptosis, permitting K+ efflux which is required to initiate caspase activation. Here, we demonstrate that HO-1 is constitutively expressed in human medulloblastoma tissue, and can be induced in the medulloblastoma cell line DAOY either chemically or by hypoxia. Induction ofHO-1markedly increases the resistance of DAOY cells to oxidant-induced apoptosis. This effect was mimicked by exogenous application of the heme degradation product CO. Furthermore we demonstrate the presence of the proapoptotic K+ channel, Kv2.1, in both human medulloblastoma tissue and DAOY cells. CO inhibited the voltage-gated K+ currents in DAOY cells, and largely reversed the oxidant-induced increase in K+ channel activity. p38 MAPK inhibition prevented the oxidant-induced increase of K+ channel activity in DAOY cells, and enhanced their resistance to apoptosis. Our findings suggest that CO-mediated inhibition of K+ channels represents an important mechanism by which HO-1 can increase the resistance to apoptosis of medulloblastoma cells, and support the idea that HO-1 inhibition may enhance the effectiveness of current chemo-and radiotherapies.	[Al-Owais, Moza M. A.; Scragg, Jason L.; Dallas, Mark L.; Boycott, Hannah E.; Warburton, Philip; Boyle, John P.; Peers, Chris] Univ Leeds, Div Cardiovasc & Neuronal Remodeling, LIGHT, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Chakrabarty, Aruna] St James Hosp, Dept Histopathol, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; Saint James's University Hospital	Peers, C (corresponding author), Univ Leeds, Div Cardiovasc & Neuronal Remodeling, LIGHT, Fac Med & Hlth, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	c.s.peers@leeds.ac.uk	Boyle, John/N-4868-2016; Dallas, Mark L/A-6654-2013; Dallas, Mark/Q-6117-2019	Dallas, Mark/0000-0002-5190-0522; Peers, Chris/0000-0002-8354-346X; Al-Owais, Moza/0000-0001-9122-7873	Yorkshire Cancer Research, UK; British Heart Foundation [PG/11/84/29146] Funding Source: researchfish	Yorkshire Cancer Research, UK; British Heart Foundation(British Heart Foundation)	This study was supported by Yorkshire Cancer Research, UK.	Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Brahimi-Horn MC, 2007, ESSAYS BIOCHEM, V43, P165, DOI 10.1042/bse0430165; Busserolles J, 2006, INT J BIOCHEM CELL B, V38, P1510, DOI 10.1016/j.biocel.2006.03.013; Carignani C, 2002, BRAIN RES, V939, P11, DOI 10.1016/S0006-8993(02)02535-0; Chen GG, 2004, J CELL BIOCHEM, V92, P1246, DOI 10.1002/jcb.20157; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dallas ML, 2008, NEUROREPORT, V19, P345, DOI 10.1097/WNR.0b013e3282f51045; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Ernest NJ, 2010, J MEMBRANE BIOL, V237, P59, DOI 10.1007/s00232-010-9306-x; Fang J, 2004, INT J CANCER, V109, P1, DOI 10.1002/ijc.11644; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kelly GL, 2011, ADV CANCER RES, V111, P39, DOI 10.1016/B978-0-12-385524-4.00002-7; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kinobe RT, 2008, CAN J PHYSIOL PHARM, V86, P577, DOI 10.1139/y08-066; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; Miyata T, 2011, AM J PHYSIOL-CELL PH, V300, pC226, DOI 10.1152/ajpcell.00430.2010; Pal S, 2003, J NEUROSCI, V23, P4798; Pena-Altamira E, 2010, CURR PHARM DESIGN, V16, P440, DOI 10.2174/138161210790232211; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Redman PT, 2009, J PHYSIOL-LONDON, V587, P4393, DOI 10.1113/jphysiol.2009.176321; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Taillandier L, 2011, REV NEUROL-FRANCE, V167, P431, DOI 10.1016/j.neurol.2011.01.014; Tanaka S, 2003, BRIT J CANCER, V88, P902, DOI 10.1038/sj.bjc.6600830; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Voloshyna I, 2008, CANCER RES, V68, P1197, DOI 10.1158/0008-5472.CAN-07-5163; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X	41	52	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24754	24764		10.1074/jbc.M112.357012	http://dx.doi.org/10.1074/jbc.M112.357012			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22593583	Green Published, hybrid			2022-12-28	WOS:000306651100068
J	Sato, S; Kawamoto, J; Sato, SB; Watanabe, B; Hiratake, J; Esaki, N; Kurihara, T				Sato, Sho; Kawamoto, Jun; Sato, Satoshi B.; Watanabe, Bunta; Hiratake, Jun; Esaki, Nobuyoshi; Kurihara, Tatsuo			Occurrence of a Bacterial Membrane Microdomain at the Cell Division Site Enriched in Phospholipids with Polyunsaturated Hydrocarbon Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHEWANELLA-LIVINGSTONENSIS AC10; COLD-ADAPTED BACTERIUM; FATTY-ACIDS; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC-ACID; OUTER-MEMBRANE; IN-VIVO; LIPIDS; PROTEIN; RHODOPSIN	In this study, we found that phospholipids containing an eicosapentaenyl group form a novel membrane microdomain at the cell division site of a Gram-negative bacterium, Shewanella livingstonensis Ac10, using chemically synthesized fluorescent probes. The occurrence of membrane microdomains in eukaryotes and prokaryotes has been demonstrated with various imaging tools for phospholipids with different polar head-groups. However, few studies have focused on the hydrocarbon chain-dependent localization of membrane-resident phospholipids in vivo. We previously found that lack of eicosapentaenoic acid (EPA), a polyunsaturated fatty acid found at the sn-2 position of glycerophospholipids, causes a defect in cell division after DNA replication of S. livingstonensis Ac10. Here, we synthesized phospholipid probes labeled with a fluorescent 7-nitro-2,1,3-benzoxadiazol-4-yl (NBD) group to study the localization of EPA-containing phospholipids by fluorescence microscopy. A fluorescent probe in which EPA was bound to the glycerol backbone via an ester bond was found to be unsuitable for imaging because EPA was released from the probe by in vivo hydrolysis. To overcome this problem, we synthesized hydrolysis-resistant ether-type phospholipid probes. Using these probes, we found that the fluorescence localized between two nucleoids at the cell center during cell division when the cells were grown in the presence of the eicosapentaenyl group-containing probe (N-NBD-1-oleoyl-2-eicosapentaenyl-sn-glycero-3-phosphoethanolamine), whereas this localization was not observed with the oleyl group-containing control probe (N-NBD-1-oleoyl-2-oleyl-sn-glycero-3-phosphoethanolamine). Thus, phospholipids containing an eicosapentaenyl group are specifically enriched at the cell division site. Formation of a membrane microdomain enriched in EPA-containing phospholipids at the nucleoid occlusion site probably facilitates cell division.	[Sato, Sho; Kawamoto, Jun; Watanabe, Bunta; Hiratake, Jun; Esaki, Nobuyoshi; Kurihara, Tatsuo] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Sato, Satoshi B.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Kurihara, T (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	kurihara@scl.kyoto-u.ac.jp		Kawamoto, Jun/0000-0002-5025-5613; Watanabe, Bunta/0000-0003-3645-5712	Japan Society for the Promotion of Science [20360372, 22404021]; Institute for Fermentation (Osaka) [22658028]; Japan Foundation for Applied Enzymology; Japan Science and Technology Agency [10-041]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation (Osaka)(Institute for Fermentation (IFO)); Japan Foundation for Applied Enzymology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by Grants-in-aid for Scientific Research (B) 20360372 and 22404021 from the Japan Society for the Promotion of Science, Grant-in-aid for Challenging Exploratory Research 22658028, and grants from the Institute for Fermentation (Osaka) and the Japan Foundation for Applied Enzymology (to T. K.); by Grant for Research for Promoting Technological Seeds 10-041 from the Japan Science and Technology Agency (to J. K.); and by Japan Society for the Promotion of Science research fellowships for young scientists (to S. S.).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carrillo-Tripp M, 2005, BIOCHEMISTRY-US, V44, P10164, DOI 10.1021/bi050822e; Dekker N, 2000, MOL MICROBIOL, V35, P711, DOI 10.1046/j.1365-2958.2000.01775.x; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Feller SE, 2008, CHEM PHYS LIPIDS, V153, P76, DOI 10.1016/j.chemphyslip.2008.02.013; Feller SE, 2005, CURR OPIN STRUC BIOL, V15, P416, DOI 10.1016/j.sbi.2005.07.002; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; HSU L, 1991, J BIOL CHEM, V266, P13783; Jao CY, 2009, P NATL ACAD SCI USA, V106, P15332, DOI 10.1073/pnas.0907864106; Kawamoto J, 2007, EXTREMOPHILES, V11, P819, DOI 10.1007/s00792-007-0098-6; Kawamoto J, 2011, ENVIRON MICROBIOL, V13, P2293, DOI 10.1111/j.1462-2920.2011.02487.x; Kawamoto J, 2009, J BACTERIOL, V191, P632, DOI 10.1128/JB.00881-08; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Miyake R, 2007, APPL ENVIRON MICROB, V73, P4849, DOI 10.1128/AEM.00824-07; Neef AB, 2009, ANGEW CHEM INT EDIT, V48, P1498, DOI 10.1002/anie.200805507; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Reutelingsperger CPM, 2002, J IMMUNOL METHODS, V265, P123, DOI 10.1016/S0022-1759(02)00075-3; Sato SB, 2011, PROSTAG LEUKOTR ESS, V84, P31, DOI 10.1016/j.plefa.2010.09.006; Sato S, 2008, EXTREMOPHILES, V12, P753, DOI 10.1007/s00792-008-0182-6; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Watts GF, 2011, CURR OPIN LIPIDOL, V22, P70, DOI 10.1097/MOL.0b013e328342b10f; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300	32	15	16	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24113	24121		10.1074/jbc.M111.318311	http://dx.doi.org/10.1074/jbc.M111.318311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648406	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000306651100006
J	Nin, V; Escande, C; Chini, CC; Giri, S; Camacho-Pereira, J; Matalonga, J; Lou, ZK; Chini, EN				Nin, Veronica; Escande, Carlos; Chini, Claudia C.; Giri, Shailendra; Camacho-Pereira, Juliana; Matalonga, Jonathan; Lou, Zhenkun; Chini, Eduardo N.			Role of Deleted in Breast Cancer 1 (DBC1) Protein in SIRT1 Deacetylase Activation Induced by Protein Kinase A and AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; INSULIN-SECRETION; SIGNALING PATHWAY; CELLULAR-RESPONSE; MAMMALIAN TARGET; TUMOR-SUPPRESSOR; NAD; PHOSPHORYLATION; RESVERATROL; GLUCOSE	The NAD(+)-dependent deacetylase SIRT1 is a key regulator of several aspects of metabolism and aging. SIRT1 activation is beneficial for several human diseases, including metabolic syndrome, diabetes, obesity, liver steatosis, and Alzheimer disease. We have recently shown that the protein deleted in breast cancer 1 (DBC1) is a key regulator of SIRT1 activity in vivo. Furthermore, SIRT1 and DBC1 form a dynamic complex that is regulated by the energetic state of the organism. Understanding how the interaction between SIRT1 and DBC1 is regulated is therefore essential to design strategies aimed to activate SIRT1. Here, we investigated which pathways can lead to the dissociation of SIRT1 and DBC1 and consequently to SIRT1 activation. We observed that PKA activation leads to a fast and transient activation of SIRT1 that is DBC1-dependent. In fact, an increase in cAMP/PKA activity resulted in the dissociation of SIRT1 and DBC1 in an AMP-activated protein kinase (AMPK)-dependent manner. Pharmacological AMPK activation led to SIRT1 activation by a DBC1-dependent mechanism. Indeed, we found that AMPK activators promote SIRT1-DBC1 dissociation in cells, resulting in an increase in SIRT1 activity. In addition, we observed that the SIRT1 activation promoted by PKA and AMPK occurs without changes in the intracellular levels of NAD(+). We propose that PKA and AMPK can acutely activate SIRT1 by inducing dissociation of SIRT1 from its endogenous inhibitor DBC1. Our experiments provide new insight on the in vivo mechanism of SIRT1 regulation and a new avenue for the development of pharmacological SIRT1 activators targeted at the dissociation of the SIRT1-DBC1 complex.	[Chini, Eduardo N.] Mayo Clin, Dept Anesthesiol, Lab Signal Transduct, Rochester, MN 55905 USA; [Nin, Veronica; Escande, Carlos; Chini, Claudia C.; Camacho-Pereira, Juliana; Matalonga, Jonathan; Chini, Eduardo N.] Mayo Clin, Kogod Aging Ctr, Rochester, MN 55905 USA; [Giri, Shailendra] Mayo Clin, Dept Expt Pathol, Rochester, MN 55905 USA; [Lou, Zhenkun] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Chini, EN (corresponding author), Mayo Clin, Dept Anesthesiol, Lab Signal Transduct, Rochester, MN 55905 USA.	chini.eduardo@mayo.edu	Camacho-Pereira, Juliana/AAZ-6174-2021	Camacho-Pereira, Juliana/0000-0002-4247-2140	NIDDK, National Institutes of Health [DK-084055]; American Federation of Aging Research; Mayo Foundation; Strickland Career Development Award; American Heart Association Postdoctoral Fellowship Award [11POST7320060]; Fundacao de Amparo A Pesquisa do Estado do Rio de Janeiro, Brazil; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA129344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084055] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Federation of Aging Research; Mayo Foundation; Strickland Career Development Award; American Heart Association Postdoctoral Fellowship Award(American Heart Association); Fundacao de Amparo A Pesquisa do Estado do Rio de Janeiro, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-084055 from the NIDDK. This work was also supported by grants from the American Federation of Aging Research and the Mayo Foundation and by the Strickland Career Development Award.; Supported by American Heart Association Postdoctoral Fellowship Award 11POST7320060.; Supported by Fundacao de Amparo A Pesquisa do Estado do Rio de Janeiro, Brazil.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066; Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Barata H, 2004, ENDOCRINOLOGY, V145, P881, DOI 10.1210/en.2003-0774; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; Chini EN, 2005, BIOCHEM J, V389, P269, DOI 10.1042/BJ20041971; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Fu JJ, 2009, J BIOL CHEM, V284, P6832, DOI 10.1074/jbc.M808988200; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hiraike H, 2010, BRIT J CANCER, V102, P1061, DOI 10.1038/sj.bjc.6605577; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Koyama S, 2010, BIOCHEM BIOPH RES CO, V392, P357, DOI 10.1016/j.bbrc.2010.01.025; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Williamson DL, 2006, J PHYSIOL-LONDON, V573, P497, DOI 10.1113/jphysiol.2005.103481; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu HM, 2011, MOL PHARMACOL, V80, P859, DOI 10.1124/mol.111.072769; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Yuan J, 2012, GENE DEV, V26, P791, DOI 10.1101/gad.188482.112; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	71	85	95	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23489	23501		10.1074/jbc.M112.365874	http://dx.doi.org/10.1074/jbc.M112.365874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22553202	Green Published, hybrid			2022-12-28	WOS:000306511300021
J	Asanuma-Date, K; Hirano, Y; Le, N; Sano, K; Kawasaki, N; Hashii, N; Hiruta, Y; Nakayama, K; Umemura, M; Ishikawa, K; Sakagami, H; Ogawa, H				Asanuma-Date, Kimie; Hirano, Yuki; Le, Na; Sano, Kotone; Kawasaki, Nana; Hashii, Noritaka; Hiruta, Yoko; Nakayama, Ken-ichi; Umemura, Mariko; Ishikawa, Kazuhiko; Sakagami, Hiromi; Ogawa, Haruko			Functional Regulation of Sugar Assimilation by N-Glycan-specific Interaction of Pancreatic alpha-Amylase with Glycoproteins of Duodenal Brush Border Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-IV; SUCRASE-ISOMALTASE; ENZYME-ACTIVITY; AMINOPEPTIDASE-N; BINDING-ACTIVITY; GLYCOSYLATION; GLUCOSE; PROTEIN; RAT; NA+	Porcine pancreatic alpha-amylase (PPA) binds to N-linked glycans of glycoproteins (Matsushita, H., Takenaka, M., and Ogawa, H. (2002) J. Biol Chem., 277, 4680-4686). Immunostaining revealed that PPA is located at the brush-border membrane (BBM) of enterocytes in the duodenum and that the binding is inhibited by mannan but not galactan, indicating that PPA binds carbohydrate-specifically to BBM. The ligands for PPA in BBM were identified as glycoprotein N-glycans that are significantly involved in the assimilation of glucose, including sucrase-isomaltase (SI) and Na+/Glc cotransporter 1 (SGLT1). Binding of SI and SGLT1 in BBM to PPA was dose-dependent and inhibited by mannan. Using BBM vesicles, we found functional changes in PPA and its ligands in BBM due to the N-glycanspecific interaction. The starch-degrading activity of PPA and maltose-degrading activity of SI were enhanced to 240 and 175%, respectively, while Glc uptake by SGLT1 was markedly inhibited by PPA at high but physiologically possible concentrations, and the binding was attenuated by the addition of mannose-specific lectins, especially from Galanthus nivalis. Additionally, recombinant human pancreatic alpha-amylases expressed in yeast and purified by single-step affinity chromatography exhibited the same carbohydrate binding specificity as PPA in binding assays with sugar-biotinyl polymer probes. The results indicate that mammalian pancreatic alpha-amylases share a common carbohydrate binding activity and specifically bind to the intestinal BBM. Interaction with N-glycans in the BBM activated PPA and SI to produce much Glc on the one hand and to inhibit Glc absorption by enterocytes via SGLT1 in order to prevent a rapid increase in blood sugar on the other.	[Asanuma-Date, Kimie; Hirano, Yuki; Le, Na; Sano, Kotone; Sakagami, Hiromi; Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Asanuma-Date, Kimie; Hirano, Yuki; Le, Na; Sano, Kotone; Sakagami, Hiromi; Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan; [Kawasaki, Nana; Hashii, Noritaka; Hiruta, Yoko] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; [Nakayama, Ken-ichi; Umemura, Mariko; Ishikawa, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan	Ochanomizu University; Ochanomizu University; National Institute of Health Sciences - Japan; National Institute of Advanced Industrial Science & Technology (AIST)	Ogawa, H (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	ogawa.haruko@ocha.ac.jp	Asanuma, Kimie/AAW-2543-2020	Asanuma, Kimie/0000-0003-4311-0544	Japan Society for the Promotion of Science [22.10385]; Hayashi Memorial Foundation for Female Natural Scientists; Daiwa Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology [17570109, 22570111]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Daiwa Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Grant 22.10385 (to K. D.) and in part by research grants of the Hayashi Memorial Foundation for Female Natural Scientists (to H. O.) and the Daiwa Health Science Foundation (to H. O.) and Grants-in-aid for Scientific Research (C) 17570109 (to H. O.) and 22570111 (to H. O.) from the Ministry of Education, Culture, Sports, Science, and Technology.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; BRUNNER J, 1979, J BIOL CHEM, V254, P1821; Cloutier M, 2006, J HISTOCHEM CYTOCHEM, V54, P781, DOI 10.1369/jhc.5A6877.2006; DAHLQVIST A, 1968, ANAL BIOCHEM, V22, P99, DOI 10.1016/0003-2697(68)90263-7; DANIELSEN EM, 1995, GASTROENTEROLOGY, V109, P1039, DOI 10.1016/0016-5085(95)90561-8; Detel D, 2008, EXP AGING RES, V34, P49, DOI 10.1080/03610730701761957; Fan H, 1997, EUR J BIOCHEM, V246, P243, DOI 10.1111/j.1432-1033.1997.00243.x; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Fukuoka S, 1992, Tanpakushitsu Kakusan Koso, V37, P795; Gallicchio MA, 2010, BBA-MOL CELL RES, V1803, P919, DOI 10.1016/j.bbamcr.2010.04.009; Georgieff MK, 1997, PLACENTA, V18, P563, DOI 10.1016/0143-4004(77)90011-X; Gordon K, 2003, BIOCHEM J, V371, P437, DOI 10.1042/BJ20021842; GORRILL ADL, 1967, J NUTR, V92, P86, DOI 10.1093/jn/92.1.86; GUPTA R, 1992, ANN NUTR METAB, V36, P288, DOI 10.1159/000177732; Harlow E., 1988, ANTIBODIES LAB MANUA; HAYES GR, 1995, GLYCOBIOLOGY, V5, P227, DOI 10.1093/glycob/5.2.227; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HEDIGER MA, 1991, BIOCHIM BIOPHYS ACTA, V1064, P360, DOI 10.1016/0005-2736(91)90323-Z; HIRAYAMA BA, 1992, BIOCHIM BIOPHYS ACTA, V1103, P37, DOI 10.1016/0005-2736(92)90054-P; HUGON J, 1966, J HISTOCHEM CYTOCHEM, V14, P629, DOI 10.1177/14.9.629; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; ISHIKAWA K, 1993, BIOCHEMISTRY-US, V32, P6259, DOI 10.1021/bi00075a020; Kenan N, 2011, CLIN CHIM ACTA, V412, P129, DOI 10.1016/j.cca.2010.09.022; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Khatri IA, 2003, BIOCHEM J, V372, P263, DOI 10.1042/BJ20021333; Le Varlet B, 1991, J Dermatol Sci, V2, P287, DOI 10.1016/0923-1811(91)90053-Z; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Matsushita H, 2002, J BIOL CHEM, V277, P4680, DOI 10.1074/jbc.M105877200; Mellitzer G, 2010, J CLIN INVEST, V120, P1708, DOI 10.1172/JCI40794; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; Nakagawa K, 2009, GLYCOCONJUGATE J, V26, P1007, DOI 10.1007/s10719-008-9220-y; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; PUSZTAI A, 1995, GLYCOCONJUGATE J, V12, P22, DOI 10.1007/BF00731865; Radoshitzky SR, 2008, P NATL ACAD SCI USA, V105, P2664, DOI 10.1073/pnas.0709254105; ROTH J, 1993, HISTOCHEM J, V25, P687; Rueda E, 2007, BRIT POULTRY SCI, V48, P696, DOI 10.1080/00071660701713526; RUSSELL JR, 1981, J ANIM SCI, V52, P1177, DOI 10.2527/jas1981.5251177x; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; SHIOSAKI K, 1990, GENE, V89, P253, DOI 10.1016/0378-1119(90)90013-H; SJOSTROM H, 1980, J BIOL CHEM, V255, P1332; SMITS HL, 1984, ARCH BIOCHEM BIOPHYS, V228, P64, DOI 10.1016/0003-9861(84)90047-X; STEVENS BR, 1990, P NATL ACAD SCI USA, V87, P1456, DOI 10.1073/pnas.87.4.1456; Takahashi K, 2001, AM J PHYSIOL-RENAL, V281, pF1109, DOI 10.1152/ajprenal.0346.2000; Takekawa H, 2006, J BIOL CHEM, V281, P8528, DOI 10.1074/jbc.M513773200; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Ueda H, 2004, BIOCHEM J, V382, P821, DOI 10.1042/BJ20040584; UENO M, 1991, J BIOL CHEM, V266, P3146; VANHALBEEK H, 1983, BIOCHIM BIOPHYS ACTA, V747, P107, DOI 10.1016/0167-4838(83)90128-0; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; Wong TP, 2007, J PHYSIOL-LONDON, V584, P613, DOI 10.1113/jphysiol.2007.138578; WRIGHT EM, 1992, ACTA PHYSIOL SCAND, V146, P201	54	15	16	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23104	23118		10.1074/jbc.M111.314658	http://dx.doi.org/10.1074/jbc.M111.314658			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584580	hybrid, Green Published			2022-12-28	WOS:000306495000066
J	Ming, M; Wang, S; Wu, WS; Senyuk, V; Le Beau, MM; Nucifora, G; Qian, ZJ				Ming, Ming; Wang, Sheng; Wu, Wenshu; Senyuk, Vitalyi; Le Beau, Michelle M.; Nucifora, Giuseppina; Qian, Zhijian			Activation of Wnt/beta-Catenin Protein Signaling Induces Mitochondria-mediated Apoptosis in Hematopoietic Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; BETA-CATENIN; STEM-CELLS; IN-VIVO; SELF-RENEWAL; EXPRESSION; SURVIVAL; PATHWAY; APC; TRANSDUCTION	The canonical Wnt/beta-catenin signaling is activated during development, tumorigenesis, and in adult homeostasis, yet its role in maintenance of hematopoietic stem/progenitor cells is not firmly established. Here, we demonstrate that conditional expression of an active form of beta-catenin in vivo induces a marked increase in the frequency of apoptosis in hematopoietic stem/progenitor cells (HSCs/HPCs). Activation of Wnt/beta catenin signaling in HPCs in vitro elevates the activity of caspases 3 and 9 and leads to a loss of mitochondrial membrane potential (Delta Psi(m)), indicating that it induces the intrinsic mitochondrial apoptotic pathway. In vivo, expression of activated beta-catenin in HPCs is associated with down-regulation of Bcl2 and expression of Casp3. Bone marrow transplantation assays reveal that enhanced cell survival by a Bcl2 transgene re-establishes the reconstitution capacity of HSCs/HPCs that express activated beta-catenin. In addition, a Bcl2 transgene prevents exhaustion of these HSCs/HPCs in vivo. Our data suggest that activation of the Wnt/beta-catenin pathway contributes to the defective function of HPCs in part by deregulating their survival.	[Ming, Ming; Wang, Sheng; Senyuk, Vitalyi; Nucifora, Giuseppina; Qian, Zhijian] Univ Illinois, Dept Med, Chicago, IL 60621 USA; [Nucifora, Giuseppina; Qian, Zhijian] Univ Illinois, Canc Res Ctr, Chicago, IL 60621 USA; [Le Beau, Michelle M.] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Le Beau, Michelle M.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Wu, Wenshu] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Qian, ZJ (corresponding author), Univ Illinois, Dept Med, 909 S Wolcott Ave,COMRB Rm 5051,M-C704, Chicago, IL 60621 USA.	zjqian@uic.edu	Wu, Wen-Shu/I-1258-2014	Wu, Wen-Shu/0000-0002-0225-2522	National Institutes of Health [CA140979]; American Cancer Society Illinois Division; NATIONAL CANCER INSTITUTE [R01CA140979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Illinois Division(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA140979 (to Z. Q.). This work was also supported in part by the American Cancer Society Illinois Division (to Z. Q.).	Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Brault V, 2001, DEVELOPMENT, V128, P1253; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Del Principe MI, 2005, HEMATOLOGY, V10, P25, DOI 10.1080/10245330400020454; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qian Z, 2009, LEUKEMIA, V23, P1650, DOI 10.1038/leu.2009.78; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; Raab MS, 2009, BLOOD, V113, P1513, DOI 10.1182/blood-2008-05-157040; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	34	70	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22683	22690		10.1074/jbc.M112.342089	http://dx.doi.org/10.1074/jbc.M112.342089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589536	Green Published, hybrid			2022-12-28	WOS:000306495000025
J	Mulepati, S; Orr, A; Bailey, S				Mulepati, Sabin; Orr, Amberly; Bailey, Scott			Crystal Structure of the Largest Subunit of a Bacterial RNA-guided Immune Complex and Its Role in DNA Target Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRISPR RNA; ANTIVIRAL DEFENSE; RECOGNITION; SYSTEM; RESISTANCE; NUCLEASE; PROTEIN; ENDORIBONUCLEASE; INTERFERENCE; MATURATION	Prokaryotes make use of small RNAs encoded by CRISPR (clustered regularly interspaced short palindromic repeat) loci to provide immunity against bacteriophage or plasmid invasion. In Escherichia coli, the CRISPR-associated complex for antiviral defense (Cascade) utilizes these RNAs to target foreign DNA for destruction. CasA, the largest subunit of Cascade, is essential for its function. Here we report the crystal structure of Thermus thermophilus CasA. The structure is composed of two domains that are arranged in a chair-like conformation with a novel fold forming the larger N-terminal domain. Docking of the crystal structure into cryo-electron microscopy maps reveals two loops in CasA that likely have important functions in DNA target binding. Finally, DNA binding experiments show that CasA is essential for binding of Cascade to DNA target.	[Mulepati, Sabin; Orr, Amberly; Bailey, Scott] Johns Hopkins Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St,W8704, Baltimore, MD 21205 USA.	scbailey@jhsph.edu	Bailey, Scott/N-7248-2019		National Institutes of Health [R01 GM097330]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM097330 (to S. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agari Y, 2008, PROTEINS, V73, P1063, DOI 10.1002/prot.22224; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Sashital D. G., 2012, MOL CELL IN PRESS; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	36	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22445	22449		10.1074/jbc.C112.379503	http://dx.doi.org/10.1074/jbc.C112.379503			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22621933	hybrid, Green Published			2022-12-28	WOS:000306495000004
J	Demmerle, J; Koch, AJ; Holaska, JM				Demmerle, Justin; Koch, Adam J.; Holaska, James M.			The Nuclear Envelope Protein Emerin Binds Directly to Histone Deacetylase 3 (HDAC3) and Activates HDAC3 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; TRANSCRIPTIONAL REPRESSOR; CAENORHABDITIS-ELEGANS; MUSCLE REGENERATION; MYOD PATHWAYS; LAMIN; ORGANIZATION; ARCHITECTURE; COMPLEXES; MEMBRANE	Organization of the genome is critical for maintaining cell-specific gene expression, ensuring proper cell function. It is well established that the nuclear lamina preferentially associates with repressed chromatin. However, the molecular mechanisms underlying repressive chromatin formation and maintenance at the nuclear lamina remain poorly understood. Here we show that emerin binds directly to HDAC3, the catalytic subunit of the nuclear co-repressor (NCoR) complex, and recruits HDAC3 to the nuclear periphery. Emerin binding stimulated the catalytic activity of HDAC3, and emerin-null cells exhibit increased H4K5 acetylation, which is the preferred target of the NCoR complex. Emerin-null cells exhibit an epigenetic signature similar to that seen in HDAC3-null cells. Emerin-null cells also had significantly less HDAC3 at the nuclear lamina. Collectively, these data support a model whereby emerin facilitates repressive chromatin formation at the nuclear periphery by increasing the catalytic activity of HDAC3.	[Demmerle, Justin; Holaska, James M.] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Koch, Adam J.; Holaska, James M.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Holaska, James M.] Univ Chicago, Comm Dev Regenerat & Stem Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Holaska, JM (corresponding author), Univ Chicago, Dept Med, Cardiol Sect, 5841 S Maryland Ave,MC6088,Rm A607, Chicago, IL 60637 USA.	jholaska@uchicago.edu	Demmerle, Justin/B-1539-2016	Demmerle, Justin/0000-0002-4005-1705; Holaska, James/0000-0003-0273-9995	National Institutes of Health [T32 GM007197, T32 HL007381]; Ellison Medical Foundation; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM007197 and T32 HL007381 (to A. J. K.). This work was also supported by the Ellison Medical Foundation (to J. M. H.) and the American Heart Association (to J. M. H.).	Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Dedeic Z, 2011, J CELL SCI, V124, P1691, DOI 10.1242/jcs.080259; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Galiova G, 2008, EUR J CELL BIOL, V87, P291, DOI 10.1016/j.ejcb.2008.01.013; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hartman HB, 2005, EMBO REP, V6, P445, DOI 10.1038/sj.embor.7400391; Holaska JM, 2008, CIRC RES, V103, P16, DOI 10.1161/CIRCRESAHA.108.172197; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Holt I, 2001, BIOCHEM BIOPH RES CO, V287, P1129, DOI 10.1006/bbrc.2001.5708; Huber MD, 2009, MOL CELL BIOL, V29, P5718, DOI 10.1128/MCB.00270-09; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Korfali N, 2010, MOL CELL PROTEOMICS, V9, P2571, DOI 10.1074/mcp.M110.002915; Lee KK, 2001, J CELL SCI, V114, P4567; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Meaburn KJ, 2007, AGING CELL, V6, P139, DOI 10.1111/j.1474-9726.2007.00270.x; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Muchir A, 2007, CURR NEUROL NEUROSCI, V7, P78, DOI 10.1007/s11910-007-0025-3; Ognibene A, 1999, MUSCLE NERVE, V22, P864, DOI 10.1002/(SICI)1097-4598(199907)22:7<864::AID-MUS8>3.3.CO;2-7; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106; Vaughan OA, 2001, J CELL SCI, V114, P2577; Vlcek S, 2007, BBA-MOL CELL RES, V1773, P661, DOI 10.1016/j.bbamcr.2006.07.002; Vlcek S, 2007, CURR OPIN CELL BIOL, V19, P298, DOI 10.1016/j.ceb.2007.04.001; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zullo J.M., 2012, CELL IN PRESS	41	110	114	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22080	22088		10.1074/jbc.M111.325308	http://dx.doi.org/10.1074/jbc.M111.325308			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570481	hybrid, Green Published			2022-12-28	WOS:000306418600045
J	George, NP; Ngo, KV; Chitteni-Pattu, S; Norais, CA; Battista, JR; Cox, MM; Keck, JL				George, Nicholas P.; Ngo, Khanh V.; Chitteni-Pattu, Sindhu; Norais, Cedric A.; Battista, John R.; Cox, Michael M.; Keck, James L.			Structure and Cellular Dynamics of Deinococcus radiodurans Single-stranded DNA (ssDNA)-binding Protein (SSB)-DNA Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; ESCHERICHIA-COLI; THERMUS-AQUATICUS; IONIZING-RADIATION; DDRB PROTEIN; SSB-GENE; GENOME; REPAIR; RECOMBINATION; THERMOPHILUS	The single-stranded DNA (ssDNA)-binding protein from the radiation-resistant bacterium Deinococcus radiodurans (DrSSB) functions as a homodimer in which each monomer contains two oligonucleotide-binding (OB) domains. This arrangement is exceedingly rare among bacterial SSBs, which typically form homotetramers of single-OB domain subunits. To better understand how this unusual structure influences the DNA binding and biological functions of DrSSB in D. radiodurans radiation resistance, we have examined the structure of DrSSB in complex with ssDNA and the DNA damage-dependent cellular dynamics of DrSSB. The x-ray crystal structure of the DrSSB-ssDNA complex shows that ssDNA binds to surfaces of DrSSB that are analogous to those mapped in homotetrameric SSBs, although there are distinct contacts in DrSSB that mediate species-specific ssDNA binding. Observations by electron microscopy reveal two salt-dependent ssDNA-binding modes for DrSSB that strongly resemble those of the homotetrameric Escherichia coli SSB, further supporting a shared overall DNA binding mechanism between the two classes of bacterial SSBs. In vivo, DrSSB levels are heavily induced following exposure to ionizing radiation. This accumulation is accompanied by dramatic time-dependent DrSSB cellular dynamics in which a single nucleoid-centric focus of DrSSB is observed within 1 h of irradiation but is dispersed by 3 h after irradiation. These kinetics parallel those of D. radiodurans postirradiation genome reconstitution, suggesting that DrSSB dynamics could play important organizational roles in DNA repair.	[Ngo, Khanh V.; Chitteni-Pattu, Sindhu; Norais, Cedric A.; Cox, Michael M.] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA; [George, Nicholas P.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Battista, John R.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Norais, Cedric A.] Ecole Polytech, Dept Biol, UMR CNRS 7654, Biochim Lab, F-91128 Palaiseau, France	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University; Institut Polytechnique de Paris	Cox, MM (corresponding author), Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA.	cox@biochem.wisc.edu; jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	National Institutes of Health [GM068061, GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM032335, R01GM032335, R01GM068061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068061 (to J. L. K.) and GM32335 (to M. M. C.).	Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bauermeister A, 2011, MICROB ECOL, V61, P715, DOI 10.1007/s00248-010-9785-4; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; CURTH U, 1993, BIOCHEMISTRY-US, V32, P2585, DOI 10.1021/bi00061a016; Dabrowski S, 2002, PROTEIN EXPRES PURIF, V26, P131, DOI 10.1016/S1046-5928(02)00504-1; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov R, 2006, NUCLEIC ACIDS RES, V34, P6708, DOI 10.1093/nar/gkl1002; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Jedrzejczak R, 2006, ACTA CRYSTALLOGR D, V62, P1407, DOI 10.1107/S0907444906036031; KITAYAMA S, 1982, BIOCHIM BIOPHYS ACTA, V697, P381, DOI 10.1016/0167-4781(82)90103-8; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P8266, DOI 10.1021/bi100920w; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Matsumoto T, 2000, J BIOCHEM, V127, P329, DOI 10.1093/oxfordjournals.jbchem.a022611; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSELEY BEB, 1971, J BACTERIOL, V105, P976, DOI 10.1128/JB.105.3.976-983.1971; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Nguyen HH, 2009, MOL MICROBIOL, V73, P240, DOI 10.1111/j.1365-2958.2009.06766.x; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Sugiman-Marangos S, 2010, NUCLEIC ACIDS RES, V38, P3432, DOI 10.1093/nar/gkq036; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Ujaoney AK, 2010, J BACTERIOL, V192, P5637, DOI 10.1128/JB.00752-10; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Witte G, 2008, BIOPHYS J, V94, P2269, DOI 10.1529/biophysj.107.121533; Yadav T., 2012, NUCL ACIDS IN PRESS; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	49	43	46	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22123	22132		10.1074/jbc.M112.367573	http://dx.doi.org/10.1074/jbc.M112.367573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570477	hybrid, Green Published			2022-12-28	WOS:000306418600049
J	Cheng, W; Wang, L; Zhang, R; Du, P; Yang, BY; Zhuang, HQ; Tang, B; Yao, C; Yu, M; Wang, YX; Zhang, J; Yin, W; Li, JH; Zheng, WJ; Lu, M; Hua, ZC				Cheng, Wei; Wang, Lu; Zhang, Rong; Du, Pan; Yang, Bingya; Zhuang, Hongqin; Tang, Bo; Yao, Chun; Yu, Mei; Wang, Yuxuan; Zhang, Jing; Yin, Wu; Li, Jiahuang; Zheng, Weijuan; Lu, Min; Hua, Zichun			Regulation of Protein Kinase C Inactivation by Fas-associated Protein with Death Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TURN MOTIF PHOSPHORYLATION; CELL-CYCLE; PHOSPHATASE 2A; MEDIATED APOPTOSIS; FADD RECRUITMENT; CANCER CELLS; ALPHA; PROLIFERATION; DEPHOSPHORYLATION; ACTIVATION	Protein kinase C (PKC) plays important roles in diverse cellular processes. PKC has been implicated in regulating Fas-associated protein with death domain (FADD), an important adaptor protein involved in regulating death receptor-mediated apoptosis. FADD also plays an important role in non-apoptosis processes. The functional interaction of PKC and FADD in non-apoptotic processes has not been examined. In this study, we show that FADD is involved in maintaining the phosphorylation of the turn motif and hydrophobic motif in the activated conventional PKC (cPKC). A phosphoryl-mimicking mutation (S191D) in FADD (FADD-D) abolished the function of FADD in the facilitation of the turn motif and hydrophobic motif dephosphorylation of cPKC, suggesting that phosphorylation of Ser-191 negatively regulates FADD. We show that FADD interacts with PP2A, which is a major phosphatase involved in dephosphorylation of activated cPKC and FADD deficiency abolished PP2A mediated dephosphorylation of cPKC. We show that FADD deficiency leads to increased stability and activity of cPKC, which, in turn, promotes cytoskeleton reorganization, cell motility, and chemotaxis. Collectively, these results reveal a novel function of FADD in a non-apoptotic process by modulating cPKC dephosphorylation, stability, and signaling termination.	[Cheng, Wei; Wang, Lu; Zhang, Rong; Du, Pan; Yang, Bingya; Zhuang, Hongqin; Yao, Chun; Yu, Mei; Wang, Yuxuan; Zhang, Jing; Yin, Wu; Li, Jiahuang; Zheng, Weijuan; Lu, Min; Hua, Zichun] Nanjing Univ, Dept Biochem, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Tang, Bo; Hua, Zichun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou 213164, Peoples R China; [Tang, Bo; Hua, Zichun] Jiangsu Target Pharma Labs Inc, Changzhou 213164, Peoples R China	Nanjing University; Nanjing University	Hua, ZC (corresponding author), Nanjing Univ, Dept Biochem, State Key Lab Pharmaceut Biotechnol, Hankou Rd 22, Nanjing 210093, Jiangsu, Peoples R China.	zchua@nju.edu.cn	Yu, Mei/K-2206-2017		Chinese Ministry of Science and Technology [2012CB967000, 2011CB933502]; Chinese National Nature Sciences Foundation [30821006, 50973046, 31071196, 81072712, 30270291, 30330530, 30425009]; Chinese Ministry of Education [200802840023, 20030284040]; Jiangsu Provincial Nature Science Foundation [BK2010046, B22010074]; Scientific Research Foundation of the Graduate School of Nanjing University	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Nature Sciences Foundation; Chinese Ministry of Education(Ministry of Education, China); Jiangsu Provincial Nature Science Foundation; Scientific Research Foundation of the Graduate School of Nanjing University(Nanjing University)	This study was supported in part by National Key Basic Research Project from the Chinese Ministry of Science and Technology Grants 2012CB967000 and 2011CB933502); Chinese National Nature Sciences Foundation Grants 30821006, 50973046, 31071196, 81072712, 30270291, 30330530, and 30425009; Specialized Research Fund for the Doctoral Program of Higher Education from the Chinese Ministry of Education Grants 200802840023 and 20030284040; Jiangsu Provincial Nature Science Foundation Grant BK2010046 and B22010074; and by the Scientific Research Foundation of the Graduate School of Nanjing University.	Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Bhojani MS, 2005, CELL CYCLE, V4, P1478; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; de Thonel A, 2001, BLOOD, V98, P3770, DOI 10.1182/blood.V98.13.3770; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gibcus JH, 2007, CLIN CANCER RES, V13, P6257, DOI 10.1158/1078-0432.CCR-07-1247; Gomez-Angelats M, 2001, J BIOL CHEM, V276, P44944, DOI 10.1074/jbc.M104919200; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gysin S, 1997, EUR J BIOCHEM, V249, P156, DOI 10.1111/j.1432-1033.1997.t01-2-00156.x; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Ikehara T, 2006, PROTEIN EXPRES PURIF, V45, P150, DOI 10.1016/j.pep.2005.06.002; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kotone-Miyahara Y, 2004, J LEUKOCYTE BIOL, V76, P1047, DOI 10.1189/jlb.0104048; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Matsuyoshi S, 2006, BRIT J CANCER, V94, P532, DOI 10.1038/sj.bjc.6602955; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; MEREDITH SD, 1995, ARCH OTOLARYNGOL, V121, P790; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Osborn SL, 2007, J BIOL CHEM, V282, P22786, DOI 10.1074/jbc.M703163200; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Shen HM, 2004, MOL CELL BIOL, V24, P5914, DOI 10.1128/MCB.24.13.5914-5922.2004; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoo NJ, 2007, PATHOL RES PRACT, V203, P73, DOI 10.1016/j.prp.2006.11.002; Zeidman R, 1999, INT J CANCER, V81, P494, DOI 10.1002/(SICI)1097-0215(19990505)81:3<494::AID-IJC26>3.0.CO;2-L; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	52	18	18	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26126	26135		10.1074/jbc.M112.342170	http://dx.doi.org/10.1074/jbc.M112.342170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22582393	Green Published, hybrid			2022-12-28	WOS:000306916300040
J	Meech, R; Rogers, A; Zhuang, LZ; Lewis, BC; Miners, JO; Mackenzie, PI				Meech, Robyn; Rogers, Anne; Zhuang, Lizhe; Lewis, Benjamin C.; Miners, John O.; Mackenzie, Peter I.			Identification of Residues That Confer Sugar Selectivity to UDP-Glycosyltransferase 3A (UGT3A) Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIVER-MICROSOMES; GLUCURONOSYLTRANSFERASE 2B7; NOMENCLATURE UPDATE; CRYSTAL-STRUCTURE; GENE SUPERFAMILY; GLUCURONIC ACID; HUMAN BILIRUBIN; GLUCOSIDATION; SPECIFICITY; METABOLISM	Recent studies in this laboratory characterized the UGT3A family enzymes, UGT3A1 and UGT3A2, and showed that neither uses the traditional UDP-glycosyltransferase UGT co-substrate UDP-glucuronic acid. Rather, UGT3A1 uses GlcNAc as preferred sugar donor and UGT3A2 uses UDP-Glc. The enzymatic characterization of UGT3A mutants, structural modeling, and multispecies gene analysis have now been employed to identify a residue within the active site of these enzymes that confers their unique sugar preferences. An asparagine (Asn-391) in the UGT signature sequence of UGT3A1 is necessary for utilization of UDP-GlcNAc. Conversely, a phenylalanine (Phe-391) in UGT3A2 favors UDP-Glc use. Mutation of Asn-391 to Phe in UGT3A1 enhances its ability to utilize UDP-Glc and completely inhibits its ability to use UDP-GlcNAc. An analysis of homology models docked with UDP-sugar donors indicates that Asn-391 in UGT3A1 is able to accommodate the N-acetyl group on C2 of UDP-GlcNAc so that the anomeric carbon atom (C1) is optimally situated for catalysis involving His-35. Replacement of Asn with Phe at position 391 disrupts this catalytically productive orientation of UDP-GlcNAc but allows a more optimal alignment of UDP-Glc for sugar donation. Multispecies sequence analysis reveals that only primates possess UGT3A sequences containing Asn-391, suggesting that other mammals may not have the capacity to N-acetylglucosaminidate small molecules. In support of this hypothesis, Asn-391-containing UGT3A forms from two non-human primates were found to use UDP-GlcNAc, whereas UGT3A isoforms from non-primates could not use this sugar donor. This work gives new insight into the residues that confer sugar specificity to UGT family members and suggests a primate-specific innovation in glycosidation of small molecules.	[Meech, Robyn] Flinders Univ S Australia, Flinders Med Ctr, Sch Med, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia	Flinders Medical Centre; Flinders University South Australia	Meech, R (corresponding author), Flinders Univ S Australia, Flinders Med Ctr, Sch Med, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia.	robyn.meech@flinders.edu.au		Meech, Robyn/0000-0002-6831-0801; Lewis, Benjamin/0000-0002-3714-9381; Mackenzie, Peter/0000-0002-0697-6878; miners, john/0000-0001-9555-9453	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia.	Battaglia E, 1998, DRUG METAB DISPOS, V26, P812; Bosio A, 1996, GENOMICS, V34, P69, DOI 10.1006/geno.1996.0242; Bowalgaha K, 2005, BRIT J CLIN PHARMACO, V60, P423, DOI 10.1111/j.1365-2125.2005.02446.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Kubo A, 2004, ARCH BIOCHEM BIOPHYS, V429, P198, DOI 10.1016/j.abb.2004.06.021; Mackenzie P, 2003, BIOCHEM PHARMACOL, V65, P417, DOI 10.1016/S0006-2952(02)01522-8; MacKenzie PI, 2011, MOL PHARMACOL, V79, P472, DOI 10.1124/mol.110.069336; Mackenzie PI, 2008, J BIOL CHEM, V283, P36205, DOI 10.1074/jbc.M807961200; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Meech R, 1997, CLIN EXP PHARMACOL P, V24, P907, DOI 10.1111/j.1440-1681.1997.tb02718.x; Meech R, 2010, DRUG METAB REV, V42, P45, DOI 10.3109/03602530903205823; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Osmani SA, 2008, PLANT PHYSIOL, V148, P1295, DOI 10.1104/pp.108.128256; Patana AS, 2007, MOL PHARMACOL, V72, P604, DOI 10.1124/mol.107.036871; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; Radominska-Pandya A, 2010, DRUG METAB REV, V42, P133, DOI 10.3109/03602530903209049; RITTER JK, 1992, J BIOL CHEM, V267, P3257; SENAFI SB, 1994, BIOCHEM J, V303, P233, DOI 10.1042/bj3030233; Tang CY, 2003, DRUG METAB DISPOS, V31, P37, DOI 10.1124/dmd.31.1.37; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Udomuksorn W, 2007, PHARMACOGENET GENOM, V17, P1017, DOI 10.1097/FPC.0b013e328256b1b6; Xiong Y, 2008, DRUG METAB DISPOS, V36, P517, DOI 10.1124/dmd.107.016469	28	24	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24122	24130		10.1074/jbc.M112.343608	http://dx.doi.org/10.1074/jbc.M112.343608			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621930	hybrid, Green Published			2022-12-28	WOS:000306651100007
J	Tripp, J; Hahn, A; Koenig, P; Flinner, N; Bublak, D; Brouwer, EM; Ertel, F; Mirus, O; Sinning, I; Tews, I; Schleiff, E				Tripp, Joanna; Hahn, Alexander; Koenig, Patrick; Flinner, Nadine; Bublak, Daniela; Brouwer, Eva M.; Ertel, Franziska; Mirus, Oliver; Sinning, Irmgard; Tews, Ivo; Schleiff, Enrico			Structure and Conservation of the Periplasmic Targeting Factor Tic22 Protein from Plants and Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-7120; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HETEROCYST DEVELOPMENT; BAM COMPLEX; CELL-WALL; ANABAENA; CHLOROPLASTS; TRANSPORTERS	Mitochondria and chloroplasts are of endosymbiotic origin. Their integration into cells entailed the development of protein translocons, partially by recycling bacterial proteins. We demonstrate the evolutionary conservation of the translocon component Tic22 between cyanobacteria and chloroplasts. Tic22 in Anabaena sp. PCC 7120 is essential. The protein is localized in the thylakoids and in the periplasm and can be functionally replaced by a plant orthologue. Tic22 physically interacts with the outer envelope biogenesis factor Omp85 in vitro and in vivo, the latter exemplified by immunoprecipitation after chemical cross-linking. The physical interaction together with the phenotype of a tic22 mutant comparable with the one of the omp85 mutant indicates a concerted function of both proteins. The three-dimensional structure allows the definition of conserved hydrophobic pockets comparable with those of ClpS or BamB. The results presented suggest a function of Tic22 in outer membrane biogenesis.	[Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci, Ctr Membrane Prote, D-60438 Frankfurt, Germany; [Koenig, Patrick; Sinning, Irmgard; Tews, Ivo] Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany	Goethe University Frankfurt; Ruprecht Karls University Heidelberg	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci, Ctr Membrane Prote, Max von Laue Str 9, D-60438 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017; Flinner, Nadine/AAZ-5668-2020; Tews, Ivo/A-2750-2010	Schleiff, Enrico/0000-0002-0518-3489; Tews, Ivo/0000-0002-4704-1139; Hahn, Alexander/0000-0003-4118-5438; Tripp, Joanna/0000-0003-1783-4098	Centre of Membrane Proteomics (Goethe University Frankfurt); interdisciplinary Ph.D. program of Baden-Wurttemberg; Cluster of Excellence Frankfurt; Volkswagenstiftung; Deutsche Forschungsgemeinschaft [TR985/1-1, SFB-TR01, SFB807, SFB638]	Centre of Membrane Proteomics (Goethe University Frankfurt); interdisciplinary Ph.D. program of Baden-Wurttemberg; Cluster of Excellence Frankfurt; Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Centre of Membrane Proteomics (Goethe University Frankfurt) (to A. H. and N. F.); the interdisciplinary Ph.D. program of Baden-Wurttemberg (to P. K.), the Cluster of Excellence Frankfurt (to P. K. and E. S.); the Volkswagenstiftung (to E. S.); Deutsche Forschungsgemeinschaft Grants TR985/1-1 (to J. T.), SFB-TR01 and SFB807 (to E. S.), and SFB638 (to I. S.).	Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c; Becker T, 2004, MOL BIOL CELL, V15, P5130, DOI 10.1091/mbc.E04-05-0405; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLACK K, 1995, J BACTERIOL, V177, P6440, DOI 10.1128/jb.177.22.6440-6448.1995; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Bohnsack MT, 2010, BBA-MOL CELL RES, V1803, P1115, DOI 10.1016/j.bbamcr.2010.06.005; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Fulda S, 1999, ARCH MICROBIOL, V171, P214, DOI 10.1007/s002030050702; Fulda S, 2002, PLANT MOL BIOL, V49, P107, DOI 10.1023/A:1014472322835; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Kalanon M, 2008, GENETICS, V179, P95, DOI 10.1534/genetics.107.085704; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladig R, 2011, PLANT J, V67, P181, DOI 10.1111/j.1365-313X.2011.04577.x; Lamzin V. S., 1999, METHOD ENZYMOL, V276, P269; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Moslavac S, 2005, J PROTEOME RES, V4, P1330, DOI 10.1021/pr050044c; Moslavac S, 2007, J BACTERIOL, V189, P7887, DOI 10.1128/JB.00750-07; Moslavac S, 2007, BIOL CHEM, V388, P823, DOI 10.1515/BC.2007.079; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolaisen K, 2010, BBA-BIOMEMBRANES, V1798, P2131, DOI 10.1016/j.bbamem.2010.07.008; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Nicolalsen K, 2009, J BASIC MICROB, V49, P5, DOI 10.1002/jobm.200800300; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Pernil R, 2008, MOL MICROBIOL, V67, P1067, DOI 10.1111/j.1365-2958.2008.06107.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roman-Hernandez G, 2009, P NATL ACAD SCI USA, V106, P8888, DOI 10.1073/pnas.0903614106; Schleiff E, 2011, BIOL CHEM, V392, P21, DOI 10.1515/BC.2011.005; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069	57	29	29	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24164	24173		10.1074/jbc.M112.341644	http://dx.doi.org/10.1074/jbc.M112.341644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22593581	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000306651100011
J	Mieczkowska, A; Basle, MF; Chappard, D; Mabilleau, G				Mieczkowska, Aleksandra; Basle, Michel F.; Chappard, Daniel; Mabilleau, Guillaume			Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BONE-MINERAL DENSITY; PPAR-GAMMA; CONTROLLED-TRIAL; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST FORMATION; CELL-LINE; IN-VITRO; ROSIGLITAZONE; ACTIVATION	Thiazolidinediones (TZDs) represent an interesting treatment of type 2 diabetes mellitus. However, adverse effects such as heart problems and bone fractures have already been reported. Previously, we reported that pioglitazone and rosiglitazone induce osteocyte apoptosis and sclerostin up-regulation; however, the molecular mechanisms leading to such effects are unknown. In this study, we found that TZDs rapidly activated Erk1/2 and p38. These activations were mediated through Ras proteins and GPR40, a receptor expressed on the surface of osteocytes. Activation of this pathway led only to osteocyte apoptosis but not sclerostin up-regulation. On the other hand, TZDs were capable of activating peroxisome proliferator-activated receptor-gamma, and activation of this signaling pathway led to sclerostin up-regulation but not osteocyte apoptosis. This study demonstrates two distinct signaling pathways activated in osteocytes in response to TZDs that could participate in the observed increase in fractures in TZD-treated patients.	[Mabilleau, Guillaume] Univ Angers, UNAM, IRIS, Inst Biol Sante,GEROM LHEA, F-49933 Angers 09, France; [Basle, Michel F.; Mabilleau, Guillaume] Univ Angers, UNAM, Inst Biol Sante, Serv Commun Imageries & Anal Microscop, F-49933 Angers 09, France; [Mieczkowska, Aleksandra; Mabilleau, Guillaume] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England	Universite d'Angers; Universite d'Angers; University of Oxford	Mabilleau, G (corresponding author), Univ Angers, UNAM, IRIS, Inst Biol Sante,GEROM LHEA, F-49933 Angers 09, France.	guillaume.mabilleau@univ-angers.fr	Mabilleau, Guillaume/M-8261-2018; Mieczkowska, Aleksandra/AAC-2979-2019	Mabilleau, Guillaume/0000-0003-1445-329X; Mieczkowska, Aleksandra/0000-0003-0155-4470	Contrat Region Pays de la Loire: Bioregos2 Program	Contrat Region Pays de la Loire: Bioregos2 Program(Region Pays de la Loire)	This work was supported by grants from the Contrat Region Pays de la Loire: Bioregos2 Program.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Berberoglu Z, 2007, J CLIN ENDOCR METAB, V92, P3523, DOI 10.1210/jc.2007-0431; Bonewald LF, 2008, PRIMER METABOLIC BON, P22; Chan BY, 2007, BONE, V40, P149, DOI 10.1016/j.bone.2006.07.029; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; Dewar BJ, 2007, MOL PHARMACOL, V72, P1146, DOI 10.1124/mol.107.037549; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dumas A, 2006, BIOMATERIALS, V27, P4204, DOI 10.1016/j.biomaterials.2006.03.044; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Gardner OS, 2003, J BIOL CHEM, V278, P46261, DOI 10.1074/jbc.M307827200; Glintborg D, 2008, J CLIN ENDOCR METAB, V93, P1696, DOI 10.1210/jc.2007-2249; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; JENNERMANN C, 1995, J BONE MINER RES, V10, pS241; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Mabilleau G, 2010, DIABETIC MED, V27, P925, DOI 10.1111/j.1464-5491.2010.03048.x; Mabilleau G, 2004, BIOMATERIALS, V25, P5155, DOI 10.1016/j.biomaterials.2003.12.026; Mabilleau Guillaume, 2011, Int J Biochem Mol Biol, V2, P240; Mbalaviele G, 2000, J BIOL CHEM, V275, P14388, DOI 10.1074/jbc.275.19.14388; Meymeh RH, 2007, CAN MED ASSOC J, V177, P723, DOI 10.1503/cmaj.071177; Okazaki R, 1999, ENDOCRINOLOGY, V140, P5060, DOI 10.1210/en.140.11.5060; Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI [10.1359/jbmr.080617, 10.1359/JBMR.080617]; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Takahashi N, 2003, METH MOLEC MED, V80, P129; Takeda K, 2001, J BIOL CHEM, V276, P48950, DOI 10.1074/jbc.M108722200; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wu PW, 2010, BIOCHEM BIOPH RES CO, V403, P36, DOI 10.1016/j.bbrc.2010.10.105; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	41	66	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23517	23526		10.1074/jbc.M111.324814	http://dx.doi.org/10.1074/jbc.M111.324814			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593579	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000306511300023
J	Plocinska, R; Purushotham, G; Sarva, K; Vadrevu, IS; Pandeeti, EVP; Arora, N; Plocinski, P; Madiraju, MV; Rajagopalan, M				Plocinska, Renata; Purushotham, Gorla; Sarva, Krishna; Vadrevu, Indumathi S.; Pandeeti, Emmanuel V. P.; Arora, Naresh; Plocinski, Przemyslaw; Madiraju, Murty V.; Rajagopalan, Malini			Septal Localization of the Mycobacterium tuberculosis MtrB Sensor Kinase Promotes MtrA Regulon Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; CELL-WALL HOMEOSTASIS; BACILLUS-SUBTILIS; RESPONSE REGULATOR; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; HISTIDINE KINASE; Z-RING; SYSTEM; DIVISION	The mechanisms responsible for activation of the MtrAB two-component regulatory signal transduction system, which includes sensor kinase MtrB and response regulator MtrA, are unknown. Here, we show that an MtrB-GFP fusion protein localized to the cell membrane, the septa, and the poles in Mycobacterium tuberculosis and Mycobacterium smegmatis. This localization was independent of MtrB phosphorylation status but dependent upon the assembly of FtsZ, the initiator of cell division. The M. smegmatis mtrB mutant was filamentous, defective for cell division, and contained lysozyme-sensitive cell walls. The mtrB phenotype was complemented by either production of MtrB protein competent for phosphorylation or overproduction of MtrA(Y102C) and MtrA(D13A) mutant proteins exhibiting altered phosphorylation potential, indicating that either MtrB phosphorylation or MtrB independent expression of MtrA regulon genes, including those involved in cell wall processing, are necessary for regulated cell division. In partial support of this observation, we found that the essential cell wall hydrolase ripA is an MtrA target and that the expression of bona fide MtrA targets ripA, fbpB, and dnaA were compromised in the mtrB mutant and partially rescued upon MtrA(Y102C) and MtrA(D13A) overproduction. MtrB septal assembly was compromised upon FtsZ depletion and exposure of cells to mitomycin C, a DNA damaging agent, which interferes with FtsZ ring assembly. Expression of MtrA targets was also compromised under the above conditions, indicating that MtrB septal localization and MtrA regulon expression are linked. We propose that MtrB septal association is a necessary feature of MtrB activation that promotes MtrA phosphorylation and MtrA regulon expression.	[Plocinska, Renata; Purushotham, Gorla; Sarva, Krishna; Vadrevu, Indumathi S.; Pandeeti, Emmanuel V. P.; Arora, Naresh; Plocinski, Przemyslaw; Madiraju, Murty V.; Rajagopalan, Malini] Univ Texas Hlth Ctr Tyler, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Madiraju, MV (corresponding author), Univ Texas Hlth Ctr Tyler, Tyler, TX 75708 USA.	murty.madiraju@uthct.edu; malini.rajagopalan@uthct.edu	Płociński, Przemysław A/S-5587-2017	Płociński, Przemysław A/0000-0002-6623-3494; Pandeeti, Emmanuel/0000-0001-8244-7401; Arora, Naresh/0000-0003-2131-735X	National Institutes of Health [AI48417, AI084734]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048417, R01AI084734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI48417 (to M.R.) and AI084734 (to M.M.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Al Zayer M, 2011, PLASMID, V65, P210, DOI 10.1016/j.plasmid.2011.01.002; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barendt SM, 2011, J BACTERIOL, V193, P2290, DOI 10.1128/JB.01555-10; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bisicchia P, 2010, MOL MICROBIOL, V75, P972, DOI 10.1111/j.1365-2958.2009.07036.x; Cangelosi GA, 2006, ANTIMICROB AGENTS CH, V50, P461, DOI 10.1128/AAC.50.2.461-468.2006; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06; Deng LL, 2005, BBA-PROTEINS PROTEOM, V1747, P57, DOI 10.1016/j.bbapap.2004.09.021; DHOPLE AM, 1980, JPN J EXP MED, V50, P469; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Dziadek J, 2003, MICROBIOL-SGM, V149, P1593, DOI 10.1099/mic.0.26023-0; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Fabret C, 1998, J BACTERIOL, V180, P6375; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Haydel SE, 2012, J BACTERIOL, V194, P354, DOI 10.1128/JB.06258-11; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Mizuguchi Y, 1975, Nihon Saikingaku Zasshi, V30, P297; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Nguyen HT, 2010, MOL MICROBIOL, V76, P348, DOI 10.1111/j.1365-2958.2010.07110.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Plocinski P, 2011, J BACTERIOL, V193, P3246, DOI 10.1128/JB.00188-11; Rajagopalan M, 2005, FEMS MICROBIOL LETT, V250, P9, DOI 10.1016/j.femsle.2005.06.043; Rajagopalan M, 2010, J BIOL CHEM, V285, P15816, DOI 10.1074/jbc.M109.040097; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Via LE, 1996, J BACTERIOL, V178, P3314, DOI 10.1128/jb.178.11.3314-3321.1996; Vollmer W, 2008, CHEM BIOL, V15, P93, DOI 10.1016/j.chembiol.2008.02.001; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000; Zahrt TC, 2003, INFECT IMMUN, V71, P6962, DOI 10.1128/IAI.71.12.6962-6970.2003	50	49	57	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23887	23899		10.1074/jbc.M112.346544	http://dx.doi.org/10.1074/jbc.M112.346544			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610443	hybrid, Green Published			2022-12-28	WOS:000306511300059
J	Bentmann, E; Neumann, M; Tahirovic, S; Rodde, R; Dormann, D; Haass, C				Bentmann, Eva; Neumann, Manuela; Tahirovic, Sabina; Rodde, Ramona; Dormann, Dorothee; Haass, Christian			Requirements for Stress Granule Recruitment of Fused in Sarcoma (FUS) and TAR DNA-binding Protein of 43 kDa (TDP-43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HIPPOCAMPAL CORNU AMMONIS-1; C-TERMINAL FRAGMENTS; NEURONAL VULNERABILITY; BASOPHILIC INCLUSIONS; SPLICING REGULATION; MUTATIONS; ALS; NUCLEAR	Cytoplasmic inclusions containing TAR DNA-binding protein of 43 kDa (TDP-43) or Fused in sarcoma (FUS) are a hallmark of amyotrophic lateral sclerosis (ALS) and several subtypes of frontotemporal lobar degeneration (FTLD). FUS-positive inclusions in FTLD and ALS patients are consistently co-labeled with stress granule (SG) marker proteins. Whether TDP-43 inclusions contain SG markers is currently still debated. We determined the requirements for SG recruitment of FUS and TDP-43 and found that cytoplasmic mislocalization is a common prerequisite for SG recruitment of FUS and TDP-43. For FUS, the arginine-glycine-glycine zinc finger domain, which is the protein's main RNA binding domain, is most important for SG recruitment, whereas the glycine-rich domain and RNA recognition motif (RRM) domain have a minor contribution and the glutamine-rich domain is dispensable. For TDP-43, both the RRM1 and the C-terminal glycine-rich domain are required for SG localization. ALS-associated point mutations located in the glycine-rich domain of TDP-43 do not affect SG recruitment. Interestingly, a 25-kDa C-terminal fragment of TDP-43, which is enriched in FTLD/ALS cortical inclusions but not spinal cord inclusions, fails to be recruited into SG. Consistently, inclusions in the cortex of FTLD patients, which are enriched for C-terminal fragments, are not co-labeled with the SG marker poly(A)-binding protein 1 (PABP-1), whereas inclusions in spinal cord, which contain full-length TDP-43, are frequently positive for this marker protein.	[Bentmann, Eva; Rodde, Ramona; Dormann, Dorothee; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Tahirovic, Sabina; Haass, Christian] DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Neumann, Manuela] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Zurich; University Zurich Hospital	Haass, C (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	christian.haass@dzne.lmu.de	Neumann, Manuela/F-6558-2011	Neumann, Manuela/0000-0002-6232-4057; Dormann, Dorothee/0000-0002-9260-2775	Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration [SFB 596]; Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF); EMBO post-doctoral fellowship; Robert Bosch Foundation; "Forschungsprofessur" of the Ludwig-Maximilians University	Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration(German Research Foundation (DFG)); Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EMBO post-doctoral fellowship(European Molecular Biology Organization (EMBO)); Robert Bosch Foundation; "Forschungsprofessur" of the Ludwig-Maximilians University	This work was supported by the Sonderforschungsbereich Molecular Mechanisms of Neurodegeneration (SFB 596), the Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF), and an EMBO post-doctoral fellowship (to D. D.).; Supported by the Robert Bosch Foundation. To whom correspondence may be addressed: Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians-University, Schillerstrasse 44, 80336 Munich, Germany. Tel.: 49-89-2180-75471; Fax: 49-89-2180-75415; E-mail: dorothee.dormann@dzne.lmu.de.; Supported by a "Forschungsprofessur" of the Ludwig-Maximilians University. To whom correspondence may be addressed: Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians-University and DZNE-German Center for Neurodegenerative Diseases, Munich, Schillerstrasse 44, 80336 Munich, Germany. Tel.: 49-89-2180-75471; Fax: 49-89-2180-75415; E-mail: christian.haass@dzne.lmu.de.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baumer D, 2010, NEUROLOGY, V75, P611, DOI 10.1212/WNL.0b013e3181ed9cde; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chio A, 2009, NEUROBIOL AGING, V30, P1272, DOI 10.1016/j.neurobiolaging.2009.05.001; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; DeGracia DJ, 2007, NEUROSCIENCE, V146, P562, DOI 10.1016/j.neuroscience.2007.01.050; Dewey C. M., 2012, BRAIN RES IN PRESS; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Fujita K, 2008, ACTA NEUROPATHOL, V116, P439, DOI 10.1007/s00401-008-0415-x; Furukawa Y, 2011, BBA-MOL BASIS DIS, V1812, P1577, DOI 10.1016/j.bbadis.2011.09.005; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kayali F, 2005, NEUROSCIENCE, V134, P1223, DOI 10.1016/j.neuroscience.2005.05.047; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lashley T, 2011, BRAIN, V134, P2548, DOI 10.1093/brain/awr160; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V121, P207, DOI 10.1007/s00401-010-0764-0; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mackenzie IRA, 2008, CURR OPIN NEUROL, V21, P693, DOI 10.1097/WCO.0b013e3283168d1d; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	74	192	195	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23079	23094		10.1074/jbc.M111.328757	http://dx.doi.org/10.1074/jbc.M111.328757			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22563080	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000306495000064
J	Kemp, MG; Reardon, JT; Lindsey-Boltz, LA; Sancar, A				Kemp, Michael G.; Reardon, Joyce T.; Lindsey-Boltz, Laura A.; Sancar, Aziz			Mechanism of Release and Fate of Excised Oligonucleotides during Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DNA-REPAIR; ESCHERICHIA-COLI; THYMINE DIMERS; HUMAN-CELLS; PYRIMIDINE DIMERS; HUMAN-FIBROBLASTS; NUCLEASE; DAMAGE	A wide range of environmental and carcinogenic agents form bulky lesions on DNA that are removed from the human genome in the form of short, similar to 30-nucleotide oligonucleotides by the process of nucleotide excision repair. Although significant insights have been made regarding the mechanisms of damage recognition, dual incisions, and repair resynthesis during nucleotide excision repair, the fate of the dual incision/excision product is unknown. Using excision assays with both mammalian cell-free extract and purified proteins, we unexpectedly discovered that lesion-containing oligonucleotides are released from duplex DNA in complex with the general transcription and repair factor, Transcription Factor IIH (TFIIH). Release of excision products from TFIIH requires ATP but not ATP hydrolysis, and release occurs slowly, with a t(1/2) of 3.3 h. Excised oligonucleotides released from TFIIH then become bound by the single-stranded binding protein Replication Protein A or are targeted by cellular nucleases. These results provide a mechanism for release and an understanding of the initial fate of excised oligonucleotides during nucleotide excision repair.	[Kemp, Michael G.; Reardon, Joyce T.; Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010; Kemp, Michael G./AAT-1545-2021	Lindsey-Boltz, Laura/0000-0001-6493-8194; Kemp, Michael G./0000-0001-8203-0745	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833 (to A. S.).	Bessho T, 1997, MOL CELL BIOL, V17, P6822, DOI 10.1128/MCB.17.12.6822; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; BOYCE RP, 1964, P NATL ACAD SCI USA, V51, P293, DOI 10.1073/pnas.51.2.293; CLEAVER JE, 1991, PHOTOCHEM PHOTOBIOL, V54, P393, DOI 10.1111/j.1751-1097.1991.tb02033.x; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HUANG JC, 1994, J BIOL CHEM, V269, P19034; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; KAYE J, 1980, CANCER RES, V40, P696; LABELLE M, 1982, PHOTOCHEM PHOTOBIOL, V36, P319, DOI 10.1111/j.1751-1097.1982.tb04381.x; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Mu D, 1997, J BIOL CHEM, V272, P28971, DOI 10.1074/jbc.272.46.28971; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; ORREN DK, 1992, J BIOL CHEM, V267, P780; Pathania S, 2011, MOL CELL, V44, P235, DOI 10.1016/j.molcel.2011.09.002; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 1996, J BIOL CHEM, V271, P19451, DOI 10.1074/jbc.271.32.19451; Reardon JT, 1997, NUCLEIC ACIDS RES, V25, P1015, DOI 10.1093/nar/25.5.1015; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; REGAN JD, 1968, BIOPHYS J, V8, P319, DOI 10.1016/S0006-3495(68)86490-2; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SETLOW RB, 1969, P NATL ACAD SCI USA, V64, P1035, DOI 10.1073/pnas.64.3.1035; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; WEINFELD M, 1986, BIOCHEMISTRY-US, V25, P2656, DOI 10.1021/bi00357a055; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	43	65	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22889	22899		10.1074/jbc.M112.374447	http://dx.doi.org/10.1074/jbc.M112.374447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573372	Green Published, hybrid			2022-12-28	WOS:000306495000046
J	Liew, CW; Nilsson, M; Chen, MW; Sun, HH; Cornvik, T; Liang, ZX; Lescar, J				Liew, Chong Wai; Nilsson, Martina; Chen, Ming Wei; Sun, Huihua; Cornvik, Tobias; Liang, Zhao-Xun; Lescar, Julien			Crystal Structure of the Acyltransferase Domain of the Iterative Polyketide Synthase in Enediyne Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; ANTITUMOR ANTIBIOTIC C-1027; COA-ACP TRANSACYLASE; MALONYL-COA; GENE-CLUSTER; 6-DEOXYERYTHRONOLIDE-B SYNTHASE; STREPTOMYCES-COELICOLOR; HELICOBACTER-PYLORI; ESCHERICHIA-COLI; DOCKING SITE	Biosynthesis of the enediyne natural product dynemicin in Micromonospora chersina is initiated by DynE8, a highly reducing iterative type I polyketide synthase that assembles polyketide intermediates from the acetate units derived solely from malonyl-CoA. To understand the substrate specificity and the evolutionary relationship between the acyltransferase (AT) domains of DynE8, fatty acid synthase, and modular polyketide synthases, we overexpressed a 44-kDa fragment of DynE8 (hereafter named AT(DYN10)) encompassing its entire AT domain and the adjacent linker domain. The crystal structure at 1.4 angstrom resolution unveils a alpha/beta hydrolase and a ferredoxin-like subdomain with the Ser-His catalytic dyad located in the cleft between the two subdomains. The linker domain also adopts a alpha/beta fold abutting the AT catalytic domain. Co-crystallization with malonyl-CoA yielded a malonyl-enzyme covalent complex that most likely represents the acyl-enzyme intermediate. The structure explains the preference for malonyl-CoA with a conserved arginine orienting the carboxylate group of malonate and several nonpolar residues that preclude alpha-alkyl malonyl-CoA binding. Co-crystallization with acetyl-CoA revealed two noncovalently bound acetates generated by the enzymatic hydrolysis of acetylCoA that acts as an inhibitor for DynE8. This suggests that the AT domain can upload the acyl groups from either malonyl-CoA or acetyl-CoA onto the catalytic Ser(651) residue. However, although the malonyl group can be transferred to the acyl carrier protein domain, transfer of the acetyl group to the acyl carrier protein domain is suppressed. Local structural differences may account for the different stability of the acyl-enzyme intermediates.	[Liew, Chong Wai; Nilsson, Martina; Chen, Ming Wei; Sun, Huihua; Cornvik, Tobias; Liang, Zhao-Xun; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Lescar, Julien] CNRS, UMR 6098, Marseille, France	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	zxliang@ntu.edu.sg; Julien@ntu.edu.sg	Liang, Zhao-Xun/A-2191-2011	Chen, Ming Wei/0000-0003-0718-866X; Sun, Huihua/0000-0002-0538-7553; Liang, Zhao-Xun/0000-0002-3128-1330	Ministry of Education of Singapore through Academic Research Council; Biomedical Research Council [08/1/22/19/589]; CNRS	Ministry of Education of Singapore through Academic Research Council(Ministry of Education, Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work is supported by the Ministry of Education of Singapore through Academic Research Council grants (to Z.-X. L.), Biomedical Research Council grant 08/1/22/19/589, and an Action Thematique et Incitative sur Programme from the CNRS (to J. L.).	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Chen AY, 2007, CHEM BIOL, V14, P784, DOI 10.1016/j.chembiol.2007.05.015; Chen AY, 2006, J AM CHEM SOC, V128, P3067, DOI 10.1021/ja058093d; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; DeLano W.L, PYMOL MOL GRAPHICS S; Dreier J, 2001, BIOCHEMISTRY-US, V40, P12407, DOI 10.1021/bi011108+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao Q, 2008, FEMS MICROBIOL LETT, V282, P105, DOI 10.1111/j.1574-6968.2008.01112.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong SK, 2010, FEBS LETT, V584, P1240, DOI 10.1016/j.febslet.2010.02.038; JOSHI VC, 1971, ARCH BIOCHEM BIOPHYS, V143, P493, DOI 10.1016/0003-9861(71)90234-7; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kim CY, 2004, BIOCHEMISTRY-US, V43, P13892, DOI 10.1021/bi048418n; Kong R, 2008, J AM CHEM SOC, V130, P8142, DOI 10.1021/ja8019643; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang ZX, 2010, NAT PROD REP, V27, P499, DOI 10.1039/b908165h; Liew CW, 2010, J MOL BIOL, V404, P291, DOI 10.1016/j.jmb.2010.09.041; Lim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020549; Liu W, 2005, CHEM BIOL, V12, P293, DOI 10.1016/j.chembiol.2004.12.013; Liu W, 2000, ANTIMICROB AGENTS CH, V44, P382, DOI 10.1128/AAC.44.2.382-392.2000; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; Liu WZ, 2006, FEBS LETT, V580, P697, DOI 10.1016/j.febslet.2005.12.085; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SERRE L, 1994, J MOL BIOL, V242, P99, DOI 10.1006/jmbi.1994.1559; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen B., 2005, FRONTIER MED CHEM, V2, P357; Smith AL, 1996, J MED CHEM, V39, P2103, DOI 10.1021/jm9600398; Sun HH, 2009, CHEM COMMUN, P7399, DOI 10.1039/b916751j; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Van Lanen SG, 2007, J AM CHEM SOC, V129, P13082, DOI 10.1021/ja073275o; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wong FT, 2011, BIOCHEMISTRY-US, V50, P6539, DOI 10.1021/bi200632j; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784; Zhang L, 2007, PROTEIN SCI, V16, P1184, DOI 10.1110/ps.072757307; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200	48	28	28	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23203	23215		10.1074/jbc.M112.362210	http://dx.doi.org/10.1074/jbc.M112.362210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589546	Green Published, hybrid			2022-12-28	WOS:000306495000075
J	Dey, S; Savant, S; Teske, BF; Hatzoglou, M; Calkhoven, CF; Wek, RC				Dey, Souvik; Savant, Sudha; Teske, Brian F.; Hatzoglou, Maria; Calkhoven, Cornelis F.; Wek, Ronald C.			Transcriptional Repression of ATF4 Gene by CCAAT/Enhancer-binding Protein beta (C/EBP beta) Differentially Regulates Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ASPARAGINE SYNTHETASE GENE; VANISHING WHITE-MATTER; AMINO-ACID DEPRIVATION; CANCER-CELL LINES; TRANSLATION INITIATION; MAMMALIAN-CELLS; MESSENGER-RNA; INCREASES TRANSLATION; MOLECULAR-MECHANISMS	Different environmental stresses induce the phosphorylation of eIF2 (eIF2 similar to P), repressing global protein synthesis coincident with preferential translation of ATF4. ATF4 is a transcriptional activator of genes involved in metabolism and nutrient uptake, antioxidation, and regulation of apoptosis. Because ATF4 is a common downstream target that integrates signaling from different eIF2 kinases and their respective stress signals, the eIF2 similar to P/ATF4 pathway is collectively referred to as the integrated stress response. Although eIF2 similar to P elicits translational control in response to many different stresses, there are selected stresses, such as exposure to UV irradiation, that do not increase ATF4 expression despite robust eIF2 similar to P. The rationale for this discordant induction of ATF4 expression and eIF2 similar to P in response to UV irradiation is that transcription of ATF4 is repressed, and therefore ATF4 mRNA is not available for preferential translation. In this study, we show that C/EBP beta is a transcriptional repressor of ATF4 during UV stress. C/EBP beta binds to critical elements in the ATF4 promoter, resulting in its transcriptional repression. Expression of C/EBP beta increases in response to UV stress, and the liver-enriched inhibitory protein (LIP) isoform of C/EBP beta, but not the liver-enriched activating protein (LAP) version, represses ATF4 transcription. Loss of the liver-enriched inhibitory protein isoform results in increased ATF4 mRNA levels in response to UV irradiation and subsequent recovery of ATF4 translation, leading to enhanced expression of its target genes. Together these results illustrate how eIF2 similar to P and translational control combined with transcription factors regulated by alternative signaling pathways can direct programs of gene expression that are specifically tailored to each environmental stress.	[Dey, Souvik; Savant, Sudha; Teske, Brian F.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Calkhoven, Cornelis F.] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany	Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu		Calkhoven, Cornelis/0000-0001-6318-7210	National Institutes of Health [GM049164, DK053307, T32DK064466]; American Heart Association Predoctoral Fellowship [11PRE7240012]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064466, R01DK053307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049164 (to R. C. W.), DK053307 (to M. H.), and T32DK064466 (a predoctoral fellowship to B. F. T.). This work was also supported by American Heart Association Predoctoral Fellowship 11PRE7240012 (to B. F. T).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Levenson VV, 2000, CANCER RES, V60, P5027; Li B, 2008, J CELL BIOCHEM, V103, P1657, DOI 10.1002/jcb.21554; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1226, DOI 10.1167/iovs.10-5775; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Schmitt-Ney M, 2000, J BIOL CHEM, V275, P40839, DOI 10.1074/jbc.M007440200; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tanabe M, 2003, CANCER RES, V63, P8592; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	67	28	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21936	21949		10.1074/jbc.M112.351783	http://dx.doi.org/10.1074/jbc.M112.351783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556424	Green Published, hybrid			2022-12-28	WOS:000306418600033
J	Mahajan, K; Coppola, D; Rawal, B; Chen, YA; Lawrence, HR; Engelman, RW; Lawrence, NJ; Mahajan, NP				Mahajan, Kiran; Coppola, Domenico; Rawal, Bhupendra; Chen, Y. Ann; Lawrence, Harshani R.; Engelman, Robert W.; Lawrence, Nicholas J.; Mahajan, Nupam P.			Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE ACK1; DOUBLE-STRAND BREAKS; DNA-DAMAGE; ATM KINASE; ACTIVATION; AUTOPHOSPHORYLATION; PROGRESSION; INHIBITOR; RESPONSES; THERAPY	Androgen deprivation therapy has been the standard of care in prostate cancer due to its effectiveness in initial stages. However, the disease recurs, and this recurrent cancer is referred to as castration-resistant prostate cancer (CRPC). Radiotherapy is the treatment of choice; however, in addition to androgen independence, CRPC is often resistant to radiotherapy, making radioresistant CRPC an incurable disease. The molecular mechanisms by which CRPC cells acquire radioresistance are unclear. Androgen receptor (AR)-tyrosine 267 phosphorylation by Ack1 tyrosine kinase (also known as TNK2) has emerged as an important mechanism of CRPC growth. Here, we demonstrate that pTyr(267)-AR is recruited to the ATM (ataxia telangiectasia mutated) enhancer in an Ack1-dependent manner to up-regulate ATM expression. Mice engineered to express activated Ack1 exhibited a significant increase in pTyr(267)-AR and ATM levels. Furthermore, primary human CRPCs with up-regulated activated Ack1 and pTyr(267)-AR also exhibited significant increase in ATM expression. The Ack1 inhibitor AIM-100 not only inhibited Ack1 activity but also was able to suppress AR Tyr(267) phosphorylation and its recruitment to the ATM enhancer. Notably, AIM-100 suppressed Ack1 mediated ATM expression and mitigated the growth of radioresistant CRPC tumors. Thus, our study uncovers a previously unknown mechanism of radioresistance in CRPC, which can be therapeutically reversed by a new synergistic approach that includes radiotherapy along with the suppression of Ack1/AR/ATM signaling by the Ack1 inhibitor, AIM-100.	[Mahajan, Kiran; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Coppola, Domenico; Engelman, Robert W.] H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL 33612 USA; [Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL 33612 USA; [Rawal, Bhupendra; Chen, Y. Ann] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA; [Lawrence, Harshani R.; Lawrence, Nicholas J.] H Lee Moffitt Canc Ctr & Res Inst, High Throughput Screening Core Facil, Tampa, FL 33612 USA; [Mahajan, Nupam P.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Mahajan, NP (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, 12902 Magnolia Dr, Tampa, FL 33612 USA.	nupam.mahajan@moffitt.org	Mahajan, Kiran/ABA-3013-2020	Mahajan, Kiran/0000-0001-7192-396X; Chen, yian/0000-0003-1468-3490	National Institutes of Health Grant [1R01CA135328]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA135328] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA135328.	Attar RM, 2009, CLIN CANCER RES, V15, P3251, DOI 10.1158/1078-0432.CCR-08-1171; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Cesaretti JA, 2005, INT J RADIAT ONCOL, V61, P196, DOI 10.1016/j.ijrobp.2004.09.031; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Di Lorenzo G, 2010, DRUGS, V70, P983, DOI 10.2165/10898600-000000000-00000; DiMauro EF, 2007, BIOORG MED CHEM LETT, V17, P2305, DOI 10.1016/j.bmcl.2007.01.057; Fang Zhiming, 2010, Genome Integr, V1, P9, DOI 10.1186/2041-9414-1-9; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kastan MB, 2001, ACTA ONCOL, V40, P686; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Kawabe T, 2004, MOL CANCER THER, V3, P513; Krempler A, 2007, CELL CYCLE, V6, P1682, DOI 10.4161/cc.6.14.4480; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Mahajan K, 2012, AM J PATHOL, V180, P1386, DOI 10.1016/j.ajpath.2011.12.028; Mahajan K, 2010, PROSTATE, V70, P1274, DOI 10.1002/pros.21163; Mahajan K, 2010, J CELL PHYSIOL, V224, P327, DOI 10.1002/jcp.22162; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Prieto-Echague V, 2010, J BIOL CHEM, V285, P10605, DOI 10.1074/jbc.M109.060459; Pugh TJ, 2009, CLIN CANCER RES, V15, P5008, DOI 10.1158/1078-0432.CCR-08-3357; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200	41	57	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22112	22122		10.1074/jbc.M112.357384	http://dx.doi.org/10.1074/jbc.M112.357384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22566699	hybrid, Green Published			2022-12-28	WOS:000306418600048
J	Sharma, P; Yamini, S; Dube, D; Singh, A; Sinha, M; Dey, S; Mitra, DK; Kaur, P; Sharma, S; Singh, TP				Sharma, Pradeep; Yamini, Shavait; Dube, Divya; Singh, Amar; Sinha, Mau; Dey, Sharmistha; Mitra, Dipendra K.; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			Structural Studies on Molecular Interactions between Camel Peptidoglycan Recognition Protein, CPGRP-S, and Peptidoglycan Moieties N-Acetylglucosamine and N-Acetylmuramic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; I-ALPHA; DROSOPHILA; INTERFACES; RECEPTOR; SUBUNIT; BINDING; FAMILY; PGRPS	Peptidoglycan (PGN) consists of repeating units of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), which are cross-linked by short peptides. It is well known that PGN forms a major cell wall component of bacteria making it an important ligand for the recognition by peptidoglycan recognition proteins (PGRPs) of the host. The binding studies showed that PGN, GlcNAc, and MurNAc bind to camel PGRP-S (CPGRP-S) with affinities corresponding to dissociation constants of 1.3 x 10(-9), 2.6 x 10(-7), and 1.8 x 10(-7) M, respectively. The crystal structure determinations of the complexes of CPGRP-S with GlcNAc and MurNAc showed that the structures consist of four crystallographically independent molecules, A, B, C, and D, in the asymmetric unit that exists as A-B and C-D units of two neighboring linear polymers. The structure determinations showed that compounds GlcNAc and MurNAc bound to CPGRP-S at the same subsite in molecule C. Both GlcNAc and MurNAc form several hydrogen bonds and extensive hydrophobic interactions with protein atoms, indicating the specific nature of their bindings. Flow cytometric studies showed that PGN enhanced the secretions of TNF-alpha and IL-6 from human peripheral blood mononuclear cells. The introduction of CPGRP-S to the PGN-challenged cultured peripheral blood mononuclear cells reduced the expressions of proinflammatory cytokines, TNF-alpha and IL-6. This showed that CPGRP-S inhibited PGN-induced production of proinflammatory cytokines and down-regulated macrophage-mediated inflammation, indicating its potential applications as an antibacterial agent.	[Sharma, Pradeep; Yamini, Shavait; Dube, Divya; Sinha, Mau; Dey, Sharmistha; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Singh, Amar; Mitra, Dipendra K.] All India Inst Med Sci, Dept Transplantat Immunol & Immunogenet, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		SINHA, MAU/0000-0003-3011-9160	Department of Science and Technology and Department of Biotechnology; Ministry of Science and Technology, Government of India (New Delhi); Department of Science and Technology Innovation in Science Pursuit for Inspired Research (INSPIRE); Department of Biotechnology Distinguished Biotechnology Research	Department of Science and Technology and Department of Biotechnology; Ministry of Science and Technology, Government of India (New Delhi); Department of Science and Technology Innovation in Science Pursuit for Inspired Research (INSPIRE); Department of Biotechnology Distinguished Biotechnology Research	This work was supported by the Department of Science and Technology and Department of Biotechnology, Ministry of Science and Technology, Government of India (New Delhi).; Recipient of a Department of Science and Technology Innovation in Science Pursuit for Inspired Research (INSPIRE) Faculty award.; Recipient of a Department of Biotechnology Distinguished Biotechnology Research Professorship grant. To whom correspondence should be addressed: Dept. of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India. Tel.: 91-11-2658-8931; Fax: 91-11-2658-8663; E-mail: tpsingh.aiims@gmail.com.	ARGOS P, 1988, PROTEIN ENG, V2, P101, DOI 10.1093/protein/2.2.101; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; Dasgupta S, 1997, PROTEINS, V28, P494, DOI 10.1002/(SICI)1097-0134(199708)28:4<494::AID-PROT4>3.0.CO;2-A; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; Doyle R.J., 2001, MOL MED MICROBIOLOGY, P137; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Dziarski R. A., 2000, GLYCOMICROBIOLOGY, P145; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2008, ACTA CRYSTALLOGR D, V64, P1, DOI 10.1107/S0907444907051554; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HOIJER MA, 1995, INFECT IMMUN, V63, P1652, DOI 10.1128/IAI.63.5.1652-1657.1995; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kappeler SR, 2004, J DAIRY SCI, V87, P2660, DOI 10.3168/jds.S0022-0302(04)73392-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2005, J BIOL CHEM, V280, P37005, DOI 10.1074/jbc.M506385200; Larson SB, 2010, ACTA CRYSTALLOGR D, V66, P1316, DOI 10.1107/S0907444910040370; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REISSIG JL, 1955, J BIOL CHEM, V217, P959; SCHLEIFER KH, 1983, ANNU REV MICROBIOL, V37, P143, DOI 10.1146/annurev.mi.37.100183.001043; Sharma P, 2008, J MOL BIOL, V378, P923, DOI 10.1016/j.jmb.2008.03.018; Sharma P, 2011, J BIOL CHEM, V286, P31723, DOI 10.1074/jbc.M111.264374; Sharma P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228163; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	41	8	8	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22153	22164		10.1074/jbc.M111.321307	http://dx.doi.org/10.1074/jbc.M111.321307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573327	Green Published, hybrid			2022-12-28	WOS:000306418600054
J	Khan, MJ; Alam, MR; Waldeck-Weiermair, M; Karsten, F; Groschner, L; Riederer, M; Hallstrom, S; Rockenfeller, P; Konya, V; Heinemann, A; Madeo, F; Graier, WF; Malli, R				Khan, Muhammad Jadoon; Alam, Muhammad Rizwan; Waldeck-Weiermair, Markus; Karsten, Felix; Groschner, Lukas; Riederer, Monika; Hallstroem, Seth; Rockenfeller, Patrick; Konya, Viktoria; Heinemann, Akos; Madeo, Frank; Graier, Wolfgang F.; Malli, Roland			Inhibition of Autophagy Rescues Palmitic Acid-induced Necroptosis of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY-ACIDS; PROGRAMMED NECROSIS; DEATH MECHANISMS; APOPTOSIS; CALCIUM; PROTEIN; BETA; DEGRADATION; MOTILITY	Accumulation of palmitic acid (PA) in cells from nonadipose tissues is known to induce lipotoxicity resulting in cellular dysfunction and death. The exact molecular pathways of PA-induced cell death are still mysterious. Here, we show that PA triggers autophagy, which did not counteract but in contrast promoted endothelial cell death. The PA-induced cell death was predominantly necrotic as indicated by annexin V and propidium iodide (PI) staining, absence of caspase activity, low levels of DNA hypoploidy, and an early ATP depletion. In addition PA induced a strong elevation of mRNA levels of ubiquitin carboxyl-terminalhydrolase(CYLD), aknownmediatorofnecroptosis. Moreover, siRNA-mediated knockdown of CYLD significantly antagonized PA-induced necrosis of endothelial cells. In contrast, inhibition and knockdown of receptor interacting protein kinase 1 (RIPK1) had no effect on PA-induced necrosis, indicating the induction of a CYLD-dependent but RIPK1-independent cell death pathway. PA was recognized as a strong and early inducer of autophagy. The inhibition of autophagy by both pharmacological inhibitors and genetic knockdown of the autophagy-specific genes, vacuolar protein sorting 34 (VPS34), and autophagy-related protein 7 (ATG7), could rescue the PA-induced death of endothelial cells. Moreover, the initiation of autophagy and cell death by PA was reduced in endothelial cells loaded with the Ca2+ chelator 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid-(acetoxymethyl) ester (BAPTA-AM), indicating that Ca2+ triggers the fatal signaling of PA. In summary, we introduce an unexpected mechanism of lipotoxicity in endothelial cells and provide several novel strategies to counteract the lipotoxic signaling of PA.	[Khan, Muhammad Jadoon; Alam, Muhammad Rizwan; Waldeck-Weiermair, Markus; Karsten, Felix; Groschner, Lukas; Riederer, Monika; Graier, Wolfgang F.; Malli, Roland] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Hallstroem, Seth] Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, A-8010 Graz, Austria; [Konya, Viktoria; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Ctr Mol Med, A-8010 Graz, Austria; [Rockenfeller, Patrick; Madeo, Frank] Graz Univ, Ctr Mol Biosci, A-8010 Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Graz	Malli, R (corresponding author), Harrachgasse 21-3, Graz, Austria.	roland.malli@medunigraz.at	Groschner, Lukas/J-9398-2012; Khan, Muhammad Jadoon/AAG-5484-2019; Waldeck-Weiermair, Markus/AAV-5193-2020; Groschner, Lukas/AHD-6319-2022; Graier, Wolfgang F./B-7052-2008; Alam, Muhammad Rizwan/AAE-2266-2019	Groschner, Lukas/0000-0002-4325-0232; Waldeck-Weiermair, Markus/0000-0002-5792-6766; Groschner, Lukas/0000-0002-4325-0232; Graier, Wolfgang F./0000-0003-1871-3298; Alam, Muhammad Rizwan/0000-0002-1578-5723; Malli, Roland/0000-0001-6327-8729; Rockenfeller, Patrick/0000-0002-1643-3885; Konya, Viktoria/0000-0002-7999-9093; Madeo, Frank/0000-0002-5070-1329; Heinemann, Akos/0000-0002-8554-2372	Austrian Science Fund (FWF) [F3010-B05 (SFB LIPOTOX), P21857-B18, P22553-B18, P23490]; FWF at Medical University of Graz; Austrian Science Fund (FWF) [P 21857, P 23490, P 22553, P 22521] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF at Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Fund (FWF) Grants F3010-B05 (SFB LIPOTOX), P21857-B18, P22553-B18, and P23490.; Supported by the FWF within the Molecular Medicine and Neuroscience Ph.D. programs at the Medical University of Graz.	Almaguel FG, 2010, BRAIN RES, V1318, P133, DOI 10.1016/j.brainres.2009.12.038; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Borradaile NA, 2005, CURR HYPERTENS REP, V7, P412, DOI 10.1007/s11906-005-0035-y; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Csordas A, 2011, CARDIOVASC RES, V92, P141, DOI 10.1093/cvr/cvr165; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Esenabhalu VE, 2003, ANTIOXID REDOX SIGN, V5, P147, DOI 10.1089/152308603764816505; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Fu M, 2011, CELL DEATH DIFFER, V18, P1057, DOI 10.1038/cdd.2010.181; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Grotemeier A, 2010, CELL SIGNAL, V22, P914, DOI 10.1016/j.cellsig.2010.01.015; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ilangovan R, 2003, J BIOL CHEM, V278, P30993, DOI 10.1074/jbc.M303763200; Johnson VL, 2000, J CELL SCI, V113, P2941; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Meyers Melissa R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P365, DOI 10.1097/MED.0b013e3282be90a8; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rockenfeller P, 2010, CELL CYCLE, V9, P2836, DOI 10.4161/cc.9.14.12346; Roh MS, 2004, APOPTOSIS, V9, P583, DOI 10.1023/B:APPT.0000038037.68908.6e; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	46	98	100	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21110	21120		10.1074/jbc.M111.319129	http://dx.doi.org/10.1074/jbc.M111.319129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556413	hybrid, Green Published			2022-12-28	WOS:000306416800032
J	Adhikary, R; Yu, WN; Oda, M; Zimmermann, J; Romesberg, FE				Adhikary, Ramkrishna; Yu, Wayne; Oda, Masayuki; Zimmermann, Joerg; Romesberg, Floyd E.			Protein Dynamics and the Diversity of an Antibody Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTHALPY-ENTROPY COMPENSATION; PHOTON-ECHO SPECTROSCOPY; MOONLIGHTING PROTEINS; MOLECULAR RECOGNITION; SOLVATION DYNAMICS; IMMUNOLOGICAL EVOLUTION; CATALYTIC PROMISCUITY; COMBINING SITE; FLEXIBILITY; BINDING	The immune system is remarkable in its ability to produce antibodies (Abs) with virtually any specificity from a limited repertoire of germ line precursors. Although the contribution of sequence diversity to this molecular recognition has been studied for decades, recent models suggest that protein dynamics may also broaden the range of targets recognized. To characterize the contribution of protein dynamics to immunological molecular recognition, we report the sequence, thermodynamic, and time-resolved spectroscopic characterization of a panel of eight Abs elicited to the chromophoric antigen 8-methoxypyrene-1,3,6-trisulfonate (MPTS). Based on the sequence data, three of the Abs arose from unique germ line Abs, whereas the remaining five comprise two sets of siblings that arose by somatic mutation of a common precursor. The thermodynamic data indicate that the Abs recognize MPTS via a variety of mechanisms. Although the spectroscopic data reveal small differences in protein dynamics, the anti-MPTS Abs generally show similar levels of flexibility and conformational heterogeneity, possibly representing the convergent evolution of the dynamics necessary for function. However, one Ab is significantly more rigid and conformationally homogeneous than the others, including a sibling Ab from which it differs by only five somatic mutations. This example of divergent evolution demonstrates that point mutations are capable of fixing significant differences in protein dynamics. The results provide unique insight into how high affinity Abs may be produced that bind virtually any target and possibly, from a more general perspective, how new protein functions are evolved.	[Adhikary, Ramkrishna; Yu, Wayne; Zimmermann, Joerg; Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan	Scripps Research Institute; Kyoto Prefectural University	Zimmermann, J (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jzimm@scripps.edu; floyd@scripps.edu	Adhikary, Ramkrishna/F-3002-2011; Zimmermann, Joerg/B-7725-2009; Romesberg, Floyd/M-2821-2017	Romesberg, Floyd/0000-0001-6317-1315; Oda, Masayuki/0000-0002-8568-4223; Adhikary, Ramkrishna/0000-0003-0569-7890; Zimmermann, Joerg/0000-0002-1210-9471	National Science Foundation Grant [CHE-0848902]; Direct For Mathematical & Physical Scien [0848902] Funding Source: National Science Foundation	National Science Foundation Grant(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grant CHE-0848902 (to F. E. R.).	Agarwal PK, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-2; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; Breinl F, 1930, H-S Z PHYSIOL CHEM, V192, P45, DOI 10.1515/bchm2.1930.192.1-3.45; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Cho MH, 1996, J PHYS CHEM-US, V100, P11944, DOI 10.1021/jp9601983; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; deBoeij WP, 1996, J PHYS CHEM-US, V100, P11806, DOI 10.1021/jp961039m; DePristo MA, 2007, HFSP J, V1, P94, DOI 10.2976/1.2754665; Dietzek B, 2006, CHEM-EUR J, V12, P5105, DOI 10.1002/chem.200501093; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fleming GR, 1996, ANNU REV PHYS CHEM, V47, P109, DOI 10.1146/annurev.physchem.47.1.109; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Gao JL, 2004, TOP CURR CHEM, V238, P113, DOI 10.1007/b94541; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Groot ML, 1998, J PHYS CHEM B, V102, P5923, DOI 10.1021/jp9808680; HARLOW E, 1988, ANTIBODIES LABORATOR, P72; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; Jimenez R, 2004, P NATL ACAD SCI USA, V101, P3803, DOI 10.1073/pnas.0305745101; Jimenez R, 2002, J PHYS CHEM B, V106, P1090, DOI 10.1021/jp013110g; Jordanides XJ, 1999, J PHYS CHEM B, V103, P7995, DOI 10.1021/jp9910993; KABAT EA, 1991, J IMMUNOL, V147, P1709; Kang JH, 2007, MOL IMMUNOL, V44, P3623, DOI 10.1016/j.molimm.2007.03.006; Larsen DS, 1999, J CHEM PHYS, V111, P8970, DOI 10.1063/1.480240; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; Nagasawa Y, 1997, J CHEM PHYS, V106, P4840, DOI 10.1063/1.473533; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Passino SA, 1997, J PHYS CHEM A, V101, P725, DOI 10.1021/jp9621383; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2; Piatigorsky J., 2007, GENE SHARING EVOLUTI; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; SASTRY L, 1989, P NATL ACAD SCI USA, V86, P5728, DOI 10.1073/pnas.86.15.5728; Silverstein AM, 2003, NAT IMMUNOL, V4, P829, DOI 10.1038/ni0903-829; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Steele E. J., 1990, SOMATIC HYPERMUTATIO; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; ULRICH HD, 1995, P NATL ACAD SCI USA, V92, P11907, DOI 10.1073/pnas.92.25.11907; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WIEDERRECHT GP, 1995, J PHYS CHEM-US, V99, P8918, DOI 10.1021/j100021a069; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zimmermann J., 2009, PROTEIN ENG HDB, P147; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	60	22	22	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27139	27147		10.1074/jbc.M112.372698	http://dx.doi.org/10.1074/jbc.M112.372698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685303	Green Published, hybrid			2022-12-28	WOS:000307386000066
J	Cao, X; Yang, F; Zheng, J; Wang, KW				Cao, Xu; Yang, Fan; Zheng, Jie; Wang, Kewei			Intracellular Proton-mediated Activation of TRPV3 Channels Accounts for the Exfoliation Effect of alpha-Hydroxyl Acids on Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL CHANNELS; CAPSAICIN RECEPTOR; 2-AMINOETHOXYDIPHENYL BORATE; GLYCOLIC ACID; ION CHANNELS; NOCICEPTIVE NEURONS; COMMON ACTIVATOR; CHORDA TYMPANI; CATION CHANNEL; HAIR-GROWTH	alpha-Hydroxyl acids (AHAs) from natural sources act as proton donors and topical compounds that penetrate skin and are well known in the cosmetic industry for their use in chemical peels and improvement of the skin. However, little is known about how AHAs cause exfoliation to expose fresh skin cells. Here we report that the transient receptor potential vanilloid 3 (TRPV3) channel in keratinocytes is potently activated by intracellular acidification induced by glycolic acid. Patch clamp recordings and cell death assay of both human keratinocyte HaCaT cells and TRPV3-expressing HEK-293 cells confirmed that intracellular acidification led to direct activation of TRPV3 and promoted cell death. Site-directed mutagenesis revealed that an N-terminal histidine residue, His-426, known to be involved in 2-aminoethyl diphenylborinate-mediated TRPV3 activation, is critical for sensing intracellular proton levels. Taken together, our findings suggest that intracellular protons can strongly activate TRPV3, and TRPV3-mediated proton sensing and cell death in keratinocytes may serve as a molecular basis for the cosmetic use of AHAs and their therapeutic potential in acidic pH-related skin disorders.	[Cao, Xu; Yang, Fan; Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Cao, Xu; Wang, Kewei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100191, Peoples R China; [Wang, Kewei] Peking Univ, Dept Mol & Cellular Pharmacol, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100191, Peoples R China	University of California System; University of California Davis; Peking University; Peking University	Zheng, J (corresponding author), Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA.	jzheng@ucdavis.edu; wangkw@bjmu.edu.cn	Cao, Xu/G-6209-2015; Yang, Fan/J-4562-2015; Yang, Fan/AAA-6904-2022; Yang, Fan/GYU-4249-2022; Yang, Fan/C-6586-2012; Zhu, Ren-Yuan/V-8966-2019	Cao, Xu/0000-0003-1796-2735; Yang, Fan/0000-0002-9406-7710; Yang, Fan/0000-0002-0520-5254; Yang, Fan/0000-0002-9406-7710; Zhu, Ren-Yuan/0000-0003-3091-7461	National Institutes of Health [R01NS072377]; National Science Foundation of China [30970919]; Ministry of Education of China 111 Project China [B07001]; China Scholarship Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China 111 Project China; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS072377 (to J. Z.) and Research Grant 30970919 from the National Science Foundation of China, the Ministry of Education of China 111 Project China (B07001) (to K. W. W.), and the China Scholarship Council (to X. C.).	Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bang S, 2012, BRIT J PHARMACOL, V165, P683, DOI 10.1111/j.1476-5381.2011.01568.x; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Bang S, 2010, J BIOL CHEM, V285, P19362, DOI 10.1074/jbc.M109.087742; Baumann TK, 2000, J NEUROSCI, V20; Bergfeld W., 1997, J AM ACAD DERMATOL, V36, P1011; Borbiro I, 2011, J INVEST DERMATOL, V131, P1605, DOI 10.1038/jid.2011.122; Boron W. F, 2005, MED PHYSL, P633; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cheng W, 2012, J BIOL CHEM, V287, P7279, DOI 10.1074/jbc.M111.305045; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clark CP, 1996, CLIN PLAST SURG, V23, P49; Colton C. K., 2007, V179, P173; Danilova V, 2002, J NEUROPHYSIOL, V88, P579, DOI 10.1152/jn.2002.88.2.579; Davidge KS, 2009, ADV MICROB PHYSIOL, V56, P85, DOI 10.1016/S0065-2911(09)05603-3; DESIMONE JA, 1995, AM J PHYSIOL-CELL PH, V268, pC1295, DOI 10.1152/ajpcell.1995.268.5.C1295; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; DiNardo JC, 1996, DERMATOL SURG, V22, P421, DOI 10.1111/j.1524-4725.1996.tb00341.x; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; Gunthorpe MJ, 2008, CURR PHARM DESIGN, V14, P32; GUTKNECHT J, 1992, MOL CELL BIOCHEM, V114, P3; GUTKNECHT J, 1973, SCIENCE, V182, P1258, DOI 10.1126/science.182.4118.1258; Hamamoto T, 2008, ACTA OTO-LARYNGOL, V128, P685, DOI 10.1080/00016480701669489; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Imura K, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-17; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; KARURI AR, 1993, BRIT J CANCER, V68, P1080, DOI 10.1038/bjc.1993.485; Kim Seong-Jin, 1998, Journal of Dermatology (Tokyo), V25, P85; Kurtzweil P, 1998, FDA Consum, V32, P30; Lee J, 2008, J DERMATOL SCI, V52, P160, DOI 10.1016/j.jdermsci.2008.06.007; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu BY, 2011, J GEN PHYSIOL, V138, P509, DOI 10.1085/jgp.201110689; MAIDORN RP, 1993, BRIT J CANCER, V67, P297, DOI 10.1038/bjc.1993.56; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Montell C, 2010, CELL, V141, P218, DOI 10.1016/j.cell.2010.03.043; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; MOY LS, 1993, J DERMATOL SURG ONC, V19, P243, DOI 10.1111/j.1524-4725.1993.tb00343.x; Moy LS, 1996, DERMATOL SURG, V22, P439, DOI 10.1111/j.1524-4725.1996.tb00344.x; Nassini R, 2010, CURR OPIN INVEST DR, V11, P535; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Reilly RM, 2011, CURR TOP MED CHEM, V11, P2210; ROENIGK HH, 1995, DERMATOL CLIN, V13, P245, DOI 10.1016/S0733-8635(18)30079-2; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Shimada Shoichi, 2004, Nihon Shinkei Seishin Yakurigaku Zasshi, V24, P243; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Steinhoff M, 2009, J INVEST DERMATOL, V129, P531, DOI 10.1038/jid.2008.440; Thueson DO, 1998, DERMATOL SURG, V24, P641, DOI 10.1111/j.1524-4725.1998.tb04221.x; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tung R C, 2000, Am J Clin Dermatol, V1, P81, DOI 10.2165/00128071-200001020-00002; Valente P, 2011, FASEB J, V25, P1628, DOI 10.1096/fj.10-174433; Vidt DG, 1997, CLEV CLIN J MED, V64, P327, DOI 10.3949/ccjm.64.6.327; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245	82	44	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25905	25916		10.1074/jbc.M112.364869	http://dx.doi.org/10.1074/jbc.M112.364869			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679014	hybrid, Green Published			2022-12-28	WOS:000306916300019
J	Hanaoka, M; Takai, N; Hosokawa, N; Fujiwara, M; Akimoto, Y; Kobori, N; Iwasaki, H; Kondo, T; Tanaka, K				Hanaoka, Mitsumasa; Takai, Naoki; Hosokawa, Norimune; Fujiwara, Masayuki; Akimoto, Yuki; Kobori, Nami; Iwasaki, Hideo; Kondo, Takao; Tanaka, Kan			RpaB, Another Response Regulator Operating Circadian Clock-dependent Transcriptional Regulation in Synechococcus elongatus PCC 7942	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAIC PHOSPHORYLATION; GENE-EXPRESSION; HIGH-LIGHT; ACETYL PHOSPHATE; PROTEIN; FEEDBACK; RHYTHMS; SASA; OSCILLATION; UPSTREAM	The circadian clock of cyanobacteria is composed of KaiA, KaiB, and KaiC proteins, and the SasA-RpaA two-component system has been implicated in the regulation of one of the output pathways of the clock. In this study, we show that another response regulator that is essential for viability, the RpaA paralog, RpaB, plays a central role in the transcriptional oscillation of clock-regulated genes. In vivo and in vitro analyses revealed that RpaB and not RpaA could specifically bind to the kaiBC promoter, possibly repressing transcription during subjective night. This suggested that binding may be terminated by RpaA to activate gene transcription during subjective day. Moreover, we found that rpoD6 and sigF2, which encode group-2 and group-3 sigma factors forRNApolymerase, respectively, were also targets of the RpaAB system, suggesting that a specific group of sigma factors can propagate genome-wide transcriptional oscillation. Our findings thus reveal a novel mechanism for a circadian output pathway that is mediated by two paralogous response regulators.	[Hanaoka, Mitsumasa; Akimoto, Yuki; Kobori, Nami; Tanaka, Kan] Chiba Univ, Div Appl Biol Chem, Grad Sch Hort, Matsudo, Chiba 2718510, Japan; [Fujiwara, Masayuki] Chiba Univ, Dept Nanobiol, Grad Sch Adv Integrat Sci, Matsudo, Chiba 2718510, Japan; [Hanaoka, Mitsumasa; Akimoto, Yuki; Tanaka, Kan] Univ Tokyo, Inst Mol & Cellular Biosci, Mol Genet Lab, Bunkyo Ku, Tokyo 1130032, Japan; [Hanaoka, Mitsumasa; Takai, Naoki; Kondo, Takao; Tanaka, Kan] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Takai, Naoki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hosokawa, Norimune; Iwasaki, Hideo] Waseda Univ, Dept Elect Engn & Biol Sci, Tokyo, Japan; [Hosokawa, Norimune; Iwasaki, Hideo] Waseda Univ, Ctr Adv Biomed Sci TWIns, Tokyo, Japan; [Iwasaki, Hideo] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Shinjuku Ku, Tokyo 1628480, Japan; [Tanaka, Kan] Tokyo Inst Technol, Chem Resources Lab, Div Bioresources, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Chiba University; Chiba University; University of Tokyo; Japan Science & Technology Agency (JST); Nagoya University; Waseda University; Waseda University; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Hanaoka, M (corresponding author), Chiba Univ, Div Appl Biol Chem, Grad Sch Hort, 648 Matsudo, Matsudo, Chiba 2718510, Japan.	mhanaoka@faculty.chiba-u.jp	Tanaka, Kan/E-3724-2015; Hanaoka, Mitsumasa/M-9904-2015	Tanaka, Kan/0000-0001-7560-7884; Iwasaki, Hideo/0000-0002-3754-4955	Special Coordination Fund for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology of Japan [16GS0304]; Japan Society for the Promotion of Science [21370015, 21770034, 20370072, 22657043, 21010517]; COE (Center of Excellence) StartUp Program of Chiba University; Waseda University [2010A-503]; Asahi Glass Foundation; Cooperative Research Program of "Network Joint Research Center for Materials and Devices"; Grants-in-Aid for Scientific Research [24117505, 23770039] Funding Source: KAKEN	Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); COE (Center of Excellence) StartUp Program of Chiba University; Waseda University; Asahi Glass Foundation; Cooperative Research Program of "Network Joint Research Center for Materials and Devices"; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Special Coordination Fund for Promoting Science and Technology (to M. H.) and Grant-in-aid 16GS0304 for Creative Scientific Research (to K. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by Grants-in-aid from the Japan Society for the Promotion of Science 21370015 (to K. T.), 21770034 (to M. H.), 20370072, 22657043, and 21010517 (to H. I.), by the COE (Center of Excellence) StartUp Program of Chiba University (to K. T.), by Waseda University Grant 2010A-503 for Special Research Projects (to H. I.), by the Asahi Glass Foundation (to H. I.), and by the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" (to M. H. and K. T.).	Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Golden SS, 2003, CURR OPIN MICROBIOL, V6, P535, DOI 10.1016/j.mib.2003.10.012; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Hosokawa N, 2011, P NATL ACAD SCI USA, V108, P15396, DOI 10.1073/pnas.1019612108; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kappell AD, 2007, ARCH MICROBIOL, V187, P337, DOI 10.1007/s00203-007-0213-1; Kutsuna S, 2005, MOL MICROBIOL, V57, P1474, DOI 10.1111/j.1365-2958.2005.04781.x; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishimura H, 2002, MICROBIOL-SGM, V148, P2903, DOI 10.1099/00221287-148-9-2903; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Seki A, 2007, J BIOL CHEM, V282, P36887, DOI 10.1074/jbc.M707582200; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Taniguchi Y, 2007, GENE DEV, V21, P60, DOI 10.1101/gad.1488107; Taniguchi Y, 2010, P NATL ACAD SCI USA, V107, P3263, DOI 10.1073/pnas.0909924107; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	30	45	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26321	26327		10.1074/jbc.M111.338251	http://dx.doi.org/10.1074/jbc.M111.338251			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22665493	hybrid, Green Published			2022-12-28	WOS:000306916300058
J	Qian, H; Le Blanc, K; Sigvardsson, M				Qian, Hong; Le Blanc, Katarina; Sigvardsson, Mikael			Primary Mesenchymal Stem and Progenitor Cells from Bone Marrow Lack Expression of CD44 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL CELLS; DIFFERENTIATION; FIBRONECTIN; TRAFFICKING; MIGRATION; ADHESION; MARKERS	Despite significant progress in our understanding of mesenchymal stem cell (MSC) biology during recent years, much of the information is based on experiments using in vitro culture-selected stromal progenitor cells. Therefore, the natural cellular identity of MSCs remains poorly defined. Numerous studies have reported that CD44 expression is one of the characteristics of MSCs in both humans and mice; however, we here have prospectively isolated bone marrow stromal cell subsets from both human and mouse bone marrow by flow cytometry and characterized them by gene expression analysis and function assays. Our data provide functional and molecular evidence suggesting that primary mesenchymal stem and progenitor cells of bone marrow reside in the CD44(-) cell fraction in both mice and humans. The finding that these CD44(-) cells acquire CD44 expression after in vitro culture provides an explanation for the previous misconceptions concerning CD44 expression on MSCs. In addition, the other previous reported MSC markers, including CD73, CD146, CD271, and CD106/VCAM1, are also differentially expressed on those two cell types. Our microarray data revealed a distinct gene expression profile of the freshly isolated CD44(-) cells and the cultured MSCs generated from these cells. Thus, we conclude that bone marrow MSCs physiologically lack expression of CD44, highlighting the natural phenotype of MSCs and opening new possibilities to prospectively isolate MSCs from the bone marrow.	[Qian, Hong] Karolinska Univ, Huddinge Hosp, HERM, Ctr Hematol & Regenerat Med,Dept Med, S-14186 Stockholm, Sweden; [Qian, Hong; Sigvardsson, Mikael] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Linkoping University	Qian, H (corresponding author), Karolinska Univ, Huddinge Hosp, HERM, Ctr Hematol & Regenerat Med,Dept Med, Novum Floor 4,Halsovagen 7, S-14186 Stockholm, Sweden.	hong.qian@ki.se	Qian, Hong/D-5588-2014; Le Blanc, Katarina/L-4631-2019	Qian, Hong/0000-0002-2512-9199; Sigvardsson, Mikael/0000-0001-8527-7276	Swedish Cancer Society; Swedish Research Council; Swedish Childhood Cancer Foundation; Faculty of Medicine at Linkoping University	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Faculty of Medicine at Linkoping University	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Childhood Cancer Foundation, and the Faculty of Medicine at Linkoping University.	Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Battula V. L., 2010, ASH ANN M, V116, P3845; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Both SK, 2007, TISSUE ENG, V13, P3, DOI 10.1089/ten.2005.0513; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Dai LJ, 2011, CANCER LETT, V305, P8, DOI 10.1016/j.canlet.2011.02.012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eslaminejad MB, 2007, DEV GROWTH DIFFER, V49, P351, DOI 10.1111/j.1440-169x.2007.00932.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gee K, 2004, ARCH IMMUNOL THER EX, V52, P13; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones E, 2008, RHEUMATOLOGY, V47, P126, DOI 10.1093/rheumatology/kem206; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Lin HY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-56; Lu FZ, 2005, J LAB CLIN MED, V146, P271, DOI 10.1016/j.lab.2005.07.003; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; Maltzman JS, 1996, MOL CELL BIOL, V16, P2283; Mareddy S, 2010, TISSUE ENG PT A, V16, P749, DOI [10.1089/ten.tea.2009.0307, 10.1089/ten.TEA.2009.0307]; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Poulsom R, 2007, KIDNEY INT, V72, P389, DOI 10.1038/sj.ki.5002398; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; Sogo Y, 2007, BIOMED MATER, V2, P116, DOI 10.1088/1748-6041/2/2/009; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Tanabe S, 2008, J BIOCHEM, V144, P399, DOI 10.1093/jb/mvn082; Thankamony SP, 2011, P NATL ACAD SCI USA, V108, P2258, DOI 10.1073/pnas.1018064108; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Tormin A, 2009, CYTOTHERAPY, V11, P114, DOI 10.1080/14653240802716590; Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534	51	103	108	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25795	25807		10.1074/jbc.M112.339622	http://dx.doi.org/10.1074/jbc.M112.339622			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654106	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000306916300010
J	Zhang, XJ; Gao, XZ; Yao, W; Cote, RH				Zhang, Xiu-Jun; Gao, Xiong-Zhuo; Yao, Wei; Cote, Rick H.			Functional Mapping of Interacting Regions of the Photoreceptor Phosphodiesterase (PDE6) gamma-Subunit with PDE6 Catalytic Dimer, Transducin, and Regulator of G-protein Signaling9-1 (RGS9-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; CGMP BINDING-SITES; ROD OUTER SEGMENTS; ALPHA-SUBUNIT; RETINITIS-PIGMENTOSA; TERMINAL REGION; GAF DOMAINS; GTPASE; ENZYME; AFFINITY	The cGMP phosphodiesterase (PDE6) involved in visual transduction in photoreceptor cells contains two inhibitory gamma-subunits (P gamma) which bind to the catalytic core (P alpha beta) to inhibit catalysis and stimulate cGMP binding to the GAF domains of P alpha beta. During visual excitation, interaction of activated transducin with P gamma relieves inhibition. P gamma also participates in a complex with RGS9-1 and other proteins to accelerate the GTPase activity of activated transducin. We studied the structural determinants for these important functions of P gamma. First, we identified two important sites in the middle region of P gamma (amino acids 27-38 and 52-54) that significantly stabilize the overall binding affinity of P gamma with P alpha beta. The ability of P gamma to stimulate noncatalytic cGMP binding to the GAF domains of PDE6 has been localized to amino acids 27-30 of P gamma. Transducin activation of PDE6 catalysis critically depends on the presence of Ile54 in the glycine-rich region of P gamma in order to relieve inhibition of catalysis. The central glycine-rich region of P gamma is also required for transducin to increase cGMP exchange at the GAF domains. Finally, Thr-65 and/or Val-66 of P gamma are critical residues for P gamma to stimulate GTPase activity of transducin in a complex with RGS9-1. We propose that the glycine-rich region of P gamma is a primary docking site for PDE6-interacting proteins involved in the activation/inactivation pathways of visual transduction. This functional mapping of P gamma with its binding partners demonstrates the remarkable versatility of this multifunctional protein and its central role in regulating the activation and lifetime of visual transduction.	[Zhang, Xiu-Jun; Gao, Xiong-Zhuo; Yao, Wei; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY-05798]; New Hampshire Agricultural Experiment Station; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Hampshire Agricultural Experiment Station; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-05798. Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is Scientific Contribution Number 2479.	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; ARSHAVSKY VY, 1994, J BIOL CHEM, V269, P19882; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; Baehr W, 2009, VISION RES, V49, P2636, DOI 10.1016/j.visres.2009.04.008; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2000, METHOD ENZYMOL, V315, P646; Cote Rick H., 2005, V307, P141; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; DETERRE P, 1986, Proteins Structure Function and Genetics, V1, P188, DOI 10.1002/prot.340010210; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2001, BIOCHEMISTRY-US, V40, P13209, DOI 10.1021/bi011127j; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2011, J BIOL CHEM, V286, P15260, DOI 10.1074/jbc.M110.210567; Guo LW, 2010, J BIOL CHEM, V285, P15209, DOI 10.1074/jbc.M109.086116; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Matte SL, 2012, J BIOL CHEM, V287, P20111, DOI 10.1074/jbc.M112.354647; MORRISON DF, 1989, J BIOL CHEM, V264, P11671; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; Pentia Dana C., 2005, V307, P125; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Uversky VN, 2002, J PROTEOME RES, V1, P149, DOI 10.1021/pr0155127; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Wensel Theodore G., 2005, V307, P289; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; YAMAZAKI A, 1982, P NATL ACAD SCI-BIOL, V79, P3702, DOI 10.1073/pnas.79.12.3702; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406; Zhang ZM, 2010, BIOCHEMISTRY-US, V49, P3862, DOI 10.1021/bi100354a	57	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26312	26320		10.1074/jbc.M112.377333	http://dx.doi.org/10.1074/jbc.M112.377333			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22665478	Green Published, hybrid			2022-12-28	WOS:000306916300057
J	Hu, X; Paul, A; Wang, B				Hu, Xin; Paul, Atanu; Wang, Bin			Rap80 Protein Recruitment to DNA Double-strand Breaks Requires Binding to Both Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE RESPONSE; TARGETS BRCA1; SITES; IDENTIFICATION; SUMOYLATION; PATHWAY; COMPLEX; CCDC98; REPAIR; UBC9	Ubiquitin (Ub) modifications at sites of DNA double-strand breaks (DSBs) play critical roles in the assembly of signaling and repair proteins. The Ub-interacting motif (UIM) domain of Rap80, which is a component of the BRCA1-A complex, interacts with Ub Lys-63 linkage conjugates and mediates the recruitment of BRCA1 to DSBs. Small ubiquitin-like modifier (SUMO) conjugation also occurs at DSBs and promotes Ub-dependent recruitment of BRCA1, but its molecular basis is not clear. In this study, we identified that Rap80 possesses a SUMO-interacting motif (SIM), capable of binding specifically to SUMO2/3 conjugates, and forms a tandem SIM-UIM-UIM motif at its N terminus. The SIM-UIM-UIM motif binds to both Ub Lys-63 linkage and SUMO2 conjugates. Both the SIM and UIM domains are required for efficient recruitment of Rap80 to DSBs immediately after damage and confer cellular resistance to ionizing radiation. These findings propose a model in which SUMO and Ub modification is coordinated to recruit Rap80 and BRCA1 to DNA damage sites.	[Hu, Xin; Paul, Atanu; Wang, Bin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Paul, Atanu; Wang, Bin] Univ Texas Grad Sch Biomed Sci, Genes & Dev Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wang, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bwang3@mdanderson.org	Paul, Atanu/J-5720-2019	Paul, Atanu/0000-0002-9967-6005	National Institutes of Health Grant from NCI [CA155025]; Mel Klein Family Fund; Sidney Kimmel scholar award; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA155025] Funding Source: NIH RePORTER	National Institutes of Health Grant from NCI; Mel Klein Family Fund; Sidney Kimmel scholar award; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA155025 from NCI, the Mel Klein Family Fund, a Sidney Kimmel scholar award, and funds from University of Texas MD Anderson Cancer Center.	Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hu X, 2011, J BIOL CHEM, V286, P11734, DOI 10.1074/jbc.M110.200857; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-6; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Yan J, 2007, BIOCHEM BIOPH RES CO, V362, P132, DOI 10.1016/j.bbrc.2007.07.158	31	57	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25510	25519		10.1074/jbc.M112.374116	http://dx.doi.org/10.1074/jbc.M112.374116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22689573	Green Published, hybrid			2022-12-28	WOS:000306651700057
J	Kaul, V; Van Kaer, L; Das, G; Das, J				Kaul, Vandana; Van Kaer, Luc; Das, Gobardhan; Das, Jyoti			Prostanoid Receptor 2 Signaling Protects T Helper 2 Cells from BALB/c Mice against Activation-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; LEISHMANIA-MAJOR; AUTOIMMUNE-DISEASE; RESPONSES; TH1; DIFFERENTIATION; ANTIGEN; POLARIZATION; PHARMACOLOGY; INFLAMMATION	T helper 2 (Th2) cells play a central role in the progression of many diseases such as allergic airway inflammation, autoimmune diseases, and infections caused by intracellular pathogens. Consequently, animals such as BALB/c mice, which exhibit a propensity for generating Th2 responses, are susceptible to allergic airway inflammation, type-II autoimmune diseases, and various infections induced by intracellular pathogens, namely, Leishmania. In contrast, C3H/OuJ mice have a tendency for generating T helper 1 (Th1) responses and show resistance to these diseases. Here, we show that prostaglandin endoperoxide E-2 selectively inhibits activation-induced cell death of Th2 cells by signaling through its receptor E-prostanoid receptor 2 (EP2). Consequently, Th2 cells derived from BALB/c mice expressed very high levels of EP2. On the other hand, Th2 cells derived from C3H/OuJ mice expressed very low levels of EP2, which failed to support the survival of Th2 cells. Furthermore, we found that this effect of EP2 on Th2 cells from BALB/c mice was executed by a granzyme B-mediated mechanism. EP2 belongs to a group of G-protein-coupled receptors that are amenable to therapeutic targeting. Our findings therefore identify EP2 as a promising target for small molecule-directed immunomodulation.	[Das, Jyoti] Natl Inst Malaria Res, Div Immunol, New Delhi 110077, India; [Kaul, Vandana; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Van Kaer, Luc] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Vanderbilt University	Das, J (corresponding author), Natl Inst Malaria Res, Div Immunol, Sect 8, New Delhi 110077, India.	jyoti@mrcindia.org	kaul, vandana/C-9788-2018; Van Kaer, Luc/H-1033-2015	kaul, vandana/0000-0002-1841-5584; Van Kaer, Luc/0000-0001-5275-2309	Wellcome Trust International senior fellowship; Ramaligaswami fellowship(Government of India); Department of Biotechnology, Government of India	Wellcome Trust International senior fellowship(Wellcome Trust); Ramaligaswami fellowship(Government of India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by a Wellcome Trust International senior fellowship, a Ramaligaswami fellowship(Government of India), and a grant from the Department of Biotechnology, Government of India.	Azar ST, 1999, CLIN DIAGN LAB IMMUN, V6, P306, DOI 10.1128/CDLI.6.3.306-310.1999; Bajenoff M, 2002, J IMMUNOL, V168, P1723, DOI 10.4049/jimmunol.168.4.1723; Biedermann T, 2004, J INVEST DERM SYMP P, V9, P5, DOI 10.1111/j.1087-0024.2004.00829.x; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Brewer JP, 1999, AM J RESP CRIT CARE, V160, P1150, DOI 10.1164/ajrccm.160.4.9806034; CHATELAIN R, 1992, J IMMUNOL, V148, P1182; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Dore S, 2006, TRENDS PHARMACOL SCI, V27, P458, DOI 10.1016/j.tips.2006.07.001; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; GOETZL EJ, 1995, J IMMUNOL, V154, P1041; GORCZYNSKI RM, 1982, DEV COMP IMMUNOL, V6, P199, DOI 10.1016/S0145-305X(82)80003-7; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Kapsenberg ML, 1999, CLIN EXP ALLERGY, V29, P33, DOI 10.1046/j.1365-2222.1999.00006.x-i2; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Launois P, 1999, MICROBES INFECT, V1, P59, DOI 10.1016/S1286-4579(99)80015-X; Mazzarella G, 2000, ALLERGY, V55, P6, DOI 10.1034/j.1398-9995.2000.00511.x; Radwanska M, 2007, PLOS PATHOG, V3, P619, DOI 10.1371/journal.ppat.0030068; SCOTT P, 1991, J IMMUNOL, V147, P3149; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Wangoo A, 2001, J IMMUNOL, V166, P3432, DOI 10.4049/jimmunol.166.5.3432; Wilson RJ, 2004, EUR J PHARMACOL, V501, P49, DOI 10.1016/j.ejphar.2004.08.025	27	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25434	25439		10.1074/jbc.C111.324707	http://dx.doi.org/10.1074/jbc.C111.324707			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654101	hybrid, Green Published			2022-12-28	WOS:000306651700050
J	Francescone, R; Scully, S; Bentley, B; Yan, W; Taylor, SL; Oh, D; Moral, L; Shao, R				Francescone, Ralph; Scully, Steve; Bentley, Brooke; Yan, Wei; Taylor, Sherry L.; Oh, Dennis; Moral, Luis; Shao, Rong			Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEVACIZUMAB PLUS IRINOTECAN; VASCULAR CHANNEL FORMATION; RECEPTOR TYROSINE KINASE; STEM-LIKE CELLS; THERAPEUTIC IMPLICATIONS; RECURRENT GLIOBLASTOMA; ENDOTHELIAL-CELLS; MALIGNANT GLIOMAS; BREAST-CANCER; LUNG-CANCER	Glioblastoma (GBM) is extremely aggressive and essentially incurable. Its malignancy is characterized by vigorous microvascular proliferations. Recent evidence has shown that tumor cells display the ability to drive blood-perfused vasculogenic mimicry (VM), an alternative microvascular circulation independent of endothelial cell angiogenesis. However, molecular mechanisms underlying this vascular pathogenesis are poorly understood. Here, we found that vascular channels of VM in GBM were composed of mural-like tumor cells that strongly express VEGF receptor 2 (Flk-1). To explore a potential role of Flk-1 in the vasculogenesis, we investigated two glioblastoma cell lines U87 and GSDC, both of which express Flk-1 and exhibit a vascular phenotype on Matrigel. Treatment of both cell lines with either Flk-1 gene knockdown or Flk-1 kinase inhibitor SU1498 abrogated Flk-1 activity and impaired vascular function. Furthermore, inhibition of Flk-1 activity suppressed intracellular signaling cascades, including focal adhesion kinase and mitogen-activated protein kinase ERK1/2. In contrast, blockade of VEGF activity by the neutralizing antibody Bevacizumab failed to recapitulate the impact of SU1498, suggesting that Flk-1-mediated VM is independent of VEGF. Xenotransplantation of SCID/Beige mice with U87 cells and GSDCs gave rise to tumors harboring robust mural cell-associated vascular channels. Flk-1 shRNA restrained VM in tumors and subsequently inhibited tumor development. Collectively, all the data demonstrate a central role of Flk-1 in the formation of VM in GBM. This study has shed light on molecular mechanisms mediating tumor aggressiveness and also provided a therapeutic target for patient treatment.	[Francescone, Ralph; Scully, Steve; Shao, Rong] Univ Massachusetts, Mol & Cellular Biol Program, Morrill Sci Ctr, Amherst, MA 01003 USA; [Bentley, Brooke; Yan, Wei; Shao, Rong] Pioneer Valley Life Sci Inst, Springfield, MA 01199 USA; [Taylor, Sherry L.; Oh, Dennis] Tufts Univ, Dept Neurosurg, Baystate Med Ctr, Springfield, MA 01199 USA; [Moral, Luis] Tufts Univ, Dept Pathol, Baystate Med Ctr, Springfield, MA 01199 USA; [Shao, Rong] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; Baystate Medical Center; Tufts University; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Shao, R (corresponding author), Univ Massachusetts, Mol & Cellular Biol Program, Morrill Sci Ctr, Amherst, MA 01003 USA.	rong.shao@bhs.org		Francescone, Ralph/0000-0002-3149-6825	National Institutes of Health from NCI [R01 CA120659]; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA120659 from NCI (to R. S.).	Basu GD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1626; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Chen YS, 2012, MED ONCOL, V29, P324, DOI 10.1007/s12032-010-9765-z; di Tomaso E, 2005, CANCER RES, V65, P5740, DOI 10.1158/0008-5472.CAN-04-4552; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Folberg R, 2004, APMIS, V112, P508, DOI 10.1111/j.1600-0463.2004.apm11207-0810.x; Folberg R, 2006, AM J PATHOL, V169, P1376, DOI 10.2353/ajpath.2006.060223; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Francescone R.A., 2011, JOVE-J VIS EXP, V55, P3040; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kozin SV, 2001, CANCER RES, V61, P39; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu C, 2002, CANCER RES, V62, P5470; Liu XM, 2011, J NEURO-ONCOL, V105, P173, DOI 10.1007/s11060-011-0578-5; Luo Y, 2006, DEV BIOL, V299, P517, DOI 10.1016/j.ydbio.2006.09.003; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Manegold C, 2008, EXPERT REV ANTICANC, V8, P689, DOI 10.1586/14737140.8.5.689; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nghiemphu PL, 2009, NEUROLOGY, V72, P1217, DOI 10.1212/01.wnl.0000345668.03039.90; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Ping YF, 2011, STEM CELLS, V29, P888, DOI 10.1002/stem.650; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sood AK, 2002, CANCER BIOL THER, V1, P661, DOI 10.4161/cbt.316; Sun JZ, 2005, ONCOGENE, V24, P4701, DOI 10.1038/sj.onc.1208391; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Timke C, 2008, CLIN CANCER RES, V14, P2210, DOI 10.1158/1078-0432.CCR-07-1893; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005	61	107	109	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24821	24831		10.1074/jbc.M111.334540	http://dx.doi.org/10.1074/jbc.M111.334540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22654102	Green Published, hybrid			2022-12-28	WOS:000306651100075
J	Jinwal, UK; Abisambra, JF; Zhang, J; Dharia, S; O'Leary, JC; Patel, T; Braswell, K; Jani, T; Gestwicki, JE; Dickey, CA				Jinwal, Umesh K.; Abisambra, Jose F.; Zhang, Juan; Dharia, Sheetal; O'Leary, John C.; Patel, Tina; Braswell, Kaitlyn; Jani, Twisha; Gestwicki, Jason E.; Dickey, Chad A.			Cdc37/Hsp90 Protein Complex Disruption Triggers an Autophagic Clearance Cascade for TDP-43 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN-43; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; HEAT-SHOCK-PROTEIN; ALZHEIMERS-DISEASE; HSP90 COCHAPERONE; RECEPTOR FUNCTION; CELL-DEATH; NUCLEAR; TAU	The RNA-binding protein, trans-active response DNA-binding protein 43 (TDP-43), is normally found in the nucleus, but in amyotrophic lateral sclerosis, frontal temporal dementia, and some cases of Alzheimer disease it is cleaved and mislocalized to the cytosol, leading to accumulation. The mechanisms contributing to this are largely unknown. Here, we show that part of the normal clearance cascade for TDP-43 involves the Cdc37/Hsp90 complex. An Hsp90 inhibitor that disrupts the Cdc37/Hsp90 complex reduced TDP-43 levels to a greater extent than a standard Hsp90 ATPase inhibitor. When Cdc37 was depleted, TDP-43 underwent proteolytic clearance that was dependent on nuclear retrotranslocation and autophagic uptake. Accumulation of the microtubule-associated protein tau prevented the clearance of cleaved TDP-43, but not its production. This caused cleaved TDP-43 to accumulate, a feature observed in the brain of persons with Alzheimer disease. Clearance of cleaved TDP-43 was also prevented by knockdown of the autophagic inducer beclin1. Thus, in cells where TDP-43 clearance is normally needed, a system that employs manipulation of the Hsp90 complex and autophagy exists. But when tau accumulation is occurring, cleaved TDP-43 can no longer be cleared, perhaps explaining the emergence of these co-pathologies.	[Jinwal, Umesh K.; Zhang, Juan; Dharia, Sheetal; Patel, Tina; Braswell, Kaitlyn; Jani, Twisha] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, Tampa, FL 33613 USA; [Abisambra, Jose F.; O'Leary, John C.; Dickey, Chad A.] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL 33613 USA; [Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Inst Life Sci, Ann Arbor, MI 48109 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Michigan System; University of Michigan	Jinwal, UK (corresponding author), Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	ujinwal@health.usf.edu; cdickey@health.usf.edu	Abisambra, Jose/V-6860-2019; Abisambra, Joe/AAP-3269-2020	Abisambra, Jose/0000-0001-6341-679X; 	National Institutes of Health [NS059690]; University of Michigan Alzheimer's Disease Center; Alzheimer's Association [IIRG-07-60067]; National Institutes of Health through NIA through NINDS [R00AG031291, R01NS073899]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899, R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Alzheimer's Disease Center; Alzheimer's Association(Alzheimer's Association); National Institutes of Health through NIA through NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health Grant NS059690, the University of Michigan Alzheimer's Disease Center, and the Alzheimer's Association Grant IIRG-07-60067.; Supported by National Institutes of Health Grant NS059690 and National Institutes of Health Grants R00AG031291 through the NIA and R01NS073899 through the NINDS. To whom correspondence may be addressed:. Dept of Molecular Medicine, USF Health Byrd Alzheimer's Institute, University of South Florida, 4001 E. Fletcher Ave., MDC 36, Tampa, FL 33613. Tel.: 813-396-0639; Fax: 813-866-1601; E-mail: cdickey@health.usf.edu.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo Ana Maria, 2003, Sci Aging Knowledge Environ, V2003, ppe25, DOI 10.1126/sageke.2003.36.pe25; D'Mello SR, 2000, J NEUROSCI RES, V59, P24, DOI 10.1002/(SICI)1097-4547(20000101)59:1<24::AID-JNR4>3.3.CO;2-#; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; GASC JM, 1990, EXP CELL RES, V186, P362, DOI 10.1016/0014-4827(90)90317-4; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Jinwal UK, 2011, J BIOL CHEM, V286, P16976, DOI 10.1074/jbc.M110.182493; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin YC, 2002, PHYTOCHEMISTRY, V59, P469, DOI 10.1016/S0031-9422(01)00470-8; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Mayer MP, 2002, MOL CELL, V10, P1255, DOI 10.1016/S1097-2765(02)00793-1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; PRATT WB, 1992, BIOESSAYS, V14, P841, DOI 10.1002/bies.950141209; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Rycyzyn MA, 2000, MOL ENDOCRINOL, V14, P1175, DOI 10.1210/me.14.8.1175; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith JR, 2009, CELL CYCLE, V8, P362, DOI 10.4161/cc.8.3.7531; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	47	49	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24814	24820		10.1074/jbc.M112.367268	http://dx.doi.org/10.1074/jbc.M112.367268			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22674575	Green Published, hybrid			2022-12-28	WOS:000306651100074
J	Knezevic, J; Pavlinic, D; Rose, WA; Leifer, CA; Bendelja, K; Gabrilovac, J; Parcina, M; Lauc, G; Kubarenko, AV; Petricevic, B; Vrbanec, D; Bulat-Kardum, L; Bekeredjian-Ding, I; Pavelic, J; Dembic, Z; Weber, ANR				Knezevic, Jelena; Pavlinic, Dinko; Rose, William A., II; Leifer, Cynthia A.; Bendelja, Kreso; Gabrilovac, Jelka; Parcina, Marijo; Lauc, Gordan; Kubarenko, Andriy V.; Petricevic, Branka; Vrbanec, Damir; Bulat-Kardum, Ljiljana; Bekeredjian-Ding, Isabelle; Pavelic, Jasminka; Dembic, Zlatko; Weber, Alexander N. R.			Heterozygous Carriage of a Dysfunctional Toll-like Receptor 9 Allele Affects CpG Oligonucleotide Responses in B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYOGENIC BACTERIAL-INFECTIONS; TOLL-LIKE-RECEPTOR-9 ACTIVATION; MYD88 DEFICIENCY; TLR9; POLYMORPHISMS; DNA; SUSCEPTIBILITY; ENCEPHALITIS; TUBERCULOSIS; VARIANTS	Toll-like receptors (TLR) are employed by the innate immune system to detect microbial pathogens based on conserved microbial pathogen molecules. For example, TLR9 is a receptor for CpG-containing microbial DNA, and its activation results in the production of cytokines and type I interferons from human B cells and plasmacytoid dendritic cells, respectively. Both are required for mounting an efficient antibacterial or antiviral immune response. These effects are mimicked by synthetic CpG oligodeoxynucleotides (ODN). Although several hyporesponsive TLR9 variants have been reported, their functional relevance in human primary cells has not been addressed. Here we report a novel TLR9 allele, R892W, which is hyporesponsive to CpG ODN and acts as a dominant-negative in a cellular model system. The R892W variant is characterized by increased MyD88 binding and defective co-localization with CpG ODN. Whereas primary plasmacytoid dendritic cells isolated from a heterozygous R892W carrier responded normally to CpG by interferon-alpha production, carrier B cells showed impaired IL-6 and IL-10 production. This suggests that heterozygous carriage of a hyporesponsive TLR9 allele is not associated with complete loss of TLR9 function but that TLR9 signals elicited in different cell types are regulated differently in human primary cells.	[Dembic, Zlatko] Univ Oslo, Mol Genet Grp, Dept Oral Biol, Fac Dent, N-0316 Oslo, Norway; [Knezevic, Jelena; Pavelic, Jasminka] Rudjer Boskovic Inst, Mol Oncol Lab, Div Mol Med, Zagreb 10000, Croatia; [Gabrilovac, Jelka] Rudjer Boskovic Inst, Lab Expt Hematol Immunol & Oncol, Zagreb 10000, Croatia; [Pavlinic, Dinko] Univ Osijek, Sch Med, DNA Lab, Osijek 31000, Croatia; [Rose, William A., II; Leifer, Cynthia A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Bendelja, Kreso] Inst Immunol, Zagreb 10000, Croatia; [Parcina, Marijo; Bekeredjian-Ding, Isabelle] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Lauc, Gordan] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia; [Knezevic, Jelena; Kubarenko, Andriy V.; Weber, Alexander N. R.] German Canc Res Ctr, Jr Grp Toll Receptors & Canc, D-69120 Heidelberg, Germany; [Petricevic, Branka; Vrbanec, Damir] Univ Hosp Ctr Zagreb, Div Oncol, Dept Med Oncol, Zagreb 10000, Croatia; [Bulat-Kardum, Ljiljana] Univ Rijeka, Clin Hosp Ctr, Rijeka 51000, Croatia; [Weber, Alexander N. R.] Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany	University of Oslo; Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of JJ Strossmayer Osijek; Cornell University; Ruprecht Karls University Heidelberg; University of Zagreb; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zagreb; University of Rijeka; Eberhard Karls University of Tubingen	Dembic, Z (corresponding author), Univ Oslo, Mol Genet Grp, Dept Oral Biol, Fac Dent, Sognsvannsveien 10,PB 1052, N-0316 Oslo, Norway.	zlatkod@odont.uio.no; alexander.weber@uni-tuebingen.de	Dembic, Zlatko/A-1833-2008; Lauc, Gordan/K-5864-2012; Parcina, Marijo/ABG-4659-2020; Bekeredjian-Ding, Isabelle/I-6197-2013	Dembic, Zlatko/0000-0002-9970-6497; Lauc, Gordan/0000-0003-1840-9560; Bekeredjian-Ding, Isabelle/0000-0001-6646-5888; Knezevic, Jelena/0000-0002-3152-3563; Weber, Alexander/0000-0002-8627-7056	Croatian Ministry of Science, Education and Sports; German Research Foundation; German Cancer Research Center; Ministry of Science, Education and Sports, Republic of Croatia [098-0982464-2394]; Deutsche Forschungsgemeinschaft [We4195-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076588] Funding Source: NIH RePORTER	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); German Research Foundation(German Research Foundation (DFG)); German Cancer Research Center(Helmholtz Association); Ministry of Science, Education and Sports, Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants from the Croatian Ministry of Science, Education and Sports, the German Research Foundation, and the German Cancer Research Center.; Supported by the German Cancer Research Center guest scientist program. To whom correspondence may be addressed: Div. of Molecular Medicine, Ruoer Boskovic Institute, Bijenicka cesta 54, 10 002 Zagreb, Croatia. Tel.: 385-1-4560-997; E-mail: jknezev@irb.hr.; Supported by Grant 098-0982464-2394 from The Ministry of Science, Education and Sports, Republic of Croatia. Supported by Deutsche Forschungsgemeinschaft Grant We4195-1 (to A. W.) and the German Cancer Research Center.	Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Bulat-Kardum L, 2006, SCAND J IMMUNOL, V63, P142, DOI 10.1111/j.1365-3083.2005.01694.x; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chockalingam A, 2012, J IMMUNOL, V188, P527, DOI 10.4049/jimmunol.1102713; Chockalingam A, 2011, EUR J IMMUNOL, V41, P2176, DOI 10.1002/eji.201041034; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Dembic Z, 2005, MOL B INT U, P18; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fraser DA, 2003, SCAND J IMMUNOL, V57, P480, DOI 10.1046/j.1365-3083.2003.01253.x; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Ivison SM, 2007, BIOCHEM BIOPH RES CO, V352, P936, DOI 10.1016/j.bbrc.2006.11.132; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Kubarenko AV, 2010, PROTEIN SCI, V19, P558, DOI 10.1002/pro.333; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2003, J IMMUNOTHER, V26, P313, DOI 10.1097/00002371-200307000-00003; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Park JE, 2008, J IMMUNOL, V181, P2044, DOI 10.4049/jimmunol.181.3.2044; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Pothlichet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007582; Rajagopal R, 2008, BIOCHEM J, V409, P275, DOI 10.1042/BJ20070519; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wang JY, 2006, J BIOL CHEM, V281, P37427, DOI 10.1074/jbc.M605311200; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	44	5	5	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24544	24553		10.1074/jbc.M111.337477	http://dx.doi.org/10.1074/jbc.M111.337477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613717	hybrid, Green Published			2022-12-28	WOS:000306651100047
J	Arbel, N; Ben-Hail, D; Shoshan-Barmatz, V				Arbel, Nir; Ben-Hail, Danya; Shoshan-Barmatz, Varda			Mediation of the Antiapoptotic Activity of Bcl-xL Protein upon Interaction with VDAC1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; MITOCHONDRIAL OUTER-MEMBRANE; CYTOCHROME-C RELEASE; APOPTOTIC CELL-DEATH; DNA-BINDING DOMAIN; FAMILY PROTEINS; MICROSCALE THERMOPHORESIS; CANCER-THERAPY; BAX; BCL-X(L)	The mitochondrial protein, the voltage-dependent anion channel (VDAC), is implicated in the control of apoptosis, including via its interaction with the pro-and antiapoptotic proteins. We previously demonstrated the direct interaction of Bcl2 with VDAC, leading to reduced channel conductance. VDAC1-based peptides interacted with Bcl2 to prevent its antiapoptotic activity. Here, using a variety of approaches, we show the interaction of the antiapoptotic protein, Bcl-xL, with VDAC1 and reveal that this interaction mediates Bcl-xL protection against apoptosis. C-terminally truncated Bcl-xL(Delta 21) interacts with purified VDAC1, as revealed by microscale thermophoresis and as reflected in the reduced channel conductivity of bilayer-reconstituted VDAC1. Overexpression of Bcl-xL prevented staurosporine-induced apoptosis in cells expressing native VDAC1 but not certain VDAC1 mutants. Having identified mutations in VDAC1 that interfere with the Bcl-xL interaction, certain peptides representing VDAC1 sequences, including the N-terminal domain, were designed and generated as recombinant and synthetic peptides. The VDAC1 N-terminal region and two internal sequences were found to bind specifically, and in a concentration-and time-dependent manner, to immobilized Bcl-xL(Delta 21), as revealed by surface plasmon resonance. Moreover, expression of the recombinant peptides in cells overexpressing Bcl-xL prevented protection offered by the protein against staurosporine-induced apoptosis. These results point to Bcl-xL acting as antiapoptotic protein, promoting tumor cell survival via binding to VDAC1. These findings suggest that interfering with Bcl-xL binding to the mitochondria by VDAC1-based peptides may serve to induce apoptosis in cancer cells and to potentiate the efficacy of conventional chemotherapeutic agents.	[Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il		Ben-Hail, Danya/0000-0002-8210-3446	Israel Science Foundation [649/09]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Grant 649/09 from the Israel Science Foundation.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dias N, 2002, MOL CANCER THER, V1, P347; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Johnson BW, 2000, J BIOL CHEM, V275, P31546, DOI 10.1074/jbc.M001363200; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Khaw SL, 2011, PATHOLOGY, V43, P525, DOI 10.1097/PAT.0b013e32834b1b34; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Oancea M, 2004, INT J HEMATOL, V80, P224, DOI 10.1532/IJH97.04107; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Reed JC, 1999, J NATL CANCER I, V91, P1099, DOI 10.1093/jnci/91.13.1099; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; TANAKA S, 1993, J BIOL CHEM, V268, P10920; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yi XL, 2003, J BIOL CHEM, V278, P16992, DOI 10.1074/jbc.M300039200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; ZEHAVA CL, 1990, J BIOL CHEM, V265, P4929; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18	60	122	126	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23152	23161		10.1074/jbc.M112.345918	http://dx.doi.org/10.1074/jbc.M112.345918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589539	hybrid, Green Published			2022-12-28	WOS:000306495000070
J	Gupta, N; Hartmann, A; Lucius, R; Voelker, DR				Gupta, Nishith; Hartmann, Anne; Lucius, Richard; Voelker, Dennis R.			The Obligate Intracellular Parasite Toxoplasma gondii Secretes a Soluble Phosphatidylserine Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MAMMALIAN-CELLS; PARASITOPHOROUS VACUOLE; MEMBRANE; INVASION; SYNTHASE; GENE; BIOSYNTHESIS; PURIFICATION; APICOMPLEXA	Toxoplasma gondii is an obligate intracellular parasite capable of causing fatal infections in immunocompromised individuals and neonates. Examination of the phosphatidylserine (PtdSer) metabolism of T. gondii reveals that the parasite secretes a soluble form of PtdSer decarboxylase (TgPSD1), which preferentially decarboxylates liposomal PtdSer with an apparent K-m of 67 mu M. The specific enzyme activity increases by 3-fold during the replication of T. gondii, and soluble phosphatidylserine decarboxylase (PSD) accounts for similar to 20% of the total PSD, prior to the parasite egress from the host cells. Extracellular T. gondii secreted similar to 20% of its total PSD activity at 37 degrees C, and the intracellular Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis (acetoxymethyl ester) inhibited the process by 50%. Cycloheximide, brefeldin A, ionic composition of the medium, and exogenous PtdSer did not modulate the enzyme secretion, which suggests a constitutive discharge of a presynthesized pool of PSD in axenic T. gondii. TgPSD1 consists of 968 amino acids with a 26-amino acid hydrophobic peptide at the N terminus and no predicted membrane domains. Parasites overexpressing TgPSD1-HA secreted 10-fold more activity compared with the parental strain. Exposure of apoptotic Jurkat cells to transgenic parasites demonstrated interfacial catalysis by secreted TgPSD1 that reduced host cell surface exposure of PtdSer. Immunolocalization experiments revealed that TgPSD1 resides in the dense granules of T. gondii and is also found in the parasitophorous vacuole of replicating parasites. Together, these findings demonstrate novel features of the parasite enzyme because a secreted, soluble, and interfacially active form of PSD has not been previously described for any organism.	[Gupta, Nishith; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Gupta, Nishith; Hartmann, Anne; Lucius, Richard] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany	National Jewish Health; Humboldt University of Berlin	Gupta, N (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	Gupta.Nishith@staff.hu-berlin.de; voelkerd@njc.org		Gupta, Nishith/0000-0003-1452-5126	National Institutes of Health [AI030060, 2R37GM32453]; German Research Foundation [SFB618, GRK1121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453, R01GM032453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI030060 and 2R37GM32453 (to D. R. V.). This work was also supported by German Research Foundation Grants SFB618 and GRK1121 (to N. G. and R. L.).	Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; BECKERS CJM, 1995, J CLIN INVEST, V95, P367, DOI 10.1172/JCI117665; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cesbron-Delauw MF, 2008, TRAFFIC, V9, P657, DOI 10.1111/j.1600-0854.2008.00728.x; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; DENNIS EA, 1970, J LIPID RES, V11, P394; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KENNEDY EP, 1959, J BIOL CHEM, V234, P1998; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kim K, 2008, MICROBES INFECT, V10, P978, DOI 10.1016/j.micinf.2008.07.015; Kuge O, 1997, BBA-LIPID LIPID MET, V1348, P151, DOI 10.1016/S0005-2760(97)00137-9; KUGE O, 1991, J BIOL CHEM, V266, P6370; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; OHTA A, 1981, J BIOL CHEM, V256, P2219; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; TYHACH RJ, 1979, J BIOL CHEM, V254, P627; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voelker DR, 1997, BBA-LIPID LIPID MET, V1348, P236, DOI 10.1016/S0005-2760(97)00101-X; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200	33	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22938	22947		10.1074/jbc.M112.373639	http://dx.doi.org/10.1074/jbc.M112.373639			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22563079	Green Published, hybrid			2022-12-28	WOS:000306495000051
J	Nottingham, RM; Pusapati, GV; Ganley, IG; Barr, FA; Lambright, DG; Pfeffer, SR				Nottingham, Ryan M.; Pusapati, Ganesh V.; Ganley, Ian G.; Barr, Francis A.; Lambright, David G.; Pfeffer, Suzanne R.			RUTBC2 Protein, a Rab9A Effector and GTPase-activating Protein for Rab36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; HUMAN-CELLS; ENDOSOMES; FAMILY; DOMAIN; IDENTIFICATION; HYDROLYSIS; PATHWAY; COMPLEX; ATPASE	Rab GTPases regulate vesicle budding, motility, docking, and fusion. In cells, their cycling between active, GTP-bound states and inactive, GDP-bound states is regulated by the action of opposing enzymes called guanine nucleotide exchange factors and GTPase-activating proteins (GAPs). The substrates for most RabGAPs are unknown, and the potential for cross-talk between different membrane trafficking pathways remains uncharted territory. Rab9A and its effectors regulate recycling of mannose 6-phosphate receptors from late endosomes to the trans Golgi network. We show here that RUTBC2 is a TBC domain-containing protein that binds to Rab9A specifically both in vitro and in cultured cells but is not a GAP for Rab9A. Biochemical screening of Rab protein substrates for RUTBC2 revealed highest GAP activity toward Rab34 and Rab36. In cells, membrane-associated RUTBC2 co-localizes with Rab36, and expression of wild type RUTBC2, but not the catalytically inactive, RUTBC2 R829A mutant, decreases the amount of membrane-associated Rab36 protein. These data show that RUTBC2 can act as a Rab36 GAP in cells and suggest that RUTBC2 links Rab9A function to Rab36 function in the endosomal system.	[Nottingham, Ryan M.; Pusapati, Ganesh V.; Ganley, Ian G.; Pfeffer, Suzanne R.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Barr, Francis A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Lambright, David G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Stanford University; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, 279 Campus Dr,B400, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Pusapati, Ganesh/0000-0002-1406-2566; Barr, Francis/0000-0001-7518-253X; Ganley, Ian/0000-0003-1481-9407	National Institutes of Health [DK37332, GM007276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037332, R01DK037332, R37DK037332] Funding Source: NIH RePORTER; MRC [MC_UP_A500_1019] Funding Source: UKRI; Medical Research Council [MC_UP_A500_1019] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DK37332 (to S. R. P.).; Supported in part by National Institutes of Health Training Grant GM007276.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Chen L, 2010, MOL MEMBR BIOL, V27, P23, DOI 10.3109/09687680903417470; Diaz E, 1997, J CELL BIOL, V138, P283, DOI 10.1083/jcb.138.2.283; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Federoff HJ, 2009, NEUROTOX RES, V16, P261, DOI 10.1007/s12640-009-9056-7; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991; Goldenberg NM, 2009, AM J PHYSIOL-CELL PH, V297, pC1053, DOI 10.1152/ajpcell.00286.2009; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Luo Y, 2008, J NEUROSCI, V28, P9277, DOI 10.1523/JNEUROSCI.3021-08.2008; Mori T, 1999, BIOCHEM BIOPH RES CO, V254, P594, DOI 10.1006/bbrc.1998.9968; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P243, DOI 10.1016/S0968-0004(97)01073-6; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Nottingham RM, 2011, J BIOL CHEM, V286, P33213, DOI 10.1074/jbc.M111.261115; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Shutes A, 2005, METHODS, V37, P183, DOI 10.1016/j.ymeth.2005.05.019; Speight P, 2005, TRAFFIC, V6, P858, DOI 10.1111/j.1600-0854.2005.00321.x; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047	37	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22740	22748		10.1074/jbc.M112.362558	http://dx.doi.org/10.1074/jbc.M112.362558			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22637480	Green Published, hybrid			2022-12-28	WOS:000306495000031
J	Sricholpech, M; Perdivara, I; Yokoyama, M; Nagaoka, H; Terajima, M; Tomer, KB; Yamauchi, M				Sricholpech, Marnisa; Perdivara, Irina; Yokoyama, Megumi; Nagaoka, Hideaki; Terajima, Masahiko; Tomer, Kenneth B.; Yamauchi, Mitsuo			Lysyl Hydroxylase 3-mediated Glucosylation in Type I Collagen MOLECULAR LOCI AND BIOLOGICAL SIGNIFICANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; BONE-COLLAGEN; OSTEOGENESIS IMPERFECTA; TRABECULAR BONE; POSTTRANSLATIONAL MODIFICATIONS; MATRIX MINERALIZATION; ARTICULAR-CARTILAGE; GLYCOSYLATED COLLAGEN; AMINO-ACIDS; RAT	Recently, by employing the short hairpin RNA technology, we have generated MC3T3-E1 (MC)-derived clones stably suppressing lysyl hydroxylase 3 (LH3) (short hairpin (Sh) clones) and demonstrated the LH3 function as glucosyltransferase in type I collagen (Sricholpech, M., Perdivara, I., Nagaoka, H., Yokoyama, M., Tomer, K. B., and Yamauchi, M. (2011) Lysyl hydroxylase 3 glucosylates galactosylhydroxylysine residues in type I collagen in osteoblast culture. J. Biol. Chem. 286, 8846-8856). To further elucidate the biological significance of this modification, we characterized and compared type I collagen phenotypes produced by Sh clones and two control groups, MC and those transfected with empty vector. Mass spectrometric analysis identified five glycosylation sites in type I collagen (i.e. alpha 1,2-87, alpha 1,2-174, and alpha 2-219. Of these, the predominant glycosylation site was alpha 1-87, one of the major helical cross-linking sites. In Sh collagen, the abundance of glucosylgalactosylhydroxylysine was significantly decreased at all of the five sites with a concomitant increase in galactosylhydroxylysine at four of these sites. The collagen cross-links were significantly diminished in Sh clones, and, for the major cross-link, dihydroxylysinonorleucine (DHLNL), glucosylgalactosyl-DHLNL was diminished with a concomitant increase in galactosyl-DHLNL. When subjected to in vitro incubation, in Sh clones, the rate of decrease in DHLNL was lower, whereas the rate of increase in its maturational cross-link, pyridinoline, was comparable with controls. Furthermore, in Sh clones, the mean diameters of collagen fibrils were significantly larger, and the onset of mineralized nodule formation was delayed when compared with those of controls. These results indicate that the LH3-mediated glucosylation occurs at the specific molecular loci in the type I collagen molecule and plays critical roles in controlling collagen cross-linking, fibrillogenesis, and mineralization.	[Yamauchi, Mitsuo] Univ N Carolina, NC Oral Hlth Inst, Sch Dent, Chapel Hill, NC 27599 USA; [Perdivara, Irina; Tomer, Kenneth B.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Yamauchi, M (corresponding author), Univ N Carolina, NC Oral Hlth Inst, Sch Dent, CB 7454, Chapel Hill, NC 27599 USA.	mitsuo_yamauchi@dentistry.unc.edu	Tomer, Kenneth B/E-8018-2013	Sricholpech, Marnisa/0000-0003-2139-0688	National Institutes of Health [R21 DE019569, DE020909, AR060978]; National Institutes of Health, NIEHS [ES050171]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE020909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050171, Z01ES050171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DE019569, DE020909, and AR060978 and the Intramural Research Program of National Institutes of Health, NIEHS, Project ES050171.	AGUILAR JH, 1973, J BIOL CHEM, V248, P5106; AMUDESWARI S, 1987, COLLAGEN REL RES, V7, P215; Atsawasuwan P, 2005, BIOCHEM BIOPH RES CO, V327, P1042, DOI 10.1016/j.bbrc.2004.12.119; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BAILEY AJ, 1973, BIOCHIM BIOPHYS ACTA, V328, P383, DOI 10.1016/0005-2795(73)90272-9; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; Batge B, 1997, J BIOCHEM, V122, P109; BRENNER RE, 1990, EUR J CLIN INVEST, V20, P8, DOI 10.1111/j.1365-2362.1990.tb01785.x; Brinckmann J, 1999, J INVEST DERMATOL, V113, P617, DOI 10.1046/j.1523-1747.1999.00735.x; BUTLER WT, 1966, J BIOL CHEM, V241, P3882; CETTA G, 1983, CONNECT TISSUE RES, V11, P103, DOI 10.3109/03008208309004847; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; CUNNINGH.LW, 1968, J BIOL CHEM, V243, P2390; Dominguez LJ, 2005, BIOCHEM BIOPH RES CO, V330, P1, DOI 10.1016/j.bbrc.2005.02.050; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2010, J BIOL CHEM, V285, P16675, DOI 10.1074/jbc.M110.111534; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; EYRE DR, 1973, BIOCHEM BIOPH RES CO, V52, P663, DOI 10.1016/0006-291X(73)90764-X; EYRE DR, 1980, BIOCHEM BIOPH RES CO, V92, P403, DOI 10.1016/0006-291X(80)90347-2; Fietzek P P, 1976, Int Rev Connect Tissue Res, V7, P1; Gineyts E, 2001, RHEUMATOLOGY, V40, P315, DOI 10.1093/rheumatology/40.3.315; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; HENKEL W, 1976, EUR J BIOCHEM, V69, P223, DOI 10.1111/j.1432-1033.1976.tb10877.x; Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; LEHMANN HW, 1995, J CANCER RES CLIN, V121, P413, DOI 10.1007/BF01212948; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MICHALSKY M, 1993, BIOCHEM BIOPH RES CO, V192, P1281, DOI 10.1006/bbrc.1993.1555; Miller EJ, 1984, EXTRACELLULAR MATRIX, P41; Mochida Y, 2003, BIOCHEM BIOPH RES CO, V305, P6, DOI 10.1016/S0006-291X(03)00693-4; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; MORGAN PH, 1970, J BIOL CHEM, V245, P5042; Moro L, 1997, EUR J CLIN CHEM CLIN, V35, P29; Moro L, 1997, EUR J CLIN CHEM CLIN, V35, P269; Moro L, 2000, CALCIFIED TISSUE INT, V66, P151, DOI 10.1007/s002230010030; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; OTSUBO K, 1992, BIOCHEMISTRY-US, V31, P396, DOI 10.1021/bi00117a013; Palmieri D, 2010, EXP CELL RES, V316, P789, DOI 10.1016/j.yexcr.2009.12.006; Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612; PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871; PINNELL SR, 1971, BIOCHIM BIOPHYS ACTA, V229, P119, DOI 10.1016/0005-2795(71)90325-4; Pornprasertsuk S, 2005, J BONE MINER RES, V20, P81, DOI 10.1359/JBMR.041026; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; ROBINS SP, 1983, BIOCHEM J, V215, P175, DOI 10.1042/bj2150175; ROBINS SP, 1975, BIOCHEM J, V149, P381, DOI 10.1042/bj1490381; ROBINS SP, 1983, BIOCHEM J, V215, P167, DOI 10.1042/bj2150167; ROBINS SP, 1977, BIOCHIM BIOPHYS ACTA, V492, P408, DOI 10.1016/0005-2795(77)90092-7; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; SAVOLAINEN ER, 1981, NEW ENGL J MED, V304, P197, DOI 10.1056/NEJM198101223040403; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; SCHOFIELD JD, 1971, BIOCHEM J, V124, P467, DOI 10.1042/bj1240467; SEGREST JP, 1970, J CLIN INVEST, V49, P1497, DOI 10.1172/JCI106367; SHINKAI H, 1979, BIOCHEM J, V177, P847, DOI 10.1042/bj1770847; Siegel R C, 1976, Adv Exp Med Biol, V74, P438; Silver FH, 2011, CONNECT TISSUE RES, V52, P242, DOI 10.3109/03008207.2010.551567; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Suarez KN, 1996, CALCIFIED TISSUE INT, V58, P65, DOI 10.1007/s002239900012; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; TENNI R, 1993, AM J MED GENET, V45, P252, DOI 10.1002/ajmg.1320450219; TOOLE BP, 1972, BIOCHEM J, V127, P715, DOI 10.1042/bj1270715; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; YAMAUCHI M, 1982, P NATL ACAD SCI-BIOL, V79, P7684, DOI 10.1073/pnas.79.24.7684; Yamauchi M, 1989, Connect Tissue Res, V21, P159, DOI 10.3109/03008208909050006; YAMAUCHI M, 1993, CONNECT TISSUE RES, V29, P81, DOI 10.3109/03008209309014236; YAMAUCHI M, 1986, BIOCHEMISTRY-US, V25, P4907, DOI 10.1021/bi00365a027; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI DOI 10.1042/BSE0520113; Yamauchi M, 1988, COLLAGEN, P157; Yamauchi M., 1989, CONNECT TISSUE RES, V21, P168; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; YANG CLL, 1993, EUR J BIOCHEM, V213, P1297, DOI 10.1111/j.1432-1033.1993.tb17881.x	81	65	67	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22998	23009		10.1074/jbc.M112.343954	http://dx.doi.org/10.1074/jbc.M112.343954			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573318	Green Published, hybrid			2022-12-28	WOS:000306495000056
J	Savalli, N; Pantazis, A; Yusifov, T; Sigg, D; Olcese, R				Savalli, Nicoletta; Pantazis, Antonios; Yusifov, Taleh; Sigg, Daniel; Olcese, Riccardo			The Contribution of RCK Domains to Human BK Channel Allosteric Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; CA2+-ACTIVATED K+ CHANNELS; VOLTAGE SENSOR ACTIVATION; GATED ION CHANNELS; POTASSIUM CHANNELS; CA2+ BINDING; GATING RING; KINETIC-PROPERTIES; BETA-SUBUNITS; DM-NITROPHEN	Large conductance voltage- and Ca2+-activated K+ (BK) channels are potent regulators of cellular processes including neuronal firing, synaptic transmission, cochlear hair cell tuning, insulin release, and smooth muscle tone. Their unique activation pathway relies on structurally distinct regulatory domains including one transmembrane voltage-sensing domain (VSD) and two intracellular high affinity Ca2+-sensing sites per subunit (located in the RCK1 and RCK2 domains). Four pairs of RCK1 and RCK2 domains form a Ca2+-sensing apparatus known as the "gating ring." The allosteric interplay between voltage- and Ca2+-sensing apparati is a fundamental mechanism of BK channel function. Using voltage- clamp fluorometry and UV photolysis of intracellular caged Ca2+, we optically resolved VSD activation prompted by Ca2+ binding to the gating ring. The sudden increase of intracellular Ca2+ concentration ([Ca2+](i)) induced a hyperpolarizing shift in the voltage dependence of both channel opening and VSD activation, reported by a fluorophore labeling position 202, located in the upper side of the S4 transmembrane segment. The neutralization of the Ca2+ sensor located in the RCK2 domain abolished the effect of [Ca2+](i) increase on the VSD rearrangements. On the other hand, the mutation of RCK1 residues involved in Ca2+ sensing did not prevent the effect of Ca2+ release on the VSD, revealing a functionally distinct interaction between RCK1 and RCK2 and the VSD. A statistical-mechanical model quantifies the complex thermodynamics interplay between Ca2+ association in two distinct sites, voltage sensor activation, and BK channel opening.	[Savalli, Nicoletta; Pantazis, Antonios; Yusifov, Taleh; Sigg, Daniel; Olcese, Riccardo] Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, David Geffen Sch Med, Los Angeles, CA 90075 USA; [Olcese, Riccardo] Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med, Los Angeles, CA 90075 USA; [Olcese, Riccardo] Univ Calif Los Angeles, Cardiovasc Res Labs, David Geffen Sch Med, Los Angeles, CA 90075 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Olcese, R (corresponding author), Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, David Geffen Sch Med, BH 570 CHS, Los Angeles, CA 90075 USA.	rolcese@ucla.edu	Pantazis, Antonios/AAB-3846-2019	Pantazis, Antonios/0000-0002-6467-1327; Sigg, Daniel/0000-0003-4944-2988	National Institutes of Health [R01GM082289]; Laubisch Foundation; American Heart Association [11POST7140046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laubisch Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM082289 (to R. O.). This work was also supported by funds from the Laubisch Foundation (to R. O.) and American Heart Association Post-doctoral Fellowship (Western States Affiliate) 11POST7140046 (to A. P.).	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Diaz L, 1998, J BIOL CHEM, V273, P32430, DOI 10.1074/jbc.273.49.32430; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Ellis-Davies GCR, 2003, METHOD ENZYMOL, V360, P226; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; Faas GC, 2005, BIOPHYS J, V88, P4421, DOI 10.1529/biophysj.104.057745; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Gandhi C. S., 2008, METHODS MOL BIOL POT; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; Horrigan FT, 2008, J GEN PHYSIOL, V131, P13, DOI 10.1085/jgp.200709877; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Javaherian AD, 2011, J BIOL CHEM, V286, P20701, DOI 10.1074/jbc.M111.235234; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; Pantazis A, 2010, J GEN PHYSIOL, V136, P645, DOI 10.1085/jgp.201010503; Pantazis A, 2010, P NATL ACAD SCI USA, V107, P4459, DOI 10.1073/pnas.0911959107; Piper DR, 2008, CELL PHYSIOL BIOCHEM, V21, P37, DOI 10.1159/000113745; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Savalli N, 2007, J GEN PHYSIOL, V130, P117, DOI 10.1085/jgp.200709803; Savalli N, 2006, P NATL ACAD SCI USA, V103, P12619, DOI 10.1073/pnas.0601176103; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Sheng JZ, 2005, BIOPHYS J, V89, P3079, DOI 10.1529/biophysj.105.063610; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Sun XP, 2004, J PHYSIOL-LONDON, V557, P207, DOI 10.1113/jphysiol.2003.060509; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Sy T, 2010, NEUROSCIENCE, V165, P715, DOI 10.1016/j.neuroscience.2009.11.003; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Yusifov T, 2010, J GEN PHYSIOL, V136, P189, DOI 10.1085/jgp.200910374; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107	68	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21741	21750		10.1074/jbc.M112.346171	http://dx.doi.org/10.1074/jbc.M112.346171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556415	Green Published, hybrid			2022-12-28	WOS:000306418600015
J	Davies, LRL; Pearce, OMT; Tessier, MB; Assar, S; Smutova, V; Pajunen, M; Sumida, M; Sato, C; Kitajima, K; Finne, J; Gagneux, P; Pshezhetsky, A; Woods, R; Varki, A				Davies, Leela R. L.; Pearce, Oliver M. T.; Tessier, Matthew B.; Assar, Siavash; Smutova, Victoria; Pajunen, Maria; Sumida, Mizuki; Sato, Chihiro; Kitajima, Ken; Finne, Jukka; Gagneux, Pascal; Pshezhetsky, Alexey; Woods, Robert; Varki, Ajit			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups RESISTANCE OF alpha 2-8-LINKED N-GLYCOLYLNEURAMINIC ACID TO ENZYMATIC CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; THIN-LAYER-CHROMATOGRAPHY; UNNATURAL SIALIC ACIDS; POLYSIALIC ACID; GLYCOLYLNEURAMINIC-ACID; BRAIN GANGLIOSIDES; ACETYLNEURAMINIC ACID; STRUCTURAL-CHARACTERIZATION; MONOCLONAL-ANTIBODY; NEURAMINIC ACID	The sialic acid (Sia) N-acetylneuraminic acid (Neu5Ac) and its hydroxylated derivative N-glycolylneuraminic acid (Neu5Gc) differ by one oxygen atom. CMP-Neu5Gc is synthesized from CMP-Neu5Ac, with Neu5Gc representing a highly variable fraction of total Sias in various tissues and among different species. The exception may be the brain, where Neu5Ac is abundant and Neu5Gc is reported to be rare. Here, we confirm this unusual pattern and its evolutionary conservation in additional samples from various species, concluding that brain Neu5Gc expression has been maintained at extremely low levels over hundreds of millions of years of vertebrate evolution. Most explanations for this pattern do not require maintaining neural Neu5Gc at such low levels. We hypothesized that resistance of alpha 2-8-linked Neu5Gc to vertebrate sialidases is the detrimental effect requiring the relative absence of Neu5Gc from brain. This linkage is prominent in polysialic acid (polySia), a molecule with critical roles in vertebrate neural development. We show that Neu5Gc is incorporated into neural polySia and does not cause in vitro toxicity. Synthetic polymers of Neu5Ac and Neu5Gc showed that mammalian and bacterial sialidases are much less able to hydrolyze alpha 2-8-linked Neu5Gc at the nonreducing terminus. Notably, this difference was not seen with acid-catalyzed hydrolysis of polySias. Molecular dynamics modeling indicates that differences in the three-dimensional conformation of terminal saccharides may partly explain reduced enzymatic activity. In keeping with this, polymers of N-propionylneuraminic acid are sensitive to sialidases. Resistance of Neu5Gc-containing polySia to sialidases provides a potential explanation for the rarity of Neu5Gc in the vertebrate brain.	[Davies, Leela R. L.; Pearce, Oliver M. T.; Assar, Siavash; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Davies, Leela R. L.; Pearce, Oliver M. T.; Assar, Siavash; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tessier, Matthew B.; Woods, Robert] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Tessier, Matthew B.; Woods, Robert] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Smutova, Victoria; Pshezhetsky, Alexey] Univ Montreal, Ctr Hosp Univ St Justine, Div Med Genet, Montreal, PQ H3T 1C5, Canada; [Pajunen, Maria; Finne, Jukka] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FI-00014 Helsinki, Finland; [Sumida, Mizuki; Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Woods, Robert] Natl Univ Ireland, Sch Chem, Galway, Ireland	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Helsinki; Nagoya University; Ollscoil na Gaillimhe-University of Galway	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Woods, Robert/F-4962-2015; SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012; Finne, Jukka/B-6881-2008	Naganawa, Shinji/0000-0002-0214-613X; Finne, Jukka/0000-0002-8076-3344; Pearce, Oliver/0000-0003-3953-1629; Woods, Robert/0000-0002-2400-6293; Pajunen, Maria/0000-0001-5484-2228	National Institutes of Health [R01GM32373, R01CA38701, GM094919]; CARTA; Mathers Foundation of New York; Cancer Research Institute; Finnish Academy; Science Foundation of Ireland [08/IN.1/B2070]; European Research Development Fund; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373, R01GM094919, P41GM103390, R01GM095882] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570133] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CARTA; Mathers Foundation of New York; Cancer Research Institute; Finnish Academy(Academy of Finland); Science Foundation of Ireland(Science Foundation Ireland); European Research Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32373 and R01CA38701 (to A. V.) and GM094919 (EUREKA) (to R. J. W.).; Supported by a CARTA fellowship funded by the Mathers Foundation of New York.; Recipient of a Samuel and Ruth Engelberg Fellowship from the Cancer Research Institute.; Supported by the Finnish Academy.; Supported by Science Foundation of Ireland Grant 08/IN.1/B2070 and the European Research Development Fund.	ANDO S, 1978, ANAL BIOCHEM, V89, P437, DOI 10.1016/0003-2697(78)90373-1; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Basma M, 2001, J COMPUT CHEM, V22, P1125, DOI 10.1002/jcc.1072; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bork K, 2007, J NEUROCHEM, V103, P65, DOI 10.1111/j.1471-4159.2007.04711.x; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Cabezas J. A., 2011, AN REAL ACAD NAC F, V77, P72; Cao HZ, 2009, ORG BIOMOL CHEM, V7, P5137, DOI 10.1039/b916305k; Case D.A., 2010, AMBER 12 2012, P1; Casellato R, 1995, EUR J BIOCHEM, V234, P786, DOI 10.1111/j.1432-1033.1995.786_a.x; Charter NW, 2000, GLYCOBIOLOGY, V10, P1049, DOI 10.1093/glycob/10.10.1049; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; CHIGORNO V, 1982, NEUROCHEM INT, V4, P397, DOI 10.1016/0197-0186(82)90082-1; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; CORFIELD AP, 1981, BIOCHEM J, V197, P293, DOI 10.1042/bj1970293; CORFIELD AP, 1982, SIALIC ACIDS CHEM ME, P5; CUNNINGHAM BA, 1983, P NATL ACAD SCI-BIOL, V80, P3116, DOI 10.1073/pnas.80.10.3116; DAHIYA R, 1988, LIPIDS, V23, P863, DOI 10.1007/BF02536206; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FINNE J, 1987, J IMMUNOL, V138, P4402; FURUKAWA K, 1988, J BIOL CHEM, V263, P14939; GHIDONI R, 1976, J NEUROCHEM, V27, P511, DOI 10.1111/j.1471-4159.1976.tb12275.x; Gottschalk A., 1960, CHEMISTRY BIOLOGY SI, P30; HASHIMOTO Y, 1983, J BIOCHEM-TOKYO, V94, P2043, DOI 10.1093/oxfordjournals.jbchem.a134559; HASHIMOTO Y, 1982, J BIOCHEM-TOKYO, V91, P1039, DOI 10.1093/oxfordjournals.jbchem.a133753; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; HIGA HH, 1985, J BIOL CHEM, V260, P8838; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; INOUE S, 1980, BIOCHEM BIOPH RES CO, V93, P162, DOI 10.1016/S0006-291X(80)80260-9; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; IWAMORI M, 1978, J BIOCHEM-TOKYO, V84, P1609, DOI 10.1093/oxfordjournals.jbchem.a132287; IWAMORI M, 1981, BIOCHIM BIOPHYS ACTA, V665, P214, DOI 10.1016/0005-2760(81)90005-9; IWAMORI M, 1978, BIOCHIM BIOPHYS ACTA, V528, P257; Jokilammi A, 2004, J IMMUNOL METHODS, V295, P149, DOI 10.1016/j.jim.2004.10.006; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katoh S, 1999, J IMMUNOL, V162, P5058; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KAWANO T, 1993, GLYCOCONJUGATE J, V10, P109, DOI 10.1007/BF00731194; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KITAJIMA K, 1988, J BIOL CHEM, V263, P18269; KOIZUMI N, 1988, JPN J EXP MED, V58, P21; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; LEPERS A, 1990, EUR J BIOCHEM, V193, P715, DOI 10.1111/j.1432-1033.1990.tb19391.x; Li YH, 2011, MOL BIOSYST, V7, P1060, DOI 10.1039/c0mb00244e; Magesh S, 2009, BIOORGAN MED CHEM, V17, P4595, DOI 10.1016/j.bmc.2009.04.065; Mahal LK, 2001, SCIENCE, V294, P380, DOI 10.1126/science.1062192; MANZI AE, 1994, J BIOL CHEM, V269, P23617; MARTENSSON E, 1958, BIOCHIM BIOPHYS ACTA, V30, P124, DOI 10.1016/0006-3002(58)90248-8; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; MCCOY RD, 1985, J BIOL CHEM, V260, P2695; MENZELEEV RF, 1993, BIOORG KHIM+, V19, P817; Mikami T, 1998, J BIOCHEM, V123, P487; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; MOPPER K, 1973, ANAL BIOCHEM, V56, P440, DOI 10.1016/0003-2697(73)90210-8; Muchmore EA, 1998, AM J PHYS ANTHROPOL, V107, P187, DOI 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.3.CO;2-M; Muhlenhoff M, 2003, J BIOL CHEM, V278, P12634, DOI 10.1074/jbc.M212048200; MURAYAMA JI, 1982, J BIOCHEM, V91, P1829, DOI 10.1093/oxfordjournals.jbchem.a133879; NAGAI K, 1985, J BIOCHEM-TOKYO, V98, P545, DOI 10.1093/oxfordjournals.jbchem.a135309; NAKAO T, 1991, BIOCHIM BIOPHYS ACTA, V1086, P305, DOI 10.1016/0005-2760(91)90174-G; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Osthoff G, 2008, COMP BIOCHEM PHYS B, V150, P74, DOI 10.1016/j.cbpb.2008.01.010; Pearce OMT, 2010, CARBOHYD RES, V345, P1225, DOI 10.1016/j.carres.2010.04.003; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; Pshezhetsky AV, 2011, GLYCOCONJUGATE J, V28, P441, DOI 10.1007/s10719-011-9350-5; Pshezhetsky AV, 1996, J BIOL CHEM, V271, P28359, DOI 10.1074/jbc.271.45.28359; Raymond JB, 2005, J BIOL CHEM, V280, P326, DOI 10.1074/jbc.M411006200; Rizzo AM, 2002, GLYCOCONJUGATE J, V19, P53, DOI 10.1023/A:1022584914778; ROY R, 1990, GLYCOCONJUGATE J, V7, P3, DOI 10.1007/BF01050399; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANAI Y, 1988, BIOCHIM BIOPHYS ACTA, V958, P368, DOI 10.1016/0005-2760(88)90222-6; SATO C, 1993, J BIOL CHEM, V268, P23675; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato C, 1999, ANAL BIOCHEM, V266, P102, DOI 10.1006/abio.1998.2921; SCHAUER R, 1968, H-S Z PHYSIOL CHEM, V349, P645, DOI 10.1515/bchm2.1968.349.1.645; Schauer R, 1978, Methods Enzymol, V50, P64; Schulz EC, 2010, J MOL BIOL, V397, P341, DOI 10.1016/j.jmb.2010.01.028; SEKI T, 1991, ANAT EMBRYOL, V184, P395, DOI 10.1007/BF00957900; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Song KH, 2010, BIOCHEM J, V427, P179, DOI 10.1042/BJ20090835; Spichtig V, 2010, ANAL BIOCHEM, V405, P28, DOI 10.1016/j.ab.2010.06.010; Spiro RG, 1996, BIOCHEM J, V319, P209, DOI 10.1042/bj3190209; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; Tao NA, 2011, J PROTEOME RES, V10, P1548, DOI 10.1021/pr1009367; TERABAYASHI T, 1992, COMP BIOCHEM PHYS B, V103, P721, DOI 10.1016/0305-0491(92)90396-9; TROY FA, 1979, ANNU REV MICROBIOL, V33, P519, DOI 10.1146/annurev.mi.33.100179.002511; Uemura Y, 2006, COMP BIOCHEM PHYS A, V145, P468, DOI 10.1016/j.cbpa.2006.08.001; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Vyas AA, 2001, BIOCHIMIE, V83, P677, DOI 10.1016/S0300-9084(01)01308-6; WAFFENSCHMIDT S, 1987, ANAL BIOCHEM, V165, P337, DOI 10.1016/0003-2697(87)90278-8; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; WANG D, 1990, JPN J VET SCI, V52, P567; WARREN L, 1961, J HISTOCHEM CYTOCHEM, V9, P400, DOI 10.1177/9.4.400; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamakawa N, 2007, BIOCHIMIE, V89, P1396, DOI 10.1016/j.biochi.2007.04.010; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P851, DOI 10.1021/bi00217a039; Yongye AB, 2008, BIOCHEMISTRY-US, V47, P12493, DOI 10.1021/bi800431c; YU RK, 1972, J LIPID RES, V13, P680; YU RK, 1970, J LIPID RES, V11, P506; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zhang Y, 1999, J BIOL CHEM, V274, P6183, DOI 10.1074/jbc.274.10.6183	113	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28917	28931		10.1074/jbc.M112.365056	http://dx.doi.org/10.1074/jbc.M112.365056			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692207	hybrid, Green Published			2022-12-28	WOS:000308074600061
J	Hatori, Y; Clasen, S; Hasan, NM; Barry, AN; Lutsenko, S				Hatori, Yuta; Clasen, Sara; Hasan, Nesrin M.; Barry, Amanda N.; Lutsenko, Svetlana			Functional Partnership of the Copper Export Machinery and Glutathione Balance in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL HOMEOSTASIS; ESCHERICHIA-COLI; WILSONS-DISEASE; CHAPERONE CCS; PROTEIN; REDOX; OXYGEN; THIOREDOXIN; METABOLISM; ATOX1	Cells use the redox properties of copper in numerous physiologic processes, including antioxidant defense, neurotransmitter biosynthesis, and angiogenesis. Copper delivery to the secretory pathway is an essential step in copper utilization and homeostatic maintenance. We demonstrate that the glutathione/glutathione disulfide (GSH/GSSG) pair controls the copper transport pathway by regulating the redox state of a copper chaperone Atox1. GSSG oxidizes copper-coordinating cysteines of Atox1 with the formation of an intramolecular disulfide. GSH alone is sufficient to reduce the disulfide, restoring the ability of Atox1 to bind copper; glutaredoxin 1 facilitates this reaction when GSH is low. In cells, high GSH both reduces Atox1 and is required for cell viability in the absence of Atox1. In turn, Atox1, which has a redox potential similar to that of glutaredoxin, becomes essential for cell survival when GSH levels decrease. Atox1(+/+) cells resist short term glutathione depletion, whereas Atox1(-/-) cells under the same conditions are not viable. We conclude that GSH balance and copper homeostasis are functionally linked and jointly maintain conditions for copper secretion and cell proliferation.	[Hatori, Yuta; Clasen, Sara; Hasan, Nesrin M.; Barry, Amanda N.; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu		Barry, Amanda/0000-0002-7992-0322	National Institutes of Health [R01 DK071865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071865 (to S. L.).	Anastassopoulou I, 2004, BIOCHEMISTRY-US, V43, P13046, DOI 10.1021/bi0487591; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Burkhead JL, 2011, J MOL BIOL, V406, P44, DOI 10.1016/j.jmb.2010.12.001; Culotta VC, 1999, ADV EXP MED BIOL, V448, P247; Filomeni G, 2006, ANTIOXID REDOX SIGN, V8, P2187, DOI 10.1089/ars.2006.8.2187; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Hamza I, 2001, P NATL ACAD SCI USA, V98, P6848, DOI 10.1073/pnas.111058498; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Hussain F, 2008, P NATL ACAD SCI USA, V105, P11158, DOI 10.1073/pnas.0802928105; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, MOL BIOSYST, V3, P816, DOI 10.1039/b711118p; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kelner GS, 2000, J BIOL CHEM, V275, P580, DOI 10.1074/jbc.275.1.580; Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; LeShane ES, 2010, J BIOL CHEM, V285, P6327, DOI 10.1074/jbc.M109.074633; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; LIZARD G, 1995, CYTOMETRY, V21, P275, DOI 10.1002/cyto.990210308; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Mitozo PA, 2011, FREE RADICAL BIO MED, V51, P69, DOI 10.1016/j.freeradbiomed.2011.03.017; Miyayama T, 2009, TOXICOL APPL PHARM, V237, P205, DOI 10.1016/j.taap.2009.03.024; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; NARTEY NO, 1987, LAB INVEST, V57, P397; Nkabyo YS, 2002, AM J PHYSIOL-GASTR L, V283, pG1352, DOI 10.1152/ajpgi.00183.2002; Ogra Y, 2010, J INORG BIOCHEM, V104, P858, DOI 10.1016/j.jinorgbio.2010.04.001; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Singleton WCJ, 2010, J BIOL CHEM, V285, P27111, DOI 10.1074/jbc.M110.154468; Steveson TC, 2003, ENDOCRINOLOGY, V144, P188, DOI 10.1210/en.2002-220716; Suzuki KT, 2002, J INORG BIOCHEM, V88, P173, DOI 10.1016/S0162-0134(01)00376-2; Tapryal N, 2010, FREE RADICAL BIO MED, V48, P1492, DOI 10.1016/j.freeradbiomed.2010.02.029; WALKER FJ, 1990, J BIOL CHEM, V265, P1834	44	60	61	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26678	26687		10.1074/jbc.M112.381178	http://dx.doi.org/10.1074/jbc.M112.381178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22648419	hybrid, Green Published			2022-12-28	WOS:000307386000019
J	Sana, TG; Hachani, A; Bucior, I; Soscia, C; Garvis, S; Termine, E; Engel, J; Filloux, A; Bleves, S				Sana, Thibault G.; Hachani, Abderrahman; Bucior, Iwona; Soscia, Chantal; Garvis, Steve; Termine, Elise; Engel, Joanne; Filloux, Alain; Bleves, Sophie			The Second Type VI Secretion System of Pseudomonas aeruginosa Strain PAO1 Is Regulated by Quorum Sensing and Fur and Modulates Internalization in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRIC UPTAKE REGULATOR; IRON STARVATION RESPONSE; GRAM-NEGATIVE BACTERIA; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; GENES; VIRULENCE; EXPRESSION; IDENTIFICATION; PROTEIN	The genome of Pseudomonas aeruginosa PAO1 contains three type VI secretion systems (T6SSs) called H1-, H2-, and H3-T6SS. The H1-T6SS secretes three identified toxins that target other bacteria, providing a fitness advantage for P. aeruginosa, and likely contributes to bacterial pathogenesis in chronic infections. However, no specific substrates or defined roles have been described for the two other systems. Here, we demonstrate that the expression of H2-T6SS genes of strain PAO1 is up-regulated during the transition from exponential to stationary phase growth and regulated by the Las and Rhl quorum sensing systems. In addition, we identify two putative Fur boxes in the promoter region and find that H2-T6SS transcription is negatively regulated by iron. We also show that the H2-T6SS system enhances bacterial uptake into HeLa cells (75% decrease in internalization with a H2-T6SS mutant) and into lung epithelial cells through a phosphatidylinositol 3-kinase-dependent pathway that induces Akt activation in the host cell (50% decrease in Akt phosphorylation). Finally, we show that H2-T6SS plays a role in P. aeruginosa virulence in the worm model. Thus, in contrast to H1-T6SS, H2-T6SS modulates interaction with eukaryotic host cells. Together, T6SS can carry out different functions that may be important in establishing chronic P. aeruginosa infections in the human host.	[Sana, Thibault G.; Hachani, Abderrahman; Soscia, Chantal; Garvis, Steve; Termine, Elise; Filloux, Alain; Bleves, Sophie] Aix Marseille Univ, F-13402 Marseille 20, France; [Sana, Thibault G.; Hachani, Abderrahman; Soscia, Chantal; Garvis, Steve; Termine, Elise; Filloux, Alain; Bleves, Sophie] CNRS, Lab Ingn Syst Macromol, UMR7255, F-13402 Marseille 20, France; [Bucior, Iwona; Engel, Joanne] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Engel, Joanne] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bleves, S (corresponding author), Aix Marseille Univ, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	bleves@imm.cnrs.fr	Bleves, SOPHIE/HII-4948-2022; Sana, Thibault G/B-1599-2013; Hachani, Abderrahman/AAV-3320-2020; Hachani, Abderrahman/H-1801-2013	Hachani, Abderrahman/0000-0001-8032-2154; garvis, steve/0000-0002-0547-0672; Sana, Thibault/0000-0003-0723-6924	EuroPathoGenomics REX Grant [LSHB-CT-2005512061-EPG]; "Pathomics" ERA-net PATHO Grant [ANR-08-PATH-004-01]; Royal Society Wellcome Trust Grant [WT097939]; National Institutes of Health [P01 AI053194, R01 AI065902]; Ph.D. fellowship from the French Research Ministry; post-doctoral fellowship from the French Research Minister; EuroPathoGenomics network of excellence; Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research Inc.; Medical Research Council [G0800171] Funding Source: researchfish; MRC [G0800171] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065902, P01AI053194] Funding Source: NIH RePORTER	EuroPathoGenomics REX Grant; "Pathomics" ERA-net PATHO Grant; Royal Society Wellcome Trust Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ph.D. fellowship from the French Research Ministry; post-doctoral fellowship from the French Research Minister; EuroPathoGenomics network of excellence; Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research Inc.; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by EuroPathoGenomics REX Grant LSHB-CT-2005512061-EPG), "Pathomics" ERA-net PATHO Grant ANR-08-PATH-004-01. This work was also supported by funds from the Royal Society Wellcome Trust Grant WT097939 (to A. F.), National Institutes of Health Grants P01 AI053194 and R01 AI065902 (to J. E.), a Ph.D. fellowship from the French Research Ministry (to T. G. S.), a post-doctoral fellowship from the French Research Minister and from EuroPathoGenomics network of excellence (to A. H.), and a Elizabeth Nash Memorial Fellowship from Cystic Fibrosis Research Inc. (to I. B.).	Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Barton HA, 1996, MOL MICROBIOL, V21, P1001, DOI 10.1046/j.1365-2958.1996.381426.x; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; CHI E, 1991, INFECT IMMUN, V59, P822, DOI 10.1128/IAI.59.3.822-828.1991; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; Engel J., 2007, PSEUDOMONAS AERUGINO, P343; Engel J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00114; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; Khajanchi BK, 2009, MICROBIOL-SGM, V155, P3518, DOI 10.1099/mic.0.031575-0; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kierbel A, 2007, J CELL BIOL, V177, P21, DOI 10.1083/jcb.200605142; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lazdunski AM, 2004, NAT REV MICROBIOL, V2, P581, DOI 10.1038/nrmicro924; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 1996, MOL MICROBIOL, V21, P1019, DOI 10.1046/j.1365-2958.1996.481425.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Southey-Pillig CJ, 2005, J BACTERIOL, V187, P8114, DOI 10.1128/JB.187.23.8114-8126.2005; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106; Zhang WP, 2011, ARCH MICROBIOL, V193, P351, DOI 10.1007/s00203-011-0680-2; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107	77	117	122	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27095	27105		10.1074/jbc.M112.376368	http://dx.doi.org/10.1074/jbc.M112.376368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22665491	Green Published, hybrid			2022-12-28	WOS:000307386000062
J	Tecalco-Cruz, AC; Sosa-Garrocho, M; Vazquez-Victorio, G; Ortiz-Garcia, L; Dominguez-Huttinger, E; Macias-Silva, M				Tecalco-Cruz, Angeles C.; Sosa-Garrocho, Marcela; Vazquez-Victorio, Genaro; Ortiz-Garcia, Layla; Dominguez-Huettinger, Elisa; Macias-Silva, Marina			Transforming Growth Factor-beta/SMAD Target Gene SKIL Is Negatively Regulated by the Transcriptional Cofactor Complex SNON-SMAD4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; ANAPHASE-PROMOTING COMPLEX; FACTOR-BETA; DOWN-REGULATION; SMAD PROTEINS; SNON ONCOPROTEIN; TUMOR-SUPPRESSOR; CANCER-CELLS; GENOME-WIDE; DEGRADATION	The human SKI-like (SKIL) gene encodes the SMAD transcriptional corepressor SNON that antagonizes TGF-beta signaling. SNON protein levels are tightly regulated by the TGF-beta pathway: whereas a short stimulation with TGF-beta decreases SNON levels by its degradation via the proteasome, longer TGF-beta treatment increases SNON levels by inducing SKIL gene expression. Here, we investigated the molecular mechanisms involved in the self-regulation of SKIL gene expression by SNON. Bioinformatics analysis showed that the human SKIL gene proximal promoter contains a TGF-beta response element (TRE) bearing four groups of SMAD-binding elements that are also conserved in mouse. Two regions of 408 and 648 bp of the human SKIL gene (similar to 2.4 kb upstream of the ATG initiation codon) containing the core promoter, transcription start site, and the TRE were cloned for functional analysis. Binding of SMAD and SNON proteins to the TRE region of the SKIL gene promoter after TGF-beta treatment was demonstrated by ChIP and sequential ChIP assays. Interestingly, the SNON-SMAD4 complex negatively regulated basal SKIL gene expression through binding the promoter and recruiting histone deacetylases. In response to TGF-beta signal, SNON is removed from the SKIL gene promoter, and then the activated SMAD complexes bind the promoter to induce SKIL gene expression. Subsequently, the up-regulated SNON protein in complex with SMAD4 represses its own expression as part of the negative feedback loop regulating the TGF-beta pathway. Accordingly, when the SNON-SMAD4 complex is absent as in some cancer cells lacking SMAD4 the regulation of some TGF-beta target genes is modified.	[Tecalco-Cruz, Angeles C.; Sosa-Garrocho, Marcela; Vazquez-Victorio, Genaro; Ortiz-Garcia, Layla; Dominguez-Huettinger, Elisa; Macias-Silva, Marina] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Macias-Silva, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico.	mmacias@ifc.unam.mx	Tecalco-Cruz, Angeles C./ABA-7761-2020; TECALCO-CRUZ, ANGELES C./K-1983-2019	TECALCO-CRUZ, ANGELES C./0000-0001-9199-3834; Macias-Silva, Marina/0000-0002-3972-0983; Dominguez Huttinger, Elisa/0000-0002-9086-099X; Vazquez-Victorio, Genaro/0000-0002-2319-8772	Universidad Nacional Autonoma de Mexico/Direccion General Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Program [IN222909, IN206012]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [49493-Q, 101826]; CONACyT	Universidad Nacional Autonoma de Mexico/Direccion General Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Program; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by Universidad Nacional Autonoma de Mexico/Direccion General Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Program Grants IN222909 and IN206012 and Consejo Nacional de Ciencia y Tecnologia (CONACyT) Grants 49493-Q and 101826.; Recipient of a Ph.D. fellowship from CONACyT.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Briones-Orta MA, 2006, BIOCHEM BIOPH RES CO, V341, P889, DOI 10.1016/j.bbrc.2006.01.041; Briones-Orta Marco A, 2011, Curr Mol Pharmacol, V4, P141; Cohen SB, 1999, NUCLEIC ACIDS RES, V27, P1006, DOI 10.1093/nar/27.4.1006; Denissova NG, 2004, J BIOL CHEM, V279, P28143, DOI 10.1074/jbc.M404961200; Edmiston JS, 2005, CANCER RES, V65, P4782, DOI 10.1158/0008-5472.CAN-04-4354; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; HernandezDamian J., 2010, CURR CHEM BIOL, V4, P124; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; HEYMAN HC, 1994, J BIOL CHEM, V269, P26996; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Izzi L, 2007, EMBO J, V26, P3132, DOI 10.1038/sj.emboj.7601753; Kalari Krishna R., 2006, In Silico Biology, V6, P237; Koinuma D, 2009, CANCER SCI, V100, P2133, DOI 10.1111/j.1349-7006.2009.01299.x; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin Xia, 2008, P287; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Macias-Silva M, 2002, J BIOL CHEM, V277, P28483, DOI 10.1074/jbc.M202403200; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Muller N, 2002, ONCOGENE, V21, P6049, DOI 10.1038/sj.onc.1205766; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; NAGASE T, 1993, J BIOL CHEM, V268, P13710; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pearson-White S, 2003, MOL CELL BIOL, V23, P5446, DOI 10.1128/MCB.23.15.5446-5459.2003; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Tan RY, 2007, J AM SOC NEPHROL, V18, P2340, DOI 10.1681/ASN.2007010128; Tan RY, 2006, J AM SOC NEPHROL, V17, P2781, DOI 10.1681/ASN.2005101055; Vazquez-Macias A, 2005, FEBS LETT, V579, P3701, DOI 10.1016/j.febslet.2005.05.057; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Yang G, 2010, INT J BIOL SCI, V6, P1; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	58	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26764	26776		10.1074/jbc.M112.386599	http://dx.doi.org/10.1074/jbc.M112.386599			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22674574	Green Published, hybrid			2022-12-28	WOS:000307386000026
J	Bohm, C; Katari, VS; Brecht, M; Goringer, HU				Boehm, Cordula; Katari, Venkata Subbaraju; Brecht, Michael; Goeringer, H. Ulrich			Trypanosoma brucei 20 S Editosomes Have One RNA Substrate-binding Site and Execute RNA Unwinding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; GUIDE RNA; EDITING COMPLEX; MESSENGER-RNA; DIRECTED ENDONUCLEASE; FOLDING LANDSCAPE; PROTEIN; MITOCHONDRIA; MOLECULES; GENE	Editing of mitochondrial pre-mRNAs in African trypanosomes generates full-length transcripts by the site-specific insertion and deletion of uridylate nucleotides. The reaction is catalyzed by a 0.8 MDa multienzyme complex, the editosome. Although the binding of substrate pre-edited mRNAs and cognate guide RNAs (gRNAs) represents the first step in the reaction cycle, the biochemical and biophysical details of the editosome/RNA interaction are not understood. Here we show that editosomes bind full-length substrate mRNAs with nanomolar affinity in a nonselective fashion. The complexes do not discriminate-neither kinetically nor thermodynamically-between different mitochondrial pre-mRNAs or between edited and unedited versions of the same transcript. They also bind gRNAs and gRNA/pre-mRNA hybrid RNAs with similar affinities and association rate constants. Gold labeling of editosome-bound RNA in combination with transmission electron microscopy identified a single RNA-binding site per editosome. However, atomic force microscopy of individual pre-mRNA-editosome complexes revealed that multiple editosomes can interact with one pre-mRNA. Lastly, we demonstrate a so far unknown activity of the editing machinery: editosome-bound RNA becomes unfolded by a chaperone-type RNA unwinding activity.	[Boehm, Cordula; Katari, Venkata Subbaraju; Brecht, Michael; Goeringer, H. Ulrich] Tech Univ Darmstadt, Dept Mol Genet, D-64287 Darmstadt, Germany	Technical University of Darmstadt	Goringer, HU (corresponding author), Tech Univ Darmstadt, Dept Mol Genet, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	goringer@hrzpub.tu-darmstadt.de			German Research Council [DFG-SFB902]; International Research Scholar Grant of the Howard Hughes Medical Institute	German Research Council(German Research Foundation (DFG)); International Research Scholar Grant of the Howard Hughes Medical Institute	This work was supported by German Research Council Grant DFG-SFB902 and an International Research Scholar Grant of the Howard Hughes Medical Institute (to H. U. G.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2003, P NATL ACAD SCI USA, V100, P10617, DOI 10.1073/pnas.1833120100; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizhev R, 2001, J BIOL CHEM, V276, P21280, DOI 10.1074/jbc.M100297200; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; BHAT GJ, 1990, CELL, V61, P885, DOI 10.1016/0092-8674(90)90199-O; Blom D, 2001, NUCLEIC ACIDS RES, V29, P2950, DOI 10.1093/nar/29.14.2950; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Carnes J, 2011, J BIOL CHEM, V286, P19320, DOI 10.1074/jbc.M111.228965; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; CruzReyes J, 1996, P NATL ACAD SCI USA, V93, P8901, DOI 10.1073/pnas.93.17.8901; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; Frech GC, 1996, MOL CELL BIOL, V16, P4584; Goringer HU, 2011, WIRES RNA, V2, P395, DOI 10.1002/wrna.67; Goeringer H. Ulrich, 2008, V20, P165; Golas MM, 2009, EMBO J, V28, P766, DOI 10.1038/emboj.2009.19; GORINGER HU, 1994, P NATL ACAD SCI USA, V91, P1776, DOI 10.1073/pnas.91.5.1776; Hajduk S, 2010, RNA BIOL, V7, P229, DOI 10.4161/rna.7.2.11393; Hansma HG, 1996, NUCLEIC ACIDS RES, V24, P713, DOI 10.1093/nar/24.4.713; Hauser R, 1996, J CELL SCI, V109, P517; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Kala S, 2010, RNA, V16, P1951, DOI 10.1261/rna.2124610; Kuznetsov YG, 2010, NUCLEIC ACIDS RES, V38, P8284, DOI 10.1093/nar/gkq662; Kwon SH, 2007, BIOCHEM BIOPH RES CO, V361, P681, DOI 10.1016/j.bbrc.2007.07.084; Minh PNL, 2009, NUCLEIC ACIDS RES, V37, P1463, DOI 10.1093/nar/gkn1078; Li F, 2011, P NATL ACAD SCI USA, V108, P3542, DOI 10.1073/pnas.1014152108; Li F, 2009, P NATL ACAD SCI USA, V106, P12306, DOI 10.1073/pnas.0901754106; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; MASLOV DA, 1992, CELL, V70, P459, DOI 10.1016/0092-8674(92)90170-H; Matsuura T, 2006, BIOSCI BIOTECH BIOCH, V70, P300, DOI 10.1271/bbb.70.300; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Mikamo-Satoh E, 2009, ANAL BIOCHEM, V394, P275, DOI 10.1016/j.ab.2009.07.033; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Moreno-Herrero F, 2003, ULTRAMICROSCOPY, V96, P167, DOI 10.1016/S0304-3991(03)00004-4; Muller UF, 2002, NUCLEIC ACIDS RES, V30, P447, DOI 10.1093/nar/30.2.447; Muller UF, 2001, EMBO J, V20, P1394, DOI 10.1093/emboj/20.6.1394; Niemann M, 2008, NUCLEIC ACIDS RES, V36, P4465, DOI 10.1093/nar/gkn410; Niemann M, 2009, NUCLEIC ACIDS RES, V37, P1897, DOI 10.1093/nar/gkp049; ODOM OW, 1980, BIOCHEMISTRY-US, V19, P5947, DOI 10.1021/bi00567a001; Park YJ, 2012, NUCLEIC ACIDS RES, V40, P1828, DOI 10.1093/nar/gkr867; Piller KJ, 1997, RNA, V3, P279; Pusnik M, 2012, EUKARYOT CELL, V11, P79, DOI 10.1128/EC.05213-11; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Reifur L, 2008, RNA, V14, P2195, DOI 10.1261/rna.1144508; Rusche LN, 2001, MOL CELL BIOL, V21, P979, DOI 10.1128/MCB.21.4.979-989.2001; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Santos S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023821; Sbicego S, 2003, EUKARYOT CELL, V2, P560, DOI 10.1128/EC.2.3.560-568.2003; SCHMID B, 1995, NUCLEIC ACIDS RES, V23, P3093, DOI 10.1093/nar/23.16.3093; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Thirumalai D, 2001, ANNU REV PHYS CHEM, V52, P751, DOI 10.1146/annurev.physchem.52.1.751	63	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26268	26277		10.1074/jbc.M112.365916	http://dx.doi.org/10.1074/jbc.M112.365916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22661715	Green Published, hybrid			2022-12-28	WOS:000306916300053
J	Chien, CH; Gao, QZ; Cooper, AJL; Lyu, JH; Sheu, SY				Chien, Chin-Hsiang; Gao, Quan-Ze; Cooper, Arthur J. L.; Lyu, Jyun-Hong; Sheu, Sheh-Yi			Structural Insights into the Catalytic Active Site and Activity of Human Nit2/omega-Amidase KINETIC ASSAY AND MOLECULAR DYNAMICS SIMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE TUMOR-SUPPRESSOR; LIVER OMEGA-AMIDASE; RAT-LIVER; GLUTAMINE TRANSAMINASE; ALPHA-KETOGLUTARAMATE; CRYSTAL-STRUCTURE; PROTEIN; ACID; IDENTIFICATION; ASPARAGINE	Human nitrilase-like protein 2 (hNit2) is a putative tumor suppressor, recently identified as omega-amidase. hNit2/omega-amidase plays a crucial metabolic role by catalyzing the hydrolysis of alpha-ketoglutaramate (the alpha-keto analog of glutamine) and alpha-ketosuccinamate (the alpha-keto analog of asparagine), yielding alpha-ketoglutarate and oxaloacetate, respectively. Transamination between glutamine and alpha-keto-gamma-methiolbutyrate closes the methionine salvage pathway. Thus, hNit2/omega-amidase links sulfur metabolism to the tricarboxylic acid cycle. To elucidate the catalytic specificity of hNit2/omega-amidase, we performed molecular dynamics simulations on the wild type enzyme and its mutants to investigate enzyme-substrate interactions. Binding free energies were computed to characterize factors contributing to the substrate specificity. The predictions resulting from these computations were verified by kinetic analyses and mutational studies. The activity of hNit2/omega-amidase was determined with alpha-ketoglutaramate and succinamate as substrates. We constructed three catalytic triad mutants (E43A, K112A, and C153A) and a mutant with a loop 116-128 deletion to validate the role of key residues and the 116-128 loop region in substrate binding and turnover. The molecular dynamics simulations successfully verified the experimental trends in the binding specificity of hNit2/omega-amidase toward various substrates. Our findings have revealed novel structural insights into the binding of substrates to hNit2/omega-amidase. A catalytic triad and the loop residues 116-128 of hNit2 play an essential role in supporting the stability of the enzyme-substrate complex, resulting in the generation of the catalytic products. These observations are predicted to be of benefit in the design of new inhibitors or activators for research involving cancer and hyperammonemic diseases.	[Sheu, Sheh-Yi] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Sheu, Sheh-Yi] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chien, Chin-Hsiang] Natl Yang Ming Univ, Dept Biochem, Sch Med, Taipei 112, Taiwan; [Gao, Quan-Ze; Sheu, Sheh-Yi] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Cooper, Arthur J. L.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; New York Medical College	Sheu, SY (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	sysheu@ym.edu.tw	Cooper, Arthur J.L./H-5171-2016		National Science Council of Taiwan [NSC-99-2113-M-010-002-MY3, NSC 99-2311-B-010-001]; National Yang-Ming University [98A-D-N309]; Aim for the Top University Plan at the National Yang-Ming University; Ministry of Education, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Yang-Ming University; Aim for the Top University Plan at the National Yang-Ming University; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported in part by the National Science Council of Taiwan Grants NSC-99-2113-M-010-002-MY3 and NSC 99-2311-B-010-001 (to S. Y. S. and C. H. C.), National Yang-Ming University International Collaboration Grant 98A-D-N309 (to C. H. C.), and the Aim for the Top University Plan at the National Yang-Ming University supported by the Ministry of Education, Taiwan.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barglow KT, 2008, BIOCHEMISTRY-US, V47, P13514, DOI 10.1021/bi801786y; BERTINO JR, 1979, CANCER-AM CANCER SOC, V43, P2136; BOLLETER WT, 1961, ANAL CHEM, V33, P592, DOI 10.1021/ac60172a034; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; COOPER AJL, 1977, J BIOL CHEM, V252, P2032; COOPER AJL, 1981, COMP BIOCHEM PHYS B, V69, P137, DOI 10.1016/0305-0491(81)90223-6; COOPER AJL, 1974, J BIOL CHEM, V249, P2554; COOPER AJL, 1987, ANAL BIOCHEM, V167, P312, DOI 10.1016/0003-2697(87)90170-9; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUFFY TE, 1974, J BIOL CHEM, V249, P7603; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; HERSH LB, 1971, BIOCHEMISTRY-US, V10, P2884, DOI 10.1021/bi00791a014; HERSH LB, 1972, BIOCHEMISTRY-US, V11, P2251, DOI 10.1021/bi00762a007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaisson S, 2009, BIOCHIMIE, V91, P1066, DOI 10.1016/j.biochi.2009.07.002; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krasnikov BF, 2009, BIOCHIMIE, V91, P1072, DOI 10.1016/j.biochi.2009.07.003; Krasnikov BF, 2009, ANAL BIOCHEM, V391, P144, DOI 10.1016/j.ab.2009.05.025; Kuhara T, 2011, ANAL BIOANAL CHEM, V400, P1843, DOI 10.1007/s00216-011-4688-x; Kumaran D, 2003, PROTEINS, V52, P283, DOI 10.1002/prot.10417; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MEISTER A, 1953, J BIOL CHEM, V200, P571; MEISTER A, 1955, J BIOL CHEM, V215, P441; Novo C, 2002, BIOCHEM J, V365, P731, DOI 10.1042/BJ20011714; OTANI TT, 1957, J BIOL CHEM, V224, P137; Pace HC, 2000, CURR BIOL, V10, P907, DOI 10.1016/S0960-9822(00)00621-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Szeliga M, 2009, NEUROCHEM INT, V55, P71, DOI 10.1016/j.neuint.2009.01.008; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vergara F, 1973, Trans Assoc Am Physicians, V86, P255; VERGARA F, 1974, SCIENCE, V183, P81, DOI 10.1126/science.183.4120.81; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	47	12	13	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25715	25726		10.1074/jbc.M111.259119	http://dx.doi.org/10.1074/jbc.M111.259119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22674578	Green Published, hybrid			2022-12-28	WOS:000306916300003
J	Hamaia, SW; Pugh, N; Raynal, N; Nemoz, B; Stone, R; Gullberg, D; Bihan, D; Farndale, RW				Hamaia, Samir W.; Pugh, Nicholas; Raynal, Nicolas; Nemoz, Benjamin; Stone, Rachael; Gullberg, Donald; Bihan, Dominique; Farndale, Richard W.			Mapping of Potent and Specific Binding Motifs, GLOGEN and GVOGEA, for Integrin alpha 1 beta 1 Using Collagen Toolkits II and III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; RECOGNITION SITE; CELL-ADHESION; A-DOMAIN; IN-VIVO; EXPRESSION; RECEPTOR; ALPHA(1)BETA(1); IV; BETA-1-INTEGRINS	Integrins are well characterized cell surface receptors for extracellular matrix proteins. Mapping integrin-binding sites within the fibrillar collagens identified GFOGER as a high affinity site recognized by alpha 2 beta 1, but with lower affinity for alpha 1 beta 1. Here, to identify specific ligands for alpha 1 beta 1, we examined binding of the recombinant human alpha 1 I domain, the rat pheochromocytoma cell line (PC12), and the rat glioma Rugli cell line to our collagen Toolkit II and III peptides using solid-phase and real-time label-free adhesion assays. We observed Mg2+-dependent binding of the alpha 1 I domain to the peptides in the following rank order: III-7 (GLOGEN), II-28 (GFOGER), II-7 and II-8 (GLOGER), II-18 (GAOGER), III-4 (GROGER). PC12 cells showed a similar profile. Using antibody blockade, we confirmed that binding of PC12 cells to peptide III-7 was mediated by integrin alpha 1 beta 1. We also identified a new alpha 1 beta 1-binding activity within peptide II-27. The sequence GVOGEA bound weakly to PC12 cells and strongly to activated Rugli cells or to an activated alpha 1 I domain, but not to the alpha 2 I domain or to C2C12 cells expressing alpha 2 beta 1 or alpha 11 beta 1. Thus, GVOGEA is specific for alpha 1 beta 1. Although recognized by both alpha 2 beta 1 and alpha 11 beta 1, GLOGEN is a better ligand for alpha 1 beta 1 compared with GFOGER. Finally, using biosensor assays, we show that although GLOGEN is able to compete for the alpha 1 I domain from collagen IV (IC50 similar to 3 mu M), GFOGER is much less potent (IC50 similar to 90 mu M), as shown previously. These data confirm the selectivity of GFOGER for alpha 2 beta 1 and establish GLOGEN as a high affinity site for alpha 1 beta 1.	[Hamaia, Samir W.; Pugh, Nicholas; Raynal, Nicolas; Nemoz, Benjamin; Stone, Rachael; Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Gullberg, Donald] Univ Bergen, Dept Biomed, NO-5009 Bergen, Norway	University of Cambridge; University of Bergen	Farndale, RW (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	rwf10@cam.ac.uk	Gullberg, Donald/H-2495-2016	Gullberg, Donald/0000-0002-7245-4437; Nemoz, Benjamin/0000-0002-3843-9380; Pugh, Nicholas/0000-0002-6916-4199	Wellcome Trust; Medical Research Council; SRU Biosystems (Woburn, NJ); Medical Research Council [G0500707, G0400701] Funding Source: researchfish; MRC [G0400701, G0500707] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SRU Biosystems (Woburn, NJ); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust, the Medical Research Council, and SRU Biosystems (Woburn, NJ).	Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bella J, 2000, STRUCTURE, V8, pR121, DOI 10.1016/S0969-2126(00)00153-2; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Castillo-Briceno P, 2011, MOL IMMUNOL, V48, P826, DOI 10.1016/j.molimm.2010.12.004; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Deschaseaux F, 2003, BRIT J HAEMATOL, V122, P506, DOI 10.1046/j.1365-2141.2003.04469.x; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FITZSIMMONS CM, 1986, THROMB HAEMOSTASIS, V56, P95; Gailit J, 1996, J CELL PHYSIOL, V169, P281, DOI 10.1002/(SICI)1097-4652(199611)169:2<281::AID-JCP7>3.0.CO;2-K; Gilhar A, 1997, MELANOMA RES, V7, P486, DOI 10.1097/00008390-199712000-00007; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; HEINO J, 1989, J BIOL CHEM, V264, P21806; Hemler M E, 1995, Curr Opin Hematol, V2, P61; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jarvis GE, 2012, J THROMB HAEMOST, V10, P268, DOI 10.1111/j.1538-7836.2011.04567.x; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Koukoulis GK, 1997, HUM PATHOL, V28, P1018, DOI 10.1016/S0046-8177(97)90054-X; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; MECHTERSHEIMER G, 1994, AM J PATHOL, V144, P1172; MENDRICK DL, 1995, LAB INVEST, V72, P367; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Pirila L, 1996, J RHEUMATOL, V23, P1691; Racine-Samson L, 1997, J BIOL CHEM, V272, P30911, DOI 10.1074/jbc.272.49.30911; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Sacca B, 2003, BIOCHEMISTRY-US, V42, P3429, DOI 10.1021/bi0206762; Sacca B, 2002, CHEMBIOCHEM, V3, P904, DOI 10.1002/1439-7633(20020902)3:9<904::AID-CBIC904>3.0.CO;2-I; SCHADENDORF D, 1993, J PATHOL, V170, P429, DOI 10.1002/path.1711700405; Schadendorf D, 1996, BRIT J CANCER, V74, P194, DOI 10.1038/bjc.1996.337; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Stewart HJS, 1997, J NEUROBIOL, V33, P914, DOI 10.1002/(SICI)1097-4695(199712)33:7<914::AID-NEU4>3.0.CO;2-B; Szulgit G, 2002, J INVEST DERMATOL, V118, P409, DOI 10.1046/j.0022-202x.2001.01680.x; TAWIL NJ, 1990, BIOCHEMISTRY-US, V29, P6540, DOI 10.1021/bi00479a028; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; ZHANG ZY, 1993, J BIOL CHEM, V268, P5557	54	45	45	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26019	26028		10.1074/jbc.M112.353144	http://dx.doi.org/10.1074/jbc.M112.353144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654115	Green Published, hybrid			2022-12-28	WOS:000306916300029
J	Xu, JK; Chen, HJ; Li, XD; Huang, ZL; Xu, H; Yang, HL; Hu, J				Xu, Jian-kun; Chen, Hong-jiang; Li, Xue-dong; Huang, Zhong-lian; Xu, Huan; Yang, Hai-long; Hu, Jun			Optimal Intensity Shock Wave Promotes the Adhesion and Migration of Rat Osteoblasts via Integrin beta 1-mediated Expression of Phosphorylated Focal Adhesion Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TYROSINE PHOSPHORYLATION; ACTIVATED PROTEIN-KINASE; LONG-BONE FRACTURES; FLUID SHEAR-STRESS; MECHANICAL STIMULATION; EXTRACELLULAR-MATRIX; SIGNALING PATHWAYS; SEGMENTAL DEFECT; GENE-EXPRESSION; BETA-CATENIN	To search for factors promoting bone fracture repair, we investigated the effects of extracorporeal shock wave (ESW) on the adhesion, spreading, and migration of osteoblasts and its specific underlying cellular mechanisms. After a single period of stimulation by 10 kV (500 impulses) of shock wave (SW), the adhesion rate was increased as compared with the vehicle control. The data from both wound healing and transwell tests confirmed an acceleration in the migration of osteoblasts by SW treatment. RT-PCR, flow cytometry, and Western blotting showed that SW rapidly increased the surface expression of alpha 5 and beta 1 subunit integrins, indicating that integrin beta 1 acted as an early signal for ESW-induced osteoblast adhesion and migration. It has also been found that a significant elevation occurred in the expression of phosphorylated beta-catenin and focal adhesion kinase (FAK) at the site of tyrosine 397 in response to SW stimulation after the increasing expression of the integrin beta 1 molecule. When siRNAs of integrin alpha 5 and beta 1 subunit were added, the level of FAK phosphorylation elevated by SW declined. Interestingly, the adhesion and migration of osteoblasts were decreased when these siRNA reagents as well as the ERK1/2 signaling pathway inhibitors, U0126 and PD98059, were present. Further studies demonstrated that U0126 could inhibit the downstream integrin-dependent signaling pathways, such as the FAK signaling pathway, whereas it had no influence on the synthesis of integrin beta 1 molecule. In conclusion, these data suggest that ESW promotes the adhesion and migration of osteoblasts via integrin beta 1-mediated expression of phosphorylated FAK at the Tyr-397 site; in addition, ERK1/2 are also important for osteoblast adhesion, spreading, migration, and integrin expression.	[Xu, Jian-kun; Chen, Hong-jiang; Li, Xue-dong; Huang, Zhong-lian; Xu, Huan; Yang, Hai-long; Hu, Jun] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Orthoped, Shantou 515041, Guangdong, Peoples R China	Shantou University	Hu, J (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Orthoped, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China.	hjzkm@yahoo.cn	yang, hailong/GXH-9625-2022					Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; Beutler S, 1999, UNFALLCHIRURG, V102, P839, DOI 10.1007/s001130050492; Birnbaum K, 2002, ARCH ORTHOP TRAUM SU, V122, P324, DOI 10.1007/s00402-001-0365-4; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Cacchio A, 2009, J BONE JOINT SURG AM, V91A, P2589, DOI 10.2106/JBJS.H.00841; Chaturvedi LS, 2007, AM J PHYSIOL-CELL PH, V292, pC1701, DOI 10.1152/ajpcell.00529.2006; Chen YJ, 2004, J ORTHOP RES, V22, P526, DOI 10.1016/j.orthres.2003.10.005; Chen YJ, 2003, FEBS LETT, V554, P154, DOI 10.1016/S0014-5793(03)01157-8; Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6; CLOVER J, 1992, J CELL SCI, V103, P267; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Faux MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014127; GRONOWICZ GA, 1995, ENDOCRINOLOGY, V136, P598, DOI 10.1210/en.136.2.598; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58; Hofmann A, 2008, J TRAUMA, V65, P1402, DOI 10.1097/TA.0b013e318173e7c2; Hsia DA, 2005, MOL CELL BIOL, V25, P9700, DOI 10.1128/MCB.25.21.9700-9712.2005; Hu J, 2006, PROG BIOCHEM BIOPHYS, V33, P452; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikeda K, 1999, J TRAUMA, V47, P946, DOI 10.1097/00005373-199911000-00024; ILLC D, 1995, NATURE, V377, P539; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee DY, 2008, J BONE MINER RES, V23, P1140, DOI 10.1359/JBMR.080302; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; McClure S., 2003, Clinical Techniques in Equine Practice, V2, P348, DOI 10.1053/j.ctep.2004.04.008; Moretti B, 2009, ULTRASOUND MED BIOL, V35, P1042, DOI 10.1016/j.ultrasmedbio.2008.12.002; Moursi AM, 1997, J CELL SCI, V110, P2187; Nakayamada S, 2003, J BIOL CHEM, V278, P45368, DOI 10.1074/jbc.M308786200; NIH, 2010, GUIDE CARE USE LAB A, V8th, DOI [10.1163/1573-3912_islam_DUM_3825, DOI 10.1163/1573-3912_ISLAM_DUM_3825]; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Rompe JD, 2001, CLIN ORTHOP RELAT R, P102, DOI 10.1097/00003086-200106000-00014; RUBIN CT, 1995, J BONE MINER RES, V10, P488; Schaden W, 2001, CLIN ORTHOP RELAT R, P90; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schneider GB, 1999, BONE, V24, P321, DOI 10.1016/S8756-3282(99)00007-1; SEIDL M, 1994, ULTRASONICS, V32, P397, DOI 10.1016/0041-624X(94)90111-2; Siebers MC, 2008, J MATER SCI-MATER M, V19, P861, DOI 10.1007/s10856-007-0166-6; Sieg DJ, 1999, J CELL SCI, V112, P2677; STEINBACH P, 1992, ULTRASOUND MED BIOL, V18, P691, DOI 10.1016/0301-5629(92)90120-Y; Tang CH, 2003, J BONE MINER RES, V18, P502, DOI 10.1359/jbmr.2003.18.3.502; Tarone G, 2000, INT J DEV BIOL, V44, P725; TUCKWELL DS, 1993, CRIT REV ONCOL HEMAT, V15, P149, DOI 10.1016/1040-8428(93)90053-7; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Uslu M M, 1999, Bull Hosp Jt Dis, V58, P114; Wang C. J., 2012, AM J SPORTS IN PRESS; Wang CJ, 2001, CLIN ORTHOP RELAT R, P112; Wang CJ, 2001, CLIN ORTHOP RELAT R, P95; Wang FS, 2004, J BIOL CHEM, V279, P10331, DOI 10.1074/jbc.M308013200; Wang FS, 2003, BONE, V32, P387, DOI 10.1016/S8756-3282(03)00029-2; Wang FS, 2001, BIOCHEM BIOPH RES CO, V287, P648, DOI 10.1006/bbrc.2001.5654; Wang LP, 2006, BIOMATERIALS, V27, P3716, DOI 10.1016/j.biomaterials.2006.02.022; Warden SJ, 2001, BIOCHEM BIOPH RES CO, V286, P443, DOI 10.1006/bbrc.2001.5412; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang RS, 2005, BONE, V36, P276, DOI 10.1016/j.bone.2004.10.009; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058	67	44	46	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26200	26212		10.1074/jbc.M112.349811	http://dx.doi.org/10.1074/jbc.M112.349811			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654119	Green Published, hybrid			2022-12-28	WOS:000306916300047
J	Zhang, J; Li, HF; Zhou, TW; Zhou, JC; Herrup, K				Zhang, Jie; Li, Huifang; Zhou, Tingwen; Zhou, Jiechao; Herrup, Karl			Cdk5 Levels Oscillate during the Neuronal Cell Cycle Cdh1 UBIQUITINATION TRIGGERS PROTEOSOME-DEPENDENT DEGRADATION DURING S-PHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; ALZHEIMERS-DISEASE BRAIN; S-PHASE ENTRY; DEPENDENT KINASE-5; NUCLEAR-LOCALIZATION; POSTMITOTIC NEURONS; REGULATORY SUBUNIT; DEATH; PROTEIN; P35	When cell cycle re-activation occurs in post-mitotic neurons it places them at increased risk for death. The cell cycle/cell death association has been reported in many neurodegenerative diseases including Alzheimer disease (AD), yet the mechanisms by which a normal neuron suppresses the cycle remain largely unknown. Recently, our laboratory has shown that Cdk5 (cyclin-dependent kinase 5) is a key player in this protective function. When a neuron is under stress, Cdk5 is transported to the cytoplasm; this eliminates its cell cycle suppression activity and the neuron re-enters S-phase. In the current study we show that a similar principle applies during a normal cell cycle. When a neuronal cell enters S phase, Cdk5 is transported to the cytoplasm where it is ubiquitinated by the E3 ligase APC-Cdh1. Ubiquitinated Cdk5 is then rapidly degraded by the proteasome. The ubiquitination site of Cdk5 appears to be in the p35 binding area; in the presence of high levels of p35, the ubiquitination of Cdk5 was blocked, and the degradation in S phase was attenuated. The data suggest an unsuspected role for Cdk5 during the progression of a normal cell cycle and offer new pharmaceutical targets for regulating neuronal cell cycling and cell death.	[Zhang, Jie; Li, Huifang; Zhou, Tingwen; Zhou, Jiechao] Xiamen Univ, Inst Neurosci, Xiamen 361005, Fujian, Peoples R China; [Zhang, Jie; Herrup, Karl] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Xiamen University; Rutgers State University New Brunswick	Zhang, J (corresponding author), Xiamen Univ, Inst Neurosci, SiMing NanLu 422, Xiamen 361005, Fujian, Peoples R China.	jiezhang@xmu.edu.cn; herrup@biology.rutgers.edu	Zhang, Jie/A-5426-2010; Herrup, Karl/C-5313-2014	Herrup, Karl/0000-0001-7786-5844	National Institutes of Health [NS20591]; Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS20591 and Rutgers University.	Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Busser J, 1998, J NEUROSCI, V18, P2801; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fischer A, 2003, NEUROSIGNALS, V12, P200, DOI 10.1159/000074621; Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gao CY, 1997, DEV GENET, V20, P267; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; HOSOI T, 1995, J BIOCHEM, V117, P741, DOI 10.1093/oxfordjournals.jbchem.a124771; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Huynh MA, 2009, J NEUROSCI, V29, P4322, DOI 10.1523/JNEUROSCI.5329-08.2009; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Maestre C, 2008, EMBO J, V27, P2736, DOI 10.1038/emboj.2008.195; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Veeranna, 1995, J NEUROCHEM, V64, P2681; Vincent I, 1997, J NEUROSCI, V17, P3588; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yang Y, 2003, J NEUROSCI, V23, P2557; Zhang J, 2008, CELL CYCLE, V7, P3487, DOI 10.4161/cc.7.22.7045; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang J, 2011, CELL CYCLE, V10, P1208, DOI 10.4161/cc.10.8.15328; Zhang J, 2010, J BIOL CHEM, V285, P14052, DOI 10.1074/jbc.M109.068262; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010; Zhang Q, 1997, DEV BIOL, V183, P222, DOI 10.1006/dbio.1996.8494	45	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25985	25994		10.1074/jbc.M112.343152	http://dx.doi.org/10.1074/jbc.M112.343152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654103	Green Published, hybrid			2022-12-28	WOS:000306916300026
J	Peralta, S; Clemente, P; Sanchez-Martinez, A; Calleja, M; Hernandez-Sierra, R; Matsushima, Y; Adan, C; Ugalde, C; Fernandez-Moreno, MA; Kaguni, LS; Garesse, R				Peralta, Susana; Clemente, Paula; Sanchez-Martinez, Alvaro; Calleja, Manuel; Hernandez-Sierra, Rosana; Matsushima, Yuichi; Adan, Cristina; Ugalde, Cristina; Angel Fernandez-Moreno, Miguel; Kaguni, Laurie S.; Garesse, Rafael			Coiled Coil Domain-containing Protein 56 (CCDC56) Is a Novel Mitochondrial Protein Essential for Cytochrome c Oxidase Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; RIBOSOMAL-RNA; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; MESSENGER-RNA; GENE; TRANSCRIPTION; MUTATION; SUBUNIT; DEFICIENCY	In Drosophila melanogaster, the mitochondrial transcription factor B1 (d-mtTFB1) transcript contains in its 5'-untranslated region a conserved upstream open reading frame denoted as CG42630 in FlyBase. We demonstrate that CG42630 encodes a novel protein, the coiled coil domain-containing protein 56 (CCDC56), conserved in metazoans. We show that Drosophila CCDC56 protein localizes to mitochondria and contains 87 amino acids in flies and 106 in humans with the two proteins sharing 42% amino acid identity. We show by rapid amplification of cDNA ends and Northern blotting that Drosophila CCDC56 protein and mtTFB1 are encoded on a bona fide bicistronic transcript. We report the generation and characterization of two ccdc56 knock-out lines in Drosophila carrying the ccdc56(D6) and ccdc56(D11) alleles. Lack of the CCDC56 protein in flies induces a developmental delay and 100% lethality by arrest of larval development at the third instar. ccdc56 knock-out larvae show a significant decrease in the level of fully assembled cytochrome c oxidase (COX) and in its activity, suggesting a defect in complex assembly; the activity of the other oxidative phosphorylation complexes remained either unaffected or increased in the ccdc56 knock-out larvae. The lethal phenotype and the decrease in COX were partially rescued by reintroduction of a wild-type UAS-ccdc56 transgene. These results indicate an important role for CCDC56 in the oxidative phosphorylation system and in particular in COX function required for proper development in D. melanogaster. We propose CCDC56 as a candidate factor required for COX biogenesis/assembly.	[Peralta, Susana; Clemente, Paula; Sanchez-Martinez, Alvaro; Hernandez-Sierra, Rosana; Adan, Cristina; Angel Fernandez-Moreno, Miguel; Garesse, Rafael] UAM, CSIC,Fac Med, Inst Invest Biomed Alberto Sols,Dept Bioquim, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28029, Spain; [Ugalde, Cristina] Inst Invest Sanitaria 12 Octubre I 12, Madrid 28041, Spain; [Calleja, Manuel] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario 12 de Octubre; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Michigan State University; Michigan State University	Garesse, R (corresponding author), UAM, CSIC,Fac Med, Inst Invest Biomed Alberto Sols,Dept Bioquim, Ctr Invest Biomed Red Enfermedades Raras CIBERER, C Arturo Duperier 4, Madrid 28029, Spain.	rafael.garesse@uam.es	Garesse, Rafael/F-3836-2012; Sanchez-Martinez, Alvaro/L-1395-2013; Ugalde, Cristina/P-7533-2016; Fernandez-Moreno, Miguel Angel/K-4425-2017; Clemente, Paula/AAA-5768-2021; Sanchez-Martinez, Alvaro/L-3851-2019	Ugalde, Cristina/0000-0002-9742-1877; Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726; Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Garesse, Rafael/0000-0002-0338-2281; Clemente, Paula/0000-0002-6885-3750	National Institutes of Health [GM45295]; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III [PI 07/0167, PI 10/0703]; Comunidad de Madrid [GEN-0269/2006]; Instituto de Salud Carlos III-Agencia Lain Entralgo [PI 08/0021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III; Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III-Agencia Lain Entralgo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45295 (to L. S. K.). This work was also supported by grants from the Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III Grants PI 07/0167 and PI 10/0703 (to R. G), Comunidad de Madrid Grant GEN-0269/2006 (to R. G.), Instituto de Salud Carlos III-Agencia Lain Entralgo Grant PI 08/0021 (to C. U.).	Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews J, 1996, GENETICS, V143, P1699; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Betran E, 2000, MOL BIOL EVOL, V17, P1344, DOI 10.1093/oxfordjournals.molbev.a026418; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; Estes PS, 2003, GENETICS, V165, P185; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Papadopoulou LC, 1999, NAT GENET, V23, P333; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Szuplewski S, 2001, GENETICS, V158, P1629; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Xu FH, 2012, BIOCHEM J, V441, P275, DOI 10.1042/BJ20110985; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469	44	18	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24174	24185		10.1074/jbc.M112.343764	http://dx.doi.org/10.1074/jbc.M112.343764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22610097	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000306651100012
J	Campbell, SJ; Edwards, RA; Leung, CCY; Neculai, D; Hodge, CD; Dhe-Paganon, S; Glover, JNM				Campbell, Stephen J.; Edwards, Ross A.; Leung, Charles C. Y.; Neculai, Dante; Hodge, Curtis D.; Dhe-Paganon, Sirano; Glover, J. N. Mark			Molecular Insights into the Function of RING Finger (RNF)-containing Proteins hRNF8 and hRNF168 in Ubc13/Mms2-dependent Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; UBIQUITIN RECOGNITION; POLYUBIQUITIN CHAINS; COMPLEX; REPLACEMENT; REVEALS; LIGASE; MODEL	The repair of DNA double strand breaks by homologous recombination relies on the unique topology of the chains formed by Lys-63 ubiquitylation of chromatin to recruit repair factors such as breast cancer 1 (BRCA1) to sites of DNA damage. The human RING finger (RNF) E3 ubiquitin ligases, RNF8 and RNF168, with the E2 ubiquitin-conjugating complex Ubc13/Mms2, perform the majority of Lys-63 ubiquitylation in homologous recombination. Here, we show that RNF8 dimerizes and binds to Ubc13/Mms2, thereby stimulating formation of Lys-63 ubiquitin chains, whereas the related RNF168 RING domain is a monomer and does not catalyze Lys-63 polyubiquitylation. The crystal structure of the RNF8/Ubc13/Mms2 ternary complex reveals the structural basis for the interaction between Ubc13 and the RNF8 RING and that an extended RNF8 coiled-coil is responsible for its dimerization. Mutations that disrupt the RNF8/Ubc13 binding surfaces, or that truncate the RNF8 coiled-coil, reduce RNF8-catalyzed ubiquitylation. These findings support the hypothesis that RNF8 is responsible for the initiation of Lys-63-linked ubiquitylation in the DNA damage response, which is subsequently amplified by RNF168.	[Glover, J. N. Mark] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada; [Neculai, Dante; Dhe-Paganon, Sirano] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada	University of Alberta; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Glover, JNM (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada.	mark.glover@ualberta.ca	Neculai, Dante/M-2884-2013; Neculai, Dante/A-9923-2011	Neculai, Dante/0000-0001-8887-9168; Hodge, Curtis/0000-0002-7528-4058	Canadian Cancer Society	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by a research grant from the Canadian Cancer Society.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lok GTM, 2012, NUCLEIC ACIDS RES, V40, P196, DOI 10.1093/nar/gkr655; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	49	56	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23900	23910		10.1074/jbc.M112.359653	http://dx.doi.org/10.1074/jbc.M112.359653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589545	Green Published, hybrid			2022-12-28	WOS:000306511300060
J	Whitcomb, SJ; Fierz, B; McGinty, RK; Holt, M; Ito, T; Muir, TW; Allis, CD				Whitcomb, Sarah J.; Fierz, Beat; McGinty, Robert K.; Holt, Matthew; Ito, Takashi; Muir, Tom W.; Allis, C. David			Histone Monoubiquitylation Position Determines Specificity and Direction of Enzymatic Cross-talk with Histone Methyltransferases Dot1L and PRC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CHROMATIN-STRUCTURE; H2B UBIQUITYLATION; TRANSCRIPTIONAL ACTIVATION; PROTEOLYTIC DIGESTION; UBIQUITIN LIGASE; GENE-EXPRESSION; H3 METHYLATION; ACTIVE GENES; HUMAN-CELLS	It is well established that chromatin is a destination for signal transduction, affecting many DNA-templated processes. Histone proteins in particular are extensively post-translationally modified. We are interested in how the complex repertoire of histone modifications is coordinately regulated to generate meaningful combinations of "marks" at physiologically relevant genomic locations. One important mechanism is "cross-talk" between pre-existing histone post-translational modifications and enzymes that subsequently add or remove modifications on chromatin. Here, we use chemically defined "designer" nucleosomes to investigate novel enzymatic cross-talk relationships between the most abundant histone ubiquitylation sites, H2AK119ub and H2BK120ub, and two important histone methyltransferases, Dot1L and PRC2. Although the presence of H2Bub in nucleosomes greatly stimulated Dot1L methylation of H3K79, we found that H2Aub did not influence Dot1L activity. In contrast, we show that H2Aub inhibited PRC2 methylation of H3K27, but H2Bub did not influence PRC2 activity. Taken together, these results highlight how the position of nucleosome monoubiquitylation affects the specificity and direction of cross-talk with enzymatic activities on chromatin.	[Whitcomb, Sarah J.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Holt, Matthew] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA; [Fierz, Beat; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [McGinty, Robert K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ito, Takashi] Nagasaki Univ, Sch Med, Nagasaki 8528523, Japan	Rockefeller University; Rockefeller University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nagasaki University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10065 USA.	alliscd@rockefeller.edu	Muir, Tom/AHD-0860-2022; Fierz, Beat/H-3143-2012	Muir, Tom/0000-0001-9635-0344; Fierz, Beat/0000-0002-2991-3044; Whitcomb, Sarah/0000-0002-1392-1496	National Institutes of Health [2R01 GM040922-27]; Swiss National Science Foundation [PP00P3_133680]; The Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM107047, R01GM040922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); The Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 GM040922-27. This work was also supported by Swiss National Science Foundation Grant PP00P3_133680 and The Rockefeller University.	Allis CD, 2011, CHEMBIOCHEM, V12, P264, DOI 10.1002/cbic.201000761; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BOHM L, 1980, EUR J BIOCHEM, V106, P525, DOI 10.1111/j.1432-1033.1980.tb04599.x; BOHM L, 1982, EUR J BIOCHEM, V123, P299, DOI 10.1111/j.1432-1033.1982.tb19767.x; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chatterjee C, 2010, J BIOL CHEM, V285, P11045, DOI 10.1074/jbc.R109.080291; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; VANHOLDE KE, 1980, BIOPHYS J, V32, P271, DOI 10.1016/S0006-3495(80)84956-3; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	45	29	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23718	23725		10.1074/jbc.M112.361824	http://dx.doi.org/10.1074/jbc.M112.361824			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619169	Green Published, hybrid			2022-12-28	WOS:000306511300042
J	Wu, YL; Sommers, JA; Loiland, JA; Kitao, H; Kuper, J; Kisker, C; Brosh, RM				Wu, Yuliang; Sommers, Joshua A.; Loiland, Jason A.; Kitao, Hiroyuki; Kuper, Jochen; Kisker, Caroline; Brosh, Robert M., Jr.			The Q Motif of Fanconi Anemia Group J Protein (FANCJ) DNA Helicase Regulates Its Dimerization, DNA Binding, and DNA Repair Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME; BREAST-CANCER; ATP BINDING; HOMOLOGOUS RECOMBINATION; INACTIVATING MUTATIONS; STRUCTURAL BASIS; RECQ HELICASES; GENE-PRODUCT; MECHANISMS; BACH1	The Q motif, conserved in a number of RNA and DNA helicases, is proposed to be important for ATP binding based on structural data, but its precise biochemical functions are less certain. FANCJ encodes a Q motif DEAH box DNA helicase implicated in Fanconi anemia and breast cancer. A Q25A mutation of the invariant glutamine in the Q motif abolished its ability to complement cisplatin or telomestatin sensitivity of a fancj null cell line and exerted a dominant negative effect. Biochemical characterization of the purified recombinant FANCJ-Q25A protein showed that the mutation disabled FANCJ helicase activity and the ability to disrupt protein-DNA interactions. FANCJ-Q25A showed impaired DNA binding and ATPase activity but displayed ATP binding and temperature-induced unfolding transition similar to FANCJ-WT. Size exclusion chromatography and sedimentation velocity analyses revealed that FANCJ-WT existed as molecular weight species corresponding to a monomer and a dimer, and the dimeric form displayed a higher specific activity for ATPase and helicase, as well as greater DNA binding. In contrast, FANCJ-Q25A existed only as a monomer, devoid of helicase activity. Thus, the Q motif is essential for FANCJ enzymatic activity in vitro and DNA repair function in vivo.	[Wu, Yuliang; Sommers, Joshua A.; Loiland, Jason A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Kitao, Hiroyuki] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Kuper, Jochen; Kisker, Caroline] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Inst Biol Struct, D-97080 Wurzburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Kyushu University; University of Wurzburg	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020; Kisker, Caroline/T-1724-2019	Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health Intramural Research Program, NIA; Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft [Forschungszentrum FZ82]; NATIONAL INSTITUTE ON AGING [ZIAAG000752, ZIAAG000753, ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NIA. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.) and Deutsche Forschungsgemeinschaft Grant Forschungszentrum FZ82 (to C. K.).	Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2003, NUCLEIC ACIDS RES, V31, P2778, DOI 10.1093/nar/gkg376; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gallivan JP, 2003, FEBS LETT, V554, P485, DOI 10.1016/S0014-5793(03)01229-8; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Guo RB, 2007, NUCLEIC ACIDS RES, V35, P6297, DOI 10.1093/nar/gkm536; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Hiom K, 2010, DNA REPAIR, V9, P250, DOI 10.1016/j.dnarep.2010.01.005; Hsieh J, 1999, J MOL BIOL, V288, P255, DOI 10.1006/jmbi.1999.2666; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Killoran MP, 2006, NUCLEIC ACIDS RES, V34, P4098, DOI 10.1093/nar/gkl538; Kitao H, 2011, GENES CELLS, V16, P714, DOI 10.1111/j.1365-2443.2011.01523.x; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; Nongkhlaw M, 2012, BIOCHEMISTRY-US, V51, P3711, DOI 10.1021/bi2014757; Oksenych V, 2010, CELL CYCLE, V9, P90, DOI 10.4161/cc.9.1.10267; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Strohmeier J, 2011, BIOL CHEM, V392, P357, DOI 10.1515/BC.2011.034; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016; Wu YL, 2010, CELL CYCLE, V9, P4080, DOI 10.4161/cc.9.20.13667; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	59	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21699	21716		10.1074/jbc.M112.351338	http://dx.doi.org/10.1074/jbc.M112.351338			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22582397	Green Published, hybrid			2022-12-28	WOS:000306418600012
J	Macaire, H; Riquet, A; Moncollin, V; Biemont-Trescol, MC; Dodon, MD; Hermine, O; Debaud, AL; Mahieux, R; Mesnard, JM; Pierre, M; Gazzolo, L; Bonnefoy, N; Valentin, H				Macaire, Heloise; Riquet, Aurelien; Moncollin, Vincent; Biemont-Trescol, Marie-Claude; Dodon, Madeleine Duc; Hermine, Olivier; Debaud, Anne-Laure; Mahieux, Renaud; Mesnard, Jean-Michel; Pierre, Marlene; Gazzolo, Louis; Bonnefoy, Nathalie; Valentin, Helene			Tax Protein-induced Expression of Antiapoptotic Bfl-1 Protein Contributes to Survival of Human T-cell Leukemia Virus Type 1 (HTLV-1)-infected T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR AP-1; BCL-X-L; HTLV-I; UP-REGULATION; GENE-EXPRESSION; CONSTITUTIVE ACTIVATION; POTENTIAL MECHANISM; BINDING PROTEIN; DOWN-REGULATION	Human T lymphotropic virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia/lymphoma (ATLL). ATLL is a severe malignancy with no effective treatment. HTLV-1 regulatory proteins Tax and HTLV-1 basic leucine zipper factor (HBZ) play a major role in ATLL development, by interfering with cellular functions such as CD4(+) T-cell survival. In this study, we observed that the expression of Bfl-1, an antiapoptotic protein of the Bcl-2 family, is restricted to HTLV-1-infected T-cell lines and to T-cells expressing both Tax and HBZ proteins. We showed that Tax-induced bfl-1 transcription through the canonical NF-kappa B pathway. Moreover, we demonstrated that Tax cooperated with c-Jun or JunD, but not JunB, transcription factors of the AP-1 family to stimulate bfl-1 gene activation. By contrast, HBZ inhibited c-Jun-induced bfl-1 gene activation, whereas it increased JunD-induced bfl-1 gene activation. We identified one NF-kappa B, targeted by RelA, c-Rel, RelB, p105/p50, and p100/p52, and two AP-1, targeted by both c-Jun and JunD, binding sites in the bfl-1 promoter of T-cells expressing both Tax and HBZ. Analyzing the potential role of antiapoptotic Bcl-2 proteins in HTLV-1-infected T-cell survival, we demonstrated that these cells are differentially sensitive to silencing of Bfl-1, Bcl-x(L), and Bcl-2. Indeed, both Bfl-1 and Bcl-x(L) knock-downs decreased the survival of HTLV-1-infected T-cell lines, although no cell death was observed after Bcl-2 knockdown. Furthermore, we demonstrated that Bfl-1 knockdown sensitizes HTLV-1-infected T-cells to ABT-737 or etoposide treatment. Our results directly implicate Bfl-1 and Bcl-x(L) in HTLV-1-infected T-cell survival and suggest that both Bfl-1 and Bcl-x(L) represent potential therapeutic targets for ATLL treatment.	[Macaire, Heloise; Riquet, Aurelien; Biemont-Trescol, Marie-Claude; Dodon, Madeleine Duc; Debaud, Anne-Laure; Mahieux, Renaud; Pierre, Marlene; Gazzolo, Louis; Bonnefoy, Nathalie; Valentin, Helene] Univ Lyon, Lyon, France; [Macaire, Heloise; Riquet, Aurelien; Biemont-Trescol, Marie-Claude; Debaud, Anne-Laure; Pierre, Marlene; Bonnefoy, Nathalie; Valentin, Helene] INSERM, U851, F-69007 Lyon, France; [Riquet, Aurelien; Moncollin, Vincent; Biemont-Trescol, Marie-Claude; Dodon, Madeleine Duc; Debaud, Anne-Laure; Mahieux, Renaud; Pierre, Marlene; Gazzolo, Louis; Valentin, Helene] Univ Lyon 1, UMS3444, US8, F-69365 Lyon, France; [Moncollin, Vincent; Dodon, Madeleine Duc; Gazzolo, Louis] Ecole Normale Super Lyon, CNRS, UMR5239, Lab Biol Mol Cellule, F-69007 Lyon, France; [Hermine, Olivier] Hop Necker Enfants Malad, CNRS, UMR8603, F-75015 Paris, France; [Mahieux, Renaud] Ecole Normale Super Lyon, INSERM, U758, F-69007 Lyon, France; [Mesnard, Jean-Michel] CNRS, UMR5236, Ctr Etud Agents Pathogenes & Biotechnol Sante, F-34060 Montpellier, France; Hosp Civils Lyon, F-69229 Lyon 02, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CHU Lyon	Valentin, H (corresponding author), Fac Med Lyon Sud, UMR5239, 165 Chemin Grand Revoyet,BP 12, F-69921 Oullins, France.	valentin@ens-lyon.fr	MONCOLLIN, Vincent/R-1941-2017; Duc-Dodon, Madeleine/I-6580-2016; Valentin, Helene/AAA-4265-2020; Hermine, Olivier/Q-7072-2018; Bonnefoy, Nathalie/J-2536-2012	MONCOLLIN, Vincent/0000-0002-4163-0231; Bonnefoy, Nathalie/0000-0003-4814-6722; Mathieu, Anne-Laure/0000-0002-2893-7001; mahieux, renaud/0000-0002-5129-6804; Hermine, Olivier/0000-0003-2574-3874; Mesnard, Jean-Michel/0000-0003-3344-5367	INSERM; UCBL; Region Rhone-Alpes Cluster 10, Cent pour Sang la Vie, Fondation de France, and the Ar'mony; Convention for Industrial Research Training (Imaxio Biotech); Ligue Nationale Contre le Cancer; National Cancer Institute (InCa)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UCBL; Region Rhone-Alpes Cluster 10, Cent pour Sang la Vie, Fondation de France, and the Ar'mony(Region Auvergne-Rhone-Alpes); Convention for Industrial Research Training (Imaxio Biotech); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); National Cancer Institute (InCa)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Institut National du Cancer (INCA) France)	This work was supported in part by institutional grants from INSERM and UCBL and from Region Rhone-Alpes Cluster 10, Cent pour Sang la Vie, Fondation de France, and the Ar'mony.; Supported by a fellowship from Convention for Industrial Research Training (Imaxio Biotech).; Supported by a fellowship from the Ligue Nationale Contre le Cancer.; Supported by a grant from National Cancer Institute (InCa).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Arnold J, 2008, BLOOD, V112, P3788, DOI 10.1182/blood-2008-04-154286; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Bellon M, 2010, BLOOD, V115, P2441, DOI 10.1182/blood-2009-08-241117; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Cavrois M, 1996, BLOOD, V88, P4646, DOI 10.1182/blood.V88.12.4646.bloodjournal88124646; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cheng QW, 2000, ONCOGENE, V19, P4936, DOI 10.1038/sj.onc.1203861; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; Chung HK, 2003, BLOOD, V102, P4130, DOI 10.1182/blood-2003-04-1043; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; D'Souza B, 2000, J VIROL, V74, P6652, DOI 10.1128/JVI.74.14.6652-6658.2000; D'Souza BN, 2004, J VIROL, V78, P1800, DOI 10.1128/JVI.78.4.1800-1816.2004; de la Fuente C, 2003, MOL CELL BIOCHEM, V245, P99, DOI 10.1023/A:1022866027585; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Etoh K, 1997, CANCER RES, V57, P4862; FRANCHINI G, 1984, P NATL ACAD SCI-BIOL, V81, P6207, DOI 10.1073/pnas.81.19.6207; Fujii MI, 2000, AIDS RES HUM RETROV, V16, P1603, DOI 10.1089/08892220050193029; FUJITA M, 1995, ONCOGENE, V11, P15; FURUKAWA Y, 1995, BLOOD, V85, P1865, DOI 10.1182/blood.V85.7.1865.bloodjournal8571865; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Hagiya K, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-19; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; Harhaj EW, 1999, ONCOGENE, V18, P1341, DOI 10.1038/sj.onc.1202405; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Hivin P, 2005, J CELL SCI, V118, P1355, DOI 10.1242/jcs.01727; Ishikawa C, 2011, CARCINOGENESIS, V32, P110, DOI 10.1093/carcin/bgq222; Ishitsuka K, 2012, CANCER LETT, V317, P218, DOI 10.1016/j.canlet.2011.11.030; Iwai K, 2001, VIROLOGY, V279, P38, DOI 10.1006/viro.2000.0669; Iwanaga Y, 1999, J VIROL, V73, P1271, DOI 10.1128/JVI.73.2.1271-1277.1999; Journo C, 2009, FUTURE MICROBIOL, V4, P425, DOI 10.2217/FMB.09.13; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kuhlmann AS, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-92; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Lemasson I, 1997, J VIROL, V71, P1975, DOI 10.1128/JVI.71.3.1975-1983.1997; Li M, 2007, J VIROL METHODS, V142, P159, DOI 10.1016/j.jviromet.2007.01.023; Mahieux R, 2001, BLOOD, V98, P3762, DOI 10.1182/blood.V98.13.3762; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Matsuoka M, 2010, MOL ASPECTS MED, V31, P359, DOI 10.1016/j.mam.2010.06.002; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Meertens L, 2004, ONCOGENE, V23, P5447, DOI 10.1038/sj.onc.1207719; Michael B, 2004, FRONT BIOSCI-LANDMRK, V9, P2556, DOI 10.2741/1417; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Mori N, 2001, VIRUS GENES, V22, P279, DOI 10.1023/A:1011158021749; Mori N, 2000, BLOOD, V95, P3915; Nagakubo D, 2007, INT J CANCER, V120, P1591, DOI 10.1002/ijc.22483; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; Nakayama T, 2008, ONCOGENE, V27, P3221, DOI 10.1038/sj.onc.1210984; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; Nicot C, 2000, BLOOD, V96, P275, DOI 10.1182/blood.V96.1.275.013k43_275_281; Olsson A, 2007, BRIT J CANCER, V97, P769, DOI 10.1038/sj.bjc.6603951; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Polster BM, 2004, BBA-MOL CELL RES, V1644, P211, DOI 10.1016/j.bbamcr.2003.11.001; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; Postigo A, 2009, MICROBES INFECT, V11, P1071, DOI 10.1016/j.micinf.2009.08.012; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Schneider TJ, 1997, J IMMUNOL, V159, P4834; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Silbermann K., 2007, Signal Transduction, V7, P34, DOI 10.1002/sita.200600119; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213; Sun SC, 1996, MOL CELL BIOL, V16, P1058; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Taylor JM, 2008, APOPTOSIS, V13, P733, DOI 10.1007/s10495-008-0208-7; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Usui T, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-34; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Villaudy J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002231; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang CY, 1999, MOL CELL BIOL, V19, P5923; White E, 2006, CELL DEATH DIFFER, V13, P1371, DOI 10.1038/sj.cdd.4401941; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zane L, 2010, VIROLOGY, V407, P341, DOI 10.1016/j.virol.2010.07.023; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	94	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21357	21370		10.1074/jbc.M112.340992	http://dx.doi.org/10.1074/jbc.M112.340992			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22553204	Green Published, hybrid			2022-12-28	WOS:000306416800054
J	Takagi, Y; Setoyama, D; Ito, R; Kamiya, H; Yamagata, Y; Sekiguchi, M				Takagi, Yasumitsu; Setoyama, Daiki; Ito, Riyoko; Kamiya, Hiroyuki; Yamagata, Yuriko; Sekiguchi, Mutsuo			Human MTH3 (NUDT18) Protein Hydrolyzes Oxidized Forms of Guanosine and Deoxyguanosine Diphosphates COMPARISON WITH MTH1 AND MTH2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MUTT HOMOLOG; OXIDATIVE DAMAGE; NUDIX HYDROLASES; DNA-SYNTHESIS; ENCODING 8-OXO-DGTPASE; MUTAGENIC SUBSTRATE; ESCHERICHIA-COLI; NUCLEOTIDES; MECHANISMS; CLONING	Most of the proteins carrying the 23-residue MutT-related sequence are capable of hydrolyzing compounds with a general structure of nucleoside diphosphate linked to another moiety X and are called the Nudix hydrolases. Among the 22 human Nudix proteins (identified by the sequence signature), some remain uncharacterized as enzymes without a defined substrate. Here, we reveal that the NUDT18 protein, whose substrate was unknown, can degrade 8-oxo-7,8-dihydroguanine (8-oxo-Gua)-containing nucleoside diphosphates to the monophosphates. Because this enzyme is closely related to MTH1 (NUDT1) and MTH2 (NUDT15), we propose that it should be named MTH3. Although these three human proteins resemble each other in their sequences, their substrate specificities differ considerably. MTH1 cleaves 8-oxo-dGTP but not 8-oxo-dGDP, whereas MTH2 can degrade both 8-oxo-dGTP and 8-oxo-dGDP, although the intrinsic enzyme activity of MTH2 is considerably lower than that of MTH1. On the other hand, MTH3 is specifically active against 8-oxo-dGDP and hardly cleaves 8-oxodGTP. Other types of oxidized nucleoside diphosphates, 2-hydroxy-dADP and 8-hydroxy-dADP, were also hydrolyzed by MTH3. Another notable feature of the MTH3 enzyme is its action toward the ribonucleotide counterpart. MTH3 can degrade 8-oxo-GDP as efficiently as 8-oxo-dGDP, which is in contrast to the finding that MTH1 and MTH2 show a limited activity against the ribonucleotide counterpart, 8-oxo-GTP. These three enzymes may function together to help maintain the high fidelity of DNA replication and transcription under oxidative stress.	Fukuoka Dent Coll, Fukuoka 8140193, Japan; [Kamiya, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan	Fukuoka Dental College (FDC); Ehime University; Kumamoto University		mseki@college.fdcnet.ac.jp	Kamiya, Hiroyuki/G-2383-2019	Kamiya, Hiroyuki/0000-0001-6866-5322	Ministry of Education, Culture, Sports, Science and Technology of Japan; MEXT-supported Program for the Strategic Research Foundation at Private Universities	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, including the MEXT-supported Program for the Strategic Research Foundation at Private Universities (2008-2012).	Arimori T, 2011, NUCLEIC ACIDS RES, V39, P8972, DOI 10.1093/nar/gkr575; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Cai JP, 2003, BIOCHEM BIOPH RES CO, V305, P1073, DOI 10.1016/S0006-291X(03)00864-7; Evans MD, 2004, BIOESSAYS, V26, P533, DOI 10.1002/bies.20027; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Gasmi L, 1999, BIOCHEM J, V344, P331, DOI 10.1042/0264-6021:3440331; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hayakawa H, 1999, BIOCHEMISTRY-US, V38, P3610, DOI 10.1021/bi982361l; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Ishibashi T, 2005, NUCLEIC ACIDS RES, V33, P3779, DOI 10.1093/nar/gki682; Ishibashi T, 2003, EMBO REP, V4, P479, DOI 10.1038/sj.embor.embor838; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; Ito R, 2011, J BIOCHEM, V149, P731, DOI 10.1093/jb/mvr028; Kamiya H, 2009, DNA REPAIR, V8, P1250, DOI 10.1016/j.dnarep.2009.07.011; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; Nakamura T, 2006, ACTA CRYSTALLOGR F, V62, P1283, DOI 10.1107/S1744309106049529; Nakamura T, 2010, J BIOL CHEM, V285, P444, DOI 10.1074/jbc.M109.066373; Nunoshiba T, 2004, NUCLEIC ACIDS RES, V32, P5339, DOI 10.1093/nar/gkh868; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sanada U, 2011, J BIOCHEM, V150, P649, DOI 10.1093/jb/mvr107; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Sekiguchi M, 1996, GENES CELLS, V1, P139, DOI 10.1046/j.1365-2443.1996.d01-232.x; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; Yang HJ, 2000, J BIOL CHEM, V275, P8844, DOI 10.1074/jbc.275.12.8844; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078	36	79	89	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21541	21549		10.1074/jbc.M112.363010	http://dx.doi.org/10.1074/jbc.M112.363010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556419	Green Published, hybrid			2022-12-28	WOS:000306416800071
J	Wang, WN; Wu, EY; Hellinga, HW; Beese, LS				Wang, Weina; Wu, Eugene Y.; Hellinga, Homme W.; Beese, Lorena S.			Structural Factors That Determine Selectivity of a High Fidelity DNA Polymerase for Deoxy-, Dideoxy-, and Ribonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I KLENOW FRAGMENT; TRANSLESION SYNTHESIS; ALLOSTERIC REGULATION; CRYSTAL-STRUCTURE; SINGLE RESIDUE; ACTIVE-SITE; REPLICATION; MECHANISM; FAMILY; SUGAR	In addition to discriminating against base pair mismatches, DNA polymerases exhibit a high degree of selectivity for deoxy-ribonucleotides over ribo- or dideoxynucleotides. It has been proposed that a single active site residue (steric gate) blocks productive binding of nucleotides containing 2'-hydroxyls. Although this steric gate plays a role in sugar moiety discrimination, its interactions do not account fully for the observed behavior of mutants. Here we present 10 high resolution crystal structures and enzyme kinetic analyses of Bacillus DNA polymerase I large fragment variants complexed with deoxy-, ribo-, and dideoxynucleotides and a DNA substrate. Taken together, these data present a more nuanced and general mechanism for nucleotide discrimination in which ensembles of intermediate conformations in the active site trap non-cognate substrates. It is known that the active site O-helix transitions from an open state in the absence of nucleotide substrates to a ternary complex closed state in which the reactive groups are aligned for catalysis. Substrate misalignment in the closed state plays a fundamental part in preventing non-cognate nucleotide misincorpation. The structures presented here show that additional O-helix conformations intermediate between the open and closed state extremes create an ensemble of binding sites that trap and misalign non-cognate nucleotides. Water-mediated interactions, absent in the fully closed state, play an important role in formation of these binding sites and can be remodeled to accommodate different non-cognate substrates. This mechanism may extend also to base pair discrimination.	[Wang, Weina; Wu, Eugene Y.; Hellinga, Homme W.; Beese, Lorena S.] DUMC, Dept Biochem, Durham, NC 27710 USA	Duke University	Beese, LS (corresponding author), DUMC, Dept Biochem, Box 3711, Durham, NC 27710 USA.	lb12@duke.edu	Wu, Eugene Y/K-5677-2015; Classen, Scott/AAY-8176-2020	Wu, Eugene Y/0000-0002-5189-7036; 	National Institutes of Health [P01 CA092584, R01 GM091487]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Department of Energy program Integrated Diffraction Analysis Technologies [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA092584 and R01 GM091487 (to L. S. B.). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Use of the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, was supported in part by the Department of Energy program Integrated Diffraction Analysis Technologies under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; DIEKMANN S, 1989, J MOL BIOL, V205, P787, DOI 10.1016/0022-2836(89)90324-0; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans RJ, 2008, P NATL ACAD SCI USA, V105, P20695, DOI 10.1073/pnas.0809989106; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henry AA, 2005, CURR OPIN BIOTECH, V16, P370, DOI 10.1016/j.copbio.2005.06.008; Holmberg RC, 2005, BIOMOL ENG, V22, P39, DOI 10.1016/j.bioeng.2004.12.001; Hsu GW, 2005, J BIOL CHEM, V280, P3764, DOI 10.1074/jbc.M411276200; Hsu GW, 2004, J BIOL CHEM, V279, P50280, DOI 10.1074/jbc.M409224200; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Kirouac KN, 2011, J MOL BIOL, V407, P382, DOI 10.1016/j.jmb.2011.01.037; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lansdon EB, 2010, J MOL BIOL, V397, P967, DOI 10.1016/j.jmb.2010.02.019; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel PH, 2000, J BIOL CHEM, V275, P40266, DOI 10.1074/jbc.M005757200; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Sherrer SM, 2010, BIOCHEMISTRY-US, V49, P10179, DOI 10.1021/bi101465n; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Steitz TA, 2004, PHILOS T R SOC B, V359, P17, DOI 10.1098/rstb.2003.1374; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANDESANDE JH, 1972, J BIOL CHEM, V247, P6140; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	67	43	43	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28215	28226		10.1074/jbc.M112.366609	http://dx.doi.org/10.1074/jbc.M112.366609			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22648417	hybrid, Green Published			2022-12-28	WOS:000308074600002
J	Kim, Y; Kim, K; Park, D; Lee, E; Lee, H; Lee, YS; Choe, J; Jeoung, D				Kim, Youngmi; Kim, Kyungjong; Park, Deokbum; Lee, Eunmi; Lee, Hansoo; Lee, Yun-Sil; Choe, Jongseon; Jeoung, Dooil			Histone Deacetylase 3 Mediates Allergic Skin Inflammation by Regulating Expression of MCP1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MAST-CELLS; VASCULAR-PERMEABILITY; GENE-EXPRESSION; AIRWAY INFLAMMATION; TYROSINE KINASES; ANGIOGENESIS; ACTIVATION; INHIBITION; MEMBRANE	We have shown the induction of histone deacetylase 3 (HDAC3) in antigen-stimulated rat basophilic leukemia cells via NF-kappa B. We investigated the role of HDAC3 in allergic skin inflammation. We used a BALB/c mouse model of triphasic cutaneous anaphylaxis (triphasic cutaneous reaction; TpCR) and passive cutaneous anaphylaxis (PCA) to examine the role of HDAC3 in allergic skin inflammation. Triphasic cutaneous reaction involved induction of HDAC3 and was mediated by HDAC3. HDAC3 showed an interaction with Fc epsilon RI beta. Trichostatin A (TSA), an inhibitor of HDAC(s), disrupted this interaction. Cytokine array analysis showed that the down-regulation of HDAC3 led to the decreased secretion of monocyte chemoattractant protein 1 (MCP1). Fc epsilon RI was necessary for induction of HDAC3 and MCP1. ChIP assays showed that HDAC3, in association with Sp1 and c-Jun, was responsible for induction of MCP1 expression. TSA exerted a negative effect on induction of MCP1. HDAC3 exerted a negative regulation on expression of HDAC2 via interaction with Rac1. The down-regulation of HDAC3 or inactivation of Rac1 induced binding of HDAC2 to MCP1 promoter sequences. TSA exerted a negative effect on HDAC3-mediated TpCR. The BALB/c mouse model of PCA involved induction of HDAC3 and MCP1. HDAC3 and MCP1 were necessary for PCA that involved ear swelling, enhanced vascular permeability, and angiogenesis. Recombinant MCP1 enhanced beta-hexosaminidase activity and histamine release and also showed angiogenic potential. TSA exerted a negative effect on PCA. Our data show HDAC3 as a valuable target for the development of allergic skin inflammation therapeutics.	[Jeoung, Dooil] Kangwon Natl Univ, Sch Biol Sci, Coll Nat Sci, Dept Biochem, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon] Kangwon Natl Univ, Coll Med, Chunchon 200701, South Korea; [Lee, Yun-Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Sch Biol Sci, Coll Nat Sci, Dept Biochem, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	Korea Research Foundation [C1007988-01-02, C1007565-01-02]; Regional Innovation Center Program of the Ministry of Education, Science, and Technology	Korea Research Foundation(National Research Foundation of Korea); Regional Innovation Center Program of the Ministry of Education, Science, and Technology	This work was supported by Korea Research Foundation Grants C1007988-01-02 and C1007565-01-02 and a grant from the Regional Innovation Center Program of the Ministry of Education, Science, and Technology.	Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Albrecht EA, 2004, AM J PATHOL, V164, P849, DOI 10.1016/S0002-9440(10)63173-2; Bao WJ, 2002, MOL CELL BIOL, V22, P4587, DOI 10.1128/MCB.22.13.4587-4597.2002; Benhamou M, 1996, J LEUKOCYTE BIOL, V59, P461, DOI 10.1002/jlb.59.3.461; Bhavsar P, 2008, J ALLERGY CLIN IMMUN, V121, P580, DOI 10.1016/j.jaci.2007.12.1156; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Chandrasekaran S, 2009, FASEB J, V23, P3851, DOI 10.1096/fj.09-132415; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Detoraki A, 2009, J ALLERGY CLIN IMMUN, V123, P1142, DOI 10.1016/j.jaci.2009.01.044; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Garcia-Roman J, 2010, BIOCHEM BIOPH RES CO, V401, P262, DOI 10.1016/j.bbrc.2010.09.047; Glenn DJ, 2009, HYPERTENSION, V53, P549, DOI 10.1161/HYPERTENSIONAHA.108.125088; Grausenburger R, 2010, J IMMUNOL, V185, P3489, DOI 10.4049/jimmunol.0903610; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Inagaki N, 1997, GEN PHARMACOL-VASC S, V28, P93, DOI 10.1016/S0306-3623(96)00166-8; Inagaki N, 2009, J PHARMACOL SCI, V110, P251, DOI 10.1254/jphs.09R01FM; Ito K., 2001, FASEB Journal, V15, P1110; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Kim DY, 2010, J IMMUNOL, V185, P273, DOI 10.4049/jimmunol.1000991; Kim Y, 2011, MOL IMMUNOL, V48, P1035, DOI 10.1016/j.molimm.2011.01.013; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Kinugasa F, 2010, TRANSPL IMMUNOL, V23, P18, DOI 10.1016/j.trim.2010.02.003; Li LB, 2010, AM J RESP CRIT CARE, V182, P877, DOI 10.1164/rccm.201001-0015OC; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Lores P, 2010, FEBS J, V277, P1453, DOI 10.1111/j.1742-4658.2010.07575.x; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Meja KK, 2008, AM J RESP CELL MOL, V39, P312, DOI 10.1165/rcmb.2008-0012OC; Melgarejo E, 2007, CELL MOL LIFE SCI, V64, P2690, DOI 10.1007/s00018-007-7331-4; N'Guessan PD, 2009, ARTERIOSCL THROM VAS, V29, P380, DOI 10.1161/ATVBAHA.108.178319; Nico B, 2008, STEM CELLS DEV, V17, P19, DOI 10.1089/scd.2007.0132; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Orecchia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024307; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Ribatti D, 2011, INT J DEV BIOL, V55, P99, DOI 10.1387/ijdb.103138dr; SAKURAI T, 1994, LIFE SCI, V54, pPL291, DOI 10.1016/0024-3205(94)00859-0; Stoeltzing O, 2003, CANCER RES, V63, P3370; Suzuki M, 1996, INT ARCH ALLERGY IMM, V111, P18, DOI 10.1159/000237339; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Tovar-Castillo LE, 2007, INT J DERMATOL, V46, P239, DOI 10.1111/j.1365-4632.2006.02962.x; Utrera-Barillas D, 2010, EXP MOL PATHOL, V89, P190, DOI 10.1016/j.yexmp.2010.06.002; Warkentin TE, 2009, EXPERT OPIN DRUG SAF, V8, P129, DOI [10.1517/14740330902778180, 10.1517/14740330902778180 ]; Zhang J, 2011, ENDOCRINOLOGY, V152, P1829, DOI 10.1210/en.2010-0828	48	46	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25844	25859		10.1074/jbc.M112.348284	http://dx.doi.org/10.1074/jbc.M112.348284			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679019	hybrid, Green Published			2022-12-28	WOS:000306916300014
J	Cavnar, PJ; Mogen, K; Berthier, E; Beebe, DJ; Huttenlocher, A				Cavnar, Peter J.; Mogen, Kevin; Berthier, Erwin; Beebe, David J.; Huttenlocher, Anna			The Actin Regulatory Protein HS1 Interacts with Arp2/3 and Mediates Efficient Neutrophil Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SPECIFIC PROTEIN-1; TYROSINE KINASE; SEQUENTIAL PHOSPHORYLATION; N-WASP; CORTACTIN; MOTILITY; ZEBRAFISH; POLARITY; DOMAIN; ROLES	HS1 is an actin regulatory protein and cortactin homolog that is expressed in hematopoietic cells. Antigen receptor stimulation induces HS1 phosphorylation, and HS1 is essential for T cell activation. HS1 is also expressed in neutrophils; however, the function of HS1 in neutrophils is not known. Here we show that HS1 localizes to the neutrophil leading edge, and is phosphorylated in response to the chemoattractant formyl-Met-Leu-Phe (fMLP) in adherent cells. Using live imaging in microchannels, we show that depletion of endogenous HS1 in the neutrophil-like PLB-985 cell line impairs chemotaxis. We also find that HS1 is necessary for chemoattractant-induced activation of Rac GTPase signaling and Vav1 phosphorylation, suggesting that HS1-mediated Rac activation is necessary for efficient neutrophil chemotaxis. We identify specific phosphorylation sites that mediate HS1-dependent neutrophil motility. Expression of HS1 Y378F, Y397F is sufficient to rescue migration of HS1-deficient neutrophils, however, a triple phosphomutant Y222F, Y378F, Y397F did not rescue migration of HS1-deficient neutrophils. Moreover, HS1 phosphorylation on Y222, Y378, and Y397 regulates its interaction with Arp2/3. Collectively, our findings identify a novel role for HS1 and its phosphorylation during neutrophil directed migration.	[Cavnar, Peter J.; Mogen, Kevin; Berthier, Erwin; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Cavnar, Peter J.; Mogen, Kevin; Berthier, Erwin; Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [Beebe, David J.] Univ Wisconsin, Wisconsin Inst Med Res, Madison, WI 53705 USA; [Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, 4205 Microbial Sci Bldg, Madison, WI 53706 USA.		Berthier, Erwin/D-2463-2012	Berthier, Erwin/0000-0002-4421-9034	National Institutes of Health Grant [RO1EB010039]; AHA Grant [10POST3230031]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1EB010039 (to A. H. and D. J. B.) and AHA Grant 10POST3230031 (to P. J. C.).	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; BENHAMOU LE, 1994, EUR J IMMUNOL, V24, P1993, DOI 10.1002/eji.1830240909; Berthier E, 2010, INTEGR BIOL-UK, V2, P630, DOI 10.1039/c0ib00030b; Brunati AM, 1999, J BIOL CHEM, V274, P7557, DOI 10.1074/jbc.274.11.7557; BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Carrizosa E, 2009, J IMMUNOL, V183, P7352, DOI 10.4049/jimmunol.0900973; Cavnar PJ, 2011, J CELL BIOL, V193, P465, DOI 10.1083/jcb.201010143; Dehring DAK, 2011, J IMMUNOL, V186, P4805, DOI 10.4049/jimmunol.1003102; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Hao JJ, 2005, J BIOL CHEM, V280, P37988, DOI 10.1074/jbc.M504552200; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kahner BN, 2007, BLOOD, V110, P2449, DOI 10.1182/blood-2006-11-056069; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; McDowall A, 1998, J BIOL CHEM, V273, P27396, DOI 10.1074/jbc.273.42.27396; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Patel AM, 1996, ONCOGENE, V12, P31; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Ruzzene M, 1996, BIOCHEMISTRY-US, V35, P5327, DOI 10.1021/bi9528614; Scielzo C, 2010, BLOOD, V116, P3537, DOI 10.1182/blood-2009-12-258814; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; TAKEMOTO Y, 1995, EMBO J, V14, P3403, DOI 10.1002/j.1460-2075.1995.tb07346.x; TANIUCHI I, 1995, EMBO J, V14, P3664, DOI 10.1002/j.1460-2075.1995.tb00036.x; TUCKER KA, 1987, BLOOD, V70, P372; Walters KB, 2010, BLOOD, V116, P2803, DOI 10.1182/blood-2010-03-276972; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015	40	24	24	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25466	25477		10.1074/jbc.M112.364562	http://dx.doi.org/10.1074/jbc.M112.364562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679023	hybrid, Green Published			2022-12-28	WOS:000306651700053
J	Kiebish, MA; Yang, K; Sims, HF; Jenkins, CM; Liu, XP; Mancuso, DJ; Zhao, ZD; Guan, SP; Abendschein, DR; Han, XL; Gross, RW				Kiebish, Michael A.; Yang, Kui; Sims, Harold F.; Jenkins, Christopher M.; Liu, Xinping; Mancuso, David J.; Zhao, Zhongdan; Guan, Shaoping; Abendschein, Dana R.; Han, Xianlin; Gross, Richard W.			Myocardial Regulation of Lipidomic Flux by Cardiolipin Synthase SETTING THE BEAT FOR BIOENERGETIC EFFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; ADP/ATP CARRIER PROTEIN; SHOTGUN LIPIDOMICS; BARTH-SYNDROME; HEART-FAILURE; MITOCHONDRIAL DYSFUNCTION; RESPIRATORY-CHAIN; TETRALINOLEOYL-CARDIOLIPIN; F0F1-ATPASE ACTIVITY; LIVER-MITOCHONDRIA	Lipidomic regulation of mitochondrial cardiolipin content and molecular species composition is a prominent regulator of bioenergetic efficiency. However, the mechanisms controlling cardiolipin metabolism during health or disease progression have remained elusive. Herein, we demonstrate that cardiac myocyte-specific transgenic expression of cardiolipin synthase results in accelerated cardiolipin lipidomic flux that impacts multiple aspects of mitochondrial bioenergetics and signaling. During the postnatal period, cardiolipin synthase transgene expression results in marked changes in the temporal maturation of cardiolipin molecular species during development. In adult myocardium, cardiolipin synthase transgene expression leads to a marked increase in symmetric tetra-18:2 molecular species without a change in total cardiolipin content. Mechanistic analysis demonstrated that these alterations result from increased cardiolipin remodeling by sequential phospholipase and transacylase/acyltransferase activities in conjunction with a decrease in phosphatidylglycerol content. Moreover, cardiolipin synthase transgene expression results in alterations in signaling metabolites, including a marked increase in the cardioprotective eicosanoid 14,15-epoxyeicosatrienoic acid. Examination of mitochondrial bioenergetic function by high resolution respirometry demonstrated that cardiolipin synthase transgene expression resulted in improved mitochondrial bioenergetic efficiency as evidenced by enhanced electron transport chain coupling using multiple substrates as well as by salutary changes in Complex III and IV activities. Furthermore, transgenic expression of cardiolipin synthase attenuated maladaptive cardiolipin remodeling and bioenergetic inefficiency in myocardium rendered diabetic by streptozotocin treatment. Collectively, these results demonstrate the unanticipated role of cardiolipin synthase in maintaining physiologic membrane structure and function even under metabolic stress, thereby identifying cardiolipin synthase as a novel therapeutic target to attenuate mitochondrial dysfunction in diabetic myocardium.	[Zhao, Zhongdan; Guan, Shaoping; Han, Xianlin; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Abendschein, Dana R.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278]; Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5PO1HL57278. This work was also supported by the Barth Syndrome Foundation. X. H. has a financial relationship with LipoSpectrum. R. W. G. has financial relationships with LipoSpectrum and Platomics.	Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Bosetti F, 2000, MOL CELL BIOCHEM, V215, P31, DOI 10.1023/A:1026558922596; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brown JCL, 2007, AM J PHYSIOL-REG I, V293, pR1833, DOI 10.1152/ajpregu.00310.2007; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; DZAU VJ, 1984, NEW ENGL J MED, V310, P347, DOI 10.1056/NEJM198402093100603; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Esposti MD, 2001, METHOD CELL BIOL, V65, P75; Frohman MA, 2010, J MOL MED, V88, P967, DOI 10.1007/s00109-010-0662-x; GELLERICH FN, 1990, FEBS LETT, V274, P167, DOI 10.1016/0014-5793(90)81355-R; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Guillet V, 2010, NEUROGENETICS, V11, P127, DOI 10.1007/s10048-009-0207-z; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Hatch GM, 1998, INT J MOL MED, V1, P33; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Jullig M, 2008, PROTEOMICS, V8, P2556, DOI 10.1002/pmic.200700977; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; King T.E., 1967, METHOD ENZYMOL, V10, P322, DOI DOI 10.1016/0076-6879(67)10061-X; Kipp JL, 2001, ENDOCRINE, V15, P165, DOI 10.1385/ENDO:15:2:165; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Li Ning, 2011, Congest Heart Fail, V17, P42, DOI 10.1111/j.1751-7133.2010.00209.x; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Mitchell RW, 2009, BBA-BIOMEMBRANES, V1788, P2015, DOI 10.1016/j.bbamem.2009.06.002; NOEL H, 1986, EUR J BIOCHEM, V155, P99, DOI 10.1111/j.1432-1033.1986.tb09463.x; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Oliveira PJ, 2006, TOXICOLOGY, V220, P160, DOI 10.1016/j.tox.2005.12.009; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Roussel D, 2000, FEBS LETT, V477, P141, DOI 10.1016/S0014-5793(00)01790-7; Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1991, J BIOL CHEM, V266, P22398; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Sudhahar V, 2010, CURR MED CHEM, V17, P1181, DOI 10.2174/092986710790827843; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; van Gestel RA, 2010, J PROTEOMICS, V73, P806, DOI 10.1016/j.jprot.2009.11.009; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang DR, 2009, P NATL ACAD SCI USA, V106, P7548, DOI 10.1073/pnas.0805806106; Wang R, 2009, PROSTAG LEUKOTR ESS, V81, P53, DOI 10.1016/j.plefa.2009.04.008; Xu FY, 2010, BBA-BIOMEMBRANES, V1798, P1577, DOI 10.1016/j.bbamem.2010.04.007; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Yonetani T, 1967, METHODS ENZYMOL, V10, P332; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhao M, 1998, J BIOL CHEM, V273, P2402, DOI 10.1074/jbc.273.4.2402; Zheng JB, 1999, EUR J PHARMACOL, V368, P95, DOI 10.1016/S0014-2999(99)00012-6	75	34	35	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25086	25097		10.1074/jbc.M112.340521	http://dx.doi.org/10.1074/jbc.M112.340521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22584571	hybrid, Green Published			2022-12-28	WOS:000306651700021
J	Kim, KS; Choi, YR; Park, JY; Lee, JH; Kim, DK; Lee, SJ; Paik, SR; Jou, I; Park, SM				Kim, Kwang Soo; Choi, Yu Ree; Park, Ji-Young; Lee, Jung-Ho; Kim, Dong Kyu; Lee, Seung-Jae; Paik, Seung R.; Jou, Ilo; Park, Sang Myun			Proteolytic Cleavage of Extracellular alpha-Synuclein by Plasmin IMPLICATIONS FOR PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA DEGRADATION; ALZHEIMERS-DISEASE; MATRIX METALLOPROTEINASES; NEURODEGENERATIVE DISEASES; ACTIVATOR INHIBITOR-1; LOCUS TRIPLICATION; FIBRIL FORMATION; IN-VITRO; AGGREGATION; MICROGLIA	Parkinson disease (PD) is the second most common neurodegenerative disease characterized by a progressive dopaminergic neuronal loss in association with Lewy body inclusions. Gathering evidence indicates that alpha-synuclein (alpha-syn), a major component of the Lewy body, plays an important role in the pathogenesis of PD. Although alpha-syn is considered to be a cytoplasmic protein, it has been detected in extracellular biological fluids, including human cerebrospinal fluid and blood plasma of healthy and diseased individuals. In addition, a prion-like spread of alpha-syn aggregates has been recently proposed to contribute to the propagation of Lewy bodies throughout the nervous system during progression of PD, suggesting that the metabolism of extracellular alpha-syn might play a key role in the pathogenesis of PD. In the present study, we found that plasmin cleaved and degraded extracellular alpha-syn specifically in a dose- and time-dependent manner. Aggregated forms of alpha-syn as well as monomeric alpha-syn were also cleaved by plasmin. Plasmin cleaved mainly the N-terminal region of alpha-syn and also inhibited the translocation of extracellular alpha-syn into the neighboring cells in addition to the activation of microglia and astrocytes by extracellular alpha-syn. Further, extracellular alpha-syn regulated the plasmin system through up-regulation of plasminogen activator inhibitor-1 (PAI-1) expression. These findings help to understand the molecular mechanism of PD and develop new therapeutic targets for PD.	[Kim, Kwang Soo; Choi, Yu Ree; Jou, Ilo; Park, Sang Myun] Ajou Univ, Dept Pharmacol, Sch Med, Suwon 442721, South Korea; [Choi, Yu Ree; Jou, Ilo; Park, Sang Myun] Ajou Univ, Neurosci Grad Program, Sch Med, Suwon 442721, South Korea; [Kim, Kwang Soo; Choi, Yu Ree; Park, Ji-Young; Jou, Ilo; Park, Sang Myun] Ajou Univ, Chron Inflammatory Dis Res Ctr, Sch Med, Suwon 442721, South Korea; [Lee, Jung-Ho; Paik, Seung R.] Seoul Natl Univ, Sch Chem & Biol Engn, Coll Engn, Seoul 151744, South Korea; [Kim, Dong Kyu; Lee, Seung-Jae] Konkuk Univ, Dept Biomed Sci & Technol, Seoul 143701, South Korea	Ajou University; Ajou University; Ajou University; Seoul National University (SNU); Konkuk University	Park, SM (corresponding author), Ajou Univ, Dept Pharmacol, Sch Med, San 5, Suwon 442721, South Korea.	sangmyun@ajou.ac.kr		Lee, Seung-Jae/0000-0002-5155-5335	Basic Science Research Program [2010-0003623]; Mid-career Researcher Program [2011-0016603]; MRC program through the National Research Foundation of Korea (NRF) [R13-2003-019]; Ministry of Education, Science, and Technology	Basic Science Research Program; Mid-career Researcher Program; MRC program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported in part by Basic Science Research Program (2010-0003623), Mid-career Researcher Program (2011-0016603), and MRC program (R13-2003-019) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology.	Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Alvarez-Erviti L, 2011, NEUROSCI RES, V69, P337, DOI 10.1016/j.neures.2010.12.020; Barker R, 2010, BRAIN RES, V1355, P7, DOI 10.1016/j.brainres.2010.08.025; Bhak G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004177; Cacquevel M, 2007, NEUROBIOL DIS, V27, P164, DOI 10.1016/j.nbd.2007.04.004; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dotti CG, 2004, NEURODEGENER DIS, V1, P205, DOI 10.1159/000080987; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Jang A, 2010, J NEUROCHEM, V113, P1263, DOI 10.1111/j.1471-4159.2010.06695.x; Joo SH, 2010, NEUROSCI LETT, V469, P352, DOI 10.1016/j.neulet.2009.12.026; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Kim KS, 2009, J LEUKOCYTE BIOL, V86, P349, DOI 10.1189/jlb.1008659; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kornblatt JA, 2003, BIOCHEM BIOPH RES CO, V305, P518, DOI 10.1016/S0006-291X(03)00804-0; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Ledesma MD, 2000, EMBO REP, V1, P530; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lee SB, 2009, BIOCHEM BIOPH RES CO, V381, P39, DOI 10.1016/j.bbrc.2009.02.002; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liu RM, 2011, NEUROBIOL AGING, V32, P1079, DOI 10.1016/j.neurobiolaging.2009.06.003; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Melchor JP, 2003, J NEUROSCI, V23, P8867; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Miller G, 2009, SCIENCE, V326, P1337, DOI 10.1126/science.326.5958.1338; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schaller J, 2011, CELL MOL LIFE SCI, V68, P785, DOI 10.1007/s00018-010-0566-5; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; SUTTON R, 1994, BLOOD COAGUL FIBRIN, V5, P167, DOI 10.1097/00001721-199404000-00002; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Tucker HM, 2000, J NEUROSCI, V20, P3937; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; WEINSTEI.MJ, 1972, BIOCHIM BIOPHYS ACTA, V258, P577, DOI 10.1016/0005-2744(72)90250-1; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	68	48	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24862	24872		10.1074/jbc.M112.348128	http://dx.doi.org/10.1074/jbc.M112.348128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22619171	hybrid, Green Published			2022-12-28	WOS:000306651700001
J	Namiki, K; Matsunaga, H; Yoshioka, K; Tanaka, K; Murata, K; Ishida, J; Sakairi, A; Kim, J; Tokuhara, N; Shibakawa, N; Shimizu, M; Wada, Y; Tokunaga, Y; Shigetomi, M; Hagihara, M; Kimura, S; Sudo, T; Fukamizu, A; Kasuya, Y				Namiki, Kana; Matsunaga, Hirofumi; Yoshioka, Kento; Tanaka, Kensuke; Murata, Kazuya; Ishida, Junji; Sakairi, Akira; Kim, Jundal; Tokuhara, Naoki; Shibakawa, Nobuhiko; Shimizu, Motohisa; Wada, Yukinori; Tokunaga, Yasunori; Shigetomi, Manabu; Hagihara, Masahiko; Kimura, Sadao; Sudo, Tatsuhiko; Fukamizu, Akiyoshi; Kasuya, Yoshitoshi			Mechanism for p38 alpha-mediated Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MULTIPLE-SCLEROSIS; T-CELLS; MAP KINASE; MESSENGER-RNA; P38 MAPK; INFLAMMATION; EXPRESSION; GAMMA; GENE	One of the mitogen-activated protein kinases, p38, has been found to play a crucial role in various inflammatory responses. In this study, we analyzed the roles of p38 alpha in multiple sclerosis, using an animal model, experimental autoimmune encephalomyelitis (EAE). p38 alpha(+/-) mice (p38 alpha(-/-) showed embryonic lethality) showed less severe neurological signs than WT mice. Adoptive transfer of lymph node cells (LNC) from sensitized WT mice with MOG(35-55) to naive WT-induced EAE was much more severe compared with the case using LNC from sensitized p38 alpha(+/-) mice. Comprehensive analysis of cytokines from MOG(35-55)-challenged LNC by Western blot array revealed that production of IL-17 was significantly reduced by a single copy disruption of the p38 alpha gene or a p38 inhibitor. Likewise, by a luciferase reporter assay, an electrophoresis mobility shift assay, and characterization of the relationship between p38 activity and IL-17 mRNA expression, we confirmed that p38 positively regulates transcription of the Il17 gene. Furthermore, oral administration of a highly specific p38 alpha inhibitor (UR-5269) to WT mice at the onset of EAE markedly suppressed the progression of EAE compared with a vehicle group. These results suggest that p38 alpha participates in the pathogenesis of EAE through IL-17 induction.	[Kasuya, Yoshitoshi] Chiba Univ, Grad Sch Med, Dept Biochem & Mol Pharmacol, Chuo Ku, Chiba 2608670, Japan; [Matsunaga, Hirofumi; Shibakawa, Nobuhiko; Shimizu, Motohisa; Wada, Yukinori; Tokunaga, Yasunori; Shigetomi, Manabu; Hagihara, Masahiko] Ube Ind Ltd, Pharmaceut Res Lab, Ube, Yamaguchi 7558633, Japan; [Murata, Kazuya; Ishida, Junji; Sakairi, Akira; Kim, Jundal; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba Adv Res Alliance, Life Sci Ctr, Tennoudai, Ibaraki 3058577, Japan; [Sudo, Tatsuhiko] RIKEN, Adv Sci Inst, Chem Biol Core Facil, Wako, Saitama 3510198, Japan; [Sudo, Tatsuhiko] RIKEN, Adv Sci Inst, Antibiot Lab, Wako, Saitama 3510198, Japan	Chiba University; Ube Industries Ltd.; University of Tsukuba; RIKEN; RIKEN	Kasuya, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Biochem & Mol Pharmacol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kasuya@faculty.chiba-u.jp	Murata, Kazuya/GLR-2334-2022; Yoshioka, Kento/AAM-4454-2021; fukamizu, akiyoshi/J-5350-2012	Murata, Kazuya/0000-0002-3328-069X; Yoshioka, Kento/0000-0003-1701-3759; fukamizu, akiyoshi/0000-0002-8786-6020; Kasuya, Yoshitoshi/0000-0003-0614-5836; Kimura, Sadao/0000-0001-6768-7474; Jun-Dal, Kim/0000-0002-7361-0999	Ministry of Education, Science, Sports and Culture of Japan [21390172, 20790201]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research (B) 21390172 (to Y. K.) and Young Scientists (B) 20790201 (to K. N.) from the Ministry of Education, Science, Sports and Culture of Japan.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Commodaro AG, 2010, INVEST OPHTH VIS SCI, V51, P3567, DOI 10.1167/iovs.09-4393; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dodon MD, 2004, J GEN VIROL, V85, P1921, DOI 10.1099/vir.0.79921-0; Farooqi N, 2010, J NEUROCHEM, V115, P829, DOI 10.1111/j.1471-4159.2010.06982.x; Fassbender K, 1998, NEUROLOGY, V51, P753, DOI 10.1212/WNL.51.3.753; Ferber IA, 1996, J IMMUNOL, V156, P5; Feuerstein N, 1996, J IMMUNOL, V156, P4582; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; Hofstetter HH, 2005, J NEUROIMMUNOL, V170, P105, DOI 10.1016/j.jneuroim.2005.09.004; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Matsuo Y, 2006, J BIOL CHEM, V281, P36767, DOI 10.1074/jbc.M604371200; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Merezak C, 2001, J VIROL, V75, P6977, DOI 10.1128/JVI.75.15.6977-6988.2001; Moldovan IR, 2003, J NEUROIMMUNOL, V141, P132, DOI 10.1016/S0165-5728(03)00221-2; Namiki K, 2007, J RECEPT SIG TRANSD, V27, P99, DOI 10.1080/10799890701357855; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; OFFNER H, 1994, J IMMUNOL, V153, P4988; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Otsu K, 2003, BIOCHEM BIOPH RES CO, V302, P56, DOI 10.1016/S0006-291X(03)00096-2; Patil C, 2004, IMMUNOL INVEST, V33, P213, DOI 10.1081/IMM-120034231; Sakurai K, 2004, J RECEPT SIG TRANSD, V24, P283, DOI 10.1081/RRS-200040324; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Takanami-Ohnishi Y, 2002, J BIOL CHEM, V277, P37896, DOI 10.1074/jbc.M207326200; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Taneja V, 2001, NAT IMMUNOL, V2, P781, DOI 10.1038/ni0901-781; Tokuhara N, 2010, J BIOL CHEM, V285, P33294, DOI 10.1074/jbc.M109.089805; Wang HH, 2011, J CLIN NEUROSCI, V18, P1313, DOI 10.1016/j.jocn.2011.01.031; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557	53	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24228	24238		10.1074/jbc.M111.338541	http://dx.doi.org/10.1074/jbc.M111.338541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637476	Green Published, hybrid			2022-12-28	WOS:000306651100017
J	Watkins, GR; Wang, N; Mazalouskas, MD; Gomez, RJ; Guthrie, CR; Kraemer, BC; Schweiger, S; Spiller, BW; Wadzinski, BE				Watkins, Guy R.; Wang, Ning; Mazalouskas, Matthew D.; Gomez, Rey J.; Guthrie, Chris R.; Kraemer, Brian C.; Schweiger, Susann; Spiller, Benjamin W.; Wadzinski, Brian E.			Monoubiquitination Promotes Calpain Cleavage of the Protein Phosphatase 2A (PP2A) Regulatory Subunit alpha 4, Altering PP2A Stability and Microtubule-associated Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; OPITZ-SYNDROME; ALZHEIMERS-DISEASE; BINDING; TAU; ENZYME; MID1; DEGRADATION; PROTEOLYSIS; RESOLUTION	Multiple neurodegenerative disorders are linked to aberrant phosphorylation of microtubule-associated proteins (MAPs). Protein phosphatase 2A (PP2A) is the major MAP phosphatase; however, little is known about its regulation at microtubules. alpha 4 binds the PP2A catalytic subunit (PP2Ac) and the microtubule-associated E3 ubiquitin ligase MID1, and through unknown mechanisms can both reduce and enhance PP2Ac stability. We show MID1-dependent monoubiquitination of alpha 4 triggers calpain-mediated cleavage and switches alpha 4's activity from protective to destructive, resulting in increased Tau phosphorylation. This regulatory mechanism appears important in MAP-dependent pathologies as levels of cleaved alpha 4 are decreased in Opitz syndrome and increased in Alzheimer disease, disorders characterized by MAP hypophosphorylation and hyperphosphorylation, respectively. These findings indicate that regulated inter-domain cleavage controls the dual functions of alpha 4, and dysregulation of alpha 4 cleavage may contribute to Opitz syndrome and Alzheimer disease.	[Watkins, Guy R.; Wang, Ning; Mazalouskas, Matthew D.; Gomez, Rey J.; Spiller, Benjamin W.; Wadzinski, Brian E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Guthrie, Chris R.; Kraemer, Brian C.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Kraemer, Brian C.] Univ Washington, Div Gerontol & Geriatr Med, Dept Med, Seattle, WA 98104 USA; [Schweiger, Susann] Univ Dundee, Sch Med, Med Res Inst, Div Neurosci, Dundee DD1 SY9, Scotland	Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Dundee	Wadzinski, BE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 424 RRB, Nashville, TN 37232 USA.	brian.wadzinski@vanderbilt.edu			National Institutes of Health [DK070787, GM051366, NS064131, T32 GM07628]; American Cancer Society [IRG-58-009-49]; Department of Veterans Affairs Merit Review Grant [114891]; Ataxia UK; Tenovus Scotland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628, R56GM051366, R01GM051366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Ataxia UK; Tenovus Scotland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants DK070787 and GM051366 (to B. E. W.), NS064131 (to B. C. K.), and T32 GM07628 (to G. R. W.); American Cancer Society IRG-58-009-49 (to B. W. S.); Department of Veterans Affairs Merit Review Grant 114891 (to B. C. K.); and Ataxia UK and Tenovus Scotland (to S. S.).	Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Guthrie CR, 2011, J MOL NEUROSCI, V45, P32, DOI 10.1007/s12031-011-9502-x; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kambe A, 2005, BRAIN RES, V1040, P36, DOI 10.1016/j.brainres.2005.01.080; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Liu Rong, 2009, Pathophysiology, V16, P273, DOI 10.1016/j.pathophys.2009.02.008; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Twomey C, 2009, BIOCHEM BIOPH RES CO, V381, P418, DOI 10.1016/j.bbrc.2009.02.051; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	36	45	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24207	24215		10.1074/jbc.M112.368613	http://dx.doi.org/10.1074/jbc.M112.368613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613722	hybrid, Green Published			2022-12-28	WOS:000306651100015
J	Chujo, M; Tarumoto, Y; Miyatake, K; Nishida, E; Ishikawa, F				Chujo, Moeko; Tarumoto, Yusuke; Miyatake, Koichi; Nishida, Eisuke; Ishikawa, Fuyuki			HIRA, a Conserved Histone Chaperone, Plays an Essential Role in Low-dose Stress Response via Transcriptional Stimulation in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; DNA-SYNTHESIS; CELL-CYCLE; GENE-TRANSCRIPTION; DIGEORGE-SYNDROME; OXIDATIVE STRESS; CHROMATIN; PATHWAY	Cells that have been pre-exposed to mild stress (priming stress) acquire transient resistance to subsequent severe stress even under different combinations of stresses. This phenomenon is called cross-tolerance. Although it has been reported that cross-tolerance occurs in many organisms, the molecular basis is not clear yet. Here, we identified slm9(+) as a responsible gene for the cross-tolerance in the fission yeast Schizosaccharomyces pombe. Slm9 is a homolog of mammalian HIRA histone chaperone. HIRA forms a conserved complex and gene disruption of other HIRA complex components, Hip1, Hip3, and Hip4, also yielded a cross-tolerance-defective phenotype, indicating that the fission yeast HIRA is involved in the cross-tolerance as a complex. We also revealed that Slm9 was recruited to the stress-responsive gene loci upon stress treatment in an Atf1-dependent manner. The expression of stress-responsive genes under stress conditions was compromised in HIRA disruptants. Consistent with this, Pol II recruitment and nucleosome eviction at these gene loci were impaired in slm9 Delta cells. Furthermore, we found that the priming stress enhanced the expression of stress-responsive genes in wild-type cells that were exposed to the severe stress. These observations suggest that HIRA functions in stress response through transcriptional regulation.	[Chujo, Moeko; Tarumoto, Yusuke; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kyoto 6068501, Japan; [Miyatake, Koichi; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021; Tarumoto, Yusuke/H-6698-2014; Tarumoto, Yusuke/AAV-5246-2020	Ishikawa, Fuyuki/0000-0002-5580-2305; Tarumoto, Yusuke/0000-0001-6652-9618	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to F. I.).; Recipient of a fellowship from the Japan Society for the Promotion of Science.	Ahmad A, 2005, J BIOL CHEM, V280, P32090, DOI 10.1074/jbc.M501426200; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Alfa C, 1993, EXPT FISSION YEAST L; Anderson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013488; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Balaji S, 2009, MOL BIOSYST, V5, P269, DOI 10.1039/b816424j; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; Calabrese EJ, 1999, TOXICOL PATHOL, V27, P195, DOI 10.1177/019262339902700207; Calabrese EJ, 2001, CRIT REV TOXICOL, V31, P353, DOI 10.1080/20014091111730; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; DAVIES JMS, 1995, ARCH BIOCHEM BIOPHYS, V317, P1, DOI 10.1006/abbi.1995.1128; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Dohke K, 2008, GENES CELLS, V13, P1027, DOI 10.1111/j.1365-2443.2008.01225.x; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Formosa T, 2002, GENETICS, V162, P1557; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; HAHN GM, 1989, INT J RADIAT BIOL, V56, P817, DOI 10.1080/09553008914552101; HENGGEARONIS R, 1993, J BACTERIOL, V175, P259, DOI 10.1128/JB.175.1.259-265.1993; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kanoh J, 2000, GENETICS, V155, P623; Keszenman DJ, 2005, ENVIRON MOL MUTAGEN, V45, P36, DOI 10.1002/em.20083; Kirov N, 1998, GENE, V212, P323, DOI 10.1016/S0378-1119(98)00143-7; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Lantermann A, 2009, METHODS, V48, P218, DOI 10.1016/j.ymeth.2009.02.004; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Larkindale J, 2004, J PLANT PHYSIOL, V161, P405, DOI 10.1078/0176-1617-01239; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mizuki F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019442; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Moskalev A, 2009, BIOGERONTOLOGY, V10, P3, DOI 10.1007/s10522-008-9147-5; Nakagawa CW, 2000, J BIOCHEM-TOKYO, V127, P233, DOI 10.1093/oxfordjournals.jbchem.a022599; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Rai TS, 2011, MOL CELL BIOL, V31, P4107, DOI 10.1128/MCB.05546-11; Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Roberts C, 1997, HUM MOL GENET, V6, P237, DOI 10.1093/hmg/6.2.237; Sanso M, 2011, NUCLEIC ACIDS RES, V39, P6369, DOI 10.1093/nar/gkr255; Santos BC, 1998, AM J PHYSIOL-RENAL, V274, pF1054, DOI 10.1152/ajprenal.1998.274.6.F1054; Scamps C, 1996, BBA-GENE STRUCT EXPR, V1306, P5, DOI 10.1016/0167-4781(96)00010-3; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SHERWOOD PW, 1993, MOL CELL BIOL, V13, P28, DOI 10.1128/MCB.13.1.28; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Spector MS, 1997, MOL CELL BIOL, V17, P545, DOI 10.1128/MCB.17.2.545; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Williams SK, 2007, CURR OPIN GENET DEV, V17, P88, DOI 10.1016/j.gde.2007.02.001; Yamane K, 2011, MOL CELL, V41, P56, DOI 10.1016/j.molcel.2010.12.009; Yonezawa M, 1996, MUTAT RES-FUND MOL M, V358, P237, DOI 10.1016/S0027-5107(96)00126-1; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x	63	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23440	23450		10.1074/jbc.M112.349944	http://dx.doi.org/10.1074/jbc.M112.349944			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589550	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000306511300017
J	Ranuncolo, SM; Ghosh, S; Hanover, JA; Hart, GW; Lewis, BA				Ranuncolo, Stella M.; Ghosh, Salil; Hanover, John A.; Hart, Gerald W.; Lewis, Brian A.			Evidence of the Involvement of O-GlcNAc-modified Human RNA Polymerase II CTD in Transcription in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; BETA-N-ACETYLGLUCOSAMINIDASE; CORE PROMOTER ELEMENTS; MAJOR LATE PROMOTER; FUNCTIONAL-CHARACTERIZATION; TETRATRICOPEPTIDE REPEATS; D-GLUCOSAMINIDASE; GLOBIN PROMOTER; SUBUNIT-IIA; PHOSPHORYLATION	The RNA polymerase II C-terminal domain (CTD), which serves as a scaffold to recruit machinery involved in transcription, is modified post-translationally. Although the O-GlcNAc modification of RNA polymerase II CTD was documented in 1993, its functional significance remained obscure. We show that O-GlcNAc transferase (OGT) modified CTD serine residues 5 and 7. Drug inhibition of OGT and OGA (N-acetylglucosaminidase) blocked transcription during preinitiation complex assembly. Polymerase II and OGT co-immunoprecipitated, and OGT is a component of the preinitiation complex. OGT shRNA experiments showed that reduction of OGT causes a reduction in transcription and RNA polymerase II occupancy at several B-cell promoters. These data suggest that the cycling of O-GlcNAc on and off of polymerase II occurs during assembly of the preinitiation complex. Our results define unexpected roles for both the CTD and O-GlcNAc in the regulation of transcription initiation in higher eukaryotes.	[Lewis, Brian A.] NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Ghosh, Salil; Hanover, John A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University	Lewis, BA (corresponding author), NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bldg 10,Rm 6B05,9000 Rockville Pike, Bethesda, MD 20892 USA.	lewisbri@mail.nih.gov		Ranuncolo, Stella/0000-0001-7775-9048; Hart, Gerald/0000-0001-7812-4351; Lewis, Brian/0000-0002-8321-0665	National Institutes of Health Intramural Research Program , NCI, Center for Cancer Research; NIDDK; National Institutes of Health [NIH R01-CA42486, R01-DK61671]; NATIONAL CANCER INSTITUTE [ZIABC011223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060102, ZIADK060103, ZIADK060101] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program , NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program grants from NCI, Center for Cancer Research (to B. A. L.) and NIDDK (to J. A. H.) and by National Institutes of Health grants NIH R01-CA42486 and R01-DK61671 (to G. W. H.).	BURATOWSKI S, 1990, MOL CELL BIOL, V10, P5562, DOI 10.1128/MCB.10.10.5562; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gebara MM, 1997, J CELL BIOCHEM, V64, P390; GERBER HP, 1995, NATURE, V374, P660, DOI 10.1038/374660a0; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; KANG ME, 1993, J BIOL CHEM, V268, P25033; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; KIM WY, 1989, J BIOL CHEM, V264, P3169; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lee TN, 2006, BIOCHEM BIOPH RES CO, V350, P1038, DOI 10.1016/j.bbrc.2006.09.155; LEWIS BA, 1995, J BIOL CHEM, V270, P28139; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; LIAO SM, 1991, GENE DEV, V5, P2431, DOI 10.1101/gad.5.12b.2431; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Lux C, 2005, NUCLEIC ACIDS RES, V33, P5139, DOI 10.1093/nar/gki802; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; REASON A J, 1991, Glycobiology, V1, P387, DOI 10.1093/glycob/1.4.387; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Zachara NE, 2002, CURR PROTOC MOL BIOL; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	55	109	109	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23549	23561		10.1074/jbc.M111.330910	http://dx.doi.org/10.1074/jbc.M111.330910			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605332	Green Published, hybrid			2022-12-28	WOS:000306511300026
J	Zhang, HD; Lee, SJ; Richardson, CC				Zhang, Huidong; Lee, Seung-Joo; Richardson, Charles C.			The Roles of Tryptophans in Primer Synthesis by the DNA Primase of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE DOMAIN; PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI PRIMASE; GENE 4 PRIMASE; TEMPLATE RECOGNITION; HELICASE ACTIVITY; ZINC MOTIF; RESIDUES; SEQUENCE; BINDING	DNA primases catalyze the synthesis of oligoribonucleotides required for the initiation of lagging strand DNA synthesis. Prokaryotic primases consist of a zinc-binding domain (ZBD) necessary for recognition of a specific template sequence and a catalytic RNA polymerase domain. Interactions of both domains with the DNA template and ribonucleotides are required for primer synthesis. Five tryptophan residues are dispersed in the primase of bacteriophage T7: Trp-42 in the ZBD and Trp-69, -97, -147, and -255 in the RNA polymerase domain. Previous studies showed that replacement of Trp-42 with alanine in the ZBD decreases primer synthesis, whereas substitution of non-aromatic residues for Trp-69 impairs both primer synthesis and delivery. However, the roles of tryptophan at position 97, 147, or 255 remain elusive. To investigate the essential roles of these residues, we replaced each tryptophan with the structurally similar tyrosine and examined the effect of this subtle alteration on primer synthesis. The substitution at position 42, 97, or 147 reduced primer synthesis, whereas substitution at position 69 or 255 did not. The functions of the tryptophans were further examined at each step of primer synthesis. Alteration of residue 42 disturbed the conformation of the ZBD and resulted in partial loss of the zinc ion, impairing binding to the ssDNA template. Replacement of Trp-97 with tyrosine reduced the binding affinity to NTP and the catalysis step. The replacement of Trp-147 with tyrosine also impaired the catalytic step. Therefore, Trp-42 is important in maintaining the conformation of the ZBD for template binding; Trp-97 contributes to NTP binding and the catalysis step; and Trp-147 maintains the catalysis step.	[Zhang, Huidong; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	ccr@hms.harvard.edu		Zhang, Huidong/0000-0001-7845-3331	National Institutes of Health [GM 54937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM054937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54937 (to C. C. R.).	Akabayov B, 2009, BIOCHEMISTRY-US, V48, P1763, DOI 10.1021/bi802123t; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Campanini B, 2003, J BIOL CHEM, V278, P37511, DOI 10.1074/jbc.M305138200; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Clark EH, 2003, BIOCHEMISTRY-US, V42, P11065, DOI 10.1021/bi034607e; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295; Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; Liu J, 2004, P NATL ACAD SCI USA, V101, P16156, DOI 10.1073/pnas.0405319101; MENDELMAN LV, 1994, EMBO J, V13, P3909, DOI 10.1002/j.1460-2075.1994.tb06702.x; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; Podobnik M, 2000, J MOL BIOL, V300, P353, DOI 10.1006/jmbi.2000.3844; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Subramaniam V, 2001, J BIOL CHEM, V276, P21506, DOI 10.1074/jbc.M102292200; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhu B, 2010, P NATL ACAD SCI USA, V107, P9099, DOI 10.1073/pnas.1004220107	34	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23644	23656		10.1074/jbc.M112.366096	http://dx.doi.org/10.1074/jbc.M112.366096			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605336	Green Published, hybrid			2022-12-28	WOS:000306511300035
J	Zhou, MY; Lu, G; Gao, C; Wang, YB; Sun, HP				Zhou, Meiyi; Lu, Gang; Gao, Chen; Wang, Yibin; Sun, Haipeng			Tissue-specific and Nutrient Regulation of the Branched-chain alpha-Keto Acid Dehydrogenase Phosphatase, Protein Phosphatase 2Cm (PP2Cm)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY-DISEASE; SKELETAL-MUSCLE; KINASE; EXPRESSION; METABOLISM; CATABOLISM; MICE; IDENTIFICATION; TRANSPORT; COMPLEX	Branched-chain amino acid (BCAA) homeostasis is maintained through highly regulated catabolic activities where the rate-limiting step is catalyzed by branched-chain alpha-keto dehydrogenase (BCKD). Our previous study has identified a mitochondria-targeted protein phosphatase, PP2Cm, as the BCKD phosphatase and thus serves as a key regulator for BCAA catabolism. In this report, we performed comprehensive molecular and biochemical studies of PP2Cm regulation using both in vivo and in vitro systems. We show that PP2Cm expression is highly enriched in brain, heart, liver, kidney, and diaphragm, but low in skeletal muscle. The PP2Cm expression is regulated at the transcriptional level in response to nutrient status. Furthermore, we have established that PP2Cm interacts with the BCKD E2 subunit and competes with the BCKD kinase in a substrate-dependent and mutually exclusive manner. These data suggest that BCAA homeostasis is at least in part contributed by nutrient-dependent PP2Cm expression and interaction with the BCKD complex. Finally, a number of human PP2Cm single nucleotide polymorphic changes as identified in the public data base can produce either inactive or constitutive active mutant phosphatases, suggesting that putative PP2Cm mutations may contribute to BCAA catabolic defects in human.	[Sun, Haipeng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol Med & Physiol,Mol Biol Inst, Div Mol Med,Cardiovasc Res Labs,CHS, Los Angeles, CA 90095 USA; [Zhou, Meiyi; Wang, Yibin; Sun, Haipeng] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol,Chinese Minist Educ, Shanghai 200025, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shanghai Jiao Tong University	Sun, HP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol Med & Physiol,Mol Biol Inst, Div Mol Med,Cardiovasc Res Labs,CHS, Rm BH 569,650 Charles E Young Dr, Los Angeles, CA 90095 USA.	hp.sun@ucla.edu		Wang, Yibin/0000-0003-0852-0767; Sun, Haipeng/0000-0003-2128-3209	National Institutes of Health [HL108186, HL103205, HL098954]; National Natural Science Foundation of China [NSFC30971094]; Ministry of Science and Technology of China [2012BAI02B05]; Science and Technology Commission of Shanghai Municipality [11410709000]; Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund; American Heart Association postdoctoral fellowship (Great Western Affiliate); American Heart Association Scientist Development Grant (National Research Center); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103205, R01HL098954, R01HL108186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund; American Heart Association postdoctoral fellowship (Great Western Affiliate)(American Heart Association); American Heart Association Scientist Development Grant (National Research Center)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL108186, HL103205, and HL098954. This work was also supported by National Natural Science Foundation of China Grant NSFC30971094, Ministry of Science and Technology of China Grant 2012BAI02B05, Science and Technology Commission of Shanghai Municipality Grant 11410709000, and the Shanghai Jiaotong University K. C. Wong Medical Fellowship Fund.; Supported by an American Heart Association postdoctoral fellowship (Great Western Affiliate) and American Heart Association Scientist Development Grant (National Research Center). To whom correspondence should be addressed: Rm. BH 569, CHS, 650 Charles E. Young Dr., David Geffen School of Medicine, UCLA, Los Angeles, CA 90095. Fax: 310-206-5907; E-mail: hp.sun@ucla.edu.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Chuang DT, 2006, J NUTR, V136, p243S, DOI 10.1093/jn/136.1.243S; Chuang JL, 2002, J BIOL CHEM, V277, P36905, DOI 10.1074/jbc.C200430200; Doering CB, 2000, AM J PHYSIOL-CELL PH, V279, pC1587, DOI 10.1152/ajpcell.2000.279.5.C1587; HARRIS RA, 1990, ADV ENZYME REGUL, V30, P245; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Harris RA, 2001, J NUTR, V131, p841S, DOI 10.1093/jn/131.3.841S; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Iwanaka N, 2010, J APPL PHYSIOL, V108, P274, DOI 10.1152/japplphysiol.00420.2009; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Lu G, 2008, CLIN EXP PHARMACOL P, V35, P107, DOI 10.1111/j.1440-1681.2007.04843.x; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Mukakami T, 2005, J NUTR SCI VITAMINOL, V51, P48, DOI 10.3177/jnsv.51.48; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishimura J, 2010, J NUTR, V140, P496, DOI 10.3945/jn.109.108977; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P48, DOI 10.1016/0003-9861(84)90361-8; POPOV KM, 1992, J BIOL CHEM, V267, P13127; POPOV KM, 1995, ARCH BIOCHEM BIOPHYS, V316, P148, DOI 10.1006/abbi.1995.1022; Sakai R, 2004, J NEUROCHEM, V88, P612, DOI 10.1111/j.1471-4159.2004.02179.x; Serdikoff C, 2001, J NUTR, V131, P1682, DOI 10.1093/jn/131.6.1682; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Yoshizawa F, 2004, BIOCHEM BIOPH RES CO, V313, P417, DOI 10.1016/j.bbrc.2003.07.013	31	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23397	23406		10.1074/jbc.M112.351031	http://dx.doi.org/10.1074/jbc.M112.351031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589535	hybrid, Green Published			2022-12-28	WOS:000306511300012
J	Craig, TJ; Jaafari, N; Petrovic, MM; Rubin, PP; Mellor, JR; Henley, JM				Craig, Tim J.; Jaafari, Nadia; Petrovic, Milos M.; Rubin, Philip P.; Mellor, Jack R.; Henley, Jeremy M.			Homeostatic Synaptic Scaling Is Regulated by Protein SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA; MECHANISMS; EXPRESSION; ARC	Homeostatic scaling allows neurons to alter synaptic transmission to compensate for changes in network activity. Here, we show that suppression of network activity with tetrodotoxin, which increases surface expression of AMPA receptors (AMPARs), dramatically reduces levels of the deSUMOylating (where SUMO is small ubiquitin-like modifier) enzyme SENP1, leading to a consequent increase in protein SUMOylation. Overexpression of the catalytic domain of SENP1 prevents this scaling effect, and we identify Arc as a SUMO substrate involved in the tetrodotoxin-induced increase in AMPAR surface expression. Thus, protein SUMOylation plays an important and previously unsuspected role in synaptic trafficking of AMPARs that underlies homeostatic scaling.	[Craig, Tim J.; Jaafari, Nadia; Rubin, Philip P.; Henley, Jeremy M.] Univ Bristol, Sch Biochem, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Petrovic, Milos M.; Mellor, Jack R.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Petrovic, Milos M.] Univ Belgrade, Inst Med Physiol, Sch Med, Belgrade 11000, Serbia	University of Bristol; University of Bristol; University of Belgrade	Henley, JM (corresponding author), Univ Bristol, Sch Biochem, MRC, Ctr Synapt Plast, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	j.m.henley@bristol.ac.uk	MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Henley, Jeremy/0000-0003-3589-8335	Medical Research Council; European Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Marie Curie fellowship; European Molecular Biology Organization short-term fellowship; Medical Research Council [G0601810] Funding Source: researchfish; MRC [G0601810] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Marie Curie fellowship(European Commission); European Molecular Biology Organization short-term fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council and the European Research Council (to J. M. H.), the Biotechnology and Biological Sciences Research Council and the Wellcome Trust (to J. M. H. and J. R. M.), and a Marie Curie fellowship and a European Molecular Biology Organization short-term fellowship (to M. M. P.).	Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Feligioni M, 2006, J NEUROCHEM, V99, P549, DOI 10.1111/j.1471-4159.2006.04087.x; Feligioni M, 2009, EUR J NEUROSCI, V29, P1348, DOI 10.1111/j.1460-9568.2009.06692.x; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Kantamneni S, 2007, J NEUROCHEM, V100, P1003, DOI 10.1111/j.1471-4159.2006.04271.x; Kantamneni S, 2011, BIOCHEM BIOPH RES CO, V409, P657, DOI 10.1016/j.bbrc.2011.05.060; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Plant LD, 2011, J GEN PHYSIOL, V137, P441, DOI 10.1085/jgp.201110604; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2007, J NEUROSCI, V27, P10037, DOI 10.1523/JNEUROSCI.0361-07.2007; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wilkinson KA, 2008, NEUROSCI LETT, V436, P239, DOI 10.1016/j.neulet.2008.03.029; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158	28	60	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22781	22788		10.1074/jbc.M112.356337	http://dx.doi.org/10.1074/jbc.M112.356337			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582390	hybrid, Green Published			2022-12-28	WOS:000306495000035
J	Sambrooks, CL; Carpio, MA; Hallak, ME				Lopez Sambrooks, Cecilia; Carpio, Marcos A.; Hallak, Marta E.			Arginylated Calreticulin at Plasma Membrane Increases Susceptibility of Cells to Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM LUMINAL ENVIRONMENT; RECEPTOR-RELATED PROTEIN; CLASS-I MOLECULES; STRESS GRANULES; ENDOPLASMIC-RETICULUM; SURFACE CALRETICULIN; CHAPERONE CALRETICULIN; BINDING PROTEIN; EXPOSURE; CALCIUM	Post-translational modifications of proteins are important for the regulation of cell fate and functions; one of these post-translational modifications is arginylation. We have previously established that calreticulin (CRT), an endoplasmic reticulum resident, is also one of the arginylated substrates found in the cytoplasm. In the present study, we describe that arginylated CRT (R-CRT) binds to the cell membrane and identified its role as a preapoptotic signal. We also show that cells lacking arginyl-tRNA protein transferase are less susceptible to apoptosis than wild type cells. Under these conditions R-CRT is present on the cell membrane but at early stages is differently localized in stress granules. Moreover, cells induced to undergo apoptosis by arsenite show increased R-CRT on their cell surface. Exogenously applied R-CRT binds to the cell membrane and is able to both increase the number of cells undergoing apoptosis in wild type cells and overcome apoptosis resistance in cells lacking arginyl-tRNA protein transferase that express R-CRT on the cell surface. Thus, these results demonstrate the importance of surface R-CRT in the apoptotic response of cells, implying that post-translational arginylation of CRT can regulate its intracellular localization, cell function, and survival.	[Lopez Sambrooks, Cecilia; Carpio, Marcos A.; Hallak, Marta E.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC CONICET, Dept Quim Biol, Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Hallak, ME (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC CONICET, Dept Quim Biol, Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	mhallak@fcq.unc.edu.ar			Agencia Nacional de Promocion Cientifica y Technologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba; CONICET;  [BID 1728/OC-AR PICT 1661]	Agencia Nacional de Promocion Cientifica y Technologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); 	This work was supported by Grant BID 1728/OC-AR PICT 1661 and grants from the Agencia Nacional de Promocion Cientifica y Technologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba.; Recipient of a fellowship from CONICET.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carpio MA, 2010, BIOCHEM J, V429, P63, DOI 10.1042/BJ20091953; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Donnelly S, 2006, ARTHRITIS RHEUM-US, V54, P1543, DOI 10.1002/art.21783; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; GRAY AJ, 1995, J BIOL CHEM, V270, P26602, DOI 10.1074/jbc.270.44.26602; Hamilton MH, 2003, P NATL ACAD SCI USA, V100, P5081, DOI 10.1073/pnas.0831228100; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kepp O, 2009, CELL CYCLE, V8, P3971, DOI 10.4161/cc.8.23.10191; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim S, 2008, MOL CELLS, V25, P390; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; Obeid M, 2007, CANCER RES, V67, P7941, DOI 10.1158/0008-5472.CAN-07-1622; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Olkku A, 2009, BONE, V44, P555, DOI 10.1016/j.bone.2008.11.013; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; SINGH NK, 1994, P NATL ACAD SCI USA, V91, P12770, DOI 10.1073/pnas.91.26.12770; Tarr JM, 2010, J MOL BIOL, V401, P799, DOI 10.1016/j.jmb.2010.06.064; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Tufi R, 2008, CELL DEATH DIFFER, V15, P274, DOI 10.1038/sj.cdd.4402275; Xiao GQ, 1999, J NEUROSCI RES, V58, P652, DOI 10.1002/(SICI)1097-4547(19991201)58:5<652::AID-JNR6>3.0.CO;2-H; Xie W, 2011, MOL BIOL INT, V2011, P1; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhu Q, 1997, BIOCHEM BIOPH RES CO, V232, P354, DOI 10.1006/bbrc.1997.6195	55	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22043	22054		10.1074/jbc.M111.338335	http://dx.doi.org/10.1074/jbc.M111.338335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577148	Green Published, hybrid			2022-12-28	WOS:000306418600042
J	Prados-Rosales, RC; Roldan-Rodriguez, R; Serena, C; Lopez-Berges, MS; Guarro, J; Martinez-del-Pozo, A; Di Pietro, A				Prados-Rosales, Rafael C.; Roldan-Rodriguez, Raquel; Serena, Carolina; Lopez-Berges, Manuel S.; Guarro, Josep; Martinez-del-Pozo, Alvaro; Di Pietro, Antonio			A PR-1-like Protein of Fusarium oxysporum Functions in Virulence on Mammalian Hosts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENESIS-RELATED PROTEIN; CANDIDA-ALBICANS; SIGNALING PATHWAYS; FUNGAL PATHOGENESIS; GENETIC DIVERSITY; FILAMENTOUS FUNGI; MAP KINASE; RESISTANCE; PLANT; HOOKWORM	The pathogenesis-related PR-1-like protein family comprises secreted proteins from the animal, plant, and fungal kingdoms whose biological function remains poorly understood. Here we have characterized a PR-1-like protein, Fpr1, from Fusarium oxysporum, an ubiquitous fungal pathogen that causes vascular wilt disease on a wide range of plant species and can produce life-threatening infections in immunocompromised humans. Fpr1 is secreted and proteolytically processed by the fungus. The fpr1 gene is required for virulence in a disseminated immunodepressed mouse model, and its function depends on the integrity of the proposed active site of PR-1-like proteins. Fpr1 belongs to a gene family that has expanded in plant pathogenic Sordariomycetes. These results suggest that secreted PR-1-like proteins play important roles in fungal pathogenicity.	[Prados-Rosales, Rafael C.; Roldan-Rodriguez, Raquel; Lopez-Berges, Manuel S.; Di Pietro, Antonio] Univ Cordoba, Fac Ciencias, Dept Genet, E-14071 Cordoba, Spain; [Serena, Carolina; Guarro, Josep] Univ Rovira & Virgili, IISPV, Fac Med & Ciencies Salut, Unitat Microbiol, E-43201 Reus, Spain; [Martinez-del-Pozo, Alvaro] Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain	Universidad de Cordoba; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Complutense University of Madrid	Di Pietro, A (corresponding author), Univ Cordoba, Fac Ciencias, Dept Genet, E-14071 Cordoba, Spain.	ge2dipia@uco.es	Serena, Carolina/J-5687-2014; Prados-Rosales, Rafael/D-5840-2019; Serena, Carolina/AAQ-6831-2021; López-Berges, Manuel Sánchez/A-1305-2017; Martinez-del-Pozo, Alvaro/L-8556-2014; Sánchez López-Berges, Manuel/ABG-1946-2021; Prados-Rosales, Rafael/B-1240-2016; Di Pietro, Antonio/K-9220-2014	Serena, Carolina/0000-0003-2251-0856; Prados-Rosales, Rafael/0000-0001-5964-0166; Serena, Carolina/0000-0003-2251-0856; López-Berges, Manuel Sánchez/0000-0002-5523-1725; Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; Sánchez López-Berges, Manuel/0000-0002-5523-1725; Di Pietro, Antonio/0000-0001-5930-5763; Guarro, Josep/0000-0002-7839-7568	Ramon y Cajal Program; Ministerio de Ciencia e Innovacion (MICINN) Grant [BIO2010-15505]; MICINN ERA-NET/PathoGenoMics project TRANSPAT Grant [BIO2008-04479-E]; MICINN/Plant KBBE Grant [EUI2009-03942]; Junta de Andalucia Grant [BIO-3847]; Marie Curie ITN ARIADNE Grant [FP7-PEOPLE-ITN-237936]; MICINN PhD fellowships	Ramon y Cajal Program(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN) Grant; MICINN ERA-NET/PathoGenoMics project TRANSPAT Grant; MICINN/Plant KBBE Grant; Junta de Andalucia Grant(Junta de Andalucia); Marie Curie ITN ARIADNE Grant; MICINN PhD fellowships	This research was supported by the Ramon y Cajal Program. This work was also supported by Ministerio de Ciencia e Innovacion (MICINN) Grant BIO2010-15505, by MICINN ERA-NET/PathoGenoMics project TRANSPAT Grant BIO2008-04479-E, MICINN/Plant KBBE Grant EUI2009-03942, Junta de Andalucia Grant BIO-3847, Marie Curie ITN ARIADNE Grant FP7-PEOPLE-ITN-237936), and MICINN PhD fellowships (to R. C. P. R. and M. S. L. B.).	ARMSTRONG GM, 1981, FUSARIUM DIS BIOL TA, P391; Azor M, 2009, J ANTIMICROB CHEMOTH, V63, P1152, DOI 10.1093/jac/dkp095; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Braun BR, 2000, GENETICS, V156, P31; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORNELISSEN BJC, 1986, EMBO J, V5, P37, DOI 10.1002/j.1460-2075.1986.tb04174.x; Daub J, 2000, PARASITOLOGY, V120, P171, DOI 10.1017/S0031182099005375; Del Valle A, 2003, MOL BIOCHEM PARASIT, V129, P167, DOI 10.1016/S0166-6851(03)00121-X; Delgado-Jarana JS, 2005, FUNGAL GENET BIOL, V42, P61, DOI 10.1016/j.fgb.2004.10.001; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Eberle HB, 2002, J CELL SCI, V115, P827; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Ellis JG, 2007, CURR OPIN MICROBIOL, V10, P326, DOI 10.1016/j.mib.2007.05.015; Fernandez C, 1997, J MOL BIOL, V266, P576, DOI 10.1006/jmbi.1996.0772; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; GUARRO J, 1995, EUR J CLIN MICROBIOL, V14, P741, DOI 10.1007/BF01690988; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Hawdon JM, 1996, CURR OPIN GENET DEV, V6, P618, DOI 10.1016/S0959-437X(96)80092-X; HAZEN GG, 1965, ANN NY ACAD SCI, V130, P761, DOI 10.1111/j.1749-6632.1965.tb12620.x; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; LU G, 1993, J IMMUNOL, V150, P2823; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; MORRISSETTE J, 1995, BIOPHYS J, V68, P2280, DOI 10.1016/S0006-3495(95)80410-8; MOYLE M, 1994, J BIOL CHEM, V269, P10008; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Navarro-Velasco GY, 2011, FUNGAL GENET BIOL, V48, P1124, DOI 10.1016/j.fgb.2011.08.004; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; O'Donnell K, 2004, J CLIN MICROBIOL, V42, P5109, DOI 10.1128/JCM.42.11.5109-5120.2004; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Prados-Rosales RC, 2006, MICROBES INFECT, V8, P2825, DOI 10.1016/j.micinf.2006.08.015; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Sexton AC, 2006, EUKARYOT CELL, V5, P1941, DOI 10.1128/EC.00277-06; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Szyperski T, 1998, P NATL ACAD SCI USA, V95, P2262, DOI 10.1073/pnas.95.5.2262; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tunlid A, 2002, CURR OPIN MICROBIOL, V5, P513, DOI 10.1016/S1369-5274(02)00355-7; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213	58	40	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21970	21979		10.1074/jbc.M112.364034	http://dx.doi.org/10.1074/jbc.M112.364034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22553200	hybrid, Green Published			2022-12-28	WOS:000306418600036
J	Mojzita, D; Herold, S; Metz, B; Seiboth, B; Richard, P				Mojzita, Dominik; Herold, Silvia; Metz, Benjamin; Seiboth, Bernhard; Richard, Peter			L-xylo-3-Hexulose Reductase Is the Missing Link in the Oxidoreductive Pathway for D-Galactose Catabolism in Filamentous Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINITOL 4-DEHYDROGENASE; L-ARABINOSE CATABOLISM; L-XYLULOSE REDUCTASE; ASPERGILLUS-NIGER; HYPOCREA-JECORINA; CELLULASE INDUCTION; METABOLISM; NIDULANS; DEHYDROGENASE; LACTOSE	In addition to the well established Leloir pathway for the catabolism of D-galactose in fungi, the oxidoreductive pathway has been recently identified. In this oxidoreductive pathway, D-galactose is converted via a series of NADPH-dependent reductions and NAD(+)-dependent oxidations into D-fructose. The pathway intermediates include galactitol, L-xylo-3-hexulose, and D-sorbitol. This study identified the missing link in the pathway, the L-xylo-3-hexulose reductase that catalyzes the conversion of L-xylo-3-hexulose to D-sorbitol. In Trichoderma reesei (Hypocrea jecorina) and Aspergillus niger, we identified the genes lxr4 and xhrA, respectively, that encode the L-xylo-3-hexulose reductases. The deletion of these genes resulted in no growth on galactitol and in reduced growth on D-galactose. The LXR4 was heterologously expressed, and the purified protein showed high specificity for L-xylo-3-hexulose with a K-m = 2.0 +/- 0.5 mM and a V-max = 5.5 +/- 1.0 units/mg. We also confirmed that the product of the LXR4 reaction is D-sorbitol.	[Mojzita, Dominik; Richard, Peter] VTT Tech Res Ctr Finland, Espoo 02044, VTT, Finland; [Herold, Silvia; Metz, Benjamin; Seiboth, Bernhard] Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, A-1040 Vienna, Austria	VTT Technical Research Center Finland; Technische Universitat Wien	Richard, P (corresponding author), VTT Tech Res Ctr Finland, Tietotie 2,POB 1000, Espoo 02044, VTT, Finland.	Peter.Richard@vtt.fi	Richard, Peter/A-4229-2009	Richard, Peter/0000-0003-0922-6092; Mojzita, Dominik/0000-0001-6078-4503; Herold, Silvia/0000-0001-7109-4997	Academy of Finland; Finnish Centre of Excellence in White Biotechnology-Green Chemistry and Sustainable Energy [118573, 131869]; Austrian Science Foundation [P19421]; Vienna University of Technology	Academy of Finland(Academy of Finland); Finnish Centre of Excellence in White Biotechnology-Green Chemistry and Sustainable Energy; Austrian Science Foundation(Austrian Science Fund (FWF)); Vienna University of Technology	This work was supported by the Academy of Finland in the following research programs: Finnish Centre of Excellence in White Biotechnology-Green Chemistry (Grant 118573) and Sustainable Energy (Grant 131869). The work was further supported by a from of the Austrian Science Foundation (Grant P19421) (to B.S.).; A member of the Applied Bioscience Technologies (AB-Tec) Ph. D. program financed by the Vienna University of Technology.	BOS CJ, 1988, CURR GENET, V14, P437, DOI 10.1007/BF00521266; Christensen U, 2011, APPL ENVIRON MICROB, V77, P7084, DOI 10.1128/AEM.05290-11; de Groot MJL, 2007, FOOD TECHNOL BIOTECH, V45, P134; de Vries RP, 2008, ASPERGILLUS IN THE GENOMIC ERA, P87; DELEY J, 1957, J BIOL CHEM, V227, P745; Elshafei AM, 2001, ENZYME MICROB TECH, V29, P76, DOI 10.1016/S0141-0229(01)00346-5; Fekete E, 2004, ARCH MICROBIOL, V181, P35, DOI 10.1007/s00203-003-0622-8; Fekete E, 2008, ACTA MICROBIOL IMM H, V55, P119, DOI 10.1556/AMicr.55.2008.2.4; Fekete E, 2012, FEMS MICROBIOL LETT, V329, P198, DOI 10.1111/j.1574-6968.2012.02524.x; Flipphi M, 2009, FUNGAL GENET BIOL, V46, pS19, DOI 10.1016/j.fgb.2008.07.018; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Koivistoinen OM, 2012, FEBS LETT, V586, P378, DOI 10.1016/j.febslet.2012.01.004; Metz B, 2009, FEBS LETT, V583, P1309, DOI 10.1016/j.febslet.2009.03.027; Mojzita D, 2012, FUNGAL GENET BIOL, V49, P152, DOI 10.1016/j.fgb.2011.11.005; Mojzita D, 2010, FEBS LETT, V584, P3540, DOI 10.1016/j.febslet.2010.06.037; Mojzita D, 2010, J BIOL CHEM, V285, P23622, DOI 10.1074/jbc.M110.113399; Pail M, 2004, EUR J BIOCHEM, V271, P1864, DOI 10.1111/j.1432-1033.2004.04088.x; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Richard P, 2002, BIOCHEMISTRY-US, V41, P6432, DOI 10.1021/bi025529i; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; ROBERTS CF, 1970, BIOCHIM BIOPHYS ACTA, V201, P267, DOI 10.1016/0304-4165(70)90301-6; Seiboth B, 2004, MOL MICROBIOL, V51, P1015, DOI 10.1046/j.1365-2958.2003.03901.x; Seiboth B, 2003, EUKARYOT CELL, V2, P867, DOI 10.1128/EC.2.5.867-875.2003; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Seiboth Bernhard, 2007, Fungal Biology Reviews, V21, P42, DOI 10.1016/j.fbr.2007.02.006; Seiboth B, 2011, APPL MICROBIOL BIOT, V89, P1665, DOI 10.1007/s00253-010-3071-8	28	21	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26010	26018		10.1074/jbc.M112.372755	http://dx.doi.org/10.1074/jbc.M112.372755			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654107	Green Published, hybrid			2022-12-28	WOS:000306916300028
J	Bagley, DC; Paradkar, PN; Kaplan, J; Ward, DM				Bagley, Dustin C.; Paradkar, Prasad N.; Kaplan, Jerry; Ward, Diane M.			Mon1a Protein Acts in Trafficking through the Secretory Apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; EARLY ENDOSOMES; COPII; COMPLEX; TRANSPORT; PATHWAY; FUSION; IDENTIFICATION	Mon1a was originally identified as a modifier gene of vesicular traffic, as a mutant Mon1a allele resulted in increased localization of cell surface proteins, whereas reduced levels of Mon1a showed decreased secretory activity. Here we show that Mon1a affects different steps in the secretory pathway including endoplasmic reticulum-to-Golgi traffic. siRNA-dependent reduction of Mon1a levels resulted in a delay in the reformation of the Golgi apparatus after Brefeldin A treatment. Endoglycosidase H treatment of ts045VSVG-GFP confirmed that knockdown of Mon1a delayed endoplasmic reticulum-to-Golgi trafficking. Reductions in Mon1a also resulted in delayed trafficking from Golgi to the plasma membrane. Immunoprecipitation and mass spectrometry analysis showed that Mon1a associates with dynein intermediate chain. Reductions in Mon1a or dynein altered steady state Golgi morphology. Reductions in Mon1a delayed formation of ERGIC-53-positive vesicles, whereas reductions in dynein did not affect vesicle formation. These data provide strong evidence for a role for Mon1a in anterograde trafficking through the secretory apparatus.	[Bagley, Dustin C.; Paradkar, Prasad N.; Kaplan, Jerry; Ward, Diane M.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Ward, DM (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	diane.mcveyward@path.utah.edu	Paradkar, Prasad/ABA-5851-2020	Paradkar, Prasad/0000-0002-6553-2214	National Institutes of Health Grant [HL26922]; National Institutes of Health Training Grant [T32DK00715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026922, R37HL026922] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL26922 (to D. M. W.).; Supported by National Institutes of Health Training Grant T32DK00715.	Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Durchfort N, 2012, TRAFFIC, V13, P108, DOI 10.1111/j.1600-0854.2011.01300.x; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Hamasaki M, 2003, CELL STRUCT FUNCT, V28, P49; Hauri HP, 2000, J CELL SCI, V113, P587; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hoffman-Sommer M, 2005, BIOCHEM BIOPH RES CO, V329, P197, DOI 10.1016/j.bbrc.2005.01.107; Hoffman-Sommer M, 2009, EUR J CELL BIOL, V88, P639, DOI 10.1016/j.ejcb.2009.07.003; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Iyadurai SJP, 2008, J CELL SCI, V121, P2643, DOI 10.1242/jcs.027144; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Kucharczyk R, 2009, FEMS YEAST RES, V9, P565, DOI 10.1111/j.1567-1364.2009.00515.x; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; PEROU CM, 1993, J CELL SCI, V106, P99; Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Raiborg C, 2001, J CELL SCI, V114, P2255; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Ryan SD, 2012, J CELL BIOL, V196, P727, DOI 10.1083/jcb.201107096; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	34	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25577	25588		10.1074/jbc.M112.354043	http://dx.doi.org/10.1074/jbc.M112.354043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665492	Green Published, hybrid			2022-12-28	WOS:000306651700065
J	Downer, EJ; Clifford, E; Amu, S; Fallon, PG; Moynagh, PN				Downer, Eric J.; Clifford, Eileen; Amu, Sylvie; Fallon, Padraic G.; Moynagh, Paul N.			The Synthetic Cannabinoid R(+)WIN55,212-2 Augments Interferon-beta Expression via Peroxisome Proliferator-activated Receptor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REMITTING MULTIPLE-SCLEROSIS; RAT MICROGLIAL CELLS; SMOOTH-MUSCLE-CELLS; PPAR-ALPHA; SIGNALING PATHWAY; TNF-ALPHA; ANTIINFLAMMATORY ACTIONS; INFLAMMATORY RESPONSES	We have demonstrated that R(+)WIN55,212-2, a synthetic cannabinoid that possesses cannabimimetic properties, acts as a novel regulator of Toll-like receptor 3 (TLR3) signaling to interferon (IFN) regulatory factor 3 (IRF3) activation and IFN-beta expression, and this is critical for manifesting its protective effects in a murine multiple sclerosis model. Here we investigated the role of peroxisome proliferator-activated receptor-alpha (PPAR alpha) in mediating the effects of R(+)WIN55,212-2 on this pathway. Data herein demonstrate that the TLR3 agonist poly(I:C) promotes IFN-beta expression and R(+)WIN55,212-2 enhances TLR3-induced IFN-beta expression in a stereoselective manner via PPAR alpha. R(+)WIN55,212-2 promotes increased transactivation and expression of PPAR alpha. Using the PPAR alpha antagonist GW6471, we demonstrate that R(+)WIN55,212-2 acts via PPAR alpha to activate JNK, activator protein-1, and positive regulatory domain IV to transcriptionally regulate the IFN-beta promoter. Furthermore, GW6471 ameliorated the protective effects of R(+) WIN55,212-2 during the initial phase of experimental autoimmune encephalomyelitis. Overall, these findings define PPAR alpha as an important mediator in manifesting the effects of R(+) WIN55,212-2 on the signaling cascade regulating IFN-beta expression. The study adds to our molecular appreciation of potential therapeutic effects of R(+)WIN55,212-2 in multiple sclerosis.	[Downer, Eric J.; Clifford, Eileen; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Maynooth, Kildare, Ireland; [Amu, Sylvie; Fallon, Padraic G.] Trinity Coll Dublin, St Jamess Hosp, Inst Mol Med, Dublin 8, Ireland	Maynooth University; Trinity College Dublin	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Inst Immunol, Maynooth, Kildare, Ireland.	Paul.Moynagh@nuim.ie	Fallon, Padraic/Y-2711-2019	Fallon, Padraic/0000-0002-8401-7293; Amu, Sylvie/0000-0001-9593-7952; Moynagh, Paul/0000-0002-4139-3061; Downer, Eric/0000-0002-6012-2291	Science Foundation Ireland; IRCSET postdoctoral fellowship	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); IRCSET postdoctoral fellowship(Irish Research Council for Science, Engineering and Technology)	This work was supported by Science Foundation Ireland (to P.N.M.) and an IRCSET postdoctoral fellowship (to E.J.D.).	Alvarado M, 2008, BIOORGAN MED CHEM, V16, P10098, DOI 10.1016/j.bmc.2008.10.023; Alvaro-Bartolome M, 2010, BRIT J PHARMACOL, V160, P643, DOI 10.1111/j.1476-5381.2010.00710.x; Atzei P, 2010, J BIOL CHEM, V285, P36804, DOI 10.1074/jbc.M110.139113; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Borner C, 2008, NEUROIMMUNOMODULAT, V14, P281, DOI 10.1159/000117809; Bosier B, 2009, BIOCHEM PHARMACOL, V77, P216, DOI 10.1016/j.bcp.2008.10.010; Carroll C. B., 2012, NEUROPATHOL IN PRESS; Cheng SM, 2010, EUR J PHARM SCI, V40, P316, DOI 10.1016/j.ejps.2010.04.003; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; Dasu MR, 2009, ENDOCRINOLOGY, V150, P3457, DOI 10.1210/en.2008-1757; De Morrow S, 2008, AM J PHYSIOL-GASTR L, V294, pG506, DOI 10.1152/ajpgi.00304.2007; Deplanque D, 2003, J NEUROSCI, V23, P6264; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Downer EJ, 2011, J BIOL CHEM, V286, P10316, DOI 10.1074/jbc.M110.188599; Downer EJ, 2010, NEUROBIOL AGING, V31, P118, DOI 10.1016/j.neurobiolaging.2008.03.017; Dunn SE, 2007, J EXP MED, V204, P321, DOI 10.1084/jem.20061839; Eichele K, 2009, PHARM RES-DORDR, V26, P346, DOI 10.1007/s11095-008-9748-3; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Froger N, 2009, J NEUROCHEM, V111, P1383, DOI 10.1111/j.1471-4159.2009.06407.x; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Germain N, 2002, INT IMMUNOPHARMACOL, V2, P537, DOI 10.1016/S1567-5769(01)00200-4; Giuliano M, 2009, BIOCHIMIE, V91, P457, DOI 10.1016/j.biochi.2008.11.003; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; Graber JJ, 2010, CLIN NEUROL NEUROSUR, V112, P583, DOI 10.1016/j.clineuro.2010.05.002; Gurley C, 2008, PPAR RES, V2008, DOI 10.1155/2008/453120; Hasseldam H, 2011, INT J NEUROSCI, V121, P510, DOI 10.3109/00207454.2011.582237; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Herzberg U, 1997, NEUROSCI LETT, V221, P157, DOI 10.1016/S0304-3940(96)13308-5; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Ji YY, 2010, CELL PHYSIOL BIOCHEM, V25, P631, DOI 10.1159/000315082; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Lee JW, 2007, GASTROENTEROLOGY, V133, P108, DOI 10.1053/j.gastro.2007.03.113; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Liu JL, 2003, MOL PHARMACOL, V63, P983, DOI 10.1124/mol.63.5.983; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Luca T, 2009, EUR J PHARMACOL, V616, P16, DOI 10.1016/j.ejphar.2009.06.004; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marchalant Y, 2007, NEUROSCIENCE, V144, P1516, DOI 10.1016/j.neuroscience.2006.11.016; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mestre L, 2009, MOL CELL NEUROSCI, V40, P258, DOI 10.1016/j.mcn.2008.10.015; Miralles F, 1998, MOL CELL BIOL, V18, P4537, DOI 10.1128/MCB.18.8.4537; Mohapatra SK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-10; Molina-Holgado F, 2002, J NEUROSCI RES, V67, P829, DOI 10.1002/jnr.10165; Moranta D, 2007, J NEUROSCI RES, V85, P656, DOI 10.1002/jnr.21140; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Nilsson O, 2006, EUR J PHARMACOL, V547, P165, DOI 10.1016/j.ejphar.2006.07.016; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; O'Sullivan SE, 2009, EUR J PHARMACOL, V612, P61, DOI 10.1016/j.ejphar.2009.03.010; O'Sullivan SE, 2006, J PHARMACOL EXP THER, V317, P428, DOI 10.1124/jpet.105.095828; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; PACHECO M, 1991, J PHARMACOL EXP THER, V257, P170; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park JM, 2011, J CELL BIOCHEM, V112, P1192, DOI 10.1002/jcb.23041; Pellerito O, 2010, MOL PHARMACOL, V77, P854, DOI 10.1124/mol.109.062257; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; Racke MK, 2008, PPAR RES, V2008, DOI 10.1155/2008/638356; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854; Ryoo S, 2004, BIOCHEM BIOPH RES CO, V318, P329, DOI 10.1016/j.bbrc.2004.04.031; Sagar DR, 2008, BRIT J PHARMACOL, V155, P1297, DOI 10.1038/bjp.2008.335; Sanchez AJ, 2006, BIOCHEM PHARMACOL, V72, P1697, DOI 10.1016/j.bcp.2006.08.018; Scuderi C, 2011, J CELL MOL MED, V15, P2664, DOI 10.1111/j.1582-4934.2011.01267.x; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Smeets PJH, 2008, J BIOL CHEM, V283, P29109, DOI 10.1074/jbc.M802143200; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Sun Y, 2007, BRIT J PHARMACOL, V152, P734, DOI 10.1038/sj.bjp.0707478; Sun Y, 2006, BIOCHEM SOC T, V34, P1095, DOI 10.1042/BST0341095; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Yang H, 2010, EXP EYE RES, V91, P462, DOI 10.1016/j.exer.2010.06.022; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	87	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25440	25453		10.1074/jbc.M112.371757	http://dx.doi.org/10.1074/jbc.M112.371757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654113	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000306651700051
J	Noborn, F; Ancsin, JB; Ubhayasekera, W; Kisilevsk, R; Li, JP				Noborn, Fredrik; Ancsin, John B.; Ubhayasekera, Wimal; Kisilevsk, Robert; Li, Jin-Ping			Heparan Sulfate Dissociates Serum Amyloid A (SAA) from Acute-phase High-density Lipoprotein, Promoting SAA Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-A AMYLOIDOSIS; PLASMON RESONANCE; APOLIPOPROTEIN-E; BINDING; FIBRILS; ANTITHROMBIN; MICE; GLYCOSAMINOGLYCANS; FIBRILLIZATION; ELECTROSTATICS	Inflammation-related (AA) amyloidosis is a severe clinical disorder characterized by the systemic deposition of the acute-phase reactant serum amyloid A (SAA). SAA is normally associated with the high-density lipoprotein (HDL) fraction in plasma, but under yet unclear circumstances, the apolipoprotein is converted into amyloid fibrils. AA amyloid and heparan sulfate (HS) display an intimate relationship in situ, suggesting a role for HS in the pathogenic process. This study reports that HS dissociates SAA from HDLs isolated from inflamed mouse plasma. Application of surface plasmon resonance spectroscopy and molecular modeling suggests that HS simultaneously binds to two apolipoproteins of HDL, SAA and ApoA-I, and thereby induce SAA dissociation. The activity requires a minimum chain length of 12-14 sugar units, proposing an explanation to previous findings that short HS fragments preclude AA amyloidosis. The results address the initial events in the pathogenesis of AA amyloidosis.	[Noborn, Fredrik; Ancsin, John B.; Ubhayasekera, Wimal; Li, Jin-Ping] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Kisilevsk, Robert] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	Uppsala University; McMaster University; Queens University - Canada	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, SE-75123 Uppsala, Sweden.	jin-ping.li@imbim.uu.se			European Commission (EURAMY European Rare Amyloidosis Network); Swedish Research Council [K2009-67X-21128-01-3]; Mizutani Foundation for Glycoscience; Swedish Cancerfonden [090717]; Polysackaridforskning Foundation (Uppsala, Sweden)	European Commission (EURAMY European Rare Amyloidosis Network)(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Mizutani Foundation for Glycoscience; Swedish Cancerfonden; Polysackaridforskning Foundation (Uppsala, Sweden)	The study was supported by grants from the European Commission (EURAMY European Rare Amyloidosis Network), the Swedish Research Council (K2009-67X-21128-01-3), the Mizutani Foundation for Glycoscience, the Swedish Cancerfonden (090717), and the Polysackaridforskning Foundation (Uppsala, Sweden).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; AXELRAD MA, 1982, LAB INVEST, V47, P139; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; Elimova E, 2004, FASEB J, V18, P1749, DOI 10.1096/fj.03-1436fje; Elimova E, 2009, FASEB J, V23, P3436, DOI 10.1096/fj.09-134981; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Harris M, 2001, ACTA CRYSTALLOGR D, V57, P1201, DOI 10.1107/S0907444901007697; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HOOK GER, 1982, J BIOL CHEM, V257, P9211; HOOK M, 1976, FEBS LETT, V66, P90, DOI 10.1016/0014-5793(76)80592-3; Jha S, 2011, J BIOL CHEM, V286, P22894, DOI 10.1074/jbc.M110.215814; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karplus K, 2001, PROTEINS, P86, DOI 10.1002/prot.10021; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Krimbou L, 1997, J LIPID RES, V38, P35; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Lortat-Jacob H, 2009, CURR OPIN STRUC BIOL, V19, P543, DOI 10.1016/j.sbi.2009.09.003; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; MORROW JF, 1981, P NATL ACAD SCI-BIOL, V78, P4718, DOI 10.1073/pnas.78.8.4718; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; Salamon Z, 2000, BIOPHYS J, V79, P2463, DOI 10.1016/S0006-3495(00)76489-7; SNOW AD, 1987, LAB INVEST, V57, P687; Staatz W D, 2001, Methods Mol Biol, V171, P41; Tam SP, 2005, J LIPID RES, V46, P2091, DOI 10.1194/jlr.M500191-JLR200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; Wall JS, 2011, P NATL ACAD SCI USA, V108, pE586, DOI 10.1073/pnas.1103247108; Westermark GT, 2009, FEBS LETT, V583, P2685, DOI 10.1016/j.febslet.2009.04.026	43	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25669	25677		10.1074/jbc.M112.363895	http://dx.doi.org/10.1074/jbc.M112.363895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654109	hybrid, Green Published			2022-12-28	WOS:000306651700074
J	Zhao, YL; Chen, SR; Chen, H; Pan, HL				Zhao, Yi-Lin; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin			Chronic Opioid Potentiates Presynaptic but Impairs Postsynaptic N-Methyl-D-aspartic Acid Receptor Activity in Spinal Cords IMPLICATIONS FOR OPIOID HYPERALGESIA AND TOLERANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; LONG-LASTING HYPERALGESIA; NMDA RECEPTORS; DORSAL-HORN; MORPHINE-TOLERANCE; SENSORY NEURONS; INTRATHECAL MORPHINE; OPIATE TOLERANCE; UP-REGULATION; RATS	Opioids are the most effective analgesics for the treatment of moderate to severe pain. However, chronic opioid treatment can cause both hyperalgesia and analgesic tolerance, which limit their clinical efficacy. In this study, we determined the role of pre- and postsynaptic NMDA receptors (NMDARs) in controlling increased glutamatergic input in the spinal cord induced by chronic systemic morphine administration. Whole-cell voltage clamp recordings of excitatory postsynaptic currents (EPSCs) were performed on dorsal horn neurons in rat spinal cord slices. Chronic morphine significantly increased the amplitude of monosynaptic EPSCs evoked from the dorsal root and the frequency of spontaneous EPSCs, and these changes were largely attenuated by blocking NMDARs and by inhibiting PKC, but not PKA. Also, blocking NR2A- or NR2B-containing NMDARs significantly reduced the frequency of spontaneous EPSCs and the amplitude of evoked EPSCs in morphine-treated rats. Strikingly, morphine treatment largely decreased the amplitude of evoked NMDAR-EPSCs and NMDAR currents of dorsal horn neurons elicited by puff NMDA application. The reduction in postsynaptic NMDAR currents caused by morphine was prevented by resiniferatoxin pretreatment to ablate TRPV1-expressing primary afferents. Furthermore, intrathecal injection of the NMDAR antagonist significantly attenuated the development of analgesic tolerance and the reduction in nociceptive thresholds induced by chronic morphine. Collectively, our findings indicate that chronic opioid treatment potentiates presynaptic, but impairs postsynaptic, NMDAR activity in the spinal cord. PKC-mediated increases in NMDAR activity at nociceptive primary afferent terminals in the spinal cord contribute critically to the development of opioid hyperalgesia and analgesic tolerance.	[Zhao, Yi-Lin; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Pain & Neurosci Res, Houston, TX 77030 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Program Neurosci, Grad Sch Biomed Sci, Houston, TX 77225 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Program Expt Therapeut, Grad Sch Biomed Sci, Houston, TX 77225 USA; [Zhao, Yi-Lin] Tongji Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Pain & Neurosci Res, Unit 110,1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM064830, NS073935]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064830 and NS073935 (to H. L. P.). This work was also supported by the N. G. and Helen T. Hawkins Endowment (to H. L. P.).	Antal M, 2008, J NEUROSCI, V28, P9692, DOI 10.1523/JNEUROSCI.1551-08.2008; AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; Bardoni R, 2004, J NEUROSCI, V24, P2774, DOI 10.1523/JNEUROSCI.4637-03.2004; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen SR, 2007, NEUROSCIENCE, V145, P676, DOI 10.1016/j.neuroscience.2006.12.016; Chen SR, 2011, J PHARMACOL EXP THER, V337, P285, DOI 10.1124/jpet.110.176586; Chen SR, 2006, BRAIN RES, V1081, P119, DOI 10.1016/j.brainres.2006.01.053; Chen SR, 2006, J NEUROPHYSIOL, V95, P3086, DOI 10.1152/jn.01343.2005; Chen SR, 2003, ANESTHESIOLOGY, V99, P1409, DOI 10.1097/00000542-200312000-00026; Chia YT, 1999, CAN J ANAESTH, V46, P872, DOI 10.1007/BF03012978; Colpaert FC, 1996, PHARMACOL REV, V48, P355; CONNELLY PA, 1987, J BIOL CHEM, V262, P4324; Devulder J, 1997, J NEUROSURG ANESTH, V9, P146, DOI 10.1097/00008506-199704000-00007; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Granados-Soto V, 2000, PAIN, V85, P395, DOI 10.1016/S0304-3959(99)00281-X; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Jolas T, 2000, NEUROSCIENCE, V95, P433; Kimura R, 2008, J PHYSIOL-LONDON, V586, P3195, DOI 10.1113/jphysiol.2008.151894; Kramer HK, 1999, J NEUROCHEM, V72, P585; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Larcher A, 1998, NEUROSCIENCE, V84, P583, DOI 10.1016/S0306-4522(97)00556-3; Laulin JP, 1999, NEUROSCIENCE, V89, P631, DOI 10.1016/S0306-4522(98)00652-6; Li DP, 2008, J PHYSIOL-LONDON, V586, P1637, DOI 10.1113/jphysiol.2007.149732; Li DP, 2012, J NEUROSCI, V32, P372, DOI 10.1523/JNEUROSCI.3222-11.2012; MAO J, 1994, J NEUROSCI, V14, P2301; MAYER DJ, 1995, PAIN, V61, P365, DOI 10.1016/0304-3959(95)00023-L; Momiyama A, 2000, J PHYSIOL-LONDON, V523, P621, DOI 10.1111/j.1469-7793.2000.t01-1-00621.x; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; OLVERMAN HJ, 1984, NATURE, V307, P460, DOI 10.1038/307460a0; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Stubhaug A, 1997, ACTA ANAESTH SCAND, V41, P1124, DOI 10.1111/j.1399-6576.1997.tb04854.x; Szallasi A, 1999, MOL PHARMACOL, V56, P581, DOI 10.1124/mol.56.3.581; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Van Elstraete AC, 2005, ANESTH ANALG, V101, P1750, DOI 10.1213/01.ANE.0000184136.08194.9B; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Woodbury CJ, 2000, J COMP NEUROL, V417, P88, DOI 10.1002/(SICI)1096-9861(20000131)417:1<88::AID-CNE7>3.0.CO;2-U; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Wu LJ, 2005, J NEUROSCI, V25, P11107, DOI 10.1523/JNEUROSCI.1678-05.2005; Xie CW, 1997, J NEUROPHYSIOL, V78, P759, DOI 10.1152/jn.1997.78.2.759; YAKSH TL, 1986, ANESTHESIOLOGY, V64, P590, DOI 10.1097/00000542-198605000-00008; YAKSH TL, 1988, J PHARMACOL EXP THER, V244, P501; Ye ZY, 2012, J BIOL CHEM, V287, P17438, DOI 10.1074/jbc.M111.331165; Zeng JS, 2006, J NEUROSCI, V26, P12033, DOI 10.1523/JNEUROSCI.2530-06.2006; Zhou HY, 2008, J PHARMACOL EXP THER, V327, P375, DOI 10.1124/jpet.108.141226; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; Zhou HY, 2009, J NEUROCHEM, V108, P305, DOI 10.1111/j.1471-4159.2008.05772.x	56	65	68	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25073	25085		10.1074/jbc.M112.378737	http://dx.doi.org/10.1074/jbc.M112.378737			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679016	Green Published, hybrid			2022-12-28	WOS:000306651700020
J	Kishikawa, J; Yokoyama, K				Kishikawa, Jun-ichi; Yokoyama, Ken			Reconstitution of Vacuolar-type Rotary H+-ATPase/Synthase from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; CENTRAL STALK; PERIPHERAL STALK; SUBUNIT; ROTATION; HYDROLYSIS; MOTOR; V-1	Vacuolar-type rotary H+-ATPase/synthase (VoV1) from Thermus thermophilus, composed of nine subunits, A, B, D, F, C, E, G, I, and L, has been reconstituted from individually isolated V-1 (A(3)B(3)D(1)F(1)) and V-o (C(1)E(2)G(2)I(1)L(12)) subcomplexes in vitro. A(3)B(3)D and A(3)B(3) also reconstituted with V-o, resulting in a holoenzyme-like complexes. However, A(3)B(3)D-V-o and A(3)B(3)-V-o did not show ATP synthesis and dicyclohexylcarbodiimide-sensitive ATPase activity. The reconstitution process was monitored in real time by fluorescence resonance energy transfer (FRET) between an acceptor dye attached to subunit F or D in V-1 or A(3)B(3)D and a donor dye attached to subunit C in V-o. The estimated dissociation constants K-d for VoV1 and A(3)B(3)D-V-o were similar to 0.3 and similar to 1 nM at 25 degrees C, respectively. These results suggest that the A(3)B(3) domain tightly associated with the two EG peripheral stalks of V-o, even in the absence of the central shaft subunits. In addition, F subunit is essential for coupling of ATP hydrolysis and proton translocation and has a key role in the stability of whole complex. However, the contribution of the F subunit to the association of A(3)B(3) with V-o is much lower than that of the EG peripheral stalks.	[Kishikawa, Jun-ichi; Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan	Kyoto Sangyo University	Yokoyama, K (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	yokoken@cc.kyoto-su.ac.jp		Kishikawa, Jun-ichi/0000-0003-3913-7330; Yokoyama, Ken/0000-0002-6813-1096	Ministry of Education, Science, Sports and Culture of Japan [21370042, 24370059]; TPRP [B-37]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); TPRP	This work was partly supported by Grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (No. 21370042 and 24370059, to K. Y.) and TPRP (B-37, to K. Y.).	Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imamura H, 2006, J BIOL CHEM, V281, P38582, DOI 10.1074/jbc.M608253200; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kakinuma Y, 1999, J BIOENERG BIOMEMBR, V31, P7, DOI 10.1023/A:1005499126939; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; TSUTSUMI S, 1991, BIOCHIM BIOPHYS ACTA, V1098, P13, DOI 10.1016/0005-2728(91)90003-7; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; YOKOYAMA K, 1990, J BIOL CHEM, V265, P21946; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Yokoyama K, 2000, J BIOL CHEM, V275, P13955, DOI 10.1074/jbc.275.18.13955	30	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24597	24603		10.1074/jbc.M112.367813	http://dx.doi.org/10.1074/jbc.M112.367813			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22582389	Green Published, hybrid			2022-12-28	WOS:000306651100054
J	Cheng, XW; Liu, Y; Chu, H; Kao, HY				Cheng, Xiwen; Liu, Yu; Chu, Hao; Kao, Hung-Ying			Promyelocytic Leukemia Protein (PML) Regulates Endothelial Cell Network Formation and Migration in Response to Tumor Necrosis Factor alpha (TNF alpha) and Interferon alpha (IFN alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; INFLAMMATORY ANGIOGENESIS; SIGNAL TRANSDUCER; INDUCED APOPTOSIS; KINASE PATHWAY; RAR-ALPHA; STAT1; ACTIVATION; RECEPTOR; INDUCTION	Promyelocytic leukemia protein (PML) is a tumor suppressor that is highly expressed in vascular endothelium and inflamed tissues, yet its role in inflammation-associated cytokine-regulated angiogenesis and underlying mechanism remains largely unclear. We show that tumor necrosis factor alpha (TNF alpha) and interferon alpha (IFN alpha) stimulate PML expression while suppressing EC network formation and migration, two key events during angiogenesis. By a knockdown approach, we demonstrate that PML is indispensable for TNF alpha- and IFN alpha-mediated inhibition of EC network formation. We further demonstrate that signal transducer and activator of transcription 1 (STAT1) binds PML promoter and that is an important regulator of PML expression. Knockdown of STAT1 reduces endogenous PML and blocks TNF alpha- and IFN alpha-induced PML accumulation and relieves TNF alpha- and IFN alpha-mediated inhibition of EC network formation. Our data also indicate that PML regulates EC migration, in part, by modulating expression of downstream genes, such as negatively regulating integrin beta 1 (ITGB1). In addition, knockdown of STAT1 or PML alleviates TNF alpha- and IFN alpha-mediated inhibition of ITGB1 expression. Antibody blockade demonstrates that ITGB1 is functionally important for PML- and STAT1-regulated EC migration. Taken together, our data provide novel mechanistic insights that PML functions as a negative regulator in EC network formation and migration.	[Cheng, Xiwen; Liu, Yu; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Cheng, Xiwen; Liu, Yu; Kao, Hung-Ying] CWRU, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Cheng, Xiwen; Liu, Yu; Kao, Hung-Ying] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Chu, Hao] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Cheng, Xiwen/B-8385-2014; Pinheiro, Maísa/E-7424-2012	Cheng, Xiwen/0000-0001-7398-1522; 	National Institutes of Health [R01 DK078965, HL093269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, R01 DK078965 and HL093269 (to H. Y. K.).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Albini A, 2005, CANCER RES, V65, P10637, DOI 10.1158/0008-5472.CAN-05-3473; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Breau MA, 2009, DEVELOPMENT, V136, P2791, DOI 10.1242/dev.031419; Caporali A, 2008, CIRC RES, V103, pE15, DOI 10.1161/CIRCRESAHA.108.177386; Caraglia M, 1999, CELL DEATH DIFFER, V6, P773, DOI 10.1038/sj.cdd.4400550; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Crowder C, 2005, BLOOD, V105, P1280, DOI 10.1182/blood-2004-04-1614; de Totero D, 2008, BLOOD, V111, P517, DOI 10.1182/blood-2007-04-087882; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dougan M, 2011, J CLIN INVEST, V121, P2436, DOI 10.1172/JCI44796; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gambaryan S, 2010, J BIOL CHEM, V285, P18352, DOI 10.1074/jbc.M109.077602; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mahboubi K, 2002, J BIOL CHEM, V277, P8012, DOI 10.1074/jbc.M107542200; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mbow ML, 2004, TRENDS BIOTECHNOL, V22, P395, DOI 10.1016/j.tibtech.2004.06.002; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; MIELE ME, 1994, EXP CELL RES, V214, P231, DOI 10.1006/excr.1994.1253; Mottet D, 2007, CIRC RES, V101, P1237, DOI 10.1161/CIRCRESAHA.107.149377; Nakao S, 2003, J IMMUNOL, V170, P5704, DOI 10.4049/jimmunol.170.11.5704; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Pradhan M, 2010, J BIOL CHEM, V285, P31100, DOI 10.1074/jbc.M110.155309; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Reineke Erin L, 2009, Cancer Ther, V7, P219; Reineke EL, 2010, J BIOL CHEM, V285, P9485, DOI 10.1074/jbc.M109.063362; Reineke EL, 2009, INT J BIOL SCI, V5, P366; ROSENBAUM JT, 1988, AM J PATHOL, V133, P47; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stadler M, 1995, ONCOGENE, V11, P2565; SUNDERKOTTER C, 1990, AM J PATHOL, V137, P511; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Team RDC, 2009, R LANG ENV STAT COMP; TERRIS B, 1995, CANCER RES, V55, P1590; Uddin S, 2000, J BIOL CHEM, V275, P27634; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wong LH, 2002, J BIOL CHEM, V277, P19408, DOI 10.1074/jbc.M111302200; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Xie B, 2001, J BIOL CHEM, V276, P19512, DOI 10.1074/jbc.M009063200	58	29	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23356	23367		10.1074/jbc.M112.340505	http://dx.doi.org/10.1074/jbc.M112.340505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589541	hybrid, Green Published			2022-12-28	WOS:000306511300009
J	McFarlan, JT; Yoshida, Y; Jain, SS; Han, XX; Snook, LA; Lally, J; Smith, BK; Glatz, JFC; Luiken, JJFP; Sayer, RA; Tupling, AR; Chabowski, A; Holloway, GP; Bonen, A				McFarlan, Jay T.; Yoshida, Yuko; Jain, Swati S.; Han, Xioa-Xia; Snook, Laelie A.; Lally, James; Smith, Brennan K.; Glatz, Jan F. C.; Luiken, Joost J. F. P.; Sayer, Ryan A.; Tupling, A. Russell; Chabowski, Adrian; Holloway, Graham P.; Bonen, Arend			In Vivo, Fatty Acid Translocase (CD36) Critically Regulates Skeletal Muscle Fuel Selection, Exercise Performance, and Training-induced Adaptation of Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; INSULIN-RESISTANCE; PALMITATE OXIDATION; GLUCOSE-TRANSPORT; LIPID-METABOLISM; BIOCHEMICAL ADAPTATIONS; MITOCHONDRIAL FAT/CD36; RESPIRATORY CAPACITY; GLYCOGEN UTILIZATION; SUBMAXIMAL EXERCISE	For similar to 40 years it has been widely accepted that (i) the exercise-induced increase in muscle fatty acid oxidation( FAO) is dependent on the increased delivery of circulating fatty acids, and (ii) exercise training-induced FAO up-regulation is largely attributable to muscle mitochondrial biogenesis. These long standing concepts were developed prior to the recent recognition that fatty acid entry into muscle occurs via a regulatable sarcolemmal CD36-mediated mechanism. We examined the role of CD36 in muscle fuel selection under basal conditions, during a metabolic challenge (exercise), and after exercise training. We also investigated whether CD36 overexpression, independent of mitochondrial changes, mimicked exercise training-induced FAO up-regulation. Under basal conditions CD36-KO versus WT mice displayed reduced fatty acid transport (-21%) and oxidation (-25%), intramuscular lipids (less than or equal to -31%), and hepatic glycogen (-20%); but muscle glycogen, VO2max, and mitochondrial content and enzymes did not differ. In acutely exercised (78% VO2max) CD36-KO mice, fatty acid transport (-41%), oxidation (-37%), and exercise duration (-44%) were reduced, whereas muscle and hepatic glycogen depletions were accelerated by 27-55%, revealing 2-fold greater carbohydrate use. Exercise training increased mtDNA and beta-hydroxyacyl-CoA dehydrogenase similarly in WT and CD36-KO muscles, but FAO was increased only in WT muscle (+90%). Comparable CD36 increases, induced by exercise training (+44%) or by CD36 overexpression (+41%), increased FAO similarly (84-90%), either when mitochondrial biogenesis and FAO enzymes were up-regulated (exercise training) or when these were unaltered(CD36 overexpression). Thus, sarcolemmal CD36 has a key role in muscle fuel selection, exercise performance, and training-induced muscle FAO adaptation, challenging long held views of mechanisms involved in acute and adaptive regulation of muscle FAO.	[McFarlan, Jay T.; Yoshida, Yuko; Jain, Swati S.; Han, Xioa-Xia; Snook, Laelie A.; Lally, James; Smith, Brennan K.; Holloway, Graham P.; Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Sayer, Ryan A.; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, PL-15222 Bialystok, Poland	University of Guelph; Maastricht University; University of Waterloo; Medical University of Bialystok	Bonen, A (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	arend.bonen@gmail.com	; Chabowski, Adrian/T-2225-2018	Tupling, A. Russell/0000-0002-3895-6767; Chabowski, Adrian/0000-0002-7407-8156	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Canada Research Chair program; Medical University of Bialystok [3-18950]; Vitamin Scholarship; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research Master's Award; Frederick Banting and Charles Best Canada Graduate Scholarship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Research Chair program(Canada Research Chairs); Medical University of Bialystok; Vitamin Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Master's Award(Canadian Institutes of Health Research (CIHR)); Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Natural Sciences and Engineering Research Council, the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and the Canada Research Chair program and Medical University of Bialystok Grant 3-18950.; Supported by a Vitamin Scholarship.; Supported by a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada.; Supported by a Canadian Institutes of Health Research Master's Award and a Frederick Banting and Charles Best Canada Graduate Scholarship.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; Alkhateeb H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1056, DOI 10.1152/ajpendo.90908.2008; BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373; Benton CR, 2010, DIABETOLOGIA, V53, P2008, DOI 10.1007/s00125-010-1773-1; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Bonen A, 2000, AM J PHYSIOL-ENDOC M, V278, pE1067, DOI 10.1152/ajpendo.2000.278.6.E1067; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Clarke DC, 2004, PHYSIOL GENOMICS, V17, P31, DOI 10.1152/physiolgenomics.00190.2003; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Dyck DJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE778, DOI 10.1152/ajpendo.2000.278.5.E778; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007; FITTS RH, 1975, AM J PHYSIOL, V228, P1029, DOI 10.1152/ajplegacy.1975.228.4.1029; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Habets DDJ, 2007, BIOCHEM BIOPH RES CO, V355, P204, DOI 10.1016/j.bbrc.2007.01.141; HAGENFELDT L, 1979, DIABETES, V28, P66, DOI 10.2337/diab.28.1.S66; Han XX, 2007, AM J PHYSIOL-ENDOC M, V293, pE566, DOI 10.1152/ajpendo.00106.2007; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; HICKSON RC, 1977, J APPL PHYSIOL, V43, P829, DOI 10.1152/jappl.1977.43.5.829; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Holloszy JO, 1996, ANNU REV NUTR, V16, P121, DOI 10.1146/annurev.nu.16.070196.001005; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Holloway GP, 2009, AM J PHYSIOL-REG I, V297, pR960, DOI 10.1152/ajpregu.91021.2008; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Jain SS, 2009, FEBS LETT, V583, P2294, DOI 10.1016/j.febslet.2009.06.020; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koonen DPY, 2004, AM J PHYSIOL-ENDOC M, V286, pE1042, DOI 10.1152/ajpendo.00531.2003; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kuang M, 2004, CIRCULATION, V109, P1550, DOI 10.1161/01.CIR.0000121730.41801.12; Kuznetsov AV, 1996, EUR J BIOCHEM, V241, P909, DOI 10.1111/j.1432-1033.1996.00909.x; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Love-Gregory L, 2011, CURR OPIN CLIN NUTR, V14, P527, DOI 10.1097/MCO.0b013e32834bbac9; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; MOLE PA, 1971, J CLIN INVEST, V50, P2323, DOI 10.1172/JCI106730; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Perry CGR, 2008, APPL PHYSIOL NUTR ME, V33, P1112, DOI 10.1139/H08-097; Raney MA, 2005, AM J PHYSIOL-ENDOC M, V288, pE592, DOI 10.1152/ajpendo.00301.2004; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shearer J, 2005, J APPL PHYSIOL, V99, P957, DOI 10.1152/japplphysiol.00275.2005; Shearer J, 2005, AM J PHYSIOL-ENDOC M, V289, pE508, DOI 10.1152/ajpendo.00100.2005; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watt MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE120, DOI 10.1152/ajpendo.00542.2003; Wright DC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1062, DOI 10.1152/ajpendo.00561.2004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YOUN JH, 1991, AM J PHYSIOL, V260, pC555, DOI 10.1152/ajpcell.1991.260.3.C555	74	73	77	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23502	23516		10.1074/jbc.M111.315358	http://dx.doi.org/10.1074/jbc.M111.315358			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22584574	Green Published, hybrid			2022-12-28	WOS:000306511300022
J	Xie, LTX; Ozeir, M; Tang, JY; Chen, JY; Jaquinod, SK; Fontecave, M; Clarke, CF; Pierrel, F				Xie, Letian X.; Ozeir, Mohammad; Tang, Jeniffer Y.; Chen, Jia Y.; Jaquinod, Sylvie-Kieffer; Fontecave, Marc; Clarke, Catherine F.; Pierrel, Fabien			Overexpression of the Coq8 Kinase in Saccharomyces cerevisiae coq Null Mutants Allows for Accumulation of Diagnostic Intermediates of the Coenzyme Q(6) Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-AMINOBENZOIC ACID; UBIQUINONE BIOSYNTHESIS; MULTISUBUNIT COMPLEX; Q(10) DEFICIENCY; GENETIC-EVIDENCE; SHUTTLE VECTORS; YEAST; POLYPEPTIDE; ENCODES; PROTEIN	Most of the Coq proteins involved in coenzyme Q (ubiquinone or Q) biosynthesis are interdependent within a multiprotein complex in the yeast Saccharomyces cerevisiae. Lack of only one Coq polypeptide, as in Delta coq strains, results in the degradation of several Coq proteins. Consequently, Delta coq strains accumulate the same early intermediate of the Q(6) biosynthetic pathway; this intermediate is therefore not informative about the deficient biosynthetic step in a particular Delta coq strain. In this work, we report that the overexpression of the protein Coq8 in Delta coq strains restores steady state levels of the unstable Coq proteins. Coq8 has been proposed to be a kinase, and we provide evidence that the kinase activity is essential for the stabilizing effect of Coq8 in the Delta coq strains. This stabilization results in the accumulation of several novel Q(6) biosynthetic intermediates. These Q intermediates identify chemical steps impaired in cells lacking Coq4 and Coq9 polypeptides, for which no function has been established to date. Several of the new intermediates contain a C4-amine and provide information on the deamination reaction that takes place when para-aminobenzoic acid is used as a ring precursor of Q(6). Finally, we used synthetic analogues of 4-hydroxybenzoic acid to bypass deficient biosynthetic steps, and we show here that 2,4-dihydroxybenzoic acid is able to restore Q(6) biosynthesis and respiratory growth in a Delta coq7 strain overexpressing Coq8. The overexpression of Coq8 and the use of 4-hydroxybenzoic acid analogues represent innovative tools to elucidate the Q biosynthetic pathway.	[Xie, Letian X.; Tang, Jeniffer Y.; Chen, Jia Y.; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Xie, Letian X.; Tang, Jeniffer Y.; Chen, Jia Y.; Clarke, Catherine F.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Ozeir, Mohammad; Fontecave, Marc; Pierrel, Fabien] CEA, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, F-38054 Grenoble, France; [Ozeir, Mohammad; Fontecave, Marc; Pierrel, Fabien] CNRS, UMR5249, F-38054 Grenoble, France; [Ozeir, Mohammad; Fontecave, Marc; Pierrel, Fabien] Univ Grenoble 1, UMR5249, F-38041 Grenoble, France; [Jaquinod, Sylvie-Kieffer] U1038 INSERM CEA UJF, Etude Dynam Proteomes, Lab Biol Grande Echelle, F-38054 Grenoble 9, France; [Fontecave, Marc] Coll France, F-75005 Paris, France	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu; fabien.pierrel@cea.fr	PIERREL, Fabien/M-6016-2014	PIERREL, Fabien/0000-0003-2083-3002	National Institutes of Health [GM45952]; Region Rhone-Alpes Program CIBLE; National Science Foundation [0919609]; Ruth L. Kirschstein National Institutes of Health Service Award [GM007185]; National Institutes of Health Grant from NCRR [S10RR024605]; Div Of Molecular and Cellular Bioscience [0919609] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region Rhone-Alpes Program CIBLE(Region Auvergne-Rhone-Alpes); National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein National Institutes of Health Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant from NCRR; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45952 (to C. F. C.). This work was also supported by Region Rhone-Alpes Program CIBLE 2009 (to F. P.) and National Science Foundation Grant 0919609 (to C. F. C.).; Supported by Ruth L. Kirschstein National Institutes of Health Service Award GM007185.; We thank Dr. Genevieve Dujardin for the gift of the pFL44 COQ8 plasmid and Dr. Agnes Rotig for the gift of the pFL44 Coq8 G130D plasmid. Antibodies to yeast Pda1 were kindly supplied by Dr. J. Gordon Lindsay. We thank Dr. Beth Marbois for advice and expertise in detection and identification of Q intermediates. The LC-MS/MS determination of quinones was supported in part by National Institutes of Health Grant S10RR024605 from the NCRR.	ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Belogrudov GI, 2001, ARCH BIOCHEM BIOPHYS, V392, P48, DOI 10.1006/abbi.2001.2448; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; Brachmann CB, 1998, YEAST, V14, P115; Brasseur G, 1997, EUR J BIOCHEM, V246, P103, DOI 10.1111/j.1432-1033.1997.t01-1-00103.x; Burke D., 2000, METHODS YEAST GENETI; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Do TQ, 1996, P NATL ACAD SCI USA, V93, P7534, DOI 10.1073/pnas.93.15.7534; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Gin P, 2005, J BIOL CHEM, V280, P2676, DOI 10.1074/jbc.M411527200; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Hsieh EJ, 2004, BIOCHEM BIOPH RES CO, V317, P648, DOI 10.1016/j.bbrc.2004.03.096; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Rea SL, 2010, DEV DISABIL RES REV, V16, P200, DOI 10.1002/ddrr.114; Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Zampol MA, 2010, BIOCHEM BIOPH RES CO, V402, P82, DOI 10.1016/j.bbrc.2010.09.118	42	70	70	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23571	23581		10.1074/jbc.M112.360354	http://dx.doi.org/10.1074/jbc.M112.360354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593570	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000306511300028
J	Agarwal, P; Zwolanek, D; Keene, DR; Schulz, JN; Blumbach, K; Heinegard, D; Zaucke, F; Paulsson, M; Krieg, T; Koch, M; Eckes, B				Agarwal, Pallavi; Zwolanek, Daniela; Keene, Douglas R.; Schulz, Jan-Niklas; Blumbach, Katrin; Heinegard, Dick; Zaucke, Frank; Paulsson, Mats; Krieg, Thomas; Koch, Manuel; Eckes, Beate			Collagen XII and XIV, New Partners of Cartilage Oligomeric Matrix Protein in the Skin Extracellular Matrix Suprastructure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; SYSTEMIC-SCLEROSIS; CAUSE PSEUDOACHONDROPLASIA; DIFFERENTIAL EXPRESSION; ENDOPLASMIC-RETICULUM; ANCHORING FIBRILS; VII COLLAGEN; IX COLLAGEN; TENASCIN-X; COMP	The tensile and scaffolding properties of skin rely on the complex extracellular matrix (ECM) that surrounds cells, vasculature, nerves, and adnexus structures and supports the epidermis. In the skin, collagen I fibrils are the major structural component of the dermal ECM, decorated by proteoglycans and by fibril-associated collagens with interrupted triple helices such as collagens XII and XIV. Here we show that the cartilage oligomeric matrix protein (COMP), an abundant component of cartilage ECM, is expressed in healthy human skin. COMP expression is detected in the dermal compartment of skin and in cultured fibroblasts, whereas epidermis and HaCaT cells are negative. In addition to binding collagen I, COMP binds to collagens XII and XIV via their C-terminal collagenous domains. All three proteins codistribute in a characteristic narrow zone in the superficial papillary dermis of healthy human skin. Ultrastructural analysis by immunogold labeling confirmed colocalization and further revealed the presence of COMP along with collagens XII and XIV in anchoring plaques. On the basis of these observations, we postulate that COMP functions as an adapter protein in human skin, similar to its function in cartilage ECM, by organizing collagen I fibrils into a suprastructure, mainly in the vicinity of anchoring plaques that stabilize the cohesion between the upper dermis and the basement membrane zone.	[Agarwal, Pallavi; Schulz, Jan-Niklas; Blumbach, Katrin; Krieg, Thomas; Eckes, Beate] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Zwolanek, Daniela; Zaucke, Frank; Paulsson, Mats] Univ Cologne, Ctr Biochem, D-50937 Cologne, Germany; [Paulsson, Mats; Krieg, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Paulsson, Mats; Krieg, Thomas; Koch, Manuel] Univ Cologne, Ctr Mol Med CMMC, D-50937 Cologne, Germany; [Koch, Manuel] Univ Cologne, Inst Dent Res & Musculoskeletal Biol, D-50937 Cologne, Germany; [Keene, Douglas R.] Shriners Hosp Children Res Unit, Microimaging Ctr, Portland, OR 97239 USA; [Heinegard, Dick] Lund Univ, S-22184 Lund, Sweden	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Lund University	Eckes, B (corresponding author), Univ Cologne, Dept Dermatol, Kerpener Str 62, D-50937 Cologne, Germany.	beate.eckes@uni-koeln.de	Zaucke, Frank/AAT-2688-2021; Zaucke, Frank/E-2077-2012; Zwolanek, Daniela/AAN-8767-2020; Agarwal, Pallavi/AAR-6007-2020; Koch, Manuel/AAG-9914-2021	Agarwal, Pallavi/0000-0003-3139-5589; Koch, Manuel/0000-0002-2962-7814; Schulz, Jan-Niklas/0000-0001-9286-206X	Deutsche Forschungsgemeinschaft [KR558/14-1, ZA561/2-1, SFB 829]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft through Grants KR558/14-1 (to T. K. and B. E.), ZA561/2-1 (to F. Z.), and SFB 829 (to M. P. and M. K.).	Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Birk DE, 1997, EUR J CELL BIOL, V72, P352; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; Dinser R, 2002, J CLIN INVEST, V110, P505, DOI 10.1172/JCI200214386; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Farina G, 2009, ANN RHEUM DIS, V68, P435, DOI 10.1136/ard.2007.086850; Farina G, 2006, MATRIX BIOL, V25, P213, DOI 10.1016/j.matbio.2006.01.007; FONT B, 1993, J BIOL CHEM, V268, P25015; Font B, 1996, MATRIX BIOL, V15, P341, DOI 10.1016/S0945-053X(96)90137-7; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Giry-Lozinguez C, 1998, MATRIX BIOL, V17, P145, DOI 10.1016/S0945-053X(98)90027-0; Gordon MK, 1990, CURR OPIN CELL BIOL, V2, P833, DOI 10.1016/0955-0674(90)90080-X; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hansen U, 2011, ARTHRITIS RHEUM-US, V63, P159, DOI 10.1002/art.30073; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Haudenschild DR, 2011, J BIOL CHEM, V286, P43250, DOI 10.1074/jbc.M111.234716; Hecht JT, 2005, MATRIX BIOL, V23, P525, DOI 10.1016/j.matbio.2004.09.006; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Hesselstrand R, 2008, ANN RHEUM DIS, V67, P1242, DOI 10.1136/ard.2007.082099; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Koch M, 2004, J BIOL CHEM, V279, P22514, DOI 10.1074/jbc.M400536200; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; KRIEG T, 1985, ANN NY ACAD SCI, V460, P375, DOI 10.1111/j.1749-6632.1985.tb51184.x; Lethias C, 2006, FEBS LETT, V580, P6281, DOI 10.1016/j.febslet.2006.10.037; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; PERLISH JS, 1988, J INVEST DERMATOL, V90, P48, DOI 10.1111/1523-1747.ep12462561; Pirog KA, 2010, HUM MOL GENET, V19, P52, DOI 10.1093/hmg/ddp466; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Saalbach A, 1997, CELL TISSUE RES, V290, P593, DOI 10.1007/s004410050964; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Schmitz M, 2006, J BIOL CHEM, V281, P32587, DOI 10.1074/jbc.M601976200; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Sodersten F, 2005, MATRIX BIOL, V24, P376, DOI 10.1016/j.matbio.2005.06.003; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Spitznagel L, 2004, BIOCHEM J, V377, P479, DOI 10.1042/BJ20031179; Suleman F, 2012, HUM MUTAT, V33, P218, DOI 10.1002/humu.21631; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; Veit G, 2006, J BIOL CHEM, V281, P27461, DOI 10.1074/jbc.M603147200; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; WALCHLI C, 1994, J CELL SCI, V107, P669; WALZER C, 1989, J INVEST DERMATOL, V92, P78, DOI 10.1111/1523-1747.ep13071253; WOTTON SF, 1988, FEBS LETT, V234, P79, DOI 10.1016/0014-5793(88)81307-3; Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5	68	92	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22549	22559		10.1074/jbc.M111.335935	http://dx.doi.org/10.1074/jbc.M111.335935			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573329	Green Published, hybrid			2022-12-28	WOS:000306495000012
J	Pitts, A; Dailey, K; Newington, JT; Chien, A; Arseneault, R; Cann, T; Thompson, LM; Cumming, RC				Pitts, Andrea; Dailey, Kyle; Newington, Jordan T.; Chien, Andrew; Arseneault, Robert; Cann, Tyler; Thompson, Leslie M.; Cumming, Robert C.			Dithiol-based Compounds Maintain Expression of Antioxidant Protein Peroxiredoxin 1 That Counteracts Toxicity of Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CELL-DEATH; DISEASE; INDUCTION; CYSTEINE; HYPEROXIDATION; INACTIVATION; SULFIREDOXIN; PATHOGENESIS; REDUCTION	Mitochondrial dysfunction and elevated reactive oxygen species are strongly implicated in both aging and various neurodegenerative disorders, including Huntington disease (HD). Because reactive oxygen species can promote the selective oxidation of protein cysteine sulfhydryl groups to disulfide bonds we examined the spectrum of disulfide-bonded proteins that were specifically altered in a HD context. Protein extracts from PC12 cells overexpressing the amino-terminal fragment of the Huntingtin (Htt) protein with either a nonpathogenic or pathogenic polyglutamine repeat (Htt-103Q) were resolved by redox two-dimensional PAGE followed by mass spectrometry analysis. Several antioxidant proteins were identified that exhibited changes in disulfide bonding unique to Htt-103Q expressing cells. In particular, the antioxidant protein peroxiredoxin 1 (Prx1) exhibited both decreased expression and hyperoxidation in response to mutant Htt expressed in either PC12 cells or immortalized striatal cells exposed to 3-nitropropionic acid. Ectopic expression of Prx1 in PC12 cells attenuated mutant Htt-induced toxicity. In contrast, short hairpin RNA-mediated knockdown of Prx1 potentiated mHtt toxicity. Furthermore, treatment with the dithiol-based compounds dimercaptopropanol and dimercaptosuccinic acid suppressed toxicity in both HD cell models, whereas monothiol compounds were relatively ineffective. Dimercaptopropanol treatment also prevented mutant Htt-induced loss of Prx1 expression in both cell models. Our studies reveal for the first time that pathogenic Htt can affect the expression and redox state of antioxidant proteins; an event countered by specific dithiol-based compounds. These findings should provide a catalyst to explore the use of dithiol-based drugs for the treatment of neurodegenerative diseases.	[Pitts, Andrea; Dailey, Kyle; Newington, Jordan T.; Chien, Andrew; Arseneault, Robert; Cann, Tyler; Cumming, Robert C.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Thompson, Leslie M.] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	Western University (University of Western Ontario); University of California System; University of California Irvine	Cumming, RC (corresponding author), 1151 Richmond St N, London, ON N6A 5B7, Canada.	rcummin5@uwo.ca	Cumming, Robert/G-2185-2010		Natural Sciences and Engineering Research Council (NSERC) of Canada [355806-2008]; Canada Foundation of Innovation Leaders Opportunity Fund (CFI-LOF)	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation of Innovation Leaders Opportunity Fund (CFI-LOF)(Canada Foundation for Innovation)	This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Grant 355806-2008 and the Canada Foundation of Innovation Leaders Opportunity Fund (CFI-LOF).	AASETH J, 1995, ANALYST, V120, P853, DOI 10.1039/an9952000853; Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Bae SH, 2009, ANTIOXID REDOX SIGN, V11, P937, DOI [10.1089/ars.2008.2325, 10.1089/ARS.2008.2325]; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; CORYSLECHTA DA, 1988, J PHARMACOL EXP THER, V246, P84; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; Cumming Robert C., 2008, V476, P165, DOI 10.1007/978-1-59745-129-1_12; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Firdaus WJJ, 2006, FEBS J, V273, P3076, DOI 10.1111/j.1742-4658.2006.05318.x; HASLAM MT, 1967, J NEUROL NEUROSUR PS, V30, P185, DOI 10.1136/jnnp.30.2.185; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Kieburtz K, 2001, NEUROLOGY, V57, P397; Kim BJ, 2006, PROTEOMICS, V6, P1250, DOI 10.1002/pmic.200500447; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; NIELSEN J M, 1955, Bull Los Angel Neuro Soc, V20, P38; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Russell RL, 1999, ARCH BIOCHEM BIOPHYS, V370, P236, DOI 10.1006/abbi.1999.1404; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Sitia Roberto, 2004, Sci STKE, V2004, ppe27, DOI 10.1126/stke.2392004pe27; Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Verbessem P, 2003, NEUROLOGY, V61, P925, DOI 10.1212/01.WNL.0000090629.40891.4B; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	47	27	28	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22717	22729		10.1074/jbc.M111.334565	http://dx.doi.org/10.1074/jbc.M111.334565			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577145	Green Published, hybrid			2022-12-28	WOS:000306495000029
J	Sekiya, M; Nakamoto, RK; Nakanishi-Matsui, M; Futai, M				Sekiya, Mizuki; Nakamoto, Robert K.; Nakanishi-Matsui, Mayumi; Futai, Masamitsu			Binding of Phytopolyphenol Piceatannol Disrupts beta/gamma Subunit Interactions and Rate-limiting Step of Steady-state Rotational Catalysis in Escherichia coli F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE F-1 SECTOR; ATP SYNTHASE; GAMMA-SUBUNIT; ROTARY MOTOR; MECHANISM; INHIBITION; REVEALS; ENERGY; RESOLUTION; MUTATIONS	In observations of single molecule behavior under V-max conditions with minimal load, the F-1 sector of the ATP synthase (F-ATPase) rotates through continuous cycles of catalytic dwells (similar to 0.2 ms) and 120 degrees rotation steps (similar to 0.6 ms). We previously established that the rate-limiting transition step occurs during the catalytic dwell at the initiation of the 120 degrees rotation. Here, we use the phytopolyphenol, piceatannol, which binds to a pocket formed by contributions from alpha and beta stator subunits and the carboxyl-terminal region of the rotor gamma subunit. Piceatannol did not interfere with the movement through the 120 degrees rotation step, but caused increased duration of the catalytic dwell. The duration time of the intrinsic inhibited state of F-1 also became significantly longer with piceatannol. All of the beads rotated at a lower rate in the presence of saturating piceatannol, indicating that the inhibitor stays bound throughout the rotational catalytic cycle. The Arrhenius plot of the temperature dependence of the reciprocal of the duration of the catalytic dwell (catalytic rate) indicated significantly increased activation energy of the rate-limiting step to trigger the 120 degrees rotation. The activation energy was further increased by combination of piceatannol and substitution of gamma subunit Met(23) with Lys, indicating that the inhibitor and the beta/gamma interface mutation affect the same transition step, even though they perturb physically separated rotor-stator interactions.	[Sekiya, Mizuki; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Yahaba, Iwate 0283694, Japan; [Sekiya, Mizuki; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Futai Special Lab, Yahaba, Iwate 0283694, Japan; [Nakamoto, Robert K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Iwate Medical University; Iwate Medical University; University of Virginia	Futai, M (corresponding author), Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Yahaba, Iwate 0283694, Japan.	futaim@iwate-med.ac.jp			Japan Science and Technology Agency, Research Seeds Quest Program	Japan Science and Technology Agency, Research Seeds Quest Program	This work was supported by a grant from Japan Science and Technology Agency, Research Seeds Quest Program.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Dadi PK, 2009, INT J BIOL MACROMOL, V45, P72, DOI 10.1016/j.ijbiomac.2009.04.004; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Futai M., 2004, HDB ATPASES BIOCH CE, P237; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; IWAMOTO A, 1990, J BIOL CHEM, V265, P5043; JEANTEURDEBEUKELAER C, 1995, J BIOL CHEM, V270, P22850; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; NAKAMOTO RK, 1993, J BIOL CHEM, V268, P867; NAKAMOTO RK, 1995, J BIOL CHEM, V270, P14042, DOI 10.1074/jbc.270.23.14042; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Sekiya M, 2009, J BIOL CHEM, V284, P22401, DOI 10.1074/jbc.M109.009019; SHIN K, 1992, J BIOL CHEM, V267, P20835; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	33	18	18	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22771	22780		10.1074/jbc.M112.374868	http://dx.doi.org/10.1074/jbc.M112.374868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582396	Green Published, hybrid			2022-12-28	WOS:000306495000034
J	Li, XF; Zhang, R; Draheim, KM; Liu, WZ; Calderwood, DA; Boggon, TJ				Li, Xiaofeng; Zhang, Rong; Draheim, Kyle M.; Liu, Weizhi; Calderwood, David A.; Boggon, Titus J.			Structural Basis for Small G Protein Effector Interaction of Ras-related Protein 1 (Rap1) and Adaptor Protein Krev Interaction Trapped 1 (KRIT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATION; DOMAIN-ASSOCIATED PROTEIN-1; CELL-CELL JUNCTIONS; FERM DOMAIN; MOLECULAR-GRAPHICS; CCM PATHOGENESIS; 2-HIT MECHANISM; ERM PROTEINS; TALIN HEAD; COMPLEX	Cerebral cavernous malformations (CCMs) affect 0.1-0.5% of the population resulting in leaky vasculature and severe neurological defects. KRIT1 (Krev interaction trapped-1) mutations associate with similar to 40% of familial CCMs. KRIT1 is an effector of Ras-related protein 1 (Rap1) GTPase. Rap1 relocalizes KRIT1 from microtubules to cell membranes to impact integrin activation, potentially important for CCM pathology. We report the 1.95 angstrom co-crystal structure of KRIT1 FERM domain in complex with Rap1. Rap1-KRIT1 interaction encompasses an extended surface, including Rap1 Switch I and II and KRIT1FERMF1 and F2 lobes. Rap1 binds KRIT1-F1 lobe using a GTPase-ubiquitin-like fold interaction but binds KRIT1-F2 lobe by a novel interaction. Point mutagenesis confirms the interaction. High similarity between KRIT1-F2/F3 and talin is revealed. Additionally, the mechanism for FERM domains acting as GTPase effectors is suggested. Finally, structure-based alignment of each lobe suggests classification of FERM domains as ERM-like and TMFK-like (talin-myosin-FAK-KRIT-like) and that FERM lobes resemble domain "modules."	[Li, Xiaofeng; Zhang, Rong; Draheim, Kyle M.; Liu, Weizhi; Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu	Calderwood, David A/AAC-6954-2019; Li, Xiaofeng/F-3735-2011	Calderwood, David A/0000-0002-0791-4142; 	American Heart Association; American Cancer Society; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Recipient of an American Heart Association Founders Affiliate Spring 2011 postdoctoral fellowship.r Recipient of an American Cancer Society postdoctoral fellowship.r Supported by the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Retief J D, 2000, Methods Mol Biol, V132, P243; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Victor M., 2001, ADAMS VICTOR PRINCIP; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2008, NEUROSURGERY, V63, P571, DOI 10.1227/01.NEU.0000325255.30268.B0	64	42	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22317	22327		10.1074/jbc.M112.361295	http://dx.doi.org/10.1074/jbc.M112.361295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577140	hybrid, Green Published			2022-12-28	WOS:000306418600069
J	Mohanty, AR; Kan, QM; Srivastava, S; Uranbileg, B; Arakawa-Takeuchi, S; Fujita, N; Okayama, H				Mohanty, Atish R.; Kan, Qiuming; Srivastava, Saumya; Uranbileg, Baasanjav; Arakawa-Takeuchi, Shiho; Fujita, Naoya; Okayama, Hiroto			Successive Phosphorylation of p27(KIP1) Protein at Serine-10 and C Terminus Crucially Controls Its Potency to Inactivate Cdk2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT-KINASE; CELL-CYCLE; MAMMALIAN TARGET; CDC6; P27; ACTIVATION; ANCHORAGE; PATHWAY; COMPLEX; STABILIZATION	During the G(1)-S transition, the activity of Cdk2 is regulated by its association with p27(KIP1), which in rodent fibroblasts undergoes phosphorylation mainly at serine 10, threonine 187, and C-terminal threonine 197 by KIS, Cdk2, and Pim or ROCK, respectively. Recently Cdc6 the AAA+ ATPase, identified initially to assemble pre-replicative complexes on origins of replication and later to activate p21(CIP1)-inactivated Cdk2, was found also to activate p27-bound Cdk2 but only after the bound p27 is C-terminally phosphorylated. On the other hand, the biological significance of the serine 10 phosphorylation remains elusive aside from its involvement in the stability of p27 itself. We report here that serine 10 phosphorylation is required for efficient C-terminal phosphorylation of its own by PIM and ROCK kinases and critically controls the potency of p27 as a Cdk2 inhibitor. In vitro, PIM1 and active ROCK1 efficiently phosphorylated free as well as Cdk2-bound p27 but only when the p27 was phosphorylated at Ser-10 in advance. Consistently, a Ser-10 nonphosphorylatable mutant p27 protein was not phosphorylated at the C terminus in vivo. Furthermore, when double-phosphorylated, free p27 was no longer a potent inhibitor of Cdk2, and Cdk2-bound p27 could be removed by Cdc6 to reactivate the Cdk2. Thus, phosphorylation at these two sites crucially controls the potency of this CDK inhibitor in two distinct modes.	[Mohanty, Atish R.; Kan, Qiuming; Srivastava, Saumya; Uranbileg, Baasanjav; Arakawa-Takeuchi, Shiho; Okayama, Hiroto] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo 1130033, Japan; [Mohanty, Atish R.; Kan, Qiuming; Srivastava, Saumya; Uranbileg, Baasanjav; Arakawa-Takeuchi, Shiho; Okayama, Hiroto] Univ Tokyo, Fac Med, Grad Sch, Tokyo 1130033, Japan; [Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan	University of Tokyo; University of Tokyo; Japanese Foundation for Cancer Research	Okayama, H (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo 1130033, Japan.	okayama@m.u-tokyo.ac.jp	Fujita, Naoya/A-7349-2010	Fujita, Naoya/0000-0002-9631-9264	Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research (S) and Global Center of Excellence from the Ministry of Education, Science, and Culture of Japan.	Abbas T, 2007, CELL CYCLE, V6, P843, DOI 10.4161/cc.6.7.4000; Arakawa-Takeuchi S, 2010, FEBS LETT, V584, P2779, DOI 10.1016/j.febslet.2010.05.005; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Jinno S, 2002, ONCOGENE, V21, P1777, DOI 10.1038/sj.onc.1205249; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Lunn CL, 2010, CELL CYCLE, V9, P4533, DOI 10.4161/cc.9.22.13789; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Nevis KR, 2009, CELL CYCLE, V8, P1952, DOI 10.4161/cc.8.12.8811; Park J, 2011, J BIOL CHEM, V286, P23132, DOI 10.1074/jbc.M110.209114; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sotillo E, 2009, J BIOL CHEM, V284, P14126, DOI 10.1074/jbc.M900687200; Uranbileg B, 2012, J BIOL CHEM, V287, P6275, DOI 10.1074/jbc.M111.318295; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	27	7	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21757	21764		10.1074/jbc.M112.346254	http://dx.doi.org/10.1074/jbc.M112.346254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22584582	hybrid, Green Published			2022-12-28	WOS:000306418600017
J	Punthambaker, S; Blum, JA; Hume, RI				Punthambaker, Sukanya; Blum, Jacob A.; Hume, Richard I.			High Potency Zinc Modulation of Human P2X2 Receptors and Low Potency Zinc Modulation of Rat P2X2 Receptors Share a Common Molecular Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SWISS-MODEL WORKSPACE; P2X(2) RECEPTORS; ATP; CHANNELS; PHYSIOLOGY; PORE; PH	Human P2X2 receptors (hP2X2) are strongly inhibited by zinc over the range of 2-100 mu M, whereas rat P2X2 receptors (rP2X2) are strongly potentiated over the same range, and then inhibited by zinc over 100 mu M. However, the biological role of zinc modulation is unknown in either species. To identify candidate regions controlling zinc inhibition in hP2X2 a homology model based on the crystal structure of zebrafish P2X4.1 was made. In this model, His-204 and His-209 of one subunit were near His-330 of the adjacent subunit. Cross-linking studies confirmed that these residues are within 8 angstrom of each other. Simultaneous mutation of these three histidines to alanines decreased the zinc potency of hP2X2 nearly 100-fold. In rP2X2, one of these histidines is replaced by a lysine, and in a background in which zinc potentiation was eliminated, mutation of Lys-197 to histidine converted rP2X2 from low potency to high potency inhibition. We explored whether the zinc-binding site lies within the vestibules running down the central axis of the receptor. Elimination of all negatively charged residues from the upper vestibule had no effect on zinc inhibition. In contrast, mutation of several residues in the hP2X2 middle vestibule resulted in dramatic changes in the potency of zinc inhibition. In particular, the zinc potency of P206C could be reversibly shifted from extremely high (similar to 10 nM) to very low (>100 mu M) by binding and unbinding MTSET. These results suggest that the cluster of histidines at the subunit interface controls access of zinc to its binding site.	[Punthambaker, Sukanya; Blum, Jacob A.; Hume, Richard I.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hume, RI (corresponding author), 830 N Univ Ave, Ann Arbor, MI USA.	rhume@umich.edu	, Richard/AAI-5000-2020; Punthambaker, Sukanya/AAR-9166-2020	Hume, Richard/0000-0001-9807-112X	National Institutes of Health Grant [NS039196]; Okkelberg Fellowship from the University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039196] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Okkelberg Fellowship from the University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS039196 (to R. I. H.) and an Okkelberg Fellowship from the University of Michigan (to S. P.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Clyne JD, 2003, NEUROPHARMACOLOGY, V44, P403, DOI 10.1016/S0028-3908(02)00406-9; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Coddou C, 2011, REV NEUROSCIENCE, V22, P335, DOI 10.1515/RNS.2011.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Koles L, 2011, ADV PHARMACOL, V61, P441, DOI 10.1016/B978-0-12-385526-8.00014-X; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nakazawa K, 1996, EUR J PHARMACOL, V296, P119, DOI 10.1016/0014-2999(95)00774-1; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Sindreu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00068; Tittle RK, 2008, J NEUROSCI, V28, P11131, DOI 10.1523/JNEUROSCI.2763-08.2008; Wildman SS, 1998, BRIT J PHARMACOL, V123, P1214, DOI 10.1038/sj.bjp.0701717	26	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22099	22111		10.1074/jbc.M112.369157	http://dx.doi.org/10.1074/jbc.M112.369157			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556417	hybrid, Green Published			2022-12-28	WOS:000306418600047
J	Rana, MK; Worthylake, RA				Rana, Manish K.; Worthylake, Rebecca A.			Novel Mechanism for Negatively Regulating Rho-Kinase (ROCK) Signaling through Coronin1B Protein in Neuregulin 1 (NRG-1)-induced Tumor Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATASE TARGET SUBUNIT; MYOSIN PHOSPHATASE; LIM-KINASE; ACTIN REORGANIZATION; CRUCIAL ROLE; PHOSPHORYLATION; BINDING; DYNAMICS; COFILIN; SLINGSHOT	Although many mechanisms that activate ROCK are known, corresponding negative regulatory mechanisms required for cytoskeletal plasticity are poorly understood. We have discovered that Coronin1B is a novel attenuator of ROCK signaling. We initially identified Coronin1A in a proteomics screen for ROCK2-binding proteins, and here we demonstrate that Coronin1A/B bind directly to ROCK2 through its PH (Pleckstrin Homology) domain. The consequence of the ROCK2-Coronin1B interaction was tested and revealed that increased expression of Coronin1B inhibited, whereas knockdown of Coronin1B stimulated, phosphorylation of the ROCK substrate myosin light chain phosphatase and subsequently, myosin light chain. Thus, Coronin1B is a previously unrecognized inhibitor of ROCK signaling to myosin. Furthermore, we found that the phosphatase Slingshot IL (SSH1L) was required for Coronin1B to inhibit ROCK signaling. To test the significance of this novel mechanism in tumor cell motility, we investigated its role in neuregulin 1 (NRG-1)-induced cell scattering. Importantly, we found that attenuation of the ROCK signaling by Coronin1B was required for NRG-1 stimulated scattering. Our data support a model in which Coronin1B fine-tunes ROCK signaling to modulate myosin activity, which is important for tumor cell motility.	[Rana, Manish K.; Worthylake, Rebecca A.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70119 USA; [Worthylake, Rebecca A.] Louisiana State Univ, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Worthylake, RA (corresponding author), 1100 Florida Ave, New Orleans, LA 70119 USA.	bworth@lsuhsc.edu			National Institutes of Health from NIDCR [R03DE19166]; National Center for Research Resources [P20RR020160]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019166] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R03DE19166 from the NIDCR. This work was also supported by National Center for Research Resources Grant P20RR020160.	Amano M, 2000, METHOD ENZYMOL, V325, P149; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Fukata Y, 1999, BIOPHYS CHEM, V82, P139, DOI 10.1016/S0301-4622(99)00113-1; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Gray SG, 2003, HORM METAB RES, V35, P857; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; Izawa T, 2000, BIOCHEM BIOPH RES CO, V278, P72, DOI 10.1006/bbrc.2000.3772; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita Michiru, 2006, Tanpakushitsu Kakusan Koso, V51, P516; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; Shum WWC, 2003, BRIT J PHARMACOL, V139, P1449, DOI 10.1038/sj.bjp.0705393; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Tumusiime S, 2009, BIOCHEM BIOPH RES CO, V381, P393, DOI 10.1016/j.bbrc.2009.02.056; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; WANG DS, 1995, BIOCHEM BIOPH RES CO, V209, P622, DOI 10.1006/bbrc.1995.1545; Wang DS, 1995, BIOCHEM BIOPH RES CO, V217, P608, DOI 10.1006/bbrc.1995.2818; Wen WY, 2008, J BIOL CHEM, V283, P26263, DOI 10.1074/jbc.M803417200; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043	58	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21836	21845		10.1074/jbc.M112.346114	http://dx.doi.org/10.1074/jbc.M112.346114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22563075	Green Published, hybrid			2022-12-28	WOS:000306418600025
J	Veldhuis, NA; Lew, MJ; Abogadie, FC; Poole, DP; Jennings, EA; Ivanusic, JJ; Eilers, H; Bunnett, NW; McIntyre, P				Veldhuis, Nicholas A.; Lew, Michael J.; Abogadie, Fe C.; Poole, Daniel P.; Jennings, Ernest A.; Ivanusic, Jason J.; Eilers, Helge; Bunnett, Nigel W.; McIntyre, Peter			N-Glycosylation Determines Ionic Permeability and Desensitization of the TRPV1 Capsaicin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; VANILLOID RECEPTOR-1; RAT TRPV1; PROTEIN-KINASE; PORE DILATION; CELL-LINE; CHANNEL; CALCIUM; PHOSPHORYLATION; SELECTIVITY	The balance of glycosylation and deglycosylation of ion channels can markedly influence their function and regulation. However, the functional importance of glycosylation of the TRPV1 receptor, a key sensor of pain-sensing nerves, is not well understood, and whether TRPV1 is glycosylated in neurons is unclear. We report that TRPV1 is N-glycosylated and that N-glycosylation is a major determinant of capsaicin-evoked desensitization and ionic permeability. Both N-glycosylated and unglycosylated TRPV1 was detected in extracts of peripheral sensory nerves by Western blotting. TRPV1 expressed in HEK-293 cells exhibited various degrees of glycosylation. A mutant of asparagine 604 (N604T) was not glycosylated but did not alter plasma membrane expression of TRPV1. Capsaicin-evoked increases in intracellular calcium ([ Ca2+](i)) were sustained in wild-type TRPV1 HEK-293 cells but were rapidly desensitized in N604T TRPV1 cells. There was marked cell-to-cell variability in capsaicin responses and desensitization between individual cells expressing wild-type TRPV1 but highly uniform responses in cells expressing N604T TRPV1, consistent with variable levels of glycosylation of the wild-type channel. These differences were also apparent when wild-type or N604T TRPV1-GFP fusion proteins were expressed in neurons from trpv1(-/-) mice. Capsaicin evoked a marked, concentration-dependent increase in uptake of the large cationic dye YO-PRO-1 in cells expressing wild-type TRPV1, indicative of loss of ion selectivity, that was completely absent in cells expressing N604T TRPV1. Thus, TRPV1 is variably N-glycosylated and glycosylation is a key determinant of capsaicin regulation of TRPV1 desensitization and permeability. Our findings suggest that physiological or pathological alterations in TRPV1 glycosylation would affect TRPV1 function and pain transmission.	[McIntyre, Peter] Univ Melbourne, Dept Pharmacol, Fac Med Dent & Hlth Sci, Parkville, Vic 3010, Australia; [Lew, Michael J.; Poole, Daniel P.; Ivanusic, Jason J.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Jennings, Ernest A.] James Cook Univ, Sch Med & Dent, Cairns, Qld 4870, Australia; [Eilers, Helge] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; James Cook University; University of California System; University of California San Francisco	McIntyre, P (corresponding author), Univ Melbourne, Dept Pharmacol, Fac Med Dent & Hlth Sci, Grattan St, Parkville, Vic 3010, Australia.	pmci@unimelb.edu.au	Mcintyre, Peter/N-4109-2013; Jennings, Ernest A/A-5439-2008; Poole, Daniel/AET-6645-2022; Ivanusic, Jason John/AAN-9056-2021	Poole, Daniel/0000-0002-6168-8422; Ivanusic, Jason John/0000-0002-7413-5704; Bunnett, Nigel W./0000-0003-3367-0644; Veldhuis, Nicholas/0000-0002-8902-9365; Lew, Michael/0000-0002-2523-7990; McIntyre, Peter/0000-0001-9506-5998; Jennings, Ernest/0000-0002-8912-6894	NHMRC [566834, 633033]; National Institutes of Health [DK57840, DK43207, DK39957]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039957, R01DK043207, R01DK057840, R37DK039957, R56DK043207] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole or in part, by NHMRC Grant 566834 (to P. M. and N. W. B.), 633033 (to N. W. B.) and National Institutes of Health Grants DK57840, DK43207, DK39957 (to N. W. B.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2009, ANESTHESIOLOGY, V111, P127, DOI 10.1097/ALN.0b013e3181a915e7; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Grant ER, 2002, J PHARMACOL EXP THER, V300, P9, DOI 10.1124/jpet.300.1.9; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; JANCSOGABOR A, 1967, J PHARM PHARMACOL, V19, P486, DOI 10.1111/j.2042-7158.1967.tb08119.x; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Karai LJ, 2004, J BIOL CHEM, V279, P16377, DOI 10.1074/jbc.M310891200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Koplas PA, 1997, J NEUROSCI, V17, P3525; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Lam PMW, 2005, BRIT J ANAESTH, V94, P649, DOI 10.1093/bja/aei098; Lu P, 2008, NEPHROL DIAL TRANSPL, V23, P3397, DOI 10.1093/ndt/gfn291; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; McIntyre P, 2001, BRIT J PHARMACOL, V132, P1084, DOI 10.1038/sj.bjp.0703918; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Sandor Z, 2005, CELL MOL BIOL LETT, V10, P499; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Toth A, 2005, LIFE SCI, V76, P2921, DOI 10.1016/j.lfs.2004.10.056; Tyrrell L, 2001, J NEUROSCI, V21, P9629, DOI 10.1523/JNEUROSCI.21-24-09629.2001; Ursu D, 2010, EUR J PHARMACOL, V641, P114, DOI 10.1016/j.ejphar.2010.05.029; Vyklicky L, 2008, PHYSIOL RES, V57, pS59, DOI 10.33549/physiolres.931478; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005	38	42	45	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21765	21772		10.1074/jbc.M112.342022	http://dx.doi.org/10.1074/jbc.M112.342022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570472	Green Published, hybrid			2022-12-28	WOS:000306418600018
J	Rangaswami, H; Schwappacher, R; Tran, T; Chan, GC; Zhuang, SH; Boss, GR; Pilz, RB				Rangaswami, Hema; Schwappacher, Raphaela; Tran, Trish; Chan, Geraldine C.; Zhuang, Shunhui; Boss, Gerry R.; Pilz, Renate B.			Protein Kinase G and Focal Adhesion Kinase Converge on Src/Akt/beta-Catenin Signaling Module in Osteoblast Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; SHEAR-STRESS; FLUID SHEAR; BETA-CATENIN; DIFFERENTIATED OSTEOBLASTS; ESTROGEN-RECEPTOR; EARLY RESPONSES; CYCLIC-GMP; BONE-CELLS; SRC KINASE	Mechanical loading of bone induces interstitial fluid flow, leading to fluid shear stress (FSS) of osteoblasts. FSS rapidly increases the intracellular calcium concentration ([Ca2+]) and nitric oxide (NO) synthesis in osteoblasts and activates the protein kinase Akt. Activated Akt stimulates osteoblast proliferation and survival, but the mechanism(s) leading to Akt activation is not well defined. Using pharmacological and genetic approaches in primary human and mouse osteoblasts and mouse MC3T3 osteoblast-like cells, we found that Akt activation by FSS occurred through two parallel pathways; one required calcium stimulation of NO synthase and NO/cGMP/protein kinase G II-dependent activation of Src, and the other required calcium activation of FAK and Src, independent of NO. Both pathways cooperated to increase PI3K-dependent Akt phosphorylation and were necessary for FSS to induce nuclear translocation of beta-catenin, c-fos, and cox-2 gene expression and osteoblast proliferation. These data explain how mechanical stimulation of osteoblasts leads to increased signaling through a growth regulatory pathway essential for maintaining skeletal integrity.	[Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Pilz, Renate B.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [R01-AR051300]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR051300 (to R. B. P., H. R., and S. Z.).; Supported by a research fellowship grant from the Deutsche Forschungsgemeinschaft.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bakker AD, 2009, ARTHRITIS RHEUM-US, V60, P3336, DOI 10.1002/art.24920; Bergula AP, 2004, BONE, V34, P562, DOI 10.1016/j.bone.2003.11.025; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Chow JWM, 1998, J BONE MINER RES, V13, P1039, DOI 10.1359/jbmr.1998.13.6.1039; Dillon JP, 2012, METHODS MOL BIOL, V816, P3, DOI 10.1007/978-1-61779-415-5_1; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Fox SW, 1996, AM J PHYSIOL-ENDOC M, V270, pE955, DOI 10.1152/ajpendo.1996.270.6.E955; Galli C, 2010, J DENT RES, V89, P331, DOI 10.1177/0022034510363963; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Hung CT, 1996, J BIOMECH, V29, P1411, DOI 10.1016/0021-9290(96)84536-2; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jamal SA, 2011, JAMA-J AM MED ASSOC, V305, P800, DOI 10.1001/jama.2011.176; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Kamioka H, 2006, J BONE MINER RES, V21, P1012, DOI 10.1359/JBMR.060408; Kanematsu M, 1997, J BONE MINER RES, V12, P1789, DOI 10.1359/jbmr.1997.12.11.1789; Klein-Nulend J, 1998, BIOCHEM BIOPH RES CO, V250, P108, DOI 10.1006/bbrc.1998.9270; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McAllister TN, 1999, J BONE MINER RES, V14, P930, DOI 10.1359/jbmr.1999.14.6.930; MikuniTakagaki Y, 1996, ENDOCRINOLOGY, V137, P2028, DOI 10.1210/en.137.5.2028; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Ponik SM, 2004, J APPL PHYSIOL, V97, P135, DOI 10.1152/japplphysiol.01260.2003; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Rangaswami H, 2009, J BIOL CHEM, V284, P14796, DOI 10.1074/jbc.M806486200; Rawlinson SCF, 1996, BONE, V19, P609, DOI 10.1016/S8756-3282(96)00260-8; Riddle RC, 2009, J ORTHOP RES, V27, P143, DOI 10.1002/jor.20723; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Schwartz MA, 2009, SCIENCE, V323, P588, DOI 10.1126/science.1169414; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Stevens HY, 2003, METH MOLEC MED, V80, P381; Turner CH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pt3; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; Wang B, 2011, BIOCHEM BIOPH RES CO, V410, P671, DOI 10.1016/j.bbrc.2011.06.054; Watanuki M, 2002, J BONE MINER RES, V17, P1015, DOI 10.1359/jbmr.2002.17.6.1015; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wimalawansa SJ, 2007, ANN NY ACAD SCI, V1117, P283, DOI 10.1196/annals.1402.066; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Young SRL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016026; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102; Zhao X, 2005, J BIOL CHEM, V280, P32683, DOI 10.1074/jbc.M505486200	63	37	42	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21509	21519		10.1074/jbc.M112.347245	http://dx.doi.org/10.1074/jbc.M112.347245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22563076	Green Published, hybrid			2022-12-28	WOS:000306416800068
J	Khalimonchuk, O; Kim, H; Watts, T; Perez-Martinez, X; Winge, DR				Khalimonchuk, Oleh; Kim, Hyung; Watts, Talina; Perez-Martinez, Xochitl; Winge, Dennis R.			Oligomerization of Heme o Synthase in Cytochrome Oxidase Biogenesis Is Mediated by Cytochrome Oxidase Assembly Factor Coa2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL MATRIX; YEAST; COX1; BIOSYNTHESIS; EXPRESSION; FARNESYLTRANSFERASE; DEFICIENCY; MATURATION	The synthesis of the heme a cofactor used in cytochrome c oxidase (CcO) is dependent on the sequential action of heme o synthase (Cox10) and heme a synthase (Cox15). The active state of Cox10 appears to be a homo-oligomeric complex, and formation of this complex is dependent on the newly synthesized CcO subunit Cox1 and the presence of an early Cox1 assembly intermediate. Cox10 multimerization is triggered by progression of Cox1 from the early assembly intermediate to downstream intermediates. The CcOassembly factor Coa2 appears important in coupling the presence of newly synthesized Cox1 to Cox10 oligomerization. Cells lacking Coa2 are impaired in Cox10 complex formation as well as the formation of a high mass Cox15 complex. Increasing Cox1 synthesis in coa2 Delta cells restores respiratory function if Cox10 protein levels are elevated. The C-terminal segment of Cox1 is important in triggering Cox10 oligomerization. Expression of the C-terminal 54 residues of Cox1 appended to a heterologous matrix protein leads to efficient Cox10 complex formation in coa2 Delta cells, but it fails to induce Cox15 complex formation. The state of Cox10 was evaluated in mutants, which predispose human patients to CcO deficiency and the neurological disorder Leigh syndrome. The presence of the D336V mutation in the yeast Cox10 backbone results in a catalytically inactive enzyme that is fully competent to oligomerize. Thus, Cox10 oligomerization and catalytic activation are separate processes and can be uncoupled.	[Khalimonchuk, Oleh; Kim, Hyung; Watts, Talina; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Khalimonchuk, Oleh; Kim, Hyung; Watts, Talina; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Dept Mol Genet, Mexico City 04510, DF, Mexico	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Universidad Nacional Autonoma de Mexico	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, SOM 5C 426, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	National Institutes of Health from the NIEHS [ES03817]; American Heart Association [10POST4300044]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IN82505];  [T32 DK007115]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, R37ES003817] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; American Heart Association(American Heart Association); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES03817 from the NIEHS (to D. R. W.) and Training Grant T32 DK007115 (to H. K.). This work was also supported by American Heart Association Grant 10POST4300044 (to O. K.) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico Grant IN82505 (to X. P.-M.).	Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAUM G, 1982, J BIOL CHEM, V257, P3028; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Mogi T, 2009, J BIOCHEM, V145, P669, DOI 10.1093/jb/mvp024; Moraes CT, 2004, BBA-BIOENERGETICS, V1659, P153, DOI 10.1016/j.bbabio.2004.09.002; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; SAIKI K, 1992, BIOCHEM BIOPH RES CO, V189, P1491, DOI 10.1016/0006-291X(92)90243-E; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; TAANMAN JW, 1992, J BIOL CHEM, V267, P22481; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Vempati UD, 2008, METHODS, V46, P241, DOI 10.1016/j.ymeth.2008.09.008; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	31	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26715	26726		10.1074/jbc.M112.377200	http://dx.doi.org/10.1074/jbc.M112.377200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22669974	Green Published, hybrid			2022-12-28	WOS:000307386000022
J	Beam, M; Silva, MC; Morimoto, RI				Beam, Monica; Catarina Silva, M.; Morimoto, Richard I.			Dynamic Imaging by Fluorescence Correlation Spectroscopy Identifies Diverse Populations of Polyglutamine Oligomers Formed in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-LIKE FIBRILS; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; MUTANT HUNTINGTIN; ALPHA-SYNUCLEIN; MONOMERIC POLYGLUTAMINE; AGGREGATION NUCLEATION; PEPTIDE AGGREGATION; PROTEIN AGGREGATION; INCLUSION FORMATION	Protein misfolding and aggregation are exacerbated by aging and diseases of protein conformation including neurodegeneration, metabolic diseases, and cancer. In the cellular environment, aggregates can exist as discrete entities, or heterogeneous complexes of diverse solubility and conformational state. In this study, we have examined the in vivo dynamics of aggregation using imaging methods including fluorescence microscopy, fluorescence recovery after photobleaching (FRAP), and fluorescence correlation spectroscopy (FCS), to monitor the diverse biophysical states of expanded polyglutamine (polyQ) proteins expressed in Caenorhabditis elegans. We show that monomers, oligomers and aggregates co-exist at different concentrations in young and aged animals expressing different polyQ-lengths. During aging, when aggregation and toxicity are exacerbated, FCS-based burst analysis and purified single molecule FCS detected a populational shift toward an increase in the frequency of brighter and larger oligomeric species. Regardless of age or polyQ-length, oligomers were maintained in a heterogeneous distribution that spans multiple orders of magnitude in brightness. We employed genetic suppressors that prevent polyQ aggregation and observed a reduction in visible immobile species with the persistence of heterogeneous oligomers, yet our analysis did not detect the appearance of any discrete oligomeric states associated with toxicity. These studies reveal that the reversible transition from monomers to immobile aggregates is not represented by discrete oligomeric states, but rather suggests that the process of aggregation involves a more complex pattern of molecular interactions of diverse intermediate species that can appear in vivo and contribute to aggregate formation and toxicity.	[Beam, Monica; Catarina Silva, M.; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA; [Catarina Silva, M.] Univ Lisbon, Fac Ciencias, Dept Chem & Biochem, P-1749016 Lisbon, Portugal; [Beam, Monica] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Northwestern University; Universidade de Lisboa; Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, 2205 Tech Dr, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu			National Institute of Health (NIGMS); Huntington's Disease Society of America Coalition for the Cure; Ellison Foundation; Daniel F. and Ada L. Rice Foundation; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/28461/2006]; National Institute of Health (NIA); National Institute of Health (NINDS); NATIONAL INSTITUTE ON AGING [R37AG026647] Funding Source: NIH RePORTER	National Institute of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Huntington's Disease Society of America Coalition for the Cure; Ellison Foundation(Lawrence Ellison Foundation); Daniel F. and Ada L. Rice Foundation; Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institute of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from the National Institutes of Health (NIGMS, NIA, NINDS), the Huntington's Disease Society of America Coalition for the Cure, the Ellison Foundation, and the Daniel F. and Ada L. Rice Foundation (to R. I. M).), and the Portuguese Fundacao para a Ciencia e Tecnologia SFRH/BD/28461/2006 (to M. C. S).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bernacki JP, 2011, BIOCHEMISTRY-US, V50, P9200, DOI 10.1021/bi201155g; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Boukari H, 2003, BIOCHEMISTRY-US, V42, P1292, DOI 10.1021/bi026751q; BRENNER S, 1974, GENETICS, V77, P71; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; de Pril R, 2007, MOL CELL NEUROSCI, V34, P10, DOI 10.1016/j.mcn.2006.09.006; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Elson EL, 2004, J BIOMED OPT, V9, P857, DOI 10.1117/1.1779234; Esler WP, 2000, J STRUCT BIOL, V130, P174, DOI 10.1006/jsbi.2000.4276; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Gerard M, 2006, FASEB J, V20, P524, DOI 10.1096/fj.05-5126fje; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Haustein E, 2004, CURR OPIN STRUC BIOL, V14, P531, DOI 10.1016/j.sbi.2004.09.004; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Herrera Federico, 2011, PLoS Curr, V3, pRRN1210, DOI 10.1371/currents.RRN1210; Inouye H, 2000, J STRUCT BIOL, V130, P123, DOI 10.1006/jsbi.2000.4258; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly JW, 2000, NAT STRUCT BIOL, V7, P824, DOI 10.1038/82815; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kohl T, 2005, ADV BIOCHEM ENG BIOT, V95, P107; Kubota H, 2011, METHODS, V53, P267, DOI 10.1016/j.ymeth.2010.12.035; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Laurence TA, 2007, BIOPHYS J, V92, P2184, DOI 10.1529/biophysj.106.093591; Lee CC, 2007, BIOCHEMISTRY-US, V46, P12810, DOI 10.1021/bi700806c; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Ramdzan YM, 2010, CHEM BIOL, V17, P371, DOI 10.1016/j.chembiol.2010.03.011; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; Smith AM, 2006, J MOL BIOL, V364, P9, DOI 10.1016/j.jmb.2006.08.081; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tjernberg LO, 1999, CHEM BIOL, V6, P53, DOI 10.1016/S1074-5521(99)80020-9; TOMSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P630, DOI 10.1016/0003-9861(92)90735-F; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Vitalis A, 2011, BIOPHYS CHEM, V159, P14, DOI 10.1016/j.bpc.2011.04.006; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Wang ZF, 2006, BIOPHYS J, V91, P343, DOI 10.1529/biophysj.105.077891; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200	84	18	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26136	26145		10.1074/jbc.M112.362764	http://dx.doi.org/10.1074/jbc.M112.362764			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669943	Green Published, hybrid			2022-12-28	WOS:000306916300041
J	Kadiyala, CSR; Zheng, L; Du, YP; Yohannes, E; Kao, HY; Miyagi, M; Kern, TS				Kadiyala, Chandra Sekhar Rao; Zheng, Ling; Du, Yunpeng; Yohannes, Elizabeth; Kao, Hung-Ying; Miyagi, Masaru; Kern, Timothy S.			Acetylation of Retinal Histones in Diabetes Increases Inflammatory Proteins EFFECTS OF MINOCYCLINE AND MANIPULATION OF HISTONE ACETYLTRANSFERASE (HAT) AND HISTONE DEACETYLASE (HDAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROINFLAMMATORY CYTOKINE; CHROMATIN MODIFICATION; ACTIVATION; GENES; CELLS; H3; DIMETHYLATION; EXPRESSION; INDUCTION	Histone acetylation was significantly increased in retinas from diabetic rats, and this acetylation was inhibited in diabetics treated with minocycline, a drug known to inhibit early diabetic retinopathy in animals. Histone acetylation and expression of inflammatory proteins that have been implicated in the pathogenesis of diabetic retinopathy were increased likewise in cultured retinal Muller glia grown in a diabetes-like concentration of glucose. Both the acetylation and induction of the inflammatory proteins in elevated glucose levels were significantly inhibited by inhibitors of histone acetyltransferase (garcinol and antisense against the histone acetylase, p300) or activators of histone deacetylase (theophylline and resveratrol) and were increased by the histone deacetylase inhibitor, suberolylanilide hydroxamic acid. We conclude that hyperglycemia causes acetylation of retinal histones (and probably other proteins) and that the acetylation contributes to the hyperglycemia-induced up-regulation of proinflammatory proteins and thereby to the development of diabetic retinopathy.	[Kadiyala, Chandra Sekhar Rao; Yohannes, Elizabeth; Miyagi, Masaru] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Du, Yunpeng; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kao, Hung-Ying; Miyagi, Masaru; Kern, Timothy S.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Miyagi, Masaru; Kern, Timothy S.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Zheng, Ling] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Wuhan University	Miyagi, M (corresponding author), Case Western Reserve Univ, Case Ctr Prote & Bioinformat, 10900 Euclid Ave, Cleveland, OH 44106 USA.	masaru.miyagi@case.edu; tsk@case.edu		Zheng, Ling/0000-0002-6545-4180	National Institutes of Health [EY00300]; Veterans Affairs; Visual Sciences Research Center of Case Western Reserve University [P30EY-11373]; Case Western Reserve University; Cleveland Foundation; NATIONAL EYE INSTITUTE [R01EY000300, P30EY011373, R56EY000300] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Visual Sciences Research Center of Case Western Reserve University; Case Western Reserve University; Cleveland Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant EY00300. This work was also supported by a merit grant from the Veterans Affairs (to T. S. K.), by Visual Sciences Research Center of Case Western Reserve University Grant P30EY-11373, and by funds from Case Western Reserve University and the Cleveland Foundation.	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; Bhatt LK, 2010, AM J TRANSL RES, V2, P181; Blumenkranz MS, 2010, EYE, V24, P428, DOI 10.1038/eye.2009.335; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; Chung S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023488; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du YP, 2002, J NEUROCHEM, V80, P771, DOI 10.1046/j.0022-3042.2001.00737.x; Gaikwad AB, 2010, AM J PATHOL, V176, P1079, DOI 10.2353/ajpath.2010.090528; Guan KL, 2010, NAT PROTOC, V5, P1583, DOI 10.1038/nprot.2010.117; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Ito T, 2000, GENE DEV, V14, P1899; Jeong JB, 2011, ARCH PHARM RES, V34, P2109, DOI 10.1007/s12272-011-1214-9; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Mukherji M, 2005, EXPERT REV PROTEOMIC, V2, P117, DOI 10.1586/14789450.2.1.117; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perrone L, 2009, J CELL PHYSIOL, V221, P262, DOI 10.1002/jcp.21852; Rao KCS, 2005, MOL CELL PROTEOMICS, V4, P1550, DOI 10.1074/mcp.M500150-MCP200; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Sayyed SG, 2010, NEPHROL DIAL TRANSPL, V25, P1811, DOI 10.1093/ndt/gfp730; Schwartz SG, 2011, CURR PHARM BIOTECHNO, V12, P347; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tikoo K, 2008, BRIT J PHARMACOL, V153, P1225, DOI 10.1038/sj.bjp.0707666; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yilmaz T, 2011, CURR PHARM BIOTECHNO, V12, P337, DOI 10.2174/138920111794480598; Yilmaz T, 2009, OPHTHALMOLOGY, V116, P902, DOI 10.1016/j.ophtha.2009.02.002; Yu ZT, 2002, J AM SOC NEPHROL, V13, P2009, DOI 10.1097/01.ASN.0000024253.59665.F1; Yun JM, 2011, J NUTR BIOCHEM, V22, P450, DOI 10.1016/j.jnutbio.2010.03.014; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789; Zhong Q, 2010, J CELL BIOCHEM, V110, P1306, DOI 10.1002/jcb.22644	54	85	92	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25869	25880		10.1074/jbc.M112.375204	http://dx.doi.org/10.1074/jbc.M112.375204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22648458	Green Published, hybrid			2022-12-28	WOS:000306916300016
J	Khan, SK; Xu, HY; Ukai-Tadenuma, M; Burton, B; Wang, YM; Ueda, HR; Liu, AC				Khan, Sanjoy K.; Xu, Haiyan; Ukai-Tadenuma, Maki; Burton, Brittany; Wang, Yongmei; Ueda, Hiroki R.; Liu, Andrew C.			Identification of a Novel Cryptochrome Differentiating Domain Required for Feedback Repression in Circadian Clock Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; GENE-EXPRESSION; MAMMALIAN CRY1; PROTEIN; MCRY2; PHOSPHORYLATION; MECHANISMS; TIME; PHOTORECEPTOR	Circadian clocks in mammals are based on a negative feedback loop in which transcriptional repression by the cryptochromes, CRY1 and CRY2, lies at the heart of the mechanism. Despite similarities in sequence, domain structure, and biochemical activity, they play distinct roles in clock function. However, detailed biochemical studies have not been straightforward and Cry function has not been examined in real clock cells using kinetic measurements. In this study, we demonstrate, through cell-based genetic complementation and real-time molecular recording, that Cry1 alone is able to maintain cell-autonomous circadian rhythms, whereas Cry2 cannot. Using this novel functional assay, we identify a cryptochrome differentiating alpha-helical domain within the photolyase homology region (PHR) of CRY1, designated as CRY1-PHR(313-426), that is required for clock function and distinguishes CRY1 from CRY2. Contrary to speculation, the divergent carboxyl-terminal tail domain (CTD) is dispensable, but serves to modulate rhythm amplitude and period length. Finally, we identify the biochemical basis of their distinct function; CRY1 is a much more potent transcriptional repressor than CRY2, and the strength of repression by various forms of CRY proteins significantly correlates with rhythm amplitude. Taken together, our results demonstrate that CRY1-PHR(313-426), not the divergent CTD, is critical for clock function. These findings provide novel insights into the evolution of the diverse functions of the photolyase/cryptochrome family of flavoproteins and offer new opportunities for mechanistic studies of CRY function.	[Khan, Sanjoy K.; Xu, Haiyan; Liu, Andrew C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Burton, Brittany; Wang, Yongmei] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [Ukai-Tadenuma, Maki; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Memphis; University of Memphis; RIKEN; RIKEN; RIKEN	Liu, AC (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	acliu@memphis.edu	Wang, Yongmei/B-7071-2008; Liu, Andrew C/B-3548-2009; Ueda, Hiroki R/C-5037-2014	Wang, Yongmei/0000-0002-7418-9489; Liu, Andrew C/0000-0003-1927-0900; Ueda, Hiroki R/0000-0001-8342-9176	National Science Foundation [IOS-0920417]; RIKEN Center for Developmental Biology (CDB); MEXT, Japan [23115006]	National Science Foundation(National Science Foundation (NSF)); RIKEN Center for Developmental Biology (CDB); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by National Science Foundation Grant IOS-0920417 (to A. C. L.), an intramural Grant-in-aid from the RIKEN Center for Developmental Biology (CDB) (to H. R. U.), and a Grant-in-aid for Scientific Research on Innovative Areas "Spying Minority in Biological Phenomena number 3306" (23115006) of MEXT, Japan (to H. R. U.).	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; McCarthy EV, 2009, MOL CELL BIOL, V29, P5465, DOI 10.1128/MCB.00641-09; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Miyamoto Y, 1999, MOL BRAIN RES, V71, P238, DOI 10.1016/S0169-328X(99)00192-8; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roy A., 2011, JOVE-J VIS EXP, V57, P3250; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van der Schalie EA, 2007, MOL CELL BIOL, V27, P2120, DOI 10.1128/MCB.01638-06; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	56	51	54	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25917	25926		10.1074/jbc.M112.368001	http://dx.doi.org/10.1074/jbc.M112.368001			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692217	Green Published, hybrid			2022-12-28	WOS:000306916300020
J	Chen, Z; Guo, L; Hadas, J; Gutowski, S; Sprang, SR; Sternweis, PC				Chen, Zhe; Guo, Liang; Hadas, Jana; Gutowski, Stephen; Sprang, Stephen R.; Sternweis, Paul C.			Activation of p115-RhoGEF Requires Direct Association of G alpha(13) and the Dbl Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RGRGS DOMAIN; RHO-GTPASES; STRUCTURAL DETERMINANTS; P115 RHOGEF; PDZ-RHOGEF; PROTEIN; COMPLEX; BINDING; MECHANISM	RGS-containing RhoGEFs (RGS-RhoGEFs) represent a direct link between the G(12) class of heterotrimeric G proteins and the monomeric GTPases. In addition to the canonical Dbl homology (DH) and pleckstrin homology domains that carry out the guanine nucleotide exchange factor (GEF) activity toward RhoA, these RhoGEFs also possess RGS homology (RH) domains that interact with activated alpha subunits of G(12) and G(13). Although the GEF activity of p115-RhoGEF (p115), an RGS-RhoGEF, can be stimulated by G alpha(13), the exact mechanism of the stimulation has remained unclear. Using combined studies with small angle x-ray scattering, biochemistry, and mutagenesis, we identify an additional binding site for activated G alpha(13) in the DH domain of p115. Small angle x-ray scattering reveals that the helical domain of G alpha(13) docks onto the DH domain, opposite to the surface of DH that binds RhoA. Mutation of a single tryptophan residue in the alpha 3b helix of DH reduces binding to activated G alpha(13) and ablates the stimulation of p115 by G alpha(13). Complementary mutations at the predicted DH-binding site in the alpha B-alpha C loop of the helical domain of G alpha(13) also affect stimulation of p115 by G alpha(13). Although the GAP activity of p115 is not required for stimulation by G alpha(13), two hydrophobic motifs in RH outside of the consensus RGS box are critical for this process. Therefore, the binding of G alpha(13) to the RH domain facilitates direct association of G alpha(13) to the DH domain to regulate its exchange activity. This study provides new insight into the mechanism of regulation of the RGS-RhoGEF and broadens our understanding of G protein signaling.	[Chen, Zhe] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hadas, Jana; Gutowski, Stephen; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Guo, Liang] Argonne Natl Lab, Adv Photon Source, BioCAT, Argonne, IL 60439 USA; [Sprang, Stephen R.] Univ Montana, Div Biol Sci, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Argonne National Laboratory; University of Montana System; University of Montana	Chen, Z (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Zhe.Chen@UTsouthwestern.edu; Paul.Sternweis@UTsouthwestern.edu		Chen, Zhe/0000-0002-1668-4051	National Institutes of Health [GM31954, DK46371, RR-08630]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046371, R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622, R01GM031954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31954 (to P. C. S.) and DK46371 (to S. R. S.). This work was also supported in part by U.S. Department of Energy, Basic Energy Sciences, Office of Science Contract W-31-109-ENG-38; National Institutes of Health Grant RR-08630; and the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Bielnicki JA, 2011, J BIOL CHEM, V286, P35163, DOI 10.1074/jbc.M111.270918; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Suzuki N, 2009, J BIOL CHEM, V284, P5000, DOI 10.1074/jbc.M804073200; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36	35	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25490	25500		10.1074/jbc.M111.333716	http://dx.doi.org/10.1074/jbc.M111.333716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661716	Green Published, hybrid			2022-12-28	WOS:000306651700055
J	Sato, K; Yoshimura, A; Kaneko, T; Ukai, T; Ozaki, Y; Nakamura, H; Li, XY; Matsumura, H; Hara, Y; Ogata, Y				Sato, Kayo; Yoshimura, Atsutoshi; Kaneko, Takashi; Ukai, Takashi; Ozaki, Yukio; Nakamura, Hirotaka; Li, Xinyue; Matsumura, Hiroyoshi; Hara, Yoshitaka; Ogata, Yorimasa			A Single Nucleotide Polymorphism in 3 '-Untranslated Region Contributes to the Regulation of Toll-like Receptor 4 Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE VARIANTS; PROSTATE-CANCER; TLR4 GENE; DISEASE; EXPRESSION; MUTATIONS; RISK; ASSOCIATION; LPS; TOLL-LIKE-RECEPTOR-4	We have previously shown that a single nucleotide polymorphism rs11536889 in the 3'-untranslated region (UTR) of TLR4 was associated with periodontitis. In this study the effects of this single nucleotide polymorphism on Toll-like receptor (TLR) 4 expression were investigated. Monocytes from subjects with the C/C genotype expressed higher levels of TLR4 on their surfaces than those from subjects with the other genotypes. Peripheral blood mononuclear cells (PBMCs) from the C/C and G/C subjects secreted higher levels of IL-8 in response to lipopolysaccharide (LPS), a TLR4 ligand, than the cells from the G/G subjects. However, there was no significant difference in TLR4 mRNA levels in PBMCs from the subjects with each genotype. After stimulation with tripalmitoylated CSK4 (Pam(3)CSK(4)), TLR4 mRNA levels increased in PBMCs from both the C/C and G/G subjects, whereas TLR4 protein levels increased in PBMCs from the C/C but not G/G subjects. Transient transfection of a series of chimeric luciferase constructs revealed that a fragment of 3'-UTR containing rs11536889 G allele, but not C allele, suppressed luciferase activity induced by LPS or IL-6. Two microRNAs, hsa-miR-1236 and hsa-miR-642a, were predicted to bind to rs11536889 G allele. Inhibition of these microRNAs reversed the suppressed luciferase activity. These microRNA inhibitors also up-regulated endogenous TLR4 protein on THP-1 cells (the G/G genotype) after LPS stimulation. Furthermore, mutant microRNAs that bind to the C allele inhibited the luciferase activity of the construct containing the C allele. These results indicate that genetic variation of rs11536889 contributes to translational regulation of TLR4, possibly by binding to microRNAs.	[Sato, Kayo; Yoshimura, Atsutoshi; Kaneko, Takashi; Ukai, Takashi; Ozaki, Yukio; Nakamura, Hirotaka; Hara, Yoshitaka] Nagasaki Univ, Dept Periodontol, Grad Sch Biomed Sci, Nagasaki 8528588, Japan; [Li, Xinyue; Matsumura, Hiroyoshi; Ogata, Yorimasa] Nihon Univ, Dept Periodontol, Sch Dent, Matsudo, Chiba 2718587, Japan	Nagasaki University; Nihon University	Yoshimura, A (corresponding author), Nagasaki Univ, Dept Periodontol, Grad Sch Biomed Sci, 1-7-1 Saka Moto, Nagasaki 8528588, Japan.	ayoshi@nagasaki-u.ac.jp		Kaneko, Takashi/0000-0001-9276-5550	Japan Society for the Promotion of Science, Tokyo, Japan [20592431]	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported Grant-in-aid for Scientific Research (C) 20592431 from the Japan Society for the Promotion of Science, Tokyo, Japan.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arroyo-Espliguero R, 2004, HEART, V90, P983, DOI 10.1136/hrt.2002.001297; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bihl F, 2003, J IMMUNOL, V170, P6141, DOI 10.4049/jimmunol.170.12.6141; Borrmann L, 2001, ONCOGENE, V20, P4537, DOI 10.1038/sj.onc.1204577; Bream JH, 2000, IMMUNOGENETICS, V51, P50, DOI 10.1007/s002510050008; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Fukusaki T, 2007, J PERIODONTAL RES, V42, P541, DOI 10.1111/j.1600-0765.2007.00979.x; Fukushima R, 2009, CIRC J, V73, P1479, DOI 10.1253/circj.CJ-08-1146; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hesketh J, 2004, BIOCHEM SOC T, V32, P990, DOI 10.1042/BST0320990; Hishida A, 2009, HELICOBACTER, V14, P47, DOI 10.1111/j.1523-5378.2009.00659.x; Kim HJ, 2012, WORLD J UROL, V30, P225, DOI 10.1007/s00345-011-0690-3; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Miedema KGE, 2011, LEUKEMIA, V25, P995, DOI 10.1038/leu.2011.27; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamaguchi R, 2009, J PERIODONTOL, V80, P512, DOI [10.1902/jop.2009.080393, 10.1902/jop.2009.080393 ]; Zheng SL, 2004, CANCER RES, V64, P2918, DOI 10.1158/0008-5472.CAN-03-3280; Zhou L, 2011, TRANSPL INFECT DIS, V13, P250, DOI 10.1111/j.1399-3062.2010.00574.x	36	58	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25163	25172		10.1074/jbc.M111.338426	http://dx.doi.org/10.1074/jbc.M111.338426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661708	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000306651700027
J	Wang, JN; Han, XZ; Feng, XJ; Wang, ZH; Zhang, YW				Wang, Jingna; Han, Xiangzi; Feng, Xiujing; Wang, Zhenghe; Zhang, Youwei			Coupling Cellular Localization and Function of Checkpoint Kinase 1 (Chk1) in Checkpoints and Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATR; PHOSPHORYLATION	Chk1 plays a key role in regulating the replication checkpoint and DNA damage response. Recent evidence suggests that mammalian Chk1 regulates both the nuclear and cytoplasmic checkpoint events. However, mechanisms regulating cellular mobilization of Chk1 were not well understood. Here, we report the identification of regions of human Chk1 that regulate its protein cellular localization and checkpoint function. We demonstrate that the two highly conserved motifs (CM1 and CM2) at the C terminus of Chk1 function as a nuclear export signal and nuclear localization signal, respectively. Mutating five highly conserved residues within these two motifs of Chk1 resulted in its accumulation mainly in the cytoplasm. These cytoplasmic Chk1 mutants were less stable and exhibited significantly reduced phosphorylation by DNA damage treatment, yet they retained, at least partially, checkpoint function. Using an adenovirus-mediated gene targeting technique, we attempted to create an HCT116 cell line in which endogenous Chk1 is mutated so that it is expressed exclusively in the cytoplasm. However, we failed to obtain homozygous mutant cell lines. We found that even the heterozygous mutant cell lines showed cell survival defects accompanied by spontaneous cell death. Together, these results reveal novel regulatory mechanisms that couple protein cellular localization with the checkpoint response and cell viability of Chk1.	[Wang, Jingna; Han, Xiangzi; Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Feng, Xiujing; Wang, Zhenghe] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, Wood Bldg,W343A,2109 Adelbert Rd, Cleveland, OH 44106 USA.	yxz169@case.edu			National Institutes of Health Howard Temin Career Development Award [R00CA126173]; NCI [R01 CA163214]; American Cancer Society Pilot Grant [IRG-91-022-15]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA163214, R00CA126173] Funding Source: NIH RePORTER	National Institutes of Health Howard Temin Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Pilot Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Howard Temin Career Development Award R00CA126173 and Grant R01 CA163214 from NCI (to Y. W. Z.). This work was also supported by American Cancer Society Pilot Grant IRG-91-022-15 (to Y. W. Z.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Enomoto M, 2009, J BIOL CHEM, V284, P34223, DOI 10.1074/jbc.C109.051540; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Liu QH, 2000, GENE DEV, V14, P1448; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Ohta M, 2003, P NATL ACAD SCI USA, V100, P11771, DOI 10.1073/pnas.2034853100; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Takai H, 2000, GENE DEV, V14, P1439; Wang JN, 2011, CELL CYCLE, V10, P500, DOI 10.4161/cc.10.3.14753; Xu N, 2012, ONCOGENE, V31, P1086, DOI 10.1038/onc.2011.310; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2006, CELL CYCLE, V5, P125, DOI 10.4161/cc.5.2.2308; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	29	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25501	25509		10.1074/jbc.M112.350397	http://dx.doi.org/10.1074/jbc.M112.350397			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22692200	Green Published, hybrid			2022-12-28	WOS:000306651700056
J	Chen, YJ; Chalouni, C; Tan, C; Clark, R; Venook, R; Ohri, R; Raab, H; Firestein, R; Mallet, W; Polakis, P				Chen, Youjun; Chalouni, Cecile; Tan, Christine; Clark, Robyn; Venook, Rayna; Ohri, Rachana; Raab, Helga; Firestein, Ron; Mallet, William; Polakis, Paul			The Melanosomal Protein PMEL17 as a Target for Antibody Drug Conjugate Therapy in Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-THERAPY; PLASMID DNA; MEMBRANE; GLYCOPROTEIN; MELANOCYTES; ORGANELLES; ENDOSOMES; CLEAVAGE; FRAGMENT; CELLS	Melanocytes uniquely express specialized genes required for pigment formation, some of which are maintained following their transformation to melanoma. Here we exploit this property to selectively target melanoma with an antibody drug conjugate (ADC) specific to PMEL17, the product of the SILV pigment-forming gene. We describe new PMEL17 antibodies that detect the endogenous protein. These antibodies help define the secretory fate of PMEL17 and demonstrate its utility as an ADC target. Although newly synthesized PMEL17 is ultimately routed to the melanosome, we find substantial amounts accessible to our antibodies at the cell surface that undergo internalization and routing to a LAMP1-enriched, lysosome-related organelle. Accordingly, an ADC reactive with PMEL17 exhibits target-dependent tumor cell killing in vitro and in vivo.	[Chen, Youjun; Clark, Robyn; Venook, Rayna; Polakis, Paul] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Chalouni, Cecile; Firestein, Ron] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Tan, Christine; Ohri, Rachana] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Raab, Helga] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Mallet, William] Novartis, Emeryville, CA 94608 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Novartis	Polakis, P (corresponding author), Genentech Inc, Dept Res Oncol, 1 DNA Way,MS 42, San Francisco, CA 94080 USA.	ppolakis@gene.com						Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Garrett CR, 2011, EXPERT OPIN BIOL TH, V11, P937, DOI 10.1517/14712598.2011.582464; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hongo JAS, 2000, HYBRIDOMA, V19, P303, DOI 10.1089/027245700429855; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Leonhardt RM, 2011, J BIOL CHEM, V286, P9321, DOI 10.1074/jbc.M110.168088; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Robila V, 2008, J IMMUNOL, V181, P7843, DOI 10.4049/jimmunol.181.11.7843; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wilhite SE, 2012, METHODS MOL BIOL, V802, P41, DOI 10.1007/978-1-61779-400-1_3; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200; Younes A, 2012, NAT REV DRUG DISCOV, V11, P19, DOI 10.1038/nrd3629; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	33	14	19	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24082	24091		10.1074/jbc.M112.361485	http://dx.doi.org/10.1074/jbc.M112.361485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613716	hybrid, Green Published			2022-12-28	WOS:000306651100003
J	Lei, IL; Gao, XL; Sham, MH; Wang, Z				Lei, Ienglam; Gao, Xiaolin; Sham, Mai Har; Wang, Zhong			SWI/SNF Protein Component BAF250a Regulates Cardiac Progenitor Cell Differentiation by Modulating Chromatin Accessibility during Second Heart Field Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REMODELING COMPLEX; NEUREGULIN RECEPTOR; MUSCLE DEVELOPMENT; OUTFLOW-TRACT; SUBUNIT; PLURIPOTENCY; REQUIREMENT; EXPRESSION; ORIGINS; DISEASE	ATP-dependent SWI/SNF chromatin remodeling complexes alter the structure of chromatin at specific loci and facilitate tissue-specific gene regulation during development. Several SWI/SNF subunits are required for cardiogenesis. However, the function and mechanisms of SWI/SNF in mediating cardiac progenitor cell (CPC) differentiation during cardiogenesis are not well understood. Our studies of the SWI/SNF chromatin remodeling complex identified that BAF250a, a regulatory subunit of the SWI/SNF, plays a key role in CPC differentiation. BAF250a ablation in mouse second heart field (SHF) led to trabeculation defects in the right ventricle, ventricular septal defect, persistent truncus arteriosus, reduced myocardial proliferation, and embryonic lethality around E13. Using an embryonic stem cell culture system that models the formation and differentiation of SHF CPCs in vivo, we have shown that BAF250a ablation in CPCs specifically inhibits cardiomyocyte formation. Moreover, BAF250a selectively regulates the expression of key cardiac factors Mef2c, Nkx2.5, and Bmp10 in SHF CPCs. Chromatin immunoprecipitation and DNase I digestion assays indicate that BAF250a regulates gene expression by binding selectively to its target gene promoters and recruiting Brg1, the catalytic subunit of SWI/SNF, to modulate chromatin accessibility. Our results thus identify BAF250a-mediated chromatin remodeling as an essential epigenetic mechanism mediating CPC differentiation.	[Lei, Ienglam; Sham, Mai Har] Univ Hong Kong, Dept Biochem, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Lei, Ienglam; Gao, Xiaolin; Wang, Zhong] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Lei, Ienglam; Gao, Xiaolin; Wang, Zhong] Harvard Stem Cell Inst, Boston, MA 02114 USA	University of Hong Kong; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Sham, MH (corresponding author), Univ Hong Kong, Dept Biochem, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.	mhsham@hku.hk; zhwang@partners.org	Sham, Mai Har/AAX-3781-2020; Lei, IENG LAM/AAT-8216-2020	Sham, Mai Har/0000-0003-1179-7839; Lei, IENG LAM/0000-0002-0248-6871	National Institutes of Health [R01 HL109054-01]; Harvard Stem Cell Institute; Massachusetts General Hospital; Stem Cell and Regenerative Medicine Consortium at Hong Kong University; Hong Kong University-Massachusetts General Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Massachusetts General Hospital(General Electric); Stem Cell and Regenerative Medicine Consortium at Hong Kong University; Hong Kong University-Massachusetts General Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL109054-01 (to Z. W.). This work was also supported by a seed grant from the Harvard Stem Cell Institute (to Z. W.), an internal grant from Massachusetts General Hospital (to Z. W.), and the Stem Cell and Regenerative Medicine Consortium at Hong Kong University (to M. H. S.).; Supported by a Hong Kong University-Massachusetts General Hospital joint Ph.D. studentship.	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Black BL, 2007, SEMIN CELL DEV BIOL, V18, P67, DOI 10.1016/j.semcdb.2007.01.001; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen J, 1998, DEVELOPMENT, V125, P1943; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Huang XL, 2008, DEV BIOL, V319, P258, DOI 10.1016/j.ydbio.2008.04.020; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Lou X, 2011, DEVELOPMENT, V138, P3113, DOI 10.1242/dev.064279; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08	35	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24255	24262		10.1074/jbc.M112.365080	http://dx.doi.org/10.1074/jbc.M112.365080			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621927	Green Published, hybrid			2022-12-28	WOS:000306651100019
J	Herrick-Davis, K; Grinde, E; Lindsley, T; Cowan, A; Mazurkiewicz, JE				Herrick-Davis, Katharine; Grinde, Ellinor; Lindsley, Tara; Cowan, Ann; Mazurkiewicz, Joseph E.			Oligomer Size of the Serotonin 5-Hydroxytryptamine 2C (5-HT2C) Receptor Revealed by Fluorescence Correlation Spectroscopy with Photon Counting Histogram Analysis EVIDENCE FOR HOMODIMERS WITHOUT MONOMERS OR TETRAMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; PLASMA-MEMBRANE; QUANTITATIVE ASSESSMENT; LIVING CELLS; LIVE CELLS; LIGAND; HETERODIMERIZATION; DIMERS; DIMERIZATION; BRIGHTNESS	Fluorescence correlation spectroscopy (FCS) and photon counting histogram (PCH) are techniques with single molecule sensitivity that are well suited for examining the biophysical properties of protein complexes in living cells. In the present study, FCS and PCH were applied to determine the diffusion coefficient and oligomeric size of G-protein-coupled receptors. FCS was used to record fluctuations in fluorescence intensity arising from fluorescence-tagged 5-hydroxytryptamine 2C (5-HT2C) receptors diffusing within the plasma membrane of HEK293 cells and rat hippocampal neurons. Autocorrelation analysis yielded diffusion coefficients ranging from 0.8 to 1.2 mu m(2)/s for fluorescence-tagged receptors. Because the molecular brightness of a fluorescent protein is directly proportional to the number of fluorescent proteins traveling together within a protein complex, it can be used to determine the oligomeric size of the protein complex. FCS and PCH analysis of fluorescence-tagged 5-HT2C receptors provided molecular brightness values that were twice that of GFP and YFP monomeric controls, similar to a dimeric GFP control, and unaltered by 5-HT. Bimolecular fluorescence complementation of the N- and C-terminal halves of YFP attached to 5-HT2C receptors was observed in endoplasmic reticulum/Golgi and plasma membranes with a brightness equal to monomeric YFP. When GFP-tagged 5-HT2C receptors were co-expressed with a large excess of untagged, non-fluorescent 5-HT2C receptors, the molecular brightness was reduced by half. PCH analysis of the FCS data were best described by a one-component dimer model without monomers or tetramers. Therefore, it is concluded that 5-HT2C receptors freely diffusing within the plasma membrane are dimeric.	[Herrick-Davis, Katharine; Grinde, Ellinor; Lindsley, Tara; Mazurkiewicz, Joseph E.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Cowan, Ann] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA	Albany Medical College; University of Connecticut	Mazurkiewicz, JE (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, MC-136,47 New Scotland Ave, Albany, NY 12208 USA.	daviskh@mail.amc.edu			National Institutes of Health [R21MH086796]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R21MH086796 (to K. H. D.).	Adler J, 2010, NAT METHODS, V7, P170, DOI 10.1038/nmeth0310-170; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; Briddon SJ, 2008, BBA-MOL CELL RES, V1783, P2262, DOI 10.1016/j.bbamcr.2008.07.006; Bubar MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020508; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Fogarty KH, 2011, BIOPHYS J, V100, P1587, DOI 10.1016/j.bpj.2011.02.008; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Harikurnar KG, 2008, BBA-BIOMEMBRANES, V1778, P2555, DOI 10.1016/j.bbamem.2008.07.008; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Herrick-Davis K, 2004, BIOCHEMISTRY-US, V43, P13963, DOI 10.1021/bi048398p; Herrick-Davis K, 2007, EUR J PHARMACOL, V568, P45, DOI 10.1016/j.ejphar.2007.04.030; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jensen NH, 2010, THESCIENTIFICWORLDJO, V10, P1870, DOI 10.1100/tsw.2010.180; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Macdonald PJ, 2010, BIOPHYS J, V99, P979, DOI 10.1016/j.bpj.2010.05.017; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mallengo G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940570; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Neugart F, 2009, BBA-BIOMEMBRANES, V1788, P1890, DOI 10.1016/j.bbamem.2009.05.013; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Pramanik A, 2001, BIOCHEMISTRY-US, V40, P10839, DOI 10.1021/bi010514q; QIAN H, 1991, APPL OPTICS, V30, P1185, DOI 10.1364/AO.30.001185; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Ross JA, 2011, BIOPHYS J, V100, pL15, DOI 10.1016/j.bpj.2010.12.3703; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SANDERSBUSH E, 1990, J PHARMACOL EXP THER, V252, P984; Savatier J, 2010, BIOCHEMISTRY-US, V49, P772, DOI 10.1021/bi9013006; Teitler M, 2012, PHARMACOL THERAPEUT, V133, P205, DOI 10.1016/j.pharmthera.2011.10.007; Unruh JR, 2008, BIOPHYS J, V95, P5385, DOI 10.1529/biophysj.108.130310; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	67	63	64	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23604	23614		10.1074/jbc.M112.350249	http://dx.doi.org/10.1074/jbc.M112.350249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593582	Green Published, hybrid			2022-12-28	WOS:000306511300031
J	Kilkenny, ML; De Piccoli, G; Perera, RL; Labib, K; Pellegrini, L				Kilkenny, Mairi L.; De Piccoli, Giacomo; Perera, Rajika L.; Labib, Karim; Pellegrini, Luca			A Conserved Motif in the C-terminal Tail of DNA Polymerase alpha Tethers Primase to the Eukaryotic Replisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK; COMPLEX-FORMATION; POL ALPHA; HELICASE; SUBUNIT; ARCHITECTURE; PROGRESSION; CTF4	The DNA polymerase alpha-primase complex forms an essential part of the eukaryotic replisome. The catalytic subunits of primase and pol alpha synthesize composite RNA-DNA primers that initiate the leading and lagging DNA strands at replication forks. The physical basis and physiological significance of tethering primase to the eukaryotic replisome via pol alpha remain poorly characterized. We have identified a short conserved motif at the extreme C terminus of pol alpha that is critical for interaction of the yeast ortholog pol1 with primase. We show that truncation of the C-terminal residues 1452-1468 of Pol1 abrogates the interaction with the primase, as does mutation to alanine of the invariant amino acid Phe(1463). Conversely, a pol1 peptide spanning the last 16 residues binds primase with high affinity, and the equivalent peptide from human Pol alpha binds primase in an analogous fashion. These in vitro data are mirrored by experiments in yeast cells, as primase does not interact in cell extracts with pol1 that either terminates at residue 1452 or has the F1463A mutation. The ability to disrupt the association between primase and pol alpha allowed us to assess the physiological significance of primase being tethered to the eukaryotic replisome in this way. We find that the F1463A mutation in Pol1 renders yeast cells dependent on the S phase checkpoint, whereas truncation of Pol1 at amino acid 1452 blocks yeast cell proliferation. These findings indicate that tethering of primase to the replisome by pol alpha is critical for the normal action of DNA replication forks in eukaryotic cells.	[De Piccoli, Giacomo; Labib, Karim] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Kilkenny, Mairi L.; Perera, Rajika L.; Pellegrini, Luca] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	Paterson Institute for Cancer Research; University of Manchester; University of Cambridge	Labib, K (corresponding author), Univ Manchester, Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	klabib@picr.man.ac.uk; lp212@cam.ac.uk	Pellegrini, Luca/AAE-2312-2022	Pellegrini, Luca/0000-0002-9300-497X; Perera, Rajika/0000-0002-4932-8168	Wellcome Trust; Cancer Research United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK)	This work was supported by a Wellcome Trust senior research fellowship in basic biomedical sciences (to L. P.) and by the Cancer Research United Kingdom (to K. L.).	BROOKE RG, 1991, J BIOL CHEM, V266, P10093; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; De Piccoli G, 2012, MOL CELL, V45, P696, DOI 10.1016/j.molcel.2012.01.007; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Lee SJ, 2011, CURR OPIN CHEM BIOL, V15, P580, DOI 10.1016/j.cbpa.2011.07.024; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; Smith RWP, 2002, FEBS LETT, V527, P143, DOI 10.1016/S0014-5793(02)03197-6; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	25	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23740	23747		10.1074/jbc.M112.368951	http://dx.doi.org/10.1074/jbc.M112.368951			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593576	hybrid, Green Published			2022-12-28	WOS:000306511300044
J	Andersen, JT; Foss, S; Kenanova, VE; Olafsen, T; Leikfoss, IS; Roopenian, DC; Wu, AM; Sandlie, I				Andersen, Jan Terje; Foss, Stian; Kenanova, Vania E.; Olafsen, Tove; Leikfoss, Ingvild S.; Roopenian, Derry C.; Wu, Anna M.; Sandlie, Inger			Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RELATED RECEPTOR; ENGINEERED ANTIBODY; IMMUNOGLOBULIN-G; IGG HOMEOSTASIS; THERAPEUTIC ANTIBODIES; COLORECTAL-CANCER; RAT HEPATOCYTES; DENDRITIC CELLS; FUSION PROTEIN; EXPRESSION	Serum half-life of IgG is controlled by the neonatal Fc receptor (FcRn) that interacts with the IgG Fc region and may be increased or decreased as a function of altered FcRn binding. Preclinical evaluations of modified IgGs are frequently carried out in mice, but such IgGs may bind differently to mouse and human FcRn (mFcRn and hFcRn). Here, we report a detailed characterization of a matched set of mouse-human chimeric T84.66 scFv-Fc variants with specificity for the tumor carcinoembryonic antigen and mutations in the FcRn-binding site. Binding to soluble mFcRn and hFcRn was measured using in vitro assays, and the results were compared with blood clearance in vivo in normal (mFcRn bearing) and hFcRn transgenic mice. All variants bound better to mFcRn than to hFcRn. The loss of affinity varied among the mutants, however, and also the hierarchy of binding differed depending on the receptor. The mutations had no major impact on binding to the classical Fc gamma receptors. Importantly, the trend of blood clearance in both strains of mice correlated with the hierarchy of binding obtained using soluble FcRn. Consequently, in vitro interaction analysis of engineered IgGs regarding their cross-species FcRn binding ability provides information for prediction of in vivo pharmacokinetics.	[Andersen, Jan Terje; Foss, Stian; Leikfoss, Ingvild S.; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, N-0316 Oslo, Norway; [Andersen, Jan Terje; Foss, Stian; Leikfoss, Ingvild S.; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Andersen, Jan Terje; Foss, Stian; Leikfoss, Ingvild S.; Sandlie, Inger] Univ Hosp, Ctr Immune Regulat, Rikshosp, N-0424 Oslo, Norway; [Andersen, Jan Terje; Foss, Stian; Leikfoss, Ingvild S.; Sandlie, Inger] Univ Hosp, Dept Immunol, Rikshosp, N-0424 Oslo, Norway; [Kenanova, Vania E.; Olafsen, Tove; Wu, Anna M.] Univ Calif Los Angeles, David Geffen Sch Med, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Leikfoss, Ingvild S.] Univ Oslo, Inst Basic Med Sci, N-0317 Oslo, Norway; [Roopenian, Derry C.] Jackson Lab, Bar Harbor, ME 04609 USA	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oslo; Jackson Laboratory	Sandlie, I (corresponding author), Natl Hosp Norway, CIR, Oslo Univ Hosp, POB 4956, N-0424 Oslo, Norway.	inger.sandlie@imbv.uio.no	Andersen, Jan Terje/AAB-6209-2020	Wu, Anna/0000-0001-8487-823X; Foss, Stian/0000-0001-6527-051X; Andersen, Jan Terje/0000-0003-1710-1628	National Institutes of Health [CA043902, CA086306, CA016042]; Norwegian Research Council [179573/V40]; South-Eastern Norway Regional Health Authority [9375]; NATIONAL CANCER INSTITUTE [R01CA043902, P30CA016042, P50CA086306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA043902, CA086306, and CA016042 (to V. E. K., T. O., and A. M. W.).; Supported by Norwegian Research Council Grant 179573/V40 and South-Eastern Norway Regional Health Authority Grant 9375. To whom correspondence may be addressed: Centre for Immune Regulation and Dept. of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P. O. Box 4956, Oslo N-0424, Norway. E-mail: j.t.andersen@imbv.uio.no.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; BLUMBERG D, 1995, METABOLISM, V44, P145, DOI 10.1016/0026-0495(95)90255-4; Blumberg RS, 2005, NAT BIOTECHNOL, V23, P1232, DOI 10.1038/nbt1005-1232; BLUMBERG RS, 1995, J CLIN INVEST, V95, P2397, DOI 10.1172/JCI117934; BOUCHER D, 1989, CANCER RES, V49, P847; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; ESTEBAN JM, 1993, HUM PATHOL, V24, P322, DOI 10.1016/0046-8177(93)90044-H; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Girgis MD, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-24; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hu SZ, 1996, CANCER RES, V56, P3055; Kamei DT, 2005, BIOTECHNOL BIOENG, V92, P748, DOI 10.1002/bit.20624; Kenanova V, 2005, CANCER RES, V65, P622; Kenanova V, 2007, CANCER RES, V67, P718, DOI 10.1158/0008-5472.CAN-06-0454; Kenanova Vania, 2006, Expert Opin Drug Deliv, V3, P53, DOI 10.1517/17425247.3.1.53; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Medesan C, 1997, J IMMUNOL, V158, P2211; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Olafsen T, 2005, CANCER RES, V65, P5907, DOI 10.1158/0008-5472.CAN-04-4472; Olafsen T, 2010, PROTEIN ENG DES SEL, V23, P243, DOI 10.1093/protein/gzp081; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Popov S, 1996, MOL IMMUNOL, V33, P521, DOI 10.1016/0161-5890(96)00004-1; Prabhat P, 2007, P NATL ACAD SCI USA, V104, P5889, DOI 10.1073/pnas.0700337104; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RAGHAVAN M, 1994, IMMUNITY, V1, P303, DOI 10.1016/1074-7613(94)90082-5; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; SPIEGELBERG HL, 1968, J CLIN INVEST, V47, P2323, DOI 10.1172/JCI105917; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; Stein C, 2012, MAMM GENOME, V23, P259, DOI 10.1007/s00335-011-9379-6; Sundaresan G, 2003, J NUCL MED, V44, P1962; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Vaccaro C, 2006, P NATL ACAD SCI USA, V103, P18709, DOI 10.1073/pnas.0606304103; Ward ES, 2003, INT IMMUNOL, V15, P187, DOI 10.1093/intimm/dxg018; Wong JYC, 2004, CLIN CANCER RES, V10, P5014, DOI 10.1158/1078-0432.CCR-03-0576; Wu AM, 2000, P NATL ACAD SCI USA, V97, P8495, DOI 10.1073/pnas.150228297; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014; Zhu XP, 2001, J IMMUNOL, V166, P3266, DOI 10.4049/jimmunol.166.5.3266	57	25	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22927	22937		10.1074/jbc.M112.355131	http://dx.doi.org/10.1074/jbc.M112.355131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570488	Green Published, hybrid			2022-12-28	WOS:000306495000050
J	Bentley, AA; Merkulov, SM; Peng, Y; Rozmarynowycz, R; Qi, XP; Pusztai-Carey, M; Merrick, WC; Yee, VC; McCrae, KR; Komar, AA				Bentley, Amber A.; Merkulov, Sergei M.; Peng, Yi; Rozmarynowycz, Rita; Qi, Xiaoping; Pusztai-Carey, Marianne; Merrick, William C.; Yee, Vivien C.; McCrae, Keith R.; Komar, Anton A.			Chimeric Glutathione S-Transferases Containing Inserts of Kininogen Peptides POTENTIAL NOVEL PROTEIN THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; INHIBITS ANGIOGENESIS; RATIONAL DESIGN; STABILITY; DOMAIN-5; LOOP; CONFORMATION; JAPONICUM; EVOLUTION; GRAPHICS	The study of synthetic peptides corresponding to discrete regions of proteins has facilitated the understanding of protein structure-activity relationships. Short peptides can also be used as powerful therapeutic agents. However, in many instances, small peptides are prone to rapid degradation or aggregation and may lack the conformation required to mimic the functional motifs of the protein. For peptides to function as pharmacologically active agents, efficient production or expression, high solubility, and retention of biological activity through purification and storage steps are required. We report here the design, expression, and functional analysis of eight engineered GST proteins (denoted GSHKTs) in which peptides ranging in size from 8 to 16 amino acids and derived from human high molecular weight kininogen (HK) domain 5 were inserted into GST (between Gly-49 and Leu-50). Peptides derived from HK are known to inhibit cell proliferation, angiogenesis, and tumor metastasis, and the biological activity of the HK peptides was dramatically (>50-fold) enhanced following insertion into GST. GSHKTs are soluble and easily purified from Escherichia coli by affinity chromatography. Functionally, these hybrid proteins cause inhibition of endothelial cell proliferation. Crystallographic analysis of GSHKT10 and GSHKT13 (harboring 10- and 13-residue HK peptides, respectively) showed that the overall GST structure was not perturbed. These results suggest that the therapeutic efficacy of short peptides can be enhanced by insertion into larger proteins that are easily expressed and purified and that GST may potentially be used as such a carrier.	[McCrae, Keith R.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [McCrae, Keith R.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Merkulov, Sergei M.; Qi, Xiaoping] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Peng, Yi; Pusztai-Carey, Marianne; Merrick, William C.; Yee, Vivien C.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland State University; Case Western Reserve University; Case Western Reserve University	McCrae, KR (corresponding author), Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA.	mccraek@ccf.org; a.komar@csuohio.edu		Komar, Anton/0000-0003-4188-0633	National Institutes of Health [HL089796, GM68079]; National American Heart Association [0730120N];  [DK075897];  [GM61388]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388, R01GM068079, U01GM061388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National American Heart Association(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089796 (to K. R. M.), GM68079 (to W. C. M.), and DK075897 and GM61388 (to V. C. Y. and Y. P.). This work was supported by National American Heart Association Grant 0730120N (to A. A. K.).	Brockwell D, 2001, PROTEIN SCI, V10, P572, DOI 10.1110/ps.46001; Cardoso RMF, 2003, PROTEINS, V51, P137, DOI 10.1002/prot.10345; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Church WB, 2001, J BIOL CHEM, V276, P33156, DOI 10.1074/jbc.M101272200; Collinet B, 2001, EUR J BIOCHEM, V268, P5107, DOI 10.1046/j.0014-2956.2001.02439.x; Colman RW, 2000, BLOOD, V95, P543, DOI 10.1182/blood.V95.2.543; Daly ME, 2003, JNCI-J NATL CANCER I, V95, P1660, DOI 10.1093/jnci/djg101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fowler SB, 2005, P NATL ACAD SCI USA, V102, P10105, DOI 10.1073/pnas.0501215102; Greenberg M, 2004, REV MED VIROL, V14, P321, DOI 10.1002/rmv.440; Kamiyama F, 2001, BIOCHEM BIOPH RES CO, V288, P975, DOI 10.1006/bbrc.2001.5864; Kawasaki M, 2003, J BIOL CHEM, V278, P49301, DOI 10.1074/jbc.M308790200; KELLEY LA, 1999, RECOMB 99 P 3 ANN C, P218; Kiyota S, 2003, J MED CHEM, V46, P2325, DOI 10.1021/jm020543e; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; Ladurner AG, 1997, J MOL BIOL, V273, P330, DOI 10.1006/jmbi.1997.1304; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazar GA, 2003, CURR OPIN STRUC BIOL, V13, P513, DOI 10.1016/S0959-440X(03)00104-0; Marshall SA, 2003, DRUG DISCOV TODAY, V8, P212, DOI 10.1016/S1359-6446(03)02610-2; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Mehta N. M., 2003, Current Pharmaceutical Design, V9, P2659, DOI 10.2174/1381612033453622; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyamoto Fusako, 2012, Antiviral Chemistry & Chemotherapy, V22, P151, DOI 10.3851/IMP1930; Moult J, 2000, CURR OPIN STRUC BIOL, V10, P384, DOI 10.1016/S0959-440X(00)00101-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pokala N, 2001, J STRUCT BIOL, V134, P269, DOI 10.1006/jsbi.2001.4349; Regan L, 1999, CURR OPIN STRUC BIOL, V9, P494, DOI 10.1016/S0959-440X(99)80070-0; Sambrook J., 2002, MOL CLONING LAB MANU; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sheffield W. P., 2001, Current Drug Targets - Cardiovascular and Haematological Disorders, V1, P1, DOI 10.2174/1568006013338150; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; SIBANDA BL, 1993, J MOL BIOL, V229, P428, DOI 10.1006/jmbi.1993.1044; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Sundaram R, 2002, BIOPOLYMERS, V66, P200, DOI 10.1002/bip.10258; Thanki N, 1997, PROTEIN ENG, V10, P159, DOI 10.1093/protein/10.2.159; Tibbetts SA, 2000, PEPTIDES, V21, P1161, DOI 10.1016/S0196-9781(00)00255-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhang JC, 2002, P NATL ACAD SCI USA, V99, P12224, DOI 10.1073/pnas.192668299; Zhang JC, 2002, CAN J PHYSIOL PHARM, V80, P85, DOI 10.1139/Y02-011	44	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22142	22150		10.1074/jbc.M112.372854	http://dx.doi.org/10.1074/jbc.M112.372854			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577144	Green Published, hybrid			2022-12-28	WOS:000306418600051
J	Oh, HJ; Abraham, LS; van Hengel, J; Stove, C; Proszynski, TJ; Gevaert, K; DiMario, JX; Sanes, JR; van Roy, F; Kim, H				Oh, Hyun J.; Abraham, Linu S.; van Hengel, Jolanda; Stove, Christophe; Proszynski, Tomasz J.; Gevaert, Kris; DiMario, Joseph X.; Sanes, Joshua R.; van Roy, Frans; Kim, Hongkyun			Interaction of alpha-Catulin with Dystrobrevin Contributes to Integrity of Dystrophin Complex in Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MUSCULAR-DYSTROPHIES; SKELETAL-MUSCLE; PROTEIN COMPLEX; BK CHANNEL; MDX MICE; GLYCOPROTEIN COMPLEX; C. ELEGANS; LOCALIZATION; PATHOGENESIS	The dystrophin complex is a multimolecular membrane-associated protein complex whose defects underlie many forms of muscular dystrophy. The dystrophin complex is postulated to function as a structural element that stabilizes the cell membrane by linking the contractile apparatus to the extracellular matrix. Abetter understanding of how this complex is organized and localized will improve our knowledge of the pathogenic mechanisms of diseases that involve the dystrophin complex. In a Caenorhabditis elegans genetic study, we demonstrate that CTN-1/alpha-catulin, a cytoskeletal protein, physically interacts with DYB-1/alpha-dystrobrevin (a component of the dystrophin complex) and that this interaction is critical for the localization of the dystrophin complex near dense bodies, structures analogous to mammalian costameres. We further show that in mouse alpha-catulin is localized at the sarcolemma and neuromuscular junctions and interacts with alpha-dystrobrevin and that the level of alpha-catulin is reduced in alpha-dystrobrevin- deficient mouse muscle. Intriguingly, in the skeletal muscle of mdx mice lacking dystrophin, we discover that the expression of alpha-catulin is increased, suggesting a compensatory role of alpha-catulin in dystrophic muscle. Together, our study demonstrates that the interaction between alpha-catulin and alpha-dystrobrevin is evolutionarily conserved in C. elegans and mammalian muscles and strongly suggests that this interaction contributes to the integrity of the dystrophin complex.	[Oh, Hyun J.; Abraham, Linu S.; DiMario, Joseph X.; Kim, Hongkyun] Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, Chicago Med Sch, N Chicago, IL 60064 USA; [van Hengel, Jolanda; Stove, Christophe; van Roy, Frans] VIB, Dept Mol Biomed Res, Ghent, Belgium; [van Hengel, Jolanda; Stove, Christophe; van Roy, Frans] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Proszynski, Tomasz J.] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02140 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Harvard University	Kim, H (corresponding author), Rosalind Franklin Univ, Dept Cell Biol & Anat, Chicago Med Sch, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	hongkyun.kim@rosalindfranklin.edu	Gevaert, Kris/D-6489-2017; Gevaert, Kris/AAE-4212-2019; Stove, Christophe/B-6057-2008; Proszynski, Tomasz/S-2221-2016; Gevaert, Kris/H-3637-2013; van Roy, Frans M/C-6123-2009	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Stove, Christophe/0000-0001-7126-348X; Proszynski, Tomasz/0000-0002-1115-0069; Gevaert, Kris/0000-0002-4237-0283; van Roy, Frans M/0000-0003-4358-1039; Oh, Kelly/0000-0001-8203-5247; Kim, Hongkyun/0000-0002-4879-7122	National Institute of Health [R01NS058814, R01NS059853, R01AR058043]; Concerted Research Actions (GOA) of Ghent University; Research Foundation-Flanders (FWO-Vlaanderen); National Center for Research Resources; NICHD, National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR058043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059853, R01NS058814] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Concerted Research Actions (GOA) of Ghent University; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institute of Health Grants R01NS058814 (to H. K.), R01NS059853 (to J. R. S.), and R01AR058043 (to J. X. D.). This work was also supported by the Concerted Research Actions (GOA) of Ghent University and the Research Foundation-Flanders (FWO-Vlaanderen) (to F. v. R.).; Some strains used in this study were provided by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources. Anti-dystrophin antibody and anti-alpha-tubulin antibody were obtained from Developmental Hybridoma Bank developed under auspices of the NICHD, National Institutes of Health.	Abraham LS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001077; Albrecht DE, 2004, J BIOL CHEM, V279, P7014, DOI 10.1074/jbc.M312205200; Baltgalvis KA, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-32; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Bohm SV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-85; BRENNER S, 1974, GENETICS, V77, P71; Brown SC, 2005, MUSCLE NERVE, V32, P715, DOI 10.1002/mus.20431; Carre-Pierrat M, 2006, J MOL BIOL, V358, P387, DOI 10.1016/j.jmb.2006.02.037; Ceccarini M, 2005, J MOL BIOL, V354, P872, DOI 10.1016/j.jmb.2005.09.069; Chen BJ, 2010, EMBO J, V29, P3184, DOI 10.1038/emboj.2010.194; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Ghesquiere B, 2006, RAPID COMMUN MASS SP, V20, P2885, DOI 10.1002/rcm.2676; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; Grisoni K, 2003, J MOL BIOL, V332, P1037, DOI 10.1016/j.jmb.2003.08.021; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Lyssand JS, 2010, P NATL ACAD SCI USA, V107, P21854, DOI 10.1073/pnas.1010819107; Moerman D. G., 2006, WORMBOOK, DOI [/10.1895/wormbook.1.7.1, DOI 10.1895/WORMBOOK.1.7.1]; Nawrotzki R, 1998, J CELL SCI, V111, P2595; Newey SE, 2001, MOL CELL NEUROSCI, V17, P127, DOI 10.1006/mcne.2000.0918; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PARDO JV, 1983, J CELL BIOL, V97, P1081, DOI 10.1083/jcb.97.4.1081; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Poon E, 2002, J BIOL CHEM, V277, P3433, DOI 10.1074/jbc.M105273200; PORTER GA, 1992, J CELL BIOL, V117, P997, DOI 10.1083/jcb.117.5.997; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sancar F, 2011, J BIOL CHEM, V286, P33501, DOI 10.1074/jbc.M111.227678; Straub V, 1998, AM J PATHOL, V153, P1623, DOI 10.1016/S0002-9440(10)65751-3; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Williams MW, 1999, J CELL BIOL, V144, P1259, DOI 10.1083/jcb.144.6.1259; YOSHIDA M, 1995, FEBS LETT, V367, P311, DOI 10.1016/0014-5793(95)00574-S	43	17	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21717	21728		10.1074/jbc.M112.369496	http://dx.doi.org/10.1074/jbc.M112.369496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577143	Green Published, hybrid			2022-12-28	WOS:000306418600013
J	Smani, Y; Docobo-Perez, F; Lopez-Rojas, R; Dominguez-Herrera, J; Ibanez-Martinez, J; Pachon, J				Smani, Younes; Docobo-Perez, Fernando; Lopez-Rojas, Rafael; Dominguez-Herrera, Juan; Ibanez-Martinez, Jose; Pachon, Jeronimo			Platelet-activating Factor Receptor Initiates Contact of Acinetobacter baumannii Expressing Phosphorylcholine with Host Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; BLOOD-BRAIN-BARRIER; MEMBRANE PROTEIN-A; C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; NEISSERIA-GONORRHOEAE; ABIOTIC SURFACES; PAF RECEPTOR; IN-VITRO; LIPOPOLYSACCHARIDE	Adhesion is an initial and important step in Acinetobacter baumannii causing infections. However, the exact molecular mechanism of such a step between A. baumannii and the host cells remains unclear. Here, we demonstrated that the phosphorylcholine (ChoP)-containing outer membrane protein of A. baumannii binds to A549 cells through platelet-activating factor receptor (PAFR), resulting in activation of G protein and intracellular calcium. Upon A. baumannii expressing ChoP binding to PAFR, clathrin and beta-arrestins, proteins involved in the direction of the vacuolar movement, are activated during invasion of A. baumannii. PAFR antagonism restricts the dissemination of A. baumannii in the pneumonia model. These results define a role for PAFR in A. baumannii interaction with host cells and suggest a mechanism for the entry of A. baumannii into the cytoplasm of host cells.	[Smani, Younes; Docobo-Perez, Fernando; Lopez-Rojas, Rafael; Dominguez-Herrera, Juan; Pachon, Jeronimo] Univ Seville, Univ Hosp Virgen del Rocio, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS,CSIC, Seville 41013, Spain; [Ibanez-Martinez, Jose] Univ Hosp Virgen Macarena, Dept Pathol, Seville 41007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario Virgen Macarena	Smani, Y (corresponding author), Univ Seville, Univ Hosp Virgen del Rocio, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS,CSIC, Av Manuel Siurot S-N, Seville 41013, Spain.	y_smani@hotmail.com	, Smani/G-5314-2013; Dominguez-Herrera, Juan/T-6416-2018; Pachon, Jeronimo/M-4337-2014; Docobo-Perez, Fernando/R-2534-2016	, Smani/0000-0001-9302-8384; Dominguez-Herrera, Juan/0000-0002-2562-1415; Docobo-Perez, Fernando/0000-0003-4038-6764; Pachon, Jeronimo/0000-0002-8166-5308	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008/0000]	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases	Funded by the Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, co-financed by the European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases (Grant REIPI RD06/0008/0000). To whom correspondence should be addressed: Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocio. Av. Manuel Siurot s/n, 41013 Seville, Spain. Tel.: 34-955-923100; E-mail: y_smani@hotmail.com or ysmani-ibis@us.es.	Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Barbier M, 2008, EUR RESPIR J, V32, P1283, DOI 10.1183/09031936.00020608; Barbier M, 2008, J INFECT DIS, V197, P465, DOI 10.1086/525048; Bierne H, 2000, CELL MICROBIOL, V2, P465, DOI 10.1046/j.1462-5822.2000.00069.x; Buommino E, 1999, INFECT IMMUN, V67, P4794, DOI 10.1128/IAI.67.9.4794-4800.1999; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Cuenca FF, 2003, J BASIC MICROB, V43, P194, DOI 10.1002/jobm.200390022; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Karlsson C, 1998, EUR J BIOCHEM, V255, P296, DOI 10.1046/j.1432-1327.1998.2550296.x; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Lee JS, 2007, BIOCHEM PHARMACOL, V74, P86, DOI 10.1016/j.bcp.2007.02.012; Luke NR, 2010, INFECT IMMUN, V78, P2017, DOI 10.1128/IAI.00016-10; Lysenko E, 2000, MOL MICROBIOL, V35, P234, DOI 10.1046/j.1365-2958.2000.01707.x; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Rijneveld AW, 2004, J INFECT DIS, V189, P711, DOI 10.1086/381392; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Roca I, 2011, ANTIMICROB AGENTS CH, V55, P1285, DOI 10.1128/AAC.01142-10; Rodriguez-Hernandez MJ, 2000, J ANTIMICROB CHEMOTH, V45, P493, DOI 10.1093/jac/45.4.493; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; Serino L, 2000, MOL MICROBIOL, V35, P1550, DOI 10.1046/j.1365-2958.2000.01825.x; Smani T, 2007, CIRC RES, V101, P1194, DOI 10.1161/CIRCRESAHA.107.159053; Smani Y, 2012, CLIN MICROBIOL INFEC, V18, pE1, DOI 10.1111/j.1469-0691.2011.03695.x; Smani Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033073; Smani Y, 2011, J INFECT DIS, V203, P1110, DOI 10.1093/infdis/jiq159; Smani Y, 2011, MICROB PATHOGENESIS, V50, P224, DOI 10.1016/j.micpath.2011.01.008; Sukumaran SK, 2003, J BIOL CHEM, V278, P45753, DOI 10.1074/jbc.M307374200; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Swords WE, 2001, CELL MICROBIOL, V3, P525, DOI 10.1046/j.1462-5822.2001.00132.x; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Valero C, 2001, Eur J Intern Med, V12, P425, DOI 10.1016/S0953-6205(01)00150-9; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631; Weiser JN, 1998, INFECT IMMUN, V66, P4263; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x	50	36	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26901	26910		10.1074/jbc.M112.344556	http://dx.doi.org/10.1074/jbc.M112.344556			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689572	hybrid, Green Published			2022-12-28	WOS:000307386000038
J	Spoerri, L; Vella, LJ; Pham, CLL; Barnham, KJ; Cappai, R				Spoerri, Loredana; Vella, Laura J.; Pham, Chi L. L.; Barnham, Kevin J.; Cappai, Roberto			The Amyloid Precursor Protein Copper Binding Domain Histidine Residues 149 and 151 Mediate APP Stability and Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; BETA-PEPTIDE; BREFELDIN-A; CEREBROSPINAL-FLUID; ALPHA-SECRETASE; MESSENGER-RNA; CLEAVAGE	One of the key pathological hallmarks of Alzheimer disease (AD) is the accumulation of the APP-derived amyloid beta peptide A beta) in the brain. Altered copper homeostasis has also been reported in AD patients and is thought to increase oxidative stress and to contribute to toxic A beta accumulation and regulate APP metabolism. The potential involvement of the N-terminal APP copper binding domain CuBD) in these events has not been investigated. Based on the tertiary structure of the APP CuBD, we examined the histidine residues of the copper binding site His(147), His(149), and His(151)). We report that histidines 149 and 151 are crucial for CuBD stability and APP metabolism. Co-mutation of the APP CuBD His(149) and His(151) to asparagine decreased APP proteolytic processing, impaired APP endoplasmic reticulum-to-Golgi trafficking, and promoted aberrant APP oligomerization in HEK293 cells. Expression of the triple H147N/H149N/H151N-APP mutant led to up-regulation of the unfolded protein response. Using recombinant protein encompassing the APP CuBD, we found that insertion of asparagines at positions 149 and 151 altered the secondary structure of the domain. This study identifies two APP CuBD residues that are crucial for APP metabolism and suggests an additional role of this domain in APP folding and stability besides its previously identified copper binding activity. These findings are of major significance for the design of novel AD therapeutic drugs targeting this APP domain.	[Spoerri, Loredana; Vella, Laura J.; Pham, Chi L. L.; Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Spoerri, Loredana; Vella, Laura J.; Pham, Chi L. L.; Barnham, Kevin J.; Cappai, Roberto] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Mental Hlth Res Inst Victoria, Melbourne, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Cappai, R (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.	r.cappai@unimelb.edu.au	Spoerri, Loredana/G-4862-2014; Vella, laura/N-2733-2017; Cappai, Roberto/B-3347-2010	Spoerri, Loredana/0000-0003-0756-9390; Vella, laura/0000-0002-1869-6291; Cappai, Roberto/0000-0002-9505-8496	Australian Research Council; National Health and Medical Research Council; Melbourne International Fee Remission Scholarship; Beaney Scholarship; May Stewart Bursary postgraduate scholarship	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Fee Remission Scholarship; Beaney Scholarship; May Stewart Bursary postgraduate scholarship	This work was supported by grants from the Australian Research Council and the National Health and Medical Research Council.; Recipient of a Melbourne International Fee Remission Scholarship, a Beaney Scholarship, and a May Stewart Bursary postgraduate scholarship.	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; ANDERSON JP, 1992, J NEUROCHEM, V59, P2328; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Berg J. M., 2002, BIOCHEMISTRY-US, P64; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Botelho HM, 2009, FEBS J, V276, P1776, DOI 10.1111/j.1742-4658.2009.06912.x; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; CLARK AW, 1989, CAN J NEUROL SCI, V16, P477, DOI 10.1017/S0317167100029802; COHEN ML, 1988, P NATL ACAD SCI USA, V85, P1227, DOI 10.1073/pnas.85.4.1227; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Kapoor A, 2009, CLIN LIVER DIS, V13, P581, DOI 10.1016/j.cld.2009.07.004; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; Kong GKW, 2005, ACTA CRYSTALLOGR F, V61, P93, DOI 10.1107/S1744309104029744; Koo EH, 1996, J CELL SCI, V109, P991; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LADINSKY MS, 1992, EUR J CELL BIOL, V59, P92; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Low LY, 2002, J MOL BIOL, V319, P87, DOI 10.1016/S0022-2836(02)00236-X; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MERUTKA G, 1989, BIOCHEMISTRY-US, V28, P352, DOI 10.1021/bi00427a048; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Preece P, 2004, MOL BRAIN RES, V122, P1, DOI 10.1016/j.molbrainres.2003.08.022; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Sodhi CP, 2008, BRAIN RES, V1198, P204, DOI 10.1016/j.brainres.2008.01.031; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Squitti R, 2004, ARCH NEUROL-CHICAGO, V61, P738, DOI 10.1001/archneur.61.5.738; Squitti R, 2002, NEUROLOGY, V59, P1153, DOI 10.1212/WNL.59.8.1153; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; VITEK MP, 1989, NEUROBIOL AGING, V10, P471, DOI 10.1016/0197-4580(89)90102-4; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	62	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26840	26853		10.1074/jbc.M112.355743	http://dx.doi.org/10.1074/jbc.M112.355743			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685292	Green Published, hybrid			2022-12-28	WOS:000307386000033
J	Tokmakov, AA; Kurotani, A; Takagi, T; Toyama, M; Shirouzu, M; Fukami, Y; Yokoyama, S				Tokmakov, Alexander A.; Kurotani, Atsushi; Takagi, Tetsuo; Toyama, Mitsutoshi; Shirouzu, Mikako; Fukami, Yasuo; Yokoyama, Shigeyuki			Multiple Post-translational Modifications Affect Heterologous Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL GENOMICS; SUCCESSFUL EXPRESSION; TRANSLATION SYSTEM; RECEPTOR-BINDING; SWISS-MODEL; PREDICTION; IDENTIFICATION; PURIFICATION; PROTEOMICS	Post-translational modifications (PTMs) are required for proper folding of many proteins. The low capacity for PTMs hinders the production of heterologous proteins in the widely used prokaryotic systems of protein synthesis. Until now, a systematic and comprehensive study concerning the specific effects of individual PTMs on heterologous protein synthesis has not been presented. To address this issue, we expressed 1488 human proteins and their domains in a bacterial cell-free system, and we examined the correlation of the expression yields with the presence of multiple PTM sites bioinformatically predicted in these proteins. This approach revealed a number of previously unknown statistically significant correlations. Prediction of some PTMs, such as myristoylation, glycosylation, palmitoylation, and disulfide bond formation, was found to significantly worsen protein amenability to soluble expression. The presence of other PTMs, such as aspartyl hydroxylation, C-terminal amidation, and Tyr sulfation, did not correlate with the yield of heterologous protein expression. Surprisingly, the predicted presence of several PTMs, such as phosphorylation, ubiquitination, SUMOylation, and prenylation, was associated with the increased production of properly folded soluble proteins. The plausible rationales for the existence of the observed correlations are presented. Our findings suggest that identification of potential PTMs in polypeptide sequences can be of practical use for predicting expression success and optimizing heterologous protein synthesis. In sum, this study provides the most compelling evidence so far for the role of multiple PTMs in the stability and solubility of heterologously expressed recombinant proteins.	[Tokmakov, Alexander A.; Fukami, Yasuo] Kobe Univ, Res Ctr Environm Genom, Nada 6578501, Japan; [Tokmakov, Alexander A.; Fukami, Yasuo] Kobe Univ, Grad Sch Sci, Nada 6578501, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tokmakov, Alexander A.; Kurotani, Atsushi; Takagi, Tetsuo; Toyama, Mitsutoshi; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Kurotani, Atsushi] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Kobe University; Kobe University; University of Tokyo; RIKEN; RIKEN	Tokmakov, AA (corresponding author), Kobe Univ, Res Ctr Environm Genom, Nada Ku, Rokko Dai 1-1, Kobe, Hyogo 6578501, Japan.	tokmak@phoenix.kobe-u.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; 	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the RIKEN Structural Genomics/Proteomics Initiative and National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Amaya M, 2011, BIOCHEM BIOPH RES CO, V416, P1, DOI 10.1016/j.bbrc.2011.10.142; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bertone P, 2001, NUCLEIC ACIDS RES, V29, P2884, DOI 10.1093/nar/29.13.2884; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Chikayama E, 2004, BIOINFORMATICS, V20, P2836, DOI 10.1093/bioinformatics/bth276; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; DeLano W.L, PYMOL MOL GRAPHICS S; Ding HT, 2002, ACTA CRYSTALLOGR D, V58, P2102, DOI 10.1107/S0907444902016359; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Eckart MR, 1996, CURR OPIN BIOTECH, V7, P525, DOI 10.1016/S0958-1669(96)80056-5; Edison AS, 1999, J NEUROSCI, V19, P6318; Ezure T, 2006, BIOTECHNOL PROGR, V22, P1570, DOI 10.1021/bp060110v; Farrokhi Naser, 2009, V513, P175, DOI 10.1007/978-1-59745-427-8_10; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Gao JH, 2009, AM J TRANSL RES, V1, P312; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gigoux V, 1999, J BIOL CHEM, V274, P20457, DOI 10.1074/jbc.274.29.20457; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; He MY, 2008, NEW BIOTECHNOL, V25, P126, DOI 10.1016/j.nbt.2008.08.004; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Idicula-Thomas S, 2006, BIOINFORMATICS, V22, P278, DOI 10.1093/bioinformatics/bti810; In Y, 2005, FEBS J, V272, P5079, DOI 10.1111/j.1742-4658.2005.04919.x; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kim DM, 2004, BIOTECHNOL BIOENG, V85, P122, DOI 10.1002/bit.10865; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Kurotani A, 2010, FASEB J, V24, P1095, DOI 10.1096/fj.09-139527; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marsden Russell L., 2008, V426, P3, DOI 10.1007/978-1-60327-058-8_1; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Merrick WC, 2007, METHOD ENZYMOL, V429, P1, DOI 10.1016/S0076-6879(07)29001-9; Mikami S, 2006, PROTEIN EXPRES PURIF, V46, P348, DOI 10.1016/j.pep.2005.09.021; Mikami S, 2006, J BIOTECHNOL, V127, P65, DOI 10.1016/j.jbiotec.2006.06.018; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Saracco SA, 2009, PLANT J, V59, P344, DOI 10.1111/j.1365-313X.2009.03862.x; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seibert C, 2008, BIOPOLYMERS, V90, P459, DOI 10.1002/bip.20821; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Xu B, 2010, DEV BIOL, V348, P3, DOI 10.1016/j.ydbio.2010.08.018; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Yokoyama Shigeyuki, 2005, Tanpakushitsu Kakusan Koso, V50, P836; Yokoyama Shigeyuki, 2008, Tanpakushitsu Kakusan Koso, V53, P632; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	68	43	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27106	27116		10.1074/jbc.M112.366351	http://dx.doi.org/10.1074/jbc.M112.366351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22674579	Green Published, hybrid			2022-12-28	WOS:000307386000063
J	Corrales, RM; Molle, V; Leiba, J; Mourey, L; de Chastellier, C; Kremer, L				Corrales, Rosa Milagros; Molle, Virginie; Leiba, Jade; Mourey, Lionel; de Chastellier, Chantal; Kremer, Laurent			Phosphorylation of Mycobacterial PcaA Inhibits Mycolic Acid Cyclopropanation CONSEQUENCES FOR INTRACELLULAR SURVIVAL AND FOR PHAGOSOME MATURATION BLOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SER/THR PROTEIN-KINASES; STRUCTURAL-CHARACTERIZATION; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; MACROPHAGES; SYNTHASE; ARREST; FUSION; AVIUM; BIOSYNTHESIS	Pathogenic mycobacteria survive within macrophages by residing in phagosomes, which they prevent from maturing and fusing with lysosomes. Although several bacterial components were seen to modulate phagosome processing, the molecular regulatory mechanisms taking part in this process remain elusive. We investigated whether the phagosome maturation block (PMB) could be modulated by signaling through Ser/Thr phosphorylation. Here, we demonstrated that mycolic acid cyclopropane synthase PcaA, but not MmaA2, was phosphorylated by mycobacterial Ser/Thr kinases at Thr-168 and Thr-183 both in vitro and in mycobacteria. Phosphorylation of PcaA was associated with a significant decrease in the methyltransferase activity, in agreement with the strategic structural localization of these two phosphoacceptors. Using a BCG Delta pcaA mutant, we showed that PcaA was required for intracellular survival and prevention of phagosome maturation in human monocyte-derived macrophages. The physiological relevance of PcaA phosphorylation was further assessed by generating PcaA phosphoablative (T168A/T183A) or phosphomimetic (T168D/T183D) mutants. In contrast to the wild-type and phosphoablative pcaA alleles, introduction of the phosphomimetic pcaA allele in the Delta pcaA mutant failed to restore the parental mycolic acid profile and cording morphotype. Importantly, the PcaA phosphomimetic strain, as the Delta pcaA mutant, exhibited reduced survival in human macrophages and was unable to prevent phagosome maturation. Our results add new insight into the importance of mycolic acid cyclopropane rings in the PMB and provide the first evidence of a Ser/Thr kinase-dependent mechanism for modulating mycolic acid composition and PMB.	[de Chastellier, Chantal] Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM 2, F-13288 Marseille, France; [Corrales, Rosa Milagros; Molle, Virginie; Leiba, Jade; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Corrales, Rosa Milagros; Molle, Virginie; Leiba, Jade; Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Mourey, Lionel] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Mourey, Lionel] Univ Toulouse 3, Univ Toulouse, IPBS, F-31077 Toulouse, France; [de Chastellier, Chantal] INSERM, U1104, F-13288 Marseille, France; [de Chastellier, Chantal] CNRS, UMR7280, F-13288 Marseille, France; [Kremer, Laurent] INSERM, DIMNP, F-34095 Montpellier 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	de Chastellier, C (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM 2, F-13288 Marseille, France.	dechastellier@ciml.univ-mrs.fr; laurent.kremer@univ-montp2.fr	Mourey, Lionel/B-5662-2009; MOLLE, Virginie/D-4050-2019; Kremer, Laurent/M-4935-2017	Mourey, Lionel/0000-0002-8259-1259; MOLLE, Virginie/0000-0002-6573-3411; Kremer, Laurent/0000-0002-6604-4458	French National Research Agency [ANR-09-MIEN-004]; Institut National de la Sante et de la Recherche Medicale (INSERM); InfectioPole Sud; Region Languedoc-Roussillon; University of Montpellier 1	French National Research Agency(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); InfectioPole Sud; Region Languedoc-Roussillon(Region Ile-de-FranceRegion Occitanie); University of Montpellier 1	This work was supported by grants from the French National Research Agency (ANR-09-MIEN-004) (to V. M. and L. K.) and funds from the Institut National de la Sante et de la Recherche Medicale (INSERM) (to C. dC.). This work was also supported by the InfectioPole Sud (to R. M. C.) and Region Languedoc-Roussillon and the University of Montpellier 1 (to J. L.).	Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Bessoles S, 2009, EUR J IMMUNOL, V39, P1025, DOI 10.1002/eji.200838929; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; de Chastellier C, 2009, CELL MICROBIOL, V11, P1190, DOI 10.1111/j.1462-5822.2009.01324.x; DECHASTELLIER C, 1987, EUR J CELL BIOL, V44, P112; DECHASTELLIER C, 1993, INFECT IMMUN, V61, P3775, DOI 10.1128/IAI.61.9.3775-3784.1993; deChastellier C, 1997, EUR J CELL BIOL, V74, P49; DECHASTELLIER C, 1995, EUR J CELL BIOL, V68, P167; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; FREHEL C, 1986, INFECT IMMUN, V52, P252, DOI 10.1128/IAI.52.1.252-262.1986; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3	48	46	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26187	26199		10.1074/jbc.M112.373209	http://dx.doi.org/10.1074/jbc.M112.373209			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22621931	Green Published, hybrid			2022-12-28	WOS:000306916300046
J	Ramakrishnan, G; Sen, B; Johnson, R				Ramakrishnan, Girija; Sen, Bhaswati; Johnson, Richard			Paralogous Outer Membrane Proteins Mediate Uptake of Different Forms of Iron and Synergistically Govern Virulence in Francisella tularensis tularensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE VACCINE STRAIN; MACROPHAGES; SIDEROPHORE; TULAREMIA; GROWTH; IDENTIFICATION; ACQUISITION; MODULATION; BACTERIA; ESCAPE	Francisella tularensis subsp. tularensis is a highly infectious bacterium causing acute disease in mammalian hosts. Mechanisms for the acquisition of iron within the iron-limiting host environment are likely to be critical for survival of this intracellular pathogen. FslE (FTT0025) and FupA (FTT0918) are paralogous proteins that are predicted to form beta-barrels in the outer membrane of virulent strain Schu S4 and are unique to Francisella species. Previous studies have implicated both FupA, initially identified as a virulence factor and FslE, encoded by the siderophore biosynthetic operon, in iron acquisition. Using single and double mutants, we demonstrated that these paralogs function in concert to promote growth under iron limitation. We used a Fe-55 transport assay to demonstrate that FslE is involved in siderophore-mediated ferric iron uptake, whereas FupA facilitates high affinity ferrous iron uptake. Optimal replication within J774A.1 macrophage-like cells required at least one of these uptake systems to be functional. In a mouse model of tularemia, the Delta fupA mutant was attenuated, but the Delta fslE Delta fupA mutant was significantly more attenuated, implying that the two systems of iron acquisition function synergistically to promote virulence. These studies highlight the importance of specific iron acquisition functions, particularly that of ferrous iron, for virulence of F. tularensis in the mammalian host.	[Ramakrishnan, Girija; Sen, Bhaswati; Johnson, Richard] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22901 USA	University of Virginia	Ramakrishnan, G (corresponding author), Univ Virginia, Dept Med, Div Infect Dis, POB 801340, Charlottesville, VA 22908 USA.	girija@virginia.edu			National Institutes of Health Grant [AI067823]; University of Virginia School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067823] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI067823 (to G.R.). This work was also supported by intramural funding from the University of Virginia School of Medicine.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; ABEL K, 1963, J BACTERIOL, V85, P1039, DOI 10.1128/JB.85.5.1039-1044.1963; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANTHONY LSD, 1988, INFECT IMMUN, V56, P2089, DOI 10.1128/IAI.56.8.2089-2093.1988; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Asare R, 2010, ENVIRON MICROBIOL, V12, P2587, DOI 10.1111/j.1462-2920.2010.02230.x; Asare R, 2010, ENVIRON MICROBIOL, V12, P2559, DOI 10.1111/j.1462-2920.2010.02229.x; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bagos PG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-29; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Buchan BW, 2008, APPL ENVIRON MICROB, V74, P2637, DOI 10.1128/AEM.02882-07; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chatfield CH, 2012, MICROBIOL-SGM, V158, P721, DOI 10.1099/mic.0.055533-0; Chatfield CH, 2011, J BACTERIOL, V193, P1563, DOI 10.1128/JB.01111-10; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Conlan J Wayne, 2011, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1914s93; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Dhungana S, 2007, APPL ENVIRON MICROB, V73, P3428, DOI 10.1128/AEM.02586-06; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hohle TH, 2011, P NATL ACAD SCI USA, V108, P15390, DOI 10.1073/pnas.1110137108; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Nallaparaju KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018201; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Pan X, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-64; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Ramakrishnan G, 2008, J BACTERIOL, V190, P5353, DOI 10.1128/JB.00181-08; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Santic M, 2009, ENVIRON MICROBIOL, V11, P1473, DOI 10.1111/j.1462-2920.2009.01875.x; Sen B, 2010, INFECT IMMUN, V78, P4276, DOI 10.1128/IAI.00503-10; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SHENKER M, 1995, SOIL SCI SOC AM J, V59, P1612, DOI 10.2136/sssaj1995.03615995005900060015x; Siddaramappa S, 2011, APPL ENVIRON MICROB, V77, P5110, DOI 10.1128/AEM.00337-11; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104	51	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25191	25202		10.1074/jbc.M112.371856	http://dx.doi.org/10.1074/jbc.M112.371856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661710	hybrid, Green Published			2022-12-28	WOS:000306651700029
J	Sun, R; Eriksson, S; Wang, LY				Sun, Ren; Eriksson, Staffan; Wang, Liya			Oxidative Stress Induced S-glutathionylation and Proteolytic Degradation of Mitochondrial Thymidine Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA DEPLETION MYOPATHY; PROTEIN GLUTATHIONYLATION; MUTATIONS; MECHANISM; DYSFUNCTION; CANCER; DAMAGE	Protein glutathionylation in response to oxidative stress can affect both the stability and activity of target proteins. Mitochondrial thymidine kinase 2 (TK2) is a key enzyme in mitochondrial DNA precursor synthesis. Using an antibody specific for glutathione (GSH), S-glutathionylated TK2 was detected after the addition of glutathione disulfide (GSSG) but not GSH. This was reversed by the addition of dithiothreitol, suggesting that S-glutathionylation of TK2 is reversible. Site-directed mutagenesis of the cysteine residues and subsequent analysis of mutant enzymes demonstrated that Cys-189 and Cys-264 were specifically glutathionylated by GSSG. These cysteine residues do not appear to be part of the active site, as demonstrated by kinetic studies of the mutant enzymes. Treatment of isolated rat mitochondria with hydrogen peroxide resulted in S-glutathionylation of added recombinant TK2. Treatment of intact cells with hydrogen peroxide led to reduction of mitochondrial TK2 activity and protein levels, as well as S-glutathionylation of TK2. Furthermore, the addition of S-glutathionylated recombinant TK2 to mitochondria isolated from hydrogen peroxide-treated cells led to degradation of the S-glutathionylated TK2, which was not observed with unmodified TK2. S-Glutathionylation on Cys-189 was responsible for the observed selective degradation of TK2 in mitochondria. These results strongly suggest that oxidative damage-induced S-glutathionylation and degradation of TK2 have significant impact on mitochondrial DNA precursor synthesis.	[Sun, Ren; Eriksson, Staffan; Wang, Liya] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden	Swedish University of Agricultural Sciences	Wang, LY (corresponding author), Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, Box 575, SE-75123 Uppsala, Sweden.	liya.wang@slu.se			Swedish Research Council; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning(Swedish Research Council Formas)	This work was supported by a grant from the Swedish Research Council and in part by a grant from the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning.	Anathy V, 2012, ANTIOXID REDOX SIGN, V16, P496, DOI 10.1089/ars.2011.4281; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bulteau AL, 2012, BBA-MOL BASIS DIS, V1822, P212, DOI 10.1016/j.bbadis.2011.11.003; Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Gotz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236; Graham JM, 1999, CURRENT PROTOCOLS CE, P331; Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; Kline ER, 2009, CARDIOVASC TOXICOL, V9, P1, DOI 10.1007/s12012-008-9029-8; Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013; Liedhegner EAS, 2012, ANTIOXID REDOX SIGN, V16, P543, DOI 10.1089/ars.2011.4119; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Sun R, 2010, NUCLEOS NUCLEOT NUCL, V29, P382, DOI 10.1080/15257771003741018; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438; Ugarte N, 2010, ANTIOXID REDOX SIGN, V13, P539, DOI 10.1089/ars.2009.2998; Verschoor ML, 2010, CAN J PHYSIOL PHARM, V88, P204, DOI 10.1139/Y09-135; Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6; Wang L, 2011, ANTIMICROB AGENTS CH, V55, P2552, DOI 10.1128/AAC.00109-11; Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005; Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200; Yusuf MA, 2010, FREE RADICAL BIO MED, V49, P908, DOI 10.1016/j.freeradbiomed.2010.06.020	35	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24304	24312		10.1074/jbc.M112.381996	http://dx.doi.org/10.1074/jbc.M112.381996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22661713	Green Published, hybrid			2022-12-28	WOS:000306651100024
J	Yang, J; Dolinger, M; Ritaccio, G; Mazurkiewicz, J; Conti, D; Zhu, XJ; Huang, YF				Yang, Jun; Dolinger, Michael; Ritaccio, Gabrielle; Mazurkiewicz, Joseph; Conti, David; Zhu, Xinjun; Huang, Yunfei			Leucine Stimulates Insulin Secretion via Down-regulation of Surface Expression of Adrenergic alpha 2A Receptor through the mTOR ( Mammalian Target of Rapamycin) Pathway IMPLICATION IN NEW-ONSET DIABETES IN RENAL TRANSPLANTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; AMINO-ACIDS; KIDNEY-TRANSPLANT; GLUCOSE-HOMEOSTASIS; BLOOD-GLUCOSE; RISK-FACTORS; METABOLISM; ISLETS; INHIBITION; MELLITUS	The amino acid leucine is a potent secretagogue, capable of inducing insulin secretion. It also plays an important role in the regulation of mTOR activity, therefore, providing impetus to investigate if a leucine-sensing mechanism in the mTOR pathway is involved in insulin secretion. We found that leucine-induced insulin secretion was inhibited by both the mTOR inhibitor rapamycin as well as the adrenergic alpha 2 receptor agonist clonidine. We also demonstrated that leucine down-regulated the surface expression of adrenergic alpha 2A receptor via activation of the mTOR pathway. The leucine stimulatory effect on insulin secretion was attenuated in diabetic Goto-Kakizaki rats that overexpress adrenergic alpha 2A receptors, confirming the role of leucine in insulin secretion. Thus, our data demonstrate that leucine regulates insulin secretion by modulating adrenergic alpha 2 receptors through the mTOR pathway. The role of the mTOR pathway in metabolic homeostasis led us to a second important finding in this study; retrospective analysis of clinical data showed that co-administration of rapamycin and clonidine was associated with an increased incidence of new-onset diabetes in renal transplantation patients over those receiving rapamycin alone. We believe that inhibition of mTOR by rapamycin along with activation of adrenergic alpha 2 receptors by clonidine represents a double-hit to pancreatic islets that synergistically disturbs glucose homeostasis. This new insight may have important implications for the clinical management of renal transplant patients.	[Yang, Jun; Mazurkiewicz, Joseph; Huang, Yunfei] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Yang, Jun; Zhu, Xinjun] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Yang, Jun; Dolinger, Michael; Ritaccio, Gabrielle; Zhu, Xinjun] Albany Med Coll, Div Gastroenterol, Dept Internal Med, Albany, NY 12208 USA; [Conti, David] Albany Med Coll, Dept Transplant Surg, Albany, NY 12208 USA	Albany Medical College; Albany Medical College; Albany Medical College; Albany Medical College	Huang, YF (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	huangy@mail.amc.edu	Dolinger, Michael/AAU-4784-2021; huang, yunfei/HCH-7746-2022	Dolinger, Michael/0000-0002-9023-4948; 	National Institutes of Health [NS062068, K08DK088950]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK088950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS062068 (NINDS; to Y. H.) and K08DK088950 (NIDDK and The GI IBD Research Fund by Michael Kerr, to X. Z.).	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bernard JR, 2011, AM J PHYSIOL-ENDOC M, V300, pE752, DOI 10.1152/ajpendo.00643.2010; Branstrom R, 1998, J BIOL CHEM, V273, P14113, DOI 10.1074/jbc.273.23.14113; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578; Devedjian JC, 2000, DIABETOLOGIA, V43, P899, DOI 10.1007/s001250051467; DITULLIO NW, 1984, J PHARMACOL EXP THER, V228, P168; Fagerholm V, 2011, BASIC CLIN PHARMACOL, V108, P365, DOI 10.1111/j.1742-7843.2011.00699.x; FLOYD JC, 1968, J CLIN ENDOCR METAB, V28, P266, DOI 10.1210/jcem-28-2-266; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; FRIEDMAN EA, 1985, AM J NEPHROL, V5, P196, DOI 10.1159/000166932; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; Giroix MH, 1999, DIABETOLOGIA, V42, P965; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; GUTHRIE GP, 1983, CLIN PHARMACOL THER, V34, P713, DOI 10.1038/clpt.1983.239; Gyurus E, 2011, TRANSPL P, V43, P1583, DOI 10.1016/j.transproceed.2011.05.001; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; HUTTON JC, 1980, J BIOL CHEM, V255, P7340; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Jonkers FC, 2001, DIABETES, V50, P540, DOI 10.2337/diabetes.50.3.540; Kalogeropoulo D, 2008, METABOLISM, V57, P1747, DOI 10.1016/j.metabol.2008.09.001; Kaposztas Z, 2011, TRANSPL P, V43, P1375, DOI 10.1016/j.transproceed.2011.04.008; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; MACDONALD MJ, 1991, J BIOL CHEM, V266, P1335; MALAISSE WJ, 1980, DIABETES, V29, P431, DOI 10.2337/diabetes.29.6.431; Mangray M, 2011, AM J KIDNEY DIS, V57, P331, DOI 10.1053/j.ajkd.2010.10.048; MILNER RDG, 1970, J ENDOCRINOL, V47, P347, DOI 10.1677/joe.0.0470347; Peterhoff M, 2003, EUR J ENDOCRINOL, V149, P343, DOI 10.1530/eje.0.1490343; Reis MAB, 1997, J NUTR, V127, P403, DOI 10.1093/jn/127.3.403; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Saunders C, 1999, PHARMACOL THERAPEUT, V84, P193, DOI 10.1016/S0163-7258(99)00032-7; Sharif A, 2010, NAT REV NEPHROL, V6, P415, DOI 10.1038/nrneph.2010.66; Shimodahira M, 2010, J ENDOCRINOL, V204, P37, DOI 10.1677/JOE-09-0216; Smith PA, 1997, J PHYSIOL-LONDON, V499, P625, DOI 10.1113/jphysiol.1997.sp021955; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x	42	44	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24795	24806		10.1074/jbc.M112.344259	http://dx.doi.org/10.1074/jbc.M112.344259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645144	Green Published, hybrid			2022-12-28	WOS:000306651100072
J	Chollangi, S; Thompson, JW; Ruiz, JC; Gardner, KH; Bruick, RK				Chollangi, Srinivas; Thompson, Joel W.; Ruiz, Julio C.; Gardner, Kevin H.; Bruick, Richard K.			Hemerythrin-like Domain within F-box and Leucine-rich Repeat Protein 5 (FBXL5) Communicates Cellular Iron and Oxygen Availability by Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN-2; CYTOSOLIC ACONITASE; RESPONSIVE ELEMENT; MOLECULAR CONTROL; BINDING ACTIVITY; HOMEOSTASIS; METABOLISM; CELLS; DISEASE; LIGASE	Iron regulatory proteins play a principal role in maintaining cellular iron homeostasis by post-transcriptionally regulating factors responsible for iron uptake, utilization, and storage. An E3 ubiquitin ligase complex containing FBXL5 targets IRP2 for proteasomal degradation under iron- and oxygen-replete conditions, whereas FBXL5 itself is degraded when iron and oxygen availability decreases. FBXL5 contains a hemerythrin-like (Hr) domain at its N terminus that mediates its own differential stability. Here, we investigated the iron- and oxygen-dependent conformational changes within FBXL5-Hr that underlie its role as a cellular sensor. As predicted, FBXL5-Hr undergoes substantive structural changes when iron becomes limiting, accounting for its switch-like behavior. However, these same changes are not observed in response to oxygen depletion, indicating that this domain accommodates two distinct sensing mechanisms. Moreover, FBXL5-Hr does not behave as a dynamic sensor that continuously samples the cellular environment, assuming conformations in equilibrium with ever-changing cellular iron levels. Instead, the isolated domain appears competent to incorporate iron only at or near the time of its own synthesis. These observations have important implications for mechanisms by which these metabolites are sensed within mammalian cells.	[Chollangi, Srinivas; Thompson, Joel W.; Ruiz, Julio C.; Gardner, Kevin H.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bruick, RK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu	Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556; Thompson, Joel/0000-0002-5131-3248	Graduate Programs Initiative from University of Texas Board of Regents; Sara and Frank McKnight graduate student fellowship; Burroughs Wellcome Fund; Robert A. Welch Foundation [I-1568]; National Institutes of Health [HL102481]; National Center for Research Resources, National Institutes of Health [C06 RR 15437-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102481] Funding Source: NIH RePORTER	Graduate Programs Initiative from University of Texas Board of Regents; Sara and Frank McKnight graduate student fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Graduate Programs Initiative from the University of Texas Board of Regents.; Howard Hughes Medical Institute Scholar. Supported by a Sara and Frank McKnight graduate student fellowship.; Michael L. Rosenberg Scholar in Medical Research. Supported by a career award in the biomedical sciences from the Burroughs Wellcome Fund, Robert A. Welch Foundation Grant I-1568, and National Institutes of Health Grant HL102481. To whom correspondence should be addressed: University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Tel.: 214-648-6477; Fax: 214-648-0320; E-mail: richard. bruick@utsouthwestern.edu.; We thank Thomas Scheuermann (University of Texas Southwestern Medical Center) for assistance with the NMR studies. This work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR 15437-01 from the National Center for Research Resources, National Institutes of Health.	Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Beinert H, 1978, Methods Enzymol, V54, P435; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Chen HB, 2005, TOXICOL APPL PHARM, V206, P275, DOI 10.1016/j.taap.2004.11.011; Crooks DR, 2007, J NEUROSCI RES, V85, P1797, DOI 10.1002/jnr.21321; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FEIG AL, 1994, CHEM REV, V94, P759, DOI 10.1021/cr00027a011; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Martelli A, 2004, J INORG BIOCHEM, V98, P1413, DOI 10.1016/j.jinorgbio.2004.04.011; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Niles BJ, 2008, J BIOL CHEM, V283, P5168, DOI 10.1074/jbc.M709043200; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; ROBBINS AH, 1989, PROTEINS, V5, P289, DOI 10.1002/prot.340050406; ROBBINS AH, 1985, J BIOL CHEM, V260, P2328; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Shu C, 2012, CHEMBIOCHEM, V13, P788, DOI 10.1002/cbic.201200043; SLATER ML, 1976, CELL, V7, P289, DOI 10.1016/0092-8674(76)90028-3; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; Traverso ME, 2010, BIOCHEMISTRY-US, V49, P7060, DOI 10.1021/bi100866b; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; VUISTER GW, 1992, J BIOMOL NMR, V2, P401, DOI 10.1007/BF01874818; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; ZENG GC, 1984, MOL CELL BIOL, V4, P1815, DOI 10.1128/MCB.4.9.1815; ZHANG JH, 1992, P NATL ACAD SCI USA, V89, P7065, DOI 10.1073/pnas.89.15.7065	38	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23710	23717		10.1074/jbc.M112.360404	http://dx.doi.org/10.1074/jbc.M112.360404			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22648410	Green Published, hybrid			2022-12-28	WOS:000306511300041
J	Clausen, TM; Christoffersen, S; Dahlback, M; Langkilde, AE; Jensen, KE; Resende, M; Agerbaek, MO; Andersen, D; Berisha, B; Ditlev, SB; Pinto, VV; Nielsen, MA; Theander, TG; Larsen, S; Salanti, A				Clausen, Thomas M.; Christoffersen, Stig; Dahlback, Madeleine; Langkilde, Annette Eva; Jensen, Kamilla E.; Resende, Mafalda; Agerbaek, Mette O.; Andersen, Daniel; Berisha, Besim; Ditlev, Sisse B.; Pinto, Vera V.; Nielsen, Morten A.; Theander, Thor G.; Larsen, Sine; Salanti, Ali			Structural and Functional Insight into How the Plasmodium falciparum VAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTED ERYTHROCYTES; VACCINE CANDIDATE; PREGNANCY; DOMAINS; ADHERENCE; ADHESION; IDENTIFICATION; PROTEOGLYCANS; EXPRESSION; PFEMP1	Malaria is a major global health problem. Pregnant women are susceptible to infection regardless of previously acquired immunity. Placental malaria is caused by parasites capable of sequestering in the placenta. This is mediated by VAR2CSA, a parasite antigen that interacts with chondroitin sulfateA(CSA). One vaccine strategy is to block this interaction with VAR2CSA-specific antibodies. It is a priority to define a small VAR2CSA fragment that can be used in an adhesion blocking vaccine. In this, the obvious approach is to define regions of VAR2CSA involved in receptor binding. It has been shown that full-length recombinant VAR2CSA binds specifically to CSA with nanomolar affinity, and that the CSA-binding site lies in the N-terminal part of the protein. In this study we define the minimal binding region by truncating VAR2CSA and analyzing CSA binding using biosensor technology. We show that the core CSA-binding site lies within the DBL2X domain and parts of the flanking interdomain regions. This is in contrast to the idea that single domains do not possess the structural requirements for specific CSA binding. Small-angle x-ray scattering measurements enabled modeling of VAR2CSA and showed that the CSA-binding DBL2X domain is situated in the center of the structure. Mutating classic sulfate-binding sites in VAR2CSA, along with testing dependence of ionic interactions, suggest that the CSA binding is not solely dependent on the sulfated CSA structure. Based on these novel PfEMP1 structure-function studies, we have constructed a small VAR2CSA antigen that has the capacity to induce highly adhesion-blocking antibodies.	[Clausen, Thomas M.; Dahlback, Madeleine; Jensen, Kamilla E.; Resende, Mafalda; Agerbaek, Mette O.; Andersen, Daniel; Berisha, Besim; Ditlev, Sisse B.; Pinto, Vera V.; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali] Rigshosp, Copenhagen Univ Hosp, Ctr Med Parasitol, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Clausen, Thomas M.; Dahlback, Madeleine; Jensen, Kamilla E.; Resende, Mafalda; Agerbaek, Mette O.; Andersen, Daniel; Berisha, Besim; Ditlev, Sisse B.; Pinto, Vera V.; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali] Rigshosp, Copenhagen Univ Hosp, Dept Int Hlth Immunol & Microbiol, DK-2100 Copenhagen, Denmark; [Christoffersen, Stig; Larsen, Sine] Univ Copenhagen, Dept Chem, DK-1014 Copenhagen, Denmark; [Langkilde, Annette Eva] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-1014 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Clausen, TM (corresponding author), Univ Copenhagen, CSS, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Oster Farigmagsgade 5A, DK-1014 Copenhagen K, Denmark.	tmc@sund.ku.dk; Stig@chem.ku.dk; Salanti@sund.ku.dk	Larsen, Sine/A-4487-2017; Theander, Thor/F-6714-2015	Larsen, Sine/0000-0003-3848-1789; Theander, Thor/0000-0002-3509-7514; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711; Nielsen, Morten Agertoug/0000-0003-2668-4992; Langkilde, Annette Eva/0000-0003-2467-4205; Agerbaek, Mette Orskov/0000-0001-5865-2034	Lundbeck Foundation; Danish Council for Independent Research Medical Sciences, Sapere Aude; University of Copenhagen-Programme of Excellence; Novo Nordisk Foundation; Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research Medical Sciences, Sapere Aude; University of Copenhagen-Programme of Excellence; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU	This work was supported grants from the Lundbeck Foundation and the Danish Council for Independent Research Medical Sciences, Sapere Aude (to A. E. L.), the University of Copenhagen-Programme of Excellence (to S. C.), the Novo Nordisk Foundation, Danish National Advanced Technology Foundation, and Proof of Concept Foundation DTU (to T. M. C., A. S., and M. N.).	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Avril M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-143; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; FALLER B, 1992, BIOCHEMISTRY-US, V31, P8285, DOI 10.1021/bi00150a023; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gruber A, 2011, INFECT IMMUN, V79, P2880, DOI 10.1128/IAI.01326-10; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Klein MM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000147; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; McGregor I A, 1987, Parassitologia, V29, P153; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	43	123	132	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23332	23345		10.1074/jbc.M112.348839	http://dx.doi.org/10.1074/jbc.M112.348839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22570492	Green Published, hybrid			2022-12-28	WOS:000306511300007
J	Kensche, T; Tokunaga, F; Ikeda, F; Goto, E; Iwai, K; Dikic, I				Kensche, Tobias; Tokunaga, Fuminori; Ikeda, Fumiyo; Goto, Eiji; Iwai, Kazuhiro; Dikic, Ivan			Analysis of Nuclear Factor-kappa B (NF-kappa B) Essential Modulator (NEMO) Binding to Linear and Lysine-linked Ubiquitin Chains and Its Role in the Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; ASSEMBLY COMPLEX; STRUCTURAL BASIS; RECOGNITION; SPECIFICITY; DOMAIN; COMPONENT; EXPLAINS; SHARPIN; C-IAP1	Nuclear factor-kappa B (NF-kappa B) essential modulator (NEMO), a component of the inhibitor of kappa B kinase (IKK) complex, controls NF-kappa B signaling by binding to ubiquitin chains. Structural studies of NEMO provided a rationale for the specific binding between the UBAN (ubiquitin binding in ABIN and NEMO) domain of NEMO and linear (Met-1-linked) di-ubiquitin chains. Full-length NEMO can also interact with Lys-11-, Lys-48-, and Lys-63-linked ubiquitin chains of varying length in cells. Here, we show that purified full-length NEMO binds preferentially to linear ubiquitin chains in competition with lysine-linked ubiquitin chains of defined length, including long Lys-63-linked deca-ubiquitins. Linear di-ubiquitins were sufficient to activate both the IKK complex in vitro and to trigger maximal NF-kappa B activation in cells. In TNF alpha-stimulated cells, NEMO chimeras engineered to bind exclusively to Lys-63-linked ubiquitin chains mediated partial NF-kappa B activation compared with cells expressing NEMO that binds to linear ubiquitin chains. We propose that NEMO functions as a high affinity receptor for linear ubiquitin chains and a low affinity receptor for long lysine-linked ubiquitin chains. This phenomenon could explain quantitatively distinct NF-kappa B activation patterns in response to numerous cell stimuli.	[Kensche, Tobias; Ikeda, Fumiyo; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Buchmann Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Kensche, Tobias; Ikeda, Fumiyo; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biol 2, D-60590 Frankfurt, Germany; [Tokunaga, Fuminori; Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Suita, Osaka 5650871, Japan; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Suita, Osaka 5650871, Japan; [Tokunaga, Fuminori; Goto, Eiji] Gunma Univ, Inst Mol & Cellular Regulat, Mol Cell Biol Lab, Maebashi, Gunma 3718512, Japan	Goethe University Frankfurt; Goethe University Frankfurt; Osaka University; Osaka University; Gunma University	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Buchmann Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Ikeda, Fumiyo/AAD-3770-2020; Dikic, Ivan/O-4650-2015; IWAI, KAZUHIRO/GSN-7385-2022	Ikeda, Fumiyo/0000-0003-0407-2768; Dikic, Ivan/0000-0001-8156-9511; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Targeted Proteins Research Program	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and the Targeted Proteins Research Program (to K. I.).	Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Saito N, 2003, J BIOL CHEM, V278, P46565, DOI 10.1074/jbc.M302549200; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	30	74	76	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23626	23634		10.1074/jbc.M112.347195	http://dx.doi.org/10.1074/jbc.M112.347195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605335	hybrid, Green Published			2022-12-28	WOS:000306511300033
J	Niki, M; Niki, M; Tateishi, Y; Ozeki, Y; Kirikae, T; Lewin, A; Inoue, Y; Matsumoto, M; Dahl, JL; Ogura, H; Kobayashi, K; Matsumoto, S				Niki, Makoto; Niki, Mamiko; Tateishi, Yoshitaka; Ozeki, Yuriko; Kirikae, Teruo; Lewin, Astrid; Inoue, Yusuke; Matsumoto, Makoto; Dahl, John L.; Ogura, Hisashi; Kobayashi, Kazuo; Matsumoto, Sohkichi			A Novel Mechanism of Growth Phase-dependent Tolerance to Isoniazid in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALASE-PEROXIDASE GENE; HISTONE-LIKE PROTEIN; DNA-BINDING PROTEIN; PENICILLIN TOLERANCE; KATG EXPRESSION; BOVIS BCG; TUBERCULOSIS; RESISTANCE; SMEGMATIS; SUSCEPTIBILITY	Tuberculosis remains one of the most deadly infectious diseases worldwide and is a leading public health problem. Although isoniazid (INH) is a key drug for the treatment of tuberculosis, tolerance to INH necessitates prolonged treatment, which is a concern for effective tuberculosis chemotherapy. INH is a prodrug that is activated by the mycobacterial enzyme, KatG. Here, we show that mycobacterial DNA-binding protein 1 (MDP1), which is a histone-like protein conserved in mycobacteria, negatively regulates katG transcription and leads to phenotypic tolerance to INH in mycobacteria. Mycobacterium smegmatis deficient for MDP1 exhibited increased expression of KatG and showed enhanced INH activation compared with the wild-type strain. Expression of MDP1 was increased in the stationary phase and conferred growth phase-dependent tolerance to INH in M. smegmatis. Regulation of KatG expression is conserved between M. smegmatis and Mycobacterium tuberculosis complex. Artificial reduction of MDP1 in Mycobacterium bovis BCG was shown to lead to increased KatG expression and susceptibility to INH. These data suggest a mechanism by which phenotypic tolerance to INH is acquired in mycobacteria.	[Niki, Makoto; Niki, Mamiko; Tateishi, Yoshitaka; Ozeki, Yuriko; Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, Osaka 5458585, Japan; [Ogura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Virol, Abeno Ku, Osaka 5458585, Japan; [Tateishi, Yoshitaka] Toneyama Natl Hosp, Natl Hosp Org, Dept Internal Med, Toyonaka, Osaka 5608552, Japan; [Ozeki, Yuriko] Sonoda Womens Univ, Dept Food & Nutr, Amagasaki, Hyogo 6618520, Japan; [Kirikae, Teruo] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo 1628655, Japan; [Lewin, Astrid] Robert Koch Inst, D-13353 Berlin, Germany; [Inoue, Yusuke; Matsumoto, Makoto] Otsuka Pharmaceut Co Ltd, Microbiol Res Inst, Kawaguchi, Tokushima 7710192, Japan; [Dahl, John L.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan	Osaka Metropolitan University; Osaka Metropolitan University; National Center for Global Health & Medicine - Japan; Robert Koch Institute; Otsuka Pharmaceutical; University of Minnesota System; University of Minnesota Duluth; National Institute of Infectious Diseases (NIID)	Niki, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	myoshi@med.osaka-cu.ac.jp; sohkichi@med.osaka-cu.ac.jp		Matsumoto, Sohkichi/0000-0002-6106-7538	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants); Japan Health Sciences Foundation; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Grants-in-Aid for Scientific Research [24501015] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants)(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, the Ministry of Health, Labor, and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants), The Japan Health Sciences Foundation, and The United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy.	Ando H, 2011, MOL MICROBIOL, V79, P1615, DOI 10.1111/j.1365-2958.2011.07547.x; Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Blasco B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002621; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; BROWN BA, 1992, ANTIMICROB AGENTS CH, V36, P1987, DOI 10.1128/AAC.36.9.1987; Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Dick T, 1998, FEMS MICROBIOL LETT, V163, P159, DOI 10.1111/j.1574-6968.1998.tb13040.x; GOODELL EW, 1978, ANTIMICROB AGENTS CH, V13, P514, DOI 10.1128/AAC.13.3.514; HANDWERGER S, 1985, REV INFECT DIS, V7, P368; Herbert D, 1996, ANTIMICROB AGENTS CH, V40, P2296, DOI 10.1128/AAC.40.10.2296; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; HILLAR A, 1995, ARCH BIOCHEM BIOPHYS, V323, P438, DOI 10.1006/abbi.1995.0065; HORNE D, 1981, ANTIMICROB AGENTS CH, V20, P128, DOI 10.1128/AAC.20.1.128; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; Katsube T, 2007, J BACTERIOL, V189, P8241, DOI 10.1128/JB.00550-07; KIM KS, 1987, J ANTIMICROB CHEMOTH, V19, P475, DOI 10.1093/jac/19.4.475; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Lewin A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-91; Matsumoto S, 1999, MICROBIOL IMMUNOL, V43, P1027, DOI 10.1111/j.1348-0421.1999.tb01232.x; Matsumoto S, 2000, FEMS MICROBIOL LETT, V182, P297, DOI 10.1016/S0378-1097(99)00606-0; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Miesel L, 1998, J BACTERIOL, V180, P2459, DOI 10.1128/JB.180.9.2459-2467.1998; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ormerod LP, 2008, THORAX, V63, P388, DOI 10.1136/thx.2007.077610; PETTIJOHN DE, 1988, J BIOL CHEM, V263, P12793; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Smith AL, 2003, CHEST, V123, P1495, DOI 10.1378/chest.123.5.1495; Takatsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020985; Timmins GS, 2004, ANTIMICROB AGENTS CH, V48, P3006, DOI 10.1128/AAC.48.8.3006-3009.2004; TUOMANEN E, 1986, REV INFECT DIS, V8, pS279; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; WALLACE RJ, 1986, J CLIN MICROBIOL, V24, P976, DOI 10.1128/JCM.24.6.976-981.1986; Wallis RS, 1999, ANTIMICROB AGENTS CH, V43, P2600, DOI 10.1128/AAC.43.11.2600; Whiteford DC, 2011, MICROBIOL-SGM, V157, P327, DOI 10.1099/mic.0.045518-0; Wilson TM, 1996, MOL MICROBIOL, V19, P1025, DOI 10.1046/j.1365-2958.1996.449980.x; Yeruva VC, 2006, CLIN VACCINE IMMUNOL, V13, P1137, DOI 10.1128/CVI.00125-06; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; ZHANG Y, 1991, MOL MICROBIOL, V5, P381, DOI 10.1111/j.1365-2958.1991.tb02120.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	50	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27743	27752		10.1074/jbc.M111.333385	http://dx.doi.org/10.1074/jbc.M111.333385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22648414	Green Published, hybrid			2022-12-28	WOS:000307840700048
J	Huang, WM; DaGloria, J; Fox, H; Ruan, QR; Tillou, J; Shi, K; Aihara, H; Aron, J; Casjens, S				Huang, Wai Mun; DaGloria, Jeanne; Fox, Heather; Ruan, Qiurong; Tillou, John; Shi, Ke; Aihara, Hideki; Aron, John; Casjens, Sherwood			Linear Chromosome-generating System of Agrobacterium tumefaciens C58 PROTELOMERASE GENERATES AND PROTECTS HAIRPIN ENDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYME-DISEASE SPIROCHETE; COVALENTLY CLOSED ENDS; PLASMID-LIKE PROPHAGE; VIBRIO-PARAHAEMOLYTICUS; BORRELIA-BURGDORFERI; NUCLEOTIDE-SEQUENCE; TELOMERIC PROTEINS; GENOMIC SEQUENCE; DNA; EVOLUTION	Agrobacterium tumefaciens C58, the pathogenic bacteria that causes crown gall disease in plants, harbors one circular and one linear chromosome and two circular plasmids. The telomeres of its unusual linear chromosome are covalently closed hairpins. The circular and linear chromosomes co-segregate and are stably maintained in the organism. We have determined the sequence of the two ends of the linear chromosome thus completing the previously published genome sequence of A. tumefaciens C58. We found that the telomeres carry nearly identical 25-bp sequences at the hairpin ends that are related by dyad symmetry. We further showed that its Atu2523 gene encodes a protelomerase (resolvase) and that the purified enzyme can generate the linear chromosomal closed hairpin ends in a sequence-specific manner. Agrobacterium protelomerase, whose presence is apparently limited to biovar 1 strains, acts via a cleavage-and-religation mechanism by making a pair of transient staggered nicks invariably at 6-bp spacing as the reaction intermediate. The enzyme can be significantly shortened at both the N and C termini and still maintain its enzymatic activity. Although the full-length enzyme can uniquely bind to its product telomeres, the N-terminal truncations cannot. The target site can also be shortened from the native 50-bp inverted repeat to 26 bp; thus, the Agrobacterium hairpin-generating system represents the most compact activity of all hairpin linear chromosome- and plasmid-generating systems to date. The biochemical analyses of the protelomerase reactions further revealed that the tip of the hairpin telomere may be unusually polymorphically capable of accommodating any nucleotide.	[Huang, Wai Mun; Aron, John; Casjens, Sherwood] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84112 USA; [Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities	Huang, WM (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84112 USA.	waimun.huang@path.utah.edu		, Ke/0000-0003-4175-3714	National Institutes of Health [GM095558, AI49003]; National Science Foundation Grant [MCB-0213124]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM095558 (to H. A.) and AI49003 (to S. R. C.). This work was also supported by National Science Foundation Grant MCB-0213124 (to W. M. H.).	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; ALLARDETSERVENT A, 1993, J BACTERIOL, V175, P7869, DOI 10.1128/JB.175.24.7869-7874.1993; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; Casjens S, 1999, CURR OPIN MICROBIOL, V2, P529, DOI 10.1016/S1369-5274(99)00012-0; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2004, J BACTERIOL, V186, P1818, DOI 10.1128/JB.186.6.1818-1832.2004; Chaconas G, 2010, ANNU REV MICROBIOL, V64, P185, DOI 10.1146/annurev.micro.112408.134037; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Delaroque N, 2003, J MOL EVOL, V57, P613, DOI 10.1007/s00239-003-2501-y; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Hertwig S, 2003, MOL MICROBIOL, V48, P989, DOI 10.1046/j.1365-2958.2003.03458.x; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Lan SF, 2009, APPL ENVIRON MICROB, V75, P2659, DOI 10.1128/AEM.02483-08; Mobberley JM, 2008, J VIROL, V82, P6618, DOI 10.1128/JVI.00140-08; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; Ravin V, 2000, J MOL BIOL, V299, P53, DOI 10.1006/jmbi.2000.3731; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Wibberg D, 2011, J BIOTECHNOL, V155, P50, DOI 10.1016/j.jbiotec.2011.01.010; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Young JM, 2001, INT J SYST EVOL MICR, V51, P89, DOI 10.1099/00207713-51-1-89; Zabala B, 2009, J VIROL, V83, P9313, DOI 10.1128/JVI.00672-09	34	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25551	25563		10.1074/jbc.M112.369488	http://dx.doi.org/10.1074/jbc.M112.369488			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22582388	Green Published, hybrid			2022-12-28	WOS:000306651700063
J	Raines, AN; Nagdas, S; Kerber, ML; Cheney, RE				Raines, Alexander N.; Nagdas, Sarbajeet; Kerber, Michael L.; Cheney, Richard E.			Headless Myo10 Is a Negative Regulator of Full-length Myo10 and Inhibits Axon Outgrowth in Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-X; FILOPODIA FORMATION; CARGO RECOGNITION; PYRAMIDAL NEURONS; ACTIN-FILAMENTS; GENE-EXPRESSION; NERVOUS-SYSTEM; MOTOR-ACTIVITY; DOMAIN; GUIDANCE	Myo10 is an unconventional myosin that localizes to and induces filopodia, structures that are critical for growing axons. In addition to the similar to 240-kDa full-length Myo10, brain expresses a similar to 165 kDa isoform that lacks a functional motor domain and is known as headless Myo10. We and others have hypothesized that headless Myo10 acts as an endogenous dominant negative of full-length Myo10, but this hypothesis has not been tested, and the function of headless Myo10 remains unknown. We find that cortical neurons express both headless and full-length Myo10 and report the first isoform-specific localization of Myo10 in brain, which shows enrichment of headless Myo10 in regions of proliferating and migrating cells, including the embryonic ventricular zone and the postnatal rostral migratory stream. We also find that headless and full-length Myo10 are expressed in embryonic and neuronal stem cells. To directly test the function of headless and full-length Myo10, we used RNAi specific to each isoform in mouse cortical neuron cultures. Knockdown of full-length Myo10 reduces axon outgrowth, whereas knockdown of headless Myo10 increases axon outgrowth. To test whether headless Myo10 antagonizes full-length Myo10, we coexpressed both isoforms in COS-7 cells, which revealed that headless Myo10 suppresses the filopodia-inducing activity of full-length Myo10. Together, these results demonstrate that headless Myo10 can function as a negative regulator of full-length Myo10 and that the two isoforms of Myo10 have opposing roles in axon outgrowth.	[Nagdas, Sarbajeet; Kerber, Michael L.; Cheney, Richard E.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Raines, Alexander N.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; [Raines, Alexander N.; Cheney, Richard E.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cheney, RE (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, 111 Mason Farm Rd, Chapel Hill, NC 27599 USA.	richard_cheney@med.unc.edu	, Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Cheney, Richard/0000-0001-6565-7888	National Institutes of Health [R01 DC03299]; Medical Science Training Program Grant [T32GM008719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Science Training Program Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DC03299 (to R. E. C.). This work was also supported by Medical Science Training Program Grant T32GM008719 (to A. N. R.).	Almagro S, 2010, MOL CELL BIOL, V30, P1703, DOI 10.1128/MCB.01226-09; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bennett RD, 2007, J BIOL CHEM, V282, P3205, DOI 10.1074/jbc.M607174200; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Dent E. W., 2011, COLD SPRING HARB PER, V3, P1; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Dent EW, 2011, CURR OPIN NEUROBIOL, V21, P175, DOI 10.1016/j.conb.2010.08.013; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; Hutton S. R., 2008, CSH PROTOC, V11, P1029; Hwang YS, 2009, DEV DYNAM, V238, P2522, DOI 10.1002/dvdy.22077; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kerber ML, 2011, J CELL SCI, V124, P3733, DOI 10.1242/jcs.023549; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Ketschek A, 2010, J NEUROSCI, V30, P12185, DOI 10.1523/JNEUROSCI.1740-10.2010; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu Y, 2012, J CELL SCI, V125, P751, DOI 10.1242/jcs.094946; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Nagy S, 2010, J BIOL CHEM, V285, P26608, DOI 10.1074/jbc.M110.104661; Nie SY, 2009, DEV BIOL, V335, P132, DOI 10.1016/j.ydbio.2009.08.018; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Polleux F, 2002, SCI STKE, V136, P19; Popko J, 2009, CYTOM PART A, V75A, P371, DOI 10.1002/cyto.a.20660; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Roussel MF, 2011, CURR TOP DEV BIOL, V94, P235, DOI 10.1016/B978-0-12-380916-2.00008-5; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang JJ, 2009, CELL BIOL INT, V33, P578, DOI 10.1016/j.cellbi.2009.02.006; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Woolner S, 2012, DEV CELL, V22, P775, DOI 10.1016/j.devcel.2012.01.002; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhong HB, 2006, P NATL ACAD SCI USA, V103, P16800, DOI 10.1073/pnas.0603959103; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	57	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24873	24883		10.1074/jbc.M112.369173	http://dx.doi.org/10.1074/jbc.M112.369173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661706	hybrid, Green Published			2022-12-28	WOS:000306651700002
J	Chakrabarti, A; Gupta, K; Sharma, JP; Yang, JB; Agarwal, A; Glick, A; Zhang, YW; Agarwal, M; Agarwal, MK; Wald, DN				Chakrabarti, Amitabha; Gupta, Kalpana; Sharma, James Prabhakar; Yang, Jinbo; Agarwal, Anju; Glick, Abigail; Zhang, Youwei; Agarwal, Munna; Agarwal, Mukesh K.; Wald, David N.			ATP Depletion Triggers Acute Myeloid Leukemia Differentiation through an ATR/Chk1 Protein-dependent and p53 Protein-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINTS; DNA-DAMAGE; K562 CELLS; CANCER; NUCLEOTIDES; NETWORK; POOLS; CHK1	Despite advances in oncology drug development, most commonly used cancer therapeutics exhibit serious adverse effects. Often the toxicities of chemotherapeutics are due to the induction of significant DNA damage that is necessary for their ability to kill cancer cells. In some clinical situations, the direct induction of significant cytotoxicity is not a requirement to meet clinical goals. For example, differentiation, growth arrest, and/or senescence is a valuable outcome in some cases. In fact, in the case of acute myeloid leukemia (AML), the use of the differentiation agent all-trans-retinoic acid (ATRA) has revolutionized the therapy for a subset of leukemia patients and led to a dramatic survival improvement. Remarkably, this therapeutic approach is possible even in many elderly patients, who would not be able to tolerate therapy with traditional cytotoxic chemotherapy. Because of the success of ATRA, there is widespread interest in identifying differentiation strategies that may be effective for the 90-95% of AML patients who do not clinically respond to ATRA. Utilizing an AML differentiation agent that is in development, we found that AML differentiation can be induced through ATP depletion and the subsequent activation of DNA damage signaling through an ATR/Chk1-dependent and p53-independent pathway. This study not only reveals mechanisms of AML differentiation but also suggests that further investigation is warranted to investigate the potential clinical use of low dose chemotherapeutics to induce differentiation instead of cytotoxicity. This therapeutic approach may be of particular benefit to patients, such as elderly AML patients, who often cannot tolerate traditional AML chemotherapy.	[Chakrabarti, Amitabha; Sharma, James Prabhakar; Agarwal, Anju; Agarwal, Munna; Agarwal, Mukesh K.] Invenio Therapeut, Cleveland, OH 44106 USA; [Gupta, Kalpana; Wald, David N.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Glick, Abigail] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Glick, Abigail; Wald, David N.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Yang, Jinbo] Cleveland Clin Fdn, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation	Agarwal, MK (corresponding author), Invenio Therapeut, 11000 Cedar Ave, Cleveland, OH 44106 USA.	mukeshagarwal@inveniotherapeutics.com; dnw@case.edu			NCI NIH HHS [R00 CA126173, R01 CA163214] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R00CA126173, R01CA163214] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adam T., 2005, KLIN BIOCH METAB, V12, P177; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Asada M, 1998, LEUKEMIA, V12, P1944, DOI 10.1038/sj.leu.2401228; BECHER H, 1978, KLIN WOCHENSCHR, V56, P275, DOI 10.1007/BF01489173; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Estey EH, 2006, SEMIN HEMATOL, V43, P89, DOI 10.1053/j.seminhematol.2006.01.002; Hastak K, 2008, P NATL ACAD SCI USA, V105, P6314, DOI 10.1073/pnas.0802080105; Huang M, 2004, LEUKEMIA, V18, P1857, DOI 10.1038/sj.leu.2403490; Huang M, 2002, MOL PHARMACOL, V62, P463, DOI 10.1124/mol.62.3.463; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kell Jonathan, 2004, Expert Opin Emerg Drugs, V9, P55, DOI 10.1517/14728214.9.1.55; Lam MH, 2004, CELL CYCLE, V3, P1355, DOI 10.4161/cc.3.11.1225; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Nobili S, 2006, CURR DRUG TARGETS, V7, P861, DOI 10.2174/138945006777709593; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; Schmitt Estelle, 2007, Journal of Zhejiang University-Science B, V8, P377, DOI 10.1631/jzus.2007.B0377; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SOKOLOSKI JA, 1987, CANCER RES, V47, P6283; SPERLING O, 1979, BIOMED EXPRESS, V31, P20; Tallmann M. S., 2004, Annals of Hematology, V83, pS81; Wald DN, 2008, CANCER RES, V68, P4369, DOI 10.1158/0008-5472.CAN-07-6559; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030	26	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23635	23643		10.1074/jbc.M111.312801	http://dx.doi.org/10.1074/jbc.M111.312801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22621920	Green Published, hybrid			2022-12-28	WOS:000306511300034
J	Cherian, MT; Wilson, EM; Shapiro, DJ				Cherian, Milu T.; Wilson, Elizabeth M.; Shapiro, David J.			A Competitive Inhibitor That Reduces Recruitment of Androgen Receptor to Androgen-responsive Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; LIGAND-BINDING DOMAIN; REFRACTORY PROSTATE-CANCER; TRANSCRIPTION COMPLEX; INCREASED EXPRESSION; CELL-GROWTH; LNCAP CELLS; ESTROGEN; ACTIVATION; ANTIANDROGEN	The androgen receptor (AR) has a critical role in the growth and progression of androgen-dependent and castration-resistant prostate cancers. To identify novel inhibitors of AR trans-activation that block growth of prostate cancer cells, a luciferase-based high-throughput screen of similar to 160,000 small molecules was performed in cells stably expressing AR and a prostate-specific antigen (PSA)-luciferase reporter. CPIC (1-(3-(2-chlorophenoxy) propyl)-1H-indole-3-carbonitrile) was identified as a small molecule that blocks AR transactivation to a greater extent than other steroid receptors. CPIC inhibited AR-mediated proliferation of androgen-sensitive prostate cancer cell lines, with minimal toxicity in AR-negative cell lines. CPIC treatment also reduced the anchorage-independent growth of LAPC-4 prostate cancer cells. CPIC functioned as a pure antagonist by inhibiting the expression of AR-regulated genes in LAPC-4 cells that express wild-type AR and exhibited weak agonist activity in LNCaP cells that express the mutant AR-T877A. CPIC treatment did not reduce AR levels or alter its nuclear localization. We used chromatin immunoprecipitation to identify the site of action of CPIC. CPIC inhibited recruitment of androgen-bound AR to the PSA promoter and enhancer sites to a greater extent than bicalutamide. CPIC is a new therapeutic inhibitor that targets AR-mediated gene activation with potential to arrest the growth of prostate cancer.	[Shapiro, David J.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cherian, Milu T.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Wilson, Elizabeth M.] Univ N Carolina, Reprod Biol Lab, Dept Pediat, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Reprod Biol Lab, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Shapiro, DJ (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	djshapir@life.illinois.edu			National Institutes of Health [DK-071909, HD16910]; National Institutes of Health (NCI) [P01-CA77739]; Department of Defense Prostate Cancer Research Program Grant [W81XWH-09-1-0309]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research Program Grant(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-071909 (to D. J. S.), HD16910 (to E. M. W.), and P01-CA77739 (NCI; to E. M. W.). This work was also supported by Department of Defense Prostate Cancer Research Program Grant W81XWH-09-1-0309 (to D. J. S.).	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P4315; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Hodgson MC, 2007, CANCER RES, V67, P8388, DOI 10.1158/0008-5472.CAN-07-0617; Jia L, 2004, CANCER RES, V64, P2619, DOI 10.1158/0008-5472.CAN-03-3486; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Joseph JD, 2009, P NATL ACAD SCI USA, V106, P12178, DOI 10.1073/pnas.0900185106; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kretzer NM, 2010, J BIOL CHEM, V285, P41863, DOI 10.1074/jbc.M110.183723; Lagarde WH, 2012, J BIOL CHEM, V287, P10905, DOI 10.1074/jbc.M111.336081; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Linja MJ, 2001, CANCER RES, V61, P3550; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Putt KS, 2004, ANAL BIOCHEM, V333, P256, DOI 10.1016/j.ab.2004.04.032; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shapiro DJ, 2011, J BIOL CHEM, V286, P4043, DOI 10.1074/jbc.R110.203026; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; WILDING G, 1989, PROSTATE, V14, P103, DOI 10.1002/pros.2990140204; Wilson EM, 2011, METHODS MOL BIOL, V776, P113, DOI 10.1007/978-1-61779-243-4_8; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; Wilson Elizabeth M., 2009, V505, P21, DOI 10.1007/978-1-60327-575-0_2; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180	51	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23368	23380		10.1074/jbc.M112.344671	http://dx.doi.org/10.1074/jbc.M112.344671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589544	Green Published, hybrid			2022-12-28	WOS:000306511300010
J	Jung, YS; Cai, ML; Clore, GM				Jung, Young-Sang; Cai, Mengli; Clore, G. Marius			Solution Structure of the IIA(Chitobiose)-HPr Complex of the N,N '-Diacetylchitobiose Branch of the Escherichia coli Phosphotransferase System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYL TRANSFER COMPLEX; PHOSPHOCARRIER PROTEIN HPR; N-TERMINAL DOMAIN; MANNITOL TRANSPORTER IIMANNITOL; TRANSIENT ENCOUNTER COMPLEXES; CYTOPLASMIC B-DOMAIN; ENZYME-I; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; NMR STRUCTURE	The solution structure of the complex of enzyme IIA of the N,N'-diacetylchitobiose (Chb) transporter with the histidine phosphocarrier protein HPr has been solved by NMR. The IIA(Chb)-HPr complex completes the structure elucidation of representative cytoplasmic complexes for all four sugar branches of the bacterial phosphoryl transfer system (PTS). The active site His-89 of IIA(Chb) was mutated to Glu to mimic the phosphorylated state. IIA(Chb)(H89E) and HPr form a weak complex with a K-D of similar to 0.7 mM. The interacting binding surfaces, concave for IIA(Chb) and convex for HPr, complement each other in terms of shape, residue type, and charge distribution, with predominantly hydrophobic residues, interspersed by some uncharged polar residues, located centrally, and polar and charged residues at the periphery. The active site histidine of HPr, His-15, is buried within the active site cleft of IIA(Chb) formed at the interface of two adjacent subunits of the IIA(Chb) trimer, thereby coming into close proximity with the active site residue, H89E, of IIA(Chb). A His89-P-His-15 pentacoordinate phosphoryl transition state can readily be modeled without necessitating any significant conformational changes, thereby facilitating rapid phosphoryl transfer. Comparison of the IIA(Chb)-HPr complex with the IIA(Chb)-IIBChb complex, as well as with other cytoplasmic complexes of the PTS, highlights a unifying mechanism for recognition of structurally diverse partners. This involves generating similar binding surfaces from entirely different underlying structural elements, large interaction surfaces coupled with extensive redundancy, and side chain conformational plasticity to optimize diverse sets of intermolecular interactions.	[Jung, Young-Sang; Cai, Mengli; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,Rm B1-30I, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018; Jung, Young-Sang/L-5068-2013	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Jung, Young-Sang/0000-0003-0817-0664	NIDDK, National Institutes of Health; Office of the Director of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural program of the NIDDK, National Institutes of Health and the Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G.M.C.).	AB E, 1997, PROTEIN SCI, V6, P304; AB E, 2001, J MOL BIOL, V308, P993, DOI 10.1006/jmbi.2001.4623; BEGLEY GS, 1982, BIOCHEMISTRY-US, V21, P5552, DOI 10.1021/bi00265a026; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Eberstadt M, 1996, BIOCHEMISTRY-US, V35, P11286, DOI 10.1021/bi960492l; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; HERZBERG O, 1992, J BIOL CHEM, V267, P24819; HERZBERG O, 1992, P NATL ACAD SCI USA, V89, P2499, DOI 10.1073/pnas.89.6.2499; Hu J, 2008, J BIOL CHEM, V283, P11024, DOI 10.1074/jbc.M800312200; JIA ZC, 1993, J BIOL CHEM, V268, P22490; Jung YS, 2010, J BIOL CHEM, V285, P4173, DOI 10.1074/jbc.M109.080937; KALBITZER HR, 1993, EUR J BIOCHEM, V216, P205, DOI 10.1111/j.1432-1033.1993.tb18134.x; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; LIAO DI, 1991, BIOCHEMISTRY-US, V30, P9583, DOI 10.1021/bi00104a004; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Marquez JA, 2006, J BIOL CHEM, V281, P32508, DOI 10.1074/jbc.M513721200; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Navdaeva V, 2011, BIOCHEMISTRY-US, V50, P1184, DOI 10.1021/bi101721f; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Oberholzer AE, 2009, J BIOL CHEM, V284, P33169, DOI 10.1074/jbc.M109.057612; Orriss GL, 2003, J MOL BIOL, V327, P1111, DOI 10.1016/S0022-2836(03)00215-8; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Schauder S, 1998, J MOL BIOL, V276, P591, DOI 10.1006/jmbi.1997.1544; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Schwieters CD, 2008, J PHYS CHEM B, V112, P6070, DOI 10.1021/jp076244o; Schwieters CD, 2010, J AM CHEM SOC, V132, P13026, DOI 10.1021/ja105485b; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; Sliz P, 1997, STRUCTURE, V5, P775, DOI 10.1016/S0969-2126(97)00232-3; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Suh JY, 2007, J AM CHEM SOC, V129, P12954, DOI 10.1021/ja0760978; Suh JY, 2007, P NATL ACAD SCI USA, V104, P3153, DOI 10.1073/pnas.0609103104; Suh JY, 2006, J BIOL CHEM, V281, P8939, DOI 10.1074/jbc.M513466200; Suh JY, 2005, J MOL BIOL, V353, P1129, DOI 10.1016/j.jmb.2005.09.033; Takayama Y., 2010, J AM CHEM SOC; Tang C, 2005, J BIOL CHEM, V280, P11770, DOI 10.1074/jbc.M414300200; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; vanMontfort RLM, 1997, STRUCTURE, V5, P217, DOI 10.1016/S0969-2126(97)00180-9; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; WITTEKIND M, 1992, PROTEIN SCI, V1, P1363, DOI 10.1002/pro.5560011016; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975	71	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23819	23829		10.1074/jbc.M112.371492	http://dx.doi.org/10.1074/jbc.M112.371492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593574	hybrid, Green Published			2022-12-28	WOS:000306511300051
J	Nemec, AA; Donigan, KA; Murphy, DL; Jaeger, J; Sweasy, JB				Nemec, Antonia A.; Donigan, Katherine A.; Murphy, Drew L.; Jaeger, Joachim; Sweasy, Joann B.			Colon Cancer-associated DNA Polymerase beta Variant Induces Genomic Instability and Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; CONSEQUENCES; SEQUENCE; LYASE	Rapidly advancing technology has resulted in the generation of the genomic sequences of several human tumors. We have identified several mutations of the DNA polymerase beta (pol beta) gene in human colorectal cancer. We have demonstrated that the expression of the pol beta G231D variant increased chromosomal aberrations and induced cellular transformation. The transformed phenotype persisted in the cells even once the expression of G231D was extinguished, suggesting that it resulted as a consequence of genomic instability. Biochemical analysis revealed that its catalytic rate was 140-fold slower than WTpol beta, and this was a result of the decreased binding affinity of nucleotides by G231D. Residue 231 of pol beta lies in close proximity to the template strand of the DNA. Molecular modeling demonstrated that the change from a small and nonpolar glycine to a negatively charged aspartate resulted in a repulsion between the template and residue 231 leading to the distortion of the dNTP binding pocket. In addition, expression of G231D was insufficient to rescue pol beta-deficient cells treated with chemotherapeutic agents suggesting that these agents may be effectively used to treat tumors harboring this mutation. More importantly, this suggests that the G231D variant has impaired base excision repair. Together, these data indicate that the G231D variant plays a role in driving cancer.	[Nemec, Antonia A.; Donigan, Katherine A.; Murphy, Drew L.; Sweasy, Joann B.] Yale Univ, Dept Therapeut Radiol, Sch Med, New Haven, CT 06520 USA; [Nemec, Antonia A.; Donigan, Katherine A.; Murphy, Drew L.; Sweasy, Joann B.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Jaeger, Joachim] New York State Dept Hlth, Wadsworth Ctr, Ctr Med Sci, Albany, NY 12208 USA	Yale University; Yale University; State University of New York (SUNY) System; Wadsworth Center	Sweasy, JB (corresponding author), Yale Univ, Dept Therapeut Radiol, Sch Med, POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu			National Institutes of Health [F32 CA156843, T32 CA009259, 1 PO1 CA129186]; NATIONAL CANCER INSTITUTE [T32CA009259, F32CA156843, P01CA129186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 CA156843 and T32 CA009259 (to A.A.N.) and 1 PO1 CA129186 (to J.B.S.).	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Dalal S, 2005, BIOCHEMISTRY-US, V44, P15664, DOI 10.1021/bi051179z; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; DeLano W.L, PYMOL MOL GRAPHICS S; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Donigan KA, 2012, DNA REPAIR, V11, P381, DOI 10.1016/j.dnarep.2012.01.004; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; Lai CC, 2005, J VIROL, V79, P1924, DOI 10.1128/JVI.79.3.1924-1929.2005; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Lang TM, 2004, P NATL ACAD SCI USA, V101, P6074, DOI 10.1073/pnas.0308571101; LOWY DR, 1978, J VIROL, V26, P291, DOI 10.1128/JVI.26.2.291-298.1978; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Murphy DL, 2011, J AM CHEM SOC, V133, P6279, DOI 10.1021/ja111099b; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Shih IM, 2001, CANCER RES, V61, P818; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Yamtich J, 2010, BIOCHEMISTRY-US, V49, P2326, DOI 10.1021/bi901735a	24	36	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23840	23849		10.1074/jbc.M112.362111	http://dx.doi.org/10.1074/jbc.M112.362111			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22573322	Green Published, hybrid			2022-12-28	WOS:000306511300053
J	Ochiai, H; Okada, S; Saito, A; Hoshi, K; Yamashita, H; Takato, T; Azuma, T				Ochiai, Hiromi; Okada, Shoko; Saito, Akiko; Hoshi, Kazuto; Yamashita, Haruto; Takato, Tsuyoshi; Azuma, Toshifumi			Inhibition of Insulin-like Growth Factor-1 (IGF-1) Expression by Prolonged Transforming Growth Factor-beta 1 (TGF-beta 1) Administration Suppresses Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; BONE MORPHOGENETIC PROTEIN-7; PERIODONTAL-LIGAMENT CELLS; FACTOR-BETA; TGF-BETA; GENE-EXPRESSION; MINERALIZATION; CANCER; JNK; INDUCTION	TGF-beta 1 can regulate osteoblast differentiation not only positively but also negatively. However, the mechanisms of negative regulation are not well understood. We previously established the reproducible model for studying the suppression of osteoblast differentiation by repeated or high dose treatment with TGF-beta 1, although single low dose TGF-beta 1 strongly induced osteoblast differentiation. The mRNA expression and protein level of insulin-like growth factor-1 (IGF-1) were remarkably decreased by repeated TGF-beta 1 administration in human periodontal ligament cells, human mesenchymal stem cells, and murine preosteoblast MC3T3-E1 cells. Repeated TGF-beta 1 administration subsequently decreased alkaline phosphatase (ALP) activity and mRNA expression of osteoblast differentiation marker genes, such as RUNX2, ALP, and bone sialoprotein (BSP). Additionally, repeated administration significantly reduced the downstream signaling pathway of IGF-1, such as Akt phosphorylation in these cells. Surprisingly, exogenous and overexpressed IGF-1 recovered ALP activity and mRNA expression of osteoblast differentiation marker genes even with repeated TGF-beta 1 administration. These facts indicate that the key mechanism of inhibition of osteoblast differentiation induced by repeated TGF-beta 1 treatment is simply due to the down-regulation of IGF-1 expression. Inhibition of IGF-1 signaling using small interfering RNA (siRNA) against insulin receptor substrate-1 (IRS-1) suppressed mRNA expression of RUNX2, ALP, BSP, and IGF-1 even with single TGF-beta 1 administration. This study showed that persistence of TGF-beta 1 inhibited osteoblast differentiation via suppression of IGF-1 expression and subsequent down-regulation of the PI3K/Akt pathway. We think this fact could open the way to use IGF-1 as a treatment tool for bone regeneration in prolonged inflammatory disease.	[Ochiai, Hiromi; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiba 2618502, Japan; [Ochiai, Hiromi; Okada, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Chiba 2618502, Japan; [Hoshi, Kazuto] Univ Tokyo, Grad Sch Med, Dept Cartilage & Bone Regenerat Fujisoft, Tokyo 1138655, Japan; [Yamashita, Haruto] Tokyo Dent Coll, Dept Pediat Dent, Chiba 2618502, Japan; [Takato, Tsuyoshi] Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Div Tissue Engn,Fac Med, Tokyo 1138655, Japan	Tokyo Dental College; Tokyo Dental College; University of Tokyo; Tokyo Dental College; University of Tokyo	Azuma, T (corresponding author), 1-2-2 Masago,Mihama Ku, Chiba 2618502, Japan.	tazuma@tdc.ac.jp			Oral Health Science Center from Tokyo Dental College; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24593050] Funding Source: KAKEN	Oral Health Science Center from Tokyo Dental College; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Oral Health Science Center Grant hrc8 from activity in murine bone marrow stromal Tokyo Dental College and by a Project for Private Universities, matching fund subsidy from Ministry of Education, Culture, Sports, Science and Technology of Japan, 2010-2012.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bernstein A, 2010, J BIOMED MATER RES B, V92B, P215, DOI 10.1002/jbm.b.31508; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Centrella M, 1996, J BIOL CHEM, V271, P18616, DOI 10.1074/jbc.271.31.18616; Chernausek SD, 2007, J CLIN ENDOCR METAB, V92, P902, DOI 10.1210/jc.2006-1610; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Davies LC, 2008, TISSUE ENG PT A, V14, P1251, DOI [10.1089/ten.tea.2007.0211, 10.1089/tea.2007.0211]; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; He WX, 2004, ARCH ORAL BIOL, V49, P911, DOI 10.1016/j.archoralbio.2004.05.005; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kadowaki Takashi, 1996, Endocrine Journal, V43, pS33, DOI 10.1507/endocrj.43.Suppl_S33; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Kwok S, 2009, J CELL BIOCHEM, V106, P161, DOI 10.1002/jcb.21991; Lee JY, 2006, J BIOMED MATER RES A, V76A, P530, DOI 10.1002/jbm.a.30434; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Miyazono A, 2007, FEBS LETT, V581, P5321, DOI 10.1016/j.febslet.2007.10.021; Nakagawa T, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-76; Nakayama Y, 2006, J CELL PHYSIOL, V208, P326, DOI 10.1002/jcp.20664; Ochiai H, 2010, J HARD TISSUE BIOL, V19, P187, DOI 10.2485/jhtb.19.187; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Power RA, 2002, BONE, V31, P143, DOI 10.1016/S8756-3282(02)00799-8; Ripamonti U, 1997, J BONE MINER RES, V12, P1584, DOI 10.1359/jbmr.1997.12.10.1584; Ripamonti U, 2009, J CRANIOFAC SURG, V20, P1544, DOI 10.1097/SCS.0b013e3181b09ca6; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Walsh S, 2003, BONE, V33, P80, DOI 10.1016/S8756-3282(03)00165-0; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yakar S, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.234; Yang L, 2010, J PERIODONTAL RES, V45, P532, DOI 10.1111/j.1600-0765.2009.01268.x; Zhang H, 2003, BIOMATERIALS, V24, P2013, DOI 10.1016/S0142-9612(02)00616-6; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	40	64	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22654	22661		10.1074/jbc.M111.279091	http://dx.doi.org/10.1074/jbc.M111.279091			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573330	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000306495000022
J	Sela, D; Chen, L; Martin-Brown, S; Washburn, MP; Florens, L; Conaway, JW; Conaway, RC				Sela, Dotan; Chen, Lu; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Conaway, Joan Weliky; Conaway, Ronald C.			Endoplasmic Reticulum Stress-responsive Transcription Factor ATF6 alpha Directs Recruitment of the Mediator of RNA Polymerase II Transcription and Multiple Histone Acetyltransferase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; SPECTRAL ABUNDANCE FACTORS; ER STRESS; IN-VIVO; SHOTGUN PROTEOMICS; ACTIVATION DOMAIN; GENE-EXPRESSION; LUMINAL DOMAIN; FACTOR ATF6; SAGA	The basic leucine zipper transcription factor ATF6 alpha functions as a master regulator of endoplasmic reticulum (ER) stress response genes. Previous studies have established that, in response to ER stress, ATF6 alpha translocates to the nucleus and activates transcription of ER stress response genes upon binding sequence specifically to ER stress response enhancer elements in their promoters. In this study, we investigate the biochemical mechanism by which ATF6 alpha activates transcription. By exploiting a combination of biochemical and multidimensional protein identification technology-based mass spectrometry approaches, we have obtained evidence that ATF6 alpha functions at least in part by recruiting to the ER stress response enhancer elements of ER stress response genes a collection of RNA polymerase II coregulatory complexes, including the Mediator and multiple histone acetyltransferase complexes, among which are the Spt-Ada-Gcn5 acetyltransferase (SAGA) and Ada-Two-A-containing (ATAC) complexes. Our findings shed new light on the mechanism of action of ATF6 alpha, and they outline a straightforward strategy for applying multidimensional protein identification technology mass spectrometry to determine which RNA polymerase II transcription factors and coregulators are recruited to promoters and other regulatory elements to control transcription.	[Sela, Dotan; Chen, Lu; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Conaway, Joan Weliky; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Chen, Lu; Conaway, Joan Weliky; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org	Chen, Lu/AAN-4886-2021	Chen, Lu/0000-0002-4571-7975; Florens, Laurence/0000-0002-9310-6650; Conaway, Joan/0000-0002-2786-0663; Washburn, Michael/0000-0001-7568-2585	National Institutes of Health [GM41628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041628, R37GM041628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41628 (to J. W. C. and R. C. C.). This work was also supported by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation.	Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bontems F, 2011, J STRUCT BIOL, V174, P245, DOI 10.1016/j.jsb.2010.10.011; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; CAREY MF, 2009, TRANSCRIPTIONAL REGU, P439; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Eletsky Alexander, 2011, Journal of Structural and Functional Genomics, V12, P159, DOI 10.1007/s10969-011-9115-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Ikeda K, 2002, GENES CELLS, V7, P49, DOI 10.1046/j.1356-9597.2001.00492.x; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Luo R, 2008, J CELL BIOCHEM, V104, P1708, DOI 10.1002/jcb.21736; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Nagy Z, 2009, MOL CELL BIOL, V29, P1649, DOI 10.1128/MCB.01076-08; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pijnappel WWMP, 2008, MOL CELL, V29, P152, DOI 10.1016/j.molcel.2008.01.007; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thuerauf DJ, 2002, J BIOL CHEM, V277, P20734, DOI 10.1074/jbc.M201749200; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	50	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23035	23045		10.1074/jbc.M112.369504	http://dx.doi.org/10.1074/jbc.M112.369504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577136	Green Published, hybrid			2022-12-28	WOS:000306495000060
J	Devaux, S; Poulain, FE; Devignot, V; Lachkar, S; Irinopoulou, T; Sobel, A				Devaux, Sara; Poulain, Fabienne E.; Devignot, Veronique; Lachkar, Sylvie; Irinopoulou, Theano; Sobel, Andre			Specific Serine-Proline Phosphorylation and Glycogen Synthase Kinase 3 beta-directed Subcellular Targeting of Stathmin 3/Sclip in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT-RAT BRAIN; GROWTH-CONE; FAMILY PROTEINS; MICROTUBULE DYNAMICS; IN-VITRO; PHYLOGENETIC CONSERVATION; MULTISITE PHOSPHORYLATION; CYTOSKELETAL DYNAMICS; PHOSPHOPROTEIN FAMILY; HIPPOCAMPAL-NEURONS	During nervous system development, neuronal growth, migration, and functional morphogenesis rely on the appropriate control of the subcellular cytoskeleton including microtubule dynamics. Stathmin family proteins play major roles during the various stages of neuronal differentiation, including axonal growth and branching, or dendritic development. We have shown previously that stathmins 2 (SCG10) and 3 (SCLIP) fulfill distinct, independent and complementary regulatory roles in axonal morphogenesis. Although the two proteins have been proposed to display the four conserved phosphorylation sites originally identified in stathmin 1, we show here that they possess distinct phosphorylation sites within their specific prolinerich domains (PRDs) that are differentially regulated by phosphorylation by proline-directed kinases involved in the control of neuronal differentiation. ERK2 or CDK5 phosphorylate the two proteins but with different site specificities. We also show for the first time that, unlike stathmin 2, stathmin 3 is a substrate for glycogen synthase kinase (GSK) 3 beta both in vitro and in vivo. Interestingly, stathmin 3 phosphorylated at its GSK-3 beta target site displays a specific subcellular localization at neuritic tips and within the actin-rich peripheral zone of the growth cone of differentiating hippocampal neurons in culture. Finally, pharmacological inhibition of GSK-3 beta induces a redistribution of stathmin 3, but not stathmin 2, from the periphery toward the Golgi region of neurons. Stathmin proteins can thus be either regulated locally or locally targeted by specific phosphorylation, each phosphoprotein of the stathmin family fulfilling distinct and specific roles in the control of neuronal differentiation.	INSERM U839, F-75005 Paris, France; Univ Paris 06, UMR S839, F-75005 Paris, France; [Sobel, Andre] Inst Fer Moulin, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Sobel, A (corresponding author), UMR S 839 INSERM UPMC, F-75005 Paris, France.	andre.sobel@inserm.fr		POULAIN, Fabienne/0000-0002-7867-748X	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre et Marie Curie (UPMC); Agence Nationale pour la Recherche (ANR)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie (UPMC); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Pierre et Marie Curie (UPMC), and the Agence Nationale pour la Recherche (ANR).	Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Atilla-Gokcumen GE, 2006, CHEMBIOCHEM, V7, P1443, DOI 10.1002/cbic.200600117; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Charbaut E, 2005, J CELL SCI, V118, P2313, DOI 10.1242/jcs.02349; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Chauvin S, 2008, BIOL CELL, V100, P577, DOI 10.1042/BC20070119; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Di Paolo G, 1997, J NEUROSCI RES, V50, P1000, DOI 10.1002/(SICI)1097-4547(19971215)50:6<1000::AID-JNR10>3.0.CO;2-8; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Gavet O, 1998, J CELL SCI, V111, P3333; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Goold RG, 2004, BIOCHEM SOC T, V32, P809, DOI 10.1042/BST0320809; Goslin K., 1998, CULTURING NERVE CELL, P339; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Gupta A, 2003, NEUROSIGNALS, V12, P173, DOI 10.1159/000074618; Hanger Diane P, 2011, Int J Alzheimers Dis, V2011, P352805, DOI 10.4061/2011/352805; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; HIMI T, 1994, NEUROSCIENCE, V60, P907, DOI 10.1016/0306-4522(94)90271-2; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Lachkar S, 2010, J BIOL CHEM, V285, P11667, DOI 10.1074/jbc.M109.096727; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; le Gouvello S, 1998, J IMMUNOL, V161, P1113; LEIGHTON IA, 1993, MOL CELL BIOCHEM, V128, P151, DOI 10.1007/BF01076766; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Manceau V, 1999, ELECTROPHORESIS, V20, P409, DOI 10.1002/(SICI)1522-2683(19990201)20:2<409::AID-ELPS409>3.3.CO;2-E; MARKLUND U, 1994, EUR J BIOCHEM, V225, P53, DOI 10.1111/j.1432-1033.1994.00053.x; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1999, J NEUROSCI RES, V56, P553, DOI 10.1002/(SICI)1097-4547(19990601)56:5<553::AID-JNR11>3.0.CO;2-J; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; SANCHEZ I, 1994, CELL MOTIL CYTOSKEL, V29, P57, DOI 10.1002/cm.970290106; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SOBEL A, 1989, J BIOL CHEM, V264, P3765; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Steinmetz MO, 2001, EMBO REP, V2, P505, DOI 10.1093/embo-reports/kve105; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Szebenyi G, 1998, J NEUROSCI, V18, P7930; Takahashi K, 2010, CELL SIGNAL, V22, P510, DOI 10.1016/j.cellsig.2009.11.005; Takahashi K, 2009, CELL SIGNAL, V21, P695, DOI 10.1016/j.cellsig.2009.01.007; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	72	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22341	22353		10.1074/jbc.M112.344044	http://dx.doi.org/10.1074/jbc.M112.344044			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577147	Green Published, hybrid			2022-12-28	WOS:000306418600071
J	Graff, JW; Dickson, AM; Clay, G; McCaffrey, AP; Wilson, ME				Graff, Joel W.; Dickson, Anne M.; Clay, Gwendolyn; McCaffrey, Anton P.; Wilson, Mary E.			Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESPONSE; ACTIVATED MACROPHAGE; SIGNALING PROTEINS; EXPRESSION; INDUCTION; CELLS; DIFFERENTIATION; STIMULATION; MONOCYTES; SHRNAS	Macrophages respond to external stimuli with rapid changes in expression of many genes. Different combinations of external stimuli lead to distinct polarized activation patterns, resulting in a spectrum of possible macrophage activation phenotypes. MicroRNAs (miRNAs) are small, noncoding RNAs that can repress the expression of many target genes. We hypothesized that miRNAs play a role in macrophage polarization. miRNA expression profiles were determined in monocyte-derived macrophages (MDMs) incubated in conditions causing activation toward M1, M2a, M2b, or M2c phenotypes. One miRNA guide strand and seven miRNA passenger strands were significantly altered. Changes were confirmed in MDMs from six separate donors. The amplitude of miRNA expression changes in MDMs was smaller than described studies of monocytes responding to inflammatory stimuli. Further investigation revealed this correlated with higher basal miRNA expression in MDMs compared with monocytes. The regulation of M1- and M2b-responsive miRNAs (miR-27a, miR-29b, miR-125a, miR-146a, miR-155, and miR-222) was similar in differentiated THP-1 cells and primary MDMs. Studies in this model revealed cross-talk between IFN gamma- and LPS-associated pathways regulating miRNA expression. Furthermore, expression of M1-associated transcripts was increased in THP-1 cells transfected with mimics of miR-29b, miR-125a-5p, or miR-155. The apparent inflammatory property of miR-29b and miR-125a-5p can be at least partially explained by repression of TNFAIP3, a negative regulator of NF-kappa B signaling. Overall, these data suggest miRNAs can contribute to changes in macrophage gene expression that occur in different exogenous activating conditions.	[Graff, Joel W.; Dickson, Anne M.; Clay, Gwendolyn; McCaffrey, Anton P.; Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Graff, Joel W.; Wilson, Mary E.] Dept Vet Affairs, Iowa City, IA 52240 USA; [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa	Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, SW34 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	mary-wilson@uiowa.edu		Wilson, Mary/0000-0001-8680-7275; Clay, Gwendolyn/0000-0001-8218-7646	OES-OIS from Department of Veterans Affairs; National Institutes of Health [R21 AI080801, R01 AI045540, R01 AI067874, R01 AI076233]; National Institutes of Health Training [T32 AI007511, T32 AI007343-21]; Veterans Affairs CDA-1 career award; Merit Review; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067874, T32AI007343, R21AI080801, R01AI045540, R01AI076233, T32AI007511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	OES-OIS from Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs CDA-1 career award; Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Merit Review and an OES-OIS program award from the Department of Veterans Affairs (to M. E. W.) and Grants R21 AI080801, R01 AI045540, R01 AI067874, and R01 AI076233 from the National Institutes of Health.; Supported by a Veterans Affairs CDA-1 career award and National Institutes of Health Training Grant T32 AI007511.; Supported National Institutes of Health Training Grant T32 AI007343-21.	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; TSUCHIYA S, 1982, CANCER RES, V42, P1530	39	267	282	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21816	21825		10.1074/jbc.M111.327031	http://dx.doi.org/10.1074/jbc.M111.327031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549785	hybrid, Green Published			2022-12-28	WOS:000306418600023
J	Kusche-Gullberg, M; Nybakken, K; Perrimon, N; Lindahl, U				Kusche-Gullberg, Marion; Nybakken, Kent; Perrimon, Norbert; Lindahl, Ulf			Drosophila Heparan Sulfate, a Novel Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-LINKAGE REGION; MAST-CELLS; CAENORHABDITIS-ELEGANS; STRUCTURAL-ANALYSIS; NONREDUCING END; TOUT-VELU; IN-VIVO; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; BIOSYNTHESIS	Heparan sulfate (HS) proteoglycans play critical roles in a wide variety of biological processes such as growth factor signaling, cell adhesion, wound healing, and tumor metastasis. Functionally important interactions between HS and a variety of proteins depend on specific structural features within the HS chains. The fruit fly (Drosophila melanogaster) is frequently applied as a model organism to study HS function in development. Previous structural studies of Drosophila HS have been restricted to disaccharide composition, without regard to the arrangement of saccharide domains typically found in vertebrate HS. Here, we biochemically characterized Drosophila HS by selective depolymerization with nitrous acid. Analysis of the generated saccharide products revealed a novel HS design, involving a peripheral, extended, presumably single, N-sulfated domain linked to an N-acetylated sequence contiguous with the linkage to core protein. The N-sulfated domain may be envisaged as a heparin structure of unusually low O-sulfate content.	[Kusche-Gullberg, Marion] Univ Bergen, Dept Biomed, NO-5009 Bergen, Norway; [Nybakken, Kent] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Howard Hughes Med Inst, Boston, MA 02115 USA; [Lindahl, Ulf] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Bergen; Boston Biomedical Research Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Uppsala University	Kusche-Gullberg, M (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, NO-5009 Bergen, Norway.	marion.kusche@biomed.uib.no	Kusche-Gullberg, Marion/P-4466-2016	Kusche-Gullberg, Marion/0000-0002-5636-1695; Perrimon, Norbert/0000-0001-7542-472X	University of Bergen; Polysackaridforskning AB, Uppsala, Sweden; National Institutes of Health Postdoctoral Training Grant [5 F32 GM064232-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064232] Funding Source: NIH RePORTER	University of Bergen; Polysackaridforskning AB, Uppsala, Sweden; National Institutes of Health Postdoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the University of Bergen (to M. K.-G.) and Polysackaridforskning AB, Uppsala, Sweden (to U. L.).; Supported by National Institutes of Health Postdoctoral Training Grant 5 F32 GM064232-02.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Dagalv A, 2011, J BIOL CHEM, V286, P44433, DOI 10.1074/jbc.M111.303891; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feta A, 2009, BIOCHEM J, V419, P585, DOI 10.1042/BJ20082081; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GALLAGHER JT, 1985, BIOCHEM J, V230, P665, DOI 10.1042/bj2300665; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kamimura K, 2011, GLYCOBIOLOGY, V21, P607, DOI 10.1093/glycob/cwq202; Kasevayuth K, 2004, BIOCHEM BIOPH RES CO, V324, P205, DOI 10.1016/j.bbrc.2004.09.036; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; KUSCHE M, 1990, J BIOL CHEM, V265, P7292; KUSCHE M, 1988, BIOCHEM J, V253, P885, DOI 10.1042/bj2530885; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; LINDAHL U, 1966, BIOCHIM BIOPHYS ACTA, V130, P368, DOI 10.1016/0304-4165(66)90233-9; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; LYON M, 1987, BIOCHEM J, V242, P493, DOI 10.1042/bj2420493; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; PEJLER G, 1987, J BIOL CHEM, V262, P11413; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; SUGAHARA K, 1995, J BIOL CHEM, V270, P22914, DOI 10.1074/jbc.270.39.22914; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493	47	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21950	21956		10.1074/jbc.M112.350389	http://dx.doi.org/10.1074/jbc.M112.350389			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556423	Green Published, hybrid			2022-12-28	WOS:000306418600034
J	Chen, Y; Lu, H; Liu, Q; Huang, GC; Lim, CP; Zhang, LH; Hao, AJ; Cao, XM				Chen, Yong; Lu, Hao; Liu, Qian; Huang, Guochang; Lim, Cheh Peng; Zhang, Lianhui; Hao, Aijun; Cao, Xinmin			Function of GRIM-19, a Mitochondrial Respiratory Chain Complex I Protein, in Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH; HYDROGEN-PEROXIDE; AUTOPHAGY; NLRX1; IDENTIFICATION; MACROPHAGES; RECEPTOR; PATHWAY; TARGETS	Mitochondria respiratory chain (RC), consisting of five multisubunit complexes, is crucial for cellular energy production, reactive oxygen species generation, and regulation of apoptosis. Recently, a few mitochondrial proteins have been reported to be essential for innate immunity, but the function of mitochondrial RC in innate immunity is largely unknown. By knock-out of GRIM-19, a newly identified subunit protein of mitochondrial complex I, in mice, we found that heterogeneous mice (GRIM-19(+/-)) are prone to spontaneous urinary tract infection, mostly by Staphylococcus saprophyticus. Macrophages derived from these mice have compromised mitochondrial complex I activity and increased reactive oxygen species level. Bacterial infection induces a rapid up-regulation of GRIM-19 and complex I activity in the wild-type macrophages, but both are reduced in the macrophages from GRIM-19(+/-) mice. These cells also have decreased intracellular killing ability against S. saprophyticus. The defects for this probably occur in the fusion of bacteria to lysosome, but not in the bacterial engulfment and macrophage migration. In addition, production of proinflammatory cytokines, such as interleukin (IL)-1, IL-12, IL-6, and interferon (IFN)-gamma, induced by both bacterial infection and lipopolysaccharide (LPS) and monodansylcadaverine treatment, is also decreased in the GRIM19(+/-) macrophages. Inhibition of mitochondrial RC activity by inhibitors shows a similar reduction on the cytokine production. Due to low cytokine production, the inflammatory response caused by in vivo bacterial challenge in the bladders of GRIM-19(+/-) mice is compromised. This study provides genetic evidence for a critical role of mitochondrial RC in innate immunity.	[Liu, Qian; Hao, Aijun; Cao, Xinmin] Shandong Univ, Dept Histol & Embryol, Jinan 250012, Peoples R China; [Chen, Yong; Lu, Hao; Huang, Guochang; Lim, Cheh Peng; Zhang, Lianhui; Cao, Xinmin] ASTAR, Inst Mol & Cell Biol, Biopolis, Singapore 138632, Singapore	Shandong University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hao, AJ (corresponding author), Shandong Univ, Dept Histol & Embryol, 44 Wenhua Xi Rd, Jinan 250012, Peoples R China.	aijunhao@sdu.edu.cn; mcbcaoxm@gmail.com			Agency for Science, Technology and Research of Singapore; Natural Science Foundation of China [81071057]	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Agency for Science, Technology and Research of Singapore and the Natural Science Foundation of China Grant 81071057.	Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Cao XM, 2009, SEMIN CELL DEV BIOL, V20, P337, DOI 10.1016/j.semcdb.2008.12.014; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen Y, 2007, MOL CELL BIOL, V27, P6420, DOI 10.1128/MCB.01946-06; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jendrysik MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028198; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Melov S, 1999, MUTAT RES-DNA REPAIR, V434, P233, DOI 10.1016/S0921-8777(99)00031-2; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Raz R, 2005, CLIN INFECT DIS, V40, P896, DOI 10.1086/428353; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975	34	37	42	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27227	27235		10.1074/jbc.M112.340315	http://dx.doi.org/10.1074/jbc.M112.340315			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22665480	Green Published, hybrid			2022-12-28	WOS:000307386000074
J	Bardowell, SA; Duan, FP; Manor, D; Swanson, JE; Parker, RS				Bardowell, Sabrina A.; Duan, Faping; Manor, Danny; Swanson, Joy E.; Parker, Robert S.			Disruption of Mouse Cytochrome P450 4f14 (Cyp4f14 Gene) Causes Severe Perturbations in Vitamin E Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOCOPHEROL TRANSFER PROTEIN; ALPHA-TOCOPHEROL; OMEGA-HYDROXYLASE; GAMMA-TOCOPHEROL; COMMON VARIANTS; LEUKOTRIENE B-4; HEPG2 CELLS; FATTY-ACIDS; HUMAN URINE; TOCOTRIENOLS	Vitamin E is a family of naturally occurring and structurally related lipophilic antioxidants, one of which, alpha-tocopherol (alpha-TOH), selectively accumulates in vertebrate tissues. The omega-hydroxylase cytochrome P450-4F2 (CYP4F2) is the only human enzyme shown to metabolize vitamin E. Using cDNA cloning, cell culture expression, and activity assays, we identified Cyp4f14 as a functional murine ortholog of CYP4F2. We then investigated the effect of Cyp4f14 deletion on vitamin E metabolism and status in vivo. Cyp4f14-null mice exhibited substrate-specific reductions in liver microsomal vitamin E-omega-hydroxylase activity ranging from 93% (gamma-TOH) to 48% (gamma-tocotrienol). In vivo data obtained from metabolic cage studies showed whole-body reductions in metabolism of gamma-TOH of 90% and of 68% for delta- and alpha-TOH. This metabolic deficit in Cyp4f14(-/-) mice was partially offset by increased fecal excretion of nonmetabolized tocopherols and of novel omega-1- and omega-2-hydroxytocopherols. 12'-OH-gamma-TOH represented 41% of whole-body production of gamma-TOH metabolites in Cyp4f14(-/-) mice fed a soybean oil diet. Despite these counterbalancing mechanisms, Cyp4f14-null mice fed this diet for 6 weeks hyper-accumulated gamma-TOH (2-fold increase over wild-type litter-mates) in all tissues and appeared normal. We conclude that CYP4F14 is the major but not the only vitamin E-omega-hydroxylase in mice. Its disruption significantly impairs whole-body vitamin E metabolism and alters the widely conserved phenotype of preferential tissue deposition of alpha-TOH. This model animal and its derivatives will be valuable in determining the biological actions of specific tocopherols and tocotrienols in vivo.	[Bardowell, Sabrina A.; Swanson, Joy E.; Parker, Robert S.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14850 USA; [Duan, Faping] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14850 USA; [Manor, Danny] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Manor, Danny] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Cornell University; Cornell University; Case Western Reserve University; Case Western Reserve University	Parker, RS (corresponding author), Cornell Univ, Div Nutr Sci, 226 Savage Hall, Ithaca, NY 14850 USA.	rsp3@cornell.edu		Gardner, Sabrina/0000-0003-2566-3743	National Institutes of Health [DK067494, DK007158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067494, T32DK007158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR007091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported, in whole or in part, by National Institutes of Health Grants DK067494 (to D. M.) and DK007158 (to S. A. B.).	Bardowel SA, 2010, J NUTR, V140, P1901, DOI 10.3945/jn.110.128579; BIERI JG, 1973, J AM DIET ASSOC, V62, P147; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; Christmas P, 2001, J BIOL CHEM, V276, P38166; Cooney RV, 2001, NUTR CANCER, V39, P66, DOI 10.1207/S15327914nc391_9; Dial Steve, 1995, P327; Ford ES, 2006, AM J CLIN NUTR, V84, P375; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Jiang Q, 2002, FREE RADICAL BIO MED, V33, P1534, DOI 10.1016/S0891-5849(02)01091-2; Kikuta Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P225, DOI 10.1006/abbi.2000.2078; Kikuta Y, 2002, PROSTAG OTH LIPID M, V68-9, P345, DOI 10.1016/S0090-6980(02)00039-4; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Mustacich DJ, 2009, J NUTR BIOCHEM, V20, P469, DOI 10.1016/j.jnutbio.2008.05.007; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; Parker RS, 2000, BIOCHEM BIOPH RES CO, V277, P531, DOI 10.1006/bbrc.2000.3706; Parker RS, 2005, BIOCHEM BIOPH RES CO, V338, P1537, DOI 10.1016/j.bbrc.2005.10.124; Parker RS, 2000, BIOCHEM BIOPH RES CO, V269, P580, DOI 10.1006/bbrc.2000.2319; Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200; SCHONFELD A, 1993, NAHRUNG, V37, P498; Sontag TJ, 2007, J LIPID RES, V48, P1090, DOI 10.1194/jlr.M600514-JLR200; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Swanson JE, 1999, J LIPID RES, V40, P665; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wechter WJ, 1996, P NATL ACAD SCI USA, V93, P6002, DOI 10.1073/pnas.93.12.6002; Yamane M, 2000, J BIOCHEM-TOKYO, V128, P827, DOI 10.1093/oxfordjournals.jbchem.a022821; Yoshida Y, 2003, CHEM PHYS LIPIDS, V123, P63, DOI 10.1016/S0009-3084(02)00164-0; You CS, 2005, J NUTR, V135, P227, DOI 10.1093/jn/135.2.227; Zhao Y, 2010, J AGR FOOD CHEM, V58, P4844, DOI 10.1021/jf904464u	31	47	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26077	26086		10.1074/jbc.M112.373597	http://dx.doi.org/10.1074/jbc.M112.373597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22665481	Green Published, hybrid			2022-12-28	WOS:000306916300035
J	Chen, LH; Liu, CD; Ko, FCF; Xu, NN; Ng, IOL; Yam, JWP; Zhu, G				Chen, Lihong; Liu, Changdong; Ko, Frankie Chi Fat; Xu, Naining; Irene Oi-Lin Ng; Yam, Judy Wai Ping; Zhu, Guang			Solution Structure of the Phosphotyrosine Binding (PTB) Domain of Human Tensin2 Protein in Complex with Deleted in Liver Cancer 1 (DLC1) Peptide Reveals a Novel Peptide Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; TUMOR-SUPPRESSOR GENE; CELL-MIGRATION; FAMILY-MEMBER; GROWTH; PROLIFERATION; LOCALIZATION; ASSIGNMENT; PROGRAM; SYSTEM	The protein deleted in liver cancer 1 (DLC1) interacts with the tensin family of focal adhesion proteins to play a role as a tumor suppressor in a wide spectrum of human cancers. This interaction has been proven to be crucial to the oncogenic inhibitory capacity and focal adhesion localization of DLC1. The phosphotyrosine binding (PTB) domain of tensin2 predominantly interacts with a novel site on DLC1, not the canonical NPXY motif. In this study, we characterized this interaction biochemically and determined the complex structure of tensin2 PTB domain with DLC1 peptide by NMR spectroscopy. Our HADDOCK-derived complex structure model elucidates the molecular mechanism by which tensin2 PTB domain recognizes DLC1 peptide and reveals a PTB-peptide binding mode that is unique in that peptide occupies the binding site opposite to the canonical NPXY motif interaction site with the peptide utilizing a non-canonical binding motif to bind in an extended conformation and that the N-terminal helix, which is unique to some Shc- and Dab-like PTB domains, is required for binding. Mutations of crucial residues defined for the PTB-DLC1 interaction affected the co-localization of DLC1 and tensin2 in cells and abolished DLC1-mediated growth suppression of hepatocellular carcinoma cells. This tensin2 PTB-DLC1 peptide complex with a novel binding mode extends the versatile binding repertoire of the PTB domains in mediating diverse cellular signaling pathways as well as provides a molecular and structural basis for better understanding the tumor-suppressive activity of DLC1 and tensin2.	[Irene Oi-Lin Ng; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, StateKey Lab Liver Res, Hong Kong 999077, Hong Kong, Peoples R China; [Ko, Frankie Chi Fat; Irene Oi-Lin Ng; Yam, Judy Wai Ping] Univ Hong Kong, Dept Pathol, Hong Kong 999077, Hong Kong, Peoples R China; [Chen, Lihong; Liu, Changdong; Xu, Naining; Zhu, Guang] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon 999077, Hong Kong, Peoples R China; [Chen, Lihong; Liu, Changdong; Xu, Naining; Zhu, Guang] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon 999077, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Yam, JWP (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, StateKey Lab Liver Res, Hong Kong 999077, Hong Kong, Peoples R China.	judyyam@pathology.hku.hk; gzhu@ust.hk	Ko, Frankie Chi Fat/C-4759-2009; Ko, Frankie Chi Fat/AAZ-8112-2021; Yam, Judy Wai Ping/C-4454-2009	Ko, Frankie Chi Fat/0000-0002-0393-9668; Ko, Frankie Chi Fat/0000-0002-0393-9668; LIU, Changdong/0000-0001-7356-9765; Yam, Judy Wai Ping/0000-0002-5637-121X; Ng, Irene Oi-lin/0000-0001-7532-2029	Hong Kong Research Grants Council [RGC664109, SEG-HKUST06, TUYF10SC03]; University of Hong Kong	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by Hong Kong Research Grants Council Grants RGC664109 (to G. Z. and J. W. P. Y.), SEG-HKUST06, and TUYF10SC03 (to G. Z).; Recipient of the University of Hong Kong Outstanding Young Researcher Award.	BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Chan LH, 2009, GLOB PUBLIC HEALTH, V4, P1, DOI 10.1080/17441690701524471; Chen HY, 2002, P NATL ACAD SCI USA, V99, P733, DOI 10.1073/pnas.022518699; Chen HY, 2003, BIOCHEM J, V370, P1039, DOI 10.1042/BJ20021308; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cui YM, 2004, MOL CANCER RES, V2, P225; Dai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021965; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhalluin C, 2000, MOL CELL, V6, P921, DOI 10.1016/S1097-2765(00)00089-7; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hafizi S, 2010, INT J BIOCHEM CELL B, V42, P52, DOI 10.1016/j.biocel.2009.09.005; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kawai K, 2010, ADV ENZYME REGUL, V50, P202, DOI 10.1016/j.advenzreg.2009.10.013; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leone M, 2008, BIOPOLYMERS, V89, P86, DOI 10.1002/bip.20862; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; LO SH, 1994, J CELL BIOL, V125, P1067, DOI 10.1083/jcb.125.5.1067; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; McCleverty CJ, 2007, PROTEIN SCI, V16, P1223, DOI 10.1110/ps.072798707; Ng IOL, 2000, CANCER RES, V60, P6581; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yang XY, 2011, CANCER RES, V71, P2916, DOI 10.1158/0008-5472.CAN-10-2158; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; ZHU G, 1992, J MAGN RESON, V100, P202, DOI 10.1016/0022-2364(92)90379-L; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	49	13	13	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26104	26114		10.1074/jbc.M112.360206	http://dx.doi.org/10.1074/jbc.M112.360206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22645138	Green Published, hybrid			2022-12-28	WOS:000306916300038
J	Zhou, LJ; Barao, S; Laga, M; Bockstael, K; Borgers, M; Gijsen, H; Annaert, W; Moechars, D; Mercken, M; Gevaer, K; De Strooper, B				Zhou, Lujia; Barao, Soraia; Laga, Mathias; Bockstael, Katrijn; Borgers, Marianne; Gijsen, Harry; Annaert, Wim; Moechars, Diederik; Mercken, Marc; Gevaer, Kris; De Strooper, Bart			The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; OLFACTORY SENSORY NEURONS; PERIPHERAL NERVOUS-SYSTEM; GATED SODIUM-CHANNELS; SPINAL-CORD-INJURY; CLOSE HOMOLOG; NEURITE OUTGROWTH; GAMMA-SECRETASE; MICE DEFICIENT	The beta-site amyloid precursor protein-cleaving enzyme BACE1 is a prime drug target for Alzheimer disease. However, the function and the physiological substrates of BACE1 remain largely unknown. In this work, we took a quantitative proteomic approach to analyze the secretome of primary neurons after acute BACE1 inhibition, and we identified several novel substrate candidates for BACE1. Many of these molecules are involved in neuronal network formation in the developing nervous system. We selected the adhesion molecules L1 and CHL1, which are crucial for axonal guidance and maintenance of neural circuits, for further validation as BACE1 substrates. Using both genetic BACE1 knock-out and acute pharmacological BACE1 inhibition in mice and cell cultures, we show that L1 and CHL1 are cleaved by BACE1 under physiological conditions. The BACE1 cleavage sites at the membrane-proximal regions of L1 (between Tyr(1086) and Glu(1087)) and CHL1 (between Gln(1061) and Asp(1062)) were determined by mass spectrometry. This work provides molecular insights into the function and the pathways in which BACE1 is involved, and it will help to predict or interpret possible side effects of BACE1 inhibitor drugs in current clinical trials.	[Zhou, Lujia; Barao, Soraia; Bockstael, Katrijn; Annaert, Wim; De Strooper, Bart] KULeuven, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Zhou, Lujia; Barao, Soraia; Bockstael, Katrijn; Annaert, Wim; De Strooper, Bart] KULeuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Zhou, Lujia; Barao, Soraia; Bockstael, Katrijn; Annaert, Wim; De Strooper, Bart] KULeuven, LIND, B-3000 Louvain, Belgium; [Laga, Mathias; Gevaer, Kris] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Laga, Mathias; Gevaer, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Borgers, Marianne; Gijsen, Harry; Moechars, Diederik; Mercken, Marc] Janssen Pharmaceut, Johnson & Johnson Pharmaceut Res & Dev, Neurosci Dept, B-2340 Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Johnson & Johnson; Janssen Pharmaceuticals	De Strooper, B (corresponding author), KULeuven, VIB Ctr Biol Dis, Herestr 49, B-3000 Louvain, Belgium.	Bart.DeStrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Gevaert, Kris/D-6489-2017	De Strooper, Bart/0000-0001-5455-5819; Gevaert, Kris/0000-0002-4237-0283	IWT Flanders; Fund for Scientific Research, Flanders; KU Leuven; Flemish Government; Foundation for Alzheimer Research (SAO/FRMA); Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office; Fundacao para a Ciencia e a Tecnologia (Portugal); Arthur Bax and Anna Vanluffelen chair for Alzheimer disease	IWT Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research, Flanders(FWO); KU Leuven(KU Leuven); Flemish Government(European Commission); Foundation for Alzheimer Research (SAO/FRMA); Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office; Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Arthur Bax and Anna Vanluffelen chair for Alzheimer disease	This work was supported in part by IWT Flanders, the Fund for Scientific Research, Flanders, KU Leuven, a Methusalem grant from KU Leuven and the Flemish Government, the Foundation for Alzheimer Research (SAO/FRMA), the Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office, and Fundacao para a Ciencia e a Tecnologia (Portugal).; Supported by the Arthur Bax and Anna Vanluffelen chair for Alzheimer disease. To whom correspondence should be addressed: VIB Center for the Biology of Disease and Center for Human Genetics, KULeuven, Herestraat 49, 3000 Leuven, Belgium. Tel.: 32-16-373-102; Fax: 32-16-330-827; E-mail: Bart.DeStrooper@cme.vib-kuleuven.be.	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Beer S, 1999, J CELL SCI, V112, P2667; Buhusi M, 2008, J NEUROSCI, V28, P177, DOI 10.1523/JNEUROSCI.3573-07.2008; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Colaert N, 2010, PROTEOMICS, V10, P1226, DOI 10.1002/pmic.200900379; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Demyanenko GP, 2011, CEREB CORTEX, V21, P401, DOI 10.1093/cercor/bhq115; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Demyanenko GP, 2003, J NEUROSCI, V23, P530, DOI 10.1523/JNEUROSCI.23-02-00530.2003; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Farah MH, 2011, J NEUROSCI, V31, P5744, DOI 10.1523/JNEUROSCI.6810-10.2011; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Helsens K, 2010, PROTEOMICS, V10, P1261, DOI 10.1002/pmic.200900409; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; Hitt BD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-31; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Irintchev A., 2011, NEUROSCIENTIST, V1; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Karagogeos D, 2003, FRONT BIOSCI-LANDMRK, V8, pS1304, DOI 10.2741/1214; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kobayashi D, 2008, NEUROBIOL AGING, V29, P861, DOI 10.1016/j.neurobiolaging.2007.01.002; Kobayashi NJ, 2007, Aminodihydrothiazine derivative. International Patent Application>, Patent No. [WO2007049532A1, 2007049532, WO2007/ 049532]; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Kurumaji A, 2001, AM J MED GENET, V105, P99; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lopes LV, 1999, J NEUROPHYSIOL, V82, P3196, DOI 10.1152/jn.1999.82.6.3196; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Miller SFC, 2007, GENE EXPR PATTERNS, V7, P635, DOI 10.1016/j.modgep.2006.12.002; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; Rajapaksha TW, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-88; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schlomann U, 2000, J NEUROSCI, V20, P7964; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; STEEGMAIER M, 1995, NATURE, V373, P615, DOI 10.1038/373615a0; Suetterlin P, 2012, SEMIN CELL DEV BIOL, V23, P1, DOI 10.1016/j.semcdb.2011.10.015; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004; Yamanaka H, 2011, J COMP NEUROL, V519, P1597, DOI 10.1002/cne.22588; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P14883, DOI 10.1073/pnas.0505164102; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138; Zhou LJ, 2011, J BIOL CHEM, V286, P8677, DOI 10.1074/jbc.M110.194860	87	133	140	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25927	25940		10.1074/jbc.M112.377465	http://dx.doi.org/10.1074/jbc.M112.377465			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692213	Green Published, hybrid			2022-12-28	WOS:000306916300021
J	Bel, S; Elkis, Y; Lerer-Goldstein, T; Nyska, A; Shpungin, S; Nir, U				Bel, Shai; Elkis, Yoav; Lerer-Goldstein, Tali; Nyska, Abraham; Shpungin, Sally; Nir, Uri			Loss of TMF/ARA160 Protein Renders Colonic Mucus Refractory to Bacterial Colonization and Diminishes Intestinal Susceptibility to Acute Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; NF-KAPPA-B; MICE; BARRIER; HOMEOSTASIS; ACTIVATION; MICROBIOTA; LAYERS; MUCIN	TMF/ARA160 is a Golgi-associated protein with several cellular functions, among them direction of the NF-kappa B subunit, p65 RelA, to ubiquitination and proteasomal degradation in stressed cells. We sought to investigate the role of TMF/ARA160 under imposed stress conditions in vivo. TMF-/- and wild-type (WT) mice were treated with the ulcerative agent dextran sulfate sodium (DSS), and the severity of the inflicted acute colitis was determined. TMF-/- mice were found to be significantly less susceptible to DSS-induced colitis, with profoundly less bacterial penetration into the colonic epithelia. Surprisingly, unlike in WT mice, no bacterial colonies were visualized in colons of healthy untreated TMF-/- mice, indicating the constitutive resistance of TMF-/- colonic mucus to bacterial retention and penetration. Gene expression analysis of colon tissues from unchallenged TMF-/- mice revealed 5-fold elevated transcription of the muc2 gene, which encodes the major component of the colonic mucus gel, the MUC2 mucin. Accordingly, the morphology of the colonic mucus in TMF-/- mice was found to differ from the mucus structure in WT colons. The NF-kappa B subunit, p65, a well known transcription inducer of muc2, was up-regulated significantly in TMF(-/-)intestinal epithelial cells. However, this did not cause spontaneous inflammation or increased colonic crypt cell proliferation. Collectively, our findings demonstrate that absence of TMF/ARA160 renders the colonic mucus refractory to bacterial colonization and the large intestine less susceptible to the onset of colitis.	[Bel, Shai; Elkis, Yoav; Lerer-Goldstein, Tali; Shpungin, Sally; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Nyska, Abraham] Tel Aviv Univ, Sackler Sch Med, IL-36576 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine	Nir, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	uri.nir@biu.ac.il	Bel, Shai/AAH-7870-2021	Bel, Shai/0000-0002-7166-4870	The Israeli Ministry of Health Chief Scientist Research Foundation	The Israeli Ministry of Health Chief Scientist Research Foundation	This work was supported by a grant from The Israeli Ministry of Health Chief Scientist Research Foundation.	Abrham G, 2009, INT J CANCER, V125, P43, DOI 10.1002/ijc.24277; Ahn DH, 2005, CELL PHYSIOL BIOCHEM, V15, P29, DOI 10.1159/000083636; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; BOUGHTONSMITH NK, 1988, AGENTS ACTIONS, V25, P115, DOI 10.1007/BF01969102; COOPER HS, 1993, LAB INVEST, V69, P238; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Ohtake K, 2010, NITRIC OXIDE-BIOL CH, V23, P65, DOI 10.1016/j.niox.2010.04.004; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rivas-Santiago CE, 2011, CLIN EXP IMMUNOL, V164, P80, DOI 10.1111/j.1365-2249.2010.04313.x; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Swidsinski A, 2007, INFLAMM BOWEL DIS, V13, P963, DOI 10.1002/ibd.20163; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Xu G, 2010, FOOD CHEM TOXICOL, V48, P390, DOI 10.1016/j.fct.2009.10.027; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yan YT, 2011, J IMMUNOL, V187, P1496, DOI 10.4049/jimmunol.1002910	35	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25631	25639		10.1074/jbc.M112.364786	http://dx.doi.org/10.1074/jbc.M112.364786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22553199	hybrid, Green Published			2022-12-28	WOS:000306651700070
J	Glew, MD; Veith, PD; Peng, B; Chen, YY; Gorasia, DG; Yang, QH; Slakeski, N; Chen, DN; Moore, C; Crawford, S; Reynolds, EC				Glew, Michelle D.; Veith, Paul D.; Peng, Benjamin; Chen, Yu-Yen; Gorasia, Dhana G.; Yang, Qiaohui; Slakeski, Nada; Chen, Dina; Moore, Caroline; Crawford, Simon; Reynolds, Eric C.			PG0026 Is the C-terminal Signal Peptidase of a Novel Secretion System of Porphyromonas gingivalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; PROTEIN SECRETION; GLIDING MOTILITY; III SECRETION; GINGIPAINS; W50; IDENTIFICATION; RGPB; BACTERIA; PERIODONTITIS	Protein substrates of a novel secretion system of Porphyromonas gingivalis contain a conserved C-terminal domain (CTD) of similar to 70-80 amino acid residues that is essential for their secretion and attachment to the cell surface. The CTD itself has not been detected in mature substrates, suggesting that it may be removed by a novel signal peptidase. More than 10 proteins have been shown to be essential for the proper functioning of the secretion system, and one of these, PG0026, is a predicted cysteine proteinase that also contains a CTD, suggesting that it may be a secreted component of the secretion system and a candidate for being the CTD signal peptidase. A PG0026 deletion mutant was constructed along with a PG0026C690A targeted mutant encoding an altered catalytic Cys residue. Analysis of clarified culture fluid fractions by SDS-PAGE and mass spectrometry revealed that the CTD was released intact into the surrounding medium in the wild type strain, but not in the PG0026 mutant strains. Western blot experiments revealed that the maturation of a model substrate was stalled at the CTD-removal step specifically in the PG0026 mutants, and whole cell ELISA experiments demonstrated partial secretion of substrates to the cell surface. The CTD was also shown to be accessible at the cell surface in the PG0026 mutants, suggesting that the CTD was secreted but could not be cleaved. The data indicate that PG0026 is responsible for the cleavage of the CTD signal after substrates are secreted across the OM.	[Glew, Michelle D.; Veith, Paul D.; Peng, Benjamin; Chen, Yu-Yen; Gorasia, Dhana G.; Yang, Qiaohui; Slakeski, Nada; Chen, Dina; Moore, Caroline; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia; [Glew, Michelle D.; Veith, Paul D.; Peng, Benjamin; Chen, Yu-Yen; Gorasia, Dhana G.; Yang, Qiaohui; Slakeski, Nada; Chen, Dina; Moore, Caroline; Reynolds, Eric C.] Univ Melbourne, Inst Bio21, Melbourne, Vic 3010, Australia; [Crawford, Simon] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, 720 Swanston St, Melbourne, Vic 3010, Australia.	e.reynolds@unimelb.edu.au	Glew, Michelle/AAW-9955-2020	Veith, Paul/0000-0002-7344-1662; Reynolds, Eric/0000-0002-6618-4856; Slakeski, Nada/0000-0001-9776-6018; Glew, Michelle/0000-0002-0690-6079				Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Fitzpatrick RE, 2009, FUTURE MICROBIOL, V4, P471, DOI 10.2217/FMB.09.18; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frazer LT, 2006, VACCINE, V24, P6542, DOI 10.1016/j.vaccine.2006.06.013; Hardham J, 2005, VET MICROBIOL, V106, P119, DOI 10.1016/j.vetmic.2004.12.018; Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; O'Brien-Simpson NM, 2004, PERIODONTOL 2000, V35, P101, DOI 10.1111/j.0906-6713.2004.003559.x; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; Osborne SE, 2011, FUTURE MICROBIOL, V6, P193, DOI 10.2217/FMB.10.172; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Rangarajan M, 1997, BIOCHEM J, V323, P701, DOI 10.1042/bj3230701; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Rhodes RG, 2011, J BACTERIOL, V193, P5322, DOI 10.1128/JB.05480-11; Saiki K, 2007, MICROBIOL IMMUNOL, V51, P483, DOI 10.1111/j.1348-0421.2007.tb03936.x; Saiki K, 2010, FEMS MICROBIOL LETT, V310, P168, DOI 10.1111/j.1574-6968.2010.02059.x; Saiki K, 2010, FEMS MICROBIOL LETT, V302, P166, DOI 10.1111/j.1574-6968.2009.01848.x; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105	43	100	101	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24605	24617		10.1074/jbc.M112.369223	http://dx.doi.org/10.1074/jbc.M112.369223			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22593568	Green Published, hybrid			2022-12-28	WOS:000306651100055
J	Irigoyen, N; Caston, JR; Rodriguez, JF				Irigoyen, Nerea; Caston, Jose R.; Rodriguez, Jose F.			Host Proteolytic Activity Is Necessary for Infectious Bursal Disease Virus Capsid Protein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC NECROSIS VIRUS; STRANDED-RNA VIRUS; CRYSTAL-STRUCTURE; STRUCTURAL POLYMORPHISM; NONENVELOPED VIRUS; MATURATION PROCESS; MOLECULAR SWITCH; CATALYTIC DYAD; INSECT CELLS; VP3	In many viruses, a precursor particle, or procapsid, is assembled and undergoes massive chemical and physical modification to produce the infectious capsid. Capsid assembly and maturation are finely tuned processes in which viral and host factors participate. We show that the precursor of the VP2 capsid protein (pVP2) of the infectious bursal disease virus (IBDV), a double-stranded RNA virus, is processed at the C-terminal domain (CTD) by a host protease, the puromycin-sensitive aminopeptidase (PurSA). The pVP2 CTD (71 residues) has an important role in determining the various conformations of VP2 (441 residues) that build the T = 13 complex capsid. pVP2 CTD activity is controlled by co- and posttranslational proteolytic modifications of different targets by the VP4 viral protease and by VP2 itself to yield the mature VP2-441 species. Puromycin-sensitive aminopeptidase is responsible for the peptidase activity that cleaves the Arg-452-Arg-453 bond to generate the intermediate pVP2-452 polypeptide. A pVP2 R453A substitution abrogates PurSA activity. We used a baculovirus-based system to express the IBDV polyprotein in insect cells and found inefficient formation of virus-like particles similar to IBDV virions, which correlates with the absence of puromycin-sensitive aminopeptidase in these cells. Virus-like particle assembly was nonetheless rescued efficiently by coexpression of chicken PurSA or pVP2-452 protein. Silencing or pharmacological inhibition of puromycin-sensitive aminopeptidase activity in cell lines permissive for IBDV replication caused a major blockade in assembly and/or maturation of infectious IBDV particles, as virus yields were reduced markedly. PurSA activity is thus essential for IBDV replication.	[Caston, Jose R.] CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Madrid 28049, Spain; [Irigoyen, Nerea; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Caston, JR (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Madrid 28049, Spain.	jrcaston@cnb.csic.es; jfrodrig@cnb.csic.es	Irigoyen, Nerea/CAJ-2485-2022; Rodríguez, José F/T-8500-2017; Caston, Jose R/L-5896-2014; Irigoyen, Nerea/A-7925-2017; Caston, Jose/AAB-8825-2021	Irigoyen, Nerea/0000-0001-6346-3369; Rodríguez, José F/0000-0001-7944-5341; Caston, Jose R/0000-0003-2350-9048; Irigoyen, Nerea/0000-0001-6346-3369; Caston, Jose/0000-0003-2350-9048	Spanish Ministry of Science and Innovation [BIO2009-12443, AGL2011-24758, BIO2008-02361, BFU2011-25902]; Spanish Ministry of Education and Science (MEC); CSIC Residencia de Estudiantes; Gobierno de Aragon	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education and Science (MEC)(Spanish Government); CSIC Residencia de Estudiantes; Gobierno de Aragon(Gobierno de Aragon)	This work was supported by Spanish Ministry of Science and Innovation Grants BIO2009-12443 and AGL2011-24758 (to J. F. R.) and BIO2008-02361 and BFU2011-25902 (to J. R. C.). This work was also supported by a fellowship from the Spanish Ministry of Education and Science (MEC) with support from the CSIC Residencia de Estudiantes and the Gobierno de Aragon (to N. I.).	Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bottcher B, 1997, J VIROL, V71, P325; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Caston Jose R., 2008, P133; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Chevalier C, 2005, J VIROL, V79, P12253, DOI 10.1128/JVI.79.19.12253-12263.2005; Chevalier C, 2002, J VIROL, V76, P2384, DOI 10.1128/JVI.76.5.2384-2392.2002; Chung HK, 1996, VIROLOGY, V225, P359, DOI 10.1006/viro.1996.0610; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Da Costa B, 2003, J VIROL, V77, P719, DOI 10.1128/JVI.77.1.719-725.2003; Dokland T, 2000, STRUCTURE, V8, pR157, DOI 10.1016/S0969-2126(00)00181-7; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X; Fischl W, 2008, J VIROL, V82, P8272, DOI 10.1128/JVI.00587-08; Galloux M, 2004, J GEN VIROL, V85, P2231, DOI 10.1099/vir.0.80012-0; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Gertsman I, 2009, NATURE, V458, P646, DOI 10.1038/nature07686; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Johnson JE, 2010, CURR OPIN STRUC BIOL, V20, P210, DOI 10.1016/j.sbi.2010.01.004; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Maraver A, 2003, J VIROL, V77, P2459, DOI 10.1128/JVI.77.4.2459-2468.2003; Martinez-Torrecuadrada JL, 2000, VIROLOGY, V278, P322, DOI 10.1006/viro.2000.0559; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Nobiron I, 2008, VIROLOGY, V371, P350, DOI 10.1016/j.virol.2007.09.022; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Saugar I, 2010, J BIOL CHEM, V285, P3643, DOI 10.1074/jbc.M109.075994; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; Vakharia VN, 1997, BIOTECHNOL ANN REV, V3, P151, DOI 10.1016/S1387-2656(08)70032-2; Vancini R, 2012, J VIROL, V86, P2390, DOI 10.1128/JVI.06614-11; Villanueva RA, 2004, J VIROL, V78, P13829, DOI 10.1128/JVI.78.24.13829-13838.2004	46	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24473	24482		10.1074/jbc.M112.356113	http://dx.doi.org/10.1074/jbc.M112.356113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22619177	hybrid, Green Published			2022-12-28	WOS:000306651100040
J	Nakamura, H; Bannai, H; Inoue, T; Michikawa, T; Sano, M; Mikoshiba, K				Nakamura, Hideki; Bannai, Hiroko; Inoue, Takafumi; Michikawa, Takayuki; Sano, Masaki; Mikoshiba, Katsuhiko			Cooperative and Stochastic Calcium Releases from Multiple Calcium Puff Sites Generate Calcium Microdomains in Intact HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENTARY CA2+ SIGNALS; INOSITOL TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; LATERAL DIFFUSION; CHANNEL; MICROSCOPY; RESPONSES; DYNAMICS; CLUSTERS	Ca2+ microdomains or locally restricted Ca2+ increases in the cell have recently been reported to regulate many essential physiological events. Ca2+ increases through the inositol 1,4,5-trisphosphate (IP3) receptor (IP3R)/Ca2+ release channels contribute to the formation of a class of such Ca2+ microdomains, which were often observed and referred to as Ca2+ puffs in their isolated states. In this report, we visualized IP3-evoked Ca2+ microdomains in histamine-stimulated intact HeLa cells using a total internal reflection fluorescence microscope, and quantitatively characterized the spatial profile by fitting recorded images to a two-dimensional Gaussian distribution. Ca2+ concentration profiles were marginally spatially anisotropic, with the size increasing linearly even after the amplitude began to decline. We found the event centroid drifted with an apparent diffusion coefficient of 4.20 +/- 0.50 mu m(2)/s, which is significantly larger than those estimated for IP(3)Rs. The sites of maximal Ca2+ increase, rather than initiation or termination sites, were detected repeatedly at the same location. These results indicate that Ca2+ microdomains in intact HeLa cell are generated from spatially distributed multiple IP3R clusters or Ca2+ puff sites, rather than a single IP3R cluster reported in cells loaded with Ca2+ buffers.	[Michikawa, Takayuki] Saitama Univ, Brain Sci Inst, Sakura Ku, Saitama 3388570, Japan; [Nakamura, Hideki; Bannai, Hiroko; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Nakamura, Hideki; Sano, Masaki] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Inoue, Takafumi; Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Corp JST, ICORP, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan; [Nakamura, Hideki; Inoue, Takafumi] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Saitama University; RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); Waseda University	Michikawa, T (corresponding author), Saitama Univ, Brain Sci Inst, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	michikawa@mail.saitama-u.ac.jp; mikosiba@brain.riken.jp	Sano, Masaki/E-4434-2012; Mikoshiba, Katsuhiko/N-7943-2015; Bannai, Hiroko/I-7130-2014; Inoue, Takafumi/AAM-9533-2020	Sano, Masaki/0000-0002-6262-9635; Bannai, Hiroko/0000-0002-0951-488X; Inoue, Takafumi/0000-0002-2728-0060; Nakamura, Hideki/0000-0003-2749-8323	Ministry of Education, Science, Sports and Culture of Japan [23650197, 16770124, 14380364, 20370054, 24500476, 2022007]; JST ICORP-SORST; Grants-in-Aid for Scientific Research [23650197, 23300121] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST ICORP-SORST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan 23650197 (to H. N.), 16770124 (to H. B.), 14380364 (to T. I.), 20370054 and 24500476 (to T. M.) and 2022007 (to K. M.), and from JST ICORP-SORST (to K. M.).	Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928; Bootman MD, 1996, CURR BIOL, V6, P855, DOI 10.1016/S0960-9822(02)00609-7; Callamaras N, 2000, EMBO J, V19, P3608, DOI 10.1093/emboj/19.14.3608; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Demuro A, 2008, CELL CALCIUM, V43, P367, DOI 10.1016/j.ceca.2007.07.002; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; PARKER I, 1990, SCIENCE, V250, P977, DOI 10.1126/science.2237441; PARKER I, 1991, P ROY SOC B-BIOL SCI, V246, P269, DOI 10.1098/rspb.1991.0154; Reber BFX, 1996, PFLUG ARCH EUR J PHY, V432, P893, DOI 10.1007/s004240050213; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Shuai JW, 2005, CELL CALCIUM, V37, P283, DOI 10.1016/j.ceca.2004.10.008; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P521, DOI 10.1113/jphysiol.2002.022103; Smith GD, 1996, BIOPHYS J, V70, P2527, DOI 10.1016/S0006-3495(96)79824-7; Smith GD, 1998, BIOPHYS J, V75, P15, DOI 10.1016/S0006-3495(98)77491-0; Smith IF, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000466; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; Thomas D, 1998, J BIOL CHEM, V273, P27130, DOI 10.1074/jbc.273.42.27130; Tovey SC, 2001, J CELL SCI, V114, P3979; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538	35	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24563	24572		10.1074/jbc.M111.311399	http://dx.doi.org/10.1074/jbc.M111.311399			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637479	Green Published, hybrid			2022-12-28	WOS:000306651100049
J	Sizemore, ST; Keri, RA				Sizemore, Steven T.; Keri, Ruth A.			The Forkhead Box Transcription Factor FOXC1 Promotes Breast Cancer Invasion by Inducing Matrix Metalloprotease 7 (MMP7) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-LINES; HELIX GENE; MONOCLONAL-ANTIBODY; CLAUDIN-LOW; IN-VITRO; MATRILYSIN; BASAL; INCREASES; RECEPTOR; PATTERNS	Therapeutic options for treatment of basal-like breast cancers are limited and identification of molecular targets for novel therapies to treat this aggressive cancer is urgently needed. Recently, FOXC1, a forkhead box transcription factor, was identified as a functionally important biomarker of breast cancer aggressiveness and the basal-like breast cancer subtype. However, the mechanism through which FOXC1 controls aggressiveness of basal-like breast cancer remains to be elucidated. Here, we identify matrix metalloprotease 7 (MMP7) as a key downstream effector of FOXC1-mediated invasiveness. Expression of FOXC1 and MMP7 is significantly correlated in breast cancer samples and cell lines at both the mRNA and protein levels. Transient expression of FOXC1 in nontransformed mammary epithelial cell lines resulted in significantly increased expression of MMP7 and an MMP7-dependent increase in invasiveness. In reciprocal experiments, silencing endogenous FOXC1 in basal-like breast cancer cell lines resulted in decreased expression of MMP7 without decreased expression of other matrix metalloproteinases. We also demonstrate that elevated co-expression of FOXC1 and MMP7 is an independent predictor of patient outcome in multivariate analyses of two breast cancer patient cohorts. Together, our findings identify MMP7 as a novel mechanism through which FOXC1 may regulate the basal-like breast cancer invasive phenotype and the propensity of these cancers to metastasize. Furthermore, our findings demonstrate for the first time a correlation between MMP7 expression and basal-like breast cancers, suggesting that MMP7 may be a useful therapeutic target for treatment of this disease.	[Sizemore, Steven T.; Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	National Institutes of Health [T32CA059366]; Department of Defense [W81XWH-09-1-0696, W81XWH-08-1-0347]; NATIONAL CANCER INSTITUTE [T32CA059366, P30CA043703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32CA059366 (to S. T. S.) and Department of Defense Grants W81XWH-09-1-0696 (to S. T. S.) and W81XWH-08-1-0347 (to R. A. K.).	Berry FB, 2008, HUM MOL GENET, V17, P490, DOI 10.1093/hmg/ddm326; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Clarke M, 1998, LANCET, V351, P1451; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Du J, 2012, BREAST CANCER RES TR, V131, P65, DOI 10.1007/s10549-011-1396-3; FERNANDEZRESA P, 1995, ANAL BIOCHEM, V224, P434, DOI 10.1006/abio.1995.1063; Fukushima H, 2001, CARCINOGENESIS, V22, P1049, DOI 10.1093/carcin/22.7.1049; Gucalp A, 2011, CHEMOTHER RES PRACT, DOI DOI 10.1155/2011/696208; Hicks DG, 2006, AM J SURG PATHOL, V30, P1097; Jacobsen LB, 2009, BIOTECHNIQUES, V47, P617, DOI 10.2144/000113132; Jiang WG, 2005, CLIN CANCER RES, V11, P6012, DOI 10.1158/1078-0432.CCR-05-0275; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; MATRISIAN LM, 1994, PRINCESS TAKAMATSU S, P152; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura H, 2002, ONCOL REP, V9, P751; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; POWELL WC, 1993, CANCER RES, V53, P417; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ray PS, 2011, ANN SURG ONCOL, V18, P3839, DOI 10.1245/s10434-011-1657-8; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Richards TJ, 2012, AM J PHYSIOL-LUNG C, V302, pL746, DOI 10.1152/ajplung.00319.2011; Sato N, 2003, JNCI-J NATL CANCER I, V95, P327, DOI 10.1093/jnci/95.4.327; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tkocz D., 2011, ONCOGENE IN PRESS; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang J., 2012, ONCOGENE IN PRESS; Wang WS, 2006, CARCINOGENESIS, V27, P1113, DOI 10.1093/carcin/bgi351; WITTY JP, 1994, CANCER RES, V54, P4805; YAMAMOTO H, 1995, INT J CANCER, V61, P218, DOI 10.1002/ijc.2910610213	44	68	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24631	24640		10.1074/jbc.M112.375865	http://dx.doi.org/10.1074/jbc.M112.375865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645147	hybrid, Green Published			2022-12-28	WOS:000306651100057
J	Werneburg, NW; Bronk, SF; Guicciardi, ME; Thomas, L; Dikeakos, JD; Thomas, G; Gores, GJ				Werneburg, Nathan W.; Bronk, Steve F.; Guicciardi, Maria Eugenia; Thomas, Laurel; Dikeakos, Jimmy D.; Thomas, Gary; Gores, Gregory J.			Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Protein-induced Lysosomal Translocation of Proapoptotic Effectors Is Mediated by Phosphofurin Acidic Cluster Sorting Protein-2 (PACS-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MEMBRANE PERMEABILIZATION; HEPATOCYTE APOPTOSIS; GENOTOXIC STRESS; MHC-I; PHOSPHORYLATION; FAMILY; BAX; ACTIVATION; BINDING	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of liver cancer cell lines requires death receptor-5 (DR5)-dependent permeabilization of lysosomal membranes. Ligated DR5 triggers recruitment of the proapoptotic proteins Bim and Bax to lysosomes, releasing cathepsin B into the cytosol where it mediates mitochondria membrane permeabilization and activation of executioner caspases. Despite the requirement for lysosome membrane permeabilization during TRAIL-induced apoptosis, little is known about the mechanism that controls recruitment of Bim and Bax to lysosomal membranes. Here we report that TRAIL induces recruitment of the multifunctional sorting protein phosphofurin acidic cluster sorting protein-2 (PACS-2) to DR5-positive endosomes in Huh-7 cells where it forms an immunoprecipitatable complex with Bim and Bax on lysosomal membranes. shRNA-targeted knockdown of PACS-2 prevents recruitment of Bim or Bax to lysosomes, blunting the TRAIL-induced lysosome membrane permeabilization. Consistent with the reduced lysosome membrane permeabilization, shRNA knockdown of PACS-2 in Huh-7 cells reduced TRAIL-induced apoptosis and increased clonogenic cell survival. The determination that recombinant PACS-2 bound Bim but not Bax in vitro and that shRNA knockdown of Bim blocked Bax recruitment to lysosomes suggests that TRAIL/DR5 triggers endosomal PACS-2 to recruit Bim and Bax to lysosomes to release cathepsin B and induce apoptosis. Together, these findings provide insight into the lysosomal pathway of apoptosis.	[Werneburg, Nathan W.; Bronk, Steve F.; Guicciardi, Maria Eugenia; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Thomas, Laurel; Dikeakos, Jimmy D.; Thomas, Gary] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Mayo Clinic; Oregon Health & Science University	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu			National Institutes of health [DK37274, CA151564, DK 63947]; Canadian Institute of Health Research [HFE-87760]; FRQS [23037]; Collins Medical Trust; NATIONAL CANCER INSTITUTE [R01CA151564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037274, R01DK063947] Funding Source: NIH RePORTER	National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); FRQS; Collins Medical Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of health Grants DK37274 and CA151564 (to G. T.) and DK 63947 (to G. J. G.). This work was also supported by Canadian Institute of Health Research fellowship HFE-87760, FRQS fellowship 23037 and the Collins Medical Trust (to J. D. D.).	Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Aslan JE, 2009, TRAFFIC, V10, P1390, DOI 10.1111/j.1600-0854.2009.00951.x; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; Bouard D, 2007, TRAFFIC, V8, P835, DOI 10.1111/j.1600-0854.2007.00581.x; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Canbay A, 2003, J CLIN INVEST, V112, P152, DOI 10.1172/JCI200317740; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Crump CM, 2003, J VIROL, V77, P11105, DOI 10.1128/JVI.77.20.11105-11113.2003; Dikeakos JD, 2012, MOL BIOL CELL, V23, P2184, DOI 10.1091/mbc.E11-11-0928; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Guicciardi ME, 2005, GASTROENTEROLOGY, V129, P269, DOI 10.1053/j.gastro.2005.05.022; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kahraman A, 2008, HEPATOLOGY, V47, P1317, DOI 10.1002/hep.22136; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takeda K, 2008, P NATL ACAD SCI USA, V105, P10895, DOI 10.1073/pnas.0802702105; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vogel S, 2012, J BIOL CHEM, V287, P9112, DOI 10.1074/jbc.M111.248906; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	50	37	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24427	24437		10.1074/jbc.M112.342238	http://dx.doi.org/10.1074/jbc.M112.342238			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645134	Green Published, hybrid			2022-12-28	WOS:000306651100036
J	Yu, PL; Zhang, ZH; Hao, BX; Zhao, YJ; Zhang, LH; Lee, HC; Zhang, LR; Yue, JB				Yu, Pei-Lin; Zhang, Zhe-Hao; Hao, Bai-Xia; Zhao, Yong-Juan; Zhang, Li-He; Lee, Hon-Cheung; Zhang, Liangren; Yue, Jianbo			A Novel Fluorescent Cell Membrane-permeable Caged Cyclic ADP-ribose Analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE DIPHOSPHORIBOSE; RYANODINE RECEPTOR; CADPR; CA2+; ACTIVATION; CHANNEL; TRPM2; DISSOCIATION; MIMICS; NAADP	Cyclic adenosine diphosphate ribose is an endogenous Ca2+ mobilizer involved in diverse cellular processes. A cell membrane-permeable cyclic adenosine diphosphate ribose analogue, cyclic inosine diphosphoribose ether (cIDPRE), can induce Ca2+ increase in intact human Jurkat T-lymphocytes. Here we synthesized a coumarin-caged analogue of cIDPRE (Co-i-cIDPRE), aiming to have a precisely temporal and spatial control of bioactive cIDPRE release inside the cell using UV uncaging. We showed that Co-i-cIDPRE accumulated inside Jurkat cells quickly and efficiently. Uncaging of Co-i-cIDPRE evoked Ca2+ release from endoplasmic reticulum, with concomitant Ca2+ influx in Jurkat cells. Ca2+ release evoked by uncaged Co-i-cIDPRE was blocked by knockdown of ryanodine receptors (RyRs) 2 and 3 in Jurkat cells. The associated Ca2+ influx, on the other hand, was abolished by double knockdown of Stim1 and TRPM2 in Jurkat cells. Furthermore, Ca2+ release or influx evoked by uncaged Co-i-cIDPRE was recapitulated in HEK293 cells that overexpress RyRs or TRPM2, respectively, but not in wild-type cells lacking these channels. In summary, our results indicate that uncaging of Co-i-cIDPRE incites Ca2+ release from endoplasmic reticulum via RyRs and triggers Ca2+ influx via TRPM2.	[Yu, Pei-Lin; Zhang, Li-He; Zhang, Liangren] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100191, Peoples R China; [Yu, Pei-Lin; Zhang, Zhe-Hao; Hao, Bai-Xia; Zhao, Yong-Juan; Lee, Hon-Cheung; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	Peking University; University of Hong Kong	Zhang, LR (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100191, Peoples R China.	liangren@bjmu.edu.cn; jyue@hku.hk	Zhang, Liang/GWM-6088-2022; Yue, Jianbo/AAC-4588-2019; Zhao, Yongjuan/AAS-9919-2021; Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/K-8002-2015	Yue, Jianbo/0000-0001-6384-5447; Zhao, Yong Juan/0000-0003-4564-1912; Hao, Helen Baixia/0000-0002-5648-3705	Research Grant Council (RGC) [HKU 784710M, HKU 782709M, HKU 785911M]; National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong [N_HKU 737/09]; NSFC [20910094, 90713005]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong; NSFC(National Natural Science Foundation of China (NSFC)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) Grants HKU 784710M, HKU 782709M, and HKU 785911M, a National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong (Grant N_HKU 737/09), NSFC Grant 20910094 and 90713005, and a Special Fellow Award from the Leukemia and Lymphoma Society of America (to J. Y.).	AARHUS R, 1995, J BIOL CHEM, V270, P7745, DOI 10.1074/jbc.270.13.7745; Dong M, 2010, ORG BIOMOL CHEM, V8, P4705, DOI 10.1039/c0ob00090f; Fukuoka M, 2000, J ORG CHEM, V65, P5238, DOI 10.1021/jo0000877; Furuta T, 1996, BIOCHEM BIOPH RES CO, V228, P193, DOI 10.1006/bbrc.1996.1638; Galione A, 2000, Sci STKE, V2000, ppe1; Gu XF, 2004, J MED CHEM, V47, P5674, DOI 10.1021/jm040092t; Guse AH, 2005, J BIOL CHEM, V280, P15952, DOI 10.1074/jbc.M414032200; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Higashida H, 2007, NEUROCHEM INT, V51, P192, DOI 10.1016/j.neuint.2007.06.023; Kirchberger T, 2006, BRIT J PHARMACOL, V149, P337, DOI 10.1038/sj.bjp.0706869; Kirchberger T, 2009, BIOCHEM J, V422, P139, DOI 10.1042/BJ20082308; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lagisetti C, 2007, J ORG CHEM, V72, P9886, DOI 10.1021/jo0711900; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; Li LJ, 2008, TETRAHEDRON LETT, V49, P4491, DOI 10.1016/j.tetlet.2008.05.076; Li LJ, 2010, ORG BIOMOL CHEM, V8, P1843, DOI 10.1039/b925295a; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Morgan AJ, 2008, METHODS, V46, P194, DOI 10.1016/j.ymeth.2008.09.013; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Qi N, 2011, CHEM COMMUN, V47, P9462, DOI 10.1039/c1cc13062e; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shirato M, 1995, Nucleic Acids Symp Ser, P165; Shuto S, 2004, CURR MED CHEM, V11, P827, DOI 10.2174/0929867043455639; Shuto Satoshi, 2007, Nucleic Acids Symp Ser (Oxf), P109; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Thomas JM, 2002, CURR BIOL, V12, P2018, DOI 10.1016/S0960-9822(02)01335-0; Thomas JM, 2001, BIOCHEM J, V359, P451, DOI 10.1042/0264-6021:3590451; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; WALSETH TF, 1993, J BIOL CHEM, V268, P26686; Wong L, 1999, BBA-GEN SUBJECTS, V1472, P555, DOI 10.1016/S0304-4165(99)00161-0; Wu HM, 2010, NEW J CHEM, V34, P956, DOI 10.1039/b9nj00595a; Xu JF, 2006, J MED CHEM, V49, P5501, DOI 10.1021/jm060320e; Yue JB, 2006, MOL CELL BIOL, V26, P5300, DOI 10.1128/MCB.00273-06; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zhang B, 2008, J ORG CHEM, V73, P1693, DOI 10.1021/jo071236p; Zhang B, 2008, J MED CHEM, V51, P1623, DOI 10.1021/jm7010386; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang X, 2009, CARDIOVASC RES, V84, P253, DOI 10.1093/cvr/cvp212	41	23	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24774	24783		10.1074/jbc.M111.329854	http://dx.doi.org/10.1074/jbc.M111.329854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22661714	Green Published, hybrid			2022-12-28	WOS:000306651100070
J	Hong, SW; Jin, DH; Shin, JS; Moon, JH; Na, YS; Jung, KA; Kim, SM; Kim, JC; Kim, KP; Hong, YS; Lee, JL; Choi, EK; Lee, JS; Kim, TW				Hong, Seung-Woo; Jin, Dong-Hoon; Shin, Jae-Sik; Moon, Jai-Hee; Na, Young-Soon; Jung, Kyung-Ah; Kim, Seung-Mi; Kim, Jin Cheon; Kim, Kyu-pyo; Hong, Yong Sang; Lee, Jae-Lyun; Choi, Eun Kyung; Lee, Jung Shin; Kim, Tae Won			Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOMA-CELLS; PATHWAY; MUTATIONS; CANCER; PROLIFERATION; INHIBITOR; PLX4032	Members of the RAF family (ARAF, BRAF, and CRAF/RAF-1) are involved in a variety of cellular activities, including growth, survival, differentiation, and transformation. An oncogene encodes BRAF, the function of which is linked to MEK activation. BRAF is the most effective RAF kinase in terms of induction of MEK/ERK activity. However, the mechanisms involved in BRAF regulation remain unclear. In the present work, we used a tandem affinity purification approach to show that RNF149 (RING finger protein 149) interacts with wild-type BRAF. The latter protein is a RING domain-containing E3 ubiquitin ligase involved in control of gene transcription, translation, cytoskeletal organization, cell adhesion, and epithelial development. We showed that RNF149 bound directly to the C-terminal kinase-containing domain of wild-type BRAF and induced ubiquitination, followed by proteasome-dependent degradation, of the latter protein. Functionally, RNF149 attenuated the increase in cell growth induced by wild-type BRAF. However, RNF149 did not bind to mutant BRAF or induce ubiquitination thereof. Thus, we show that RNF149 is an E3 ubiquitin ligase active on wild-type BRAF.	[Hong, Seung-Woo; Jin, Dong-Hoon; Shin, Jae-Sik; Moon, Jai-Hee; Na, Young-Soon; Jung, Kyung-Ah; Kim, Seung-Mi; Kim, Kyu-pyo; Hong, Yong Sang; Lee, Jae-Lyun; Choi, Eun Kyung; Lee, Jung Shin; Kim, Tae Won] Univ Ulsan, Inst Innovat Canc Res, Coll Med, Seoul 138736, South Korea; [Hong, Seung-Woo; Jin, Dong-Hoon; Shin, Jae-Sik; Moon, Jai-Hee; Na, Young-Soon; Jung, Kyung-Ah; Kim, Seung-Mi; Kim, Kyu-pyo; Hong, Yong Sang; Lee, Jae-Lyun; Lee, Jung Shin; Kim, Tae Won] Univ Ulsan, Dept Oncol, Coll Med, Asan Med Ctr, Seoul 138736, South Korea; [Choi, Eun Kyung] Univ Ulsan, Dept Radiat Oncol, Coll Med, Asan Med Ctr, Seoul 138736, South Korea; [Kim, Jin Cheon] Univ Ulsan, Dept Surg, Coll Med, Asan Med Ctr, Seoul 138736, South Korea	University of Ulsan; University of Ulsan; University of Ulsan; University of Ulsan	Kim, TW (corresponding author), Univ Ulsan, Inst Innovat Canc Res, Coll Med, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.	twkimmd@amc.seoul.kr			Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs, Republic of Korea [A102059]; Asan Institute for Life Sciences, Seoul, Republic of Korea [2012-231]	Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs, Republic of Korea; Asan Institute for Life Sciences, Seoul, Republic of Korea	This work was supported by Grant A102059 from the Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs, Republic of Korea and Grant 2012-231 from the Asan Institute for Life Sciences, Seoul, Republic of Korea.	Calipel A, 2003, J BIOL CHEM, V278, P42409, DOI 10.1074/jbc.M308709200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Lee J, 2011, JNCI-J NATL CANCER I, V103, P674, DOI 10.1093/jnci/djr070; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Ovaa H, 2007, NAT REV CANCER, V7, P613, DOI 10.1038/nrc2128; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	18	22	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24017	24025		10.1074/jbc.M111.319822	http://dx.doi.org/10.1074/jbc.M111.319822			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22628551	Green Published, hybrid			2022-12-28	WOS:000306511300070
J	Cheng, W; Wang, L; Jiang, YL; Bai, XH; Chu, J; Li, Q; Yu, G; Liang, QL; Zhou, CZ; Chen, YX				Cheng, Wang; Wang, Lei; Jiang, Yong-Liang; Bai, Xiao-Hui; Chu, Jun; Li, Qiong; Yu, Ge; Liang, Qiu-Ling; Zhou, Cong-Zhao; Chen, Yuxing			Structural Insights into the Substrate Specificity of Streptococcus pneumoniae beta(1,3)-Galactosidase BgaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SEQUENCE-BASED CLASSIFICATION; BETA-GALACTOSIDASE; GLYCOSYL HYDROLASES; CRYSTAL-STRUCTURE; SULFOLOBUS-SOLFATARICUS; KLUYVEROMYCES-LACTIS; VIRULENCE FACTORS; ESCHERICHIA-COLI; SURFACE PROTEIN	The surface-exposed beta-galactosidase BgaC from Streptococcus pneumoniae was reported to be a virulence factor because of its specific hydrolysis activity toward the beta(1,3)-linked galactose and N-acetylglucosamine (Gal beta(1,3) NAG) moiety of oligosaccharides on the host molecules. Here we report the crystal structure of BgaC at 1.8 angstrom and its complex with galactose at 1.95 angstrom. At pH 5.5-8.0, BgaC exists as a stable homodimer, each subunit of which consists of three distinct domains: a catalytic domain of a classic (beta/alpha)(8) TIM barrel, followed by two all-beta domains (ABDs) of unknown function. The side walls of the TIM beta-barrel and a loop extended from the first ABD constitute the active site. Superposition of the galactose-complexed structure to the apo-form revealed significant conformational changes of residues Trp-243 and Tyr-455. Simulation of a putative substrate entrance tunnel and modeling of a complex structure with Gal beta(1,3) NAG enabled us to assign three key residues to the specific catalysis. Site-directed mutagenesis in combination with activity assays further proved that residues Trp-240 and Tyr-455 contribute to stabilizing the N-acetylglucosamine moiety, whereas Trp-243 is critical for fixing the galactose ring. Moreover, we propose that BgaC and other galactosidases in the GH-35 family share a common domain organization and a conserved substrate-determinant aromatic residue protruding from the second domain.	[Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zcz@ustc.edu.cn; cyxing@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014; Wang, Lei/AAA-1917-2020	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Wang, Lei/0000-0002-3024-8627; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2009CB918804]; National Natural Science Foundation of China [30870488]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2009CB918804 and National Natural Science Foundation of China Grant 30870488.	Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Ahn YO, 2007, PHYTOCHEMISTRY, V68, P1510, DOI 10.1016/j.phytochem.2007.03.021; ALPERS DH, 1969, J BIOL CHEM, V244, P1238; ANDERSSON B, 1988, ACTA OTO-LARYNGOL, P163; ASP NG, 1972, ANAL BIOCHEM, V47, P527, DOI 10.1016/0003-2697(72)90147-9; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; CAMARA M, 1994, INFECT IMMUN, V62, P3688; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W.L, PYMOL MOL GRAPHICS S; DICKSON RC, 1979, J BACTERIOL, V137, P51, DOI 10.1128/JB.137.1.51-61.1979; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; HONDA S, 1989, ANAL BIOCHEM, V180, P351, DOI 10.1016/0003-2697(89)90444-2; Huber RE, 2003, BIOCHEMISTRY-US, V42, P1796, DOI 10.1021/bi0270642; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; Jeong JK, 2009, J BACTERIOL, V191, P3011, DOI 10.1128/JB.01601-08; Juers DH, 1999, PROTEIN SCI, V8, P122; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kestwal RA, 2007, BBA-GEN SUBJECTS, V1770, P1506, DOI 10.1016/j.bbagen.2007.07.002; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Maksimainen M, 2012, FEBS J, V279, P1788, DOI 10.1111/j.1742-4658.2012.08555.x; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; Miller J. H., 1972, EXPT MOL GENETICS, P398; NUCCI R, 1993, BIOTECHNOL APPL BIOC, V17, P239; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; Pereira-Rodriguez A, 2012, J STRUCT BIOL, V177, P392, DOI 10.1016/j.jsb.2011.11.031; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Shaikh SA, 1999, BBA-GEN SUBJECTS, V1472, P314, DOI 10.1016/S0304-4165(99)00138-5; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; STIRK HJ, 1992, FEBS LETT, V308, P1, DOI 10.1016/0014-5793(92)81036-L; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tong HH, 1999, MICROB PATHOGENESIS, V26, P111, DOI 10.1006/mpat.1998.0257; Wang ZH, 2000, J INHERIT METAB DIS, V23, P593, DOI 10.1023/A:1005630013448; Yang XB, 2005, ANAL SCI, V21, P1177, DOI 10.2116/analsci.21.1177; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000	46	27	28	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22910	22918		10.1074/jbc.M112.367128	http://dx.doi.org/10.1074/jbc.M112.367128			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593580	Green Published, hybrid			2022-12-28	WOS:000306495000048
J	Dodge, ME; Moon, J; Tuladhar, R; Lu, JM; Jacob, LS; Zhang, LS; Shi, HP; Wang, XL; Moro, E; Mongera, A; Argenton, F; Karner, CM; Carroll, TJ; Chen, C; Amatruda, JF; Lum, L				Dodge, Michael E.; Moon, Jesung; Tuladhar, Rubina; Lu, Jianming; Jacob, Leni S.; Zhang, Li-shu; Shi, Heping; Wang, Xiaolei; Moro, Enrico; Mongera, Alessandro; Argenton, Francesco; Karner, Courtney M.; Carroll, Thomas J.; Chen, Chuo; Amatruda, James F.; Lum, Lawrence			Diverse Chemical Scaffolds Support Direct Inhibition of the Membrane-bound O-Acyltransferase Porcupine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT PROTEINS; STEM-CELLS; SECRETION; ZEBRAFISH; HEDGEHOG; REVEALS; DIFFERENTIATION; GASTRULATION; REGENERATION; INSIGHTS	Secreted Wnt proteins constitute one of the largest families of intercellular signaling molecules in vertebrates with essential roles in embryonic development and adult tissue homeostasis. The functional redundancy of Wnt genes and the many forms of cellular responses they elicit, including some utilizing the transcriptional co-activator beta-catenin, has limited the ability of classical genetic strategies to uncover their roles in vivo. We had previously identified a chemical compound class termed Inhibitor of Wnt Production (or IWP) that targets Porcupine (Porcn), an acyltransferase catalyzing the addition of fatty acid adducts onto Wnt proteins. Here we demonstrate that diverse chemical structures are able to inhibit Porcn by targeting its putative active site. When deployed in concert with small molecules that modulate the activity of Tankyrase enzymes and glycogen synthase kinase 3 beta (GSK3 beta), additional transducers of Wnt/beta-catenin signaling, the IWP compounds reveal an essential role for Wnt protein fatty acylation in eliciting beta-catenin-dependent and -independent forms of Wnt signaling during zebrafish development. This collection of small molecules facilitates rapid dissection of Wnt gene function in vivo by limiting the influence of redundant Wnt gene functions on phenotypic outcomes and enables temporal manipulation of Wnt-mediated signaling in vertebrates.	[Dodge, Michael E.; Tuladhar, Rubina; Jacob, Leni S.; Zhang, Li-shu; Lum, Lawrence] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Moon, Jesung; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Lu, Jianming; Shi, Heping; Wang, Xiaolei; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Karner, Courtney M.; Carroll, Thomas J.; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Karner, Courtney M.; Carroll, Thomas J.; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Moro, Enrico; Mongera, Alessandro; Argenton, Francesco] Univ Padua, Dipartimento Biol, Padua, Italy	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Padua	Amatruda, JF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat Mol Biol & Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.amatruda@utsouthwestern.edu; lawrence.lum@utsouthwestern.edu	shi, heping/G-3238-2015; Argenton, Francesco/AAS-8494-2021; Moro, Enrico/A-3000-2014; wang, xiaolei/K-6888-2014	Argenton, Francesco/0000-0002-0803-8236; Chen, Chuo/0000-0002-3118-4901; Karner, Courtney/0000-0003-0387-4486; Moro, Enrico/0000-0003-3166-8102; Mongera, Alessandro/0000-0001-9344-9808; wang, xiaolei/0000-0002-8867-6528	National Institutes of Health [5R21HD061303, R01DK080004, P30DK079328]; Cancer Prevention and Research Institute of Texas [RP100119]; Welch Foundation [I-1665]; CARIPARO grant; Ministry of Health [GR-2008-1139743]; Mary Kay Ash Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, R01DK080004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); CARIPARO grant(Fondazione Cariparo); Ministry of Health; Mary Kay Ash Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R21HD061303 (to J.F.A., C. C., and L. L.), R01DK080004 & P30DK079328 (to T. C.), Cancer Prevention and Research Institute of Texas (RP100119; to L. L. and C. C.), and the Welch Foundation (I-1665; to L. L.), a CARIPARO grant (to F. A.), the Ministry of Health (Grant GR-2008-1139743; to E. M.), and the Mary Kay Ash Foundation.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Buckles GR, 2004, MECH DEVELOP, V121, P437, DOI 10.1016/j.mod.2004.03.026; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen Q., 2012, J CELL SCI IN PRESS; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; EKKER M, 1992, DEVELOPMENT, V116, P1001; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Marlow F, 2004, DEVELOPMENT, V131, P203, DOI 10.1242/dev.00915; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Ren YM, 2011, J MOL CELL CARDIOL, V51, P280, DOI 10.1016/j.yjmcc.2011.04.012; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sepich DS, 2011, DEVELOPMENT, V138, P543, DOI 10.1242/dev.053959; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	32	67	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23246	23254		10.1074/jbc.M112.372029	http://dx.doi.org/10.1074/jbc.M112.372029			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593577	Green Published, hybrid			2022-12-28	WOS:000306495000079
J	Kraushaar, DC; Rai, S; Condac, E; Nairn, A; Zhang, SY; Yamaguchi, Y; Moremen, K; Dalton, S; Wang, LC				Kraushaar, Daniel C.; Rai, Sumit; Condac, Eduard; Nairn, Alison; Zhang, Siyuan; Yamaguchi, Yu; Moremen, Kelley; Dalton, Stephen; Wang, Lianchun			Heparan Sulfate Facilitates FGF and BMP Signaling to Drive Mesoderm Differentiation of Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE STREAK; SELF-RENEWAL; PROTEOGLYCANS; GROWTH; WNT; WINGLESS; RECEPTOR; BIOSYNTHESIS; GASTRULATION; ACTIVATION	Heparan sulfate (HS) has been implicated in regulating cell fate decisions during differentiation of embryonic stem cells (ESCs) into advanced cell types. However, the necessity and the underlying molecular mechanisms of HS in early cell lineage differentiation are still largely unknown. In this study, we examined the potential of EXT1(-/-) mouse ESCs (mESCs), that are deficient in HS, to differentiate into primary germ layer cells. We observed that EXT1(-/-) mESCs lost their differentiation competence and failed to differentiate into Pax6(+)-neural precursor cells and mesodermal cells. More detailed analyses highlighted the importance of HS for the induction of Brachyury(+) pan-mesoderm as well as normal gene expression associated with the dorso-ventral patterning of mesoderm. Examination of developmental cell signaling revealed that EXT1 ablation diminished FGF and BMP but not Wnt signaling. Furthermore, restoration of FGF and BMP signaling each partially rescued mesoderm differentiation defects. We further show that BMP4 is more prone to degradation in EXT1(-/-) mESCs culture medium compared with that of wild type cells. Therefore, our data reveal that HS stabilizes BMP ligand and thereby maintains the BMP signaling output required for normal mesoderm differentiation. In summary, our study demonstrates that HS is required for ESC pluripotency, in particular lineage specification into mesoderm through facilitation of FGF and BMP signaling.	[Kraushaar, Daniel C.; Rai, Sumit; Condac, Eduard; Nairn, Alison; Zhang, Siyuan; Moremen, Kelley; Dalton, Stephen; Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Kraushaar, Daniel C.; Rai, Sumit; Condac, Eduard; Nairn, Alison; Zhang, Siyuan; Moremen, Kelley; Dalton, Stephen; Wang, Lianchun] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Yamaguchi, Yu] Burnham Inst Med Res, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Sanford Burnham Prebys Medical Discovery Institute	Wang, LC (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	Lwang@ccrc.uga.edu	Moremen, Kelley/AAD-4661-2019	Nairn, Alison/0000-0002-4453-7593; Dalton, Stephen/0000-0002-3450-1263	National Institutes of Health [R01HL093339, RR005351/GM103390, 5P01GM085354, RR018502]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351, P41RR018502] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, P01GM085354, P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants R01HL093339 (to L. W.), RR005351/GM103390 (to L. W.), 5P01GM085354 (pilot project, to L. W.) and RR018502 (to K. M.) from the National Institutes of Health.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Baeg GH, 2001, DEVELOPMENT, V128, P87; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Binari RC, 1997, DEVELOPMENT, V124, P2623; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boyd NL, 2007, EXP BIOL MED, V232, P833; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Forsberg M., 2012, J BIOL CHEM IN PRESS; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Holley RJ, 2011, J BIOL CHEM, V286, P6241, DOI 10.1074/jbc.M110.178483; Hu ZH, 2009, J CELL SCI, V122, P1145, DOI 10.1242/jcs.034736; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Matsumoto Y, 2010, J BIOL CHEM, V285, P19227, DOI 10.1074/jbc.M110.105338; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miura S, 2006, DEVELOPMENT, V133, P3767, DOI 10.1242/dev.02552; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Padera R, 1999, FASEB J, V13, P1677, DOI 10.1096/fasebj.13.13.1677; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sasaki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008262; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Willems E, 2008, DIFFERENTIATION, V76, P745, DOI 10.1111/j.1432-0436.2007.00257.x; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wine-Lee L, 2004, DEVELOPMENT, V131, P5393, DOI 10.1242/dev.01379; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zheng ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012555	52	61	62	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22691	22700		10.1074/jbc.M112.368241	http://dx.doi.org/10.1074/jbc.M112.368241			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22556407	Green Published, hybrid			2022-12-28	WOS:000306495000026
J	Murakami, J; Terao, Y; Morisaki, I; Hamada, S; Kawabata, S				Murakami, Jumpei; Terao, Yutaka; Morisaki, Ichijiro; Hamada, Shigeyuki; Kawabata, Shigetada			Group A Streptococcus Adheres to Pharyngeal Epithelial Cells with Salivary Proline-rich Proteins via GrpE Chaperone Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; PORPHYROMONAS-GINGIVALIS; PLAQUE ACCUMULATION; TOTAL LYSOZYME; PYOGENES; GENE; IDENTIFICATION; LACTOFERRIN	Group A Streptococcus pyogenes (GAS) is an important human pathogen that frequently causes pharyngitis. GAS organisms can adhere to and invade pharyngeal epithelial cells, which are overlaid by salivary components. However, the role of salivary components in GAS adhesion to pharyngeal cells has not been reported precisely. We collected human saliva and purified various salivary components, including proline-rich protein (PRP), statherin, and amylase, and performed invasion assays. The GAS-HEp-2 association ratio (invasion/adhesion ratio) and invasion ratio of GAS were increased significantly with whole human saliva and PRP, while the anti-PRP antibody inhibited the latter. GAS strain NY-5, which lacks M and F proteins on the cell surface, was promoted to cohere with HEp-2 cells by whole human saliva and PRP. The 28-kDa protein of GAS bound to PRP and was identified as GrpE, a chaperone protein, whereas the N-terminal of GrpE was found to bind to PRP. A GrpE-deficient mutant of GAS strain B514Sm, TR-45, exhibited a reduced ability to adhere to and invade HEp-2 cells. Microscopic observations showed the GrpE was mainly expressed on the surface of the cell division site of GAS. Furthermore, GrpE-deficient mutants of GAS and Streptococcus pneumoniae showed an elongated morphology as compared with the wild type. Taken together, this is the first study to show an interaction between salivary PRP and GAS GrpE, which plays an important role in GAS infection on the pharynx, whereas the expression of GrpE on the surface of GAS helps to maintain morphology.	[Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Murakami, Jumpei; Morisaki, Ichijiro] Osaka Univ, Div Special Care Dent, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Hamada, Shigeyuki] Minist Publ Hlth, Dept Med Sci, Res Collaborat Ctr Emerging & Reemerging Infect 6, Muang Nonthaburi 11000, Thailand	Osaka University; Osaka University; Ministry of Public Health - Thailand	Kawabata, S (corresponding author), Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp		Terao, Yutaka/0000-0002-4450-5583	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Challenging Exploratory Research; Japan Society for the Promotion of Science; Bill and Melinda Gates Foundation; Grants-in-Aid for Scientific Research [24659812, 23592700] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by grants-in-aid for Scientific Research (B), Young Scientists (A), and Challenging Exploratory Research, the Japan Society for the Promotion of Science, and a grant from the Bill and Melinda Gates Foundation.	Amano A, 1998, INFECT IMMUN, V66, P2072, DOI 10.1128/IAI.66.5.2072-2077.1998; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; Chia JS, 2001, INFECT IMMUN, V69, P6987, DOI 10.1128/IAI.69.11.6987-6998.2001; Choglay AA, 2001, GENE, V267, P125, DOI 10.1016/S0378-1119(01)00396-1; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Du LD, 2000, INFECT IMMUN, V68, P4834, DOI 10.1128/IAI.68.8.4834-4837.2000; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; GRECO R, 1995, RES MICROBIOL, V146, P551, DOI 10.1016/0923-2508(96)80561-4; HAMADA S, 1989, J GEN MICROBIOL, V135, P335; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; JALIL RA, 1993, J PERIODONTAL RES, V28, P130, DOI 10.1111/j.1600-0765.1993.tb01060.x; JALIL RA, 1992, ARCH ORAL BIOL, V37, P23, DOI 10.1016/0003-9969(92)90148-2; Kataoka K, 1999, INFECT IMMUN, V67, P3780, DOI 10.1128/IAI.67.8.3780-3785.1999; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251, DOI 10.1177/10454411930040030101; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Liu B, 2000, BIOCHEM J, V345, P557, DOI 10.1042/0264-6021:3450557; Massidda O, 1998, MICROBIOL-SGM, V144, P3069, DOI 10.1099/00221287-144-11-3069; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Roger P, 2011, J APPL MICROBIOL, V111, P631, DOI 10.1111/j.1365-2672.2011.05077.x; Rudney JD, 1999, J DENT RES, V78, P759, DOI 10.1177/00220345990780030801; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; SUGAI M, 1991, ARCH MICROBIOL, V155, P199, DOI 10.1007/BF00248617; Sun SX, 2011, MICROBIOL MOL BIOL R, V75, P543, DOI 10.1128/MMBR.00006-11; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Uehara T, 2001, GENES CELLS, V6, P803, DOI 10.1046/j.1365-2443.2001.00463.x; van Wely KHM, 2001, FEMS MICROBIOL REV, V25, P437, DOI 10.1016/S0168-6445(01)00062-6; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Wu C, 2011, J BACTERIOL, V193, P3197, DOI 10.1128/JB.00173-11; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	38	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22266	22275		10.1074/jbc.M112.350082	http://dx.doi.org/10.1074/jbc.M112.350082			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22566698	Green Published, hybrid			2022-12-28	WOS:000306418600064
J	Finn, TE; Nunez, AC; Sunde, M; Easterbrook-Smith, SB				Finn, Thomas E.; Nunez, Andrea C.; Sunde, Margaret; Easterbrook-Smith, Simon B.			Serum Albumin Prevents Protein Aggregation and Amyloid Formation and Retains Chaperone-like Activity in the Presence of Physiological Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; CHAIN FATTY-ACIDS; MOLECULAR CHAPERONE; EXTRACELLULAR CHAPERONE; ALPHA-CRYSTALLIN; PLASMA-PROTEINS; BINDING PROPERTIES; SELF-ASSOCIATION; FIBRIL FORMATION; SHEAR-STRESS	Although serum albumin has an established function as a transport protein, evidence is emerging that serum albumin may also have a role as a molecular chaperone. Using established techniques to characterize chaperone interactions, this study demonstrates that bovine serum albumin: 1) preferentially binds stressed over unstressed client proteins; 2) forms stable, soluble, high molecular weight complexes with stressed client proteins; 3) reduces the aggregation of client proteins when it is present at physiological levels; and 4) inhibits amyloid formation by both WT and L55P transthyretin. Although the antiaggregatory effect of serum albumin is maintained in the presence of physiological levels of Ca2+ and Cu2+, the presence of free fatty acids significantly alters this activity: stabilizing serum albumin at normal levels but diminishing chaperone-like activity at high concentrations. Moreover, here it is shown that depletion of albumin from human plasma leads to a significant increase in aggregation under physiologically relevant heat and shear stresses. This study demonstrates that serum albumin possesses chaperone-like properties and that this activity is maintained under a number of physiologically relevant conditions.	[Sunde, Margaret] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Sunde, M (corresponding author), Univ Sydney, Discipline Pharmacol, Bldg D06, Sydney, NSW 2006, Australia.	margaret.sunde@sydney.edu.au	Sunde, Margaret/ABH-2584-2020; Finn, Thomas Edward/U-6315-2019; Sunde, Margaret/A-5186-2016	Sunde, Margaret/0000-0002-0150-3203; Sunde, Margaret/0000-0002-0150-3203; Finn, Thomas/0000-0002-5158-2819				Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BENVENGA S, 1986, ANN CLIN LAB SCI, V16, P231; BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buczek O, 2007, BIOPOLYMERS, V88, P8, DOI 10.1002/bip.20615; CARVER JA, 1994, BBA-PROTEIN STRUCT M, V1204, P195, DOI 10.1016/0167-4838(94)90009-4; CHANG BS, 1995, BIOTECHNOL APPL BIOC, V22, P203; CHEN RF, 1967, J BIOL CHEM, V242, P173; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi JK, 2002, J LIPID RES, V43, P1000, DOI 10.1194/jlr.M200041-JLR200; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dardik A, 2005, J VASC SURG, V41, P869, DOI 10.1016/j.jvs.2005.01.020; Davis DP, 2001, J MOL BIOL, V313, P1021, DOI 10.1006/jmbi.2001.5092; Ely BR, 2009, J APPL PHYSIOL, V107, P1519, DOI 10.1152/japplphysiol.00577.2009; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Galeazzi L, 2002, NEUROREPORT, V13, P2149, DOI 10.1097/00001756-200211150-00032; GIANAZZA E, 1982, BIOCHEM J, V203, P637, DOI 10.1042/bj2030637; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Huang BX, 2004, J AM SOC MASS SPECTR, V15, P1237, DOI 10.1016/j.jasms.2004.05.004; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; Kugimiya T, 2011, LAB INVEST, V91, P1219, DOI 10.1038/labinvest.2011.71; KUMAR KL, 1986, WESTERN J MED, V144, P753; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Marini I, 2005, CELL MOL LIFE SCI, V62, P3092, DOI 10.1007/s00018-005-5397-4; MASUOKA J, 1994, J BIOL CHEM, V269, P25557; McGugan E A, 2001, Emerg Med (Fremantle), V13, P116, DOI 10.1046/j.1442-2026.2001.00189.x; MCLACHLAN AD, 1977, J MOL BIOL, V112, P543, DOI 10.1016/S0022-2836(77)80163-0; Meng Z, 2007, J SEP SCI, V30, P1537, DOI 10.1002/jssc.200600344; MINTON KW, 1982, P NATL ACAD SCI-BIOL, V79, P7107, DOI 10.1073/pnas.79.23.7107; Morrissey C, 2001, J BIOCHEM BIOPH METH, V48, P13, DOI 10.1016/S0165-022X(00)00137-8; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Nagase S, 1980, Jikken Dobutsu, V29, P33; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Rahil-Khazen R, 2000, CLIN CHEM LAB MED, V38, P765, DOI 10.1515/CCLM.2000.109; RAO PV, 1993, BIOCHEM BIOPH RES CO, V190, P786, DOI 10.1006/bbrc.1993.1118; Rasmussen T, 2010, PHARM RES-DORDR, V27, P1337, DOI 10.1007/s11095-010-0116-8; REED RG, 1977, J BIOL CHEM, V252, P7483; Ren GP, 2003, J PROTEIN CHEM, V22, P431, DOI 10.1023/B:JOPC.0000005458.08802.11; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; ROSS PD, 1988, J BIOL CHEM, V263, P11196; RUSSI E, 1983, KLIN WOCHENSCHR, V61, P541, DOI 10.1007/BF01486843; SAIFER A, 1961, J LIPID RES, V2, P268; Sheluho D, 2001, J BIOL CHEM, V276, P39945, DOI 10.1074/jbc.M107252200; Snoussi K, 2005, BIOPHYS J, V88, P2855, DOI 10.1529/biophysj.104.055871; SOLTYS BJ, 1977, J BIOL CHEM, V252, P4043; SPECTOR AA, 1969, J LIPID RES, V10, P56; Sztefko K, 2001, PANCREATOLOGY, V1, P230, DOI 10.1159/000055816; Torricelli C, 2004, J MOL ENDOCRINOL, V33, P335, DOI 10.1677/jme.1.01530; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Wilkinson-White LE, 2007, BIOCHEMISTRY-US, V46, P9123, DOI 10.1021/bi700607z; Wyatt AR, 2010, J BIOL CHEM, V285, P3532, DOI 10.1074/jbc.M109.079566; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	75	105	106	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21530	21540		10.1074/jbc.M112.372961	http://dx.doi.org/10.1074/jbc.M112.372961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549788	Green Published, hybrid			2022-12-28	WOS:000306416800070
J	Li, GD; Pone, EJ; Tran, DC; Patel, PJ; Dao, LS; Xu, ZM; Casali, P				Li, Guideng; Pone, Egest J.; Tran, Daniel C.; Patel, Pina J.; Dao, Lisa; Xu, Zhenming; Casali, Paolo			Iron Inhibits Activation-induced Cytidine Deaminase Enzymatic Activity and Modulates Immunoglobulin Class Switch DNA Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-CELL DIFFERENTIATION; SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; B-CELLS; SOMATIC HYPERMUTATION; CYTOSINE DEAMINASE; AID EXPRESSION; HIV-1; GENE; HEMOCHROMATOSIS	Immunoglobulin (Ig) class switch DNA recombination (CSR) and somatic hypermutation (SHM) are critical for the maturation of the antibody response. Activation-induced cytidine deaminase (AID) initiates CSR and SHM by deaminating deoxycytidines (dCs) in switch (S) and V(D) J region DNA, respectively, to generate deoxyuracils (dUs). Processing of dUs by uracil DNA glycosylase (UNG) yields abasic sites, which are excised by apurinic/apyrimidinic endonucleases, eventually generating double strand DNA breaks, the obligatory intermediates of CSR. Here, we found that the bivalent iron ion (Fe2+, ferrous) suppressed CSR, leading to decreased number of switched B cells, decreased postrecombination I mu-C-H transcripts, and reduced titers of secreted class-switched IgG1, IgG3, and IgA antibodies, without alterations in critical CSR factors, such as AID, 14-3-3 gamma, or PTIP, or in general germline I-H-S-C-H transcription. Fe2+ did not affect B cell proliferation or plasmacytoid differentiation. Rather, it inhibited AID-mediated dC deamination in a dose-dependent fashion. The inhibition of intrinsic AID enzymatic activity by Fe2+ was specific, as shown by lack of inhibition of AID-mediated dC deamination by other bivalent metal ions, such as Zn2+, Mn2+, Mg2+, or Ni2+,and the inability of Fe2+ to inhibit UNG-mediated dU excision. Overall, our findings have outlined a novel role of iron in modulating a B cell differentiation process that is critical to the generation of effective antibody responses to microbial pathogens and tumoral cells. They also suggest a possible role of iron in dampening AID-dependent autoimmunity and neoplastic transformation.	[Xu, Zhenming] Univ Calif Irvine, Inst Immunol, Sch Med, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Med, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Xu, ZM (corresponding author), Univ Calif Irvine, Inst Immunol, Sch Med, Irvine, CA 92697 USA.	zhenming@uci.edu			National Institutes of Health; obligatory CSR intermediates [AI 045011, AI 060573, AI 079705]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573, R56AI079705, R01AI079705, R56AI045011, R01AI045011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); obligatory CSR intermediates; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health double strand DNA breaks, the obligatory CSR intermediates Grants AI 045011, AI 060573, and AI 079705 (to P. C.).	Annamalai N, 2009, INDIAN J BIOTECHNOL, V8, P291; Barton JC, 2003, BLOOD CELL MOL DIS, V31, P102, DOI 10.1016/S1079-9796(03)00116-5; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; BULLEN JJ, 1968, IMMUNOLOGY, V14, P889; Casali P., 2009, LEWINS GENES, P570; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Golenser J, 2006, J PARASITOL, V92, P170, DOI 10.1645/GE-3517.1; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gordeuk VR, 1996, BLOOD, V87, P3470, DOI 10.1182/blood.V87.8.3470.bloodjournal8783470; Hsu HC, 2011, ARTHRITIS RHEUM-US, V63, P2038, DOI 10.1002/art.30257; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Kadiu I, 2011, J PROTEOME RES, V10, P3225, DOI 10.1021/pr200262q; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kobayashi K, 2007, WORLD J MICROB BIOT, V23, P1033, DOI 10.1007/s11274-006-9318-y; KOCHAN I, 1984, INFECT IMMUN, V43, P543, DOI 10.1128/IAI.43.2.543-548.1984; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Konijn AM, 1999, BLOOD, V94, P2128, DOI 10.1182/blood.V94.6.2128.418k20_2128_2134; LEITER LM, 1995, J NUTR, V125, P474; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mai T, 2010, J BIOL CHEM, V285, P37797, DOI 10.1074/jbc.M110.169086; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Mencacci A, 1997, J INFECT DIS, V175, P1467, DOI 10.1086/516481; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO, P387; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; PORTER DJT, 1993, J BIOL CHEM, V268, P24005; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rudnicka D, 2009, NAT IMMUNOL, V10, P933, DOI 10.1038/ni0909-933; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Van Vlierberghe H, 2001, J HEPATOL, V35, P707, DOI 10.1016/S0168-8278(01)00203-3; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; White CA, 2011, AUTOIMMUNITY, V44, P585, DOI 10.3109/08916934.2011.577128; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Xu Z., 2012, NAT REV IMM IN PRESS; Xu ZM, 2007, CRIT REV IMMUNOL, V27, P367, DOI 10.1615/CritRevImmunol.v27.i4.60; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zan H, 2008, MOL IMMUNOL, V46, P45, DOI 10.1016/j.molimm.2008.07.003; Zan H, 2009, AUTOIMMUNITY, V42, P89, DOI 10.1080/08916930802629554	65	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21520	21529		10.1074/jbc.M112.366732	http://dx.doi.org/10.1074/jbc.M112.366732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556412	Green Published, hybrid			2022-12-28	WOS:000306416800069
J	Lin, ZJ; Zhao, WJ; Diao, WT; Xie, XQ; Wang, Z; Zhang, JX; Shen, YQ; Long, JF				Lin, Zhijie; Zhao, Weijing; Diao, Wentao; Xie, Xingqiao; Wang, Zheng; Zhang, Jinxiu; Shen, Yuequan; Long, Jiafu			Crystal Structure of Elongator Subcomplex Elp4-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FAMILIAL DYSAUTONOMIA; TRANSCRIPTIONAL ELONGATION; HISTONE ACETYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; HOLO-ELONGATOR; IN-VIVO; COMPLEX; PROTEIN; CHROMATIN	Elongator is a multiprotein complex composed of two subcomplexes, Elp1-3 and Elp4-6. Elongator is highly conserved between yeast and humans and plays an important role in RNA polymerase II-mediated transcriptional elongation and many other processes, including cytoskeleton organization, exocytosis, and tRNA modification. Here, we determined the crystal structure of the Elp4-6 subcomplex of yeast. The overall structure of Elp4-6 revealed that Elp6 acts as a bridge to assemble Elp4 and Elp5. Detailed structural and sequence analyses revealed that each subunit in the Elp4-6 subcomplex forms a RecA-ATPase-like fold, although it lacks the key sequence signature of ATPases. Site-directed mutagenesis and biochemical analyses indicated that the Elp4-6 subcomplex can assemble into a hexameric ring-shaped structure in vitro and in vivo. Furthermore, GST pulldown assays showed that the ring-shaped assembly of the Elp4-6 subcomplex is important for its specific histone H3 binding. Our results may shed light on the substrate recognition and assembly of the holo-Elongator complex.	[Shen, Yuequan; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Lin, Zhijie; Zhao, Weijing; Diao, Wentao; Xie, Xingqiao; Wang, Zheng; Zhang, Jinxiu; Shen, Yuequan; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com; jflong@nankai.edu.cn	Long, Jiafu/B-7420-2012; Lin, Zhijie/Y-4836-2019; Shen, Yuequan/C-8950-2013	Long, Jiafu/0000-0002-6625-0147; Shen, Yuequan/0000-0002-3775-0900	973 Program [2009CB825504, 2012CB917201]; Natural Science Foundation of China [31100527, 31140029, 31170684]; Fundamental Research Funds for the Central Universities [65011621, 65020241]	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the 973 Program (Grants 2009CB825504 and 2012CB917201), the Natural Science Foundation of China (Grants 31100527, 31140029, and 31170684), and the Fundamental Research Funds for the Central Universities (Grants 65011621 and 65020241).	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2002, MOL MICROBIOL, V45, P817, DOI 10.1046/j.1365-2958.2002.03055.x; Frohloff F, 2003, J BIOL CHEM, V278, P956, DOI 10.1074/jbc.M210060200; Glatt S, 2012, NAT STRUCT MOL BIOL, V19, P314, DOI 10.1038/nsmb.2234; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kleinjan DA, 2002, MAMM GENOME, V13, P102, DOI 10.1007/s00335-001-3058-y; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leipe DD, 2000, GENOME RES, V10, P5; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Q, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000684; Li Y, 2001, J BIOL CHEM, V276, P29628, DOI 10.1074/jbc.C100274200; Nelissen H, 2010, P NATL ACAD SCI USA, V107, P1678, DOI 10.1073/pnas.0913559107; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Strug LJ, 2009, EUR J HUM GENET, V17, P1171, DOI 10.1038/ejhg.2008.267; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Zhang XH, 2011, MOL VIS, V17, P548; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	51	30	33	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21501	21508		10.1074/jbc.M112.341560	http://dx.doi.org/10.1074/jbc.M112.341560			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556426	Green Published, hybrid			2022-12-28	WOS:000306416800067
J	Bhargava, A; Voronov, I; Wang, YQ; Glogauer, M; Kartner, N; Manolson, MF				Bhargava, Ajay; Voronov, Irina; Wang, Yongqiang; Glogauer, Michael; Kartner, Norbert; Manolson, Morris F.			Osteopetrosis Mutation R444L Causes Endoplasmic Reticulum Retention and Misprocessing of Vacuolar H+-ATPase a3 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; RENAL TUBULAR-ACIDOSIS; UNFOLDED PROTEIN RESPONSE; CYSTIC-FIBROSIS MUTATION; YEAST V-ATPASE; QUALITY-CONTROL; HUMAN-DISEASES; GENE ENCODES; PROTON PUMP; MEMBRANE	Osteopetrosis is a genetic bone disease characterized by increased bone density and fragility. The R444L missense mutation in the human V-ATPase a3 subunit (TCIRG1) is one of several known mutations in a3 and other proteins that can cause this disease. The autosomal recessive R444L mutation results in a particularly malignant form of infantile osteopetrosis that is lethal in infancy, or early childhood. We have studied this mutation using the pMSCV retroviral vector system to integrate the cDNA construct for green fluorescent protein (GFP)-fused a3(R445L) mutant protein into the RAW 264.7 mouse osteoclast differentiation model. In comparison with wild-type a3, the mutant glycoprotein localized to the ER instead of lysosomes and its oligosaccharide moiety was misprocessed, suggesting inability of the core-glycosylated glycoprotein to traffic to the Golgi. Reduced steady-state expression of the mutant protein, in comparison with wild type, suggested that the former was being degraded, likely through the endoplasmic reticulum-associated degradation pathway. In differentiated osteoclasts, a3(R445L) was found to degrade at an increased rate over the course of osteoclastogenesis. Limited proteolysis studies suggested that the R445L mutation alters mouse a3 protein conformation. Together, these data suggest that Arg-445 plays a role in protein folding, or stability, and that infantile malignant osteopetrosis caused by the R444L mutation in the human V-ATPase a3 subunit is another member of the growing class of protein folding diseases. This may have implications for early-intervention treatment, using protein rescue strategies.	[Bhargava, Ajay; Voronov, Irina; Wang, Yongqiang; Glogauer, Michael; Kartner, Norbert; Manolson, Morris F.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON M5G 1G6, Canada; [Manolson, Morris F.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5G 1G6, Canada	University of Toronto; University of Toronto	Manolson, MF (corresponding author), Univ Toronto, Fac Dent, Dent Res Inst, 124 Edward St, Toronto, ON M5G 1G6, Canada.	m.manolson@utoronto.ca	Glogauer, Michael/D-2504-2011	Manolson, Morris/0000-0001-8755-5460; Glogauer, Michael/0000-0002-6248-5977	Canadian Institutes of Health Research [FRN-79322]; Canadian Institutes of Health Research Senior Investigator Award [SOW-90384]; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Senior Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported in part by Operating Grant FRN-79322 from the Canadian Institutes of Health Research.; Supported by Canadian Institutes of Health Research Senior Investigator Award SOW-90384. Graduate student and postdoctoral fellowship support was provided in part by the Canadian Arthritis Network. To whom correspondence should be addressed: Faculty of Dentistry, University of Toronto, 124 Edward St., Toronto, Ontario M5G 1G6, Canada. Tel.: 416-979-4900; Fax: 416-979-4936; E-mail: m.manolson@utoronto.ca.	BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Brown D, 1997, J EXP BIOL, V200, P257; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Clarke M, 2002, J CELL SCI, V115, P2893; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; deCarvalho ACV, 2002, MOL MED, V8, P75, DOI 10.1007/BF03402077; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Driessen GJA, 2003, BONE MARROW TRANSPL, V32, P657, DOI 10.1038/sj.bmt.1704194; Fasth A, 1999, Pediatr Transplant, V3 Suppl 1, P102; Gruber G, 2008, BIOESSAYS, V30, P1096, DOI 10.1002/bies.20827; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lerch-Bader M, 2008, P NATL ACAD SCI USA, V105, P4127, DOI 10.1073/pnas.0711580105; Li XH, 1998, PLANT CELL, V10, P119, DOI 10.1105/tpc.10.1.119; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Nakamura I, 1997, FEBS LETT, V401, P207, DOI 10.1016/S0014-5793(96)01454-8; NORDSTROM T, 1995, J BIOL CHEM, V270, P2203, DOI 10.1074/jbc.270.5.2203; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; Ochotny N, 2006, J BIOL CHEM, V281, P26102, DOI 10.1074/jbc.M601118200; Ochotny N, 2011, J BONE MINER RES, V26, P1484, DOI 10.1002/jbmr.355; OGUR G, 1995, PRENATAL DIAG, V15, P477; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Phadke SR, 2010, INDIAN J MED RES, V131, P508; Saroussi S, 2009, J EXP BIOL, V212, P1604, DOI 10.1242/jeb.025866; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Stehberger PA, 2003, J AM SOC NEPHROL, V14, P3027, DOI 10.1097/01.ASN.0000099375.74789.AB; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Vostrikov VV, 2010, J BIOL CHEM, V285, P31723, DOI 10.1074/jbc.M110.152470; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XL, 2012, J NEUROSCI, V32, P8633, DOI 10.1523/JNEUROSCI.0556-12.2012; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	55	29	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26829	26839		10.1074/jbc.M112.345702	http://dx.doi.org/10.1074/jbc.M112.345702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685294	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000307386000032
J	Lee, E; Sidoryk-Wegrzynowicz, M; Wang, N; Webb, A; Son, DS; Lee, K; Aschner, M				Lee, Eunsook; Sidoryk-Wegrzynowicz, Marta; Wang, Ning; Webb, Anton; Son, Deok-Soo; Lee, Kyuwon; Aschner, Michael			GPR30 Regulates Glutamate Transporter GLT-1 Expression in Rat Primary Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; GROWTH-FACTOR RECEPTOR; AMINO-ACID TRANSPORTER-2; HEAT-SHOCK PROTEINS; NF-KAPPA-B; ESTROGEN-RECEPTOR; NERVOUS-SYSTEM; HYPOTHALAMIC ASTROCYTES; NEUROACTIVE STEROIDS; BCL-2 EXPRESSION	The G protein-coupled estrogen receptor GPR30 contributes to the neuroprotective effects of 17 beta-estradiol (E2); however, the mechanisms associated with this protection have yet to be elucidated. Given that E2 increases astrocytic expression of glutamate transporter-1 (GLT-1), which would prevent excitotoxic-induced neuronal death, we proposed that GPR30 mediates E2 action on GLT-1 expression. To investigate this hypothesis, we examined the effects of G1, a selective agonist of GPR30, and GPR30 siRNA on astrocytic GLT-1 expression, as well as glutamate uptake in rat primary astrocytes, and explored potential signaling pathways linking GPR30 to GLT-1. G1 increased GLT-1 protein and mRNA levels, subject to regulation by both MAPK and PI3K signaling. Inhibition of TGF-alpha receptor suppressed the G1-induced increase in GLT-1 expression. Silencing GPR30 reduced the expression of both GLT-1 and TGF-alpha and abrogated the G1-induced increase in GLT-1 expression. Moreover, the G1-induced increase in GLT-1 protein expression was abolished by a protein kinase A inhibitor and an NF-kappa B inhibitor. G1 also enhanced cAMP response element-binding protein (CREB), as well as both NF-kappa B p50 and NF-kappa B p65 binding to the GLT-1 promoter. Finally, to model dysfunction of glutamate transporters, manganese was used, and G1 was found to attenuate manganese-induced impairment in GLT-1 protein expression and glutamate uptake. Taken together, the present data demonstrate that activation of GPR30 increases GLT-1 expression via multiple pathways, suggesting that GPR30 is worthwhile as a potential target to be explored for developing therapeutics of excitotoxic neuronal injury.	[Lee, Eunsook; Wang, Ning; Webb, Anton; Son, Deok-Soo] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Sidoryk-Wegrzynowicz, Marta; Aschner, Michael] Vanderbilt Univ, Dept Pediat, Nashville, TN 37212 USA; [Lee, Kyuwon] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Meharry Medical College; Vanderbilt University; Harvard University	Lee, E (corresponding author), Meharry Med Coll, Dept Physiol, 1005 DB Todd Jr Blvd, Nashville, TN 37208 USA.	elee@mmc.edu		Sidoryk-Wegrzynowicz, Marta/0000-0003-3916-7660	National Institutes of Health [SC1 089630]; National Institute of Environmental Health Sciences [ES R01 10563]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM089630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants SC1 089630 and National Institute of Environmental Health Sciences ES R01 10563.	Abdelhamid R, 2011, ACS CHEM NEUROSCI, V2, P256, DOI 10.1021/cn100106a; Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Allritz C, 2010, J NEUROSCI RES, V88, P1234, DOI 10.1002/jnr.22303; Alyea RA, 2008, J NEUROCHEM, V106, P1525, DOI 10.1111/j.1471-4159.2008.05491.x; Amorino GP, 2002, MOL BIOL CELL, V13, P2233, DOI 10.1091/mbc.01-12-0572; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Barlow CA, 2007, AM J PHYSIOL-LUNG C, V292, pL1361, DOI 10.1152/ajplung.00279.2006; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Blasko E, 2009, J NEUROIMMUNOL, V214, P67, DOI 10.1016/j.jneuroim.2009.06.023; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Buchanan CD, 2000, BIOL REPROD, V62, P1710, DOI 10.1095/biolreprod62.6.1710; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Cimarosti H, 2005, NEUROSCI LETT, V385, P52, DOI 10.1016/j.neulet.2005.05.006; COTZIAS GC, 1968, NEUROLOGY, V18, P376, DOI 10.1212/WNL.18.4.376; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; DonCarlos Lydia L, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS113, DOI 10.1016/j.psyneuen.2009.04.012; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Galbiati M, 2002, J NEUROENDOCRINOL, V14, P829, DOI 10.1046/j.1365-2826.2002.00852.x; Gampe K, 2011, BRAIN RES, V1376, P31, DOI 10.1016/j.brainres.2010.11.040; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Ghosh M, 2011, J NEUROSCI, V31, P9159, DOI 10.1523/JNEUROSCI.0302-11.2011; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Kanda N, 2003, J INVEST DERMATOL, V120, P1058, DOI 10.1046/j.1523-1747.2003.12255.x; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Lee E, 2012, GLIA, V60, P1024, DOI 10.1002/glia.22329; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Liang Z, 2002, J NEUROCHEM, V80, P807, DOI 10.1046/j.0022-3042.2002.00779.x; Liu SB, 2011, CLIN EXP PHARMACOL P, V38, P577, DOI 10.1111/j.1440-1681.2011.05549.x; Lu AG, 2002, J CEREBR BLOOD F MET, V22, P183, DOI 10.1097/00004647-200202000-00006; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Magnaghi V, 2001, BRAIN RES REV, V37, P360, DOI 10.1016/S0165-0173(01)00140-0; Melcangi RC, 2001, BRAIN RES REV, V37, P223, DOI 10.1016/S0165-0173(01)00120-5; Melcangi RC, 2001, INT REV NEUROBIOL, V46, P145; Mutkus L, 2005, BIOL TRACE ELEM RES, V107, P221, DOI 10.1385/BTER:107:3:221; MYDLARSKI MB, 1995, NEUROBIOL AGING, V16, P977, DOI 10.1016/0197-4580(95)02018-7; Nagai M, 2003, MICROBIOL-SGM, V149, P2455, DOI 10.1099/mic.0.26414-0; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Simpkins James W., 1997, American Journal of Medicine, V103, p19S, DOI 10.1016/S0002-9343(97)00260-X; Sims KD, 1999, CRIT REV NEUROBIOL, V13, P169, DOI 10.1615/CritRevNeurobiol.v13.i2.30; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Thone-Reineke C, 2008, J HYPERTENS, V26, P2426, DOI 10.1097/HJH.0b013e328313e403; TRANQUE PA, 1987, BRAIN RES, V406, P348, DOI 10.1016/0006-8993(87)90805-5; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Xu H, 2009, NEUROSCIENCE, V158, P1599, DOI 10.1016/j.neuroscience.2008.11.028; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667	58	65	69	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26817	26828		10.1074/jbc.M112.341867	http://dx.doi.org/10.1074/jbc.M112.341867			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22645130	Green Published, hybrid			2022-12-28	WOS:000307386000031
J	Purohit, AA; Li, WQ; Qu, C; Dwyer, T; Shao, QQ; Guan, KL; Liu, GF				Purohit, Anish A.; Li, Weiquan; Qu, Chao; Dwyer, Trisha; Shao, Qiangqiang; Guan, Kun-Liang; Liu, Guofa			Down Syndrome Cell Adhesion Molecule (DSCAM) Associates with Uncoordinated-5C (UNC5C) in Netrin-1-mediated Growth Cone Collapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NETRIN RECEPTOR; COLORECTAL-CANCER; SELF-AVOIDANCE; AXON GUIDANCE; TYROSINE PHOSPHORYLATION; COMMISSURAL AXONS; DROSOPHILA DSCAM; SPINAL-CORD; DCC; MOUSE	In the developing nervous system, neuronal growth cones explore the extracellular environment for guidance cues, which can guide them along specific trajectories toward their targets. Netrin-1, a bifunctional guidance cue, binds to deleted in colorectal cancer (DCC) and DSCAM mediating axon attraction, and UNC5 mediating axon repulsion. Here, we show that DSCAM interacts with UNC5C and this interaction is stimulated by netrin-1 in primary cortical neurons and postnatal cerebellar granule cells. DSCAM partially co-localized with UNC5C in primary neurons and brain tissues. Netrin-1 induces axon growth cone collapse of mouse cerebellum external granule layer (EGL) cells, and the knockdown of DSCAM or UNC5C by specific shRNAs or blocking their signaling by overexpressing dominant negative mutants suppresses netrin-1-induced growth cone collapse. Similarly, the simultaneous knockdown of DSCAM and UNC5C also blocks netrin-1-induced growth cone collapse in EGL cells. Netrin-1 increases tyrosine phosphorylation of endogenous DSCAM, UNC5C, FAK, Fyn, and PAK1, and promotes complex formation of DSCAM with these signaling molecules in primary postnatal cerebellar neurons. Inhibition of Src family kinases efficiently reduces the interaction of DSCAM with UNC5C, FAK, Fyn, and PAK1 and tyrosine phosphorylation of these proteins as well as growth cone collapse of mouse EGL cells induced by netrin-1. The knockdown of DSCAM inhibits netrin-induced tyrosine phosphorylation of UNC5C and Fyn as well as the interaction of UNC5C with Fyn. The double knockdown of both receptors abolishes the induction of Fyn tyrosine phosphorylation by netrin-1. Our study reveals the first evidence that DSCAM coordinates with UNC5C in netrin-1 repulsion.	[Purohit, Anish A.; Qu, Chao; Dwyer, Trisha; Shao, Qiangqiang; Liu, Guofa] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Li, Weiquan] Univ Michigan, Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, Dept Pharmacol, La Jolla, CA 92093 USA	University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Liu, GF (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Guofa.Liu@utoledo.edu	Guan, Kun-Liang/ADK-7088-2022; Li, Weiquan/B-4897-2011; Shao, Qiangqiang/GXZ-6789-2022	Shao, Qiangqiang/0000-0002-0674-1868	National Institutes of Health; Whitehall Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation	This work was supported, in whole or in part, by the National Institutes of Health (to G. L. and K. G.) and the Whitehall Foundation (to G. L.).	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Barlow GM, 2002, BIOCHEM BIOPH RES CO, V293, P881, DOI 10.1016/S0006-291X(02)00307-8; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Cooper HM, 1995, ONCOGENE, V11, P2243; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Guijarro P, 2006, MOL CELL NEUROSCI, V33, P389, DOI 10.1016/j.mcn.2006.08.010; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Killeen M, 2002, DEV BIOL, V251, P348, DOI 10.1006/dbio.2002.0825; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li WQ, 2006, J CELL SCI, V119, P47, DOI 10.1242/jcs.02697; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li WQ, 2004, J BIOL CHEM, V279, P32824, DOI 10.1074/jbc.M401878200; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu GF, 2007, J NEUROSCI, V27, P957, DOI 10.1523/JNEUROSCI.4616-06.2007; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Lucanic M, 2006, DEVELOPMENT, V133, P4549, DOI 10.1242/dev.02648; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Matthews BJ, 2011, CURR BIOL, V21, P1480, DOI 10.1016/j.cub.2011.07.040; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tang XL, 2008, NAT CELL BIOL, V10, P698, DOI 10.1038/ncb1732; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Williams ME, 2003, J NEUROSCI, V23, P11279; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	73	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27126	27138		10.1074/jbc.M112.340174	http://dx.doi.org/10.1074/jbc.M112.340174			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685302	hybrid, Green Published			2022-12-28	WOS:000307386000065
J	Hayashi, H; Eguchi, Y; Fukuchi-Nakaishi, Y; Takeya, M; Nakagata, N; Tanaka, K; Vance, JE; Tanihara, H				Hayashi, Hideki; Eguchi, Yuko; Fukuchi-Nakaishi, Yuko; Takeya, Motohiro; Nakagata, Naomi; Tanaka, Kohichi; Vance, Jean E.; Tanihara, Hidenobu			A Potential Neuroprotective Role of Apolipoprotein E-containing Lipoproteins through Low Density Lipoprotein Receptor-related Protein 1 in Normal Tension Glaucoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-ANGLE GLAUCOMA; RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; GLIAL LIPOPROTEINS; VISUAL IMPAIRMENT; GROWTH-FACTOR; EXPRESSION; JAPANESE; NEURONS; CHOLESTEROL	Glaucoma is an optic neuropathy and the second major cause of blindness worldwide next to cataracts. The protection from retinal ganglion cell (RGC) loss, one of the main characteristics of glaucoma, would be a straightforward treatment for this disorder. However, the clinical application of neuroprotection has not, so far, been successful. Here, we report that apolipoprotein E-containing lipoproteins (E-LPs) protect primary cultured RGCs from Ca2+-dependent, and mitochondrion-mediated, apoptosis induced by glutamate. Binding of E-LPs to the low density lipoprotein receptor-related protein 1 recruited the N-methyl-D-aspartate receptor, blocked intracellular Ca2+ elevation, and inactivated glycogen synthase kinase 3 beta, thereby inhibiting apoptosis. When compared with contralateral eyes treated with phosphate-buffered saline, intravitreal administration of E-LPs protected against RGC loss in glutamate aspartate transporter-deficient mice, a model of normal tension glaucoma that causes glaucomatous optic neuropathy without elevation of intraocular pressure. Although the presence of alpha 2-macroglobulin, another ligand of the low density lipoprotein receptor-related protein 1, interfered with the neuroprotective effect of E-LPs against glutamate-induced neurotoxicity, the addition of E-LPs overcame the inhibitory effect of alpha 2-macroglobulin. These findings may provide a potential therapeutic strategy for normal tension glaucoma by an LRP1-mediated pathway.	[Hayashi, Hideki; Eguchi, Yuko] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8608556, Japan; [Fukuchi-Nakaishi, Yuko] Kumamoto Univ, Dept Ophthalmol & Visual Sci, Kumamoto 8608556, Japan; [Takeya, Motohiro] Kumamoto Univ, Dept Cell Pathol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto 8608556, Japan; [Tanaka, Kohichi] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo 1138510, Japan; [Tanaka, Kohichi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1138510, Japan; [Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Alberta; University of Alberta	Hayashi, H (corresponding author), Kumamoto Univ, Prior Org Innovat & Excellence, 509 Gen Res Bldg,1-1-1 Honjo, Kumamoto 8608556, Japan.	hhayashi@kumamoto-u.ac.jp		Nakagata, Naomi/0000-0002-5737-9993	Ministry of Education, Culture, Sport, Science and Technology of Japan [22790254, 24500441]; Life Science Foundation of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aids for Young Scientists B 22790254, Scientific Research C 24500441, the Special Coordination Funds for Promoting Science and Technology, the "Understanding of molecular and environmental bases for brain health" project under the Strategic Research Program for Brain Sciences, and the Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit) from the Ministry of Education, Culture, Sport, Science and Technology of Japan, the Life Science Foundation of Japan, and the Takeda Science Foundation.	Almeida S, 2004, NEUROBIOL DIS, V17, P435, DOI 10.1016/j.nbd.2004.07.002; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Bai YJ, 2011, INVEST OPHTH VIS SCI, V52, P5260, DOI 10.1167/iovs.10-6691; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Bessero AC, 2010, CURR OPIN NEUROL, V23, P10, DOI 10.1097/WCO.0b013e3283344461; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Fernandez-Monreal M, 2004, MOL CELL NEUROSCI, V25, P594, DOI 10.1016/j.mcn.2003.11.002; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Krumbiegel M, 2010, J GLAUCOMA, V19, P561, DOI 10.1097/IJG.0b013e3181ca76c4; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Mabuchi F, 2005, MOL VIS, V11, P609; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mansberger SL, 2005, AM J PUBLIC HEALTH, V95, P881, DOI 10.2105/AJPH.2004.054221; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Orgul S, 2005, OPHTHALMOLOGICA, V219, P317, DOI 10.1159/000088372; Pekmezci M, 2009, ARCH OPHTHALMOL-CHIC, V127, P167, DOI 10.1001/archophthalmol.2008.593; Petegnief V, 2001, NEUROSCIENCE, V104, P223, DOI 10.1016/S0306-4522(01)00046-X; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schmidt KG, 2008, CURR NEUROPHARMACOL, V6, P164, DOI 10.2174/157015908784533851; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Zetterberg M, 2007, AM J OPHTHALMOL, V143, P1059, DOI 10.1016/j.ajo.2007.01.031	42	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25395	25406		10.1074/jbc.M112.370130	http://dx.doi.org/10.1074/jbc.M112.370130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22674573	Green Published, hybrid			2022-12-28	WOS:000306651700047
J	Tong, X; Buelow, K; Guha, A; Rausch, R; Yin, L				Tong, Xin; Buelow, Katie; Guha, Anirvan; Rausch, Rebecca; Yin, Lei			USP2a Protein Deubiquitinates and Stabilizes the Circadian Protein CRY1 in Response to Inflammatory Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WIDE EXPRESSION ANALYSIS; REV-ERB-ALPHA; GENE-EXPRESSION; TNF-ALPHA; CLOCK GENES; PROSTATE-CANCER; ENZYME USP2A; MOUSE-LIVER; DEGRADATION; CRYPTOCHROME	The mammalian circadian clock coordinates various physiological activities with environmental cues to achieve optimal adaptation. The clock manifests oscillations of key clock proteins, which are under dynamic control at multiple post-translational levels. As a major post-translational regulator, the ubiquitination-dependent proteasome degradation system is counterbalanced by a large group of deubiquitin proteases with distinct substrate preference. Until now, whether deubiquitination by ubiquitin-specific proteases can regulate the clock protein stability and circadian pathways remains largely unclear. The mammalian clock protein, cryptochrome 1 (CRY1), is degraded via the FBXL3-mediated ubiquitination pathway, suggesting that it is also likely to be targeted by the deubiquitination pathway. Here, we identified that USP2a, a circadian-controlled deubiquitinating enzyme, interacts with CRY1 and enhances its protein stability via deubiquitination upon serum shock. Depletion of Usp2a by shRNA greatly enhances the ubiquitination of CRY1 and dampens the oscillation amplitude of the CRY1 protein during a circadian cycle. By stabilizing the CRY1 protein, USP2a represses the Per2 promoter activity as well as the endogenous Per2 gene expression. We also demonstrated that USP2a-dependent deubiquitination and stabilization of the CRY1 protein occur in the mouse liver. Interestingly, the pro-inflammatory cytokine, TNF-alpha, increases the CRY1 protein level and inhibits circadian gene expression in a USP2a-dependent fashion. Therefore, USP2a potentially mediates circadian disruption by suppressing the CRY1 degradation during inflammation.	[Tong, Xin; Buelow, Katie; Guha, Anirvan; Rausch, Rebecca; Yin, Lei] Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI 48103 USA	University of Michigan System; University of Michigan	Yin, L (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI 48103 USA.	leiyin@umich.edu		Buelow, Katie/0000-0002-2616-1756; TONG, XIN/0000-0002-4832-8940; Guha, Anirvan/0000-0001-6018-1438	National Institutes of Health Grant [K99/R00 DK077449]; Michigan Gastrointestinal Hormone Research Core Center [5P3ODKO34933]; University of Michigan Diabetes and Research Training Center [P60DK020572]	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Gastrointestinal Hormone Research Core Center; University of Michigan Diabetes and Research Training Center	This work was supported, in whole or in part, by National Institutes of Health Grant K99/R00 DK077449 (to L.Y.). This work was also supported by Pilot Grant 5P3ODKO34933 (to L.Y.) from Michigan Gastrointestinal Hormone Research Core Center and Pilot Grant P60DK020572 from University of Michigan Diabetes and Research Training Center.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2004, J IMMUNOL, V172, P2811, DOI 10.4049/jimmunol.172.5.2811; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Baggs JE, 2010, CURR OPIN GENET DEV, V20, P581, DOI 10.1016/j.gde.2010.08.009; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Chaves I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023447; Cutolo M, 2008, AUTOIMMUN REV, V7, P223, DOI 10.1016/j.autrev.2007.11.019; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Haimerl F, 2009, J BIOL CHEM, V284, P495, DOI 10.1074/jbc.M803533200; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Kaneko K, 2009, BRAIN RES, V1263, P58, DOI 10.1016/j.brainres.2008.12.071; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Mahul-Mellier AL, 2012, CELL DEATH DIFFER, V19, P891, DOI 10.1038/cdd.2011.185; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Paschos GK, 2010, ANNU REV PHARMACOL, V50, P187, DOI 10.1146/annurev.pharmtox.010909.105621; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Scoma HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025382; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shi Y, 2011, J BIOL CHEM, V286, P38960, DOI 10.1074/jbc.M111.231498; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Sun YM, 2006, J BIOMED SCI, V13, P845, DOI 10.1007/s11373-006-9108-4; Sun YM, 2006, IMMUNOLOGY, V119, P451, DOI 10.1111/j.1365-2567.2006.02456.x; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamanini Filippo, 2007, Methods Mol Biol, V362, P443; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Treeck O, 2008, BRIT J CANCER, V99, P1246, DOI 10.1038/sj.bjc.6604692; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; Wang SX, 2010, PATHOL INT, V60, P184, DOI 10.1111/j.1440-1827.2010.02496.x; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yang YL, 2007, INT J NANOTECHNOL, V4, P4, DOI 10.1504/IJNT.2007.012313; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x	77	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25280	25291		10.1074/jbc.M112.340786	http://dx.doi.org/10.1074/jbc.M112.340786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669941	Green Published, hybrid			2022-12-28	WOS:000306651700036
J	Couture, LA; Piao, WJ; Ru, LW; Vogel, SN; Toshchakov, VY				Couture, Leah A.; Piao, Wenji; Ru, Lisa W.; Vogel, Stefanie N.; Toshchakov, Vladimir Y.			Targeting Toll-like Receptor (TLR) Signaling by Toll/Interleukin-1 Receptor (TIR) Domain-containing Adapter Protein/MyD88 Adapter-like (TIRAP/Mal)-derived Decoy Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CUTTING EDGE; BB LOOPS; TRANSDUCTION; FAMILY; IDENTIFICATION; RECRUITMENT; ENDOCYTOSIS; PATHWAYS; MOLECULE	Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal) is an adapter protein that facilitates recruitment of MyD88 to TLR4 and TLR2 signaling complexes. We previously generated a library of cell-permeating TLR4 TIR-derived decoy peptides fused to the translocating segment of the Drosophila Antennapedia homeodomain and examined each peptide for the ability to inhibit TLR4 signaling (Toshchakov, V. Y., Szmacinski, H., Couture, L. A., Lakowicz, J. R., and Vogel, S. N. (2011) J. Immunol. 186, 4819-4827). We have now expanded this study to test TIRAP decoy peptides. Five TIRAP peptides, TR3 (for TIRAP region 3), TR5, TR6, TR9, and TR11, inhibited LPS-induced cytokine mRNA expression and MAPK activation. Inhibition was confirmed at the protein level; select peptides abolished the LPS-induced cytokine production measured in cell culture 24 h after a single treatment. Two of the TLR4 inhibitory peptides, TR3 and TR6, also inhibited cytokine production induced by a TLR2/TLR1 agonist, S-(2,3-bis(palmitoyloxy)-(2R,2S)-propyl)-N-palmitoyl-(R)-CysSer-Lys(4)-OH; however, a higher peptide concentration was required to achieve comparable inhibition of TLR2 versus TLR4 signaling. Two TLR4 inhibitory peptides, TR5 and TR6, were examined for the ability to inhibit TLR4-driven cytokine induction in mice. Pretreatment with either peptide significantly reduced circulating TNF-alpha and IL-6 in mice following LPS injection. This study has identified novel TLR inhibitory peptides that block cellular signaling at low micromolar concentrations in vitro and in vivo. Comparison of TLR4 inhibition by TLR4 and TIRAP TIR-derived peptides supports the view that structurally diverse regions mediate functional interactions of TIR domains.	[Couture, Leah A.; Piao, Wenji; Ru, Lisa W.; Vogel, Stefanie N.; Toshchakov, Vladimir Y.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Toshchakov, VY (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Rm 380,685 W Baltimore St, Baltimore, MD 21201 USA.	vtoshchakov@som.umaryland.edu	Toshchakov, Vladimir/C-2798-2014	Toshchakov, Vladimir/0000-0002-7942-2294	National Institutes of Health [AI-082299, AI-018797]; Howard Hughes Medical Institute Research Training Fellowship for Medical Students; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018797, R01AI082299, R37AI018797, R56AI018797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Research Training Fellowship for Medical Students; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-082299 (to V. Y. T.) and AI-018797 (to S. N. V.). This work was also supported by the 2010 Howard Hughes Medical Institute Research Training Fellowship for Medical Students (to L. A. C.).	Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Knapp S, 2010, WIEN MED WOCHENSCHR, V160, P107, DOI 10.1007/s10354-010-0765-6; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Toshchakov VY, 2007, EXPERT OPIN BIOL TH, V7, P1035, DOI 10.1517/14712598.7.7.1035; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VY, 2011, J IMMUNOL, V186, P4819, DOI 10.4049/jimmunol.1002424; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	33	55	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24641	24648		10.1074/jbc.M112.360925	http://dx.doi.org/10.1074/jbc.M112.360925			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648407	Green Published, hybrid			2022-12-28	WOS:000306651100058
J	Fu, JR; Jin, J; Cichewicz, RH; Hageman, SA; Ellis, TK; Xiang, L; Peng, Q; Jiang, M; Arbez, N; Hotaling, K; Ross, CA; Duan, WZ				Fu, Jinrong; Jin, Jing; Cichewicz, Robert H.; Hageman, Serena A.; Ellis, Trevor K.; Xiang, Lan; Peng, Qi; Jiang, Mali; Arbez, Nicolas; Hotaling, Katelyn; Ross, Christopher A.; Duan, Wenzhen			trans-(-)-epsilon-Viniferin Increases Mitochondrial Sirtuin 3 (SIRT3), Activates AMP-activated Protein Kinase (AMPK), and Protects Cells in Models of Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESVERATROL PROTECTS; DEACETYLASE SIRT3; NATURAL-PRODUCTS; DYSFUNCTION; DEFECTS; LKB1; PGC-1-ALPHA; APOPTOSIS; CANCER; DAMAGE	Huntington disease (HD) is an inherited neurodegenerative disorder caused by an abnormal polyglutamine expansion in the protein Huntingtin (Htt). Currently, no cure is available for HD. The mechanisms by which mutant Htt causes neuronal dysfunction and degeneration remain to be fully elucidated. Nevertheless, mitochondrial dysfunction has been suggested as a key event mediating mutant Htt-induced neurotoxicity because neurons are energy-demanding and particularly susceptible to energy deficits and oxidative stress. SIRT3, a member of sirtuin family, is localized to mitochondria and has been implicated in energy metabolism. Notably, we found that cells expressing mutant Htt displayed reduced SIRT3 levels. trans-(-)-epsilon-Viniferin (viniferin), a natural product among our 22 collected naturally occurring and semisynthetic stilbenic compounds, significantly attenuated mutant Htt-induced depletion of SIRT3 and protected cells from mutant Htt. We demonstrate that viniferin decreases levels of reactive oxygen species and prevents loss of mitochondrial membrane potential in cells expressing mutant Htt. Expression of mutant Htt results in decreased deacetylase activity of SIRT3 and further leads to reduction in cellular NAD(+) levels and mitochondrial biogenesis in cells. Viniferin activates AMP-activated kinase and enhances mitochondrial biogenesis. Knockdown of SIRT3 significantly inhibited viniferin-mediated AMP-activated kinase activation and diminished the neuroprotective effects of viniferin, suggesting that SIRT3 mediates the neuroprotection of viniferin. In conclusion, we establish a novel role for mitochondrial SIRT3 in HD pathogenesis and discovered a natural product that has potent neuroprotection in HD models. Our results suggest that increasing mitochondrial SIRT3 might be considered as a new therapeutic approach to counteract HD, as well as other neurodegenerative diseases with similar mechanisms.	[Fu, Jinrong; Jin, Jing; Xiang, Lan; Peng, Qi; Jiang, Mali; Arbez, Nicolas; Hotaling, Katelyn; Ross, Christopher A.; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21287 USA; [Ross, Christopher A.; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA; [Cichewicz, Robert H.; Hageman, Serena A.; Ellis, Trevor K.] Univ Oklahoma, Stephenson Life Sci Res Ctr, Dept Chem & Biochem, Nat Prod Discovery Grp, Norman, OK 73019 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Oklahoma System; University of Oklahoma - Norman	Duan, WZ (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	wduan2@jhmi.edu	Cichewicz, Robert H/H-5233-2012; Ross, Christopher A/H-8395-2013		National Institutes of Health [NINDS NS064313, NINDS NS16375]; CHDI Foundation, Inc. [CHDI A2120]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016375, P01NS016375, R21NS064313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NINDS NS064313 (to R. H. C.) and NINDS NS16375 (to C. A. R.). This work was also supported by Grant CHDI A2120 from the CHDI Foundation, Inc. (to W. D.).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Harper PS, 1996, J ROY COLL PHYS LOND, V30, P221; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Joyner PM, 2011, NAT PROD REP, V28, P26, DOI 10.1039/c0np00017e; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; MANN VM, 1990, LANCET, V336, P749, DOI 10.1016/0140-6736(90)92242-A; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; STAHL WL, 1974, NEUROLOGY, V24, P813, DOI 10.1212/WNL.24.9.813; Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wang WF, 2005, NEUROBIOL DIS, V20, P500, DOI 10.1016/j.nbd.2005.03.026; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Yang YJ, 2010, J BIOL CHEM, V285, P7417, DOI 10.1074/jbc.M109.053421; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9	58	142	147	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24460	24472		10.1074/jbc.M112.382226	http://dx.doi.org/10.1074/jbc.M112.382226			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648412	hybrid, Green Published			2022-12-28	WOS:000306651100039
J	Hotze, EM; Wilson-Kubalek, E; Farrand, AJ; Bentsen, L; Parker, MW; Johnson, AE; Tweten, RK				Hotze, Eileen M.; Wilson-Kubalek, Elizabeth; Farrand, Allison J.; Bentsen, Lori; Parker, Michael W.; Johnson, Arthur E.; Tweten, Rodney K.			Monomer-Monomer Interactions Propagate Structural Transitions Necessary for Pore Formation by the Cholesterol-dependent Cytolysins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGOLYSIN-O; MEMBRANE INSERTION; MECHANISM; PROTEIN; PREPORE; BINDING; COMPLEX; DOMAIN; SHEET	The assembly of the cholesterol-dependent cytolysin (CDC) oligomeric pore complex requires a complex choreography of secondary and tertiary structural changes in domain 3 (D3) of the CDC monomer structure. A point mutation was identified in the archetype CDC, perfringolysin O, that blocks detectable D3 structural changes and traps the membrane-bound monomers in an early and reversible stage of oligomer assembly. Using this and other mutants we show that specific D3 structural changes are propagated from one membrane-bound monomer to another. Propagation of these structural changes results in the exposure of a beta-strand in D3 that allows it to pair and form edge-on interactions with a second beta-strand of a free membrane-bound monomer. Pairing of these strands establishes the final geometry of the pore complex and is necessary to drive the formation of the beta-barrel pore. These studies provide new insights into how structural information is propagated between membrane-bound monomers of a self-assembling system and the interactions that establish the geometry of the final pore complex.	[Hotze, Eileen M.; Farrand, Allison J.; Bentsen, Lori; Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Wilson-Kubalek, Elizabeth] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Scripps Research Institute; St. Vincent's Institute of Medical Research; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Tweten, RK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB-1053, 940 Stanton L,Young Blvd, Oklahoma City, OK 73104 USA.	rod-tweten@ouhsc.edu	Johnson, Arthur E/G-3457-2012; Parker, Michael W/F-9069-2013	Parker, Michael W/0000-0002-3101-1138	National Institutes of Health through the NIAID [AI037657]; Robert A. Welch Foundation [BE-0017]; Victorian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037657] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert A. Welch Foundation(The Welch Foundation); Victorian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI037657 through the NIAID. This work was also supported by the Robert A. Welch Foundation Chair Grant BE-0017 and by the Victorian Government Operational Infrastructure Support Scheme to St. Vincent's Institute.	Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Feil SC, 1996, FEBS LETT, V397, P290, DOI 10.1016/S0014-5793(96)01200-8; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Hotze E, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P23; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lovelace LL, 2011, J BIOL CHEM, V286, P17585, DOI 10.1074/jbc.M111.219766; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15	30	45	45	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24534	24543		10.1074/jbc.M112.380139	http://dx.doi.org/10.1074/jbc.M112.380139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645132	hybrid, Green Published			2022-12-28	WOS:000306651100046
J	Urresti, S; Albesa-Jove, D; Schaeffer, F; Pham, HT; Kaur, D; Gest, P; van der Woerd, MJ; Carreras-Gonzalez, A; Lopez-Fernandez, S; Alzari, PM; Brennan, PJ; Jackson, M; Guerin, ME				Urresti, Saioa; Albesa-Jove, David; Schaeffer, Francis; Pham, Ha T.; Kaur, Devinder; Gest, Petra; van der Woerd, Mark J.; Carreras-Gonzalez, Ana; Lopez-Fernandez, Sonia; Alzari, Pedro M.; Brennan, Patrick J.; Jackson, Mary; Guerin, Marcelo E.			Mechanistic Insights into the Retaining Glucosyl-3-phosphoglycerate Synthase from Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLGLUCOSE LIPOPOLYSACCHARIDE BIOSYNTHESIS; INDUCED CONFORMATIONAL-CHANGES; ENZYMATIC GLYCOSYL TRANSFER; PALMITOYL-COENZYME-A; CRYSTAL-STRUCTURE; HUMAN GLUCURONOSYLTRANSFERASE; MANNOSYLTRANSFERASE PIMA; NEISSERIA-MENINGITIDIS; SUBSTRATE RECOGNITION; MOLECULAR RECOGNITION	Considerable progress has been made in recent years in our understanding of the structural basis of glycosyl transfer. Yet the nature and relevance of the conformational changes associated with substrate recognition and catalysis remain poorly understood. We have focused on the glucosyl-3-phosphoglycerate synthase (GpgS), a "retaining" enzyme, that initiates the biosynthetic pathway of methylglucose lipopolysaccharides in mycobacteria. Evidence is provided that GpgS displays an unusually broad metal ion specificity for a GT-A enzyme, with Mg2+, Mn2+, Ca2+, Co2+, and Fe2+ assisting catalysis. In the crystal structure of the apo-form of GpgS, we have observed that a flexible loop adopts a double conformation L-A and L-I in the active site of both monomers of the protein dimer. Notably, the L-A loop geometry corresponds to an active conformation and is conserved in two other relevant states of the enzyme, namely the GpgS.metal.nucleotide sugar donor and the GpgS.metal.nucleotide.acceptor-bound complexes, indicating that GpgS is intrinsically in a catalytically active conformation. The crystal structure of GpgS in the presence of Mn2+.UDP.phosphoglyceric acid revealed an alternate conformation for the nucleotide sugar beta-phosphate, which likely occurs upon sugar transfer. Structural, biochemical, and biophysical data point to a crucial role of the beta-phosphate in donor and acceptor substrate binding and catalysis. Altogether, our experimental data suggest a model wherein the catalytic site is essentially preformed, with a few conformational changes of lateral chain residues as the protein proceeds along the catalytic cycle. This model of action may be applicable to a broad range of GT-A glycosyltransferases.	[Pham, Ha T.; Kaur, Devinder; Gest, Petra; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Microbiol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Pham, Ha T.; Kaur, Devinder; Gest, Petra; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Immunol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Pham, Ha T.; Kaur, Devinder; Gest, Petra; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Urresti, Saioa; Albesa-Jove, David; Carreras-Gonzalez, Ana; Lopez-Fernandez, Sonia; Guerin, Marcelo E.] Univ Pais Vasco Euskal Herriko Unibertsitatea, Unidad Biofis, Ctr Mixto, Consejo Super Invest Cient, Leioa 48940, Bizkaia, Spain; [Urresti, Saioa; Albesa-Jove, David; Carreras-Gonzalez, Ana; Lopez-Fernandez, Sonia; Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain; [Guerin, Marcelo E.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Schaeffer, Francis; Alzari, Pedro M.] Inst Pasteur, Unite Microbiol Struct, F-75724 Paris 15, France; [Schaeffer, Francis; Alzari, Pedro M.] Inst Pasteur, CNRS, URA 2185, F-75724 Paris 15, France; [van der Woerd, Mark J.] Colorado State Univ, Dept Biochem & Mol Biol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Colorado State University	Jackson, M (corresponding author), Colorado State Univ, Dept Microbiol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu; mrcguerin@gmail.com	Jackson, Mary/D-5345-2017; Albesa-Jové, David/O-3822-2019; Albesa-Jové, David/F-5683-2016; Brennan, Patrick J/G-6896-2017; Guerin, Marcelo M/N-7245-2016	Jackson, Mary/0000-0002-9212-0258; Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Guerin, Marcelo M/0000-0001-9524-3184; Alzari, Pedro/0000-0002-4233-1903; Urresti, Saioa/0000-0002-8678-8358	National Institutes of Health from NIAID [AI064798]; European Commission [LSHP-CT-2005-018923, HEALTH-F3-2011-260872]; Spanish Ministry of Science and Innovation [SAF2010-19096, IKERBASQUE]; Basque Foundation for Science; Fundacion Biofisica Bizkaia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Foundation for Science; Fundacion Biofisica Bizkaia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798 from NIAID. This work was also supported by European Commission Contract LSHP-CT-2005-018923 (New Medicines for Tuberculosis), More Medicines for Tuberculosis Contract HEALTH-F3-2011-260872, the Spanish Ministry of Science and Innovation Contract SAF2010-19096, IKERBASQUE, the Basque Foundation for Science, and the Fundacion Biofisica Bizkaia.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Ardevol A, 2011, ANGEW CHEM INT EDIT, V50, P10897, DOI 10.1002/anie.201104623; Pereira PJB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003748; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Brew K, 2010, J BIOL CHEM, V285, P37121, DOI 10.1074/jbc.R110.176248; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Costa J, 2007, J BACTERIOL, V189, P1648, DOI 10.1128/JB.00841-06; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Empadinhas N, 2011, MOL MICROBIOL, V79, P76, DOI 10.1111/j.1365-2958.2010.07432.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Frantom PA, 2010, J AM CHEM SOC, V132, P6626, DOI 10.1021/ja101231a; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Gest P, 2008, ACTA CRYSTALLOGR F, V64, P1121, DOI 10.1107/S1744309108032892; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gomez H, 2012, J AM CHEM SOC, V134, P4743, DOI 10.1021/ja210490f; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; HINDSGAUL O, 1984, BIOCHEMISTRY-US, V23, P577, DOI 10.1021/bi00298a028; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; Kakuda S, 2004, J BIOL CHEM, V279, P22693, DOI 10.1074/jbc.M400622200; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; Kaur D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005447; KELLER JM, 1968, J BIOL CHEM, V243, P2905; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lobsanov YD, 2004, J BIOL CHEM, V279, P17921, DOI 10.1074/jbc.M312720200; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; MACHIDA Y, 1973, P NATL ACAD SCI USA, V70, P1146, DOI 10.1073/pnas.70.4.1146; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; Nielsen MM, 2011, J BIOL CHEM, V286, P15155, DOI 10.1074/jbc.M110.199844; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; REARICK JI, 1979, J BIOL CHEM, V254, P4444; Rini J, 2009, ESSENTIALS GLYCOBIOL; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YABUSAKI KK, 1978, P NATL ACAD SCI USA, V75, P691, DOI 10.1073/pnas.75.2.691; YABUSAKI KK, 1979, J BIOL CHEM, V254, P2314	67	15	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24649	24661		10.1074/jbc.M112.368191	http://dx.doi.org/10.1074/jbc.M112.368191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637481	hybrid, Green Published			2022-12-28	WOS:000306651100059
J	Zhao, XH; Park, YN; Todor, H; Moomau, C; Masison, D; Eisenberg, E; Greene, LE				Zhao, Xiaohong; Park, Yang-Nim; Todor, Horia; Moomau, Christine; Masison, Daniel; Eisenberg, Evan; Greene, Lois E.			Sequestration of Sup35 by Aggregates of huntingtin Fragments Causes Toxicity of [PSI+] Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY FORMATION; POLYGLUTAMINE AGGREGATION; SACCHAROMYCES-CEREVISIAE; MOLECULAR PATHOGENESIS; CHAPERONE PROTEINS; PRION PROPAGATION; MUTANT HUNTINGTIN; NEURONAL DEATH; DISEASE; OLIGOMERS	Expression of huntingtin fragments with 103 glutamines (HttQ103) is toxic in yeast containing either the [PIN+] prion, which is the amyloid form of Rnq1, or [PSI+] prion, which is the amyloid form of Sup35. We find that HttQP103, which has a polyproline region at the C-terminal end of the polyQ repeat region, is significantly more toxic in [PSI+] yeast than in [PIN+], even though HttQP103 formed multiple aggregates in both [PSI+] and [PIN+] yeast. This toxicity was only observed in the strong [PSI+] variant, not the weak [PSI+] variant, which has more soluble Sup35 present than the strong variant. Furthermore, expression of the MC domains of Sup35, which retains the C-terminal domain of Sup35, but lacks the N-terminal prion domain, almost completely rescued HttQP103 toxicity, but was less effective in rescuing HttQ103 toxicity. Therefore, the toxicity of HttQP103 in yeast containing the [PSI+] prion is primarily due to sequestration of the essential protein, Sup35.	[Zhao, Xiaohong; Park, Yang-Nim; Todor, Horia; Moomau, Christine; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Masison, Daniel] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Greene, LE (corresponding author), NHLBI, Cell Biol Lab, NIH, 50 South Dr,Rm 2537 MSC 8017, Bethesda, MD 20892 USA.	greenel@helix.nih.gov			National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was authored, in whole or in part, by National Institutes of Health staff.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Cox B, 2003, GENETICS, V165, P23; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jung G, 2000, GENETICS, V156, P559; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kirkland PA, 2011, GENETICS, V188, P565, DOI 10.1534/genetics.111.129460; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Vishveshwara N, 2009, MOL MICROBIOL, V73, P1101, DOI 10.1111/j.1365-2958.2009.06836.x; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114	30	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23346	23355		10.1074/jbc.M111.287748	http://dx.doi.org/10.1074/jbc.M111.287748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22573320	hybrid, Green Published			2022-12-28	WOS:000306511300008
J	Fan, MM; Zhang, WK; Buraei, Z; Yang, J				Fan, Mingming; Zhang, Wei K.; Buraei, Zafir; Yang, Jian			Molecular Determinants of Gem Protein Inhibition of P/Q-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; BETA-SUBUNIT; RGK-FAMILY; NUCLEAR TRANSPORT; CA(V)1.2 CHANNELS; CALCIUM-CHANNELS; REM GTPASE; CELL-SHAPE; CALMODULIN; RAD	The RGK family of monomeric GTP-binding proteins potently inhibits high voltage-activated Ca2+ channels. The molecular mechanisms of this inhibition are largely unclear. In Xenopus oocytes, Gem suppresses the activity of P/Q-type Ca2+ channels on the plasma membrane. This is presumed to occur through direct interactions of one or more Gem inhibitory sites and the pore-forming Ca(v)2.1 subunit in a manner dependent on the Ca2+ channel subunit beta (Ca-v beta). In this study we investigated the molecular determinants in Gem that are critical for this inhibition. Like other RGK proteins, Gem contains a conserved Ras-like core and extended N and C termini. A 12-amino acid fragment in the C terminus was found to be crucial for and sufficient to produce Ca-v beta-dependent inhibition, suggesting that this region forms an inhibitory site. A three-amino acid motif in the core was also found to be critical, possibly forming another inhibitory site. Mutating either site individually did not hamper Gem inhibition, but mutating both sites together completely abolished Gem inhibition without affecting Gem protein expression level or disrupting Gem interaction with Ca(v)2.1 or Ca-v beta. Mutating Gem residues that are crucial for interactions with previously demonstrated RGK modulators such as calmodulin, 14-3-3, and phosphatidylinositol lipids did not significantly affect Gem inhibition. These results suggest that Gem contains two candidate inhibitory sites, each capable of producing full inhibition of P/Q-type Ca2+ channels.	[Yang, Jian] Columbia Univ, Dept Biol Sci, Fairchild Ctr 917, New York, NY 10027 USA	Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr 917, MC2462, New York, NY 10027 USA.	jy160@columbia.edu	Zhang, Wei/M-4241-2019	Zhang, Wei/0000-0003-4960-6137; , Zafir/0000-0001-6485-8987	National Institutes of Health [NS053494, NS045383]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045383, R01NS053494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS053494 and NS045383 (to J. Y.).	Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Correll RN, 2007, J BIOL CHEM, V282, P28431, DOI 10.1074/jbc.M706176200; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Felix R, 2005, J RECEPT SIG TRANSD, V25, P57, DOI 10.1081/RRS-200068102; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 1999, ARCH BIOCHEM BIOPHYS, V368, P401, DOI 10.1006/abbi.1999.1316; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Flynn R, 2008, BIOCHEM BIOPH RES CO, V368, P827, DOI 10.1016/j.bbrc.2008.02.020; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Kelly K, 2005, TRENDS CELL BIOL, V15, P640, DOI 10.1016/j.tcb.2005.10.002; Leyris JP, 2009, FASEB J, V23, P2627, DOI 10.1096/fj.08-122135; Mahalakshmi RN, 2007, TRAFFIC, V8, P1164, DOI 10.1111/j.1600-0854.2007.00599.x; Mahalakshmi RN, 2007, TRAFFIC, V8, P1150, DOI 10.1111/j.1600-0854.2007.00598.x; Moyers JS, 1997, J BIOL CHEM, V272, P11832, DOI 10.1074/jbc.272.18.11832; Pang CY, 2010, CHANNELS, V4, P192, DOI 10.4161/chan.4.3.11867; Sasaki T, 2005, J BIOL CHEM, V280, P9308, DOI 10.1074/jbc.M413773200; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Splingard A, 2007, J BIOL CHEM, V282, P1905, DOI 10.1074/jbc.M604363200; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; Xu XH, 2010, CIRC RES, V107, P620, DOI 10.1161/CIRCRESAHA.110.224717; Yada H, 2007, CIRC RES, V101, P69, DOI 10.1161/CIRCRESAHA.106.146399; Yang T, 2007, NAT CHEM BIOL, V3, P795, DOI 10.1038/nchembio.2007.42; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203; Yanuar A, 2006, GENES CELLS, V11, P961, DOI 10.1111/j.1365-2443.2006.00994.x	35	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22749	22758		10.1074/jbc.M111.291872	http://dx.doi.org/10.1074/jbc.M111.291872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589533	Green Published, hybrid			2022-12-28	WOS:000306495000032
J	Patsalo, V; Yondola, MA; Luan, BW; Shoshani, I; Kisker, C; Green, DF; Raleigh, DP; Hearing, P				Patsalo, Vadim; Yondola, Mark A.; Luan, Bowu; Shoshani, Ilana; Kisker, Caroline; Green, David F.; Raleigh, Daniel P.; Hearing, Patrick			Biophysical and Functional Analyses Suggest That Adenovirus E4-ORF3 Protein Requires Higher-order Multimerization to Function against Promyelocytic Leukemia Protein Nuclear Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E4 ORF3 PROTEIN; MESSENGER-RNA EXPORT; 5 E1B 55K; DNA-REPLICATION; ANTIVIRAL DEFENSE; MRE11-RAD50-NBS1 COMPLEX; 55-KILODALTON PROTEIN; E4ORF3 PROTEIN; VIRAL-DNA; INFECTION	The early region 4 open reading frame 3 protein (E4-ORF3; UniProt ID P04489) is the most highly conserved of all adenovirus- encoded gene products at the amino acid level. A conserved attribute of the E4-ORF3 proteins of different human adenoviruses is the ability to disrupt PML nuclear bodies from their normally punctate appearance into heterogeneous filamentous structures. This E4-ORF3 activity correlates with the inhibition of PML-mediated antiviral activity. The mechanism of E4-ORF3-mediated reorganization of PML nuclear bodies is unknown. Biophysical analysis of the purified WT E4-ORF3 protein revealed an ordered secondary/tertiary structure and the ability to form heterogeneous higher-order multimers in solution. Importantly, a nonfunctional E4-ORF3 mutant protein, L103A, forms a stable dimer with WT secondary structure content. Because the L103A mutant is incapable of PML reorganization, this result suggests that higher-order multimerization of E4-ORF3 may be required for the activity of the protein. In support of this hypothesis, we demonstrate that the E4-ORF3 L103A mutant protein acts as a dominant-negative effector when coexpressed with theWTE4-ORF3 in mammalian cells. It preventsWTE4-ORF3-mediated PML track formation presumably by binding to the WT protein and inhibiting the formation of higher-order multimers. In vitro protein binding studies support this conclusion as demonstrated by copurification of coexpressed WT and L103A proteins in Escherichia coli and coimmunoprecipitation of WT.L103A E4-ORF3 complexes in mammalian cells. These results provide new insight into the properties of the Ad E4-ORF3 protein and suggest that higher-order protein multimerization is essential for E4-ORF3 activity.	[Yondola, Mark A.; Shoshani, Ilana; Hearing, Patrick] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Patsalo, Vadim; Green, David F.] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Luan, Bowu; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Kisker, Caroline] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hearing, P (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	phearing@ms.cc.sunysb.edu	Kisker, Caroline/T-1724-2019	Patsalo, Vadim/0000-0001-6047-5858; raleigh, daniel/0000-0003-3248-7493; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [CA122677, GM078114, GM086199, CA009176, GM007518]; NATIONAL CANCER INSTITUTE [R01CA122677, T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078114, T32GM007518, R01GM086199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122677 (to P. H.), GM078114 (to D. P. R.), and GM086199 (to D. F. G.) and by Training Grants CA009176 and GM007518 (to M. A. Y.).	Araujo FD, 2005, J VIROL, V79, P11382, DOI 10.1128/JVI.79.17.11382-11391.2005; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Blanchette P, 2008, J VIROL, V82, P2642, DOI 10.1128/JVI.02309-07; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Evans JD, 2005, J VIROL, V79, P6207, DOI 10.1128/JVI.79.10.6207-6215.2005; Evans JD, 2003, J VIROL, V77, P5295, DOI 10.1128/JVI.77.9.5295-5304.2003; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Forrester NA, 2012, J VIROL, V86, P3167, DOI 10.1128/JVI.06583-11; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Goodrum FD, 1999, J VIROL, V73, P7474, DOI 10.1128/JVI.73.9.7474-7488.1999; Gualfetti PJ, 1999, BIOCHEMISTRY-US, V38, P13367, DOI 10.1021/bi991296s; Guinier A, 1955, SMALL ANGLE XRAY SCA; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Karen KA, 2009, J VIROL, V83, P4565, DOI 10.1128/JVI.00042-09; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Koide S, 1999, BIOCHEMISTRY-US, V38, P4757, DOI 10.1021/bi982443+; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lakdawala SS, 2008, J VIROL, V82, P8362, DOI 10.1128/JVI.00900-08; Leppard KN, 1999, J GEN VIROL, V80, P997, DOI 10.1099/0022-1317-80-4-997; Lethbridge KJ, 2003, J GEN VIROL, V84, P259, DOI 10.1099/vir.0.18820-0; Liao DQ, 1999, VIROLOGY, V254, P11, DOI 10.1006/viro.1998.9512; Liu Y, 2005, J VIROL, V79, P14004, DOI 10.1128/JVI.79.22.14004-14016.2005; Mathew SS, 2007, VIROLOGY, V365, P346, DOI 10.1016/j.virol.2007.03.049; Mathew SS, 2008, VIROLOGY, V374, P11, DOI 10.1016/j.virol.2007.12.034; Nevels M, 1999, J VIROL, V73, P1591, DOI 10.1128/JVI.73.2.1591-1600.1999; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; OHMAN K, 1993, VIROLOGY, V194, P50, DOI 10.1006/viro.1993.1234; Orazio NI, 2011, J VIROL, V85, P1887, DOI 10.1128/JVI.02134-10; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; SANDLER AB, 1989, J VIROL, V63, P624, DOI 10.1128/JVI.63.2.624-630.1989; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Shepard RN, 2004, J VIROL, V78, P9924, DOI 10.1128/JVI.78.18.9924-9935.2004; Shepard RN, 2003, J VIROL, V77, P8593, DOI 10.1128/JVI.77.15.8593-8595.2003; Skolnick J, 1997, J MOL BIOL, V265, P217, DOI 10.1006/jmbi.1996.0720; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Ullman AJ, 2008, J VIROL, V82, P7325, DOI 10.1128/JVI.00723-08; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; Vink EI, 2012, VIROLOGY, V422, P317, DOI 10.1016/j.virol.2011.10.033; WEIDEN MD, 1994, P NATL ACAD SCI USA, V91, P153, DOI 10.1073/pnas.91.1.153; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Weitzman MD, 2005, ONCOGENE, V24, P7686, DOI 10.1038/sj.onc.1209063; Woo JL, 2007, J VIROL, V81, P575, DOI 10.1128/JVI.01725-06; Yondola MA, 2007, J VIROL, V81, P4264, DOI 10.1128/JVI.02629-06	47	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22573	22583		10.1074/jbc.M112.344234	http://dx.doi.org/10.1074/jbc.M112.344234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573317	Green Published, hybrid			2022-12-28	WOS:000306495000014
J	van Domselaar, R; Quadir, R; van der Made, AM; Broekhuizen, R; Bovenschen, N				van Domselaar, Robert; Quadir, Razi; van der Made, Astrid M.; Broekhuizen, Roel; Bovenschen, Niels			All Human Granzymes Target hnRNP K That Is Essential for Tumor Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RIBONUCLEOPROTEIN-K; ASSEMBLY PROTEIN SET; STRANDED-DNA NICKS; MITOCHONDRIAL DAMAGE; POOR-PROGNOSIS; DEATH; CARCINOMA; APOPTOSIS; CANCER; CYTOTOXICITY	Granule exocytosis by cytotoxic lymphocytes is the key mechanism to eliminate virus-infected cells and tumor cells. These lytic granules contain the pore-forming protein perforin and a set of five serine proteases called granzymes. All human granzymes display distinct substrate specificities and induce cell death by cleaving critical intracellular death substrates. In the present study, we show that all human granzymes directly cleaved the DNA/RNA-binding protein heterogeneous nuclear ribonucleoprotein K (hnRNP K), designating hnRNP K as the first known pan-granzyme substrate. Cleavage of hnRNP K was more efficient in the presence of RNA and occurred in two apparent proteolysis-sensitive amino acid regions, thereby dissecting the functional DNA/RNA-binding hnRNP K domains. HnRNP K was cleaved under physiological conditions when purified granzymes were delivered into living tumor cells and during lymphokine-activated killer cell-mediated attack. HnRNP K is essential for tumor cell viability, since knockdown of hnRNP K resulted in spontaneous tumor cell apoptosis with caspase activation and reactive oxygen species production. This apoptosis was more pronounced at low tumor cell density where hnRNP K knockdown also triggered a caspase-independent apoptotic pathway. This suggests that hnRNP K promotes tumor cell survival in the absence of cell-cell contact. Silencing of hnRNP K protein expression rendered tumor cells more susceptible to cellular cytotoxicity. We conclude that hnRNP K is indispensable for tumor cell viability and our data suggest that targeting of hnRNP K by granzymes contributes to or reinforces the cell death mechanisms by which cytotoxic lymphocytes eliminate tumor cells.	[van Domselaar, Robert; Quadir, Razi; van der Made, Astrid M.; Broekhuizen, Roel; Bovenschen, Niels] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bovenschen, N (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	n.bovenschen@umcutrecht.nl			Netherlands Organization for Scientific Research (NWO) [916.66.044]; Dutch Cancer Society [UU-2009-4302]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	This study was supported by The Netherlands Organization for Scientific Research (NWO) (Grant 916.66.044) and the Dutch Cancer Society (UU-2009-4302) (to N. B.).	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bovenschen N, 2008, J IMMUNOL, V180, P8184, DOI 10.4049/jimmunol.180.12.8184; Bovenschen N, 2010, IMMUNOL REV, V235, P117, DOI 10.1111/j.0105-2896.2010.00889.x; Bovenschen N, 2009, J BIOL CHEM, V284, P3504, DOI 10.1074/jbc.M806716200; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Chen L. C., 2010, ANTIAPOPTOTIC PROTEI; Chen LC, 2008, CLIN CANCER RES, V14, P3807, DOI 10.1158/1078-0432.CCR-08-0155; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cullen SP, 2009, J BIOL CHEM, V284, P5137, DOI 10.1074/jbc.M807913200; de Poot SAH, 2011, BIOCHEM J, V437, P431, DOI 10.1042/BJ20110210; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fellows E, 2007, BLOOD, V110, P544, DOI 10.1182/blood-2006-10-051649; Gao FH, 2009, EXP CELL RES, V315, P3250, DOI 10.1016/j.yexcr.2009.09.005; Guo YM, 2008, MOL IMMUNOL, V45, P2225, DOI 10.1016/j.molimm.2007.11.020; Guo YM, 2010, J IMMUNOL, V185, P5348, DOI 10.4049/jimmunol.0903792; Hou Q, 2008, MOL IMMUNOL, V45, P1044, DOI 10.1016/j.molimm.2007.07.032; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Hua GQ, 2009, J IMMUNOL, V182, P2152, DOI 10.4049/jimmunol.0802307; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Ng LFP, 2005, PLOS MED, V2, P673, DOI 10.1371/journal.pmed.0020163; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Plasman K., 2011, MOL CELL PR IN PRESS; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Roychoudhury P, 2007, BRIT J CANCER, V97, P574, DOI 10.1038/sj.bjc.6603911; Schmidt T, 2010, FEBS LETT, V584, P4361, DOI 10.1016/j.febslet.2010.09.038; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Van Damme P, 2010, BIOL CHEM, V391, P983, DOI 10.1515/BC.2010.096; Van Damme P, 2010, NAT METHODS, V7, P512, DOI [10.1038/NMETH.1469, 10.1038/nmeth.1469]; van Domselaar R, 2010, EXPERT REV PROTEOMIC, V7, P347, DOI 10.1586/EPR.10.24; Wang S, 2012, CELL DEATH DIFFER, V19, P605, DOI 10.1038/cdd.2011.130; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Zhao T, 2007, CELL DEATH DIFFER, V14, P489, DOI 10.1038/sj.cdd.4402040; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744; Zhu PC, 2006, EMBO REP, V7, P431, DOI 10.1038/sj.embor.7400622	45	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22854	22864		10.1074/jbc.M112.365692	http://dx.doi.org/10.1074/jbc.M112.365692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582387	Green Published, hybrid			2022-12-28	WOS:000306495000042
J	Boldogh, I; Hajas, G; Aguilera-Aguirre, L; Hegde, ML; Radak, Z; Bacsi, A; Sur, S; Hazra, TK; Mitra, S				Boldogh, Istvan; Hajas, Gyorgy; Aguilera-Aguirre, Leopoldo; Hegde, Muralidhar L.; Radak, Zsolt; Bacsi, Attila; Sur, Sanjiv; Hazra, Tapas K.; Mitra, Sankar			Activation of Ras Signaling Pathway by 8-Oxoguanine DNA Glycosylase Bound to Its Excision Product, 8-Oxoguanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL INTERACTION; REPAIR; 8-HYDROXYGUANINE; ACCUMULATION; DAMAGE	8-Oxo-7,8-dihydroguanine (8-oxoG), arguably the most abundant base lesion induced in mammalian genomes by reactive oxygen species, is repaired via the base excision repair pathway that is initiated with the excision of 8-oxoG by OGG1. Here we show that OGG1 binds the 8-oxoG base with high affinity and that the complex then interacts with canonical Ras family GTPases to catalyze replacement of GDP with GTP, thus serving as a guanine nuclear exchange factor. OGG1-mediated activation of Ras leads to phosphorylation of the mitogen-activated kinases MEK1,2/ERK1,2 and increasing downstream gene expression. These studies document for the first time that in addition to its role in repairing oxidized purines, OGG1 has an independent guanine nuclear exchange factor activity when bound to 8-oxoG.	[Boldogh, Istvan; Hajas, Gyorgy; Aguilera-Aguirre, Leopoldo; Radak, Zsolt; Bacsi, Attila] Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sur, Sanjiv; Hazra, Tapas K.; Mitra, Sankar] Univ Texas Med Branch Galveston, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Hegde, Muralidhar L.; Mitra, Sankar] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sur, Sanjiv; Hazra, Tapas K.] Univ Texas Med Branch Galveston, Dept Internal Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Boldogh, I (corresponding author), Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA.	sboldogh@utmb.edu	Classen, Scott/AAY-8176-2020; Aguilera-Aguirre, Leopoldo/B-9864-2012	Hegde, Muralidhar/0000-0001-7333-8123; Radak, Zsolt/0000-0003-1297-6804; Bacsi, Attila/0000-0002-2311-2975; Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402	National Institutes of Health from the NIEHS [RO1 ES018948]; NIA/AG [021830]; NIAID [NIAID/AI062885-01]; NHLBI Proteomic Center [N01HV00245, R01CA81063]; NIEHS [T32 ES007254]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, T32ES007254, R01ES018948] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; NIA/AG; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI Proteomic Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES018948 (to I. B.) from the NIEHS, 021830 (to I. B.) from the NIA/AG, and NIAID/AI062885-01 (to I. B.) from the NIAID and the Grants N01HV00245 (to Dr. A. Kurosky) and R01CA81063 (to S. M.) from the NHLBI Proteomic Center.; An Environmental Toxicology Research Training Fellow (Grant T32 ES007254 from the NIEHS).	Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CHATAWAY TK, 1995, MOL CELL BIOCHEM, V144, P167, DOI 10.1007/BF00944396; CHENG KC, 1992, J BIOL CHEM, V267, P166; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; FIELD J, 1987, MOL CELL BIOL, V7, P2128, DOI 10.1128/MCB.7.6.2128; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Mitra S, 1997, MOL CELLS, V7, P305; MOSTELLER RD, 1994, MOL CELL BIOL, V14, P1104, DOI 10.1128/MCB.14.2.1104; Nakabeppu Y, 2010, MUTAT RES-GEN TOX EN, V703, P51, DOI 10.1016/j.mrgentox.2010.06.006; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wittinghofer F, 1998, NATURE, V394, P317, DOI 10.1038/28492	28	101	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20769	20773		10.1074/jbc.C112.364620	http://dx.doi.org/10.1074/jbc.C112.364620			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22568941	Green Published, hybrid			2022-12-28	WOS:000306416800001
J	Mehner, D; Osadnik, H; Lunsdorf, H; Bruser, T				Mehner, Denise; Osadnik, Hendrik; Luensdorf, Heinrich; Brueser, Thomas			The Tat System for Membrane Translocation of Folded Proteins Recruits the Membrane-stabilizing Psp Machinery in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE SIGNAL PEPTIDE; PHAGE-SHOCK; TRANSPORT SYSTEM; COMPONENT; EXPRESSION; PRECURSOR; COMPLEX; BINDING; STRESS; VIPP1	Tat systems transport folded proteins across energized membranes of bacteria, archaea, and plant plastids. In Escherichia coli, TatBC complexes recognize the transported proteins, and TatA complexes are recruited to facilitate transport. We achieved an abstraction of TatA from membranes without use of detergents and observed a co-purification of PspA, a membrane-stress response protein. The N-terminal transmembrane domain of TatA was required for the interaction. Electron microscopy displayed TatA complexes in direct contact with PspA. PspB and PspC were important for the TatA-PspA contact. The activator protein PspF was not involved in the PspA-TatA interaction, demonstrating that basal levels of PspA already interact with TatA. Elevated TatA levels caused membrane stress that induced a strictly PspBC- and PspF-dependent up-regulation of PspA. TatA complexes were found to destabilize membranes under these conditions. At native TatA levels, PspA deficiency clearly affected anaerobic TMAO respiratory growth, suggesting that energetic costs for transport of large Tat substrates such as TMAO reductase can become growth limiting in the absence of PspA. The physiological role of PspA recruitment to TatA may therefore be the control of membrane stress at active translocons.	[Mehner, Denise; Osadnik, Hendrik; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, D-30167 Hannover, Germany; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Leibniz University Hannover; Helmholtz Association; Helmholtz-Center for Infection Research	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Schneiderberg 50, D-30167 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306; Mehner-Breitfeld, Denise/0000-0002-6785-898X	Deutsche Forschungsgemeinschaft [BR2285/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (Grant BR2285/1-3).	Adams H, 2003, J BACTERIOL, V185, P1174, DOI 10.1128/JB.185.4.1174-1180.2003; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alder NN, 2003, CELL, V112, P231, DOI 10.1016/S0092-8674(03)00032-1; Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; BERGLER H, 1994, MICROBIOL-SGM, V140, P1937, DOI 10.1099/13500872-140-8-1937; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; CARTER CW, 1974, J BIOL CHEM, V249, P4212; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Elderkin S, 2005, J BACTERIOL, V187, P3238, DOI 10.1128/JB.187.9.3238-3248.2005; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; Gueguen E, 2009, MOL MICROBIOL, V74, P619, DOI 10.1111/j.1365-2958.2009.06885.x; Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Jouhet J, 2009, PLANT SIGNAL BEHAV, V4, P986, DOI 10.4161/psb.4.10.9665; Jovanovic G, 2010, MICROBIOL-SGM, V156, P2920, DOI 10.1099/mic.0.040055-0; KLEEREBEZEM M, 1993, MOL MICROBIOL, V7, P947, DOI 10.1111/j.1365-2958.1993.tb01186.x; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Liu CM, 2005, MOL BIOL CELL, V16, P1165, DOI 10.1091/mbc.E04-08-0736; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; OVERMANN J, 1992, ARCH MICROBIOL, V157, P329, DOI 10.1007/BF00248677; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P208, DOI 10.1016/0167-4838(89)90220-3; Standar K, 2008, FEBS LETT, V582, P3585, DOI 10.1016/j.febslet.2008.09.002; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Vrancken K, 2008, J BACTERIOL, V190, P3475, DOI 10.1128/JB.01966-07; Vrancken K, 2007, APPL MICROBIOL BIOT, V73, P1150, DOI 10.1007/s00253-006-0571-7; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; WARNOCK DG, 1982, AM J PHYSIOL, V242, pF733, DOI 10.1152/ajprenal.1982.242.6.F733; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Yamaguchi S, 2012, J MICROBIOL, V50, P1, DOI 10.1007/s12275-012-1578-7; Yamaguchi S, 2010, MOL MICROBIOL, V78, P429, DOI 10.1111/j.1365-2958.2010.07344.x	64	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27834	27842		10.1074/jbc.M112.374983	http://dx.doi.org/10.1074/jbc.M112.374983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22689583	hybrid, Green Published			2022-12-28	WOS:000307840700057
J	Ren, WY; Cheema, S; Du, KY				Ren, Wenying; Cheema, Sarwat; Du, Keyong			The Association of ClipR-59 Protein with AS160 Modulates AS160 Protein Phosphorylation and Adipocyte Glut4 Protein Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; RAT ADIPOSE-CELLS; INSULIN-RESISTANCE; PLASMA-MEMBRANE; GAP; TRAFFICKING; DOMAIN; AKT; GLUCOSE-TRANSPORTER-4; TARGET	ClipR-59 is a membrane-associated protein and has been implicated in membrane signaling and vesicle trafficking. Recently, we have identified ClipR-59 as an Akt-interacting protein, and we have found that, by interacting with Akt, ClipR-59 modulates Akt subcellular compartmentalization and Akt substrate AS160 phosphorylation, thereby promoting Glut4 membrane translocation. Here, we have further investigated the regulatory effects of ClipR-59 on AS160 phosphorylation and subsequent adipocyte glucose transport. Our data showed that ClipR-59 interacted with AS160, which was mediated by the ankyrin repeats of ClipR-59 and regulated by insulin signaling. Moreover, the data also demonstrated that the interaction of ClipR-59 with AS160 was required for ClipR-59 to modulate Glut4 membrane translocation as Delta ANK-ClipR-59, an AS160 interaction-defective mutant, failed to promote AS160 phosphorylation, Glut4 membrane translocation, and glucose transport induced by insulin in 3T3-L1 adipocytes. Because ClipR-59 also interacts with Akt and enhances the interaction between Akt and AS160, we suggest that ClipR-59 functions as a scaffold protein to facilitate Akt-mediated AS160 phosphorylation, thereby regulating glucose transport.	[Ren, Wenying; Cheema, Sarwat; Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Du, KY (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org			National Institutes of Health [RO1 DK084319, R56 DK084319]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319, R56DK084319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK084319 and R56 DK084319 (to K. D.).; Recipient of a career development award from the American Diabetes Association. To whom correspondence should be addressed: Molecular Oncology Research Institute, Tufts Medical Center, 800 Washington St., Boston, MA 02111. Tel.: 617-636-6476; Fax: 617-636-6127; E-mail: kdu@tuftsmedicalcenter.org.	Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lin HV, 2011, DIABETES, V60, P700, DOI 10.2337/db10-1056; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	29	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26890	26900		10.1074/jbc.M112.357699	http://dx.doi.org/10.1074/jbc.M112.357699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689584	Green Published, hybrid			2022-12-28	WOS:000307386000037
J	Huang, W; Lv, XB; Liu, CY; Zha, ZY; Zhang, H; Jiang, Y; Xiong, Y; Lei, QY; Guan, KL				Huang, Wei; Lv, Xianbo; Liu, Chenying; Zha, Zhengyu; Zhang, Heng; Jiang, Ying; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCF beta-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL DIFFERENTIATION; BREAST-CANCER CELLS; TUMOR-SUPPRESSOR; HIPPO PATHWAY; TAZ INTERACTS; COACTIVATOR; PROMOTES; GROWTH; PHOSPHORYLATION	The Hippo tumor suppressor pathway plays a major role in development and organ size control, and its dysregulation contributes to tumorigenesis. TAZ (transcriptional co-activator with PDZ-binding motif; also known as WWTR1) is a transcription co-activator acting downstream of the Hippo pathway, and increased TAZ protein levels have been associated with human cancers, such as breast cancer. Previous studies have shown that TAZ is inhibited by large tumor suppressor (LATS)-dependent phosphorylation, leading to cytoplasmic retention and ubiquitin-dependent degradation. The LATS kinase, a core component of the Hippo pathway, phosphorylates the C-terminal phosphodegron in TAZ to promote its degradation. In this study, we have found that the N-terminal phosphodegron of TAZ also plays a role in TAZ protein level regulation, particularly in response to different status of cellular PI3K signaling. GSK3, which can be inhibited by high PI3K via AKT-dependent inhibitory phosphorylation, phosphorylates the N-terminal phosphodegron in TAZ, and the phosphorylated TAZ binds to beta-TrCP subunit of the SCF beta-TrCP E3 ubiquitin ligase, thereby leading to TAZ ubiquitylation and degradation. We observed that the TAZ protein level is elevated in tumor cells with high PI3K signaling, such as in PTEN mutant cancer cells. This study provides a novel mechanism of TAZ regulation and suggests a role of TAZ in modulating tissue growth and tumor development in response to PI3K signaling.	[Huang, Wei; Lv, Xianbo; Liu, Chenying; Zhang, Heng; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China; [Huang, Wei; Lv, Xianbo; Liu, Chenying; Zha, Zhengyu; Zhang, Heng; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Huang, Wei; Lv, Xianbo; Liu, Chenying; Zhang, Heng; Xiong, Yue] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Jiang, Ying] Shanghai Fudan Univ, Shanghai Zhongshan Hosp, Dept Gen Surg, Shanghai 200032, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Lei, QY (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; Huang, Wei/0000-0002-0750-969X; zha, zhengyu/0000-0002-8619-3661	973 Program [2009CB918401, 2011CB910600, NCET-09-0315]; National Science Foundation of China (NSFC) [31071192, 30972937]; NSFC-NIH [81110313]; 100 Talents Program of Shanghai Health [XBR2011041]; "Scholar of Dawn" Program of the Shanghai Education Commission; 985 Program and the Shanghai Leading Academic Discipline Project [B110]; National Institutes of Health [CA132809, CIRM RB2-01547]; NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC-NIH; 100 Talents Program of Shanghai Health; "Scholar of Dawn" Program of the Shanghai Education Commission; 985 Program and the Shanghai Leading Academic Discipline Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by 973 Program Grants 2009CB918401, 2011CB910600, and NCET-09-0315; National Science Foundation of China (NSFC) Grants 31071192 and 30972937; NSFC-NIH Grant 81110313; 100 Talents Program of Shanghai Health Grant XBR2011041; and the "Scholar of Dawn" Program of the Shanghai Education Commission (to Q. Y. L.). This work was also supported by the 985 Program and the Shanghai Leading Academic Discipline Project (Project B110). This work is also supported by National Institutes of Health Grants CA132809 and CIRM RB2-01547 (to K. L. G.).	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; ZHAO JJ, 2006, SCI STKE, pPE52, DOI DOI 10.1126/STKE.3652006PE52; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	36	114	116	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26245	26253		10.1074/jbc.M112.382036	http://dx.doi.org/10.1074/jbc.M112.382036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692215	Green Published, hybrid			2022-12-28	WOS:000306916300051
J	Phongsak, T; Sucharitakul, J; Thotsaporn, K; Oonanant, W; Yuvaniyama, J; Svasti, J; Ballou, DP; Chaiyen, P				Phongsak, Thanawat; Sucharitakul, Jeerus; Thotsaporn, Kittisak; Oonanant, Worrapoj; Yuvaniyama, Jirundon; Svasti, Jisnuson; Ballou, David P.; Chaiyen, Pimchai			The C-terminal Domain of 4-Hydroxyphenylacetate 3-Hydroxylase from Acinetobacter baumannii Is an Autoinhibitory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; NITRIC-OXIDE SYNTHASE; FLAVIN-REDUCTASE; CRYSTAL-STRUCTURE; OXYGENASE COMPONENT; DEPENDENT MONOOXYGENASE; ELECTRON-TRANSFER; SWISS-MODEL; MECHANISM; 3-MONOOXYGENASE	p-Hydroxyphenylacetate (HPA) 3-hydroxylase from Acinetobacter baumannii consists of a reductase component (C-1) and an oxygenase component (C-2). C-1 catalyzes the reduction of FMN by NADH to provide FMNH- as a substrate for C-2. The rate of reduction of flavin is enhanced similar to 20-fold by binding HPA. The N-terminal domain of C-1 is homologous to other flavin reductases, whereas the C-terminal domain (residues 192-315) is similar to MarR, a repressor protein involved in bacterial antibiotic resistance. In this study, three forms of truncated C-1 variants and single site mutation variants of residues Arg-21, Phe-216, Arg-217, Ile-246, and Arg-247 were constructed to investigate the role of the C-terminal domain in regulating C-1. In the absence of HPA, the C-1 variant in which residues 179-315 were removed (t178C(1)) was reduced by NADH and released FMNH- at the same rates as wild-type enzyme carries out these functions in the presence of HPA. In contrast, variants with residues 231-315 removed behaved similarly to the wild-type enzyme. Thus, residues 179-230 are involved in repressing the production of FMNH- in the absence of HPA. These results are consistent with the C-terminal domain in the wild-type enzyme being an autoinhibitory domain that upon binding the effector HPA undergoes conformational changes to allow faster flavin reduction and release. Most of the single site variants investigated had catalytic properties similar to those of the wild-type enzyme except for the F216A variant, which had a rate of reduction that was not stimulated by HPA. F216A could be involved with HPA binding or in the required conformational change for stimulation of flavin reduction by HPA.	[Phongsak, Thanawat; Oonanant, Worrapoj; Yuvaniyama, Jirundon; Svasti, Jisnuson; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Phongsak, Thanawat; Oonanant, Worrapoj; Yuvaniyama, Jirundon; Svasti, Jisnuson; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [Sucharitakul, Jeerus; Thotsaporn, Kittisak] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10300, Thailand; [Ballou, David P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Mahidol University; Mahidol University; Chulalongkorn University; University of Michigan System; University of Michigan	Chaiyen, P (corresponding author), Mahidol Univ, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	pimchai.cha@mahidol.ac.th	Svasti, Jisnuson/J-9262-2016; Chaiyen, Pimchai/R-5052-2019	Svasti, Jisnuson/0000-0002-2217-4517; Chaiyen, Pimchai/0000-0002-8533-1604; Yuvaniyama, Jirundon/0000-0002-6800-8944	Thailand Research Fund [BRG5480001, MRG5380240]; Faculty of Science, Mahidol University; Office of the Higher Education Commission, Thailand through the Strategic Scholarships Fellowships Frontier Research Networks Project	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Office of the Higher Education Commission, Thailand through the Strategic Scholarships Fellowships Frontier Research Networks Project	This work was supported in part by The Thailand Research Fund Grants BRG5480001 (to P. C.) and MRG5380240 (to J. S.) and a grant from the Faculty of Science, Mahidol University (to P. C.).; Supported by the Office of the Higher Education Commission, Thailand through the Strategic Scholarships Fellowships Frontier Research Networks Project.	Abdurachim K, 2006, J BACTERIOL, V188, P8153, DOI 10.1128/JB.00966-06; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P150; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P11795; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Chosrowjan H, 2009, J PHYS CHEM B, V113, P8439, DOI 10.1021/jp901136y; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; DUCH DS, 1971, ANAL BIOCHEM, V44, P42, DOI 10.1016/0003-2697(71)90343-5; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Feng CJ, 2009, DALTON T, P6692, DOI 10.1039/b902884f; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Gibello A, 1997, ARCH MICROBIOL, V167, P160, DOI 10.1007/s002030050429; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Laursen T, 2011, BBA-PROTEINS PROTEOM, V1814, P132, DOI 10.1016/j.bbapap.2010.07.003; Low JC, 2003, PHOTOCHEM PHOTOBIOL, V77, P446, DOI 10.1562/0031-8655(2003)077<0446:ETEFIV>2.0.CO;2; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Oonanant W, 2012, ACTA CRYSTALLOGR F, V68, P720, DOI 10.1107/S1744309112016909; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; Tu SC, 2008, PHOTOCH PHOTOBIO SCI, V7, P183, DOI 10.1039/b713462b; UETZ T, 1992, J BACTERIOL, V174, P1179, DOI 10.1128/jb.174.4.1179-1188.1992; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682; Zhang Y, 2011, ACTA CRYSTALLOGR F, V67, P1100, DOI 10.1107/S1744309111012541	47	20	22	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26213	26222		10.1074/jbc.M112.354472	http://dx.doi.org/10.1074/jbc.M112.354472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22661720	Green Published, hybrid			2022-12-28	WOS:000306916300048
J	Cyphert, HA; Ge, XM; Kohan, AB; Salati, LM; Zhang, YQ; Hillgartner, FB				Cyphert, Holly A.; Ge, Xuemei; Kohan, Alison B.; Salati, Lisa M.; Zhang, Yanqiao; Hillgartner, F. Bradley			Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY RAT HEPATOCYTES; GLUCAGON-LIKE PEPTIDE-1; BILE-ACID; NUCLEAR RECEPTOR; PPAR-ALPHA; GENE-EXPRESSION; HIGH-FAT; ENERGY-EXPENDITURE; METABOLIC STATE; GLUCOSE	Previous studies have shown that starvation or consumption of a high fat, low carbohydrate (HF-LC) ketogenic diet induces hepatic fibroblast growth factor 21 (FGF21) gene expression in part by activating the peroxisome proliferator-activated receptor-alpha (PPAR alpha). Using primary hepatocyte cultures to screen for endogenous signals that mediate the nutritional regulation of FGF21 expression, we identified two sources of PPAR alpha activators (i.e. nonesterified unsaturated fatty acids and chylomicron remnants) that induced FGF21 gene expression. In addition, we discovered that natural (i.e. bile acids) and synthetic (i.e. GW4064) activators of the farnesoid X receptor (FXR) increased FGF21 gene expression and secretion. The effects of bile acids were additive with the effects of nonesterified unsaturated fatty acids in regulating FGF21 expression. FXR activation of FGF21 gene transcription was mediated by an FXR/retinoid X receptor binding site in the 5'-flanking region of the FGF21 gene. FGF19, a gut hormone whose expression and secretion is induced by intestinal bile acids, also increased hepatic FGF21 secretion. Deletion of FXR in mice suppressed the ability of an HF-LC ketogenic diet to induce hepatic FGF21 gene expression. The results of this study identify FXR as a new signaling pathway activating FGF21 expression and provide evidence that FXR activators work in combination with PPAR alpha activators to mediate the stimulatory effect of an HF-LC ketogenic diet on FGF21 expression. We propose that the enhanced enterohepatic flux of bile acids during HF-LC consumption leads to activation of hepatic FXR and FGF19 signaling activity and an increase in FGF21 gene expression and secretion.	[Cyphert, Holly A.; Kohan, Alison B.; Salati, Lisa M.; Hillgartner, F. Bradley] W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Ge, Xuemei; Zhang, Yanqiao] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA	West Virginia University; Northeast Ohio Medical University (NEOMED)	Hillgartner, FB (corresponding author), W Virginia Univ, Dept Biochem, POB 9142, Morgantown, WV 26506 USA.	fbhillgartner@hsc.wvu.edu		Kohan, Alison/0000-0003-3127-7283	American Diabetes Association [1-12-BS-75]; United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative [2010-65206-20618]; National Institutes of Health [R01-HL103227, R01-DK46897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046897, R15DK088733] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Diabetes Association Basic Science Award 1-12-BS-75 (to F. B. H.) and United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative Competitive Grant 2010-65206-20618 (to F. B. H.). This work was also supported, in whole or in part, by National Institutes of Health Grants R01-HL103227 (to Y. Z.) and R01-DK46897 (to L. M. S.).	Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Bielohuby M, 2011, AM J PHYSIOL-ENDOC M, V300, pE65, DOI 10.1152/ajpendo.00478.2010; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Collier JJ, 2004, MOL ENDOCRINOL, V18, P1051, DOI 10.1210/me.2003-0357; Corring T, 1989, Nutr Res Rev, V2, P161, DOI 10.1079/NRR19890013; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; DUMASWALA R, 1994, AM J PHYSIOL-GASTR L, V267, pG836, DOI 10.1152/ajpgi.1994.267.5.G836; FLOREN CH, 1977, BIOCHEM BIOPH RES CO, V74, P520, DOI 10.1016/0006-291X(77)90335-7; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang XQ, 2006, MOL CARCINOGEN, V45, P934, DOI 10.1002/mc.20241; HYLEMON PB, 1985, J BIOL CHEM, V260, P1015; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ichihara A, 1980, Ann N Y Acad Sci, V349, P77, DOI 10.1111/j.1749-6632.1980.tb29517.x; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; JUSTE C, 1983, J NUTR, V113, P1691, DOI 10.1093/jn/113.9.1691; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kohan AB, 2011, J NUTR, V141, P171, DOI 10.3945/jn.110.129106; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Lu WJ, 2007, AM J PHYSIOL-GASTR L, V293, pG963, DOI 10.1152/ajpgi.00146.2007; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Miles JM, 2007, HORM METAB RES, V39, P726, DOI 10.1055/s-2007-990273; MOONEY RA, 1981, J BIOL CHEM, V256, P1724; Nakahara M, 2002, J BIOL CHEM, V277, P37229, DOI 10.1074/jbc.M206749200; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Oishi K, 2010, BIOCHEM BIOPH RES CO, V401, P313, DOI 10.1016/j.bbrc.2010.09.060; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; REDGRAVE T G, 1970, Journal of Clinical Investigation, V49, P465, DOI 10.1172/JCI106255; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stabile LP, 1998, J LIPID RES, V39, P1951; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; TSO P, 1995, AM J PHYSIOL-GASTR L, V268, pG568, DOI 10.1152/ajpgi.1995.268.4.G568; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	69	107	114	5	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25123	25138		10.1074/jbc.M112.375907	http://dx.doi.org/10.1074/jbc.M112.375907			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661717	Green Published, hybrid			2022-12-28	WOS:000306651700024
J	Bledzka, K; Liu, JM; Xu, Z; Perera, HD; Yadav, SP; Bialkowska, K; Qin, J; Ma, YQ; Plow, EF				Bledzka, Kamila; Liu, Jianmin; Xu, Zhen; Perera, H. Dhanuja; Yadav, Satya P.; Bialkowska, Katarzyna; Qin, Jun; Ma, Yan-Qing; Plow, Edward F.			Spatial Coordination of Kindlin-2 with Talin Head Domain in Interaction with Integrin beta Cytoplasmic Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; INSIDE-OUT; LEUKOCYTE ADHESION; POINT MUTATION; ACTIVATION; BINDING; ALPHA(IIB)BETA(3); PROTEIN; SUBUNIT; FILAMIN	Both talin head domain and kindlin-2 interact with integrin beta cytoplasmic tails, and they function in concert to induce integrin activation. Binding of talin head domain to beta cytoplasmic tails has been characterized extensively, but information on the interaction of kindin-2 with this integrin segment is limited. In this study, we systematically examine the interactions of kindlin-2 with integrin beta tails. Kindlin-2 interacted well with beta(1) and beta(3) tails but poorly with the beta(2) cytoplasmic tail. This binding selectivity was determined by the non-conserved residues, primarily the three amino acids at the extreme Cterminus of the beta(3) tail, and the sequence in beta(2) was non-permissive. The region at the C termini of integrin beta(1) and beta(3) tails recognized by kindlin-2 was a binding core of 12 amino acids. Kindlin-2 and talin head do not interact with one another but can bind simultaneously to the integrin beta(3) tail without enhancing or inhibiting the interaction of the other binding partner. Kindlin-2 itself failed to directly unclasp integrin alpha/beta tail complex, indicating that kindlin-2 must cooperate with talin to support the integrin activation mechanism.	[Xu, Zhen; Ma, Yan-Qing] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Bledzka, Kamila; Liu, Jianmin; Perera, H. Dhanuja; Bialkowska, Katarzyna; Qin, Jun; Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol NB 50, Cleveland, OH 44195 USA; [Yadav, Satya P.] Cleveland Clin, Res Core Serv, Dept Mol Biotechnol, Lerner Res Inst, Cleveland, OH 44195 USA	Versiti Blood Center of Wisconsin; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ma, YQ (corresponding author), Blood Ctr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	yanqing.ma@bcw.edu; plowe@ccf.org		Qin, Jun/0000-0002-2647-9270	National Institutes of Health from the NHLBI [P01HL073311, R01 HL096062]; American Heart Association [10SDG2610277, POST4310067]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL096062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL073311 and R01 HL096062 from the NHLBI. This work was also supported by Scientist Development Grant 10SDG2610277 and a postdoctoral fellowship (Great Rivers Affiliate POST4310067) from the American Heart Association.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dimitriou AA, 2009, PLATELETS, V20, P539, DOI 10.3109/09537100903324219; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hers I., 2000, ARTERIOSCLER THROMB, V20, P1651; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; HOYER D, 1993, TRENDS PHARMACOL SCI, V14, P270, DOI 10.1016/0165-6147(93)90129-8; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kodoyianni V, 2011, BIOTECHNIQUES, V50, P32, DOI 10.2144/000113569; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; PLOW EF, 2001, HEMOSTASIS THROMBOSI, P479; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vinogradova O, 2012, TOP CURR CHEM, V326, P35, DOI 10.1007/128_2011_216; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	57	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24585	24594		10.1074/jbc.M111.336743	http://dx.doi.org/10.1074/jbc.M111.336743			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648415	hybrid, Green Published			2022-12-28	WOS:000306651100051
J	Boeglin, WE; Brash, AR				Boeglin, William E.; Brash, Alan R.			Cytochrome P450-type Hydroxylation and Epoxidation in a Tyrosine-liganded Hemoprotein, Catalase-related Allene Oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID METABOLISM; LIPOXYGENASE FUSION PROTEIN; BIS-ALLYLIC HYDROXYLATION; RAT-LIVER MICROSOMES; FATTY-ACID; ELECTROPHILIC OXIDANT; THROMBOXANE SYNTHASE; QM/MM CALCULATIONS; EPOXY ALCOHOLS; P450	The ability of hemoproteins to catalyze epoxidation or hydroxylation reactions is usually associated with a cysteine as the proximal ligand to the heme, as in cytochrome P450 or nitric oxide synthase. Catalase-related allene oxide synthase (cAOS) from the coral Plexaura homomalla, like catalase itself, has tyrosine as the proximal heme ligand. Its natural reaction is to convert 8R-hydroperoxy-eicosatetraenoic acid (8R-HPETE) to an allene epoxide, a reaction activated by the ferric heme, forming product via the Fe-IV-OH intermediate, Compound II. Here we oxidized cAOS to Compound I (Fe-V=O) using the oxygen donor iodosylbenzene and investigated the catalytic competence of the enzyme. 8R-hydroxyeicosatetraenoic acid (8R-HETE), the hydroxy analog of the natural substrate, normally unreactive with cAOS, was thereby epoxidized stereospecifically on the 9,10 double bond to form 8R-hydroxy-9R, 10R-trans-epoxy-eicosa-5Z,11Z,14Z-trienoic acid as the predominant product; the turnover was 1/s using 100 mu M iodosylbenzene. The enantiomer, 8S-HETE, was epoxidized stereospecifically, although with less regiospecificity, and was hydroxylated on the 13- and 16-carbons. Arachidonic acid was converted to two major products, 8R-HETE and 8R,9S-eicosatrienoic acid (8R,9S-EET), plus other chiral monoepoxides and bis-allylic 10S-HETE. Linoleic acid was epoxidized, whereas stearic acid was not metabolized. We conclude that when cAOS is charged with an oxygen donor, it can act as a stereospecific monooxygenase. Our results indicate that in the tyrosine-liganded cAOS, a catalase-related hemoprotein in which a polyunsaturated fatty acid can enter the active site, the enzyme has the potential to mimic the activities of typical P450 epoxygenases and some capabilities of P450 hydroxylases.	[Brash, Alan R.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, RRB Room 510, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health [GM 074888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 074888 (to A. R. B.).	ADACHI S, 1993, BIOCHEMISTRY-US, V32, P241, DOI 10.1021/bi00052a031; Aldag C, 2009, P NATL ACAD SCI USA, V106, P5481, DOI 10.1073/pnas.0810503106; BERNART MW, 1994, PHYTOCHEMISTRY, V36, P1233, DOI 10.1016/S0031-9422(00)89643-0; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; BRASH AR, 1995, ARCH BIOCHEM BIOPHYS, V321, P485, DOI 10.1006/abbi.1995.1421; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; Cho KB, 2011, ARCH BIOCHEM BIOPHYS, V507, P14, DOI 10.1016/j.abb.2010.07.016; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Franke A, 2008, ANGEW CHEM INT EDIT, V47, P5238, DOI 10.1002/anie.200800907; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; GELB MH, 1982, P NATL ACAD SCI-BIOL, V79, P5758, DOI 10.1073/pnas.79.19.5758; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; Guengerich FP, 2007, J BIOCHEM MOL TOXIC, V21, P163, DOI 10.1002/jbt.20174; GUSTAFSSON JA, 1979, BIOCHEMISTRY-US, V18, P865, DOI 10.1021/bi00572a020; Hamberg M, 1997, ARCH BIOCHEM BIOPHYS, V344, P194, DOI 10.1006/abbi.1997.0194; HAMBERG M, 1986, BIOCHIM BIOPHYS ACTA, V879, P410, DOI 10.1016/0005-2760(86)90233-X; HECKER M, 1987, EUR J BIOCHEM, V169, P563, DOI 10.1111/j.1432-1033.1987.tb13646.x; Jiang YY, 2009, ANGEW CHEM INT EDIT, V48, P7193, DOI 10.1002/anie.200901485; Jin SX, 2004, J BIOL INORG CHEM, V9, P644, DOI 10.1007/s00775-004-0575-7; LICHTENBERGER F, 1976, BIOCHEM BIOPH RES CO, V70, P939, DOI 10.1016/0006-291X(76)90682-3; Luo G, 1998, ARCH BIOCHEM BIOPHYS, V357, P45, DOI 10.1006/abbi.1998.0806; MERCIER J, 1974, CHEM PHYS LIPIDS, V12, P239, DOI 10.1016/0009-3084(74)90078-4; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; OLIW EH, 1993, ARCH BIOCHEM BIOPHYS, V300, P434, DOI 10.1006/abbi.1993.1059; Ost TWB, 2000, FEBS LETT, V486, P173, DOI 10.1016/S0014-5793(00)02267-5; PEERS KE, 1983, CHEM PHYS LIPIDS, V32, P49, DOI 10.1016/0009-3084(83)90069-5; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; Rossiter B. E., 1979, TETRAHEDRON LETT, V20, P4733; Saltzman H., 1973, ORG SYNTH, P658; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; Ullrich V, 2003, ARCH BIOCHEM BIOPHYS, V409, P45, DOI 10.1016/S0003-9861(02)00410-1; Vaz ADN, 1998, P NATL ACAD SCI USA, V95, P3555, DOI 10.1073/pnas.95.7.3555; Watanabe Y, 2007, ACCOUNTS CHEM RES, V40, P554, DOI 10.1021/ar600046a; YAMAZAKI H, 1995, BIOCHEMISTRY-US, V34, P8380, DOI 10.1021/bi00026a020; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438	44	8	8	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24139	24147		10.1074/jbc.M112.364216	http://dx.doi.org/10.1074/jbc.M112.364216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22628547	Green Published, hybrid			2022-12-28	WOS:000306651100009
J	Yagi, H; Saito, T; Yanagisawa, M; Yu, RK; Kato, K				Yagi, Hirokazu; Saito, Takuya; Yanagisawa, Makoto; Yu, Robert K.; Kato, Koichi			Lewis X-carrying N-Glycans Regulate the Proliferation of Mouse Embryonic Neural Stem Cells via the Notch Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PROTEIN; ASTROCYTES; OLIGOSACCHARIDES; INVOLVEMENT; GENERATION; DIVISION; THERAPY; NEURONS	Neural stem cells (NSCs) possess high proliferative potential and the capacity for self-renewal with retention of multipotency to differentiate into brain-forming cells. Several signaling pathways have been shown to be involved in the fate determination process of NSCs, but the molecular mechanisms underlying the maintenance of neural cell stemness remain largely unknown. Our previous study showed that human natural killer carbohydrate epitopes expressed specifically by mouse NSCs modulate the Ras-MAPK pathway, raising the possibility of regulatory roles of glycoprotein glycans in the specific signaling pathways involved in NSC fate determination. To address this issue, we performed comparative N-glycosylation profiling of NSCs before and after differentiation in a comprehensive and quantitative manner. We found that Lewis X-carrying N-glycans were specifically displayed on undifferentiated cells, whereas paucimannose-type N-glycans were predominantly expressed on differentiated cells. Furthermore, by knocking down a fucosyltransferase 9 with short interfering RNA, we demonstrated that the Lewis X-carrying N-glycans were actively involved in the proliferation of NSCs via modulation of the expression level of Musashi-1, which is an activator of the Notch signaling pathway. Our findings suggest that Lewis X carbohydrates, which have so far been characterized as undifferentiation markers, actually operate as activators of the Notch signaling pathway for the maintenance of NSC stemness during brain development.	[Yanagisawa, Makoto; Yu, Robert K.] Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Yanagisawa, Makoto; Yu, Robert K.] Georgia Hlth Sci Univ, Med Coll Georgia, Inst Neurosci, Augusta, GA 30912 USA; [Yagi, Hirokazu; Saito, Takuya; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Yu, RK (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	ryu@georgiahealth.edu; kkatonmr@ims.ac.jp	Yagi, Hirokazu/ABH-6151-2020	Yagi, Hirokazu/0000-0001-9296-0225; Kato, Koichi/0000-0001-7187-9612	National Institutes of Health from USPHS [NS11853]; Naito Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [22790076, 23110002]; Japan-United States Brain Research Cooperative Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011853] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-United States Brain Research Cooperative Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS11853 (to R. Y.) from USPHS. This work was also supported by the Naito Foundation and Grants-in-aid for Young Scientists (B) 22790076 (to H. Y.) and Scientific Research on Innovative Areas (No. 23110002, Deciphering sugar chain-based signals regulating integrative neuronal functions) (to H. Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by the Japan-United States Brain Research Cooperative Program.	Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bithell A, 2005, CLIN SCI, V108, P13, DOI 10.1042/CS20040276; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chen J, 2008, STROKE, V39, P220, DOI 10.1161/STROKEAHA.107.490946; de Filippis L, 2011, HISTOL HISTOPATHOL, V26, P1093, DOI 10.14670/HH-26.1093; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; EGGENS I, 1989, J BIOL CHEM, V264, P9476; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garwood J, 1999, J NEUROSCI, V19, P3888; Hennen E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201095; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Klassen H, 2001, NEUROSCI LETT, V312, P180, DOI 10.1016/S0304-3940(01)02215-7; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Moriguchi K, 2007, J BIOCHEM, V142, P213, DOI 10.1093/jb/mvm128; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakatani Y, 2010, GLYCOBIOLOGY, V20, P78, DOI 10.1093/glycob/cwp149; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Sarafian V, 1998, INT J CANCER, V75, P105, DOI 10.1002/(SICI)1097-0215(19980105)75:1<105::AID-IJC16>3.3.CO;2-L; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shimoda Y, 2002, J BIOL CHEM, V277, P2033, DOI 10.1074/jbc.M108495200; STREIT A, 1990, J NEUROCHEM, V55, P1494, DOI 10.1111/j.1471-4159.1990.tb04931.x; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; Suzuki Y, 2010, J BIOL CHEM, V285, P18443, DOI 10.1074/jbc.M110.114645; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; Tomlinson J, 2000, INT J ONCOL, V16, P347; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; Yagi H, 2008, CARBOHYD RES, V343, P1373, DOI 10.1016/j.carres.2008.03.031; Yagi H, 2008, GLYCOBIOLOGY, V18, P145, DOI 10.1093/glycob/cwm128; Yagi H, 2010, J BIOL CHEM, V285, P37293, DOI 10.1074/jbc.M110.157081; Yagi H, 2010, GLYCOBIOLOGY, V20, P976, DOI 10.1093/glycob/cwq054; Yagi H, 2010, CARBOHYD RES, V345, P442, DOI 10.1016/j.carres.2009.12.002; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yanagisawa M, 1999, MOL BIOCHEM PARASIT, V102, P225, DOI 10.1016/S0166-6851(99)00102-4; Yanagisawa M, 2011, ASN NEURO, V3, DOI 10.1042/AN20110006; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhou ZD, 2010, IUBMB LIFE, V62, P618, DOI 10.1002/iub.362	51	43	48	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24356	24364		10.1074/jbc.M112.365643	http://dx.doi.org/10.1074/jbc.M112.365643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645129	Green Published, hybrid			2022-12-28	WOS:000306651100030
J	Diaz-Albiter, H; Sant'Anna, MRV; Genta, FA; Dillon, RJ				Diaz-Albiter, Hector; Sant'Anna, Mauricio R. V.; Genta, Fernando A.; Dillon, Rod J.			Reactive Oxygen Species-mediated Immunity against Leishmania mexicana and Serratia marcescens in the Phlebotomine Sand Fly Lutzomyia longipalpis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL LEISHMANIASIS; MIDGUT TRANSCRIPTOME; GENE-EXPRESSION; INFECTION; DIPTERA; PEROXIDOXIN; CHAGASI; VECTOR; VIRUS; FLIES	Phlebotomine sand flies are the vectors of medically important Leishmania. The Leishmania protozoa reside in the sand fly gut, but the nature of the immune response to the presence of Leishmania is unknown. Reactive oxygen species (ROS) are a major component of insect innate immune pathways regulating gut-microbe homeostasis. Here we show that the concentration of ROS increased in sand fly midguts after they fed on the insect pathogen Serratia marcescens but not after feeding on the Leishmania that uses the sand fly as a vector. Moreover, the Leishmania is sensitive to ROS either by oral administration of ROS to the infected fly or by silencing a gene that expresses a sand fly ROS-scavenging enzyme. Finally, the treatment of sand flies with an exogenous ROS scavenger (uric acid) altered the gut microbial homeostasis, led to an increased commensal gut microbiota, and reduced insect survival after oral infection with S. marcescens. Our study demonstrates a differential response of the sand fly ROS system to gut microbiota, an insect pathogen, and the Leishmania that utilize the sand fly as a vehicle for transmission between mammalian hosts.	[Sant'Anna, Mauricio R. V.; Dillon, Rod J.] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England; [Diaz-Albiter, Hector] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Genta, Fernando A.] Inst Oswaldo Cruz, Lab Insect Biochem & Physiol, BR-21040360 Rio De Janeiro, Brazil	Lancaster University; Liverpool School of Tropical Medicine; University of Liverpool; Fundacao Oswaldo Cruz	Dillon, RJ (corresponding author), Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England.	r.dillon@lancaster.ac.uk	Sant'Anna, Mauricio Roberto Via/AAQ-6084-2021; DIAZ-ALBITER, HECTOR/G-4327-2012; Sant'Anna, Mauricio Roberto Viana/AAQ-4093-2021; Genta, Fernando/F-1791-2011	Sant'Anna, Mauricio Roberto Viana/0000-0002-2504-0979; Genta, Fernando/0000-0001-9558-1116; Dillon, Rod/0000-0002-3551-0030; Diaz-Albiter, Hector/0000-0003-2937-0569	Consejo Nacional de Ciencia y Tecnologia Fellow [207646]; Leverhulme Trust [F/00 808/C]	Consejo Nacional de Ciencia y Tecnologia Fellow; Leverhulme Trust(Leverhulme Trust)	This work was supported by the Consejo Nacional de Ciencia y Tecnologia Fellow (Reference 207646) and the Leverhulme Trust (Reference F/00 808/C).	Acestor N, 2006, J INFECT DIS, V194, P1160, DOI 10.1086/507646; ALEXANDER B, 1995, AM J TROP MED HYG, V52, P354, DOI 10.4269/ajtmh.1995.52.354; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barr SD, 2001, J BIOL CHEM, V276, P34279, DOI 10.1074/jbc.M104406200; BATES PA, 1994, PARASITOLOGY, V108, P1, DOI 10.1017/S0031182000078458; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Charrel RN, 2005, EMERG INFECT DIS, V11, P1657, DOI 10.3201/eid1111.050869; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; COMER JA, 1990, AM J TROP MED HYG, V42, P483, DOI 10.4269/ajtmh.1990.42.483; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Dostalova A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-223; FREEMAN BA, 1982, LAB INVEST, V47, P412; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Goyal N, 1996, FREE RADICAL BIO MED, V21, P683, DOI 10.1016/0891-5849(96)00130-X; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Holzer TR, 2006, MOL BIOCHEM PARASIT, V146, P198, DOI 10.1016/j.molbiopara.2005.12.009; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; Maingon RDC, 2008, TRENDS PARASITOL, V24, P12, DOI 10.1016/j.pt.2007.10.003; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; McGonigle S, 1998, PARASITOL TODAY, V14, P139, DOI 10.1016/S0169-4758(97)01211-8; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; Modi G. B., 1997, The molecular biology of insect disease vectors: a methods manual., P21; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Munks RJL, 2005, INSECT MOL BIOL, V14, P483, DOI 10.1111/j.1365-2583.2005.00579.x; Myskova J, 2007, MICROBES INFECT, V9, P317, DOI 10.1016/j.micinf.2006.12.010; Costa CHN, 2008, CAD SAUDE PUBLICA, V24, P2959, DOI 10.1590/S0102-311X2008001200027; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Owusu-Ansah E., 2008, PROTOC EXCH, DOI [10.1038/nprot.2008.23, DOI 10.1038/NPROT.2008.23]; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; Ramalho-Ortigao M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-300; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Soares RPP, 2003, AN ACAD BRAS CIENC, V75, P301, DOI 10.1590/S0001-37652003000300005; Steenkamp DJ, 2002, ANTIOXID REDOX SIGN, V4, P105, DOI 10.1089/152308602753625906; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Volf P, 2011, J VECTOR ECOL, V36, pS1, DOI 10.1111/j.1948-7134.2011.00106.x; WHO, 2010, WHO TECH REP SER, V949, P1	48	65	70	1	41	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23995	24003		10.1074/jbc.M112.376095	http://dx.doi.org/10.1074/jbc.M112.376095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645126	Green Published, hybrid			2022-12-28	WOS:000306511300068
J	DiTacchio, L; Bowles, J; Shin, S; Lim, DS; Koopman, P; Janknecht, R				DiTacchio, Luciano; Bowles, Josephine; Shin, Sook; Lim, Dae-Sik; Koopman, Peter; Janknecht, Ralf			Transcription Factors ER71/ETV2 and SOX9 Participate in a Positive Feedback Loop in Fetal and Adult Mouse Testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS PROTEIN ER81; SRY-RELATED GENE; AUTOSOMAL SEX REVERSAL; P72 RNA HELICASE; CAMPOMELIC DYSPLASIA; CONCERTED ACTIVATION; FUNCTIONAL-ANALYSIS; ANDROGEN RECEPTOR; UP-REGULATION; COLON-CANCER	ER71, also known as ETV2, is an ETS transcription factor that is expressed during embryogenesis and in adult testes. We show that Er71 transcription can be up-regulated by SRY, the key determinant of male differentiation. Accordingly, SRY bound to and activated the Er71 promoter, and mutation of a putative SRY binding site abolished this promoter activation. In turn, ER71 was able to bind to the promoter of Sox9, the primary target of SRY and a critical transcription factor for maintenance of the Sertoli cell phenotype. Mutation of the ER71 binding site in the Sox9 promoter suppressed ER71-dependent up-regulation of Sox9 transcription, and a dominant-negative ER71 molecule severely reduced Sox9 transcription in a Sertoli cell line. Conversely, SOX9 bound the Er71 promoter in vivo and Sox9 down-regulation reduced Er71 transcript levels. Together, these data suggest a mechanism by which SRY induces Sox9 and Er71 transcription early in testis differentiation, whereas ER71 and SOX9 participate in an autoregulatory loop to sustain each other's expression after Sry expression has subsided in mice. Thereby, ER71 and SOX9 may affect late testis development as well as the function of the adult male gonad.	[Janknecht, Ralf] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [DiTacchio, Luciano] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Bowles, Josephine; Koopman, Peter] Univ Queensland, Brisbane, Qld 4072, Australia; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Taejon 305701, South Korea	University of Oklahoma System; University of Oklahoma Health Sciences Center; Salk Institute; University of Queensland; Korea Advanced Institute of Science & Technology (KAIST)	Janknecht, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St,BRC 1464, Oklahoma City, OK 73104 USA.	ralf-janknecht@ouhsc.edu	Lim, Dae-Sik/C-1599-2011; Bowles, Josephine/AAG-4903-2020; Koopman, Peter A/C-9416-2009; DiTacchio, Luciano/D-6341-2011; Bowles, Josephine/B-6583-2013	Lim, Dae-Sik/0000-0003-2356-7555; Bowles, Josephine/0000-0003-2867-7438; Koopman, Peter A/0000-0001-6939-0914; DiTacchio, Luciano/0000-0001-9570-7348; Bowles, Josephine/0000-0003-2867-7438; Janknecht, Ralf/0000-0003-1741-1562	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded in part by the National Health and Medical Research Council of Australia.	Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Assumpcao JG, 2005, J ENDOCRINOL INVEST, V28, P651, DOI 10.1007/BF03347266; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bowles J, 2009, DEV DYNAM, V238, P2073, DOI 10.1002/dvdy.22024; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; BUEHR M, 1993, METHOD ENZYMOL, V225, P58; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Haro L, 2005, GENOMICS, V85, P493, DOI 10.1016/j.ygeno.2004.12.003; De Haro L, 2002, NUCLEIC ACIDS RES, V30, P2972; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Desclozeaux M, 1998, BBA-GENE STRUCT EXPR, V1397, P247, DOI 10.1016/S0167-4781(98)00041-4; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hargrave Murray, 2006, Methods Mol Biol, V326, P103; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Holt JE, 2006, DEV BIOL, V293, P449, DOI 10.1016/j.ydbio.2006.02.012; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; Jeske YWA, 1996, MOL REPROD DEV, V44, P153, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;153::AID-MRD3&gt;3.0.CO;2-M; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; Kent J, 1996, DEVELOPMENT, V122, P2813; Kim J, 2010, BIOCHEM BIOPH RES CO, V401, P412, DOI 10.1016/j.bbrc.2010.09.068; Kim TD, 2008, BIOCHEM BIOPH RES CO, V366, P563, DOI 10.1016/j.bbrc.2007.12.013; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Monsees TK, 1997, ADV EXP MED BIOL, V424, P111; Mooney SM, 2010, J BIOL CHEM, V285, P30443, DOI 10.1074/jbc.M110.143792; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Papoutsopoulou S, 2000, MOL CELL BIOL, V20, P7300, DOI 10.1128/MCB.20.19.7300-7310.2000; Polanco JC, 2007, DEV BIOL, V302, P13, DOI 10.1016/j.ydbio.2006.08.049; Qin YJ, 2005, HUM MOL GENET, V14, P1221, DOI 10.1093/hmg/ddi133; Rossow KL, 2001, CANCER RES, V61, P2690; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Schafer AJ, 1996, ANN NY ACAD SCI, V785, P137, DOI 10.1111/j.1749-6632.1996.tb56252.x; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shin S, 2007, J CELL BIOCHEM, V101, P1252, DOI 10.1002/jcb.21250; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Shin S, 2008, J CELL BIOCHEM, V105, P866, DOI 10.1002/jcb.21884; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	73	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23657	23666		10.1074/jbc.M111.320101	http://dx.doi.org/10.1074/jbc.M111.320101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613723	hybrid, Green Published			2022-12-28	WOS:000306511300036
J	Donigan, KA; Sun, KW; Nemec, AA; Murphy, DL; Cong, XY; Northrup, V; Zelterman, D; Sweasy, JB				Donigan, Katherine A.; Sun, Ka-Wai; Nemec, Antonia A.; Murphy, Drew L.; Cong, Xiangyu; Northrup, Veronika; Zelterman, Daniel; Sweasy, Joann B.			Human POLB Gene Is Mutated in High Percentage of Colorectal Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; BASE-EXCISION-REPAIR; MISMATCH REPAIR; COLON-CANCER; PROMOTER HYPERMETHYLATION; CELLULAR-TRANSFORMATION; CATALYTIC MECHANISM; GASTRIC-CANCER; MUTATIONS; VARIANT	Previous small scale sequencing studies have indicated that DNA polymerase beta (pol beta) variants are present on average in 30% of human tumors of varying tissue origin. Many of these variants have been shown to have aberrant enzyme function in vitro and to induce cellular transformation and/or genomic instability in vivo, suggesting that their presence is associated with tumorigenesis or its progression. In this study, the human POLB gene was sequenced in a collection of 134 human colorectal tumors and was found to contain coding region mutations in 40% of the samples. The variants map to many different sites of the pol beta protein and are not clustered. Many variants are non-synonymous amino acid substitutions predicted to affect enzyme function. A subset of these variants was found to have reduced enzyme activity in vitro and failed to fully rescue pol beta-deficient cells from methylmethane sulfonate-induced cytotoxicity. Tumors harboring variants with reduced enzyme activity may have compromised base excision repair function, as evidenced by our methylmethane sulfonate sensitivity studies. Such compromised base excision repair may drive tumorigenesis by leading to an increase in mutagenesis or genomic instability.	[Donigan, Katherine A.; Sun, Ka-Wai; Nemec, Antonia A.; Murphy, Drew L.; Sweasy, Joann B.] Yale Univ, Dept Therapeut Radiol & Genet, Sch Med, New Haven, CT 06520 USA; [Cong, Xiangyu; Northrup, Veronika; Zelterman, Daniel] Yale Univ, Dept Epidemiol & Publ Hlth, Sch Med, New Haven, CT 06520 USA	Yale University; Yale University	Sweasy, JB (corresponding author), Yale Univ, Dept Therapeut Radiol, Hunter Radiat Therapy Ctr, POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu		Zelterman, Daniel/0000-0003-0711-8688	National Institutes of Health [CA120098, 5-U19-CA105010]; National Institutes of Health Predoctoral Genetics Training Grant [T32 GM007499]; NATIONAL CANCER INSTITUTE [R21CA120098, U19CA105010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Predoctoral Genetics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA120098 and 5-U19-CA105010 (to J.B.S.).; Supported by National Institutes of Health Predoctoral Genetics Training Grant T32 GM007499.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Bhattacharyya N, 1997, P NATL ACAD SCI USA, V94, P10324, DOI 10.1073/pnas.94.19.10324; Bhattacharyya N, 2001, LIFE SCI, V69, P271, DOI 10.1016/S0024-3205(01)01120-1; Bhattacharyya N, 2001, BIOCHEMISTRY-US, V40, P9005, DOI 10.1021/bi0028789; BORRESEN AL, 1995, HUM MOL GENET, V4, P2065, DOI 10.1093/hmg/4.11.2065; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Esteller M, 2001, CANCER RES, V61, P4689; Esteller M, 2000, CANCER RES, V60, P2368; Fink D, 1998, CLIN CANCER RES, V4, P1; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Ginty F, 2008, CLIN CANCER RES, V14, P3814, DOI 10.1158/1078-0432.CCR-08-0180; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Iwanaga A, 1999, MUTAT RES-DNA REPAIR, V435, P121, DOI 10.1016/S0921-8777(99)00036-1; Jiricny J, 2003, CURR OPIN GENET DEV, V13, P61, DOI 10.1016/S0959-437X(03)00004-2; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Kosa J. L., 1999, THESIS YALE U; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Lang TM, 2004, P NATL ACAD SCI USA, V101, P6074, DOI 10.1073/pnas.0308571101; Lefevre JH, 2010, FAM CANCER, V9, P589, DOI 10.1007/s10689-010-9367-0; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lynch HT, 1999, J MED GENET, V36, P801; Maitra M, 2002, J BIOL CHEM, V277, P35550, DOI 10.1074/jbc.M204953200; Meyers M, 2004, ENVIRON MOL MUTAGEN, V44, P249, DOI 10.1002/em.20056; Muniappan BP, 2002, CANCER RES, V62, P3271; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Murphy DL, 2011, J AM CHEM SOC, V133, P6279, DOI 10.1021/ja111099b; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nemec AA, 2012, J BIOL CHEM, V287, P23840, DOI 10.1074/jbc.M112.362111; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sarnowska E, 2007, NUCLEIC ACIDS RES, V35, P5499, DOI 10.1093/nar/gkm502; Shima K, 2011, CANCER CAUSE CONTROL, V22, P301, DOI 10.1007/s10552-010-9698-z; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1999, CARCINOGENESIS, V20, P1049, DOI 10.1093/carcin/20.6.1049; Starcevic D, 2004, CELL CYCLE, V3, P998; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; WANG LM, 1992, CANCER RES, V52, P4824; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; WIDEN SG, 1988, J BIOL CHEM, V263, P16992; Yamtich J, 2009, DNA REPAIR, V8, P579, DOI 10.1016/j.dnarep.2008.12.005	53	67	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23830	23839		10.1074/jbc.M111.324947	http://dx.doi.org/10.1074/jbc.M111.324947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22577134	Green Published, hybrid			2022-12-28	WOS:000306511300052
J	Linn, DE; Yang, X; Xie, YQ; Alfano, A; Deshmukh, D; Wang, X; Shimelis, H; Chen, HG; Li, W; Xu, KX; Chen, MY; Qiu, Y				Linn, Douglas E.; Yang, Xi; Xie, Yingqiu; Alfano, Alan; Deshmukh, Dhanraj; Wang, Xin; Shimelis, Hermela; Chen, Hegang; Li, Wei; Xu, Kexin; Chen, Mingyuan; Qiu, Yun			Differential Regulation of Androgen Receptor by PIM-1 Kinases via Phosphorylation-dependent Recruitment of Distinct Ubiquitin E3 Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; LIGAND-INDEPENDENT ACTIVATION; TYROSINE PHOSPHORYLATION; C-MYC; TRANSCRIPTIONAL ACTIVATION; SIGNALING PATHWAY; RESISTANT GROWTH; SPLICE VARIANT; PROTEIN; PROMOTES	Androgen receptor (AR) plays a pivotal role in prostate cancer. Regulation of AR transcriptional activity by post-translational modifications, such as phosphorylation by multiple kinases, is well documented. Here, we report that two PIM-1 kinase isoforms which are up-regulated during prostate cancer progression, namely PIM-1S and PIM-1L, modulate AR stability and transcriptional activity through differentially phosphorylating AR at serine 213 (Ser-213) and threonine 850 (Thr-850). Although both kinases are capable of interacting with and phosphorylating AR at Ser-213, only PIM-1L could phosphorylate Thr-850. We also showed that PIM-1S induced Ser-213 phosphorylation destabilizes AR by recruiting the ubiquitin E3 ligase Mdm2 and promotes AR degradation in a cell cycle-dependent manner, while PIM-1L-induced Thr-850 phosphorylation stabilizes AR by recruiting the ubiquitin E3 ligase RNF6 and promotes AR-mediated transcription under low-androgen conditions. Furthermore, both PIM-1 isoforms could promote prostate cancer cell growth under low-androgen conditions. Our data suggest that these kinases regulate AR stability and transcriptional activity through recruitment of different functional partners in a phosphorylation-dependent manner. As AR turnover has been previously shown to be critical for cell cycle progression in prostate cancer cells, PIM-1 kinase isoforms may promote prostate cancer cell growth, at least in part, through modulating AR activity via distinct mechanisms.	[Linn, Douglas E.; Yang, Xi; Xie, Yingqiu; Alfano, Alan; Deshmukh, Dhanraj; Wang, Xin; Shimelis, Hermela; Li, Wei; Xu, Kexin; Chen, Mingyuan; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Qiu, Y (corresponding author), Univ Maryland, Dept Pharmacol, Sch Med, 655 W Baltimore St,BRB Rm 4-002, Baltimore, MD 21202 USA.	yqiu@som.umaryland.edu	Deshmukh, Dhanraj/Y-5195-2019; Chen, Ming/GVU-8412-2022; Xie, Yingqiu/C-5346-2011	Shimelis, Hermela/0000-0003-1284-8909	National Institutes of Health [CA106504, W81XWH-08-1-0068, W81XWH-10-1-0492]; NATIONAL CANCER INSTITUTE [R01CA106504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (CA106504) (to Y. Q.) and pre-doctoral fellowships (W81XWH-08-1-0068) (to D. L.) and (W81XWH-10-1-0492) (to H. S.).	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; Cinar B, 2005, CANCER RES, V65, P2547, DOI 10.1158/0008-5472.CAN-04-3411; Culig Z, 2002, ENDOCR-RELAT CANCER, V9, P155, DOI 10.1677/erc.0.0090155; Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111; CUYPERS HT, 1984, CELL, V37, P141; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; FRIEDMANN M, 1992, ARCH BIOCHEM BIOPHYS, V298, P594, DOI 10.1016/0003-9861(92)90454-5; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 2001, CANCER RES, V61, P2892; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; Hong H, 2004, CANCER-AM CANCER SOC, V101, P83, DOI 10.1002/cncr.20327; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Kim O, 2004, ONCOGENE, V23, P1838, DOI 10.1038/sj.onc.1207304; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Kraus S, 2006, CANCER RES, V66, P11047, DOI 10.1158/0008-5472.CAN-06-0596; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Liang H, 1996, ARCH BIOCHEM BIOPHYS, V330, P259, DOI 10.1006/abbi.1996.0251; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Marcelli M, 1999, J CLIN ENDOCR METAB, V84, P3463, DOI 10.1210/jc.84.10.3463; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McPhaul MJ, 2003, J INVEST DERM SYMP P, V8, P1, DOI 10.1046/j.1523-1747.2003.12163.x; Milne D, 2004, FEBS LETT, V577, P270, DOI 10.1016/j.febslet.2004.09.081; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Taneja SS, 2005, J BIOL CHEM, V280, P40916, DOI 10.1074/jbc.M508442200; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Vander Griend DJ, 2007, CELL CYCLE, V6, P647; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Wang ZP, 2001, ARCH BIOCHEM BIOPHYS, V390, P9, DOI 10.1006/abbi.2001.2370; Wood NT, 2009, FEBS LETT, V583, P615, DOI 10.1016/j.febslet.2009.01.003; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Yang X, 2011, J BIOL CHEM, V286, P36152, DOI 10.1074/jbc.M111.265124; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	75	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22959	22968		10.1074/jbc.M111.338350	http://dx.doi.org/10.1074/jbc.M111.338350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584579	Green Published, hybrid			2022-12-28	WOS:000306495000053
J	Wang, JY; Papke, RL; Stokes, C; Horenstein, NA				Wang, Jingyi; Papke, Roger L.; Stokes, Clare; Horenstein, Nicole A.			Potential State-selective Hydrogen Bond Formation Can Modulate Activation and Desensitization of the alpha 7 Nicotinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIDBRAIN DOPAMINE AREAS; ALZHEIMERS-DISEASE; BINDING; AGONIST; SITE; SCHIZOPHRENIA; DIVERSITY; MECHANISM; PROTEIN; RAT	A series of arylidene anabaseines were synthesized to probe the functional impact of hydrogen bonding on human alpha 7 nicotinic acetylcholine receptor (nAChR) activation and desensitization. The aryl groups were either hydrogen bond acceptors (furans), donors (pyrroles), or neither (thiophenes). These compounds were tested against a series of point mutants of the ligand-binding domain residue Gln-57, a residue hypothesized to be proximate to the aryl group of the bound agonist and a putative hydrogen bonding partner. Q57K, Q57D, Q57E, and Q57L were chosen to remove the dual hydrogen bonding donor/acceptor ability of Gln-57 and replace it with hydrogen bond donating, hydrogen bond accepting, or nonhydrogen bonding ability. Activation of the receptor was compromised with hydrogen bonding mismatches, for example, pairing a pyrrole with Q57K or Q57L, or a furan anabaseine with Q57D or Q57E. Ligand co-applications with the positive allosteric modulator PNU-120596 produced significantly enhanced currents whose degree of enhancement was greater for 2-furans or -pyrroles than for their 3-substituted isomers, whereas the nonhydrogen bonding thiophenes failed to show this correlation. Interestingly, the PNU-120596 agonist co-application data revealed that for wild-type alpha 7 nAChR, the 3-furan desensitized state was relatively stabilized compared with that of 2-furan, a reversal of the relationship observed with respect to the barrier for entry into the desensitized state. These data highlight the importance of hydrogen bonding on the receptor-ligand state, and suggest that it may be possible to fine-tune features of agonists that mediate state selection in the nAChR.	[Wang, Jingyi; Horenstein, Nicole A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Papke, Roger L.; Stokes, Clare] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Horenstein, NA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	horen@chem.ufl.edu	wang, jing/GRS-7509-2022		National Institutes of Health Grant [R01 GM057481]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM057481 (to R. L. P.).	[Anonymous], 2008, AMBER 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Horenstein NA, 2008, MOL PHARMACOL, V74, P1496, DOI 10.1124/mol.108.048892; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kem WR, 2000, BEHAV BRAIN RES, V113, P169, DOI 10.1016/S0166-4328(00)00211-4; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Martin LF, 2007, INT REV NEUROBIOL, V78, P225, DOI 10.1016/S0074-7742(06)78008-4; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2011, J PHARMACOL EXP THER, V337, P367, DOI 10.1124/jpet.110.177485; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Puskar NL, 2011, J BIOL CHEM, V286, P14618, DOI 10.1074/jbc.M110.206565; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; Roncarati R, 2009, J PHARMACOL EXP THER, V329, P459, DOI 10.1124/jpet.108.150094; SEGUELA P, 1993, J NEUROSCI, V13, P596; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Terry AV, 2008, CURR NEUROPHARMACOL, V6, P286, DOI 10.2174/157015908785777247; Wang JY, 2010, MOL PHARMACOL, V78, P1012, DOI 10.1124/mol.110.066662; Wang JY, 2009, BIOORG MED CHEM LETT, V19, P474, DOI 10.1016/j.bmcl.2008.11.044; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; ZOLTEWICZ JA, 1993, HETEROCYCLES, V35, P171	32	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21957	21969		10.1074/jbc.M112.339796	http://dx.doi.org/10.1074/jbc.M112.339796			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556416	hybrid, Green Published			2022-12-28	WOS:000306418600035
J	Huo, YQ; Guo, X; Li, HG; Xu, H; Halim, V; Zhang, WY; Wang, H; Fan, YY; Ong, KT; Woo, SL; Chapkin, RS; Mashek, DG; Chen, YM; Dong, H; Lu, F; Wei, L; Wu, CD				Huo, Yuqing; Guo, Xin; Li, Honggui; Xu, Hang; Halim, Vera; Zhang, Weiyu; Wang, Huan; Fan, Yang-Yi; Ong, Kuok Teong; Woo, Shih-Lung; Chapkin, Robert S.; Mashek, Douglas G.; Chen, Yanming; Dong, Hui; Lu, Fuer; Wei, Lai; Wu, Chaodong			Targeted Overexpression of Inducible 6-Phosphofructo-2-kinase in Adipose Tissue Increases Fat Deposition but Protects against Diet-induced Insulin Resistance and Inflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; RECEPTOR-GAMMA ACTIVATION; HEPATIC STEATOSIS; LIVER-DISEASE; MICE; SENSITIVITY; OBESITY; HEPATOCYTES; GLUCOSE; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE	Increasing evidence demonstrates the dissociation of fat deposition, the inflammatory response, and insulin resistance in the development of obesity-related metabolic diseases. As a regulatory enzyme of glycolysis, inducible 6-phosphofructo-2-kinase (iPFK2, encoded by PFKFB3) protects against diet-induced adipose tissue inflammatory response and systemic insulin resistance independently of adiposity. Using aP2-PFKFB3 transgenic (Tg) mice, we explored the ability of targeted adipocyte PFKFB3/iPFK2 overexpression to modulate diet-induced inflammatory responses and insulin resistance arising from fat deposition in both adipose and liver tissues. Compared with wild-type littermates (controls) on a high fat diet (HFD), Tg mice exhibited increased adiposity, decreased adipose inflammatory response, and improved insulin sensitivity. In a parallel pattern, HFD-fed Tg mice showed increased hepatic steatosis, decreased liver inflammatory response, and improved liver insulin sensitivity compared with controls. In both adipose and liver tissues, increased fat deposition was associated with lipid profile alterations characterized by an increase in palmitoleate. Additionally, plasma lipid profiles also displayed an increase in palmitoleate in HFD-Tg mice compared with controls. In cultured 3T3-L1 adipocytes, overexpression of PFKFB3/iPFK2 recapitulated metabolic and inflammatory changes observed in adipose tissue of Tg mice. Upon treatment with conditioned medium from iPFK2-overexpressing adipocytes, mouse primary hepatocytes displayed metabolic and inflammatory responses that were similar to those observed in livers of Tg mice. Together, these data demonstrate a unique role for PFKFB3/iPFK2 in adipocytes with regard to diet-induced inflammatory responses in both adipose and liver tissues.	[Huo, Yuqing] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Guo, Xin; Li, Honggui; Xu, Hang; Halim, Vera; Fan, Yang-Yi; Woo, Shih-Lung; Chapkin, Robert S.; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, Intercollegiate Fac Nutr, College Stn, TX 77843 USA; [Zhang, Weiyu; Wang, Huan] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ong, Kuok Teong; Mashek, Douglas G.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA; [Chen, Yanming] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol, Guangzhou 510630, Guangdong, Peoples R China; [Dong, Hui; Lu, Fuer] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Integrated Chinese & Western Med, Wuhan 430030, Hubei, Peoples R China; [Wei, Lai] Peking Univ, Hlth Sci Ctr, Inst Hepatol, Beijing 100044, Peoples R China	University System of Georgia; Augusta University; Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Sun Yat Sen University; Huazhong University of Science & Technology; Peking University	Huo, YQ (corresponding author), Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA.	YHUO@georgiahealth.edu; cdwu@tamu.edu	Ong, Kuok Teong/H-8274-2015; Mashek, Douglas/ABD-6844-2021	Ong, Kuok Teong/0000-0001-8605-375X; Chapkin, Robert/0000-0002-6515-3898; Mashek, Douglas/0000-0001-7033-3386	National Institutes of Health [HL78679, HL080569]; American Diabetes Association [1-10-BS-76, 1-10-JF-54]; American Heart Association [12BGIA9050003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095556, R01HL080569, R21HL108922, R01HL078679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78679 and HL080569 (to Y. H.). This work was also supported by American Diabetes Association Grants 1-10-BS-76 (to Y. H.) and 1-10-JF-54 and American Heart Association Grant 12BGIA9050003 (to C. W.).	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; CHAPKIN RS, 1990, LIPIDS, V25, P827, DOI 10.1007/BF02535905; Clement S, 2008, HEPATOLOGY, V48, P799, DOI 10.1002/hep.22404; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Iozzo P, 2010, GASTROENTEROLOGY, V139, P846, DOI 10.1053/j.gastro.2010.05.039; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Liu XQ, 2010, ARTERIOSCL THROM VAS, V30, P31, DOI 10.1161/ATVBAHA.109.195636; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	37	41	41	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21492	21500		10.1074/jbc.M112.370379	http://dx.doi.org/10.1074/jbc.M112.370379			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556414	Green Published, hybrid			2022-12-28	WOS:000306416800066
J	Kelly, GM; Buckley, DA; Kiely, PA; Adams, DR; O'Connor, R				Kelly, Geraldine M.; Buckley, Deirdre A.; Kiely, Patrick A.; Adams, David R.; O'Connor, Rosemary			Serine Phosphorylation of the Insulin-like Growth Factor I (IGF-1) Receptor C-terminal Tail Restrains Kinase Activity and Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; CRYSTAL-STRUCTURE; TYROSINE KINASE; TUMOR-CELLS; TRANSFORMING ACTIVITIES; SUBSTRATE-SPECIFICITY; INTERACTING PROTEIN; CARBOXYL-TERMINUS; ACTIVATION-LOOP; AKT ACTIVATION	Insulin-like growth factor I receptor (IGF-1R) signaling is essential for cell, organ, and animal growth. The C-terminal tail of the IGF-1R exhibits regulatory function, but the mechanism is unknown. Here, we show that mutation of Ser-1248 (S1248A) enhances IGF-1R in vitro kinase activity, autophosphorylation, Akt/mammalian target of rapamycin activity, and cell growth. Ser-1248 phosphorylation is mediated by GSK-3 beta in a mechanism that involves a priming phosphorylation on Ser-1252. GSK-3 beta knock-out cells exhibit reduced IGF-1R cell surface expression, enhanced IGF-1R kinase activity, and signaling. Examination of crystallographic structures of the IGF-1R kinase domain revealed that the (SFYYS1252)-S-1248 motif adopts a conformation tightly packed against the kinase C-lobe when Ser-1248 is in the unphosphorylated state that favors kinase activity. S1248A mutation is predicted to lock the motif in this position. In contrast, phosphorylation of Ser-1248 will drive profound structural transition of the sequence, critically affecting connection of the C terminus as well as exposing potential protein docking sites. Decreased kinase activity of a phosphomimetic S1248E mutant and enhanced kinase activity in mutants of its predicted target residue Lys-1081 support this auto-inhibitory model. Thus, the SFYYS motif controls the organization of the IGF-1R C terminus relative to the kinase domain. Its phosphorylation by GSK-3 beta restrains kinase activity and regulates receptor trafficking and signaling.	[Kelly, Geraldine M.; Buckley, Deirdre A.; Kiely, Patrick A.; O'Connor, Rosemary] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cell Biol Lab, BioSci Inst, Cork, Ireland; [Adams, David R.] Heriot Watt Univ, Edinburgh EH14 4AS, Midlothian, Scotland	University College Cork; Heriot Watt University	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cell Biol Lab, BioSci Inst, Cork, Ireland.	r.oconnor@ucc.ie	O'Connor, Rosemary/B-7902-2014; Adams, David R/E-3916-2010	O'Connor, Rosemary/0000-0002-0687-3422; Adams, David R/0000-0002-7154-7332	Science Foundation Ireland; Health Research Board; Cancer Research Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Cancer Research Ireland	This work was supported by Science Foundation Ireland, The Health Research Board, and Cancer Research Ireland.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Baserga R, 2007, CELL CYCLE, V6, P814, DOI 10.4161/cc.6.7.4049; Blakesley VA, 1996, ENDOCRINOLOGY, V137, P410, DOI 10.1210/en.137.2.410; Blakesley VA, 1998, J BIOL CHEM, V273, P18411, DOI 10.1074/jbc.273.29.18411; Brodt P, 2001, J BIOL CHEM, V276, P33608, DOI 10.1074/jbc.M102754200; Chen H, 1998, CELL GROWTH DIFFER, V9, P939; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Craddock B. P., 2012, J SIGNAL T, P20121; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Du J, 2010, P NATL ACAD SCI USA, V107, P11573, DOI 10.1073/pnas.0913138107; Esposito DL, 1997, ENDOCRINOLOGY, V138, P2979, DOI 10.1210/en.138.7.2979; Farghaian H, 2011, J BIOL CHEM, V286, P25274, DOI 10.1074/jbc.M111.251629; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hongo A, 1996, ONCOGENE, V12, P1231; Hongo A, 1998, CANCER RES, V58, P2477; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Leahy M, 2004, J BIOL CHEM, V279, P18306, DOI 10.1074/jbc.M309234200; Li SL, 1998, FEBS LETT, V421, P45, DOI 10.1016/S0014-5793(97)01523-8; Li SW, 1996, J BIOL CHEM, V271, P12254, DOI 10.1074/jbc.271.21.12254; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu YM, 1998, CANCER RES, V58, P570; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Mayer SC, 2008, BIOORG MED CHEM LETT, V18, P3641, DOI 10.1016/j.bmcl.2008.04.044; Miller LM, 2009, BIOORG MED CHEM LETT, V19, P62, DOI 10.1016/j.bmcl.2008.11.037; Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415; Munshi S, 2002, J BIOL CHEM, V277, P38797, DOI 10.1074/jbc.M205580200; Nemecek C, 2010, CHEM BIOL DRUG DES, V76, P100, DOI 10.1111/j.1747-0285.2010.00991.x; Niu XL, 2002, J BIOL CHEM, V277, P31768, DOI 10.1074/jbc.M203995200; O'Connor R, 2003, HORM METAB RES, V35, P771; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Pautsch A, 2001, STRUCTURE, V9, P955, DOI 10.1016/S0969-2126(01)00655-4; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sampognaro AJ, 2010, BIOORG MED CHEM LETT, V20, P5027, DOI 10.1016/j.bmcl.2010.07.045; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; SURMACZ E, 1995, EXP CELL RES, V218, P370, DOI 10.1006/excr.1995.1168; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Velaparthi U, 2007, BIOORG MED CHEM LETT, V17, P2317, DOI 10.1016/j.bmcl.2007.01.102; VOSKAS D, 2010, BIOL REP, V2, P82; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Wu JH, 2008, EMBO J, V27, P1985, DOI 10.1038/emboj.2008.116; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006	59	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28180	28194		10.1074/jbc.M112.385757	http://dx.doi.org/10.1074/jbc.M112.385757			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22685298	Green Published, hybrid			2022-12-28	WOS:000307840700091
J	Chen, ZW; Friedland, GD; Pereira, JH; Reveco, SA; Chan, R; Park, JI; Thelen, MP; Adams, PD; Arkin, AP; Keasling, JD; Blanch, HW; Simmons, BA; Sale, KL; Chivian, D; Chhabra, SR				Chen, Zhiwei; Friedland, Gregory D.; Pereira, Jose H.; Reveco, Sonia A.; Chan, Rosa; Park, Joshua I.; Thelen, Michael P.; Adams, Paul D.; Arkin, Adam P.; Keasling, Jay D.; Blanch, Harvey W.; Simmons, Blake A.; Sale, Kenneth L.; Chivian, Dylan; Chhabra, Swapnil R.			Tracing Determinants of Dual Substrate Specificity in Glycoside Hydrolase Family 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM THERMOTOGA-MARITIMA; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; ENZYME PROMISCUITY; BETA-MANNANASE; SEQUENCE; GENE; ANNOTATION; CELLULASE; ALIGNMENT	Enzymes are traditionally viewed as having exquisite substrate specificity; however, recent evidence supports the notion that many enzymes have evolved activities against a range of substrates. The diversity of activities across glycoside hydrolase family 5(GH5) suggests that this family of enzymes may contain numerous members with activities on multiple substrates. In this study, we combined structure- and sequence-based phylogenetic analysis with biochemical characterization to survey the prevalence of dual specificity for glucan- and mannan-based substrates in the GH5 family. Examination of amino acid profile differences between the subfamilies led to the identification and subsequent experimental confirmation of an active site motif indicative of dual specificity. The motif enabled us to successfully discover several new dually specific members of GH5, and this pattern is present in over 70 other enzymes, strongly suggesting that dual endoglucanase-mannanase activity is widespread in this family. In addition, reinstatement of the conserved motif in a wild type member of GH5 enhanced its catalytic efficiency on glucan and mannan substrates by 175 and 1,600%, respectively. Phylogenetic examination of other GH families further indicates that the prevalence of enzyme multispecificity in GHs may be greater than has been experimentally characterized. Single domain multispecific GHs may be exploited for developing improved enzyme cocktails or facile engineering of microbial hosts for consolidated bioprocessing of lignocellulose.	[Chen, Zhiwei; Friedland, Gregory D.; Pereira, Jose H.; Reveco, Sonia A.; Park, Joshua I.; Thelen, Michael P.; Adams, Paul D.; Arkin, Adam P.; Keasling, Jay D.; Blanch, Harvey W.; Simmons, Blake A.; Sale, Kenneth L.; Chivian, Dylan; Chhabra, Swapnil R.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Chen, Zhiwei; Friedland, Gregory D.; Park, Joshua I.; Simmons, Blake A.; Sale, Kenneth L.] Sandia Natl Labs, Livermore, CA 94551 USA; [Pereira, Jose H.; Reveco, Sonia A.; Adams, Paul D.; Arkin, Adam P.; Keasling, Jay D.; Blanch, Harvey W.; Chhabra, Swapnil R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Chan, Rosa] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Adams, Paul D.; Arkin, Adam P.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.; Blanch, Harvey W.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Thelen, Michael P.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Chivian, D (corresponding author), Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.	dcchivian@lbl.gov; schhabra@intrexon.com	Arkin, Adam P/A-6751-2008; Adams, Paul David/A-1977-2013; Thelen, Michael P/G-2032-2014; Thelen, Michael/C-6834-2008; Simmons, Blake/N-6022-2016; Keasling, Jay D/J-9162-2012; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Adams, Paul David/0000-0001-9333-8219; Thelen, Michael P/0000-0002-2479-5480; Thelen, Michael/0000-0002-2479-5480; Simmons, Blake/0000-0002-1332-1810; Keasling, Jay D/0000-0003-4170-6088; Arkin, Adam/0000-0002-4999-2931; Chivian, Dylan/0000-0001-8189-8729	Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bourgault R, 2005, PROTEIN SCI, V14, P1233, DOI 10.1110/ps.041260905; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elifantz H, 2008, FEMS MICROBIOL ECOL, V63, P316, DOI 10.1111/j.1574-6941.2007.00429.x; FOONG F, 1991, J GEN MICROBIOL, V137, P1729, DOI 10.1099/00221287-137-7-1729; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plewczynski Dariusz, 2002, Appl Bioinformatics, V1, P223; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reitinger S, 2010, BIOCHEMISTRY-US, V49, P2464, DOI 10.1021/bi100036f; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Stebbings LA, 2004, NUCLEIC ACIDS RES, V32, pD203, DOI 10.1093/nar/gkh027; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Tyler L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-600; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Wang YG, 2010, J MOL CATAL B-ENZYM, V66, P294, DOI 10.1016/j.molcatb.2010.06.006; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; WHITEHEAD TR, 1993, CURR MICROBIOL, V27, P27, DOI 10.1007/BF01576830; Wu TH, 2011, BBA-PROTEINS PROTEOM, V1814, P1832, DOI 10.1016/j.bbapap.2011.07.020; Xiao ZZ, 2005, ANAL BIOCHEM, V342, P176, DOI 10.1016/j.ab.2005.01.052; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	45	33	36	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25335	25343		10.1074/jbc.M112.362640	http://dx.doi.org/10.1074/jbc.M112.362640			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22645145	hybrid, Green Published			2022-12-28	WOS:000306651700041
J	Lim, JC; Gruschus, JM; Ghesquiere, B; Kim, G; Piszczek, G; Tjandra, N; Levine, RL				Lim, Jung Chae; Gruschus, James M.; Ghesquiere, Bart; Kim, Geumsoo; Piszczek, Grzegorz; Tjandra, Nico; Levine, Rodney L.			Characterization and Solution Structure of Mouse Myristoylated Methionine Sulfoxide Reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN	Methionine sulfoxide reductase A is an essential enzyme in the antioxidant system which scavenges reactive oxygen species through cyclic oxidation and reduction of methionine and methionine sulfoxide. The cytosolic form of the enzyme is myristoylated, but it is not known to translocate to membranes, and the function of myristoylation is not established. We compared the biochemical and biophysical properties of myristoylated and nonmyristoylated mouse methionine sulfoxide reductase A. These were almost identical for both forms of the enzyme, except that the myristoylated form reduced methionine sulfoxide in protein much faster than the nonmyristoylated form. We determined the solution structure of the myristoylated protein and found that the myristoyl group lies in a relatively surface exposed "myristoyl nest." We propose that this structure functions to enhance protein-protein interaction.	[Lim, Jung Chae; Ghesquiere, Bart; Kim, Geumsoo; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Gruschus, James M.; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Ghesquiere, Bart] NHLBI, Biophys Core Facil, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Piszczek, Grzegorz] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ghent University; Flanders Institute for Biotechnology (VIB)	Levine, RL (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 50,Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov	Piszczek, Grzegorz/GYU-2029-2022; Ghesquiere, Bart/HGU-8736-2022; Levine, Rodney L/D-9885-2011	Ghesquiere, Bart/0000-0003-1547-1705; 	Intramural Research Program of the National Institutes of Health through the NHLBI; fellowship from the Fund for Scientific Research, Flanders; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338, ZIAHL001048, ZIAHL000225] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health through the NHLBI; fellowship from the Fund for Scientific Research, Flanders; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health through the NHLBI. This work was also supported by a fellowship from the Fund for Scientific Research, Flanders (to B. G.).	Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Amor JC, 2001, J BIOL CHEM, V276, P42477, DOI 10.1074/jbc.M106660200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cole NB, 2010, EXP GERONTOL, V45, P596, DOI 10.1016/j.exger.2010.01.016; Folmer RHA, 1997, J BIOMOL NMR, V9, P245, DOI 10.1023/A:1018670623695; Gaffarogullari EC, 2011, J MOL BIOL, V411, P823, DOI 10.1016/j.jmb.2011.06.034; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Losonczi JA, 1998, BIOCHEMISTRY-US, V37, P706, DOI 10.1021/bi9717791; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Morgan CR, 2011, BIOCHEMISTRY-US, V50, P3394, DOI 10.1021/bi200197e; Pankhurst G, 2003, J LIPID RES, V44, P349, DOI 10.1194/jlr.M200256-JLR200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stadtman E. R., 2006, REDOX PROTEOMICS PRO, P3; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zhao H, 2011, AM J PHYSIOL-HEART C, V301, pH1513, DOI 10.1152/ajpheart.00441.2011; Zhao H, 2010, FREE RADICAL BIO MED, V49, P641, DOI 10.1016/j.freeradbiomed.2010.05.017; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	29	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25589	25595		10.1074/jbc.M112.368936	http://dx.doi.org/10.1074/jbc.M112.368936			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661718	hybrid, Green Published			2022-12-28	WOS:000306651700066
J	Zhou, L; Wang, LJ; Lu, LN; Jiang, PY; Sun, H; Wang, HT				Zhou, Liang; Wang, Lijun; Lu, Leina; Jiang, Peiyong; Sun, Hao; Wang, Huating			A Novel Target of MicroRNA-29, Ring1 and YY1-binding Protein (Rybp), Negatively Regulates Skeletal Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; POLYCOMB; YY1; COMPLEXES; MUSCLE; DOMAIN; DIFFERENTIATION; COMPONENTS; MECHANISM	Skeletal muscle cell differentiation (myogenesis) is a process orchestrated by a complex network involving transcription factors, epigenetic regulators, and microRNAs. Previous studies identified miR-29 as a pro-myogenic factor that interacts with components of Polycomb repressive complex, YY1 and Ezh2. In a genome-wide survey of miR-29-mediated transcriptome changes in C2C12 myoblasts, many epigenetic factors were found to be down-regulated by miR-29. Among them, Rybp was shown to be a direct target of miR-29 through binding to its 3' UTR. Functional studies demonstrated that Rybp is down-regulated during myogenesis and acts as a negative regulator of skeletal myogenesis both in vitro during C2C12 differentiation and in vivo in injury-induced muscle regeneration. Furthermore, we found that Rybp and YY1 co-occupy several myogenic loci, including miR-29 itself, to silence their expression, thus forming a Rybp-miR-29 feedback loop. Rybp overexpression was found to enhance the enrichment of Ezh2 and trimethylation of H3K27 at target loci, suggesting it may facilitate the recruitment or stabilization of the Polycomb repressive complex. Collectively, our results identify Rybp as a novel regulator of myogenesis that co-acts with YY1 to silence miR-29 and other myogenic loci.	[Zhou, Liang; Wang, Lijun; Lu, Leina; Jiang, Peiyong; Sun, Hao; Wang, Huating] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Zhou, Liang; Wang, Lijun; Wang, Huating] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Lu, Leina; Jiang, Peiyong; Sun, Hao] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Sun, H (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci 306G, Shatin, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk; huating.wang@cuhk.edu.hk	Zhou, Liang/P-4174-2015; Sun, Hao/T-5576-2019; Wang, Huating/C-6719-2014; Sun, Hao/J-9964-2013; JIANG, Peiyong/AAZ-9898-2020; sun, hao/GRS-7732-2022	Zhou, Liang/0000-0001-5973-7873; Sun, Hao/0000-0002-5547-9501; Wang, Huating/0000-0001-5474-2905; Sun, Hao/0000-0002-5547-9501; Jiang, Peiyong/0000-0003-4523-3476	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China; Chinese University of Hong Kong (CUHK) [476309, 476310, 473211]; CUHK Grants [2041492, 2041662, 2041474]	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); CUHK Grants	The work was supported by General Research Funds from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China, Chinese University of Hong Kong (CUHK) 476309 and 476310 (to H.W.) and 473211 (to H.S.), CUHK Grants 2041492 and 2041662 (to H.W.), and CUHK Grant 2041474 (to H.S.).	Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Danen-van Oorschot AAAM, 2004, CELL DEATH DIFFER, V11, P564, DOI 10.1038/sj.cdd.4401391; Diao YR, 2009, MOL CELL BIOL, V29, P5084, DOI 10.1128/MCB.00267-09; Enright AJ, 2004, GENOME BIOL, V5; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wang H, 2009, CELL CYCLE, V8, P1833, DOI 10.4161/cc.8.12.8851; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35; Wilkinson F, 2010, J CELL BIOCHEM, V109, P478, DOI 10.1002/jcb.22424; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033766	35	76	82	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25255	25265		10.1074/jbc.M112.357053	http://dx.doi.org/10.1074/jbc.M112.357053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661705	hybrid, Green Published			2022-12-28	WOS:000306651700034
J	Chami, L; Buggia-Prevot, V; Duplan, E; Delprete, D; Chami, M; Peyron, JF; Checler, F				Chami, Linda; Buggia-Prevot, Virginie; Duplan, Eric; Delprete, Dolores; Chami, Mounia; Peyron, Jean-Francois; Checler, Frederic			Nuclear Factor-kappa B Regulates beta APP and beta- and gamma-Secretases Differently at Physiological and Supraphysiological A beta Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PRESENILIN-1 EXPRESSION; CELL BIOLOGY; IN-VITRO; P53; INHIBITION; ACTIVATION; PROMOTER; DEATH	Anatomical lesions in Alzheimer disease-affected brains mainly consist of senile plaques, inflammation stigmata, and oxidative stress. The nuclear factor-kappa B (NF-kappa B) is a stress-activated transcription factor that is activated around senile plaques. We have assessed whether NF-kappa B could be differentially regulated at physiological or supraphysiological levels of amyloid beta (A beta) peptides. Under these experimental conditions, we delineated the putative NF-kappa B-dependent modulation of all cellular participants in A beta production, namely its precursor beta APP (beta-amyloid precursor protein) and the beta- and gamma-secretases, the two enzymatic machines involved in A beta genesis. Under physiological conditions, NF-kappa B lowers the transcriptional activity of the promoters of beta APP, beta-secretase (beta-site APP-cleaving enzyme 1, BACE1), and of the four protein components (Aph-1, Pen-2, nicastrin, presenilin-1, or presenilin-2) of the gamma-secretase in HEK293 cells. This was accompanied by a reduction of both protein levels and enzymatic activities, thereby ultimately yielding lower amounts of A beta and AICD (APP intracellular domain). In stably transfected Swedish beta APP-expressing HEK293 cells triggering supraphysiological concentrations of A beta peptides, NF-kappa B activates the transcription of beta APP, BACE1, and some of the gamma-secretase members and increases protein expression and enzymatic activities, resulting in enhanced A beta production. Our pharmacological approach using distinct NF-kappa B kinase modulators indicates that both NF-kappa B canonical and alternative pathways are involved in the control of A beta production. Overall, our data demonstrate that under physiological conditions, NF-kappa B triggers a repressive effect on A beta production that contributes to maintaining its homeostasis, while NF-kappa B participates in a degenerative cycle where A beta would feed its own production under pathological conditions.	[Chami, Linda; Buggia-Prevot, Virginie; Duplan, Eric; Delprete, Dolores; Chami, Mounia; Checler, Frederic] CNRS UNSA, Equipe Labellisee Fdn Rech Med & Excellence Lab D, Inst Pharmacol Mol & Cellulaire, UMR7275, F-06560 Valbonne, France; [Peyron, Jean-Francois] INSERM, Ctr Mediterraneen Med Mol, UMR UNS U895, F-06204 Nice 3, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm)	Checler, F (corresponding author), CNRS UNSA, Equipe Labellisee Fdn Rech Med & Excellence Lab D, Inst Pharmacol Mol & Cellulaire, UMR7275, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Peyron, Jean-Francois/M-5682-2016; Duplan, Eric/AAK-8224-2020; Chami, Mounia/S-6471-2019; Jean-Francois, Peyron/AAA-9496-2022; Checler, Frederic/C-1241-2009	Peyron, Jean-Francois/0000-0001-6113-916X; Duplan, Eric/0000-0002-1348-1507; Chami, Mounia/0000-0003-1498-7187; Jean-Francois, Peyron/0000-0001-6113-916X; Checler, Frederic/0000-0003-2098-1750; Gary-Chami, Linda/0000-0001-9607-2807	Fondation pour la Recherche Medicale (FRM); Conseil General des Alpes Maritimes; Ministere de l'enseignement superieur et de la Recherche; LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer disease)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Ministere de l'enseignement superieur et de la Recherche; LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer disease)	This work was supported by the Fondation pour la Recherche Medicale (FRM), by the Conseil General des Alpes Maritimes, and by the Ministere de l'enseignement superieur et de la Recherche. This work has been developed and supported through the LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer disease).	Ait-Ghezala G, 2007, EUR J NEUROSCI, V25, P1685, DOI 10.1111/j.1460-9568.2007.05424.x; Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Araki W, 2000, ANN NY ACAD SCI, V920, P241; Arevalo MA, 2009, J NEUROCHEM, V111, P1425, DOI 10.1111/j.1471-4159.2009.06412.x; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Checler F, 2010, NEURODEGENER DIS, V7, P50, DOI 10.1159/000283483; Chen CH, 2011, INT J NEUROPSYCHOPH, V18, P1, DOI DOI 10.1017/S1461145711000149; Chevallier N, 1997, BRIT J PHARMACOL, V121, P556, DOI 10.1038/sj.bjp.0701151; Choi DY, 2012, NEUROCHEM INT, V60, P68, DOI 10.1016/j.neuint.2011.11.005; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Dunys J, 2009, J CELL SCI, V122, P4003, DOI 10.1242/jcs.051169; GRILLI M, 1995, J BIOL CHEM, V270, P26774, DOI 10.1074/jbc.270.45.26774; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Guglielmotto M., 2010, NEUROBIOL AGING, V33, P113; Guglielmotto M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.003.2010; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Heber S, 2000, J NEUROSCI, V20, P7951; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; Lee JW, 2009, J NUTR, V139, P1987, DOI 10.3945/jn.109.109785; Lee YJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-132; Lefranc-Jullien S, 2005, BRIT J PHARMACOL, V145, P228, DOI 10.1038/sj.bjp.0706183; Martin AG, 2010, CELL CYCLE, V9, P3131, DOI 10.4161/cc.9.16.12780; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pandey NR, 2009, NEUROSCIENCE, V164, P1744, DOI 10.1016/j.neuroscience.2009.09.062; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Paris D, 2011, BIOINFORMATION, V6, P229, DOI 10.6026/97320630006229; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Pastorcic M, 2000, J BIOL CHEM, V275, P34938, DOI 10.1074/jbc.M005411200; Pennypacker KR, 1998, MOL BRAIN RES, V56, P57, DOI 10.1016/S0169-328X(98)00028-X; Roperch JP, 1998, NAT MED, V4, P835, DOI 10.1038/nm0798-835; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Sevalle J, 2009, J NEUROCHEM, V110, P275, DOI 10.1111/j.1471-4159.2009.06131.x; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Sun X., 2012, J NEUROCHEM S1, P62; Sun X., 2012, J NEUROCHEM S1, P120; Sung S, 2004, AM J PATHOL, V165, P2197, DOI 10.1016/S0002-9440(10)63269-5; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tamagno E., 2011, NEUROTOX RE IN PRESS; Terai K, 1996, BRAIN RES, V735, P159; TERRY RD, 1980, ANNU REV NEUROSCI, V3, P77, DOI 10.1146/annurev.ne.03.030180.000453; Tomita S, 2000, J BIOL CHEM, V275, P13056, DOI 10.1074/jbc.C000019200; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; WU HY, 1994, J BIOL CHEM, V269, P20067	64	96	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24573	24584		10.1074/jbc.M111.333054	http://dx.doi.org/10.1074/jbc.M111.333054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22654105	Green Published, hybrid			2022-12-28	WOS:000306651100050
J	Miralem, T; Lerner-Marmarosh, N; Gibbs, PEM; Tudor, C; Hagen, FK; Maines, MD				Miralem, Tihomir; Lerner-Marmarosh, Nicole; Gibbs, Peter E. M.; Tudor, Cicerone; Hagen, Fred K.; Maines, Mahin D.			The Human Biliverdin Reductase-based Peptide Fragments and Biliverdin Regulate Protein Kinase C delta Activity THE PEPTIDES ARE INHIBITORS OR SUBSTRATE FOR THE PROTEIN KINASE C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PKC-DELTA; HEME OXYGENASE-1; OXIDATIVE STRESS; TYROSINE KINASE; ACTIVATION MECHANISMS; GOODPASTURE ANTIGEN; SIGNALING PATHWAYS; STRUCTURAL BASIS; BINDING PROTEIN	PKC delta, a Ser/Thr kinase, promotes cell growth, tumorigenesis, and apoptosis. Human biliverdin reductase (hBVR), a Ser/Thr/Tyr kinase, inhibits apoptosis by reducing biliverdin-IX to antioxidant bilirubin. The enzymes are activated by similar stimuli. Reportedly, hBVR is a kinase-independent activator of PKC delta and is transactivated by the PKC (Gibbs, P. E., Miralem, T., Lerner-Marmarosh, N., Tudor, C., and Maines, M. D. (2012) J. Biol. Chem. 287, 1066-1079). Presently, we examined interactions between the two proteins in the context of regulation of their activities and defining targets of hBVR phosphorylation by PKC delta. LC-MS/MS analysis of PKC delta-activated intact hBVR identified phosphorylated serine positions 21, 33, 230, and 237, corresponding to the hBVR Src homology-2 domain motif (Ser(230) and Ser(237)), flanking the ATP-binding motif (Ser(21)) and in PHPS sequence (Ser(33)) as targets of PKC delta. Ser(21) and Ser(230) were also phosphorylated in hBVR-based peptides. The Ser(230)-containing peptide was a high affinity substrate for PKC delta in vitro and in cells; the relative affinity was PKC delta > PKC beta II > PKC zeta. Two overlapping peptides spanning this substrate, KRNRYLSF and SFHFKSGSL, were effective inhibitors of PKC delta kinase activity and PKC delta-supported activation of transcription factors Elk1 and NF-kappa B. Only SFHFKSGSL, in PKC delta-transfected phorbol 12-myristate 13-acetate-stimulated cells, caused membrane blebbing and cell loss. Biliverdin noncovalently inhibited PKC delta, whereas PKC delta potentiated hBVR reductase activity and accelerated the rate of bilirubin formation. This study, together with previous findings, reveals an unexpected regulatory interplay between PKC delta and hBVR in modulating cell death/survival in response to various activating stimuli. In addition, this study has identified novel substrates for and inhibitors of PKC delta. We suggest that hBVR-based technology may have utility to modulate PKC delta-mediated functions in the cell.	[Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Tudor, Cicerone] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Hagen, Fred K.] Univ Rochester, Sch Med & Dent, Rochester Prote Ctr, Rochester, NY 14642 USA	University of Rochester; Max Planck Society; University of Rochester	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu	Miralem, Tihomir/F-7576-2013	Miralem, Tihomir/0000-0001-7705-0442	National Institutes of Health [ES04066, ES12187]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012187, R01ES004066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health cifically PKC beta II and PKC delta, the conventional and atypical Grants ES04066 and ES12187.	Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Brandt S, 2009, CELL MOTIL CYTOSKEL, V66, P874, DOI 10.1002/cm.20373; Clark AS, 2003, CANCER RES, V63, P780; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Ding B, 2011, FASEB J, V25, P301, DOI 10.1096/fj.10-166454; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; EWING JF, 1991, P NATL ACAD SCI USA, V88, P5364, DOI 10.1073/pnas.88.12.5364; Fukunaga M, 2001, BIOCHEM BIOPH RES CO, V289, P573, DOI 10.1006/bbrc.2001.6025; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Gibbs PEM, 2012, J BIOL CHEM, V287, P1066, DOI 10.1074/jbc.M111.279612; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gschwendt M, 1999, EUR J BIOCHEM, V259, P555, DOI 10.1046/j.1432-1327.1999.00120.x; Hampton MB, 1998, TOXICOL LETT, V103, P355, DOI 10.1016/S0378-4274(98)00333-6; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANNUN YA, 1990, J BIOL CHEM, V265, P2962; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Immenschuh S, 2005, CELL MOL BIOL, V51, P471, DOI 10.1170/T652; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kabu K, 2006, J IMMUNOL, V177, P1296, DOI 10.4049/jimmunol.177.2.1296; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Kim YK, 2006, BIOCHEM BIOPH RES CO, V347, P1088, DOI 10.1016/j.bbrc.2006.06.196; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Kumar S, 2001, J BIOL CHEM, V276, P17281, DOI 10.1074/jbc.M101414200; Kwon MJ, 2007, MOL IMMUNOL, V44, P2841, DOI 10.1016/j.molimm.2007.01.035; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maines MD, 2007, ANTIOXID REDOX SIGN, V9, P2187, DOI 10.1089/ars.2007.1805; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; MAINES MD, 1993, ARCH BIOCHEM BIOPHYS, V300, P320, DOI 10.1006/abbi.1993.1044; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Majewski M, 2007, INT IMMUNOL, V19, P719, DOI 10.1093/intimm/dxm034; Mancuso C, 2006, REDOX REP, V11, P207, DOI 10.1179/135100006X154978; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; McCracken MA, 2003, MOL CANCER THER, V2, P273; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Miralem T, 2010, J BIOL CHEM, V285, P12551, DOI 10.1074/jbc.M109.032771; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Ryer EJ, 2005, J BIOL CHEM, V280, P35310, DOI 10.1074/jbc.M507187200; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Shindo M, 2001, BIOORGAN MED CHEM, V9, P2073, DOI 10.1016/S0968-0896(01)00100-6; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; Stempka L, 1997, J BIOL CHEM, V272, P6805, DOI 10.1074/jbc.272.10.6805; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wegiel B, 2009, J BIOL CHEM, V284, P21369, DOI 10.1074/jbc.M109.027433; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Zhao J, 1998, J BIOL CHEM, V273, P23072, DOI 10.1074/jbc.273.36.23072	81	17	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24698	24712		10.1074/jbc.M111.326504	http://dx.doi.org/10.1074/jbc.M111.326504			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22584576	Green Published, hybrid			2022-12-28	WOS:000306651100063
J	Robbins, GR; Truax, AD; Davis, BK; Zhang, L; Brickey, WJ; Ting, JPY				Robbins, Gregory R.; Truax, Agnieszka D.; Davis, Beckley K.; Zhang, Lu; Brickey, W. June; Ting, Jenny P. -Y.			Regulation of Class I Major Histocompatibility Complex (MHC) by Nucleotide-binding Domain, Leucine-rich Repeat-containing (NLR) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER NLRC5; NF-KAPPA-B; GTP-BINDING; ATP BINDING; TRANSACTIVATOR; EXPRESSION; CIITA; DEFICIENCY; ACTIVATION; INDUCTION	Most of the nucleotide-binding domain, leucine-rich repeat (NLR) proteins regulate responses to microbial and damage-associated products. Class II transactivator (CIITA) has a distinct function as the master regulator of class II major histocompatibility complex (MHC-II) transcription. Recently, human NLRC5 was found to regulate MHC-I in cell lines; however, a host of conflicting positive and negative functions has been attributed to this protein. To address the function of NLRC5 in a physiologic setting, we generated an Nlrc5(-/-) strain that contains a deletion in the exon that encodes the nucleotide-binding domain. We have not detected a role for this protein in cytokine induction by pathogen-associated molecular patterns and viruses. However, Nlrc5(-/-) cells showed a dramatic decrease of classical (H-2K) and nonclassical (Tla) MHC-I expression by T/B lymphocytes, natural killer (NK) cells, and myeloid-monocytic lineages. As a comparison, CIITA did not affect mouse MHC-I expression. Nlrc5(-/-) splenocytes and bone marrow-derived macrophages were able to up-regulate MHC-I in response to IFN-gamma; however, the absolute levels of MHC-I expression were significantly lower than WT controls. Chromatin immunoprecipitation of IFN-gamma-treated cells indicates that Nlrc5 reduced the silencing H3K27me3 histone modification, but did not affect the activating AcH3 modification on a MHC-I promoter. In summary, we conclude that Nlrc5 is important in the regulation of MHC-I expression by reducing H3K27me3 on MHC-I promoter and joins CIITA as an NLR subfamily that controls MHC gene transcription.	[Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Inflammatory Dis, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Translat Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Inflammatory Dis, Dept Microbiol & Immunol, CB 7295, Chapel Hill, NC 27599 USA.	jpyting@gmail.com	, UNC Flow Cytometry Core/AGU-9839-2022; Zhang, Lu/P-6929-2015		National Institutes of Health [NIAID R37-AI029564, NCI T32 CA009156, NCI CA131645]; National Institutes of Health Center Core Support Grant through the NCI [P30CA06086]; NATIONAL CANCER INSTITUTE [P30CA016086, R21CA131645, T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center Core Support Grant through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants NIAID R37-AI029564 (to J. P. Y. T.), NCI T32 CA009156 (to G. R. R.), and NCI CA131645 (to B. K. D.).; The University of North Carolina (UNC) Flow Cytometry Core Facility is supported in part by a National Institutes of Health Center Core Support Grant (P30CA06086) through the NCI to the UNC Lineberger Comprehensive Cancer Center.	Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; Itoh-Lindstrom Y, 1999, J IMMUNOL, V163, P2425; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Masternak K, 2000, GENE DEV, V14, P1156; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Meissner TB, 2012, BIOCHEM BIOPH RES CO, V418, P786, DOI 10.1016/j.bbrc.2012.01.104; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Moayeri M, 2012, MICROBES INFECT, V14, P392, DOI 10.1016/j.micinf.2011.12.005; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Raval A, 2003, J IMMUNOL, V170, P922, DOI 10.4049/jimmunol.170.2.922; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Truax AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036013; Truax AD, 2012, METHODS MOL BIOL, V809, P175, DOI 10.1007/978-1-61779-376-9_12; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000	38	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24294	24303		10.1074/jbc.M112.364604	http://dx.doi.org/10.1074/jbc.M112.364604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645137	Green Published, hybrid			2022-12-28	WOS:000306651100023
J	Tarrago, L; Kaya, A; Weerapana, E; Marino, SM; Gladyshev, VN				Tarrago, Lionel; Kaya, Alaattin; Weerapana, Eranthie; Marino, Stefano M.; Gladyshev, Vadim N.			Methionine Sulfoxide Reductases Preferentially Reduce Unfolded Oxidized Proteins and Protect Cells from Oxidative Protein Unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISORDERED REGIONS; PRION PROTEIN; R-SULFOXIDE; PREDICTION; CALMODULIN; EXPRESSION; MEMBRANE; SEQUENCE; AFFINITY; RESIDUES	Reduction of methionine sulfoxide (MetO) residues in proteins is catalyzed by methionine sulfoxide reductases A (MSRA) and B (MSRB), which act in a stereospecific manner. Catalytic properties of these enzymes were previously established mostly using low molecular weight MetO-containing compounds, whereas little is known about the catalysis of MetO reduction in proteins, the physiological substrates of MSRA and MSRB. In this work we exploited an NADPH-dependent thioredoxin system and determined the kinetic parameters of yeast MSRA and MSRB using three different MetO-containing proteins. Both enzymes showed Michaelis-Menten kinetics with the Km lower for protein than for small MetO containing substrates. MSRA reduced both oxidized proteins and low molecular weight MetO-containing compounds with similar catalytic efficiencies, whereas MSRB was specialized for the reduction of MetO in proteins. Using oxidized glutathione S-transferase as a model substrate, we showed that both MSR types were more efficient in reducing MetO in unfolded than in folded proteins and that their activities increased with the unfolding state. Biochemical quantification and identification of MetO reduced in the substrates by mass spectrometry revealed that the increased activity was due to better access to oxidized MetO in unfolded proteins; it also showed that MSRA was intrinsically more active with unfolded proteins regardless of MetO availability. Moreover, MSRs most efficiently protected cells from oxidative stress that was accompanied by protein unfolding. Overall, this study indicates that MSRs serve a critical function in the folding process by repairing oxidatively damaged nascent polypeptides and unfolded proteins.	[Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Tarrago, Lionel; Kaya, Alaattin; Marino, Stefano M.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Weerapana, Eranthie] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston College	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/J-6187-2013; Kaya, Alaattin/T-6427-2017; Tarrago, Lionel/CAH-1308-2022; Gladyshev, Vadim N/A-9894-2013; Tarrago, Lionel/N-3534-2016	Kaya, Alaattin/0000-0002-6132-5197; Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [AG021518]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518.	Achilli C, 2008, J LEUKOCYTE BIOL, V83, P181, DOI 10.1189/jlb.0707492; [Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Beal JL, 2009, BIOCHEMISTRY-US, V48, P11142, DOI 10.1021/bi901343d; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; CREAMER LK, 1981, ARCH BIOCHEM BIOPHYS, V211, P689, DOI 10.1016/0003-9861(81)90505-1; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172; Gao J, 2001, BIOPHYS J, V80, P1791, DOI 10.1016/S0006-3495(01)76149-8; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kochanczyk M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-34; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laugier E, 2010, PLANT J, V61, P271, DOI 10.1111/j.1365-313X.2009.04053.x; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Mahawar M, 2011, J BIOL CHEM, V286, P19159, DOI 10.1074/jbc.M111.223677; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; Minniti AN, 2009, AGING CELL, V8, P690, DOI 10.1111/j.1474-9726.2009.00521.x; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Mulinacci F, 2011, J PHARM SCI-US, V100, P110, DOI 10.1002/jps.22268; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Shchedrina VA, 2011, J BIOL CHEM, V286, P29449, DOI 10.1074/jbc.M111.257600; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tarrago L, 2012, ANTIOXID REDOX SIGN, V16, P79, DOI 10.1089/ars.2011.4153; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Xiong YJ, 2006, BIOCHEMISTRY-US, V45, P14642, DOI 10.1021/bi0612465; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang XH, 2008, BIOL REV, V83, P249, DOI 10.1111/j.1469-185X.2008.00042.x	45	62	64	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24448	24459		10.1074/jbc.M112.374520	http://dx.doi.org/10.1074/jbc.M112.374520			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22628550	Green Published, hybrid			2022-12-28	WOS:000306651100038
J	Yeom, J; Lee, Y; Park, W				Yeom, Jinki; Lee, Yunho; Park, Woojun			ATP-dependent RecG Helicase Is Required for the Transcriptional Regulator OxyR Function in Pseudomonas species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SUBSTRATE-SPECIFICITY; DNA; REPLICATION; SUPEROXIDE; STRESS; EXPRESSION; AERUGINOSA; PUTIDA	The oxyR gene appears to reside in an operon with the recG helicase gene in many bacteria, including pathogenic Pseudomonas aeruginosa and Pseudomonas putida. Analysis of P. putida transcriptomes shows that many OxyR-controlled genes are regulated by the ATP-dependent RecG helicase and that RecG alone modulates the expression of many genes. We found that purified RecG binds to the promoters of many OxyR-controlled genes and that expression of these genes was not induced under conditions of oxidative stress in recG mutants of P. aeruginosa, P. putida, and Escherichia coli. In vitro data revealed that promoters containing palindromic sequences are essential for RecG binding and that single-strand binding proteins and ATP are also needed for RecG to promote transcription, whereas a magnesium ion has the opposite effect. The OxyR tetramer preferentially binds to promoters after RecG has generated linear DNA in the presence of ATP; otherwise, the OxyR dimer has higher affinity. This study provides new insights into the mechanism of bacterial transcription by demonstrating that RecG might be required for the induction of the OxyR regulon by unwinding palindromic DNA for transcription. This work describes a novel bacterial transcriptional function by RecG helicase with OxyR and may provide new targets for controlling Pseudomonas species pathogen.	[Park, Woojun] Korea Univ, Div Environm Sci & Ecol Engn, Dept Environm Sci & Ecol Engn, Seoul 136713, South Korea	Korea University	Park, W (corresponding author), Korea Univ, Div Environm Sci & Ecol Engn, Dept Environm Sci & Ecol Engn, Seoul 136713, South Korea.	wpark@korea.ac.kr		Yeom, Jinki/0000-0002-5332-2658	National Research Foundation; Korean government (Ministry of Education, Science and Technology) [2012-0005277]	National Research Foundation; Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation Grant funded by the Korean government (Ministry of Education, Science and Technology) (2012-0005277).	Briggs GS, 2005, J BIOL CHEM, V280, P13921, DOI 10.1074/jbc.M412054200; Brown SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/mcp.M500394-MCP200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Dai X, 1998, GENE DEV, V12, P2782, DOI 10.1101/gad.12.17.2782; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hishinuma S, 2008, FEMS MICROBIOL LETT, V289, P138, DOI 10.1111/j.1574-6968.2008.01374.x; Huang YH, 2011, PROTEIN J, V30, P102, DOI 10.1007/s10930-011-9309-1; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Kaan T, 2002, MICROBIOL-SGM, V148, P3441, DOI 10.1099/00221287-148-11-3441; Kang JG, 1997, NUCLEIC ACIDS RES, V25, P2566, DOI 10.1093/nar/25.13.2566; Knapp GS, 2009, PROTEIN SCI, V18, P101, DOI 10.1002/pro.5; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Ohara N, 2006, MICROBIOL-SGM, V152, P955, DOI 10.1099/mic.0.28537-0; Panmanee W, 2009, FEMS MICROBIOL LETT, V295, P238, DOI 10.1111/j.1574-6968.2009.01605.x; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Rudolph CJ, 2009, MOL MICROBIOL, V73, P352, DOI 10.1111/j.1365-2958.2009.06773.x; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; Shida T, 1996, J BIOL CHEM, V271, P26105, DOI 10.1074/jbc.271.42.26105; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; TAYLOR AF, 1992, P NATL ACAD SCI USA, V89, P5226, DOI 10.1073/pnas.89.12.5226; Vologodskaia MY, 1999, J MOL BIOL, V289, P851, DOI 10.1006/jmbi.1999.2811; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Yeom S, 2010, MICROBIOL-SGM, V156, P1487, DOI 10.1099/mic.0.034181-0; Zaim J, 2003, NUCLEIC ACIDS RES, V31, P1444, DOI 10.1093/nar/gkg234; Zeller T, 2004, MICROBIOL-SGM, V150, P3451, DOI 10.1099/mic.0.27308-0; Zhao JJ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/126986; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	36	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24492	24504		10.1074/jbc.M112.356964	http://dx.doi.org/10.1074/jbc.M112.356964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621928	Green Published, hybrid			2022-12-28	WOS:000306651100042
J	Bao, Y; Zheng, J; Han, CF; Jin, J; Han, HX; Liu, YP; Lau, YL; Tu, WW; Cao, XT				Bao, Yan; Zheng, Jian; Han, Chaofeng; Jin, Jing; Han, Huanxing; Liu, Yinping; Lau, Yu-Lung; Tu, Wenwei; Cao, Xuetao			Tyrosine Kinase Btk Is Required for NK Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; B-CELLS; ADAPTIVE IMMUNITY; X-CHROMOSOME; LIVER-INJURY; IFN-GAMMA; B-1 CELLS; T-CELLS; INNATE; MICE	Bruton tyrosine kinase (Btk) is not only critical for B cell development and differentiation but is also involved in the regulation of Toll-like receptor-triggered innate response of macrophages. However, whether Btk is involved in the regulation of natural killer (NK) cell innate function remains unknown. Here, we show that Btk expression is up-regulated during maturation and activation of mouse NK cells. Murine Btk(-/-) NKcells have decreased innate immune responses to the TLR3 ligand, with reduced expressions of IFN-gamma, perforin, and granzyme-B and decreased cytotoxic activity. Furthermore, Btk is found to promote TLR3-triggered NK cell activation mainly by activating the NF-kappa B pathway. Poly(I:C)-induced NK cell-mediated acute hepatitis was observed to be attenuated in Btk(-/-) mice or the mice with in vivo administration of the Btk inhibitor. Correspondingly, liver damage was aggravated in Btk(-/-) mice after the adoptive transfer of Btk(+/+) NK cells, further indicating that Btk-mediated NK cell activation contributes to TLR3-triggered acute liver injury. Importantly, reduced TLR3-triggered activation of human NK cells was observed in Btk-deficient patients with X-linked agammaglobulinemia, as evidenced by the reduced IFN-gamma, CD69, and CD107a expression and cytotoxic activity. These results indicate that Btk is required for activation of NK cells, thus providing insight into the physiological significance of Btk in the regulation of immune cell functions and innate inflammatory response.	[Bao, Yan; Han, Chaofeng; Jin, Jing; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Bao, Yan; Han, Chaofeng; Jin, Jing; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; Changzheng Hosp, Translat Med Ctr, Shanghai 200433, Peoples R China; [Zheng, Jian; Liu, Yinping; Lau, Yu-Lung; Tu, Wenwei] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; University of Hong Kong	Bao, Y (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, 7th Floor,Lib Bldg,800 Xiangyin Rd, Shanghai 200433, Peoples R China.	baoyan@yahoo.cn; wwtu@hku.hk	Lau, Yu Lung/C-4322-2009; Tu, Wenwei/C-4429-2009	Lau, Yu Lung/0000-0002-4780-0289; Tu, Wenwei/0000-0002-6801-8798				Bao Y, 2011, EUR J IMMUNOL, V41, P657, DOI 10.1002/eji.201040840; Becknell B, 2007, BLOOD, V109, P2481, DOI 10.1182/blood-2006-10-050096; Bouaziz A, 2007, THROMB HAEMOSTASIS, V98, P375, DOI 10.1160/TH07-01-0061; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Contreras CM, 2007, MOL IMMUNOL, V44, P2719, DOI 10.1016/j.molimm.2006.11.023; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Khare A, 2011, APOPTOSIS, V16, P334, DOI 10.1007/s10495-010-0569-6; Kubo T, 2009, J EXP MED, V206, P1971, DOI 10.1084/jem.20082392; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Liu Y., 2012, J CLIN IMMU IN PRESS; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Ng YY, 2010, LEUKEMIA, V24, P1617, DOI 10.1038/leu.2010.140; Nisitani S, 2000, P NATL ACAD SCI USA, V97, P2737, DOI 10.1073/pnas.050583597; Ormsby T, 2011, BLOOD, V118, P936, DOI 10.1182/blood-2010-11-317016; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Smith MA, 2010, J IMMUNOL, V185, P6058, DOI 10.4049/jimmunol.1001682; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Tato CM, 2006, INT IMMUNOL, V18, P505, DOI 10.1093/intimm/dxh391; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Vijayan V, 2011, J IMMUNOL, V187, P817, DOI 10.4049/jimmunol.1003631; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang NH, 2010, J IMMUNOL, V185, P5683, DOI 10.4049/jimmunol.1001974; Zhang MG, 2009, HEPATOLOGY, V50, P1606, DOI 10.1002/hep.23168; Zheng JA, 2011, EUR J IMMUNOL, V41, P128, DOI 10.1002/eji.201040724	37	49	50	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23769	23778		10.1074/jbc.M112.372425	http://dx.doi.org/10.1074/jbc.M112.372425			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589540	Green Published, hybrid			2022-12-28	WOS:000306511300047
J	Lee, MJ; Kim, DE; Zakrzewska, A; Yoo, YD; Kim, SH; Kim, ST; Seo, JW; Lee, YS; Dorn, GW; Oh, U; Kim, BY; Kwon, YT				Lee, Min Jae; Kim, Dong Eun; Zakrzewska, Adriana; Yoo, Young Dong; Kim, Su-Hyeon; Kim, Sung Tae; Seo, Jai Wha; Lee, Young Sook; Dorn, Gerald W., II; Oh, UhTaek; Kim, Bo Yeon; Kwon, Yong Tae			Characterization of Arginylation Branch of N-end Rule Pathway in G-protein-mediated Proliferation and Signaling of Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR PRINCIPLES; UBIQUITIN LIGASE; HEART-FAILURE; EXPRESSION; RECOGNITION; MOUSE; MICE; RGS4; ARGINYLTRANSFERASE; COMPONENT	The N-end rule pathway is a proteolytic system in which destabilizing N-terminal amino acids of short lived proteins are recognized by recognition components (N-recognins) as an essential element of degrons, called N-degrons. In eukaryotes, the major way to generate N-degrons is through arginylation by ATE1 arginyl-tRNA-protein transferases, which transfer Arg from aminoacyl-tRNA to N-terminal Asp and Glu (and Cys as well in mammals). We have shown previously that ATE1-deficient mice die during embryogenesis with defects in cardiac and vascular development. Here, we characterized the arginylation-dependent N-end rule pathway in cardiomyocytes. Our results suggest that the cardiac and vascular defects in ATE1-deficient embryos are independent from each other and cell-autonomous. ATE1-deficient myocardium and cardiomyocytes therein, but not non-cardiomyocytes, showed reduced DNA synthesis and mitotic activity similar to 24 h before the onset of cardiac and vascular defects at embryonic day 12.5 associated with the impairment in the phospholipase C/PKC-MEK1-ERK axis of G alpha(q)-mediated cardiac signaling pathways. Cardiac overexpression of G alpha(q) rescued ATE1-deficient embryos from thin myocardium and ventricular septal defect but not from vascular defects, genetically dissecting vascular defects from cardiac defects. The misregulation in cardiovascular signaling can be attributed in part to the failure in hypoxia-sensitive degradation of RGS4, a GTPase-activating protein for G alpha(q). This study is the first to characterize the N-end rule pathway in cardiomyocytes and reveals the role of its arginylation branch in G alpha(q)-mediated signaling of cardiomyocytes in part through N-degron-based, oxygen-sensitive proteolysis of G-protein regulators.	[Lee, Min Jae; Kim, Dong Eun; Zakrzewska, Adriana; Kim, Sung Tae; Seo, Jai Wha; Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Lee, Min Jae] Kyung Hee Univ, Dept Appl Chem, Coll Appl Sci, Yongin 446701, South Korea; [Lee, Min Jae; Kim, Dong Eun; Zakrzewska, Adriana; Kim, Sung Tae; Seo, Jai Wha; Kwon, Yong Tae] Univ Pittsburgh, Dept Pharmaceut Sci, Sch Pharm, Pittsburgh, PA 15261 USA; [Yoo, Young Dong; Oh, UhTaek; Kwon, Yong Tae] Seoul Natl Univ, World Class Univ WCU Program, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul 110799, South Korea; [Yoo, Young Dong; Oh, UhTaek; Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul 110799, South Korea; [Kim, Su-Hyeon; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, WCI, Ochang 363883, South Korea; [Lee, Young Sook] Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Dorn, Gerald W., II] Washington Univ, Dept Med, Ctr Pharmacogen, Sch Med, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyung Hee University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Kwon, YT (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, 3501 Terrace St, Pittsburgh, PA 15261 USA.	yok5@pitt.edu	Lee, Min Jae/C-9814-2015	Lee, Min Jae/0000-0002-3252-6467	National Institutes of Health [HL083365, HL067050]; World Class University Grant [R31-2008-000-10103-0]; World Class Institute; Ministry of Education, Science, and Technology [2011-0007990, 2011-0030938]; Ministry of Health and Welfare Grant [A111227]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050, R01HL083365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University Grant; World Class Institute; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083365 (to Y.T.K.) and HL067050 (to Y.S.L.). This work was also supported by World Class University Grant R31-2008-000-10103-0 (to Y.T.K.), the World Class Institute (to B.Y.K.), Ministry of Education, Science, and Technology Grants 2011-0007990 and 2011-0030938 (to M.J.L.), and Ministry of Health and Welfare Grant A111227 (to M.J.L.).	Adams LD, 2000, CIRC RES, V87, P623, DOI 10.1161/01.RES.87.7.623; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BALZI E, 1990, J BIOL CHEM, V265, P7464; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Decca MB, 2006, NEUROCHEM RES, V31, P401, DOI 10.1007/s11064-005-9037-z; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2009, P NATL ACAD SCI USA, V106, P13618, DOI 10.1073/pnas.0906404106; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; KAJI H, 1963, BIOCHIM BIOPHYS ACTA, V76, P477; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kurosaka S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000878; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Leu NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007734; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Owen VJ, 2001, EUR HEART J, V22, P1015, DOI 10.1053/euhj.2000.2578; Patten M, 2003, N-S ARCH PHARMACOL, V368, P360, DOI 10.1007/s00210-003-0798-0; Rogers JH, 2001, J MOL CELL CARDIOL, V33, P209, DOI 10.1006/jmcc.2000.1307; Spradling AC, 1999, GENETICS, V153, P135; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x	45	39	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24043	24052		10.1074/jbc.M112.364117	http://dx.doi.org/10.1074/jbc.M112.364117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22577142	hybrid, Green Published			2022-12-28	WOS:000306511300072
J	Pietri, R; Zerbs, S; Corgliano, DM; Allaire, M; Collart, FR; Miller, LM				Pietri, Ruth; Zerbs, Sarah; Corgliano, Danielle M.; Allaire, Marc; Collart, Frank R.; Miller, Lisa M.			Biophysical and Structural Characterization of a Sequence-diverse Set of Solute-binding Proteins for Aromatic Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; BACTERIUM RHODOPSEUDOMONAS-PALUSTRIS; STRUCTURE PREDICTION; RESOLUTION STRUCTURE; BIOLOGICAL MACROMOLECULES; ABC TRANSPORTERS; ACTIVE-TRANSPORT; I-TASSER; SERVER	Rhodopseudomonas palustris metabolizes aromatic compounds derived from lignin degradation products and has the potential for bioremediation of xenobiotic compounds. We recently identified four possible solute-binding proteins in R. palustris that demonstrated binding to aromatic lignin monomers. Characterization of these proteins in the absence and presence of the aromatic ligands will provide unprecedented insights into the specificity and mode of aromatic ligand binding in solute-binding proteins. Here, we report the thermodynamic and structural properties of the proteins with aromatic ligands using isothermal titration calorimetry, small/wide angle x-ray scattering, and theoretical predictions. The proteins exhibit high affinity for the aromatic substrates with dissociation constants in the low micromolar to nanomolar range. The global shapes of the proteins are characterized by flexible ellipsoid-like structures with maximum dimensions in the 80-90-angstrom range. The data demonstrate that the global shapes remained unaltered in the presence of the aromatic ligands. However, local structural changes were detected in the presence of some ligands, as judged by the observed features in the wide angle x-ray scattering regime at q similar to 0.20- 0.40 angstrom(-1). The theoretical models confirmed the elongated nature of the proteins and showed that they consist of two domains linked by a hinge. Evaluation of the protein-binding sites showed that the ligands were found in the hinge region and that ligand stabilization was primarily driven by hydrophobic interactions. Taken together, this study shows the capability of identifying solute-binding proteins that interact with lignin degradation products using high throughput genomic and biophysical approaches, which can be extended to other organisms.	[Miller, Lisa M.] Brookhaven Natl Lab, Natl Synchrotron Light Source, Photon Sci Directorate, Upton, NY 11973 USA; [Zerbs, Sarah; Corgliano, Danielle M.; Collart, Frank R.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Miller, LM (corresponding author), Brookhaven Natl Lab, Natl Synchrotron Light Source, Photon Sci Directorate, Bldg 725D,75 Brookhaven Ave, Upton, NY 11973 USA.	lmiller@bnl.gov		Collart, Frank/0000-0001-6942-4483; Miller, Lisa/0000-0002-2912-7991	United States Department of Energy, Office of Biological and Environmental Research; United States Department of Energy [DE-AC02-98CH10886]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy, Office of Biological and Environmental Research, as part of the BER Genomic Science Program. This contribution originates from the "Environment Sensing and Response" Scientific Focus Area Program at Argonne National Laboratory.; We thank Dr. Lin Yang for scientific and technical support at beamline X9. The National Synchrotron Light Source is supported by United States Department of Energy Contract DE-AC02-98CH10886.	Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Chan S, 2010, ACTA CRYSTALLOGR F, V66, P242, DOI 10.1107/S1744309109055158; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; ELDER DJE, 1992, ARCH MICROBIOL, V157, P148, DOI 10.1007/BF00245283; Fischetti RF, 2004, CHEM BIOL, V11, P1431, DOI 10.1016/j.chembiol.2004.08.013; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Giuliani SE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S8; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lee HS, 2009, J CHEM INF MODEL, V49, P2419, DOI 10.1021/ci9002365; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Makowski L, 2008, J MOL BIOL, V375, P529, DOI 10.1016/j.jmb.2007.07.075; Makowski L, 2011, BIOPOLYMERS, V95, P531, DOI 10.1002/bip.21631; Makowski Lee, 2010, Journal of Structural and Functional Genomics, V11, P9, DOI 10.1007/s10969-009-9075-x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Pan C, 2008, MOL CELL PROTEOMICS, V7, P938, DOI 10.1074/mcp.M700147-MCP200; PFLUGRATH JW, 1988, J MOL BIOL, V200, P163, DOI 10.1016/0022-2836(88)90341-5; RAHALKAR SB, 1993, CURR MICROBIOL, V26, P1, DOI 10.1007/BF01577235; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shoreit Ahmed A. M., 1994, Biodegradation, V5, P71; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	38	13	13	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23748	23756		10.1074/jbc.M112.352385	http://dx.doi.org/10.1074/jbc.M112.352385			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22577139	Green Published, hybrid			2022-12-28	WOS:000306511300045
J	Baljuls, A; Beck, M; Oenel, A; Robubi, A; Kroschewski, R; Hekman, M; Rudel, T; Rapp, UR				Baljuls, Angela; Beck, Matthias; Oenel, Ayla; Robubi, Armin; Kroschewski, Ruth; Hekman, Mirko; Rudel, Thomas; Rapp, Ulf R.			The Tumor Suppressor DiRas3 Forms a Complex with H-Ras and C-RAF Proteins and Regulates Localization, Dimerization, and Kinase Activity of C-RAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER CELLS; GENE ARHI; WILD-TYPE; B-RAF; BREAST CANCERS; ACTIVATION; BINDING; HETERODIMERIZATION; PATHWAY; PROGRESSION	The maternally imprinted Ras-related tumor suppressor gene DiRas3 is lost or down-regulated in more than 60% of ovarian and breast cancers. The anti-tumorigenic effect of DiRas3 is achieved through several mechanisms, including inhibition of cell proliferation, motility, and invasion, as well as induction of apoptosis and autophagy. Re-expression of DiRas3 in cancer cells interferes with the signaling through Ras/MAPK and PI3K. Despite intensive research, the mode of interference of DiRas3 with the Ras/RAF/MEK/ERK signal transduction is still a matter of speculation. In this study, we show that DiRas3 associates with the H-Ras oncogene and that activation of H-Ras enforces this interaction. Furthermore, while associated with DiRas3, H-Ras is able to bind to its effector protein C-RAF. The resulting multimeric complex consisting of DiRas3, C-RAF, and active H-Ras is more stable than the two protein complexes H-Ras center dot C-RAF or H-Ras center dot DiRas3, respectively. The consequence of this complex formation is a DiRas3-mediated recruitment and anchorage of C-RAF to components of the membrane skeleton, suppression of C-RAF/B-RAF heterodimerization, and inhibition of C-RAF kinase activity.	[Baljuls, Angela; Oenel, Ayla; Hekman, Mirko; Rudel, Thomas; Rapp, Ulf R.] Univ Wurzburg, Dept Microbiol, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany; [Robubi, Armin] Univ Wurzburg, Dept Bioinformat, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany; [Beck, Matthias; Kroschewski, Ruth] Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	University of Wurzburg; University of Wurzburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Baljuls, A (corresponding author), Univ Wurzburg, Dept Microbiol, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany.	angela_baljuls@gmx.de		Kroschewski, Ruth/0000-0002-6032-2568	Deutsche Forschungsgemeinschaft [SFB 487, C3]; ETHZ research council fellowship; Novartis Foundation for medical-biological research; Roche Research Foundation [2000-206]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ETHZ research council fellowship; Novartis Foundation for medical-biological research; Roche Research Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, Project C3.; We thank Ignacio Rubio (University of Jena) for generously providing the plasmids encoding lipidation mutants of H-Ras12V. The work at ETH-Zurich was supported by an ETHZ research council fellowship, the Novartis Foundation for medical-biological research, and Roche Research Foundation Grant 2000-206.	Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Badgwell DB, 2012, ONCOGENE, V31, P68, DOI 10.1038/onc.2011.213; Bao JJ, 2002, CANCER RES, V62, P7264; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Dudler T, 1996, J BIOL CHEM, V271, P11541, DOI 10.1074/jbc.271.19.11541; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212; Hisatomi H, 2002, ONCOLOGY-BASEL, V62, P136, DOI 10.1159/000048259; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Luo RZ, 2003, ONCOGENE, V22, P2897, DOI 10.1038/sj.onc.1206380; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Niault T, 2009, J CELL BIOL, V187, P335, DOI 10.1083/jcb.200906178; Nishimoto A, 2005, CANCER RES, V65, P6701, DOI 10.1158/0008-5472.CAN-05-0130; Piazzolla D, 2005, J CELL BIOL, V171, P1013, DOI 10.1083/jcb.200504137; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rosen DG, 2004, CLIN CANCER RES, V10, P6559, DOI 10.1158/1078-0432.CCR-04-0698; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang L, 2003, CLIN CANCER RES, V9, P3660; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214; Yu YH, 2006, METHOD ENZYMOL, V407, P455, DOI 10.1016/S0076-6879(05)07037-0	58	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23128	23140		10.1074/jbc.M112.343780	http://dx.doi.org/10.1074/jbc.M112.343780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22605333	hybrid, Green Published			2022-12-28	WOS:000306495000068
J	Kundumani-Sridharan, V; Quyen, DV; Subramani, J; Singh, NK; Chin, YE; Rao, GN				Kundumani-Sridharan, Venkatesh; Dong Van Quyen; Subramani, Jaganathan; Singh, Nikhlesh K.; Chin, Y. Eugene; Rao, Gadiparthi N.			Novel Interactions between NFATc1 (Nuclear Factor of Activated T Cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) Mediate G Protein-coupled Receptor Agonist, Thrombin-induced Biphasic Expression of Cyclin D1, with First Phase Influencing Cell Migration and Second Phase Directing Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; INDUCED NEOINTIMA FORMATION; TYROSINE KINASE; GENE-EXPRESSION; DEPENDENT KINASES; VASCULAR INJURY; BREAST-CANCER; DNA-SYNTHESIS; GROWTH	Thrombin, a G protein-coupled receptor agonist, induced a biphasic expression of cyclin D1 in primary vascular smooth muscle cells. Although both phases of cyclin D1 expression require binding of the newly identified cooperative complex, NFATc1.STAT-3, to its promoter, the second phase, which is more robust, depends on NFATc1-mediated recruitment of p300 onto the complex and the subsequent acetylation of STAT-3. In addition, STAT-3 is tyrosine-phosphorylated in a biphasic manner, and the late phase requires NFATc1-mediated p300-dependent acetylation. Furthermore, interference with acetylation of STAT-3 by overexpression of acetylation null STAT-3 mutant led to the loss of the late phase of cyclin D1 expression. EMSA analysis and reporter gene assays revealed that NFATc1.STAT-3 complex binding to the cyclin D1 promoter led to an enhanceosome formation and facilitated cyclin D1 expression. In the early phase of its expression, cyclin D1 is localized mostly in the cytoplasm and influenced cell migration. However, during the late and robust phase of its expression, cyclin D1 is translocated to the nucleus and directed cell proliferation. Together, these results demonstrate for the first time that the dual function of cyclin D1 in cell migration and proliferation is temperospatially separated by its biphasic expression, which is mediated by cooperative interactions between NFATc1 and STAT-3.	[Kundumani-Sridharan, Venkatesh; Dong Van Quyen; Subramani, Jaganathan; Singh, Nikhlesh K.; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Chin, Y. Eugene] Brown Univ, Dept Surg, Sch Med, Providence, RI 02903 USA	University of Tennessee System; University of Tennessee Health Science Center; Brown University	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Subramani, Jaganathan/I-5155-2016; Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Singh, Nikhlesh/AAA-4253-2020	Subramani, Jaganathan/0000-0002-5707-8621; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health from NHLBI [HL069908]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL069908) from NHLBI (to G. N. R.).	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Bittman K, 1997, J NEUROSCI, V17, P7037; Boehm M, 2001, CIRCULATION, V103, P2879, DOI 10.1161/01.CIR.103.24.2879; Boehm Manfred, 2003, Prog Cell Cycle Res, V5, P19; Bonneton C, 1999, CELL MOTIL CYTOSKEL, V43, P288, DOI 10.1002/(SICI)1097-0169(1999)43:4<288::AID-CM2>3.3.CO;2-P; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; Casimiro MC, 2012, J CLIN INVEST, V122, P833, DOI 10.1172/JCI60256; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Cullen BR, 2005, NAT GENET, V37, P1163, DOI 10.1038/ng1105-1163; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Gansauge S, 1997, CANCER RES, V57, P1634; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Gui T, 2007, THROMB RES, V121, P225, DOI 10.1016/j.thromres.2007.03.026; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haque NS, 2004, BLOOD, V103, P1296, DOI 10.1182/blood-2002-05-1480; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hou T, 2008, J BIOL CHEM, V283, P30725, DOI 10.1074/jbc.M805941200; Ishihara S, 2011, J IMMUNOL, V187, P3292, DOI 10.4049/jimmunol.1003173; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kawamura T, 2004, CIRC RES, V94, P1492, DOI 10.1161/01.RES.0000129701.14494.52; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Kundumani-Sridharan V, 2010, BLOOD, V115, P2105, DOI 10.1182/blood-2009-09-241802; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li L, 2011, CIRC RES, V108, P1180, DOI 10.1161/CIRCRESAHA.110.237875; Li Z, 2008, J BIOL CHEM, V283, P7007, DOI 10.1074/jbc.M706992200; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Neeli I, 2004, J BIOL CHEM, V279, P46122, DOI 10.1074/jbc.M406922200; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; OWENS GK, 1995, PHYSIOL REV, V75, P487; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Schaper W, 1996, CIRC RES, V79, P911, DOI 10.1161/01.RES.79.5.911; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; Suemoto H, 2007, DEV BIOL, V312, P572, DOI 10.1016/j.ydbio.2007.10.001; Sui SG, 2007, J CELL BIOL, V178, P231, DOI 10.1083/jcb.200611081; Sun JZ, 2005, ONCOGENE, V24, P4701, DOI 10.1038/sj.onc.1208391; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368; Zwicker J, 1999, ONCOGENE, V18, P19, DOI 10.1038/sj.onc.1202286	88	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22463	22482		10.1074/jbc.M112.362996	http://dx.doi.org/10.1074/jbc.M112.362996			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22566696	Green Published, hybrid			2022-12-28	WOS:000306495000006
J	Lade, A; Ranganathan, S; Luo, JH; Monga, SPS				Lade, Abigale; Ranganathan, Sarangarajan; Luo, Jianhua; Monga, Satdarshan P. S.			Calpain Induces N-terminal Truncation of beta-Catenin in Normal Murine Liver Development DIAGNOSTIC IMPLICATIONS IN HEPATOBLASTOMAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; PROGENITOR CELLS; ADIPOCYTE DIFFERENTIATION; MAMMARY-GLAND; MOUSE-LIVER; FEMALE MICE; ACTIVATION; GENE; WNT; REGENERATION	Hepatic competence, specification, and liver bud expansion during development depend on precise temporal modulation of the Wnt/beta-catenin signaling. Also, loss- and gain-of-function studies have revealed pleiotropic roles of beta-catenin in proliferation and hepatocyte and biliary epithelial cell differentiation, but precise mechanisms remain unknown. Here we utilize livers from different stages of murine development to determine beta-catenin signaling and downstream targets. Although during early liver development full-length beta-catenin is the predominant form, at late stages, where full-length beta-catenin localizes to developing biliary epithelial cells only, a 75-kDa truncated beta-catenin species is the principal form localizing at the membrane and in the nucleus of differentiating hepatocytes. The truncated species lacks 95 N-terminal amino acids and is transcriptionally active. Our evidence points to proteolytic cleavage of beta-catenin by calpain as the mechanism of truncation in cell-free and cell-based assays. Intraperitoneal injection of a short term calpain inhibitor to timed pregnant female mice abrogated beta-catenin truncation in the embryonic livers. RNA-seq revealed a unique set of targets transcribed in cells expressing truncated versus full-length beta-catenin, consistent with different functionalities. A further investigation using N- and C-terminal-specific beta-catenin antibodies on human hepatoblastomas revealed a correlation between full-length versus truncated beta-catenin and differentiation status, with embryonal hepatoblastomas expressing full-length beta-catenin and fetal hepatoblastomas expressing beta-catenin lacking its N terminus. Thus we conclude that calpain-mediated cleavage of beta-catenin plays a role in regulating hepatoblast differentiation in mouse and human liver, and the presence of the beta-catenin N terminus correlates with differentiation status in hepatoblastomas.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monga, SPS (corresponding author), 200 Lothrop St,S-421 BST, Pittsburgh, PA 15261 USA.	smonga@pitt.edu	Luo, jian/HGE-7331-2022	Monga, Satdarshan/0000-0002-8437-3378; Ranganathan, Sarangarajan/0000-0001-6214-9167	National Institutes of Health [1R01DK62277, 1R01CA124414]; Rango's Fund for the Enhancement of Pathology Research; NATIONAL CANCER INSTITUTE [R01CA124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rango's Fund for the Enhancement of Pathology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK62277 and 1R01CA124414 (to S. P. S. M.). This work was also supported by Rango's Fund for the Enhancement of Pathology Research.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Apte U, 2009, AM J PATHOL, V175, P1056, DOI 10.2353/ajpath.2009.080976; Barnoy S, 1997, BBA-MOL CELL RES, V1358, P181, DOI 10.1016/S0167-4889(97)00068-2; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Burke ZD, 2006, BIOESSAYS, V28, P1072, DOI 10.1002/bies.20485; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Colletti M, 2009, GASTROENTEROLOGY, V137, P660, DOI 10.1053/j.gastro.2009.05.038; Curia MC, 2008, MODERN PATHOL, V21, P7, DOI 10.1038/modpathol.3800977; Dalgetty DM, 2009, AM J PHYSIOL-GASTR L, V297, pG241, DOI 10.1152/ajpgi.00138.2009; Deato MDE, 2008, COLD SH Q B, V73, P217, DOI 10.1101/sqb.2008.73.028; Decaens T, 2008, HEPATOLOGY, V47, P247, DOI 10.1002/hep.21952; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Finley KR, 2003, GENE EXPR PATTERNS, V3, P681, DOI 10.1016/S1567-133X(03)00091-7; Garach-Jehoshua O, 1998, BRIT J DERMATOL, V139, P950; Giera S, 2010, TOXICOL SCI, V115, P22, DOI 10.1093/toxsci/kfq033; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Hussain SZ, 2004, EXP CELL RES, V292, P157, DOI 10.1016/j.yexcr.2003.08.020; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jeng YM, 2000, CANCER LETT, V152, P45, DOI 10.1016/S0304-3835(99)00433-4; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Koch A, 1999, CANCER RES, V59, P269; Kramerova I, 2006, MOL CELL BIOL, V26, P8437, DOI 10.1128/MCB.01296-06; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Li JJ, 2007, BIOCHEM BIOPH RES CO, V357, P648, DOI 10.1016/j.bbrc.2007.03.184; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Lopez-Terrada D, 2009, HUM PATHOL, V40, P783, DOI 10.1016/j.humpath.2008.07.022; Lu D, 2012, ONCOGENE, V31, P842, DOI 10.1038/onc.2011.287; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Moyen C, 2004, INT J BIOCHEM CELL B, V36, P728, DOI 10.1016/S1357-2725(03)00265-6; Murray SS, 1997, EXP CELL RES, V233, P297, DOI 10.1006/excr.1997.3550; Navarro-Alvarez N, 2009, CURR STEM CELL RES T, V4, P141, DOI 10.2174/157488809788167418; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Patel YM, 1999, P NATL ACAD SCI USA, V96, P1279, DOI 10.1073/pnas.96.4.1279; Pilcher Karen E., 2002, Gene Expression Patterns, V2, P369, DOI 10.1016/S1567-133X(02)00023-6; Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048; Sekine S, 2007, HEPATOLOGY, V45, P361, DOI 10.1002/hep.21523; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sodhi D, 2005, J HEPATOL, V43, P132, DOI 10.1016/j.jhep.2005.02.019; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Suksaweang S, 2004, DEV BIOL, V266, P109, DOI 10.1016/j.ydbio.2003.10.010; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Ueda Y, 1998, INT J BIOCHEM CELL B, V30, P679, DOI 10.1016/S1357-2725(98)00023-5; von Schweinitz D, 1997, INT J CANCER, V74, P593, DOI 10.1002/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; WEINBERG AG, 1983, HUM PATHOL, V14, P512, DOI 10.1016/S0046-8177(83)80005-7; Williams JM, 2010, AM J PATHOL, V176, P2732, DOI 10.2353/ajpath.2010.080486; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Yajima Y, 2002, BIOL CHEM, V383, P757, DOI 10.1515/BC.2002.079; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Zhao XY, 2010, J BIOL CHEM, V285, P27924, DOI 10.1074/jbc.M110.136077; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	68	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22789	22798		10.1074/jbc.M112.378224	http://dx.doi.org/10.1074/jbc.M112.378224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613727	Green Published, hybrid			2022-12-28	WOS:000306495000036
J	Winter, R; Kuhn, U; Hause, G; Schwarz, E				Winter, Reno; Kuehn, Uwe; Hause, Gerd; Schwarz, Elisabeth			Polyalanine-independent Conformational Conversion of Nuclear Poly(A)-binding Protein 1 (PABPN1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; MESSENGER-RNA POLYADENYLATION; N-TERMINAL DOMAIN; AMYLOID-LIKE FIBRILS; POLY(A) TAIL LENGTH; PHYSICAL-PROPERTIES; SPECIFICITY FACTOR; CRYSTAL-STRUCTURE; BINDING; AGGREGATION	Oculopharyngeal muscular dystrophy is a late-onset disease caused by an elongation of a natural 10-alanine segment within the N-terminal domain of the nuclear poly(A)-binding protein 1 (PABPN1) to maximally 17 alanines. The disease is characterized by intranuclear deposits consisting primarily of PABPN1. In previous studies, we could show that the N-terminal domain of PABPN1 forms amyloid-like fibrils. Here, we analyze fibril formation of full-length PABPN1. Unexpectedly, fibril formation was independent of the presence of the alanine segment. With regard to fibril formation kinetics and resistance against denaturants, fibrils formed by full-length PABPN1 had completely different properties from those formed by the N-terminal domain. Fourier transformed infrared spectroscopy and limited proteolysis showed that fibrillar PABPN1 has a structure that differs from native PABPN1. Circumstantial evidence is presented that the C-terminal domain is involved in fibril formation.	[Winter, Reno; Schwarz, Elisabeth] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Saale, Germany; [Hause, Gerd] Univ Halle Wittenberg, Bioctr, D-06120 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Schwarz, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Saale, Germany.	elisabeth.schwarz@biochemtech.uni-halle.de			"Protein Conformational States with Cell Biological and Medical Relevance" [SFB610]	"Protein Conformational States with Cell Biological and Medical Relevance"	This work was supported by the SFB610 "Protein Conformational States with Cell Biological and Medical Relevance" Subproject A9.	Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bosse-Doenecke E, 2008, PROTEIN EXPRES PURIF, V58, P114, DOI 10.1016/j.pep.2007.10.012; Bousset L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009760; Brais B, 1999, SEMIN NEUROL, V19, P59, DOI 10.1055/s-2008-1040826; BRAIS B, 1995, HUM MOL GENET, V4, P429, DOI 10.1093/hmg/4.3.429; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; BROWN P, 1990, J INFECT DIS, V161, P467, DOI 10.1093/infdis/161.3.467; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Chartier A, 2006, EMBO J, V25, P2253, DOI 10.1038/sj.emboj.7601117; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; DURANCEAU AC, 1983, SURG CLIN N AM, V63, P825; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; FRIED K, 1975, J MED GENET, V12, P416, DOI 10.1136/jmg.12.4.416; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; Ge HH, 2008, PROTEINS, V71, P1539, DOI 10.1002/prot.21973; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Lodderstedt G, 2007, FEBS J, V274, P346, DOI 10.1111/j.1742-4658.2006.05595.x; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Sackewitz M, 2008, J AM CHEM SOC, V130, P7172, DOI 10.1021/ja800120s; Sackewitz M, 2008, PROTEIN SCI, V17, P1044, DOI 10.1110/ps.073276308; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scheuermann T, 2003, PROTEIN SCI, V12, P2685, DOI 10.1110/ps.03214703; Schroder-Tittmann K, 2010, BIOCHEMISTRY-US, V49, P7956, DOI 10.1021/bi101159s; Song JK, 2008, P NATL ACAD SCI USA, V105, P15317, DOI 10.1073/pnas.0801274105; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Tome FMS, 1997, NEUROMUSCULAR DISORD, V7, pS63, DOI 10.1016/S0960-8966(97)00085-0; Verheesen P, 2006, HUM MOL GENET, V15, P105, DOI 10.1093/hmg/ddi432; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800	43	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22662	22671		10.1074/jbc.M112.362327	http://dx.doi.org/10.1074/jbc.M112.362327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570486	Green Published, hybrid			2022-12-28	WOS:000306495000023
J	Zimmermann, M; Arachchige-Don, AS; Donaldson, MS; Dallapiazza, RF; Cowan, CE; Horne, MC				Zimmermann, Maike; Arachchige-Don, Aruni S.; Donaldson, Michaela S.; Dallapiazza, Robert F.; Cowan, Colleen E.; Horne, Mary C.			Elevated Cyclin G2 Expression Intersects with DNA Damage Checkpoint Signaling and Is Required for a Potent G(2)/M Checkpoint Arrest Response to Doxorubicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BREAST-CANCER CELLS; GENE-EXPRESSION; IONIZING-RADIATION; PHOSPHOINOSITIDE 3-KINASE; INDEPENDENT MECHANISMS; TRANSCRIPTION FACTORS; CHK2; ATR; GROWTH	To maintain genomic integrity DNA damage response (DDR), signaling pathways have evolved that restrict cellular replication and allow time for DNA repair. CCNG2 encodes an unconventional cyclin homolog, cyclin G2 (CycG2), linked to growth inhibition. Its expression is repressed by mitogens but up-regulated during cell cycle arrest responses to anti-proliferative signals. Here we investigate the potential link between elevated CycG2 expression and DDR signaling pathways. Expanding our previous finding that CycG2 overexpression induces a p53-dependent G(1)/S phase cell cycle arrest in HCT116 cells, we now demonstrate that this arrest response also requires the DDR checkpoint protein kinase Chk2. In accord with this finding we establish that ectopic CycG2 expression increases phosphorylation of Chk2 on threonine 68. We show that DNA double strand break-inducing chemotherapeutics stimulate CycG2 expression and correlate its up-regulation with checkpoint-induced cell cycle arrest and phospho-modification of proteins in the ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR) signaling pathways. Using pharmacological inhibitors and ATM-deficient cell lines, we delineate the DDR kinase pathway promoting CycG2 up-regulation in response to doxorubicin. Importantly, RNAi-mediated blunting of CycG2 attenuates doxorubicin-induced cell cycle checkpoint responses in multiple cell lines. Employing stable clones, we test the effect that CycG2 depletion has on DDR proteins and signals that enforce cell cycle checkpoint arrest. Our results suggest that CycG2 con-tributes to DNA damage-induced G(2)/M checkpoint by enforcing checkpoint inhibition of CycB1-Cdc2 complexes.	[Zimmermann, Maike; Donaldson, Michaela S.; Horne, Mary C.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Zimmermann, Maike; Arachchige-Don, Aruni S.; Dallapiazza, Robert F.; Cowan, Colleen E.; Horne, Mary C.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	University of California System; University of California Davis; University of Iowa	Horne, MC (corresponding author), Univ Calif Davis, Dept Pharmacol, Tupper Hall,Rm 2219B,451 E Hlth Sci Dr, Davis, CA 95616 USA.	mhorne@ucdavis.edu		Horne, Mary/0000-0002-2799-3212; Zimmermann, Maike/0000-0001-9005-3795	National Institutes of Health [P20CA103672]; NATIONAL CANCER INSTITUTE [P20CA103672, P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P20CA103672 (University of Iowa Cancer and Aging Program's NIA/NCI program project (pilot grand sub-awarded to M. C. H.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Arlander SJH, 2008, CANCER RES, V68, P89, DOI 10.1158/0008-5472.CAN-07-0675; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Bates S, 1996, ONCOGENE, V13, P1103; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carlessi L, 2010, BBA-MOL CELL RES, V1803, P1213, DOI 10.1016/j.bbamcr.2010.06.002; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chabalier-Taste C, 2008, BBA-MOL CELL RES, V1783, P2223, DOI 10.1016/j.bbamcr.2008.08.006; Chehab NH, 2000, GENE DEV, V14, P278; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Darbon JM, 2000, J BIOL CHEM, V275, P15363, DOI 10.1074/jbc.275.20.15363; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Faradji F, 2011, CELL CYCLE, V10, P805, DOI 10.4161/cc.10.5.14959; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Freeman AK, 2010, CELL CYCLE, V9, P736, DOI 10.4161/cc.9.4.10613; Gajate C, 2002, J BIOL CHEM, V277, P41580, DOI 10.1074/jbc.M204644200; Golan A, 2010, CELL CYCLE, V9, P2647, DOI 10.4161/cc.9.13.12121; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; HARPER JW, 1993, CELL, V75, P805; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ito Y, 2003, ANTICANCER RES, V23, P2335; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jensen MR, 1999, GENE, V230, P171, DOI 10.1016/S0378-1119(99)00057-8; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Landsverk KS, 2011, CELL CYCLE, V10, P819, DOI 10.4161/cc.10.5.14968; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Lee J, 2009, MOL BIOL CELL, V20, P1891, DOI 10.1091/mbc.E08-08-0818; Lee KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212969; Lemaire M, 2010, FEBS LETT, V584, P1199, DOI 10.1016/j.febslet.2010.02.043; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; McSherry TD, 2004, MOL CELL BIOL, V24, P9968, DOI 10.1128/MCB.24.22.9968-9985.2004; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Miyata H, 2001, CANCER RES, V61, P3188; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Ohtsuka T, 2004, ONCOGENE, V23, P5405, DOI 10.1038/sj.onc.1207693; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Okamoto K, 1999, ONCOGENE, V18, P4606, DOI 10.1038/sj.onc.1202821; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarkaria JN, 1999, CANCER RES, V59, P4375; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Shimizu A, 1998, BIOCHEM BIOPH RES CO, V242, P529, DOI 10.1006/bbrc.1997.8004; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Shiotani B, 2009, J CELL SCI, V122, P301, DOI 10.1242/jcs.035105; Siu WY, 2004, MOL CANCER THER, V3, P621; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Suenaga Y, 2009, J BIOL CHEM, V284, P35433, DOI 10.1074/jbc.M109.050047; Theard D, 2001, BIOCHEM BIOPH RES CO, V289, P1199, DOI 10.1006/bbrc.2001.6095; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai MH, 2006, ONCOGENE, V25, P622, DOI 10.1038/sj.onc.1209082; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang XQ, 2007, RADIAT RES, V168, P706, DOI 10.1667/RR1075.1; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu GX, 2008, MOL BIOL CELL, V19, P4968, DOI 10.1091/mbc.E08-03-0259; ZAUBERMAN A, 1995, ONCOGENE, V10, P2361; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao L, 2003, MOL CANCER RES, V1, P195; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	84	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22838	22853		10.1074/jbc.M112.376855	http://dx.doi.org/10.1074/jbc.M112.376855			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589537	hybrid, Green Published			2022-12-28	WOS:000306495000041
J	Kawamura, S; Colozo, AT; Ge, L; Muller, DJ; Park, PSH				Kawamura, Shiho; Colozo, Alejandro T.; Ge, Lin; Mueller, Daniel J.; Park, Paul S. -H.			Structural, Energetic, and Mechanical Perturbations in Rhodopsin Mutant That Causes Congenital Stationary Night Blindness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC FORCE SPECTROSCOPY; PROTEIN-COUPLED RECEPTOR; NATIVE BOVINE RHODOPSIN; SCHIFF-BASE COUNTERION; MOLECULAR-INTERACTIONS; MEMBRANE-PROTEINS; RETINITIS-PIGMENTOSA; G90D RHODOPSIN; ACTIVATION; ADHESION	Several point mutations in rhodopsin cause retinal diseases including congenital stationary night blindness and retinitis pigmentosa. The mechanism by which a single amino acid residue substitution leads to dysfunction is poorly understood at the molecular level. A G90D point mutation in rhodopsin causes constitutive activity and leads to congenital stationary night blindness. It is unclear which perturbations the mutation introduces and how they can cause the receptor to be constitutively active. To reveal insight into these mechanisms, we characterized the perturbations introduced into dark state G90D rhodopsin from a transgenic mouse model expressing exclusively the mutant rhodopsin in rod photoreceptor cells. UV-visible absorbance spectroscopy revealed hydroxylamine accessibility to the chromophore-binding pocket of dark state G90D rhodopsin, which is not detected in dark state wild-type rhodopsin but is detected in light-activated wild-type rhodopsin. Single-molecule force spectroscopy suggested that the structural changes introduced by the mutation are small. Dynamic single-molecule force spectroscopy revealed that, compared with dark state wild-type rhodopsin, the G90D mutation decreased energetic stability and increased mechanical rigidity of most structural regions in the dark state mutant receptor. The observed structural, energetic, and mechanical changes in dark state G90D rhodopsin provide insights into the nature of perturbations caused by a pathological point mutation. Moreover, these changed properties observed for dark state G90D rhodopsin are consistent with properties expected for an active state.	[Kawamura, Shiho; Ge, Lin; Mueller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Colozo, Alejandro T.; Park, Paul S. -H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Case Western Reserve University	Muller, DJ (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	daniel.mueller@bsse.ethz.ch; paul.park@case.edu	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665	National Institutes of Health [R00EY018085, R01EY021731, P30EY011373]; European Community [211800]; Deutsche Forschungsgemeinschaft; Ohio Lions Eye Research Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R00EY018085, P30EY011373, R01EY021731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ohio Lions Eye Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R00EY018085, R01EY021731, and P30EY011373. This work was also supported by the European Community's Seventh Framework Programme FP7/2007-2013 Grant 211800, Deutsche Forschungsgemeinschaft, Research to Prevent Blindness (an unrestricted grant and career development award), and the Ohio Lions Eye Research Foundation.	Azevedo AW, 2011, J NEUROSCI, V31, P3670, DOI 10.1523/JNEUROSCI.4750-10.2011; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dizhoor AM, 2008, J NEUROSCI, V28, P11662, DOI 10.1523/JNEUROSCI.4006-08.2008; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1998, FARADAY DISCUSS, V111, P1; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; Fahmy K, 1996, BIOCHEMISTRY-US, V35, P15065, DOI 10.1021/bi961486s; Fanelli F, 2010, FASEB J, V24, P3196, DOI 10.1096/fj.09-151084; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Grater F, 2007, J STRUCT BIOL, V157, P557, DOI 10.1016/j.jsb.2006.11.005; Howard J., 2001, MECH MOTOR PROTEINS; Jager S, 1997, BIOCHEMISTRY-US, V36, P1999, DOI 10.1021/bi962320u; Janovjak H, 2008, CHEMPHYSCHEM, V9, P954, DOI 10.1002/cphc.200700662; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kawamura S, 2010, BIOCHEMISTRY-US, V49, P10412, DOI 10.1021/bi101345x; Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Naash MI, 2004, J COMP NEUROL, V478, P149, DOI 10.1002/cne.20283; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Park PSH, 2012, CURR MED CHEM, V19, P1146; Park PSH, 2007, J BIOL CHEM, V282, P11377, DOI 10.1074/jbc.M610341200; Park PSH, 2009, BIOCHEMISTRY-US, V48, P4294, DOI 10.1021/bi900417b; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z; Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008; SIEVING PA, 1995, P NATL ACAD SCI USA, V92, P880, DOI 10.1073/pnas.92.3.880; Sieving PA, 2001, J NEUROSCI, V21, P5449, DOI 10.1523/JNEUROSCI.21-15-05449.2001; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sum CS, 2002, J BIOL CHEM, V277, P36188, DOI 10.1074/jbc.M201731200; Toledo D, 2011, J BIOL CHEM, V286, P39993, DOI 10.1074/jbc.M110.201517; Vogel R, 2002, BIOCHEMISTRY-US, V41, P3536, DOI 10.1021/bi016024f; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Wilson MH, 2000, BIOCHEMISTRY-US, V39, P693, DOI 10.1021/bi9920275; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; Zvyaga TA, 1996, BIOCHEMISTRY-US, V35, P7536, DOI 10.1021/bi960391n	47	20	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21826	21835		10.1074/jbc.M112.340182	http://dx.doi.org/10.1074/jbc.M112.340182			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549882	hybrid, Green Published			2022-12-28	WOS:000306418600024
J	Amato, AA; Rajagopalan, S; Lin, JZ; Carvalho, BM; Figueira, ACM; Lu, J; Ayers, SD; Mottin, M; Silveira, RL; Souza, PCT; Mourao, RHV; Saad, MJA; Togashi, M; Simeoni, LA; Abdalla, DSP; Skaf, MS; Polikparpov, I; Lima, MCA; Galdino, SL; Brennan, RG; Baxter, JD; Pitta, IR; Webb, P; Phillips, KJ; Neves, FAR				Amato, Angelica A.; Rajagopalan, Senapathy; Lin, Jean Z.; Carvalho, Bruno M.; Figueira, Ana C. M.; Lu, Jenny; Ayers, Stephen D.; Mottin, Melina; Silveira, Rodrigo L.; Souza, Paulo C. T.; Mourao, Rosa H. V.; Saad, Mario J. A.; Togashi, Marie; Simeoni, Luiz A.; Abdalla, Dulcineia S. P.; Skaf, Munir S.; Polikparpov, Igor; Lima, Maria C. A.; Galdino, Suely L.; Brennan, Richard G.; Baxter, John D.; Pitta, Ivan R.; Webb, Paul; Phillips, Kevin J.; Neves, Francisco A. R.			GQ-16, a Novel Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Ligand, Promotes Insulin Sensitization without Weight Gain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; MOLECULAR-DYNAMICS; THIAZOLIDINEDIONE; ROSIGLITAZONE; OBESITY; SYSTEM; AGONIST	The recent discovery that peroxisome proliferator-activated receptor gamma (PPAR gamma) targeted anti-diabetic drugs function by inhibiting Cdk5-mediated phosphorylation of the receptor has provided a new viewpoint to evaluate and perhaps develop improved insulin-sensitizing agents. Herein we report the development of a novel thiazolidinedione that retains similar anti-diabetic efficacy as rosiglitazone in mice yet does not elicit weight gain or edema, common side effects associated with full PPAR gamma activation. Further characterization of this compound shows GQ-16 to be an effective inhibitor of Cdk5-mediated phosphorylation of PPAR gamma. The structure of GQ-16 bound to PPAR gamma demonstrates that the compound utilizes a binding mode distinct from other reported PPAR gamma ligands, although it does share some structural features with other partial agonists, such as MRL-24 and PA-082, that have similarly been reported to dissociate insulin sensitization from weight gain. Hydrogen/deuterium exchange studies reveal that GQ-16 strongly stabilizes the beta-sheet region of the receptor, presumably explaining the compound's efficacy in inhibiting Cdk5-mediated phosphorylation of Ser-273. Molecular dynamics simulations suggest that the partial agonist activity of GQ-16 results from the compound's weak ability to stabilize helix 12 in its active conformation. Our results suggest that the emerging model, whereby "ideal" PPAR gamma-based therapeutics stabilize the beta-sheet/Ser-273 region and inhibit Cdk5-mediated phosphorylation while minimally invoking adipogenesis and classical agonism, is indeed a valid framework to develop improved PPAR gamma modulators that retain antidiabetic actions while minimizing untoward effects.	[Rajagopalan, Senapathy; Lu, Jenny; Ayers, Stephen D.; Baxter, John D.; Webb, Paul; Phillips, Kevin J.] Methodist Hosp, Res Inst, Diabet Res Ctr, Houston, TX 77030 USA; [Amato, Angelica A.; Togashi, Marie; Simeoni, Luiz A.; Neves, Francisco A. R.] Univ Brasilia, Lab Farmacol Mol, Dept Ciencias Farmaceut, Fac Ciencias Saude, BR-70919970 Brasilia, DF, Brazil; [Lin, Jean Z.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Carvalho, Bruno M.; Saad, Mario J. A.] Univ Estadual Campinas, Dept Med Interna, BR-13083887 Sao Paulo, Brazil; [Figueira, Ana C. M.] Brazilian Assoc Synchrotron Light Technol, Natl Inst Biosci, BR-13083970 Sao Paulo, Brazil; [Mottin, Melina; Silveira, Rodrigo L.; Souza, Paulo C. T.; Skaf, Munir S.] Univ Estadual Campinas, Inst Chem, BR-13084862 Sao Paulo, Brazil; [Abdalla, Dulcineia S. P.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508900 Sao Paulo, Brazil; [Mourao, Rosa H. V.] Univ Fed Oeste Para, Lab Bioprospeccao & Biol Expt, BR-68040070 Santarem, Para, Brazil; [Lima, Maria C. A.; Galdino, Suely L.; Pitta, Ivan R.] Univ Fed Pernambuco, Dept Antibiot, BR-50670901 Recife, PE, Brazil; [Polikparpov, Igor] Univ Sao Paulo, BR-13560970 Sao Carlos, SP, Brazil; [Polikparpov, Igor] Inst Fis Sao Carlos, Dept Fis, BR-13560970 Sao Carlos, SP, Brazil; [Brennan, Richard G.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Universidade de Brasilia; University of Houston System; University of Houston; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal do Oeste do Para; Universidade Federal de Pernambuco; Universidade de Sao Paulo; Duke University	Phillips, KJ (corresponding author), Methodist Hosp, Res Inst, Diabet Res Ctr, 6535 Fannin, Houston, TX 77030 USA.	kphillips@tmhs.org; nevesfar@gmail.com	Togashi, Marie/L-3092-2018; Saad, Mario/ABD-8262-2020; Carvalho, Bruno/G-1255-2012; Simeoni, Luiz Alberto/A-9088-2008; Telles de Souza, Paulo Cesar/E-5072-2013; Skaf, Munir S/B-1614-2013; Ayers, Stephen D/O-4535-2014; Pitta, Ivan/C-9265-2014; Silveira, Rodrigo L/I-3961-2014; Amato, Angélica/B-9247-2015; Mottin, Melina/D-8700-2016; Figueira, Ana Carolina/X-1649-2019	Carvalho, Bruno/0000-0002-6792-0288; Simeoni, Luiz Alberto/0000-0003-3401-290X; Telles de Souza, Paulo Cesar/0000-0003-0660-1301; Skaf, Munir S/0000-0001-7485-1228; Ayers, Stephen D/0000-0003-1390-8969; Pitta, Ivan/0000-0002-2899-4049; Silveira, Rodrigo L/0000-0001-9515-3082; Amato, Angélica/0000-0002-8454-5504; Mottin, Melina/0000-0003-0878-9029; Figueira, Ana Carolina/0000-0002-7023-8490; Brennan, Richard/0000-0001-7647-485X	MCT/CNPq/CT-Infra/CT-Grant [620195/2008-8, 485811/2011-1]; Fundacao de Amparo a Pesquisa do Estado de Sao 598 Paulo (FAPESP) [2010/17048-8]; FAPESP [2010/08680-2, 2009/14108-2]; National Institutes of Health, NIGMS; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]	MCT/CNPq/CT-Infra/CT-Grant; Fundacao de Amparo a Pesquisa do Estado de Sao 598 Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE))	The Molecular Pharmacology Laboratory Group was supported by MCT/CNPq/CT-Infra/CT-Grant 620195/2008-8 and 485811/2011-1.; Supported by Fundacao de Amparo a Pesquisa do Estado de Sao 598 Paulo (FAPESP) Grant 2010/17048-8.; Supported by FAPESP Grant 2010/08680-2.; Supported by FAPESP Grant 2009/14108-2.; We thank Dr. Carlos Pantoja for invaluable assistance with the adipogenesis studies, Rilva Soares Pinho Grigorio for excellent technical assistance, and Eduardo J. Pilau and Fabio C. Gozzo of the Dalton Mass Spectrometry Group at UNICAMP for assistance with the HDX studies. The Berkeley Center for Structural Biology is supported in part by National Institutes of Health, NIGMS, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Leite LFCD, 2007, EUR J MED CHEM, V42, P1263, DOI 10.1016/j.ejmech.2007.02.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Figueira ACM, 2011, MOL ENDOCRINOL, V25, P15, DOI 10.1210/me.2010-0202; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Hansson A, 2011, INT J QUANTUM CHEM, V111, P1346, DOI 10.1002/qua.22638; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Leach A., 2001, MOL MODELLING PRINCI; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Mourao RH, 2005, EUR J MED CHEM, V40, P1129, DOI 10.1016/j.ejmech.2005.06.002; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Yaturu S, 2007, DIABETES CARE, V30, P1574, DOI 10.2337/dc06-2606; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102	45	85	90	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28169	28179		10.1074/jbc.M111.332106	http://dx.doi.org/10.1074/jbc.M111.332106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22584573	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000307840700090
J	Ren, CC; Amm, HM; DeVilliers, P; Wu, YX; Deatherage, JR; Liu, ZY; MacDougall, M				Ren, Changchun; Amm, Hope M.; DeVilliers, Patricia; Wu, Yixin; Deatherage, Joseph R.; Liu, Zhongyu; MacDougall, Mary			Targeting the Sonic Hedgehog Pathway in Keratocystic Odontogenic Tumor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENIGN CYSTIC NEOPLASM; SHH SIGNALING PATHWAY; AGGRESSIVE NATURE; ENAMEL MINERALIZATION; CANCER-CELLS; CYCLOPAMINE; MUTATIONS; GENE; PROLIFERATION; INHIBITION	Keratocystic odontogenic tumors (KCOT) may occur sporadically or associated with the nevoid basal cell carcinoma syndrome. It is a benign aggressive tumor of odontogenic epithelial origin with a high rate of recurrence. A primary human keratocystic odontogenic tumor cell population, KCOT-1, has been established from a tumor explant culture. The KCOT-1 cells were characterized by growth rate, gene expression profiles of major tooth enamel matrix proteins (EMPs), amelogenin (AMELX), enamelin (ENAM), ameloblastin (AMBN), amelotin (AMTN), tumor-related proteins enamelysin (MMP-20), kallikrein-4 (KLK-4), and odontogenic ameloblast-associated protein (ODAM) using quantitative real-time reverse transcription-polymerase chain reaction. Cytokeratin 14 (CK14) was examined by immunohistochemistry. In addition, expression of the members of the sonic hedgehog (SHH) pathway, SHH, patched (PTCH-1), smoothened (SMO), GLI-1, and GLI-2 and of the NOTCH signaling pathway, NOTCH-1, NOTCH-2, NOTCH-3, JAG-2 (Jagged-2), and Delta-like-1 (DLL-1) were evaluated. KCOT-1 cells were treated with SMO antagonist cyclopamine. We found that cyclopamine significantly arrested the growth of KCOT-1 cells in a dose-dependent manner and that the effects of cyclopamine were abolished by adding SHH protein. The protein expression of the SHH pathway was down-regulated by cyclopamine, further confirming that cyclopamine inhibits the SHH signaling pathway; SHH down-regulation correlated with the down-regulation of the NOTCH signaling pathway as well. In conclusion, using an established KCOT-1 cell population, we characterized the gene expression profiles related to the EMPs, SHH, and NOTCH signaling pathway and confirmed that cyclopamine significantly arrested the growth of KCOT-1 cells and may be a viable agent as a novel therapeutic.	[Ren, Changchun; Amm, Hope M.; Wu, Yixin; Liu, Zhongyu; MacDougall, Mary] Univ Alabama Birmingham, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [Ren, Changchun; Deatherage, Joseph R.; MacDougall, Mary] Univ Alabama Birmingham, Dept Oral & Maxillofacial Surg, Birmingham, AL 35294 USA; [DeVilliers, Patricia] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	MacDougall, M (corresponding author), 1919 7th Ave,S Rm SDB 702, Birmingham, AL 35294 USA.	macdouga@uab.edu	MacDougall, Mary/ABG-8212-2021	Amm, Hope/0000-0003-2416-9575	Institute of Oral Health Research, School of Dentistry, University of Alabama at Birmingham; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088010] Funding Source: NIH RePORTER	Institute of Oral Health Research, School of Dentistry, University of Alabama at Birmingham; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Institute of Oral Health Research, School of Dentistry, University of Alabama at Birmingham.	BARNES L, 2005, WHO CLASSIFICATION T, P306; Barreto DC, 2000, J DENT RES, V79, P1418, DOI 10.1177/00220345000790061101; Buchtova M, 2008, DEV BIOL, V319, P132, DOI 10.1016/j.ydbio.2008.03.004; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Diniz MG, 2009, ORAL ONCOL, V45, P291, DOI 10.1016/j.oraloncology.2008.05.020; FARNDON PA, 1992, LANCET, V339, P581, DOI 10.1016/0140-6736(92)90868-4; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Heikinheimo K, 2007, J DENT RES, V86, P544, DOI 10.1177/154405910708600611; Heretsch P, 2010, BIOORGAN MED CHEM, V18, P6613, DOI 10.1016/j.bmc.2010.07.038; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Katase N, 2007, J ORAL PATHOL MED, V36, P550, DOI 10.1111/j.1600-0714.2007.00578.x; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Kolar Z, 2006, J ORAL PATHOL MED, V35, P75, DOI 10.1111/j.1600-0714.2006.00382.x; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d; Lench NJ, 1996, ORAL ONCOL, V32B, P202, DOI 10.1016/0964-1955(95)00053-4; Li TJ, 2008, ORAL DIS, V14, P174, DOI 10.1111/j.1601-0825.2007.01369.x; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; MEISELMAN F, 1994, J ORAL MAXIL SURG, V52, P960, DOI 10.1016/S0278-2391(10)80080-1; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; Mitsiadis TA, 2005, ARCH ORAL BIOL, V50, P137, DOI 10.1016/j.archoralbio.2004.10.006; Mitsiadis TA, 1998, DEV BIOL, V204, P420, DOI 10.1006/dbio.1998.9092; Miyazaki KI, 2006, JPN J OPHTHALMOL, V50, P305, DOI 10.1007/s10384-006-0341-1; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Murphy CL, 2008, AMYLOID, V15, P89, DOI 10.1080/13506120802005965; Nishimaki H, 2004, BIOCHEM BIOPH RES CO, V314, P313, DOI 10.1016/j.bbrc.2003.12.097; Park JC, 2007, EUR J ORAL SCI, V115, P153, DOI 10.1111/j.1600-0722.2007.00435.x; Ren C, 2011, CELLS TISSUES ORGANS, V194, P296, DOI 10.1159/000324759; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sacedon R, 2005, J IMMUNOL, V174, P1456, DOI 10.4049/jimmunol.174.3.1456; Shear M, 2002, ORAL ONCOL, V38, P407, DOI 10.1016/S1368-8375(01)00067-7; Shear M, 2002, ORAL ONCOL, V38, P323, DOI 10.1016/S1368-8375(01)00066-5; Shear M, 2002, ORAL ONCOL, V38, P219, DOI 10.1016/S1368-8375(01)00065-3; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Sun LS, 2008, J DENT RES, V87, P575, DOI 10.1177/154405910808700616; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Zavros Y, 2007, J BIOL CHEM, V282, P33265, DOI 10.1074/jbc.M707090200; Zhang L, 2006, MED HYPOTHESES, V67, P1242, DOI 10.1016/j.mehy.2006.04.062	42	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27117	27125		10.1074/jbc.M112.367680	http://dx.doi.org/10.1074/jbc.M112.367680			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22679015	Green Published, hybrid			2022-12-28	WOS:000307386000064
J	Yao, X; Chong, HH; Zhang, C; Qiu, ZL; Qin, B; Han, RY; Waltersperger, S; Wang, MT; He, YX; Cui, S				Yao, Xue; Chong, Huihui; Zhang, Chao; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; Waltersperger, Sandro; Wang, Meitian; He, Yuxian; Cui, Sheng			Structural Basis of Potent and Broad HIV-1 Fusion Inhibitor CP32M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 CORE STRUCTURE; MEMBRANE-FUSION; ANTIRETROVIRAL ACTIVITY; PEPTIDE INHIBITOR; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; RESISTANT HIV-1; COILED-COIL; ENFUVIRTIDE	CP32M is a newly designed peptide fusion inhibitor possessing potent anti-HIV activity, especially against T20-resistant HIV-1 strains. In this study, we show that CP32M can efficiently inhibit a large panel of diverse HIV-1 variants, including subtype B', CRF07_BC, and CRF01_AE recombinants and naturally occurring or induced T20-resistant viruses. To elucidate its mechanism of action, we determined the crystal structure of CP32M complexed with its target sequence. Differing from its parental peptide, CP621-652, the (VEWNEMT627)-V-621 motif of CP32M folds into two alpha-helix turns at the N terminus of the pocket-binding domain, forming a novel layer in the six-helix bundle structure. Prominently, the residue Asn-624 of the (VEWNEMT627)-V-621 motif is engaged in the polar interaction with a hydrophilic ridge that borders the hydrophobic pocket on the N-terminal coiled coil. The original inhibitor design of CP32M provides several intra- and salt bridge/hydrogen bond interactions favoring the stability of the helical conformation of CP32M and its interactions with N-terminal heptad repeat ( NHR) targets. We identified a novel salt bridge between Arg-557 on the NHR and Glu-648 of CP32M that is critical for the binding of CP32M and resistance against the inhibitor. Therefore, our data present important information for developing novel HIV-1 fusion inhibitors for clinical use.	[Yao, Xue; Chong, Huihui; Zhang, Chao; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; He, Yuxian; Cui, Sheng] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Yao, Xue; Chong, Huihui; Zhang, Chao; Qiu, Zonglin; Qin, Bo; Han, Ruiyun; He, Yuxian; Cui, Sheng] Peking Union Med Coll, Beijing 100730, Peoples R China; [Waltersperger, Sandro; Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	He, YX (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	yhe@ipb.pumc.edu.cn; cui.sheng@ipb.pumc.edu.cn	Cui, Sheng/AAQ-1721-2020; Wang, Meitian/D-3208-2013; Sheng, CUI/M-6405-2013	Sheng, CUI/0000-0001-6329-3582; Wang, Meitian/0000-0002-5340-3036	National Outstanding Youth Award of the Natural Science Foundation of China (NSFC) [81025009]; NSFC [30870123]; National 973 Program of China [2010CB530100]; Beijing Natural Science Foundation [7122116]	National Outstanding Youth Award of the Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Grants 81025009 from the National Outstanding Youth Award of the Natural Science Foundation of China (NSFC), 30870123 from the NSFC, 2010CB530100 from the National 973 Program of China, and 7122116 from the Beijing Natural Science Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chinnadurai R, 2005, AIDS, V19, P1401, DOI 10.1097/01.aids.0000180785.25800.de; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Chong HH, 2012, J BIOL CHEM, V287, P20281, DOI 10.1074/jbc.M112.354126; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P11129, DOI 10.1128/JVI.01060-08; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Shimura K, 2010, J BIOL CHEM, V285, P39471, DOI 10.1074/jbc.M110.145789; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Yao X, 2012, J BIOL CHEM, V287, P6788, DOI 10.1074/jbc.M111.317883; Yu XW, 2012, J VIROL, V86, P589, DOI 10.1128/JVI.05066-11; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	48	20	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26618	26629		10.1074/jbc.M112.381079	http://dx.doi.org/10.1074/jbc.M112.381079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22679024	Green Published, hybrid			2022-12-28	WOS:000307386000014
J	Eckert, T; Link, S; Le, DTV; Sobczak, JP; Gieseke, A; Richter, K; Woehlke, G				Eckert, Thomas; Link, Susanne; Doan Tuong-Van Le; Sobczak, Jean-Philippe; Gieseke, Anja; Richter, Klaus; Woehlke, Guenther			Subunit Interactions and Cooperativity in the Microtubule-severing AAA ATPase Spastin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAPLEGIA PROTEIN SPASTIN; ESCRT-III COMPLEX; EXPRESSION ANALYSIS; STRUCTURAL BASIS; PLUS PROTEINS; MOTOR DOMAIN; MUTATIONS; SYNTHASE; IDENTIFICATION; HYDROLYSIS	Spastin is a hexameric ring AAA ATPase that severs microtubules. To see whether the ring complex funnels the energy of multiple ATP hydrolysis events to the site of mechanical action, we investigate here the cooperativity of spastin. Several lines of evidence indicate that interactions among two subunits dominate the cooperative behavior: (i) the ATPase activity shows a sigmoidal dependence on the ATP concentration; (ii) ATP gamma S displays a mixed-inhibition behavior for normal ATP turnover; and (iii) inactive mutant subunits inhibit the activity of spastin in a hyperbolic dependence, characteristic for two interacting species. A quantitative model based on neighbor interactions fits mutant titration experiments well, suggesting that each subunit is mainly influenced by one of its neighbors. These observations are relevant for patients suffering from SPG4-type hereditary spastic paraplegia and explain why single amino acid exchanges lead to a dominant negative phenotype. In severing assays, wild type spastin is even more sensitive toward the presence of inactive mutants than in enzymatic assays, suggesting a weak coupling of ATPase and severing activity.	[Eckert, Thomas; Link, Susanne; Doan Tuong-Van Le; Gieseke, Anja; Woehlke, Guenther] Tech Univ Munich, Dept Phys Biophys E22, D-85748 Garching, Germany; [Sobczak, Jean-Philippe] Tech Univ Munich, Walter Schottky Inst, Lab Biomol Nanotechnol, D-85748 Garching, Germany; [Richter, Klaus] Tech Univ Munich, Dept Chem, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Woehlke, G (corresponding author), Tech Univ Munich, Dept Phys Biophys E22, James Franck Str 1, D-85748 Garching, Germany.	guenther.woehlke@mytum.de	Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642; Woehlke, Gunther/0000-0001-8462-9962	Deutsche Forschungsgemeinschaft [Wo614/4-1, SFB 863]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Wo614/4-1 and SFB 863. This work was also scientifically and financially supported by Prof. Matthias Rief, Prof. Johannes Buchner, and Prof. Hendrik Dietz.	Abbondanzieri EA, 2009, NATURE, V457, P392, DOI 10.1038/457392a; Adair GS, 1925, J BIOL CHEM, V63, P529; Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Adio S, 2009, FEBS J, V276, P3641, DOI 10.1111/j.1742-4658.2009.07083.x; Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; CHA S, 1968, MOL PHARMACOL, V4, P621; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Ding CM, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-8; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fersht A., 1984, ENZYME STRUCTURE MEC, P98; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Proukakis C, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9108; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Sauter S, 2002, HUM MUTAT, V20, P127, DOI 10.1002/humu.10105; Segel I.H., 1975, ENZYME KINETICS; Svenson IK, 2005, NEUROGENETICS, V6, P135, DOI 10.1007/s10048-005-0219-2; Svenson IK, 2001, AM J HUM GENET, V68, P1077, DOI 10.1086/320111; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	48	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26278	26290		10.1074/jbc.M111.291898	http://dx.doi.org/10.1074/jbc.M111.291898			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22637577	Green Published, hybrid			2022-12-28	WOS:000306916300054
J	Graham, LM; Gupta, V; Schafer, G; Reid, DM; Kimberg, M; Dennehy, KM; Hornsell, WG; Guler, R; Campanero-Rhodes, MA; Palma, AS; Feizi, T; Kim, SK; Sobieszczuk, P; Willment, JA; Brown, GD				Graham, Lisa M.; Gupta, Vandana; Schafer, Georgia; Reid, Delyth M.; Kimberg, Matti; Dennehy, Kevin M.; Hornsell, William G.; Guler, Reto; Campanero-Rhodes, Maria A.; Palma, Angelina S.; Feizi, Ten; Kim, Stella K.; Sobieszczuk, Peter; Willment, Janet A.; Brown, Gordon D.			The C-type Lectin Receptor CLECSF8 (CLEC4D) Is Expressed by Myeloid Cells and Triggers Cellular Activation through Syk Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTOR; BETA-GLUCAN RECEPTOR; DENDRITIC CELLS; CANDIDA-ALBICANS; GAMMA-CHAIN; DECTIN-1; MACROPHAGES; MONOCYTES; RESPONSES; MINCLE	CLECSF8 is a poorly characterized member of the "Dectin-2 cluster" of C-type lectin receptors and was originally thought to be expressed exclusively by macrophages. We show here that CLECSF8 is primarily expressed by peripheral blood neutrophils and monocytes and weakly by several subsets of peripheral blood dendritic cells. However, expression of this receptor is lost upon in vitro differentiation of monocytes into dendritic cells or macrophages. Like the other members of the Dectin-2 family, which require association of their transmembrane domains with signaling adaptors for surface expression, CLECSF8 is retained intracellularly when expressed in non-myeloid cells. However, we demonstrate that CLECSF8 does not associate with any known signaling adaptor molecule, including DAP10, DAP12, or the FcR gamma chain, and we found that the C-type lectin domain of CLECSF8 was responsible for its intracellular retention. Although CLECSF8 does not contain a signaling motif in its cytoplasmic domain, we show that this receptor is capable of inducing signaling via Syk kinase in myeloid cells and that it can induce phagocytosis, proinflammatory cytokine production, and the respiratory burst. These data therefore indicate that CLECSF8 functions as an activation receptor on myeloid cells and associates with a novel adaptor molecule. Characterization of the CLECSF8-deficient mice and screening for ligands using oligosaccharide microarrays did not provide further insights into the physiological function of this receptor.	[Willment, Janet A.; Brown, Gordon D.] Univ Aberdeen, Sect Immunol & Infect, Div Appl Med, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Graham, Lisa M.; Gupta, Vandana; Schafer, Georgia; Kimberg, Matti; Dennehy, Kevin M.; Hornsell, William G.; Guler, Reto; Willment, Janet A.; Brown, Gordon D.] Univ Cape Town, Inst Infect Dis & Mol Med, Cent Lab Serv, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Campanero-Rhodes, Maria A.; Palma, Angelina S.; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Glycosci Lab, London W12 0NN, England; [Kim, Stella K.] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94143 USA; [Sobieszczuk, Peter] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1142, New Zealand	University of Aberdeen; University of Cape Town; Imperial College London; University of California System; University of California San Francisco; University of Auckland	Willment, JA (corresponding author), Univ Aberdeen, Sect Immunol & Infect, Div Appl Med, Inst Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	janet.willment@abdn.ac.uk; gordon.brown@abdn.ac.uk	Horsnell, William GC/A-9512-2013; Campanero-Rhodes, María Asunción/M-3158-2014; Guler, Reto/A-4013-2011; Palma, Angelina S/D-2052-2013	Campanero-Rhodes, María Asunción/0000-0002-3373-0064; Palma, Angelina S/0000-0001-5797-6555; brown, gordon/0000-0002-0287-5383; Feizi, Ten/0000-0001-6495-0329; Graham, Lisa/0000-0002-7865-7833; Horsnell, William Gordon Charles/0000-0001-7172-408X; Willment, Janet/0000-0002-7040-0857	Wellcome Trust; National Research Foundation; Deutscher Akademischer Austauschdienst; University of Cape Town; UK Research Council Basic Technology Initiative "Glycoarrays" [GRS/79268]; UK Medical Research Council; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/26515/2006]; Consejo Superior de Investigaciones Cientificas, Programe "Junta para la Ampliacion de Estudios" [JaeDoc/098/2011]; Fondo Social Europeo; EPSRC [EP/G037604/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S79268/02, EP/G037604/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Research Foundation; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); University of Cape Town; UK Research Council Basic Technology Initiative "Glycoarrays"; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Consejo Superior de Investigaciones Cientificas, Programe "Junta para la Ampliacion de Estudios"; Fondo Social Europeo(European Social Fund (ESF)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Wellcome Trust, the National Research Foundation, the Deutscher Akademischer Austauschdienst, the University of Cape Town, the UK Research Council Basic Technology Initiative "Glycoarrays" (GRS/79268), and the UK Medical Research Council. A. S. P is a fellow of the Fundacao para a Ciencia e Tecnologia (SFRH/BPD/26515/2006, Portugal) and M. A. C. of the Consejo Superior de Investigaciones Cientificas, Programe "Junta para la Ampliacion de Estudios" (JaeDoc/098/2011) cofinanced by the Fondo Social Europeo.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Balch SG, 1998, J BIOL CHEM, V273, P18656, DOI 10.1074/jbc.273.29.18656; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	36	90	92	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25964	25974		10.1074/jbc.M112.384164	http://dx.doi.org/10.1074/jbc.M112.384164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689578	Green Published, hybrid			2022-12-28	WOS:000306916300024
J	Johnson, AE; Collier, SE; Ohi, MD; Gould, KL				Johnson, Alyssa E.; Collier, Scott E.; Ohi, Melanie D.; Gould, Kathleen L.			Fission Yeast Dma1 Requires RING Domain Dimerization for Its Ubiquitin Ligase Activity and Mitotic Checkpoint Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; CYTOKINESIS; RNF4; CHFR; EXIT; CELL; SIN	In fission yeast (Schizosaccharomyces pombe), the E3 ubiquitin ligase Dma1 delays cytokinesis if chromosomes are not properly attached to the mitotic spindle. Dma1 contains a C-terminal RING domain, and we have found that the Dma1 RING domain forms a stable homodimer. Although the RING domain is required for dimerization, residues in the C-terminal tail are also required to help form or stabilize the dimeric structure because mutation of specific residues in this region disrupts Dma1 dimerization. Further analyses showed that Dma1 dimerization is required for proper localization at spindle pole bodies and the cell division site, E3 ligase activity, and mitotic checkpoint function. Thus, Dma1 forms an obligate dimer via its RING domain, which is essential for efficient transfer of ubiquitin to its substrate(s). This study further supports the mechanistic paradigm that many RING E3 ligases function as RING dimers.	[Johnson, Alyssa E.; Gould, Kathleen L.] Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA; [Johnson, Alyssa E.; Collier, Scott E.; Ohi, Melanie D.; Gould, Kathleen L.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Collier, Scott E.; Ohi, Melanie D.] Vanderbilt Univ, Sch Med, Struct Biol Ctr, Nashville, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University; Vanderbilt University	Gould, KL (corresponding author), Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, 221 Kirkland Hall, Nashville, TN 37232 USA.	kathy.gould@vanderbilt.edu		Gould, Kathleen/0000-0002-3810-4070	National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program [T32 GM08554]; Molecular Biophysics Training Program [T32 GM008320]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biophysics Training Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program Grant T32 GM08554 (to A. E. J.) and Molecular Biophysics Training Program Grant T32 GM008320 (to S. E. C.). This work was also supported by the Howard Hughes Medical Institute.	Brooks L, 2008, CELL MOL LIFE SCI, V65, P3458, DOI 10.1007/s00018-008-8220-1; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fraschini R, 2004, MOL BIOL CELL, V15, P3796, DOI 10.1091/mbc.E04-02-0094; Garcia-Cortes JC, 2009, J CELL BIOL, V186, P739, DOI 10.1083/jcb.200902116; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; Guertin DA, 2002, DEV CELL, V3, P779, DOI 10.1016/S1534-5807(02)00367-2; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; James P, 1996, GENETICS, V144, P1425; Johnson AE, 2011, EMBO J, V30, P341, DOI 10.1038/emboj.2010.317; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murone M, 1996, EMBO J, V15, P6605, DOI 10.1002/j.1460-2075.1996.tb01051.x; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Sohrmann M, 1998, GENE DEV, V12, P84, DOI 10.1101/gad.12.1.84; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985	26	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25741	25748		10.1074/jbc.M112.349712	http://dx.doi.org/10.1074/jbc.M112.349712			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669973	hybrid, Green Published			2022-12-28	WOS:000306916300005
J	Johnson, X; Alric, J				Johnson, Xenie; Alric, Jean			Interaction between Starch Breakdown, Acetate Assimilation, and Photosynthetic Cyclic Electron Flow in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-I; FERMENTATIVE METABOLISM; CHLOROPLASTS; TRANSPORT; LIGHT; CHLORORESPIRATION; STABILIZATION; MITOCHONDRIA; CELLS; POOL	Spectroscopic studies on photosynthetic electron transfer generally are based upon the monitoring of dark to light changes in the electron transfer chain. These studies, which focus on the light reactions of photosynthesis, also indirectly provide information on the redox or metabolic state of the chloroplast in the dark. Here, using the unicellular microalga Chlamydomonas reinhardtii, we study the impact of heterotrophic/mixotrophic acetate feeding on chloroplast carbon metabolism by using the spectrophotometric detection of P700(+), the photooxidized primary electron donor of photosystem I. We show that, when photosynthetic linear and cyclic electron flows are blocked (DCMU inhibiting PSII and methylviologen accepting electrons from PSI), the post-illumination reduction kinetics of P700(+) directly reflect the dark metabolic production of reductants (mainly NAD(P)H) in the stroma of chloroplasts. Such results can be correlated to other metabolic studies: in the absence of acetate, for example, the P700(+) reduction rate matches the rate of starch breakdown reported previously, confirming the chloroplast localization of the upstream steps of the glycolytic pathway in Chlamydomonas. Furthermore, the question of the interplay between photosynthetic and non-photosynthetic carbon metabolism can be addressed. We show that cyclic electron flow around photosystem I is twice as fast in a starchless mutant fed with acetate than it is in the WT, and we relate how changes in the flux of electrons from carbohydrate metabolism modulate the redox poise of the plastoquinone pool in the dark through chlororespiration.	[Alric, Jean] Univ Paris 06, Inst Biol Physicochim, F-75005 Paris, France; CNRS, UMR 7141, F-75005 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Alric, J (corresponding author), Univ Paris 06, Inst Biol Physicochim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	jean.alric@ibpc.fr	Alric, Jean/E-3538-2013; Johnson, Xenie/T-7151-2019	Alric, Jean/0000-0003-3574-2234; Johnson, Xenie/0000-0003-3424-7047	Agence Nationale pour la Recherche [ANR-08-BIOE-002 ALGOMICS]; European Commission EUFP7 [SUNBIOPATH-GA-245070]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Commission EUFP7	This work was supported by Agence Nationale pour la Recherche ANR-08-BIOE-002 ALGOMICS and European Commission EUFP7 SUNBIOPATH-GA-245070.	Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Alric J, 2010, PHOTOSYNTH RES, V106, P47, DOI 10.1007/s11120-010-9566-4; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; ARNON DI, 1975, P NATL ACAD SCI USA, V72, P4961, DOI 10.1073/pnas.72.12.4961; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ball S., 1998, ADV PHOTOSYNTHESIS M, V7, P550; BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; Bukhov N, 2002, PLANTA, V215, P812, DOI 10.1007/s00425-002-0808-3; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1016, P253, DOI 10.1016/0005-2728(90)90066-D; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; FELL DA, 1984, TRENDS BIOCHEM SCI, V9, P515, DOI 10.1016/0968-0004(84)90277-9; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; GIBBS M, 1986, PLANT PHYSIOL, V82, P160, DOI 10.1104/pp.82.1.160; Harris E.H, 2009, INTRO CHLAMYDOMONAS; HEBER U, 1974, ANNU REV PLANT PHYS, V25, P393, DOI 10.1146/annurev.pp.25.060174.002141; Hoefnagel MHN, 1998, BBA-BIOENERGETICS, V1366, P235, DOI 10.1016/S0005-2728(98)00126-1; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Ivanov B, 2005, PLANTA, V220, P572, DOI 10.1007/s00425-004-1367-6; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; KLEIN U, 1986, PLANTA, V167, P81, DOI 10.1007/BF00446372; KLOCK G, 1991, BIOCHIM BIOPHYS ACTA, V1073, P410, DOI 10.1016/0304-4165(91)90150-F; LAVERGNE J, 1984, FEBS LETT, V173, P9, DOI 10.1016/0014-5793(84)81006-6; LENDZIAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P260, DOI 10.1016/0005-2728(75)90040-7; Livingston AK, 2010, PLANT CELL ENVIRON, V33, P1779, DOI 10.1111/j.1365-3040.2010.02183.x; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; MAXWELL PC, 1976, BIOCHEMISTRY-US, V15, P3975, DOI 10.1021/bi00663a011; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; NEALE PJ, 1986, J PHYCOL, V22, P531, DOI 10.1111/j.1529-8817.1986.tb02497.x; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; PRINGSHEIM EG, 1960, NATURE, V188, P919, DOI 10.1038/188919a0; RACKER E, 1984, TRENDS BIOCHEM SCI, V9, P516, DOI 10.1016/0968-0004(84)90278-0; REBEILLE F, 1988, PLANT PHYSIOL, V88, P973, DOI 10.1104/pp.88.4.973; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Spalding MH, 2009, CHLAMYDOMONAS SOURCE, V2, P257; STITT M, 1981, PLANT PHYSIOL, V68, P755, DOI 10.1104/pp.68.3.755; Terashima M, 2011, CURR GENET, V57, P151, DOI 10.1007/s00294-011-0339-1; Toth SZ, 2007, PHOTOSYNTH RES, V93, P193, DOI 10.1007/s11120-007-9179-8; WALKER DA, 1967, NATURE, V216, P597, DOI 10.1038/216597a0; WIESSNER W, 1965, NATURE, V205, P56, DOI 10.1038/205056a0; WILLEFORD KO, 1989, PLANT PHYSIOL, V90, P1084, DOI 10.1104/pp.90.3.1084; Zabawinski C, 2001, J BACTERIOL, V183, P1069, DOI 10.1128/JB.183.3.1069-1077.2001	46	81	82	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26445	26452		10.1074/jbc.M112.370205	http://dx.doi.org/10.1074/jbc.M112.370205			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692199	hybrid, Green Published			2022-12-28	WOS:000306916300069
J	Cvetesic, N; Perona, JJ; Gruic-Sovulj, I				Cvetesic, Nevena; Perona, John J.; Gruic-Sovulj, Ita			Kinetic Partitioning between Synthetic and Editing Pathways in Class I Aminoacyl-tRNA Synthetases Occurs at Both Pre-transfer and Post-transfer Hydrolytic Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; CRYSTAL-STRUCTURE; QUALITY-CONTROL; INDUCED-FIT; SPECIFICITY; MECHANISM; ENZYME; ACIDS; COMPLEX; DOMAIN	Comprehensive steady-state and transient kinetic studies of the synthetic and editing activities of Escherichia coli leucyl-tRNA synthetase (LeuRS) demonstrate that the enzyme depends almost entirely on post-transfer editing to endow the cell with specificity against incorporation of norvaline into protein. Among the three class I tRNA synthetases possessing a dedicated post-transfer editing domain (connective peptide 1; CP1 domain), LeuRS resembles valyl-tRNA synthetase in its reliance on post-transfer editing, whereas isoleucyl-tRNA synthetase differs in retaining a distinct tRNA-dependent synthetic site pre-transfer editing activity to clear noncognate amino acids before misacylation. Further characterization of the post-transfer editing activity in LeuRS by single-turnover kinetics demonstrates that the rate-limiting step is dissociation of deacylated tRNA and/or amino acid product and highlights the critical role of a conserved aspartate residue in mediating the first-order hydrolytic steps on the enzyme. Parallel analyses of adenylate and aminoacyl-tRNA formation reactions by wild-type and mutant LeuRS demonstrate that the efficiency of post-transfer editing is controlled by kinetic partitioning between hydrolysis and dissociation of misacylated tRNA and shows that trans editing after rebinding is a competent kinetic pathway. Together with prior analyses of isoleucyl-tRNA synthetase and valyl-tRNA synthetase, these experiments provide the basis for a comprehensive model of editing by class I tRNA synthetases, in which kinetic partitioning plays an essential role at both pre-transfer and post-transfer steps.	[Cvetesic, Nevena; Gruic-Sovulj, Ita] Univ Zagreb, Dept Chem, Fac Sci, Zagreb 10000, Croatia; [Perona, John J.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Perona, John J.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	University of Zagreb; Portland State University; Oregon Health & Science University	Gruic-Sovulj, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, Zagreb 10000, Croatia.	gruic@chem.pmf.hr		Cvetesic, Nevena/0000-0002-1575-5612	National Institutes of Health Grants [1R03TW008024, GM63713]; Ministry of Science, Education, and Sports of the Republic of Croatia Grant [119-0982913-1358]; FOGARTY INTERNATIONAL CENTER [R03TW008024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063713] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Education, and Sports of the Republic of Croatia Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03TW008024 (to J. J. P. and I. G. S.) and GM63713 (to J. J. P.) This work was also supported by Ministry of Science, Education, and Sports of the Republic of Croatia Grant 119-0982913-1358 (to I. Weygand-Durasevic).	Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Dulic M, 2011, BIOCHIMIE, V93, P1761, DOI 10.1016/j.biochi.2011.06.013; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fersht A, 1999, STRUCTURE MECH PROTE, P132; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1238, DOI 10.1021/bi00574a019; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; Francklyn CS, 2008, BIOCHEMISTRY-US, V47, P11695, DOI 10.1021/bi801500z; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Gruic-Sovulj I, 2011, CROAT CHEM ACTA, V84, P179, DOI 10.5562/cca1823; Gutfreund H, 1995, KINETICS LIFE SCI, P103; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1999, NUCLEIC ACIDS RES, V27, P3631, DOI 10.1093/nar/27.18.3631; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Johnson AA, 2001, J BIOL CHEM, V276, P38097; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; Kumar S, 2012, J BIOL CHEM, V287, P3175, DOI 10.1074/jbc.M111.313619; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Lue SW, 2007, BIOCHEMISTRY-US, V46, P4466, DOI 10.1021/bi0618215; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Mascarenhas A. P., 2009, V22, P155; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; Minajigi A, 2011, BIOCHEMISTRY-US, V50, P1101, DOI 10.1021/bi101360a; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Mursinna RS, 2004, BIOCHEMISTRY-US, V43, P155, DOI 10.1021/bi034919h; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Pasman Z, 2011, BIOCHEMISTRY-US, V50, P1474, DOI 10.1021/bi1013535; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Soini J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-30; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	72	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25381	25394		10.1074/jbc.M112.372151	http://dx.doi.org/10.1074/jbc.M112.372151			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22648413	Green Published, hybrid			2022-12-28	WOS:000306651700046
J	Karauzum, H; Chen, G; Abaandou, L; Mahmoudieh, M; Boroun, AR; Shulenin, S; Devi, VS; Stavale, E; Warfield, KL; Zeitlin, L; Roy, CJ; Sidhu, SS; Aman, MJ				Karauzum, Hatice; Chen, Gang; Abaandou, Laura; Mahmoudieh, Mahta; Boroun, Atefeh R.; Shulenin, Sergey; Devi, V. Sathya; Stavale, Eric; Warfield, Kelly L.; Zeitlin, Larry; Roy, Chad J.; Sidhu, Sachdev S.; Aman, M. Javad			Synthetic Human Monoclonal Antibodies toward Staphylococcal Enterotoxin B (SEB) Protective against Toxic Shock Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT EXPRESSION; IMMUNOGLOBULIN-G; IMMUNE EVASION; HUMAN-DISEASE; SUPERANTIGENS; BINDING; PLANTS; SPECIFICITIES; GENERATION; LIBRARIES	Staphylococcal enterotoxin B (SEB) is a potent toxin that can cause toxic shock syndrome and act as a lethal and incapacitating agent when used as a bioweapon. There are currently no vaccines or immunotherapeutics available against this toxin. Using phage display technology, human antigen-binding fragments (Fabs) were selected against SEB, and proteins were produced in Escherichia coli cells and characterized for their binding affinity and their toxin neutralizing activity in vitro and in vivo. Highly protective Fabs were converted into full-length IgGs and produced in mammalian cells. Additionally, the production of anti-SEB antibodies was explored in the Nicotiana benthamiana plant expression system. Affinity maturation was performed to produce optimized lead anti-SEB antibody candidates with subnanomolar affinities. IgGs produced in N. benthamiana showed characteristics comparable with those of counterparts produced in mammalian cells. IgGs were tested for their therapeutic efficacy in the mouse toxic shock model using different challenge doses of SEB and a treatment with 200 mu g of IgGs 1 h after SEB challenge. The lead candidates displayed full protection from lethal challenge over a wide range of SEB challenge doses. Furthermore, mice that were treated with anti-SEB IgG had significantly lower IFN gamma and IL-2 levels in serum compared with mock-treated mice. In summary, these anti-SEB monoclonal antibodies represent excellent therapeutic candidates for further preclinical and clinical development.	[Chen, Gang; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Karauzum, Hatice; Abaandou, Laura; Mahmoudieh, Mahta; Boroun, Atefeh R.; Shulenin, Sergey; Devi, V. Sathya; Stavale, Eric; Warfield, Kelly L.; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD 20878 USA; [Chen, Gang; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Zeitlin, Larry] Mapp Biopharmaceut, San Diego, CA 92121 USA; [Roy, Chad J.] Tulane Sch Med, Tulane Natl Primate Res Ctr, Covington, LA 70433 USA	University of Toronto; University of Toronto; Tulane University	Sidhu, SS (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada.	sachdev.sidhu@utoronto.ca; javad@integratedbiotherapeutics.com	Venkatarmani, Sathyadevi/AAP-1068-2020	Venkatarmani, Sathyadevi/0000-0003-1242-8162; Roy, Chad/0000-0002-1710-6974; Chen, Gang/0000-0002-6304-9173	National Institutes of Health, NIAID [U01 AI078023-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082276, U01AI078023] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant U01 AI078023-05 (to Integrated BioTherapeutics, Inc.).	Almagro JC, 2004, J MOL RECOGNIT, V17, P132, DOI 10.1002/jmr.659; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; BERTHOLD F, 1981, BLUT, V43, P367, DOI 10.1007/BF00320315; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; Coffman JD, 2002, PROTEIN EXPRES PURIF, V24, P302, DOI 10.1006/prep.2001.1556; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Drozdowski Brian, 2010, J Immune Based Ther Vaccines, V8, P9, DOI 10.1186/1476-8518-8-9; Fellouse F. A., 2006, PHAGE DISPLAY BIOTEC, P709; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fraser John D., 2007, V93, P1, DOI 10.1159/000100851; Hiatt A, 2006, P NATL ACAD SCI USA, V103, P14645, DOI 10.1073/pnas.0607089103; Kabat E. A., 1991, SEQUENCES PROTEINS I; KABAT EA, 1991, J IMMUNOL, V147, P1709; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; Larkin EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013253; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Mazor Y, 2007, J IMMUNOL METHODS, V321, P41, DOI 10.1016/j.jim.2007.01.008; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pogue GP, 2010, PLANT BIOTECHNOL J, V8, P638, DOI 10.1111/j.1467-7652.2009.00495.x; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; SCHLIEVERT PM, 1993, J INFECT DIS, V167, P997, DOI 10.1093/infdis/167.5.997; SCHLIEVERT PM, 1986, LANCET, V1, P1149; Sidhu SS, 2006, NAT CHEM BIOL, V2, P682, DOI 10.1038/nchembio843; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Ulrich RG, 1997, TXB MILITARY MED 1, P621; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	38	51	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25203	25215		10.1074/jbc.M112.364075	http://dx.doi.org/10.1074/jbc.M112.364075			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22645125	Green Published, hybrid			2022-12-28	WOS:000306651700030
J	Menssen, R; Schweiggert, J; Schreiner, J; Kusevic, D; Reuther, J; Braun, B; Wolf, DH				Menssen, Ruth; Schweiggert, Joerg; Schreiner, Jens; Kusevic, Denis; Reuther, Julia; Braun, Bernhard; Wolf, Dieter H.			Exploring the Topology of the Gid Complex, the E3 Ubiquitin Ligase Involved in Catabolite-induced Degradation of Gluconeogenic Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; IN-VIVO; FRUCTOSE-1,6-BISPHOSPHATASE; YEAST; INACTIVATION; DIMERIZATION; COMPONENTS; MUSKELIN; MODULES	In the yeast Saccharomyces cerevisiae, key regulatory enzymes of gluconeogenesis such as fructose-1,6-bisphosphatase are degraded via the ubiquitin proteasome system when cells are replenished with glucose. Polyubiquitination is carried out by the Gid complex, a multisubunit ubiquitin ligase that consists of seven different Gid (glucose-induced degradation-deficient) proteins. Under gluconeogenic conditions the E3 ligase is composed of six subunits (Gid1/Vid30, Gid2/Rmd5, Gid5/Vid28, Gid7, Gid8, and Gid9/Fyv10). Upon the addition of glucose the regulatory subunit Gid4/Vid24 appears, binds to the Gid complex, and triggers ubiquitination of fructose-1,6-bisphosphatase. All seven proteins are essential for this process; however, nothing is known about the arrangement of the subunits in the complex. Interestingly, each Gid protein possesses several remarkable motifs (e.g. SPRY, LisH, CTLH domains) that may play a role in protein-protein interaction. We, therefore, generated altered versions of individual Gid proteins by deleting or mutating these domains and performed co-immunoprecipitation experiments to analyze the interaction between distinct subunits. Thus, we were able to create an initial model of the topology of this unusual E3 ubiquitin ligase.	[Menssen, Ruth; Schweiggert, Joerg; Schreiner, Jens; Kusevic, Denis; Reuther, Julia; Braun, Bernhard; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	University of Stuttgart	Wolf, DH (corresponding author), Univ Stuttgart, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	dieter.wolf@ibc.uni-stuttgart.de	Schweiggert, Jörg/M-9631-2016	Schweiggert, Jörg/0000-0002-1272-3762	Deutsche Forschungsgemeinschaft, Bonn; Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg within the Schlieben-Lange-Programm	Deutsche Forschungsgemeinschaft, Bonn(German Research Foundation (DFG)); Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg within the Schlieben-Lange-Programm	This work was supported by the Deutsche Forschungsgemeinschaft, Bonn.; Supported by the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg within the Schlieben-Lange-Programm.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Ausubel FM, 1992, CURRENT PROTOCOLS MO; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; GANCEDO C, 1965, BIOCHEM BIOPH RES CO, V20, P15, DOI 10.1016/0006-291X(65)90944-7; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; MAZON MJ, 1982, J BIOL CHEM, V257, P1128; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; MULLER M, 1981, J BIOL CHEM, V256, P723; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; SCHORK SM, 1994, NATURE, V369, P283, DOI 10.1038/369283a0; Snowdon C, 2008, FEMS YEAST RES, V8, P204, DOI 10.1111/j.1567-1364.2007.00327.x; Suzuki T, 2008, BIOCHEM J, V411, P581, DOI 10.1042/BJ20071312; Tomaru Koji, 2010, Open Biochem J, V4, P1, DOI 10.2174/1874091X01004010001; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; van der Merwe GK, 2001, J BIOL CHEM, V276, P28659, DOI 10.1074/jbc.M102280200; VONHERRATH M, 1988, Z LEBENSM UNTERS FOR, V186, P427; Wolf DH, 2011, FEBS LETT, V585, P2769, DOI 10.1016/j.febslet.2011.08.020; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994	42	71	72	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25602	25614		10.1074/jbc.M112.363762	http://dx.doi.org/10.1074/jbc.M112.363762			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22645139	hybrid, Green Published			2022-12-28	WOS:000306651700068
J	Na, HW; Shin, WS; Ludwig, A; Lee, ST				Na, Hye-Won; Shin, Won-Sik; Ludwig, Andreas; Lee, Seung-Taek			The Cytosolic Domain of Protein-tyrosine Kinase 7 (PTK7), Generated from Sequential Cleavage by a Disintegrin and Metalloprotease 17 (ADAM17) and gamma-Secretase, Enhances Cell Proliferation and Migration in Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CREST MIGRATION; INTRACELLULAR DOMAIN; ENDOTHELIAL-CELLS; TISSUE INHIBITOR; BREAST-CANCER; OFF-TRACK; EXPRESSION; RECEPTOR; CARCINOMA; PROTEASES	Protein-tyrosine kinase 7 (PTK7) is a member of the defective receptor protein-tyrosine kinases and is known to function as a regulator of planar cell polarity during development. Its expression is up-regulated in some cancers including colon carcinomas. A 100-kDa fragment of PTK7 was detected in the culture media from colon cancer cells and HEK293 cells. The shed fragment was named sPTK7-Ig1-7 because its molecular mass was very similar to that of the entire extracellular domain of PTK7 that contains immunoglobulin-like loops 1 to 7 (Ig1-7). The shedding of sPTK7-Ig1-7 was enhanced by treatment with phorbol 12-myristate 13-acetate. In addition to the sPTK7-Ig1-7 found in the culture medium, two C-terminal fragments of PTK7 were detected in the cell lysates: PTK7-CTF1, which includes a transmembrane segment and a cytoplasmic domain, and PTK7-CTF2, which lacks most of the transmembrane segment from PTK7-CTF1. Analysis of PTK7 processing in the presence of various protease inhibitors or after knockdown of potential proteases suggests that shedding of PTK7 into sPTK7-Ig1-7 and PTK7-CTF1 is catalyzed by ADAM17, and further cleavage of PTK7-CTF1 into PTK7-CTF2 is mediated by the gamma-secretase complex. PTK7-CTF2 localizes to the nucleus and enhances proliferation, migration, and anchorage-independent colony formation. Our findings demonstrate a novel role for PTK7 in the tumorigenesis via generation of PTK7-CTF2 by sequential cleavage of ADAM17 and gamma-secretase.	[Na, Hye-Won; Shin, Won-Sik; Lee, Seung-Taek] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Ludwig, Andreas] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, D-52074 Aachen, Germany	Yonsei University; RWTH Aachen University	Lee, ST (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	stlee@yonsei.ac.kr	Ludwig, Andreas/I-5685-2012	Ludwig, Andreas/0000-0001-8536-4986; Shin, Won-Sik/0000-0001-9432-1320; Lee, Seung-Taek/0000-0001-7300-9784	Basic Research Program Grant [2009-0076146]; Studies on Ubiquitome Functions Grant [2005-2001143]; Mid-Career Researcher Program Grant of the National Research Foundation [2010-0026103]; Ministry of Education, Science, and Technology, Republic of Korea; National R&D Program for Cancer Control Grant, Ministry of Health and Welfare, Republic of Korea [1120110]	Basic Research Program Grant; Studies on Ubiquitome Functions Grant; Mid-Career Researcher Program Grant of the National Research Foundation; Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control Grant, Ministry of Health and Welfare, Republic of Korea	This work was supported by grants from the Basic Research Program Grant 2009-0076146, Studies on Ubiquitome Functions Grant 2005-2001143, and the Mid-Career Researcher Program Grant 2010-0026103 of the National Research Foundation, Ministry of Education, Science, and Technology, Republic of Korea and by the National R&D Program for Cancer Control Grant 1120110, Ministry of Health and Welfare, Republic of Korea (to S.-T. L.).	Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Dello Sbarba P, 2002, BIOL CHEM, V383, P69; Ding X, 2004, WORLD J GASTROENTERO, V10, P2735, DOI 10.3748/wjg.v10.i18.2735; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Franovic A, 2006, CANCER RES, V66, P8083, DOI 10.1158/0008-5472.CAN-06-1595; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Gobble RM, 2011, CANCER RES, V71, P2697, DOI 10.1158/0008-5472.CAN-10-3588; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jung JW, 2004, GENE, V328, P75, DOI 10.1016/j.gene.2003.12.006; Karan D, 2003, INT J ONCOL, V23, P1365; Kim HI, 2005, J BIOL CHEM, V280, P28973, DOI 10.1074/jbc.M504568200; LEE ST, 1993, ONCOGENE, V8, P3403; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; Meng L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014018; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Park SK, 1996, J BIOCHEM, V119, P235; Peradziryi H, 2012, ARCH BIOCHEM BIOPHYS, V524, P71, DOI 10.1016/j.abb.2011.12.019; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Roemer A, 2004, J UROLOGY, V172, P2162, DOI 10.1097/01.ju.0000144602.01322.49; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wagner G, 2010, BIOCHEM BIOPH RES CO, V402, P402, DOI 10.1016/j.bbrc.2010.10.044; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wigler M, 1992, Biotechnology, V24, P444; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Xue H, 2010, J PROTEOME RES, V9, P545, DOI 10.1021/pr9008817; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	56	46	46	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25001	25009		10.1074/jbc.M112.348904	http://dx.doi.org/10.1074/jbc.M112.348904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665490	Green Published, hybrid			2022-12-28	WOS:000306651700013
J	Chen, CH; Thompson, DA; Koutalos, Y				Chen, Chunhe; Thompson, Debra A.; Koutalos, Yiannis			Reduction of All-trans-retinal in Vertebrate Rod Photoreceptors Requires the Combined Action of RDH8 and RDH12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; LIGHT-INDUCED DEGENERATION; VISUAL CYCLE; BINDING PROTEIN; SUBSTRATE-SPECIFICITY; DARK-ADAPTATION; OUTER SEGMENTS; MOUSE; RPE65; MUTATIONS	In vertebrate rod cells, retinoid dehydrogenases/reductases (RDHs) are critical for reducing the reactive aldehyde all-trans-retinal that is released by photoactivated rhodopsin, to all-trans-retinol (vitamin A). Previous studies have shown that RDH8 localizes to photoreceptor outer segments and is a strong candidate for performing this role. However, RDH12 function in the photoreceptor inner segments is also key, because loss of function mutations cause retinal degeneration in some forms of Leber congenital amaurosis. To investigate the in vivo roles of RDH8 and RDH12, we used fluorescence imaging to examine all-trans-retinol production in single isolated rod cells from wild-type mice and knock-out mice lacking either one or both RDHs. Outer segments of rods deficient in Rdh8 failed to reduce all-trans-retinal, but those deficient in Rdh12 were unaffected. Following exposure to light, a leak of retinoids from outer to inner segments was detected in rods from both wild-type and knock-out mice. In cells lacking Rdh8 or Rdh12, this leak was mainly all-trans-retinal. Wild-type rods incubated with all-trans-retinal reduced moderate loads of retinal within the cell interior, but this ability was lost by cells deficient in Rdh8 or Rdh12. Our findings are consistent with localization of RDH8 to the outer segment where it provides most of the activity needed to reduce all-trans-retinal generated by the light response. In contrast, RDH12 in inner segments can protect vital cell organelles against aldehyde toxicity caused by an intracellular leak of all-trans-retinal, as well as other aldehydes originating both inside and outside the cell.	[Chen, Chunhe; Koutalos, Yiannis] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48105 USA; [Koutalos, Yiannis] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Medical University of South Carolina	Koutalos, Y (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA.	koutalo@musc.edu		Thompson, Debra/0000-0003-3485-0794	National Institutes of Health [P30-EY07003, R01-EY014850]; Foundation Fighting Blindness, Research to Prevent Blindness; National Institutes of Health from Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; Research to Prevent Blindness Senior Scientific Investigator Award; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness, Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health from Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Senior Scientific Investigator Award(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-EY07003 and R01-EY014850. This work was also supported by the Foundation Fighting Blindness, Research to Prevent Blindness. This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources.; Recipient of a Research to Prevent Blindness Senior Scientific Investigator Award.	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; BEAUCHAMP RO, 1985, CRC CR REV TOXICOL, V14, P309, DOI 10.3109/10408448509037461; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Chen CH, 2005, BIOPHYS J, V88, P2278, DOI 10.1529/biophysj.104.054254; Chen CH, 2010, PHOTOCH PHOTOBIO SCI, V9, P1475, DOI 10.1039/c0pp00124d; Chen CH, 2009, INVEST OPHTH VIS SCI, V50, P3589, DOI 10.1167/iovs.08-3336; Danciger M, 2003, INVEST OPHTH VIS SCI, V44, P2442, DOI 10.1167/iovs.02-1252; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Hargrave PA, 2001, INVEST OPHTH VIS SCI, V42, P3; HUBBARD R., 1971, Methods in Enzymology, V18C, P615, DOI 10.1016/S0076-6879(71)18045-7; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kanan Y, 2008, INVEST OPHTH VIS SCI, V49, P1071, DOI 10.1167/iovs.07-1207; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; OKAJIMA TIL, 1989, EXP EYE RES, V49, P629, DOI 10.1016/S0014-4835(89)80059-4; OKAJIMA TIL, 1990, P NATL ACAD SCI USA, V87, P6907, DOI 10.1073/pnas.87.17.6907; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Travis G. H., 2011, ARVO M, V52, P3357; Tsina E, 2004, J GEN PHYSIOL, V124, P429, DOI 10.1085/jgp.200409078; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707	46	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24662	24670		10.1074/jbc.M112.354514	http://dx.doi.org/10.1074/jbc.M112.354514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621924	Green Published, hybrid			2022-12-28	WOS:000306651100060
J	Paul, MF; Alushin, GM; Barros, MH; Rak, M; Tzagoloff, A				Paul, Marie-Francoise; Alushin, Gregory M.; Barros, Mario H.; Rak, Malgorzata; Tzagoloff, Alexander			The Putative GTPase Encoded by MTG3 Functions in a Novel Pathway for Regulating Assembly of the Small Subunit of Yeast Mitochondrial Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASES; B MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; BACILLUS-SUBTILIS; GENE ENCODES; PROTEINS; YQEH; DNA; TRANSLATION; STEP	Very little is known about biogenesis of mitochondrial ribosomes. The GTPases encoded by the nuclear MTG1 and MTG2 genes of Saccharomyces cerevisiae have been reported to play a role in assembly of the ribosomal 54 S subunit. In the present study biochemical screens of a collection of respiratory deficient yeast mutants have enabled us to identify a third gene essential for expression of mitochondrial ribosomes. This gene codes for a member of the YqeH family of GTPases, which we have named MTG3 in keeping with the earlier convention. Mutations in MTG3 cause the accumulation of the 15 S rRNA precursor, previously shown to have an 80-nucleotide 5' extension. Sucrose gradient sedimentation of mitochondrial ribosomes from temperature-sensitive mtg3 mutants grown at the permissive and restrictive temperatures, combined with immunobloting with subunit-specific antibodies, indicate that Mtg3p is required for assembly of the 30 S but not 54 S ribosomal subunit. The respiratory deficient growth phenotype of an mtg3 null mutant is partially rescued by overexpression of the Mrpl4p constituent located at the peptide exit site of the 54 S subunit. The rescue is accompanied by an increase in processed 15 S rRNA. This suggests that Mtg3p and Mrpl4p jointly regulate assembly of the small subunit by modulating processing of the 15 S rRNA precursor.	[Paul, Marie-Francoise; Alushin, Gregory M.; Barros, Mario H.; Rak, Malgorzata; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@cubpet2.bio.columbia.edu	Barros, Mario/Q-6358-2019; Barros, Mario H/B-8118-2012	Barros, Mario/0000-0003-2977-9815; Alushin, Gregory/0000-0001-7250-4484	National Institutes of Health [HL02274]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL02274 (to A. T.) and grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to M. H. B.).	ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Anand B, 2009, BIOCHEM BIOPH RES CO, V386, P602, DOI 10.1016/j.bbrc.2009.06.078; Barrientos A, 2003, MOL BIOL CELL, V14, P2292, DOI 10.1091/mbc.E02-10-0636; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2011, J BIOL CHEM, V286, P32937, DOI 10.1074/jbc.M111.265371; BOERNER P, 1981, NUCLEIC ACIDS RES, V9, P6379, DOI 10.1093/nar/9.23.6379; BONITZ SG, 1980, P NATL ACAD SCI-BIOL, V77, P3167, DOI 10.1073/pnas.77.6.3167; BORST P, 1971, FEBS LETT, V13, P73, DOI 10.1016/0014-5793(71)80204-1; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; CHATTON B, 1988, J BIOL CHEM, V263, P52; Connolly K, 2009, TRENDS BIOCHEM SCI, V34, P256, DOI 10.1016/j.tibs.2009.01.011; Datta K, 2005, MOL BIOL CELL, V16, P954, DOI 10.1091/mbc.E04-07-0622; Ellis TP, 2005, GENETICS, V171, P949, DOI 10.1534/genetics.104.036467; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fekete Z, 2008, J BIOL CHEM, V283, P3767, DOI 10.1074/jbc.M709617200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glick BS, 1995, METHOD ENZYMOL, V260, P224, DOI 10.1016/0076-6879(95)60140-6; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Hage Aziz El, 2004, RNA Biol, V1, P10; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; Karbstein K, 2007, BIOPOLYMERS, V87, P1, DOI 10.1002/bip.20762; Kaur J, 2011, EMBO REP, V12, P950, DOI 10.1038/embor.2011.133; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI M, 1982, J BIOL CHEM, V257, P5921; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MORIMOTO R, 1979, J BIOL CHEM, V254, P2461; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; OSINGA KA, 1981, NUCLEIC ACIDS RES, V9, P1351, DOI 10.1093/nar/9.6.1351; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; TERPSTRA P, 1979, J BIOL CHEM, V254, P2653; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Tzagoloff A, 1990, Prog Nucleic Acid Res Mol Biol, V39, P129, DOI 10.1016/S0079-6603(08)60625-X; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Wiesenberger G., 1997, MOL CELL BIOL, V28, P16	47	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24346	24355		10.1074/jbc.M112.363309	http://dx.doi.org/10.1074/jbc.M112.363309			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621929	Green Published, hybrid			2022-12-28	WOS:000306651100029
J	Sutherland, C; Walsh, MP				Sutherland, Cindy; Walsh, Michael P.			Myosin Regulatory Light Chain Diphosphorylation Slows Relaxation of Arterial Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; OKADAIC ACID; PROTEIN PHOSPHATASE; BLACK SPONGE; SWINE MODEL; RHO-KINASE; PHOSPHORYLATION; CONTRACTION; CALCIUM; ACTIVATION	The principal signal to activate smooth muscle contraction is phosphorylation of the regulatory light chains of myosin (LC20) at Ser(19) by Ca2+/calmodulin-dependent myosin light chain kinase. Inhibition of myosin light chain phosphatase leads to Ca2+-independent phosphorylation at both Ser(19) and Thr(18) by integrin-linked kinase and/or zipper-interacting protein kinase. The functional effects of phosphorylation at Thr(18) on steady-state isometric force and relaxation rate were investigated in Triton-skinned rat caudal arterial smooth muscle strips. Sequential phosphorylation at Ser(19) and Thr(18) was achieved by treatment with adenosine 5'-O-(3-thiotriphosphate) in the presence of Ca2+, which induced stoichiometric thiophosphorylation at Ser(19), followed by microcystin (phosphatase inhibitor) in the absence of Ca2+, which induced phosphorylation at Thr(18). Phosphorylation at Thr(18) had no effect on steady-state force induced by Ser(19) thiophosphorylation. However, phosphorylation of Ser(19) or both Ser(19) and Thr(18) to comparable stoichiometries (0.5 mol of P-i/mol of LC20) and similar levels of isometric force revealed differences in the rates of dephosphorylation and relaxation following removal of the stimulus: t(1/2) values for dephosphorylation were 83.3 and 560 s, and for relaxation were 560 and 1293 s, for monophosphorylated (Ser(19)) and diphosphorylated LC20, respectively. We conclude that phosphorylation at Thr(18) decreases the rates of LC20 dephosphorylation and smooth muscle relaxation compared with LC20 phosphorylated exclusively at Ser(19). These effects of LC20 diphosphorylation, combined with increased Ser(19) phosphorylation (Ca2+-independent), may underlie the hypercontractility that is observed in response to certain physiological contractile stimuli, and under pathological conditions such as cerebral and coronary arterial vasospasm, intimal hyperplasia, and hypertension.	[Sutherland, Cindy; Walsh, Michael P.] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary	Walsh, MP (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	walsh@ucalgary.ca			Canadian Institutes of Health Research [MOP-111262]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-111262 (to M.P.W.).	ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; BIALOJAN C, 1988, J PHYSIOL-LONDON, V398, P81, DOI 10.1113/jphysiol.1988.sp017030; BRESNICK AR, 1995, BIOCHEMISTRY-US, V34, P12576, DOI 10.1021/bi00039a012; CASSIDY P, 1979, J BIOL CHEM, V254, P1148; Cho YE, 2011, CARDIOVASC RES, V91, P162, DOI 10.1093/cvr/cvr043; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; Craig M, 1996, BIOCHEM CELL BIOL, V74, P569, DOI 10.1139/o96-061; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; GONG MC, 1992, J BIOL CHEM, V267, P14662; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; GRATECOS D, 1974, BIOCHEM BIOPH RES CO, V58, P960, DOI 10.1016/S0006-291X(74)80237-8; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; HARADA T, 1995, NEUROSURGERY, V36, P1178, DOI 10.1227/00006123-199506000-00018; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; HIRANO K, 1989, BRIT J PHARMACOL, V98, P1261, DOI 10.1111/j.1476-5381.1989.tb12672.x; HORI M, 1991, FEBS LETT, V285, P145, DOI 10.1016/0014-5793(91)80745-O; IKEBE M, 1988, J BIOL CHEM, V263, P6432; IKEBE M, 1986, J BIOL CHEM, V261, P36; IKEBE M, 1985, J BIOL CHEM, V260, P27; ISHIHARA H, 1989, J PHARMACOL EXP THER, V250, P388; KAMISOYAMA H, 1994, BIOCHEMISTRY-US, V33, P840, DOI 10.1021/bi00169a027; Katsumata N, 1997, CIRCULATION, V96, P4357; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; MILLERHANCE WC, 1988, J BIOL CHEM, V263, P13979; Mita M, 2002, BIOCHEM J, V364, P431, DOI 10.1042/BJ20020191; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; NGAI PK, 1984, J BIOL CHEM, V259, P3656; NGAI PK, 1984, BIOCHEM J, V218, P863, DOI 10.1042/bj2180863; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; OBARA K, 1989, PFLUG ARCH EUR J PHY, V414, P134, DOI 10.1007/BF00580954; Obara K, 2005, J VASC RES, V42, P67, DOI 10.1159/000083093; OZAKI H, 1987, J PHARMACOL EXP THER, V243, P1167; SETO M, 1990, PFLUG ARCH EUR J PHY, V415, P484, DOI 10.1007/BF00373627; SETO M, 1991, EUR J PHARMACOL, V195, P267, DOI 10.1016/0014-2999(91)90545-2; SETO M, 1993, EXP MOL PATHOL, V58, P1, DOI 10.1006/exmp.1993.1001; SHERRY JMF, 1978, BIOCHEMISTRY-US, V17, P4411, DOI 10.1021/bi00614a009; SHIBATA S, 1982, J PHARMACOL EXP THER, V223, P135; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SUZUKI A, 1993, BRIT J PHARMACOL, V109, P703, DOI 10.1111/j.1476-5381.1993.tb13631.x; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Takeya K, 2011, FASEB J, V25; UMEMOTO S, 1989, J BIOL CHEM, V264, P1431; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; WALSH MP, 1991, BIOCHEM CELL BIOL, V69, P771, DOI 10.1139/o91-119; WALSH MP, 1983, FED PROC, V42, P45; WALSH MP, 1984, BIOCHEM J, V224, P117, DOI 10.1042/bj2240117; WALSH MP, 1982, J BIOL CHEM, V257, P5987; WALSH MP, 1985, BIOCHEMISTRY-US, V24, P3724, DOI 10.1021/bi00335a047; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wilson DP, 2002, J BIOL CHEM, V277, P2186, DOI 10.1074/jbc.M110056200	58	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24064	24076		10.1074/jbc.M112.371609	http://dx.doi.org/10.1074/jbc.M112.371609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22661704	Green Published, hybrid			2022-12-28	WOS:000306651100001
J	Sato, Y; Hatta, M; Karim, MF; Sawa, T; Wei, FY; Sato, S; Magnuson, MA; Gonzalez, FJ; Tomizawa, K; Akaike, T; Yoshizawa, T; Yamagata, K				Sato, Yoshifumi; Hatta, Mitsutoki; Karim, Md Fazlul; Sawa, Tomohiro; Wei, Fan-Yan; Sato, Shoki; Magnuson, Mark A.; Gonzalez, Frank J.; Tomizawa, Kazuhito; Akaike, Takaaki; Yoshizawa, Tatsuya; Yamagata, Kazuya			Anks4b, a Novel Target of HNF4 alpha Protein, Interacts with GRP78 Protein and Regulates Endoplasmic Reticulum Stress-induced Apoptosis in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 4-ALPHA; HYPERINSULINEMIC HYPOGLYCEMIA; INSULIN-SECRETION; ALPHA-GENE; HEPATOCYTE; EXPRESSION; TRANSCRIPTION; MUTATIONS; YOUNG; SIGNALS	Mutations of the HNF4A gene cause a form of maturity-onset diabetes of the young (MODY1) that is characterized by impairment of pancreatic beta-cell function. HNF4 alpha is a transcription factor belonging to the nuclear receptor superfamily (NR2A1), but its target genes in pancreatic beta-cells are largely unknown. Here, we report that ankyrin repeat and sterile alpha motif domain containing 4b (Anks4b) is a target of HNF4 alpha in pancreatic beta-cells. Expression of Anks4b was decreased in both beta HNF4 alpha KO islets and HNF4 alpha knockdown MIN6 beta-cells, and HNF4 alpha activated Anks4b promoter activity. Anks4b bound to glucose-regulated protein 78 (GRP78), a major endoplasmic reticulum (ER) chaperone protein, and overexpression of Anks4b enhanced the ER stress response and ER stress-associated apoptosis of MIN6 cells. Conversely, suppression of Anks4b reduced beta-cell susceptibility to ER stress-induced apoptosis. These results indicate that Anks4b is a HNF4 alpha target gene that regulates ER stress in beta-cells by interacting with GRP78, thus suggesting that HNF4 alpha is involved in maintenance of the ER.	[Sato, Yoshifumi; Hatta, Mitsutoki; Karim, Md Fazlul; Sato, Shoki; Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan; [Sawa, Tomohiro; Akaike, Takaaki] Kumamoto Univ, Fac Life Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Sawa, Tomohiro] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 332001, Japan; [Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Kumamoto 8608556, Japan; [Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20814 USA	Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST); Kumamoto University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yamagata, K (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan.	k-yamaga@kumamoto-u.ac.jp	Magnuson, Mark/AAY-7172-2021; Sato, Yoshifumi/GYQ-7230-2022; Wei, Fan-Yan/AAD-8461-2021; Tomizawa, Kazuhito/F-2405-2015; Magnuson, Mark A/B-1335-2009	Magnuson, Mark/0000-0002-8824-6499; Tomizawa, Kazuhito/0000-0002-5663-2627; Magnuson, Mark A/0000-0002-8824-6499; Wei, Fan-Yan/0000-0002-4843-724X; Yoshizawa, Tatsuya/0000-0002-5728-1996; Sato, Yoshifumi/0000-0003-0697-1476	Ministry of Health Labour and Welfare; Takeda Science Foundation; Novo Nordisk Insulin Research Foundation; Banyu Life Science Foundation International; Japan Diabetes Foundation; International Priority Graduate Programs Advanced Graduate Courses for International Students, Ministry of Education, Culture, Sports, Science, and Technology in Japan; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23126521] Funding Source: KAKEN	Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novo Nordisk Insulin Research Foundation; Banyu Life Science Foundation International(Banyu Life Science Foundation International); Japan Diabetes Foundation; International Priority Graduate Programs Advanced Graduate Courses for International Students, Ministry of Education, Culture, Sports, Science, and Technology in Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (B), a grant-in-aid for scientific research (S), a grant-in-aid for scientific research in innovative areas, a grant from the Ministry of Health Labour and Welfare, a grant from Takeda Science Foundation, a grant from Novo Nordisk Insulin Research Foundation, a grant from Banyu Life Science Foundation International, and a grant from Japan Diabetes Foundation.; Supported by a scholarship from the International Priority Graduate Programs Advanced Graduate Courses for International Students, Ministry of Education, Culture, Sports, Science, and Technology in Japan.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; [Anonymous], 2001, NUCL RECEPTORS GENET; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Boj SF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000970; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eeckhoute J, 2004, NUCLEIC ACIDS RES, V32, P2586, DOI 10.1093/nar/gkh581; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Ihara A, 2005, BIOCHEM BIOPH RES CO, V329, P984, DOI 10.1016/j.bbrc.2005.02.072; Johnston AM, 2004, GENES CELLS, V9, P967, DOI 10.1111/j.1365-2443.2004.00776.x; Kapoor RR, 2008, DIABETES, V57, P1659, DOI 10.2337/db07-1657; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Nammo T, 2008, GENE EXPR PATTERNS, V8, P96, DOI 10.1016/j.modgep.2007.09.006; Ozeki T, 2001, BIOCHEM J, V355, P537, DOI 10.1042/0264-6021:3550537; Pagny S, 1999, J EXP BOT, V50, P157, DOI 10.1093/jexbot/50.331.157; Pearson ER, 2007, PLOS MED, V4, P760, DOI 10.1371/journal.pmed.0040118; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang Q, 2000, DIABETOLOGIA, V43, P520, DOI 10.1007/s001250051338; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679	41	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23236	23245		10.1074/jbc.M112.368779	http://dx.doi.org/10.1074/jbc.M112.368779			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589549	Green Published, hybrid			2022-12-28	WOS:000306495000078
J	Christie, JM; Hitomi, K; Arvai, AS; Hartfield, KA; Mettlen, M; Pratt, AJ; Tainer, JA; Getzoff, ED				Christie, John M.; Hitomi, Kenichi; Arvai, Andrew S.; Hartfield, Kimberly A.; Mettlen, Marcel; Pratt, Ashley J.; Tainer, John A.; Getzoff, Elizabeth D.			Structural Tuning of the Fluorescent Protein iLOV for Improved Photostability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOACTIVE YELLOW PROTEIN; BLUE-LIGHT RECEPTOR; LOV2 DOMAIN; PHOTORECEPTOR PHOTOTROPIN; MUTATIONAL ANALYSIS; REPORTER PROTEINS; PHOTOCYCLE; OXYGEN; DIMERIZATION; CHROMOPHORE	Fluorescent proteins derived from light, oxygen, or voltage (LOV) domains offer advantages over green fluorescent protein (GFP) from their small size and efficacy under anaerobic conditions. The flavoprotein improved LOV (iLOV) was engineered from the blue light receptor phototropin as a reporter of viral infection. To inform the molecular basis for the improved, photoreversible, fluorescent properties of iLOV, we employed directed evolution and determined five LOV crystallographic structures. Comparative structural analyses between iLOV and its progenitors reveal mutation-induced constraints in the environment of the flavin mononucleotide (FMN) chromophore; in iLOV, the methyl group of Thr-394 "crowds" the FMN isoalloxazine ring, Leu-470 triggers side chain "flipping" of Leu-472, and the terminal FMN phosphate shows increased anchoring. We further engineered iLOV variants that are readily detectable in bacterial and mammalian cells due to order-of-magnitude photostability increases. Structure determination of a resulting representative photostable iLOV (phiLOV) variant reveals additional constraints on the chromophore. Aromatic residues Tyr-401 and Phe-485 in phiLOV sandwich the FMN isoalloxazine ring from both sides, whereas Ser-390 anchors the side chain of FMN-interacting Gln-489 Our combined structural and mutational results reveal that constraining the FMN fluorophore yields improved photochemical properties for iLOV and its new photostable derivative. These findings provide a framework for structural fine-tuning of LOV scaffold proteins to maximize their potential as oxygen-independent fluorescent reporters.	[Christie, John M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Christie, John M.; Hitomi, Kenichi; Arvai, Andrew S.; Hartfield, Kimberly A.; Pratt, Ashley J.; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Christie, John M.; Hitomi, Kenichi; Arvai, Andrew S.; Hartfield, Kimberly A.; Pratt, Ashley J.; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Mettlen, Marcel] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hitomi, Kenichi] Natl Inst Biomed Innovat, Sect Lab Equipment, Osaka 5670085, Japan	University of Glasgow; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute of Health Sciences - Japan	Christie, JM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	john.christie@glasgow.ac.uk; edg@scripps.edu	Pratt, Ashley/A-1754-2012; Tainer, John/GWQ-4878-2022; Mettlen, Marcel B/A-2357-2011	Pratt, Ashley/0000-0002-9702-8805; Tainer, John/0000-0003-1659-2429; Mettlen, Marcel B/0000-0001-7047-2749; Christie, John/0000-0002-9976-0055; , ENIGMA/0000-0002-0894-2831	Royal Society University Research Fellowship; National Institutes of Health [GM37684]; Skaggs Institute for Chemical Biology; United States Department of Energy (DOE) [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER	Royal Society University Research Fellowship(Royal Society of London); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; United States Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the award of a Royal Society University Research Fellowship (to J. M. C.), National Institutes of Health Grant GM37684 (to E. D. G.), and a grant from the Skaggs Institute for Chemical Biology (to K. H.).; We are very grateful to Sandra Schmid for providing cell culture and imaging facilities. The SIBYLS beamline facilities at the Advanced Light Source of Lawrence Berkeley National Laboratory are supported in part by the United States Department of Energy (DOE) program Integrated Diffraction Analysis Technologies under Contract DE-AC02-05CH11231, with John Tainer's effort on anaerobic tags by DOE program ENIGMA. We also thank Hideki Kandori and Tatsuya Iwata for helpful discussions and Chiharu Hitomi for technical assistance.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BACA M, 1994, BIOCHEMISTRY-US, V33, P14369, DOI 10.1021/bi00252a001; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Eisenreich W, 2009, BIOCHEM SOC T, V37, P382, DOI 10.1042/BST0370382; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Genick UK, 1998, NATURE, V392, P206, DOI 10.1038/32462; Iwata T, 2005, BIOCHEMISTRY-US, V44, P7427, DOI 10.1021/bi047281y; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kay CWM, 2003, J BIOL CHEM, V278, P10973, DOI 10.1074/jbc.M205509200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pathak GP, 2009, ENVIRON MICROBIOL, V11, P2388, DOI 10.1111/j.1462-2920.2009.01967.x; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2004, FEBS LETT, V572, P8, DOI 10.1016/j.febslet.2004.06.081; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto A, 2008, BIOCHEMISTRY-US, V47, P922, DOI 10.1021/bi701851v	39	110	113	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22295	22304		10.1074/jbc.M111.318881	http://dx.doi.org/10.1074/jbc.M111.318881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573334	Green Published, hybrid			2022-12-28	WOS:000306418600067
J	Kim, DK; Ryu, D; Koh, M; Lee, MW; Lim, D; Kim, MJ; Kim, YH; Cho, WJ; Lee, CH; Park, SB; Koo, SH; Choi, HS				Kim, Don-Kyu; Ryu, Dongryeol; Koh, Minseob; Lee, Min-Woo; Lim, Donghyun; Kim, Min-Jung; Kim, Yong-Hoon; Cho, Won-Jea; Lee, Chul-Ho; Park, Seung Bum; Koo, Seung-Hoi; Choi, Hueng-Sik			Orphan Nuclear Receptor Estrogen-Related Receptor gamma (ERR gamma) Is Key Regulator of Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; INDEPENDENT TRANSCRIPTIONAL ACTIVATION; PYRUVATE-DEHYDROGENASE KINASE; SMALL-HETERODIMER-PARTNER; GLUCOSE-METABOLISM; GENE-EXPRESSION; CYCLIC-AMP; DEPENDENT REGULATION; COACTIVATOR TORC2; ALPHA	Glucose homeostasis is tightly controlled by hormonal regulation of hepatic glucose production. Dysregulation of this system is often associated with insulin resistance and diabetes, resulting in hyperglycemia in mammals. Here, we show that the orphan nuclear receptor estrogen-related receptor gamma (ERR gamma) is a novel downstream mediator of glucagon action in hepatic gluconeogenesis and demonstrate a beneficial impact of the inverse agonist GSK5182. Hepatic ERR gamma expression was increased by fasting-dependent activation of the cAMP-response element-binding protein-CRTC2 pathway. Overexpression of ERR gamma induced Pck1 and G6PC gene expression and glucose production in primary hepatocytes, whereas abolition of ERR gamma gene expression attenuated forskolin-mediated induction of gluconeogenic gene expression. Deletion and mutation analyses of the Pck1 promoter showed that ERR gamma directly regulates the Pck1 gene transcription via ERR response elements of the Pck1 promoter as confirmed by ChIP assay and in vivo imaging analysis. We also demonstrate that GSK5182, an inverse agonist of ERR gamma, specifically inhibits the transcriptional activity of ERR gamma in a PGC-1 alpha dependent manner. Finally, the ERR gamma inverse agonist ameliorated hyperglycemia through inhibition of hepatic gluconeogenesis in db/db mice. Control of hepatic glucose production by an ERR gamma-specific inverse agonist is a new potential therapeutic approach for the treatment of type 2 diabetes.	[Koh, Minseob; Park, Seung Bum] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul 151747, South Korea; [Cho, Won-Jea] Chonnam Natl Univ, Coll Pharm & Res Inst Drug Dev, Kwangju 500757, South Korea; [Ryu, Dongryeol; Lee, Min-Woo; Kim, Min-Jung; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; [Ryu, Dongryeol; Lee, Min-Woo; Kim, Min-Jung; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea; [Lim, Donghyun; Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151747, South Korea; [Kim, Yong-Hoon; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biomed Sci, Kwangju 501746, South Korea; [Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea	Seoul National University (SNU); Chonnam National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University; Chonnam National University	Park, SB (corresponding author), Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul 151747, South Korea.	sbpark@snu.ac.kr; shkoo@skku.edu; hsc@chonnam.ac.kr	Park, Seung Bum/N-1901-2014; Ryu, Dongryeol/AAQ-3642-2020; Koo, Seung-Hoi/E-2763-2015	Park, Seung Bum/0000-0003-1753-1433; Ryu, Dongryeol/0000-0001-5905-6760; Koo, Seung-Hoi/0000-0001-8769-2879; Lim, Donghyun/0000-0002-6070-198X; Koh, Minseob/0000-0003-1935-4776	National Creative Research Initiatives from Korean Ministry of Education, Science and Technology [20110018305]; Korea Healthcare Technology Research and Development Project; National Research Foundation of Korea (NRF) from the Ministry of Education, Science and Technology [20100019512]; Brain Korea 21 Program fellowship award; Seoul Science fellowship award; NRF [2011-0016454, 2011-0019448]; Ministry of Land, Transport and Maritime Affairs (MLTM), Korea; Korea government (Ministry of Education, Science and Technology)	National Creative Research Initiatives from Korean Ministry of Education, Science and Technology; Korea Healthcare Technology Research and Development Project; National Research Foundation of Korea (NRF) from the Ministry of Education, Science and Technology(National Research Foundation of Korea); Brain Korea 21 Program fellowship award; Seoul Science fellowship award; NRF; Ministry of Land, Transport and Maritime Affairs (MLTM), Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); Korea government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported in part by National Creative Research Initiatives Grant 20110018305 from the Korean Ministry of Education, Science and Technology and Korea Healthcare Technology Research and Development Project and Future-based Technology Development Program (BIO Fields) Grant 20100019512 through the National Research Foundation of Korea (NRF) from the Ministry of Education, Science and Technology.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Ariazi EA, 2002, CANCER RES, V62, P6510; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Horard B, 2004, J MOL ENDOCRINOL, V33, P493, DOI 10.1677/jme.1.01538; Huppunen J, 2004, BIOCHEM BIOPH RES CO, V314, P964, DOI 10.1016/j.bbrc.2003.12.194; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; LIU JS, 1991, J BIOL CHEM, V266, P19095; Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359; Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Park YY, 2004, MOL ENDOCRINOL, V18, P1082, DOI 10.1210/me.2003-0339; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Razzaque MA, 2004, GENE, V340, P275, DOI 10.1016/j.gene.2004.07.010; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sanyal S, 2004, MOL ENDOCRINOL, V18, P312, DOI 10.1210/me.2003-0165; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhang ZP, 2007, MOL CELL ENDOCRINOL, V264, P128, DOI 10.1016/j.mce.2006.11.002	59	94	95	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21628	21639		10.1074/jbc.M111.315168	http://dx.doi.org/10.1074/jbc.M111.315168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549789	Green Published, hybrid			2022-12-28	WOS:000306418600006
J	Sugitani, H; Hirano, E; Knutsen, RH; Shifren, A; Wagenseil, JE; Ciliberto, C; Kozel, BA; Urban, Z; Davis, EC; Broekelmann, TJ; Mecham, RP				Sugitani, Hideki; Hirano, Eiichi; Knutsen, Russell H.; Shifren, Adrian; Wagenseil, Jessica E.; Ciliberto, Christopher; Kozel, Beth A.; Urban, Zsolt; Davis, Elaine C.; Broekelmann, Thomas J.; Mecham, Robert P.			Alternative Splicing and Tissue-specific Elastin Misassembly Act as Biological Modifiers of Human Elastin Gene Frameshift Mutations Associated with Dominant Cutis Laxa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL ARTIFICIAL CHROMOSOMES; MESSENGER-RNA; POINT MUTATIONS; FIBER FORMATION; TROPOELASTIN; DISEASE; FIBULIN-4; IDENTIFICATION; MECHANISMS; DEPOSITION	Elastin is the extracellular matrix protein in vertebrates that provides elastic recoil to blood vessels, the lung, and skin. Because the elastin gene has undergone significant changes in the primate lineage, modeling elastin diseases in non-human animals can be problematic. To investigate the pathophysiology underlying a class of elastin gene mutations leading to autosomal dominant cutis laxa, we engineered a cutis laxa mutation (single base deletion) into the human elastin gene contained in a bacterial artificial chromosome. When expressed as a transgene in mice, mutant elastin was incorporated into elastic fibers in the skin and lung with adverse effects on tissue function. In contrast, only low levels of mutant protein incorporated into aortic elastin, which explains why the vasculature is relatively unaffected in this disease. RNA stability studies found that alternative exon splicing acts as a modifier of disease severity by influencing the spectrum of mutant transcripts that survive nonsense-mediated decay. Our results confirm the critical role of the C-terminal region of tropoelastin in elastic fiber assembly and suggest tissue-specific differences in the elastin assembly pathway.	[Sugitani, Hideki; Hirano, Eiichi; Knutsen, Russell H.; Shifren, Adrian; Ciliberto, Christopher; Broekelmann, Thomas J.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Wagenseil, Jessica E.] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA; [Kozel, Beth A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Urban, Zsolt] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3Z 1J4, Canada	Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McGill University	Mecham, RP (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	bmecham@wustl.edu	Kozel, Beth/AAP-9177-2020; Urban, Zsolt/A-2018-2013; Wagenseil, Jessica/C-2801-2014	Kozel, Beth/0000-0002-9757-7118; Urban, Zsolt/0000-0003-3890-1843; Wagenseil, Jessica/0000-0001-7972-448X	National Institutes of Health [HL53325, HL74138, HL105314, HL084922, K12 HL089968, HL087563]; Canadian Institutes of Heath Research Grant [MOP86713]; National Marfan Foundation; Grant National Institutes of Health [HL29594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090648, K12HL089968, R01HL053325, R01HL074138, P01HL029594, P50HL084922, R37HL053325, R00HL087563, R01HL105314, K99HL087563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Heath Research Grant(Canadian Institutes of Health Research (CIHR)); National Marfan Foundation; Grant National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL53325, HL74138, HL105314, and HL084922 (to R. P. M.), K12 HL089968 (to A. S.), and HL087563 (to J. E. W.). This work was also by Canadian Institutes of Heath Research Grant MOP86713 (to E. C. D.) and by a grant from the National Marfan Foundation (to R. P. M.).; We thank Ron McCarthy of the Washington University Pulmonary Mouse Core (supported by Grant National Institutes of Health Grant HL29594) for oocyte injection and production of the hBAC<SUP>CL</SUP> mice. We also thank Terese Hall for administrative support.	BARRINEAU LL, 1981, DEV BIOL, V87, P46, DOI 10.1016/0012-1606(81)90059-2; BAULE VJ, 1988, BIOCHEM BIOPH RES CO, V154, P1054, DOI 10.1016/0006-291X(88)90247-1; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Callewaert B, 2011, HUM MUTAT, V32, P445, DOI 10.1002/humu.21462; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Claus S, 2008, J INVEST DERMATOL, V128, P1442, DOI 10.1038/sj.jid.5701211; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; DAMKIER A, 1991, CLIN GENET, V39, P321; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; DAVIS EC, 1993, LAB INVEST, V68, P89; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; FOSTER JA, 1990, AM J PHYSIOL, V259, pL13, DOI 10.1152/ajplung.1990.259.2.L13; Graul-Neumann LM, 2008, AM J MED GENET A, V146A, P977, DOI 10.1002/ajmg.a.32242; HEIM RA, 1991, MATRIX, V11, P359, DOI 10.1016/S0934-8832(11)80207-6; Hirano E, 2007, CIRC RES, V101, P523, DOI 10.1161/CIRCRESAHA.107.153510; Hsiao H, 1999, CONNECT TISSUE RES, V40, P83, DOI 10.3109/03008209909029104; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Hu QR, 2010, MATRIX BIOL, V29, P621, DOI 10.1016/j.matbio.2010.06.005; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; INDIK Z, 1987, CONNECT TISSUE RES, V16, P197, DOI 10.3109/03008208709006976; Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Kozel BA, 2011, BIOL EXTRACELL MATR, P267, DOI 10.1007/978-3-642-16555-9_8; Lalioti MD, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e14; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; LIEM KF, 1988, AM ZOOL, V28, P739; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Muyrers JPP, 2000, EMBO REP, V1, P239, DOI 10.1093/embo-reports/kvd049; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; OLSON TM, 1995, HUM MOL GENET, V4, P1677, DOI 10.1093/hmg/4.9.1677; Pedersen L, 2003, SKIN RES TECHNOL, V9, P111, DOI 10.1034/j.1600-0846.2003.00021.x; Pober BR, 2008, J CLIN INVEST, V118, P1606, DOI 10.1172/JCI35309; Rodriguez-Revenga L, 2004, ARCH DERMATOL, V140, P1135, DOI 10.1001/archderm.140.9.1135; Shifren A, 2007, AM J PHYSIOL-LUNG C, V292, pL778, DOI 10.1152/ajplung.00352.2006; Szabo Z, 2006, J MED GENET, V43, P255, DOI 10.1136/jmg.2005.034157; Szabo Z, 1999, J MOL EVOL, V49, P664, DOI 10.1007/PL00006587; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; Urban Z, 2000, HUM GENET, V106, P577, DOI 10.1007/s004390050028; Urban Z, 2005, J INVEST DERMATOL, V124, P1193, DOI 10.1111/j.0022-202X.2005.23758.x; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WRENN DS, 1987, J BIOL CHEM, V262, P2244; YEH H, 1989, BIOCHEMISTRY-US, V28, P2365, DOI 10.1021/bi00432a003; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	51	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22055	22067		10.1074/jbc.M111.327940	http://dx.doi.org/10.1074/jbc.M111.327940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573328	hybrid, Green Published			2022-12-28	WOS:000306418600043
J	Zhang, GT; Liu, RJ; Zhong, YF; Plotnikov, AN; Zhang, WJ; Zeng, L; Rusinova, E; Gerona-Nevarro, G; Moshkina, N; Joshua, J; Chuang, PY; Ohlmeyer, M; He, JC; Zhou, MM				Zhang, Guangtao; Liu, Ruijie; Zhong, Yifei; Plotnikov, Alexander N.; Zhang, Weijia; Zeng, Lei; Rusinova, Elena; Gerona-Nevarro, Guillermo; Moshkina, Natasha; Joshua, Jennifer; Chuang, Peter Y.; Ohlmeyer, Michael; He, John Cijiang; Zhou, Ming-Ming			Down-regulation of NF-kappa B Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR EPITHELIAL-CELLS; PROBE LEVEL DATA; DIABETIC-NEPHROPATHY; TRANSGENIC MICE; APOPTOSIS; ACTIVATION; INFECTION; THERAPY; NMR; GLOMERULOSCLEROSIS	NF-kappa B-mediated inflammation is the major pathology in chronic kidney diseases, including HIV-associated nephropathy (HIVAN) that ultimately progresses to end stage renal disease. HIV infection in the kidney induces NF-kappa B activation, leading to the production of proinflammatory chemokines, cytokines, and adhesion molecules. In this study, we explored selective inhibition of NF-kappa B transcriptional activity by small molecule blocking NF-kappa B binding to the transcriptional cofactor BRD4, which is required for the assembly of the productive transcriptional complex comprising positive transcription elongation factor b and RNA polymerase II. We showed that our BET (Bromodomain and Extra-Terminal domain)-specific bromodomain inhibitor MS417, designed to block BRD4 binding to the acetylated NF-kappa B, effectively attenuates NF-kappa B transcriptional activation of proinflammatory genes in kidney cells treated with TNF alpha or infected by HIV. MS417 ameliorates inflammation and kidney injury in HIV-1 transgenic mice, an animal model for HIVAN. Our study suggests that BET bromodomain inhibition, targeting at the proinflammatory activity of NF-kappa B, represents a new therapeutic approach for treating NF-kappa B-mediated inflammation and kidney injury in HIVAN.	[Zhang, Guangtao; Plotnikov, Alexander N.; Zeng, Lei; Rusinova, Elena; Gerona-Nevarro, Guillermo; Moshkina, Natasha; Joshua, Jennifer; Ohlmeyer, Michael; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Liu, Ruijie; Zhang, Weijia; Chuang, Peter Y.; He, John Cijiang] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Liu, Ruijie; He, John Cijiang] James J Peters Vet Affairs Med Ctr, Dept Med, Bronx, NY 10486 USA; [Zhong, Yifei] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Nephrol, Shanghai 201203, Peoples R China	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Shanghai University of Traditional Chinese Medicine	He, JC (corresponding author), 1425 Madison Ave,Box 1677, New York, NY 10029 USA.	cijiang.he@mssm.edu; ming-ming.zhou@mssm.edu	Zhang, Guangtao/C-7341-2011		National Institutes of Health [HG004508, DK088541]; Veterans Affairs Merit Award [1I01BX000345]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HG004508 (to M.-M. Z.) and DK088541 (to J. C. H.). This work was also supported by Veterans Affairs Merit Award 1I01BX000345 (to J. C. H.).	Atta MG, 2007, CLIN INFECT DIS, V45, P1625, DOI 10.1086/523728; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Bruggeman LA, 2001, KIDNEY INT, V59, P2174, DOI 10.1046/j.1523-1755.2001.0590062174.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen P, 2011, J AM SOC NEPHROL, V22, P496, DOI 10.1681/ASN.2010040379; Chiang Cheng-Ming, 2009, F1000 Biol Rep, V1, P98, DOI 10.3410/B1-98; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Criswell LA, 2010, IMMUNOL REV, V233, P55, DOI 10.1111/j.0105-2896.2009.00862.x; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; DAGATI V, 1989, KIDNEY INT, V35, P1358, DOI 10.1038/ki.1989.135; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Lu TC, 2006, CURR OPIN NEPHROL HY, V15, P233, DOI 10.1097/01.mnh.0000222688.69217.8e; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522; Martinka S, 2006, AM J PHYSIOL-RENAL, V290, pF657, DOI 10.1152/ajprenal.00208.2005; Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084; Mikulak J, 2010, AM J PHYSIOL-RENAL, V299, pF664, DOI 10.1152/ajprenal.00629.2009; Miyoshi S., 2008, Antitumor agent, Patent No. [US 2010/0286127 A1, 20100286127]; Miyoshi S., 2008, International Patent, Patent No. [PCT/JP2008/073864 (US2010/0286127 A1), 2008073864]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Rangan G, 2009, FRONT BIOSCI-LANDMRK, V14, P3496, DOI 10.2741/3467; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Ross MJ, 2006, JAIDS-J ACQ IMM DEF, V42, P1, DOI 10.1097/01.qai.0000218353.60099.4f; Ross MJ, 2005, J AM SOC NEPHROL, V16, P2403, DOI 10.1681/ASN.2004121101; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Tanji N, 2006, HISTOL HISTOPATHOL, V21, P393, DOI 10.14670/HH-21.393; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wyatt CM, 2007, CLIN J AM SOC NEPHRO, V2, pS20, DOI 10.2215/CJN.03561006; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zheng L, 2006, HUM PATHOL, V37, P637, DOI 10.1016/j.humpath.2006.01.002	53	151	204	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28840	28851		10.1074/jbc.M112.359505	http://dx.doi.org/10.1074/jbc.M112.359505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22645123	Green Published, hybrid			2022-12-28	WOS:000308074600056
J	Le Goff, MM; Sutton, MJ; Slevin, M; Latif, A; Humphries, MJ; Bishop, PN				Le Goff, Magali M.; Sutton, Matthew J.; Slevin, Mark; Latif, Ayse; Humphries, Martin J.; Bishop, Paul N.			Opticin Exerts Its Anti-angiogenic Activity by Regulating Extracellular Matrix Adhesiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL MORPHOGENESIS; VASCULAR MORPHOGENESIS; ENDOGENOUS INHIBITOR; BINDING-SITES; IV COLLAGEN; ENDOSTATIN; ALPHA(V)BETA(3); ORGANIZATION; EXPRESSION; TUMSTATIN	Opticin is an extracellular matrix glycoprotein that we identified associated with the collagen network of the vitreous humor of the eye. Recently, we discovered that opticin possesses anti-angiogenic activity using a murine oxygen-induced retinopathy model: here, we investigate the underlying mechanism. Using an ex vivo chick chorioallantoic membrane assay, we show that opticin inhibits angiogenesis when stimulated by a range of growth factors. We show that it suppresses capillary morphogenesis, inhibits endothelial invasion, and promotes capillary network regression in three-dimensional matrices of collagen and Matrigel (TM). We then show that opticin binds to collagen and thereby competitively inhibits endothelial cell interactions with collagen via alpha(1)beta(1) and alpha(2)beta(1) integrins, thereby preventing the strong adhesion that is required for proangiogenic signaling via these integrins.	[Le Goff, Magali M.; Sutton, Matthew J.; Latif, Ayse; Bishop, Paul N.] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Latif, Ayse; Bishop, Paul N.] Cent Manchester Univ Hosp NHS Fdn Trust, Ctr Adv Discovery & Expt Therapeut, Manchester M13 9WH, Lancs, England; [Latif, Ayse; Bishop, Paul N.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WH, Lancs, England; [Slevin, Mark] Manchester Metropolitan Univ, Sch Biol Chem & Hlth Sci, Manchester M1 5GD, Lancs, England; [Slevin, Mark] Hosp Santa Creu & Sant Pau, Inst Catala Ciencies Cardiovasc, Barcelona 08025, Spain	University of Manchester; University of Manchester; University of Manchester; Manchester Royal Eye Hospital; University of Manchester; Manchester Metropolitan University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Bishop, PN (corresponding author), Univ Manchester, Fac Med & Human Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Paul.Bishop@manchester.ac.uk	Latif, A/U-4241-2019; Slevin, Mark/AFT-1420-2022; slevin, mark a/A-1593-2008	Latif, A/0000-0002-7245-8729; Humphries, Martin/0000-0002-4331-6967; Bishop, Paul/0000-0001-7937-7932	Manchester National Institute of Health Research Biomedical Research Centre; Manchester Royal Eye Hospital and Guide Dogs; Wellcome Trust [045225, 074941, 057940]; Diabetes UK; Banco Bilbao Vizcaya Argentaria Foundation	Manchester National Institute of Health Research Biomedical Research Centre; Manchester Royal Eye Hospital and Guide Dogs; Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); Banco Bilbao Vizcaya Argentaria Foundation	This work was supported by Manchester National Institute of Health Research Biomedical Research Centre and Manchester Royal Eye Hospital and Guide Dogs. This work was also supported by Wellcome Trust Grants 045225 and 074941 (to M.J.H.) and 057940 (to P.N.B.).; Supported by a grant from Diabetes UK and the Banco Bilbao Vizcaya Argentaria Foundation.	Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; BISHOP PN, 1994, BIOCHEM J, V299, P497, DOI 10.1042/bj2990497; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Colorado PC, 2000, CANCER RES, V60, P2520; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Fiedler LR, 2009, CELL ADHES MIGR, V3, P3, DOI 10.4161/cam.3.1.7275; Frolova EI, 2004, GENE EXPR PATTERNS, V4, P335, DOI 10.1016/j.modgep.2003.10.002; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Guidetti GF, 2003, BBA-MOL CELL RES, V1640, P43, DOI 10.1016/S0167-4889(02)00401-9; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Hamano Y, 2005, BIOCHEM BIOPH RES CO, V333, P292, DOI 10.1016/j.bbrc.2005.05.130; Hindson VJ, 2005, INVEST OPHTH VIS SCI, V46, P4417, DOI 10.1167/iovs.05-0883; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; HOSODA Y, 1992, OPHTHALMIC RES, V24, P260, DOI 10.1159/000267176; Hurskainen M, 2005, FASEB J, V19, P1564, DOI 10.1096/fj.04-3101fje; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Laurens N, 2009, ANGIOGENESIS, V12, P275, DOI 10.1007/s10456-009-9150-8; Le Goff MM, 2012, INVEST OPHTH VIS SCI, V53, P228, DOI 10.1167/iovs.11-8514; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; LUTTY GA, 1983, INVEST OPHTH VIS SCI, V24, P52; Maatta M, 2007, GRAEF ARCH CLIN EXP, V245, P74, DOI 10.1007/s00417-006-0281-y; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; Monfort J, 2008, OSTEOARTHR CARTILAGE, V16, P749, DOI 10.1016/j.joca.2007.11.007; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ramesh S, 2004, BRIT J OPHTHALMOL, V88, P697, DOI 10.1136/bjo.2003.031989; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; SATTAR A, 1992, SEMIN ARTHRITIS RHEU, V22, P37, DOI 10.1016/0049-0172(92)90047-H; Schonherr E, 2001, J CELL PHYSIOL, V187, P37, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1048>3.0.CO;2-W; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Takanosu M, 2001, INVEST OPHTH VIS SCI, V42, P2202; Thuret G, 2003, BRIT J OPHTHALMOL, V87, P346, DOI 10.1136/bjo.87.3.346; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; VERNON RB, 1995, AM J PATHOL, V147, P873; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; WEST DC, 2001, METHODS MOL MED ANGI, P107; Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200; Wickstrom SA, 2002, CANCER RES, V62, P5580; Wiegand S. J., 1884, INVEST OPHTHALMOL VI, V45; Wistow G, 2002, MOL VIS, V8, P185; WONG HC, 1989, GRAEF ARCH CLIN EXP, V227, P237, DOI 10.1007/BF02172755	55	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28027	28036		10.1074/jbc.M111.331157	http://dx.doi.org/10.1074/jbc.M111.331157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22669977	hybrid, Green Published			2022-12-28	WOS:000307840700076
J	May, D; Baastrup, J; Nientit, MR; Binder, A; Schunke, M; Baron, R; Cascorbi, I				May, Denisa; Baastrup, Jonas; Nientit, Maria Raphaela; Binder, Andreas; Schuenke, Michael; Baron, Ralf; Cascorbi, Ingolf			Differential Expression and Functionality of TRPA1 Protein Genetic Variants in Conditions of Thermal Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL TRPA1; COVALENT MODIFICATION; COLD HYPERALGESIA; SENSORY NEURONS; CALCIUM-IONS; PAIN; ACTIVATION; SENSITIVITY; MECHANISMS; DIAGNOSIS	The role of genetic modifications of the TRPA1 receptor has been well documented in inflammatory and neuropathic pain. We recently reported that the E179K variant of TRPA1 appears to be crucial for the generation of paradoxical heat sensation in pain patients. Here, we describe the consequences of the single amino acid exchange at position 179 in the ankyrin repeat 4 of human TRPA1. TRPA1 wild type Lys-179 protein expressed in HEK cells exhibited intact biochemical properties, inclusive trafficking into the plasma membrane, formation of large protein complexes, and the ability to be activated by cold. Additionally, a strong increase of Lys-179 protein expression was observed in cold (4 degrees C) and heat (49 degrees C)-treated cells. In contrast, HEK cells expressing the variant Lys-179 TRPA1 failed to get activated by cold possibly due to the loss of ability to interact with other proteins or other TRPA1 monomers during oligomerization. In conclusion, the detailed understanding of TRPA1 genetic variants might provide a fruitful strategy for future development of pain treatments.	[May, Denisa; Baastrup, Jonas; Nientit, Maria Raphaela; Cascorbi, Ingolf] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, D-24105 Kiel, Germany; [Binder, Andreas; Baron, Ralf] Univ Hosp Schleswig Holstein, Dept Neurol, Div Neurol Pain Res & Therapy, D-24105 Kiel, Germany; [Schuenke, Michael] Univ Kiel, Inst Anat, D-24118 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Cascorbi, I (corresponding author), Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, Arnold Heller Str 3, D-24105 Kiel, Germany.	cascorbi@pharmakologie.uni-kiel.de	Cascorbi, Ingolf/AAT-1927-2021	Cascorbi, Ingolf/0000-0002-2182-9534	Medical Faculty (University of Kiel)	Medical Faculty (University of Kiel)	This work was supported by a grant from the Medical Faculty (University of Kiel).	Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Binder A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017387; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Donnerer J, 2011, TISSUE CELL, V43, P178, DOI 10.1016/j.tice.2011.02.002; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Ji G, 2008, NEUROSCIENCE, V154, P1054, DOI 10.1016/j.neuroscience.2008.04.039; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Katsura H, 2006, EXP NEUROL, V200, P112, DOI 10.1016/j.expneurol.2006.01.031; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Liu MG, 2011, BRAIN RES, V1382, P57, DOI 10.1016/j.brainres.2011.01.076; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mizushima T, 2006, NEUROSCIENCE, V140, P1337, DOI 10.1016/j.neuroscience.2006.03.024; Mizushima T, 2005, PAIN, V113, P51, DOI 10.1016/j.pain.2004.09.038; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Story GM, 2006, CURR NEUROPHARMACOL, V4, P183, DOI 10.2174/157015906778019482; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 2009, BRAIN RES REV, V60, P2, DOI 10.1016/j.brainresrev.2008.12.018; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	31	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27087	27094		10.1074/jbc.M112.341776	http://dx.doi.org/10.1074/jbc.M112.341776			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22665484	hybrid, Green Published			2022-12-28	WOS:000307386000061
J	Bennetts, B; Yu, YW; Chen, TY; Parker, MW				Bennetts, Brett; Yu, Yawei; Chen, Tsung-Yu; Parker, Michael W.			Intracellular beta-Nicotinamide Adenine Dinucleotide Inhibits the Skeletal Muscle ClC-1 Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; ATP INHIBITION; CBS DOMAINS; C-TERMINUS; PH; MUTATIONS; EXCITABILITY; MECHANISMS; DEPENDENCE; MOVEMENT	ClC-1 is the dominant sarcolemmal chloride channel and plays an important role in regulating membrane excitability that is underscored by ClC-1 mutations in congenital myotonia. Here we show that the coenzyme beta-nicotinamide adenine dinucleotide (NAD), an important metabolic regulator, robustly inhibits ClC-1 when included in the pipette solution in whole cell patch clamp experiments and when transiently applied to inside-out patches. The oxidized (NAD(+)) form of the coenzyme was more efficacious than the reduced (NADH) form, and inhibition by both was greatly enhanced by acidification. Molecular modeling, based on the structural coordinates of the homologous ClC-5 and CmClC proteins and in silico docking, suggest that NAD(+) binds with the adenine base deep in a cleft formed by ClC-1 intracellular cystathionine beta-synthase domains, and the nicotinamide base interacts with the membrane-embedded channel domain. Consistent with predictions from the models, mutation of residues in cystathionine beta-synthase and channel domains either attenuated (G200R, T636A, H847A) or abrogated (L848A) the effect of NAD(+). In addition, the myotonic mutations G200R and Y261C abolished potentiation of NAD(+) inhibition at low pH. Our results identify a new biological role for NAD and suggest that the main physiological relevance may be the exquisite sensitivity to intracellular pH that NAD(+) inhibition imparts to ClC-1 gating. These findings are consistent with the reduction of sarcolemmal chloride conductance that occurs upon acidification of skeletal muscle and suggest a previously unexplored mechanism in the pathophysiology of myotonia.	[Bennetts, Brett; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Yu, Yawei; Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Yu, Yawei; Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Davis, CA 95618 USA; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	St. Vincent's Institute of Medical Research; University of California System; University of California Davis; University of California System; University of California Davis; University of Melbourne	Bennetts, B (corresponding author), St Vincents Inst Med Res, Biota Struct Biol Lab, 9 Princes St, Fitzroy, Vic 3065, Australia.	bbennetts@svi.edu.au	Parker, Michael W/F-9069-2013	Parker, Michael W/0000-0002-3101-1138	National Institutes of Health [R01GM065447]; Victorian Government Operational Infrastructure Support Scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Government Operational Infrastructure Support Scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM065447 (to T.-Y. C.). This work was also supported by funding from the Victorian Government Operational Infrastructure Support Scheme to St Vincent's Institute (to T.-Y. C.).	Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; Accardi A, 2001, J PHYSIOL-LONDON, V534, P745, DOI 10.1111/j.1469-7793.2001.00745.x; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bennetts B, 2007, J BIOL CHEM, V282, P32780, DOI 10.1074/jbc.M703259200; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Chen MF, 1997, J PHYSIOL-LONDON, V504, P75, DOI 10.1111/j.1469-7793.1997.075bf.x; Chen TY, 1998, J GEN PHYSIOL, V112, P715, DOI 10.1085/jgp.112.6.715; De Angeli A, 2009, J BIOL CHEM, V284, P26526, DOI 10.1074/jbc.M109.005132; Dutzler R, 2004, FEBS LETT, V564, P229, DOI 10.1016/S0014-5793(04)00210-8; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Grahnert A, 2009, PURINERG SIGNAL, V5, P309, DOI 10.1007/s11302-009-9144-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HERMANSEN L, 1972, J APPL PHYSIOL, V32, P304, DOI 10.1152/jappl.1972.32.3.304; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Klein C, 2009, CELL CALCIUM, V46, P263, DOI 10.1016/j.ceca.2009.08.004; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Li Y, 2005, BIOPHYS J, V88, P3936, DOI 10.1529/biophysj.104.055012; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Ma LL, 2011, BIOCHEM J, V436, P415, DOI 10.1042/BJ20102153; Mailander V, 1996, AM J HUM GENET, V58, P317; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; METZGER JM, 1987, J APPL PHYSIOL, V62, P1392, DOI 10.1152/jappl.1987.62.4.1392; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; MOORE CE, 1969, ANAL BIOCHEM, V29, P149, DOI 10.1016/0003-2697(69)90018-9; Niemeyer MI, 2004, PHYSIOL GENOMICS, V19, P74, DOI 10.1152/physiolgenomics.00070.2004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pedersen TH, 2005, J GEN PHYSIOL, V125, P237, DOI 10.1085/jgp.200409173; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; ROOS A, 1978, AM J PHYSIOL, V235, pC49, DOI 10.1152/ajpcell.1978.235.1.C49; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; Rychkov GY, 2001, J PHYSIOL-LONDON, V530, P379, DOI 10.1111/j.1469-7793.2001.0379k.x; SAHLIN K, 1978, J APPL PHYSIOL, V45, P474, DOI 10.1152/jappl.1978.45.3.474; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; THOMPSON LV, 1992, AM J PHYSIOL, V262, pC1507, DOI 10.1152/ajpcell.1992.262.6.C1507; Tseng PY, 2007, J GEN PHYSIOL, V130, P217, DOI 10.1085/jgp.200709817; Tseng PY, 2011, J GEN PHYSIOL, V137, P357, DOI 10.1085/jgp.201010495; Wellhauser L, 2006, BIOCHEM J, V398, P289, DOI 10.1042/BJ20060142; Wellhauser L, 2011, J BIOL CHEM, V286, P6733, DOI 10.1074/jbc.M110.175877; WILSON JR, 1988, J APPL PHYSIOL, V64, P2333, DOI 10.1152/jappl.1988.64.6.2333; Wollnik B, 1997, HUM MOL GENET, V6, P805, DOI 10.1093/hmg/6.5.805; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhang XD, 2008, J GEN PHYSIOL, V132, P421, DOI 10.1085/jgp.200810023; Zifarelli G, 2009, EMBO REP, V10, P1111, DOI 10.1038/embor.2009.159	59	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25808	25820		10.1074/jbc.M111.327551	http://dx.doi.org/10.1074/jbc.M111.327551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689570	Green Published, hybrid			2022-12-28	WOS:000306916300011
J	Cloutier, SC; Ma, WK; Nguyen, LT; Tran, EJ				Cloutier, Sara C.; Ma, Wai Kit; Nguyen, Luyen T.; Tran, Elizabeth J.			The DEAD-box RNA Helicase Dbp2 Connects RNA Quality Control with Repression of Aberrant Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTS; LONG NONCODING RNAS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CRYPTIC TRANSCRIPTION; ELONGATION-FACTORS; 3'-END FORMATION; SEN1 HELICASE; GENE LOOPS; PROTEIN	DEAD-box proteins are a class of RNA-dependent ATP hydrolysis enzymes that rearrange RNA and RNA-protein (ribonucleoprotein) complexes. In an effort to characterize the cellular function of individual DEAD-box proteins, our laboratory has uncovered a previously unrecognized link between the DEAD-box protein Dbp2 and the regulation of transcription in Saccharomyces cerevisiae. Here, we report that Dbp2 is a double-stranded RNA-specific ATPase that associates directly with chromatin and is required for transcriptional fidelity. In fact, loss of DBP2 results in multiple gene expression defects, including accumulation of noncoding transcripts, inefficient 3' end formation, and appearance of aberrant transcriptional initiation products. We also show that loss of DBP2 is synthetic lethal with deletion of the nuclear RNA decay factor, RRP6, pointing to a global role for Dbp2 in prevention of aberrant transcriptional products. Taken together, we present a model whereby Dbp2 functions to cotranscriptionally modulate RNA structure, a process that facilitates ribonucleoprotein assembly and clearance of transcripts from genomic loci. These studies suggest that Dbp2 is a missing link in RNA quality control that functions to maintain the fidelity of transcriptional processes.	[Tran, Elizabeth J.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tran, EJ (corresponding author), Purdue Univ, Dept Biochem, BCHM 305,175 S Univ St, W Lafayette, IN 47907 USA.	ejtran@purdue.edu	Tran, Elizabeth/G-7818-2018	Tran, Elizabeth/0000-0002-9541-004X	National Institutes of Health [R01GM097332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM097332 (to E. J. T.).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Banroques J, 2011, J MOL BIOL, V413, P451, DOI 10.1016/j.jmb.2011.08.032; BARTA I, 1995, EMBO J, V14, P3800, DOI 10.1002/j.1460-2075.1995.tb00049.x; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Bond AT, 2001, MOL CELL BIOL, V21, P7366, DOI 10.1128/MCB.21.21.7366-7379.2001; Brickner JH, 2009, CURR OPIN CELL BIOL, V21, P127, DOI 10.1016/j.ceb.2009.01.007; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Du HN, 2010, J BIOL CHEM, V285, P11704, DOI 10.1074/jbc.M109.085043; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fasken MB, 2009, RNA BIOL, V6, P237, DOI 10.4161/rna.6.3.8330; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Prather D, 2005, MOL CELL BIOL, V25, P10122, DOI 10.1128/MCB.25.22.10122-10135.2005; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Rougemaille M, 2010, ADV EXP MED BIOL, V702, P122, DOI 10.1007/978-1-4419-7841-7_10; Schmid M, 2010, WIRES RNA, V1, P474, DOI 10.1002/wrna.24; Sellick CA, 2008, INT REV CEL MOL BIO, V269, P111, DOI 10.1016/S1937-6448(08)01003-4; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinan S, 2011, J BIOL CHEM, V286, P37304, DOI 10.1074/jbc.M111.287706; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; TAJIMA M, 1986, MOL CELL BIOL, V6, P246, DOI 10.1128/MCB.6.1.246; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zhou H, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	74	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26155	26166		10.1074/jbc.M112.383075	http://dx.doi.org/10.1074/jbc.M112.383075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679025	hybrid, Green Published			2022-12-28	WOS:000306916300043
J	Liu, ML; Zhou, LJ; Wei, L; Villarreal, R; Yang, X; Hu, DR; Riojas, RA; Holmes, BM; Langlais, PR; Lee, H; Dong, LQ				Liu, Meilian; Zhou, Lijun; Wei, Li; Villarreal, Ricardo; Yang, Xin; Hu, Derong; Riojas, Ramon A.; Holmes, Bekke M.; Langlais, Paul R.; Lee, Hakjoo; Dong, Lily Q.			Phosphorylation of Adaptor Protein Containing Pleckstrin Homology Domain, Phosphotyrosine Binding Domain, and Leucine Zipper Motif 1 (APPL1) at Ser(430) Mediates Endoplasmic Reticulum (ER) Stress-induced Insulin Resistance in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C ISOFORMS ALPHA; KINASE-C; ADIPONECTIN RECEPTORS; ACTIVATION; PATHWAY; CELLS; AKT; LOCALIZATION; INHIBITION; MUSCLES	APPL1 is an adaptor protein that plays a critical role in regulating adiponectin and insulin signaling. However, how APPL1 is regulated under normal and pathological conditions remains largely unknown. In this study, we show that APPL1 undergoes phosphorylation at Ser(430) and that this phosphorylation is enhanced in the liver of obese mice displaying insulin resistance. In cultured mouse hepatocytes, APPL1 phosphorylation at Ser(430) is stimulated by phorbol 12-myristate 13-acetate, an activator of classic PKC isoforms, and by the endoplasmic reticulum (ER) stress inducer, thapsigargin. Overexpression of wild-type but not dominant negative PKC alpha increases APPL1 phosphorylation at Ser(430) in mouse hepatocytes. In addition, suppressing PKC alpha expression by shRNA in hepatocytes reduces ER stress-induced APPL1 phosphorylation at Ser(430) as well as the inhibitory effect of ER stress on insulin-stimulated Akt phosphorylation. Consistent with a negative regulatory role of APPL1 phosphorylation at Ser(430) in insulin signaling, overexpression of APPL1(S430D) but not APPL1(S430A) impairs the potentiating effect of APPL1 on insulin-stimulated Akt phosphorylation at Thr(308). Taken together, our results identify APPL1 as a novel target in ER stress-induced insulin resistance and PKC alpha as the kinase mediating ER stress-induced phosphorylation of APPL1 at Ser(430).	[Liu, Meilian; Hu, Derong] UTHSCSA, Dept Pharmacol, San Antonio, TX 78229 USA; [Zhou, Lijun; Villarreal, Ricardo; Yang, Xin; Lee, Hakjoo; Dong, Lily Q.] UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Riojas, Ramon A.; Langlais, Paul R.] UTHSCSA, Dept Biochem, San Antonio, TX 78229 USA; [Holmes, Bekke M.] UTHSCSA, Dept Physiol, San Antonio, TX 78229 USA; [Wei, Li] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University	Liu, ML (corresponding author), UTHSCSA, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	lium2@uthscsa.edu; DONGQ@uthscsa.edu	Zhou, Li/GSE-4531-2022		National Institutes of Health [DK080344, DK69930]; American Heart Association [11BGIA7620074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080344, R01DK069930, R56DK069930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080344 and DK69930 (to L. Q.D.). This work was also supported in part by American Heart Association Beginning-in-Aid Award 11BGIA7620074 (to M. L.).	Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Buechler C, 2010, FEBS LETT, V584, P4280, DOI 10.1016/j.febslet.2010.09.035; Cassese A, 2008, J BIOL CHEM, V283, P36088, DOI 10.1074/jbc.M801698200; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Gant-Branum RL, 2010, J PROTEOME RES, V9, P1541, DOI 10.1021/pr901043e; Kanoh Y, 2001, ENDOCRINOLOGY, V142, P1595, DOI 10.1210/en.142.4.1595; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rosenzweig T, 2002, DIABETES, V51, P1921, DOI 10.2337/diabetes.51.6.1921; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Tournier C, 1997, EUR J BIOCHEM, V244, P587, DOI 10.1111/j.1432-1033.1997.00587.x; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Xin X, 2011, AM J PHYSIOL-ENDOC M, V300, pE103, DOI 10.1152/ajpendo.00427.2010; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	25	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26087	26093		10.1074/jbc.M112.372292	http://dx.doi.org/10.1074/jbc.M112.372292			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685300	Green Published, hybrid			2022-12-28	WOS:000306916300036
J	Locatelli, D; Terao, M; Fratelli, M; Zanetti, A; Kurosaki, M; Lupi, M; Barzago, MM; Uggetti, A; Capra, S; D'Errico, P; Battaglia, GS; Garattini, E				Locatelli, Denise; Terao, Mineko; Fratelli, Maddalena; Zanetti, Adriana; Kurosaki, Mami; Lupi, Monica; Barzago, Maria Monica; Uggetti, Andrea; Capra, Silvia; D'Errico, Paolo; Battaglia, Giorgio S.; Garattini, Enrico			Human Axonal Survival of Motor Neuron (a-SMN) Protein Stimulates Axon Growth, Cell Motility, C-C Motif Ligand 2 (CCL2), and Insulin-like Growth Factor-1 (IGF1) Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; RETINOIC ACID; NERVOUS-SYSTEM; MOUSE MODEL; CYCLE EXIT; DIFFERENTIATION; ACTIVATION; CHEMOKINES; ADULT; NEUROBLASTOMA	Spinal muscular atrophy is a fatal genetic disease of motoneurons due to loss of full-length survival of motor neuron protein, the main product of the disease gene SMN1. Axonal SMN (a-SMN) is an alternatively spliced isoform of SMN1, generated by retention of intron 3. To study a-SMN function, we generated cellular clones for the expression of the protein in mouse motoneuron-like NSC34 cells. The model was instrumental in providing evidence that a-SMN decreases cell growth and plays an important role in the processes of axon growth and cellular motility. In our conditions, low levels of a-SMN expression were sufficient to trigger the observed biological effects, which were not modified by further increasing the amounts of the expressed protein. Differential transcriptome analysis led to the identification of novel a-SMN-regulated factors, i.e. the transcripts coding for the two chemokines, C-C motif ligands 2 and 7 (CCL2 and CCL7), as well as the neuronal and myotrophic factor, insulin-like growth factor-1 (IGF1). a-SMN-dependent induction of CCL2 and IGF1 mRNAs resulted in increased intracellular levels and secretion of the respective protein products. Induction of CCL2 contributes to the a-SMN effects, mediating part of the action on axon growth and random cell motility, as indicated by chemokine knockdown and re-addition studies. Our results shed new light on a-SMN function and the underlying molecular mechanisms. The data provide a rational framework to understand the role of a-SMN deficiency in the etiopathogenesis of spinal muscular atrophy.	[Terao, Mineko; Fratelli, Maddalena; Zanetti, Adriana; Kurosaki, Mami; Barzago, Maria Monica; Garattini, Enrico] Ist Ric Farmacol Mario Negri, Mol Biol Lab, I-20156 Milan, Italy; [Lupi, Monica] Ist Ric Farmacol Mario Negri, Dept Oncol, I-20156 Milan, Italy; [Locatelli, Denise; Capra, Silvia; D'Errico, Paolo; Battaglia, Giorgio S.] Ist Neurol C Besta, Mol Neuroanat Lab, Dept Expt Neurophysiol & Epileptol, I-20133 Milan, Italy; [Uggetti, Andrea] Ist Neurol C Besta, Div Neuropathol, I-20126 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta	Garattini, E (corresponding author), Ist Ric Farmacol Mario Negri, Mol Biol Lab, Via La Masa 19, I-20156 Milan, Italy.	enrico.garattini@marionegri.it	KUROSAKI, Mami/ABG-2224-2020; Fratelli, Maddalena/AAA-6446-2020; adriana, zanetti/ABA-1189-2020; Terao, Mineko/AAA-6415-2020; Garattini, Enrico/AAI-1998-2019; Barzago, Maria Monica/AAA-6402-2020; terao, mineko/AAU-8089-2020; Locatelli, Denise/J-8655-2016; Lupi, Monica/AAH-5704-2019	KUROSAKI, Mami/0000-0001-8231-713X; Fratelli, Maddalena/0000-0002-1769-3427; adriana, zanetti/0000-0002-5825-9707; Terao, Mineko/0000-0002-9976-9869; Barzago, Maria Monica/0000-0002-6952-0069; Locatelli, Denise/0000-0001-9783-7111; Lupi, Monica/0000-0002-9835-7870; Garattini, Enrico/0000-0001-8983-886X	Telethon-Italy Foundation [GGP07223]; Fondazione Cariplo [2008_2307]; Italian Ministry of Health [RF-INN-2007-644440]; Fondazione Italo Monzino, Girotondo/Onlus and Smarathon/ONLUS; Negri-Weizmann Foundation; Ministero della Salute	Telethon-Italy Foundation(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Italo Monzino, Girotondo/Onlus and Smarathon/ONLUS; Negri-Weizmann Foundation; Ministero della Salute(Ministry of Health, Italy)	This work was supported by Telethon-Italy Foundation Grant GGP07223, Fondazione Cariplo Grant 2008_2307, Italian Ministry of Health Grant RF-INN-2007-644440, the Fondazione Italo Monzino, Girotondo/Onlus and Smarathon/ONLUS, the Negri-Weizmann Foundation, and in part by Ministero della Salute.	Banisor I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-7; Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Comini-Frota ER, 2011, CNS DRUGS, V25, P971, DOI 10.2165/11595060-000000000-00000; Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dansereau MA, 2008, J NEUROCHEM, V106, P757, DOI 10.1111/j.1471-4159.2008.05429.x; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; ELEMER GS, 1994, J BIOL CHEM, V269, P3159; Farrar NR, 2009, J NEUROSCI, V29, P14136, DOI 10.1523/JNEUROSCI.2921-09.2009; Gianni M, 2000, CELL DEATH DIFFER, V7, P447, DOI 10.1038/sj.cdd.4400673; Giavazzi A, 2006, J NEUROPATH EXP NEUR, V65, P267, DOI 10.1097/01.jnen.0000205144.54457.a3; Gomez TM, 2004, NEURON, V42, P1, DOI 10.1016/S0896-6273(04)00188-6; Gordon RJ, 2012, EXP NEUROL, V233, P587, DOI 10.1016/j.expneurol.2011.11.029; Gunadi, 2008, ANN HUM GENET, V72, P288, DOI 10.1111/j.1469-1809.2007.00409.x; Hall AA, 2009, GLIA, V57, P744, DOI 10.1002/glia.20802; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hou ST, 2008, INT REV CEL MOL BIO, V267, P125, DOI 10.1016/S1937-6448(08)00603-5; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Johnson-Farley NN, 2006, J PHARMACOL EXP THER, V316, P1062, DOI 10.1124/jpet.105.094433; Kapfhammer Josef P., 1992, Current Opinion in Cell Biology, V4, P863, DOI 10.1016/0955-0674(92)90112-P; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Kim MD, 2002, J NEUROSCI, V22, P1794, DOI 10.1523/JNEUROSCI.22-05-01794.2002; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; Locatelli D, 2012, J NEUROCHEM, V121, P465, DOI 10.1111/j.1471-4159.2012.07689.x; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Marzinke MA, 2012, EXP CELL RES, V318, P85, DOI 10.1016/j.yexcr.2011.10.002; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Mirabelli-Badenier M, 2011, THROMB HAEMOSTASIS, V105, P409, DOI 10.1160/TH10-10-0662; Murakami M, 2010, J NEUROCHEM, V112, P511, DOI 10.1111/j.1471-4159.2009.06486.x; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ogawa C, 2009, J BIOL CHEM, V284, P14609, DOI 10.1074/jbc.M809031200; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Reimer MM, 2009, J NEUROSCI, V29, P15073, DOI 10.1523/JNEUROSCI.4748-09.2009; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sendtner M, 2010, NAT NEUROSCI, V13, P795, DOI 10.1038/nn.2565; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; Simic G, 2008, ACTA NEUROPATHOL, V115, P313, DOI 10.1007/s00401-007-0327-1; Terao M, 2011, J BIOL CHEM, V286, P4027, DOI 10.1074/jbc.M110.184994; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Valerio A, 2004, J NEUROSCI RES, V78, P371, DOI 10.1002/jnr.20250; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; Vogt DL, 2007, MOL CELL NEUROSCI, V36, P332, DOI 10.1016/j.mcn.2007.07.004; Yahiaoui L, 2008, J PHYSIOL-LONDON, V586, P3991, DOI 10.1113/jphysiol.2008.152090; Yu WQ, 2001, J NEUROCYTOL, V30, P861, DOI 10.1023/A:1020622530831; Zhou Y, 2011, J NEUROCHEM, V116, P406, DOI 10.1111/j.1471-4159.2010.07121.x	63	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25782	25794		10.1074/jbc.M112.362830	http://dx.doi.org/10.1074/jbc.M112.362830			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669976	hybrid, Green Published			2022-12-28	WOS:000306916300009
J	Nie, J; Sun, C; Faruque, O; Ye, GM; Li, J; Liang, QR; Chang, ZJ; Yang, WNA; Han, X; Shi, YG				Nie, Jia; Sun, Chao; Faruque, Omar; Ye, Guangming; Li, Jia; Liang, Qiangrong; Chang, Zhijie; Yang, Wannian; Han, Xiao; Shi, Yuguang			Synapses of Amphids Defective (SAD-A) Kinase Promotes Glucose-stimulated Insulin Secretion through Activation of p21-activated Kinase (PAK1) in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL POLARIZATION; LKB1 DELETION; IN-VIVO; PROTEINS; CDC42; MECHANISMS; PHOSPHORYLATION; EXOCYTOSIS; POLARITY; PATHWAY	The p21-activated kinase-1 (PAK1) is implicated in regulation of insulin exocytosis as an effector of Rho GTPases. PAK1 is activated by the onset of glucose-stimulated insulin secretion (GSIS) through phosphorylation of Thr-423, a major activation site by Cdc42 and Rac1. However, the kinase(s) that phosphorylates PAK1 at Thr-423 in islet beta-cells remains elusive. The present studies identified SAD-A (synapses of amphids defective), a member of AMP-activated protein kinase-related kinases exclusively expressed in brain and pancreas, as a key regulator of GSIS through activation of PAK1. We show that SAD-A directly binds to PAK1 through its kinase domain. The interaction is mediated by the p21-binding domain (PBD) of PAK1 and requires both kinases in an active conformation. The binding leads to direct phosphorylation of PAK1 at Thr-423 by SAD-A, triggering the onset of GSIS from islet beta-cells. Consequently, ablation of PAK1 kinase activity or depletion of PAK1 expression completely abolishes the potentiating effect of SAD-A on GSIS. Consistent with its role in regulating GSIS, overexpression of SAD-A in MIN6 islet beta-cells significantly stimulated cytoskeletal remodeling, which is required for insulin exocytosis. Together, the present studies identified a critical role of SAD-A in the activation of PAK1 during the onset of insulin exocytosis.	[Nie, Jia; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China; [Nie, Jia; Sun, Chao; Faruque, Omar; Ye, Guangming; Li, Jia; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Sun, Chao] NW A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Liang, Qiangrong] Univ S Dakota, Sanford Res, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Chang, Zhijie] Tsinghua Univ, Sch Med, Inst Biomed, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yang, Wannian] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA	Nanjing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Northwest A&F University - China; Sanford Health; University of South Dakota; Tsinghua University	Han, X (corresponding author), Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China.	hanxiao@njmu.edu.cn; yus11@psu.edu	Chang, Zhijie/AAH-8109-2019; nie, jia/AAE-8355-2019	nie, jia/0000-0001-9085-7224; Chang, Zhijie/0000-0003-1567-3227	National Institutes of Health [DK076685]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076685, R56DK076685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076685 (to Y. S).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Asahara SI, 2008, DIABETES, V57, pA55; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Fujimoto T, 2008, BIOCHEMISTRY-US, V47, P4151, DOI 10.1021/bi702528r; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Guo ZK, 2006, BIOCHEM BIOPH RES CO, V347, P867, DOI 10.1016/j.bbrc.2006.06.178; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; Mountjoy PD, 2007, EXP PHYSIOL, V92, P311, DOI 10.1113/expphysiol.2006.036004; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi YG, 1999, J BIOL CHEM, V274, P5723, DOI 10.1074/jbc.274.9.5723; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	45	27	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26435	26444		10.1074/jbc.M112.378372	http://dx.doi.org/10.1074/jbc.M112.378372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669945	Green Published, hybrid			2022-12-28	WOS:000306916300068
J	Sato, Y; Yamagata, A; Goto-Ito, S; Kubota, K; Miyamoto, R; Nakada, S; Fukai, S				Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Kubota, Keiko; Miyamoto, Rikako; Nakada, Shinichiro; Fukai, Shuya			Molecular Basis of Lys-63-linked Polyubiquitination Inhibition by the Interaction between Human Deubiquitinating Enzyme OTUB1 and Ubiquitin-conjugating Enzyme UBC13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; STRUCTURAL BASIS; DNA; RAP80; RNF8; RECOGNITION; CHAINS; BRCA1	UBC13 is the only known E2 ubiquitin (Ub)-conjugating enzyme that produces Lys-63-linked Ub chain with its cofactor E2 variant UEV1a or MMS2. Lys-63-linked ubiquitination is crucial for recruitment of DNA repair and damage response molecules to sites of DNA double-strand breaks (DSBs). A deubiquitinating enzyme OTUB1 suppresses Lys-63-linked ubiquitination of chromatin surrounding DSBs by binding UBC13 to inhibit its E2 activity independently of the isopeptidase activity. OTUB1 strongly suppresses UBC13-dependent Lys-63-linked tri-Ub production, whereas it allows di-Ub production in vitro. The mechanism of this non-canonical OTUB1-mediated inhibition of ubiquitination remains to be elucidated. Furthermore, the atomic level information of the interaction between human OTUB1 and UBC13 has not been reported. Here, we determined the crystal structure of human OTUB1 in complex with human UBC13 and MMS2 at 3.15 angstrom resolution. The presented atomic-level interactions were confirmed by surface-plasmon resonance spectroscopy with structure-based mutagenesis. The designed OTUB1 mutants cannot inhibit Lys-63-linked Ub chain formation in vitro and histone ubiquitination and 53BP1 assembly around DSB sites in vivo. Finally, we propose a model for how capping of di-Ub by the OTUB1-UBC13-MMS2/UEV1a complex efficiently inhibits Lys-63-linked tri-Ub formation.	[Nakada, Shinichiro] Osaka Univ, Dept Bioregulat & Cellular Response, Grad Sch Med, Suita, Osaka 5650871, Japan; [Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Kubota, Keiko; Fukai, Shuya] Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan; [Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Kubota, Keiko; Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Sato, Yusuke; Yamagata, Atsushi; Fukai, Shuya] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Chiba 2778501, Japan; [Miyamoto, Rikako; Nakada, Shinichiro] Keio Univ, Ctr Integrated Med Res, Sch Med, Tokyo 1608582, Japan	Osaka University; University of Tokyo; University of Tokyo; University of Tokyo; Keio University	Nakada, S (corresponding author), Osaka Univ, Dept Bioregulat & Cellular Response, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	snakada.res@gmail.com; fukai@iam.u-tokyo.ac.jp	Sato, Yusuke/GPW-9280-2022; Fukai, Shuya/X-4838-2018; OsakaU/AAY-3661-2020	Sato, Yusuke/0000-0001-8495-8950; Fukai, Shuya/0000-0002-1241-1443; Nakada, Shinichiro/0000-0001-9297-1565	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan; MEXT; Takeda Science Foundation; Kato Memorial Bioscience Foundation; Nakajima Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Bioscience Foundation; Nakajima Foundation	This work was supported by KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan (to S. F., Y. S., and S. N.), the Promotion of Environmental Improvement for Independence of Young Researchers "Kanrinmaru Project" from MEXT (to S. N.), and grants from Takeda Science Foundation (to S. N.), Kato Memorial Bioscience Foundation (to S. N.), and The Nakajima Foundation (to S. F.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046	29	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25860	25868		10.1074/jbc.M112.364752	http://dx.doi.org/10.1074/jbc.M112.364752			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679021	hybrid, Green Published			2022-12-28	WOS:000306916300015
J	Schumacher, MA; Ye, QZ; Barge, MT; Zampini, M; Barilla, D; Hayes, F				Schumacher, Maria A.; Ye, Qiaozhen; Barge, Madhuri T.; Zampini, Massimiliano; Barilla, Daniela; Hayes, Finbarr			Structural Mechanism of ATP-induced Polymerization of the Partition Factor ParF IMPLICATIONS FOR DNA SEGREGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC ACTIN HOMOLOG; PLASMID PARTITION; BACTERIAL SEGROSOME; DYNAMIC INSTABILITY; PROTEIN; BINDING; COMPLEX; MIND; TUBZ; CENTROMERE	Segregation of the bacterial multidrug resistance plasmid TP228 requires the centromere-binding protein ParG, the parH centromere, and the Walker box ATPase ParF. The cycling of ParF between ADP-and ATP-bound states drives TP228 partition; ATP binding stimulates ParF polymerization, which is essential for segregation, whereas ADP binding antagonizes polymerization and inhibits DNA partition. The molecular mechanism involved in this adenine nucleotide switch is unclear. Moreover, it is unknown how any Walker box protein polymerizes in an ATP-dependent manner. Here, we describe multiple ParF structures in ADP- and phosphomethylphosphonic acid adenylate ester (AMPPCP)-bound states. ParF-ADP is monomeric but dimerizes when complexed with AMPPCP. Strikingly, in ParF-AMPPCP structures, the dimers interact to create dimer-of-dimer "units" that generate a specific linear filament. Mutation of interface residues prevents both polymerization and DNA segregation in vivo. Thus, these data provide insight into a unique mechanism by which a Walker box protein forms polymers that involves the generation of ATP-induced dimer-of-dimer building blocks.	[Schumacher, Maria A.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Ye, Qiaozhen] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Barge, Madhuri T.; Barilla, Daniela] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Zampini, Massimiliano; Hayes, Finbarr] Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Zampini, Massimiliano; Hayes, Finbarr] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	Duke University; University of Texas System; UTMD Anderson Cancer Center; University of York - UK; University of Manchester; University of Manchester	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, 255 Nanaline H Duke,POB 3711, Durham, NC 27710 USA.	maria.schumacher@duke.edu; daniela.barilla@york.ac.uk; finbarr.hayes@manchester.ac.uk		Barilla, Daniela/0000-0002-3486-7492; Ye, Qiaozhen/0000-0002-3942-4121	National Institutes of Health [GM074815]; MD Anderson Trust; Burroughs Wellcome career development award; Biotechnology and Biological Sciences Research Council [G003114]; Medical Research Council [G0801162]; BBSRC [BB/G003114/1] Funding Source: UKRI; MRC [G0801162] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003114/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Trust; Burroughs Wellcome career development award(Burroughs Wellcome Fund); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074815 (to M. A. S.). This work was also supported by an MD Anderson Trust fellowship and a Burroughs Wellcome career development award (to M. A. S.). Work in the laboratory of F. H. was supported by the Biotechnology and Biological Sciences Research Council, Grant G003114. Work in the laboratory of D. B. was supported by Medical Research Council Grant G0801162.	Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delano W. L., 2001, PYMOL MOL GRAPHICS S; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Hayashi I, 2001, EMBO J, V20, P1819, DOI 10.1093/emboj/20.8.1819; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Hayes F, 2006, TRENDS BIOCHEM SCI, V31, P247, DOI 10.1016/j.tibs.2006.03.002; JONES CS, 1993, J GEN MICROBIOL, V139, P735, DOI 10.1099/00221287-139-4-735; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Lutkenhaus J, 2003, MOL MICROBIOL, V48, P295, DOI 10.1046/j.1365-2958.2003.03427.x; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; MOODIE SL, 1993, NUCLEIC ACIDS RES, V21, P1369, DOI 10.1093/nar/21.6.1369; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Sakai N, 2001, STRUCTURE, V9, P817, DOI 10.1016/S0969-2126(01)00638-4; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Surtees JA, 2001, J BIOL CHEM, V276, P12385, DOI 10.1074/jbc.M009370200; Wu MY, 2011, NUCLEIC ACIDS RES, V39, P5082, DOI 10.1093/nar/gkr115; Zampini M, 2009, J BACTERIOL, V191, P3832, DOI 10.1128/JB.01630-08	37	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26146	26154		10.1074/jbc.M112.373696	http://dx.doi.org/10.1074/jbc.M112.373696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22674577	Green Published, hybrid			2022-12-28	WOS:000306916300042
J	Lohse, S; Brunke, C; Derer, S; Peipp, M; Boross, P; Kellner, C; Beyer, T; Dechant, M; van der Winkel, JGJ; Leusen, JHW; Valerius, T				Lohse, Stefan; Brunke, Christina; Derer, Stefanie; Peipp, Matthias; Boross, Peter; Kellner, Christian; Beyer, Thomas; Dechant, Michael; van der Winkel, Jan G. J.; Leusen, Jeanette H. W.; Valerius, Thomas			Characterization of a Mutated IgA2 Antibody of the m(1) Allotype against the Epidermal Growth Factor Receptor for the Recruitment of Monocytes and Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-ALPHA-RI; TUMOR-ASSOCIATED MACROPHAGES; FAB-ARM EXCHANGE; EFFECTOR MECHANISMS; IMMUNOGLOBULIN-A; IGG4 ANTIBODIES; NEUTROPHILS; CELLS; CD89; THERAPEUTICS	IgA antibodies constitute an important part of the mucosal immune system, but their immunotherapeutic potential remains rather unexplored, in part due to biotechnological issues. For example, the IgA2m(1) allotype carries an unusual heavy and light chain pairing, which may confer production and stability concerns. Here, we report the generation and the biochemical and functional characterization of a P221R-mutated IgA2m(1) antibody against the epidermal growth factor receptor (EGFR). Compared with wild type, the mutated antibody demonstrated heavy chains covalently linked to light chains in monomeric as well as in joining (J)-chain containing dimeric IgA. Functional studies with wild type and mutated IgA2m(1) revealed similar binding to EGFR and direct effector functions such as EGFR down-modulation and growth inhibition. Furthermore, both IgA molecules triggered similar levels of indirect tumor cell killing such as antibody-dependent cell-mediated cytotoxicity (ADCC) by isolated monocytes, activated polymorphonuclear cells, and human whole blood. Interestingly, the dimeric IgA antibodies demonstrated higher efficiency in direct as well as in indirect effector mechanisms compared with their respective monomeric forms. Both wild type and mutated antibody triggered effective Fc alpha RI-mediated tumor cell killing by macrophages already at low effector to target cell ratios. Interestingly, also polarized macrophages mediated significant IgA2-mediated ADCC. M2 macrophages, which have been described as promoting tumor growth and progression, may convert to ADCC-mediating effector cells in the presence of EGFR-directed antibodies. In conclusion, these results provide further insight into the immunotherapeutic potential of recombinant IgA antibodies for tumor immunotherapy and suggest macrophages as an additional effector cell population.	[Lohse, Stefan; Brunke, Christina; Derer, Stefanie; Peipp, Matthias; Kellner, Christian; Valerius, Thomas] Univ Kiel, Div Stem Cell Transplantat & Immunotherapy, Dept Internal Med 2, D-24105 Kiel, Germany; [Beyer, Thomas; Dechant, Michael] Univ Kiel, Dept Internal Med Nephrol & Hypertens 4, D-24105 Kiel, Germany; [Boross, Peter; van der Winkel, Jan G. J.; Leusen, Jeanette H. W.] Univ Med Ctr Utrecht, Dept Immunol, Lab Immunotherapy, NL-3584 EA Utrecht, Netherlands; [van der Winkel, Jan G. J.] Genmab BV, NL-3584 EA Utrecht, Netherlands	University of Kiel; University of Kiel; Utrecht University; Utrecht University Medical Center; Genmab	Valerius, T (corresponding author), Univ Kiel, Div Stem Cell Transplantat & Immunotherapy, Dept Internal Med 2, Schittenhelmstr 12, D-24105 Kiel, Germany.	t.valerius@med2.uni-kiel.de	, Jeanette/AAG-3736-2019; beyer, thomas/AAN-1789-2020; Leusen, Jeanette/I-9010-2014; Kellner, Christian/G-4238-2015; Valerius, Thomas/A-3086-2011; Lohse, Stefan/P-6627-2016; Derer, Stefanie/B-9963-2014; Derer, Stefanie/B-9300-2017; Boross, Peter/AAD-8928-2022; Peipp, Matthias/A-8775-2013	Kellner, Christian/0000-0002-2562-6902; Lohse, Stefan/0000-0003-2529-1900; Leusen, Jeanette/0000-0003-4982-6914; Beyer, Thomas/0000-0002-8308-3918; Peipp, Matthias/0000-0002-5088-3804	German Research Organization (Deutsche Forschungsgemeinschaft) [Va 124/7-1, De 1478/1-1, Lo 1853/1-1]; Wilhelm Sander Foundation [2009.098.1]	German Research Organization (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Wilhelm Sander Foundation	This work was supported by the German Research Organization (Deutsche Forschungsgemeinschaft, Va 124/7-1, De 1478/1-1, and Lo 1853/1-1) and the Wilhelm Sander Foundation (2009.098.1).	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Bakema JE, 2008, J IMMUNOL, V181, P4080, DOI 10.4049/jimmunol.181.6.4080; Beyer T, 2009, J IMMUNOL METHODS, V346, P26, DOI 10.1016/j.jim.2009.05.002; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chintalacharuvu KR, 2002, J IMMUNOL, V169, P5072, DOI 10.4049/jimmunol.169.9.5072; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dechant M, 2002, BLOOD, V100, P4574, DOI 10.1182/blood-2002-03-0687; Dechant M, 2007, J IMMUNOL, V179, P2936, DOI 10.4049/jimmunol.179.5.2936; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Furtado PB, 2004, J MOL BIOL, V338, P921, DOI 10.1016/j.jmb.2004.03.007; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Huls G, 1999, CANCER RES, V59, P5778; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lohse S, 2011, J IMMUNOL, V186, P3770, DOI 10.4049/jimmunol.1003082; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Maruoka T, 2004, IMMUNOGENETICS, V55, P712, DOI 10.1007/s00251-003-0626-1; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; Oortwijn BD, 2006, J AM SOC NEPHROL, V17, P3529, DOI 10.1681/ASN.2006040388; Otten MA, 2007, J IMMUNOL, V179, P2918, DOI 10.4049/jimmunol.179.5.2918; Pander J, 2011, CLIN CANCER RES, V17, P5668, DOI 10.1158/1078-0432.CCR-11-0239; Peipp M, 2008, CURR OPIN IMMUNOL, V20, P436, DOI 10.1016/j.coi.2008.05.012; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Pleass RJ, 1996, BIOCHEM J, V318, P771, DOI 10.1042/bj3180771; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Rifai A, 2000, J EXP MED, V191, P2171, DOI 10.1084/jem.191.12.2171; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Senior BW, 2005, J IMMUNOL, V174, P7792, DOI 10.4049/jimmunol.174.12.7792; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; STOPPACCIARO A, 1993, J EXP MED, V178, P151, DOI 10.1084/jem.178.1.151; Togo S, 2003, FEBS LETT, V535, P205, DOI 10.1016/S0014-5793(02)03891-7; TSUZUKIDA Y, 1979, P NATL ACAD SCI USA, V76, P1104, DOI 10.1073/pnas.76.3.1104; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; Wang AC, 1973, J IMMUNOGENET, V1, P31; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yin N, 2007, J LEUKOCYTE BIOL, V82, P551, DOI 10.1189/jlb.0207112; Yoo EM, 2011, MOL IMMUNOL, V48, P1818, DOI 10.1016/j.molimm.2011.05.011	49	28	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25139	25150		10.1074/jbc.M112.353060	http://dx.doi.org/10.1074/jbc.M112.353060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679018	Green Published, hybrid			2022-12-28	WOS:000306651700025
J	Milano, SK; Kwon, W; Pereira, R; Antonyak, MA; Cerione, RA				Milano, Shawn K.; Kwon, Woojin; Pereira, Ryan; Antonyak, Marc A.; Cerione, Richard A.			Characterization of a Novel Activated Ran GTPase Mutant and Its Ability to Induce Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN IMPORT; GROWTH-FACTOR; TRIPHOSPHATE CONFORMATION; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; BINDING PROTEIN; DNA-SYNTHESIS; EXPRESSION; SMOC-2; TRANSPORT	Ran (Ras-related nuclear) protein, a member of the Ras superfamily of GTPases, is best known for its roles in nucleocytoplasmic transport, mitotic spindle fiber assembly, and nuclear envelope formation. Recently, we have shown that the overexpression of Ran in fibroblasts induces cellular transformation and tumor formation in mice (Ly, T. K., Wang, J., Pereira, R., Rojas, K. S., Peng, X., Feng, Q., Cerione, R. A., and Wilson, K. F. (2010) J. Biol. Chem. 285, 5815-5826). Here, we describe a novel activated Ran mutant, Ran(K152A), which is capable of an increased rate of GDP-GTP exchange and an accelerated GTP binding/GTP hydrolytic cycle compared with wild-type Ran. We show that its expression in NIH-3T3 fibroblasts induces anchorage-independent growth and stimulates cell invasion, as well as activates signaling pathways that lead to extracellular regulated kinase (ERK) activity. Furthermore, Ran(K152A) expression in the human mammary SKBR3 adenocarcinoma cell line gives rise to an enhanced transformed phenotype and causes a robust stimulation of both ERK and the N-terminal c-Jun kinase (JNK). Microarray analysis reveals that the expression of the gene encoding SMOC-2 (secreted modular calcium-binding protein-2), which has been shown to synergize with different growth factors, is increased by at least 50-fold in cells stably expressing Ran(K152A) compared with cells expressing control vector. Knocking down SMOC-2 expression greatly reduces the ability of Ran(K152A) to stimulate anchorage-independent growth in NIH-3T3 cells and in SKBR3 cells and also inhibits cell invasion in fibroblasts. Collectively, our findings highlight a novel connection between the hyper-activation of the small GTPase Ran and the matricellular protein SMOC-2 that has important consequences for oncogenic transformation.	[Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM040654] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe H, 2008, INT J CANCER, V122, P2391, DOI 10.1002/ijc.23400; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; CLARKE PR, 1995, J CELL SCI, V108, P1217; Cool RH, 1999, MOL CELL BIOL, V19, P6297; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; Joseph J, 2006, J CELL SCI, V119, P3481, DOI 10.1242/jcs.03071; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Lin Q, 2003, CURR BIOL, V13, P1469, DOI 10.1016/S0960-9822(03)00613-4; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Ly TK, 2010, J BIOL CHEM, V285, P5815, DOI 10.1074/jbc.M109.071886; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Partridge JR, 2009, J MOL BIOL, V391, P375, DOI 10.1016/j.jmb.2009.06.011; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; REN MD, 1994, MOL CELL BIOL, V14, P4216, DOI 10.1128/MCB.14.6.4216; Rensen WM, 2008, FRONT BIOSCI-LANDMRK, V13, P4097, DOI 10.2741/2996; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sato M, 2010, NUCLEUS-PHILA, V1, P231, DOI 10.1038/embor.2009.158; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tu SS, 2002, BIOCHEMISTRY-US, V41, P12350, DOI 10.1021/bi026167h; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Wang JB, 2005, J BIOL CHEM, V280, P22883, DOI 10.1074/jbc.M414375200	41	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24955	24966		10.1074/jbc.M111.306514	http://dx.doi.org/10.1074/jbc.M111.306514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679017	hybrid, Green Published			2022-12-28	WOS:000306651700009
J	Ng, KS; Leung, HW; Wong, PTH; Low, CM				Ng, Kay-Siong; Leung, How-Wing; Wong, Peter T. -H.; Low, Chian-Ming			Cleavage of the NR2B Subunit Amino Terminus of N-Methyl-D-aspartate (NMDA) Receptor by Tissue Plasminogen Activator IDENTIFICATION OF THE CLEAVAGE SITE AND CHARACTERIZATION OF IFENPRODIL AND GLYCINE AFFINITIES ON TRUNCATED NMDA RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL VASCULAR-DISEASE; ACUTE ISCHEMIC-STROKE; BLOOD-BRAIN-BARRIER; CARDIOVASCULAR RADIOLOGY; BINDING-SITE; DOMAIN; SYSTEM; SERINE; HIPPOCAMPUS; MODULATION	Thrombolysis using tissue plasminogen activator (tPA) has been the key treatment for patients with acute ischemic stroke for the past decade. Recent studies, however, suggest that this clot-busting protease also plays various roles in brain physiological and pathophysiological glutamatergic-dependent processes, such as synaptic plasticity and neurodegeneration. In addition, increasing evidence implicates tPA as an important neuromodulator of the N-methyl-D-aspartate (NMDA) receptors. Here, we demonstrate that recombinant human tPA cleaves the NR2B subunit of NMDA receptor. Analysis of NR2B in rat brain lysates and cortical neurons treated with tPA revealed concentration- and time-dependent degradation of NR2B proteins. Peptide sequencing studies performed on the cleaved-off products obtained from the tPA treatment on a recombinant fusion protein of the amino-terminal domain of NR2B revealed that tPA-mediated cleavage occurred at arginine 67 (Arg(67)). This cleavage is tPA-specific, plasmin-independent, and removes a predicted similar to 4-kDa fragment (Arg(27)-Arg(67)) from the amino-terminal domain of the NR2B protein. Site-directed mutagenesis of putative cleavage site Arg(67) to Ala(67) impeded tPA-mediated degradation of recombinant protein. This analysis revealed that NR2B is a novel substrate of tPA and suggested that an Arg(27)-Arg(67)-truncated NR2B-containing NMDA receptor could be formed. Heterologous expression of NR2B with Gln(29)-Arg(67) deleted is functional but exhibits reduced ifen-prodil inhibition and increased glycine EC50 with no change in glutamate EC50. Our results confirmed NR2B as a novel proteolytic substrate of tPA, where tPA may directly interact with NR2B subunits leading to a change in pharmacological properties of NR2B-containing NMDA receptors.	[Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Life Sci Inst,Ctr Life Sci, Singapore S117456, Singapore; [Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Anaesthesia, Singapore S117456, Singapore; [Wong, Peter T. -H.; Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Neurobiol, Singapore S117456, Singapore; [Wong, Peter T. -H.; Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Ageing Programme, Singapore S117456, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Low, CM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Life Sci Inst,Ctr Life Sci, Rm 04-06, Singapore S117456, Singapore.	phclowcm@nus.edu.sg	Low, Chian-Ming/V-9271-2017	Low, Chian-Ming/0000-0002-1154-4842	Academic Research Fund Committee Ministry of Education, Singapore; National University of Singapore Academic Research Funds; National Medical Research Council, and Biomedical Research Council grants	Academic Research Fund Committee Ministry of Education, Singapore(Ministry of Education, Singapore); National University of Singapore Academic Research Funds(National University of Singapore); National Medical Research Council, and Biomedical Research Council grants	This work was supported by the Academic Research Fund Committee Ministry of Education, Singapore (to P. T.-H. W. and C.-M. L.), National University of Singapore Academic Research Funds, National Medical Research Council, and Biomedical Research Council grants (to C.-M. L).	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Baron A, 2010, CELL DEATH DIFFER, V17, P860, DOI 10.1038/cdd.2009.172; Basham ME, 2001, J NEUROCHEM, V77, P318, DOI 10.1046/j.1471-4159.2001.t01-1-00239.x; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Butenas S, 1997, BIOCHEMISTRY-US, V36, P2123, DOI 10.1021/bi9617670; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong YN, 2006, J NEUROCHEM, V99, P206, DOI 10.1111/j.1471-4159.2006.04096.x; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Fujimoto S, 2008, J CEREBR BLOOD F MET, V28, P506, DOI 10.1038/sj.jcbfm.9600547; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Gualandris A, 1996, J NEUROSCI, V16, P2220; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kew JNC, 1998, J NEUROSCI, V18, P1935; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Meyers PM, 2010, J NEUROINTERV SURG, V2, P177, DOI 10.1161/CIRCULATIONAHA.109.192217; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Mony L, 2009, MOL PHARMACOL, V75, P60, DOI 10.1124/mol.108.050971; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Nagy Z, 1998, BLOOD COAGUL FIBRIN, V9, P471, DOI 10.1097/00001721-199809000-00003; Ng FM, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-16; Ng FM, 2007, BIOCHEM BIOPH RES CO, V362, P69, DOI 10.1016/j.bbrc.2007.07.164; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Norris EH, 2007, P NATL ACAD SCI USA, V104, P13473, DOI 10.1073/pnas.0705848104; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Tsirka SE, 1997, J NEUROSCI, V17, P543; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wee XK, 2010, BRIT J PHARMACOL, V159, P449, DOI 10.1111/j.1476-5381.2009.00549.x; Yang CR, 2008, PHARMACOL THERAPEUT, V120, P317, DOI 10.1016/j.pharmthera.2008.08.004; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Yuan HJ, 2009, J BIOL CHEM, V284, P12862, DOI 10.1074/jbc.M805123200; Zhuo M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-4; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	60	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25520	25529		10.1074/jbc.M112.374397	http://dx.doi.org/10.1074/jbc.M112.374397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22610100	hybrid, Green Published			2022-12-28	WOS:000306651700058
J	Nyarko, A; Song, YJ; Barbar, E				Nyarko, Afua; Song, Yujuan; Barbar, Elisar			Intrinsic Disorder in Dynein Intermediate Chain Modulates Its Interactions with NudE and Dynactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; MULTIPLE-MODES; LIGHT-CHAINS; PROTEIN; COMPLEX; KINETOCHORE; TRANSPORT; BINDING; MOTOR	The functional diversity of cytoplasmic dynein is in part attributed to multiple interactions between noncatalytic dynein subunits and an array of regulatory proteins. This study focuses on the interaction between the dynein intermediate chain subunit (IC) and a dynein regulator protein (NudE). We use isothermal titration calorimetry and NMR spectroscopy to map their interacting sections to their respective N-terminal domains, which are predicted to form dimeric coiled-coils. Interestingly, the specific residues within IC that interact with NudE are a subset of the bi-segmental binding region reported for p150(Glued), a subunit of the dynein activator protein dynactin. Although the IC binding domains of both NudE and p150(Glued) form dimeric coiled-coils and bind IC at a common site, we observe distinct binding modes for each regulatory protein: 1) NudE binds region 1 of the bi-segmental binding footprint of p150(Glued), whereas p150(Glued) requires regions 1 and 2 to match the binding affinity of NudE with region 1 alone. 2) Compared with unbound IC, NudE-bound IC shows a slight increase in flexibility in region 2, in contrast to the increase in ordered structure observed for p150(Glued)-bound IC (Morgan, J. L., Song, Y., and Barbar, E. (2011) J. Biol. Chem. 286, 39349-39359). 3) Although NudE has a higher affinity for the common binding segment on IC, when all three proteins are in solution, IC preferentially binds p150(Glued). These results underscore the importance of a bi-segmental binding region of IC and disorder in region 2 and flanking linkers in selecting which regulatory protein binds IC.	[Nyarko, Afua; Song, Yujuan; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu	Nyarko, Afua/R-9872-2019	Barbar, Elisar/0000-0003-4892-5259	National Science Foundation [0818896];  [00210]	National Science Foundation(National Science Foundation (NSF)); 	This work was supported by National Science Foundation Grant 0818896.; We acknowledge the support of the nucleic acid and protein core and the mass spectrometry facilities and services core in the OSU Environmental Health Sciences Center supported by National Institutes of Health NIEHS Grant 00210. We also thank Prof. Clare Woodward for valuable discussions.	Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Boylan KLM, 2002, GENETICS, V162, P1211; Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Goddard T. D., SPARKY 3; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 2002, MOL BIOL CELL, V13, P1722, DOI 10.1091/mbc.02-02-0011; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; Morgan JL, 2011, J BIOL CHEM, V286, P39349, DOI 10.1074/jbc.M111.296277; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Schaar BT, 2004, NEURON, V44, P213, DOI 10.1016/j.neuron.2004.10.002; SCHROER TA, 1994, CURR OPIN CELL BIOL, V6, P69, DOI 10.1016/0955-0674(94)90118-X; Shim SY, 2008, J BIOL CHEM, V283, P12232, DOI 10.1074/jbc.M710200200; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wainman A, 2009, J CELL SCI, V122, P1747, DOI 10.1242/jcs.041798; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	50	27	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24884	24893		10.1074/jbc.M112.376038	http://dx.doi.org/10.1074/jbc.M112.376038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669947	Green Published, hybrid			2022-12-28	WOS:000306651700003
J	Wu, CH; Tang, SC; Wang, PH; Lee, H; Ko, JL				Wu, Chih-Hsien; Tang, Sheau-Chung; Wang, Po-Hui; Lee, Huei; Ko, Jiunn-Liang			Nickel-induced Epithelial-Mesenchymal Transition by Reactive Oxygen Species Generation and E-cadherin Promoter Hypermethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; MOLECULAR-MECHANISMS; LUNG-CANCER; HYPOXIA; METHYLATION; EXPRESSION; CARCINOGENESIS; GENE; INACTIVATION; GENOTOXICITY	Epithelial-mesenchymal transition (EMT) is considered a critical event in the pathogenesis of lung fibrosis and tumor metastasis. During EMT, the expression of differentiation markers switches from cell-cell junction proteins such as E-cadherin to mesenchymal markers such as fibronectin. Although nickel-containing compounds have been shown to be associated with lung carcinogenesis, the role of nickel in the EMT process in bronchial epithelial cells is not clear. The aim of this study was to examine whether nickel contributes to EMT in human bronchial epithelial cells. We also attempted to clarify the mechanisms involved in NiCl2-induced EMT. Our results showed that NiCl2 induced EMT phenotype marker alterations such as up-regulation of fibronectin and down-regulation of E-cadherin. In addition, the potent antioxidant N-acetylcysteine blocked EMT and expression of HIF-1 alpha induced by NiCl2, whereas the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine restored the down-regulation of E-cadherin induced by NiCl2. Promoter hypermethylation of E-cadherin, determined by quantitative real time methyl-specific PCR and bisulfate sequencing, was also induced by NiCl2. These results shed new light on the contribution of NiCl2 to carcinogenesis. Specifically, NiCl2 induces down-regulation of E-cadherin by reactive oxygen species generation and promoter hypermethylation. This study demonstrates for the first time that nickel induces EMT in bronchial epithelial cells.	[Wu, Chih-Hsien; Tang, Sheau-Chung; Wang, Po-Hui; Lee, Huei; Ko, Jiunn-Liang] Chung Shan Med Univ, Inst Med, Taichung 40203, Taiwan; [Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung 40203, Taiwan; [Ko, Jiunn-Liang] Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med, Taichung 40203, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Ko, JL (corresponding author), Chung Shan Med Univ, Inst Med, 110,Sect 1,Chien Kuo N Rd, Taichung 40203, Taiwan.	jlko@csmu.edu.tw		Ko, Jiunn-Liang/0000-0001-6855-9239	National Science Council, Taiwan [NSC-99-2314-B-040-012-MY3]; National Research Program for Genomic Medicine, National Science Council Grant [NSC-97-3112-B-001-016]; National Science Council, Ministry of Education; Chung Shan Medical University	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine, National Science Council Grant; National Science Council, Ministry of Education(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	This work was supported by National Science Council, Taiwan, Grant NSC-99-2314-B-040-012-MY3.; RNAi reagents were obtained from the National RNAi Core Facility (Institute of Molecular Biology/Genomic Research Center, Academia Sinica), which is supported by National Research Program for Genomic Medicine, National Science Council Grant NSC-97-3112-B-001-016. Confocal microscopy was performed by the Instrument Center of Chung Shan Medical University, which is supported in part by the National Science Council, Ministry of Education, and Chung Shan Medical University.	Cameron Keyuna S., 2011, Reviews on Environmental Health, V26, P81, DOI 10.1515/REVEH.2011.012; Chen CY, 2003, TOXICOL APPL PHARM, V189, P153, DOI 10.1016/S0041-008X(03)00086-3; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Corn PG, 2000, CLIN CANCER RES, V6, P4243; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; Costa M, 2003, J ENVIRON MONITOR, V5, P222, DOI 10.1039/b210260a; Davidson T, 2005, MOL CELL BIOCHEM, V279, P157, DOI 10.1007/s11010-005-8288-y; EDELMAN DA, 1989, ENVIRON HEALTH PERSP, V81, P221, DOI 10.2307/3430832; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Galanis A, 2009, MUTAT RES-GEN TOX EN, V674, P31, DOI 10.1016/j.mrgentox.2008.10.008; Galaris D, 2002, CRIT REV ONCOL HEMAT, V42, P93, DOI 10.1016/S1040-8428(01)00212-8; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Giannoni E, 2012, ANTIOXID REDOX SIGN, V16, P1248, DOI 10.1089/ars.2011.4280; Guan DY, 2010, MOL CARCINOGEN, V49, P68, DOI 10.1002/mc.20578; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hiraki M, 2010, ANN SURG ONCOL, V17, P1177, DOI 10.1245/s10434-009-0815-8; Hsin IL, 2010, MUTAT RES-FUND MOL M, V688, P72, DOI 10.1016/j.mrfmmm.2010.03.011; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kim DS, 2007, CANCER-AM CANCER SOC, V110, P2785, DOI 10.1002/cncr.23113; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Maeda G, 2007, ODONTOLOGY, V95, P24, DOI 10.1007/s10266-007-0068-6; Nojima D, 2001, MOL CARCINOGEN, V32, P19, DOI 10.1002/mc.1060; Patel E, 2012, TOXICOL APPL PHARM, V258, P367, DOI 10.1016/j.taap.2011.11.019; Salnikow Konstantin, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P307; Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Vladimirov YA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1545, DOI 10.1134/S0006297909130082; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Xu ZG, 2011, TOXICOLOGY, V285, P25, DOI 10.1016/j.tox.2011.03.016; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1; Zhang KH, 2009, CANCER RES, V69, P5340, DOI 10.1158/0008-5472.CAN-09-0112; Zhao JH, 2004, TOXICOL APPL PHARM, V194, P60, DOI 10.1016/j.taap.2003.08.011	44	72	74	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25292	25302		10.1074/jbc.M111.291195	http://dx.doi.org/10.1074/jbc.M111.291195			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22648416	hybrid, Green Published			2022-12-28	WOS:000306651700037
J	Bensing, BA; Yen, YT; Seepersaud, R; Sullam, PM				Bensing, Barbara A.; Yen, Yihfen T.; Seepersaud, Ravin; Sullam, Paul M.			A Specific Interaction between SecA2 and a Region of the Preprotein Adjacent to the Signal Peptide Occurs during Transport via the Accessory Sec System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-GSPB; STREPTOCOCCUS-PNEUMONIAE ADHESIN; SURFACE GLYCOPROTEIN GSPB; STAPHYLOCOCCUS-AUREUS; HUMAN PLATELETS; ATPASE SECA; GORDONII; EXPORT; GLYCOSYLATION; TRANSLOCATION	The accessory Sec systems of streptococci and staphylococci mediate the transport of a family of large, serine-rich glycoproteins to the bacterial cell surface. These systems are comprised of SecA2, SecY2, and three core accessory Sec proteins (Asp1-3). In Streptococcus gordonii, transport of the serine-rich glycoprotein GspB requires both a unique 90-residue N-terminal signal peptide and an adjacent 24-residue segment (the AST domain). We used in vivo site-specific photo-cross-linking to identify proteins that interact with the AST domain during transport. To facilitate this analysis, the entire accessory Sec system of S. gordonii was expressed in Escherichia coli. The determinants of GspB trafficking to the accessory Sec system in E. coli matched those in S. gordonii, establishing the validity of this approach. When the photo-cross-linker was placed within the AST domain, the preprotein was found to cross-link to SecA2. Importantly, no cross-linking to SecA was detected. Cross-linking of the N-terminal end of the AST domain to SecA2 occurred regardless of whether Asp1-3 were present. However, cross-linking to the C-terminal end was dependent on the Asps. The combined results indicate that full engagement of the AST domain by SecA2 is modulated by one or more of the Asps, and suggest that this process is important for initiating transport.	San Francisco VA Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Sullam, PM (corresponding author), VA Med Ctr, Div Infect Dis, 111W,4150 Clement St, San Francisco, CA 94121 USA.	paul.sullam@ucsf.edu			National Institutes of Health [RO1AI41513]; Dept. of Veterans Affairs; VA Merit Review program; Northern California Institute for Research and Education; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041513] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs(US Department of Veterans Affairs); VA Merit Review program(US Department of Veterans Affairs); Northern California Institute for Research and Education; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the National Institutes of Health Grant RO1AI41513 (to P. S.), the Dept. of Veterans Affairs, and the VA Merit Review program, the Northern California Institute for Research and Education, and by a Postdoctoral Fellowship Award from the American Heart Association (to Y. Y.).	Auclair SM, 2010, BIOCHEMISTRY-US, V49, P782, DOI 10.1021/bi901446r; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2007, J BACTERIOL, V189, P3846, DOI 10.1128/JB.00027-07; Bensing BA, 2010, J BACTERIOL, V192, P4223, DOI 10.1128/JB.00373-10; Bensing BA, 2009, J BACTERIOL, V191, P3482, DOI 10.1128/JB.00365-09; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gouridis G, 2009, NATURE, V462, P363, DOI 10.1038/nature08559; Handley PS, 2005, ORAL MICROBIOL IMMUN, V20, P131, DOI 10.1111/j.1399-302X.2004.00190.x; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MACRINA FL, 1983, GENE, V25, P145; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Takahashi Y, 2006, INFECT IMMUN, V74, P740, DOI 10.1128/IAI.74.1.740-743.2006; Takahashi Y, 1997, INFECT IMMUN, V65, P5042, DOI 10.1128/IAI.65.12.5042-5051.1997; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Yen YT, 2011, J BACTERIOL, V193, P3165, DOI 10.1128/JB.00057-11; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	42	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24438	24447		10.1074/jbc.M112.378059	http://dx.doi.org/10.1074/jbc.M112.378059			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22654116	Green Published, hybrid			2022-12-28	WOS:000306651100037
J	Foley, CJ; Luo, C; O'Callaghan, K; Hinds, PW; Covic, L; Kuliopulos, A				Foley, Caitlin J.; Luo, Chi; O'Callaghan, Katie; Hinds, Philip W.; Covic, Lidija; Kuliopulos, Athan			Matrix Metalloprotease-1a Promotes Tumorigenesis and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; CELL-PENETRATING PEPDUCINS; BREAST-CANCER METASTASIS; INTERSTITIAL COLLAGENASE; COUPLED RECEPTORS; PROGNOSTIC VALUE; POOR-PROGNOSIS; SIGNALING AXIS; METALLOPROTEINASE-1; EXPRESSION	Matrix metalloprotease-1 (MMP1), a collagenase and activator of the G protein-coupled protease activated receptor-1 (PAR1), is an emerging new target implicated in oncogenesis and metastasis in diverse cancers. However, the functional mouse homologue of MMP1 in cancer models has not yet been clearly defined. We report here that Mmp1a is a functional MMP1 homologue that promotes invasion and metastatic progression of mouse lung cancer and melanoma. LLC1 (Lewis lung carcinoma) and primary mouse melanoma cells harboring active BRAF express high levels of endogenous Mmp1a, which is required for invasion through collagen. Silencing of either Mmp1a or PAR1 suppressed invasive stellate growth of lung cancer cells in three-dimensional matrices. Conversely, ectopic expression of Mmp1a conferred an invasive phenotype in epithelial cells that do not express endogenous Mmp1a. Consistent with Mmp1a acting as a PAR1 agonist in an autocrine loop, inhibition or silencing of PAR1 resulted in a loss of the Mmp1a-driven invasive phenotype. Knockdown of Mmp1a on tumor cells resulted in significantly decreased tumorigenesis, invasion, and metastasis in xenograft models. Together, these data demonstrate that cancer cell-derived Mmp1a acts as a robust functional homologue of MMP1 by conferring protumorigenic and metastatic behavior to cells.	[Foley, Caitlin J.; Luo, Chi; O'Callaghan, Katie; Hinds, Philip W.; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Tufts Med Ctr, Mol Oncol Res Inst, Sch Med, Boston, MA 02111 USA; [Foley, Caitlin J.; Luo, Chi; Hinds, Philip W.; Kuliopulos, Athan] Tufts Univ, Genet Program, Sackler Sch Grad Biomed Sci, Sch Med, Boston, MA 02111 USA; [Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Tufts Med Ctr, Mol Oncol Res Inst, Sch Med, MORI Box 7510,800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu		LUO, CHI/0000-0001-7669-9506	National Institutes of Health [F30-HL104835, CA122992, HL64701, CA104406, CA095798, CA104322]; Sackler Family Cancer Award; NATIONAL CANCER INSTITUTE [R01CA095798, R01CA122992, R01CA104406, R01CA104322] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064701, F30HL104835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Family Cancer Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health grants F30-HL104835 (to C. J. F.), CA122992 and HL64701 (to A. K.), CA104406 (to L. C.), CA095798, and CA104322 and a Sackler Family Cancer Award (to P. W. H. and C. L.).	Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bostrom P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-348; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Depasquale I, 2008, HISTOPATHOLOGY, V52, P500, DOI 10.1111/j.1365-2559.2008.02978.x; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Du XL, 2011, JPN J CLIN ONCOL, V41, P1086, DOI 10.1093/jjco/hyr108; Eck SM, 2009, MOL CANCER RES, V7, P1033, DOI 10.1158/1541-7786.MCR-09-0015; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Ghio P, 2006, CLIN LUNG CANCER, V7, P395, DOI 10.3816/CLC.2006.n.023; Giricz Orsi, 2010, J Biomol Tech, V21, P194; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grisaru-Granovsky S, 2005, INT J CANCER, V113, P372, DOI 10.1002/ijc.20607; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Kamath L, 2001, CANCER RES, V61, P5933; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kuliopulos A, 2003, LIFE SCI, V74, P255, DOI 10.1016/j.lfs.2003.09.012; Liao MM, 2012, PATHOL ONCOL RES, V18, P397, DOI 10.1007/s12253-011-9458-8; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Murray GI, 1998, J PATHOL, V185, P256; Nakopoulou L, 1999, HUM PATHOL, V30, P436, DOI 10.1016/S0046-8177(99)90120-X; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Nikkola J, 2002, INT J CANCER, V97, P432, DOI 10.1002/ijc.1636; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Pfaffen S, 2010, EXP CELL RES, V316, P836, DOI 10.1016/j.yexcr.2009.11.004; Poola I, 2005, NAT MED, V11, P481, DOI 10.1038/nm1243; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rutter JL, 1998, CANCER RES, V58, P5321; Ryu B, 2011, J INVEST DERMATOL, V131, P1579, DOI 10.1038/jid.2011.65; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Shah SA, 2010, J THORAC CARDIOV SUR, V139, P984, DOI 10.1016/j.jtcvs.2009.12.016; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Swift S, 2000, J BIOL CHEM, V275, P2627, DOI 10.1074/jbc.275.4.2627; Tomita M, 2007, TOXICOLOGY, V231, P200, DOI 10.1016/j.tox.2006.12.005; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Ugalde AP, 2010, METHODS MOL BIOL, V622, P3, DOI 10.1007/978-1-60327-299-5_1; VAIDYA AB, 1978, VIROLOGY, V90, P12, DOI 10.1016/0042-6822(78)90328-8; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Whitehead IP, 2001, ONCOGENE, V20, P1547, DOI 10.1038/sj.onc.1204188; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Ye S, 2001, CANCER RES, V61, P1296	71	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24330	24338		10.1074/jbc.M112.356303	http://dx.doi.org/10.1074/jbc.M112.356303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22573325	Green Published, hybrid			2022-12-28	WOS:000306651100027
J	Golczak, M; Kiser, PD; Sears, AE; Lodowski, DT; Blaner, WS; Palczewski, K				Golczak, Marcin; Kiser, Philip D.; Sears, Avery E.; Lodowski, David T.; Blaner, William S.; Palczewski, Krzysztof			Structural Basis for the Acyltransferase Activity of Lecithin:Retinol Acyltransferase-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-SPECIFIC PHOSPHOLIPASE; RETINOL ACYLTRANSFERASE; BIOCHEMICAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-LIPIDS; SULFENIC ACIDS; TRUNCATED FORM; ACYL; MODEL	Lecithin: retinol acyltransferase-like proteins, also referred to as HRAS-like tumor suppressors, comprise a vertebrate subfamily of papain-like or NlpC/P60 thiol proteases that function as phospholipid-metabolizing enzymes. HRAS-like tumor suppressor 3, a representative member of this group, plays a key role in regulating triglyceride accumulation and energy expenditure in adipocytes and therefore constitutes a novel pharmacological target for treatment of metabolic disorders causing obesity. Here, we delineate a catalytic mechanism common to lecithin: retinol acyltransferase-like proteins and provide evidence for their alternative robust lipid-dependent acyltransferase enzymatic activity. We also determined high resolution crystal structures of HRAS-like tumor suppressor 2 and 3 to gain insight into their active site architecture. Based on this structural analysis, two conformational states of the catalytic Cys-113 were identified that differ in reactivity and thus could define the catalytic properties of these two proteins. Finally, these structures provide a model for the topology of these enzymes and allow identification of the protein-lipid bilayer interface. This study contributes to the enzymatic and structural understanding of HRAS-like tumor suppressor enzymes.	[Golczak, Marcin; Kiser, Philip D.; Sears, Avery E.; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Lodowski, David T.] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Blaner, William S.] Columbia Univ, Dept Med, New York, NY 10032 USA	Case Western Reserve University; Case Western Reserve University; Columbia University	Golczak, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxg149@case.edu; kxp65@case.edu			National Institutes of Health [EY008061, EY009339, DK079221, EY019718]; National Institutes of Health Grant from NCRR [5P41RR015301-10, P41RR012408]; National Institutes of Health Grant from NIGMS [8 P41 GM103403-10, P41GM103473]; United States Department of Energy [DE-AC02-06CH11357]; Office of Biological and Environmental Research United States Department of Energy; Office of Basic Energy Sciences of United States Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, P41RR012408] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K99EY019718, R29EY008061, R01EY008061, R01EY009339, R00EY019718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P41GM103473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant from NCRR; National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research United States Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 (to K. P., M. G., and A. E. S.), EY009339 (to K. P., M. G., P. D. K, and A. E. S.), DK079221 (to W. B.), and EY019718 (to D. T. L.). This work was based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines supported by National Institutes of Health Grants 5P41RR015301-10 from NCRR and Grant 8 P41 GM103403-10 from NIGMS.; We thank Dr. Xiongying Tu for initial x-ray diffraction data collection on HRASLS3 crystals, Dr. Tivadar Orban for help in modeling missing regions in HRASLS3, and Drs. Leslie Webster, Jr., and Michael Maguire for help in preparation of this manuscript. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by the Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Data for this study were obtained at beamline X29 of the National Synchrotron Light Source. Its financial support is derived principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and by National Institutes of Health Grant P41RR012408 from NCRR Grant P41GM103473 from NIGMS.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BURGER A, 1993, FEBS LETT, V329, P25, DOI 10.1016/0014-5793(93)80185-W; Bussieres S, 2008, BBA-BIOMEMBRANES, V1778, P1324, DOI 10.1016/j.bbamem.2008.01.014; Bussieres S, 2012, LANGMUIR, V28, P3516, DOI 10.1021/la203896n; Chahinian H, 2009, PROTEIN PEPTIDE LETT, V16, P1149, DOI 10.2174/092986609789071333; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; Ezzili C, 2010, BIOORG MED CHEM LETT, V20, P5959, DOI 10.1016/j.bmcl.2010.08.048; Farrell EK, 2008, DRUG DISCOV TODAY, V13, P558, DOI 10.1016/j.drudis.2008.02.006; Fernandis AZ, 2007, CURR OPIN LIPIDOL, V18, P121, DOI 10.1097/MOL.0b013e328082e4d5; Fournand D, 2001, J APPL MICROBIOL, V91, P381, DOI 10.1046/j.1365-2672.2001.01378.x; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; Han BG, 2010, PROTEIN EXPRES PURIF, V71, P103, DOI 10.1016/j.pep.2010.01.018; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoareau L, 2009, OBESITY, V17, P431, DOI 10.1038/oby.2008.591; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jiang Y, 2011, CHEMBIOCHEM, V12, P768, DOI 10.1002/cbic.201000693; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Ladokhin AS, 2004, BIOCHEMISTRY-US, V43, P5782, DOI 10.1021/bi0361259; LIU M, 1994, P NATL ACAD SCI USA, V91, P6035, DOI 10.1073/pnas.91.13.6035; Lomize AL, 2011, J CHEM INF MODEL, V51, P930, DOI 10.1021/ci200020k; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Matias I, 2007, BRIT J PHARMACOL, V152, P676, DOI 10.1038/sj.bjp.0707424; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Ren XB, 2010, FEBS LETT, V584, P4222, DOI 10.1016/j.febslet.2010.09.015; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Torshin IY, 2002, PROTEIN ENG, V15, P359, DOI 10.1093/protein/15.5.359; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Verhoeckx KCM, 2011, BBA-MOL CELL BIOL L, V1811, P578, DOI 10.1016/j.bbalip.2011.07.008; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolf G, 2009, NUTR REV, V67, P551, DOI 10.1111/j.1753-4887.2009.00227.x; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133	69	49	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23790	23807		10.1074/jbc.M112.361550	http://dx.doi.org/10.1074/jbc.M112.361550			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605381	Green Published, hybrid			2022-12-28	WOS:000306511300049
J	Hou, S; Wieczorek, SA; Kaminski, TS; Ziebacz, N; Tabaka, M; Sorto, NA; Foss, MH; Shaw, JT; Thanbichler, M; Weibel, DB; Nieznanski, K; Holyst, R; Garstecki, P				Hou, Sen; Wieczorek, Stefan A.; Kaminski, Tomasz S.; Ziebacz, Natalia; Tabaka, Marcin; Sorto, Nohemy A.; Foss, Marie H.; Shaw, Jared T.; Thanbichler, Martin; Weibel, Douglas B.; Nieznanski, Krzysztof; Holyst, Robert; Garstecki, Piotr			Characterization of Caulobacter crescentus FtsZ Protein Using Dynamic Light Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL DIVISION; MYCOBACTERIUM-TUBERCULOSIS FTSZ; SYMMETRIC TOP MACROMOLECULES; ESCHERICHIA-COLI; CIRCULAR-CYLINDERS; ASSEMBLY DYNAMICS; RING FORMATION; POLYMERIZATION; VISUALIZATION; CYTOSKELETON	The self-assembly of the tubulin homologue FtsZ at the mid-cell is a critical step in bacterial cell division. We introduce dynamic light scattering (DLS) spectroscopy as a new method to study the polymerization kinetics of FtsZ in solution. Analysis of the DLS data indicates that the FtsZ polymers are remarkably monodisperse in length, independent of the concentrations of GTP, GDP, and FtsZ monomers. Measurements of the diffusion coefficient of the polymers demonstrate that their length is remarkably stable until the free GTP is consumed. We estimated the mean size of the FtsZ polymers within this interval of stable length to be between 9 and 18 monomers. The rates of FtsZ polymerization and depolymerization are likely influenced by the concentration of GDP, as the repeated addition of GTP to FtsZ increased the rate of polymerization and slowed down depolymerization. Increasing the FtsZ concentration did not change the size of FtsZ polymers; however, it increased the rate of the depolymerization reaction by depleting free GTP. Using transmission electron microscopy we observed that FtsZ forms linear polymers in solutions which rapidly convert to large bundles upon contact with surfaces at time scales as short as several seconds. Finally, the best studied small molecule that binds to FtsZ, PC190723, had no stabilizing effect on Caulobacter crescentus FtsZ filaments in vitro, which complements previous studies with Escherichia coli FtsZ and confirms that this class of small molecules binds Gram-negative FtsZ weakly.	[Hou, Sen; Wieczorek, Stefan A.; Kaminski, Tomasz S.; Ziebacz, Natalia; Tabaka, Marcin; Holyst, Robert; Garstecki, Piotr] Polish Acad Sci, Inst Phys Chem, PL-01224 Warsaw, Poland; [Sorto, Nohemy A.; Shaw, Jared T.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Foss, Marie H.; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Thanbichler, Martin] Philipps Univ, Max Planck Inst Terr Microbiol, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany; [Thanbichler, Martin] Philipps Univ, Fac Biol, D-35043 Marburg, Germany; [Nieznanski, Krzysztof] Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Philipps University Marburg; Philipps University Marburg; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Holyst, R (corresponding author), Polish Acad Sci, Inst Phys Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland.	holyst@ptys.ichf.edu.pl; garst@ichf.edu.pl	Kaminski, Tomasz/AAD-6449-2020; hou, sen/B-6733-2011; Thanbichler, Martin/E-6035-2010; Garstecki, Piotr/ABA-9188-2020; Nieznanski, Krzysztof/R-4220-2016	Kaminski, Tomasz/0000-0001-5124-4548; hou, sen/0000-0002-6871-4419; Garstecki, Piotr/0000-0001-9101-7163; Nieznanski, Krzysztof/0000-0003-0440-2632; Wieczorek, Stefan/0000-0003-4174-3591; Holyst, Robert/0000-0002-3211-4286; Tabaka, Marcin/0000-0002-6166-2820; Shaw, Jared/0000-0001-5190-493X	National Institutes of Health Grant [R01AI08093]; Human Frontier Science Program [RGY0069/2008-C103]; European Union "European Regional Development Fund": NanoFun [POIG.02.02.00-00-025/09]; Foundation for Polish Science [TEAM/2008-2/2]; European Union; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080931] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); European Union "European Regional Development Fund": NanoFun; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported, in whole or in part, by National Institutes of Health Grant R01AI08093 (to J.T.S.). This work was also supported by Collaborative Research Grant RGY0069/2008-C103 from the Human Frontier Science Program (to P.G., M.T., and D.B.W.) and by programs co-financed by the European Union "European Regional Development Fund": NanoFun POIG.02.02.00-00-025/09 and TEAM/2008-2/2 operated by the Foundation for Polish Science. Microscopic studies were performed in the Laboratory of Electron Microscopy (Nencki Institute of Experimental Biology, Warsaw, Poland) using equipment installed within the project sponsored by the European Union Structural Funds: Centre of Advanced Technology BIM, equipment purchase for the Laboratory of Biological and Medical Imaging.	Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Andreu JM, 2010, J BIOL CHEM, V285, P14239, DOI 10.1074/jbc.M109.094722; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BLOOMFIE.V, 1967, BIOPOLYMERS, V5, P135, DOI 10.1002/bip.1967.360050202; Casini GL, 2004, VIROLOGY, V325, P320, DOI 10.1016/j.virol.2004.04.034; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hamon L, 2009, LANGMUIR, V25, P3331, DOI 10.1021/la8035743; Harry EJ, 2001, MOL MICROBIOL, V40, P795, DOI 10.1046/j.1365-2958.2001.02370.x; Hou S, 2011, SOFT MATTER, V7, P6967, DOI 10.1039/c1sm05449j; Kiessling J, 2000, J CELL BIOL, V151, P945, DOI 10.1083/jcb.151.4.945; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Paez A, 2009, SOFT MATTER, V5, P2625, DOI 10.1039/b902935d; Popp D, 2010, J BIOL CHEM, V285, P11281, DOI 10.1074/jbc.M109.084079; Quardokus EM, 2002, MOL MICROBIOL, V45, P605, DOI 10.1046/j.1365-2958.2002.03040.x; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; SEILS J, 1995, MACROMOLECULES, V28, P661, DOI 10.1021/ma00107a001; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Sorto NA, 2010, J ORG CHEM, V75, P7946, DOI 10.1021/jo101720y; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; TIRADO MM, 1979, J CHEM PHYS, V71, P2581, DOI 10.1063/1.438613; TIRADO MM, 1980, J CHEM PHYS, V73, P1986, DOI 10.1063/1.440288; VANDESANDE W, 1985, J PHYS CHEM-US, V89, P404, DOI 10.1021/j100249a007; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Wyatt PJ, 1998, J COLLOID INTERF SCI, V197, P9, DOI 10.1006/jcis.1997.5215	38	18	19	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23878	23886		10.1074/jbc.M111.309492	http://dx.doi.org/10.1074/jbc.M111.309492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22573335	hybrid, Green Published			2022-12-28	WOS:000306511300058
J	Moriyama, K; Yoshizawa-Sugata, N; Obuse, C; Tsurimoto, T; Masai, H				Moriyama, Kenji; Yoshizawa-Sugata, Naoko; Obuse, Chikashi; Tsurimoto, Toshiki; Masai, Hisao			Epstein-Barr Nuclear Antigen 1 (EBNA1)-dependent Recruitment of Origin Recognition Complex (Orc) on oriP of Epstein-Barr Virus with Purified Proteins STIMULATION BY Cdc6 THROUGH ITS DIRECT INTERACTION WITH EBNA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATENT REPLICATION ORIGIN; DNA-REPLICATION; PLASMID REPLICATION; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; BINDING PROTEIN; T-ANTIGEN; IN-VITRO; TRANSCRIPTION	Origin recognition complex (Orc) plays an essential role in directing assembly of prereplicative complex at selective sites on chromosomes. However, Orc from vertebrates is reported to bind to DNA in a sequence-nonspecific manner, and it is still unclear how it selects specific genomic loci and how Cdc6, another conserved AAA(+) factor known to interact with Orc, participates in this process. Replication from oriP, the latent origin of Epstein-Barr virus, provides an excellent model system for the study of initiation on the host chromosomes because it is known to depend on prereplicative complex factors, including Orc and Mcm. Here, we show that Orc is recruited selectively at the essential dyad symmetry element in nuclear extracts in a manner dependent on EBNA1, which specifically binds to dyad symmetry. With purified proteins, EBNA1 can recruit both Cdc6 and Orc independently on a DNA containing EBNA1 binding sites, and Cdc6 facilitates the Orc recruitment by EBNA1. Purified Cdc6 directly binds to EBNA1, whereas association of Orc with EBNA1 requires the presence of the oriP DNA. Nuclease protection assays suggest that Orc associates with DNA segments on both sides adjacent to the EBNA1 binding sites and that this process is stimulated by the presence of Cdc6. Thus, EBNA1 can direct localized assembly of Orc in a process that is facilitated by Cdc6. The possibility of similar modes of recruitment of Orc/Cdc6 at the human chromosomal origins will be discussed.	[Moriyama, Kenji; Yoshizawa-Sugata, Naoko; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Dept Genome Med, Setagaya Ku, Tokyo 1568506, Japan; [Obuse, Chikashi] Hokkaido Univ, Div Mol Life Sci, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Tsurimoto, Toshiki] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan	Tokyo Metropolitan Institute of Medical Science; Hokkaido University; Kyushu University	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Dept Genome Med, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp	Obuse, Chikashi/F-5273-2011	Tsurimoto, Toshiki/0000-0001-7597-2216; Yoshizawa-Sugata, Naoko/0000-0001-8792-8669	Ministry of Education, Culture, Sports, Science, and Technology of Japan [14208079, 17570125, 17080014]; Grants-in-Aid for Scientific Research [23657081, 23570243] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (A) 14208079 (to H.M.), Grant-in-Aid for Scientific Research (C) 17570125 (to K.M.), and Grant-in-Aid for Scientific Research on Priority Area "Chromosome Cycle" 17080014 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H.M.).	Aiyar A, 1998, EMBO J, V17, P6394, DOI 10.1093/emboj/17.21.6394; Almqvist J, 2005, J GEN VIROL, V86, P1261, DOI 10.1099/vir.0.80620-0; AMBINDER RF, 1990, J VIROL, V64, P2369, DOI 10.1128/JVI.64.5.2369-2379.1990; Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Bochkarev A, 1998, J MOL BIOL, V284, P1273, DOI 10.1006/jmbi.1998.2247; Borestrom C, 2012, J GEN VIROL, V93, P1065, DOI 10.1099/vir.0.038752-0; BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Deng Z, 2002, MOL CELL, V9, P493, DOI 10.1016/S1097-2765(02)00476-8; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRAPPIER L, 1992, J VIROL, V66, P1786, DOI 10.1128/JVI.66.3.1786-1790.1992; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; HEARING J, 1992, J VIROL, V66, P694, DOI 10.1128/JVI.66.2.694-705.1992; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Hirai K, 2001, CURR TOP MICROBIOL, V258, P13; Kanda T, 2001, MOL CELL BIOL, V21, P3576, DOI 10.1128/MCB.21.10.3576-3588.2001; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Koons MD, 2001, J VIROL, V75, P10582, DOI 10.1128/JVI.75.22.10582-10592.2001; KOWALSKI D, 1984, NUCLEIC ACIDS RES, V12, P7071, DOI 10.1093/nar/12.18.7071; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Lim C, 2002, J VIROL, V76, P10320, DOI 10.1128/JVI.76.20.10320-10331.2002; Liu SX, 2011, P NATL ACAD SCI USA, V108, P7373, DOI 10.1073/pnas.1013676108; Mackey D, 1999, MOL CELL BIOL, V19, P3349, DOI 10.1128/mcb.19.5.3349; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Matsunaga F, 2010, EXTREMOPHILES, V14, P21, DOI 10.1007/s00792-009-0284-9; Minami H, 2006, MOL CELL BIOL, V26, P8770, DOI 10.1128/MCB.00949-06; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Norseen J, 2008, EMBO J, V27, P3024, DOI 10.1038/emboj.2008.221; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; PARSONS R, 1990, J VIROL, V64, P509, DOI 10.1128/JVI.64.2.509-518.1990; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; Saitoh Y, 2002, NUCLEIC ACIDS RES, V30, P5205, DOI 10.1093/nar/gkf642; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; SEXTON CJ, 1989, J VIROL, V63, P5505, DOI 10.1128/JVI.63.12.5505-5508.1989; SHALLOWAY D, 1980, CELL, V20, P411, DOI 10.1016/0092-8674(80)90627-3; Shirakata M, 1998, J BIOCHEM-TOKYO, V123, P175; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Sideridou M, 2011, J CELL BIOL, V195, P1123, DOI 10.1083/jcb.201108121; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Tanaka T, 2006, J BIOL CHEM, V281, P3484, DOI 10.1074/jbc.M510979200; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Tempera I, 2010, BBA-GENE REGUL MECH, V1799, P236, DOI 10.1016/j.bbagrm.2009.10.004; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang LD, 2005, J CELL BIOCHEM, V94, P247, DOI 10.1002/jcb.20324; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Zhou J, 2010, J VIROL, V84, P4979, DOI 10.1128/JVI.01300-09; Zhou J, 2009, J VIROL, V83, P2154, DOI 10.1128/JVI.02115-08	68	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23977	23994		10.1074/jbc.M112.368456	http://dx.doi.org/10.1074/jbc.M112.368456			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589552	Green Published, hybrid			2022-12-28	WOS:000306511300067
J	Chatani, E; Yagi, H; Naiki, H; Goto, Y				Chatani, Eri; Yagi, Hisashi; Naiki, Hironobu; Goto, Yuji			Polymorphism of beta(2)-Microglobulin Amyloid Fibrils Manifested by Ultrasonication-enhanced Fibril Formation in Trifluoroethanol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORINE-SUBSTITUTED ALCOHOLS; ATOMIC-FORCE MICROSCOPY; SOLID-STATE NMR; NEUTRAL PH; IN-VITRO; TRYPTOPHAN MUTAGENESIS; STRUCTURAL BASIS; DISULFIDE BOND; H/D-EXCHANGE; PROTEIN	The polymorphic property of amyloid structures has been focused on as a molecular basis of the presence and propagation of different phenotypes of amyloid diseases, although little is known about the molecular mechanism for expressing diverse structures from only one protein sequence. Here, we have found that, in combination with an enhancing effect of ultrasonication on nucleation, beta(2)-microglobulin, a protein responsible for dialysis-related amyloidosis, generates distinct fibril conformations in a concentration-dependent manner in the presence of 2,2,2-trifluoroethanol (TFE). Although the newly formed fibrils all exhibited a similar needle-like morphology with an extensive cross-beta core, as suggested by Fourier transform infrared absorption spectra, they differed in thioflavin T intensity, extension kinetics, and tryptophan fluorescence spectra even in the same solvents, representing polymorphic structures. The hydrophobic residues seemed to be more exposed in the fibrils originating at higher concentrations of TFE, as indicated by the increased binding of 1-anilinonaphthalene-8-sulfonic acid, suggesting that the modulation of hydrophobic interactions is critical to the production of polymorphic amyloid structures. Interestingly, the fibrils formed at higher TFE concentrations showed significantly higher stability against guanidium hydrochloride, the perturbation of ionic strength, and, furthermore, pressurization. The cross-beta structure inside the fibrils seems to have been more idealized, resulting in increased stability when nucleation occurred in the presence of the alcohol, indicating that a weaker contribution of hydrophobic interactions is intrinsically more amenable to the formation of a non-defective amyloid structure.	[Chatani, Eri] Kobe Univ, Dept Chem, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Chatani, Eri; Yagi, Hisashi; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Naiki, Hironobu] Univ Fukui, Div Mol Pathol, Dept Pathol Sci, Fac Med Sci, Fukui 9101193, Japan	Kobe University; Osaka University; University of Fukui	Chatani, E (corresponding author), Kobe Univ, Dept Chem, Grad Sch Sci, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	chatani@crystal.kobe-u.ac.jp	Naiki, Hironobu/G-5599-2014		Japanese Ministry of Education, Culture, Sports, Science, and Technology [21370044, 23770188]; Japan Society for the Promotion of Science [22810014]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Japanese Ministry of Education, Culture, Sports, Science, and Technology Scientific Research Grant-in-Aid 21370044 and Young Scientists Grant-in-Aid 23770188 and by Japan Society for the Promotion of Science Research Activity Start-up Grant-in-Aid 22810014.	Andersen CB, 2010, J MOL BIOL, V397, P932, DOI 10.1016/j.jmb.2010.02.012; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hirota N, 1998, J MOL BIOL, V275, P365, DOI 10.1006/jmbi.1997.1468; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kihara M, 2006, J BIOL CHEM, V281, P31061, DOI 10.1074/jbc.M605358200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Madine J, 2008, J AM CHEM SOC, V130, P14990, DOI 10.1021/ja802483d; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Ohhashi Y, 2002, J BIOCHEM, V131, P45, DOI 10.1093/oxfordjournals.jbchem.a003076; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Rennella E, 2010, J MOL BIOL, V401, P286, DOI 10.1016/j.jmb.2010.06.016; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688	53	36	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22827	22837		10.1074/jbc.M111.333310	http://dx.doi.org/10.1074/jbc.M111.333310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22566695	hybrid, Green Published			2022-12-28	WOS:000306495000040
J	Pollak, AJ; Reich, NO				Pollak, Adam J.; Reich, Norbert O.			Proximal Recognition Sites Facilitate Intrasite Hopping by DNA Adenine Methyltransferase MECHANISTIC EXPLORATION OF EPIGENETIC GENE REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE VARIATION; DAM; METHYLATION; PROTEIN; TARGET; STRANDS; TRANSLOCATION; GLYCOSYLASE; PATHWAYS; SEQUENCE	The methylation of adenine in palindromic 5'-GATC-3' sites by Escherichia coli Dam supports diverse roles, including the essential regulation of virulence genes in several human pathogens. As a result of a unique hopping mechanism, Dam methylates both strands of the same site prior to fully dissociating from the DNA, a process referred to as intrasite processivity. The application of a DpnI restriction endonuclease-based assay allowed the direct interrogation of this mechanism with a variety of DNA substrates. Intrasite processivity is disrupted when the DNA flanking a single GATC site is longer than 400 bp on either side. Interestingly, the introduction of a second GATC site within this flanking DNA reinstates intrasite methylation of both sites. Our results show that intrasite methylation occurs only when GATC sites are clustered, as is found in gene segments both known and postulated to undergo in vivo epigenetic regulation by Dam methylation. We propose a model for intrasite methylation in which Dam bound to flanking DNA is an obligate intermediate. Our results provide insights into how intrasite processivity, which appears to be context-dependent, may contribute to the diverse biological roles that are carried out by Dam.	[Pollak, Adam J.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu						BOYE E, 1992, J BACTERIOL, V174, P1682, DOI 10.1128/jb.174.5.1682-1685.1992; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Coffin SR, 2008, J BIOL CHEM, V283, P20106, DOI 10.1074/jbc.M802502200; Coffin SR, 2009, J BIOL CHEM, V284, P18390, DOI 10.1074/jbc.M109.005876; Coffin SR, 2009, BIOCHEMISTRY-US, V48, P7399, DOI 10.1021/bi9008006; Fersht A., 1998, STRUCTURE MECH PROTE, P143; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Kaminska R, 2010, J BACTERIOL, V192, P1937, DOI 10.1128/JB.01629-09; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Mashhoon N, 2004, J BIOL CHEM, V279, P52075, DOI 10.1074/jbc.M408182200; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Rau DC, 2010, J MOL BIOL, V395, P408, DOI 10.1016/j.jmb.2009.10.049; RINGQUIST S, 1992, P NATL ACAD SCI USA, V89, P4539, DOI 10.1073/pnas.89.10.4539; Sasnauskas G, 2011, NUCLEIC ACIDS RES, V39, P8844, DOI 10.1093/nar/gkr588; Sasnauskas G, 2010, NUCLEIC ACIDS RES, V38, P2399, DOI 10.1093/nar/gkp1194; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Tafvizi A, 2011, CHEMPHYSCHEM, V12, P1481, DOI 10.1002/cphc.201100112; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; Touzain F, 2011, NAT REV MICROBIOL, V9, P15, DOI 10.1038/nrmicro2477; van der Woude MW, 2011, CURR OPIN MICROBIOL, V14, P205, DOI 10.1016/j.mib.2011.01.002; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Zhou HX, 2011, P NATL ACAD SCI USA, V108, P8651, DOI 10.1073/pnas.1101555108; Zinoviev VV, 2007, BIOL CHEM, V388, P1199, DOI 10.1515/BC.2007.142	34	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22873	22881		10.1074/jbc.M111.332502	http://dx.doi.org/10.1074/jbc.M111.332502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570478	Green Published, hybrid			2022-12-28	WOS:000306495000044
J	Sabourin, J; Antigny, F; Robin, E; Frieden, M; Raddatz, E				Sabourin, Jessica; Antigny, Fabrice; Robin, Elodie; Frieden, Maud; Raddatz, Eric			Activation of Transient Receptor Potential Canonical 3 (TRPC3)-mediated Ca2+ Entry by A(1) Adenosine Receptor in Cardiomyocytes Disturbs Atrioventricular Conduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RABBIT PORTAL-VEIN; ANOXIA-REOXYGENATION; TRPC CHANNELS; SARCOPLASMIC-RETICULUM; DIRECT INHIBITION; DEVELOPING HEART; CATION CHANNELS; PHORBOL ESTERS; CRAC CHANNEL	Although the activation of the A(1)-subtype of the adenosine receptors (A(1)AR) is arrhythmogenic in the developing heart, little is known about the underlying downstream mechanisms. The aim of this study was to determine to what extent the transient receptor potential canonical (TRPC) channel 3, functioning as receptor-operated channel (ROC), contributes to the A(1)AR-induced conduction disturbances. Using embryonic atrial and ventricular myocytes obtained from 4-day-old chick embryos, we found that the specific activation of A(1)AR by CCPA induced sarcolemmal Ca2+ entry. However, A1AR stimulation did not induce Ca2+ release from the sarcoplasmic reticulum. Specific blockade of TRPC3 activity by Pyr3, by a dominant negative of TRPC3 construct, or inhibition of phospholipase Cs and PKCs strongly inhibited the A(1)AR-enhanced Ca2+ entry. Ca2+ entry through TRPC3 was activated by the 1,2-diacylglycerol (DAG) analog OAG via PKC-independent and -dependent mechanisms in atrial and ventricular myocytes, respectively. In parallel, inhibition of the atypical PKC zeta by myristoylated PKC zeta pseudosubstrate inhibitor significantly decreased the A(1)AR-enhanced Ca2+ entry in both types of myocytes. Additionally, electrocardiography showed that inhibition of TRPC3 channel suppressed transient A(1)AR-induced conduction disturbances in the embryonic heart. Our data showing that A(1)AR activation subtly mediates a proarrhythmic Ca2+ entry through TRPC3-encoded ROC by stimulating the phospholipase C/DAG/PKC cascade provide evidence for a novel pathway whereby Ca2+ entry and cardiac function are altered. Thus, the A(1)AR-TRPC3 axis may represent a potential therapeutic target.	[Sabourin, Jessica; Robin, Elodie; Raddatz, Eric] Univ Lausanne, Dept Physiol, Fac Biol & Med, CH-1005 Lausanne, Switzerland; [Antigny, Fabrice] Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; [Frieden, Maud] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Lausanne; University of Geneva; University of Geneva	Raddatz, E (corresponding author), Univ Lausanne, Dept Physiol, Fac Biol & Med, 7 Rue Bugnon, CH-1005 Lausanne, Switzerland.	eric.raddatz@unil.ch	Antigny, Fabrice/Q-3999-2018	Antigny, Fabrice/0000-0002-9515-6571; Frieden, Maud/0000-0001-7135-0874; Sabourin, Jessica/0000-0002-2980-8455	Swiss National Science Foundation [310030-127633]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 310030-127633.	Albert AP, 2002, J PHYSIOL-LONDON, V544, P113, DOI 10.1113/jphysiol.2002.022574; Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Alvarez J, 2008, AM J PHYSIOL-HEART C, V295, pH21, DOI 10.1152/ajpheart.00135.2008; Ambudkar IS, 2006, CELL CALCIUM, V40, P495, DOI 10.1016/j.ceca.2006.08.011; AMOROSO S, 1995, BBA-BIOMEMBRANES, V1239, P67, DOI 10.1016/0005-2736(95)00143-Q; Ansari HR, 2009, AM J PHYSIOL-HEART C, V297, pH1032, DOI 10.1152/ajpheart.00374.2009; Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Basheer R, 2002, J NEUROSCI, V22, P7680; BOGOYEVITCH MA, 1993, CIRC RES, V72, P757, DOI 10.1161/01.RES.72.4.757; Brenner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000802; Bruchez P, 2008, J CARDIOVASC ELECTR, V19, P1196, DOI 10.1111/j.1540-8167.2008.01218.x; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cerniway RJ, 2002, BASIC RES CARDIOL, V97, P232, DOI 10.1007/s003950200016; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Eder Petra, 2007, P331; Ethier MF, 2006, AM J RESP CELL MOL, V35, P496, DOI 10.1165/rcmb.2005-0290OC; Firth AL, 2007, BBA-MOL BASIS DIS, V1772, P895, DOI 10.1016/j.bbadis.2007.02.009; Fredholm BB, 2003, CELL MOL NEUROBIOL, V23, P379, DOI 10.1023/A:1023644822539; Freichel M, 1999, CELL PHYSIOL BIOCHEM, V9, P270, DOI 10.1159/000016321; Garcia-Hoz C, 2012, J BIOL CHEM, V287, P7792, DOI 10.1074/jbc.M111.282210; Gardner AM, 2003, J BIOL CHEM, V278, P15421, DOI 10.1074/jbc.M208366200; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Gorlach A, 2005, CIRC RES, V97, P1, DOI 10.1161/01.RES.0000174112.36064.77; Gundlfinger A, 2007, J PHYSIOL-LONDON, V582, P263, DOI 10.1113/jphysiol.2007.132613; Helliwell RM, 1997, J PHYSIOL-LONDON, V499, P417, DOI 10.1113/jphysiol.1997.sp021938; Henry P, 1996, CIRC RES, V78, P161, DOI 10.1161/01.RES.78.1.161; Hioki M, 2012, HEART VESSELS, V27, P221, DOI 10.1007/s00380-011-0159-8; Hirose M, 2011, CIRC J, V75, P2333, DOI 10.1253/circj.CJ-10-1213; Hleihel W, 2006, EXP PHYSIOL, V91, P681, DOI 10.1113/expphysiol.2006.033175; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Ju Yue-kun, 2007, Heart Lung Circ, V16, P349, DOI 10.1016/j.hlc.2007.07.004; Juranek I., 2004, Central European Journal of Public Health, V12, pS33; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Lof C, 2011, ADV EXP MED BIOL, V704, P125, DOI 10.1007/978-94-007-0265-3_6; Mori Y, 2001, JPN J PHARMACOL, V87, P245, DOI 10.1254/jjp.87.245; Morrison RR, 2006, AM J PHYSIOL-HEART C, V291, pH1875, DOI 10.1152/ajpheart.00158.2005; Nishida M, 2010, YAKUGAKU ZASSHI, V130, P295, DOI 10.1248/yakushi.130.295; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Parsons M, 2000, FASEB J, V14, P1423, DOI 10.1096/fj.14.10.1423; Peart J, 2000, AM J PHYSIOL-HEART C, V279, pH2166, DOI 10.1152/ajpheart.2000.279.5.H2166; Poteser M, 2008, FEBS LETT, V582, P2696, DOI 10.1016/j.febslet.2008.06.049; Priviero F, 2004, CLIN EXP PHARMACOL P, V31, P741, DOI 10.1111/j.1440-1681.2004.04064.x; Putney J W Jr, 2001, Mol Interv, V1, P84; Robin E, 2011, J MOL CELL CARDIOL, V51, P945, DOI 10.1016/j.yjmcc.2011.08.023; Rogel A, 2006, NUCLEOS NUCLEOT NUCL, V25, P1283, DOI 10.1080/15257770600890939; Roscoe AK, 2000, ANESTHESIOLOGY, V92, P1692, DOI 10.1097/00000542-200006000-00029; Rose'Meyer RB, 2010, CLIN EXP PHARMACOL P, V37, P46, DOI 10.1111/j.1440-1681.2009.05228.x; Rybin VO, 1997, AM J PHYSIOL-HEART C, V272, pH1636, DOI 10.1152/ajpheart.1997.272.4.H1636; Sabourin J, 2011, CARDIOVASC RES, V92, P226, DOI 10.1093/cvr/cvr167; Sabourin J, 2009, J BIOL CHEM, V284, P36248, DOI 10.1074/jbc.M109.012872; Saleh SN, 2006, J PHYSIOL-LONDON, V577, P479, DOI 10.1113/jphysiol.2006.119305; Saleh SN, 2008, J PHYSIOL-LONDON, V586, P2463, DOI 10.1113/jphysiol.2008.152157; Sarre A, 2006, J CARDIOVASC ELECTR, V17, P1350, DOI 10.1111/j.1540-8167.2006.00637.x; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Steinckwich N, 2007, J LEUKOCYTE BIOL, V81, P1054, DOI 10.1189/jlb.0406248; Takahashi T, 2010, BRIT J PHARMACOL, V161, P1806, DOI 10.1111/j.1476-5381.2010.01002.x; Tenthorey D, 1998, J CARDIOVASC PHARM, V31, P195, DOI 10.1097/00005344-199802000-00004; Vassort G, 2009, CAN J PHYSIOL PHARM, V87, P100, DOI 10.1139/Y08-112; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yang ZG, 2009, BBA-MOL CELL RES, V1793, P1868, DOI 10.1016/j.bbamcr.2009.10.007; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshida J, 2005, EUR J PHARMACOL, V510, P217, DOI 10.1016/j.ejphar.2005.01.029; Yoshino T, 2007, EUR J PHARMACOL, V560, P225, DOI 10.1016/j.ejphar.2007.01.012; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	73	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26688	26701		10.1074/jbc.M112.378588	http://dx.doi.org/10.1074/jbc.M112.378588			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22692208	Green Published, hybrid			2022-12-28	WOS:000307386000020
J	Busch, F; Mobasheri, A; Shayan, P; Stahlmann, R; Shakibaei, M				Busch, Franziska; Mobasheri, Ali; Shayan, Parviz; Stahlmann, Ralf; Shakibaei, Mehdi			Sirt-1 Is Required for the Inhibition of Apoptosis and Inflammatory Responses in Human Tenocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN ARTICULAR CHONDROCYTES; TUMOR-SUPPRESSOR PROTEIN; HUMAN TENDON CELLS; CALORIE RESTRICTION; IN-VITRO; DEPENDENT TRANSCRIPTION; RESVERATROL; ACTIVATION; P53	Tendon overuse injuries and tendinitis are accompanied by catabolic processes and apoptosis of tenocytes. However, the precise molecular mechanisms of the destructive processes in tendon are not fully understood. Sirt-1, a nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase, has been linked to transcriptional silencing and appears to play a key role in inflammation. The purpose of this study was to examine whether down-regulation of Sirt-1 using antisense oligonucleotides (ASO) affects inflammatory and apoptotic signaling in tenocytes. Transient transfection of tenocytes with ASO against Sirt-1 induced expression of Bax and other proteins involved in apoptosis (cleaved caspase-3 and poly(ADP-ribose) polymerase), acetylation of tumor suppressor p53, and mitochondrial degradation. Interestingly, Sirt-1 was found to interact directly with p53. In contrast, Sirt-1 activator resveratrol inhibited interleukin-1 beta (IL-1 beta)- and nicotinamide-induced NF-kappa B activation and p65 acetylation and suppressed the activation of I kappa B-alpha kinase. Resveratrol also reversed the IL-1 beta- or nicotinamide-induced up-regulation of various gene products that mediate inflammation (cyclooxygenase-2) and matrix degradation (matrix metalloproteinase-9) that are known to be regulated by NF-kappa B. Knockdown of Sirt-1 by using ASO abolished the inhibitory effects of resveratrol on inflammatory and apoptotic signaling including Akt activation and SCAX suppression. Down-regulation of histone deacetylase Sirt-1 by mRNA interference abrogated the effect of resveratrol on NF-kappa B suppression, thus highlighting the crucial homeostatic role of this enzyme. Overall, these results suggest for the first time that Sirt-1 can regulate p53 and NF-kappa B signaling via deacetylation, demonstrating a novel role for resveratrol in the treatment of tendinitis/tendinopathy.	[Shakibaei, Mehdi] Univ Munich, Inst Anat, Musculoskeletal Res Grp, D-80336 Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Loughborough LE12 5RD, Leics, England; [Shayan, Parviz] Invest Inst Mol Biol Syst Transfer, Tehran 1417863171, Iran; [Stahlmann, Ralf] Charite, Inst Clin Pharmacol & Toxicol, D-13353 Berlin, Germany	University of Munich; University of Nottingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Musculoskeletal Res Grp, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Mobasheri, Ali/D-5770-2011; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Mobasheri, Ali/0000-0001-6261-1286; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506				Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Anitua E, 2005, J ORTHOP RES, V23, P281, DOI 10.1016/j.orthres.2004.08.015; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; BORING CC, 1991, CA-CANCER J CLIN, V41, P19, DOI 10.3322/canjclin.41.1.19; Cao ZX, 2004, EUR J PHARMACOL, V489, P39, DOI 10.1016/j.ejphar.2004.02.031; Chalk AM, 2002, BIOINFORMATICS, V18, P1567, DOI 10.1093/bioinformatics/18.12.1567; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Holmes-McNary M, 2000, CANCER RES, V60, P3477; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lian OB, 2005, AM J SPORT MED, V33, P561, DOI 10.1177/0363546504270454; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Mizutani K, 1998, BIOCHEM BIOPH RES CO, V253, P859, DOI 10.1006/bbrc.1998.9870; Pan WH, 2006, J CELL BIOCHEM, V98, P14, DOI 10.1002/jcb.20790; Pirollo KF, 2003, PHARMACOL THERAPEUT, V99, P55, DOI 10.1016/S0163-7258(03)00053-6; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Savouret JF, 2002, BIOMED PHARMACOTHER, V56, P84, DOI 10.1016/S0753-3322(01)00158-5; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Scott A, 2005, J ORTHOP RES, V23, P1219, DOI 10.1016/j.orthres.2004.12.011; Shakibaei M, 1997, CELL BIOL INT, V21, P75, DOI 10.1006/cbir.1996.0119; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Tang JB, 2004, PLAST RECONSTR SURG, V113, P1703, DOI 10.1097/01.PRS.0000117365.48381.42; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	54	66	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25770	25781		10.1074/jbc.M112.355420	http://dx.doi.org/10.1074/jbc.M112.355420			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689577	Green Published, hybrid			2022-12-28	WOS:000306916300008
J	McDaniel, BK; Binder, BM				McDaniel, Brittany K.; Binder, Brad M.			Ethylene Receptor 1 (ETR1) Is Sufficient and Has the Predominant Role in Mediating Inhibition of Ethylene Responses by Silver in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE KINASE-ACTIVITY; GOLD(I) COMPLEXES; GENE FAMILY; BINDING; GROWTH; MUTATIONS; DOMAIN; PATHWAY; MUTANT; COPPER	Ethylene influences many processes in Arabidopsis thaliana through the action of five receptor isoforms. All five isoforms use copper as a cofactor for binding ethylene. Previous research showed that silver can substitute for copper as a cofactor for ethylene binding activity in the ETR1 ethylene receptor yet also inhibit ethylene responses in plants. End-point and rapid kinetic analyses of dark-grown seedling growth revealed that the effects of silver are mostly dependent upon ETR1, and ETR1 alone is sufficient for the effects of silver. Ethylene responses in etr1-6 etr2-3 ein4-4 triple mutants were not blocked by silver. Transformation of these triple mutants with cDNA for each receptor isoform under the promoter control of ETR1 revealed that the cETR1 transgene completely rescued responses to silver while the cETR2 transgene failed to rescue these responses. The other three isoforms partially rescued responses to silver. Ethylene binding assays on the binding domains of the five receptor isoforms expressed in yeast showed that silver supports ethylene binding to ETR1 and ERS1 but not the other isoforms. Thus, silver may have an effect on ethylene signaling outside of the ethylene binding pocket of the receptors. Ethylene binding to ETR1 with silver was similar to 30% of binding with copper. However, alterations in the K-d for ethylene binding to ETR1 and the half-time of ethylene dissociation from ETR1 do not underlie this lower binding. Thus, it is likely that the lower ethylene binding activity of ETR1 with silver is due to fewer ethylene binding sites generated with silver versus copper.	[McDaniel, Brittany K.; Binder, Brad M.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Binder, BM (corresponding author), M407 Walters Life Sci Bldg,1414 Cumberland Ave, Knoxville, TN 37996 USA.	bbinder@utk.edu		Binder, Brad/0000-0002-8172-2034	NSF [MCB0918430]; BCMB Dept. Hunsicker Research Incentive Award; Direct For Biological Sciences [0918430] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); BCMB Dept. Hunsicker Research Incentive Award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by an NSF Grant (MCB0918430) and a BCMB Dept. Hunsicker Research Incentive Award (to B. M. B.).	Abeles F, 1992, ETHYLENE PLANT BIOL; BEYER EM, 1976, PLANT PHYSIOL, V58, P268, DOI 10.1104/pp.58.3.268; Binder B. M., 2012, ANN PLANT REV PLANT, P117; Binder BM, 2003, ACTA HORTIC, P177, DOI 10.17660/ActaHortic.2003.628.21; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Binder BM, 2007, FEBS LETT, V581, P5105, DOI 10.1016/j.febslet.2007.09.057; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Binder BM, 2006, PLANT PHYSIOL, V142, P1690, DOI 10.1104/pp.106.087858; Binder BM, 2010, J BIOL CHEM, V285, P37263, DOI 10.1074/jbc.M110.170027; BLANKENSHIP SM, 1993, J AM SOC HORTIC SCI, V118, P609, DOI 10.21273/JASHS.118.5.609; BURG SP, 1967, PLANT PHYSIOL, V42, P144, DOI 10.1104/pp.42.1.144; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2009, PLANT SIGNAL BEHAV, V4, P1152, DOI 10.4161/psb.4.12.9943; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; GUO BC, 1991, CHEM PHYS LETT, V181, P16, DOI 10.1016/0009-2614(91)90214-T; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; Hertwig RH, 1996, J PHYS CHEM-US, V100, P12253, DOI 10.1021/jp953064i; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Kim H, 2011, PLANT PHYSIOL, V156, P417, DOI 10.1104/pp.110.170621; Liu Q, 2012, PLANT PHYSIOL, V158, P1193, DOI 10.1104/pp.111.187757; Liu Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-60; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; O'Malley RC, 2005, PLANT J, V41, P651, DOI [10.1111/j.1365-313X.2004.02331.x, 10.1111/j.1365-313X.2004.02331.X]; Parks BM, 1999, P NATL ACAD SCI USA, V96, P14142, DOI 10.1073/pnas.96.24.14142; Plett JM, 2009, PHYSIOL MOL PLANT P, V74, P18, DOI 10.1016/j.pmpp.2009.08.004; Plett JM, 2009, J EXP BOT, V60, P3923, DOI 10.1093/jxb/erp228; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Resnick JS, 2008, PLANT J, V56, P423, DOI 10.1111/j.1365-313X.2008.03615.x; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Rivarola M, 2009, PLANT PHYSIOL, V150, P547, DOI 10.1104/pp.109.138461; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Roithova J, 2009, COORDIN CHEM REV, V253, P666, DOI 10.1016/j.ccr.2008.06.007; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; SANDERS IO, 1991, ANN BOT-LONDON, V68, P97, DOI 10.1093/oxfordjournals.aob.a088242; Schaller GE, 2007, METHOD ENZYMOL, V422, P270, DOI 10.1016/S0076-6879(06)22013-5; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schroder D, 1998, INORG CHEM, V37, P624, DOI 10.1021/ic970986m; SCHRODER D, 1995, ORGANOMETALLICS, V14, P312, DOI 10.1021/om00001a045; Seifert GJ, 2004, PLANT CELL, V16, P723, DOI 10.1105/tpc.019661; Sievers MR, 1998, J AM CHEM SOC, V120, P1891, DOI 10.1021/ja973834z; SISLER E C, 1977, Tobacco Science, V21, P43; Sisler EC, 1999, BOT BULL ACAD SINICA, V40, P1; Sisler EC, 1996, PLANT GROWTH REGUL, V18, P169, DOI 10.1007/BF00024378; SISLER EC, 1979, PLANT PHYSIOL, V64, P538, DOI 10.1104/pp.64.4.538; Sisler EC, 1996, PLANT GROWTH REGUL, V18, P79, DOI 10.1007/BF00028491; SISLER EC, 1991, PLANT HORMONE ETHYLE, P81; Strader LC, 2009, PLANT CELL, V21, P3585, DOI 10.1105/tpc.108.065185; THOMPSON JS, 1983, J AM CHEM SOC, V105, P3522, DOI 10.1021/ja00349a026; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zimmermann M, 2009, BIOCHEMISTRY-US, V48, P11640, DOI 10.1021/bi901573b	72	76	82	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26094	26103		10.1074/jbc.M112.383034	http://dx.doi.org/10.1074/jbc.M112.383034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692214	Green Published, hybrid			2022-12-28	WOS:000306916300037
J	Moutier, E; Ye, T; Choukrallah, MA; Urban, S; Osz, J; Chatagnon, A; Delacroix, L; Langer, D; Rochel, N; Moras, D; Benoit, G; Davidson, I				Moutier, Emmanuel; Ye, Tao; Choukrallah, Mohamed-Amin; Urban, Sylvia; Osz, Judit; Chatagnon, Amandine; Delacroix, Laurence; Langer, Diana; Rochel, Natacha; Moras, Dino; Benoit, Gerard; Davidson, Irwin			Retinoic Acid Receptors Recognize the Mouse Genome through Binding Elements with Diverse Spacing and Topology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNION-OF-PHARMACOLOGY; EMBRYONIC STEM-CELLS; RESPONSE ELEMENT; CHIP-SEQ; NUCLEAR RECEPTORS; GENE-EXPRESSION; WIDE ANALYSIS; RNA-SEQ; TRANSCRIPTION; DNA	Retinoic acid receptors (RARs) heterodimerize with retinoid X receptors(RXRs) and bind to RA response elements(RAREs) in the regulatory regions of their target genes. Although previous studies on limited sets of RA-regulated genes have defined canonical RAREs as direct repeats of the consensus RGKTCA separated by 1, 2, or 5 nucleotides (DR1, DR2, DR5), we show that in mouse embryoid bodies or F9 embryonal carcinoma cells, RARs occupy a large repertoire of sites with DR0, DR8, and IR0 (inverted repeat 0) elements. Recombinant RAR-RXR binds these non-canonical spacings in vitro with comparable affinities to DR2 and DR5. Most DR8 elements comprise three half-sites with DR2 and DR0 spacings. This specific half-site organization constitutes a previously unrecognized but frequent signature of RAR binding elements. In functional assays, DR8 and IR0 elements act as independent RAREs, whereas DR0 does not. Our results reveal an unexpected diversity in the spacing and topology of binding elements for the RAR-RXR heterodimer. The differential ability of RAR-RXR bound to DR0 compared to DR2, DR5, and DR8 to mediate RA-dependent transcriptional activation indicates that half-site spacing allosterically regulates RAR function.	[Moutier, Emmanuel; Ye, Tao; Urban, Sylvia; Osz, Judit; Langer, Diana; Rochel, Natacha; Moras, Dino; Davidson, Irwin] CNRS INSERM UDS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Choukrallah, Mohamed-Amin] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Chatagnon, Amandine; Benoit, Gerard] Univ Lyon 1, CNRS UMR5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Delacroix, Laurence] CHU, GIGA Neurosci, B-4000 Liege, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Friedrich Miescher Institute for Biomedical Research; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Liege	Davidson, I (corresponding author), CNRS INSERM UDS, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	irwin@titus.u-strasbg.fr	Rochel, Natacha/A-5718-2016	Rochel, Natacha/0000-0002-3573-5889; Delacroix, Laurence/0000-0003-3440-5359; BENOIT, Gerard/0000-0001-9462-6570; Davidson, Irwin/0000-0001-5533-1171	CNRS; INSERM; Universite de Strasbourg; Association pour la Recherche contre le Cancer; Ligue Nationale contre le Cancer, Institut National du Cancer [2008-037]; EuTRACC program of the European union; French Agence Nationale de la Recherche project Rapssodi	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer, Institut National du Cancer(Institut National du Cancer (INCA) France); EuTRACC program of the European union; French Agence Nationale de la Recherche project Rapssodi(French National Research Agency (ANR))	This work was supported by grants from the CNRS, the INSERM, the Universite de Strasbourg, the Association pour la Recherche contre le Cancer, the Ligue Nationale contre le Cancer, Institut National du Cancer Grant 2008-037, the EuTRACC program of the European union, and the French Agence Nationale de la Recherche project Rapssodi.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; BOUTERFA HL, 1995, DNA CELL BIOL, V14, P909, DOI 10.1089/dna.1995.14.909; Cao X, 1996, J BIOL CHEM, V271, P20650, DOI 10.1074/jbc.271.34.20650; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chang YS, 2006, CANCER BIOL THER, V5, P586, DOI 10.4161/cbt.5.6.2658; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; HEERY DM, 1994, NUCLEIC ACIDS RES, V22, P726, DOI 10.1093/nar/22.5.726; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; Krebs A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-533; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lee CH, 1999, BIOCHEMISTRY-US, V38, P8820, DOI 10.1021/bi9903547; LEE MO, 1995, MOL CELL BIOL, V15, P4194; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mangelsdorf David J., 1994, P319; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Simandi Z, 2010, FEBS LETT, V584, P3123, DOI 10.1016/j.febslet.2010.05.052; STEPHANOU A, 1995, ENDOCRINOLOGY, V136, P933, DOI 10.1210/en.136.3.933; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Whitington T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr341; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zechel C, 2005, MOL REPROD DEV, V72, P550, DOI 10.1002/mrd.20377; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	95	95	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26328	26341		10.1074/jbc.M112.361790	http://dx.doi.org/10.1074/jbc.M112.361790			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22661711	Green Published, hybrid			2022-12-28	WOS:000306916300059
J	Sanchez-Mir, L; Franco, A; Madrid, M; Vicente-Soler, J; Villar-Tajadura, MA; Soto, T; Perez, P; Gacto, M; Cansado, J				Sanchez-Mir, Laura; Franco, Alejandro; Madrid, Marisa; Vicente-Soler, Jero; Antonia Villar-Tajadura, M.; Soto, Teresa; Perez, Pilar; Gacto, Mariano; Cansado, Jose			Biological Significance of Nuclear Localization of Mitogen-activated Protein Kinase Pmk1 in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INTEGRITY PATHWAY; RNA-BINDING PROTEIN; SCHIZOSACCHAROMYCES-POMBE; MAP KINASE; GENE-EXPRESSION; STRESS; SIGNAL; MORPHOGENESIS; PHOSPHATASES; ENCODES	Mitogen-activated protein kinase (MAPK) signaling pathways play a fundamental role in the response of eukaryotic cells to environmental changes. Also, much evidence shows that the stimulus-dependent nuclear targeting of this class of regulatory kinases is crucial for adequate regulation of distinct cellular events. In the fission yeast Schizosaccharomyces pombe, the cell integrity MAPK pathway, whose central element is the MAPK Pmk1, regulates multiple processes such as cell wall integrity, vacuole fusion, cytokinesis, and ionic homeostasis. In non-stressed cells Pmk1 is constitutively localized in both cytoplasm and nucleus, and its localization pattern appears unaffected by its activation status or in response to stress, thus questioning the biological significance of the presence of this MAPK into the nucleus. We have addressed this issue by characterizing mutants expressing Pmk1 versions excluded from the cell nucleus and anchored to the plasma membrane in different genetic backgrounds. Although nuclear Pmk1 partially regulates cell wall integrity at a transcriptional level, membrane-tethered Pmk1 performs many of the biological functions assigned to wild type MAPK like regulation of chloride homeostasis, vacuole fusion, and cellular separation. However, we found that down-regulation of nuclear Pmk1 by MAPK phosphatases induced by the stress activated protein kinase pathway is important for the fine modulation of extranuclear Pmk1 activity. These results highlight the importance of the control of MAPK activity at subcellular level.	[Sanchez-Mir, Laura; Franco, Alejandro; Madrid, Marisa; Vicente-Soler, Jero; Soto, Teresa; Gacto, Mariano; Cansado, Jose] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain; [Antonia Villar-Tajadura, M.; Perez, Pilar] Univ Salamanca, Inst Biol Func & Genom, Consejo Super Invest Cient, Dept Microbiol & Genet, Salamanca 37007, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Cansado, J (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, Campus Univ Espinardo, E-30071 Murcia, Spain.	jcansado@um.es	Madrid, Marisa/AAV-2154-2020; Perez, Pilar/B-4948-2010; Madrid, Marisa/K-7755-2014; Cansado, Jose/ABC-6872-2020; Vicente-Soler, Jerónima/ABF-6293-2020; Cansado, Jose/K-5212-2014; Mir, Laura Sanchez/H-5409-2015; Franco, Alejandro/ABG-6823-2020; Pino, Teresa Soto/AAC-6096-2020	Madrid, Marisa/0000-0002-7970-2587; Perez, Pilar/0000-0003-3557-2247; Madrid, Marisa/0000-0002-7970-2587; Cansado, Jose/0000-0002-2342-8152; Vicente-Soler, Jerónima/0000-0001-8759-6545; Mir, Laura Sanchez/0000-0002-3898-5840; Franco, Alejandro/0000-0001-7461-3414; Pino, Teresa Soto/0000-0003-2965-318X	Ministerio de Educacion, Cultura y Deporte [BFU2011-22517, BFU2010-15641]; Fundacion Seneca, Spain [15280/PI/10]	Ministerio de Educacion, Cultura y Deporte; Fundacion Seneca, Spain(Fundacion Seneca)	This work was supported in part by Ministerio de Educacion, Cultura y Deporte Grants BFU2011-22517 (to J. C.) and BFU2010-15641 (to P. P.) and 15280/PI/10 from Fundacion Seneca, Spain.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Alfa C., 1993, EXPT FISSION YEAST, P16; Arellano M, 1997, J CELL SCI, V110, P2547; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Hirata D, 1998, J CELL SCI, V111, P149; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; KRISAK L, 1994, GENE DEV, V8, P2151, DOI 10.1101/gad.8.18.2151; Loewith R, 2000, J CELL SCI, V113, P153; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Martinez-Bono B, 2010, FEMS YEAST RES, V10, P28, DOI 10.1111/j.1567-1364.2009.00591.x; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nguyen AN, 2002, MOL BIOL CELL, V13, P2651, DOI 10.1091/mbc.02-03-0043; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; Papadopoulou K, 2008, J CELL SCI, V121, P38, DOI 10.1242/jcs.019489; Papadopoulou K, 2010, J CELL SCI, V123, P4374, DOI 10.1242/jcs.073056; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Satoh R, 2009, MOL BIOL CELL, V20, P2473, DOI 10.1091/mbc.E08-09-0893; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Sugiura R, 2003, NATURE, V424, P961, DOI 10.1038/nature01907; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Takada H, 2010, MOL BIOL CELL, V21, P674, DOI 10.1091/mbc.E09-09-0810; Toda T, 1996, MOL CELL BIOL, V16, P6752; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	40	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26038	26051		10.1074/jbc.M112.345611	http://dx.doi.org/10.1074/jbc.M112.345611			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685296	hybrid, Green Published			2022-12-28	WOS:000306916300031
J	Mottillo, EP; Bloch, AE; Leff, T; Granneman, JG				Mottillo, Emilio P.; Bloch, Ainsley E.; Leff, Todd; Granneman, James G.			Lipolytic Products Activate Peroxisome Proliferator-activated Receptor (PPAR) alpha and delta in Brown Adipocytes to Match Fatty Acid Oxidation with Supply	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; WHITE ADIPOSE-TISSUE; UNCOUPLING PROTEIN-1 GENE; DIET-INDUCED OBESITY; MITOCHONDRIAL-FUNCTION; ADAPTIVE THERMOGENESIS; CELLULAR PLASTICITY; METABOLIC DISEASES; UPSTREAM ENHANCER; LIPID-METABOLISM	beta-adrenergic receptors (beta-ARs) promote brown adipose tissue (BAT) thermogenesis by mobilizing fatty acids and inducing the expression of oxidative genes. beta-AR activation increases the expression of oxidative genes by elevating cAMP, but whether lipolytic products can modulate gene expression is not known. This study examined the role that adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) plays in the induction of gene expression. Activation of brown adipocytes by beta-AR agonism or 8-bromo-cyclic AMP increased the expression of PGC1 alpha, PDK4, PPAR alpha, uncoupling protein 1 (UCP1), and neuron-derived orphan receptor-1 (NOR-1), and concurrent inhibition of HSL reduced the induction of PGC1 alpha, PDK4, PPAR alpha, and UCP1 but not NOR-1. Similar results were observed in the BAT of mice following pharmacological or genetic inhibition of HSL and in brown adipocytes with stable knockdown of ATGL. Conversely, treatments that increase endogenous fatty acids elevated the expression of oxidative genes. Pharmacological antagonism and siRNA knockdown indicate that PPAR alpha and PPAR delta modulate the induction of oxidative genes by beta-AR agonism. Using a live cell fluorescent reporter assay of PPAR activation, we demonstrated that ligands for PPAR alpha and -delta, but not PPAR gamma, were rapidly generated at the lipid droplet surface and could transcriptionally activate PPAR alpha and -delta. Knockdown of ATGL reduced cAMP-mediated induction of genes involved in fatty acid oxidation and oxidative phosphorylation. Consequently, ATGL knockdown reduced maximal oxidation of fatty acids, but not pyruvate, in response to cAMP stimulation. Overall, the results indicate that lipolytic products can activate PPAR alpha and PPAR delta in brown adipocytes, thereby expanding the oxidative capacity to match enhanced fatty acid supply.	[Mottillo, Emilio P.; Bloch, Ainsley E.; Leff, Todd; Granneman, James G.] Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Sch Med, Detroit, MI 48201 USA; [Leff, Todd] Wayne State Univ, Cardiovasc Res Inst, Sch Med, Detroit, MI 48201 USA; [Mottillo, Emilio P.; Leff, Todd; Granneman, James G.] Wayne State Univ, Dept Pathol, Sch Med, Detroit, MI 48201 USA; [Granneman, James G.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48201 USA; [Granneman, James G.] John D Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Sch Med, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu	Leff, Todd/U-9084-2018	Leff, Todd/0000-0001-6923-3900	National Institutes of Health [DK092741, DK076229, DK062292]; Department of Veterans Affairs; Canadian Institutes of Health Research (CIHR) [MDR-214349]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062292, P30DK020572, R01DK062292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK092741, DK076229, and DK062292. This work also was supported by the Department of Veterans Affairs.; Supported by Doctoral Research Award MDR-214349 from the Canadian Institutes of Health Research (CIHR).	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Ahmed W, 2007, J INTERN MED, V262, P184, DOI 10.1111/j.1365-2796.2007.01825.x; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chang JS, 2012, J BIOL CHEM, V287, P9100, DOI 10.1074/jbc.M111.320200; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Jonckheere AI, 2010, CLIN CHEM, V56, P424, DOI 10.1373/clinchem.2009.131441; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Karamitri A, 2009, J BIOL CHEM, V284, P20738, DOI 10.1074/jbc.M109.021766; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Muzik Otto, 2012, Front Endocrinol (Lausanne), V3, P15, DOI 10.3389/fendo.2012.00015; NECHAD M, 1987, AM J PHYSIOL, V253, pC889, DOI 10.1152/ajpcell.1987.253.6.C889; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Ravnskjaer K, 2010, J LIPID RES, V51, P1370, DOI 10.1194/jlr.M001123; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Spiegelman BM, 2007, NOVART FDN SYMP, V287, P60; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351	55	150	157	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25038	25048		10.1074/jbc.M112.374041	http://dx.doi.org/10.1074/jbc.M112.374041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22685301	Green Published, hybrid			2022-12-28	WOS:000306651700017
J	Zhang, YY; Li, F; Patterson, AD; Wang, Y; Krausz, KW; Neale, G; Thomas, S; Nachagari, D; Vogel, P; Vore, M; Gonzalez, FJ; Schuetz, JD				Zhang, Yuanyuan; Li, Fei; Patterson, Andrew D.; Wang, Yao; Krausz, Kristopher W.; Neale, Geoffrey; Thomas, Sarah; Nachagari, Deepa; Vogel, Peter; Vore, Mary; Gonzalez, Frank J.; Schuetz, John D.			Abcb11 Deficiency Induces Cholestasis Coupled to Impaired beta-Fatty Acid Oxidation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT EXPORT PUMP; FAMILIAL INTRAHEPATIC CHOLESTASIS; FARNESOID-X-RECEPTOR; P-GLYCOPROTEIN; KNOCKOUT MICE; BILE-ACIDS; MOLECULAR-MECHANISMS; NUCLEAR RECEPTOR; EXPRESSION; LIVER	The bile salt export pump (BSEP) is an ATP-binding cassette transporter that serves as the primary system for removing bile salts from the liver. In humans, deficiency of BSEP, which is encoded by the ABCB11 gene, causes severe progressive cholestatic liver disease from early infancy. In previous studies of Abcb11 deficiency in mice generated on a mixed genetic background, the animals did not recapitulate the human disease. We reasoned that ABCB11 deficiency may cause unique changes in hepatic metabolism that are predictive of liver injury. To test this possibility, we first determined that Abcb11 knock-out (KO) C57BL/6J mice recapitulate human deficiency. Before the onset of cholestasis, Abcb11 KO mice have altered hepatic lipid metabolism coupled with reduced expression of genes important in mitochondrial fatty acid oxidation. This was associated with increased serum free-fatty acids, reduced total white adipose, and marked impairment of long-chain fatty acid beta-oxidation. Importantly, metabolomic analysis confirmed that Abcb11 KO mice have impaired mitochondrial fatty acid beta-oxidation with the elevated fatty acid metabolites phenylpropionylglycine and phenylacetylglycine. These metabolic changes precede cholestasis but may be of relevance to cholestatic disease progression because altered fatty acid metabolism can enhance reactive oxygen species that might exacerbate cholestatic liver damage.	[Zhang, Yuanyuan; Wang, Yao; Thomas, Sarah; Nachagari, Deepa; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Li, Fei; Patterson, Andrew D.; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20852 USA; [Vore, Mary] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40506 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Kentucky	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, MS 313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Schuetz, John D/N-2692-2018; Li, Fei/F-6849-2013; zhang, yuanyuan/GYA-4428-2022; Vogel, Peter/N-2490-2018; Patterson, Andrew/G-3852-2012; Patterson, Andrew/ABF-1575-2020	Vogel, Peter/0000-0002-7535-0545; Patterson, Andrew/0000-0003-2073-0070; Patterson, Andrew/0000-0003-2073-0070	National Institutes of Health [2R01-GM60904, R21HL114066, P30 CA21745, CA21865]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [ZIABC005562, ZIABC005708, R01CA194206] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL114066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01-GM60904, R21HL114066, P30 CA21745, and CA21865. This work was also supported by the American Lebanese Syrian Associated Charities.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2004, FASEB J, V18, P1258, DOI 10.1096/fj.03-1127fje; Cho JY, 2010, J LIPID RES, V51, P1063, DOI 10.1194/jlr.M002923; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Desvergne B, 2007, BBA-MOL CELL BIOL L, V1771, P913, DOI 10.1016/j.bbalip.2007.07.005; Evason K, 2011, AM J SURG PATHOL, V35, P687, DOI 10.1097/PAS.0b013e318212ec87; FALANY CN, 1994, J BIOL CHEM, V269, P19375; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; GREGO AV, 1995, CLIN NUTR, V14, P143, DOI 10.1016/S0261-5614(95)80011-5; Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734; Hayashi H, 2005, HEPATOLOGY, V41, P916, DOI 10.1002/hep.20627; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; HOFMANN AF, 1967, ANNU REV MED, V18, P333, DOI 10.1146/annurev.me.18.020167.002001; Holloway GP, 2011, J PHYSIOL-LONDON, V589, P169, DOI 10.1113/jphysiol.2010.198663; Holloway GP, 2009, AM J PHYSIOL-REG I, V297, pR960, DOI 10.1152/ajpregu.91021.2008; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansen PLM, 1999, GASTROENTEROLOGY, V117, P1370, DOI 10.1016/S0016-5085(99)70287-8; Kagawa T, 2008, AM J PHYSIOL-GASTR L, V294, pG58, DOI 10.1152/ajpgi.00367.2007; Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287; Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e; Lam P, 2007, AM J PHYSIOL-CELL PH, V293, pC1709, DOI 10.1152/ajpcell.00327.2007; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lewis D F, 2001, ScientificWorldJournal, V1, P151; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Muhfeld A, 2003, ARCH BIOCHEM BIOPHYS, V413, P32, DOI 10.1016/S0003-9861(03)00098-5; Narayan SB, 2005, CLIN CHEM, V51, P644, DOI 10.1373/clinchem.2004.045005; Noe J, 2005, J HEPATOL, V43, P536, DOI 10.1016/j.jhep.2005.05.020; Perwaiz S, 2003, J LIPID RES, V44, P494, DOI 10.1194/jlr.M200394-JLR200; PETTERSEN JE, 1972, CLIN CHIM ACTA, V38, P17, DOI 10.1016/0009-8981(72)90202-1; PREISS B, 1964, J BIOL CHEM, V239, P85; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; RINALDO P, 1988, NEW ENGL J MED, V319, P1308, DOI 10.1056/NEJM198811173192003; Savkur RS, 2005, BIOCHEM BIOPH RES CO, V329, P391, DOI 10.1016/j.bbrc.2005.01.141; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Talanian JL, 2010, AM J PHYSIOL-ENDOC M, V299, pE180, DOI 10.1152/ajpendo.00073.2010; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wang RX, 2003, HEPATOLOGY, V38, P1489, DOI 10.1016/j.hep.2003.09.037; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	55	50	75	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24784	24794		10.1074/jbc.M111.329318	http://dx.doi.org/10.1074/jbc.M111.329318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22619174	Green Published, hybrid			2022-12-28	WOS:000306651100071
J	Moses, RE; O'Malley, BW				Moses, Robb E.; O'Malley, Bert W.			DNA Transcription and Repair: A Confluence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEOTIDE EXCISION-REPAIR; DEPENDENT PROTEIN-KINASE; FANCONI-ANEMIA PATHWAY; TOPOISOMERASE-II-BETA; RNA-POLYMERASE-II; XERODERMA-PIGMENTOSUM; COCKAYNES-SYNDROME; DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; PYRIMIDINE DIMERS	DNA repair and transcription process complex nucleic acid structures. The mammalian cell can cross-utilize select components of either pathway to respond to general or special situations arising in either path. These functions comprise activity networks capable of addressing unique requirements for each process. Here, we discuss examples of such networks that are tailored to respond to the demands of both DNA repair and transcription.	[Moses, Robb E.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moses, RE (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	remoses@bcm.edu			National Institutes of Health [HD8188]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD008188, R01HD007857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD8188 (to B. W. O.).	Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; CLEAVER JE, 1991, MUTAT RES, V257, P1, DOI 10.1016/0165-1110(91)90016-O; Costelloe T, 2010, SUBCELL BIOCHEM, V50, P43, DOI 10.1007/978-90-481-3471-7_3; Diderich K, 2011, DNA REPAIR, V10, P772, DOI 10.1016/j.dnarep.2011.04.025; Friedberg E. C., 2006, DNA REPAIR MUTAGENES, P817; FRIEDBERG EC, 1995, PHILOS T ROY SOC B, V347, P63, DOI 10.1098/rstb.1995.0010; Gorski JJ, 2011, NUCLEIC ACIDS RES, V39, P9536, DOI 10.1093/nar/gkr679; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hejna J, 2008, J BIOL CHEM, V283, P9844, DOI 10.1074/jbc.M709076200; Hejna J, 2010, CELL BIOL INT, V34, P893, DOI 10.1042/CBI20090251; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kong XM, 2011, CELL SIGNAL, V23, P1273, DOI 10.1016/j.cellsig.2011.04.005; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; LEHMANN AR, 1979, CANCER RES, V39, P4237; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; LOMMEL L, 1991, MUTAT RES, V255, P183, DOI 10.1016/0921-8777(91)90052-Q; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Malewicz M, 2011, GENE DEV, V25, P2031, DOI 10.1101/gad.16872411; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; MAYNE LV, 1982, CANCER RES, V42, P1473; MAYNE LV, 1982, MUTAT RES, V106, P179, DOI 10.1016/0027-5107(82)90200-7; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Peng Lirong, 2011, Handb Exp Pharmacol, V206, P39, DOI 10.1007/978-3-642-21631-2_3; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; Ramirez-Herrick AM, 2011, BLOOD, V117, P2681, DOI 10.1182/blood-2010-02-267906; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Rosen Eliot M., 2009, P53, DOI 10.1007/978-0-387-09463-2_5; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Thompson LH, 1996, PROG CLIN BIOL RES, V395, P175; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang CG, 2008, MOL ENDOCRINOL, V22, P539, DOI 10.1210/me.2007-0379; Wang CG, 2011, J STEROID BIOCHEM, V123, P91, DOI 10.1016/j.jsbmb.2010.12.003; Wang JH, 2008, J BIOL CHEM, V283, P36249, DOI 10.1074/jbc.M803693200; Wang Y, 2000, GENE DEV, V14, P927; WEIGEL NL, 1992, MOL ENDOCRINOL, V6, P8, DOI 10.1210/me.6.1.8; Wong RHF, 2009, CELL CYCLE, V8, P1977; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163; Zhu QZ, 2010, J CELL PHYSIOL, V223, P283, DOI 10.1002/jcp.22060	72	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23266	23270		10.1074/jbc.R112.377135	http://dx.doi.org/10.1074/jbc.R112.377135			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605334	hybrid, Green Published			2022-12-28	WOS:000306511300001
J	Shioda, N; Ishikawa, K; Tagashira, H; Ishizuka, T; Yawo, H; Fukunaga, K				Shioda, Norifumi; Ishikawa, Kiyoshi; Tagashira, Hideaki; Ishizuka, Toru; Yawo, Hiromu; Fukunaga, Kohji			Expression of a Truncated Form of the Endoplasmic Reticulum Chaperone Protein, sigma 1 Receptor, Promotes Mitochondrial Energy Depletion and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; CELL-DEATH; MOUSE-BRAIN; LIGAND-BINDING; CA2+; AUTOPHAGY; CALCIUM; ISCHEMIA; CHANNELS; CLONING	The sigma 1 receptor (sigma R-1) regulates endoplasmic reticulum (ER)/mitochondrial interorganellar Ca2+ mobilization through the inositol 1,4,5-trisphosphate receptor (IP3R). Here, we observed that expression of a novel splice variant of sigma R-1, termed short form sigma R-1 (sigma 1SR), has a detrimental effect on mitochondrial energy production and cell survival. sigma 1SR mRNA lacks 47 ribo-nucleotides encoding exon 2, resulting in a frameshift and formation of a truncated receptor. sigma 1SR localizes primarily in the ER at perinuclear regions and forms a complex with sigma R-1 but not with IP3R in the mitochondrion-associated ER membrane. Overexpression of both sigma R-1 and the truncated isoform promotes mitochondrial elongation with increased ER mitochondrial contact surface. sigma R-1 overexpression increases the efficiency of mitochondrial Ca2+ uptake in response to IP3R-driven stimuli, whereas sigma 1SR overexpression reduces it. Most importantly, sigma R-1 promotes ATP production via increased mitochondrial Ca2+ uptake, promoting cell survival in the presence of ER stress. By contrast, sigma 1SR suppresses ATP production following ER stress, enhancing cell death. Taken together, the newly identified sigma 1SR isoform interferes with sigma R-1 function relevant to mitochondrial energy production under ER stress conditions, promoting cellular apoptosis.	[Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan	Tohoku University; Tohoku University	Fukunaga, K (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9808578, Japan.	kfukunaga@m.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Fukunaga, Kohji/AAI-8811-2021; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288; Fukunaga, Kohji/0000-0001-8526-2824; Ishikawa, Kiyoshi/0000-0001-5816-1948	Ministry of Education, Science, Sports and Culture of Japan; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [22390109, 24659024, 23790072, 23110501]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [24659024] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on innovative areas (Foundation of Synapse and Neurocircuit Pathology), Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan and Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, 22390109 and 24659024 (to K. F.) and 23790072 and 23110501 (to N. S.), and from the Smoking Research Foundation (to K. F.).	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hajnoczky G, 2000, J BIOENERG BIOMEMBR, V32, P15, DOI 10.1023/A:1005504210587; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; HELLEWELL SB, 1994, EUR J PHARM-MOLEC PH, V268, P9, DOI 10.1016/0922-4106(94)90115-5; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Luty AA, 2010, ANN NEUROL, V68, P639, DOI 10.1002/ana.22274; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schetz JA, 2007, BRAIN RES, V1181, P1, DOI 10.1016/j.brainres.2007.08.068; Seth P, 1997, BIOCHEM BIOPH RES CO, V241, P535, DOI 10.1006/bbrc.1997.7840; Shioda N, 2008, NEUROSCIENCE, V155, P876, DOI 10.1016/j.neuroscience.2008.05.056; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tagashira H, 2010, AM J PHYSIOL-HEART C, V299, pH1535, DOI 10.1152/ajpheart.00198.2010; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Tanimura A, 1996, J BIOL CHEM, V271, P30904, DOI 10.1074/jbc.271.48.30904; Urani A, 2004, EUR J PHARMACOL, V486, P151, DOI 10.1016/j.ejphar.2003.12.018; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200	56	61	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23318	23331		10.1074/jbc.M112.349142	http://dx.doi.org/10.1074/jbc.M112.349142			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619170	hybrid, Green Published			2022-12-28	WOS:000306511300006
J	Whitney, JC; Colvin, KM; Marmont, LS; Robinson, H; Parsek, MR; Howell, PL				Whitney, John C.; Colvin, Kelly M.; Marmont, Lindsey S.; Robinson, Howard; Parsek, Matthew R.; Howell, P. Lynne			Structure of the Cytoplasmic Region of PelD, a Degenerate Diguanylate Cyclase Receptor That Regulates Exopolysaccharide Production in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-GMP; CYCLIC DIGUANYLATE; ALLOSTERIC CONTROL; PILZ DOMAIN; EXTRACELLULAR POLYSACCHARIDES; ALGINATE BIOSYNTHESIS; RESPONSE REGULATOR; BIOFILM FORMATION; EAL DOMAIN; PROTEIN	High cellular concentrations of bis-(3',5')-cyclic dimeric guanosine mono-phosphate (c-di-GMP) regulate a diverse range of phenotypes in bacteria including biofilm development. The opportunistic pathogen Pseudomonas aeruginosa produces the PEL polysaccharide to form a biofilm at the air-liquid interface of standing cultures. Among the proteins required for PEL polysaccharide production, PelD has been identified as a membrane-bound c-di-GMP-specific receptor. In this work, we present the x-ray crystal structure of a soluble cytoplasmic region of PelD in its apo and c-di-GMP complexed forms. The structure of PelD reveals an N-terminal GAF domain and a C-terminal degenerate GGDEF domain, the latter of which binds dimeric c-di-GMP at an RXXD motif that normally serves as an allosteric inhibition site for active diguanylate cyclases. Using isothermal titration calorimetry, we demonstrate that PelD binds c-di-GMP with low micromolar affinity and that mutation of residues involved in binding not only decreases the affinity of this interaction but also abrogates PEL-specific phenotypes in vivo. Bioinformatics analysis of the juxtamembrane region of PelD suggests that it contains an alpha-helical stalk region that connects the soluble region to the transmembrane domains and that similarly to other GAF domain containing proteins, this region likely forms a coiled-coil motif that mediates dimerization. PelD with Alg44 and BcsA of the alginate and cellulose secretion systems, respectively, collectively constitute a group of c-di-GMP receptors that appear to regulate exopolysaccharide assembly at the protein level through activation of their associated glycosyl transferases.	[Whitney, John C.; Marmont, Lindsey S.; Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Whitney, John C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Colvin, Kelly M.; Parsek, Matthew R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Brookhaven National Laboratory	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca			Canadian Institutes of Health Research [MT43998]; National Institutes of Health [R01 AI077628-01A1]; National Science Foundation [MCB0822405]; U.S. Department of Energy; National Institutes of Health National Center for Research Resources; Natural Sciences and Engineering Research Council of Canada; Cystic Fibrosis Canada; Ontario Graduate Scholarship Program; The Hospital for Sick Children Foundation Student Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0822405] Funding Source: National Science Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cystic Fibrosis Canada; Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); The Hospital for Sick Children Foundation Student Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by Canadian Institutes of Health Research Grant MT43998 (to P. L. H.). This work was also supported by National Institutes of Health Grant R01 AI077628-01A1 (to M. R. P.) and National Science Foundation Grant MCB0822405 (to M. R. P.). Beamline X29 at the National Synchrotron Light Source was supported by the U.S. Department of Energy and the National Institutes of Health National Center for Research Resources.; Supported by graduate scholarships from the Natural Sciences and Engineering Research Council of Canada, Cystic Fibrosis Canada, the Ontario Graduate Scholarship Program, and The Hospital for Sick Children Foundation Student Scholarship Program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Marmont LS, 2012, ACTA CRYSTALLOGR F, V68, P181, DOI 10.1107/S1744309111052109; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Merritt J. H., 2011, CURRENT PROTOCOLS MI; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Oglesby LL, 2008, MICROBIOL-SGM, V154, P1605, DOI 10.1099/mic.0.2007/015305-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006; Remminghorst U, 2006, FEBS LETT, V580, P3883, DOI 10.1016/j.febslet.2006.05.077; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Wang HC, 2010, J BIOL CHEM, V285, P38149, DOI 10.1074/jbc.M110.141614; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x; Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714	55	78	84	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23582	23593		10.1074/jbc.M112.375378	http://dx.doi.org/10.1074/jbc.M112.375378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605337	Green Published, hybrid			2022-12-28	WOS:000306511300029
J	Huang, GC; Redelman-Sidi, G; Rosen, N; Glickman, MS; Jiang, XJ				Huang, Guochang; Redelman-Sidi, Gil; Rosen, Neal; Glickman, Michael S.; Jiang, Xuejun			Inhibition of Mycobacterial Infection by the Tumor Suppressor PTEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; CELL-CYCLE ARREST; PHAGOSOME MATURATION; PROTEIN; FIBRONECTIN; CANCER; BCG; INTERNALIZATION; APOPTOSIS; MIGRATION	The tumor suppressor PTEN is a lipid phosphatase that is frequently mutated in various human cancers. PTEN suppresses tumor cell proliferation, survival, and growth mainly by inhibiting the PI3K-Akt signaling pathway through dephosphorylation of phosphatidylinositol 3,4,5-triphosphate. In addition to it role in tumor suppression, the PTEN-PI3K pathway controls many cellular functions, some of which may be important for cellular resistance to infection. Currently, the intersection between tumorigenic signaling pathways and cellular susceptibility to infection is not well defined. In this study we report that PTEN signaling regulates infection of both noncancerous and cancerous cells by multiple intracellular mycobacterial pathogens and that pharmacological modulation of PTEN signaling can affect mycobacterial infection. We found that PTEN deficiency renders multiple types of cells hyper-susceptible to infection by Mycoplasma and Mycobacterium bovis Bacillus Calmette-Guerin ( BCG). The lipid phosphatase activity of PTEN is required for attenuating infection. Furthermore, we found mycobacterial infection activates host cell Akt phosphorylation, and pharmacological inhibition of Akt or PI3K activity reduced levels of intracellular infection. Intriguingly, inhibition of mTOR, one of the downstream components of the Akt signaling and a promising cancer therapeutic target, also lowered intracellular Bacillus Calmette-Guerin levels in mammary epithelial cancer MCF-7cells. These findings demonstrate a critical role of PTEN-regulated pathways in pathogen infection. The relationship of PTEN-PI3K-Akt mTOR status and susceptibility to mycobacterial infection suggests that the interaction of mycobacterial pathogens with cancer cells may be influenced by genetic alterations in the tumor cells.	[Huang, Guochang; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Redelman-Sidi, Gil; Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10065 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10065 USA.	jiangx@mskcc.org	Rosen, Neal/ABF-2677-2020	Glickman, Michael S/0000-0001-7918-5164	National Institutes of Health [R01CA113890]; Geoffrey Beene Cancer Research fund; NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Research fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA113890 (to X. J.). This work was also supported by the Geoffrey Beene Cancer Research fund (to M. S. G. and X. J.).	Chiu HC, 2009, ANTIMICROB AGENTS CH, V53, P5236, DOI 10.1128/AAC.00555-09; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Hlobilkova A, 2000, EXP CELL RES, V256, P571, DOI 10.1006/excr.2000.4867; HUDSON MA, 1990, CANCER RES, V50, P3843; Ikeda N, 2002, INT J UROL, V9, P29, DOI 10.1046/j.1442-2042.2002.00415.x; Kim DH, 2003, CURR TOP MICROBIOL, V279, P259; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Lee YG, 2011, FRONT BIOSCI-LANDMRK, V16, P517, DOI 10.2741/3702; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Loskog A, 2007, J UROLOGY, V177, P353, DOI 10.1016/j.juro.2006.08.078; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Luo Y, 2006, CLIN EXP IMMUNOL, V146, P181, DOI 10.1111/j.1365-2249.2006.03191.x; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pook SH, 2007, ONCOL REP, V18, P1315; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; RATLIFF TL, 1988, J UROLOGY, V139, P410, DOI 10.1016/S0022-5347(17)42445-1; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Zhao WC, 2000, INT J CANCER, V86, P83, DOI 10.1002/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R	30	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23196	23202		10.1074/jbc.M112.351940	http://dx.doi.org/10.1074/jbc.M112.351940			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613768	hybrid, Green Published			2022-12-28	WOS:000306495000074
J	Leksa, V; Pfisterer, K; Ondrovicova, G; Binder, B; Lakatosova, S; Donner, C; Schiller, HB; Zwirzitz, A; Mrvova, K; Pevala, V; Kutejova, E; Stockinger, H				Leksa, Vladimir; Pfisterer, Karin; Ondrovicova, Gabriela; Binder, Brigitte; Lakatosova, Silvia; Donner, Clemens; Schiller, Herbert B.; Zwirzitz, Alexander; Mrvova, Katarina; Pevala, Vladimir; Kutejova, Eva; Stockinger, Hannes			Dissecting Mannose 6-Phosphate-Insulin-like Growth Factor 2 Receptor Complexes That Control Activation and Uptake of Plasminogen in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE RECEPTOR; 6-PHOSPHATE RECEPTOR; EARLY ENDOSOMES; ENDOTHELIAL-CELLS; PROTEIN COMPLEXES; BINDING SITES; SURFACE; MEMBRANE; UPAR; MIGRATION	The plasminogen (Plg) activation cascade on the cell surface plays a central role in cell migration and is involved in a plethora of physiological and pathological processes. Its regulation is coordinated by many receptors, in particular the urokinase-type plasminogen activator receptor (uPAR, CD87), receptors that physically interact and functionally cooperate with uPAR, and Plg binding molecules. Here we studied the impact of one of the Plg binding molecules, the mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P-IGF2R, CD222), on cellular Plg activation. By developing both in vitro and in vivo Plg activation assays on size-fractionated lysates of M6P-IGF2R-silenced cells, we identified Plg-associated complexes with M6P-IGF2R as the regulatory factor. Using lipid raft preserving versus dissolving detergents, we found lipid dependence of the Plg regulatory function of these complexes. Furthermore, M6P-IGF2R-silencing in uPAR-positive human cell lines reduced internalization of Plg, resulting in elevated Plg activation. In contrast, the expression of human M6P-IGF2R in mouse embryonic fibroblasts derived from M6P-IGF2R knock-out mice enhanced Plg internalization. Finally, peptide 18-36 derived from the Plg-binding site within M6P-IGF2R enhanced Plg uptake. Thus, by targeting Plg to endocytic pathways, M6P-IGF2R appears to control Plg activation within cells that might be important to restrict plasmin activity to specific sites and substrates.	[Leksa, Vladimir; Pfisterer, Karin; Binder, Brigitte; Donner, Clemens; Schiller, Herbert B.; Zwirzitz, Alexander; Stockinger, Hannes] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Mol Immunol Unit, A-1090 Vienna, Austria; [Leksa, Vladimir; Ondrovicova, Gabriela; Lakatosova, Silvia; Mrvova, Katarina; Pevala, Vladimir; Kutejova, Eva] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia	Medical University of Vienna; Slovak Academy of Sciences	Leksa, V (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Mol Immunol Unit, Lazarettgasse 19, A-1090 Vienna, Austria.	Vladimir.Leksa@meduniwien.ac.at	Kutejova, Eva/AAI-2544-2021; Pevala, Vladimir/M-8513-2015; Leksa, Vladimir/ABE-7876-2020; Pfisterer, Karin/Y-5010-2019; Kutejova, Eva/K-6550-2014; Schiller, Herbert/O-1877-2013; Stockinger, Hannes/E-5173-2011	Kutejova, Eva/0000-0002-0973-679X; Pevala, Vladimir/0000-0001-5110-8837; Pfisterer, Karin/0000-0003-1723-6266; Kutejova, Eva/0000-0002-0973-679X; Stockinger, Hannes/0000-0001-6404-4430; Leksa, vladimir/0000-0002-5430-2763; Zwirzitz, Alexander/0000-0002-0703-0005	Austrian Science Fund [P19014-B13, P22908, I00300]; Science and Technology Assistance Agency of the Slovak Republic [APVT-51-026204]; Slovak Grant Agency VEGA [2/5119/25]; Bilateral Cooperation Slovakia-Austria [SK-11-AUT-9]; Austrian Science Fund (FWF) [P 22908] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Science and Technology Assistance Agency of the Slovak Republic; Slovak Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Bilateral Cooperation Slovakia-Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Grants P19014-B13, P22908, and I00300 and grants from the Science and Technology Assistance Agency of the Slovak Republic (APVT-51-026204), the Slovak Grant Agency VEGA (2/5119/25), and the Bilateral Cooperation Slovakia-Austria (SK-11-AUT-9).	Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Andronicos NM, 2001, BRIT J CANCER, V85, P909, DOI 10.1054/bjoc.2001.2022; Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; BAIER G, 1994, BIOTECHNIQUES, V17, P94; Bohnsack RN, 2010, BIOCHEMISTRY-US, V49, P635, DOI 10.1021/bi901779p; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Bugge Thomas H., 2008, P183, DOI 10.1007/978-0-387-69057-5_10; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; DAMKE H, 1991, J BIOL CHEM, V266, P24829; Drbal K, 2007, INT IMMUNOL, V19, P675, DOI 10.1093/intimm/dxm032; El-Shewy HM, 2009, VITAM HORM, V80, P667, DOI 10.1016/S0083-6729(08)00624-9; Ellis V, 1999, BIOCHEMISTRY-US, V38, P651, DOI 10.1021/bi981714d; Ellis V, 2003, CURR TOP DEV BIOL, V54, P263, DOI 10.1016/S0070-2153(03)54012-1; Engelholm LH, 2001, TRENDS CARDIOVAS MED, V11, P7, DOI 10.1016/S1050-1738(01)00076-7; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GHOSH RN, 1994, J CELL SCI, V107, P2177; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Godar S., 2002, LEUKOCYTE TYPING, P482; Gonias Steven L., 2001, Frontiers in Bioscience, V6, pd1403, DOI 10.2741/Gonias; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Gonzalez-Gronow M, 2008, FRONT BIOSCI-LANDMRK, V13, P1610, DOI 10.2741/2785; GONZALEZGRONOW M, 1993, BIOCHIM BIOPHYS ACTA, V1180, P283, DOI 10.1016/0925-4439(93)90051-2; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Herren T, 2003, FRONT BIOSCI-LANDMRK, V8, pD1, DOI 10.2741/916; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Khatib AM, 2001, INT J CANCER, V91, P300, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1055>3.3.CO;2-E; KUDINOV SA, 1985, UKR BIOKHIM ZH+, V57, P23; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Leksa V, 2002, J BIOL CHEM, V277, P40575, DOI 10.1074/jbc.M207979200; Leksa V, 2011, CIRC RES, V108, P676, DOI 10.1161/CIRCRESAHA.110.234732; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; MAGDOLEN V, 1995, ELECTROPHORESIS, V16, P813, DOI 10.1002/elps.11501601134; MCGUIRE PG, 1992, DEV DYNAM, V193, P24, DOI 10.1002/aja.1001930105; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; Olson LJ, 2004, EMBO J, V23, P2019, DOI 10.1038/sj.emboj.7600215; Otahal P, 2010, J IMMUNOL, V184, P3689, DOI 10.4049/jimmunol.0902075; Phipps KD, 2011, CANCER RES, V71, P6676, DOI 10.1158/0008-5472.CAN-11-1748; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Prager GW, 2004, CIRC RES, V94, P1562, DOI 10.1161/01.RES.0000131498.36194.6b; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schiller HB, 2009, MOL BIOL CELL, V20, P745, DOI 10.1091/mbc.E08-06-0569; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stepanova VV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P109, DOI 10.1023/A:1013912500373; Stillfried GE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1647; Swift S., 1999, CURRENT PROTOCOLS IM, P101714; Tarui T, 2006, THROMB HAEMOSTASIS, V95, P524, DOI 10.1160/TH05-06-0457; Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200; Tjelle TE, 1996, J CELL SCI, V109, P2905; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110; Zhang X, 2003, MOL VIS, V9, P238; Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455	65	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22450	22462		10.1074/jbc.M112.339663	http://dx.doi.org/10.1074/jbc.M112.339663			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613725	Green Published, hybrid			2022-12-28	WOS:000306495000005
J	Mileykovskaya, E; Penczek, PA; Fang, J; Mallampalli, VKPS; Sparagna, GC; Dowhan, W				Mileykovskaya, Eugenia; Penczek, Pawel A.; Fang, Jia; Mallampalli, Venkata K. P. S.; Sparagna, Genevieve C.; Dowhan, William			Arrangement of the Respiratory Chain Complexes in Saccharomyces cerevisiae Supercomplex III2IV2 Revealed by Single Particle Cryo-Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; C-OXIDASE; MEMBRANE-PROTEIN; YEAST; CARDIOLIPIN; ORGANIZATION; ROLES; PURIFICATION; RESPIRASOME; COMPONENTS	Here we present for the first time a three-dimensional cryo-EM map of the Saccharomyces cerevisiae respiratory supercomplex composed of dimeric complex III flanked on each side by one monomeric complex IV. A precise fit of the existing atomic x-ray structures of complex III from yeast and complex IV from bovine heart into the cryo-EM map resulted in a pseudo-atomic model of the three-dimensional structure for the supercomplex. The distance between cytochrome c binding sites of complexes III and IV is about 6 nm, which supports proposed channeling of cytochrome c between the individual complexes. The opposing surfaces of complexes III and IV differ considerably from those reported for the bovine heart supercomplex as determined by cryo-EM. A closer association between the individual complex domains at the aqueous membrane interface and larger spaces between the membrane-embedded domains where lipid molecules may reside are also demonstrated. The supercomplex contains about 50 molecules of cardiolipin ( CL) with a fatty acid composition identical to that of the inner membrane CL pool, consistent with CL-dependent stabilization of the supercomplex.	[Mileykovskaya, Eugenia; Penczek, Pawel A.; Fang, Jia; Mallampalli, Venkata K. P. S.; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sparagna, Genevieve C.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Texas System; University of Texas Health Science Center Houston; University of Colorado System; University of Colorado Boulder	Dowhan, W (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,Suite 6-200, Houston, TX 77030 USA.	William.Dowhan@uth.tmc.edu	Mallampalli, Venkata KPS/I-3208-2019	Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health [GM R01 56389, GM R01 60635, GM-069338]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, U54GM069338, R01GM056389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R01 56389 and the John Dunn Research Foundation (to W. D.), National Institutes of Health Grant GM R01 60635 (to P. A. P.).; We thank Dr. Richard Kulmacz for use of his Clark electrode and Drs. Srinivas Mullapudi and Jun Liu for assistance with operation of the Polara electron microscope, which is supported in part, through the Structural Biology Imaging Center at UTHSC-Houston. We thank Dr. Robert Murphy for the use of the LIPID MAPS mass spectrometry facility at the University of Colorado at Denver, which is supported by the National Institutes of Health Large Scale Collaborative Grant GM-069338. The Texas Advanced Computing Center at The University of Texas at Austin provided high performance computing resources for this project.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Boumans H, 1998, J BIOL CHEM, V273, P4872, DOI 10.1074/jbc.273.9.4872; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Braun HP, 2009, METHOD ENZYMOL, V456, P183, DOI 10.1016/S0076-6879(08)04410-8; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	44	96	99	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23095	23103		10.1074/jbc.M112.367888	http://dx.doi.org/10.1074/jbc.M112.367888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573332	Green Published, hybrid			2022-12-28	WOS:000306495000065
J	Scheidt, HA; Morgado, I; Huster, D				Scheidt, Holger A.; Morgado, Isabel; Huster, Daniel			Solid-state NMR Reveals a Close Structural Relationship between Amyloid-beta Protofibrils and Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ATOMIC-FORCE MICROSCOPY; FIBRIL FORMATION; PEPTIDE; DYNAMICS; STABILIZATION; RESOLUTION; DOMAIN; SHEET; MODEL	We have studied tertiary contacts in protofibrils and mature fibrils of amyloid-beta (A beta) peptides using solid-state NMR spectroscopy. Although intraresidue contacts between Glu-22 and Ile-31 were found in A beta protofibrils, these contacts were completely absent in mature A beta fibrils. This is consistent with the current models of mature A beta fibrils. As these intramolecular contacts have also been reported in A beta oligomers, our measurements suggest that A beta protofibrils are structurally more closely related to oligomers than to mature fibrils. This suggests that some structural alterations have to take place on the pathway from A beta oligomers/protofibrils to mature fibrils, in agreement with a model that suggests a conversion of intramolecular hydrogen-bonded structures of A beta oligomers to the intermolecular stabilized mature fibrils (Hoyer, W., Gronwall, C., Jonsson, A., Stahl, S., and Hard, T. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 5099-5104).	[Scheidt, Holger A.; Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, D-04107 Leipzig, Germany; [Morgado, Isabel] Univ Halle Wittenberg, Inst Biochem Biotechnol, D-06120 Halle, Germany	Leipzig University; Martin Luther University Halle Wittenberg	Huster, D (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.	daniel.huster@medizin.uni-leipzig.de	Scheidt, Holger A./C-1416-2014; Morgado, Isabel/J-4798-2013	Morgado, Isabel/0000-0002-7826-997X	Deutsche Forschungsgemeinschaft [Transregio-SFB 102, A6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants Transregio-SFB 102 and A6 and a personal grant to I. M.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Antzutkin ON, 2004, MAGN RESON CHEM, V42, P231, DOI 10.1002/mrc.1341; Barre P, 2003, BIOCHEMISTRY-US, V42, P8377, DOI 10.1021/bi034239e; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; DaSilva KA, 2010, EXP NEUROL, V223, P311, DOI 10.1016/j.expneurol.2009.08.032; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hard T, 2011, FEBS J, V278, P3884, DOI 10.1111/j.1742-4658.2011.08295.x; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Haupt C, 2012, ANGEW CHEM INT EDIT, V51, P1576, DOI 10.1002/anie.201105638; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Huster D, 2005, PROG NUCL MAG RES SP, V46, P79, DOI 10.1016/j.pnmrs.2005.01.001; Huster D, 2001, BIOCHEMISTRY-US, V40, P7662, DOI 10.1021/bi0027231; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; Morgado I, 2011, CURR OPIN COLLOID IN, V16, P508, DOI 10.1016/j.cocis.2011.06.016; MUNOWITZ MG, 1981, J AM CHEM SOC, V103, P2529, DOI 10.1021/ja00400a007; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; RHIM WK, 1973, J CHEM PHYS, V58, P1772, DOI 10.1063/1.1679423; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Schmidt-Rohr K., 1994, MULTIDIMENSIONAL SOL, P95; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Zhang FL, 2004, J AM CHEM SOC, V126, P13180, DOI 10.1021/ja047241h	34	61	63	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22822	22826		10.1074/jbc.M112.367474	http://dx.doi.org/10.1074/jbc.M112.367474			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589542	Green Published, hybrid			2022-12-28	WOS:000306495000039
J	Fisher, JT; Liu, XM; Yan, ZY; Luo, MH; Zhang, YL; Zhou, WH; Lee, BJ; Song, Y; Guo, CH; Wang, YJ; Lukacs, GL; Engelhardt, JF				Fisher, John T.; Liu, Xiaoming; Yan, Ziying; Luo, Meihui; Zhang, Yulong; Zhou, Weihong; Lee, Ben J.; Song, Yi; Guo, Chenhong; Wang, Yujiong; Lukacs, Gergely L.; Engelhardt, John F.			Comparative Processing and Function of Human and Ferret Cystic Fibrosis Transmembrane Conductance Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CHLORIDE CHANNELS; CFTR; GENE; IDENTIFICATION; DEGRADATION; STABILITY; MEMBRANE; DISEASE; MUTATION	The most common cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation is Delta F508, and this causes cystic fibrosis (CF). New CF models in the pig and ferret have been generated that develop lung, pancreatic, liver, and intestinal pathologies that reflect disease in CF patients. Species-specific biology in the processing of CFTR has demonstrated that pig and mouse Delta F508-CFTR proteins are more effectively processed to the apical membrane of airway epithelia than human Delta F508-CFTR. The processing behavior of ferret WT- and Delta F508-CFTR proteins remains unknown, and such information is important to predicting the utility of a Delta F508-CFTR ferret. To this end, we sought to compare processing, membrane stability, and function of human and ferret WT- and Delta F508-CFTR proteins in a heterologous expression system using HT1080, HEK293T, BHK21, and Cos7 cells as well as human and ferret CF polarized airway epithelia. Analysis of the protein processing and stability by metabolic pulse-chase and surface On-Cell Western blots revealed that WT-fCFTR half-life and membrane stability were increased relative to WT-hCFTR. Furthermore, in BHK21, Cos7, and CuFi cells, human and ferret Delta F508-CFTR processing was negligible, whereas low levels of processing of Delta F508-fCFTR could be seen in HT1080 and HEK293T cells. Only the WT-fCFTR, but not Delta F508-fCFTR, produced functional cAMP-inducible chloride currents in both CF human and ferret airway epithelia. Further elucidation of the mechanism responsible for elevated fCFTR protein stability may lead to new therapeutic approaches to augment CFTR function. These findings also suggest that generation of a ferret CFTR Delta F508/Delta F508 animal model may be useful.	[Engelhardt, John F.] Univ Iowa, Sch Med, Dept Anat & Cell Biol, Coll Med, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Coll Med, Ctr Gene Therapy Cyst Fibrosis & Other Genet Dis, Iowa City, IA 52242 USA; [Guo, Chenhong; Wang, Yujiong] Ningxia Univ, Coll Life Sci, Ningxia 750021, Peoples R China; [Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	University of Iowa; University of Iowa; University of Iowa; Ningxia University; McGill University	Engelhardt, JF (corresponding author), Univ Iowa, Sch Med, Dept Anat & Cell Biol, Coll Med, 51 Newton Rd,Rm 1-111 BSB, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu		Yan, Ziying/0000-0001-8210-5567; Engelhardt, John/0000-0003-2389-9277; Lukacs, Gergely/0000-0003-0900-0675; LIU, XIAOMING/0000-0002-3902-9105	National Institutes of Health [DK047967, HL108902, HL091842, DK075302, DK54759]; Cystic Fibrosis Foundation; Canadian Institute of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108902, P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075302, R37DK047967, P30DK054759, R01DK047967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK047967, HL108902, HL091842, DK075302, and DK54759. This work was also supported by the Cystic Fibrosis Foundation and the Canadian Institute of Health Research.	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Egan M, 2009, DRUG DISCO TODAY DIS, V6, P35, DOI DOI 10.1016/J.DDM0D.2009.03.009; Farinha CM, 2004, MOL CELL PROBE, V18, P235, DOI 10.1016/j.mcp.2004.03.005; Fisher JT, 2011, METHODS MOL BIOL, V742, P311, DOI 10.1007/978-1-61779-120-8_19; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Liu XM, 2007, AM J RESP CELL MOL, V36, P313, DOI 10.1165/rcmb.2006-0286OC; Liu YL, 2008, BIOCHEM BIOPH RES CO, V373, P113, DOI 10.1016/j.bbrc.2008.06.009; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Skach WR, 2000, KIDNEY INT, V57, P825, DOI 10.1046/j.1523-1755.2000.00921.x; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; WARD CL, 1994, J BIOL CHEM, V269, P25710; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	34	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21673	21685		10.1074/jbc.M111.336537	http://dx.doi.org/10.1074/jbc.M111.336537			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570484	Green Published, hybrid			2022-12-28	WOS:000306418600010
J	Kaneko, H; Kobayashi, E; Yamamoto, M; Shimizu, R				Kaneko, Hiroshi; Kobayashi, Eri; Yamamoto, Masayuki; Shimizu, Ritsuko			N- and C-terminal Transactivation Domains of GATA1 Protein Coordinate Hematopoietic Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; UROPORPHYRINOGEN-III SYNTHASE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; ERYTHROID-SPECIFIC EXPRESSION; X-LINKED THROMBOCYTOPENIA; DNA-BINDING DOMAIN; DEFINITIVE ERYTHROPOIESIS; CHROMATIN OCCUPANCY; IN-VIVO; MEGAKARYOBLASTIC LEUKEMIA	Transcription factor GATA1 regulates the expression of a cluster of genes important for hematopoietic cell differentiation toward erythroid and megakaryocytic lineages. Three functional domains have been identified in GATA1, a transactivation domain located in the N terminus (N-TAD) and two zinc finger domains located in the middle of the molecule. Although N-TAD is known as a solitary transactivation domain for GATA1, clinical observations in Down syndrome leukemia suggest that there may be additional transactivation domains. In this study, we found in reporter co-transfection assays that transactivation activity of GATA1 was markedly reduced by deletion of the C-terminal 95 amino acids without significant attenuation of the DNA binding activity or self-association potential. We therefore generated transgenic mouse lines that expressed GATA1 lacking the C-terminal region (GATA1-Delta CT). When we crossed these transgenic mouse lines to the Gata1-deficient mouse, we found that the GATA1-Delta CT transgene rescued Gata1-deficient mice from embryonic lethality. The embryos rescued with an almost similar level of GATA1 Delta CT to endogenous GATA1 developed beyond embryonic 13.5 days, showing severe anemia with accumulation of immature erythroid cells, as was the case for the embryos rescued by endogenous levels of GATA1 lacking N-TAD (GATA1-Delta NT). Distinct sets of target genes were affected in the embryos rescued by GATA1-Delta CT and GATA1-Delta NT. We also found attenuated GATA1 function in cell cycle control of immature megakaryocytes in both lines of rescued embryos. These results thus demonstrate that GATA1 has two independent transactivation domains, N-TAD and C-TAD. Both N-TAD and C-TAD retain redundant as well as specific activities for proper hematopoiesis in vivo.	[Kaneko, Hiroshi; Kobayashi, Eri; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kaneko, Hiroshi; Kobayashi, Eri; Shimizu, Ritsuko] Tohoku Univ, Grad Sch Med, Dept Mol Hematol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University	Yamamoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	masiyamamoto@med.tohoku.ac.jp; rshimizu@med.tohoku.ac.jp	cheng, yong/I-4270-2012; Yamamoto, Masayuki/A-4873-2010; Shimizu, Ritsuko/A-4877-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Shimizu, Ritsuko/0000-0001-6672-7606	Ministry of Education, Science, Sports and Culture; Naito Foundation; Takeda Foundation; Mitsubishi Foundation; Asahi Glass Foundation; Network Medicine Global-COE program; Grants-in-Aid for Scientific Research [24659456] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Asahi Glass Foundation; Network Medicine Global-COE program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research on priority areas (to M. Y.), for scientific research (to R. S. and M. Y.), and for exploratory research (to M. Y.) from the Ministry of Education, Science, Sports and Culture, the Naito Foundation (to M. Y.), the Takeda Foundation (to R. S. and M. Y.), the Mitsubishi Foundation (to R. S. and M. Y.), the Asahi Glass Foundation (to R. S.) and the Network Medicine Global-COE program to conquest diseases.	Aizencang G, 2000, GENOMICS, V70, P223, DOI 10.1006/geno.2000.6373; Aizencang GI, 2000, J BIOL CHEM, V275, P2295, DOI 10.1074/jbc.275.4.2295; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; Ferreira R, 2007, BLOOD, V109, P5481, DOI 10.1182/blood-2006-11-060491; Freson K, 2002, HUM MOL GENET, V11, P147, DOI 10.1093/hmg/11.2.147; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Hasegawa A, 2012, BLOOD, V119, P2615, DOI 10.1182/blood-2011-09-382473; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hollanda LM, 2006, NAT GENET, V38, P807, DOI 10.1038/ng1825; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; Hosoya-Ohmura S, 2006, J BIOL CHEM, V281, P32820, DOI 10.1074/jbc.M605735200; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kinross KM, 2006, BLOOD, V108, P886, DOI 10.1182/blood-2005-09-008656; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kuhl C, 2005, MOL CELL BIOL, V25, P8592, DOI 10.1128/MCB.25.19.8592-8606.2005; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Lurie LJ, 2008, BIOCHEMISTRY-US, V47, P859, DOI 10.1021/bi701692p; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Mehaffey MG, 2001, BLOOD, V98, P2681, DOI 10.1182/blood.V98.9.2681; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Nakano M, 2005, GENES CELLS, V10, P47, DOI 10.1111/j.1365-2443.2005.00814.x; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Phillips JD, 2007, BLOOD, V109, P2618, DOI 10.1182/blood-2006-06-022848; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Roy A, 2009, BRIT J HAEMATOL, V147, P3, DOI 10.1111/j.1365-2141.2009.07789.x; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shimizu R, 2007, J BIOL CHEM, V282, P15862, DOI 10.1074/jbc.M701936200; Shimizu R, 2009, GENES CELLS, V14, P1119, DOI 10.1111/j.1365-2443.2009.01338.x; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Solis C, 2001, J CLIN INVEST, V107, P753, DOI 10.1172/JCI10642; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Takayama M, 2010, MOL CELL BIOL, V30, P2668, DOI 10.1128/MCB.01304-09; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Wassarman P. M., 1993, METHODS ENZYMOLOGY G, V225, P747; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201; Yu CN, 2002, BLOOD, V100, P2040, DOI 10.1182/blood-2002-02-0387; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21439	21449		10.1074/jbc.M112.370437	http://dx.doi.org/10.1074/jbc.M112.370437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556427	Green Published, hybrid			2022-12-28	WOS:000306416800061
J	Cook, ZC; Gray, MA; Cann, MJ				Cook, Zara C.; Gray, Michael A.; Cann, Martin J.			Elevated Carbon Dioxide Blunts Mammalian cAMP Signaling Dependent on Inositol 1,4,5-Triphosphate Receptor-mediated Ca2+ Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANYLYL CYCLASE-D; ADENYLYL-CYCLASE; CAENORHABDITIS-ELEGANS; CO2 LEVELS; OK CELLS; ACUTE HYPERCAPNIA; IP3 RECEPTORS; BICARBONATE; INHIBITION; STIMULATION	ElevatedCO(2) is generally detrimental to animal cells, suggesting an interaction with core processes in cell biology. We demonstrate that elevated CO2 blunts G protein-activated cAMP signaling. The effect of CO2 is independent of changes in intracellular and extracellular pH, independent of the mechanism used to activate the cAMP signaling pathway, and is independent of cell context. A combination of pharmacological and genetic tools demonstrated that the effect of elevated CO2 on cAMPlevels required the activity of the IP3 receptor. Consistent with these findings, CO2 caused an increase in steady state cytoplasmic Ca2+ concentrations not observed in the absence of the IP3 receptor or under nonspecific acidotic conditions. We examined the well characterized cAMP-dependent inhibition of the isoform 3 Na+/H+ antiporter (NHE3) to demonstrate a functional relevance for CO2-mediated reductions in cellular cAMP. Consistent with the cellular biochemistry, elevated CO2 abrogated the inhibitory effect of cAMP on NHE3 function via an IP3 receptor-dependent mechanism.	[Cook, Zara C.; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Biophys Sci Inst, Durham DH1 3LE, England; [Gray, Michael A.] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Durham University; Newcastle University - UK	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Biophys Sci Inst, South Rd, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Cann, Martin/G-2864-2012	Cann, Martin/0000-0001-6305-8769; GRAY, MICHAEL/0000-0002-6774-6283	Leverhulme Trust [F/00 128/AU]; Biotechnology and Biological Sciences Research Council [BB/I011994/1]; Wellcome Trust [GR083381MA]; BBSRC [BB/I011994/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Leverhulme Trust Grant F/00 128/AU, Biotechnology and Biological Sciences Research Council Grant BB/I011994/1, and Wellcome Trust Grant GR083381MA (to M. J. C.).	Adrogue H E, 2001, Respir Care, V46, P328; Alexander RT, 2009, J EXP BIOL, V212, P1630, DOI 10.1242/jeb.027375; Beerling DJ, 2002, P NATL ACAD SCI USA, V99, P7836, DOI 10.1073/pnas.122573099; Bouyer P, 2003, AM J PHYSIOL-RENAL, V285, pF674, DOI 10.1152/ajprenal.00107.2003; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chao YC, 2010, BIOCHEM J, V432, P267, DOI 10.1042/BJ20100617; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; Cundari TR, 2009, J CHEM INF MODEL, V49, P2111, DOI 10.1021/ci9002377; Gopalakrishnan P, 2011, CARDIOL REV, V19, P279, DOI 10.1097/CRD.0b013e318223bd08; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; GUNTUPALLI J, 1987, AM J PHYSIOL, V253, pF34, DOI 10.1152/ajprenal.1987.253.1.F34; GUNTUPALLI J, 1985, KIDNEY INT, V27, P116; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Hammer A, 2006, BIOCHEM J, V396, P215, DOI 10.1042/BJ20060372; Hegyi P, 2004, PANCREAS, V28, P427, DOI 10.1097/00006676-200405000-00012; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Jehle AW, 1999, AM J PHYSIOL-RENAL, V276, pF46, DOI 10.1152/ajprenal.1999.276.1.F46; Johnson MS, 2010, ECOHYDROLOGY, V3, P68, DOI 10.1002/eco.95; JOHNSON ME, 1994, J NEUROSCI, V14, P4040; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kaplan A, 2001, P NATL ACAD SCI USA, V98, P4817, DOI 10.1073/pnas.101119898; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; KOYAMA H, 1978, IN VITRO CELL DEV B, V14, P239; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Laffey JG, 1999, LANCET, V354, P1283, DOI 10.1016/S0140-6736(99)02388-0; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; Leclerc P, 1999, J ANDROL, V20, P126; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; LORIMER GH, 1983, TRENDS BIOCHEM SCI, V8, P65, DOI 10.1016/0968-0004(83)90393-6; MARTIN TJ, 1976, NATURE, V260, P436, DOI 10.1038/260436a0; Mou TC, 2009, BIOCHEMISTRY-US, V48, P3387, DOI 10.1021/bi802122k; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nichol AD, 2009, CRIT CARE MED, V37, P2953, DOI 10.1097/CCM.0b013e3181b028ce; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; Rossi A, 2011, BIOCH BIOPHYS ACTA; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Short AD, 2000, J BIOL CHEM, V275, P1807, DOI 10.1074/jbc.275.3.1807; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Townsend PD, 2009, J BIOL CHEM, V284, P784, DOI 10.1074/jbc.M807239200; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vohwinkel CU, 2011, J BIOL CHEM, V286, P37067, DOI 10.1074/jbc.M111.290056; Weinman EJ, 2001, AM J PHYSIOL-RENAL, V281, pF374, DOI 10.1152/ajprenal.2001.281.2.F374; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978; Zhou YH, 2006, AM J PHYSIOL-RENAL, V291, pF358, DOI 10.1152/ajprenal.00520.2005	61	14	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26291	26301		10.1074/jbc.M112.349191	http://dx.doi.org/10.1074/jbc.M112.349191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22654111	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000306916300055
J	Du, YM; Kong, GY; You, XN; Zhang, S; Zhang, T; Gao, Y; Ye, LH; Zhang, XD				Du, Yumei; Kong, Guangyao; You, Xiaona; Zhang, Shuai; Zhang, Tao; Gao, Yuen; Ye, Lihong; Zhang, Xiaodong			Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG NONCODING RNA; HEPATOCELLULAR-CARCINOMA; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; TILING ARRAYS; BREAST-CANCER; TUMOR-GROWTH; GENE; EXPRESSION; GENOME	Long noncoding RNAs (lncRNAs) play crucial roles in human cancers. It has been reported that lncRNA highly up-regulated in liver cancer (HULC) is dramatically up-regulated in hepatocellular carcinoma (HCC). Hepatitis B virus X protein (HBx) contributes importantly to the development of HCC. However, the function of HULC in HCC mediated by HBx remains unclear. Here, we report that HULC is involved in HBx-mediated hepatocarcinogenesis. We found that the expression levels of HULC were positively correlated with those of HBx in clinical HCC tissues. Moreover, we revealed that HBx up-regulated HULC in human immortalized normal liver L-O2 cells and hepatoma HepG2 cells. Luciferase reporter gene assay and chromatin immunoprecipitation (ChIP) assay showed that HBx activated the HULC promoter via cAMP-responsive element-binding protein. We further demonstrated that HULC promoted cell proliferation by methyl thiazolyl tetrazolium, 5-ethynyl-2'-de-oxyuridine, colony formation assay, and tumorigenicity assay. Next, we hypothesized that HULC might function through regulating a tumor suppressor gene p18 located near HULC in the same chromosome. We found that the mRNA levels of p18 were inversely correlated with those of HULC in the above clinical HCC specimens. Then, we validated that HULC down-regulated p18, which was involved in the HULC-enhanced cell proliferation in vitro and in vivo. Furthermore, we observed that knockdown of HULC could abolish the HBx-enhanced cell proliferation through up-regulating p18. Thus, we conclude that the up-regulated HULC by HBx promotes proliferation of hepatoma cells through suppressing p18. This finding provides new insight into the roles of lncRNAs in HBx-related hepatocarcinogenesis.	[Ye, Lihong] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Biochem, Tianjin 300071, Peoples R China; [Du, Yumei; Kong, Guangyao; You, Xiaona; Zhang, Shuai; Zhang, Tao; Gao, Yuen; Zhang, Xiaodong] Nankai Univ, Inst Mol Biol, Minist Educ, Dept Canc Res,Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Ye, LH (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Biochem, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Ibrahim, Essam Hassan/G-1960-2018; Kong, Guangyao/L-2162-2013; Zhang, Tao/F-4366-2018; Gao, Yuen/AAM-7541-2021	Ibrahim, Essam Hassan/0000-0003-0130-2257; Zhang, Tao/0000-0002-4749-6774; Gao, Yuen/0000-0002-2807-2976; Zhang, Shuai/0000-0003-0272-0856; You, Xiaona/0000-0001-9996-1466	National Basic Research Program of China (973 Program) [2009CB521702, 2011CB512113]; Natural Scientific Foundation of China [81071624, 81071623]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Basic Research Program of China (973 Program, Grants 2009CB521702 and 2011CB512113) and the Natural Scientific Foundation of China (Grants 81071624 and 81071623).	Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kew MC, 1997, HEPATOLOGY, V25, P1037, DOI 10.1002/hep.510250442; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Ko YG, 2002, PROTEOMICS, V2, P1304, DOI 10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kwak YT, 2011, MOL CANCER RES, V9, P341, DOI 10.1158/1541-7786.MCR-10-0248; Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Liu QY, 2011, J BIOL CHEM, V286, P17168, DOI 10.1074/jbc.M110.167783; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martin-Lluesma S, 2008, HEPATOLOGY, V48, P1467, DOI 10.1002/hep.22542; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Petrovics G, 2004, ONCOGENE, V23, P605, DOI 10.1038/sj.onc.1207069; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Waris G, 2003, J BIOSCIENCES, V28, P311, DOI 10.1007/BF02970150; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yoo YG, 2004, J BIOL CHEM, V279, P36242, DOI 10.1074/jbc.M401290200; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466	47	294	331	0	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26302	26311		10.1074/jbc.M112.342113	http://dx.doi.org/10.1074/jbc.M112.342113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22685290	Green Published, hybrid			2022-12-28	WOS:000306916300056
J	Javadi, M; Hofstatter, E; Stickle, N; Beattie, BK; Jaster, R; Carter-Su, C; Barber, DL				Javadi, Mojib; Hofstaetter, Edda; Stickle, Natalie; Beattie, Bryan K.; Jaster, Robert; Carter-Su, Christin; Barber, Dwayne L.			The SH2B1 Adaptor Protein Associates with a Proximal Region of the Erythropoietin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; EPO RECEPTOR; STAT5A(-/-)5B(-/-) MICE; ERYTHROID PROGENITORS; LYMPHOID DEVELOPMENT; GROWTH-FACTOR; IN-VIVO; ACTIVATION; JAK2; DOMAIN	Gene targeting experiments have shown that the cytokine erythropoietin (EPO), its cognate erythropoietin receptor (EPO-R), and associated Janus tyrosine kinase, JAK2, are all essential for erythropoiesis. Structural-functional and murine knock-in experiments have suggested that EPO-R Tyr-343 is important in EPO-mediated mitogenesis. Although Stat5 binds to EPO-R phosphotyrosine 343, the initial Stat5-deficient mice did not have profound erythroid abnormalities suggesting that additional Src homology 2 (SH2) domain-containing effectors may bind to EPO-R Tyr-343 and couple to downstream signaling pathways. We have utilized cloning of ligand target (COLT) screening to demonstrate that EPO-R Tyr(P)-343 and Tyr(P)-401 bind to the SH2 domain-containing adaptor protein SH2B1 beta. Immunoprecipitation and in vitro mixing experiments reveal that EPO-R binds to SH2B1 in an SH2 domain-dependent manner and that the sequence that confers SH2B1 binding to the EPO-R is pYXXL. Previous studies have shown that SH2B1 binds directly to JAK2, but we show that in hematopoietic cells, SH2B1 beta preferentially associates with the EPO-R. SH2B1 is capable of constitutive association with EPO-R, which is necessary for its optimal SH2-dependent recruitment to EPO-R-Tyr(P)-343/Tyr(P)-401. We also demonstrate that SH2B1 is responsive to EPO stimulation and becomes phosphorylated, most likely on serines/threonines, in an EPO dose-and time-dependent manner. In the absence of SH2B1, we observe enhanced activation of signaling pathways downstream of the EPO-R, indicating that SH2B1 is a negative regulator of EPO signaling.	[Javadi, Mojib; Hofstaetter, Edda; Stickle, Natalie; Beattie, Bryan K.; Barber, Dwayne L.] Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2M9, Canada; [Barber, Dwayne L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Barber, Dwayne L.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; [Jaster, Robert] Univ Rostock, Dept Gastroenterol, D-18057 Rostock, Germany; [Carter-Su, Christin] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Rostock; University of Michigan System; University of Michigan	Barber, DL (corresponding author), Ontario Canc Inst, Campbell Family Canc Res Inst, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	dbarber@uhnres.utoronto.ca		Barber, Dwayne/0000-0001-5528-8150	National Institutes of Health [RO1-DK54222]; Canadian Institutes of Health Research [MOP-13612]; Rotary International scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rotary International scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK54222 (to C. C. S.). This work was also supported by Grant MOP-13612 (to D. L. B.) from Canadian Institutes of Health Research.; Supported by a Rotary International scholarship.	BARBER DL, 1994, MOL CELL BIOL, V14, P2257, DOI 10.1128/MCB.14.4.2257; Barber DL, 2001, BLOOD, V97, P2230, DOI 10.1182/blood.V97.8.2230; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Halupa A, 2005, EXP CELL RES, V309, P1, DOI 10.1016/j.yexcr.2005.04.030; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Haq R, 2002, J BIOL CHEM, V277, P17359, DOI 10.1074/jbc.M201842200; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; Kurzer JH, 2006, MOL CELL BIOL, V26, P6381, DOI 10.1128/MCB.00570-06; Kurzer JH, 2004, MOL CELL BIOL, V24, P4557, DOI 10.1128/MCB.24.10.4557-4570.2004; Li K, 2003, BLOOD, V102, P3147, DOI 10.1182/blood-2003-01-0078; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Mason JM, 2000, J BIOL CHEM, V275, P4398, DOI 10.1074/jbc.275.6.4398; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Maures TJ, 2011, J CELL SCI, V124, P1542, DOI 10.1242/jcs.078949; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; Miller CP, 2002, BLOOD, V99, P898, DOI 10.1182/blood.V99.3.898; MIURA O, 1994, BLOOD, V84, P1501; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nishi M, 2005, MOL CELL BIOL, V25, P2607, DOI 10.1128/MCB.25.7.2607-2621.2005; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Qian XZ, 2001, MOL CELL BIOL, V21, P1613, DOI 10.1128/MCB.21.5.1613-1620.2001; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rui LY, 2000, MOL CELL BIOL, V20, P3168, DOI 10.1128/MCB.20.9.3168-3177.2000; Rui LY, 1999, J BIOL CHEM, V274, P26485, DOI 10.1074/jbc.274.37.26485; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 1997, J BIOL CHEM, V272, P14009, DOI 10.1074/jbc.272.22.14009; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; von Lindern M, 2000, J BIOL CHEM, V275, P34719, DOI 10.1074/jbc.M007042200; Wakioka T, 1999, LEUKEMIA, V13, P760, DOI 10.1038/sj.leu.2401397; Walters DK, 2005, BLOOD, V105, P2952, DOI 10.1182/blood-2004-07-2758; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156; Zhang MC, 2008, J CELL BIOCHEM, V103, P162, DOI 10.1002/jcb.21397; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	54	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26223	26234		10.1074/jbc.M112.382721	http://dx.doi.org/10.1074/jbc.M112.382721			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669948	Green Published, hybrid			2022-12-28	WOS:000306916300049
J	Wang, YJ; Li, PX; Wang, S; Hu, J; Chen, XA; Wu, JH; Fisher, M; Oshaben, K; Zhao, N; Gu, Y; Wang, D; Chen, G; Wang, YM				Wang, Yuji; Li, Pingxin; Wang, Shu; Hu, Jing; Chen, Xiangyun Amy; Wu, Jianhui; Fisher, Megan; Oshaben, Kira; Zhao, Na; Gu, Ying; Wang, Dong; Chen, Gong; Wang, Yanming			Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; ARGININE METHYLATION; GENE-EXPRESSION; P53; PROTEIN; CANCER; TRANSCRIPTION; CHROMATIN; CELLS; DEMETHYLIMINATION	Tumor suppressor genes are frequently silenced in cancer cells by enzymes catalyzing epigenetic histone modifications. The peptidylarginine deiminase family member PAD4 (also called PADI4) is markedly overexpressed in a majority of human cancers, suggesting that PAD4 is a putative target for cancer treatment. Here, we have generated novel PAD inhibitors with low micromolar IC50 in PAD activity and cancer cell growth inhibition. The lead compound YW3-56 alters the expression of genes controlling the cell cycle and cell death, including SESN2 that encodes an upstream inhibitor of the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. Guided by the gene expression profile analyses with YW3-56, we found that PAD4 functions as a corepressor of p53 to regulate SESN2 expression by histone citrullination in cancer cells. Consistent with the mTORC1 inhibition by SESN2, the phosphorylation of its substrates including p70S6 kinase (p70S6K) and 4E-BP1 was decreased. Furthermore, macroautophagy is perturbed after YW3-56 treatment in cancer cells. In a mouse xenograft model, YW3-56 demonstrates cancer growth inhibition activity with little if any detectable adverse effect to vital organs, whereas a combination of PAD4 and histone deacetylase inhibitors further decreases tumor growth. Taken together, our work found that PAD4 regulates the mTORC1 signaling pathway and that PAD inhibitors are potential anticancer reagents that activate tumor suppressor gene expression alone or in combination with histone deacetylase inhibitors.	[Wang, Yuji; Wu, Jianhui; Chen, Gong] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Wang, Yuji; Li, Pingxin; Wang, Shu; Hu, Jing; Chen, Xiangyun Amy; Wu, Jianhui; Fisher, Megan; Oshaben, Kira; Zhao, Na; Gu, Ying; Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Wang, Yuji; Wu, Jianhui] Capital Med Univ, Coll Pharmaceut Sci, Beijing 100069, Peoples R China; [Wang, Dong] Univ Nebraska, Dept Stat, Lincoln, NE 68583 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Capital Medical University; University of Nebraska System; University of Nebraska Lincoln	Chen, G (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	guc11@psu.edu; yuw12@psu.edu	Chen, Gong/A-8063-2013	Chen, Gong/0000-0002-5067-9889; Wang, Yanming/0000-0002-0710-043X	National Institutes of Health from the NCI [R01 CA136856]; Pennsylvania State University; PSU Clinical and Translation Science Institute Pilot Grant Award; NATIONAL CANCER INSTITUTE [R01CA136856] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pennsylvania State University; PSU Clinical and Translation Science Institute Pilot Grant Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA136856 (to Y. M. W.) from the NCI. This work was also supported by a start-up fund from Pennsylvania State University (to G. C.). In addition, the work was made possible by a PSU Clinical and Translation Science Institute Pilot Grant Award (to G. C. and Y. M. W.).	ALFARO G, 1992, VET IMMUNOL IMMUNOP, V30, P385, DOI 10.1016/0165-2427(92)90107-2; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Berardi DE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/595092; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BOYDE TRC, 1980, ANAL BIOCHEM, V107, P424, DOI 10.1016/0003-2697(80)90404-2; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Causey CP, 2008, TETRAHEDRON LETT, V49, P4383, DOI 10.1016/j.tetlet.2008.05.021; Causey CP, 2011, J MED CHEM, V54, P6919, DOI 10.1021/jm2008985; Chang XT, 2011, INT J BIOL SCI, V7, P769, DOI 10.7150/ijbs.7.769; Chang XT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-40; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Conaway JW, 2012, ANNU REV BIOCHEM, V81, P61, DOI 10.1146/annurev-biochem-090711-093103; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Darrah E, 2012, ANN RHEUM DIS, V71, P92, DOI 10.1136/ard.2011.151712; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Guo Q, 2011, J BIOL CHEM, V286, P17069, DOI 10.1074/jbc.M111.230961; Hao G, 2009, J AM SOC MASS SPECTR, V20, P723, DOI 10.1016/j.jasms.2008.12.012; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jones JE, 2012, ACS CHEM BIOL, V7, P160, DOI 10.1021/cb200258q; Kan R, 2011, DEV BIOL, V350, P311, DOI 10.1016/j.ydbio.2010.11.033; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakashima K, 1999, J BIOL CHEM, V274, P27786, DOI 10.1074/jbc.274.39.27786; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tanikawa C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1676; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang GG, 2009, CELL CYCLE, V8, P1982; Wang L, 2010, INT J BIOL SCI, V6, P454; Wang WJ, 2011, MOL BIOSYST, V7, P766, DOI 10.1039/c0mb00049c; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Ying SB, 2009, J DERMATOL SCI, V53, P2, DOI 10.1016/j.jdermsci.2008.09.009; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang XS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002112; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	59	105	109	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25941	25953		10.1074/jbc.M112.375725	http://dx.doi.org/10.1074/jbc.M112.375725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22605338	Green Published, hybrid			2022-12-28	WOS:000306916300022
J	Saraiva, IH; Newman, DK; Louro, RO				Saraiva, Ivo H.; Newman, Dianne K.; Louro, Ricardo O.			Functional Characterization of the FoxE Iron Oxidoreductase from the Photoferrotroph Rhodobacter ferrooxidans SW2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHEWANELLA-ONEIDENSIS MR-1; FERROUS IRON; FE(II)-OXIDIZING BACTERIA; OXIDIZING BACTERIA; EARLY EVOLUTION; OXIDATION; CYTOCHROME; PROTEINS; NMR; PHOTOSYNTHESIS	Photoferrotrophy is presumed to be an ancient type of photosynthetic metabolism in which bacteria use the reducing power of ferrous iron to drive carbon fixation. In this work the putative iron oxidoreductase of the photoferrotroph Rhodobacter ferrooxidans SW2 was cloned, purified, and characterized for the first time. This protein, FoxE, was characterized using spectroscopic, thermodynamic, and kinetic techniques. It is a c-type cytochrome that forms a trimer or tetramer in solution; the two hemes of each monomer are hexacoordinated by histidine and methionine. The hemes have positive reduction potentials that allow downhill electron transfer from many geochemically relevant ferrous iron forms to the photosynthetic reaction center. The reduction potentials of the hemes are different and are cross- assigned to fast and slow kinetic phases of ferrous iron oxidation in vitro. Lower reactivity was observed at high pH and may contribute to prevent ferric iron precipitation inside or at the surface of the cell. These results help fill in the molecular details of a metabolic process that likely contributed to the deposition of precambrian banded iron formations, globally important sedimentary rocks that are found on every continent today.	[Saraiva, Ivo H.; Louro, Ricardo O.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Newman, Dianne K.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Newman, Dianne K.] CALTECH, Howard Hughes Med Inst, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Universidade Nova de Lisboa; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Howard Hughes Medical Institute	Louro, RO (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, P-2780157 Oeiras, Portugal.	louro@itqb.unl.pt	Louro, Ricardo O./AAB-4601-2020; Saraiva, Ivo/M-6213-2013; Guo, aitong/G-5439-2012	Louro, Ricardo O./0000-0002-2392-6450; Saraiva, Ivo/0000-0002-5833-7699; 	MIT-Portugal Program [MIT-Pt/BS-BB/0014/2008]; Fundacao para a Ciencia e a Tecnologia [REEQ/336/BIO/2005, PEst-OE/EQB/LA0004/2011]; Fundacao para a Ciencia e a Tecnologia Grant [SFRH/BD/36582/2007]	MIT-Portugal Program; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia Grant	This research was supported by the MIT-Portugal Program (MIT-Pt/BS-BB/0014/2008) and Fundacao para a Ciencia e a Tecnologia (REEQ/336/BIO/2005, PEst-OE/EQB/LA0004/2011).; Recipient of Fundacao para a Ciencia e a Tecnologia Grant SFRH/BD/36582/2007.	Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bird LJ, 2011, TRENDS MICROBIOL, V19, P330, DOI 10.1016/j.tim.2011.05.001; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Catarino T, 2001, CHEMBIOCHEM, V2, P416, DOI 10.1002/1439-7633(20010601)2:6<416::AID-CBIC416>3.3.CO;2-Q; Croal LR, 2007, J BACTERIOL, V189, P1774, DOI 10.1128/JB.01395-06; Dantas JM, 2011, DALTON T, V40, P12713, DOI 10.1039/c1dt10975h; EHRENREICH A, 1994, APPL ENVIRON MICROB, V60, P4517, DOI 10.1128/AEM.60.12.4517-4526.1994; Fonseca BM, 2009, J BIOL INORG CHEM, V14, P375, DOI 10.1007/s00775-008-0455-7; FRANCIS RT, 1984, ANAL BIOCHEM, V136, P509, DOI 10.1016/0003-2697(84)90253-7; Hegler F, 2008, FEMS MICROBIOL ECOL, V66, P250, DOI 10.1111/j.1574-6941.2008.00592.x; Hegler F, 2010, FEMS MICROBIOL ECOL, V74, P592, DOI 10.1111/j.1574-6941.2010.00975.x; Heising S, 1998, MICROBIOL-SGM, V144, P2263, DOI 10.1099/00221287-144-8-2263; INUBUSHI T, 1983, J MAGN RESON, V51, P128, DOI 10.1016/0022-2364(83)90109-9; Jeffrey V., 1991, GENE, V100, P189; Kappler A, 2005, GEOLOGY, V33, P865, DOI 10.1130/G21658.1; Kappler A, 2004, GEOCHIM COSMOCHIM AC, V68, P1217, DOI 10.1016/j.gca.2003.09.006; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Louro RO, 2004, FEBS LETT, V576, P77, DOI 10.1016/j.febslet.2004.08.066; Miot J, 2009, APPL ENVIRON MICROB, V75, P5586, DOI 10.1128/AEM.00490-09; MOSER CC, 1992, BIOCHIM BIOPHYS ACTA, V1101, P171, DOI 10.1016/S0005-2728(05)80012-X; Parkhurst D.L., 1999, USERS GUIDE PHREEQC; Pessanha M, 2009, BBA-BIOENERGETICS, V1787, P113, DOI 10.1016/j.bbabio.2008.11.007; Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327; Press W, 1989, NUMERICAL RECIPES AR; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; Schadler S, 2009, GEOMICROBIOL J, V26, P93, DOI 10.1080/01490450802660573; Straub KL, 2001, FEMS MICROBIOL ECOL, V34, P181, DOI 10.1016/S0168-6496(00)00088-X; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; XAVIER AV, 1978, NATURE, V275, P245, DOI 10.1038/275245a0; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	32	25	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25541	25548		10.1074/jbc.M112.360636	http://dx.doi.org/10.1074/jbc.M112.360636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661703	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000306651700060
J	Amengual, J; Golczak, M; Palczewski, K; von Lintig, J				Amengual, Jaume; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes			Lecithin: Retinol Acyltransferase Is Critical for Cellular Uptake of Vitamin A from Serum Retinol-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; MICE LACKING; PLASMA RETINOL; KNOCKOUT MICE; ACID RECEPTOR; VISUAL CYCLE; EXPRESSION; FENRETINIDE; METABOLISM; STRA6	Vitamin A (all-trans-retinol) must be adequately distributed within the mammalian body to produce visual chromophore in the eyes and all-trans-retinoic acid in other tissues. Vitamin A is transported in the blood bound to retinol-binding protein (holo-RBP), and its target cells express an RBP receptor encoded by the Stra6 (stimulated by retinoic acid 6) gene. Here we show in mice that cellular uptake of vitamin A from holo-RBP depends on functional coupling of STRA6 with intracellular lecithin: retinol acyltransferase (LRAT). Thus, vitamin A uptake from recombinant holo-RBP exhibited by wild type mice was impaired in Lrat(-/-) mice. We further provide evidence that vitamin A uptake is regulated by all-trans-retinoic acid in non-ocular tissues of mice. When in excess, vitamin A was rapidly taken up and converted to its inert ester form in peripheral tissues, such as lung, whereas in vitamin A deficiency, ocular retinoid uptake was favored. Finally, we show that the drug fenretinide, used clinically to presumably lower blood RBP levels and thus decrease circulating retinol, targets the functional coupling of STRA6 and LRAT to increase cellular vitamin A uptake in peripheral tissues. These studies provide mechanistic insights into how vitamin A is distributed to peripheral tissues in a regulated manner and identify LRAT as a critical component of this process.	[Amengual, Jaume; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W333, 10900 Euclid Ave, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu		von Lintig, Johannes/0000-0002-2079-2143	National Institutes of Health [EY019641, EY020551]; NATIONAL EYE INSTITUTE [R01EY019641, R01EY020551, R01EY009339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019641 and EY020551.	Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Cooper JP, 2011, BRIT J PHARMACOL, V163, P1263, DOI 10.1111/j.1476-5381.2011.01310.x; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; DECENSI A, 1994, J NATL CANCER I, V86, P105, DOI 10.1093/jnci/86.2.105; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Felipe F, 2004, DIABETES, V53, P882, DOI 10.2337/diabetes.53.4.882; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; GOODMAN DS, 1965, J LIPID RES, V6, P390; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; KAISERKUPFER MI, 1986, ARCH OPHTHALMOL-CHIC, V104, P69; KAJI EH, 1993, J BIOL CHEM, V268, P22188; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Matsuura T, 1997, J NUTR, V127, P218, DOI 10.1093/jn/127.2.218; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Paik J, 2004, J NUTR, V134, p276S, DOI 10.1093/jn/134.1.276S; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; van Bennekum AM, 1999, J LIPID RES, V40, P565; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Wu LL, 2010, J LIPID RES, V51, P378, DOI 10.1194/jlr.M001222; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; ZHAO ZR, 1994, NAT IMMUN, V13, P280; Zolfaghari R, 2002, J NUTR, V132, P1160, DOI 10.1093/jn/132.6.1160	42	71	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24216	24227		10.1074/jbc.M112.353979	http://dx.doi.org/10.1074/jbc.M112.353979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637576	hybrid, Green Published			2022-12-28	WOS:000306651100016
J	Hochstatter, J; Holzel, M; Rohrmoser, M; Schermelleh, L; Leonhardt, H; Keough, R; Gonda, TJ; Imhof, A; Eick, D; Langst, G; Nemeth, A				Hochstatter, Julia; Hoelzel, Michael; Rohrmoser, Michaela; Schermelleh, Lothar; Leonhardt, Heinrich; Keough, Rebecca; Gonda, Thomas J.; Imhof, Axel; Eick, Dirk; Laengst, Gernot; Nemeth, Attila			Myb-binding Protein 1a (Mybbp1a) Regulates Levels and Processing of Pre-ribosomal RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-I TRANSCRIPTION; FACTOR TIF-IA; NUCLEAR ANTIGEN 1; SACCHAROMYCES-CEREVISIAE; NUCLEOLAR PROTEIN; MOLECULAR-CLONING; GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; YEAST; CHROMATIN	Ribosomal RNA gene transcription, co-transcriptional processing, and ribosome biogenesis are highly coordinated processes that are tightly regulated during cell growth. In this study we discovered that Mybbp1a is associated with both the RNA polymerase I complex and the ribosome biogenesis machinery. Using a reporter assay that uncouples transcription and RNA processing, we show that Mybbp1a represses rRNA gene transcription. In addition, overexpression of the protein reduces RNA polymerase I loading on endogenous rRNA genes as revealed by chromatin immunoprecipitation experiments. Accordingly, depletion of Mybbp1a results in an accumulation of the rRNA precursor in vivo but surprisingly also causes growth arrest of the cells. This effect can be explained by the observation that the modulation of Mybbp1a protein levels results in defects in pre-rRNA processing within the cell. Therefore, the protein may play a dual role in the rRNA metabolism, potentially linking and coordinating ribosomal DNA transcription and pre-rRNA processing to allow for the efficient synthesis of ribosomes.	[Hochstatter, Julia; Laengst, Gernot; Nemeth, Attila] Univ Regensburg, Biochem Ctr Regensburg, D-93053 Regensburg, Germany; [Hoelzel, Michael; Rohrmoser, Michaela; Eick, Dirk] Helmholtz Ctr Munich, Dept Mol Epigenet, D-81377 Munich, Germany; [Hoelzel, Michael; Rohrmoser, Michaela; Eick, Dirk] Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Hochstatter, Julia; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Hochstatter, Julia; Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Keough, Rebecca] Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia; [Gonda, Thomas J.] Univ Queensland Res Wing, Diamantina Inst Canc Immunol & Metab Med, Buranda, Qld 4102, Australia; [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Dept Biol, D-82152 Martinsried, Germany; [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci, D-82152 Martinsried, Germany	University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich; Flinders University South Australia; University of Queensland; University of Munich; University of Munich	Langst, G (corresponding author), Univ Regensburg, Biochem Ctr Regensburg, Univ Str 31, D-93053 Regensburg, Germany.	gernot.laengst@vkl.uni-regensburg.de; attila.nemeth@vkl.uni-regensburg.de	Schermelleh, Lothar/H-4588-2019; Imhof, Axel/AAU-5313-2021; Längst, Gernot/G-5287-2015; Leonhardt, Heinrich/B-2791-2014	Schermelleh, Lothar/0000-0002-1612-9699; Imhof, Axel/0000-0003-2993-8249; Längst, Gernot/0000-0002-8232-1179; Gonda, Thomas/0000-0002-8792-3021; Groth, Julia/0000-0002-7676-6964	Deutsche Forschungsgemeinschaft; Bayerisches Genomforschungsnetzwerk (BayGene)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerisches Genomforschungsnetzwerk (BayGene)	This work was supported by Deutsche Forschungsgemeinschaft grants (to G. L., D. E., A. I., and H. L.) and the Bayerisches Genomforschungsnetzwerk (BayGene) (to G. L.).	Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; CHRISTENSEN ME, 1992, CELL BIOL INT REP, V16, P1119, DOI 10.1016/S0309-1651(05)80038-4; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; EVERS R, 1995, EMBO J, V14, P1248, DOI 10.1002/j.1460-2075.1995.tb07108.x; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Gambe AE, 2009, FEBS LETT, V583, P1951, DOI 10.1016/j.febslet.2009.05.033; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Holmstrom TH, 2008, J BIOL CHEM, V283, P7046, DOI 10.1074/jbc.M709613200; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Hong B, 1997, MOL CELL BIOL, V17, P378, DOI 10.1128/MCB.17.1.378; Jones LC, 2002, J BIOL CHEM, V277, P22515, DOI 10.1074/jbc.M200740200; Keough R, 1999, GENOMICS, V62, P483, DOI 10.1006/geno.1999.6035; Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Li JW, 2006, EMBO J, V25, P5735, DOI 10.1038/sj.emboj.7601454; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Melnik S, 2011, NAT METHODS, V8, P963, DOI [10.1038/NMETH.1705, 10.1038/nmeth.1705]; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; MOUGEY EB, 1993, GENE DEV, V7, P1609, DOI 10.1101/gad.7.8.1609; Nadeem FK, 2006, MOL GENET GENOMICS, V276, P391, DOI 10.1007/s00438-006-0144-6; Nemeth A, 2004, NUCLEIC ACIDS RES, V32, P4091, DOI 10.1093/nar/gkh732; Nemeth A, 2008, EPIGENETICS-US, V3, P243, DOI 10.4161/epi.3.5.6913; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Perrera C, 2010, J BIOL CHEM, V285, P11775, DOI 10.1074/jbc.M109.068312; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; SCHNAPP A, 1990, EMBO J, V9, P2857, DOI 10.1002/j.1460-2075.1990.tb07475.x; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Seither P, 1996, GENOMICS, V37, P135, DOI 10.1006/geno.1996.0531; Seither P, 1997, CHROMOSOMA, V106, P216, DOI 10.1007/s004120050242; Shimizu K, 2002, P NATL ACAD SCI USA, V99, P9133, DOI 10.1073/pnas.142277999; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Tavner FJ, 1998, MOL CELL BIOL, V18, P989, DOI 10.1128/MCB.18.2.989; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Tsujii R, 2000, GENES CELLS, V5, P543, DOI 10.1046/j.1365-2443.2000.00346.x; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wu H, 2000, EMBO REP, V1, P140, DOI 10.1093/embo-reports/kvd026; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x; Yanagida M, 2004, J BIOL CHEM, V279, P1607, DOI 10.1074/jbc.M305604200; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4	69	29	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24365	24377		10.1074/jbc.M111.303719	http://dx.doi.org/10.1074/jbc.M111.303719			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645127	hybrid, Green Published			2022-12-28	WOS:000306651100031
J	Alluri, RK; Li, ZW				Alluri, Ravi K.; Li, Zhongwei			Novel One-step Mechanism for tRNA 3 '-End Maturation by the Exoribonuclease RNase R of Mycoplasma genitalium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; PHYLOGENETIC DISTRIBUTION; BACILLUS-SUBTILIS; STABLE RNAS; PRECURSORS; DEGRADATION	Mycoplasma genitalium is expected to metabolize RNA using unique pathways because its minimal genome encodes very few ribonucleases. In this work, we report that the only exoribonuclease identified in M. genitalium, RNase R, is able to remove tRNA 3'-trailers and generate mature 3'-ends. Several sequence and structural features of a tRNA precursor determine its precise processing at the 3'-end by RNase R in a purified system. The aminoacyl-acceptor stem plays a major role in stopping RNase R digestion at the mature 3'-end. Disruption of the stem causes partial or complete degradation of the pre-tRNA by RNase R, whereas extension of the stem results in the formation of a product terminating downstream at the new mature 3'-end. In addition, the 3'-terminal CCA sequence and the discriminator residue influence the ability of RNase R to stop at the mature 3'-end. RNase R-mediated generation of the mature 3'-end prefers a sequence of RCCN at the 3' terminus of tRNA. Variations of this sequence may cause RNase R to trim further and remove terminal CA residues from the mature 3'-end. Therefore, M. genitalium RNase R can precisely remove the 3'-trailer of a tRNA precursor by recognizing features in the terminal domains of tRNA, a process requiring multiple RNases in most bacteria.	[Alluri, Ravi K.; Li, Zhongwei] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Li, ZW (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, 777 Glades Rd,BC71, Boca Raton, FL 33431 USA.	zli@fau.edu			National Institutes of Health [S06-GM073621, GM097693]; Florida Atlantic University; Florida Atlantic University Integrated Biology Ph.D. Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM073621, R15GM097693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Atlantic University; Florida Atlantic University Integrated Biology Ph.D. Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants S06-GM073621 and GM097693 (to Z. L.). This work was also supported by a new project development grant from Florida Atlantic University.; Supported by the Florida Atlantic University Integrated Biology Ph.D. Program.	Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Coburn GA, 1996, J BIOL CHEM, V271, P1048, DOI 10.1074/jbc.271.2.1048; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Kikovska E, 2005, NUCLEIC ACIDS RES, V33, P2012, DOI 10.1093/nar/gki344; Lalonde M. S., 2006, THESIS FLORIDA ATLAN; Lalonde MS, 2007, RNA, V13, P1957, DOI 10.1261/rna.706207; Li Z., 2004, ESCHERICHIA COLI SAL; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 2005, RNA, V11, P567, DOI 10.1261/rna.7287505; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; LI ZW, 1994, J BIOL CHEM, V269, P6064; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Maes A, 2012, MOL MICROBIOL, V83, P436, DOI 10.1111/j.1365-2958.2011.07943.x; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Mohanty BK, 2010, NUCLEIC ACIDS RES, V38, P597, DOI 10.1093/nar/gkp997; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Zuo YH, 2002, J BIOL CHEM, V277, P50155, DOI 10.1074/jbc.M207706200; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	25	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23427	23433		10.1074/jbc.M111.324970	http://dx.doi.org/10.1074/jbc.M111.324970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605341	Green Published, hybrid			2022-12-28	WOS:000306511300015
J	Sanyal, S; Claessen, JHL; Ploegh, HL				Sanyal, Sumana; Claessen, Jasper H. L.; Ploegh, Hidde L.			A Viral Deubiquitylating Enzyme Restores Dislocation of Substrates from the Endoplasmic Reticulum (ER) in Semi-intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HEAVY-CHAINS; PROTEIN DISLOCATION; RETRO-TRANSLOCATION; DEGRADATION; COMPLEX; CYTOSOL; TRANSPORT; RETROTRANSLOCATION; GLYCOPROTEIN; PROTEASOME	Terminally misfolded glycoproteins are ejected from the endoplasmic reticulum (ER) to the cytosol and are destroyed by the ubiquitin proteasome system. A dominant negative version of the deubiquitylating enzyme Yod1 (Yod1C160S) causes accumulation of dislocation substrates in the ER. Failure to remove ubiquitin from the dislocation substrate might therefore stall the reaction at the exit site from the ER. We hypothesized that addition of a promiscuous deubiquitylase should overcome this blockade and restore dislocation. We monitored ER-to-cytosol transport of misfolded proteins in cells permeabilized at high cell density by perfringolysin O, a pore-forming cytolysin. This method allows ready access of otherwise impermeant reagents to the intracellular milieu with minimal dilution of cytoplasmic components. We show that addition of the purified Epstein-Barr virus deubiquitylase to semi-intact cells indeed initiates dislocation of a stalled substrate intermediate, resulting in stabilization of substrates in the cytosol. Our data provide new mechanistic insight in the dislocation reaction and support a model where failure to deubiquitylate an ER-resident protein occludes the dislocon and causes upstream misfolded intermediates to accumulate.	[Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Sanyal, Sumana/AAF-5155-2020; Sanyal, Sumana/I-7975-2013	Sanyal, Sumana/0000-0002-6230-5366	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants (to H. L. P.).	BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nelson LD, 2010, BIOPHYS J, V99, P3255, DOI 10.1016/j.bpj.2010.09.028; Olzmann JA, 2011, J BIOL CHEM, V286, P27872, DOI 10.1074/jbc.C111.266452; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	32	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23594	23603		10.1074/jbc.M112.365312	http://dx.doi.org/10.1074/jbc.M112.365312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619172	hybrid, Green Published			2022-12-28	WOS:000306511300030
J	Zhao, T; Huang, XH; Han, L; Wang, XH; Cheng, HQ; Zhao, YG; Chen, Q; Chen, J; Cheng, HP; Xiao, RP; Zheng, M				Zhao, Ting; Huang, Xiaohu; Han, Liang; Wang, Xianhua; Cheng, Hongqiang; Zhao, Yungang; Chen, Quan; Chen, Ju; Cheng, Heping; Xiao, Ruiping; Zheng, Ming			Central Role of Mitofusin 2 in Autophagosome-Lysosome Fusion in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FUSION; ISCHEMIA/REPERFUSION INJURY; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; PROTEIN; GTPASE; MUSCLE; ACCUMULATION; MEMBRANES; HEART	In the heart, autophagy has been implicated in cardioprotection and ischemia-reperfusion tolerance, and the dysregulation of autophagy is associated with the development of heart failure. Mitochondrial dynamic proteins are profoundly involved in autophagic processes, especially the initiation and formation of autophagosomes, but it is not clear whether they play any role in cardiac autophagy. We previously reported that mitofusin 2 (MFN2), a mitochondrial outer membrane protein, serves as a major determinant of cardiomyocyte apoptosis mediated by oxidative stress. Here, we reveal a novel and essential role of MFN2 in mediating cardiac autophagy. We found that specific deletion of MFN2 in cardiomyocytes caused extensive accumulation of autophagosomes. In particular, the fusion of autophagosomes with lysosomes, a critical step in autophagic degradation, was markedly retarded without altering the formation of autophagosomes and lysosomes in response to ischemia-reperfusion stress. Importantly, MFN2 co-immunoprecipitated with RAB7 in the heart, and starvation further increased it. Knockdown of MFN2 by shRNA prevented, whereas re-expression of MFN2 restored, the autophagosome-lysosome fusion in neonatal cardiomyocytes. Hearts from cardiac-specific MFN2 knockout mice had abnormal mitochondrial and cellular metabolism and were vulnerable to ischemia-reperfusion challenge. Our study defined a novel and essential role of MFN2 in the cardiac autophagic process by mediating the maturation of autophagy at the phase of autophagosome-lysosome fusion; deficiency of MFN2 caused multiple molecular and functional defects that undermined cardiac reserve and gradually led to cardiac vulnerability and dysfunction.	[Zhao, Ting; Huang, Xiaohu; Han, Liang; Wang, Xianhua; Zhao, Yungang; Cheng, Heping; Xiao, Ruiping; Zheng, Ming] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Cheng, Hongqiang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chen, Quan] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Peking University; University of California System; University of California San Diego; Chinese Academy of Sciences; Institute of Zoology, CAS	Zheng, M (corresponding author), Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	zhengm@pku.edu.cn	Chen, Ju/E-5579-2011; Huang, Xiaohu/R-2399-2017; cheng, heping/A-7299-2011; Yimei, Wang/AAE-4083-2019; Xiao, Rui-Ping/AAE-2629-2019; Heping, Cheng/AAE-2680-2019; Huang, Xiaohu/H-6446-2019	Huang, Xiaohu/0000-0003-4580-4582; Heping, Cheng/0000-0002-9604-6702; Huang, Xiaohu/0000-0003-4580-4582; Chen, Quan/0000-0001-7539-8728; Cheng, Hongqiang/0000-0001-9662-1570	National Science Foundation of China [30770870, 30971062]; National Key Basic Research Program of China [2007CB512100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066100] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Science Foundation of China Grants 30770870 and 30971062 and National Key Basic Research Program of China Grant 2007CB512100.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; BING RJ, 1954, AM J MED, V16, P504, DOI 10.1016/0002-9343(54)90365-4; Birkedal R, 2006, AM J PHYSIOL-CELL PH, V291, pC1148, DOI 10.1152/ajpcell.00236.2006; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McEwan DG, 2010, CELL, V141, P564, DOI 10.1016/j.cell.2010.04.030; Minamisawa S, 1999, J BIOL CHEM, V274, P10066, DOI 10.1074/jbc.274.15.10066; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Sciarretta S, 2011, PEDIATR CARDIOL, V32, P275, DOI 10.1007/s00246-010-9855-x; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stroikin Y, 2004, EUR J CELL BIOL, V83, P583, DOI 10.1078/0171-9335-00433; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zheng M, 2010, J MOL MED, V88, P987, DOI 10.1007/s00109-010-0675-5; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	60	142	150	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23615	23625		10.1074/jbc.M112.379164	http://dx.doi.org/10.1074/jbc.M112.379164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619176	Green Published, hybrid			2022-12-28	WOS:000306511300032
J	Feng, CZ; Zuo, ZY				Feng, Chenzhuo; Zuo, Zhiyi			Regulatory Factor X1-induced Down-regulation of Transforming Growth Factor beta 2 Transcription in Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR ANTIGEN; PROTEIN-KINASE; FACTOR X1; TGF-BETA; EXPRESSION; RFX1; GENE; IDENTIFICATION; PROMOTER; MATURE	Regulatory factor X (RFX) proteins are transcription factors. Seven mammalian RFX proteins have been identified. RFX1 is the prototype RFX. However, its biological functions are not known. Here, RFX1 overexpression reduced fetal bovine serum-stimulated proliferation of SH-SY5Y cells, a human neuroblastoma cell line. This inhibition is associated with decreased transforming growth factor beta 2 (TGF beta 2) and phospho-extracellular signal-regulated kinase (ERK). Exogenous TGF beta 2 increased cell proliferation and phospho-ERK in cells overexpressing RFX1. An anti-TGF beta 2 antibody and PD98059, an ERK activation inhibitor, inhibited SH-SY5Y cell proliferation. TGF beta 2 promoter activity was decreased in cells overexpressing RFX1. Chromosome immunoprecipitation assay showed that RFX1 bound the TGF beta 2 promoter. RFX1 down-regulation increased TGF beta 2 in SH-SY5Y and HCN-1A cells, a normal human neuronal cell line. More importantly, TGF beta 2 concentrations were negatively correlated with RFX1 levels in human medulloblastoma tissues with a R-2 of 0.464. These results suggest that RFX1 reduces cell proliferation through inhibiting the TGF beta 2-ERK signaling pathway. RFX1 blocks TGF beta 2 expression through its direct action on TGF beta 2 transcription. This effect also appears in human brain tumor tissues. Because TGF beta is known to be involved in cancer development, our results provide initial evidence to suggest that RFX1 may play an important role in human tumor biology.	[Feng, Chenzhuo; Zuo, Zhiyi] Univ Virginia, Sch Med, Dept Anesthesiol, Charlottesville, VA 22908 USA	University of Virginia	Zuo, ZY (corresponding author), 1 Hosp Dr,POB 800710, Charlottesville, VA 22908 USA.	zz3c@virginia.edu	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	National Institutes of Health [R01 GM065211]; International Anesthesia Research Society (Frontiers in Anesthesia Research Award, Cleveland, OH); American Heart Association Mid-Atlantic Affiliate, Baltimore, MD [10GRNT3900019]; Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Anesthesia Research Society (Frontiers in Anesthesia Research Award, Cleveland, OH); American Heart Association Mid-Atlantic Affiliate, Baltimore, MD(American Heart Association); Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065211 (to Z. Z.), a International Anesthesia Research Society (2007 Frontiers in Anesthesia Research Award, Cleveland, OH (to Z. Z.), Grant-in-Aid 10GRNT3900019 from the American Heart Association Mid-Atlantic Affiliate, Baltimore, MD(to Z. Z.), and the Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Bickler PE, 2006, ANESTH ANALG, V103, P419, DOI 10.1213/01.ane.0000223671.49376.b2; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Chen L, 2000, J BIOL CHEM, V275, P32227, DOI 10.1074/jbc.M002645200; Clausen BE, 1998, IMMUNITY, V8, P143, DOI 10.1016/S1074-7613(00)80467-7; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; ECKENSTEIN FP, 1994, PROG BRAIN RES, V103, P55; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Feng CZ, 2011, FEBS LETT, V585, P2488, DOI 10.1016/j.febslet.2011.06.032; Feng CZ, 2011, FOLIA HISTOCHEM CYTO, V49, P344, DOI 10.5603/FHC.2011.0047; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Ma KW, 2006, J BIOL CHEM, V281, P21250, DOI 10.1074/jbc.M600521200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Ohashi Y, 2004, ONCOGENE, V23, P7772, DOI 10.1038/sj.onc.1208058; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Watts JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002277; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhai YS, 2008, EUR J PHARMACOL, V587, P196, DOI 10.1016/j.ejphar.2008.03.006	23	23	27	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22730	22739		10.1074/jbc.M111.338590	http://dx.doi.org/10.1074/jbc.M111.338590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582395	Green Published, hybrid			2022-12-28	WOS:000306495000030
J	Maesako, M; Uemura, K; Kubota, M; Kuzuya, A; Sasaki, K; Hayashida, N; Asada-Utsugi, M; Watanabe, K; Uemura, M; Kihara, T; Takahashi, R; Shimohama, S; Kinoshita, A				Maesako, Masato; Uemura, Kengo; Kubota, Masakazu; Kuzuya, Akira; Sasaki, Kazuki; Hayashida, Naoko; Asada-Utsugi, Megumi; Watanabe, Kiwamu; Uemura, Maiko; Kihara, Takeshi; Takahashi, Ryosuke; Shimohama, Shun; Kinoshita, Ayae			Exercise Is More Effective than Diet Control in Preventing High Fat Diet-induced beta-Amyloid Deposition and Memory Deficit in Amyloid Precursor Protein Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMER-DISEASE; COGNITIVE IMPAIRMENT; SYNAPTIC PLASTICITY; MEDITERRANEAN DIET; RISK; DEMENTIA; MIDLIFE; ROSIGLITAZONE; EXPRESSION; OBESITY	Accumulating evidence suggests that some dietary patterns, specifically high fat diet (HFD), increase the risk of developing sporadic Alzheimer disease (AD). Thus, interventions targeting HFD-induced metabolic dysfunctions may be effective in preventing the development of AD. We previously demonstrated that amyloid precursor protein (APP)-overexpressing transgenic mice fed HFD showed worsening of cognitive function when compared with control APP mice on normal diet. Moreover, we reported that voluntary exercise ameliorates HFD-induced memory impairment and beta-amyloid (A beta) deposition. In the present study, we conducted diet control to ameliorate the metabolic abnormality caused by HFD on APP transgenic mice and compared the effect of diet control on cognitive function with that of voluntary exercise as well as that of combined (diet control plus exercise) treatment. Surprisingly, we found that exercise was more effective than diet control, although both exercise and diet control ameliorated HFD-induced memory deficit and A beta deposition. The production of A beta was not different between the exercise-and the diet control-treated mice. On the other hand, exercise specifically strengthened the activity of neprilysin, the A beta-degrading enzyme, the level of which was significantly correlated with that of deposited A beta in our mice. Notably, the effect of the combination treatment (exercise and diet control) on memory and amyloid pathology was not significantly different from that of exercise alone. These studies provide solid evidence that exercise is a useful intervention to rescue HFD-induced aggravation of cognitive decline in transgenic model mice of AD.	[Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Uemura, Kengo; Kuzuya, Akira; Watanabe, Kiwamu; Uemura, Maiko; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Shimohama, Shun] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido 0608556, Japan	Kyoto University; Kyoto University; Sapporo Medical University	Kinoshita, A (corresponding author), Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, 53 Shogoinkawahara Cho, Kyoto 6068507, Japan.	akinoshita@hs.med.kyoto-u.ac.jp	Uemura, Maiko/L-7293-2016	Uemura, Maiko/0000-0001-8356-1409	Kyoto University; Ministry of Education, Culture, Sports, Science and Technology [23591243]; Takeda Science Foundation	Kyoto University; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	The work was financially supported by a Core Backup Stage Grant from Kyoto University (to A. Kinoshita), Grant-in-Aid 23591243 from the Ministry of Education, Culture, Sports, Science and Technology (to K. U.) and a research grant from the Takeda Science Foundation (to K. U.).	Finder VH, 2010, J ALZHEIMERS DIS, V22, pS5, DOI 10.3233/JAD-2010-100975; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Ho AJ, 2010, NEUROBIOL AGING, V31, P1326, DOI 10.1016/j.neurobiolaging.2010.04.006; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Kitaguchi H, 2009, BRAIN RES, V1294, P202, DOI 10.1016/j.brainres.2009.07.078; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; Maesako M, 2011, J BIOL CHEM, V286, P25309, DOI 10.1074/jbc.M111.248922; Magkos F, 2009, ANNU REV NUTR, V29, P223, DOI 10.1146/annurev-nutr-080508-141200; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Panza F, 2006, J AM GERIATR SOC, V54, P1963, DOI 10.1111/j.1532-5415.2006.00988.x; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Scarmeas N, 2007, NEUROLOGY, V69, P1084, DOI 10.1212/01.wnl.0000277320.50685.7c; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1239, DOI 10.1001/archneurol.2011.203; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Solfrizzi V, 2003, J NEURAL TRANSM, V110, P95, DOI 10.1007/s00702-002-0766-8; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3	35	98	99	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23024	23033		10.1074/jbc.M112.367011	http://dx.doi.org/10.1074/jbc.M112.367011			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22563077	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000306495000059
J	Duxin, JP; Moore, HR; Sidorova, J; Karanja, K; Honaker, Y; Dao, B; Piwnica-Worms, H; Campbell, JL; Monnat, RJ; Stewart, SA				Duxin, Julien P.; Moore, Hayley R.; Sidorova, Julia; Karanja, Kenneth; Honaker, Yuchi; Dao, Benjamin; Piwnica-Worms, Helen; Campbell, Judith L.; Monnat, Raymond J., Jr.; Stewart, Sheila A.			Okazaki Fragment Processing-independent Role for Human Dna2 Enzyme during DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE DNA2; YEAST DNA2; END-RESECTION; TELOMERE STABILITY; ENDONUCLEASE ACTIVITIES; FLAP ENDONUCLEASE-1; POLYMERASE-ALPHA; GENOME STABILITY; XENOPUS DNA2; LIGASE I	Dna2 is an essential helicase/nuclease that is postulated to cleave long DNA flaps that escape FEN1 activity during Okazaki fragment (OF) maturation in yeast. We previously demonstrated that the human Dna2 orthologue (hDna2) localizes to the nucleus and contributes to genomic stability. Here we investigated the role hDna2 plays in DNA replication. We show that Dna2 associates with the replisome protein And-1 in a cell cycle-dependent manner. Depletion of hDna2 resulted in S/G(2) phase-specific DNA damage as evidenced by increased gamma-H2AX, replication protein A foci, and Chk1 kinase phosphorylation, a readout for activation of the ATR-mediated S phase checkpoint. In addition, we observed reduced origin firing in hDna2-depleted cells consistent with Chk1 activation. We next examined the impact of hDna2 on OF maturation and replication fork progression in human cells. As expected, FEN1 depletion led to a significant reduction in OF maturation. Strikingly, the reduction in OF maturation had no impact on replication fork progression, indicating that fork movement is not tightly coupled to lagging strand maturation. Analysis of hDna2-depleted cells failed to reveal a defect in OF maturation or replication fork progression. Prior work in yeast demonstrated that ectopic expression of FEN1 rescues Dna2 defects. In contrast, we found that FEN1 expression in hDna2-depleted cells failed to rescue genomic instability. These findings suggest that the genomic instability observed in hDna2-depleted cells does not arise from defective OF maturation and that hDna2 plays a role in DNA replication that is distinct from FEN1 and OF maturation.	[Duxin, Julien P.; Moore, Hayley R.; Honaker, Yuchi; Dao, Benjamin; Piwnica-Worms, Helen; Stewart, Sheila A.] Dept Cell Biol & Physiol, St Louis, MO USA; [Duxin, Julien P.; Moore, Hayley R.; Honaker, Yuchi; Dao, Benjamin; Piwnica-Worms, Helen; Stewart, Sheila A.] BRIGHT Inst, St Louis, MO USA; [Sidorova, Julia; Monnat, Raymond J., Jr.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Karanja, Kenneth; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA; [Piwnica-Worms, Helen; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Med, St Louis, MO USA	University of Washington; University of Washington Seattle; California Institute of Technology; Washington University (WUSTL)	Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	sheila.stewart@wustl.edu	Piwnica-Worms, Helen/C-5214-2012; Stewart, Sheila A/C-5213-2012	Stewart, Sheila/0000-0002-2260-9576; Sidorova, Julia/0000-0001-5502-4323	National Institutes of Health [GM95924, GM04701, GM04707, P01 CA77852, GM078666]; Department of Defense Grant [CDMRP 09-0-0041]; Cancer Biology Pathway, Siteman Cancer Center at Barnes-Jewish Hospital; Washington University School of Medicine in St Louis; NATIONAL CANCER INSTITUTE [P01CA077852, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078666, R01GM095924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Grant(United States Department of Defense); Cancer Biology Pathway, Siteman Cancer Center at Barnes-Jewish Hospital; Washington University School of Medicine in St Louis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM95924 (to S. A. S.), GM04701 and GM04707 (to H. P.-W.), P01 CA77852 (to R. J. M.), and GM078666 (to J. L. C.). This work was also supported by the Department of Defense Grant CDMRP 09-0-0041, Cancer Biology Pathway, Siteman Cancer Center at Barnes-Jewish Hospital, and Washington University School of Medicine in St Louis (to J. P. D. and H. R. M.).	Araki Y, 2003, GENES CELLS, V8, P465, DOI 10.1046/j.1365-2443.2003.00648.x; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Das-Bradoo S, 2010, CELL CYCLE, V9, P3674, DOI 10.4161/cc.9.18.13121; Das-Bradoo S, 2010, NAT CELL BIOL, V12, P74, DOI 10.1038/ncb2007; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Formosa T, 1999, GENETICS, V151, P1459; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Jackman J, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0803s00; Kang HY, 2000, GENETICS, V155, P1055; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kohn EA, 2003, CANCER RES, V63, P31; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Liu QQ, 2000, J BIOL CHEM, V275, P1615, DOI 10.1074/jbc.275.3.1615; Mackenney VJ, 1997, J BIOL CHEM, V272, P11550; Mandahl N, 1998, CANCER GENET CYTOGEN, V103, P25, DOI 10.1016/S0165-4608(97)00268-9; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Murante RS, 1998, P NATL ACAD SCI USA, V95, P2244, DOI 10.1073/pnas.95.5.2244; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Peng G., 2012, CANC RES IN PRESS; Pike JE, 2010, J BIOL CHEM, V285, P41712, DOI 10.1074/jbc.M110.146894; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Saharia A, 2009, ONCOGENE, V28, P1162, DOI 10.1038/onc.2008.458; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Saharia A, 2010, J BIOL CHEM, V285, P27057, DOI 10.1074/jbc.M110.112276; Shi W, 2010, CARCINOGENESIS, V31, P994, DOI 10.1093/carcin/bgq035; Sidorova JM, 2009, NAT PROTOC, V4, P849, DOI 10.1038/nprot.2009.54; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Wawrousek KE, 2010, CELL CYCLE, V9, P1156, DOI 10.4161/cc.9.6.11049; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	61	43	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21980	21991		10.1074/jbc.M112.359018	http://dx.doi.org/10.1074/jbc.M112.359018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570476	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000306418600037
J	Zuo, DY; Bzdega, T; Olszewski, RT; Moffett, JR; Neale, JH				Zuo, Daiying; Bzdega, Tomasz; Olszewski, Rafal T.; Moffett, John R.; Neale, Joseph H.			Effects of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibition on Release of Glutamate and Dopamine in Prefrontal Cortex and Nucleus Accumbens in Phencyclidine Model of Schizophrenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MGLU2/3 RECEPTOR AGONIST; D-ASPARTATE RECEPTORS; CARBOXYPEPTIDASE-II; ACETYLASPARTATE IMMUNOREACTIVITIES; ANIMAL-MODELS; IN-VIVO; MGLUR3; LY379268; POTENT; GRM3	The "glutamate" theory of schizophrenia emerged from the observation that phencyclidine (PCP), an open channel antagonist of the NMDA subtype of glutamate receptor, induces schizophrenia-like behaviors in humans. PCP also induces a complex set of behaviors in animal models of this disorder. PCP also increases glutamate and dopamine release in the medial prefrontal cortex and nucleus accumbens, brain regions associated with expression of psychosis. Increased motor activation is among the PCP-induced behaviors that have been widely validated as models for the characterization of new antipsychotic drugs. The peptide transmitter N-acetylaspartylglutamate (NAAG) activates a group II metabotropic receptor, mGluR3. Polymorphisms in this receptor have been associated with schizophrenia. Inhibitors of glutamate carboxypeptidase II, an enzyme that inactivates NAAG following synaptic release, reduce several behaviors induced by PCP in animal models. This research tested the hypothesis that two structurally distinct NAAG peptidase inhibitors, ZJ43 and 2-(phosphonomethyl)-pentane- 1,5-dioic acid, would elevate levels of synaptically released NAAG and reduce PCP-induced increases in glutamate and dopamine levels in the medial prefrontal cortex and nucleus accumbens. NAAG-like immunoreactivity was found in neurons and presumptive synaptic endings in both regions. These peptidase inhibitors reduced the motor activation effects of PCP while elevating extracellular NAAG levels. They also blocked PCP-induced increases in glutamate but not dopamine or its metabolites. The mGluR2/3 antagonist LY341495 blocked these behavioral and neurochemical effects of the peptidase inhibitors. The data reported here provide a foundation for assessment of the neurochemical mechanism through which NAAG achieves its antipsychotic-like behavioral effects and support the conclusion NAAG peptidase inhibitors warrant further study as a novel antipsychotic therapy aimed at mGluR3.	[Zuo, Daiying; Bzdega, Tomasz; Olszewski, Rafal T.; Neale, Joseph H.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Zuo, Daiying] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China; [Moffett, John R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Neurosci Program, Bethesda, MD 20014 USA	Georgetown University; Shenyang Pharmaceutical University; Uniformed Services University of the Health Sciences - USA	Neale, JH (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	nealej@georgetown.edu			National Institutes of Health [R01 MH 79983]; Nancy and Daniel Paduano; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy and Daniel Paduano; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 MH 79983. This work was also supported by an endowment and generous gifts from Nancy and Daniel Paduano. The patent for ZJ43 is held by Georgetown University, but the authors have no proprietary interest in this compound.	Adams BW, 2001, BIOL PSYCHIAT, V50, P750, DOI 10.1016/S0006-3223(01)01195-7; Adedoyin MO, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-60; Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Arun P, 2008, J NEUROCHEM, V106, P1669, DOI 10.1111/j.1471-4159.2008.05524.x; Baune BT, 2010, GENES BRAIN BEHAV, V9, P459, DOI 10.1111/j.1601-183X.2010.00573.x; Berger UV, 1999, J COMP NEUROL, V415, P52, DOI 10.1002/(SICI)1096-9861(19991206)415:1<52::AID-CNE4>3.0.CO;2-K; Bondi C, 2012, CURR PHARM DESIGN, V18, P1593, DOI 10.2174/138161212799958576; Carlsson Arvid, 2006, Dialogues Clin Neurosci, V8, P137; Cartmell J, 1999, J PHARMACOL EXP THER, V291, P161; Cartmell J, 2000, PSYCHOPHARMACOLOGY, V148, P423, DOI 10.1007/s002130050072; Cartmell J, 2000, EUR J PHARMACOL, V400, P221, DOI 10.1016/S0014-2999(00)00423-4; CASSIDY M, 1993, NEUROPEPTIDES, V24, P271, DOI 10.1016/0143-4179(93)90015-3; Deutsch SI, 2002, EUR J PHARMACOL, V449, P121, DOI 10.1016/S0014-2999(02)02041-1; DiIorio P, 1996, J NEUROCHEM, V67, P302; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; FUHRMAN S, 1994, J NEUROCHEM, V62, P275; Gregory KJ, 2011, NEUROPHARMACOLOGY, V60, P66, DOI 10.1016/j.neuropharm.2010.07.007; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Karch S., 2012, CURR PHARM IN PRESS; Katayama T, 2007, NEUROSCIENCE, V150, P442, DOI 10.1016/j.neuroscience.2007.09.007; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Kinon BJ, 2011, J CLIN PSYCHOPHARM, V31, P349, DOI 10.1097/JCP.0b013e318218dcd5; Kozikowski AP, 2004, J MED CHEM, V47, P1729, DOI 10.1021/jm0306226; Makoff A, 1996, MOL BRAIN RES, V40, P55, DOI 10.1016/0169-328X(96)00037-X; Mikell CB, 2009, STEREOT FUNCT NEUROS, V87, P256, DOI 10.1159/000225979; MOFFETT JR, 1993, J HISTOCHEM CYTOCHEM, V41, P559, DOI 10.1177/41.4.8450195; MOFFETT JR, 1995, J NEUROCYTOL, V24, P409, DOI 10.1007/BF01181604; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Ninan I, 2003, NEUROPHARMACOLOGY, V44, P462, DOI 10.1016/S0028-3908(03)00033-9; Olszewski RT, 2008, BIOL PSYCHIAT, V63, P86, DOI 10.1016/j.biopsych.2007.04.016; Olszewski RT, 2012, SCHIZOPHR RES, V136, P160, DOI 10.1016/j.schres.2012.01.007; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pehrson AL, 2010, PSYCHOPHARMACOLOGY, V211, P443, DOI 10.1007/s00213-010-1914-8; Profaci CP, 2011, PSYCHOPHARMACOLOGY, V216, P235, DOI 10.1007/s00213-011-2200-0; Rorick-Kehn LM, 2007, J PHARMACOL EXP THER, V321, P308, DOI 10.1124/jpet.106.110809; ROWLEY HL, 1995, J NEUROSCI METH, V57, P93, DOI 10.1016/0165-0270(94)00132-Z; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; Sartorius LJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2626, DOI 10.1038/sj.npp.1301669; Schlumberger C, 2009, BEHAV PHARMACOL, V20, P56, DOI 10.1097/FBP.0b013e3283242f57; Sebban C, 2002, BRIT J PHARMACOL, V135, P65, DOI 10.1038/sj.bjp.0704451; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Takatsu Y, 2011, BRAIN RES, V1371, P82, DOI 10.1016/j.brainres.2010.11.048; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; WILLIAMSON LC, 1988, BRAIN RES, V456, P375, DOI 10.1016/0006-8993(88)90243-0; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; Wroblewska B, 2006, J NEUROCHEM, V96, P1071, DOI 10.1111/j.1471-4159.2005.03569.x; Wroblewska B, 2011, NEUROCHEM INT, V58, P176, DOI 10.1016/j.neuint.2010.11.012; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Yamamoto T, 2007, EUR J NEUROSCI, V25, P147, DOI 10.1111/j.1460-9568.2006.05272.x; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903	62	38	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21773	21782		10.1074/jbc.M112.363226	http://dx.doi.org/10.1074/jbc.M112.363226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570482	Green Published, hybrid			2022-12-28	WOS:000306418600019
J	Dharmarajan, V; Lee, JH; Patel, A; Skalnik, DG; Cosgrove, MS				Dharmarajan, Venkatasubramanian; Lee, Jeong-Heon; Patel, Anamika; Skalnik, David G.; Cosgrove, Michael S.			Structural Basis for WDR5 Interaction (Win) Motif Recognition in Human SET1 Family Histone Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED LINEAGE LEUKEMIA; PARTIAL TANDEM DUPLICATION; ACUTE MYELOID-LEUKEMIA; H3 LYSINE-4; SACCHAROMYCES-CEREVISIAE; MOLECULAR RECOGNITION; STRUCTURE VALIDATION; TRITHORAX FAMILY; METHYLATION; PROTEIN	Translocations and amplifications of the mixed lineage leukemia-1 (MLL1) gene are associated with aggressive myeloid and lymphocytic leukemias in humans. MLL1 is a member of the SET1 family of histone H3 lysine 4 (H3K4) methyltransferases, which are required for transcription of genes involved in hema-topoiesis and development. MLL1 associates with a subcomplex containing WDR5, RbBP5, Ash2L, and DPY-30 (WRAD), which together form the MLL1 core complex that is required for sequential mono- and dimethylation of H3K4. We previously demonstrated that WDR5 binds the conserved WDR5 interaction (Win) motif of MLL1 in vitro, an interaction that is required for the H3K4 dimethylation activity of the MLL1 core complex. In this investigation, we demonstrate that arginine 3765 of the MLL1 Win motif is required to co-immunoprecipitate WRAD from mammalian cells, suggesting that the WDR5-Win motif interaction is important for the assembly of the MLL1 core complex in vivo. We also demonstrate that peptides that mimic SET1 family Win motif sequences inhibit H3K4 dimethylation by the MLL1 core complex with varying degrees of efficiency. To understand the structural basis for these differences, we determined structures of WDR5 bound to six different naturally occurring Win motif sequences at resolutions ranging from 1.9 to 1.2 angstrom. Our results reveal that binding energy differences result from interactions between non-conserved residues C-terminal to the Win motif and to a lesser extent from subtle variation of residues within the Win motif. These results highlight a new class of methylation inhibitors that may be useful for the treatment of MLL1-related malignancies.	[Dharmarajan, Venkatasubramanian; Patel, Anamika; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Dharmarajan, Venkatasubramanian] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Lee, Jeong-Heon] Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA; [Skalnik, David G.] Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu			National Institutes of Health [R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA140522 (to M. S. C.). We have recently been awarded a patent for use of Win motif inhibitors for inhibition of SET1 family complexes. We currently have no financial arrangements with any company.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALIGIURI MA, 1994, CANCER RES, V54, P370; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cosgrove MS, 2006, STRUCTURE, V14, P1096, DOI 10.1016/j.str.2006.06.004; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dharmarajan V., 2011, ACUTE LEUKEMIA SCI P, P157; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorrance AM, 2008, BLOOD, V112, P2508, DOI 10.1182/blood-2008-01-134338; Dorrance AM, 2006, J CLIN INVEST, V116, P2707, DOI 10.1172/JCI25546; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; FitzGerald KT, 1999, GENOMICS, V59, P187, DOI 10.1006/geno.1999.5860; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karatas H, 2010, J MED CHEM, V53, P5179, DOI 10.1021/jm100139b; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Paulussen ADC, 2011, HUM MUTAT, V32, pE2018, DOI 10.1002/humu.21416; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Quentmeier H, 2003, LEUKEMIA, V17, P980, DOI 10.1038/sj.leu.2402911; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; SCHICHMAN SA, 1994, P NATL ACAD SCI USA, V91, P6236, DOI 10.1073/pnas.91.13.6236; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Whitman SP, 2005, BLOOD, V106, P345, DOI 10.1182/blood-2005-01-0204; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235	66	73	73	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27275	27289		10.1074/jbc.M112.364125	http://dx.doi.org/10.1074/jbc.M112.364125			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22665483	Green Published, hybrid			2022-12-28	WOS:000307840700001
J	Utkin, YN; Weise, C; Kasheverov, IE; Andreeva, TV; Kryukova, EV; Zhmak, MN; Starkov, VG; Hoang, NA; Bertrand, D; Ramerstorfer, J; Sieghart, W; Thompson, AJ; Lummis, SCR; Tsetlin, VI				Utkin, Yuri N.; Weise, Christoph; Kasheverov, Igor E.; Andreeva, Tatyana V.; Kryukova, Elena V.; Zhmak, Maxim N.; Starkov, Vladislav G.; Ngoc Anh Hoang; Bertrand, Daniel; Ramerstorfer, Joachim; Sieghart, Werner; Thompson, Andrew J.; Lummis, Sarah C. R.; Tsetlin, Victor I.			Azemiopsin from Azemiops feae Viper Venom, a Novel Polypeptide Ligand of Nicotinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIMERESURUS-WAGLERI; TOXINOLOGICAL IMPLICATIONS; 3-FINGERED TOXINS; BINDING PROTEIN; LETHAL PEPTIDES; NAJA-KAOUTHIA; COBRA VENOM; PIT VIPER; RESIDUES; SITES	Azemiopsin, a novel polypeptide, was isolated from the Azemiops feae viper venom by combination of gel filtration and reverse-phase HPLC. Its amino acid sequence (DNWWPKP-PHQGPRPPRPRPKP) was determined by means of Edman degradation and mass spectrometry. It consists of 21 residues and, unlike similar venom isolates, does not contain cysteine residues. According to circular dichroism measurements, this peptide adopts a beta-structure. Peptide synthesis was used to verify the determined sequence and to prepare peptide in sufficient amounts to study its biological activity. Azemiopsin efficiently competed with alpha-bungarotoxin for binding to Torpedo nicotinic acetylcholine receptor (nAChR) (IC50 0.18 +/- 0.03 mu M) and with lower efficiency to human alpha 7 nAChR (IC50 22 +/- 2 mu M). It dose-dependently blocked acetylcholine-induced currents in Xenopus oocytes heterologously expressing human muscle-type nAChR and was more potent against the adult form (alpha 1 beta 1 epsilon delta) than the fetal form (alpha 1 beta 1 gamma delta), EC50 being 0.44 +/- 0.1 mu M and 1.56 +/- 0.37 mu M, respectively. The peptide had no effect on GABA(A) (alpha 1 beta 3 gamma 2 or alpha 2 beta 3 gamma 2) receptors at a concentration up to 100 mu M or on 5-HT3 receptors at a concentration up to 10 mu M. Ala scanning showed that amino acid residues at positions 3-6, 8-11, and 13-14 are essential for binding to Torpedo nAChR. In biological activity azemiopsin resembles waglerin, a disulfide-containing peptide from the Tropidechis wagleri venom, shares with it a homologous C-terminal hexapeptide, but is the first natural toxin that blocks nAChRs and does not possess disulfide bridges.	[Utkin, Yuri N.; Kasheverov, Igor E.; Andreeva, Tatyana V.; Kryukova, Elena V.; Zhmak, Maxim N.; Starkov, Vladislav G.; Tsetlin, Victor I.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Gsp Moscow 117997, Russia; [Utkin, Yuri N.; Kasheverov, Igor E.; Zhmak, Maxim N.] Syneuro, Gsp Moscow 117997, Russia; [Weise, Christoph] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Ngoc Anh Hoang] Vietnam Acad Sci & Technol, Inst Appl Mat Sci, Ho Chi Minh City, Vietnam; [Bertrand, Daniel] HiQScreen Sarl, CH-1211 Geneva 12, Switzerland; [Ramerstorfer, Joachim; Sieghart, Werner] Med Univ Vienna, Div Biochem & Mol Biol, Ctr Brain Res, A-1090 Vienna, Austria; [Thompson, Andrew J.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB 1QW, England	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Free University of Berlin; Vietnam Academy of Science & Technology (VAST); Medical University of Vienna; University of Cambridge	Utkin, YN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ulitsa Miklukho Maklaya 16-10, Gsp Moscow 117997, Russia.	utkin@mx.ibch.ru	Sieghart, Werner/A-4877-2013; Utkin, Yuri/L-2952-2019; Utkin, Yuri N./F-1958-2014; Tsetlin, Victor/X-2491-2018; Kasheverov, Igor E/F-6024-2014	Sieghart, Werner/0000-0002-0443-0302; Utkin, Yuri/0000-0002-4609-970X; Utkin, Yuri N./0000-0002-4609-970X; Thompson, Andrew/0000-0002-7046-6792	Neurocypress European Union FP7 Program Grant [202033]; Russian Ministry of Education and Science Contract [02.740.11.0865]; Russian Foundation for Basic Research Grant [09-04-01061]; Wellcome Trust Grant [01925]	Neurocypress European Union FP7 Program Grant; Russian Ministry of Education and Science Contract; Russian Foundation for Basic Research Grant(Russian Foundation for Basic Research (RFBR)); Wellcome Trust Grant(Wellcome Trust)	This work was supported by Neurocypress European Union FP7 Program Grant 202033, Russian Ministry of Education and Science Contract 02.740.11.0865, Russian Foundation for Basic Research Grant 09-04-01061, and Wellcome Trust Grant 01925.	Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; BARLOS K, 1991, INT J PEPT PROT RES, V37, P513; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chuang LC, 1996, BBA-PROTEIN STRUCT M, V1292, P145, DOI 10.1016/0167-4838(95)00181-6; Fernandez J, 2011, J PROTEOME RES, V10, P1816, DOI 10.1021/pr101091a; Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148; Fry BG, 2002, RAPID COMMUN MASS SP, V16, P600, DOI 10.1002/rcm.613; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Hsiao YM, 1996, BIOCHEM BIOPH RES CO, V227, P59, DOI 10.1006/bbrc.1996.1467; Kasheverov IE, 2006, FEBS J, V273, P4470, DOI 10.1111/j.1742-4658.2006.05453.x; McArdle JJ, 1999, J PHARMACOL EXP THER, V289, P543; MEBS D, 1994, TOXICON, V32, P1275, DOI 10.1016/0041-0101(94)90358-1; Molles BE, 2002, J BIOL CHEM, V277, P5433, DOI 10.1074/jbc.M109232200; Ohler M, 2010, J PROTEOME RES, V9, P2422, DOI 10.1021/pr901128x; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; Osipov AV, 2004, EUR J BIOCHEM, V271, P2018, DOI 10.1111/j.1432-1033.2004.04115.x; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Quik M, 1996, J NEUROCHEM, V67, P145; Ramazanova AS, 2008, TOXICON, V51, P524, DOI 10.1016/j.toxicon.2007.11.001; Ramazanova AS, 2009, TOXICON, V53, P162, DOI 10.1016/j.toxicon.2008.11.001; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; SCHIPPERS PH, 1981, ANAL CHEM, V53, P778, DOI 10.1021/ac00229a008; SCHMIDT JJ, 1992, TOXICON, V30, P1027, DOI 10.1016/0041-0101(92)90047-9; Sellin LC, 1996, BIOPHYS J, V70, P3, DOI 10.1016/S0006-3495(96)79559-0; Shelukhina IV, 2009, J NEUROCHEM, V109, P1087, DOI 10.1111/j.1471-4159.2009.06033.x; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Teichert RW, 2008, ANN NY ACAD SCI, V1132, P61, DOI 10.1196/annals.1405.015; Thompson AJ, 2011, MOL PHARMACOL, V80, P183, DOI 10.1124/mol.111.071415; TSAI MC, 1995, TOXICON, V33, P363, DOI 10.1016/0041-0101(94)00158-5; TSETLIN VI, 1979, FEBS LETT, V106, P47, DOI 10.1016/0014-5793(79)80692-4; Tsetlin V, 2009, BIOCHEM PHARMACOL, V78, P720, DOI 10.1016/j.bcp.2009.05.032; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Utkin YN, 2012, DOKL BIOCHEM BIOPHYS, V442, P33, DOI 10.1134/S1607672912010103; Utkin YN, 2007, CURR PHARM DESIGN, V13, P2906, DOI 10.2174/138161207782023757; Vulfius CA, 2011, TOXICON, V57, P787, DOI 10.1016/j.toxicon.2011.02.013; WEINSTEIN SA, 1991, TOXICON, V29, P227, DOI 10.1016/0041-0101(91)90107-3; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019	38	42	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27079	27086		10.1074/jbc.M112.363051	http://dx.doi.org/10.1074/jbc.M112.363051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22613724	hybrid, Green Published			2022-12-28	WOS:000307386000060
J	Benevides, RG; Ganne, G; Simoes, RD; Schubert, V; Niemietz, M; Unverzagt, C; Chazalet, V; Breton, C; Varrot, A; Cavada, BS; Imberty, A				Benevides, Raquel Guimaraes; Ganne, Geraldine; Simoes, Rafael da Conceicao; Schubert, Volker; Niemietz, Mathaeus; Unverzagt, Carlo; Chazalet, Valerie; Breton, Christelle; Varrot, Annabelle; Cavada, Benildo Sousa; Imberty, Anne			A Lectin from Platypodium elegans with Unusual Specificity and Affinity for Asymmetric Complex N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTEROCARPUS-ANGOLENSIS LECTIN; CONCANAVALIN-A; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LEGUME LECTINS; BIANTENNARY OLIGOSACCHARIDES; CARBOHYDRATE-BINDING; CORE TRIMANNOSIDE; RECOGNITION; PROTEINS	Lectin activity with specificity for mannose and glucose has been detected in the seed of Platypodium elegans, a legume plant from the Dalbergieae tribe. The gene of Platypodium eleganslectin A has been cloned, and the resulting 261-amino acid protein belongs to the legume lectin family with similarity with Pterocarpus angolensis agglutinin from the same tribe. The recombinant lectin has been expressed in Escherichia coli and refolded from inclusion bodies. Analysis of specificity by glycan array evidenced a very unusual preference for complex type N-glycans with asymmetrical branches. A short branch consisting of one mannose residue is preferred on the 6-arm of the N-glycan, whereas extensions by GlcNAc, Gal, and NeuAc are favorable on the 3-arm. Affinities have been obtained by microcalorimetry using symmetrical and asymmetrical Asn-linked heptasaccharides prepared by the semisynthetic method. Strong affinity with K-d of 4.5 mu M was obtained for both ligands. Crystal structures of Platypodium elegans lectin A complexed with branched trimannose and symmetrical complex-type Asn-linked heptasaccharide have been solved at 2.1 and 1.65 angstrom resolution, respectively. The lectin adopts the canonical dimeric organization of legume lectins. The trimannose bridges the binding sites of two neighboring dimers, resulting in the formation of infinite chains in the crystal. The Asn-linked heptasaccharide binds with the 6-arm in the primary binding site with extensive additional contacts on both arms. The GlcNAc on the 6-arm is bound in a constrained conformation that may rationalize the higher affinity observed on the glycan array for N-glycans with only a mannose on the 6-arm.	[Benevides, Raquel Guimaraes; Ganne, Geraldine; Chazalet, Valerie; Breton, Christelle; Varrot, Annabelle; Cavada, Benildo Sousa; Imberty, Anne] Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France; [Benevides, Raquel Guimaraes; Ganne, Geraldine; Chazalet, Valerie; Breton, Christelle; Varrot, Annabelle; Cavada, Benildo Sousa; Imberty, Anne] Inst Chim Mol Grenoble, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France; [Benevides, Raquel Guimaraes; Simoes, Rafael da Conceicao] Univ Fed Ceara, Dept Bioquim & Biol Mol, BR-60440970 Fortaleza, Ceara, Brazil; [Schubert, Volker; Niemietz, Mathaeus; Unverzagt, Carlo] Univ Bayreuth, D-95440 Bayreuth, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universidade Federal do Ceara; University of Bayreuth	Cavada, BS (corresponding author), Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble, France.	bscavada@ufc.br; imberty@cermav.cnrs.fr	Cavada, Benildo/CEA-4997-2022; Imberty, Anne/P-6451-2018	Cavada, Benildo/0000-0002-5791-6170; Guimaraes Benevides, Raquel/0000-0002-5410-6973; Imberty, Anne/0000-0001-6825-9527; Varrot, Annabelle/0000-0001-6667-8162	CNRS; French Ministry of Research; German Research Foundation (DFG); National Institutes of Health from NIGMS [GM62116]; CAPES; CNPq; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by CNRS and the French Ministry of Research and the German Research Foundation (DFG).; The glycan microarray analysis was provided by the Consortium for Functional Glycomics funded by National Institutes of Health Grant GM62116 from NIGMS. We acknowledge the European Synchrotron Radiation Facility for provision of synchrotron radiation facilities, and we are grateful for the assistance in using beamline BM30A.; Recipient of CAPES and CNPq grants from the Brazilian government.	Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g; Buts L, 2006, FEBS J, V273, P2407, DOI 10.1111/j.1742-4658.2006.05248.x; Cavada B. S., 1993, Revista Brasileira de Fisiologia Vegetal, V5, P193; Dam TK, 1998, J BIOL CHEM, V273, P32812, DOI 10.1074/jbc.273.49.32812; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Delatorre P, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-52; DEREWENDA Z, 1989, EMBO J, V8, P2189, DOI 10.1002/j.1460-2075.1989.tb08341.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Pino A, 2007, PLANT PHYSIOL, V144, P1733, DOI 10.1104/pp.107.100867; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gourdine JP, 2008, J BIOL CHEM, V283, P30112, DOI 10.1074/jbc.M804353200; Hirsch AM, 1999, CURR OPIN PLANT BIOL, V2, P320, DOI 10.1016/S1369-5266(99)80056-9; IMBERTY A, 1991, GLYCOCONJUGATE J, V8, P456, DOI 10.1007/BF00769847; Kajihara Y, 2004, CHEM-EUR J, V10, P971, DOI 10.1002/chem.200305115; Lameignere E, 2010, GLYCOBIOLOGY, V20, P87, DOI 10.1093/glycob/cwp151; Lorenzi H, 1998, ARVORES BRASILEIRAS; Loris R, 2004, J MOL BIOL, V335, P1227, DOI 10.1016/j.jmb.2003.11.043; Loris R, 2003, J BIOL CHEM, V278, P16297, DOI 10.1074/jbc.M211148200; Loris R, 1996, J BIOL CHEM, V271, P30614, DOI 10.1074/jbc.271.48.30614; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mezzato S, 2010, CARBOHYD RES, V345, P1306, DOI 10.1016/j.carres.2010.02.022; Moothoo DN, 1998, GLYCOBIOLOGY, V8, P173, DOI 10.1093/glycob/8.2.173; Moreira A., 1977, PLANT PHYSIOL, V59, P783; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen LR, 1997, BIOCHEMISTRY-US, V36, P15073, DOI 10.1021/bi971828+; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Rozwarski DA, 1998, J BIOL CHEM, V273, P32818, DOI 10.1074/jbc.273.49.32818; Rudiger H, 1998, ACTA ANAT, V161, P130; Rudiger H, 2000, CURR MED CHEM, V7, P389, DOI 10.2174/0929867003375164; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Srinivas VR, 2001, BBA-GEN SUBJECTS, V1527, P102, DOI 10.1016/S0304-4165(01)00153-2; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILLIAMS BA, 1992, J BIOL CHEM, V267, P22907; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wright CS, 1996, STRUCTURE, V4, P1339, DOI 10.1016/S0969-2126(96)00141-4; YOUNG NM, 1992, J MOL BIOL, V228, P924, DOI 10.1016/0022-2836(92)90875-K	40	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26352	26364		10.1074/jbc.M112.375816	http://dx.doi.org/10.1074/jbc.M112.375816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692206	hybrid, Green Published			2022-12-28	WOS:000306916300061
J	Shen, M; Lin, F; Zhang, JQ; Tang, YT; Chen, WK; Liu, HL				Shen, Ming; Lin, Fei; Zhang, Jiaqing; Tang, Yiting; Chen, Wei-Kang; Liu, Honglin			Involvement of the Up-regulated FoxO1 Expression in Follicular Granulosa Cell Apoptosis Induced by Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; 3-NITROPROPIONIC ACID; RAT-LIVER; GENE-EXPRESSION; MITOCHONDRIAL TOXIN; HYDROGEN-PEROXIDE; OVARIAN-FOLLICLES; MOUSE STRIATUM; ATRESIA; CYCLE	Follicular atresia is common in female mammalian ovaries, where most follicles undergo degeneration at any stage of growth and development. Oxidative stress gives rise to triggering granulosa cell apoptosis, which has been suggested as a major cause of follicular atresia. However, the underlying mechanism by which the oxidative stress induces follicular atresia remains unclear. FoxO transcription factors are known as critical mediators in the regulation of oxidative stress and apoptosis. In this study, the involvement of FoxO1 in oxidative stress-induced apoptosis of mouse follicular granulosa cells (MGCs) was investigated in vivo and in vitro. It was observed that increased apoptotic signals correlated with elevated expression of FoxO1 in MGCs when mice were treated with the oxidant. Correspondingly, the expressions of FoxO1 target genes, such as proapoptotic genes and antioxidative genes, were also up-regulated. In primary cultured MGCs, treatment with H2O2 led to FoxO1 nuclear translocation. Further studies with overexpression and knockdown of FoxO1 demonstrated the critical role of FoxO1 in the induction of MGC apoptosis by oxidative stress. Finally, inactivation of FoxO1 by insulin treatment confirmed that FoxO1 induced by oxidative stress played a pivotal role in up-regulating the expression of downstream apoptosis-related genes in MGCs. Our results suggest that up-regulation of FoxO1 by oxidative stress leads to apoptosis of granulosa cells, which eventually results in follicular atresia in mice.	[Shen, Ming; Lin, Fei; Zhang, Jiaqing; Tang, Yiting; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Peoples R China; [Chen, Wei-Kang] K&R BioPharmaceut, Nanjing 210009, Peoples R China	Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Peoples R China.	chen.50@osu.edu; liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022; Lin, Fei/AEI-9957-2022	liu, honglin/0000-0002-1254-3163; 	key project of the Chinese National Programs for Fundamental Research and Development (973 Program) [2007CB947403]	key project of the Chinese National Programs for Fundamental Research and Development (973 Program)(National Basic Research Program of China)	This work was supported by a grant from a key project of the Chinese National Programs for Fundamental Research and Development (973 Program 2007CB947403).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Asselin E, 2000, BIOL SIGNAL RECEPT, V9, P87; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; BEAL MF, 1993, J NEUROCHEM, V61, P1147, DOI 10.1111/j.1471-4159.1993.tb03633.x; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buczynska Alina, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P331; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; CLOPTON DA, 1995, BIOCHEM BIOPH RES CO, V210, P189, DOI 10.1006/bbrc.1995.1645; Cui M, 2009, ADV EXP MED BIOL, V665, P143; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dlamini Z, 2004, PHARMACOL THERAPEUT, V101, P1, DOI 10.1016/j.pharmthera.2003.08.005; Droge W, 2008, ANTIOXID REDOX SIGN, V10, P661, DOI 10.1089/ars.2007.1953; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Farombi EO, 2004, CELL BIOL TOXICOL, V20, P71, DOI 10.1023/B:CBTO.0000027916.61347.bc; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Fontaine M A, 2000, J Neurochem, V75, P1709, DOI 10.1046/j.1471-4159.2000.0751709.x; Franco R, 2009, MUTAT RES-GEN TOX EN, V674, P3, DOI 10.1016/j.mrgentox.2008.11.012; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; GILLE JJP, 1992, MUTAT RES, V275, P405, DOI 10.1016/0921-8734(92)90043-O; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grotowski W, 1997, Ginekol Pol, V68, P317; Gupta RK, 2009, TOXICOL APPL PHARM, V240, P1, DOI 10.1016/j.taap.2009.07.007; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Hoyer PB, 2007, BIRTH DEFECTS RES B, V80, P113, DOI 10.1002/bdrb.20103; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Inoue N, 2006, J REPROD DEVELOP, V52, P723, DOI 10.1262/jrd.18043; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; Kaczara P, 2010, FREE RADICAL BIO MED, V48, P1064, DOI 10.1016/j.freeradbiomed.2010.01.022; Kajihara T, 2009, MED MOL MORPHOL, V42, P216, DOI 10.1007/s00795-009-0466-7; Kim GW, 2001, NEUROBIOL DIS, V8, P114, DOI 10.1006/nbdi.2000.0327; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P119, DOI 10.1097/00004647-200001000-00016; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kumar M, 2010, ARCH GYNECOL OBSTET, V282, P695, DOI 10.1007/s00404-010-1623-x; Kumar P, 2011, J PSYCHOPHARMACOL, V25, P1399, DOI 10.1177/0269881110364269; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Matsuda-Minehata F, 2006, J REPROD DEVELOP, V52, P695, DOI 10.1262/jrd.18069; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Melov S, 2002, INT J BIOCHEM CELL B, V34, P1395, DOI 10.1016/S1357-2725(02)00086-9; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Montilla P, 2004, EUR J PHARMACOL, V488, P19, DOI 10.1016/j.ejphar.2004.02.004; Morales AE, 2004, COMP BIOCHEM PHYS C, V139, P153, DOI 10.1016/j.cca.2004.10.008; Mujahid A, 2007, POULTRY SCI, V86, P364, DOI 10.1093/ps/86.2.364; Murdoch WJ, 1998, J REPROD FERTIL, V114, P127, DOI 10.1530/jrf.0.1140127; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Ortega-Camarillo C, 2009, REPRODUCTION, V137, P979, DOI 10.1530/REP-08-0463; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; SCHIAFFONATI L, 1990, J CELL PHYSIOL, V143, P79, DOI 10.1002/jcp.1041430110; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Sener G, 2005, PHARMACOLOGY, V74, P37, DOI 10.1159/000083245; Shen B, 2010, AM J PHYSIOL-HEART C, V299, pH1419, DOI 10.1152/ajpheart.00591.2010; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Silva RH, 2004, NEUROPHARMACOLOGY, V46, P895, DOI 10.1016/j.neuropharm.2003.11.032; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Valdez KE, 2005, REPRODUCTION, V130, P71, DOI 10.1530/rep.1.00430; Venditti P, 2006, J EXP BIOL, V209, P817, DOI 10.1242/jeb.02045; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Zafir A, 2009, INDIAN J BIOCHEM BIO, V46, P53	83	113	128	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25727	25740		10.1074/jbc.M112.349902	http://dx.doi.org/10.1074/jbc.M112.349902			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669940	hybrid, Green Published			2022-12-28	WOS:000306916300004
J	Xu, YQ; Parmar, A; Roux, E; Balbis, A; Dumas, V; Chevalier, S; Posner, BI				Xu, Yanqing; Parmar, Amanda; Roux, Emmanuelle; Balbis, Alejandro; Dumas, Victor; Chevalier, Stephanie; Posner, Barry I.			Epidermal Growth Factor-induced Vacuolar (H+)-ATPase Assembly A ROLE IN SIGNALING VIA mTORC1 ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; INDUCED DNA-SYNTHESIS; YEAST V-ATPASE; H+-ATPASE; FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MAMMALIAN TARGET; CELL-GROWTH; RAG GTPASES; INSULIN	Using proteomics and immunofluorescence, we demonstrated epidermal growth factor (EGF) induced recruitment of extrinsic V-1 subunits of the vacuolar (H+)-ATPase (V-ATPase) to rat liver endosomes. This was accompanied by reduced vacuolar pH. Bafilomycin, an inhibitor of V-ATPase, inhibited EGF-stimulated DNA synthesis and mammalian target of rapamycin complex 1 (mTORC1) activation as indicated by a decrease in eukaryotic initiation factor 4E-binding 1 (4E-BP1) phosphorylation and p70 ribosomal S6 protein kinase (p70S6K) phosphorylation and kinase activity. There was no corresponding inhibition of EGF-induced Akt and extracellular signal-regulated kinase (Erk) activation. Chloroquine, a neutralizer of vacuolar pH, mimicked bafilomycin effects. Bafilomycin did not inhibit the association of mTORC1 with Raptor nor did it affect AMP-activated protein kinase activity. Rather, the intracellular concentrations of essential but not non-essential amino acids were decreased by bafilomycin in EGF-treated primary rat hepatocytes. Cycloheximide, a translation elongation inhibitor known to augment intracellular amino acid levels, prevented the effect of bafilomycin on amino acids levels and completely reversed its inhibition of EGF-induced mTORC1 activation. In vivo administration of EGF stimulated the recruitment of Ras homologue enriched in brain (Rheb) but not mammalian target of rapamycin (mTOR) to endosomes and lysosomes. This was inhibited by chloroquine treatment. Our results suggest a role for vacuolar acidification in EGF signaling to mTORC1.	[Posner, Barry I.] McGill Univ, Fac Med, Polypeptide Hormone Lab, Montreal, PQ H3A 2B2, Canada; [Chevalier, Stephanie] McGill Univ, Ctr Hlth, McGill Nutr & Food Sci Ctr, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; Royal Victoria Hospital	Posner, BI (corresponding author), McGill Univ, Fac Med, Polypeptide Hormone Lab, 3640 Univ St,Suite W315, Montreal, PQ H3A 2B2, Canada.	barry.posner@mcgill.ca	Chevalier, Stephanie/AAA-5386-2021		Canadian Institutes for Health Research (CIHR); Genome Canada and Genome Quebec	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada and Genome Quebec	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) and both Genome Canada and Genome Quebec. Part of this work was presented at ENDO 2010, The 92nd Annual Meeting and Expo, June 23-26, 2010, San Diego, CA.	AbdelNabi R, 1996, ALCOHOL, V13, P171, DOI 10.1016/0741-8329(95)02031-4; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Balbis A, 2000, ENDOCRINOLOGY, V141, P4041, DOI 10.1210/en.141.11.4041; Balbis A, 2004, J BIOL CHEM, V279, P39348, DOI 10.1074/jbc.M404280200; Balbis A, 2004, J BIOL CHEM, V279, P12777, DOI 10.1074/jbc.M311493200; Balbis A, 2007, ENDOCRINOLOGY, V148, P2944, DOI 10.1210/en.2006-1674; Band CJ, 1999, ENDOCRINOLOGY, V140, P5626, DOI 10.1210/en.140.12.5626; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bevan AP, 1996, TRENDS ENDOCRIN MET, V7, P13, DOI 10.1016/1043-2760(95)00179-4; BEVAN AP, 1995, J BIOL CHEM, V270, P10784, DOI 10.1074/jbc.270.18.10784; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; Croce AC, 2004, PHOTOCH PHOTOBIO SCI, V3, P920, DOI 10.1039/b407358d; Dadmarz M, 1998, LIFE SCI, V63, P1485, DOI 10.1016/S0024-3205(98)00415-9; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Drose S, 1997, J EXP BIOL, V200, P1; FAURE R, 1992, J BIOL CHEM, V267, P11215; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; KANE PM, 1995, J BIOL CHEM, V270, P17025; KAY DG, 1986, J BIOL CHEM, V261, P8473; KHAN MN, 1986, J BIOL CHEM, V261, P8462; KHAN MN, 1981, P NATL ACAD SCI-BIOL, V78, P4980, DOI 10.1073/pnas.78.8.4980; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; Kong M, 2003, J BIOL CHEM, V278, P5837, DOI 10.1074/jbc.M208286200; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; Lim JH, 2006, MOL PHARMACOL, V70, P1856, DOI 10.1124/mol.106.028076; Liu G, 2011, EMBO J, V30, P2990, DOI 10.1038/emboj.2011.195; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lusa S, 2001, J CELL SCI, V114, P1893; MANABE T, 1993, J CELL PHYSIOL, V157, P445, DOI 10.1002/jcp.1041570303; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; McConahey P J, 1980, Methods Enzymol, V70, P210; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mineo C, 1996, EXP CELL RES, V224, P237, DOI 10.1006/excr.1996.0133; Nascimento Emmani B. M., 2009, Archives of Physiology and Biochemistry, V115, P163, DOI 10.1080/13813450902988580; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Reinehr R, 2009, BIOL CHEM, V390, P1033, DOI 10.1515/BC.2009.106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saurin AJ, 1996, BIOCHEM J, V313, P65, DOI 10.1042/bj3130065; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Valovka T, 2003, MOL CELL BIOL, V23, P852, DOI 10.1128/MCB.23.3.852-863.2003; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wang Y, 2009, J CELL BIOCHEM, V107, P96, DOI 10.1002/jcb.22105; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; Waugh MG, 2006, J BIOL CHEM, V281, P3757, DOI 10.1074/jbc.M506527200; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	85	38	38	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26409	26422		10.1074/jbc.M112.352229	http://dx.doi.org/10.1074/jbc.M112.352229			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689575	hybrid, Green Published			2022-12-28	WOS:000306916300066
J	Tiberia, E; Turnbull, J; Wang, T; Ruggieri, A; Zhao, XC; Pencea, N; Israelian, J; Wang, Y; Ackerley, CA; Wang, PX; Liu, Y; Minassian, BA				Tiberia, Erica; Turnbull, Julie; Wang, Tony; Ruggieri, Alessandra; Zhao, Xiao-Chu; Pencea, Nela; Israelian, Johan; Wang, Yin; Ackerley, Cameron A.; Wang, Peixiang; Liu, Yan; Minassian, Berge A.			Increased Laforin and Laforin Binding to Glycogen Underlie Lafora Body Formation in Malin-deficient Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; SPECIFICITY PROTEIN PHOSPHATASE; E3 UBIQUITIN LIGASE; POLYGLUCOSAN BODIES; EPM2A GENE; ACCUMULATION; MUTATIONS; MICE; NEURODEGENERATION; DEGRADATION	The solubility of glycogen, essential to its metabolism, is a property of its shape, a sphere generated through extensive branching during synthesis. Lafora disease (LD) is a severe teenage-onset neurodegenerative epilepsy and results from multiorgan accumulations, termed Lafora bodies (LB), of abnormally structured aggregation-prone and digestion-resistant glycogen. LD is caused by loss-of-function mutations in the EPM2A or EPM2B gene, encoding the interacting laforin phosphatase and malin E3 ubiquitin ligase enzymes, respectively. The substrate and function of malin are unknown; an early counterintuitive observation in cell culture experiments that it targets laforin to proteasomal degradation was not pursued until now. The substrate and function of laforin have recently been elucidated. Laforin dephosphorylates glycogen during synthesis, without which phosphate ions interfere with and distort glycogen construction, leading to LB. We hypothesized that laforin in excess or not removed following its action on glycogen also interferes with glycogen formation. We show in malin-deficient mice that the absence of malin results in massively increased laforin preceding the appearance of LB and that laforin gradually accumulates in glycogen, which corresponds to progressive LB generation. We show that increasing the amounts of laforin in cell culture causes LB formation and that this occurs only with glycogen binding-competent laforin. In summary, malin deficiency causes increased laforin, increased laforin binding to glycogen, and LB formation. Furthermore, increased levels of laforin, when it can bind glycogen, causes LB. We conclude that malin functions to regulate laforin and that malin deficiency at least in part causes LB and LD through increased laforin binding to glycogen.	[Tiberia, Erica; Turnbull, Julie; Wang, Tony; Ruggieri, Alessandra; Zhao, Xiao-Chu; Pencea, Nela; Israelian, Johan; Wang, Peixiang; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Pencea, Nela; Ackerley, Cameron A.] Hosp Sick Children, Div Pathol, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Div Neurol, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Turnbull, Julie] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Minassian, Berge A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Wang, Yin; Liu, Yan] Univ Michigan, Dept Surg, Div Immunotherapy, Sect Gen Surg, Ann Arbor, MI 48109 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Michigan System; University of Michigan	Turnbull, J (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada.	jturnbull@sickkids.ca; berge.minassian@sickkids.ca	Ruggieri, Alessandra/J-2881-2018	Ruggieri, Alessandra/0000-0002-2777-6226	National Institutes of Health Grant [1R21NS062391]; Canadian Institutes of Health Research Grant [MOP14667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062391] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21NS062391 (to Y. L.). This work was also supported by Canadian Institutes of Health Research Grant MOP14667 (to B. A. M.).	ANDERSEN DH, 1956, LAB INVEST, V5, P11; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; Bao Y, 1996, J CLIN INVEST, V97, P941, DOI 10.1172/JCI118517; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Couarch P, 2011, J MOL MED, V89, P915, DOI 10.1007/s00109-011-0758-y; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ganesh S, 2004, BIOCHEM BIOPH RES CO, V313, P1101, DOI 10.1016/j.bbrc.2003.12.043; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Girard JM, 2006, BIOCHIMIE, V88, P1961, DOI 10.1016/j.biochi.2006.08.002; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Nielsen JN, 2001, J PHYSIOL-LONDON, V531, P757, DOI 10.1111/j.1469-7793.2001.0757h.x; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; ROBITAILLE Y, 1980, BRAIN, V103, P315, DOI 10.1093/brain/103.2.315; SCHOCHET SS, 1970, ARCH PATHOL, V90, P354; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Van Heycop Ten Ham M., 1975, LAFORA DIS FORM PROG; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200	40	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25650	25659		10.1074/jbc.M111.331611	http://dx.doi.org/10.1074/jbc.M111.331611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669944	Green Published, hybrid			2022-12-28	WOS:000306651700072
J	Cuny, H; de Faoite, A; Huynh, TG; Yasuda, T; Berecki, G; Adams, DJ				Cuny, Hartmut; de Faoite, Andrew; Huynh, Thuan G.; Yasuda, Takahiro; Berecki, Geza; Adams, David J.			gamma-Aminobutyric Acid Type B (GABA(B)) Receptor Expression Is Needed for Inhibition of N-type (Ca(v)2.2) Calcium Channels by Analgesic alpha-Conotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SENSORY NEURONS; NICOTINIC ACETYLCHOLINE-RECEPTORS; NEUROPATHIC PAIN; MODULATION; CURRENTS; BLOCKS; VC1.1; RGIA	alpha-Conotoxins Vc1.1 and RgIA are small peptides isolated from the venom of marine cone snails. They have effective anti-nociceptive actions in rat models of neuropathic pain. Pharmacological studies in rodent dorsal root ganglion (DRG) show their analgesic effect is mediated by inhibition of N-type (Ca(v)2.2) calcium channels via a pathway involving gamma-aminobutyric acid type B (GABA(B)) receptor. However, there is no direct demonstration that functional GABA(B) receptors are needed for inhibition of the Cav2.2 channel by analgesic alpha-conotoxins. This study examined the effect of the GABA(B) agonist baclofen and alpha-conotoxins Vc1.1 and RgIA on calcium channel currents after transient knockdown of the GABA(B) receptor using RNA interference. Isolated rat DRG neurons were transfected with small interfering RNAs(siRNA) targeting GABA(B) subunits R1 and R2. Efficient knockdown of GABA(B) receptor expression at mRNA and protein levels was confirmed by quantitative real time PCR (qRT-PCR) and immunocytochemical analysis, respectively. Whole-cell patch clamp recordings conducted 2-4 days after transfection showed that inhibition of N-type calcium channels in response to baclofen, Vc1.1 and RgIA was significantly reduced in GABA(B) receptor knockdown DRG neurons. In contrast, neurons transfected with a scrambled nontargeting siRNA were indistinguishable from untransfected neurons. In the HEK 293 cell heterologous expression system, Vc1.1 and RgIA inhibition of Ca(v)2.2 channels needed functional expression of both human GABA(B) receptor subunits. Together, these results confirm that GABA(B) receptors must be activated for the modulation of N-type (Ca(v)2.2) calcium channels by analgesic alpha-conotoxins Vc1.1 and RgIA.	[Cuny, Hartmut; de Faoite, Andrew; Huynh, Thuan G.; Yasuda, Takahiro; Berecki, Geza; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia	Royal Melbourne Institute of Technology (RMIT)	Adams, DJ (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia.	david.adams@rmit.edu.au	Adams, David/J-9125-2014; Adams, David John/K-3578-2019; Berecki, Geza/T-5016-2017	Adams, David/0000-0002-7030-2288; Adams, David John/0000-0002-7030-2288; Cuny, Hartmut/0000-0002-1551-2354	National Health and Medical Research Council Program Grant [569927]; Australian Research Council Project Grant [DP1093177]	National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Project Grant(Australian Research Council)	This work was supported by National Health and Medical Research Council Program Grant 569927 and Australian Research Council Project Grant DP1093177.	Adams D. J., 2011, 2011 NEUR M PLANN SO; Adams DJ, 2012, BRIT J PHARMACOL, V166, P486, DOI 10.1111/j.1476-5381.2011.01781.x; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; CAMPBELL V, 1993, J PHYSIOL-LONDON, V470, P1; Clark RJ, 2008, FEBS LETT, V582, P597, DOI 10.1016/j.febslet.2008.01.027; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Cousins MJ, 2004, PAIN, V112, P1, DOI 10.1016/j.pain.2004.09.002; Dai G, 2008, ASSAY DRUG DEV TECHN, V6, P195, DOI 10.1089/adt.2008.136; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; Dray A, 2008, BRIT J ANAESTH, V101, P48, DOI 10.1093/bja/aen107; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Hand KSP, 2000, NEUROSCI LETT, V290, P49, DOI 10.1016/S0304-3940(00)01317-3; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Jensen TS, 2001, EUR J PHARMACOL, V429, P1, DOI 10.1016/S0014-2999(01)01302-4; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Lang PM, 2005, NEUROREPORT, V16, P479, DOI 10.1097/00001756-200504040-00012; Lee HY, 2007, SYNAPSE, V61, P622, DOI 10.1002/syn.20416; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Luo SQ, 1998, J NEUROSCI, V18, P8571; Murali SS, 2012, J PHYSIOL-LONDON, V590, P1655, DOI 10.1113/jphysiol.2012.228429; Naseer MI, 2010, SYNAPSE, V64, P181, DOI 10.1002/syn.20712; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; NOMURA K, 1994, J PHARMACOL EXP THER, V270, P466; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Rohl T, 2006, J NEUROCHEM, V99, P371, DOI 10.1111/j.1471-4159.2006.04082.x; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SCHROEDER JE, 1993, J NEUROSCI, V13, P867; TATEBAYASHI H, 1992, J PHYSIOL-LONDON, V447, P391, DOI 10.1113/jphysiol.1992.sp019008; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Vincler M, 2007, EXPERT OPIN THER TAR, V11, P891, DOI 10.1517/14728222.11.7.891; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	40	42	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23948	23957		10.1074/jbc.M112.342998	http://dx.doi.org/10.1074/jbc.M112.342998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613715	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000306511300064
J	Zhou, X; Ma, Y; Kato, T; Kuno, T				Zhou, Xin; Ma, Yan; Kato, Toshiaki; Kuno, Takayoshi			A Measurable Activation of the bZIP Transcription Factor Atf1 in a Fission Yeast Strain Devoid of Stress-activated and Cell Integrity Mitogen-activated Protein Kinase (MAPK) Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; OXIDATIVE STRESS; PATHWAY; PHOSPHORYLATION; ENCODES; LOCALIZATION; ATP	In Schizosaccharomyces pombe, the stress-activated Sty1 MAPK pathway is essential for cell survival under stress conditions. The Sty1 MAPK regulates Atf1 transcription factor to elicit stress responses in extreme conditions of osmolarity and reactive oxygen species-generating agents such as hydrogen peroxide, heat, low glucose, and heavy metal. Herein, using a newly developed Renilla luciferase reporter assay with enhanced detection sensitivity and accuracy, we show that distinct signaling pathways respond to cadmium and other reactive oxygen species-generating agents for the activation of Atf1. Also, surprisingly, a measurable activation of Atf1 transcription factor was still observed devoid of Sty1 MAPK activity. Further genetic and biological analyses revealed that the residual activation is caused by the activation of the cell wall integrity Pmk1 MAPK pathway and a redox-mediated activation of Atf1.	[Zhou, Xin; Ma, Yan; Kato, Toshiaki; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Jinzhou 121001, Liaoning, Peoples R China	Kobe University; Jinzhou Medical University	Zhou, X (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen,Chuo Ku, Kusunoki Cho 6-5-1, Kobe, Hyogo 6500017, Japan.	zhouxin@med.kobe-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by research grants from the Japan Society for the Promotion of Science.	Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; HOLMSEN H, 1977, J BIOL CHEM, V252, P1752; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NICHOLLS DG, 1992, NATURE, V360, P106, DOI 10.1038/360106a0; Ors A, 2009, J BIOL CHEM, V284, P23989, DOI 10.1074/jbc.M109.018309; Osorio H, 2003, EUR J BIOCHEM, V270, P1578, DOI 10.1046/j.1432-1033.2003.03529.x; OTTILIE S, 1992, MOL CELL BIOL, V12, P5571, DOI 10.1128/MCB.12.12.5571; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Samejima I, 1997, EMBO J, V16, P6162, DOI 10.1093/emboj/16.20.6162; Samejima I, 1998, MOL BIOL CELL, V9, P2325, DOI 10.1091/mbc.9.8.2325; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Takada H, 2010, MOL BIOL CELL, V21, P674, DOI 10.1091/mbc.E09-09-0810; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Toda T, 1996, MOL CELL BIOL, V16, P6752; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764	33	13	15	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23434	23439		10.1074/jbc.C111.338715	http://dx.doi.org/10.1074/jbc.C111.338715			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22661707	Green Published, hybrid			2022-12-28	WOS:000306511300016
J	Draber, P; Stepanek, O; Hrdinka, M; Drobek, A; Chmatal, L; Mala, L; Ormsby, T; Angelisova, P; Horejsi, V; Brdicka, T				Draber, Peter; Stepanek, Ondrej; Hrdinka, Matous; Drobek, Ales; Chmatal, Lukas; Mala, Linda; Ormsby, Tereza; Angelisova, Pavla; Horejsi, Vaclav; Brdicka, Tomas			LST1/A Is a Myeloid Leukocyte-specific Transmembrane Adaptor Protein Recruiting Protein Tyrosine Phosphatases SHP-1 and SHP-2 to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TNF REGION; MOTH-EATEN; T-CELLS; GENE; INFLAMMATION; RECEPTOR; SIGLECS; IDENTIFICATION; INTERFERON	Transmembrane adaptor proteins are membrane-anchored proteins consisting of a short extracellular part, a transmembrane domain, and a cytoplasmic part with various protein-protein interaction motifs but lacking any enzymatic activity. They participate in the regulation of various signaling pathways by recruiting other proteins to the proximity of cellular membranes where the signaling is often initiated and propagated. In this work, we show that LST1/A, an incompletely characterized protein encoded by MHCIII locus, is a palmitoylated transmembrane adaptor protein. It is expressed specifically in leukocytes of the myeloid lineage, where it localizes to the tetraspanin-enriched microdomains. In addition, it binds SHP-1 and SHP-2 phosphatases in a phosphotyrosine-dependent manner, facilitating their recruitment to the plasma membrane. These data suggest a role for LST1/A in negative regulation of signal propagation.	[Draber, Peter; Stepanek, Ondrej; Hrdinka, Matous; Drobek, Ales; Chmatal, Lukas; Mala, Linda; Ormsby, Tereza; Angelisova, Pavla; Horejsi, Vaclav; Brdicka, Tomas] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Brdicka, T (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague, Czech Republic.	tomas.brdicka@img.cas.cz	Stepanek, Ondrej/F-8882-2013; Brdicka, Tomas/G-6205-2014; Stepanek, Ondrej/AAG-3180-2020; Angelisova, Pavla/G-3131-2014; Hrdinka, Matous/B-9187-2011; Draber, Peter/G-3141-2014; Drobek, Aleš/T-3994-2017; Horejsi, Vaclav/G-3113-2014; Ormsby, Tereza/O-3854-2018; Ormsby, Tereza/AAA-4527-2022	Stepanek, Ondrej/0000-0002-2735-3311; Brdicka, Tomas/0000-0002-1560-4398; Stepanek, Ondrej/0000-0002-2735-3311; Hrdinka, Matous/0000-0002-2981-2825; Draber, Peter/0000-0001-8658-4614; Horejsi, Vaclav/0000-0003-4925-0142; Ormsby, Tereza/0000-0002-2953-9208; Ormsby, Tereza/0000-0002-2953-9208; Drobek, Ales/0000-0003-1066-9413	Academy of Sciences of the Czech Republic [AVOZ50520514, RVO68378050]; GACR [MEM/09/E011, P302/12/G101]; Center of Molecular and Cellular Immunology project, Ministry of Education, Youth and Sports of the Czech Republic [1M0506]; Faculty of Science, Charles University, Prague, Czech Republic	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); GACR(Grant Agency of the Czech Republic); Center of Molecular and Cellular Immunology project, Ministry of Education, Youth and Sports of the Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic(Czech Republic Government)	This work was supported by Academy of Sciences of the Czech Republic (AVOZ50520514 and RVO68378050), GACR Projects MEM/09/E011 and P302/12/G101, and by Center of Molecular and Cellular Immunology Project 1M0506, Ministry of Education, Youth and Sports of the Czech Republic.; Supported in part by the Faculty of Science, Charles University, Prague, Czech Republic.	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; ANGELISOVA P, 1994, IMMUNOGENETICS, V39, P249; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Bauler TJ, 2011, DIS MODEL MECH, V4, P228, DOI 10.1242/dmm.006130; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251, DOI 10.14670/HH-22.1251; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; deBaey A, 1997, GENOMICS, V45, P591, DOI 10.1006/geno.1997.4963; Draber P, 2011, MOL CELL BIOL, V31, P4550, DOI 10.1128/MCB.05817-11; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; HOLZINGER I, 1995, IMMUNOGENETICS, V42, P315, DOI 10.1007/BF00179392; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hrdinka M, 2011, J BIOL CHEM, V286, P19617, DOI 10.1074/jbc.M110.175117; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mulcahy H, 2006, IMMUNOGENETICS, V57, P893, DOI 10.1007/s00251-005-0057-2; Paul SP, 2000, BLOOD, V96, P483; Raghunathan A, 2001, EXP CELL RES, V268, P230, DOI 10.1006/excr.2001.5290; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rollinger-Holzinger I, 2000, J IMMUNOL, V164, P3169, DOI 10.4049/jimmunol.164.6.3169; Schiller C, 2009, HYBRIDOMA, V28, P281, DOI 10.1089/hyb.2009.0021; SPIES T, 1989, SCIENCE, V243, P214, DOI 10.1126/science.2911734; Staub E, 2004, CELL SIGNAL, V16, P435, DOI 10.1016/j.cellsig.2003.08.013; TSUGE I, 1987, IMMUNOGENETICS, V26, P378, DOI 10.1007/BF00343709; Tsui FWL, 2006, IMMUNOL RES, V35, P127, DOI 10.1385/IR:35:1:127; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Ulyanova T, 2001, J BIOL CHEM, V276, P14451, DOI 10.1074/jbc.M011650200; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Walter RB, 2008, TRAFFIC, V9, P267, DOI 10.1111/j.1600-0854.2007.00682.x; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X	41	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22812	22821		10.1074/jbc.M112.339143	http://dx.doi.org/10.1074/jbc.M112.339143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589543	Green Published, hybrid			2022-12-28	WOS:000306495000038
J	Kurtz, L; Kao, LY; Newman, D; Kurtz, I; Zhu, QS				Kurtz, Lisa; Kao, Liyo; Newman, Debra; Kurtz, Ira; Zhu, Quansheng			Integrin alpha(IIb)beta(3) Inside-out Activation AN IN SITU CONFORMATIONAL ANALYSIS REVEALS A NEW MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAINS; STRUCTURAL BASIS; TRANSMEMBRANE DOMAINS; TAIL; MEMBRANES; TOPOLOGY; BINDING; REGION	Integrins are a family of heterodimeric adhesion receptors that transmit signals bi-directionally across the plasma membranes. The transmembrane domain (TM) of integrin plays a critical role in mediating transition of the receptor from the default inactive to the active state on the cell surfaces. In this study, we successfully applied the substituted cysteine scanning accessibility method to determine the intracellular border of the integrin alpha(IIb)beta(3) TM in the inactive and active states in living cells. We examined the aqueous accessibility of 75 substituted cysteines comprising the C terminus of both alpha(IIb) and beta(3) TMs, the intracellular membrane-proximal regions, and the whole cytoplasmic tails, to the labeling of a membrane-permeable, cysteine-specific chemical biotin maleimide (BM). The active state of integrin alpha(IIb)beta(3) heterodimer was generated by co-expression of activating partners with the cysteine-substituted constructs. Our data revealed that, in the inactive state, the intracellular lipid/aqueous border of alpha(IIb) TM was at Lys(994) and beta(3) TM was at Phe(727) respectively; in the active state, the border of alpha(IIb) TM shifted to Pro(998), whereas the border of beta 3 TM remained unchanged, suggesting that complex conformational changes occurred in the TMs upon alpha(IIb)beta(3) inside-out activation. On the basis of the results, we propose a new inside-out activation mechanism for integrin alpha(IIb)beta(3) and by inference, all of the integrins in their native cellular environment.	[Kurtz, Lisa; Kao, Liyo; Newman, Debra; Kurtz, Ira; Zhu, Quansheng] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, QS (corresponding author), Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, 7-155 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	quzhu@mednet.ucla.edu			Factor Foundation	Factor Foundation	This work was supported by the Factor Foundation.	Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Armulik A, 1999, J BIOL CHEM, V274, P37030, DOI 10.1074/jbc.274.52.37030; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Williams Michael J., 1994, Trends in Cell Biology, V4, P109, DOI 10.1016/0962-8924(94)90059-0; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2010, J BIOL CHEM, V285, P37178, DOI 10.1074/jbc.M110.169201; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286	42	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23255	23265		10.1074/jbc.M112.360966	http://dx.doi.org/10.1074/jbc.M112.360966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613710	Green Published, hybrid			2022-12-28	WOS:000306495000080
J	Lee, J; Komatsu, K; Lee, BC; Lim, JH; Jono, H; Xu, HD; Kai, H; Zhang, ZJ; Yan, C; Li, JD				Lee, Jiyun; Komatsu, Kensei; Lee, Byung Cheol; Lim, Jae Hyang; Jono, Hirofumi; Xu, Haidong; Kai, Hirofumi; Zhang, Z. John; Yan, Chen; Li, Jian-Dong			Phosphodiesterase 4B Mediates Extracellular Signal-regulated Kinase-dependent Up-regulation of Mucin MUC5AC Protein by Streptococcus pneumoniae by Inhibiting cAMP-protein Kinase A-dependent MKP-1 Phosphatase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; NF-KAPPA-B; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; PNEUMOCOCCAL CONJUGATE VACCINE; GROWTH-FACTOR-BETA; MIDDLE-EAR MUCOSA; OBSTRUCTIVE PULMONARY-DISEASE; SENSORINEURAL HEARING-LOSS; OTITIS-MEDIA; P38 MAPK	Otitis media (OM) is the most common childhood bacterial infection and the major cause of conductive hearing loss in children. Mucus overproduction is a hallmark of OM. Streptococcus pneumoniae is the most common Gram-positive bacterial pathogen causing OM. Among many mucin genes, MUC5AC has been found to be greatly up-regulated in the middle ear mucosa of human patients with OM. We previously reported that S. pneumoniae up-regulates MUC5AC expression in a MAPK ERK-dependent manner. We also found that MAPK phosphatase-1 (MKP-1) negatively regulates S. pneumoniae-induced ERK-dependent MUC5AC up-regulation. Therapeutic strategies for up-regulating the expression of negative regulators such as MKP-1 may have significant therapeutic potential for treating mucus overproduction in OM. However, the underlying molecular mechanism by which MKP-1 expression is negatively regulated during S. pneumoniae infection is unknown. In this study we show that phosphodiesterase 4B (PDE4B) mediates S. pneumoniae-induced MUC5AC up-regulation by inhibiting the expression of a negative regulator MKP-1, which in turn leads to enhanced MAPK ERK activation and subsequent up-regulation of MUC5AC. PDE4B inhibits MKP-1 expression in a cAMP-PKA-dependent manner. PDE4-specific inhibitor rolipram inhibits S. pneumoniae-induced MUC5AC up-regulation both in vitro and in vivo. Moreover, we show that PDE4B plays a critical role in MUC5AC induction. Finally, topical and post-infection administration of rolipram into the middle ear potently inhibited S. pneumoniae-induced MUC5AC up-regulation. Collectively, these data demonstrate that PDE4B mediates ERK-dependent up-regulation of mucin MUC5AC by S. pneumoniae by inhibiting cAMP-PKA-dependent MKP-1 pathway. This study may lead to novel therapeutic strategy for inhibiting mucus overproduction.	[Lee, Jiyun; Komatsu, Kensei; Lee, Byung Cheol; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Lee, Jiyun; Komatsu, Kensei; Lee, Byung Cheol; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Jono, Hirofumi] Kumamoto Univ, Dept Diagnost Med, Kumamoto 8608556, Japan; [Zhang, Z. John] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Yan, Chen] Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Kumamoto University; University System of Georgia; Georgia Institute of Technology; University of Rochester	Lim, JH (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Box 5090, Atlanta, GA 30302 USA.	jlim19@gsu.edu; jdli@gsu.edu	Komatsu, Kensei/AAO-6492-2021	Yan, Chen/0000-0002-1397-6358; Li, Jian-Dong/0000-0002-5593-050X; Lim, Jae Hyang/0000-0003-0972-9271; Komatsu, Kensei/0000-0001-7418-3805	National Institutes of Health [DC004562, DC005843, HL088400]; American Heart Association [10SDG2630077]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23790091] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants DC004562 and DC005843 (to J.-D. L) and HL088400 (to C. Y.). This work was also supported by American Heart Association Grant 10SDG2630077 (to J. H. L.).	Banner KH, 2009, BRIT J PHARMACOL, V157, P892, DOI 10.1111/j.1476-5381.2009.00170.x; Basbaum C, 1999, AM J RESP CRIT CARE, V160, pS44, DOI 10.1164/ajrccm.160.supplement_1.12; Basbaum CB, 1998, CILIA, MUCUS, AND MUCOCILIARY INTERACTIONS, P349; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; BLUESTONE CD, 1973, LARYNGOSCOPE, V83, P594, DOI 10.1288/00005537-197304000-00015; BLUESTONE CD, 1982, NEW ENGL J MED, V306, P1399, DOI 10.1056/NEJM198206103062305; CARRIE S, 1992, ACTA OTO-LARYNGOL, V112, P504, DOI 10.3109/00016489209137432; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Chen RW, 2007, NEUROSCI LETT, V418, P165, DOI 10.1016/j.neulet.2007.03.033; Chen YP, 2001, ACTA OTO-LARYNGOL, V121, P45; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chua TC, 2009, PATHOL ONCOL RES, V15, P671, DOI 10.1007/s12253-009-9170-0; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Cortijo J, 2009, BRIT J PHARMACOL, V156, P534, DOI 10.1111/j.1476-5381.2008.00041.x; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Farrell DJ, 2007, PEDIATR INFECT DIS J, V26, P123, DOI 10.1097/01.inf.0000253059.84602.c3; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Fletcher MA, 2007, VACCINE, V25, P2507, DOI 10.1016/j.vaccine.2006.09.027; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Gates GA, 1996, OTOLARYNG HEAD NECK, V114, P525, DOI 10.1016/S0194-5998(96)70243-7; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; GIEBINK GS, 1991, ADV EXP MED BIOL, V303, P149; Ha UH, 2008, J BIOL CHEM, V283, P30624, DOI 10.1074/jbc.M802519200; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Herr BD, 2005, OTOLARYNG HEAD NECK, V132, P527, DOI 10.1016/j.otohns.2004.09.138; Huang YX, 2007, BIOCHEM BIOPH RES CO, V359, P691, DOI 10.1016/j.bbrc.2007.05.170; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Ishinaga H, 2009, BIOCHEM J, V417, P583, DOI 10.1042/BJ20080781; Jacobs MR, 2008, J CLIN MICROBIOL, V46, P982, DOI 10.1128/JCM.02321-07; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Jono H, 2002, J BIOL CHEM, V277, P45547, DOI 10.1074/jbc.M206883200; Jung H. H., 1999, REC ADV OT MED EFF P, P251; Kerschner JE, 2009, ARCH OTOLARYNGOL, V135, P33, DOI 10.1001/archoto.2008.513; Kerschner JE, 2007, LARYNGOSCOPE, V117, P1666, DOI 10.1097/MLG.0b013e31806db531; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kodimuthali A, 2008, J MED CHEM, V51, P5471, DOI 10.1021/jm800582j; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Komatsu K, 2008, BIOCHEM BIOPH RES CO, V377, P763, DOI 10.1016/j.bbrc.2008.10.091; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Li JD, 2003, J PHARMACOL SCI, V91, P1, DOI 10.1254/jphs.91.1; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim DJ, 2000, VACCINE, V19, pS17, DOI 10.1016/S0264-410X(00)00273-5; Lim JH, 2008, CELL MICROBIOL, V10, P2247, DOI 10.1111/j.1462-5822.2008.01204.x; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Lim JH, 2009, AM J TRANSL RES, V1, P300; Lim JH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-40; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MAJIMA Y, 1988, ANN OTO RHINOL LARYN, V97, P272, DOI 10.1177/000348948809700311; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Miro N, 2000, OTOLARYNG HEAD NECK, V123, P617, DOI 10.1067/mhn.2000.107888; Moore MR, 2008, CLIN INFECT DIS, V46, P183, DOI 10.1086/524661; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nikolaev VO, 2005, J BIOL CHEM, V280, P1716, DOI 10.1074/jbc.C400505200; O'Byrne PM, 2009, LANCET, V374, P665, DOI 10.1016/S0140-6736(09)61538-5; Palacios SD, 2002, J INFECT DIS, V186, P1761, DOI 10.1086/345798; Palacios SD, 2002, LARYNGOSCOPE, V112, P420, DOI 10.1097/00005537-200203000-00002; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Rahman A, 2007, CLIN THER, V29, P1950, DOI 10.1016/j.clinthera.2007.09.005; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; REICHMAN J, 1983, J LEARN DISABIL, V16, P272, DOI 10.1177/002221948301600506; Rose AS, 1997, OTOLARYNG HEAD NECK, V116, P308, DOI 10.1016/S0194-5998(97)70265-1; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Shen H, 2008, BIOCHEM BIOPH RES CO, V365, P795, DOI 10.1016/j.bbrc.2007.11.060; Smirnova MG, 2000, CYTOKINE, V12, P1732, DOI 10.1006/cyto.2000.0763; Sousa LP, 2009, BIOCHEM PHARMACOL, V78, P396, DOI 10.1016/j.bcp.2009.04.030; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; Stenner M, 2006, LARYNGO RHINO OTOL, V85, P32, DOI 10.1055/s-2005-870274; Straetemans M, 2003, PEDIATR INFECT DIS J, V22, P515, DOI 10.1097/00006454-200306000-00007; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Van Bambeke F, 2007, DRUGS, V67, P2355, DOI 10.2165/00003495-200767160-00005; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; Wall GM, 2009, PEDIATR INFECT DIS J, V28, P141, DOI 10.1097/INF.0b013e31818b0c9c; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Wu GJ, 2001, GENE, V279, P17, DOI 10.1016/S0378-1119(01)00736-3; Yan FG, 2008, BIOCHEM BIOPH RES CO, V366, P513, DOI 10.1016/j.bbrc.2007.11.172; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008; Zippe CD, 1998, UROLOGY, V52, P963, DOI 10.1016/S0090-4295(98)00443-9	95	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22799	22811		10.1074/jbc.M111.337378	http://dx.doi.org/10.1074/jbc.M111.337378			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22610099	Green Published, hybrid			2022-12-28	WOS:000306495000037
J	Pehar, M; Lehnus, M; Karst, A; Puglielli, L				Pehar, Mariana; Lehnus, Massimiliano; Karst, Anna; Puglielli, Luigi			Proteomic Assessment Shows That Many Endoplasmic Reticulum (ER)-resident Proteins Are Targeted by N-epsilon-Lysine Acetylation in the Lumen of the Organelle and Predicts Broad Biological Impact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACE1 LEVELS; ER	In addition to the nucleus, cytosol, and mitochondrial lumen, N-epsilon-lysine acetylation also occurs in the lumen of the endoplasmic reticulum ( ER). However, the impact of such an event on ER functions is still unknown. Here, we analyzed the "ER acetyllysine proteome" by nano-LC-MS/MS and discovered that a large number of ER-resident and -transiting proteins undergo N-epsilon-lysine acetylation in the lumen of the organelle. The list of ER-resident proteins includes chaperones and enzymes involved with post-translational modification and folding. Grouping of all acetylated proteins into major functional categories suggests that the ER-based acetylation machinery regulates very diverse biological events. As such, it is predicted to play a fundamental role in human physiology as well as human pathology.	[Puglielli, Luigi] Univ Wisconsin, Dept Med, VAH GRECC, Madison, WI 53705 USA; [Puglielli, Luigi] Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, VAH GRECC, 2500 Overlook Terr, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health through NIA [AG028569, AG033514]; NATIONAL INSTITUTE ON AGING [R01AG028569, P50AG033514] Funding Source: NIH RePORTER	National Institutes of Health through NIA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG028569 and AG033514 (to L.P.) through the NIA.	Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Ding Y, 2012, J BIOL CHEM, V287, P8424, DOI 10.1074/jbc.M111.310136; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; GAUT JR, 1993, J BIOL CHEM, V268, P7248; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599	16	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22436	22440		10.1074/jbc.C112.362871	http://dx.doi.org/10.1074/jbc.C112.362871			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22628546	Green Published, hybrid			2022-12-28	WOS:000306495000002
J	Thomas, RM; Gamper, CJ; Ladle, BH; Powell, JD; Wells, AD				Thomas, Rajan M.; Gamper, Christopher J.; Ladle, Brian H.; Powell, Jonathan D.; Wells, Andrew D.			De Novo DNA Methylation Is Required to Restrict T Helper Lineage Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; IFN-GAMMA PROMOTER; METHYLTRANSFERASE 3A; H3K4 METHYLATION; TH17 CELLS; DIFFERENTIATION; GENE; CYTOKINE; TRANSCRIPTION; BET	Naive CD4+ T cells are highly plastic and can differentiate into discrete lineages with unique functions during an immune response. Once differentiated, helper T cells maintain a stable transcriptional memory of their initial lineage choice and resist redifferentiation. During embryogenesis, de novo DNA methylation operates on the hypomethylated genome of the blastocyst to achieve tissue-specific patterns of gene expression. Similarly, the ifn gamma promoter is hypomethylated in naive T cells, but Th2, Th17, and iTreg differentiation is accompanied by substantial de novo DNA methylation at this locus. To determine whether de novo DNA methylation is required to restrict T helper lineage plasticity, we used mice with T cell-specific deletion of the methyltransferase DNMT3a. Induction of lineage-specific cytokines occurred normally in the absence of DNMT3a, however, DNMT3a-deficient Th2, Th17, and iTreg completely failed to methylate the ifn gamma promoter. This was accompanied by an increase in the transcriptionally permissive trimethyl H3K4 mark, and a reduction in inhibitory H3K27 methylation at the ifn gamma locus. Failed de novo methylation resulted in failed silencing of the ifn gamma gene, as DNMT3a-deficient Th2, Th17, and iTreg cells produced significant levels of IFN gamma following restimulation in the presence of IL-12. Therefore, DNMT3a-mediated DNA methylation restricts T helper plasticity by establishing an epigenetically silent chromatin structure at regulatory regions of the ifn gamma gene.	[Thomas, Rajan M.; Wells, Andrew D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Thomas, Rajan M.; Wells, Andrew D.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Gamper, Christopher J.; Ladle, Brian H.; Powell, Jonathan D.] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21287 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University	Gamper, CJ (corresponding author), 1650 Orleans St, Baltimore, MD 21287 USA.	cgamper1@jhmi.edu; adwells@mail.med.upenn.edu	Thomas, Rajan M/AAW-7207-2021	Gamper, Christopher/0000-0003-0253-2177	National Institutes of Health [AI070807, HL108346]; American Cancer Society [RSG109185]; Hyundai Scholar Award; Joan and Jonas Cash Foundation; Optimist International Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL108346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Hyundai Scholar Award; Joan and Jonas Cash Foundation; Optimist International Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI070807 (to A. D. W.) and HL108346 (to C. J. G.). This work was also supported by American Cancer Society Grant RSG109185 (to J. D. P.).; A St. Baldrick's Scholar (180359) and supported by a Hyundai Scholar Award and the Joan and Jonas Cash Foundation. To whom correspondence may be addressed: 1650 Orleans St., Baltimore, MD 21287. Tel.: 410-502-2342; E-mail: cgamper1@jhmi.edu.; Supported by an Optimist International Research Fellowship.	Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chang SJ, 2008, J IMMUNOL, V181, P8372, DOI 10.4049/jimmunol.181.12.8372; Cohen CJ, 2011, J IMMUNOL, V187, P5615, DOI 10.4049/jimmunol.1101058; Gamper CJ, 2009, J IMMUNOL, V183, P2267, DOI 10.4049/jimmunol.0802960; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Lande-Diner L, 2007, J BIOL CHEM, V282, P12194, DOI 10.1074/jbc.M607838200; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Rowel E, 2008, CURR OPIN IMMUNOL, V20, P272, DOI 10.1016/j.coi.2008.03.012; Thomas RM, 2007, GENES IMMUN, V8, P613, DOI 10.1038/sj.gene.6364415; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Tong YK, 2005, P NATL ACAD SCI USA, V102, P2034, DOI 10.1073/pnas.0409510102; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Winders BR, 2004, J IMMUNOL, V173, P7377, DOI 10.4049/jimmunol.173.12.7377; YOUNG HA, 1994, J IMMUNOL, V153, P3603	34	54	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22900	22909		10.1074/jbc.M111.312785	http://dx.doi.org/10.1074/jbc.M111.312785			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584578	hybrid, Green Published			2022-12-28	WOS:000306495000047
J	Osada, M; Inoue, O; Ding, G; Shirai, T; Ichise, H; Hirayama, K; Takano, K; Yatomi, Y; Hirashima, M; Fujii, H; Suzuki-Inoue, K; Ozaki, Y				Osada, Makoto; Inoue, Osamu; Ding, Guo; Shirai, Toshiaki; Ichise, Hirotake; Hirayama, Kazuyoshi; Takano, Katsuhiro; Yatomi, Yutaka; Hirashima, Masanori; Fujii, Hideki; Suzuki-Inoue, Katsue; Ozaki, Yukio			Platelet Activation Receptor CLEC-2 Regulates Blood/Lymphatic Vessel Separation by Inhibiting Proliferation, Migration, and Tube Formation of Lymphatic Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; BONE MORPHOGENETIC PROTEIN-9; PHOSPHOLIPASE C-GAMMA-2; INTEGRIN ACTIVATION; GLYCOPROTEIN-VI; MICE LACKING; PODOPLANIN; BLOOD; SYK; ANGIOGENESIS	The platelet activation receptor CLEC-2 plays crucial roles in thrombosis/hemostasis, tumor metastasis, and lymphangiogenesis, although its role in thrombosis/hemostasis remains controversial. An endogenous ligand for CLEC-2, podoplanin, is expressed in lymphatic endothelial cells (LECs). We and others have reported that CLEC-2-deficiency is lethal at mouse embryonic/neonatal stages associated with blood-filled lymphatics, indicating that CLEC-2 is essential for blood/lymphatic vessel separation. However, its mechanism, and whether CLEC-2 in platelets is necessary for this separation, remains unknown. We found that specific deletion of CLEC-2 from platelets leads to the misconnection of blood/lymphatic vessels. CLEC-2(+/+) platelets platelets, but not by CLEC-2(-/-) platelets, inhibited LEC migration, proliferation, and tube formation but had no effect on human umbilical vein endothelial cells. Additionally, supernatants from activated platelets significantly inhibited these three functions in LECs, suggesting that released granule contents regulate blood/lymphatic vessel separation. Bone morphologic protein-9 (BMP-9), which we found to be present in platelets and released upon activation, appears to play a key role in regulating LEC functions. Only BMP-9 inhibited tube formation, although other releasates including transforming growth factor-beta and platelet factor 4 inhibited proliferation and/or migration. We propose that platelets regulate blood/lymphatic vessel separation by inhibiting the proliferation, migration, and tube formation of LECs, mainly because of the release of BMP-9 upon activation by CLEC-2/podoplanin interaction.	[Osada, Makoto; Inoue, Osamu; Shirai, Toshiaki; Takano, Katsuhiro; Suzuki-Inoue, Katsue; Ozaki, Yukio] Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, Yamanashi 4093898, Japan; [Ding, Guo; Hirashima, Masanori] Kobe Univ, Grad Sch Med, Div Vasc Biol, Dept Physiol & Cell Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ichise, Hirotake] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Dev Genet, Tokyo 1088639, Japan; [Hirayama, Kazuyoshi; Fujii, Hideki] Univ Yamanashi, Fac Med, Dept Surg 1, Chuo Ku, Yamanashi 4093898, Japan; [Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Lab Med, Tokyo 1138655, Japan	University of Yamanashi; Kobe University; University of Tokyo; University of Yamanashi; University of Tokyo	Suzuki-Inoue, K (corresponding author), Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	katsuei@yamanashi.ac.jp	Ichise, Hirotake/V-3536-2019; Hirashima, Masanori/ABC-9204-2021	Ichise, Hirotake/0000-0002-3424-6637; Hirashima, Masanori/0000-0002-0190-4381; Yatomi, Yutaka/0000-0003-1719-4297	Ministry of Education, Culture, Sports, Science, and Technology; Council for Science and Technology Policy (CSTP); Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23591984] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (CSTP).	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Banfi C, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2008.03204.x; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Carramolino L, 2010, CIRC RES, V106, P1197, DOI 10.1161/CIRCRESAHA.110.218073; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Chang CH, 2010, J THROMB HAEMOST, V8, P2563, DOI 10.1111/j.1538-7836.2010.04045.x; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Chung CH, 2004, BLOOD, V103, P2105, DOI 10.1182/blood-2003-07-2483; Colonna M, 2000, EUR J IMMUNOL, V30, P697; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Ho-Tin-Noe B, 2011, J THROMB HAEMOST, V9, P56, DOI 10.1111/j.1538-7836.2011.04317.x; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Inoue O, 2009, FEBS LETT, V583, P81, DOI 10.1016/j.febslet.2008.11.026; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; Kandler B, 2004, J PERIODONTOL, V75, P1255, DOI 10.1902/jop.2004.75.9.1255; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641; Navarro A, 2011, AM J PHYSIOL-LUNG C, V300, pL32, DOI 10.1152/ajplung.00171.2010; Navdaev A, 2001, J BIOL CHEM, V276, P20882, DOI 10.1074/jbc.M101585200; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Osada M., 2010, BLOOD, V116, P160; Pipili-Synetos E, 1998, BRIT J PHARMACOL, V125, P1252, DOI 10.1038/sj.bjp.0702191; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Shao XJ, 2005, LYMPHOLOGY, V38, P146; Shao XJ, 2005, LYMPHOLOGY, V38, P1; SHIVDASANI RA, 1995, P NATL ACAD SCI USA, V92, P8690, DOI 10.1073/pnas.92.19.8690; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Suzuki-Inoue K, 2001, J BIOL CHEM, V276, P1643, DOI 10.1074/jbc.M006191200; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tsuruo T, 2008, P JPN ACAD A-MATH, V84, P189, DOI 10.2183/pjab/84.189; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Yamashita H, 1996, BONE, V19, P569, DOI 10.1016/S8756-3282(96)00259-1	51	98	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22241	22252		10.1074/jbc.M111.329987	http://dx.doi.org/10.1074/jbc.M111.329987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556408	Green Published, hybrid			2022-12-28	WOS:000306418600062
J	Choi, SG; Jia, J; Pfeffer, RL; Sealfon, SC				Choi, Soon-Gang; Jia, Jingjing; Pfeffer, Robert L.; Sealfon, Stuart C.			G Proteins and Autocrine Signaling Differentially Regulate Gonadotropin Subunit Expression in Pituitary Gonadotrope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; BONE MORPHOGENETIC PROTEIN-2; LUTEINIZING-HORMONE; HUMAN ENDOMETRIAL; CANCER-CELLS; BETA-SUBUNIT; RECEPTOR; ACTIVIN; GNRH; TRANSCRIPTION	Gonadotropin-releasing hormone (GnRH) acts at gonadotropes to direct the synthesis of the gonadotropins, follicle-stimulating hormone (FSH), and luteinizing hormone (LH). The frequency of GnRH pulses determines the pattern of gonadotropin synthesis. Several hypotheses for how the gonadotrope decodes GnRH frequency to regulate gonadotropin subunit genes differentially have been proposed. However, key regulators and underlying mechanisms remain uncertain. We investigated the role of individual G proteins by perturbations using siRNA or bacterial toxins. In L beta T2 gonadotrope cells, FSH beta gene induction depended predominantly on G alpha(q/11), whereas LH beta expression depended on G alpha(s). Specifically reducing G alpha(s) signaling also disinhibited FSH beta expression, suggesting the presence of a G alpha(s)-dependent signal that suppressed FSH biosynthesis. The presence of secreted factors influencing FSH beta expression levels was tested by studying the effects of conditioned media from G alpha(s) knockdown and cholera toxin-treated cells on FSH beta expression. These studies and related Transwell culture experiments implicate G alpha(s)-dependent secreted factors in regulating both FSH beta and LH beta gene expression. siRNA studies identify inhibin alpha as a G alpha(s)-dependent GnRH-induced autocrine regulatory factor that contributes to feedback suppression of FSH beta expression. These results uncover differential regulation of the gonadotropin genes by G alpha(q/11) and by G alpha(s) and implicate autocrine and gonadotrope-gonadotrope paracrine regulatory loops in the differential induction of gonadotropin genes.	Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sealfon, SC (corresponding author), Neurol Box 1137,1 Gustave L Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	choi, soon gang/AAE-3187-2019; Choi, Soon Gang/G-8337-2013	choi, soon gang/0000-0003-0314-3958; Choi, Soon Gang/0000-0003-0314-3958; SEALFON, Stuart/0000-0001-5791-1217	National Institutes of Health [R01DK046943]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK046943	Achermann JC, 2001, MOL CELL ENDOCRINOL, V179, P89, DOI 10.1016/S0303-7207(01)00474-9; AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bowles R, 2011, JOVE-J VIS EXP, DOI 10.3791/2766; Brothers SP, 2003, J CLIN ENDOCR METAB, V88, P6107, DOI 10.1210/jc.2003-031047; Burger LL, 2002, ENDOCRINOLOGY, V143, P3243, DOI 10.1210/en.2002-220216; Cheung LWT, 2008, FEBS J, V275, P5479, DOI 10.1111/j.1742-4658.2008.06677.x; Ciccone NA, 2008, MOL ENDOCRINOL, V22, P1908, DOI 10.1210/me.2007-0455; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Fink MY, 2010, MOL ENDOCRINOL, V24, P1863, DOI 10.1210/me.2009-0530; Grundker C, 2001, ENDOCRINOLOGY, V142, P2369, DOI 10.1210/en.142.6.2369; Grundker C, 2001, EUR J ENDOCRINOL, V145, P651, DOI 10.1530/eje.0.1450651; Hall JE, 1998, J ENDOCRINOL INVEST, V21, P602, DOI 10.1007/BF03350785; Ho CC, 2010, ENDOCRINOLOGY, V151, P3445, DOI 10.1210/en.2010-0071; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2275, DOI 10.1210/en.142.6.2275; KANYICSKA B, 1991, ENDOCRINOLOGY, V129, P2607, DOI 10.1210/endo-129-5-2607; Kimura A, 1999, CANCER RES, V59, P5133; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Krsmanovic LZ, 2003, P NATL ACAD SCI USA, V100, P2969, DOI 10.1073/pnas.0535708100; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; MAPARA MY, 1995, BLOOD, V85, P1836, DOI 10.1182/blood.V85.7.1836.bloodjournal8571836; MARSHALL JC, 1991, RECENT PROG HORM RES, V47, P155; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; Popovics P, 2011, J ENDOCRINOL, V210, P71, DOI 10.1530/JOE-10-0485; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; SHAH BH, 1994, MOL PHARMACOL, V46, P1; Shimoni Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000828; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Smyth VA, 2008, J BIOL CHEM, V283, P10881, DOI 10.1074/jbc.M710454200; Stanislaus D, 1997, MOL ENDOCRINOL, V11, P738, DOI 10.1210/me.11.6.738; Tang SK, 2010, INT J SYST EVOL MICR, V60, P2113, DOI 10.1099/ijs.0.018440-0; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; Wu JC, 2004, ENDOCRINOLOGY, V145, P5832, DOI 10.1210/en.2004-0257; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Zhu J, 2012, J BIOL CHEM, V287, P8060, DOI 10.1074/jbc.M111.293381	50	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21550	21560		10.1074/jbc.M112.348607	http://dx.doi.org/10.1074/jbc.M112.348607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549790	hybrid, Green Published			2022-12-28	WOS:000306416800072
J	Xiao, GZ; Cheng, HQ; Cao, HL; Chen, K; Tu, YZ; Yu, SB; Jiao, HL; Yang, SY; Im, HJ; Chen, D; Chen, J; Wu, CY				Xiao, Guozhi; Cheng, Hongqiang; Cao, Huiling; Chen, Ka; Tu, Yizeng; Yu, Shibing; Jiao, Hongli; Yang, Shengyong; Im, Hee-Jeong; Chen, Di; Chen, Ju; Wu, Chuanyue			Critical Role of Filamin-binding LIM Protein 1 (FBLP-1)/Migfilin in Regulation of Bone Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLAST-OSTEOBLAST COMMUNICATION; ACTIVATING TRANSCRIPTION FACTOR-4; OSTEOCALCIN GENE-EXPRESSION; CELL-MATRIX ADHESION; RANKL EXPRESSION; PARATHYROID-HORMONE; STEM-CELLS; MIGFILIN; DIFFERENTIATION; INTEGRIN	Bone remodeling is a complex process that must be precisely controlled to maintain a healthy life. We show here that filamin-binding LIM protein 1 (FBLP-1, also known as migfilin), a kind-lin- and filamin-binding focal adhesion protein, is essential for proper control of bone remodeling. Genetic inactivation of FBLIM1 (the gene encoding FBLP-1) in mice resulted in a severe osteopenic phenotype. Primary FBLP-1 null bone marrow stromal cells (BMSCs) exhibited significantly reduced extracellular matrix adhesion and migration compared with wild type BMSCs. Loss of FBLP-1 significantly impaired the growth and survival of BMSCs in vitro and decreased the number of osteoblast (OB) progenitors in bone marrow and OB differentiation in vivo. Furthermore, the loss of FBLP-1 caused a dramatic increase of osteoclast (OCL) differentiation in vivo. The level of receptor activator of nuclear factor kappa B ligand (RANKL), a key regulator of OCL differentiation, was markedly increased in FBLP-1 null BMSCs. The capacity of FBLP-1 null bone marrow monocytes (BMMs) to differentiate into multinucleated OCLs in response to exogenously supplied RANKL, however, was not different from that of WT BMMs. Finally, we show that a loss of FBLP-1 promotes activating phosphorylation of ERK1/2. Inhibition of ERK1/2 activation substantially suppressed the increase of RANKL induced by the loss of FBLP-1. Our results identify FBLP-1 as a key regulator of bone homeostasis and suggest that FBLP-1 functions in this process through modulating both the intrinsic properties of OB/BMSCs (i.e., BMSC-extracellular matrix adhesion and migration, cell growth, survival, and differentiation) and the communication between OB/BMSCs and BMMs (i.e., RANKL expression) that controls osteoclastogenesis.	[Xiao, Guozhi; Jiao, Hongli; Im, Hee-Jeong; Chen, Di] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Xiao, Guozhi; Cao, Huiling; Yu, Shibing; Jiao, Hongli; Yang, Shengyong] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15240 USA; [Cheng, Hongqiang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chen, Ka; Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Rush University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, GZ (corresponding author), Rush Univ, Med Ctr, Dept Biochem, Cohn Res Bldg,Rm 518,1735 W Harrison St, Chicago, IL 60612 USA.	xiaogz118@gmail.com; juchen@ucsd.edu; carywu@pitt.edu	Chen, Ju/E-5579-2011; Chen, Di/AAJ-3665-2021	Jiao, Hongli/0000-0001-8005-8496; Cheng, Hongqiang/0000-0001-9662-1570	National Institutes of Health [AR059647, GM65188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055915, R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AR059647 (to G. X.) and GM65188 (to C. W.).	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Camacho C. L., 2011, THESIS U MANCHESTER; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Cao X, 2011, NAT MED, V17, P1344, DOI 10.1038/nm.2499; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gkretsi V, 2005, J CELL SCI, V118, P697, DOI 10.1242/jcs.01638; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Lai-Cheong JE, 2010, INT J BIOCHEM CELL B, V42, P595, DOI 10.1016/j.biocel.2009.10.015; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lee JH, 2009, J BIOL CHEM, V284, P13725, DOI 10.1074/jbc.M806941200; Liang XQ, 2005, MOL CELL BIOL, V25, P3056, DOI 10.1128/MCB.25.8.3056-3062.2005; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moursi AM, 1996, J CELL SCI, V109, P1369; Nakahama K, 2010, CELL MOL LIFE SCI, V67, P4001, DOI 10.1007/s00018-010-0479-3; Nishida S, 2005, BIOCHEM BIOPH RES CO, V328, P91, DOI 10.1016/j.bbrc.2004.12.145; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; TERMINE JD, 1990, EXP GERONTOL, V25, P217, DOI 10.1016/0531-5565(90)90055-7; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Walker CG, 2010, BONE, V47, P1020, DOI 10.1016/j.bone.2010.08.025; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; Yu SB, 2008, ENDOCRINOLOGY, V149, P1960, DOI 10.1210/en.2007-1573; Yu SB, 2008, J BIOL CHEM, V283, P5542, DOI 10.1074/jbc.M705653200; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200; Zhang YJ, 2002, J BIOL CHEM, V277, P318, DOI 10.1074/jbc.M108257200; Zhao JP, 2009, J BIOL CHEM, V284, P34308, DOI 10.1074/jbc.M109.045021; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	57	41	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21450	21460		10.1074/jbc.M111.331249	http://dx.doi.org/10.1074/jbc.M111.331249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556421	Green Published, hybrid			2022-12-28	WOS:000306416800062
J	Jin, QY; Ding, W; Mulder, KM				Jin, Qunyan; Ding, Wei; Mulder, Kathleen M.			The TGF beta Receptor-interacting Protein km23-1/DYNLRB1 Plays an Adaptor Role in TGF beta 1 Autoinduction via Its Association with Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; BREAST-CANCER CELLS; LIGHT-CHAIN KM23-1; EPITHELIAL-CELLS; CYTOPLASMIC DYNEIN; C-JUN; TRANSFORMING GROWTH-FACTOR-BETA-1; CARCINOMA CELLS; COGNATE GAP; ACTIVATION	We have previously elucidated the signaling events that are required for TGF beta 1 autoinduction (Yue, J., and Mulder, K. M. (2000) J. Biol. Chem. 275, 30765-30773). Further, we have reported that the TGF beta receptor (T beta R)-interacting protein km23-1 plays an important role in TGF beta signal transduction (Jin, Q., Ding, W., and Mulder, K. M. (2007) J. Biol. Chem. 282, 19122-19132). Here we examined the role of km23-1 in TGF beta 1 autoinduction in TGF beta-sensitive epithelial cells. siRNA blockade of km23-1 reduced TGF beta 1 mRNA expression, as well as DNA binding and transcriptional activation of the relevant activator protein-1 site in the human TGF beta 1 promoter. Further, knockdown of km23-1 inhibited TGF beta-mediated activation of ERK and JNK, phosphorylation of c-Jun, and transactivation of the c-Jun promoter. Sucrose gradient analyses indicate that km23-1 was present in lipid rafts together with Ras and T beta RII after TGF beta treatment. Immunoprecipitation/blot analyses revealed the formation of a TGF beta-inducible complex between Ras and km23-1 in vivo within minutes of TGF beta addition. Moreover, we demonstrate for the first time that km23-1 is required for Ras activation by TGF beta. Our results indicate that km23-1 is required for TGF beta 1 autoinduction through Smad2-independent Ras/ERK/JNK pathways. More importantly, our findings demonstrate that km23-1 functions as a critical adaptor coupling T beta R activation to activation of Ras effector pathways downstream.	[Jin, Qunyan; Ding, Wei; Mulder, Kathleen M.] Penn State Hershey Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mulder, KM (corresponding author), Penn State Hershey Coll Med, Dept Biochem & Mol Biol MC H171, 500 Univ Dr, Hershey, PA 17033 USA.	kmm15@psu.edu			National Institutes of Health [CA090765, CA092889, CA100239, CA092889-08S1]; NATIONAL CANCER INSTITUTE [R01CA100239, R01CA090765, R01CA092889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090765, CA092889, CA100239, and CA092889-08S1 (to K. M. M.).	Campbell IG, 2006, CLIN CANCER RES, V12, P3713, DOI 10.1158/1078-0432.CCR-06-0800; Chapnick DA, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-42; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1996, CURR BIOL, V6, P1226, DOI 10.1016/S0960-9822(96)00702-6; Ding Wei, 2004, Cancer Treat Res, V119, P315; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Frey RS, 1997, CANCER LETT, V117, P41, DOI 10.1016/S0304-3835(97)00211-5; Frey RS, 1997, CANCER RES, V57, P628; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Hartsough MT, 1997, PHARMACOL THERAPEUT, V75, P21, DOI 10.1016/S0163-7258(97)00020-X; Ilangovan U, 2005, J MOL BIOL, V352, P338, DOI 10.1016/j.jmb.2005.07.002; Jiang JM, 2001, GENE, V281, P103, DOI 10.1016/S0378-1119(01)00787-9; Jin Q, 2007, J BIOL CHEM, V282, P19122, DOI 10.1074/jbc.M609915200; Jin QY, 2009, J CELL PHYSIOL, V221, P707, DOI 10.1002/jcp.21910; Jin QY, 2005, CELL SIGNAL, V17, P1363, DOI 10.1016/j.cellsig.2005.02.004; Kang HC, 2007, CANCER GENET CYTOGEN, V175, P173, DOI 10.1016/j.cancergencyto.2007.02.004; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KATO M, 1995, J BIOL CHEM, V270, P12373, DOI 10.1074/jbc.270.21.12373; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KIM SJ, 1989, J BIOL CHEM, V264, P402; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; LASSUS P, 2002, SCI STKE; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114; Lin S, 2011, J BIOL CHEM, V286, P44023, DOI 10.1074/jbc.M111.265397; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu GM, 2006, J BIOL CHEM, V281, P29479, DOI 10.1074/jbc.M600579200; Liu GM, 2006, MOL CARCINOGEN, V45, P582, DOI 10.1002/mc.20189; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Mulder K. M., 1989, CELL MOL BIOL COLON, P45; MULDER KM, 1993, J CELL PHYSIOL, V154, P162, DOI 10.1002/jcp.1041540120; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nikulina K, 2004, CELL MOTIL CYTOSKEL, V57, P233, DOI 10.1002/cm.10172; Pandey MK, 2012, INT J CANCER, V130, P213, DOI 10.1002/ijc.25997; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Pulipati NR, 2011, INT J CANCER, V129, P553, DOI 10.1002/ijc.25954; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wong C, 1999, MOL CELL BIOL, V19, P1821; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Yue J, 2004, J CELL PHYSIOL, V199, P284, DOI 10.1002/jcp.10469; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	60	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26453	26463		10.1074/jbc.M112.344887	http://dx.doi.org/10.1074/jbc.M112.344887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22637579	hybrid, Green Published			2022-12-28	WOS:000306916300070
J	Nagy, P; Lechte, TP; Das, AB; Winterbourn, CC				Nagy, Peter; Lechte, Thomas P.; Das, Andrew B.; Winterbourn, Christine C.			Conjugation of Glutathione to Oxidized Tyrosine Residues in Peptides and Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLET OXYGEN; CYSTEINE DIOXYGENASE; PHENOXYL RADICALS; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; SUPEROXIDE; MYELOPEROXIDASE; ELECTROPHILE; PEROXIDES; ACID	Tyrosine residues are sensitive to oxidation and can be converted to hydroperoxides either by superoxide reacting with the Tyr radical or by singlet oxygen. These hydroperoxides rearrange to bicyclic derivatives that are readily reduced to more stable hydroxides. The aromatic character of tyrosine is lost, but the product contains an alpha-beta unsaturated carbonyl group and is, therefore, an electrophile. We have generated hydroxide derivatives of several Tyr-containing peptides and shown using liquid chromatography/mass spectrometry that they undergo Michael addition with GSH. For Tyr-Gly, rate constants of 9.2 and 11.8 M(-1)min(-1) were measured for the two chromatographically distinct isomers. Unusual for GSH addition to an electrophile, the reaction is reversible, with a half-life of many hours for the reverse reaction. These kinetics indicate that with a typical cellular concentration of 5 mM GSH, >95% Tyr-Gly hydroxide would become conjugated with a half-life of similar to 15 min. Sperm whale myoglobin forms a hydroperoxide on Tyr-151 in a hydrogen peroxide/superoxide-dependent reaction. We show that its hydroxide derivative reacts with GSH to form a conjugate. Detection of the conjugate required stabilization by reduction; otherwise, the reverse reaction occurred during tryptic digestion and analysis. Our findings represent a novel mechanism for peptide or protein glutathionylation involving a carbon-sulfur cross-link between oxidized Tyr and Cys. As with other electrophiles, the oxidized Tyr should undergo a similar reaction with Cys residues in proteins to give intramolecular or intermolecular protein cross-links. This mechanism could give rise to protein cross-linking in conditions of oxidative stress.	[Nagy, Peter; Lechte, Thomas P.; Das, Andrew B.; Winterbourn, Christine C.] Univ Otago, Dept Pathol, Free Rad Res Grp, Christchurch 8040, New Zealand	University of Otago	Winterbourn, CC (corresponding author), Univ Otago, Dept Pathol, Free Rad Res Grp, POB 4345, Christchurch 8040, New Zealand.	christine.winterbourn@otago.ac.nz	Das, Andrew/I-8352-2018; Nagy, Peter/C-6768-2008	Das, Andrew/0000-0001-6509-4886; Nagy, Peter/0000-0003-3393-235X	New Zealand Marsden Fund	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the New Zealand Marsden Fund.	Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Das AB, 2010, FREE RADICAL BIO MED, V48, P1540, DOI 10.1016/j.freeradbiomed.2010.02.039; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Espenson J. H., 1995, CHEM KINETICS REACTI, P46; ESTERBAUER H, 1975, Z NATURFORSCH C, V30, P466; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Gieseg S, 2000, BIOCHEM J, V350, P215, DOI 10.1042/0264-6021:3500215; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Higdon A. N., 2012, ANTIOXID REDOX SIGNA; Hill BG, 2012, J MOL CELL CARDIOL, V52, P559, DOI 10.1016/j.yjmcc.2011.07.009; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; JIN FM, 1993, J CHEM SOC PERK T 2, P1583, DOI 10.1039/p29930001583; JONSSON M, 1993, J PHYS CHEM-US, V97, P8229, DOI 10.1021/j100133a018; Lardinois OM, 2003, J BIOL CHEM, V278, P36214, DOI 10.1074/jbc.M304726200; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Morgan PE, 2004, FREE RADICAL BIO MED, V36, P484, DOI 10.1016/j.freeradbiomed.2003.11.021; Morgan PE, 2002, EUR J BIOCHEM, V269, P1916, DOI 10.1046/j.1432-1033.2002.02845.x; Nagy P, 2010, FREE RADICAL BIO MED, V49, P792, DOI 10.1016/j.freeradbiomed.2010.05.033; Nagy P, 2009, J BIOL CHEM, V284, P14723, DOI 10.1074/jbc.M809396200; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; Rahmanto AS, 2010, FREE RADICAL BIO MED, V49, P1505, DOI 10.1016/j.freeradbiomed.2010.08.006; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; SAITO I, 1975, J AM CHEM SOC, V97, P5272, DOI 10.1021/ja00851a042; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SCHUPPE I, 1992, BIOCHEM PHARMACOL, V44, P1757, DOI 10.1016/0006-2952(92)90069-U; Schwobel JAH, 2010, SAR QSAR ENVIRON RES, V21, P693, DOI 10.1080/1062936X.2010.528943; Siakkou E, 2011, BBA-PROTEINS PROTEOM, V1814, P2003, DOI 10.1016/j.bbapap.2011.07.019; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Winterbourn CC, 1997, ARCH BIOCHEM BIOPHYS, V338, P15, DOI 10.1006/abbi.1996.9773; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Wright A, 2002, PHOTOCHEM PHOTOBIOL, V76, P35, DOI 10.1562/0031-8655(2002)076<0035:SOMPOE>2.0.CO;2	38	24	24	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26068	26076		10.1074/jbc.M112.371690	http://dx.doi.org/10.1074/jbc.M112.371690			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22648418	Green Published, hybrid			2022-12-28	WOS:000306916300034
J	Groner, AC; Tschopp, P; Challet, L; Dietrich, JE; Verp, S; Offner, S; Barde, I; Rodriguez, I; Hiiragi, T; Trono, D				Groner, Anna C.; Tschopp, Patrick; Challet, Ludivine; Dietrich, Jens-Erik; Verp, Sonia; Offner, Sandra; Barde, Isabelle; Rodriguez, Ivan; Hiiragi, Takashi; Trono, Didier			The Kruppel-associated Box Repressor Domain Can Induce Reversible Heterochromatization of a Mouse Locus in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; SMALL-INTERFERING-RNA; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; LENTIVIRAL VECTORS; TRANSGENIC MICE; STEM-CELLS; COREPRESSOR; METHYLATION; SUPPRESSION	The study of chromatin and its regulators is key to understanding and manipulating transcription. We previously exploited the Kruppel-associated box (KRAB) transcriptional repressor domain, present in hundreds of vertebrate-specific zinc finger proteins, to assess the effect of its binding to gene bodies. These experiments revealed that the ectopic and doxycycline (dox)-controlled tet repressor KRAB fusion protein (tTRKRAB) can induce reversible and long-range silencing of cellular promoters. Here, we extend this system to in vivo applications and use tTRKRAB to achieve externally controllable repression of an endogenous mouse locus. We employed lenti-viral-mediated transgenesis with promoterless TetO-containing gene traps to engineer a mouse line where the endogenous kinesin family member 2A (Kif2A) promoter drives a YFP reporter gene. When these mice were crossed to animals expressing the TetO-binding tTRKRAB repressor, this regulator was recruited to the Kif2A locus, and YFP expression was reduced. This effect was reversed when dox was given to embryos or adult mice, demonstrating that the cellular Kif2A promoter was only silenced upon repressor binding. Molecular analyses confirmed that tTRKRAB induced transcriptional repression through the spread of H3K9me3-containing heterochromatin, without DNA methylation of the trapped Kif2A promoter. Therefore, we demonstrate that targeting of tTRKRAB to a gene body in vivo results in reversible transcriptional repression through the spreading of facultative heterochromatin. This finding not only sheds light on KRAB-mediated transcriptional processes, but also suggests approaches for the externally controllable and reversible modulation of chromatin and transcription in vivo.	[Groner, Anna C.; Verp, Sonia; Offner, Sandra; Barde, Isabelle; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Groner, Anna C.; Tschopp, Patrick; Challet, Ludivine; Rodriguez, Ivan; Trono, Didier] Univ Geneva, Frontiers Genet Natl Ctr Competence Res, CH-1211 Geneva, Switzerland; [Tschopp, Patrick; Challet, Ludivine; Rodriguez, Ivan] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland; [Dietrich, Jens-Erik; Hiiragi, Takashi] Max Planck Inst Mol Biomed, Mammalian Dev Lab, D-48149 Munster, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; Max Planck Society	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, SV-DO Stn 19, CH-1015 Lausanne, Switzerland.	Didier.trono@epfl.ch		Dietrich, Jens Erik/0000-0003-0022-9502; Hiiragi, Takashi/0000-0003-4964-7203; rodriguez, ivan/0000-0002-6468-0565	Swiss National Science Foundation; European Research Council; European Union FP7 program (PERSIST)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Union FP7 program (PERSIST)	This work was supported by grants from the Swiss National Science Foundation, the European Research Council, and the European Union FP7 program (PERSIST) (to D. T.).	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Barde I., 2010, CURRENT PROTOCOLS NE, P21; Barde I, 2009, J VIROL, V83, P5574, DOI 10.1128/JVI.00001-09; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; BERWIN B, 1993, NUCLEIC ACIDS RES, V21, P2399, DOI 10.1093/nar/21.10.2399; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Laurenti E, 2010, STEM CELLS, V28, P1390, DOI 10.1002/stem.460; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marquis J, 2009, GENE THER, V16, P70, DOI 10.1038/gt.2008.138; Meylan S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-378; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Mussolino C, 2011, EMBO MOL MED, V3, P118, DOI 10.1002/emmm.201000119; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Sauvain MO, 2008, J VIROL, V82, P7111, DOI 10.1128/JVI.00623-08; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; THIESEN HJ, 1991, NUCLEIC ACIDS RES, V19, P3996, DOI 10.1093/nar/19.14.3996; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang CQ, 2010, ORAL ONCOL, V46, P65, DOI 10.1016/j.oraloncology.2009.11.003; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5	40	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25361	25369		10.1074/jbc.M112.350884	http://dx.doi.org/10.1074/jbc.M112.350884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22605343	Green Published, hybrid			2022-12-28	WOS:000306651700044
J	He, GA; Sun, DX; Ou, ZY; Ding, AH				He, Guoan; Sun, Dongxu; Ou, Zhiying; Ding, Aihao			The Protein Zfand5 Binds and Stabilizes mRNAs with AU-rich Elements in Their 3 '-Untranslated Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSFERRIN RECEPTOR; GENE-REGULATION; CANCER CELLS; C-FOS; TRISTETRAPROLIN; ACTIVATION; ALPHA; DEADENYLATION; TURNOVER	AU-rich elements (AREs) in the 3'-UTR of unstable transcripts play a vital role in the regulation of many inflammatory mediators. To identify novel ARE-dependent gene regulators, we screened a human leukocyte cDNA library for candidates that enhanced the activity of a luciferase reporter bearing the ARE sequence from TNF (ARE(TNF)). Among 171 hits, we focused on Zfand5 (zinc finger, AN1-type domain 5), a 23-kDa protein containing two zinc finger domains. Zfand5 expression was induced in macrophages in response to IFN gamma and Toll-like receptor ligands. Knockdown of Zfand5 in macrophages decreased expression of ARE class II transcripts TNF and COX2, whereas overexpression stabilized TNF mRNA by suppressing deadenylation. Zfand5 specifically bound to ARE(TNF) mRNA and competed with tristetraprolin, a protein known to bind and destabilize class II ARE-containing RNAs. Truncation studies indicated that both zinc fingers of Zfand5 contributed to its mRNA-stabilizing function. These findings add Zfand5 to the growing list of RNA-binding proteins and suggest that Zfand5 can enhance ARE-containing mRNA stability by competing with tristetraprolin for mRNA binding.	[He, Guoan; Ding, Aihao] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10065 USA; [Ding, Aihao] Cornell Univ, Grad Program Immunol & Microbial Pathogenesis, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Sun, Dongxu] Cleveland Clin, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Ou, Zhiying] Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China	Cornell University; Cornell University; Cleveland Clinic Foundation	Ding, AH (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10065 USA.	ahding@med.cornell.edu			National Institutes of Health [AI030165]; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030165, R29AI030165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI030165 (to A. D.). The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chang SH, 2011, TRENDS MOL MED, V17, P650, DOI 10.1016/j.molmed.2011.06.008; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Dixit AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020921; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Ghosh AK, 1999, MOL CELL BIOL, V19, P2880; Gingerich Timothy J., 2004, Animal Health Research Reviews, V5, P49, DOI [10.1079/AHR200460, 10.1079/AHRR200460]; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; HAN JH, 1991, BIOCHIM BIOPHYS ACTA, V1090, P22, DOI 10.1016/0167-4781(91)90032-H; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Hishiya A, 2005, J RECEPT SIG TRANSD, V25, P199, DOI 10.1080/10799890500240781; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; LUDWIG LB, 1995, NUCLEIC ACIDS RES, V23, P3792, DOI 10.1093/nar/23.18.3792; MICHAEL WM, 1995, CELL, V83, P415; Milone J, 2004, RNA, V10, P448, DOI 10.1261/rna.5180304; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Oh YK, 2008, MOL CANCER RES, V6, P1232, DOI 10.1158/1541-7786.MCR-07-0297; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Scott DA, 1998, GENE, V215, P461, DOI 10.1016/S0378-1119(98)00316-3; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang S, 1999, METHODS, V17, P46, DOI 10.1006/meth.1998.0706; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	53	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24967	24977		10.1074/jbc.M112.362020	http://dx.doi.org/10.1074/jbc.M112.362020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665488	Green Published, hybrid			2022-12-28	WOS:000306651700010
J	Ochoa, CD; Alexeyev, M; Pastukh, V; Balczon, R; Stevens, T				Ochoa, Cristhiaan D.; Alexeyev, Mikhail; Pastukh, Viktoriya; Balczon, Ron; Stevens, Troy			Pseudomonas aeruginosa Exotoxin Y Is a Promiscuous Cyclase That Increases Endothelial Tau Phosphorylation and Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMERS-DISEASE; BARRIER FUNCTION; CYCLIC-GMP; MICROVASCULAR PERMEABILITY; ADENOSINE-MONOPHOSPHATE; POTENT INHIBITORS	Exotoxin Y (ExoY) is a type III secretion system effector found in similar to 90% of the Pseudomonas aeruginosa isolates. Although it is known that ExoY causes inter-endothelial gaps and vascular leak, the mechanisms by which this occurs are poorly understood. Using both a bacteria-delivered and a codon-optimized conditionally expressed ExoY, we report that this toxin is a dual soluble adenylyl and guanylyl cyclase that results in intracellular cAMP and cGMP accumulation. The enzymatic activity of ExoY caused phosphorylation of endothelial Tau serine 214, accumulation of insoluble Tau, inter-endothelial cell gap formation, and increased macromolecular permeability. To discern whether the cAMP or cGMP signal was responsible for Tau phosphorylation and barrier disruption, pulmonary microvascular endothelial cells were engineered for the conditional expression of either wild-type guanylyl cyclase, which synthesizes cGMP, or a mutated guanylyl cyclase, which synthesizes cAMP. Sodium nitroprusside stimulation of the cGMP-generating cyclase resulted in transient Tau serine 214 phosphorylation and gap formation, whereas stimulation of the cAMP-generating cyclase induced a robust increase in Tau serine 214 phosphorylation, gap formation, and macromolecular permeability. These results indicate that the cAMP signal is the dominant stimulus for Tau phosphorylation. Hence, ExoY is a promiscuous cyclase and edema factor that uses cAMP and, to some extent, cGMP to induce the hyperphosphorylation and insolubility of endothelial Tau. Because hyperphosphorylated and insoluble Tau are hallmarks in neurodegenerative tauopathies such as Alzheimer disease, acute Pseudomonas infections cause a pathophysiological sequela in endothelium previously recognized only in chronic neurodegenerative diseases.	[Ochoa, Cristhiaan D.; Pastukh, Viktoriya; Stevens, Troy] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Stevens, Troy] Univ S Alabama, Coll Med, Dept Med, Mobile, AL 36688 USA; [Alexeyev, Mikhail; Balczon, Ron] Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Ochoa, Cristhiaan D.; Alexeyev, Mikhail; Pastukh, Viktoriya; Balczon, Ron; Stevens, Troy] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Stevens, T (corresponding author), Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA.	tstevens@jaguar1.usouthal.edu		Ochoa, Cristhiaan/0000-0001-9113-2137	National Institutes of Health Grants [HL-60024, HL-66299, HL-76125, HL-107122, 1RO1RR031286]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR031286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076125, F31HL107122, R37HL060024, P01HL066299, R01HL060024] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL-60024 and HL-66299 (to T. S.), HL-76125 and HL-107122 (to C. D. O.), and 1RO1RR031286 (to M. A.).	Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Adamson RH, 1998, AM J PHYSIOL-HEART C, V274, pH1885, DOI 10.1152/ajpheart.1998.274.6.H1885; Ahuja N, 2004, CRIT REV MICROBIOL, V30, P187, DOI 10.1080/10408410490468795; Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; Balin BJ, 2008, J ALZHEIMERS DIS, V13, P371; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BERTHIAUME Y, 1987, J CLIN INVEST, V79, P335, DOI 10.1172/JCI112817; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Bouchard M, 2011, CAN J NEUROL SCI, V38, P547, DOI 10.1017/S0317167100012087; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Cowell BA, 2005, FEMS MICROBIOL LETT, V250, P71, DOI 10.1016/j.femsle.2005.06.044; Creighton J, 2008, J CELL SCI, V121, P110, DOI 10.1242/jcs.011692; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Frank S, 2008, ACTA NEUROPATHOL, V115, P39, DOI 10.1007/s00401-007-0291-9; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gairhe S, 2011, AM J PHYSIOL-LUNG C, V301, pL527, DOI 10.1152/ajplung.00091.2011; GEORGE WJ, 1970, P NATL ACAD SCI USA, V66, P398, DOI 10.1073/pnas.66.2.398; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; Goldberg N D, 1975, Adv Cyclic Nucleotide Res, V5, P307; Grimley JS, 2008, BIOORG MED CHEM LETT, V18, P759, DOI 10.1016/j.bmcl.2007.11.044; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hirata-Fukae C, 2009, NEUROSCI LETT, V450, P51, DOI 10.1016/j.neulet.2008.11.023; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Jacobson J. R., 2010, MURRAY NADELS TXB RE, P1; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kemp SF, 2008, ALLERGY, V63, P1061, DOI 10.1111/j.1398-9995.2008.01733.x; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Kinoshita J, 2004, NEUROBIOL AGING, V25, P639, DOI 10.1016/j.neurobiolaging.2004.02.007; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; Kuebler WM, 2011, AM J PHYSIOL-LUNG C, V301, pL157, DOI 10.1152/ajplung.00192.2011; Lampugnani MG, 2004, SPRING LAB MAN, P103; Lorimer D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-36; Lory S, 2004, INT J MED MICROBIOL, V293, P479, DOI 10.1078/1438-4221-00297; Lowe K, 2010, CRIT CARE MED, V38, P1458, DOI 10.1097/CCM.0b013e3181de18f0; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Moldobaeva A, 2006, AM J PHYSIOL-LUNG C, V290, pL919, DOI 10.1152/ajplung.00434.2005; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Ofori-Acquah SF, 2008, MICROVASC RES, V75, P391, DOI 10.1016/j.mvr.2007.10.006; Parker JC, 2006, AM J PHYSIOL-LUNG C, V291, pL30, DOI 10.1152/ajplung.00317.2005; Parra-Bonilla G, 2010, AM J PHYSIOL-LUNG C, V299, pL513, DOI 10.1152/ajplung.00274.2009; Prasain N., 2009, THESIS U S ALABAMA M; Prasain N, 2009, AM J PHYSIOL-LUNG C, V297, pL73, DOI 10.1152/ajplung.90577.2008; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Rentsendorj O, 2008, AM J PHYSIOL-LUNG C, V294, pL686, DOI 10.1152/ajplung.00417.2007; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Roelofs J, 2001, EMBO J, V20, P4341, DOI 10.1093/emboj/20.16.4341; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Sawa Teiji, 2004, Anesthesiol Clin North Am, V22, P591, DOI 10.1016/j.atc.2004.05.002; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V301, pL117, DOI 10.1152/ajplung.00417.2009; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V300, pL667, DOI 10.1152/ajplung.00433.2010; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; Stevens T., 2007, ENDOTHELIAL BIOMEDIC, P1160; Stevens Troy, 2008, Proc Am Thorac Soc, V5, P783, DOI 10.1513/pats.200803-027HR; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Weber DJ, 2007, INFECT CONT HOSP EP, V28, P825, DOI 10.1086/518460; Wei JY, 2002, BRAIN RES, V927, P42, DOI 10.1016/S0006-8993(01)03323-6; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Williams S, 2005, NEUROPATH APPL NEURO, V31, P414, DOI 10.1111/j.1365-2990.2005.00663.x; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Zhu B, 2010, AM J PHYSIOL-LUNG C, V299, pL493, DOI 10.1152/ajplung.00431.2009	84	73	74	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25407	25418		10.1074/jbc.M111.301440	http://dx.doi.org/10.1074/jbc.M111.301440			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22637478	Green Published, hybrid			2022-12-28	WOS:000306651700048
J	Gounder, AP; Wiens, ME; Wilson, SS; Lu, WY; Smith, JG				Gounder, Anshu P.; Wiens, Mayim E.; Wilson, Sarah S.; Lu, Wuyuan; Smith, Jason G.			Critical Determinants of Human alpha-Defensin 5 Activity against Non-enveloped Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; ADENOVIRUS; INFECTION; CELLS; HD5; BINDING; PROTEIN	Human alpha-defensins, such as human alpha-defensin 5 (HD5), block infection of non-enveloped viruses, including human adenoviruses (AdV), papillomaviruses (HPV), and polyomaviruses. Through mutational analysis of HD5, we have identified arginine residues that contribute to antiviral activity against AdV and HPV. Of two arginine residues paired on one face of HD5, Arg-28 is critical for both viruses, while Arg-9 is only important for AdV. Two arginine residues on the opposite face of the molecule (Arg-13 and Arg-32) and unpaired Arg-25 are less important for both. In addition, hydrophobicity at residue 29 is a major determinant of anti-adenoviral activity, and a chemical modification that prevents HD5 self-association was strongly attenuating. Although HD5 binds to the capsid of AdV, the molecular basis for this interaction is undefined. Capsid binding by HD5 is not purely charge-dependent, as substitution of lysine for Arg-9 and Arg-28 was deleterious. Analysis of HD5 analogs that retained varying levels of potency demonstrated that anti-adenoviral activity is directly correlated with HD5 binding to the virus, confirming that the viral capsid rather than the cell is the relevant target. Also, AdV aggregation induced by HD5 binding is not sufficient for neutralization. Rather, these studies confirm that the major mechanism of HD5-mediated neutralization of AdV depends upon specific binding to the viral capsid through interactions mediated in part by critical arginine residues, hydrophobicity at residue 29, and multimerization of HD5, which increases initial binding of virus to the cell but prevents subsequent viral uncoating and genome delivery to the nucleus.	[Gounder, Anshu P.; Wiens, Mayim E.; Wilson, Sarah S.; Smith, Jason G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore	Smith, JG (corresponding author), Univ Washington, Dept Microbiol, Box 357735,1705 NE Pacific St, Seattle, WA 98195 USA.	jgsmith2@uw.edu	Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017	Lu, Wuyuan/0000-0003-1318-9968; Wilson, Sarah/0000-0002-0838-6847; Smith, Jason/0000-0001-6727-5269	National Institutes of Health [K22 AI081870, T32 AI083203, R01 AI072732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, K22AI081870, T32AI083203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 AI081870 (to J. G. S.), T32 AI083203 (to S. S. W.), and R01 AI072732 (to W. L.).	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; BORDERS CL, 1994, PROTEIN SCI, V3, P541; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cauet G, 2005, BIOCHEMISTRY-US, V44, P5453, DOI 10.1021/bi047702b; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; de Leeuw E, 2009, FEBS LETT, V583, P2507, DOI 10.1016/j.febslet.2009.06.051; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; Nguyen EK, 2010, J VIROL, V84, P4041, DOI 10.1128/JVI.02471-09; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Rajabi M, 2012, J BIOL CHEM, V287, P21615, DOI 10.1074/jbc.M112.367995; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Wang CHK, 2011, BIOMATERIALS, V32, P9536, DOI 10.1016/j.biomaterials.2011.08.069; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	28	53	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24554	24562		10.1074/jbc.M112.354068	http://dx.doi.org/10.1074/jbc.M112.354068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637473	Green Published, hybrid			2022-12-28	WOS:000306651100048
J	Hullin-Matsuda, F; Tomishige, N; Sakai, S; Ishitsuka, R; Ishii, K; Makino, A; Greimel, P; Abe, M; Laviad, EL; Lagarde, M; Vidal, H; Saito, T; Osada, H; Hanada, K; Futerman, AH; Kobayashi, T				Hullin-Matsuda, Francoise; Tomishige, Nario; Sakai, Shota; Ishitsuka, Reiko; Ishii, Kumiko; Makino, Asami; Greimel, Peter; Abe, Mitsuhiro; Laviad, Elad L.; Lagarde, Michel; Vidal, Hubert; Saito, Tamio; Osada, Hiroyuki; Hanada, Kentaro; Futerman, Anthony H.; Kobayashi, Toshihide			Limonoid Compounds Inhibit Sphingomyelin Biosynthesis by Preventing CERT Protein-dependent Extraction of Ceramides from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID SYNTHESIS; NONVESICULAR TRAFFICKING; TRANSBILAYER MOVEMENT; PHOSPHOLIPID-VESICLES; LIVING CELLS; MEMBRANE; TRANSPORT; METABOLISM	To identify novel inhibitors of sphingomyelin (SM) metabolism, a new and selective high throughput microscopy-based screening based on the toxicity of the SM-specific toxin, lysenin, was developed. Out of a library of 2011 natural compounds, the limonoid, 3-chloro-8 beta-hydroxycarapin-3,8-hemiacetal (CHC), rendered cells resistant to lysenin by decreasing cell surface SM. CHC treatment selectively inhibited the de novo biosynthesis of SM without affecting glycolipid and glycerophospholipid biosynthesis. Pretreatment with brefeldin A abolished the limonoid-induced inhibition of SM synthesis suggesting that the transport of ceramide (Cer) from the endoplasmic reticulum to the Golgi apparatus is affected. Unlike the Cer transporter (CERT) inhibitor HPA-12, CHC did not change the transport of a fluorescent short chain Cer analog to the Golgi apparatus or the formation of fluorescent and short chain SM from the corresponding Cer. Nevertheless, CHC inhibited the conversion of de novo synthesized Cer to SM. We show that CHC specifically inhibited the CERT-mediated extraction of Cer from the endoplasmic reticulum membranes in vitro. Subsequent biochemical screening of 21 limonoids revealed that some of them, such as 8 beta-hydroxycarapin-3,8-hemiacetal and gedunin, which exhibits anti-cancer activity, inhibited SM biosynthesis and CERT-mediated extraction of Cer from membranes. Model membrane studies suggest that 8 beta-hy-droxycarapin-3,8-hemiacetal reduced the miscibility of Cer with membrane lipids and thus induced the formation of Cerrich membrane domains. Our study shows that certain limonoids are novel inhibitors of SM biosynthesis and suggests that some biological activities of these limonoids are related to their effect on the ceramide metabolism.	[Hullin-Matsuda, Francoise; Tomishige, Nario; Sakai, Shota; Ishitsuka, Reiko; Ishii, Kumiko; Makino, Asami; Greimel, Peter; Abe, Mitsuhiro; Kobayashi, Toshihide] RIKEN, Adv Sci Inst, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Hullin-Matsuda, Francoise; Lagarde, Michel; Vidal, Hubert; Kobayashi, Toshihide] Univ Lyon 1, Inserm, U 1060, F-69621 Villeurbanne, France; [Laviad, Elad L.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Weizmann Institute of Science; National Institute of Infectious Diseases (NIID)	Hullin-Matsuda, F (corresponding author), RIKEN, Adv Sci Inst, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hullin-matsuda@riken.jp; kobayasi@riken.jp	Vidal, Hubert/M-6674-2017; KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015; Hullin-Matsuda, Françoise/N-3880-2017; Abe, Mitsuhiro/C-3602-2017; Osada, Hiroyuki/AAY-6254-2020	Vidal, Hubert/0000-0002-9467-0317; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Hullin-Matsuda, Françoise/0000-0002-6042-2841; Abe, Mitsuhiro/0000-0002-6244-1771; Hanada, Kentaro/0000-0003-1383-2781; Greimel, Peter/0000-0002-4931-6183; Futerman, Anthony/0000-0003-0013-0115	Lipid Dynamics Program of RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390018, 24657143]; Grants-in-Aid for Scientific Research [23790115] Funding Source: KAKEN	Lipid Dynamics Program of RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Lipid Dynamics Program of RIKEN and Grants-in-aid for Scientific Research 22390018 and 24657143 (to T. K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Behenna DC, 2008, J AM CHEM SOC, V130, P6720, DOI 10.1021/ja802376g; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRUNING A, 1992, J BIOL CHEM, V267, P5052; Carrer DC, 1999, J LIPID RES, V40, P1978; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; CHAPMAN D., 1967, CHEM PHYS LIPIDS, V1, P445, DOI 10.1016/0009-3084(67)90023-0; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hanada K, 2002, J EXP MED, V195, P23, DOI 10.1084/jem.20010724; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; HASHIMOTO M, 1994, BER BUNSEN PHYS CHEM, V98, P793, DOI 10.1002/bbpc.19940980606; Hayakawa T, 2006, BIOCHEMISTRY-US, V45, P9198, DOI 10.1021/bi060722o; Hayakawa Tomohiro, 2007, Membrane, V32, P221; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; HORN WS, 1992, J ANTIBIOT, V45, P1692, DOI 10.7164/antibiotics.45.1692; HURD CD, 1966, J CHEM EDUC, V43, P527, DOI 10.1021/ed043p527; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Kaur K, 2009, BIOORGAN MED CHEM, V17, P3229, DOI 10.1016/j.bmc.2009.02.050; Kikuchi T, 2011, J NAT PROD, V74, P866, DOI 10.1021/np100783k; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; LAUER SA, 1995, P NATL ACAD SCI USA, V92, P9181, DOI 10.1073/pnas.92.20.9181; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lopez-Montero I, 2005, J BIOL CHEM, V280, P25811, DOI 10.1074/jbc.M412052200; MacKinnon S, 1997, J NAT PROD, V60, P336, DOI 10.1021/np9605394; MANDON EC, 1992, J BIOL CHEM, V267, P11144; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Nakamura Y, 2003, J MED CHEM, V46, P3688, DOI 10.1021/jm0300779; OWENS K, 1966, BIOCHEM J, V100, P354, DOI 10.1042/bj1000354; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; Roy A, 2006, BIOL PHARM BULL, V29, P191, DOI 10.1248/bpb.29.191; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Segui B, 2006, BBA-BIOMEMBRANES, V1758, P2104, DOI 10.1016/j.bbamem.2006.05.024; SHAH J, 1995, J LIPID RES, V36, P1936; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Simon CG, 1999, BIOCHEMISTRY-US, V38, P14676, DOI 10.1021/bi991537w; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solchinger A, 2007, CRYST GROWTH DES, V7, P2380, DOI 10.1021/cg070377h; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Takahashi M, 2007, MOL BIOL CELL, V18, P2667, DOI 10.1091/mbc.E06-10-0924; Tuuf J, 2011, BBA-BIOMEMBRANES, V1808, P229, DOI 10.1016/j.bbamem.2010.09.011; Uddin SJ, 2007, PHYTOTHER RES, V21, P757, DOI 10.1002/ptr.2159; Veitch GE, 2008, ANGEW CHEM INT EDIT, V47, P9402, DOI 10.1002/anie.200802675; WANG E, 1991, J BIOL CHEM, V266, P14486; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji-Hasegawa A, 2005, BIOCHEMISTRY-US, V44, P268, DOI 10.1021/bi048605l; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; ZWEERINK MM, 1992, J BIOL CHEM, V267, P25032	78	25	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24397	24411		10.1074/jbc.M112.344432	http://dx.doi.org/10.1074/jbc.M112.344432			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22605339	Green Published, hybrid			2022-12-28	WOS:000306651100034
J	Karacosta, LG; Foster, BA; Azabdaftari, G; Feliciano, DM; Edelman, AM				Karacosta, Loukia G.; Foster, Barbara A.; Azabdaftari, Gissou; Feliciano, David M.; Edelman, Arthur M.			A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MOLECULAR-CLONING; EXTRACELLULAR CALCIUM; IN-VIVO; ACTIVATION; CELLS; CALMODULIN; BETA; CASCADE; PHOSPHORYLATION	The androgen receptor (AR) plays a critical role in prostate cancer (PCa) progression, however, the molecular mechanisms by which the AR regulates cell proliferation in androgen-dependent and castration-resistant PCa are incompletely understood. We report that Ca2+/calmodulin-dependent kinase kinase 2 (CaMKK2) expression increases and becomes nuclear or perinuclear in advanced PCa. In the TRAMP (transgenic adenocarcinoma of mouse prostate) model of PCa, CaMKK2 expression increases with PCa progression with many cells exhibiting nuclear staining. CaMKK2 expression is higher in human castration-resistant tumor xenografts compared with androgen-responsive xenografts and is markedly higher in the AR-expressing, tumorigenic cell line LNCaP compared with cell lines that are AR-nonexpressing and/or nontumorigenic. In LNCaP cells, dihydrotestosterone induced CaMKK2 mRNA and protein expression and translocation of CaMKK2 to the nucleus. Conversely, androgen withdrawal suppressed CaMKK2 expression. Knockdown of CaMKK2 expression by RNAi reduced LNCaP cell proliferation and increased percentages of cells in G1 phase, whereas correspondingly reducing percentages in S phase, of the cell cycle. CaMKK2 knockdown reduced expression of the AR target gene prostate-specific antigen at both mRNA and protein levels, AR transcriptional activity driven by androgen responsive elements from the prostate-specific probasin gene promoter and levels of the AR-regulated cell cycle proteins, cyclin D1 and hyperphosphorylated Rb. Our results suggest that in PCa progression, CaMKK2 and the AR are in a feedback loop in which CaMKK2 is induced by the AR to maintain AR activity, AR-dependent cell cycle control, and continued cell proliferation.	[Karacosta, Loukia G.; Feliciano, David M.; Edelman, Arthur M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Foster, Barbara A.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Azabdaftari, Gissou] Roswell Pk Canc Inst, Dept Pathol & Lab Med, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Edelman, AM (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA.	aedelman@buffalo.edu	Feliciano, David/ADM-6724-2022	Feliciano, David/0000-0001-5985-9109	National Institutes of Health [NS50385, CA095367]; University at Buffalo Foundation; RPCI Cancer Center [CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA095367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University at Buffalo Foundation; RPCI Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS50385 (to A. M. E.) and CA095367 (to B. A. F.) and University at Buffalo Foundation and RPCI Cancer Center Support Grant CA016056.	Aletta JM, 1996, J BIOL CHEM, V271, P20930, DOI 10.1074/jbc.271.34.20930; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Balk SP, 2008, NUCL RECEPT SIGNAL, V6, pe001, DOI DOI 10.1621/NRS.06001; Bluemn EG, 2012, CURR OPIN ONCOL, V24, P251, DOI 10.1097/CCO.0b013e32835105b3; BOYNTON AL, 1977, CANCER RES, V37, P2657; Cifuentes E, 2004, P NATL ACAD SCI USA, V101, P464, DOI 10.1073/pnas.0307161101; Colomer J., 2007, V45, P169; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Feliciano DM, 2009, J BIOL CHEM, V284, P26466, DOI 10.1074/jbc.M109.027680; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; Gregory CW, 2001, CANCER RES, V61, P2892; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kahl CR, 2004, J BIOL CHEM, V279, P15411, DOI 10.1074/jbc.M312543200; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liao JH, 2006, CANCER RES, V66, P9065, DOI 10.1158/0008-5472.CAN-06-0317; Lozano JJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-109; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Nagabhushan M, 1996, CANCER RES, V56, P3042; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Schiewer MJ, 2012, MOL CELL ENDOCRINOL, V352, P34, DOI 10.1016/j.mce.2011.06.033; Schmitt JM, 2010, MOL CELL BIOCHEM, V335, P155, DOI 10.1007/s11010-009-0252-9; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; STEINSAPIR J, 1991, BIOCHEM BIOPH RES CO, V179, P90, DOI 10.1016/0006-291X(91)91338-D; Tararova ND, 2007, PROSTATE, V67, P1801, DOI 10.1002/pros.20662; TILLEY WD, 1990, CANCER RES, V50, P5382; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tokumitsu H, 2011, BIOCHEMISTRY-US, V50, P8193, DOI 10.1021/bi201005g; Tomlins Scott A., 2007, P247, DOI 10.1007/978-1-59745-224-3_14; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Welsh JB, 2001, CANCER RES, V61, P5974; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yang CS, 2007, MOL CELL BIOL, V27, P3390, DOI 10.1128/MCB.02411-06; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	57	54	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24832	24843		10.1074/jbc.M112.370783	http://dx.doi.org/10.1074/jbc.M112.370783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22654108	Green Published, hybrid			2022-12-28	WOS:000306651100076
J	Yu, ZP; Fan, DS; Gui, B; Shi, L; Xuan, CH; Shan, L; Wang, Q; Shang, YF; Wang, Y				Yu, Zhipeng; Fan, Dongsheng; Gui, Bin; Shi, Lei; Xuan, Chenghao; Shan, Lin; Wang, Qian; Shang, Yongfeng; Wang, Yan			Neurodegeneration-associated TDP-43 Interacts with Fragile X Mental Retardation Protein (FMRP)/Staufen (STAU1) and Regulates SIRT1 Expression in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; DNA-BINDING PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; MESSENGER-RNA TRANSPORT; FUNCTIONAL IMPLICATIONS; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; TARDBP MUTATIONS	Despite the identification of the 43 kDa transactive response DNA- binding protein (TDP-43) as a major pathological signatory protein in a wide range of neurodegenerative diseases, the mechanistic role of TDP-43 in neurodegenerative disorders is still poorly understood. Here, we report that TDP-43 is physically associated with fragile X mental retardation protein (FMRP) and Staufen (STAU1) to form a functional complex. Differential microarray analysis revealed that the expression of a collection of functionally important genes including Sirtuin (SIRT1) is regulated by this complex. RNA-immunoprecipitation (RIP) and RNA pull-down assays demonstrated that TDP43/FMRP/STAU1 specifically binds to the 3'-UTR of SIRT1 mRNA, and that knockdown the expression of any one of these three proteins resulted in the reduction of SIRT1 mRNA and protein. SIRT1 is implicated in double-stranded DNA break repair and is required for cell survival. Indeed, depletion of TDP-43/FMRP/STAU1 sensitizes cells to apoptosis and DNA damages. Collectively, our results revealed a molecular mechanism for the cellular function of TDP-43 and might shed new light on the understanding of the mechanistic role of TDP-43 in neurodegenerative diseases.	[Yu, Zhipeng; Fan, Dongsheng; Gui, Bin] Peking Univ, Hosp 3, Beijing 100191, Peoples R China; [Shi, Lei; Xuan, Chenghao; Shan, Lin; Wang, Qian; Shang, Yongfeng; Wang, Yan] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Fan, DS (corresponding author), 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	fandongshengls@126.com; yanwang@tmu.edu.cn			National Natural Science Foundation of China [90919053, 31171240, 81030019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 90919053 and 31171240 (to Y. W.) and 81030019 (to D. F.) from the National Natural Science Foundation of China.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Cook C, 2008, EXPERT OPIN BIOL TH, V8, P969, DOI 10.1517/14712598.8.7.969 ; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; DUBERLEY RM, 1995, J NEUROL SCI, V129, P109, DOI 10.1016/0022-510X(95)00079-H; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HSIANG YH, 1989, CANCER RES, V49, P5077; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Montie HL, 2011, J NEUROSCI, V31, P17425, DOI 10.1523/JNEUROSCI.3958-11.2011; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tosar Leandro Julian Martinez, 2012, Front Biosci (Schol Ed), V4, P432; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	65	41	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22560	22572		10.1074/jbc.M112.357582	http://dx.doi.org/10.1074/jbc.M112.357582			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584570	Green Published, hybrid			2022-12-28	WOS:000306495000013
J	Bai, XY; Meng, G; Luo, M; Zheng, XF				Bai, Xiaoyun; Meng, Geng; Luo, Ming; Zheng, Xiaofeng			Rigidity of Wedge Loop in PACSIN 3 Protein Is a Key Factor in Dictating Diameters of Tubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE INVAGINATION; BAR DOMAINS; SYNDAPIN-II; CURVATURE; DYNAMIN; AMPHIPHYSIN; RECRUITMENT; MECHANISM; BIND; PITS	BAR (Bin/amphiphysin/Rvs) domain-containing proteins participate in cellular membrane remodeling. The F-BAR proteins normally generate low curvature tubules. However, in the PACSIN subfamily, the F-BAR domain from PACSIN 1 and 2 can induce both high and low curvature tubules. We found that unlike PACSIN 1 and 2, PACSIN 3 could only induce low curvature tubules. To elucidate the key factors that dictate the tubule curvature, crystal structures of all three PACSIN F-BAR domains were determined. A novel type of lateral interaction mediated by a wedge loop is observed between the F-BAR neighboring dimers. Comparisons of the structures of PACSIN 3 with PACSIN 1 and 2 indicate that the wedge loop of PACSIN 3 is more rigid, which influences the lateral interactions between assembled dimers. We further identified the residues that affect the rigidity of the loop by mutagenesis and determined the structures of two PACSIN 3 wedge loop mutants. Our results suggest that the rigidity-mediated conformations of the wedge loop correlate well with the various crystal packing modes and membrane tubulations. Thus, the rigidity of the wedge loop is a key factor in dictating tubule diameters.	[Bai, Xiaoyun; Meng, Geng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Bai, Xiaoyun; Meng, Geng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Luo, Ming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Peking University; Peking University; University of Alabama System; University of Alabama Birmingham	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	Meng, Geng/ACY-1510-2022		National High Technology and Development Program of China [2010CB911804]; National Science Foundation of China [30930020]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN09-01]	National High Technology and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Centre for Genetic Engineering and Biotechnology	This work was supported by National High Technology and Development Program of China Grant 2010CB911804, National Science Foundation of China Grant 30930020, and International Centre for Genetic Engineering and Biotechnology Project CRP/CHN09-01.	Bai XY, 2010, ACTA CRYSTALLOGR F, V66, P73, DOI 10.1107/S1744309109049549; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dvorak AM, 2001, J HISTOCHEM CYTOCHEM, V49, P419, DOI 10.1177/002215540104900401; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Futterer K, 2007, CELL, V129, P655, DOI 10.1016/j.cell.2007.05.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Grimm-Gunter EMS, 2008, EXP CELL RES, V314, P1991, DOI 10.1016/j.yexcr.2008.03.015; Halbach A, 2007, FEBS J, V274, P773, DOI 10.1111/j.1742-4658.2006.05622.x; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kessels MM, 2006, J CELL SCI, V119, P1504, DOI 10.1242/jcs.02877; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Modregger J, 2000, J CELL SCI, V113, P4511; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Plomann M, 2010, J MOL BIOL, V400, P129, DOI 10.1016/j.jmb.2010.05.008; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rippe B, 2002, J VASC RES, V39, P375, DOI 10.1159/000064521; Ritter B, 1999, FEBS LETT, V454, P356, DOI 10.1016/S0014-5793(99)00830-3; Scott IC, 2003, NATURE, V425, P461, DOI 10.1038/425461a; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shimada A, 2010, FEBS LETT, V584, P1111, DOI 10.1016/j.febslet.2010.02.058; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106	38	12	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22387	22396		10.1074/jbc.M112.358960	http://dx.doi.org/10.1074/jbc.M112.358960			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573331	hybrid, Green Published			2022-12-28	WOS:000306418600075
J	Hughes, RM; Vrana, JD; Song, JQ; Tucker, CL				Hughes, Robert M.; Vrana, Justin D.; Song, Junqi; Tucker, Chandra L.			Light-dependent, Dark-promoted Interaction between Arabidopsis Cryptochrome 1 and Phytochrome B Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT; FUNCTIONAL INTERACTION; FLORAL INITIATION; COP1 ACTIVITY; NUCLEAR; SPA1; PHOTOMORPHOGENESIS; PHOTORECEPTOR; TRANSCRIPTION; SYNERGISM	Plant photoreceptors transduce environmental light cues to downstream signaling pathways, regulating a wide array of processes during growth and development. Two major plant photoreceptors with critical roles in photomorphogenesis are phytochrome B (phyB), a red/far-red absorbing photoreceptor, and cryptochrome 1 (CRY1), a UV-A/blue photoreceptor. Despite substantial genetic evidence for cross-talk between phyB and CRY1 pathways, a direct interaction between these proteins has not been observed. Here, we report that Arabidopsis phyB interacts directly with CRY1 in a light-dependent interaction. Surprisingly, the interaction is light-dissociated; CRY1 interacts specifically with the dark/far-red (Pr) state of phyB, but not with the red light-activated (Pfr) or the chromophore unconjugated form of the enzyme. The interaction is also regulated by light activation of CRY1; phyB Pr interacts only with the unstimulated form of CRY1 but not with the photostimulated protein. Further studies reveal that a small domain extending from the photolyase homology region (PHR) of CRY1 regulates the specificity of the interaction with different conformational states of phyB. We hypothesize that in plants, the phyB/CRY1 interaction may mediate cross-talk between the red/far-red- and blue/UV-sensing pathways, enabling fine-tuning of light responses to different spectral inputs.	[Vrana, Justin D.; Tucker, Chandra L.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Hughes, Robert M.; Song, Junqi; Tucker, Chandra L.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University	Tucker, CL (corresponding author), Univ Colorado Denver, Dept Pharmacol, Mail Stop 8303, Aurora, CO 80045 USA.	chandra.tucker@ucdenver.edu	Tucker, Chandra/F-6842-2011; Song, Junqi/N-9219-2019	Song, Junqi/0000-0002-2555-3408; Tucker, Chandra/0000-0003-3033-1786; Hughes, Robert/0000-0002-4465-4212	National Institutes of Health [R01 GM100225]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM100225 (to C. L. T).	Ahmad M, 1997, PLANT J, V11, P421, DOI 10.1046/j.1365-313X.1997.11030421.x; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; CASAL JJ, 1995, PLANTA, V197, P213; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Castillon A, 2009, GENETICS, V182, P161, DOI 10.1534/genetics.108.099887; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Exner V, 2010, PLANT PHYSIOL, V154, P1633, DOI 10.1104/pp.110.160895; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Hennig L, 1999, PLANT J, V20, P289, DOI 10.1046/j.1365-313X.1999.t01-1-00599.x; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li Jigang, 2011, Arabidopsis Book, V9, pe0148, DOI 10.1199/tab.0148; LI LM, 1994, P NATL ACAD SCI USA, V91, P12535, DOI 10.1073/pnas.91.26.12535; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Lian HL, 2011, GENE DEV, V25, P1023, DOI 10.1101/gad.2025111; Liu B, 2011, GENE DEV, V25, P1029, DOI 10.1101/gad.2025011; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Meijer G, 1965, PHOTOCHEM PHOTOBIOL, V4, P251; Miller J. H, 1972, EXPT MOL GENETICS; Mohr Hans, 1994, P353; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Sakamoto K, 1996, PLANT J, V10, P859, DOI 10.1046/j.1365-313X.1996.10050859.x; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shin DH, 2010, J BIOL CHEM, V285, P32151, DOI 10.1074/jbc.M110.133710; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Toettcher JE, 2011, METHOD ENZYMOL, V497, P409, DOI 10.1016/B978-0-12-385075-1.00017-2; Tucker CL, 2009, GENETICS, V182, P1377, DOI 10.1534/genetics.109.103069; Usami T, 2004, PLANT CELL PHYSIOL, V45, P1798, DOI 10.1093/pcp/pch205; Usami T, 2007, PLANT CELL PHYSIOL, V48, P424, DOI 10.1093/pcp/pcm012; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu G, 2007, P NATL ACAD SCI USA, V104, P18813, DOI 10.1073/pnas.0705082104; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135, DOI 10.1199/tab.0135; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	51	28	36	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22165	22172		10.1074/jbc.M112.360545	http://dx.doi.org/10.1074/jbc.M112.360545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577138	Green Published, hybrid			2022-12-28	WOS:000306418600055
J	Kim, B; Nguyen, LA; Daddacha, W; Hollenbaugh, JA				Kim, Baek; Nguyen, Laura A.; Daddacha, Waaqo; Hollenbaugh, Joseph A.			Tight Interplay among SAMHD1 Protein Level, Cellular dNTP Levels, and HIV-1 Proviral DNA Synthesis Kinetics in Human Primary Monocyte-derived Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE MUTANT; RESTRICTION FACTOR SAMHD1; RIBONUCLEOTIDE REDUCTASE; DENDRITIC CELLS; VPX; REPLICATION; SUBSTRATE; TRIPHOSPHATES; MECHANISM	Recently, SAMHD1 has come under intense focus as a host anti-HIV factor. SAMHD1 is a dNTP triphosphohydrolase, which leads to the regulation of DNA metabolism in host cells. HIV-2/SIV (simian immunodeficiency virus) viral protein x (Vpx) has been shown to promote the degradation of SAMHD1. In this study, we examine the kinetics of SAMHD1 degradation, the increase in the dNTP pool level, and the efficiency of proviral DNA synthesis in Vpx+ virus-like particle (VLP)-treated monocyte-derived macrophages (MDMs). Our results indicate a very close temporal link with a reduction in SAMHD1 detected within the first few hours of Vpx+ VLP treatment. This loss of SAMHD1 is followed by a significant increase in cellular dNTP levels by 8 h after Vpx+ VLP addition, ultimately leading to the enhancement of the HIV proviral DNA synthesis rate and HIV infection in MDMs. Finally, the pretreatment of MDMs with the Vpx+ VLPs, which is a widely used protocol, displayed identical proviral DNA synthesis as compared with MDMs co-treated with Vpx+ VLP and HIV vector. These findings further indicate that Vpx degradation of SAMHD1 is sufficiently rapid to enable appropriate progression of reverse transcription in MDMs, even when present at the time of infection. Overall, this study demonstrates a tight interplay between SAMHD1 level, dNTP levels, and HIV proviral DNA synthesis kinetics in MDMs.	[Kim, Baek; Daddacha, Waaqo; Hollenbaugh, Joseph A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Nguyen, Laura A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu			National Institutes of Health [AI049781, F31 GM095190, F32 AI089079-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI089079, R01AI049781, R56AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095190, R01GM104198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049781 (to K. B.), F31 GM095190 to (W. D.) and F32 AI089079-01A1 (to J. A. H.).	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kennedy EM, 2011, J BIOL CHEM, V286, P25047, DOI 10.1074/jbc.M111.234047; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Muthumani K, 2000, DNA CELL BIOL, V19, P179, DOI 10.1089/104454900314564; Nguyen LA, 2012, J MOL BIOL, V415, P248, DOI 10.1016/j.jmb.2011.11.014; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Schultz J, 1997, PROTEIN SCI, V6, P249; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; TRISTEM M, 1990, NATURE, V347, P341, DOI 10.1038/347341b0; Ueno F, 2003, MICROBES INFECT, V5, P387, DOI 10.1016/S1286-4579(03)00042-X; Van Cor-Hosmer SK, 2012, VIROLOGY, V422, P393, DOI 10.1016/j.virol.2011.11.004; Van Cor-Hosmer SK, 2010, VIROLOGY, V406, P253, DOI 10.1016/j.virol.2010.07.028; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r	36	155	156	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21570	21574		10.1074/jbc.C112.374843	http://dx.doi.org/10.1074/jbc.C112.374843			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22589553	hybrid, Green Published			2022-12-28	WOS:000306418600001
J	Paramanik, V; Thakur, MK				Paramanik, Vijay; Thakur, Mahendra Kumar			Estrogen Receptor beta and Its Domains Interact with Casein Kinase 2, Phosphokinase C, and N-Myristoylation Sites of Mitochondrial and Nuclear Proteins in Mouse Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; HISTONE DEACETYLASE; TYROSINE KINASES; ER-BETA; COACTIVATOR; GENE; COMPLEX; ALPHA; CELLS; PHOSPHORYLATION	The localization of estrogen receptor (ER)beta in mitochondria suggests ER beta-dependent regulation of genes, which is poorly understood. Here, we analyzed the ER beta interacting mitochondrial as well as nuclear proteins in mouse brain using pull-down assay and matrix-assisted laser desorption ionization mass spectroscopy (MALDI-MS). In the case of mitochondria, ER beta interacted with six proteins of 35-152 kDa, its transactivation domain (TAD) interacted with four proteins of 37-172 kDa, and ligand binding domain (LBD) interacted with six proteins of 37-161 kDa. On the other hand, in nuclei, ER beta interacted with seven proteins of 30-203 kDa, TAD with ten proteins of 31-160 kDa, and LBD with fourteen proteins of 42-179 kDa. For further identification, these proteins were cleaved by trypsin into peptides and analyzed by MALDI-MS using mascot search engine, immunoprecipitation, immunoblotting, and far-Western blotting. To find the consensus binding motifs in interacting proteins, their unique tryptic peptides were analyzed by the motif scan software. All the interacting proteins were found to contain casein kinase (CK) 2, phosphokinase (PK)C phosphorylation, and N-myristoylation sites. These were further confirmed by peptide pull-down assays using specific mutations in the interacting sites. Thus, the present findings provide evidence for the interaction of ER beta with specific mitochondrial and nuclear proteins through consensus CK2, PKC phosphorylation, and N-myristoylation sites, and may represent an essential step toward designing selective ER modulators for regulating estrogen-mediated signaling.	[Paramanik, Vijay; Thakur, Mahendra Kumar] Banaras Hindu Univ, Dept Zool, Ctr Adv Study, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Thakur, MK (corresponding author), Banaras Hindu Univ, Dept Zool, Ctr Adv Study, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	mkt_bhu@yahoo.com			Indian Council of Medical Research (ICMR); Department of Biotechnology [DBT/BT/PR3593/Med/14/468/2003]; Government of India; Senior Research Fellowship from ICMR	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology; Government of India; Senior Research Fellowship from ICMR	This work was supported by the Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT/BT/PR3593/Med/14/468/2003), Government of India (to M. K. T.) and a Senior Research Fellowship from ICMR (to V. P.).	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; Gascard P, 2000, CURR OPIN HEMATOL, V7, P123, DOI 10.1097/00062752-200003000-00009; Hadrys T, 1998, DEVELOPMENT, V125, P33; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Kato S, 2005, CANCER CHEMOTH PHARM, V56, pS4, DOI 10.1007/s00280-005-0102-8; Klein FAC, 2005, J BIOL CHEM, V280, P5682, DOI 10.1074/jbc.M411697200; KUBOTA R, 1995, GENOMICS, V26, P430, DOI 10.1016/0888-7543(95)80239-I; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007489; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; McPartland JM, 2007, GENE, V397, P126, DOI 10.1016/j.gene.2007.04.017; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Okazaki N, 2003, DNA RES, V10, P35, DOI 10.1093/dnares/10.1.35; ONATE SA, 1995, SCIENCE, V270, P1354; Paramanik V, 2011, BIOGERONTOLOGY, V12, P321, DOI 10.1007/s10522-011-9330-y; Paramanik V, 2011, MOL BIOL REP, V38, P4657, DOI 10.1007/s11033-010-0600-6; Paramanik V, 2011, MOL BIOTECHNOL, V47, P26, DOI 10.1007/s12033-010-9308-z; Paramanik V, 2010, CELL MOL NEUROBIOL, V30, P961, DOI 10.1007/s10571-010-9526-8; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Schiller D, 2008, MOL CELL BIOL, V28, P4424, DOI 10.1128/MCB.00007-08; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Selvam R, 2003, MOL CELL BIOCHEM, V243, P1, DOI 10.1023/A:1021641223419; Shao G, 2000, MOL ENDOCRINOL, V14, P1198, DOI 10.1210/me.14.8.1198; Shao WL, 2002, MOL CELL BIOL, V22, P3358, DOI 10.1128/MCB.22.10.3358-3372.2002; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Singh K, 2008, BIOGERONTOLOGY, V9, P455, DOI 10.1007/s10522-008-9178-y; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Streuli M, 1996, CURR OPIN CELL BIOL, V8, P182, DOI 10.1016/S0955-0674(96)80064-0; Stukenberg PT, 1997, CURR BIOL, V7, P338, DOI 10.1016/S0960-9822(06)00157-6; Takahashi H, 2004, BIOCHEM BIOPH RES CO, V314, P830, DOI 10.1016/j.bbrc.2003.12.163; Thakur MK, 2009, HORM RES, V71, P194, DOI 10.1159/000201107; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	54	9	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22305	22316		10.1074/jbc.M112.351262	http://dx.doi.org/10.1074/jbc.M112.351262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22566700	Green Published, hybrid			2022-12-28	WOS:000306418600068
J	Zhang, P; Cai, Y; Soofi, A; Dressler, GR				Zhang, Peng; Cai, Yi; Soofi, Abdul; Dressler, Gregory R.			Activation of Wnt11 by Transforming Growth Factor-beta Drives Mesenchymal Gene Expression through Non-canonical Wnt Protein Signaling in Renal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBROBLAST TRANSITION; NUCLEAR TRANSLOCATION; INTERSTITIAL FIBROSIS; STEM-CELLS; KINASE-II; CATENIN; MECHANISMS; DISEASE; DIFFERENTIATION; PATHWAYS	Transforming growth factor beta 1 (TGF-beta) promotes renal interstitial fibrosis in vivo and the expression of mesenchymal genes in vitro; however, most of its direct targets in epithelial cells are still elusive. In a screen for genes directly activated by TGF-beta, we found that components of the Wnt signaling pathway, especially Wnt11, were targets of activation by TGF-beta and Smad3 in primary renal epithelial cells. In gain and loss of function experiments, Wnt11 mediated the actions of TGF-beta through enhanced activation of mesenchymal marker genes, such as Zeb1, Snail1, Pai1, and alpha SMA, without affecting Smad3 phosphorylation. Inhibition of Wnt11 by receptor knockdown or treatment with Wnt inhibitors limited the effects of TGF-beta on gene expression. We found no evidence that Wnt11 activated the canonical Wnt signaling pathway in renal epithelial cells; rather, the function of Wnt11 was mediated by the c-Jun N-terminal kinase (JNK) pathway. Consistent with the in vitro results, all the TGF-beta, Wnt11, and JNK targets were activated in a unilateral ureteral obstruction (UUO) model of renal fibrosis in vivo. Our findings demonstrated cooperativity among the TGF-beta, Wnt11, and JNK signaling pathways and suggest new targets for anti-fibrotic therapy in renal tissue.	[Zhang, Peng; Cai, Yi; Soofi, Abdul; Dressler, Gregory R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Dressler, GR (corresponding author), Univ Michigan, Dept Pathol, BSRB 2049,109 Zina Pitcher Dr, Ann Arbor, MI 48109 USA.	dressler@umich.edu			National Institutes of Health [DK062914, DK073722]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073722, R01DK062914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062914 and DK073722 (to G. R. D.).	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Cha SW, 2009, CURR BIOL, V19, P1573, DOI 10.1016/j.cub.2009.07.062; Djiane A, 2000, DEVELOPMENT, V127, P3091; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; ERNEST S, 1995, AM J PHYSIOL-CELL PH, V269, pC323, DOI 10.1152/ajpcell.1995.269.2.C323; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Garriock RJ, 2007, DEV BIOL, V304, P127, DOI 10.1016/j.ydbio.2006.12.020; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kopp JB, 1996, LAB INVEST, V74, P991; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Ledbetter S, 2000, KIDNEY INT, V58, P2367, DOI 10.1046/j.1523-1755.2000.00420.x; Lin JM, 2006, MOL CELL BIOL, V26, P4577, DOI 10.1128/MCB.02127-05; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schiro MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025021; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; Wang Y, 2008, AM J PHYSIOL-REG I, V295, pR1115, DOI 10.1152/ajpregu.90383.2008; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Yamanaka H, 2007, GENES CELLS, V12, P961, DOI 10.1111/j.1365-2443.2007.01106.x; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112	55	55	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21290	21302		10.1074/jbc.M112.357202	http://dx.doi.org/10.1074/jbc.M112.357202			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556418	hybrid, Green Published			2022-12-28	WOS:000306416800048
J	Quinlan, CL; Orr, AL; Perevoshchikova, IV; Treberg, JR; Ackrell, BA; Brand, MD				Quinlan, Casey L.; Orr, Adam L.; Perevoshchikova, Irina V.; Treberg, Jason R.; Ackrell, Brian A.; Brand, Martin D.			Mitochondrial Complex II Can Generate Reactive Oxygen Species at High Rates in Both the Forward and Reverse Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE PRODUCTION; SUCCINATE-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; ELECTRON-TRANSPORT CHAIN; SUPEROXIDE-PRODUCTION; ESCHERICHIA-COLI; DROSOPHILA MITOCHONDRIA; FUMARATE REDUCTASE; RESPIRATORY-CHAIN; INNER MEMBRANE	Respiratory complex II oxidizes succinate to fumarate as part of the Krebs cycle and reduces ubiquinone in the electron transport chain. Previous experimental evidence suggested that complex II is not a significant contributor to the production of reactive oxygen species (ROS) in isolated mitochondria or intact cells unless mutated. However, we find that when complex I and complex III are inhibited and succinate concentration is low, complex II in rat skeletal muscle mitochondria can generate superoxide or H2O2 at high rates. These rates approach or exceed the maximum rates achieved by complex I or complex III. Complex II generates these ROS in both the forward reaction, with electrons supplied by succinate, and the reverse reaction, with electrons supplied from the reduced ubiquinone pool. ROS production in the reverse reaction is prevented by inhibition of complex II at either the ubiquinone-binding site (by atpenin A5) or the flavin (by malonate), whereas ROS production in the forward reaction is prevented by malonate but not by atpenin A5, showing that the ROS from complex II arises only from the flavin site (site IIF). We propose a mechanism for ROS production by complex II that relies upon the occupancy of the substrate oxidation site and the reduction state of the enzyme. We suggest that complex II may be an important contributor to physiological and pathological ROS production.	[Quinlan, Casey L.; Orr, Adam L.; Perevoshchikova, Irina V.; Ackrell, Brian A.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA; [Treberg, Jason R.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB R3T 2N2, Canada; [Treberg, Jason R.] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB R3T 2N2, Canada	Buck Institute for Research on Aging; University of Manitoba; University of Manitoba	Quinlan, CL (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	cquinlan@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Treberg, Jason/0000-0001-5112-7325; Quinlan, Casey/0000-0002-7808-8271	National Institutes of Health [R01 AG033542, P01 AG025901, PL1 AG032118, TL1 AG032116]; Ellison Medical Foundation [AG-SS-2288-09]; Canada Research Chairs Program; NATIONAL INSTITUTE ON AGING [R01AG033542, PL1AG032118, TL1AG032116, P01AG025901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Canada Research Chairs Program(Canada Research Chairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG033542, P01 AG025901, PL1 AG032118, and TL1 AG032116 and by The Ellison Medical Foundation, Grant AG-SS-2288-09.; Supported by the Canada Research Chairs Program.	Ackrell B A, 1978, Methods Enzymol, V53, P466; ACKRELL BAC, 1975, J BIOL CHEM, V250, P7114; Ackrell BAC, 2002, MOL ASPECTS MED, V23, P369, DOI 10.1016/S0098-2997(02)00012-2; Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11; AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; BELIKOVA YO, 1988, BIOCHIM BIOPHYS ACTA, V936, P1, DOI 10.1016/0005-2728(88)90245-9; BONOMI F, 1983, EUR J BIOCHEM, V134, P439, DOI 10.1111/j.1432-1033.1983.tb07586.x; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bunik VI, 2002, EUR J BIOCHEM, V269, P5004, DOI 10.1046/j.1432-1033.2002.03204.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Drahota Z, 2002, J BIOENERG BIOMEMBR, V34, P105, DOI 10.1023/A:1015123908918; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; GUTMAN, 1971, BIOCHEMISTRY-US, V10, P4763, DOI 10.1021/bi00801a025; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hatefi Y, 1978, Methods Enzymol, V53, P21; Hirst J, 1996, J AM CHEM SOC, V118, P5031, DOI 10.1021/ja9534361; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Ishii T, 2005, CANCER RES, V65, P203; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; MERLI A, 1979, BIOCHEMISTRY-US, V18, P1393, DOI 10.1021/bi00575a001; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; MOWERY PC, 1977, ARCH BIOCHEM BIOPHYS, V178, P495, DOI 10.1016/0003-9861(77)90220-X; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x; Paranagama MP, 2010, MITOCHONDRION, V10, P158, DOI 10.1016/j.mito.2009.12.145; Quinlan C. L., 2011, HDB BIOL AGING, P45; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; RAMSAY RR, 1981, P NATL ACAD SCI-BIOL, V78, P825, DOI 10.1073/pnas.78.2.825; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; YU L, 1987, J BIOL CHEM, V262, P1137; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhao ZW, 2006, BIOCHEM CELL BIOL, V84, P1013, DOI 10.1139/O06-188	51	436	446	16	131	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27255	27264		10.1074/jbc.M112.374629	http://dx.doi.org/10.1074/jbc.M112.374629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689576	hybrid, Green Published			2022-12-28	WOS:000307386000077
J	Sengerova, B; Allerston, CK; Abu, M; Lee, SY; Hartley, J; Kiakos, K; Schofield, CJ; Hartley, JA; Gileadi, O; McHugh, PJ				Sengerova, Blanka; Allerston, Charles K.; Abu, Mika; Lee, Sook Y.; Hartley, Janet; Kiakos, Konstantinos; Schofield, Christopher J.; Hartley, John A.; Gileadi, Opher; McHugh, Peter J.			Characterization of the Human SNM1A and SNM1B/Apollo DNA Repair Exonucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; FANCONI-ANEMIA PATHWAY; STRUCTURE-SPECIFIC ENDONUCLEASE; STRUCTURE-SPECIFIC NUCLEASES; IONIZING-RADIATION; S-PHASE; REPLICATION; PROTEIN; POLYMERASE; TELOMERES	Human SNM1A and SNM1B/Apollo have both been implicated in the repair of DNA interstrand cross-links (ICLs) by cellular studies, and SNM1B is also required for telomere protection. Here, we describe studies on the biochemical characterization of the SNM1A and SNM1B proteins. The results reveal some fundamental differences in the mechanisms of the two proteins. Both SNM1A and SNM1B digest double-stranded and single-stranded DNA with a 5'-to-3' directionality in a reaction that is stimulated by divalent cations, and both nucleases are inhibited by the zinc chelator o-phenanthroline. We find that SNM1A has greater affinity for single-stranded DNA over double-stranded DNA that is not observed with SNM1B. Although both proteins demonstrate a low level of processivity on low molecular weight DNA oligonucleotide substrates, when presented with high molecular weight DNA, SNM1A alone is rendered much more active, being capable of digesting kilobase-long stretches of DNA. Both proteins can digest past ICLs induced by the non-distorting minor groove cross-linking agent SJG-136, albeit with SNM1A showing a greater capacity to achieve this. This is consistent with the proposal that SNM1A and SNM1B might exhibit some redundancy in ICL repair. Together, our work establishes differences in the substrate selectivities of SNM1A and SNM1B that are likely to be relevant to their in vivo roles and which might be exploited in the development of selective inhibitors.	[Sengerova, Blanka; Abu, Mika; Lee, Sook Y.; McHugh, Peter J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Dept Oncol, Oxford OX3 9DS, England; [Allerston, Charles K.; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Hartley, Janet; Kiakos, Konstantinos; Hartley, John A.] UCL, UCL Canc Inst, Canc Res UK Drug DNA Interact Res Grp, London WC1E 6BT, England; [Lee, Sook Y.; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford; University of Oxford; Cancer Research UK; University of London; University College London; University of Oxford	McHugh, PJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Dept Oncol, Oxford OX3 9DS, England.	peter.mchugh@imm.ox.ac.uk	Hartley, John/GRY-6691-2022; Collis, Blanka/ABB-6858-2020; Gileadi, Opher/F-1105-2013	Gileadi, Opher/0000-0001-6886-898X; Schofield, Christopher/0000-0002-0290-6565; McHugh, Peter/0000-0002-8679-4627	Cancer Research UK Programme Grant; National Science Scholarship (Ph.D.) from Singaporean Agency for Science, Technology, and Research (A*STAR); Cancer Research UK [9994] Funding Source: researchfish	Cancer Research UK Programme Grant(Cancer Research UK); National Science Scholarship (Ph.D.) from Singaporean Agency for Science, Technology, and Research (A*STAR); Cancer Research UK(Cancer Research UK)	This work was supported by a Cancer Research UK Programme Grant to PMcH.; Funded by a National Science Scholarship (Ph.D.) from the Singaporean Agency for Science, Technology, and Research (A*STAR).	Akhter S, 2010, AGING CELL, V9, P1047, DOI 10.1111/j.1474-9726.2010.00631.x; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bae JB, 2008, ONCOGENE, V27, P5045, DOI 10.1038/onc.2008.139; Biggins John B., 2006, V335, P83; Bonatto D, 2005, PROTEIN J, V24, P399, DOI 10.1007/s10930-005-7594-2; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; de Villartay JP, 2009, DNA REPAIR, V8, P202, DOI 10.1016/j.dnarep.2008.10.010; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Demuth I, 2008, DNA REPAIR, V7, P1192, DOI 10.1016/j.dnarep.2008.03.020; Dorjsuren D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1082; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Elisseeva E, 1999, J BIOL CHEM, V274, P25151, DOI 10.1074/jbc.274.35.25151; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Freibaum BD, 2006, J BIOL CHEM, V281, P15033, DOI 10.1074/jbc.C600038200; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Hazrati A, 2008, DNA REPAIR, V7, P230, DOI 10.1016/j.dnarep.2007.09.013; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; HENRIQUES JAP, 1980, GENETICS, V95, P273; Herbette Stephane, 2010, Plant Physiol, V153, P1932, DOI 10.1104/pp.110.155200; Hutton RD, 2010, NUCLEIC ACIDS RES, V38, P1664, DOI 10.1093/nar/gkp1104; Hutton RD, 2008, NUCLEIC ACIDS RES, V36, P6720, DOI 10.1093/nar/gkn745; Jose TJ, 1999, J BIOL INORG CHEM, V4, P814, DOI 10.1007/s007750050355; Kiakos K, 2010, METHODS MOL BIOL, V613, P283, DOI 10.1007/978-1-60327-418-0_18; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kumari A, 2008, J BIOL CHEM, V283, P27433, DOI 10.1074/jbc.M801237200; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee G, 2011, NAT CHEM BIOL, V7, P367, DOI [10.1038/NCHEMBIO.561, 10.1038/nchembio.561]; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Li XR, 2005, DNA REPAIR, V4, P163, DOI 10.1016/j.dnarep.2004.08.012; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Mason JM, 2011, HUM MOL GENET, V20, P2549, DOI 10.1093/hmg/ddr153; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; RUHLAND A, 1981, MUTAT RES, V91, P457, DOI 10.1016/0165-7992(81)90052-X; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; SLATER JP, 1971, BIOCHEM BIOPH RES CO, V44, P37, DOI 10.1016/S0006-291X(71)80155-9; Spanswick VJ, 2002, BLOOD, V100, P224, DOI 10.1182/blood.V100.1.224; Ho TV, 2011, NUCLEIC ACIDS RES, V39, P7455, DOI 10.1093/nar/gkr448; Tiefenbach T, 2012, NUCLEIC ACIDS RES, V40, P2131, DOI 10.1093/nar/gkr1059; Touzot F, 2010, P NATL ACAD SCI USA, V107, P10097, DOI 10.1073/pnas.0914918107; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; WILLIAMS RO, 1973, J CELL BIOL, V58, P594, DOI 10.1083/jcb.58.3.594; Wu P, 2010, MOL CELL, V39, P606, DOI 10.1016/j.molcel.2010.06.031; Yang Chaoyong James, 2006, V335, P71; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032	62	32	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26254	26267		10.1074/jbc.M112.367243	http://dx.doi.org/10.1074/jbc.M112.367243			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692201	Green Published, hybrid			2022-12-28	WOS:000306916300052
J	Guttenberg, G; Hornei, S; Jank, T; Schwan, C; Lu, W; Einsle, O; Papatheodorou, P; Aktories, K				Guttenberg, Gregor; Hornei, Sven; Jank, Thomas; Schwan, Carsten; Lu, Wei; Einsle, Oliver; Papatheodorou, Panagiotis; Aktories, Klaus			Molecular Characteristics of Clostridium perfringens TpeL Toxin and Consequences of Mono-O-GlcNAcylation of Ras in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFICILE TOXIN; LETHAL TOXIN; CATALYZED GLUCOSYLATION; RHO-PROTEINS; GLYCOSYLTRANSFERASES; TRANSLOCATION; CYTOTOXINS; CLEAVAGE; DISEASE	TpeL is a member of the family of clostridial glucosylating toxins produced by Clostridium perfringens type A, B, and C strains. In contrast to other members of this toxin family, it lacks a C-terminal polypeptide repeat domain, which is suggested to be involved in target cell binding. It was shown that the glucosyltransferase domain of TpeL modifies Ras in vitro by mono-O-glucosylation or mono-O-GlcNAcylation (Nagahama, M., Ohkubo, A., Oda, M., Kobayashi, K., Amimoto, K., Miyamoto, K., and Sakurai, J. (2011) Infect. Immun. 79, 905-910). Here we show that TpeL preferably utilizes UDP-N-acetylglucosamine (UDP-GlcNAc) as a sugar donor. Change of alanine 383 of TpeL to isoleucine turns the sugar donor preference from UDP-GlcNAc to UDP-glucose. In contrast to previous studies, we show that Rac is a poor substrate in vitro and in vivo and requires 1-2 magnitudes higher toxin concentrations for modification by TpeL. The toxin is autoproteolytically processed in the presence of inositol hexakisphosphate (InsP(6)) by an intrinsic cysteine protease domain, located next to the glucosyltransferase domain. A C-terminally extended TpeL full-length variant (TpeL1-1779) induces apoptosis in HeLa cells (most likely by mono-O-GlcNAcylation of Ras), and inhibits Ras signaling including Ras-Raf interaction and ERK activation. In addition, TpeL blocks Ras signaling in rat pheochromocytoma PC12 cells. TpeL is a glucosylating toxin, which modifies Ras and induces apoptosis in target cells without having a typical C-terminal polypeptide repeat domain.	[Guttenberg, Gregor; Hornei, Sven; Jank, Thomas; Schwan, Carsten; Papatheodorou, Panagiotis; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Lu, Wei; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25,Otto Krayer Haus, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Papatheodorou, Panagiotis/N-7509-2015; Jank, Thomas/R-9627-2017	Aktories, Klaus/0000-0002-5397-0436; Schwan, Carsten/0000-0003-3876-8739; Papatheodorou, Panagiotis/0000-0003-3571-695X; Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [AK6/16-3]; Center for Biological Signaling Studies (BIOSS) in Freiburg (Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biological Signaling Studies (BIOSS) in Freiburg (Germany)	This work was supported by the Deutsche Forschungsgemeinschaft (AK6/16-3) and the Center for Biological Signaling Studies (BIOSS) in Freiburg (Germany).	Amimoto K, 2007, MICROBIOL-SGM, V153, P1198, DOI 10.1099/mic.0.2006/002287-0; Borriello S.P., 2005, TOPLEY WILSONS MICRO; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Dreger SC, 2009, BIOCHEMISTRY-US, V48, P1785, DOI 10.1021/bi800708b; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Genth H, 2011, EUR J CELL BIOL, V90, P959, DOI 10.1016/j.ejcb.2010.10.009; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Guttenberg G, 2011, J BIOL CHEM, V286, P14779, DOI 10.1074/jbc.M110.200691; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Huelsenbeck SC, 2009, FEBS LETT, V583, P3133, DOI 10.1016/j.febslet.2009.09.006; Jank T, 2005, J BIOL CHEM, V280, P37833, DOI 10.1074/jbc.M506836200; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Nagahama M, 2011, INFECT IMMUN, V79, P905, DOI 10.1128/IAI.01019-10; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Stevens D. L., 1997, NECROTIZING CLOSTRID; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192	37	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24929	24940		10.1074/jbc.M112.347773	http://dx.doi.org/10.1074/jbc.M112.347773			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665487	hybrid, Green Published			2022-12-28	WOS:000306651700007
J	Keuylian, Z; de Baaij, JHF; Glorian, M; Rouxel, C; Merlet, E; Lipskaia, L; Blaise, R; Mateo, V; Limon, I				Keuylian, Zela; de Baaij, Jeroen H. F.; Glorian, Martine; Rouxel, Clotilde; Merlet, Elise; Lipskaia, Larissa; Blaise, Regis; Mateo, Veronique; Limon, Isabelle			The Notch Pathway Attenuates Interleukin 1 beta (IL1 beta)-mediated Induction of Adenylyl Cyclase 8 (AC8) Expression during Vascular Smooth Muscle Cell (VSMC) Trans-differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; DEPENDENT PATHWAY; ALPHA-ACTIN; CROSS-TALK; JAGGED1; RECEPTORS; MIGRATION; BETA; REPRESSION; IL-1-BETA	Vascular smooth muscle cell (VSMC) trans-differentiation, or their switch from a contractile/quiescent to a secretory/inflammatory/migratory state, is known to play an important role in pathological vascular remodeling including atherosclerosis and postangioplasty restenosis. Several reports have established the Notch pathway as tightly regulating VSMC response to various stress factors through growth, migration, apoptosis, and de-differentiation. More recently, we showed that alterations of the Notch pathway also govern VSMC acquisition of the inflammatory state, one of the major events accelerating atherosclerosis. We also evidenced that the inflammatory context of atherosclerosis triggers a de novo expression of adenylyl cyclase isoform 8 (AC8), associated with the properties developed by trans-differentiated VSMCs. As an initial approach to understanding the regulation of AC8 expression, we examined the role of the Notch pathway. Here we show that inhibiting the Notch pathway enhances the effect of IL1 beta on AC8 expression, amplifies its deleterious effects on the VSMC trans-differentiated phenotype, and decreases Notch target genes Hrt1 and Hrt3. Conversely, Notch activation resulted in blocking AC8 expression and up-regulated Hrt1 and Hrt3 expression. Furthermore, overexpressing Hrt1 and Hrt3 significantly decreased IL1 beta-induced AC8 expression. In agreement with these in vitro findings, the in vivo rat carotid balloon-injury model of restenosis evidenced that AC8 de novo expression coincided with down-regulation of the Notch3 pathway. These results, demonstrating that the Notch pathway attenuates IL1 beta-mediated AC8 up-regulation in trans-differentiated VSMCs, suggest that AC8 expression, besides being induced by the proinflammatory cytokine IL1 beta, is also dependent on down-regulation of the Notch pathway occurring in an inflammatory context.	[Keuylian, Zela; de Baaij, Jeroen H. F.; Glorian, Martine; Rouxel, Clotilde; Blaise, Regis; Mateo, Veronique; Limon, Isabelle] Univ Paris 06, UR4, Paris, France; [Merlet, Elise] UPMC Univ Paris 06, UMRS 956, Paris, France; [Lipskaia, Larissa] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY 10029 USA	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Icahn School of Medicine at Mount Sinai	Limon, I (corresponding author), 7 Quai St Bernard,Bat A 5eme Etage, F-75005 Paris, France.	isabelle.limon@snv.jussieu.fr	Mateo, Véronique/AAD-1379-2019; Limon, Isabelle/AAJ-6169-2020; Lipskaia, Larissa/AAK-9322-2020; Limon, Isabelle/P-2750-2017; de Baaij, Jeroen/P-5704-2015; Mateo, Véronique/O-9738-2017	Mateo, Véronique/0000-0002-9327-1277; Limon, Isabelle/0000-0002-8773-6971; Limon, Isabelle/0000-0002-8773-6971; de Baaij, Jeroen/0000-0003-2372-8486; Mateo, Véronique/0000-0002-9327-1277; GLORIAN, Martine/0000-0002-4502-3543; Keuylian, Zela/0000-0002-0702-8888; Rouxel, Clotilde/0000-0002-9374-3609; Blaise, Regis/0000-0001-7759-3244	Pierre and Marie Curie University; l'Agence Nationale de la Recherche [11 BSV1 034 01]	Pierre and Marie Curie University; l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Pierre and Marie Curie University and l'Agence Nationale de la Recherche Grant 11 BSV1 034 01.	Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1983, P NATL ACAD SCI-BIOL, V80, P1977, DOI 10.1073/pnas.80.7.1977; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Caolo V, 2011, ARTERIOSCL THROM VAS, V31, P1059, DOI 10.1161/ATVBAHA.110.217935; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; Clement N, 2006, J CELL PHYSIOL, V208, P495, DOI 10.1002/jcp.20673; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; Delbosc S, 2008, AM J PATHOL, V172, P1430, DOI 10.2353/ajpath.2008.070951; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gueguen M, 2010, J PATHOL, V221, P331, DOI 10.1002/path.2716; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Mallat Z, 2005, J AM COLL CARDIOL, V46, P1249, DOI 10.1016/j.jacc.2005.06.056; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Ponio JBD, 2007, HUM MOL GENET, V16, P2683, DOI 10.1093/hmg/ddm222; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Selzman CH, 1999, ANN THORAC SURG, V67, P1227, DOI 10.1016/S0003-4975(99)00252-0; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Trifonova R, 2004, J BIOL CHEM, V279, P13285, DOI 10.1074/jbc.C300564200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Willoughby D, 2007, J BIOL CHEM, V282, P34235, DOI 10.1074/jbc.M706765200; Wu XJ, 2011, ARTERIOSCL THROM VAS, V31, P2000, DOI 10.1161/ATVBAHA.111.225144	38	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24978	24989		10.1074/jbc.M111.292516	http://dx.doi.org/10.1074/jbc.M111.292516			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22613711	Green Published, hybrid			2022-12-28	WOS:000306651700011
J	Zhong, DL; Lefebre, M; Kaur, K; McDowell, MA; Gdowski, C; Jo, S; Wang, Y; Benedict, SH; Lea, SM; Galan, JE; De Guzman, RN				Zhong, Dalian; Lefebre, Matthew; Kaur, Kawaljit; McDowell, Melanie A.; Gdowski, Courtney; Jo, Sunhwan; Wang, Yu; Benedict, Stephen H.; Lea, Susan M.; Galan, Jorge E.; De Guzman, Roberto N.			The Salmonella Type III Secretion System Inner Rod Protein PrgJ Is Partially Folded	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEEDLE COMPLEX; SUBSTRATE-SPECIFICITY; NLRC4 INFLAMMASOME; SHIGELLA-FLEXNERI; NMR; SPECTROSCOPY; SENSITIVITY; INJECTISOME; ACTIVATION; COMPONENTS	The type III secretion system (T3SS) is essential in the pathogenesis of many bacteria. The inner rod is important in the assembly of the T3SS needle complex. However, the atomic structure of the inner rod protein is currently unknown. Based on computational methods, others have suggested that the Salmonella inner rod protein PrgJ is highly helical, forming a folded 3 helix structure. Here we show by CD and NMR spectroscopy that the monomeric form of PrgJ lacks a tertiary structure, and the only well-structured part of PrgJ is a short alpha-helix at the C-terminal region from residues 65-82. Disruption of this helix by glycine or proline mutation resulted in defective assembly of the needle complex, rendering bacteria incapable of secreting effector proteins. Likewise, CD and NMR data for the Shigella inner rod protein MxiI indicate this protein lacks a tertiary structure as well. Our results reveal that the monomeric forms of the T3SS inner rod proteins are partially folded.	[Zhong, Dalian; Kaur, Kawaljit; Gdowski, Courtney; Jo, Sunhwan; Wang, Yu; Benedict, Stephen H.; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Lefebre, Matthew; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [McDowell, Melanie A.; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Kansas; Yale University; University of Oxford	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu	wang, yu/A-3473-2011; Lea, Susan M/B-7678-2009	Lea, Susan M/0000-0001-9287-8053; Jo, Sunhwan/0000-0002-4104-6473; McDowell, Melanie/0000-0002-5231-8809	National Institutes of Health Grant [AI074856, AI030492]; KU Diabetes Institute; Wellcome Trust Studentship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030492, R29AI030492, R01AI030492, R01AI074856] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KU Diabetes Institute; Wellcome Trust Studentship(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074856 (to R. N. D.), National Institutes of Health Grant AI030492 (to J. G.), KU Diabetes Institute (to S. B.), and Wellcome Trust Studentship (to M. A. M).	Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Chatterjee S, 2011, PROTEIN SCI, V20, P75, DOI 10.1002/pro.537; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Davies John Q, 2005, Methods Mol Biol, V290, P91; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Fujii T, 2012, P NATL ACAD SCI USA, V109, P4461, DOI 10.1073/pnas.1116126109; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GODDARD T, 2000, SPARKY NMR ANAL SOFT; Gong H, 2010, MICROBIOL-SGM, V156, P116, DOI 10.1099/mic.0.032318-0; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Huth JR, 1997, PROTEIN SCI, V6, P2359; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Klein JR, 2000, INFECT IMMUN, V68, P3368, DOI 10.1128/IAI.68.6.3368-3376.2000; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; MELTZER MS, 1981, J IMMUNOL, V127, P179; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warren SE, 2011, EUR J IMMUNOL, V41, P1934, DOI 10.1002/eji.201041214; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Zhang LL, 2006, J MOL BIOL, V359, P322, DOI 10.1016/j.jmb.2006.03.028; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6; Zughaier SM, 1999, INFECT IMMUN, V67, P1505, DOI 10.1128/IAI.67.3.1505-1507.1999	47	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25303	25311		10.1074/jbc.M112.381574	http://dx.doi.org/10.1074/jbc.M112.381574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654099	hybrid, Green Published			2022-12-28	WOS:000306651700038
J	Karlberg, T; Thorsell, AG; Kallas, A; Schuler, H				Karlberg, Tobias; Thorsell, Ann-Gerd; Kallas, Asa; Schuler, Herwig			Crystal Structure of Human ADP-ribose Transferase ARTD15/PARP16 Reveals a Novel Putative Regulatory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE MUTATIONS; POLY(ADP-RIBOSE) POLYMERASE; PROTEIN-STRUCTURE; CATALYTIC FRAGMENT; DIPHTHERIA-TOXIN; FAMILY; PARP; INHIBITOR; SEQUENCE; BINDING	ADP-ribosylation is involved in the regulation of DNA repair, transcription, and other processes. The 18 human ADP-ribose transferases with diphtheria toxin homology include ARTD1/PARP1, a cancer drug target. Knowledge of other family members may guide therapeutics development and help evaluate potential drug side effects. Here, we present the crystal structure of human ARTD15/PARP16, a previously uncharacterized enzyme. ARTD15 features an alpha-helical domain that packs against its transferase domain without making direct contact with the NAD(+)-binding crevice or the donor loop. Thus, this novel domain does not resemble the regulatory domain of ARTD1. ARTD15 displays auto-mono(ADP-ribosylation) activity and is affected by canonical poly(ADP-ribose) polymerase inhibitors. These results add to a framework that will facilitate research on a medically important family of enzymes.	[Karlberg, Tobias; Thorsell, Ann-Gerd; Kallas, Asa; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden; [Karlberg, Tobias; Thorsell, Ann-Gerd; Schuler, Herwig] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Schuler, H (corresponding author), Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501	Structural Genomics Consortium; Canadian Institutes of Health Research [1097737]; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Swedish Foundation for Strategic Research [RBc08-0014]	Structural Genomics Consortium(University of Toronto); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by the Structural Genomics Consortium, a registered charity (1097737) that received funds from the Canadian Institutes of Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. This work was also supported by Swedish Foundation for Strategic Research Grant RBc08-0014.	Blanc E., 2011, BUSTER VERSION 2 11; BLANKE SR, 1994, BIOCHEMISTRY-US, V33, P5155, DOI 10.1021/bi00183a019; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; CHERNEY BW, 1987, P NATL ACAD SCI USA, V84, P8370, DOI 10.1073/pnas.84.23.8370; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Di Paola S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037352; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; UCHIDA K, 1987, BIOCHEM BIOPH RES CO, V148, P617, DOI 10.1016/0006-291X(87)90921-1; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; WILSON BA, 1994, J BIOL CHEM, V269, P23296	31	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24077	24081		10.1074/jbc.M112.379289	http://dx.doi.org/10.1074/jbc.M112.379289			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22661712	Green Published, hybrid			2022-12-28	WOS:000306651100002
J	Mayer, S; Roeser, M; Lachmann, P; Ishii, S; Suh, JM; Harlander, S; Desch, M; Brunssen, C; Morawietz, H; Tsai, SY; Tsai, MJ; Hohenstein, B; Hugo, C; Todorov, VT				Mayer, Sandra; Roeser, Marc; Lachmann, Peter; Ishii, Sumiyashi; Suh, Jae Mi; Harlander, Sabine; Desch, Michael; Brunssen, Coy; Morawietz, Henning; Tsai, Sophia Y.; Tsai, Ming-Jer; Hohenstein, Bernd; Hugo, Christian; Todorov, Vladimir T.			Chicken Ovalbumin Upstream Promoter Transcription Factor II Regulates Renin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR COUP-TFII; RESPONSIVE ELEMENT; NUCLEAR RECEPTORS; ORPHAN; MICE; CAMP; ALPHA; IDENTIFICATION; GAMMA; MECHANISMS	This study aimed to investigate the possible involvement of the orphan nuclear receptor chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) in the regulation of renin gene expression. COUP-TFII colocalized with renin in the juxtaglomerular cells of the kidney, which are the main source of renin in vivo. Protein-DNA binding studies demonstrated that COUP-TFII binds to an imperfect direct repeat COUP-TFII recognition sequence (termed hereafter proxDR) in the proximal renin promoter. Because cAMP signaling plays a central role in the control of the renin gene expression, we suggested that COUP-TFII may modulate this cAMP effect. Accordingly, knockdown of COUP-TFII in the clonal renin-producing cell lines As4.1 and Calu-6 diminished the stimulation of the renin mRNA expression by cAMP agonists. In addition, the mutation of the proxDR element in renin promoter reporter gene constructs abrogated the inducibility by cAMP. The proxDR sequence was found to be necessary for the function of a proximal renin promoter cAMP-response element (CRE). Knockdown of COUP-TFII or cAMP-binding protein (CREB), which is the archetypal transcription factor binding to CRE, decreased the basal renin gene expression. However, the deficiency of COUP-TFII did not further diminish the renin expression when CREB was knocked down. In agreement with the cell culture studies, mutant mice deficient in COUP-TFII have lower renin expression than their control strain. Altogether our data show that COUP-TFII is involved in the control of renin gene expression.	[Lachmann, Peter; Todorov, Vladimir T.] Tech Univ Dresden, Lab Expt Nephrol, D-01307 Dresden, Germany; [Lachmann, Peter; Todorov, Vladimir T.] Tech Univ Dresden, Div Nephrol, D-01307 Dresden, Germany; [Brunssen, Coy; Morawietz, Henning] Tech Univ Dresden, Div Vasc Endothelium & Microcirculat, D-01307 Dresden, Germany; [Brunssen, Coy; Morawietz, Henning] Tech Univ Dresden, Dept Med 3, D-01307 Dresden, Germany; [Mayer, Sandra; Roeser, Marc; Harlander, Sabine; Desch, Michael; Hohenstein, Bernd; Hugo, Christian; Todorov, Vladimir T.] Univ Regensburg, Inst Physiol, D-93040 Regensburg, Germany; [Ishii, Sumiyashi; Suh, Jae Mi; Tsai, Sophia Y.; Tsai, Ming-Jer] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; University of Regensburg; Baylor College of Medicine	Todorov, VT (corresponding author), Tech Univ Dresden, Univ Hosp Dresden, Div Nephrol, Lab Expt Nephrol, Fiedlerstr 42, D-01307 Dresden, Germany.	vladimir.todorov@uniklinikum-dresden.de		Harlander, Sabine/0000-0003-2827-425X; Todorov, Vladimir/0000-0002-7011-8130	National Institutes of Health [DK45641, HL76448, DK59820, DK62434]; Deutsche Forschungsgemeinschaft [SFB 699/B1, TO 679/1-1, MO 1695/4-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045641, U19DK062434, R37DK045641, P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45641 (to M. J. T.), HL76448 (to S. Y. T.), and DK59820 and DK62434 (to M. J. T. and S. Y. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB 699/B1 and TO 679/1-1 (to V. T. T.) and MO 1695/4-1 (to H. M.).	BURT DW, 1989, J BIOL CHEM, V264, P7357; Castrop H, 2010, PHYSIOL REV, V90, P607, DOI 10.1152/physrev.00011.2009; Chen LM, 2007, AM J PHYSIOL-RENAL, V292, pF27, DOI 10.1152/ajprenal.00193.2006; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Desch M, 2011, PFLUG ARCH EUR J PHY, V461, P567, DOI 10.1007/s00424-011-0956-z; Desch M, 2010, MOL ENDOCRINOL, V24, P2139, DOI 10.1210/me.2010-0134; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; HORIUCHI M, 1993, J CLIN INVEST, V92, P1805, DOI 10.1172/JCI116770; Kim SM, 2007, HYPERTENSION, V50, P103, DOI 10.1161/HYPERTENSIONAHA.107.087577; Klar J, 2002, PFLUG ARCH EUR J PHY, V444, P335, DOI 10.1007/s00424-002-0818-9; Konoshita T, 2004, J CELL BIOCHEM, V93, P327, DOI 10.1002/jcb.20151; Konoshita T, 2007, J CELL BIOCHEM, V102, P1043, DOI 10.1002/jcb.21341; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Lang JA, 1996, AM J PHYSIOL-RENAL, V271, pF94, DOI 10.1152/ajprenal.1996.271.1.F94; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Lin FJ, 2010, J CLIN INVEST, V120, P1694, DOI 10.1172/JCI40101; Liu XB, 2003, CIRC RES, V92, P1033, DOI 10.1161/01.RES.0000071355.82009.43; Mercure C, 2009, HYPERTENSION, V53, P1062, DOI 10.1161/HYPERTENSIONAHA.108.115444; Morris BJ, 2004, ACTA PHYSIOL SCAND, V181, P369, DOI 10.1111/j.1365-201X.2004.01307.x; Neubauer B, 2009, AM J PHYSIOL-RENAL, V296, pF1006, DOI 10.1152/ajprenal.90448.2008; Pan L, 2005, HYPERTENSION, V45, P3, DOI 10.1161/01.HYP.0000149717.55920.45; Pan L, 2001, J BIOL CHEM, V276, P45530, DOI 10.1074/jbc.M103010200; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Shi Q, 2001, J BIOL CHEM, V276, P3597, DOI 10.1074/jbc.M008361200; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; Suh JM, 2006, MOL ENDOCRINOL, V20, P3412, DOI 10.1210/me.2006-0312; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Todorov V, 2002, AM J PHYSIOL-REG I, V283, pR1046, DOI 10.1152/ajpregu.00142.2002; Todorov V, 2001, KIDNEY BLOOD PRESS R, V24, P75, DOI 10.1159/000054210; Todorov VT, 2008, ENDOCRINOLOGY, V149, P4647, DOI 10.1210/en.2008-0127; Todorov VT, 2007, HYPERTENSION, V50, P939, DOI 10.1161/HYPERTENSIONAHA.107.092817; Todorov VT, 2004, J BIOL CHEM, V279, P1458, DOI 10.1074/jbc.M308697200; Wang Lee-Ho, 1991, Gene Expression, V1, P207; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Weatherford ET, 2012, AM J PHYSIOL-RENAL, V302, pF1025, DOI 10.1152/ajprenal.00362.2011; Yang TX, 2000, AM J PHYSIOL-RENAL, V279, pF819, DOI 10.1152/ajprenal.2000.279.5.F819; Ying LH, 1997, J BIOL CHEM, V272, P2412; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511	45	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24483	24491		10.1074/jbc.M111.329474	http://dx.doi.org/10.1074/jbc.M111.329474			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645148	Green Published, hybrid			2022-12-28	WOS:000306651100041
J	Nisar, SP; Cunningham, M; Saxena, K; Pope, RJ; Kelly, E; Mundell, SJ				Nisar, Shaista P.; Cunningham, Margaret; Saxena, Kunal; Pope, Robert J.; Kelly, Eamonn; Mundell, Stuart J.			Arrestin Scaffolds NHERF1 to the P2Y(12) Receptor to Regulate Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARATHYROID-HORMONE RECEPTOR; PROTEIN-COUPLED-RECEPTORS; HUMAN PLATELETS; FACTOR-I; BETA(2)-ADRENERGIC RECEPTOR; DEPENDENT MECHANISMS; TYROSINE KINASES; NA+/H+ EXCHANGE; DOWN-REGULATION; BETA-ARRESTIN	We have recently shown in a patient with mild bleeding that the PDZ-binding motif of the platelet G protein-coupled P2Y(12) receptor (P2Y(12)R) is required for effective receptor traffic in human platelets. In this study we show for the first time that the PDZ motif-binding protein NHERF1 exerts a major role in potentiating G protein-coupled receptor (GPCR) internalization. NHERF1 interacts with the C-tail of the P2Y(12)R and unlike many other GPCRs, NHERF1 interaction is required for effective P2Y(12)R internalization. In vitro and prior to agonist stimulation P2Y(12)R/NHERF1 interaction requires the intact PDZ binding motif of this receptor. Interestingly on receptor stimulation NHERF1 no longer interacts directly with the receptor but instead binds to the receptor via the endocytic scaffolding protein arrestin. These findings suggest a novel model by which arrestin can serve as an adaptor to promote NHERF1 interaction with a GPCR to facilitate effective NHERF1-dependent receptor internalization.	[Nisar, Shaista P.; Cunningham, Margaret; Saxena, Kunal; Pope, Robert J.; Kelly, Eamonn; Mundell, Stuart J.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Mundell, SJ (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	s.j.mundell@bris.ac.uk		Cunningham, Margaret/0000-0001-6454-8671; Mundell, Stuart/0000-0001-7754-3271	British Heart Foundation [PG/09/091, FS/11/49/28751]; Medical Research Council [G1000432]; MRC [G1000432] Funding Source: UKRI; British Heart Foundation [PG/09/091/28074] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work was supported in part by British Heart Foundation Grant PG/09/091 and Medical Research Council Grant G1000432.; Supported by British Heart Foundation Research Fellowship FS/11/49/28751. To whom correspondence should be addressed. Tel.: 44-117-3311440; Fax: 44-117-925-0168; E-mail: s.j.mundell@bris.ac.uk.	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Klenk C, 2010, J BIOL CHEM, V285, P30355, DOI 10.1074/jbc.M110.114900; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mundell SJ, 2008, J THROMB HAEMOST, V6, P1393, DOI 10.1111/j.1538-7836.2008.03039.x; Mundell SJ, 2010, BRIT J PHARMACOL, V159, P518, DOI 10.1111/j.1476-5381.2009.00598.x; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Nisar S, 2011, BLOOD, V118, P5641, DOI 10.1182/blood-2011-02-336826; Paasche JD, 2005, MOL PHARMACOL, V67, P1581, DOI 10.1124/mol.104.007013; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rochdi MD, 2003, J BIOL CHEM, V278, P17827, DOI 10.1074/jbc.M210319200; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Simon J, 2002, J BIOL CHEM, V277, P31390, DOI 10.1074/jbc.M110714200; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Stalker TJ, 2009, J THROMB HAEMOST, V7, P1886, DOI 10.1111/j.1538-7836.2009.03606.x; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wheeler D, 2006, ENDOCRINE, V30, P343, DOI 10.1007/s12020-006-0013-4; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zhang FL, 2001, J BIOL CHEM, V276, P8608, DOI 10.1074/jbc.M009718200	39	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24505	24515		10.1074/jbc.M112.347104	http://dx.doi.org/10.1074/jbc.M112.347104			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22610101	Green Published, hybrid			2022-12-28	WOS:000306651100043
J	Sears, CR; Turchi, JJ				Sears, Catherine R.; Turchi, John J.			Complex Cisplatin-Double Strand Break (DSB) Lesions Directly Impair Cellular Non-Homologous End-Joining (NHEJ) Independent of Downstream Damage Response (DDR) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; IONIZING-RADIATION; DNA; REPAIR; ADDUCTS; CELLS; DRUG; RECOMBINATION; CYTOTOXICITY; INHIBITION	The treatment for advanced stage non-small cell lung cancer (NSCLC) often includes platinum-based chemotherapy and IR. Cisplatin and IR combination therapy display schedule and dose-dependent synergy, the mechanism of which is not completely understood. In a series of in vitro and cell culture assays in a NSCLC model, we investigated both the downstream and direct treatment and damage effects of cisplatin on NHEJ catalyzed repair of a DNA DSB. The results demonstrate that extracts prepared from cisplatin-treated cells are fully capable of NHEJ catalyzed repair of a DSB using a non-cisplatin-damaged DNA substrate in vitro. Similarly, using two different host cell reactivation assays, treatment of cells prior to transfection of a linear, undamaged reporter plasmid revealed no reduction in NHEJ compared with untreated cells. In contrast, transfection of a linear GFP-reporter plasmid containing site-specific, cisplatin lesions 6-bp from the termini revealed a significant impairment in DSB repair of the cisplatin-damaged DNA substrates in the absence of cellular treatment with cisplatin. Together, these data demonstrate that impaired NHEJ in combined cisplatin-IR treated cells is likely the result of a direct effect of cisplatin-DNA lesions near a DSB and that the indirect cellular effects of cisplatin treatment are not significant contributors to the synergistic cytotoxicity observed with combination cisplatin-IR treatment.	[Turchi, John J.] Indiana Univ Sch Med, Dept Med, Div Hematol & Oncol, Indianapolis, IN 46202 USA; [Turchi, John J.] Indiana Univ Sch Med, Dept Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Turchi, JJ (corresponding author), Indiana Univ Sch Med, Dept Med, Div Hematol & Oncol, 980 W Walnut Joseph E Walther Hall,R3 C650, Indianapolis, IN 46202 USA.	jturchi@iupui.edu	Turchi, John J/B-5807-2015	Turchi, John J/0000-0001-5375-2992; Sears, Catherine/0000-0002-5797-3458	National Institutes of Health [CA082741]; NATIONAL CANCER INSTITUTE [R01CA082741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA082741 (to J. J. T.).	America Cancer Society, 2011, CANC FACTS FIG; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Boeckman HJ, 2005, MOL CANCER RES, V3, P277, DOI 10.1158/1541-7786.MCR-04-0032; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Diggle CP, 2005, NUCLEIC ACIDS RES, V33, P2531, DOI 10.1093/nar/gki528; Dolling JA, 1998, INT J RADIAT BIOL, V74, P61, DOI 10.1080/095530098141735; Gorodetsky R, 1998, INT J CANCER, V75, P635, DOI 10.1002/(SICI)1097-0215(19980209)75:4<635::AID-IJC23>3.0.CO;2-6; GROEN HJM, 1995, BRIT J CANCER, V72, P1406, DOI 10.1038/bjc.1995.522; Henkels KM, 1999, CANCER RES, V59, P3077; Jeggo P, 2009, INT J RADIAT BIOL, V85, P1061, DOI 10.3109/09553000903261263; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jett JR, 2007, CHEST, V132, p266S, DOI 10.1378/chest.07-1380; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Koberle B, 1997, INT J CANCER, V70, P551, DOI 10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; LIMOLI CL, 1995, MUTAGENESIS, V10, P453, DOI 10.1093/mutage/10.5.453; MASCHARAK PK, 1983, P NATL ACAD SCI-BIOL, V80, P6795, DOI 10.1073/pnas.80.22.6795; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Myint WK, 2002, INT J RADIAT BIOL, V78, P417, DOI 10.1080/09553000110113047; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; O'Rourke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002140.pub3; PARKER RJ, 1991, J CLIN INVEST, V87, P772, DOI 10.1172/JCI115080; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Pawelczak KS, 2005, NUCLEIC ACIDS RES, V33, P152, DOI 10.1093/nar/gki157; Raaphorst GP, 1996, INT J RADIAT BIOL, V69, P623, DOI 10.1080/095530096145634; Raaphorst GP, 2005, ANTICANCER RES, V25, P53; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; SORENSON CM, 1988, CANCER RES, V48, P4484; TAYLOR SG, 1994, J CLIN ONCOL, V12, P385, DOI 10.1200/JCO.1994.12.2.385; Tornaletti S, 2003, J BIOL CHEM, V278, P35791, DOI 10.1074/jbc.M305394200; Turchi JJ, 2000, NUCLEIC ACIDS RES, V28, P4634, DOI 10.1093/nar/28.23.4634; Turchi JJ, 1996, J BIOL CHEM, V271, P13861, DOI 10.1074/jbc.271.23.13861; VRANA O, 1986, INT J RADIAT BIOL, V50, P995, DOI 10.1080/09553008614551411; Wahl GM, 1997, CANCER SURV, V29, P183; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Wu XM, 2003, CLIN CANCER RES, V9, P5874; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452	39	39	43	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24263	24272		10.1074/jbc.M112.344911	http://dx.doi.org/10.1074/jbc.M112.344911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621925	hybrid, Green Published			2022-12-28	WOS:000306651100020
J	Bogan, JS; Rubin, BR; Yu, CF; Loffler, MG; Orme, CM; Belman, JP; McNally, LJ; Hao, MM; Cresswell, JA				Bogan, Jonathan S.; Rubin, Bradley R.; Yu, Chenfei; Loeffler, Michael G.; Orme, Charisse M.; Belman, Jonathan P.; McNally, Leah J.; Hao, Mingming; Cresswell, James A.			Endoproteolytic Cleavage of TUG Protein Regulates GLUT4 Glucose Transporter Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE STORAGE COMPARTMENT; NEWLY SYNTHESIZED GLUT4; END RULE PATHWAY; 3T3-L1 ADIPOCYTES; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; SURFACE EXPRESSION; GOLGI PROTEIN; GTPASE TC10; P97 ATPASE	To promote glucose uptake into fat and muscle cells, insulin causes the translocation of GLUT4 glucose transporters from intracellular vesicles to the cell surface. Previous data support a model in which TUG traps GLUT4-containing vesicles and tethers them intracellularly in unstimulated cells and in which insulin mobilizes this pool of vesicles by releasing this tether. Here we show that TUG undergoes site-specific endoproteolytic cleavage, which separates a GLUT4-binding, N-terminal region of TUG from a C-terminal region previously suggested to bind an intracellular anchor. Cleavage is accelerated by insulin stimulation in 3T3-L1 adipocytes and is highly dependent upon adipocyte differentiation. The N-terminal TUG cleavage product has properties of a novel 18-kDa ubiquitin-like modifier, which we call TUGUL. The C-terminal product is observed at the expected size of 42 kDa and also as a 54-kDa form that is released from membranes into the cytosol. In transfected cells, intact TUG links GLUT4 to PIST and also binds Golgin-160 through its C-terminal region. PIST is an effector of TC10 alpha, a GTPase previously shown to transmit an insulin signal required for GLUT4 translocation, and we show using RNAi that TC10 alpha is required for TUG proteolytic processing. Finally, we demonstrate that a cleavage-resistant form of TUG does not support highly insulin-responsive GLUT4 translocation or glucose uptake in 3T3-L1 adipocytes. Together with previous results, these data support a model whereby insulin stimulates TUG cleavage to liberate GLUT4 storage vesicles from the Golgi matrix, which promotes GLUT4 translocation to the cell surface and enhances glucose uptake.	[Bogan, Jonathan S.; Rubin, Bradley R.; Yu, Chenfei; Loeffler, Michael G.; Orme, Charisse M.; Belman, Jonathan P.; McNally, Leah J.; Hao, Mingming; Cresswell, James A.] Yale Univ, Sch Med, Sect Endocrinol & Metab, Dept Internal Med, New Haven, CT 06520 USA; [Bogan, Jonathan S.; Rubin, Bradley R.; Orme, Charisse M.; Belman, Jonathan P.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Bogan, JS (corresponding author), Yale Univ, Sch Med, Sect Endocrinol & Metab, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Bogan, Jonathan S/A-1575-2010; Löffler, Michael/F-1748-2013	Bogan, Jonathan S/0000-0001-6463-8466; Löffler, Michael/0000-0002-6529-9723; Belman, Jonathan/0000-0002-1051-6938	National Institutes of Health Grant [R01DK075772, F30DK086109, T32GM07205, F30DK093198, K01DK078625, P30DK45735]; American Diabetes Association [1-05-RA-17, 1-12-BS-16]; Yale O'Brien Kidney Center [P30DK079310]; W.M. Keck Foundation; American Heart Association Grant [0815746D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078625, F30DK086109, P30DK045735, F30DK093198, P30DK079310, R01DK075772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Yale O'Brien Kidney Center; W.M. Keck Foundation(W.M. Keck Foundation); American Heart Association Grant(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK075772 (to J.S.B.). This work was also supported by American Diabetes Association Grants 1-05-RA-17 and 1-12-BS-16, by a pilot grant from the Yale O'Brien Kidney Center P30DK079310, and by a Distinguished Young Scholar in Medical Research Award from the W.M. Keck Foundation (to J.S.B.).; Supported by American Heart Association Grant 0815746D.; Supported by National Institutes of Health Grant F30DK086109; Supported by National Institutes of Health Grant T32GM07205.; Supported by National Institutes of Health Grant F30DK093198.; Supported by National Institutes of Health Grant K01DK078625.; We thank Mark Hochstrasser, Thomas Gniadek, Derek Toomre, Emily Stoops, Whitney Harris, and Hongjie Li for assistance, advice, and comments on the manuscript. We thank Xuedong Liu, Dirk Bohmann, Hamid Band, and Carolyn Machamer for reagents. This work used the Cell Biology Core of the Yale Diabetes Endocrinology Research Center (supported by National Institutes of Health Grant P30DK45735) as well as services provided by the W.M. Keck Foundation Biotechnology Resource Laboratory at Yale University.	Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Brandon E, 2003, EUR J CELL BIOL, V82, P411, DOI 10.1078/0171-9335-00327; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; BUTT TR, 1988, J BIOL CHEM, V263, P16364; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; Foster LJ, 2006, J PROTEOME RES, V5, P64, DOI 10.1021/pr0502626; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; Hicks SW, 2006, TRAFFIC, V7, P1666, DOI 10.1111/j.1600-0854.2006.00504.x; Hicks SW, 2005, J BIOL CHEM, V280, P28944, DOI 10.1074/jbc.M504937200; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KANDROR KV, 1995, BIOCHEM J, V307, P383, DOI 10.1042/bj3070383; Khan AH, 2004, J BIOL CHEM, V279, P37505, DOI 10.1074/jbc.M405694200; Kim DW, 2003, BIOCHEM BIOPH RES CO, V303, P370, DOI 10.1016/S0006-291X(03)00341-3; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Lampson MA, 2000, J CELL SCI, V113, P4065; Laney J. D., 2011, CURR PROTOC PROTEIN; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Marie M, 2009, MOL BIOL CELL, V20, P4458, DOI 10.1091/mbc.E08-12-1229; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Neudauer CL, 2001, BIOCHEM BIOPH RES CO, V280, P541, DOI 10.1006/bbrc.2000.4160; Orme CM, 2012, J BIOL CHEM, V287, P6679, DOI 10.1074/jbc.M111.284232; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rubin BR, 2009, VITAM HORM, V80, P155, DOI 10.1016/S0083-6729(08)00607-9; Schertzer JD, 2009, ENDOCRINOLOGY, V150, P1935, DOI 10.1210/en.2008-1372; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Watson RT, 2008, J CELL SCI, V121, P1243, DOI 10.1242/jcs.017517; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Wente W, 2005, FEBS LETT, V579, P6305, DOI 10.1016/j.febslet.2005.10.009; WILKINSON KD, 1981, J BIOL CHEM, V256, P9235; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yao RJ, 2001, BIOCHEM BIOPH RES CO, V286, P771, DOI 10.1006/bbrc.2001.5430; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9	95	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23932	23947		10.1074/jbc.M112.339457	http://dx.doi.org/10.1074/jbc.M112.339457			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610098	Green Published, hybrid			2022-12-28	WOS:000306511300063
J	Collak, FK; Yagiz, K; Luthringer, DJ; Erkaya, B; Cinar, B				Collak, Filiz Kisaayak; Yagiz, Kader; Luthringer, Daniel J.; Erkaya, Bahriye; Cinar, Bekir			Threonine-120 Phosphorylation Regulated by Phosphoinositide-3-Kinase/Akt and Mammalian Target of Rapamycin Pathway Signaling Limits the Antitumor Activity of Mammalian Sterile 20-Like Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; ORGAN SIZE CONTROL; PROSTATE-CANCER; CELL-PROLIFERATION; NUCLEAR TRANSLOCATION; ANDROGEN RECEPTOR; CASPASE CLEAVAGE; ANTIGEN PROMOTER; MST1; MTOR	Mst1/Stk4, a hippo-like serine-threonine kinase, is implicated in many cancers, including prostate cancer. However, the mechanisms regulating Mst1 remain obscure. Here, we characterized the effects of phospho-Thr-120 on Mst1 in prostate cancer cells. We demonstrated that phospho-Thr-120 did not alter the nuclear localization or cleavage of Mst1 in a LNCaP or castration-resistant C4-2 prostate tumor cell model, as revealed by a mutagenesis approach. Phospho-Thr-120 appeared to be specific to cancer cells and predominantly localized in the nucleus. In contrast, phospho-Thr-183, a critical regulator of Mst1 cell death, was exclusively found in the cytoplasm. As assessed by immunohistochemistry, a similar distribution of phospho-Mst1-Thr-120/Thr-183 was also observed in a prostate cancer specimen. In addition, the blockade of PI3K signaling by a small molecule inhibitor, LY294002, increased cytoplasmic phospho-Mst1-Thr-183 without having a significant effect on nuclear phospho-Mst1-Thr-120. However, the attenuation of mammalian target of rapamycin (mTOR) activity by a selective pharmacologic inhibitor, Ku0063794 or CCI-779, caused the up-regulation of nuclear phospho-Mst1-Thr-120 without affecting cytoplasmic phospho-Mst1-Thr-183. This suggests that PI3K and mTOR pathway signaling differentially regulate phospho-Mst1-Thr-120/Thr-183. Moreover, mutagenesis and RNAi data revealed that phospho-Thr-120 resulted in C4-2 cell resistance to mTOR inhibition and reduced the Mst1 suppression of cell growth and androgen receptor-driven gene expression. Collectively, these findings indicate that phospho-Thr-120 leads to the loss of Mst1 functions, supporting cancer cell growth and survival.	[Collak, Filiz Kisaayak; Yagiz, Kader; Erkaya, Bahriye; Cinar, Bekir] Cedars Sinai Med Ctr, Dept Med & Biomed Sci, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Collak, Filiz Kisaayak; Yagiz, Kader; Erkaya, Bahriye; Cinar, Bekir] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Luthringer, Daniel J.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Cinar, B (corresponding author), Cedars Sinai Med Ctr, Dept Med & Biomed Sci, Samuel Oschin Comprehens Canc Inst, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	bekir.cinar@cshs.org	CİNAR, BEKIR MURAT/AAL-4474-2021	CİNAR, BEKIR MURAT/0000-0002-7906-5039; Cinar, Bekir/0000-0003-4028-7600	New York Academy of Medicine; Jesse and Donna Garber Foundation; Cedars-Sinai Medical Center Fellowship Award	New York Academy of Medicine; Jesse and Donna Garber Foundation; Cedars-Sinai Medical Center Fellowship Award	This work was supported by an Edwin Beer Fellowship Award from the New York Academy of Medicine (to B. C.) and a Jesse and Donna Garber Foundation and Cedars-Sinai Medical Center Fellowship Award (to B. C.).	Behbakht K, 2011, GYNECOL ONCOL, V123, P19, DOI 10.1016/j.ygyno.2011.06.022; Bhagwat SV, 2010, CURR OPIN INVEST DR, V11, P638; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Cinar B, 2011, CANCER RES, V71, P4303, DOI 10.1158/0008-5472.CAN-10-4532; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Deocampo N D, 2003, Minerva Endocrinol, V28, P145; Ding ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009910; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Kim D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009616; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Minoo P, 2007, MODERN PATHOL, V20, P331, DOI 10.1038/modpathol.3800740; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Seidel C, 2007, MOL CARCINOGEN, V46, P865, DOI 10.1002/mc.20317; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Steinmann K, 2009, ONCOL REP, V22, P1519, DOI 10.3892/or_00000596; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Werzowa J, 2009, BRIT J DERMATOL, V160, P955, DOI 10.1111/j.1365-2133.2008.08991.x; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	46	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23698	23709		10.1074/jbc.M112.358713	http://dx.doi.org/10.1074/jbc.M112.358713			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22619175	hybrid, Green Published			2022-12-28	WOS:000306511300040
J	Islam, MN; Paquet, N; Fox, D; Dray, E; Zheng, XF; Klein, H; Sung, P; Wang, WD				Islam, M. Nurul; Paquet, Nicolas; Fox, David, III; Dray, Eloise; Zheng, Xiao-Feng; Klein, Hannah; Sung, Patrick; Wang, Weidong			A Variant of the Breast Cancer Type 2 Susceptibility Protein (BRC) Repeat Is Essential for the RECQL5 Helicase to Interact with RAD51 Recombinase for Genome Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; PRESYNAPTIC FILAMENT; PROMOTES; EXCHANGE; REPAIR; BLM; CROSSOVERS; DISRUPTION; MECHANISMS	The BRC repeat is a structural motif in the tumor suppressor BRCA2 (breast cancer type 2 susceptibility protein), which promotes homologous recombination (HR) by regulating RAD51 recombinase activity. To date, the BRC repeat has not been observed in other proteins, so that its role in HR is inferred only in the context of BRCA2. Here, we identified a BRC repeat variant, named BRCv, in the RECQL5 helicase, which possesses anti-recombinase activity in vitro and suppresses HR and promotes cellular resistance to camptothecin-induced replication stress in vivo. RECQL5-BRCv interacted with RAD51 through two conserved motifs similar to those in the BRCA2-BRC repeat. Mutations of either motif compromised functions of RECQL5, including association with RAD51, inhibition of RAD51-mediated D-loop formation, suppression of sister chromatid exchange, and resistance to camptothecin-induced replication stress. Potential BRCvs were also found in other HR regulatory proteins, including Srs2 and Sgs1, which possess anti-recombinase activities similar to that of RECQL5. A point mutation in the predicted Srs2-BRCv disrupted the ability of the protein to bind RAD51 and to inhibit D-loop formation. Thus, BRC is a common RAD51 interaction module that can be utilized by different proteins to either promote HR, as in the case of BRCA2, or to suppress HR, as in RECQL5.	[Islam, M. Nurul; Paquet, Nicolas; Dray, Eloise; Zheng, Xiao-Feng; Sung, Patrick] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Islam, M. Nurul; Fox, David, III; Wang, Weidong] NIA, Genet Lab, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Klein, Hannah] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); New York University	Sung, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Sch Med, POB 6666, New Haven, CT 06520 USA.	patrick.sung@yale.edu; wangw@grc.nia.nih.gov	Wang, Weidong/AAV-2446-2021; Dray, Eloise/E-3938-2012; Dray, Eloise/AAD-5147-2021	Dray, Eloise/0000-0001-6793-9838; Zheng, Xiao-Feng/0000-0001-8769-4604; Wang, Weidong/0000-0002-0658-7928; Paquet, Nicolas/0000-0001-9140-4673; Klein, Hannah/0000-0003-4228-8535	National Institutes of Health, NIA, Intramural Research Program [Z01:AG000657-09]; National Institutes of Health [ES016532, ES015252]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES015252, R21ES016532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000661, Z01AG000657] Funding Source: NIH RePORTER	National Institutes of Health, NIA, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Intramural Research Program Grant Z01:AG000657-09 (to W. W.) and National Institutes of Health Grants ES016532 and ES015252 (to P. S.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Carreira A, 2011, P NATL ACAD SCI USA, V108, P10448, DOI 10.1073/pnas.1106971108; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Hu YD, 2009, MOL BIOL CELL, V20, P114, DOI 10.1091/mbc.E08-06-0565; Islam MN, 2010, MOL CELL BIOL, V30, P2460, DOI 10.1128/MCB.01583-09; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Ochiai K, 2011, FEBS LETT, V585, P1771, DOI 10.1016/j.febslet.2011.05.027; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Rajendra E, 2010, NUCLEIC ACIDS RES, V38, P82, DOI 10.1093/nar/gkp873; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Schwendener S, 2010, J BIOL CHEM, V285, P15739, DOI 10.1074/jbc.M110.110478; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Wang WS, 2003, MOL CELL BIOL, V23, P3527, DOI 10.1128/MCB.23.10.3527-3535.2003; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636	40	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23808	23818		10.1074/jbc.M112.375014	http://dx.doi.org/10.1074/jbc.M112.375014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645136	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000306511300050
J	Rucktooa, P; Haseler, CA; van Elk, R; Smit, AB; Gallagher, T; Sixma, TK				Rucktooa, Prakash; Haseler, Claire A.; van Elk, Rene; Smit, August B.; Gallagher, Timothy; Sixma, Titia K.			Structural Characterization of Binding Mode of Smoking Cessation Drugs to Nicotinic Acetylcholine Receptors through Study of Ligand Complexes with Acetylcholine-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; 10-SUBSTITUTED CYTISINE DERIVATIVES; CYS-LOOP RECEPTOR; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; HOMOLOG ACHBP; AGONISTS; DETERMINANTS; SELECTIVITY; RESOLUTION	Smoking cessation is an important aim in public health worldwide as tobacco smoking causes many preventable deaths. Addiction to tobacco smoking results from the binding of nicotine to nicotinic acetylcholine receptors (nAChRs) in the brain, in particular the alpha 4 beta 2 receptor. One way to aid smoking cessation is by the use of nicotine replacement therapies or partial nAChR agonists like cytisine or varenicline. Here we present the co-crystal structures of cytisine and varenicline in complex with Aplysia californica acetylcholine-binding protein and use these as models to investigate binding of these ligands binding to nAChRs. This analysis of the binding properties of these two partial agonists provides insight into differences with nicotine binding to nAChRs. A mutational analysis reveals that the residues conveying subtype selectivity in nAChRs reside on the binding site complementary face and include features extending beyond the first shell of contacting residues.	[Rucktooa, Prakash; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Rucktooa, Prakash; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Haseler, Claire A.; Gallagher, Timothy] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [van Elk, Rene; Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Bristol; Vrije Universiteit Amsterdam	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands.	t.sixma@nki.nl		Sixma, Titia K/0000-0001-6180-0632; Rucktooa, Prakash/0000-0003-2050-7389	European Union [HEALTH-F2-2007-202088]; TiPharma Grant [D2-103]; European Molecular Biology Organization	European Union(European Commission); TiPharma Grant; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the European Union Seventh Framework Programme under Grant agreement HEALTH-F2-2007-202088 ("Neuro-Cypres" project) and from TiPharma Grant D2-103 (to A. B. S.).; Supported by a long term fellowship from the European Molecular Biology Organization.	Abin-Carriquiry JA, 2010, BIOORG MED CHEM LETT, V20, P3683, DOI 10.1016/j.bmcl.2010.04.092; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bricogne G., 2011, BUSTER; Carbonnelle E, 2003, EUR J PHARMACOL, V471, P85, DOI 10.1016/S0014-2999(03)01817-X; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chellappan SK, 2006, J MED CHEM, V49, P2673, DOI 10.1021/jm051196m; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Daly JW, 2005, CELL MOL NEUROBIOL, V25, P513, DOI 10.1007/s10571-005-3968-4; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dwoskin LP, 2009, BIOCHEM PHARMACOL, V78, P732, DOI 10.1016/j.bcp.2009.06.002; Eaton JB, 2003, MOL PHARMACOL, V64, P1283, DOI 10.1124/mol.64.6.1283; Edink E, 2011, J AM CHEM SOC, V133, P5363, DOI 10.1021/ja110571r; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Huang XQ, 2006, J MED CHEM, V49, P7661, DOI 10.1021/jm0606701; Imming P, 2001, EUR J MED CHEM, V36, P375, DOI 10.1016/S0223-5234(01)01222-3; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kozikowski AP, 2007, CHEMMEDCHEM, V2, P1157, DOI 10.1002/cmdc.200700073; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lancaster T, 2008, EXPERT OPIN PHARMACO, V9, P15, DOI 10.1517/14656566.9.1.15; Lummis SCR, 2011, J PHARMACOL EXP THER, V339, P125, DOI 10.1124/jpet.111.185306; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Slater YE, 2003, NEUROPHARMACOLOGY, V44, P503, DOI 10.1016/S0028-3908(03)00025-X; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Tasso B, 2009, J MED CHEM, V52, P4345, DOI 10.1021/jm900225j; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768	53	38	43	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23283	23293		10.1074/jbc.M112.360347	http://dx.doi.org/10.1074/jbc.M112.360347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22553201	Green Published, hybrid			2022-12-28	WOS:000306511300003
J	Sanz-Garcia, M; Monsalve, DM; Sevilla, A; Lazo, PA				Sanz-Garcia, Marta; Monsalve, Diana M.; Sevilla, Ana; Lazo, Pedro A.			Vaccinia-related Kinase 1 (VRK1) Is an Upstream Nucleosomal Kinase Required for the Assembly of 53BP1 Foci in Response to Ionizing Radiation-induced DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HUMAN VACCINIA-RELATED-KINASE-1 VRK1; HISTONE H2AX; CELL-CYCLE; DEPENDENT PHOSPHORYLATION; MAMMALIAN-CELLS; BINDING-SITE; P53; ATM; CHECKPOINT	Cellular responses to DNA damage require the formation of protein complexes in a highly organized fashion. The complete molecular components that participate in the sequential signaling response to DNA damage remain unknown. Here we demonstrate that vaccinia-related kinase 1 (VRK1) in resting cells plays an important role in the formation of ionizing radiation-induced foci that assemble on the 53BP1 scaffold protein during the DNA damage response. The kinase VRK1 is activated by DNA double strand breaks induced by ionizing radiation (IR) and specifically phosphorylates 53BP1 in serum-starved cells. VRK1 knockdown resulted in the defective formation of 53BP1 foci in response to IR both in number and size. This observed effect on 53BP1 foci is p53- and ataxia-telangiectasia mutated (ATM)-independent and can be rescued with VRK1 mutants resistant to siRNA. VRK1 knockdown also prevented the activating phosphorylation of ATM, CHK2, and DNA-dependent protein kinase in response to IR. VRK1 activation in response to DNA damage is a novel and early step in the signaling of mammalian DNA damage responses.	[Lazo, Pedro A.] Univ Salamanca, CSIC, Expt Therapeut & Translat Oncol Program, IBMCC,Ctr Invest Canc, E-37007 Salamanca, Spain; [Monsalve, Diana M.; Lazo, Pedro A.] Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Lazo, PA (corresponding author), Univ Salamanca, CSIC, Expt Therapeut & Translat Oncol Program, IBMCC,Ctr Invest Canc, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.	pedro.lazo@csic.es	Sevilla, Ana/N-8579-2017; Lazo, Pedro A./M-6435-2014; Monsalve, Diana M./J-2374-2016	Sevilla, Ana/0000-0002-9251-4759; Lazo, Pedro A./0000-0001-8997-3025; Monsalve, Diana M./0000-0002-1145-1312	Ministerio de Ciencia e Innovacion [SAF2010-14935, CSD2007-0017]; Junta de Castilla y Leon [CSI006A11-2, GR-15]; Kutxa-Fundacion Inbiomed.; Junta para la Ampliacion de Estudios-CSIC-Fondo Social Europeo fellowships	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Kutxa-Fundacion Inbiomed.; Junta para la Ampliacion de Estudios-CSIC-Fondo Social Europeo fellowships	This work was supported in part by Ministerio de Ciencia e Innovacion Grants SAF2010-14935 and CSD2007-0017, Junta de Castilla y Leon Grants CSI006A11-2 and GR-15, and the Kutxa-Fundacion Inbiomed.; Supported by Junta para la Ampliacion de Estudios-CSIC-Fondo Social Europeo fellowships.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Choi YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015254; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; CRICK F, 1974, NATURE, V248, P766, DOI 10.1038/248766a0; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kim W, 2012, J BIOL CHEM, V287, P5278, DOI 10.1074/jbc.M111.281709; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Lakin ND, 1999, ONCOGENE, V18, P3989, DOI 10.1038/sj.onc.1202973; Lancaster OM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001179; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee SE, 1997, MOL CELL BIOL, V17, P1425, DOI 10.1128/MCB.17.3.1425; Lin WC, 2001, GENE DEV, V15, P1833; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Lopez-Sanchez I, 2009, MOL CELL BIOL, V29, P1189, DOI 10.1128/MCB.01341-08; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Mochan TA, 2003, CANCER RES, V63, P8586; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Park CH, 2011, MOL BIOL CELL, V22, P1398, DOI 10.1091/mbc.E10-08-0717; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schober CS, 2011, MECH DEVELOP, V128, P178, DOI 10.1016/j.mod.2011.01.004; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shin J, 2011, J BIOL CHEM, V286, P22131, DOI 10.1074/jbc.M110.200162; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suzuki Y, 2010, J BIOL CHEM, V285, P24032, DOI 10.1074/jbc.M110.116640; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, LUNG CANCER, V58, P303, DOI 10.1016/j.lungcan.2007.06.023; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002649; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Vazquez-Cedeira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023235; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527	74	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23757	23768		10.1074/jbc.M112.353102	http://dx.doi.org/10.1074/jbc.M112.353102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22621922	hybrid, Green Published			2022-12-28	WOS:000306511300046
J	Brandmayr, J; Poomvanicha, M; Domes, K; Ding, J; Blaich, A; Wegener, JW; Moosmang, S; Hofmann, F				Brandmayr, Julia; Poomvanicha, Montatip; Domes, Katrin; Ding, Jie; Blaich, Anne; Wegener, Joerg W.; Moosmang, Sven; Hofmann, Franz			Deletion of the C-terminal Phosphorylation Sites in the Cardiac beta-Subunit Does Not Affect the Basic beta-Adrenergic Response of the Heart and the Cav1.2 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA(V)1.2 CALCIUM-CHANNEL; CA2+ CHANNELS; FACILITATION; STIMULATION; EXPRESSION; ALPHA(1C); REQUIRES; CARDIOMYOCYTES; IDENTIFICATION	Phosphorylation of the cardiac beta subunit (Ca-v beta(2)) of the Cav1.2 L-type Ca2+ channel complex has been proposed as a mechanism for regulation of L-type Ca2+ channels by various protein kinases including PKA, CaMKII, Akt/PKB, and PKG. To test this hypothesis directly in vivo, we generated a knock-in mouse line with targeted mutation of the Ca-v beta(2) gene by insertion of a stop codon after proline 501 in exon 14 (mouse sequence Cacnb2; beta Stop mouse). This mutation prevented translation of the Ca-v beta(2) C terminus that contains the relevant phosphorylation sites for the above protein kinases. Homozygous cardiac beta Stop mice were born at Mendelian ratio, had a normal life expectancy, and normal basal L-type I-Ca. The regulation of the L-type current by stimulation of the beta-adrenergic receptor was unaffected in vivo and in cardiomyocytes (CMs). beta Stop mice were cross-bred with mice expressing the Cav1.2 gene containing the mutation S1928A (SA beta Stop) or S1512A and S1570A (SF beta Stop) in theCterminus of the alpha(1C) subunit. The beta-adrenergic regulation of the cardiac ICa was unaltered in these mouse lines. In contrast, truncation of the Cav1.2 at Asp1904 abolished beta-adrenergic up-regulation of ICa in murine embryonic CMs. We conclude that phosphorylation of the C-terminal sites in Ca-v beta(2), Ser1928, Ser1512, and Ser1570 of the Cav1.2 protein is functionally not involved in the adrenergic regulation of the murine cardiac Cav1.2 channel.	[Brandmayr, Julia; Poomvanicha, Montatip; Domes, Katrin; Ding, Jie; Blaich, Anne; Wegener, Joerg W.; Moosmang, Sven; Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, Forschergrp 923, D-80802 Munich, Germany	Technical University of Munich	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, FOR923, Biedersteiner Str 29, D-80802 Munich, Germany.	franz.hofmann@mytum.de		Wegener, Jorg/0000-0002-8129-1537	Deutsche Forschungsgemeinschaft; Fond der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie)	This work was supported by grants from Deutsche Forschungsgemeinschaft and Fond der Chemischen Industrie.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blaich A, 2010, P NATL ACAD SCI USA, V107, P10285, DOI 10.1073/pnas.0914287107; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Catterall WA, 2006, J RECEPT SIG TRANSD, V26, P577, DOI 10.1080/10799890600915100; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Domes K, 2011, J BIOL CHEM, V286, P33863, DOI 10.1074/jbc.M111.252312; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Fu Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175307; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Jiang LH, 2000, J BIOL CHEM, V275, P6135, DOI 10.1074/jbc.275.9.6135; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Ludwig A, 1997, J NEUROSCI, V17, P1339; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; McHugh D, 2000, P NATL ACAD SCI USA, V97, P12334, DOI 10.1073/pnas.210384297; Meissner M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227819; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Poomvanicha M, 2011, J BIOL CHEM, V286, P26702, DOI 10.1074/jbc.M111.247841; REUTER H, 1974, J PHYSIOL-LONDON, V242, P429, DOI 10.1113/jphysiol.1974.sp010716; SCULPTOREANU A, 1993, P NATL ACAD SCI USA, V90, P10135, DOI 10.1073/pnas.90.21.10135; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; SINGERLAHAT D, 1992, FEBS LETT, V306, P113, DOI 10.1016/0014-5793(92)80980-U; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Yang L, 2007, CIRC RES, V101, P465, DOI 10.1161/CIRCRESAHA.107.156976; Yang L, 2009, BIOCHEMISTRY-US, V48, P6674, DOI 10.1021/bi900322a	42	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22584	22592		10.1074/jbc.M112.366484	http://dx.doi.org/10.1074/jbc.M112.366484			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589548	hybrid, Green Published			2022-12-28	WOS:000306495000015
J	Sundvall, M; Korhonen, A; Vaparanta, K; Anckar, J; Halkilahti, K; Salah, Z; Aqeilan, RI; Palvimo, JJ; Sistonen, L; Elenius, K				Sundvall, Maria; Korhonen, Anna; Vaparanta, Katri; Anckar, Julius; Halkilahti, Kalle; Salah, Zaidoun; Aqeilan, Rami I.; Palvimo, Jorma J.; Sistonen, Lea; Elenius, Klaus			Protein Inhibitor of Activated STAT3 (PIAS3) Protein Promotes SUMOylation and Nuclear Sequestration of the Intracellular Domain of ErbB4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; BH3-ONLY PROTEIN; MAMMARY-GLAND; EXPRESSION; ISOFORM; GROWTH; CANCER; DIFFERENTIATION; LOCALIZATION; CLEAVAGE	ErbB4 is a receptor tyrosine kinase implicated in the development and homeostasis of the heart, central nervous system, and mammary gland. Cleavable isoforms of ErbB4 release a soluble intracellular domain (ICD) that can translocate to the nucleus and function as a transcriptional coregulator. In search of regulatory mechanisms of ErbB4 ICD function, we identified PIAS3 as a novel interaction partner of ErbB4 ICD. In keeping with the small ubiquitin-like modifier (SUMO) E3 ligase function of protein inhibitor of activated STAT (PIAS) proteins, we showed that the ErbB4 ICD is modified by SUMO, and that PIAS3 stimulates the SUMOylation. Upon overexpression of PIAS3, the ErbB4 ICD generated from the full-length receptor accumulated into the nucleus in a manner that was dependent on the functional nuclear localization signal of ErbB4. In the nucleus, ErbB4 colocalized with PIAS3 and SUMO-1 in promyelocytic leukemia nuclear bodies, nuclear domains involved in regulation of transcription. Accordingly, PIAS3 overexpression had an effect on the transcriptional coregulatory activity of ErbB4, repressing its ability to coactivate transcription with Yes-associated protein. Finally, knockdown of PIAS3 with siRNA partially rescued the inhibitory effect of the ErbB4 ICD on differentiation of MDA-MB-468 breast cancer and HC11 mammary epithelial cells. Our findings illustrate that PIAS3 is a novel regulator of ErbB4 receptor tyrosine kinase, controlling its nuclear sequestration and function.	[Sundvall, Maria; Korhonen, Anna; Vaparanta, Katri; Halkilahti, Kalle; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Sundvall, Maria; Korhonen, Anna; Vaparanta, Katri; Halkilahti, Kalle; Elenius, Klaus] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; [Korhonen, Anna] Univ Turku, Turku Doctoral Program Biomed Sci, FIN-20520 Turku, Finland; [Sundvall, Maria; Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland; [Anckar, Julius; Sistonen, Lea] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Anckar, Julius; Sistonen, Lea] Abo Akad Univ, Turku, Finland; [Salah, Zaidoun; Aqeilan, Rami I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, IL-91120 Jerusalem, Israel; [Palvimo, Jorma J.] Univ Eastern Finland, Inst Biomed Med Biochem, Kuopio 70211, Finland; [Palvimo, Jorma J.] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Abo Akademi University; Hebrew University of Jerusalem; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Elenius, Klaus/AAI-7594-2021; Aqeilan, Rami/R-4443-2016; Aqeilan, Rami/AAT-7785-2020	Elenius, Klaus/0000-0001-5700-0827; Aqeilan, Rami/0000-0002-6034-023X; Palvimo, Jorma/0000-0003-2373-0578; Sistonen, Lea/0000-0003-1341-2867; Sundvall, Maria H/0000-0002-0494-2965	Academy of Finland; EU; Finnish Cancer Organizations; Finnish Cultural Foundation; Juselius Foundation; Turku Doctoral Program of Biomedical Sciences; Turku University Central Hospital; Turku University Foundation	Academy of Finland(Academy of Finland); EU(European Commission); Finnish Cancer Organizations; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Juselius Foundation; Turku Doctoral Program of Biomedical Sciences; Turku University Central Hospital; Turku University Foundation	This study was supported by the Academy of Finland, the EU-FP7 Marie Curie Grant, Finnish Cancer Organizations, the Finnish Cultural Foundation, the Juselius Foundation, the Turku Doctoral Program of Biomedical Sciences, Turku University Central Hospital, and the Turku University Foundation.	Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kew TY, 2000, BRIT J CANCER, V82, P1163, DOI 10.1054/bjoc.1999.1057; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; McHale K, 2008, MODERN PATHOL, V21, P565, DOI 10.1038/modpathol.2008.7; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Srinivasan R, 2000, CANCER RES, V60, P1483; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Thor AD, 2009, AM J PATHOL, V175, P1802, DOI 10.2353/ajpath.2009.090204; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Wang LM, 2004, ONCOL REP, V11, P1319; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	45	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23216	23226		10.1074/jbc.M111.335927	http://dx.doi.org/10.1074/jbc.M111.335927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584572	hybrid, Green Published			2022-12-28	WOS:000306495000076
J	Boyer, NP; Higbee, D; Currin, MB; Blakeley, LR; Chen, CH; Ablonczy, Z; Crouch, RK; Koutalos, Y				Boyer, Nicholas P.; Higbee, Daniel; Currin, Mark B.; Blakeley, Lorie R.; Chen, Chunhe; Ablonczy, Zsolt; Crouch, Rosalie K.; Koutalos, Yiannis			Lipofuscin and N-Retinylidene-N-Retinylethanolamine (A2E) Accumulate in Retinal Pigment Epithelium in Absence of Light Exposure THEIR ORIGIN IS 11-cis-RETINAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER ABCA4; STARGARDT-DISEASE; RPE LIPOFUSCIN; FLUOROPHORE; BIOSYNTHESIS; FLUORESCENCE; CELLS; DEGENERATION; GENERATION; SUBSTRATE	The age-dependent accumulation of lipofuscin in the retinal pigment epithelium (RPE) has been associated with the development of retinal diseases, particularly age-related macular degeneration and Stargardt disease. A major component of lipofuscin is the bis-retinoid N-retinylidene-N-retinylethanolamine (A2E). The current model for the formation of A2E requires photoactivation of rhodopsin and subsequent release of all-trans-retinal. To understand the role of light exposure in the accumulation of lipofuscin and A2E, we analyzed RPEs and isolated rod photoreceptors from mice of different ages and strains, reared either in darkness or cyclic light. Lipofuscin levels were determined by fluorescence imaging, whereas A2E levels were quantified by HPLC and UV-visible absorption spectroscopy. The identity of A2E was confirmed by tandem mass spectrometry. Lipofuscin and A2E levels in the RPE increased with age and more so in the Stargardt model Abca4(-/-) than in the wild type strains 129/sv and C57Bl/6. For each strain, the levels of lipofuscin precursor fluorophores in dark-adapted rods and the levels and rates of increase of RPE lipofuscin and A2E were not different between dark-reared and cyclic light-reared animals. Both 11-cis-and all-trans-retinal generated lipofuscin-like fluorophores when added to metabolically compromised rod outer segments; however, it was only 11-cis-retinal that generated such fluorophores when added to metabolically intact rods. The results suggest that lipofuscin originates from the free 11-cis-retinal that is continuously supplied to the rod for rhodopsin regeneration and outer segment renewal. The physiological role of Abca4 may include the translocation of 11-cis-retinal complexes across the disk membrane.	[Koutalos, Yiannis] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Koutalos, Y (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave, Charleston, SC 29425 USA.	koutalo@musc.edu			National Institutes of Health [EY020661, EY004939, EY014850, EY014793]; Extramural Research Facilities Program of NCRR [C06 RR015455]; Foundation Fighting Blindness, Inc.; Departments of Ophthalmology at Medical University of South Carolina from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019065, R21EY020661, R01EY004939, R01EY014850, R24EY014793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extramural Research Facilities Program of NCRR; Foundation Fighting Blindness, Inc.; Departments of Ophthalmology at Medical University of South Carolina from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of NCRR.; This work was supported, in whole or in part, by National Institutes of Health Grants EY020661 (to Z. A. and R. K. C.), EY004939 (to R. K. C.), EY014850 (to Y. K.), and EY014793 (to Medical University of South Carolina Vision Core). This work was also supported by the Foundation Fighting Blindness, Inc. (to R. K. C.) and unrestricted awards to the Departments of Ophthalmology at Medical University of South Carolina from Research to Prevent Blindness.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Boyer N. P., 2012, PHOTOCHEM P IN PRESS; Bui TV, 2006, J BIOL CHEM, V281, P18112, DOI 10.1074/jbc.M601380200; Chen CH, 2010, PHOTOCH PHOTOBIO SCI, V9, P1475, DOI 10.1039/c0pp00124d; Chen CH, 2009, INVEST OPHTH VIS SCI, V50, P3589, DOI 10.1167/iovs.08-3336; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; Grey AC, 2011, INVEST OPHTH VIS SCI, V52, P3926, DOI 10.1167/iovs.10-7020; Gutierrez DB, 2010, PHOTOCH PHOTOBIO SCI, V9, P1513, DOI 10.1039/c0pp00230e; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; KATZ ML, 1989, INVEST OPHTH VIS SCI, V30, P37; KATZ ML, 1986, EXP EYE RES, V43, P561, DOI 10.1016/S0014-4835(86)80023-9; Katz ML, 2002, ARCH GERONTOL GERIAT, V34, P169, DOI 10.1016/S0167-4943(02)00005-5; Katz ML, 1996, MECH AGEING DEV, V92, P159, DOI 10.1016/S0047-6374(96)01817-9; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; Ng KP, 2008, MOL CELL PROTEOMICS, V7, P1397, DOI 10.1074/mcp.M700525-MCP200; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rozanowska M, 1998, FREE RADICAL BIO MED, V24, P1107, DOI 10.1016/S0891-5849(97)00395-X; Salvador GA, 1998, LIPIDS, V33, P853, DOI 10.1007/s11745-998-0281-z; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601; Winkler BS, 1999, MOL VIS, V5; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	54	90	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22276	22286		10.1074/jbc.M111.329235	http://dx.doi.org/10.1074/jbc.M111.329235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570475	Green Published, hybrid			2022-12-28	WOS:000306418600065
J	Schmidt, NW; Tai, KP; Kamdar, K; Mishra, A; Lai, GH; Zhao, K; Ouellette, AJ; Wong, GCL				Schmidt, Nathan W.; Tai, Kenneth P.; Kamdar, Karishma; Mishra, Abhijit; Lai, Ghee Hwee; Zhao, Kun; Ouellette, Andre J.; Wong, Gerard C. L.			Arginine in alpha-Defensins DIFFERENTIAL EFFECTS ON BACTERICIDAL ACTIVITY CORRESPOND TO GEOMETRY OF MEMBRANE CURVATURE GENERATION AND PEPTIDE-LIPID PHASE BEHAVIOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; NEUTROPHIL DEFENSINS; MOUSE CRYPTDIN-4; LIPID COMPLEXES; F-ACTIN; CURVATURE; PHASE; TRANSLOCATION; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; GUANIDINIUM	The conserved tridisulfide array of the alpha-defensin family imposes a common triple-stranded beta-sheet topology on peptides that may have highly diverse primary structures, resulting in differential outcomes after targeted mutagenesis. In mouse cryptdin-4 (Crp4) and rhesus myeloid alpha-defensin-4 (RMAD4), complete substitutions of Arg with Lys affect bactericidal peptide activity very differently. Lys-for-Arg mutagenesis attenuates Crp4, but RMAD4 activity remains mostly unchanged. Here, we show that the differential biological effect of Lys-for-Arg replacements can be understood by the distinct phase behavior of the experimental peptide-lipid system. In Crp4, small-angle x-ray scattering analyses showed that Arg-to-Lys replacements shifted the induced nanoporous phases to a different range of lipid compositions compared with the Arg-rich native peptide, consistent with the attenuation of bactericidal activity by Lys-for-Arg mutations. In contrast, such phases generated by RMAD4 were largely unchanged. The concordance between small-angle x-ray scattering measurements and biological activity provides evidence that specific types of alpha-defensin-induced membrane curvature-generating tendencies correspond directly to bactericidal activity via membrane destabilization.	[Schmidt, Nathan W.; Mishra, Abhijit; Lai, Ghee Hwee; Zhao, Kun; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Tai, Kenneth P.; Kamdar, Karishma; Ouellette, Andre J.] Univ So Calif, Keck Sch Med, USC Norris Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90089 USA; [Mishra, Abhijit] Indian Inst Technol, Dept Met Engn & Mat Sci, Ahmadabad 382424, Gujarat, India	University of California System; University of California Los Angeles; University of Southern California; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Gandhinagar	Wong, GCL (corresponding author), Univ Calif Los Angeles, Dept Bioengn, 5121 Engn V, Los Angeles, CA 90095 USA.	gclwong.ucla@gmail.com	zhao, kun/A-1998-2011; Mishra, Abhijit/K-4486-2019; Lai, GH/GRX-9180-2022	Mishra, Abhijit/0000-0003-1057-3550; 	National Institutes of Health [R01 DK044632, R01 AI059346]; USC Norris Cancer Center Support Grant [P30 CA014089, 1UO1 AI082192-01]; National Science Foundation [DMR0846582, DMR1106106, DMR0409769]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; UCLA California NanoSystems Institute; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082192, R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC Norris Cancer Center Support Grant; National Science Foundation(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); UCLA California NanoSystems Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK044632 and R01 AI059346 and USC Norris Cancer Center Support Grant P30 CA014089 (to A.J.O.) and Grant 1UO1 AI082192-01. This work was also supported by National Science Foundation Grants DMR0846582, DMR1106106, and DMR0409769.; We thank the Aspen Center for Physics for promoting this multidisciplinary collaboration. X-ray research was carried out at the Stanford Synchrotron Radiation Lightsource; at the SLAC National Accelerator Laboratory, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University; at the Advance Light Source, supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231; and at the UCLA California NanoSystems Institute.	ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; ANDERSON DM, 1988, P NATL ACAD SCI USA, V85, P5364, DOI 10.1073/pnas.85.15.5364; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Befus AD, 1999, J IMMUNOL, V163, P947; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Figueredo S, 2010, METHODS MOL BIOL, V618, P47, DOI 10.1007/978-1-60761-594-1_4; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Harper PE, 2000, EUR PHYS J E, V2, P217, DOI 10.1007/PL00013660; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; May S, 1997, BIOPHYS J, V73, P2427, DOI 10.1016/S0006-3495(97)78271-7; Mishra A, 2008, ANGEW CHEM INT EDIT, V47, P2986, DOI 10.1002/anie.200704444; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Sanders LK, 2007, P NATL ACAD SCI USA, V104, P15994, DOI 10.1073/pnas.0705898104; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Schug KA, 2005, CHEM REV, V105, P67, DOI 10.1021/cr040603j; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shearman GC, 2006, J PHYS-CONDENS MAT, V18, pS1105, DOI 10.1088/0953-8984/18/28/S01; SHYAMSUNDER E, 1988, BIOCHEMISTRY-US, V27, P2332, DOI 10.1021/bi00407a014; Siegel DP, 2004, BIOPHYS J, V87, P366, DOI 10.1529/biophysj.104.040782; SO PTC, 1993, PHYS REV LETT, V70, P3455, DOI 10.1103/PhysRevLett.70.3455; Som A, 2009, J AM CHEM SOC, V131, P15102, DOI 10.1021/ja9067063; Su YC, 2009, BIOCHEMISTRY-US, V48, P4587, DOI 10.1021/bi900080d; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Vasudevan S, 2008, J BIOL CHEM, V283, P35869, DOI 10.1074/jbc.M806915200; Wong GCL, 2000, SCIENCE, V288, P2035, DOI 10.1126/science.288.5473.2035; Yang LH, 2004, NAT MATER, V3, P615, DOI 10.1038/nmat1195; Yang LH, 2007, J AM CHEM SOC, V129, P12141, DOI 10.1021/ja072310o; Yang LH, 2008, P NATL ACAD SCI USA, V105, P20595, DOI 10.1073/pnas.0806456105; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; [No title captured], DOI DOI 10.1038/NBT0795-658	44	46	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21866	21872		10.1074/jbc.M112.358721	http://dx.doi.org/10.1074/jbc.M112.358721			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22566697	Green Published, hybrid			2022-12-28	WOS:000306418600028
J	Borgal, L; Habbig, S; Hatzold, J; Liebau, MC; Dafinger, C; Sacarea, I; Hammerschmidt, M; Benzing, T; Schermer, B				Borgal, Lori; Habbig, Sandra; Hatzold, Julia; Liebau, Max C.; Dafinger, Claudia; Sacarea, Ilinca; Hammerschmidt, Matthias; Benzing, Thomas; Schermer, Bernhard			The Ciliary Protein Nephrocystin-4 Translocates the Canonical Wnt Regulator Jade-1 to the Nucleus to Negatively Regulate beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; PRIMARY CILIUM; NEPHRONOPHTHISIS; PHOSPHORYLATION; MECHANISMS; DEFECTS; PATHWAY; MORPHOGENESIS; INACTIVATION; HOMEOSTASIS	Nephronophthisis (NPH) is an autosomal-recessive cystic kidney disease and represents the most common genetic cause for end-stage renal disease in children and adolescents. It can be caused by the mutation of genes encoding for the nephrocystin proteins (NPHPs). All NPHPs localize to primary cilia, classifying this disease as a "ciliopathy." The primary cilium is a critical regulator of several cell signaling pathways. Cystogenesis in the kidney is thought to involve overactivation of canonical Wnt signaling, which is negatively regulated by the primary cilium and several NPH proteins, although the mechanism remains unclear. Jade-1 has recently been identified as a novel ubiquitin ligase targeting the canonical Wnt downstream effector beta-catenin for proteasomal degradation. Here, we identify Jade-1 as a novel component of the NPHP protein complex. Jade-1 colocalizes with NPHP1 at the transition zone of primary cilia and interacts with NPHP4. Furthermore, NPHP4 stabilizes protein levels of Jade-1 and promotes the translocation of Jade-1 to the nucleus. Finally, NPHP4 and Jade-1 additively inhibit canonical Wnt signaling, and this genetic interaction is conserved in zebrafish. The stabilization and nuclear translocation of Jade-1 by NPHP4 enhances the ability of Jade-1 to negatively regulate canonical Wnt signaling. Loss of this repressor function in nephronophthisis might be an important factor promoting Wnt activation and contributing to cyst formation.	[Borgal, Lori; Habbig, Sandra; Liebau, Max C.; Dafinger, Claudia; Sacarea, Ilinca; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, D-50937 Cologne, Germany; [Borgal, Lori; Habbig, Sandra; Liebau, Max C.; Dafinger, Claudia; Sacarea, Ilinca; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany; [Habbig, Sandra; Liebau, Max C.] Univ Cologne, Dept Pediat, D-50937 Cologne, Germany; [Hatzold, Julia; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany; [Hammerschmidt, Matthias; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schermer, B (corresponding author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	bernhard.schermer@uk-koeln.de	Benzing, Thomas/X-5476-2019; Borgal, Lori/ABB-9343-2021; Schermer, Bernhard/E-9972-2014; Liebau, Max Christoph/K-3470-2019; Habbig, Sandra/AHC-1168-2022; Hatzold, Julia/AAN-2996-2021	Schermer, Bernhard/0000-0002-5194-9000; Liebau, Max Christoph/0000-0003-0494-9080; Hatzold, Julia/0000-0002-5491-1921	Deutsche Forschungsgemeinschaft Grants [SCHE1562, SFB832, BE2212, SFB829, SFB 572]; Center for Molecular Medicine Cologne	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); Center for Molecular Medicine Cologne	This work was supported by Deutsche Forschungsgemeinschaft Grants SCHE1562 and SFB832 (to B. S.), BE2212 and SFB829 (to T. B.), and SFB 572 (to T. B. and M. H.) and by the Center for Molecular Medicine Cologne (to T. B. and B. S.).	Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Bellavia S, 2010, NEPHROL DIAL TRANSPL, V25, P4097, DOI 10.1093/ndt/gfq519; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Burckle C, 2011, HUM MOL GENET, V20, P2611, DOI 10.1093/hmg/ddr164; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dale T, 2006, NAT STRUCT MOL BIOL, V13, P9, DOI 10.1038/nsmb0106-9; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; DiBella LM, 2009, HUM MOL GENET, V18, P595, DOI 10.1093/hmg/ddn384; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Krishnan R, 2008, KIDNEY BLOOD PRESS R, V31, P152, DOI 10.1159/000129648; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Liebau MC, 2011, J BIOL CHEM, V286, P14237, DOI 10.1074/jbc.M110.165464; Lienkamp S, 2012, DIFFERENTIATION, V83, pS49, DOI 10.1016/j.diff.2011.11.012; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Olsen O, 2007, J CELL BIOL, V179, P151, DOI 10.1083/jcb.200702054; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slanchev K, 2011, HUM MOL GENET, V20, P3119, DOI 10.1093/hmg/ddr214; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; van Reeuwijk J, 2011, HUM MOL GENET, V20, pR149, DOI 10.1093/hmg/ddr354; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wiens CJ, 2010, J BIOL CHEM, V285, P16218, DOI 10.1074/jbc.M109.070953; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	58	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25370	25380		10.1074/jbc.M112.385658	http://dx.doi.org/10.1074/jbc.M112.385658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654112	hybrid, Green Published			2022-12-28	WOS:000306651700045
J	George, AA; Lucero, LM; Damaj, MI; Lukas, RJ; Chen, XN; Whiteaker, P				George, Andrew A.; Lucero, Linda M.; Damaj, M. Imad; Lukas, Ronald J.; Chen, Xiangning; Whiteaker, Paul			Function of Human alpha 3 beta 4 alpha 5 Nicotinic Acetylcholine Receptors Is Reduced by the alpha 5(D398N) Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; ALTERNATE STOICHIOMETRIES; SUBUNIT INTERFACES; UP-REGULATION; DEPENDENCE; RISK; BINDING; SENSITIVITY; ACTIVATION; INHIBITION	Genome-wide studies have strongly associated a non-synonymous polymorphism (rs16969968) that changes the 398th amino acid in the nAChR alpha 5 subunit from aspartic acid to asparagine (D398N), with greater risk for increased nicotine consumption. We have used a pentameric concatemer approach to express defined and consistent populations of alpha 3 beta 4 alpha 5 nAChR in Xenopus oocytes. alpha 5(Asn-398; risk) variant incorporation reduces ACh-evoked function compared with inclusion of the common alpha 5(Asp-398) variant without altering agonist or antagonist potencies. Unlinked alpha 3, beta 4, and alpha 5 subunits assemble to form a uniform nAChR population with pharmacological properties matching those of concatemeric alpha 3 beta 4* nAChRs. alpha 5 subunit incorporation reduces alpha 3 beta 4* nAChR function after coinjection with unlinked alpha 3 and beta 4 subunits but increases that of alpha 3 beta 4 alpha 5 versus alpha 3 beta 4-only concatemers. alpha 5 subunit incorporation into alpha 3 beta 4* nAChR also alters the relative efficacies of competitive agonists and changes the potency of the non-competitive antagonist mecamylamine. Additional observations indicated that in the absence of alpha 5 subunits, free alpha 3 and beta 4 subunits form at least two further subtypes. The pharmacological profiles of these free subunit alpha 3 beta 4-only subtypes are dissimilar both to each other and to those of alpha 3 beta 4 alpha 5 nAChR. The alpha 5 variant-induced change in alpha 3 beta 4 alpha 5 nAChR function may underlie some of the phenotypic changes associated with this polymorphism.	[George, Andrew A.; Lucero, Linda M.; Lukas, Ronald J.; Whiteaker, Paul] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; [Damaj, M. Imad] Virginia Commonwealth Univ, Dept Pharmacol Toxicol, Richmond, VA 23298 USA; [Chen, Xiangning] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA	Barrow Neurological Institute; Virginia Commonwealth University; Virginia Commonwealth University	Whiteaker, P (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	paul.whiteaker@dignityhealth.org			National Institutes of Health [R21 DA027070-02S1, R21 DA026627]; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026627, R21DA027070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DA027070-02S1 (to P. W., X. C., M. I. D., and R. J. L.) and R21 DA026627 (to P. W.). This work was also supported by an endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation (to P. W.). Portions of this work were presented as a Society for Neuroscience abstract (46).	Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Chang YC, 2002, J NEUROSCI, V22, P7982; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Dash B, 2011, J BIOL CHEM, V286, P37905, DOI 10.1074/jbc.M111.264044; David R, 2010, EUR J NEUROSCI, V31, P978, DOI 10.1111/j.1460-9568.2010.07133.x; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Gahring LC, 2010, J BIOL CHEM, V285, P26049, DOI 10.1074/jbc.M110.105346; George A. A., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grishin AA, 2010, J BIOL CHEM, V285, P22254, DOI 10.1074/jbc.M110.111880; Groot-Kormelink PJ, 2006, MOL PHARMACOL, V69, P558, DOI 10.1124/mol.105.019356; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Papke RL, 2010, J PHARMACOL EXP THER, V333, P501, DOI 10.1124/jpet.109.164566; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Sigel E, 2006, BIOCHEM SOC T, V34, P868, DOI 10.1042/BST0340868; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Stokes C., 2012, NEUROPHARMA IN PRESS; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Zhou Y, 2003, J NEUROSCI, V23, P9004; ZOLI M, 1995, J NEUROSCI, V15, P1912, DOI 10.1523/JNEUROSCI.15-03-01912.1995; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	46	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25151	25162		10.1074/jbc.M112.379339	http://dx.doi.org/10.1074/jbc.M112.379339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665477	Green Published, hybrid			2022-12-28	WOS:000306651700026
J	Guo, HB; Nairn, A; dela Rosa, M; Nagy, T; Zhao, SY; Moremen, K; Pierce, M				Guo, Huabei; Nairn, Alison; dela Rosa, Mitche; Nagy, Tamas; Zhao, Shaying; Moremen, Kelley; Pierce, Michael			Transcriptional Regulation of the Protocadherin beta Cluster during Her-2 Protein-induced Mammary Tumorigenesis Results from Altered N-Glycan Branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; BETA-1,6-BRANCHED OLIGOSACCHARIDES; TUMOR-SUPPRESSOR; DNA METHYLATION; MESSENGER-RNA; CELL-ADHESION; NEU ONCOGENE; EXPRESSION; CARCINOMA; GLYCOSYLATION	Changes in the levels of N-acetylglucosaminyltransferase V (GnT-V) can alter the function of several types of cell surface receptors and adhesion molecules by causing altered N-linked glycan branching. Using a her-2 mammary tumor mouse model, her-2 receptor signaling was down-regulated by GnT-V knockout, resulting in a significant delay in the onset of her-2-induced mammary tumors. To identify the genes that contributed to this GnT-V regulation of early events in tumorigenesis, microarray analysis was performed using her-2 induced mammary tumors from wild-type and GnT-V-null mice. We found that 142 genes were aberrantly expressed (>2.0-fold) with 64 genes up-regulated and 78 genes down-regulated after deletion of GnT-V. Among differentially expressed genes, the expression of a subgroup of the cadherin superfamily, the protocadherin beta (Pcdh beta) cluster, was up-regulated in GnT-V-null tumors. Altered expression of the Pcdh beta cluster in GnT-V-null tumors was not due to changes in promoter methylation; instead, impaired her-2-mediated signaling pathways were implicated at least in part resulting from reduced microRNA-21 expression. Overexpression of Pcdh beta genes inhibited tumor cell growth, decreased the proportion of tumor-initiating cells, and decreased tumor formation in vivo, demonstrating that expression of the Pcdh beta gene cluster can serve as an inhibitor of the transformed phenotype. Our results suggest the up-regulation of the Pcdh beta gene cluster as a mechanism for reduced her-2-mediated tumorigenesis resulting from GnT-V deletion.	[Guo, Huabei; Nairn, Alison; dela Rosa, Mitche; Zhao, Shaying; Moremen, Kelley; Pierce, Michael] Univ Georgia, Dept Biochem & Mol Biol, Coll Vet Med, Athens, GA 30602 USA; [Guo, Huabei; Nairn, Alison; dela Rosa, Mitche; Moremen, Kelley; Pierce, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Coll Vet Med, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Dept Pathol, Coll Vet Med, Athens, GA 30602 USA; [Pierce, Michael] Univ Georgia, Ctr Canc, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Pierce, M (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Coll Vet Med, 315 Riverbend Rd, Athens, GA 30602 USA.	hawkeye@uga.edu	Moremen, Kelley/AAD-4661-2019	Nairn, Alison/0000-0002-4453-7593	National Institutes of Health [U01CA128454, P41RR018502]; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01CA128454 (to M. P.) and P41RR018502 (to M. P. and K. M.).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Buchanan SM, 2010, P NATL ACAD SCI USA, V107, P17774, DOI 10.1073/pnas.1013105107; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carlsson J, 2004, BRIT J CANCER, V90, P2344, DOI 10.1038/sj.bjc.6601881; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Granovsky M, 2000, NAT MED, V6, P306; Gurlevik E, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp374; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2010, P NATL ACAD SCI USA, V107, P21116, DOI 10.1073/pnas.1013405107; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Guo HB, 2009, GLYCOBIOLOGY, V19, P547, DOI 10.1093/glycob/cwp023; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; Hoque MO, 2009, CANCER EPIDEM BIOMAR, V18, P2694, DOI 10.1158/1055-9965.EPI-08-0821; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Moreira F, 2011, AM J PATHOL, V179, P462, DOI 10.1016/j.ajpath.2011.03.044; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; OBATA S, 1995, J CELL SCI, V108, P3765; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pierce JM, 2009, HANDBOOK OF GLYCOMICS, P399; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Seelentag WKF, 1998, CANCER RES, V58, P5559; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Terada K, 2009, CARCINOGENESIS, V30, P466, DOI 10.1093/carcin/bgp021; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 2000, P NATL ACAD SCI USA, V97, P3124, DOI 10.1073/pnas.060027397; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169; Yamamoto H, 2000, CANCER RES, V60, P134; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x	59	19	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24941	24954		10.1074/jbc.M112.369355	http://dx.doi.org/10.1074/jbc.M112.369355			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665489	hybrid, Green Published			2022-12-28	WOS:000306651700008
J	Sardar, HS; Gilbert, SP				Sardar, Harjinder S.; Gilbert, Susan P.			Microtubule Capture by Mitotic Kinesin Centromere Protein E (CENP-E)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE KINETOCHORE MOTOR; ATP HYDROLYSIS; DIMERIC EG5; PATHWAY; MITOSIS; ANAPHASE; STEP; PROMETAPHASE; PROCESSIVITY; CHROMOSOMES	Centromere protein E, CENP-E, is a kinetochore-associated kinesin-7 that establishes the microtubule-chromosome linkage and transports monooriented chromosomes to the spindle equator along kinetochore fibers of already bioriented chromosomes. As a processive kinesin, CENP-E uses a hand-over-hand mechanism, yet a number of studies suggest that CENP-E exhibits mechanistic differences from other processive kinesins that may be important for its role in chromosome congression. The results reported here show that association of CENP-E with the microtubule is unusually slow at 0.08 mu M-1 s(-1) followed by slow ADP release at 0.9 s(-1). ATP binding and hydrolysis are fast with motor dissociation from the microtubule at 1.4 s(-1), suggesting that CENP-E head detachment from the microtubule, possibly controlled by phosphate release, determines the rate of stepping during a processive run because the rate of microtubule gliding corresponds to 1.4 steps/s. We hypothesize that the unusually slow CENP-E microtubule association step favors CENP-E binding of stable microtubules over dynamic ones, a mechanism that would bias CENP-E binding to kinetochore fibers.	[Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol, 110 8th St, Troy, NY 12180 USA.	sgilbert@rpi.edu			National Institutes of Health [R01 GM54141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM54141 (to S. P. G.).	Bakhoum SF, 2012, CURR OPIN CELL BIOL, V24, P64, DOI 10.1016/j.ceb.2011.11.012; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Brown KD, 1996, J CELL SCI, V109, P961; BROWN KD, 1994, J CELL BIOL, V125, P1303, DOI 10.1083/jcb.125.6.1303; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; Gilbert SP, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P321, DOI 10.1016/B978-0-12-374920-8.00421-5; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Klumpp LM, 2003, BIOCHEMISTRY-US, V42, P2595, DOI 10.1021/bi026715r; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rosenfeld SS, 2002, J BIOL CHEM, V277, P36731, DOI 10.1074/jbc.M205261200; Rosenfeld SS, 2009, J BIOL CHEM, V284, P32858, DOI 10.1074/jbc.M109.041210; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Waitzman JS, 2011, BIOPHYS J, V101, P2760, DOI 10.1016/j.bpj.2011.10.032; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yardimci H, 2008, P NATL ACAD SCI USA, V105, P6016, DOI 10.1073/pnas.0711314105; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	52	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24894	24904		10.1074/jbc.M112.376830	http://dx.doi.org/10.1074/jbc.M112.376830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22637578	hybrid, Green Published			2022-12-28	WOS:000306651700004
J	Depetris, RS; Julien, JP; Khayat, R; Lee, JH; Pejchal, R; Katpally, U; Cocco, N; Kachare, M; Massi, E; David, KB; Cupo, A; Marozsan, AJ; Olson, WC; Ward, AB; Wilson, IA; Sanders, RW; Moore, JP				Depetris, Rafael S.; Julien, Jean-Philippe; Khayat, Reza; Lee, Jeong Hyun; Pejchal, Robert; Katpally, Umesh; Cocco, Nicolette; Kachare, Milind; Massi, Evan; David, Kathryn B.; Cupo, Albert; Marozsan, Andre J.; Olson, William C.; Ward, Andrew B.; Wilson, Ian A.; Sanders, Rogier W.; Moore, John P.			Partial Enzymatic Deglycosylation Preserves the Structure of Cleaved Recombinant HIV-1 Envelope Glycoprotein Trimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; SITE-SPECIFIC ANALYSIS; N-LINKED GLYCANS; GLYCOSYLATION SITES; LIGHT-SCATTERING; TYPE-1 GP120; NEUTRALIZATION SENSITIVITY; BROAD NEUTRALIZATION; CHEMOKINE RECEPTORS	The trimeric envelope glycoprotein complex (Env) is the focus of vaccine development programs aimed at generating protective humoral responses to human immunodeficiency virus type 1 (HIV-1). N-Linked glycans, which constitute almost half of the molecular mass of the external Env domains, produce considerable structural heterogeneity and are a major impediment to crystallization studies. Moreover, by shielding the peptide backbone, glycans can block attempts to generate neutralizing antibodies against a substantial subset of potential epitopes when Env proteins are used as immunogens. Here, we describe the partial deglycosylation of soluble, cleaved recombinant Env trimers by inhibition of the synthesis of complex N-glycans during Env production, followed by treatment with glycosidases under conditions that preserve Env trimer integrity. The partially deglycosylated trimers are stable, and neither abnormally sensitive to proteolytic digestion nor prone to aggregation. Moreover, the deglycosylated trimers retain or increase their ability to bind CD4 and antibodies that are directed to conformational epitopes, including the CD4-binding site and the V3 region. However, as expected, they do not react with glycan-dependent antibodies 2G12 and PGT123, or the C-type lectin receptor DC-SIGN. Electron microscopic analysis shows that partially deglycosylated trimers have a structure similar to fully glycosylated trimers, indicating that removal of glycans does not substantially perturb the structural integrity of the trimer. The gly-can-depleted Env trimers should be useful for structural and immunogenicity studies.	[Depetris, Rafael S.; Cocco, Nicolette; Kachare, Milind; Massi, Evan; David, Kathryn B.; Cupo, Albert; Marozsan, Andre J.; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Julien, Jean-Philippe; Khayat, Reza; Lee, Jeong Hyun; Pejchal, Robert; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katpally, Umesh; Olson, William C.] Progen Pharmaceut Inc, Tarrytown, NY 10591 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Cornell University; Scripps Research Institute; University of Amsterdam; Academic Medical Center Amsterdam	Sanders, RW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	rws2002@med.cornell.edu; jpm2003@med.cornell.edu	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Julien, Jean-Philippe/0000-0001-7602-3995; Lee, Jeong Hyun/0000-0001-7371-845X	National Institutes of Health [P01 AI82362, R01 AI36082]; International AIDS Vaccine Initiative (IAVI); Canadian Institutes of Health Research (CIHR); Vidi from the Netherlands Organization for Scientific Research (NWO); European Research Council [ERC-StG-2011-280829-SHEV]; National Institutes of Health through the National Center for Research Resources' P41 program [RR017573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082362, R37AI036082, R01AI084817, R01AI036082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative (IAVI); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vidi from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health through the National Center for Research Resources' P41 program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AI82362 and R01 AI36082 and the International AIDS Vaccine Initiative (IAVI).; Recipient of a Canadian Institutes of Health Research (CIHR) Fellowship.; Recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV).; We thank James Robinson and Dennis Burton for donating reagents and Kenneth Kang for technical assistance. The electron microscopy data were collected by the authors at the National Resource for Automated Molecular Microscopy (NRAMM), which is supported by the National Institutes of Health through the National Center for Research Resources' P41 program Grant RR017573.	ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; Arakawa T, 2001, ANAL BIOCHEM, V299, P158, DOI 10.1006/abio.2001.5432; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Banerjee K, 2012, AIDS RES HUM RETROV, V28, P206, DOI 10.1089/aid.2011.0101; Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Beddows S, 2006, AIDS RES HUM RETROV, V22, P569, DOI 10.1089/aid.2006.22.569; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; FENOUILLET E, 1990, J VIROL, V64, P2841, DOI 10.1128/JVI.64.6.2841-2848.1990; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; FENOUILLET E, 1989, J EXP MED, V169, P807, DOI 10.1084/jem.169.3.807; FISCHER E, 1995, GLYCOCONJUGATE J, V12, P707, DOI 10.1007/BF00731268; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Go EP, 2007, ANAL CHEM, V79, P1708, DOI 10.1021/ac061548c; Go EP, 2011, INT J MASS SPECTROM, V305, P209, DOI 10.1016/j.ijms.2010.11.009; Go EP, 2009, J PROTEOME RES, V8, P4231, DOI 10.1021/pr9002728; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P4108, DOI 10.1073/pnas.87.11.4108; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Iyer SPN, 2007, AIDS RES HUM RETROV, V23, P817, DOI 10.1089/aid.2006.0261; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; Klasse PJ, 2012, AIDS RES HUM RETROV, V28, P1, DOI [10.1089/aid.2011.0053, 10.1089/AID.2011.0053]; KORNFELD S, 1978, J BIOL CHEM, V253, P7771; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Losman B, 1999, FEBS LETT, V454, P47, DOI 10.1016/S0014-5793(99)00740-1; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Malenbaum SE, 2000, J VIROL, V74, P11008, DOI 10.1128/JVI.74.23.11008-11016.2000; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Marzi A, 2007, VIROLOGY, V368, P322, DOI 10.1016/j.virol.2007.07.004; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Means RE, 2000, J VIROL, V74, P11181, DOI 10.1128/JVI.74.23.11181-11190.2000; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MONTEFIORI DC, 1993, J VIROL, V67, P2699, DOI 10.1128/JVI.67.5.2699-2706.1993; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; MOORE JP, 1995, J VIROL, V69, P122, DOI 10.1128/JVI.69.1.122-130.1995; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perrin C, 1998, VIROLOGY, V242, P338, DOI 10.1006/viro.1997.9016; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; SNAITH SM, 1968, BIOCHEM J, V110, P663, DOI 10.1042/bj1100663; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stansell E, 2011, J VIROL, V85, P582, DOI 10.1128/JVI.01871-10; Stansell Elizabeth, 2010, Yale Journal of Biology and Medicine, V83, P201; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	84	43	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24239	24254		10.1074/jbc.M112.371898	http://dx.doi.org/10.1074/jbc.M112.371898			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645128	Green Published, hybrid			2022-12-28	WOS:000306651100018
J	Grunewald, M; Johnson, S; Lu, DY; Wang, Z; Lomberk, G; Albert, PR; Stockmeier, CA; Meyer, JH; Urrutia, R; Miczek, KA; Austin, MC; Wang, JM; Paul, IA; Woolverton, WL; Seo, S; Sittman, DB; Ou, XM				Grunewald, Matthew; Johnson, Shakevia; Lu, Deyin; Wang, Zhe; Lomberk, Gwen; Albert, Paul R.; Stockmeier, Craig A.; Meyer, Jeffrey H.; Urrutia, Raul; Miczek, Klaus A.; Austin, Mark C.; Wang, Junming; Paul, Ian A.; Woolverton, William L.; Seo, Seungmae; Sittman, Donald B.; Ou, Xiao-Ming			Mechanistic Role for a Novel Glucocorticoid-KLF11 (TIEG2) Protein Pathway in Stress-induced Monoamine Oxidase A Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR DEPRESSIVE DISORDER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-DEATH; INSULIN-BIOSYNTHESIS; SOCIAL STRESS; BRAIN; GENE; MICE; TRANSCRIPTION; BINDING	Chronic stress is a risk factor for psychiatric illnesses, including depressive disorders, and is characterized by increased blood glucocorticoids and brain monoamine oxidase A (MAO A, which degrades monoamine neurotransmitters). This study elucidates the relationship between stress-induced MAO A and the transcription factor Kruppel-like factor 11 (KLF11, also called TIEG2, a member of the Sp/KLF-family), which inhibits cell growth. We report that 1) a glucocorticoid (dexamethasone) increases KLF11 mRNA and protein levels in cultured neuronal cells; 2) overexpressing KLF11 increases levels of MAO A mRNA and enzymatic activity, which is further enhanced by glucocorticoids; in contrast, siRNA-mediated KLF11 knockdown reduces glucocorticoid-induced MAO A expression in cultured neurons; 3) induction of KLF11 and translocation of KLF11 from the cytoplasm to the nucleus are key regulatory mechanisms leading to increased MAO A catalytic activity and mRNA levels because of direct activation of the MAO A promoter via Sp/KLF-binding sites; 4) KLF11 knockout mice show reduced MAOA mRNA and catalytic activity in the brain cortex compared with wild-type mice; and 5) exposure to chronic social defeat stress induces blood glucocorticoids and activates the KLF11 pathway in the rat brain, which results in increased MAO A mRNA and enzymatic activity. Thus, this study reveals for the first time that KLF11 is an MAO A regulator and is produced in response to neuronal stress, which transcriptionally activates MAOA. The novel glucocorticoid-KLF11-MAOA pathway may play a crucial role in modulating distinct pathophysiological steps in stress-related disorders.	[Grunewald, Matthew; Johnson, Shakevia; Lu, Deyin; Wang, Zhe; Stockmeier, Craig A.; Austin, Mark C.; Paul, Ian A.; Woolverton, William L.; Ou, Xiao-Ming] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Wang, Junming] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Sittman, Donald B.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Lomberk, Gwen; Urrutia, Raul; Seo, Seungmae] Mayo Clin, GI Res Unit, Epigenet & Chromatin Dynam Lab, Rochester, MN 55905 USA; [Albert, Paul R.] Ottawa Hosp, Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada; [Meyer, Jeffrey H.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; [Meyer, Jeffrey H.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Miczek, Klaus A.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Stockmeier, Craig A.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Mayo Clinic; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Tufts University; Case Western Reserve University	Ou, XM (corresponding author), Univ Mississippi, Med Ctr, Div Neurobiol & Behav Res, Dept Psychiat & Human Behav G 109, 2500 N State St, Jackson, MS 39216 USA.	xou@umc.edu	Lomberk, Gwen/AAL-8490-2020; Albert, Paul/E-4804-2010	Lomberk, Gwen/0000-0001-5463-789X; Albert, Paul/0000-0002-1809-3554; Seo, Seungmae/0000-0003-2175-6440	National Institutes of Health [DK 52913]; National Institute on Alcohol Abuse and Alcoholism [R01AA020103]; Public Health Service [P20 RR 017701]; National Alliance for Research on Schizophrenia and Depression; Canadian Institutes of Health Research; University of Mississippi Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R56DK052913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Alliance for Research on Schizophrenia and Depression(NARSAD); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Mississippi Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 52913 (to R. U.) and by National Institute on Alcohol Abuse and Alcoholism Grant R01AA020103 (to X. O.). This work was also supported by Public Health Service Grant P20 RR 017701 (to C. A. S.), by the National Alliance for Research on Schizophrenia and Depression (to J. H. M. and X. O.), by the Canadian Institutes of Health Research (to P. R. A. and J. H. M.), and by an intramural research support grant from the University of Mississippi Medical Center (to J. W. and X. O.). J. H. M. has applied for a patent to employ MAO measures to diagnose or identify subtypes of major depressive disorder. He has had operating grant support/consultation with GlaxoSmithKline, BristolMyersSquibb, Lundbeck, SK Life Sciences, and Eli-Lilly.	Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Buttar NS, 2010, J BIOL CHEM, V285, P11433, DOI 10.1074/jbc.M109.077065; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chen Y, 2007, PHYTOMEDICINE, V14, P523, DOI 10.1016/j.phymed.2006.09.007; Chen Y, 2012, STRESS, V15, P74, DOI 10.3109/10253890.2011.585188; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Doyle A, 1996, LIFE SCI, V59, P1357, DOI 10.1016/0024-3205(96)00461-4; Du LS, 2002, NEUROREPORT, V13, P1195, DOI 10.1097/00001756-200207020-00025; Du LS, 2004, NEUROREPORT, V15, P2097, DOI 10.1097/00001756-200409150-00020; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Filipenko ML, 2002, NEUROSCI LETT, V321, P25, DOI 10.1016/S0304-3940(01)02495-8; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Jahng JW, 2008, EUR J PHARMACOL, V581, P64, DOI 10.1016/j.ejphar.2007.11.029; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Johnson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2139, DOI 10.1038/npp.2011.105; Johnson S, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00180; Kieran N, 2010, NEUROSCI LETT, V469, P380, DOI 10.1016/j.neulet.2009.12.032; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lu DY, 2008, DRUG DISCOV THER, V2, P289; Manoli I, 2005, FASEB J, V19, P1359, DOI 10.1096/fj.04-3660fje; Mao QQ, 2009, J ETHNOPHARMACOL, V124, P316, DOI 10.1016/j.jep.2009.04.019; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Meyer JH, 2009, ARCH GEN PSYCHIAT, V66, P1304, DOI 10.1001/archgenpsychiatry.2009.156; MICZEK KA, 1982, SCIENCE, V215, P1520, DOI 10.1126/science.7199758; Miczek KA, 2011, J NEUROSCI, V31, P9848, DOI 10.1523/JNEUROSCI.0637-11.2011; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Ou XM, 2006, J BIOL CHEM, V281, P21512, DOI 10.1074/jbc.M600250200; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Ou XM, 2010, BIOL PSYCHIAT, V67, P855, DOI 10.1016/j.biopsych.2009.10.032; Ou XM, 2009, NEUROTOX RES, V16, P148, DOI 10.1007/s12640-009-9064-7; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Sacher J, 2010, ARCH GEN PSYCHIAT, V67, P468, DOI 10.1001/archgenpsychiatry.2010.32; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; SCHILDKRAUT JJ, 1967, SCIENCE, V156, P21, DOI 10.1126/science.156.3771.21; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Thorpe LW, 1987, J HISTOCHEM CYTOCHEM, V35, P23, DOI 10.1177/35.1.3025289; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; Verhoeven WMA, 2010, PSYCHOPATHOLOGY, V43, P63, DOI 10.1159/000260045; Vialou V, 2010, J NEUROSCI, V30, P14585, DOI 10.1523/JNEUROSCI.2496-10.2010; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	46	70	72	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24195	24206		10.1074/jbc.M112.373936	http://dx.doi.org/10.1074/jbc.M112.373936			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22628545	hybrid, Green Published			2022-12-28	WOS:000306651100014
J	Liu, S; Xie, ZW; Zhao, QW; Pang, H; Turk, J; Calderon, L; Su, W; Zhao, GG; Xu, HF; Gong, MC; Guo, ZH				Liu, Shu; Xie, Zhongwen; Zhao, Qingwei; Pang, Huan; Turk, John; Calderon, Lindsay; Su, Wen; Zhao, Guogang; Xu, Haifei; Gong, Ming C.; Guo, Zhenheng			Smooth Muscle-specific Expression of Calcium-independent Phospholipase A(2)beta (iPLA(2)beta) Participates in the Initiation and Early Progression of Vascular Inflammation and Neointima Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; MECHANISM-BASED DISCRIMINATION; G-PROTEIN SIGNALING-2; DIABETIC DB/DB MICE; UP-REGULATION; 13-HYDROPEROXYOCTADECADIENOIC ACID; RESPONSE ELEMENT; ANGIOTENSIN-II; CAROTID-ARTERY; RHO KINASE	Whether group VIA phospholipase A(2) (iPLA(2)beta) is involved in vascular inflammation and neointima formation is largely unknown. Here, we report that iPLA(2)beta expression increases in the vascular tunica media upon carotid artery ligation and that neointima formation is suppressed by genetic deletion of iPLA(2)beta or by inhibiting its activity or expression via perivascular delivery of bromoenol lactone or of antisense oligonucleotides, respectively. To investigate whether smooth muscle-specific iPLA(2)beta is involved in neointima formation, we generated transgenic mice in which iPLA(2)beta is expressed specifically in smooth muscle cells and demonstrate that smooth muscle-specific expression of iPLA(2)beta exacerbates ligation-induced neointima formation and enhanced both production of proinflammatory cytokines and vascular infiltration by macrophages. With cultured vascular smooth muscle cell, angiotensin II, arachidonic acid, and TNF-alpha markedly induce increased expression of IL-6 and TNF-alpha mRNAs, all of which were suppressed by inhibiting iPLA(2)beta activity or expression with bromoenol lactone, antisense oligonucleotides, and genetic deletion, respectively. Similar suppression also results from genetic deletion of 12/15-lipoxygenase or inhibiting its activity with nordihydroguaiaretic acid or luteolin. Expression of iPLA(2)beta protein in cultured vascular smooth muscle cells was found to depend on the phenotypic state and to rise upon incubation with TNF-alpha. Our studies thus illustrate that smooth muscle cell-specific iPLA(2)beta participates in the initiation and early progression of vascular inflammation and neointima formation and suggest that iPLA(2)beta may represent a novel therapeutic target for preventing cardiovascular diseases.	[Liu, Shu; Su, Wen; Zhao, Guogang; Xu, Haifei; Guo, Zhenheng] Univ Kentucky, Dept Internal Med, Sch Med, Lexington, KY 40536 USA; [Xie, Zhongwen; Zhao, Qingwei; Pang, Huan; Calderon, Lindsay; Gong, Ming C.; Guo, Zhenheng] Univ Kentucky, Dept Physiol, Sch Med, Lexington, KY 40536 USA; [Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Kentucky; University of Kentucky; Washington University (WUSTL)	Guo, ZH (corresponding author), Univ Kentucky, Dept Internal Med, Sch Med, 515 Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	zguo2@uky.edu	xu, haifei/C-9659-2016	Calderon, Lindsay/0000-0003-0919-0077	National Institutes of Health from NCRR [HL088389, HL088389-02S1, HL082791, P20 RR021954]; NIGMS [P20 GM103527]; USPHS [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; Commonwealth of Kentucky Diabetes Research Trust Fund; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954, P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082791, R01HL088389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R37DK034388, P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Commonwealth of Kentucky Diabetes Research Trust Fund; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health HL088389 and HL088389-02S1 (to Z. G.), HL082791 (to M. G.), P20 RR021954 from NCRR and P20 GM103527 from NIGMS, and USPHS Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341 (to J. T.). This work was also supported by the Commonwealth of Kentucky Diabetes Research Trust Fund (to Z. G.) and a postdoctoral fellowship from the American Heart Association (to S. L.).	Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Dwarakanath RS, 2004, J MOL CELL CARDIOL, V36, P585, DOI 10.1016/j.yjmcc.2004.02.007; Franchi L, 2009, J INNATE IMMUN, V1, P607, DOI 10.1159/000227263; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Guo ZH, 2003, J BIOL CHEM, V278, P1856, DOI 10.1074/jbc.M211075200; Harmon KJ, 2000, AM J PATHOL, V156, P1741, DOI 10.1016/S0002-9440(10)65045-6; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kallmeier RC, 1995, J BIOL CHEM, V270, P30949, DOI 10.1074/jbc.270.52.30949; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kumar A, 1997, CIRCULATION, V96, P4333; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; LEHMAN JJ, 1993, J BIOL CHEM, V268, P20713; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu SJ, 1998, AM J PHYSIOL-HEART C, V275, pH1462, DOI 10.1152/ajpheart.1998.275.4.H1462; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Natarajan R, 2001, ARTERIOSCL THROM VAS, V21, P1408, DOI 10.1161/hq0901.095278; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pang H, 2006, AM J PHYSIOL-CELL PH, V290, pC892, DOI 10.1152/ajpcell.00378.2005; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Schober A, 2005, ANTIOXID REDOX SIGN, V7, P1249, DOI 10.1089/ars.2005.7.1249; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Seashols SJ, 2004, BBA-MOL CELL BIOL L, V1684, P29, DOI 10.1016/j.bbalip.2004.05.003; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Stec DE, 2001, BIOTECHNIQUES, V31, P256, DOI 10.2144/01312bm03; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; VILLA AE, 1995, CIRC RES, V76, P505, DOI 10.1161/01.RES.76.4.505; Walev I, 2000, J IMMUNOL, V164, P5120, DOI 10.4049/jimmunol.164.10.5120; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Yellaturu CR, 2003, J BIOL CHEM, V278, P43831, DOI 10.1074/jbc.M301472200; Zhou RH, 2008, LIFE SCI, V82, P174, DOI 10.1016/j.lfs.2007.10.025	51	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24739	24753		10.1074/jbc.M112.340216	http://dx.doi.org/10.1074/jbc.M112.340216			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637477	hybrid, Green Published			2022-12-28	WOS:000306651100067
J	Ramos, TN; Darley, MM; Weckbach, S; Stahel, PF; Tomlinson, S; Barnum, SR				Ramos, Theresa N.; Darley, Meghan M.; Weckbach, Sebastian; Stahel, Philip F.; Tomlinson, Stephen; Barnum, Scott R.			The C5 Convertase Is Not Required for Activation of the Terminal Complement Pathway in Murine Experimental Cerebral Malaria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL SIMIAN MALARIA; C6 DEFICIENCY; TARGETED EXPRESSION; PLASMINOGEN-BINDING; FACTOR-B; MICE; COAGULATION; COMPONENT; C3; SUSCEPTIBILITY	Cerebral malaria (CM) is the most severe manifestation of clinical malaria syndromes and has a high fatality rate especially in the developing world. Recent studies demonstrated that C5(-/-) mice are resistant to experimental CM (ECM) and that protection was due to the inability to form the membrane attack complex. Unexpectedly, we observed that C4(-/-) and factor B-/- mice were fully susceptible to disease, indicating that activation of the classical or alternative pathways is not required for ECM. C3(-/-) mice were also susceptible to ECM, indicating that the canonical C5 convertases are not required for ECM development and progression. Abrogation of ECM by treatment with anti-C9 antibody and detection of C5a in serum of C3(-/-) mice confirmed that C5 activation occurs in ECM independent of C5 convertases. Our data indicate that activation of C5 in ECM likely occurs via coagulation enzymes of the extrinsic protease pathway.	[Ramos, Theresa N.; Darley, Meghan M.; Barnum, Scott R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Ramos, Theresa N.; Darley, Meghan M.; Barnum, Scott R.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Weckbach, Sebastian; Stahel, Philip F.] Univ Colorado, Dept Orthoped Surg, Denver, CO 80204 USA; [Weckbach, Sebastian; Stahel, Philip F.] Univ Colorado, Dept Neurosurg, Denver, CO 80204 USA; [Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Tomlinson, Stephen] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Barnum, SR (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S,BBRB-842, Birmingham, AL 35294 USA.	sbarnum@uab.edu			National Institutes of Health [T32 AI07051, NS077811, AI08382, HL82485]; Veterans Affairs Grant [NURC-051-10F]; German Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Grant(US Department of Veterans Affairs); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 AI07051 and NS077811 (to T. N. R.), AI08382 (to S. R. B.), and HL82485 (to S. T.). This work was also supported by Veterans Affairs Grant NURC-051-10F (to S. T.) and a research fellowship from the German Research Foundation (to S. W.).	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; ATKINSON JP, 1975, J INFECT DIS, V131, P26, DOI 10.1093/infdis/131.1.26; Barnum SR, 2006, BRAIN RES REV, V52, P58, DOI 10.1016/j.brainresrev.2005.12.002; Christiansen VJ, 1997, ARTERIOSCL THROM VAS, V17, P164, DOI 10.1161/01.ATV.17.1.164; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Dasari P, 2012, BLOOD, V119, P4301, DOI 10.1182/blood-2011-11-392134; Davoust N, 1999, J IMMUNOL, V163, P6551; Delahaye NF, 2006, J INFECT DIS, V193, P312, DOI 10.1086/498579; GABRIEL J, 1983, CLIN EXP IMMUNOL, V52, P129; Ghosh K, 2008, PARASITOL RES, V102, P571, DOI 10.1007/s00436-007-0832-0; GLEW RH, 1975, J INFECT DIS, V131, P17, DOI 10.1093/infdis/131.1.17; Grau GER, 2012, FUTURE MICROBIOL, V7, P291, DOI [10.2217/FMB.11.155, 10.2217/fmb.11.155]; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Hobart MJ, 1998, HUM GENET, V103, P506, DOI 10.1007/s004390050858; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Malowany JI, 2012, SEMIN DIAGN PATHOL, V29, P49, DOI 10.1053/j.semdp.2011.07.005; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Moxon CA, 2009, MOL BIOCHEM PARASIT, V166, P99, DOI 10.1016/j.molbiopara.2009.03.006; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Pang XL, 1998, VACCINE, V16, P1299, DOI 10.1016/S0264-410X(98)00057-7; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Ramos TN, 2011, J IMMUNOL, V186, P6657, DOI 10.4049/jimmunol.1100603; Ramos TN, 2009, NEUROSCI LETT, V467, P234, DOI 10.1016/j.neulet.2009.10.045; Read RW, 2006, EXP EYE RES, V82, P389, DOI 10.1016/j.exer.2005.07.011; REINARTZ J, 1995, J IMMUNOL, V154, P844; Silver KL, 2010, CELL MICROBIOL, V12, P1036, DOI 10.1111/j.1462-5822.2010.01492.x; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; WARD PA, 1981, J IMMUNOL, V126, P1826; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WETSEL RA, 1983, J EXP MED, V157, P2029, DOI 10.1084/jem.157.6.2029; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wohler JE, 2009, EUR J IMMUNOL, V39, P1516, DOI 10.1002/eji.200839176; Wurzner R, 2003, CLIN EXP IMMUNOL, V133, P156, DOI 10.1046/j.1365-2249.2003.02230.x; Zhu ZB, 2000, CLIN EXP IMMUNOL, V119, P305	44	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24734	24738		10.1074/jbc.C112.378364	http://dx.doi.org/10.1074/jbc.C112.378364			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22689574	Green Published, hybrid			2022-12-28	WOS:000306651100066
J	Vecchio, AJ; Orlando, BJ; Nandagiri, R; Malkowski, MG				Vecchio, Alex J.; Orlando, Benjamin J.; Nandagiri, Ritwik; Malkowski, Michael G.			Investigating Substrate Promiscuity in Cyclooxygenase-2 THE ROLE OF ARG-120 AND RESIDUES LINING THE HYDROPHOBIC GROOVE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; ACTIVE-SITE; ARACHIDONIC-ACID; ENDOCANNABINOID OXYGENATION; MOLECULAR-GRAPHICS; STRUCTURAL BASIS; LINOLENIC ACID; ARGININE 120; FATTY-ACIDS; CROSS-TALK	The cyclooxygenases (COX-1 and COX-2) generate prostaglandin H-2 from arachidonic acid (AA). In its catalytically productive conformation, AA binds within the cyclooxygenase channel with its carboxylate near Arg-120 and Tyr-355 and omega-end located within a hydrophobic groove above Ser-530. Although AA is the preferred substrate for both isoforms, COX-2 can oxygenate a broad spectrum of substrates. Mutational analyses have established that an interaction of the carboxylate of AA with Arg-120 is required for high affinity binding by COX-1 but not COX-2, suggesting that hydrophobic interactions between the omega-end of substrates and cyclooxygenase channel residues play a significant role in COX-2-mediated oxygenation. We used structure-function analyses to investigate the role that Arg-120 and residues lining the hydrophobic groove play in the binding and oxygenation of substrates by murine (mu) COX-2. Mutations to individual amino acids within the hydrophobic groove exhibited decreased rates of oxygenation toward AA with little effect on binding. R120A muCOX-2 oxygenated 18-carbon omega-6 and omega-3 substrates albeit at reduced rates, indicating that an interaction with Arg-120 is not required for catalysis. Structural determinations of Co3+-protoporphyrin IX-reconstituted muCOX-2 with alpha-linolenic acid and G533V muCOX-2 with AA indicate that proper bisallylic carbon alignment is the major determinant for efficient substrate oxygenation by COX-2. Overall, these findings implicate Arg-120 and hydrophobic groove residues as determinants that govern proper alignment of the bisallylic carbon below Tyr-385 for catalysis in COX-2 and confirm nuances between COX isoforms that explain substrate promiscuity.	[Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), SUNY Buffalo, Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	malkowski@hwi.buffalo.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Vecchio, Alex/0000-0002-4222-7874; Malkowski, Michael/0000-0002-1203-7463	National Science Foundation [DMR-0225180]; National Institutes of Health [RR-01646, GM077176]; KeyBank; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077176] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KeyBank; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X-ray diffraction experiments were conducted at the Cornell High Energy Synchrotron Source (CHESS), supported by National Science Foundation Award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, supported by National Institutes of Health Award RR-01646.; This work was supported, in whole or in part, by National Institutes of Health Grant GM077176.; Supported by graduate fellowships from KeyBank.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novak EM, 2012, PROSTAG LEUKOTR ESS, V86, P107, DOI 10.1016/j.plefa.2012.01.003; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	39	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24619	24630		10.1074/jbc.M112.372243	http://dx.doi.org/10.1074/jbc.M112.372243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22637474	Green Published, hybrid			2022-12-28	WOS:000306651100056
J	Benziane, B; Bjornholm, M; Pirkmajer, S; Austin, RL; Kotova, O; Viollet, B; Zierath, JR; Chibalin, AV				Benziane, Boubacar; Bjornholm, Marie; Pirkmajer, Sergej; Austin, Reginald L.; Kotova, Olga; Viollet, Benoit; Zierath, Juleen R.; Chibalin, Alexander V.			Activation of AMP-activated Protein Kinase Stimulates Na+,K+-ATPase Activity in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; PHOSPHATASE 2A; PLASMA-MEMBRANE; ALPHA-SUBUNIT; INDUCED ENDOCYTOSIS; PUMP REGULATION; KEY SENSOR; NA,K-ATPASE; PHOSPHORYLATION; TRANSPORT	Contraction stimulates Na+,K+-ATPase and AMP-activated proteinkinase (AMPK) activity in skeletal muscle. Whether AMPK activation affects Na+,K+-ATPase activity in skeletal muscle remains to be determined. Short term stimulation of rat L6 myotubes with the AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), activates AMPK and promotes translocation of the Na+,K+-ATPase alpha(1)-subunit to the plasma membrane and increases Na+,K+-ATPase activity as assessed by ouabain-sensitive Rb-86(+) uptake. Cyanide-induced artificial anoxia, as well as a direct AMPK activator (A-769662) also increase AMPK phosphorylation and Na+,K+-ATPase activity. Thus, different stimuli that target AMPK concomitantly increase Na+,K+-ATPase activity. The effect of AICAR on Na+,K+-ATPase in L6 myotubes was attenuated by Compound C, an AMPK inhibitor, as well as siRNA-mediated AMPK silencing. The effects of AICAR on Na+,K+-ATPase were completely abolished in cultured primary mouse muscle cells lacking AMPK alpha-subunits. AMPK stimulation leads to Na+,K+-ATPase alpha(1)-subunit dephosphorylation at Ser(18), which may prevent endocytosis of the sodium pump. AICAR stimulation leads to methylation and dephosphorylation of the catalytic subunit of the protein phosphatase (PP) 2A in L6 myotubes. Moreover, AICAR-triggered dephosphorylation of the Na+,K+-ATPase was prevented in L6 myotubes deficient in PP2A-specific protein phosphatase methylesterase-1 (PME-1), indicating a role for the PP2A center dot PME-1 complex in AMPK-mediated regulation of Na+,K+-ATPase. Thus contrary to the common paradigm, we report AMPK-dependent activation of an energy-consuming ion pumping process. This activation may be a potential mechanism by which exercise and metabolic stress activate the sodium pump in skeletal muscle.	[Bjornholm, Marie; Pirkmajer, Sergej; Austin, Reginald L.; Kotova, Olga; Zierath, Juleen R.; Chibalin, Alexander V.] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Benziane, Boubacar; Zierath, Juleen R.] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Viollet, Benoit] Univ Paris 05, CNRS, Inst Cochin,UMR 8104, INSERM,Dept Endocrinol Metab & Canc,U1016, Paris, France	Karolinska Institutet; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chibalin, AV (corresponding author), Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden.	alexander.chibalin@ki.se	Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Chibalin, Alexander/0000-0002-6339-6271; Zierath, Juleen/0000-0001-6891-7497; Pirkmajer, Sergej/0000-0003-1459-6936	Swedish Research Council; Novo Nordisk Foundation; European Foundation for the Study of Diabetes; Commission of the European Communities [LSHM-CT-2004-512013 EUGENEHEART, LSHM-CT-2004-005272 EXGENESIS]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Foundation for the Study of Diabetes; Commission of the European Communities(European Commission)	This work was supported by grants from the Swedish Research Council, the Novo Nordisk Foundation, and the European Foundation for the Study of Diabetes and Commission of the European Communities Contracts LSHM-CT-2004-512013 EUGENEHEART and LSHM-CT-2004-005272 EXGENESIS.	Al-Khalili L, 2004, J BIOL CHEM, V279, P25211, DOI 10.1074/jbc.M402152200; Almaca J, 2009, PFLUG ARCH EUR J PHY, V458, P713, DOI 10.1007/s00424-009-0660-4; Alves DS, 2010, MOL BIOL CELL, V21, P4400, DOI 10.1091/mbc.E10-06-0507; BARLETBAS C, 1990, J BIOL CHEM, V265, P7799; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE553, DOI 10.1152/ajpendo.90261.2008; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BlotChabaud M, 1996, J MEMBRANE BIOL, V153, P233, DOI 10.1007/s002329900126; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Cheng SXJ, 1999, J PHYSIOL-LONDON, V518, P37, DOI 10.1111/j.1469-7793.1999.0037r.x; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 2001, ENDOCRINOLOGY, V142, P3474, DOI 10.1210/en.142.8.3474; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; Comellas AP, 2010, J CELL SCI, V123, P1343, DOI 10.1242/jcs.066464; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Done SC, 2002, J BIOL CHEM, V277, P17108, DOI 10.1074/jbc.M201326200; Efendiev R, 2007, BRIT J PHARMACOL, V151, P1006, DOI 10.1038/sj.bjp.0707304; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Hardie DG, 2004, MED SCI SPORT EXER, V36, P28, DOI 10.1249/01.MSS.0000106171.38299.64; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HARRIS SI, 1981, J BIOL CHEM, V256, P319; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Hulo S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-64; HUNDAL HS, 1994, MOL MEMBR BIOL, V11, P255, DOI 10.3109/09687689409160435; Juel C, 2000, AM J PHYSIOL-REG I, V278, pR1107, DOI 10.1152/ajpregu.2000.278.4.R1107; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Kongsuphol P, 2009, PFLUG ARCH EUR J PHY, V457, P1071, DOI 10.1007/s00424-008-0577-3; Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Lecuona E, 2000, FEBS LETT, V481, P217, DOI 10.1016/S0014-5793(00)02009-3; Lecuona E, 2006, FASEB J, V20, P2618, DOI 10.1096/fj.06-6503fje; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; Murphy KT, 2004, J PHYSIOL-LONDON, V556, P507, DOI 10.1113/jphysiol.2003.054981; Nielsen O B, 2000, Exerc Sport Sci Rev, V28, P159; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; Ragolia L, 1997, J BIOL CHEM, V272, P23653, DOI 10.1074/jbc.272.38.23653; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Seo-Mayer PW, 2011, AM J PHYSIOL-RENAL, V301, pF1346, DOI 10.1152/ajprenal.00420.2010; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Sweeney G, 2001, AM J PHYSIOL-CELL PH, V281, pC1797, DOI 10.1152/ajpcell.2001.281.6.C1797; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Wang MY, 2005, AM J PHYSIOL-ENDOC M, V288, pE216, DOI 10.1152/ajpendo.00004.2004; Woollhead AM, 2007, BRIT J PHARMACOL, V151, P1204, DOI 10.1038/sj.bjp.0707343; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Zheng D, 2008, AM J PHYSIOL-CELL PH, V294, pC126, DOI 10.1152/ajpcell.00464.2007	62	50	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23451	23463		10.1074/jbc.M111.331926	http://dx.doi.org/10.1074/jbc.M111.331926			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610379	Green Published, hybrid			2022-12-28	WOS:000306511300018
J	Galdieri, L; Vancura, A				Galdieri, Luciano; Vancura, Ales			Acetyl-CoA Carboxylase Regulates Global Histone Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; COENZYME-A SYNTHETASE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; GENOME-WIDE; GENE-EXPRESSION; PROTEIN ACETYLATION; CELLULAR-METABOLISM; LYSINE ACETYLATION; PROMOTER SYSTEM	Histone acetylation depends on intermediary metabolism for supplying acetyl-CoA in the nucleocytosolic compartment. However, because nucleocytosolic acetyl-CoA is also used for de novo synthesis of fatty acids, histone acetylation and synthesis of fatty acids compete for the same acetyl-CoA pool. The first and rate-limiting reaction in de novo synthesis of fatty acids is carboxylation of acetyl-CoA to form malonyl-CoA, catalyzed by acetyl-CoA carboxylase. In yeast Saccharomyces cerevisiae, acetyl-CoA carboxylase is encoded by the ACC1 gene. In this study, we show that attenuated expression of ACC1 results in increased acetylation of bulk histones, globally increased acetylation of chromatin histones, and altered transcriptional regulation. Together, our data indicate that Acc1p activity regulates the availability of acetyl-CoA for histone acetyltransferases, thus representing a link between intermediary metabolism and epigenetic mechanisms of transcriptional regulation.	[Galdieri, Luciano; Vancura, Ales] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA	Saint John's University	Vancura, A (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA.	vancuraa@stjohns.edu	Galdieri, Luciano/GYD-4538-2022	Vancura, Ales/0000-0002-5895-1218	National Institutes of Health Grant [GM087674]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM087674] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087674 (to A.V.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; ALLIS CD, 1979, P NATL ACAD SCI USA, V76, P4857, DOI 10.1073/pnas.76.10.4857; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chang CS, 2009, GENETICS, V183, P149, DOI 10.1534/genetics.109.103846; CHIRALA SS, 1994, NUCLEIC ACIDS RES, V22, P412, DOI 10.1093/nar/22.3.412; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; GANSHEROFF LJ, 1995, GENETICS, V139, P523; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Geng FQ, 2001, MOL CELL BIOL, V21, P4311, DOI 10.1128/MCB.21.13.4311-4320.2001; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; GREGOLIN C, 1966, P NATL ACAD SCI USA, V56, P148, DOI 10.1073/pnas.56.1.148; Guarente L, 2011, CELL METAB, V14, P151, DOI 10.1016/j.cmet.2011.07.007; Guha N, 2007, MOL BIOL CELL, V18, P2419, DOI 10.1091/mbc.E06-10-0946; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Heyland J, 2009, MICROBIOL-SGM, V155, P3827, DOI 10.1099/mic.0.030213-0; HUDAK KA, 1994, GENETICS, V136, P475; Ivessa AS, 1997, EUR J CELL BIOL, V74, P399; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lafon A, 2007, ONCOGENE, V26, P5373, DOI 10.1038/sj.onc.1210606; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Matsuhashi M., 1969, METHOD ENZYMOL, V14, P3; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Mitchell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025336; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pilch DR, 2004, METHOD ENZYMOL, V375, P76; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Rathmell JC, 2009, SCIENCE, V324, P1021, DOI 10.1126/science.1174665; Richon VM, 2004, METHOD ENZYMOL, V376, P199; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Shukla V, 2008, MUTAT RES-FUND MOL M, V637, P1, DOI 10.1016/j.mrfmmm.2007.07.012; Smedsgaard J, 2005, J EXP BOT, V56, P273, DOI 10.1093/jxb/eri068; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wishart JA, 2005, YEAST, V22, P565, DOI 10.1002/yea.1225; WOODS A, 1994, J BIOL CHEM, V269, P19509; Zadra G, 2010, CLIN CANCER RES, V16, P3322, DOI 10.1158/1078-0432.CCR-09-1955; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	75	126	128	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23865	23876		10.1074/jbc.M112.380519	http://dx.doi.org/10.1074/jbc.M112.380519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22580297	Green Published, hybrid			2022-12-28	WOS:000306511300057
J	Brown, MS; Goldstein, JL				Brown, Michael S.; Goldstein, Joseph L.			Scientific Side Trips: Six Excursions from the Beaten Path	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							LOW-DENSITY-LIPOPROTEIN; RAB GERANYLGERANYL TRANSFERASE; STEROL REGULATORY ELEMENT; CYTOPLASMIC CHOLESTERYL ESTERS; RECEPTOR-MEDIATED ENDOCYTOSIS; LEPTIN-REPLACEMENT THERAPY; LEUCINE ZIPPER PROTEIN; O-ACYLTRANSFERASE GOAT; PURIFIED NPC1 PROTEIN; CDNA CLONING		[Brown, Michael S.; Goldstein, Joseph L.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu						Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; ARMSTRONG SA, 1993, J BIOL CHEM, V268, P12221; BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; Binder CJ, 2007, J AM COLL CARDIOL, V50, P547, DOI 10.1016/j.jacc.2007.04.054; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brown MS, 2011, J CELL BIOL, V193, DOI 10.1083/jcb.201104136; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 2004, ATHEROSCLEROSIS SUPP, V5, P13, DOI 10.1016/j.atherosclerosissup.2004.08.007; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1993, NATURE, V366, P14, DOI 10.1038/366014a0; BROWN MS, 1980, J BIOL CHEM, V255, P9344; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; CHEN WJ, 1991, P NATL ACAD SCI USA, V88, P11368, DOI 10.1073/pnas.88.24.11368; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346; FAUST J, 1987, J BIOL CHEM, V262, P1996; FOGELMAN AM, 1980, P NATL ACAD SCI-BIOL, V77, P2214, DOI 10.1073/pnas.77.4.2214; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gavrilova O, 2000, NATURE, V403, P850, DOI 10.1038/35002663; Glomset J. A., 1991, CURR OPIN LIPIDOL, V2, P118; Goldstein JL, 2011, COLD SH Q B, V76, P121, DOI 10.1101/sqb.2011.76.010447; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GOLDSTEIN JL, 1991, J BIOL CHEM, V266, P15575; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HALESTRAP AP, 1974, BIOCHEM J, V138, P313, DOI 10.1042/bj1380313; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; HO YK, 1980, J LIPID RES, V21, P391; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; KIM CM, 1992, J BIOL CHEM, V267, P23113; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Li RL, 2012, J BIOL CHEM, V287, P17942, DOI 10.1074/jbc.M112.358051; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; LOWY DR, 1989, NATURE, V341, P384, DOI 10.1038/341384a0; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; Nass R, 2008, J CLIN ENDOCR METAB, V93, P1988, DOI 10.1210/jc.2007-2234; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Oral EA, 2010, ENDOCR PRACT, V16, P324, DOI 10.4158/EP09155.RA; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; REISS Y, 1991, J BIOL CHEM, V266, P10672; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SCHAFER WR, 1990, SCIENCE, V249, P1133, DOI 10.1126/science.2204115; SCHMIDT RA, 1984, J BIOL CHEM, V259, P175; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Steinberg D, 2011, J BIOL CHEM, V286, P37895, DOI 10.1074/jbc.X111.302950; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Tolmachova T, 2012, J GENE MED, V14, P158, DOI 10.1002/jgm.1652; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; WANG XD, 1993, J BIOL CHEM, V268, P14497; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	113	4	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22418	22435		10.1074/jbc.X112.381681	http://dx.doi.org/10.1074/jbc.X112.381681			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22584575	hybrid, Green Published			2022-12-28	WOS:000306495000001
J	Franceschini, S; van Beek, HL; Pennetta, A; Martinoli, C; Fraaije, MW; Mattevi, A				Franceschini, Stefano; van Beek, Hugo L.; Pennetta, Alessandra; Martinoli, Christian; Fraaije, Marco W.; Mattevi, Andrea			Exploring the Structural Basis of Substrate Preferences in Baeyer-Villiger Monooxygenases INSIGHT FROM STEROID MONOOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOHEXANONE MONOOXYGENASE; CRYSTAL-STRUCTURES; OXIDATION; MECHANISM; COFACTOR; PATHWAY; ENZYME	Steroid monooxygenase (STMO) from Rhodococcus rhodochrous catalyzes the Baeyer-Villiger conversion of progesterone into progesterone acetate using FAD as prosthetic group and NADPHas reducing cofactor. The enzyme shares high sequence similarity with well characterized Baeyer-Villiger monooxygenases, including phenylacetone monooxygenase and cyclohexanone monooxygenase. The comparative biochemical and structural analysis of STMO can be particularly insightful with regard to the understanding of the substrate-specificity properties of Baeyer-Villiger monooxygenases that are emerging as promising tools in biocatalytic applications and as targets for prodrug activation. The crystal structures of STMO in the native, NADP(+)-bound, and two mutant forms reveal structural details on this microbial steroid-degrading enzyme. The binding of the nicotinamide ring of NADP(+) is shifted with respect to the flavin compared with that observed in other monooxygenases of the same class. This finding fully supports the idea that NADP( H) adopts various positions during the catalytic cycle to perform its multiple functions in catalysis. The active site closely resembles that of phenylacetone monooxygenase. This observation led us to discover that STMO is capable of acting also on phenylacetone, which implies an impressive level of substrate promiscuity. The investigation of six mutants that target residues on the surface of the substrate-binding site reveals that enzymatic conversions of both progesterone and phenylacetone are largely insensitive to relatively drastic amino acid changes, with some mutants even displaying enhanced activity on progesterone. These features possibly reflect the fact that these enzymes are continuously evolving to acquire new activities, depending on the emerging availabilities of new compounds in the living environment.	[van Beek, Hugo L.; Fraaije, Marco W.] Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Franceschini, Stefano; Pennetta, Alessandra; Martinoli, Christian; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy	University of Groningen; University of Pavia	Fraaije, MW (corresponding author), Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl; andrea.mattevi@unipv.it	Fraaije, Marco/E-8421-2014; Mattevi, Andrea/R-4469-2019; mattevi, andrea/K-5464-2012	Mattevi, Andrea/0000-0002-9523-7128; mattevi, andrea/0000-0002-9523-7128; Fraaije, Marco/0000-0001-6346-5014; van Beek, Hugo/0000-0001-7115-4224	European Union [212281]; Fondazione Cariplo [2008.3148]	European Union(European Commission); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by European Union Project Oxygreen number 212281 and Fondazione Cariplo number 2008.3148.	Beam MP, 2009, BIOCHEMISTRY-US, V48, P4476, DOI 10.1021/bi8023509; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraaije MW, 2005, APPL MICROBIOL BIOT, V66, P393, DOI 10.1007/s00253-004-1749-5; Jensen CN, 2012, CHEMBIOCHEM, V13, P872, DOI 10.1002/cbic.201200006; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Leisch H, 2012, APPL ENVIRON MICROB, V78, P2200, DOI 10.1128/AEM.07694-11; Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; MIYAMOTO M, 1995, BBA-PROTEIN STRUCT M, V1251, P115, DOI 10.1016/0167-4838(95)00090-H; Morii S, 1999, J BIOCHEM-TOKYO, V126, P624, DOI 10.1093/oxfordjournals.jbchem.a022494; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Pazmino DET, 2010, CURR OPIN CHEM BIOL, V14, P138, DOI 10.1016/j.cbpa.2009.11.017; PETERSON GE, 1957, J BACTERIOL, V74, P684, DOI 10.1128/JB.74.5.684-688.1957; Polyak I, 2012, J AM CHEM SOC, V134, P2732, DOI 10.1021/ja2103839; Reetz MT, 2009, J AM CHEM SOC, V131, P15424, DOI 10.1021/ja906212k; Riebel A., 2012, APPL MICROB IN PRESS, P10; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; TURFITT GE, 1948, BIOCHEM J, V42, P376, DOI 10.1042/bj0420376; van Beek HL, 2012, CHEM COMMUN, V48, P3288, DOI 10.1039/c2cc17656d; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu S, 2010, P NATL ACAD SCI USA, V107, P2775, DOI 10.1073/pnas.0911656107	27	39	39	9	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22626	22634		10.1074/jbc.M112.372177	http://dx.doi.org/10.1074/jbc.M112.372177			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22605340	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000306495000019
J	Gwozdz, T; Dutko-Gwozdz, J; Schafer, C; Bolotina, VM				Gwozdz, Tomasz; Dutko-Gwozdz, Joanna; Schafer, Claudia; Bolotina, Victoria M.			Overexpression of Orai1 and STIM1 Proteins Alters Regulation of Store-operated Ca2+ Entry by Endogenous Mediators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-INDEPENDENT PHOSPHOLIPASE A(2); CALCIUM INFLUX FACTOR; CHANNEL ACTIVATION; CRAC CHANNELS; MECHANISM; DEPLETION; DOMAINS; PATHWAY; COMPLEX; CELLS	Orai1 and STIM1 have been identified as the main determinants of the store-operated Ca2+ entry (SOCE). Their specific roles in SOCE and their molecular interactions have been studied extensively following heterologous overexpression or molecular knockdown and extrapolated to the endogenous processes in naive cells. Using molecular and imaging techniques, we found that variation of expression levels of Orai1 or STIM1 can significantly alter expression and role of some endogenous regulators of SOCE. Although functional inhibition of Ca2+-independent phospholipase A(2) beta (iPLA(2)beta or PLA2g6A), or depletion of plasma membrane cholesterol caused a dramatic loss of endogenous SOCE in HEK293 cells, these effects were attenuated significantly when either Orai1 or STIM1 were overexpressed. Molecular knockdown of iPLA(2)beta impaired SOCE in both control cells and cells overexpressing STIM1. We also discovered important cross-talk between expression of Orai1 and a specific plasma membrane variant of iPLA(2)beta but not STIM1. These data confirm the role of iPLA(2)beta as an essential mediator of endogenous SOCE and demonstrate that its physiological role can be obscured by Orai1 and STIM1 overexpression.	[Gwozdz, Tomasz; Dutko-Gwozdz, Joanna; Schafer, Claudia; Bolotina, Victoria M.] Boston Univ, Sch Med, Dept Med, Ion Channel & Calcium Signaling Unit, Boston, MA 02118 USA	Boston University	Bolotina, VM (corresponding author), Boston Univ, Sch Med, Dept Med, Ion Channel & Calcium Signaling Unit, 650 Albany St,X-704, Boston, MA 02118 USA.	bolotina@bu.edu		Bolotina, Victoria/0000-0001-5862-181X	National Institutes of Health [RO1HL54150, RO1HL71793]; Cellular Imaging Core in the Department of Medicine of the Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054150, R01HL071793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular Imaging Core in the Department of Medicine of the Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL54150 and RO1HL71793. This work was also supported by the Cellular Imaging Core in the Department of Medicine of the Boston University School of Medicine.	Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; Boittin FX, 2008, AM J PHYSIOL-HEART C, V295, pH2466, DOI 10.1152/ajpheart.00639.2008; Bolotina VM, 2008, J PHYSIOL-LONDON, V586, P3035, DOI 10.1113/jphysiol.2008.154997; Clapham DE, 2009, CELL, V136, P814, DOI 10.1016/j.cell.2009.02.022; Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; Csutora P, 2006, J BIOL CHEM, V281, P34926, DOI 10.1074/jbc.M606504200; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Derler I, 2008, EXPERT OPIN DRUG DIS, V3, P787, DOI 10.1517/17460441.3.7.787; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Gwozdz T, 2008, AM J PHYSIOL-CELL PH, V295, pC1133, DOI 10.1152/ajpcell.00306.2008; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Kato N, 2003, BIOCHEMISTRY-US, V42, P11808, DOI 10.1021/bi034758h; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Martinez J, 2005, BIOCHEM PHARMACOL, V70, P733, DOI 10.1016/j.bcp.2005.04.045; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ross K, 2007, J CELL PHYSIOL, V211, P569, DOI 10.1002/jcp.20993; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	37	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22865	22872		10.1074/jbc.M112.356626	http://dx.doi.org/10.1074/jbc.M112.356626			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22549787	Green Published, hybrid			2022-12-28	WOS:000306495000043
J	Liu, GD; Razanau, A; Hai, Y; Yu, JK; Sohail, M; Lobo, VG; Chu, JY; Kung, SKP; Xie, JY				Liu, Guodong; Razanau, Aleh; Hai, Yan; Yu, Jiankun; Sohail, Muhammad; Lobo, Vincent G.; Chu, Jiayou; Kung, Sam K. P.; Xie, Jiuyong			A Conserved Serine of Heterogeneous Nuclear Ribonucleoprotein L (hnRNP L) Mediates Depolarization-regulated Alternative Splicing of Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACT-BINDING-PROTEIN; MESSENGER-RNA; BK CHANNELS; IV; RECOGNITION; STRESS; CELLS; TRANSLATION; ELEMENTS; COMPLEX	Molecular mechanisms of gene regulation underlying the activity-dependent long term changes of cellular electrical properties, such as those during memory, are largely unknown. We have shown that alternative splicing can be dynamically regulated in response to membrane depolarization and Ca2+/calmodulin-dependent protein kinase IV (CaMKIV) activation, through special CaM kinase responsive RNA elements. However, proteins that mediate this regulation and how they are affected by CaMKIV are not known. Here we show that the regulation of the stress axis-regulated exon of the Slo1 potassium channel transcripts by membrane depolarization requires a highly conserved CaMKIV target serine (Ser-513) of the heterogeneous ribonucleoprotein L. Ser-513 phosphorylation within the RNA recognition motif 4 enhanced heterogeneous ribonucleoprotein L interaction with the CaMKIV-responsive RNA element 1 of stress axis-regulated exon and inhibited binding of the large subunit of the U2 auxiliary factor U2AF65. Both of these activities were abolished by a S513A mutation. Thus, through Ser-513, membrane depolarization/calcium signaling controls a critical spliceosomal assembly step to regulate the variant subunit composition of potassium channels.	[Liu, Guodong; Razanau, Aleh; Hai, Yan; Yu, Jiankun; Sohail, Muhammad; Lobo, Vincent G.; Xie, Jiuyong] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R3E 0J9, Canada; [Kung, Sam K. P.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0J9, Canada; [Xie, Jiuyong] Univ Manitoba, Fac Med, Dept Biochem & Mol Genet, Winnipeg, MB R3E 0J9, Canada; [Yu, Jiankun; Chu, Jiayou] Chinese Acad Med Sci, Inst Med Biol, Kunming 650018, Peoples R China; [Yu, Jiankun; Chu, Jiayou] Peking Union Med Coll, Kunming 650018, Peoples R China	University of Manitoba; University of Manitoba; University of Manitoba; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xie, JY (corresponding author), 439 BMSB,745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	xiej@cc.umanitoba.ca	Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033; Yu, Jiankun/0000-0001-9916-1012	Canadian Institutes of Health Research (CIHR) [FRN106608]; Manitoba Health Research Council	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council	This work was supported by Canadian Institutes of Health Research (CIHR) Grant FRN106608 (to J. X.), by a Manitoba Health Research Council post-doctoral fellowship (to Y. H.), and by a Manitoba Health Research Council graduate studentship (to G. L.).	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Brunton PJ, 2007, ENDOCRINOLOGY, V148, P5496, DOI 10.1210/en.2007-0319; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cao WG, 2011, RNA BIOL, V8, P1061, DOI 10.4161/rna.8.6.16691; Corcoran EE, 2003, J BIOL CHEM, V278, P10516, DOI 10.1074/jbc.M210642200; Gray AC, 2007, CELL CALCIUM, V42, P409, DOI 10.1016/j.ceca.2007.04.003; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, RNA, V9, P931, DOI 10.1261/rna.5660803; Hwang B, 2009, BIOCHEM BIOPH RES CO, V378, P584, DOI 10.1016/j.bbrc.2008.11.091; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; Kung SKP, 2010, METHODS MOL BIOL, V612, P233, DOI 10.1007/978-1-60761-362-6_16; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Moore MJ, 2000, NAT STRUCT BIOL, V7, P14, DOI 10.1038/71207; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rohmann KN, 2009, MOL BIOL EVOL, V26, P1509, DOI 10.1093/molbev/msp060; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Skrisovska L, 2008, J MOL BIOL, V375, P151, DOI 10.1016/j.jmb.2007.09.030; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yu JK, 2009, J BIOL CHEM, V284, P1505, DOI 10.1074/jbc.M805113200; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	36	54	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22709	22716		10.1074/jbc.M112.357343	http://dx.doi.org/10.1074/jbc.M112.357343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570490	Green Published, hybrid			2022-12-28	WOS:000306495000028
J	Mertz, EL; Facchini, M; Pham, AT; Gualeni, B; De Leonardis, F; Rossi, A; Forlino, A				Mertz, Edward L.; Facchini, Marcella; Pham, Anna T.; Gualeni, Benedetta; De Leonardis, Fabio; Rossi, Antonio; Forlino, Antonella			Matrix Disruptions, Growth, and Degradation of Cartilage with Impaired Sulfation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SULFUR; CHONDROITIN SULFATE; INDIAN HEDGEHOG; BIOCHEMICAL-CHARACTERIZATION; CHONDROCYTE DIFFERENTIATION; SKELETAL DEVELOPMENT; CHOLESTEROL SULFATE; ARTICULAR-CARTILAGE; CULTURE-MEDIUM; DYSPLASIA	Diastrophic dysplasia (DTD) is an incurable recessive chondrodysplasia caused by mutations in the SLC26A2 transporter responsible for sulfate uptake by chondrocytes. The mutations cause undersulfation of glycosaminoglycans in cartilage. Studies of dtd mice with a knock-in Slc26a2 mutation showed an unusual progression of the disorder: net undersulfation is mild and normalizing with age, but the articular cartilage degrades with age and bones develop abnormally. To understand underlying mechanisms, we studied newborn dtd mice. We developed, verified and used high-definition infrared hyperspectral imaging of cartilage sections at physiological conditions, to quantify collagen and its orientation, noncollagenous proteins, and chondroitin chains, and their sulfation with 6-mu m spatial resolution and without labeling. We found that chondroitin sulfation across the proximal femur cartilage varied dramatically in dtd, but not in the wild type. Corresponding undersulfation of dtd was mild in most regions, but strong in narrow articular and growth plate regions crucial for bone development. This undersulfation correlated with the chondroitin synthesis rate measured via radioactive sulfate incorporation, explaining the sulfation normalization with age. Collagen orientation was reduced, and the reduction correlated with chondroitin undersulfation. Such disorientation involved the layer of collagen covering the articular surface and protecting cartilage from degradation. Malformation of this layer may contribute to the degradation progression with age and to collagen and proteoglycan depletion from the articular region, which we observed in mice already at birth. The results provide clues to in vivo sulfation, DTD treatment, and cartilage growth.	[Mertz, Edward L.; Pham, Anna T.] Eunice Kennedy Shriver NICHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; [Facchini, Marcella; Gualeni, Benedetta; De Leonardis, Fabio; Rossi, Antonio; Forlino, Antonella] Univ Pavia, Biochem Sect, Dept Mol Med, I-27100 Pavia, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Pavia	Mertz, EL (corresponding author), Eunice Kennedy Shriver NICHD, Sect Phys Biochem, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E125, Bethesda, MD 20892 USA.	mertze@mail.nih.gov	Forlino, Antonella/H-5385-2015; Rossi, Antonio/E-9935-2012	Forlino, Antonella/0000-0002-6385-1182; Gualeni, Benedetta/0000-0002-5216-1151; Facchini, Marcella/0000-0002-6500-8842	National Institutes of Health Director's Challenge Fund; NICHD Intramural Research Program; PRIN [20094C2H2M]; Regione Lombardia [REGLOM16]; European Community FP6 EuroGrow Grant [LSHM-CT-2007-037471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008810] Funding Source: NIH RePORTER	National Institutes of Health Director's Challenge Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Lombardia(Regione Lombardia); European Community FP6 EuroGrow Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Director's Challenge Fund, the NICHD Intramural Research Program, PRIN 20094C2H2M, Regione Lombardia REGLOM16, and European Community FP6 EuroGrow Grant LSHM-CT-2007-037471.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Arrington CB, 2009, DEVELOPMENT, V136, P3143, DOI 10.1242/dev.031492; Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892; BELANGER LF, 1954, CAN J BIOCHEM PHYS, V32, P161; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; BUCKWALTER JA, 1986, J BONE JOINT SURG AM, V68A, P243, DOI 10.2106/00004623-198668020-00010; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chen XS, 2008, ARTHRITIS RHEUM-US, V58, P3788, DOI 10.1002/art.23985; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; DIAB M, 1994, AM J MED GENET, V49, P402, DOI 10.1002/ajmg.1320490411; Dukor R. K., 2002, APPL VIBRATIONAL SPE, P3335; DZIEWIATKOWSKI DD, 1952, J EXP MED, V95, P489, DOI 10.1084/jem.95.5.489; DZIEWIATKOWSKI DD, 1951, J EXP MED, V93, P451, DOI 10.1084/jem.93.5.451; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Forlino A., 2006, NOVART FDN SYMP, V273, P206; Forlino A., 2006, NOVART FDN SYMP, V273, P261; Forlino Antonella, 2006, Novartis Found Symp, V273, P193; FRASER RDB, 1958, J CHEM PHYS, V28, P1113, DOI 10.1063/1.1744353; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Galante LL, 2007, J CELL BIOL, V179, P999, DOI 10.1083/jcb.200707150; GHADIALLY FN, 1983, FINE STRUCTURE SYNOV; Gualeni B, 2007, CALCIFIED TISSUE INT, V80, pS77; Gualeni B, 2010, MATRIX BIOL, V29, P453, DOI 10.1016/j.matbio.2010.05.001; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; HORTON WA, 1978, J PEDIATR-US, V93, P609, DOI 10.1016/S0022-3476(78)80896-8; HUNZIKER EB, 1989, J PHYSIOL-LONDON, V414, P55, DOI 10.1113/jphysiol.1989.sp017676; Kester MHA, 2003, AM J PHYSIOL-ENDOC M, V285, pE592, DOI 10.1152/ajpendo.00046.2003; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lamb R, 2007, ARTHRITIS RHEUM-US, V56, P1286, DOI 10.1002/art.22444; Makitie O, 1997, J PEDIATR-US, V130, P641, DOI 10.1016/S0022-3476(97)70250-6; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; MAROUDAS A, 1974, BIOCHIM BIOPHYS ACTA, V338, P265, DOI 10.1016/0304-4165(74)90355-9; Mertz E. L., 2008, United States patent, Patent No. [7,355,697, 7355697]; Mertz EL, 2004, BIOCHEMISTRY-US, V43, P14901, DOI 10.1021/bi048788b; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOURAO PAS, 1979, COMP BIOCHEM PHYS B, V62, P115, DOI 10.1016/0305-0491(79)90023-3; Myette JR, 2002, BIOCHEM BIOPH RES CO, V290, P1206, DOI 10.1006/bbrc.2001.6268; OOHIRA A, 1974, J BIOL CHEM, V249, P1637; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; ORKIN RW, 1977, J CELL BIOL, V73, P287, DOI 10.1083/jcb.73.2.287; Pecora F, 2006, BIOCHEM J, V398, P509, DOI 10.1042/BJ20060566; Potter K, 2001, ARTHRITIS RHEUM, V44, P846, DOI 10.1002/1529-0131(200104)44:4<846::AID-ANR141>3.0.CO;2-E; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Rieppo J, 2009, OSTEOARTHR CARTILAGE, V17, P448, DOI 10.1016/j.joca.2008.09.004; Rosenberg L. C., 1983, LIMB DEV REGENERAT B, P67; Rossi A, 1997, EUR J BIOCHEM, V248, P741, DOI 10.1111/j.1432-1033.1997.t01-1-00741.x; Rossi A, 1998, MATRIX BIOL, V17, P361, DOI 10.1016/S0945-053X(98)90088-9; SCHECK M, 1978, VIRCHOWS ARCH A, V378, P347, DOI 10.1007/BF00465601; Schwartz NB, 1998, CHEM-BIOL INTERACT, V109, P143, DOI 10.1016/S0009-2797(97)00129-4; SERIZAWA S, 1990, CLIN EXP DERMATOL, V15, P13, DOI 10.1111/j.1365-2230.1990.tb02010.x; SHAPIRO F, 1992, CALCIFIED TISSUE INT, V51, P324, DOI 10.1007/BF00334495; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; STANESCU V, 1994, AM J MED GENET, V51, P22, DOI 10.1002/ajmg.1320510106; STANESCU V, 1984, J BONE JOINT SURG AM, V66A, P817, DOI 10.2106/00004623-198466060-00002; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Superti-Furga A., 2002, CONNECTIVE TISSUE IT, P939; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; TORCHIA DA, 1977, J BIOL CHEM, V252, P3617; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; WALKER BA, 1972, MEDICINE, V51, P41, DOI 10.1097/00005792-197201000-00003; WIKSTROM B, 1985, COLLAGEN REL RES, V5, P193; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Xu D, 2007, J BIOL CHEM, V282, P8356, DOI 10.1074/jbc.M608062200; Yamauchi S, 1999, J BIOL CHEM, V274, P2456, DOI 10.1074/jbc.274.4.2456; Yin JH, 2010, APPL SPECTROSC, V64, P1199, DOI 10.1366/000370210793335124	75	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22030	22042		10.1074/jbc.M110.116467	http://dx.doi.org/10.1074/jbc.M110.116467			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556422	Green Published, hybrid			2022-12-28	WOS:000306418600041
J	Nanjundaiah, SM; Venkatesha, SH; Yu, H; Tong, L; Stains, JP; Moudgil, KD				Nanjundaiah, Siddaraju M.; Venkatesha, Shivaprasad H.; Yu, Hua; Tong, Li; Stains, Joseph P.; Moudgil, Kamal D.			Celastrus and Its Bioactive Celastrol Protect against Bone Damage in Autoimmune Arthritis by Modulating Osteoimmune Cross-talk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; SYNOVIAL T-CELLS; RHEUMATOID-ARTHRITIS; OSTEOCLAST FORMATION; IN-VITRO; TEA POLYPHENOLS; SUPPRESSES; DESTRUCTION; RESORPTION; INFLIXIMAB	Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by bone erosion and cartilage destruction in the joints. Many of the conventional antiarthritic drugs are effective in suppressing inflammation, but they do not offer protection against bone damage. Furthermore, the prolonged use of these drugs is associated with severe adverse reactions. Thus, new therapeutic agents that can control both inflammation and bone damage but with minimal side effects are sought. Celastrus is a Chinese herb that has been used for centuries in folk medicine for the treatment of various inflammatory diseases. However, its utility for protection against inflammation-induced bone damage in arthritis and the mechanisms involved therein have not been examined. We tested celastrus and its bioactive component celastrol for this attribute in the adjuvant-induced arthritis model of RA. The treatment of arthritic rats with celastrus/celastrol suppressed inflammatory arthritis and reduced bone and cartilage damage in the joints as demonstrated by histology and bone histomorphometry. The protective effects against bone damage are mediated primarily via the inhibition of defined mediators of osteoclastic bone remodeling (e. g. receptor activator of nuclear factor-kappa B ligand (RANKL)), the deviation of RANKL/osteoprotegerin ratio in favor of antiosteoclastic activity, and the reduction in osteoclast numbers. Furthermore, both theupstreaminducers(proinflammatory cytokines) and the down-stream effectors (MMP-9) of the osteoclastogenic mediators were altered. Thus, celastrus and celastrol controlled inflammation-induced bone damage by modulating the osteoimmune cross-talk. These natural products deserve further consideration and evaluation as adjuncts to conventional therapy for RA.	[Nanjundaiah, Siddaraju M.; Venkatesha, Shivaprasad H.; Yu, Hua; Moudgil, Kamal D.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Moudgil, Kamal D.] Univ Maryland, Dept Med, Sch Med, Div Rheumatol, Baltimore, MD 21201 USA; [Stains, Joseph P.] Univ Maryland, Dept Orthopaed, Sch Med, Baltimore, MD 21201 USA; [Tong, Li] So Med Univ, Sch Tradit Chinese Med, Guangzhou 510510, Guangdong, Peoples R China	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Southern Medical University - China	Moudgil, KD (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Sch Med, 685 W Baltimore St,HSF 1,Suite 380, Baltimore, MD 21201 USA.	kmoud001@umaryland.edu	Venkatesha, Shivaprasad/S-3141-2016; yu, hua/F-8948-2012		National Institutes of Health [R01AT004321]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AT004321.	Ahmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Astry B, 2011, J INTERF CYTOK RES, V31, P927, DOI 10.1089/jir.2011.0094; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dai SM, 2004, ANN RHEUM DIS, V63, P1379, DOI 10.1136/ard.2003.018481; Fonseca JE, 2009, CLIN RHEUMATOL, V28, P1213, DOI 10.1007/s10067-009-1207-y; FRANCK H, 1994, J RHEUMATOL, V21, P1256; Franco GCN, 2011, EXP CELL RES, V317, P1454, DOI 10.1016/j.yexcr.2011.03.014; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Gorman CL, 2008, BEST PRACT RES CL RH, V22, P221, DOI 10.1016/j.berh.2008.01.003; Grassi F, 2004, J CELL PHYSIOL, V199, P244, DOI 10.1002/jcp.10445; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hahn B, 2004, JCR-J CLIN RHEUMATOL, V10, pS3, DOI 10.1097/01.rhu.0000130683.61892.b2; HILL PA, 1995, ENDOCRINOLOGY, V136, P124, DOI 10.1210/en.136.1.124; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Idris AI, 2009, MOL CANCER THER, V8, P2339, DOI 10.1158/1535-7163.MCT-09-0133; Jones D, 2011, J CLIN INVEST, V121, P2534, DOI 10.1172/JCI46262; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim DH, 2009, EUR J CLIN INVEST, V39, P819, DOI 10.1111/j.1365-2362.2009.02186.x; Kim JL, 2012, J CELL BIOCHEM, V113, P247, DOI 10.1002/jcb.23351; Kim WK, 2011, J CELL BIOCHEM, V112, P3159, DOI 10.1002/jcb.23242; Kim Y, 2011, CELL PHYSIOL BIOCHEM, V28, P175, DOI 10.1159/000331729; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komeh-Nkrumah SA, 2012, PHYTOTHER RES, V26, P54, DOI 10.1002/ptr.3509; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kremers HM, 2004, J RHEUMATOL, V31, P2366; Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752; Lipsky P. E., 2008, HARRISONS PRINCIPLES, V2, P2083; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu Z, 2011, MOLECULES, V16, P5283, DOI 10.3390/molecules16065283; Lubberts E, 2000, J CLIN INVEST, V105, P1697, DOI 10.1172/JCI7739; Maruotti N, 2011, CLIN EXP MED, V11, P137, DOI 10.1007/s10238-010-0117-2; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; Ohshima S, 2002, ARTHRITIS RHEUM, V46, P1094, DOI 10.1002/art.10143; Oka Y, 2012, J PHARMACOL SCI, V118, P55, DOI 10.1254/jphs.11082FP; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rajaiah R, 2011, J BIOL CHEM, V286, P2817, DOI 10.1074/jbc.M110.187013; Schett G, 2006, WIEN MED WOCHENSCHR, V156, P34, DOI 10.1007/s10354-005-0244-7; Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002; Shahrara S, 2005, ARTHRITIS RHEUM, V52, P1907, DOI 10.1002/art.21033; Shen CL, 2010, OSTEOPOROSIS INT, V21, P1841, DOI 10.1007/s00198-009-1122-8; Shen CL, 2011, J NUTR BIOCHEM, V22, P673, DOI 10.1016/j.jnutbio.2010.05.007; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Steiner G, 1999, RHEUMATOLOGY, V38, P202, DOI 10.1093/rheumatology/38.3.202; Strand V, 2004, RHEUMATOLOGY, V43, P10, DOI 10.1093/rheumatology/keh202; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tong L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2268; Tozawa K, 2011, INT J ONCOL, V39, P1117, DOI 10.3892/ijo.2011.1161; Venkatesha SH, 2011, J BIOL CHEM, V286, P15138, DOI 10.1074/jbc.M111.226365; Wu SH, 2004, J CHROMATOGR A, V1028, P171, DOI 10.1016/j.chroma.2003.11.072; Xu S., 2011, RHEUMATOL I IN PRESS; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yang YH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/642027; Yu H, 2011, ARTHRITIS RHEUM-US, V63, P981, DOI 10.1002/art.30219; Zhang F, 2010, CONNECT TISSUE RES, V51, P359, DOI 10.3109/03008200903456942; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379	63	73	75	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22216	22226		10.1074/jbc.M112.356816	http://dx.doi.org/10.1074/jbc.M112.356816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22549786	Green Published, hybrid			2022-12-28	WOS:000306418600060
J	Guengerich, F				Guengerich, Fred			Human Cytochrome P450s: The Work of Frederick Peter Guengerich	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									Vanderbilt Univ, Nashville, TN 37235 USA	Vanderbilt University	Guengerich, F (corresponding author), Vanderbilt Univ, Nashville, TN 37235 USA.								0	3	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15798	15800		10.1074/jbc.O112.000003	http://dx.doi.org/10.1074/jbc.O112.000003			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22563099	Green Published, hybrid			2022-12-28	WOS:000304006300057
J	Macauley, MS; Chan, J; Zandberg, WF; He, Y; Whitworth, GE; Stubbs, KA; Yuzwa, SA; Bennet, AJ; Varki, A; Davies, GJ; Vocadlo, DJ				Macauley, Matthew S.; Chan, Jefferson; Zandberg, Wesley F.; He, Yuan; Whitworth, Garrett E.; Stubbs, Keith A.; Yuzwa, Scott A.; Bennet, Andrew J.; Varki, Ajit; Davies, Gideon J.; Vocadlo, David J.			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups INTRACELLULAR beta-O-LINKED N-GLYCOLYLGLUCOSAMINE (GlcNGc), UDP-GlcNGc, AND THE BIOCHEMICAL AND STRUCTURAL RATIONALE FOR THE SUBSTRATE TOLERANCE OF beta-O-LINKED beta-N-ACETYLGLUCOSAMINIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC ACIDS; CAPILLARY-ELECTROPHORESIS; TETRATRICOPEPTIDE REPEATS; ASSISTED CATALYSIS; NUCLEOTIDE SUGARS; GLCNACASE; MECHANISM; PROTEIN; CELLS; GLYCOSYLATION	The O-GlcNAc modification involves the attachment of single beta-O-linked N-acetylglucosamine residues to serine and threonine residues of nucleocytoplasmic proteins. Interestingly, previous biochemical and structural studies have shown that O-GlcNAcase (OGA), the enzyme that removes O-GlcNAc from proteins, has an active site pocket that tolerates various N-acyl groups in addition to the N-acetyl group of GlcNAc. The remarkable sequence and structural conservation of residues comprising this pocket suggest functional importance. We hypothesized this pocket enables processing of metabolic variants of O-GlcNAc that could be formed due to inaccuracy within the metabolic machinery of the hexosamine biosynthetic pathway. In the accompanying paper (Bergfeld, A. K., Pearce, O. M., Diaz, S. L., Pham, T., and Varki, A. (2012) J. Biol. Chem. 287, 28865-28881), N-glycolylglucosamine (GlcNGc) was shown to be a catabolite of NeuNGc. Here, we show that the hexosamine salvage pathway can convert GlcNGc to UDP-GlcNGc, which is then used to modify proteins with O-GlcNGc. The kinetics of incorporation and removal of O-GlcNGc in cells occur in a dynamic manner on a time frame similar to that of O-GlcNAc. Enzymatic activity of O-GlcNAcase (OGA) toward a GlcNGc glycoside reveals OGA can process glycolyl-containing substrates fairly efficiently. A bacterial homolog (BtGH84) of OGA, from a human gut symbiont, also processes O-GlcNGc substrates, and the structure of this enzyme bound to a GlcNGc-derived species reveals the molecular basis for tolerance and binding of GlcNGc. Together, these results demonstrate that analogs of GlcNAc, such as GlcNGc, are metabolically viable species and that the conserved active site pocket of OGA likely evolved to enable processing of mis-incorporated analogs of O-GlcNAc and thereby prevent their accumulation. Such plasticity in carbohydrate processing enzymes may be a general feature arising from inaccuracy in hexosamine metabolic pathways.	[Macauley, Matthew S.; Chan, Jefferson; Zandberg, Wesley F.; Whitworth, Garrett E.; Bennet, Andrew J.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Yuzwa, Scott A.; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [He, Yuan; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Stubbs, Keith A.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia; [Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Simon Fraser University; Simon Fraser University; University of York - UK; University of Western Australia; University of California System; University of California San Diego; University of California System; University of California San Diego	Vocadlo, DJ (corresponding author), 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014; Davies, Gideon J/A-9042-2011; Stubbs, Keith/H-5909-2014; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; Davies, Gideon J/0000-0002-7343-776X; He, Yuan/0000-0002-1712-0776; Macauley, Matthew/0000-0003-4579-1048; Chan, Jefferson/0000-0003-4139-4379; Stubbs, Keith/0000-0001-6899-402X	National Institutes of Health [R01GM32373]; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; University of York; Australian Research Council; Biotechnology and Biological Sciences Research Council; Royal Society/Wolfson Research Merit Award; BBSRC [BB/F007124/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007124/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); University of York(European Commission); Australian Research Council(Australian Research Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society/Wolfson Research Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM32373 (to A. V.). This work was also supported by the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council of Canada (to D. J. V.).; Recipient of a senior scholarship from the Michael Smith Foundation for Health Research and Natural Sciences and Engineering Research Council of Canada.; Recipient of Ph.D. support from the Wild Fund of the University of York.; Recipient of support from the Australian Research Council.; Royal Society/Wolfson Research Merit Award recipient and supported by the Biotechnology and Biological Sciences Research Council.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUMANN W, 1989, BIOL CHEM H-S, V370, P141, DOI 10.1515/bchm3.1989.370.1.141; Bergfeld AK, 2012, J BIOL CHEM, V287, P28865, DOI 10.1074/jbc.M112.363549; Bergfeld AK, 2012, J BIOL CHEM, V287, P28898, DOI 10.1074/jbc.M112.363499; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boomkamp Stephanie D., 2008, V49, P441, DOI 10.1007/978-1-4020-8831-5_17; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; CHOU CF, 1992, J BIOL CHEM, V267, P3901; Cunha AC, 1999, J CHEM EDUC, V76, P79, DOI 10.1021/ed076p79; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DIAZ S, 1985, ANAL BIOCHEM, V150, P32, DOI 10.1016/0003-2697(85)90438-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng HT, 2008, J CHROMATOGR B, V870, P131, DOI 10.1016/j.jchromb.2008.05.038; FERNANDE.A, 1971, J BIOL CHEM, V246, P3485; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Greig IR, 2009, J AM CHEM SOC, V131, P13415, DOI 10.1021/ja904506u; Hart G., 2008, ESSENTIALS GLYCOBIOL; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; He Y, 2010, J AM CHEM SOC, V132, P1807, DOI 10.1021/ja9086769; KENT PW, 1968, BIOCHEM J, V106, P645, DOI 10.1042/bj1060645; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Lagarrigue M, 2008, J CHROMATOGR A, V1178, P239, DOI 10.1016/j.chroma.2007.11.024; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Martinez-Fleites C, 2010, BBA-GEN SUBJECTS, V1800, P122, DOI 10.1016/j.bbagen.2009.07.019; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Schauer R, 1996, BIOL CHEM H-S, V377, P293, DOI 10.1515/bchm3.1996.377.5.293; SINAY P, 1971, CARBOHYD RES, V16, P113, DOI 10.1016/S0008-6215(00)86104-2; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; VAMECQ J, 1990, BIOCHEM CELL BIOL, V68, P846, DOI 10.1139/o90-125; Varki A, 1996, GLYCOBIOLOGY, V6, P707, DOI 10.1093/glycob/6.7.707; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	57	16	16	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28882	28897		10.1074/jbc.M112.363721	http://dx.doi.org/10.1074/jbc.M112.363721			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692202	Green Published, hybrid			2022-12-28	WOS:000308074600059
J	Yin, KJ; Olsen, K; Hamblin, M; Zhang, JF; Schwendeman, SP; Chen, YE				Yin, Ke-Jie; Olsen, Karl; Hamblin, Milton; Zhang, Jifeng; Schwendeman, Steven P.; Chen, Y. Eugene			Vascular Endothelial Cell-specific MicroRNA-15a Inhibits Angiogenesis in Hindlimb Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PROSTATE-CANCER; IN-VITRO; VEGF; EXPRESSION; MIR-15A; DISEASE; TUMOR; TRANSLATION; MECHANISM	The effects and potential mechanisms of the vascular endothelial cell (EC)-enriched microRNA-15a (miR-15a) on angiogenesis remain unclear. Here, we show a novel finding that EC-selective miR-15a transgenic overexpression leads to reduced blood vessel formation and local blood flow perfusion in mouse hindlimbs at 1-3 weeks after hindlimb ischemia. Mechanistically, gain- or loss-of-miR-15a function by lentiviral infection in ECs significantly reduces or increases tube formation, cell migration, and cell differentiation, respectively. By FGF2 and VEGF 3'-UTR luciferase reporter assays, Real-time PCR, and immunoassays, we further identified that the miR-15a directly targets FGF2 and VEGF to facilitate its anti-angiogenic effects. Our data suggest that the miR-15a in ECs can significantly suppress cell-autonomous angiogenesis through direct inhibition of endogenous endothelial FGF2 and VEGF activities. Pharmacological modulation of miR-15a function may provide a new therapeutic strategy to intervene against angiogenesis in a variety of pathological conditions.	[Yin, Ke-Jie; Hamblin, Milton; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Olsen, Karl; Schwendeman, Steven P.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yin, KJ (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	kejie@umich.edu; echenum@umich.edu		Yin, Ke-Jie/0000-0002-7169-3858	National Institutes of Health [NS066652, HL089544, HL68345, T32 HL007853]; American Heart Association [0630209N, 0835237N, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853, R01HL089544, R01HL068345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS066652, HL089544 (to Y. E. C.), and HL68345 (to S. P. S.) and T32 HL007853 (to M. H.). This work was also supported by American Heart Association Grants 0630209N (to K.-J. Y.), 0835237N (to J. Z.), and 0840025N (to Y. E. C.).	Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Duan J, 2000, CIRCULATION, V102, P370; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hayashi T, 2006, CURR NEUROVASC RES, V3, P119, DOI 10.2174/156720206776875902; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Karaa ZS, 2009, RNA, V15, P249, DOI 10.1261/rna.1301109; Krupinski Jerzy, 1993, Patologia Polska, V44, P203; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Musumeci M, 2011, ONCOGENE, V30, P4231, DOI 10.1038/onc.2011.140; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Shiba Y, 2008, CURR PHARM DESIGN, V14, P371, DOI 10.2174/138161208783497741; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313; Yin KJ, 2011, ARTERIOSCL THROM VAS, V31, P574, DOI 10.1161/ATVBAHA.110.221267; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Yin KJ, 2002, STROKE, V33, P2471, DOI 10.1161/01.STR.0000030316.79601.03; Zhang CX, 2010, J CARDIOVASC TRANSL, V3, P235, DOI 10.1007/s12265-010-9164-z; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	47	107	111	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27055	27064		10.1074/jbc.M112.364414	http://dx.doi.org/10.1074/jbc.M112.364414			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22692216	hybrid, Green Published			2022-12-28	WOS:000307386000058
J	Nystrom, S; Mishra, R; Hornemann, S; Aguzzi, A; Nilsson, KPR; Hammarstrom, P				Nystrom, Sofie; Mishra, Rajesh; Hornemann, Simone; Aguzzi, Adriano; Nilsson, K. Peter R.; Hammarstrom, Per			Multiple Substitutions of Methionine 129 in Human Prion Protein Reveal Its Importance in the Amyloid Fibrillation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; THERMODYNAMIC STABILITY; DNA POLYMORPHISM; GENE; VARIANT; AGGREGATION; CONVERSION; GENOTYPE; KINETICS	The role of the polymorphism Met or Val in position 129 in the human prion protein is well documented regarding disease susceptibility and clinical manifestations. However, little is known about the molecular background to this phenomenon. We investigated herein the conformational stability, amyloid fibrillation kinetics, and seeding propensity of different 129 mutants, located in beta-strand 1 of PrP (Met(129) (WT), M129A, M129V, M129L, M129W, M129P, M129E, M129K, and M129C) in HuPrP(90-231). The mutations M129V, M129L, M129K, and M129C did not affect stability (midpoints of thermal denaturation, T-m = 65-66 degrees C), whereas the mutants M129A and M129E and the largest side chain M129W were destabilized by 3-4 degrees C. The most destabilizing substitution was M129P, which lowered the T-m by 7.2 degrees C. All mutants, except for M129C, formed amyloid-like fibrils within hours during fibril formation under near physiological conditions. Fibril-forming mutants showed a sigmoidal kinetic profile and showed shorter lag times during seeding with preformed amyloid fibrils implicating a nucleated polymerization reaction. In the spontaneous reactions, the lag time of fibril formation was rather uniform for the mutants M129A, M129V, and M129L resembling the wild type. When the substituted amino acid had a distinct feature discriminating it from the wild type, such as size (M129W), charge (M129E, M129K), or rotational constraint (M129P), the fibrillation was impeded. M129C did not form ThT/Congo red-positive fibrils, and non-reducing SDS-PAGE of M129C during fibrillation conditions at different time points revealed covalent dimer formation already 15 min after fibrillation reaction initiation. Position 129 appears to be a key site for dictating PrP receptiveness toward recruitment into the amyloid state.	[Nystrom, Sofie; Mishra, Rajesh; Nilsson, K. Peter R.; Hammarstrom, Per] Linkoping Univ, IFM Dept Chem, S-58183 Linkoping, Sweden; [Hornemann, Simone; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	Linkoping University; University of Zurich; University Zurich Hospital	Hammarstrom, P (corresponding author), Linkoping Univ, IFM Dept Chem, S-58183 Linkoping, Sweden.	perha@ifm.liu.se	Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708; Nystrom, Sofie/0000-0002-4303-4783	EU-FP7 Health Programme Project LUPAS; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Linkoping University Center for Neuroscience	EU-FP7 Health Programme Project LUPAS; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Linkoping University Center for Neuroscience	This work was supported by the EU-FP7 Health Programme Project LUPAS (to A. A., P. H., P. R. N., S. H., and S. N.), the Swedish Research Council (to P. H.), Knut and Alice Wallenberg Foundation (to P. H. and P. N.), The Swedish Foundation for Strategic Research (to P. H. and P. N.), and the Linkoping University Center for Neuroscience (to R. M.).	Almstedt K, 2009, PRION, V3, P224, DOI 10.4161/pri.3.4.10112; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Baskakov I, 2005, FEBS LETT, V579, P2589, DOI 10.1016/j.febslet.2005.03.075; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; DLOUHY SR, 1992, NAT GENET, V1, P64, DOI 10.1038/ng0492-64; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Gerber R, 2008, J MOL BIOL, V381, P212, DOI 10.1016/j.jmb.2008.05.057; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hainfellner JA, 1999, ANN NEUROL, V45, P812; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hosszu LLP, 2010, BIOCHEMISTRY-US, V49, P8729, DOI 10.1021/bi100572j; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kazlauskaite J, 2005, BIOCHEM BIOPH RES CO, V328, P292, DOI 10.1016/j.bbrc.2004.12.172; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Koh E, 2006, BIOINFORMATICS, V22, P297, DOI 10.1093/bioinformatics/bti775; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Lewis PA, 2006, J GEN VIROL, V87, P2443, DOI 10.1099/vir.0.81630-0; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Margalith I, 2012, J BIOL CHEM, V287, P18872, DOI 10.1074/jbc.M112.355958; Masel J, 2005, J MOL BIOL, V345, P1243, DOI 10.1016/j.jmb.2004.10.088; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; OWEN F, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Petraroli R, 1996, AM J HUM GENET, V58, P888; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; POULTER M, 1992, BRAIN, V115, P675, DOI 10.1093/brain/115.3.675; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Tahiri-Alaoui A, 2004, J BIOL CHEM, V279, P31390, DOI 10.1074/jbc.M401754200; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1	61	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25975	25984		10.1074/jbc.M112.372136	http://dx.doi.org/10.1074/jbc.M112.372136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22669942	Green Published, hybrid			2022-12-28	WOS:000306916300025
J	Yoshida, T; Yamashita, M; Hayashi, M				Yoshida, Tadashi; Yamashita, Maho; Hayashi, Matsuhiko			Kruppel-like Factor 4 Contributes to High Phosphate-induced Phenotypic Switching of Vascular Smooth Muscle Cells into Osteogenic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC KIDNEY-DISEASE; GENE-EXPRESSION; IN-VIVO; OXIDIZED PHOSPHOLIPIDS; DIFFERENTIATION MARKERS; TRANSCRIPTION FACTORS; HISTONE DEACETYLASES; MEDIA CALCIFICATION; DOWN-REGULATION; MYOCARDIN	Hyperphosphatemia in chronic kidney disease is highly associated with vascular calcification. Previous studies have shown that high phosphate-induced phenotypic switching of vascular smooth muscle cells (SMCs) into osteogenic cells plays an important role in the calcification process. In the present study, we determined whether Kruppel-like factor 4 (Klf4) and phosphorylated Elk-1, transcriptional repressors of SMC differentiation marker genes activated by intimal atherogenic stimuli, contributed to this process. Rat aortic SMCs were cultured in the medium with normal (0.9 mmol/liter) or high (4.5 mmol/liter) phosphate concentration. Results showed that high phosphate concentration induced SMC calcification. Moreover, high phosphate decreased expression of SMC differentiation marker genes including smooth muscle alpha-actin and SM22 alpha, whereas it increased expression of osteogenic genes, such as Runx2 and osteopontin. High phosphate also induced Klf4 expression, although it did not phosphorylate Elk-1. In response to high phosphate, Klf4 selectively bound to the promoter regions of SMC differentiation marker genes. Of importance, siRNA-mediated knockdown of Klf4 blunted high phosphate-induced suppression of SMC differentiation marker genes, as well as increases in expression of osteogenic genes and calcium deposition. Klf4 was also induced markedly in the calcified aorta of adenine-induced uremic rats. Results provide novel evidence that Klf4 mediates high phosphate-induced conversion of SMCs into osteogenic cells.	[Yoshida, Tadashi] Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Yoshida, T (corresponding author), Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tayoshida-npr@umin.ac.jp	Hayashi, Matsuhiko/J-4748-2013		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Ministry of Health Labour and Welfare; Takeda Science Foundation; Keio Gijuku Academic Development Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Keio Gijuku Academic Development Fund	This study was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. H.), a grant for Research on Measures for Intractable Diseases from Japanese Ministry of Health Labour and Welfare (to M. H.), Takeda Science Foundation (to T. Y.), and Keio Gijuku Academic Development Fund (to T. Y.).	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Moe SM, 2002, KIDNEY INT, V61, P638, DOI 10.1046/j.1523-1755.2002.00170.x; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Oyama Y, 2002, CIRC RES, V90, P348, DOI 10.1161/hh0302.105098; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2010, J BIOL CHEM, V285, P21175, DOI 10.1074/jbc.M110.112482; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhao MM, 2011, KIDNEY INT, V79, P1071, DOI 10.1038/ki.2011.18; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005	29	50	52	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25706	25714		10.1074/jbc.M112.361360	http://dx.doi.org/10.1074/jbc.M112.361360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22679022	Green Published, hybrid			2022-12-28	WOS:000306916300002
J	Homer, CR; Kabi, A; Marina-Garcia, N; Sreekumar, A; Nesvizhskii, AI; Nickerson, KP; Chinnaiyan, AM; Nunez, G; McDonald, C				Homer, Craig R.; Kabi, Amrita; Marina-Garcia, Noemi; Sreekumar, Arun; Nesvizhskii, Alexey I.; Nickerson, Kourtney P.; Chinnaiyan, Arul M.; Nunez, Gabriel; McDonald, Christine			A Dual Role for Receptor-interacting Protein Kinase 2 (RIP2) Kinase Activity in Nucleotide-binding Oligomerization Domain 2 (NOD2)-dependent Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENOME-WIDE ASSOCIATION; PHOSPHATASE 2A; CROHNS-DISEASE; COORDINATED REGULATION; SUSCEPTIBILITY LOCI; SIGNALING PATHWAYS; P38 MAPK; NOD2; ACTIVATION	Autophagy is triggered by the intracellular bacterial sensor NOD2 (nucleotide-binding, oligomerization domain 2) as an anti-bacterial response. Defects in autophagy have been implicated in Crohn's disease susceptibility. The molecular mechanisms of activation and regulation of this process by NOD2 are not well understood, with recent studies reporting conflicting requirements for RIP2 (receptor-interacting protein kinase 2) in autophagy induction. We examined the requirement of NOD2 signaling mediated by RIP2 for anti-bacterial autophagy induction and clearance of Salmonella typhimurium in the intestinal epithelial cell line HCT116. Our data demonstrate that NOD2 stimulates autophagy in a process dependent on RIP2 tyrosine kinase activity. Autophagy induction requires the activity of the mitogen-activated protein kinases MEKK4 and p38 but is independent of NF kappa B signaling. Activation of autophagy was inhibited by a PP2A phosphatase complex, which interacts with both NOD2 and RIP2. PP2A phosphatase activity inhibited NOD2-dependent autophagy but not activation of NF kappa B or p38. Upon stimulation of NOD2, the phosphatase activity of the PP2A complex is inhibited through tyrosine phosphorylation of the catalytic subunit in a process dependent on RIP2 activity. These findings demonstrate that RIP2 tyrosine kinase activity is not only required for NOD2-dependent autophagy but plays a dual role in this process. RIP2 both sends a positive autophagy signal through activation of p38 MAPK and relieves repression of autophagy mediated by the phosphatase PP2A.	[Homer, Craig R.; Kabi, Amrita; Nickerson, Kourtney P.; McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Marina-Garcia, Noemi; Nesvizhskii, Alexey I.; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun] Baylor Coll Med, Dept Mol & Cell Biol, Alkek Ctr Mol Discovery, Houston, TX 77030 USA; [Nickerson, Kourtney P.; McDonald, Christine] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44105 USA	Cleveland Clinic Foundation; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Baylor College of Medicine; Case Western Reserve University; Cleveland Clinic Foundation	McDonald, C (corresponding author), Cleveland Clin, Lerner Res Inst NC22, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcdonac2@ccf.org	Nesvizhskii, Alexey/A-5410-2012; Nuñez, Gabriel/A-7160-2014	Nesvizhskii, Alexey/0000-0002-2806-7819; McDonald, Christine/0000-0002-6745-9487; Marina, Noemi/0000-0003-0019-8072	National Institutes of Health [R01DK082437, R01DK61707]; Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Institutes of Health [UL1 RR024989]; NCRR; Crohn's & Colitis Foundation of America; Gerald and Nancy Goldberg; NATIONAL CANCER INSTITUTE [R01CA133458] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082437, R01DK061707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Institutes of Health; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Crohn's & Colitis Foundation of America; Gerald and Nancy Goldberg; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK082437 (to C. M.) and R01DK61707 (to G. N.) and Case Western Reserve University/Cleveland Clinic CTSA Grant UL1 RR024989 from the National Institutes of Health, NCRR. This work was also supported by a research grant from the Crohn's & Colitis Foundation of America (to C. M.). These studies were also supported in part by the generosity of Gerald and Nancy Goldberg.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Inohara N, 2000, J BIOL CHEM, V275, P27823; Islam Z, 2006, TOXICOL APPL PHARM, V213, P235, DOI 10.1016/j.taap.2005.11.001; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kabi A, 2012, INFLAMM BOWEL DIS, V18, P782, DOI 10.1002/ibd.21868; LEE J, 1993, J BIOL CHEM, V268, P19192; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Luo Y, 2011, EXP GERONTOL, V46, P860, DOI 10.1016/j.exger.2011.07.005; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ohama T, 2010, J BIOL CHEM, V285, P8711, DOI 10.1074/jbc.M109.099788; Park IH, 2008, IMMUNOPHARM IMMUNOT, V30, P837, DOI [10.1080/08923970802135732, 10.1080/08923970802135732 ]; Prickett TD, 2007, MOL CELL BIOL, V27, P4217, DOI 10.1128/MCB.00067-07; Qi ZF, 2011, NEUROCHEM INT, V59, P572, DOI 10.1016/j.neuint.2011.03.023; Richmond AL, 2012, GASTROENTEROLOGY, V142, P1483, DOI 10.1053/j.gastro.2012.02.040; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; Sundaresan P, 2002, FEBS LETT, V528, P139, DOI 10.1016/S0014-5793(02)03277-5; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008	46	61	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25565	25576		10.1074/jbc.M111.326835	http://dx.doi.org/10.1074/jbc.M111.326835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665475	Green Published, hybrid			2022-12-28	WOS:000306651700064
J	Mahawar, M; Atianand, MK; Dotson, RJ; Mora, V; Rabadi, SM; Metzger, DW; Huntley, JF; Harton, JA; Malik, M; Bakshi, CS				Mahawar, Manish; Atianand, Maninjay K.; Dotson, Rachel J.; Mora, Vanessa; Rabadi, Seham M.; Metzger, Dennis W.; Huntley, Jason F.; Harton, Jonathan A.; Malik, Meenakshi; Bakshi, Chandra Shekhar			Identification of a Novel Francisella tularensis Factor Required for Intramacrophage Survival and Subversion of Innate Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN-A; ESCHERICHIA-COLI K1; NF-KAPPA-B; MICROVASCULAR ENDOTHELIAL-CELLS; SCHU S4; SALMONELLA-ENTERICA; VACCINE STRAIN; LIVE VACCINE; HOST-CELLS; IV PILI	Francisella tularensis, the causative agent of tularemia, is one of the deadliest agents of biological warfare and bioterrorism. Extremely high virulence of this bacterium is associated with its ability to dampen or subvert host innate immune response. The objectives of this study were to identify factors and understand the mechanisms of host innate immune evasion by F. tularensis. We identified and explored the pathogenic role of a mutant interrupted at gene locus FTL_0325, which encodes an OmpA-like protein. Our results establish a pathogenic role of FTL_0325 and its ortholog FTT0831c in the virulent F. tularensis SchuS4 strain in intramacrophage survival and suppression of proinflammatory cytokine responses. This study provides mechanistic evidence that the suppressive effects on innate immune responses are due specifically to these proteins and that FTL_0325 and FTT0831c mediate immune subversion by interfering with NF-kappa B signaling. Furthermore, FTT0831c inhibits NF-kappa B activity primarily by preventing the nuclear translocation of p65 subunit. Collectively, this study reports a novel F. tularensis factor that is required for innate immune subversion caused by this deadly bacterium.	[Dotson, Rachel J.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Sch Arts & Sci, Albany, NY 12208 USA; [Mahawar, Manish; Atianand, Maninjay K.; Metzger, Dennis W.; Harton, Jonathan A.; Malik, Meenakshi; Bakshi, Chandra Shekhar] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Huntley, Jason F.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, Toledo, OH USA; [Mora, Vanessa; Rabadi, Seham M.; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	Albany College of Pharmacy & Health Sciences; Albany Medical College; University System of Ohio; University of Toledo; New York Medical College	Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Sch Arts & Sci, 106 New Scotland Ave, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu; Shekhar_Bakshi@nymc.edu	Atianand, Maninjay/AAF-7823-2019; Huntley, Jason F/N-3848-2015; Harton, Jonathan A/AAW-5283-2021; Harton, Jonathan/F-2848-2010; Metzger, Dennis W/I-2771-2019; Malik, Meenakshi/F-1501-2015	Atianand, Maninjay/0000-0003-4135-2515; Huntley, Jason F/0000-0002-0501-6103; Harton, Jonathan A/0000-0002-0350-1877; Harton, Jonathan/0000-0002-0350-1877; Metzger, Dennis W/0000-0002-8000-9907; Malik, Meenakshi/0000-0003-0051-4485	National Institutes of Health Grants [2P01AI056320, 1R21AI075250-01A2, 7R56AI090072-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R56AI090072, R21AI075250] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 2P01AI056320, 1R21AI075250-01A2 (to M. Malik), and 7R56AI090072-02 (to C.S.B.).	Alvarez JI, 2005, FRONT BIOSCI, V10, P582, DOI 10.2741/1554; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Chakraborty S, 2008, INFECT IMMUN, V76, P2852, DOI 10.1128/IAI.01726-07; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Dabo SM, 2003, MICROB PATHOGENESIS, V35, P147, DOI 10.1016/S0882-4010(03)00098-6; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; Gallagher-Smith Melissa, 2004, Clin Lab Sci, V17, P35; Gil H, 2004, INFECT IMMUN, V72, P3042, DOI 10.1128/IAI.72.5.3042-3047.2004; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Mahawar M, 2009, J BACTERIOL, V191, P4798, DOI 10.1128/JB.00212-09; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; March C, 2011, J BIOL CHEM, V286, P9956, DOI 10.1074/jbc.M110.181008; Marsh D, 2000, J MOL BIOL, V297, P803, DOI 10.1006/jmbi.2000.3557; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Mittal R, 2008, J IMMUNOL, V181, P2672, DOI 10.4049/jimmunol.181.4.2672; Mortensen BL, 2010, INFECT IMMUN, V78, P5022, DOI 10.1128/IAI.00544-10; Mukherjee S, 2008, METHOD ENZYMOL, V438, P343, DOI 10.1016/S0076-6879(07)38024-5; Nair MKM, 2009, FOODBORNE PATHOG DIS, V6, P495, DOI 10.1089/fpd.2008.0228; Nallaparaju KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018201; Nicholson TF, 2009, INFECT IMMUN, V77, P5245, DOI 10.1128/IAI.00670-09; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pavlova B, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-16; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Pierson T, 2011, J PROTEOME RES, V10, P954, DOI 10.1021/pr1009756; Platz GJ, 2010, INFECT IMMUN, V78, P1022, DOI 10.1128/IAI.00992-09; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Regueiro V, 2011, CELL MICROBIOL, V13, P135, DOI 10.1111/j.1462-5822.2010.01526.x; Reiterer V, 2011, CELL SIGNAL, V23, P1188, DOI 10.1016/j.cellsig.2011.03.006; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Sanapala S, 2012, INFECT IMMUN, V80, P2177, DOI 10.1128/IAI.00036-12; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Selvaraj SK, 2005, J LEUKOCYTE BIOL, V78, P544, DOI 10.1189/jlb.0904516; Serino L, 2007, MOL MICROBIOL, V64, P1391, DOI 10.1111/j.1365-2958.2007.05745.x; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Soundararajan V, 2011, INNATE IMMUN-LONDON, V17, P548, DOI 10.1177/1753425910377099; Starnino S, 2010, NEW MICROBIOL, V33, P167; Sukumaran SK, 2004, INFECT IMMUN, V72, P6012, DOI 10.1128/IAI.72.10.6012-6022.2004; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Tarnvik A, 2004, SCAND J INFECT DIS, V36, P350, DOI 10.1080/00365540410020442; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120	69	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25216	25229		10.1074/jbc.M112.367672	http://dx.doi.org/10.1074/jbc.M112.367672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654100	Green Published, hybrid			2022-12-28	WOS:000306651700031
J	Sato-Nishiuchi, R; Nakano, I; Ozawa, A; Sato, Y; Takeichi, M; Kiyozumi, D; Yamazaki, K; Yasunaga, T; Futaki, S; Sekiguchi, K				Sato-Nishiuchi, Ryoko; Nakano, Itsuko; Ozawa, Akio; Sato, Yuya; Takeichi, Makiko; Kiyozumi, Daiji; Yamazaki, Kiyoshi; Yasunaga, Teruo; Futaki, Sugiko; Sekiguchi, Kiyotoshi			Polydom/SVEP1 Is a Ligand for Integrin alpha 9 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; STRUCTURAL REQUIREMENTS; ALPHA-4-BETA-1 INTEGRIN; BINDING SPECIFICITIES; RECOGNITION SEQUENCE; GROWTH-FACTOR; EDA SEGMENT; III REPEAT; A-DOMAINS; FIBRONECTIN	A variety of proteins, including tenascin-C and osteopontin, have been identified as ligands for integrin alpha 9 beta 1. However, their affinities for integrin alpha 9 beta 1 are apparently much lower than those of other integrins (e.g. alpha 3 beta 1, alpha 5 beta 1, and alpha 8 beta 1) for their specific ligands, leaving the possibility that physiological ligands for integrin alpha 9 beta 1 still remain unidentified. In this study, we found that polydom (also named SVEP1) mediates cell adhesion in an integrin alpha 9 beta 1-dependent manner and binds directly to recombinant integrin alpha 9 beta 1 with an affinity that far exceeds those of the known ligands. Using a series of recombinant polydom proteins with N-terminal deletions, we mapped the integrin-binding site to the 21st complement control protein domain. Alanine-scanning mutagenesis revealed that the EDDMMEVPY sequence (amino acids 2636-2644) in the 21st complement control protein domain was involved in the binding to integrin alpha 9 beta 1 and that Glu(2641) was the critical acidic residue for the integrin binding. The importance of this sequence was further confirmed by integrin binding inhibition assays using synthetic peptides. Immunohistochemical analyses of mouse embryonic tissues showed that polydom colocalized with integrin alpha 9 in the stomach, intestine, and other organs. Furthermore, in situ integrin alpha 9 beta 1 binding assays using frozen mouse tissues showed that polydom accounts for most, but not all, of the integrin alpha 9 beta 1 ligands in tissues. Taken together, the present findings indicate that polydom is a hitherto unknown ligand for integrin alpha 9 beta 1 that functions as a physiological ligand in vivo.	[Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Yamazaki, Kiyoshi; Yasunaga, Teruo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp	Kiyozumi, Daiji/A-2112-2015	Kiyozumi, Daiji/0000-0003-3289-227X	New Energy and Industrial Technology Development Organization of Japan;  [22122006];  [06001294-0];  [10001843-0]	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); ; ; 	This study was supported in part by Grant-in-Aid for Scientific Research on Innovative Areas 22122006 and Research Contracts 06001294-0 and 10001843-0 with the New Energy and Industrial Technology Development Organization of Japan.	Bazan-Socha S, 2004, BIOCHEMISTRY-US, V43, P1639, DOI 10.1021/bi035853t; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; CLEMENTS JM, 1994, J CELL SCI, V107, P2127; COLOMBATTI A, 1985, J CELL BIOL, V100, P18, DOI 10.1083/jcb.100.1.18; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; EDMAN KAP, 1950, ACTA PHYSIOL SCAND, V21, P230, DOI 10.1111/j.1748-1716.1950.tb00731.x; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Gilges D, 2000, BIOCHEM J, V352, P49, DOI 10.1042/0264-6021:3520049; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Humphries MJ, 2002, ARTHRITIS RES THER, V4, pS69, DOI 10.1186/ar563; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Katayama M, 2003, CANCER RES, V63, P222; Kikkawa Y, 2000, J CELL SCI, V113, P869; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; Kozaki T, 2003, J BIOL CHEM, V278, P50546, DOI 10.1074/jbc.M307432200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Meredith JE, 1996, ENDOCR REV, V17, P207, DOI 10.1210/er.17.3.207; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Saini A, 1997, INT J CANCER, V73, P264, DOI 10.1002/(SICI)1097-0215(19971009)73:2<264::AID-IJC17>3.3.CO;2-V; Sato Y, 2009, J BIOL CHEM, V284, P14524, DOI 10.1074/jbc.M900200200; Schwarz RS, 2008, DEV COMP IMMUNOL, V32, P1192, DOI 10.1016/j.dci.2008.03.007; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P4359; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Shur I, 2006, J CELL PHYSIOL, V206, P420, DOI 10.1002/jcp.20497; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; STEPP MA, 1995, J HISTOCHEM CYTOCHEM, V43, P353, DOI 10.1177/43.4.7534781; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Verdone G, 2008, J BIOL CHEM, V283, P18947, DOI 10.1074/jbc.M801085200; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; WANG A, 1995, DEV DYNAM, V204, P421, DOI 10.1002/aja.1002040408; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	59	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25615	25630		10.1074/jbc.M112.355016	http://dx.doi.org/10.1074/jbc.M112.355016			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654117	hybrid, Green Published			2022-12-28	WOS:000306651700069
J	Thomas, RM; Sai, H; Wells, AD				Thomas, Rajan M.; Sai, Hong; Wells, Andrew D.			Conserved Intergenic Elements and DNA Methylation Cooperate to Regulate Transcription at the il17 Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROR-GAMMA-T; CELL-DIFFERENTIATION; GENE-EXPRESSION; CYTOKINE; LINEAGE; IL-23; STAT3; INFLAMMATION; PLASTICITY; RESPONSES	Naive CD4(+) T cells can differentiate into distinct lineages with unique immune functions. The cytokines TGF beta and IL-6 promote the development of Th17 cells that produce IL-17, an inflammatory cytokine not expressed by other T helper lineages. To further understand how IL-17 production is controlled, we studied an similar to 120-kb genomic region containing the murine il17a and il17f genes and seven evolutionarily conserved, intergenic noncoding sequences. We show that the +28-kb noncoding sequence cooperates with STAT3, ROR gamma t, and Runx1 to enhance transcription from both il17a and il17f promoters. This enhancer and both promoters exhibited Th17 lineage-specific DNA demethylation, accompanied by demethylation of lysine 27 of histone H3 (H3K27) and increased H3K4 methylation. Loss of DNA methylation tended to occur at STAT3 consensus elements, and we show that methylation of one of these elements in the il17a promoter directly inhibits STAT3 binding and transcriptional activity. These results demonstrate that TGF beta and IL-6 synergize to epigenetically poise the il17 loci for expression in Th17 cells, and suggest a general mechanism by which active STAT3 may be epigenetically excluded from STAT3-responsive genes in non-Th17 lineages.	Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Wells, AD (corresponding author), Abramson Res Ctr, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu	Thomas, Rajan M/AAW-7207-2021		National Institutes of Health [AI054643, AI070807]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054643, R56AI054643, R01AI070807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI054643 and AI070807 (to A. D. W.).	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Rowel E, 2008, CURR OPIN IMMUNOL, V20, P272, DOI 10.1016/j.coi.2008.03.012; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	28	54	55	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25049	25059		10.1074/jbc.M112.351916	http://dx.doi.org/10.1074/jbc.M112.351916			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665476	Green Published, hybrid			2022-12-28	WOS:000306651700018
J	Jez, J; Antes, B; Castilho, A; Kainer, M; Wiederkum, S; Grass, J; Ruker, F; Woisetschlager, M; Steinkellner, H				Jez, Jakub; Antes, Bernhard; Castilho, Alexandra; Kainer, Manuela; Wiederkum, Susanne; Grass, Josephine; Rueker, Florian; Woisetschlaeger, Max; Steinkellner, Herta			Significant Impact of Single N-Glycan Residues on the Biological Activity of Fc-based Antibody-like Fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; MONOCLONAL-ANTIBODIES; GAMMA-RIII; GLYCOSYLATION PATTERN; DEVELOPMENT TRENDS; CARBOHYDRATE; TRANSFECTION; EXPRESSION; VACCINES; RECEPTOR	Recent studies have demonstrated that IgG-Fc fragments (Fcabs) can be engineered to form antigen-binding sites with antibody properties. Thus they may serve as an attractive alternative to conventional antibodies in therapeutic applications. The critical influence of Fc glycosylation on effector functions of IgGs is well documented; however, whether this applies to Fcabs is not known. Here we used human cells, wild type, and glycoengineered plants to generate four different glycoforms of H10-03-6, an Fcab with engineered HER2/neu-binding sites. Plant-derived H10-03-6 differed in the presence/absence of single oligosaccharide residues, i.e., core fucose and xylose, and terminal galactose. All of the glycoforms had similar binding to HER2/neu expressed on human tumor cells. By contrast, glycoforms that lacked core oligosaccharide modifications (i.e., core alpha 1,3-fucose and beta 1,2-xylose) showed significantly enhanced binding to the Fc gamma receptor IIIa, irrespective of whether plant or human expression systems were used. Consistent with this finding, plant-derived H10-03-6 glycoforms lacking core N-glycan residues mediated higher antibody-dependent cellular cytotoxicity against human tumor cells. No alteration in gamma-receptor binding and antibody-dependent cellular cytotoxicity activity was observed upon decoration of N-glycans by terminal galactose. The results point to a significant impact of distinct N-glycan residues on effector functions of Fcabs. Moreover, the outcomes imply that the effector functions mediated by H10-03-6 can be optimized by altering the N-glycosylation profile. Biasing vaccine-induced immune responses toward optimal Fc glycosylation patterns could result in improved vaccine efficacy.	[Jez, Jakub; Castilho, Alexandra; Steinkellner, Herta] Univ Nat Resources & Life Sci BOKU Wien, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Grass, Josephine] Univ Nat Resources & Life Sci BOKU Wien, Dept Chem, A-1190 Vienna, Austria; [Rueker, Florian] Univ Nat Resources & Life Sci BOKU Wien, Dept Biotechnol, A-1190 Vienna, Austria; [Antes, Bernhard; Kainer, Manuela; Wiederkum, Susanne; Woisetschlaeger, Max] F Star Biotechnol Forsch, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Steinkellner, H (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	herta.steinkellner@boku.ac.at	Castilho, Alexandra/AAC-8927-2020; Steinkellner, Herta/N-4267-2016	Castilho, Alexandra/0000-0003-4114-7861; Steinkellner, Herta/0000-0003-4823-1505; Rueker, Florian/0000-0001-7639-2686; Jez, Jakub/0000-0002-6481-4383	Der Wissenschaftsfonds [FWF-TR]; Die Osterreichische Forschungsforderungs-Gesellschaft [L575-B13]; Laura Bassi Centres of Expertise [822757]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish	Der Wissenschaftsfonds(Austrian Science Fund (FWF)); Die Osterreichische Forschungsforderungs-Gesellschaft; Laura Bassi Centres of Expertise; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Der Wissenschaftsfonds Grant FWF-TR, Die Osterreichische Forschungsforderungs-Gesellschaft Grant L575-B13, and Laura Bassi Centres of Expertise Grant 822757.	Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Castilho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026040; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Loos A, 2011, PLANT PHYSIOL, V155, P2036, DOI 10.1104/pp.110.171330; Loos A, 2011, PLANT BIOTECHNOL J, V9, P179, DOI 10.1111/j.1467-7652.2010.00540.x; Lux A, 2011, ADV EXP MED BIOL, V780, P113, DOI 10.1007/978-1-4419-5632-3_10; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Whaley KJ, 2011, HUM VACCINES, V7, P349, DOI 10.4161/hv.7.3.14266; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Wurch T, 2008, CURR PHARM BIOTECHNO, V9, P502, DOI 10.2174/138920108786786385; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575	30	20	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24313	24319		10.1074/jbc.M112.360701	http://dx.doi.org/10.1074/jbc.M112.360701			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22589538	hybrid, Green Published			2022-12-28	WOS:000306651100025
J	Toda, M; Kuo, CH; Borman, SK; Richardson, RM; Inoko, A; Inagaki, M; Collins, A; Schneider, K; Ono, SJ				Toda, Masako; Kuo, Chuan-Hui; Borman, Satty K.; Richardson, Ricardo Micheler; Inoko, Akihito; Inagaki, Masaki; Collins, Andrea; Schneider, Klaus; Ono, Santa Jeremy			Evidence That Formation of Vimentin.Mitogen-activated Protein Kinase (MAPK) Complex Mediates Mast Cell Activation following Fc epsilon RI/CC Chemokine Receptor 1 Cross-talk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTERMEDIATE-FILAMENTS; HYPERSENSITIVITY REACTIONS; PHOSPHORYLATION SITES; POLYACRYLAMIDE-GELS; SIGNAL-TRANSDUCTION; I HYPERSENSITIVITY; TNF-ALPHA; IDENTIFICATION; RELEASE	Accumulating evidence points to cross-talk between Fc epsilon RI and CC chemokine receptor (CCR)-mediated signaling pathways in mast cells. Here, we propose that vimentin, a protein comprising type III intermediate filament, participates in such cross-talk for CCL2/monocyte chemotactic protein 1 (MCP-1) production in mast cells, which is a mechanism for allergic inflammation. Co-stimulation via Fc epsilon RI, using IgE/antigen, and CCR1, using recombinant CCL3/macrophage inflammatory protein-1 alpha (MIP-1 alpha), increased expression of phosphorylated, disassembled, and soluble vimentin in rat basophilic leukemia (RBL)-2H3 cells expressing human CCR1 (RBL-CCR1 cells) and bone marrow-derived murine mast cells, both models of mucosal type mast cells. Furthermore, co-stimulation enhanced production of CCL2 as well as phosphorylation of MAPK. Treating the cells with p38 MAPK inhibitor SB203580, but not with MEK inhibitor PD98058, reduced CCL2 production, suggesting that p38 MAPK, but not ERK1/2, plays a critical role in the chemokine production. Immunoprecipitation analysis showed that vimentin interacts with phosphorylated ERK1/2 and p38 MAPKs in the co-simulated cells. Preventing disassembly of the vimentin by aggregating vimentin filaments using beta,beta'-imino-dipropionitrile reduced the interaction of vimentin with phosphorylated MAPKs as well as CCL2 production in the cells. Taken together, disassembled vimentin interacting with phosphorylated p38 MAPK could mediate CCL2 production in mast cells upon Fc epsilon RI and CCR1 activation.	[Toda, Masako; Kuo, Chuan-Hui; Collins, Andrea; Ono, Santa Jeremy] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45221 USA; [Ono, Santa Jeremy] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Borman, Satty K.; Schneider, Klaus] GlaxoSmithKline Res & Dev Ltd, Dept Computat & Struct Chem, Stevenage SG1 2NY, Herts, England; [Richardson, Ricardo Micheler] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Inoko, Akihito; Inagaki, Masaki] Aichi Canc Ctr Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; GlaxoSmithKline; University of North Carolina; North Carolina Central University; Aichi Cancer Center	Toda, M (corresponding author), Paul Ehrlich Inst, Jr Res Grp Expt Allergol 1, Paul Ehrlich Str 59, D-63225 Langen, Germany.	Masako.Toda@pei.de; onosa@ucmail.uc.edu	Inagaki, Masaki/B-9920-2016; Schneider, Klaus/N-6604-2014; Toda, Masako/S-9810-2019	Schneider, Klaus/0000-0002-3068-8681; Inoko, Akihito/0000-0002-6739-2948	National Institutes of Health (NIH) [R01-EY-019630-01]; NIH, NIAID [AI-38910]; GlaxoSmithKline Pharmaceutical PLC.; NATIONAL EYE INSTITUTE [R01EY019630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038910, R01AI038910] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline Pharmaceutical PLC.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01-EY-019630-01 and NIH, NIAID, Grant AI-38910. This work was also supported by GlaxoSmithKline Pharmaceutical PLC.	Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; Aye CC, 2012, EXP MOL PATHOL, V92, P267, DOI 10.1016/j.yexmp.2012.02.002; Beer F, 2007, IMMUNOL REV, V217, P96, DOI 10.1111/j.1600-065X.2007.00521.x; Campbell EM, 1999, J IMMUNOL, V163, P2160; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chou YH, 1996, J CELL SCI, V109, P817; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Fifadara NH, 2009, INT IMMUNOL, V21, P991, DOI 10.1093/intimm/dxp066; Gaga M, 2008, ALLERGY, V63, P703, DOI 10.1111/j.1398-9995.2007.01578.x; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Holgate ST, 1997, AM J RESP CRIT CARE, V156, P1377, DOI 10.1164/ajrccm.156.5.9610064; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; IZUSHI K, 1992, IMMUNOPHARMACOLOGY, V23, P153; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; McDonald JR, 2011, RECENT PATENTS INFLA, V5, P1, DOI 10.2174/187221311794474829; Miyazaki D, 2005, J CLIN INVEST, V115, P434, DOI 10.1172/JCI200518452; Nahm DH, 2003, BIOCHEM BIOPH RES CO, V310, P202, DOI 10.1016/j.bbrc.2003.08.132; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Ono SJ, 2003, J ALLERGY CLIN IMMUN, V111, P1185, DOI 10.1067/mai.2003.1594; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Richardson RM, 2000, J BIOL CHEM, V275, P9201, DOI 10.1074/jbc.275.13.9201; SAHARA N, 1990, J HISTOCHEM CYTOCHEM, V38, P975, DOI 10.1177/38.7.1693935; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; SOUSA AR, 1994, AM J RESP CELL MOL, V10, P142, DOI 10.1165/ajrcmb.10.2.8110469; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Teshima R, 2000, INT ARCH ALLERGY IMM, V121, P34, DOI 10.1159/000024295; Toda M, 2004, J BIOL CHEM, V279, P48443, DOI 10.1074/jbc.M408725200; Toda Masako, 2007, Expert Rev Clin Immunol, V3, P351, DOI 10.1586/1744666X.3.3.351; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Valgeirsdottir S, 1998, J CELL SCI, V111, P1973; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wong CK, 2006, ALLERGY, V61, P289, DOI 10.1111/j.1398-9995.2006.00972.x; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407	45	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24516	24524		10.1074/jbc.M111.319624	http://dx.doi.org/10.1074/jbc.M111.319624			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613718	hybrid, Green Published			2022-12-28	WOS:000306651100044
J	Inubushi, T; Kawazoe, A; Miyauchi, M; Kudo, Y; Ao, M; Ishikado, A; Makino, T; Takata, T				Inubushi, Toshihiro; Kawazoe, Aki; Miyauchi, Mutsumi; Kudo, Yasusei; Ao, Min; Ishikado, Atsushi; Makino, Taketoshi; Takata, Takashi			Molecular Mechanisms of the Inhibitory Effects of Bovine Lactoferrin on Lipopolysaccharide-mediated Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR RECEPTOR; BINDING PROTEIN; SPLICE VARIANT; IN-VIVO; ACTIVATION; INTERLEUKIN-1; DIFFERENTIATION; INFLAMMATION; EXPRESSION	Lactoferrin (LF) is an important modulator of the immune response and inflammation. It has also been implicated in the regulation of bone tissue. In our previous study we demonstrated that bovine LF (bLF) reduces LPS-induced bone resorption through a reduction of TNF-alpha production in vivo. However, it was not known how bLF inhibits LPS-mediated TNF-alpha and RANKL (receptor activator of nuclear factor kappa B ligand) production in osteoblasts. In this study we show that bLF impairs LPS-mediated TNF-alpha and RANKL production. bLF inhibited LPS-mediated osteoclastogenesis via osteoblasts in a co-culture system. Furthermore, bLF pretreatment inhibited LPS-induced NF kappa B DNA binding activity as well as I kappa B alpha and IKK beta (I kappa B kinase beta) phosphorylation. MAP kinase activation was also inhibited by bLF pretreatment. However, bLF pretreatment failed to block the degradation of IRAK1 (interleukin-1 receptor-associated kinase 1), which is an essential event after its activation. Remarkably, we found that bLF pretreatment inhibited LPS-mediated Lys-63-linked polyubiquitination of TNF receptor-associated factor 6 (TRAF6). We also found that bLF is mainly endocytosed through LRP1 (lipoprotein receptor-related protein-1) and intracellular distributed bLF binds to endogenous TRAF6. In addition, bLF inhibited IL-1 beta- and flagellin-induced TRAF6-dependent activation of the NF kappa B signaling pathway. Collectively, our findings demonstrate that bLF inhibits NF kappa B and MAP kinase activation, which play critical roles in chronic inflammatory disease by interfering with the TRAF6 polyubiquitination process. Thus, bLF could be a potent therapeutic agent for inflammatory diseases associated with bone destruction, such as periodontitis and rheumatoid arthritis.	[Miyauchi, Mutsumi; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Minami Ku, Hiroshima 7348553, Japan; [Kawazoe, Aki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthodont & Craniofacial Dev Biol, Hiroshima 7348553, Japan; [Ao, Min] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pediat Dent, Hiroshima 7348553, Japan; [Ishikado, Atsushi; Makino, Taketoshi] Sunstar, Hlth Care R&D Div, Osaka 5691195, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Miyauchi, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	mmiya@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp		Kudo, Yasusei/0000-0002-0392-7720				Agunod M., 1969, AM J DIG DIS, V14, P401; Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Boabaid F, 2004, J PERIODONTOL, V75, P1247, DOI 10.1902/jop.2004.75.9.1247; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BRINES RD, 1983, BIOCHIM BIOPHYS ACTA, V759, P229, DOI 10.1016/0304-4165(83)90317-3; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Elass-Rochard E, 1998, INFECT IMMUN, V66, P486, DOI 10.1128/IAI.66.2.486-491.1998; Guillen C, 2000, ARTHRITIS RHEUM, V43, P2073, DOI 10.1002/1529-0131(200009)43:9<2073::AID-ANR19>3.0.CO;2-U; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Jensen LE, 2001, J BIOL CHEM, V276, P29037, DOI 10.1074/jbc.M103815200; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; MACHNICKI M, 1993, INT J EXP PATHOL, V74, P433; Qi GY, 2010, ORAL ONCOL, V46, P263, DOI 10.1016/j.oraloncology.2010.01.004; Rao N, 2005, MOL CELL BIOL, V25, P6521, DOI 10.1128/MCB.25.15.6521-6532.2005; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Song JJ, 2008, ACTA OTO-LARYNGOL, V128, P1303, DOI 10.1080/00016480801947082; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wilson M, 1996, J PERIODONTAL RES, V31, P393, DOI 10.1111/j.1600-0765.1996.tb00508.x; Yamano E, 2010, LAB INVEST, V90, P1236, DOI 10.1038/labinvest.2010.80	38	41	47	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23527	23536		10.1074/jbc.M111.324673	http://dx.doi.org/10.1074/jbc.M111.324673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593578	Green Published, hybrid			2022-12-28	WOS:000306511300024
J	Kuong, KJ; Kuzminov, A				Kuong, Kawai J.; Kuzminov, Andrei			Disintegration of Nascent Replication Bubbles during Thymine Starvation Triggers RecA- and RecBCD-dependent Replication Origin Destruction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHROMOSOMAL FRAGMENTATION; DEFICIENT MUTANTS; DNA-REPLICATION; DEATH; REPAIR; URACIL; INACTIVATION; MECHANISM; DUTPASE	Thymineless death strikes cells unable to synthesize DNA precursor dTTP, with the nature of chromosomal damage still unclear. Thymine starvation stalls replication forks, whereas accumulating evidence indicates the replication origin is also affected. Using a novel DNA labeling technique, here we show that replication slowly continues in thymine-starved cells, but the newly synthesized DNA becomes fragmented and degraded. This degradation apparently releases enough thymine to sustain initiation of new replication bubbles from the chromosomal origin, which destabilizes the origin in a RecA-dependent manner. Marker frequency analysis with gene arrays 1) reveals destruction of the origin-centered chromosomal segment in RecA(+) cells; 2) confirms origin accumulation in the recA mutants; and 3) identifies the sites around the origin where destruction initiates in the recBCD mutants. We propose that thymineless cells convert persistent single-strand gaps behind replication forks into double-strand breaks, using the released thymine for new initiations, whereas subsequent disintegration of small replication bubbles causes replication origin destruction.	[Kuong, Kawai J.; Kuzminov, Andrei] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kuzminov, A (corresponding author), B103 C&LSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	kuzminov@life.illinois.edu			National Institutes of Health Grant [GM 073115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073115] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 073115.	AHMAD SI, 1980, Z NATURFORSCH C, V35, P279; Ahmad SI, 1998, ANNU REV MICROBIOL, V52, P591, DOI 10.1146/annurev.micro.52.1.591; BREITMAN TR, 1972, J BACTERIOL, V112, P646, DOI 10.1128/JB.112.1.646-648.1972; Chernyshev A, 2007, APPL MICROBIOL BIOT, V74, P282, DOI 10.1007/s00253-006-0763-1; CLARK AJ, 1966, J MOL BIOL, V19, P442, DOI 10.1016/S0022-2836(66)80015-3; COHEN SS, 1971, ANN NY ACAD SCI, V186, P292; CUMMINGS DJ, 1967, J BACTERIOL, V93, P1917, DOI 10.1128/JB.93.6.1917-1924.1967; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DRLICA K, 1980, P NATL ACAD SCI-BIOL, V77, P6879, DOI 10.1073/pnas.77.11.6879; Duggin IG, 2008, P NATL ACAD SCI USA, V105, P16737, DOI 10.1073/pnas.0806414105; Fonville NC, 2011, GENETICS, V189, P23, DOI 10.1534/genetics.111.130161; Fonville NC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000865; GALLANT J, 1961, J BACTERIOL, V82, P187, DOI 10.1128/JB.82.2.187-194.1961; Guarino E, 2007, J BACTERIOL, V189, P5782, DOI 10.1128/JB.00411-07; INOUYE M, 1971, J BACTERIOL, V106, P539, DOI 10.1128/JB.106.2.539-542.1971; Khan SR, 2012, J BIOL CHEM, V287, P6250, DOI 10.1074/jbc.M111.322990; KHIDHIR MA, 1985, MOL GEN GENET, V199, P133, DOI 10.1007/BF00327522; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Kouzminova EA, 2006, J MOL BIOL, V355, P20, DOI 10.1016/j.jmb.2005.10.044; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Kouzminova EA, 2008, MOL MICROBIOL, V68, P202, DOI 10.1111/j.1365-2958.2008.06149.x; Kouzminova EA, 2012, MOL MICROBIOL, V84, P1079, DOI 10.1111/j.1365-2958.2012.08076.x; KUNZ BA, 1982, MUTAT RES, V93, P353, DOI 10.1016/0027-5107(82)90150-6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kuong KJ, 2010, GENES CELLS, V15, P619, DOI 10.1111/j.1365-2443.2010.01405.x; Kuong KJ, 2009, J MOL BIOL, V390, P845, DOI 10.1016/j.jmb.2009.05.038; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov Andrei, 2005, P349; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; Martin CM, 2011, DNA REPAIR, V10, P94, DOI 10.1016/j.dnarep.2010.10.005; Miranda A, 2003, GENETICS, V163, P1255; Morganroth PA, 2006, J BACTERIOL, V188, P5286, DOI 10.1128/JB.00543-06; MUKHERJEE P, 1971, MUTAT RES, V12, P341, DOI 10.1016/0027-5107(71)90084-4; Nakayama H, 2005, MUTAT RES-FUND MOL M, V577, P228, DOI 10.1016/j.mrfmmm.2005.02.015; NAKAYAMA H, 1982, CAN J MICROBIOL, V28, P425, DOI 10.1139/m82-064; NAKAYAMA K, 1994, J MOL BIOL, V243, P611, DOI 10.1016/0022-2836(94)90036-1; NAKAYAMA K, 1988, CAN J MICROBIOL, V34, P905, DOI 10.1139/m88-157; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PRITCHARD RH, 1964, J MOL BIOL, V9, P288, DOI 10.1016/S0022-2836(64)80208-4; RAMAREDDY G, 1970, J MOL BIOL, V50, P525, DOI 10.1016/0022-2836(70)90209-3; Regamey A, 2000, MOL MICROBIOL, V38, P423, DOI 10.1046/j.1365-2958.2000.02130.x; REITER H, 1970, J MOL BIOL, V50, P533, DOI 10.1016/0022-2836(70)90210-X; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Sangurdekar DP, 2010, MOL MICROBIOL, V75, P1455, DOI 10.1111/j.1365-2958.2010.07072.x; Seno T, 1985, Basic Life Sci, V31, P241; SHARMA RC, 1987, J BACTERIOL, V169, P4559, DOI 10.1128/jb.169.10.4559-4564.1987; SILVERSTEIN JL, 1976, VIROLOGY, V72, P212, DOI 10.1016/0042-6822(76)90324-X; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Van Triest B, 1999, ONCOLOGY-BASEL, V57, P179, DOI 10.1159/000012030; WACHSMAN JT, 1964, J BACTERIOL, V87, P1079, DOI 10.1128/JB.87.5.1079-1086.1964; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104; ZALKIN H, 1996, ESCHERICHIA COLI SAL, P561	53	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23958	23970		10.1074/jbc.M112.359687	http://dx.doi.org/10.1074/jbc.M112.359687			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22621921	Green Published, hybrid			2022-12-28	WOS:000306511300065
J	Lang, I; Fick, A; Schafer, V; Giner, T; Siegmund, D; Wajant, H				Lang, Isabell; Fick, Andrea; Schaefer, Viktoria; Giner, Tina; Siegmund, Daniela; Wajant, Harald			Signaling Active CD95 Receptor Molecules Trigger Co-translocation of Inactive CD95 Molecules into Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FAS-MEDIATED APOPTOSIS; DEATH RECEPTOR; CELL-DEATH; DOWN-REGULATION; TYROSINE PHOSPHORYLATION; RESTRICTED ACTIVATION; COMPLEX-FORMATION; GAMMA-INTERFERON; FAMILY-MEMBERS	The capability of soluble CD95L trimers to trigger CD95-associated signaling pathways is drastically increased by oligomerization. The latter can be achieved, for example, by antibodies recognizing a N-terminal epitope tag in recombinant CD95L variants or by genetic engineering-enforced formation of hexamers. Using highly sensitive and accurate binding studies with recombinant CD95L variants equipped with a Gaussia princeps luciferase reporter domain, we found that oligomerization of CD95L has no major effect on CD95 occupancy. This indicates that the higher activity of oligomerized CD95L trimers is not related to an avidity-related increase in apparent affinity and points instead to a crucial role of aggregation of initially formed trimeric CD95L-CD95 complexes in CD95 activation. Furthermore, binding of soluble CD95L trimers was found to be insufficient to increase the association of CD95 with the lipid raft-containing membrane fraction. However, when Gaussia princeps luciferase-CD95L trimers were used as tracers to "mark" inactive CD95 molecules, increased association of these inactive receptors was observed upon activation of the remaining CD95 molecules by help of highly active hexameric Fc-CD95L or membrane CD95L. Moreover, in cells expressing endogenous CD95 and chimeric CD40-CD95 receptors, triggering of CD95 signaling via endogenous CD95 resulted in co-translocation of CD40-CD95 to the lipid raft fraction, whereas vice versa activation of CD95-associated pathways with Fc-CD40L via CD40-CD95 resulted in co-translocation of endogenous CD95. In sum, this shows that signaling-active CD95 molecules not only enhance their own association with the lipid raft-containing membrane fraction but also those of inactive CD95 molecules.	[Lang, Isabell; Fick, Andrea; Schaefer, Viktoria; Siegmund, Daniela; Wajant, Harald] Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, D-97070 Wurzburg, Germany; [Giner, Tina] Univ Hosp Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Wajant, H (corresponding author), Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, Rontgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949; Lang, Isabell/0000-0002-6369-4973	Deutsche Forschungsgemeinschaft [DFG Wa 1025/21-1, SFB 487, TP B7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG Wa 1025/21-1 and SFB 487, TP B7.	AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336; BAGLIONI C, 1985, J BIOL CHEM, V260, P3395; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bremer E, 2006, BLOOD, V107, P2863, DOI 10.1182/blood-2005-07-2929; Bremer E, 2008, CANCER RES, V68, P597, DOI 10.1158/0008-5472.CAN-07-5171; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Fulda S, 2000, CANCER RES, V60, P3947; Fumarola C, 2001, CELL DEATH DIFFER, V8, P1004, DOI 10.1038/sj.cdd.4400902; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2001, BIOCHEM BIOPH RES CO, V284, P1016, DOI 10.1006/bbrc.2001.5045; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; HAAKE AR, 1995, CELL DEATH DIFFER, V2, P183; Hao ZY, 2010, J MOL CELL BIOL, V2, P63, DOI 10.1093/jmcb/mjp034; Henkler F, 2005, J CELL BIOL, V168, P1087, DOI 10.1083/jcb.200501048; Herrero R, 2011, J CLIN INVEST, V121, P1174, DOI 10.1172/JCI43004; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imanishi T, 2000, J VASC RES, V37, P523, DOI 10.1159/000054085; Janssen O, 1996, IMMUNOL LETT, V49, P63, DOI 10.1016/0165-2478(95)02482-4; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Rossin A, 2010, EXP CELL RES, V316, P1513, DOI 10.1016/j.yexcr.2010.03.002; Samel D, 2003, J BIOL CHEM, V278, P32077, DOI 10.1074/jbc.M304866200; Sancho-Martinez I, 2009, CELL CYCLE, V8, P838, DOI 10.4161/cc.8.6.7906; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Siegmund D, 2002, MOL MED, V8, P725, DOI 10.1007/BF03402036; Siegmund D, 2005, MOL CELL BIOL, V25, P6363, DOI 10.1128/MCB.25.15.6363-6379.2005; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tauzin S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001090; Wajant H, 2003, CYTOKINE GROWTH F R, V14, P53, DOI 10.1016/S1359-6101(02)00072-2; Wajant H., 2011, CANC LETT IN PRESS; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597	64	21	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24026	24042		10.1074/jbc.M111.328211	http://dx.doi.org/10.1074/jbc.M111.328211			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645131	hybrid, Green Published			2022-12-28	WOS:000306511300071
J	Pan, YW; Zou, JH; Wang, WB; Sakagami, H; Garelick, MG; Abel, G; Kuo, CT; Storm, DR; Xia, ZG				Pan, Yung-Wei; Zou, Junhui; Wang, Wenbin; Sakagami, Hiroyuki; Garelick, Michael G.; Abel, Glen; Kuo, Chay T.; Storm, Daniel R.; Xia, Zhengui			Inducible and Conditional Deletion of Extracellular Signal-regulated Kinase 5 Disrupts Adult Hippocampal Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; DENTATE GYRUS; NEUROTROPHIC FACTOR; STEM-CELL; ANTIDEPRESSANT TREATMENT; TARGETED DELETION; CORTICAL-NEURONS; RAT HIPPOCAMPUS	Recent studies have led to the exciting idea that adult-born neurons in the dentate gyrus of the hippocampus may play a role in hippocampus-dependent memory formation. However, signaling mechanisms that regulate adult hippocampal neurogenesis are not well defined. Here we report that extracellular signal-regulated kinase 5 (ERK5), a member of the mitogen-activated protein kinase family, is selectively expressed in the neurogenic regions of the adult mouse brain. We present evidence that shRNA suppression of ERK5 in adult hippocampal neural stem/progenitor cells (aNPCs) reduces the number of neurons while increasing the number of cells expressing markers for stem/progenitor cells or proliferation. Furthermore, shERK5 attenuates both transcription and neuronal differentiation mediated by Neurogenin 2, a transcription factor expressed in adult hippocampal neural progenitor cells. By contrast, ectopic activation of endogenous ERK5 signaling via expression of constitutive active MEK5, an upstream activating kinase for ERK5, promotes neurogenesis in cultured aNPCs and in the dentate gyrus of the mouse brain. Moreover, neurotrophins including NT3 activate ERK5 and stimulate neuronal differentiation in aNPCs in an ERK5-dependent manner. Finally, inducible and conditional deletion of ERK5 specifically in the neurogenic regions of the adult mouse brain delays the normal progression of neuronal differentiation and attenuates adult neurogenesis in vivo. These data suggest ERK5 signaling as a critical regulator of adult hippocampal neurogenesis.	[Zou, Junhui; Wang, Wenbin; Abel, Glen; Xia, Zhengui] Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Seattle, WA 98195 USA; [Pan, Yung-Wei; Xia, Zhengui] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Garelick, Michael G.; Storm, Daniel R.; Xia, Zhengui] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sakagami, Hiroyuki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2288555, Japan; [Kuo, Chay T.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Kuo, Chay T.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kitasato University; Duke University; Duke University	Xia, ZG (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Box 357234, Seattle, WA 98195 USA.	zxia@u.washington.edu			National Institutes of Health [AG19193, NS20498, T32HD007183, F31DC011216]; NICHD [P30 HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183, P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, R01NS078192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants AG19193 (to Z. X.), NS20498 (to D. R. S.), T32HD007183 and F31DC011216 (to Y. W. P) and Grant P30 HD02274 from the NICHD.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; Athos J., 2001, CURR PROTOCOLS NEURO; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bruel-Jungerman E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007901; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Cundiff P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005204; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Di Benedetto B, 2007, J COMP NEUROL, V500, P542, DOI 10.1002/cne.21186; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu LD, 2006, P NATL ACAD SCI USA, V103, P9697, DOI 10.1073/pnas.0603373103; Ma DK, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-16; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ozen I, 2007, EUR J NEUROSCI, V25, P2591, DOI 10.1111/j.1460-9568.2007.05541.x; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Russo-Neustadt AA, 2004, NEUROPSYCHOPHARMACOL, V29, P2189, DOI 10.1038/sj.npp.1300514; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005; Wang YP, 2006, J BIOL CHEM, V281, P35965, DOI 10.1074/jbc.M605503200; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	67	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23306	23317		10.1074/jbc.M112.344762	http://dx.doi.org/10.1074/jbc.M112.344762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22645146	Green Published, hybrid			2022-12-28	WOS:000306511300005
J	Chen, G; Ghosh, P; O'Farrell, T; Munk, R; Rezanka, LJ; Sasaki, CY; Longo, DL				Chen, Gang; Ghosh, Paritosh; O'Farrell, Thomas; Munk, Rachel; Rezanka, Louis J.; Sasaki, Carl Y.; Longo, Dan L.			Transforming Growth Factor beta 1 (TGF-beta 1) Suppresses Growth of B-cell Lymphoma Cells by p14(ARF)-dependent Regulation of Mutant p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARF TUMOR-SUPPRESSOR; FUNCTION PHENOTYPE; GENE-EXPRESSION; CYCLE ARREST; WILD-TYPE; IN-VIVO; GAIN; P19(ARF); MDM2; PROTEINS	Previously we reported that TGF-beta 1-induced growth suppression was associated with a decrease in mutant p53 levels in B-cell lymphoma cells. The goal of the present study was to understand the mechanism involved in TGF-beta 1-mediated down-regulation of mutant p53. In RL and CA46, two B-cell lymphoma cell lines, TGF-beta 1 treatment caused down-regulation of E2F-1 transcription factor resulting in the down-regulation of both p14(ARF) and mutant p53, leading to growth arrest. Experimental overexpression of E2F-1 increased p14(ARF) level and blocked TGF-beta 1-induced down-regulation of p14(ARF). Overexpression of p14(ARF) blocked the down-regulation of mutant p53 and prevented growth arrest. p14(ARF) also attenuated TGF-beta 1-induced p21(Cip1/WAF1) induction, which was reversible by p53 siRNA, indicating the involvement of mutant p53 in controlling the TGF-beta 1-induced expression of p21(Cip1/WAF1). The interaction observed between phospho-Smad2 and mutant p53 in the nucleus could be the mechanism responsible for blocking the growth-suppressive effects of TGF-beta 1. In RL cells, p14(ARF) is present in a trimer consisting of mutant p53-Mdm2-p14(ARF) and in a dimer consisting of Mdm2-p14(ARF). Because it is known that Mdm2 can degrade p53, it is possible that, in its trimeric form, p14(ARF) is able to stabilize mutant p53 by inhibiting Mdm2. In its dimeric form, p14(ARF) may be sequestering Mdm2, limiting its ability to degrade p53. Collectively, these data demonstrate a unique mechanism in which the inhibition of TGF-beta 1-mediated growth suppression by mutant p53 can be reversed by the down-regulation of its stabilizing protein p14(ARF). This work suggests that the high levels of p14(ARF) often found in tumor cells could be a potential therapeutic target.	[Ghosh, Paritosh] NIA, Lymphocyte Cell Biol Unit, Lab Mol Biol & Immunol, Biomed Res Ctr,Intramural Res Program,NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ghosh, P (corresponding author), NIA, Lymphocyte Cell Biol Unit, Lab Mol Biol & Immunol, Biomed Res Ctr,Intramural Res Program,NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	ghoshp@grc.nia.nih.gov	Longo, Dan L./F-6022-2011		NIA, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZIAAG000166] Funding Source: NIH RePORTER	NIA, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the NIA, National Institutes of Health Intramural Research Program.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; BECKWITH M, 1995, BLOOD, V85, P2461, DOI 10.1182/blood.V85.9.2461.bloodjournal8592461; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Cardinali M, 1997, MOL CARCINOGEN, V18, P78, DOI 10.1002/(SICI)1098-2744(199702)18:2<78::AID-MC3>3.0.CO;2-M; Chen G, 2007, BLOOD, V109, P5301, DOI 10.1182/blood-2006-06-032128; Chen G, 2011, MOL CANCER RES, V9, P78, DOI 10.1158/1541-7786.MCR-10-0216; CHEN YM, 1994, MOL CELL BIOL, V14, P6764, DOI 10.1128/MCB.14.10.6764; Cong F, 1999, ONCOGENE, V18, P7731, DOI 10.1038/sj.onc.1203290; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Freeman-Anderson NE, 2009, DEVELOPMENT, V136, P2081, DOI 10.1242/dev.033548; GERWIN BI, 1992, P NATL ACAD SCI USA, V89, P2759, DOI 10.1073/pnas.89.7.2759; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hixon ML, 2000, HISTOL HISTOPATHOL, V15, P551, DOI 10.14670/HH-15.551; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; HSIAO M, 1994, AM J PATHOL, V145, P702; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lanyi A, 1998, ONCOGENE, V16, P3169, DOI 10.1038/sj.onc.1201857; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; LI CCH, 1995, LEUKEMIA, V9, P650; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; O'Farrell TJ, 2004, CANCER RES, V64, P8199, DOI 10.1158/0008-5472.CAN-03-3639; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669; REISS M, 1993, CANCER RES, V53, P899; RENSCHLER MF, 1995, CANCER RES, V55, P5642; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; Salmon P, 2000, BLOOD, V96, P3392; Sanchez-Aguilera A, 2002, BLOOD, V99, P1411, DOI 10.1182/blood.V99.4.1411; Sasaki CY, 2007, CANCER RES, V67, P11218, DOI 10.1158/0008-5472.CAN-07-0922; SHAULSKY G, 1991, CANCER RES, V51, P5232; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Spender LC, 2009, J BIOL CHEM, V284, P1435, DOI 10.1074/jbc.M808080200; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Uzzo RG, 1999, J CLIN INVEST, V104, P769, DOI 10.1172/JCI6775; Vijayachandra K, 2009, MOL CARCINOGEN, V48, P181, DOI 10.1002/mc.20472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XJ, 1998, MOL CARCINOGEN, V23, P185, DOI 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5; Yarbrough WG, 2002, CANCER RES, V62, P1171; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	57	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23184	23195		10.1074/jbc.M112.351411	http://dx.doi.org/10.1074/jbc.M112.351411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22621932	Green Published, hybrid			2022-12-28	WOS:000306495000073
J	Szeto, SSW; Reinke, SN; Oyedotun, KS; Sykes, BD; Lemire, BD				Szeto, Samuel S. W.; Reinke, Stacey N.; Oyedotun, Kayode S.; Sykes, Brian D.; Lemire, Bernard D.			Expression of Saccharomyces cerevisiae Sdh3p and Sdh4p Paralogs Results in Catalytically Active Succinate Dehydrogenase Isoenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL COMPLEX-II; QUINONE-BINDING-SITES; UBIQUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; RESPIRATORY-CHAIN; INNER MEMBRANE; FUMARATE REDUCTASE; CYTOCHROME B(562); IMPORTED PROTEINS; ELECTRON-TRANSFER	Succinate dehydrogenase (SDH), also known as complex II, is required for respiratory growth; it couples the oxidation of succinate to the reduction of ubiquinone. The enzyme is composed of two domains. A membrane-extrinsic catalytic domain composed of the Sdh1p and Sdh2p subunits harbors the flavin and iron-sulfur cluster cofactors. A membrane-intrinsic domain composed of the Sdh3p and Sdh4p subunits interacts with ubiquinone and may coordinate a b-type heme. In many organisms, including Saccharomyces cerevisiae, possible alternative SDH subunits have been identified in the genome. S. cerevisiae contains one paralog of the Sdh3p subunit, Shh3p (YMR118c), and two paralogs of the Sdh4p subunit, Shh4p (YLR164w) and Tim18p (YOR297c). We cloned and expressed these alternative subunits. Shh3p and Shh4p were able to complement Delta sdh3 and Delta sdh4 deletion mutants, respectively, and support respiratory growth. Tim18p was unable to do so. Microarray and proteomics data indicate that the paralogs are expressed under respiratory and other more restrictive growth conditions. Strains expressing hybridSDH enzymes have distinct metabolic profiles that we distinguished by H-1 NMR analysis of metabolites. Surprisingly, the Sdh3p subunit can form SDH isoenzymes with Sdh4p or with Shh4p as well as be a subunit of the TIM22 mitochondrial protein import complex.	[Lemire, Bernard D.] Univ Alberta, Dept Biochem, Sch Translat Med, Edmonton, AB T6G 2H7, Canada	University of Alberta	Lemire, BD (corresponding author), Univ Alberta, Dept Biochem, Sch Translat Med, Edmonton, AB T6G 2H7, Canada.	bernard.lemire@ualberta.ca		Reinke, Stacey/0000-0002-0758-0330	Canadian Institutes of Health Research [MT-15290, MOP-84455, MOP-37769]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants MT-15290 and MOP-84455 (to B. D. L.) and MOP-37769 (to B. D. S.).	Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; Arikawa Y, 1999, J BIOSCI BIOENG, V87, P333, DOI 10.1016/S1389-1723(99)80041-3; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Brasseur G, 1997, EUR J BIOCHEM, V246, P103, DOI 10.1111/j.1432-1033.1997.t01-1-00103.x; Briere JJ, 2005, CELL MOL LIFE SCI, V62, P2317, DOI 10.1007/s00018-005-5237-6; BRUEL C, 1995, J BIOL CHEM, V270, P22321, DOI 10.1074/jbc.270.38.22321; BULLIS BL, 1994, J BIOL CHEM, V269, P6543; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Colby G, 1998, YEAST, V14, P1001, DOI 10.1002/(SICI)1097-0061(199808)14:11<1001::AID-YEA304>3.0.CO;2-K; COLE ST, 1985, BIOCHIM BIOPHYS ACTA, V811, P381, DOI 10.1016/0304-4173(85)90008-4; DAIGNANFORNIER B, 1994, J BIOL CHEM, V269, P15469; Ebeler SE, 2001, FOOD REV INT, V17, P45, DOI 10.1081/FRI-100000517; Elorza A, 2006, PLANT CELL PHYSIOL, V47, P14, DOI 10.1093/pcp/pci218; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Eriksson L, 2006, MOL DIVERS, V10, P169, DOI 10.1007/s11030-006-9024-6; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gebert N, 2011, MOL CELL, V44, P811, DOI 10.1016/j.molcel.2011.09.025; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Hederstedt L, 1999, SCIENCE, V284, P1941, DOI 10.1126/science.284.5422.1941; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii T, 2005, CANCER RES, V65, P203; Iwata F, 2008, PARASITOL INT, V57, P54, DOI 10.1016/j.parint.2007.08.002; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Koehler CM, 2000, MOL CELL BIOL, V20, P1187, DOI 10.1128/MCB.20.4.1187-1193.2000; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lemire BD, 2002, BBA-BIOENERGETICS, V1553, P102, DOI 10.1016/S0005-2728(01)00229-8; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P747, DOI 10.1016/j.bbabio.2010.01.019; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Morales J, 2009, J BIOL CHEM, V284, P7255, DOI 10.1074/jbc.M806623200; Oyedotun KS, 2007, BBA-BIOENERGETICS, V1767, P1436, DOI 10.1016/j.bbabio.2007.09.008; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Oyedotun KS, 2004, J BIOL CHEM, V279, P9432, DOI 10.1074/jbc.M311877200; Oyedotun KS, 1999, FEBS LETT, V442, P203, DOI 10.1016/S0014-5793(98)01657-3; Oyedotun KS, 2001, J BIOL CHEM, V276, P16936, DOI 10.1074/jbc.M100184200; Oyedotun KS, 1999, J BIOL CHEM, V274, P23956, DOI 10.1074/jbc.274.34.23956; Oyedotun KS, 1997, J BIOL CHEM, V272, P31382, DOI 10.1074/jbc.272.50.31382; Pasini B, 2008, EUR J HUM GENET, V16, P79, DOI 10.1038/sj.ejhg.5201904; Polychroniadou E, 2003, BIORESOURCE TECHNOL, V87, P337, DOI 10.1016/S0960-8524(02)00237-7; Reinke SN, 2010, MOL GENET METAB, V100, P274, DOI 10.1016/j.ymgme.2010.03.013; Rich P, 1999, BIOCHEM SOC T, V27, P561, DOI 10.1042/bst0270561; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Robinson KM, 1995, METHOD ENZYMOL, V260, P34, DOI 10.1016/0076-6879(95)60128-7; ROBINSON KM, 1991, J BIOL CHEM, V266, P21347; Romano P, 2003, INT J FOOD MICROBIOL, V86, P169, DOI 10.1016/S0168-1605(03)00290-3; ROOS MH, 1994, MOL BIOCHEM PARASIT, V66, P273, DOI 10.1016/0166-6851(94)90154-6; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7; Schimke RN, 2010, AM J MED GENET A, V152A, P1531, DOI 10.1002/ajmg.a.33384; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sitkin Y, 2007, BBA-BIOENERGETICS, V1767, P143, DOI 10.1016/j.bbabio.2006.11.017; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tran QM, 2007, P NATL ACAD SCI USA, V104, P18007, DOI 10.1073/pnas.0707732104; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	72	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22509	22520		10.1074/jbc.M112.344275	http://dx.doi.org/10.1074/jbc.M112.344275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573324	hybrid, Green Published			2022-12-28	WOS:000306495000009
J	Bao, JQ; Li, D; Wang, L; Wu, JW; Hu, YQ; Wang, ZG; Chen, Y; Cao, XK; Jiang, CZ; Yan, W; Xu, C				Bao, Jianqiang; Li, Ding; Wang, Li; Wu, Jingwen; Hu, Yanqin; Wang, Zhugang; Chen, Yan; Cao, Xinkai; Jiang, Cizhong; Yan, Wei; Xu, Chen			MicroRNA-449 and MicroRNA-34b/c Function Redundantly in Murine Testes by Targeting E2F Transcription Factor-Retinoblastoma Protein (E2F-pRb) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE GERM-CELLS; MIR-17-92 CLUSTER; PROSTATE-CANCER; MALE-FERTILITY; MESSENGER-RNA; DNA-BINDING; SPERMATOGENESIS; EXPRESSION; MICE; GENE	MicroRNAs (miRNAs) mainly function as post-transcriptional regulators and are involved in a wide range of physiological and pathophysiological processes such as cell proliferation, differentiation, apoptosis, and tumorigenesis. Mouse testes express a large number of miRNAs. However, the physiological roles of these testicular miRNAs remain largely unknown. Using microarray and quantitative real time PCR assays, we identified that miRNAs of the microRNA-449 (miR-449) cluster were preferentially expressed in the mouse testis, and their levels were drastically up-regulated upon meiotic initiation during testicular development and in adult spermatogenesis. The expression pattern of the miR-449 cluster resembled that of microRNA-34b/c (miR-34b/c) during spermatogenesis. Further analyses identified that cAMP-responsive element modulator tau and SOX5, two transcription factors essential for regulating male germ cell gene expression, acted as the upstream transactivators to stimulate the expression of the miR-449 cluster in mouse testes. Despite its abundant expression in testicular germ cells, miR-449-null male mice developed normally and exhibited normal spermatogenesis and fertility. Our data further demonstrated that miR-449 shared a cohort of target genes that belong to the E2F transcription factor-retinoblastoma protein pathway with the miR-34 family, and levels of miR-34b/c were significantly up-regulated in miR-449-null testes. Taken together, our data suggest that the miR-449 cluster and miR-34b/c function redundantly in the regulation of male germ cell development in murine testes.	[Bao, Jianqiang; Yan, Wei] Univ Nevada, Dept Physiol & Cell Biol, Sch Med, Reno, NV 89557 USA; [Bao, Jianqiang; Li, Ding; Wang, Li; Wu, Jingwen; Hu, Yanqin; Xu, Chen] Shanghai Jiao Tong Univ, Sch Med, Dept Histol & Embryol, Shanghai 200025, Peoples R China; [Bao, Jianqiang; Li, Ding; Wang, Li; Wu, Jingwen; Hu, Yanqin; Xu, Chen] Shanghai Key Lab Reprod Med, Shanghai 200025, Peoples R China; [Wang, Zhugang; Chen, Yan] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Shanghai 200025, Peoples R China; [Wang, Zhugang; Chen, Yan] Shanghai Res Ctr Model Organisms, Shanghai 200025, Peoples R China; [Cao, Xinkai; Jiang, Cizhong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Nevada System of Higher Education (NSHE); University of Nevada Reno; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Yan, W (corresponding author), Univ Nevada, Dept Physiol & Cell Biol, Sch Med, 1664 N Virginia St,MS575, Reno, NV 89557 USA.	wyan@unr.edu; chenx@shsmu.edu.cn	Bao, Jianqiang/G-9184-2016; Bao, Jianqiang/T-7299-2019; Yan, Wei/AAH-7943-2019	Bao, Jianqiang/0000-0003-1248-2687; Chen, Yan/0000-0001-5325-1151	National Institutes of Health [HD050281, HD060858]; National Natural Science Foundation of China [30771139, 30900776]; Shanghai Natural Science Foundation [09ZR1416200]; Science and Technology Commission of Shanghai Municipality [10DZ2270600]; Shanghai Leading Academic Discipline Project [S30201]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants HD050281 and HD060858 (to W. Y.). This work was also supported by National Natural Science Foundation of China Grants 30771139 and 30900776, Shanghai Natural Science Foundation Grant 09ZR1416200, Science and Technology Commission of Shanghai Municipality Grant 10DZ2270600, and Shanghai Leading Academic Discipline Project Grant S30201 (to C. X.).	Bao JQ, 2011, MOL CELL ENDOCRINOL, V333, P134, DOI 10.1016/j.mce.2010.12.021; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; CONNER F, 1994, NUCLEIC ACIDS RES, V22, P3339, DOI 10.1093/nar/22.16.3339; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; De Cesare D, 2003, MOL ENDOCRINOL, V17, P2554, DOI 10.1210/me.2003-0280; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Feng M, 2010, CELL CYCLE, V9, P213, DOI 10.4161/cc.9.2.10502; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hoja MR, 2004, CELL DEATH DIFFER, V11, P354, DOI 10.1038/sj.cdd.4401362; Holmberg C, 1998, ONCOGENE, V17, P143, DOI 10.1038/sj.onc.1201915; Idler R. K., 2012, J ANDROL IN PRESS; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Kimble J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002683; Kiselak EA, 2010, J BIOL CHEM, V285, P30496, DOI 10.1074/jbc.M110.121590; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Lu WJ, 2010, SCIENCE, V328, P1278, DOI 10.1126/science.1185640; Luan L, 2001, CELL DEATH DIFFER, V8, P316, DOI 10.1038/sj.cdd.4400828; Macho B, 2002, SCIENCE, V298, P2388, DOI 10.1126/science.1077265; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Monaco L, 2004, INT J ANDROL, V27, P322, DOI 10.1111/j.1365-2605.2004.00494.x; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Novotny GW, 2007, CELL DEATH DIFFER, V14, P879, DOI 10.1038/sj.cdd.4402090; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Redshaw N, 2009, BRAIN RES, V1250, P20, DOI 10.1016/j.brainres.2008.11.020; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schwartz D, 1999, CELL GROWTH DIFFER, V10, P665; Singh S, 2010, BBA-GENE REGUL MECH, V1799, P788, DOI 10.1016/j.bbagrm.2010.07.004; Spiller CM, 2010, BIOL REPROD, V82, P433, DOI 10.1095/biolreprod.109.078691; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wu JW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-64; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	61	155	170	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21686	21698		10.1074/jbc.M111.328054	http://dx.doi.org/10.1074/jbc.M111.328054			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570483	Green Published, hybrid			2022-12-28	WOS:000306418600011
J	Eek, P; Jarving, R; Jarving, I; Gilbert, NC; Newcomer, ME; Samel, N				Eek, Priit; Jaerving, Reet; Jaerving, Ivar; Gilbert, Nathaniel C.; Newcomer, Marcia E.; Samel, Nigulas			Structure of a Calcium-dependent 11R-Lipoxygenase Suggests a Mechanism for Ca2+ Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLATELET 12-LIPOXYGENASE; X-RAY; MAMMALIAN LIPOXYGENASES; POSITIONAL SPECIFICITY; MOUSE 8S-LIPOXYGENASE; PRIMARY DETERMINANT; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ARACHIDONIC-ACID; MEMBRANE-BINDING	Lipoxygenases (LOXs) are a key part of several signaling pathways that lead to inflammation and cancer. Yet, the mechanisms of substrate binding and allosteric regulation by the various LOX isoforms remain speculative. Here we report the 2.47-angstrom resolution crystal structure of the arachidonate 11R-LOX from Gersemia fruticosa, which sheds new light on the mechanism of LOX catalysis. Our crystallographic and mutational studies suggest that the aliphatic tail of the fatty acid is bound in a hydrophobic pocket with two potential entrances. We speculate that LOXs share a common T-shaped substrate channel architecture that gives rise to the varying positional specificities. A general allosteric mechanism is proposed for transmitting the activity-inducing effect of calcium binding from the membrane-targeting PLAT (polycystin-1/lipoxygenase/alpha-toxin) domain to the active site via a conserved pi-cation bridge.	[Eek, Priit; Jaerving, Reet; Jaerving, Ivar; Samel, Nigulas] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Gilbert, Nathaniel C.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Tallinn University of Technology; Louisiana State University System; Louisiana State University	Samel, N (corresponding author), Tallinn Univ Technol, Dept Chem, Akad Tee 15, EE-12618 Tallinn, Estonia.	nigulas.samel@ttu.ee	Eek, Priit/A-1842-2019; Gilbert, Nathaniel/I-8223-2018; Samel, Nigulas/A-1420-2019	Eek, Priit/0000-0003-0702-9466; Gilbert, Nathaniel/0000-0002-6706-811X	Louisiana Governors' Biotechnology Initiative; National Center for Research Resources at the National Institutes of Health [RR-15301]; United States DOE [DE-AC02-06CH11357]; National Science Foundation [MCB 0818387]; Estonian Science Foundation [8276, 9410]; Estonian Ministry of Education and Research [SF140010s08]; European Union [VFP414]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER	Louisiana Governors' Biotechnology Initiative; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States DOE(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Cory LaCrouts for expert assistance in protein expression and purification, and Dr. David Neau in data collection. Preliminary work was performed at the Center for Advanced Microstructures and Devices (Baton Rouge), funded in part by the Louisiana Governors' Biotechnology Initiative. X-ray data were collected at Beam Line 24-ID-E of NE-CAT at the Advanced Photon Source, supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357.; This work was supported by National Science Foundation Grant MCB 0818387 (to M. E. N.), Estonian Science Foundation Grants 8276 (to I. J.) and 9410 (to N. S.), the Estonian Ministry of Education and Research Grant SF140010s08 (to N. S.), and the European Union Seventh Framework Programme Project VFP414 (to Prof. Mihkel Kaljurand and Dr. Mihkel Koel).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHEN XS, 1993, FASEB J, V7, P694, DOI 10.1096/fasebj.7.8.8500694; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Chruszcz M, 2008, BIOPHYS J, V95, P1, DOI 10.1529/biophysj.108.131789; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Gan QF, 1996, J BIOL CHEM, V271, P25412, DOI 10.1074/jbc.271.41.25412; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Ivanov I, 2011, BBA-MOL CELL BIOL L, V1811, P1001, DOI 10.1016/j.bbalip.2011.08.008; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jankun J, 2008, CURR MOL MED, V8, P768, DOI 10.2174/156652408786733757; Jisaka M, 2005, BIOCHEM BIOPH RES CO, V338, P136, DOI 10.1016/j.bbrc.2005.08.029; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Mortimer M, 2006, ARCH BIOCHEM BIOPHYS, V445, P147, DOI 10.1016/j.abb.2005.10.023; Naylor CE, 1999, J MOL BIOL, V294, P757, DOI 10.1006/jmbi.1999.3279; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Palmieri-Thiers C, 2011, ARCH BIOCHEM BIOPHYS, V509, P82, DOI 10.1016/j.abb.2011.02.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shang WF, 2011, J MOL BIOL, V409, P654, DOI 10.1016/j.jmb.2011.04.035; Skrzypczak-Jankun E, 2006, ACTA CRYSTALLOGR D, V62, P766, DOI 10.1107/S0907444906016982; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Toledo L, 2011, J COMPUT AID MOL DES, V25, P825, DOI 10.1007/s10822-011-9466-5; Toledo L, 2010, J PHYS CHEM B, V114, P7037, DOI 10.1021/jp912120n; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Walther M, 2004, J BIOL CHEM, V279, P3717, DOI 10.1074/jbc.M309564200; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182	59	42	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22377	22386		10.1074/jbc.M112.343285	http://dx.doi.org/10.1074/jbc.M112.343285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22573333	Green Published, hybrid			2022-12-28	WOS:000306418600074
J	Ishikawa, Y; Vranka, JA; Boudko, SP; Pokidysheva, E; Mizuno, K; Zientek, K; Keene, DR; Rashmir-Raven, AM; Nagata, K; Winand, NJ; Bachinger, HP				Ishikawa, Yoshihiro; Vranka, Janice A.; Boudko, Sergei P.; Pokidysheva, Elena; Mizuno, Kazunori; Zientek, Keith; Keene, Douglas R.; Rashmir-Raven, Ann M.; Nagata, Kazuhiro; Winand, Nena J.; Baechinger, Hans Peter			Mutation in Cyclophilin B That Causes Hyperelastosis Cutis in American Quarter Horse Does Not Affect Peptidylprolyl cis-trans Isomerase Activity but Shows Altered Cyclophilin B-Protein Interactions and Affects Collagen Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; REGIONAL DERMAL ASTHENIA; I PROCOLLAGEN INCELLULO; X-RAY-STRUCTURE; TRIPLE-HELIX; ENDOPLASMIC-RETICULUM; PROLYL 3-HYDROXYLATION; FK506-BINDING PROTEIN; TARGETED DISRUPTION; MISSENSE MUTATION	The rate-limiting step of folding of the collagen triple helix is catalyzed by cyclophilin B (CypB). The G6R mutation in cyclophilin B found in the American Quarter Horse leads to autosomal recessive hyperelastosis cutis, also known as hereditary equine regional dermal asthenia. The mutant protein shows small structural changes in the region of the mutation at the side opposite the catalytic domain of CypB. The peptidylprolyl cis-trans isomerase activity of the mutant CypB is normal when analyzed in vitro. However, the biosynthesis of type I collagen in affected horse fibroblasts shows a delay in folding and secretion and a decrease in hydroxylysine and glucosyl-galactosyl hydroxylysine. This leads to changes in the structure of collagen fibrils in tendon, similar to those observed in P3H1 null mice. In contrast to cyclophilin B null mice, where little 3-hydroxylation was found in type I collagen, 3-hydroxylation of type I collagen in affected horses is normal. The mutation disrupts the interaction of cyclophilin B with the P-domain of calreticulin, with lysyl hydroxylase 1, and probably other proteins, such as the formation of the P3H1.CypB.cartilage-associated protein complex, resulting in less effective catalysis of the rate-limiting step in collagen folding in the rough endoplasmic reticulum.	[Winand, Nena J.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Ishikawa, Yoshihiro; Vranka, Janice A.; Boudko, Sergei P.; Pokidysheva, Elena; Mizuno, Kazunori; Zientek, Keith; Keene, Douglas R.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Boudko, Sergei P.; Pokidysheva, Elena; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Lab Mol & Cellular Biol, Kyoto 6038555, Japan; [Rashmir-Raven, Ann M.] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Cornell University; Oregon Health & Science University; Kyoto Sangyo University; Michigan State University	Winand, NJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	njw2@cornell.edu; hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Boudko, Sergei/0000-0003-3856-4859; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospitals for Children; American Quarter Horse Association	Shriners Hospitals for Children; American Quarter Horse Association	This work was supported by grants from Shriners Hospitals for Children (to H. P. B. and D. R. K.) and the American Quarter Horse Association (to A. R. R.).	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Borges AS, 2005, VET DERMATOL, V16, P125, DOI 10.1111/j.1365-3164.2005.00431.x; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Brounts SH, 2001, VET DERMATOL, V12, P219, DOI 10.1046/j.0959-4493.2001.00256.x; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Faiyaz-Ul-Haque M, 2004, AM J MED GENET A, V128A, P39, DOI 10.1002/ajmg.a.30005; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; HARDY MH, 1988, LAB INVEST, V59, P253; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; LERNER DJ, 1978, J EQUINE MED SURG, V2, P350; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Mochal CA, 2010, JAVMA-J AM VET MED A, V237, P304, DOI 10.2460/javma.237.3.304; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Rashmir-Raven A. M., 2004, Proceedings of the 50th Annual Convention of the American Association of Equine Practitioners, Denver, Colorado, USA, 4-8 December, 2004, P47; Rycyzyn MA, 2000, MOL ENDOCRINOL, V14, P1175, DOI 10.1210/me.14.8.1175; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; SPITZFADEN C, 1994, J BIOMOL NMR, V4, P463, DOI 10.1007/BF00156614; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; SWANSON SKH, 1992, P NATL ACAD SCI USA, V89, P3741, DOI 10.1073/pnas.89.9.3741; Swiderski C., 2006, P 24 ANN AM COLL VET, P756; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; Tryon RC, 2005, AM J VET RES, V66, P437, DOI 10.2460/ajvr.2005.66.437; Tryon RC, 2007, GENOMICS, V90, P93, DOI 10.1016/j.ygeno.2007.03.009; Tryon RC, 2009, JAVMA-J AM VET MED A, V234, P120, DOI 10.2460/javma.234.1.120; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; White SD, 2004, VET DERMATOL, V15, P207, DOI 10.1111/j.1365-3164.2004.00402.x; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7356, DOI 10.1021/bi9602775	60	55	57	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22253	22265		10.1074/jbc.M111.333336	http://dx.doi.org/10.1074/jbc.M111.333336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556420	hybrid, Green Published			2022-12-28	WOS:000306418600063
J	Jaldety, Y; Glick, Y; Orr-Urtreger, A; Ickowicz, D; Gerber, D; Breitbart, H				Jaldety, Yael; Glick, Yair; Orr-Urtreger, Avi; Ickowicz, Debby; Gerber, Doron; Breitbart, Haim			Sperm Epidermal Growth Factor Receptor (EGFR) Mediates alpha 7 Acetylcholine Receptor (AChR) Activation to Promote Fertilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACROSOME REACTION; ZONA-PELLUCIDA; MOUSE SPERM; MICE DEFICIENT; CHOLINE-ACETYLTRANSFERASE; TYROSINE PHOSPHORYLATION; EGG ZP3; CHANNELS; TRANSACTIVATION; IDENTIFICATION	To attain fertilization the spermatozoon binds to the egg zona pellucida (ZP) via sperm receptor(s) and undergoes an acrosome reaction (AR). Several sperm receptors have been described in the literature; however, the identity of this receptor is not yet certain. In this study, we suggest that the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) might be a sperm receptor activated by ZP to induce epidermal growth factor receptor (EGFR)-mediated AR. We found that isolated ZP or alpha 7 agonists induced the AR in sperm from WT but not alpha 7-null spermatozoa, and the induced AR was inhibited by alpha 7 or EGFR antagonists. Moreover, alpha 7-null sperm showed very little binding to the egg, and microfluidic affinity in vitro assay clearly showed that alpha 7nAChR, as well as EGFR, interacted with ZP3. Induction of EGFR activation and the AR by an alpha 7 agonist was inhibited by a Src family kinase (SFK) inhibitor. In conclusion we suggest that activation of alpha 7 by ZP leads to SFK-dependent EGFR activation, Ca2+ influx, and the acrosome reaction.	[Jaldety, Yael; Glick, Yair; Ickowicz, Debby; Gerber, Doron; Breitbart, Haim] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Orr-Urtreger, Avi] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Genet Inst, IL-69978 Tel Aviv, Israel; [Orr-Urtreger, Avi] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Breitbart, H (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	haim.breitbart@biu.ac.il		Orr-Urtreger, Avi/0000-0001-9305-6203				Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, J CELL BIOL, V134, P637, DOI 10.1083/jcb.134.3.637; Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; Blanchet MR, 2006, AM J PHYSIOL-LUNG C, V291, pL757, DOI 10.1152/ajplung.00409.2005; BLEIL JD, 1986, J CELL BIOL, V102, P1363, DOI 10.1083/jcb.102.4.1363; Bodis J, 2002, GYNECOL ENDOCRINOL, V16, P259, DOI 10.1080/713603093; Bray C, 2005, MOL HUM REPROD, V11, P881, DOI 10.1093/molehr/gah245; Bray C, 2005, BIOL REPROD, V73, P807, DOI 10.1095/biolreprod.105.042184; Bray C, 2002, BIOL REPROD, V67, P782, DOI 10.1095/biolreprod.102.004580; Breitbart H, 2010, MOL CELL ENDOCRINOL, V314, P234, DOI 10.1016/j.mce.2009.06.009; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cohen G, 2004, DEV BIOL, V267, P230, DOI 10.1016/j.ydbio.2003.10.034; Daniel L, 2010, DEV BIOL, V344, P650, DOI 10.1016/j.ydbio.2010.05.490; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; Escoffier J, 2007, J CELL PHYSIOL, V212, P753, DOI 10.1002/jcp.21075; Etkovitz N, 2007, BIOL REPROD, V77, P263, DOI 10.1095/biolreprod.106.056705; Etkovitz N, 2009, DEV BIOL, V334, P447, DOI 10.1016/j.ydbio.2009.08.002; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; FLORMAN HM, 1989, DEV BIOL, V135, P133, DOI 10.1016/0012-1606(89)90164-4; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951; Fukami K, 2003, J CELL BIOL, V161, P79, DOI 10.1083/jcb.200210057; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; IBANEZ CF, 1991, P NATL ACAD SCI USA, V88, P3676, DOI 10.1073/pnas.88.9.3676; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kassner PD, 1998, MOL CELL NEUROSCI, V10, P258, DOI 10.1006/mcne.1998.0664; Kornya L, 2001, GYNECOL OBSTET INVES, V52, P104, DOI 10.1159/000052952; Kumar P, 2005, J BIOL CHEM, V280, P25928, DOI 10.1074/jbc.M502435200; LAX Y, 1994, FEBS LETT, V339, P234, DOI 10.1016/0014-5793(94)80422-2; Lyng Robert, 2007, Soc Reprod Fertil Suppl, V65, P335; Mayerhofer A, 1999, MEDICINA-BUENOS AIRE, V59, P542; Meizel S, 2005, MOL REPROD DEV, V72, P250, DOI 10.1002/mrd.20336; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Mitchell LA, 2008, MOL HUM REPROD, V14, P235, DOI 10.1093/molehr/gan007; Mitsui T, 2000, J CELL BIOCHEM, V77, P584, DOI 10.1002/(SICI)1097-4644(20000615)77:4<584::AID-JCB6>3.0.CO;2-U; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; NELSON L, 1976, EXP CELL RES, V101, P221, DOI 10.1016/0014-4827(76)90371-2; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; PLACZEK R, 1988, ARCH ANDROLOGY, V21, P1; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Shah BH, 2003, TRENDS PHARMACOL SCI, V24, P239, DOI 10.1016/S0165-6147(03)00079-8; Shirakawa H, 1999, DEV BIOL, V208, P70, DOI 10.1006/dbio.1998.9194; Shoop RD, 2000, J NEUROSCI, V20, P4021; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Son JH, 2003, BIOL REPROD, V68, P1348, DOI 10.1095/biolreprod.102.011163; STEWART TA, 1978, BIOL REPROD, V19, P271, DOI 10.1095/biolreprod19.2.271; STEWART TA, 1978, BIOL REPROD, V19, P965, DOI 10.1095/biolreprod19.5.965; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; SWOPE SL, 1995, ANN NY ACAD SCI, V757, P197, DOI 10.1111/j.1749-6632.1995.tb17476.x; Trevino CL, 2004, FEBS LETT, V563, P87, DOI 10.1016/S0014-5793(04)00257-1; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WARD CR, 1993, DEV BIOL, V158, P9, DOI 10.1006/dbio.1993.1165; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; YOSHIMATSU N, 1988, GAMETE RES, V21, P115, DOI 10.1002/mrd.1120210202; YOUNG RJ, 1991, MOL REPROD DEV, V28, P55, DOI 10.1002/mrd.1080280109	74	19	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22328	22340		10.1074/jbc.M111.292292	http://dx.doi.org/10.1074/jbc.M111.292292			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22577141	Green Published, hybrid			2022-12-28	WOS:000306418600070
J	Stanger, K; Gorelik, M; Davidson, AR				Stanger, Karen; Gorelik, Maryna; Davidson, Alan R.			Yeast Adaptor Protein, Nbp2p, Is Conserved Regulator of Fungal Ptc1p Phosphatases and Is Involved in Multiple Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH3 DOMAIN; VACUOLE INHERITANCE; KINASE; SPECIFICITY; DELETION; PROVIDES; NETWORK; TARGETS	Nbp2p is an Src homology 3 (SH3) domain-containing yeast protein that is involved in a variety of cellular processes. This small adaptor protein binds to a number of different proteins through its SH3 domain, and a region N-terminal to the SH3 domain binds to the protein phosphatase, Ptc1p. Despite its involvement in a large number of physical and genetic interactions, the only well characterized function of Nbp2p is to recruit Ptc1p to the high osmolarity glycerol pathway, which results in down-regulation of this pathway. In this study, we have discovered that Nbp2p orthologues exist in all Ascomycete and Basidiomycete fungal genomes and that all possess an SH3 domain and a conserved novel Ptc1p binding motif. The ubiquitous occurrence of these two features, which we have shown are both critical for Nbp2p function in Saccharomyces cerevisiae, implies that a conserved role of Nbp2p in all of these fungal species is the targeting of Ptc1p to proteins recognized by the SH3 domain. We also show that in a manner analogous to its role in the high osmolarity glycerol pathway, Nbp2p functions in the down-regulation of the cell wall integrity pathway through SH3 domain-mediated interaction with Bck1p, a component kinase of this pathway. Based on functional studies on the Schizosaccharomyces pombe and Neurospora crassa Nbp2p orthologues and the high conservation of the Nbp2p binding site in Bck1p orthologues, this function of Nbp2p appears to be conserved across Ascomycetes. Our results also clearly imply a function for the Nbp2p-Ptc1p complex other cellular processes.	[Gorelik, Maryna; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Stanger, Karen; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca			Canadian Institutes of Health Research Operating Grant [MOP-13609]; Natural Sciences and Engineering Research Council Scholarship PGS-D; Natural Sciences and Engineering Research Council Scholarship PGS-M	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council Scholarship PGS-D; Natural Sciences and Engineering Research Council Scholarship PGS-M	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-13609 and Natural Sciences and Engineering Research Council Scholarships PGS-D (to M. G.) and PGS-M (to K. S.).	Bartholomew CR, 2009, EUKARYOT CELL, V8, P560, DOI 10.1128/EC.00111-08; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Carbo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001009; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Gorelik M, 2012, J BIOL CHEM, V287, P9168, DOI 10.1074/jbc.M111.330753; Gorelik M, 2011, J BIOL CHEM, V286, P19470, DOI 10.1074/jbc.M111.229294; Haynes J, 2007, GENETICS, V176, P193, DOI 10.1534/genetics.106.070300; Hoang A, 2001, AM J HEALTH-SYST PH, V58, P1206, DOI 10.1093/ajhp/58.13.1206; Hruby A, 2011, J CELL SCI, V124, P35, DOI 10.1242/jcs.077065; Jin Y, 2009, MOL BIOL CELL, V20, P1312, DOI 10.1091/mbc.E08-09-0954; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Ohkuni K, 2003, GENETICS, V165, P517; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Winters MJ, 2005, MOL CELL BIOL, V25, P2177, DOI 10.1128/MCB.25.6.2177-2190.2005; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425	30	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22133	22141		10.1074/jbc.M112.348052	http://dx.doi.org/10.1074/jbc.M112.348052			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570491	Green Published, hybrid			2022-12-28	WOS:000306418600050
J	Ji, QJ; Zhang, L; Sun, F; Deng, X; Liang, HH; Bae, TO; He, C				Ji, Quanjiang; Zhang, Liang; Sun, Fei; Deng, Xin; Liang, Haihua; Bae, Taeok; He, Chuan			Staphylococcus aureus CymR Is a New Thiol-based Oxidation-sensing Regulator of Stress Resistance and Oxidative Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GLOBAL REGULATOR; SULFENIC ACID; OXYR; MECHANISM; PEROXIDE; OHRR; MGRA; PURIFICATION; REDUCTASE	As a human pathogen, Staphylococcus aureus must cope with oxidative stress generated by the human immune system. Here, we report that CymR utilizes its sole Cys-25 to sense oxidative stress. Oxidation followed by thiolation of this cysteine residue leads to dissociation of CymR from its cognate promoter DNA. In contrast, the DNA binding of the CymRC25S mutant was insensitive to oxidation and thiolation, suggesting that CymR senses oxidative stress through oxidation of its sole cysteine to form a mixed disulfide with low molecular weight thiols. The determined crystal structures of the reduced and oxidized forms of CymR revealed that Cys-25 is oxidized to Cys-25-SOH in the presence of H2O2. Deletion of cymR reduced the resistance of S. aureus to oxidative stresses, and the resistance was restored by expressing a C25S mutant copy of cymR. In a C25S substitution mutant, the expression of two genes, tcyP and mccB, was constitutively repressed and did not respond to hydrogen peroxide stress, whereas the expression of the genes were highly induced under oxidative stress in a wild-type strain, indicating the critical role of Cys-25 in redox signaling in vivo. Thus, CymR is another master regulator that senses oxidative stress and connects stress responses to virulence regulation in S. aureus.	[Ji, Quanjiang; Zhang, Liang; Sun, Fei; Deng, Xin; Liang, Haihua; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Bae, Taeok] Indiana Univ Sch Med NW, Gary, IN 46408 USA	University of Chicago; Indiana University System; Indiana University Northwest	He, C (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Ji, Quanjiang/G-5569-2012; Liang, Haihua/T-2441-2017; Deng, Xin/G-5591-2012; Ji, Quanjiang/AAP-9111-2020; Ji, Quanjiang/AAZ-9793-2020; Zhang, Liang/F-8064-2013	Ji, Quanjiang/0000-0002-2321-8462; Ji, Quanjiang/0000-0002-2321-8462; Zhang, Liang/0000-0002-7672-1168; Bae, Taeok/0000-0002-0576-2851	National Institutes of Health [AI077564, AI074658]; American Heart Association [0835158N]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074658, R01AI077564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077564 (to T. B.) and AI074658 (to C. H.). This work was also supported by Scientist Development Grant 0835158N from the American Heart Association (to T. B.), and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (to C. H.).	Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Ballal A, 2010, J BACTERIOL, V192, P336, DOI 10.1128/JB.01202-09; Ballal A, 2009, J BACTERIOL, V191, P1656, DOI 10.1128/JB.01555-08; Chander M, 2004, J BIOL CHEM, V279, P41603, DOI 10.1074/jbc.M405512200; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; delCardayre SB, 1998, J BIOL CHEM, V273, P5744, DOI 10.1074/jbc.273.10.5744; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Fujimoto DF, 2009, MOL MICROBIOL, V74, P1445, DOI 10.1111/j.1365-2958.2009.06942.x; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Helmann JD, 2011, ANTIOXID REDOX SIGN, V15, P123, DOI 10.1089/ars.2010.3562; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Jonsson TJ, 2007, BIOCHEMISTRY-US, V46, P5709, DOI 10.1021/bi7001218; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lithgow JK, 2004, J BACTERIOL, V186, P1579, DOI 10.1128/JB.186.6.1579-1590.2004; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Maruyama A, 2003, MICROBIOL-SGM, V149, P389, DOI 10.1099/mic.0.25796-0; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Pother DC, 2009, J BACTERIOL, V191, P7520, DOI 10.1128/JB.00937-09; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Shepard W, 2011, FEBS J, V278, P2689, DOI 10.1111/j.1742-4658.2011.08195.x; Soonsanga S, 2008, J BACTERIOL, V190, P5738, DOI 10.1128/JB.00576-08; Soutourina O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000894; Soutourina O, 2009, MOL MICROBIOL, V73, P194, DOI 10.1111/j.1365-2958.2009.06760.x	41	31	31	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					21102	21109		10.1074/jbc.M112.359737	http://dx.doi.org/10.1074/jbc.M112.359737			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22553203	Green Published, hybrid			2022-12-28	WOS:000306416800031
J	Lee, JH; Jin, YT; He, GF; Zeng, SX; Wang, YYV; Wahl, GM; Lu, H				Lee, Jun-Ho; Jin, Yetao; He, Guifen; Zeng, Shelya X.; Wang, Yunyuan V.; Wahl, Geoffrey M.; Lu, Hua			Hypoxia Activates Tumor Suppressor p53 by Inducing ATR-Chk1 Kinase Cascade-mediated Phosphorylation and Consequent 14-3-3 gamma Inactivation of MDMX Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; LIGASE ACTIVITY; FACTOR 1-ALPHA; DEGRADATION; ATM; INHIBITION; REOXYGENATION; APOPTOSIS; DOMAIN; CHK1	It has been known that p53 can be induced and activated by hypoxia, an abnormal condition that often occurs in rapidly growing solid tumors or when normal tissues undergo ischemia. Although the ATR-Chk1 kinase cascade was associated with hypoxia-induced p53 activation, molecules that directly link this hypoxia-ATR-Chk1 pathway to p53 activation have been elusive. Here, we showed that hypoxia could induce phosphorylation of MDMX at Ser-367 and enhance the binding of this phosphorylated MDMX to 14-3-3 gamma, consequently leading to p53 activation. A Chk1 inhibitor or knockdown of ATR and Chk1 inhibited the phosphorylation of MDMX at Ser-367 and impaired the binding of MDMX to 14-3-3 gamma in addition to p53 activation in response to hypoxia. In primary mouse embryonic fibroblast cells that harbor a mutant MDMX, including the S367A mutation, hypoxia also failed to induce the binding of this mutant MDMX to 14-3-3 gamma and to activate p53 and its direct targets. These results demonstrate that hypoxia can activate p53 through inactivation of MDMX by the ATR-Chk1-MDMX-14-3-3 gamma pathway.	[Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Ctr Canc, New Orleans, LA 70112 USA; [Lee, Jun-Ho; Jin, Yetao; He, Guifen; Zeng, Shelya X.; Lu, Hua] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Lee, Jun-Ho; Jin, Yetao; He, Guifen; Zeng, Shelya X.; Lu, Hua] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Wang, Yunyuan V.; Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Wang, Yunyuan V.; Wahl, Geoffrey M.] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul 110799, South Korea	Tulane University; Tulane University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Salk Institute; Seoul National University (SNU)	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu			National Institutes of Health, NCI [CA095441, CA079721, CA129828, R01 CA 061449]; NATIONAL CANCER INSTITUTE [R01CA061449, R01CA095441, R01CA129828, R01CA079721] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, NCI Grants CA095441, CA079721, and CA129828 (to H. L.).; Supported by National Institutes of Health, NCI Grants R01 CA 061449.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hammond EM, 2006, CANCER LETT, V238, P161, DOI 10.1016/j.canlet.2005.06.029; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JC, 2004, CELL CYCLE, V3, P900; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Ravi R, 2000, GENE DEV, V14, P34; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schmaltz C, 1998, MOL CELL BIOL, V18, P2845, DOI 10.1128/MCB.18.5.2845; Semenza GL, 2000, GENE DEV, V14, P1983; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; VAUPEL P, 1991, CANCER RES, V51, P3316; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; Wenger RH, 1998, CANCER RES, V58, P5678; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200	49	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20898	20903		10.1074/jbc.M111.336875	http://dx.doi.org/10.1074/jbc.M111.336875			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22556425	hybrid, Green Published			2022-12-28	WOS:000306416800011
J	Kalhan, SC; Hanson, RW				Kalhan, Satish C.; Hanson, Richard W.			Resurgence of Serine: An Often Neglected but Indispensable Amino Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HYDROGEN-SULFIDE; IN-VIVO; PHOSPHOGLYCERATE DEHYDROGENASE; HOMOCYSTEINE REMETHYLATION; SYNTHESIS PATHWAY; METABOLISM; GLYCINE; METHIONINE; CYSTEINE; ENZYMES	Serine is generally classified as a nutritionally nonessential (dispensable) amino acid, but metabolically, serine is indispensible and plays an essential role in several cellular processes. Serine is the major source of one-carbon units for methylation reactions that occur via the generation of S-adenosylmethionine. The regulation of serine metabolism in mammalian tissues is thus of critical importance for the control of methyl group transfer. In addition to the well known role of D-serine in the brain, L-serine has recently been implicated in breast cancer and other tumors due in part to the genomic copy number gain for 3-phosphoglycerate dehydrogenase, the enzyme that controls the entry of glycolytic intermediates into the pathway of serine synthesis. Here, we review recent information regarding the synthesis of serine and the regulation of its metabolism and discuss the role played by phosphoenolpyruvate carboxykinase in this process.	[Kalhan, Satish C.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA; [Hanson, Richard W.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Kalhan, SC (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA.	sck@case.edu		Kalhan, Satish/0000-0002-8012-4171	National Institutes of Health [DK079937]; Ellison Foundation [AG-SS-2420-10]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK079937 (to S. C. K.). This work was also supported by Ellison Foundation Senior Scholar Award AG-SS-2420-10 (to R. W. H.).	Achouri Y, 1999, BIOCHEM J, V344, P15, DOI 10.1042/0264-6021:3440015; Antflick JE, 2010, AMINO ACIDS, V39, P145, DOI 10.1007/s00726-009-0387-8; BROSNAN JT, 1989, CAN J PHYSIOL PHARM, V67, P1058, DOI 10.1139/y89-167; BRUNDIN T, 1994, AM J PHYSIOL-ENDOC M, V267, pE648, DOI 10.1152/ajpendo.1994.267.5.E648; CETIN I, 1992, AM J PHYSIOL, V263, pE786, DOI 10.1152/ajpendo.1992.263.4.E786; CETIN I, 1988, AM J OBSTET GYNECOL, V158, P120, DOI 10.1016/0002-9378(88)90792-2; CETIN I, 1991, AM J PHYSIOL, V260, pE371, DOI 10.1152/ajpendo.1991.260.3.E371; Chung M, 1998, AM J PHYSIOL-ENDOC M, V274, pE13, DOI 10.1152/ajpendo.1998.274.1.E13; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Cuskelly GJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1182, DOI 10.1152/ajpendo.2001.281.6.E1182; Dasarathy J, 2010, AM J CLIN NUTR, V91, P357, DOI 10.3945/ajcn.2009.28457; Dasarathy S, 2009, AM J PHYSIOL-GASTR L, V297, pG567, DOI 10.1152/ajpgi.00042.2009; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; DeBerardinis RJ, 2011, CELL METAB, V14, P285, DOI 10.1016/j.cmet.2011.08.004; Divino JC, 1999, AM J PHYSIOL-ENDOC M, V277, pE693, DOI 10.1152/ajpendo.1999.277.4.E693; Dominy JE, 2004, NUTR REV, V62, P348, DOI 10.1301/nr.2004.sept.348-353; FELL DA, 1988, BIOCHEM J, V256, P97, DOI 10.1042/bj2560097; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; HIRAMATSU T, 1994, AM J CLIN NUTR, V60, P525, DOI 10.1093/ajcn/60.4.525; Ingenbleek Y, 2002, NUTRITION, V18, P40, DOI 10.1016/S0899-9007(01)00783-3; Ingenbleek Y, 2012, NUTRITION, V28, P148, DOI 10.1016/j.nut.2011.04.009; Kalhan SC, 2011, J BIOL CHEM, V286, P5266, DOI 10.1074/jbc.M110.185991; Kalhan SC, 2003, AM J PHYSIOL-ENDOC M, V284, pE733, DOI 10.1152/ajpendo.00167.2002; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; LOWRY M, 1987, AM J PHYSIOL, V252, pF304, DOI 10.1152/ajprenal.1987.252.2.F304; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; MAURON J, 1973, EUR J BIOCHEM, V32, P331, DOI 10.1111/j.1432-1033.1973.tb02614.x; Nagao K, 2009, AMINO ACIDS, V36, P555, DOI 10.1007/s00726-008-0117-7; Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; SNELL K, 1987, BIOCHEM J, V245, P609, DOI 10.1042/bj2450609; SNELL K, 1986, BIOCHEM J, V233, P617, DOI 10.1042/bj2330617; Tabatabaie L, 2010, MOL GENET METAB, V99, P256, DOI 10.1016/j.ymgme.2009.10.012; Whiteman M, 2011, CLIN SCI, V121, P459, DOI 10.1042/CS20110267; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	40	174	182	7	43	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19786	19791		10.1074/jbc.R112.357194	http://dx.doi.org/10.1074/jbc.R112.357194			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22566694	Green Published, hybrid			2022-12-28	WOS:000306414500002
J	Tnimov, Z; Guo, Z; Gambin, Y; Nguyen, UTT; Wu, YW; Abankwa, D; Stigter, A; Collins, BM; Waldmann, H; Goody, RS; Alexandrov, K				Tnimov, Zakir; Guo, Zhong; Gambin, Yann; Nguyen, Uyen T. T.; Wu, Yao-Wen; Abankwa, Daniel; Stigter, Anouk; Collins, Brett M.; Waldmann, Herbert; Goody, Roger S.; Alexandrov, Kirill			Quantitative Analysis of Prenylated RhoA Interaction with Its Chaperone, RhoGDI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP DISSOCIATION INHIBITOR; GUANINE-NUCLEOTIDE EXCHANGE; GTP-BINDING PROTEIN; RAB ESCORT PROTEIN; EZRIN/RADIXIN/MOESIN PROTEINS; GERANYLGERANYL TRANSFERASE; MEMBRANE EXTRACTION; MIGRATING CELLS; CDC42; GTPASES	Small GTPases of the Rho family regulate cytoskeleton remodeling, cell polarity, and transcription, as well as the cell cycle, in eukaryotic cells. Membrane delivery and recycling of the Rho GTPases is mediated by Rho GDP dissociation inhibitor (RhoGDI), which forms a stable complex with prenylated Rho GTPases. We analyzed the interaction of RhoGDI with the active and inactive forms of prenylated and unprenylated RhoA. We demonstrate that RhoGDI binds the prenylated form of RhoA center dot GDP with unexpectedly high affinity (K-d = 5 pM). The very long half-life of the complex is reduced 25-fold on RhoA activation, with a concomitant reduction in affinity (K-d = 3 nM). The 2.8-angstrom structure of the RhoA center dot guanosine 5'-[beta,gamma-imido] triphosphate (GMPPNP)center dot RhoGDI complex demonstrated that complex formation forces the activated RhoA into a GDP-bound conformation in the absence of nucleotide hydrolysis. We demonstrate that membrane extraction of Rho GTPase by RhoGDI is a thermodynamically favored passive process that operates through a series of progressively tighter intermediates, much like the one that is mediated by RabGDI.	[Tnimov, Zakir; Guo, Zhong; Gambin, Yann; Collins, Brett M.; Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Dept Mol Cell Biol, St Lucia, Qld 4072, Australia; [Nguyen, Uyen T. T.; Wu, Yao-Wen; Goody, Roger S.] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Stigter, Anouk; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany; [Abankwa, Daniel] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Abankwa, Daniel] Abo Akad Univ, FIN-20520 Turku, Finland	University of Queensland; Max Planck Society; Max Planck Society; University of Turku; Abo Akademi University	Alexandrov, K (corresponding author), Univ Queensland, Inst Mol Biosci, Dept Mol Cell Biol, 306 Carmody Rd, St Lucia, Qld 4072, Australia.	k.alexandrov@uq.edu.au	Goody, Roger S/J-8845-2014; Tnimov, Zakir Tnimov/G-6764-2012; Waldmann, Herbert/B-7406-2017; GUO, Zhong/J-8723-2014; GAMBIN, Yann/AAI-8501-2021; GAMBIN, Yann/M-8799-2014; Tnimov, Zakir/L-3052-2019; Collins, Brett/J-1563-2014; Wu, Yaowen/N-9802-2015; Alexandrov, Kirill/A-5830-2013; GUO, Zhong/J-8723-2014	Goody, Roger S/0000-0002-0772-0444; Tnimov, Zakir Tnimov/0000-0003-2466-2220; Waldmann, Herbert/0000-0002-9606-7247; GUO, Zhong/0000-0003-0285-5021; Tnimov, Zakir/0000-0003-2466-2220; Collins, Brett/0000-0002-6070-3774; Wu, Yaowen/0000-0002-2573-8736; Alexandrov, Kirill/0000-0002-0957-6511; GUO, Zhong/0000-0002-2277-0087; GAMBIN, Yann/0000-0001-7378-8976; Abankwa, Daniel/0000-0003-2769-0745	Australian Research Council DP Grant [DP1094080]; ARC FF Grant [FT0991611]; National Health Research Council project Grant [569652]	Australian Research Council DP Grant(Australian Research Council); ARC FF Grant(Australian Research Council); National Health Research Council project Grant	This work was supported in part by Australian Research Council DP Grant DP1094080, ARC FF Grant FT0991611, and National Health Research Council project Grant 569652 (to K. A.).	Abramovitz A, 2012, BIOCHEMISTRY-US, V51, P715, DOI 10.1021/bi201211v; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864, DOI 10.1074/jbc.270.14.7864; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Chiba Y, 2009, AM J PHYSIOL-LUNG C, V297, pL984, DOI 10.1152/ajplung.00178.2009; CHUANG TH, 1993, J BIOL CHEM, V268, P775; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Golovanov AP, 2001, J MOL BIOL, V305, P121, DOI 10.1006/jmbi.2000.4262; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ignatev A, 2008, J BIOL CHEM, V283, P18377, DOI 10.1074/jbc.M709718200; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Maeda M, 1999, ONCOGENE, V18, P4788, DOI 10.1038/sj.onc.1202871; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Rak A, 2002, PROTEIN EXPRES PURIF, V25, P23, DOI 10.1006/prep.2001.1605; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rigler R., 1993, DIFFUSION SINGLE MOL, P235; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Tschantz WR, 1997, J BIOL CHEM, V272, P9989; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Ugolev Y, 2006, J BIOL CHEM, V281, P19204, DOI 10.1074/jbc.M600042200; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	61	33	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26549	26562		10.1074/jbc.M112.371294	http://dx.doi.org/10.1074/jbc.M112.371294			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22628549	Green Published, hybrid			2022-12-28	WOS:000307386000008
J	Mansfield, C; West, TG; Curtin, NA; Ferenczi, MA				Mansfield, Catherine; West, Tim G.; Curtin, Nancy A.; Ferenczi, Michael A.			Stretch of Contracting Cardiac Muscle Abruptly Decreases the Rate of Phosphate Release at High and Low Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBERS; MYOSIN; FORCE; TITIN; FILAMENT; RABBIT; HEART	The contractile performance of the heart is linked to the energy that is available to it. Yet, the heart needs to respond quickly to changing demands. During diastole, the heart fills with blood and the heart chambers expand. Upon activation, contraction of cardiac muscle expels blood into the circulation. Early in systole, parts of the left ventricle are being stretched by incoming blood, before contraction causes shrinking of the ventricle. We explore here the effect of stretch of contracting permeabilized cardiac trabeculae of the rat on the rate of inorganic phosphate (P-i) release resulting from ATP hydrolysis, using a fluorescent sensor for P-i with millisecond time resolution. Stretch immediately reduces the rate of P-i release, an effect observed both at full calcium activation (32 mu mol/liter of Ca2+), and at a physiological activation level of 1 mu mol/liter of Ca2+. The results suggest that stretch redistributes the actomyosin cross-bridges toward their P-i-containing state. The redistribution means that a greater fraction of cross-bridges will be poised to rapidly produce a force-generating transition and movement, compared with cross-bridges that have not been subjected to stretch. At the same time stretch modifies the Pi balance in the cytoplasm, which may act as a cytoplasmic signal for energy turnover.	[Mansfield, Catherine; Curtin, Nancy A.; Ferenczi, Michael A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London SW7 2AZ, England; [West, Tim G.] Univ London, Royal Vet Coll, London AL9 7TA, Herts, England	Imperial College London; University of London; University of London Royal Veterinary College	Ferenczi, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London SW7 2AZ, England.	m.ferenczi@imperial.ac.uk	Ferenczi, Michael/F-9510-2015	Ferenczi, Michael/0000-0002-0349-331X; Mansfield, Catherine/0000-0002-5063-5181	British Heart Foundation [RG/11/20/29266] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Ashikaga H, 2009, JACC-CARDIOVASC IMAG, V2, P202, DOI 10.1016/j.jcmg.2008.11.009; Bickham DC, 2011, BIOPHYS J, V101, P2445, DOI 10.1016/j.bpj.2011.10.007; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104; Calaghan SC, 1999, PROG BIOPHYS MOL BIO, V71, P59, DOI 10.1016/S0079-6107(98)00037-6; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Choi HS, 2000, J PHYSIOL-LONDON, V529, P661, DOI 10.1111/j.1469-7793.2000.00661.x; Curtin N A, 1975, J Mechanochem Cell Motil, V3, P147; Curtin NA, 2003, ADV EXP MED BIOL, V538, P613; CURTIN NA, 1973, COLD SPRING HARB SYM, V37, P619, DOI 10.1101/SQB.1973.037.01.074; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Ferenczi M. A., 1985, J PHYSL, V369, P72; FERENCZI MA, 1984, J PHYSIOL-LONDON, V350, P519, DOI 10.1113/jphysiol.1984.sp015216; Fujita H, 2004, AM J PHYSIOL-HEART C, V287, pH2528, DOI 10.1152/ajpheart.00553.2004; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V354, P577, DOI 10.1113/jphysiol.1984.sp015394; He ZH, 2000, BIOPHYS J, V79, P945, DOI 10.1016/S0006-3495(00)76349-1; He ZH, 1998, ADV EXP MED BIOL, V453, P331; He ZH, 1997, J PHYSIOL-LONDON, V501, P125, DOI 10.1111/j.1469-7793.1997.125bo.x; Herzog W, 2003, J EXP BIOL, V206, P3635, DOI 10.1242/jeb.00645; Lee EJ, 2010, J MOL CELL CARDIOL, V49, P449, DOI 10.1016/j.yjmcc.2010.05.006; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC1398, DOI 10.1152/ajpcell.00222.2010; LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171; Linari M, 2003, J PHYSIOL-LONDON, V548, P461, DOI 10.1113/jphysiol.2002.032185; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; MCCRAY JA, 1980, P NATL ACAD SCI-BIOL, V77, P7237, DOI 10.1073/pnas.77.12.7237; Millman BM, 1998, PHYSIOL REV, V78, P359, DOI 10.1152/physrev.1998.78.2.359; MOISESCU DG, 1978, J PHYSIOL-LONDON, V275, P241, DOI 10.1113/jphysiol.1978.sp012188; Muhlfeld C, 2005, COMP BIOCHEM PHYS A, V141, P310, DOI 10.1016/j.cbpb.2005.06.001; MULIERI LA, 1989, CIRC RES, V65, P1441, DOI 10.1161/01.RES.65.5.1441; Pinniger GJ, 2006, J PHYSIOL-LONDON, V573, P627, DOI 10.1113/jphysiol.2005.095448; Schmitz JPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034118; Stevens C, 2003, PROG BIOPHYS MOL BIO, V82, P229, DOI 10.1016/S0079-6107(03)00023-3; van der Velden J, 1998, J PHYSIOL-LONDON, V507, P497, DOI 10.1111/j.1469-7793.1998.497bt.x; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732	35	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25696	25705		10.1074/jbc.M112.373498	http://dx.doi.org/10.1074/jbc.M112.373498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692210	hybrid, Green Published			2022-12-28	WOS:000306916300001
J	Chen, YT; Collins, TRL; Guan, ZQ; Chen, VB; Hsieh, TS				Chen, Yu-Tsung; Collins, Tammy R. L.; Guan, Ziqiang; Chen, Vincent B.; Hsieh, Tao-Shih			Probing Conformational Changes in Human DNA Topoisomerase II alpha by Pulsed Alkylation Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; DROSOPHILA-MELANOGASTER; CHEMICAL-MODIFICATION; ARGININE RESIDUES; PROTEIN CLAMP; ATPASE DOMAIN; CLEAVAGE; YEAST; INHIBITION; MECHANISM	Type II topoisomerases are essential enzymes for solving DNA topological problems by passing one segment of DNA duplex through a transient double-strand break in a second segment. The reaction requires the enzyme to precisely control DNA cleavage and gate opening coupled with ATP hydrolysis. Using pulsed alkylation mass spectrometry, we were able to monitor the solvent accessibilities around 13 cysteines distributed throughout human topoisomerase II alpha by measuring the thiol reactivities with monobromobimane. Most of the measured reactivities are in accordance with the predicted ones based on a homology structural model generated from available crystal structures. However, these results reveal new information for both the residues not covered in the structural model and potential differences between the modeled and solution holoenzyme structures. Furthermore, on the basis of the reactivity changes of several cysteines located at the N-gate and DNA gate, we could monitor the movement of topoisomerase II in the presence of cofactors and detect differences in the DNA gate between two closed clamp enzyme conformations locked by either 5'-adenylyl beta,gamma-imidodiphosphate or the anticancer drug ICRF-193.	[Chen, Yu-Tsung; Collins, Tammy R. L.; Guan, Ziqiang; Chen, Vincent B.; Hsieh, Tao-Shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Hsieh, Tao-Shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Duke University; Academia Sinica - Taiwan	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	thsieh@duke.edu	Hsieh, Tao-shih/G-9305-2012; Wu, Wan-lin/G-8937-2012; Guan, Ziqiang/AAE-5110-2019	Collins, Tammy/0000-0002-8023-256X; Chen, Vincent/0000-0003-2492-979X	National Institutes of Health [GM29006]; Academia Sinica; United States Department of Defense Breast Cancer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academia Sinica(Academia Sinica - Taiwan); United States Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from National Institutes of Health (GM29006) and an intramural grant from Academia Sinica.; Supported in part by a grant from the United States Department of Defense Breast Cancer Research Program. Present address: Lab. of Molecular Genetics, NIEHS, NIH, Research Triangle Park, NC 27709.	Apuy JL, 2001, BIOCHEMISTRY-US, V40, P15153, DOI 10.1021/bi0112199; ATASSI MZ, 1972, IMMUNOCHEMISTRY, V9, P907, DOI 10.1016/0019-2791(72)90164-4; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Bender RP, 2006, BIOCHEMISTRY-US, V45, P10140, DOI 10.1021/bi0524666; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21335; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Fass D, 1999, NAT STRUCT BIOL, V6, P322; HABEEB AFS, 1972, BIOCHIM BIOPHYS ACTA, V263, P339, DOI 10.1016/0005-2795(72)90087-6; HANAI R, 1994, P NATL ACAD SCI USA, V91, P11904, DOI 10.1073/pnas.91.25.11904; HSIEH TS, 1983, METHOD ENZYMOL, V100, P161; Hu T, 2002, J BIOL CHEM, V277, P5944, DOI 10.1074/jbc.M111394200; Jensen LH, 2005, CANCER RES, V65, P7470, DOI 10.1158/0008-5472.CAN-05-0707; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim YJ, 2004, ANAL BIOCHEM, V332, P376, DOI 10.1016/j.ab.2004.06.033; KOSOWER EM, 1980, J AM CHEM SOC, V102, P4983, DOI 10.1021/ja00535a028; LEE MP, 1994, J MOL BIOL, V235, P436, DOI 10.1006/jmbi.1994.1004; Li W, 1997, J BIOL CHEM, V272, P31190, DOI 10.1074/jbc.272.49.31190; Lin RK, 2011, J BIOL CHEM, V286, P33591, DOI 10.1074/jbc.M111.258137; LIU LF, 1983, J BIOL CHEM, V258, P5365; Meczes EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001754; MORRISON A, 1979, CELL, V17, P175, DOI 10.1016/0092-8674(79)90305-2; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SANDER M, 1983, J BIOL CHEM, V258, P8421; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; Tu BP, 1999, P NATL ACAD SCI USA, V96, P4862, DOI 10.1073/pnas.96.9.4862; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WASSERMAN RA, 1993, CANCER RES, V53, P3591; Wei H, 2005, J BIOL CHEM, V280, P37041, DOI 10.1074/jbc.M506520200; Wood TD, 1998, P NATL ACAD SCI USA, V95, P3362, DOI 10.1073/pnas.95.7.3362; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Wu X, 2008, CHEM RES TOXICOL, V21, P483, DOI 10.1021/tx700341n; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	42	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25660	25668		10.1074/jbc.M112.377606	http://dx.doi.org/10.1074/jbc.M112.377606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679013	Green Published, hybrid			2022-12-28	WOS:000306651700073
J	Joubert, MK; Hokom, M; Eakin, C; Zhou, L; Deshpande, M; Baker, MP; Goletz, TJ; Kerwin, BA; Chirmule, N; Narhi, LO; Jawa, V				Joubert, Marisa K.; Hokom, Martha; Eakin, Catherine; Zhou, Lei; Deshpande, Meghana; Baker, Matthew P.; Goletz, Theresa J.; Kerwin, Bruce A.; Chirmule, Naren; Narhi, Linda O.; Jawa, Vibha			Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLERANT MICE; HEMOPHILIA-A; FC-RECEPTOR; FACTOR-VIII; WILD-TYPE; IMMUNOGENICITY; ACTIVATION; COMPLEXES; PARTICLES; MECHANISMS	Aggregation of biotherapeutics has the potential to induce an immunogenic response. Here, we show that aggregated therapeutic antibodies, previously generated and determined to contain a variety of attributes (Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., and Narhi, L.O. (2011) J. Biol. Chem. 286, 25118-25133), can enhance the in vitro innate immune response of a population of naive human peripheral blood mononuclear cells. This response depended on the aggregate type, inherent immunogenicity of the monomer, and donor responsiveness, and required a high number of particles, well above that detected in marketed drug products, at least in this in vitro system. We propose a cytokine signature as a potential biomarker of the in vitro peripheral blood mononuclear cell response to aggregates. The cytokines include IL-1 beta, IL-6, IL-10, MCP-1, MIP-1 alpha, MIP-1 beta, MMP-2, and TNF-alpha. IL-6 and IL-10 might have an immunosuppressive effect on the long term immune response. Aggregates made by stirring induced the highest response compared with aggregates made by other methods. Particle size in the 2-10 mu m range and the retention of some folded structure were associated with an increased response. The mechanism of aggregate activation at the innate phase was found to occur through specific cell surface receptors ( the toll-like receptors TLR-2 and TLR-4, Fc gamma Rs, and the complement system). The innate signal was shown to progress to an adaptive T-cell response characterized by T-cell proliferation and secretion of T-cell cytokines. Investigating the ability of aggregates to induce cytokine signatures as biomarkers of immune responses is essential for determining their risk of immunogenicity.	[Joubert, Marisa K.; Narhi, Linda O.] Amgen Inc, Dept Prod Attribute Sci, Thousand Oaks, CA 91320 USA; [Hokom, Martha; Deshpande, Meghana; Chirmule, Naren; Jawa, Vibha] Amgen Inc, Dept Clin Immunol, Thousand Oaks, CA 91320 USA; [Zhou, Lei] Amgen Inc, Dept Med Sci, Thousand Oaks, CA 91320 USA; [Eakin, Catherine] Amgen Inc, Dept Drug Substance Dev, Seattle, WA 98119 USA; [Kerwin, Bruce A.] Amgen Inc, Dept Drug Prod Dev, Seattle, WA 98119 USA; [Goletz, Theresa J.] Amgen Inc, Dept Clin Immunol, Seattle, WA 98119 USA; [Baker, Matthew P.] Antitope Ltd, Babraham Inst, Cambridge CB22 3AT, England	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Joubert, MK (corresponding author), 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mjoubert@amgen.com; vjawa01@amgen.com						ANDERSON CL, 1980, J IMMUNOL, V125, P2735; Babiuk S, 2004, J MED VIROL, V72, P138, DOI 10.1002/jmv.10540; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Braun A, 1997, PHARMACEUT RES, V14, P1472, DOI 10.1023/A:1012193326789; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brinks V, 2011, PHARM RES-DORDR, V28, P2379, DOI 10.1007/s11095-011-0523-5; Bussiere J L, 2003, Dev Biol (Basel), V112, P135; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.0.CO;2-I; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Demeule B, 2006, EUR J PHARM BIOPHARM, V62, P121, DOI 10.1016/j.ejpb.2005.08.008; den Engelsman J, 2011, PHARM RES-DORDR, V28, P920, DOI 10.1007/s11095-010-0297-1; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; Descotes J, 2007, CYTOKINES HUMAN HLTH, P193; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Fradkin AH, 2011, J PHARM SCI-US, V100, P4953, DOI 10.1002/jps.22683; Fradkin AH, 2009, J PHARM SCI-US, V98, P3247, DOI 10.1002/jps.21834; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Hermeling S, 2005, PHARM RES-DORDR, V22, P1997, DOI 10.1007/s11095-005-8177-9; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Jaber Amer, 2007, Drugs R D, V8, P335; Jaber A, 2007, J PHARMACEUT BIOMED, V43, P1256, DOI 10.1016/j.jpba.2006.10.023; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Laborde EA, 2007, J IMMUNOL, V179, P673, DOI 10.4049/jimmunol.179.1.673; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Luo QZ, 2011, J BIOL CHEM, V286, P25134, DOI 10.1074/jbc.M110.160440; Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200; Magi M, 2004, J ALLERGY CLIN IMMUN, V114, P545, DOI 10.1016/j.jaci.2004.04.014; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Patten P A, 2003, Dev Biol (Basel), V112, P81; Perry LCA, 2008, DRUGS R&D, V9, P385, DOI 10.2165/0126839-200809060-00004; Popi AF, 2004, IMMUNOLOGY, V113, P348, DOI 10.1111/j.1365-2567.2004.01969.x; Prior S, 2002, EUR J PHARM SCI, V15, P197, DOI 10.1016/S0928-0987(01)00218-4; Purohit VS, 2006, J PHARM SCI-US, V95, P358, DOI 10.1002/jps.20529; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Reichert JM, 2010, MABS-AUSTIN, V2, P84, DOI 10.4161/mabs.2.1.10677; Reipert BM, 2007, BRIT J HAEMATOL, V136, P12, DOI 10.1111/j.1365-2141.2006.06359.x; Roberts J. P., 2011, GENET ENG BIOTECHNOL, V31, P7; ROBINSON JJ, 1994, ANN RHEUM DIS, V53, P515, DOI 10.1136/ard.53.8.515; Ronnelid J, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.1.37; Rosenberg A, 2011, IMMUNOGENICITY 2011, P6; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Ryff JC, 2002, TRENDS PHARMACOL SCI, V23, P254, DOI 10.1016/S0165-6147(02)02024-2; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Seaver S, 2008, BIOQUALITY, V13, P3; Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; Singh SK, 2011, J PHARM SCI-US, V100, P354, DOI 10.1002/jps.22276; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Vultaggio A, 2011, CURR OPIN ALLERGY CL, V11, P262, DOI 10.1097/ACI.0b013e3283464bcd; Wang W, 2003, PHARM RES-DORDR, V20, P693, DOI 10.1023/A:1023271405005; WILLS RJ, 1992, CLIN PHARMACOKINET, V23, P406, DOI 10.2165/00003088-199223060-00002; Wullner D, 2010, CLIN IMMUNOL, V137, P5, DOI 10.1016/j.clim.2010.06.018; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016	65	184	195	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25266	25279		10.1074/jbc.M111.330902	http://dx.doi.org/10.1074/jbc.M111.330902			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22584577	Green Published, hybrid			2022-12-28	WOS:000306651700035
J	Li, L; Yan, B; Shi, YQ; Zhang, WQ; Wen, ZL				Li, Li; Yan, Bo; Shi, Yu-Qian; Zhang, Wen-Qing; Wen, Zi-Long			Live Imaging Reveals Differing Roles of Macrophages and Neutrophils during Zebrafish Tail Fin Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; GRANULOCYTE APOPTOSIS; GENE-EXPRESSION; INFLAMMATION; RESOLUTION; CELLS; IDENTIFICATION; BEHAVIOR; INJURY; REPAIR	Macrophages and neutrophils are the pivotal immune phagocytes that enter the wound after tissue injury to remove the cell debris and invaded microorganisms, which presumably facilitate the regrowth of injured tissues. Taking advantage of the regeneration abilities of zebrafish and the newly generated leukocyte-specific zebrafish lines with labeling of both leukocyte lineages, we assessed the behaviors and functions of neutrophils and macrophages during tail fin regeneration. Live imaging showed that within 6 hours post amputation, the inflammatory stage, neutrophils were the primary cells scavenging apoptotic bodies and small cell debris, although they had limited phagocytic capacity and quickly underwent apoptosis. From 6 hours post amputation on, the resolution and regeneration stage, macrophages became the dominant scavengers, efficiently resolving inflammation and facilitating tissue remodeling and regrowth. Ablation of macrophages but not neutrophils severely impaired the inflammatory resolution and tissue regeneration, resulting in the formation of large vacuoles in the regenerated fins. In contrast, removal of neutrophils slightly accelerates the regrowth of injured fin. Our study documents the differing behaviors and functions of macrophages and neutrophils during tissue regeneration.	[Zhang, Wen-Qing] So Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China; [Li, Li] Southwest Univ, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Three Gorges Area,Sch Life Sci, State Key Lab Breeding Base Ecoenvironm & Bioreso, Chongqing 400715, Peoples R China; [Li, Li; Yan, Bo; Shi, Yu-Qian; Wen, Zi-Long] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Kowloon 999077, Hong Kong, Peoples R China	Southern Medical University - China; Southwest University - China; Hong Kong University of Science & Technology	Zhang, WQ (corresponding author), So Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China.	zzwwqq@smu.edu.cn; zilong@ust.hk	zhang, wenqing/GYA-0786-2022; Shi, Yuqian/D-7230-2017	Shi, Yuqian/0000-0002-7218-5337; Wen, Zilong/0000-0002-4260-7682	Research Grants Council of the Hong Kong Special Administrative Region General Research Fund [663109, HKUST6/CRF/09]; National Basic Research Program of China Grant [2012CB945102]; National Natural Science Foundation of China Grants [31171403, 30828020]	Research Grants Council of the Hong Kong Special Administrative Region General Research Fund; National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grants Council of the Hong Kong Special Administrative Region General Research Fund Grants 663109 and HKUST6/CRF/09, National Basic Research Program of China Grant 2012CB945102, and National Natural Science Foundation of China Grants 31171403 and 30828020.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; Dobson JT, 2009, BRIT J HAEMATOL, V144, P732, DOI 10.1111/j.1365-2141.2008.07527.x; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Gray C, 2011, THROMB HAEMOSTASIS, V105, P811, DOI 10.1160/TH10-08-0525; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hallett JM, 2008, TRENDS PHARMACOL SCI, V29, P250, DOI 10.1016/j.tips.2008.03.002; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Jin H, 2006, DEV DYNAM, V235, P60, DOI 10.1002/dvdy.20613; Jin H., 2012, BLOOD IN PRESS; Jin H, 2009, DEVELOPMENT, V136, P647, DOI 10.1242/dev.029637; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; LEIBOVICH SJ, 1976, AM J PATHOL, V84, P501; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Leitch AE, 2008, MUCOSAL IMMUNOL, V1, P350, DOI 10.1038/mi.2008.31; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Westerfield M, 1999, METHOD CELL BIOL, V60, P339; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Zhang Y, 2008, J IMMUNOL, V181, P2155, DOI 10.4049/jimmunol.181.3.2155	46	215	220	8	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25353	25360		10.1074/jbc.M112.349126	http://dx.doi.org/10.1074/jbc.M112.349126			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22573321	Green Published, hybrid			2022-12-28	WOS:000306651700043
J	Schramm, A; Lee, B; Higgs, PI				Schramm, Andreas; Lee, Bongsoo; Higgs, Penelope I.			Intra- and Interprotein Phosphorylation between Two-hybrid Histidine Kinases Controls Myxococcus xanthus Developmental Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; 2-COMPONENT SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; PROTEIN-KINASE; CELL-DIFFERENTIATION; PHOSPHATASE-ACTIVITY; PERIPHERAL RODS; DOMAINS; SYSTEMS; AGGREGATION	Histidine-aspartate phosphorelay signaling systems are used to couple stimuli to cellular responses. A hallmark feature is the highly modular signal transmission modules that can form both simple "two-component" systems and sophisticated multicomponent systems that integrate stimuli over time and space to generate coordinated and fine-tuned responses. The deltaproteobacterium Myxococcus xanthus contains a large repertoire of signaling proteins, many of which regulate its multicellular developmental program. Here, we assign an orphan hybrid histidine protein kinase, EspC, to the Esp signaling system that negatively regulates progression through the M. xanthus developmental program. The Esp signal system consists of the hybrid histidine protein kinase, EspA, two serine/threonine protein kinases, and a putative transport protein. We demonstrate that EspC is an essential component of this system because Delta espA, Delta espC, and Delta espA Delta espC double mutants share an identical developmental phenotype. Neither substitution of the phosphoaccepting histidine residue nor deletion of the entire catalytic ATPase domain in EspC produces an in vivo mutant developmental phenotype. In contrast, substitution of the receiver phosphoaccepting residue yields the null phenotype. Although the EspC histidine kinase can efficiently autophosphorylate in vitro, it does not act as a phosphodonor to its own receiver domain. Our in vitro and in vivo analyses suggest the phosphodonor is instead the EspA histidine kinase. We propose EspA and EspC participate in a novel hybrid histidine protein kinase signaling mechanism involving both inter- and intraprotein phosphotransfer. The output of this signaling system appears to be the combined phosphorylated state of the EspA and EspC receiver modules. This system regulates the proteolytic turnover of MrpC, an important regulator of the developmental program.	[Schramm, Andreas; Lee, Bongsoo; Higgs, Penelope I.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	Max Planck Society	Higgs, PI (corresponding author), Max Planck Inst Terr Microbiol, Dept Ecophysiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	higgs@mpi-marburg.mpg.de	Lee, BongSoo/AAP-3262-2020; Higgs, Penelope/Y-8862-2019	Higgs, Penelope/0000-0003-4726-3329	Max Planck Society; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology	Max Planck Society(Max Planck Society); International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology	This work was supported in part by the Max Planck Society.; Supported by the International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ARIAS IM, 1969, J BIOL CHEM, V244, P3303; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; CAMPOS JM, 1975, P NATL ACAD SCI USA, V72, P518, DOI 10.1073/pnas.72.2.518; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09; Cho KY, 1999, MOL MICROBIOL, V34, P714, DOI 10.1046/j.1365-2958.1999.01633.x; Cho KY, 2000, J BACTERIOL, V182, P6614, DOI 10.1128/JB.182.23.6614-6621.2000; Dutta R, 2000, J BIOL CHEM, V275, P38645, DOI 10.1074/jbc.M005872200; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Higgs PI, 2008, J BACTERIOL, V190, P4416, DOI 10.1128/JB.00265-08; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Huntley S, 2012, J BACTERIOL, V194, P3012, DOI 10.1128/JB.00397-12; Huntley S, 2011, MOL BIOL EVOL, V28, P1083, DOI 10.1093/molbev/msq292; Inclan YF, 2008, MOL MICROBIOL, V68, P1328, DOI 10.1111/j.1365-2958.2008.06238.x; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Inouye S, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P191; Ivanova N, 2010, STAND GENOMIC SCI, V2, P96, DOI 10.4056/sigs.69.1277; Jagadeesan S, 2009, J BIOL CHEM, V284, P21435, DOI 10.1074/jbc.M109.033415; JANSSEN GR, 1985, DEV BIOL, V112, P194, DOI 10.1016/0012-1606(85)90133-2; Jiang P, 2000, BIOCHEMISTRY-US, V39, P13433, DOI 10.1021/bi000794u; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Lee B, 2005, J BACTERIOL, V187, P5029, DOI 10.1128/JB.187.14.5029-5031.2005; Lee B, 2010, METHOD ENZYMOL, V471, P253, DOI 10.1016/S0076-6879(10)71014-4; Li ZF, 2011, J BACTERIOL, V193, P5015, DOI 10.1128/JB.05516-11; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Maniatis T., 1982, MOL CLONING; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Muller FD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-264; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; NATH K, 1970, J BIOL CHEM, V245, P2889; Nikolskaya AN, 2003, J MOL MICROB BIOTECH, V5, P11, DOI 10.1159/000068720; OCONNOR KA, 1991, J BACTERIOL, V173, P3342, DOI 10.1128/jb.173.11.3342-3355.1991; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rasmussen AA, 2003, J BACTERIOL, V185, P5452, DOI 10.1128/JB.185.18.5452-5464.2003; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; SEGAL HL, 1963, P NATL ACAD SCI USA, V50, P912, DOI 10.1073/pnas.50.5.912; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; Stein EA, 2006, MOL MICROBIOL, V60, P1414, DOI 10.1111/j.1365-2958.2006.05195.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun H, 2001, J BACTERIOL, V183, P6733, DOI 10.1128/JB.183.23.6733-6739.2001; Sun H, 2001, J BACTERIOL, V183, P4786, DOI 10.1128/JB.183.16.4786-4795.2001; Thomas SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002103; TuAnh NH, 2010, P NATL ACAD SCI USA, V107, P21140, DOI 10.1073/pnas.1013081107; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; Wegener-Feldbrugge S, 2009, J BACTERIOL, V191, P1765, DOI 10.1128/JB.01405-08; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P169; Whitworth DE, 2008, MICROBIOL-SGM, V154, P360, DOI 10.1099/mic.0.2007/013672-0; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	67	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25060	25072		10.1074/jbc.M112.387241	http://dx.doi.org/10.1074/jbc.M112.387241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22661709	Green Published, hybrid			2022-12-28	WOS:000306651700019
J	Geijer, C; Ahmadpour, D; Palmgren, M; Filipsson, C; Klein, DM; Tamas, MJ; Hohmann, S; Lindkvist-Petersson, K				Geijer, Cecilia; Ahmadpour, Doryaneh; Palmgren, Madelene; Filipsson, Caroline; Klein, Dagmara Medrala; Tamas, Markus J.; Hohmann, Stefan; Lindkvist-Petersson, Karin			Yeast Aquaglyceroporins Use the Transmembrane Core to Restrict Glycerol Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY DOMAIN; CHANNEL; PROTEIN; AQUAPORIN; FPS1; FACILITATOR; SELECTIVITY; MEMBRANE; ARSENITE; STRESS	Aquaglyceroporins are transmembrane proteins belonging to the family of aquaporins, which facilitate the passage of specific uncharged solutes across membranes of cells. The yeast aquaglyceroporin Fps1 is important for osmoadaptation by regulating intracellular glycerol levels during changes in external osmolarity. Upon high osmolarity conditions, yeast accumulates glycerol by increased production of the osmolyte and by restricting glycerol efflux through Fps1. The extended cytosolic termini of Fps1 contain short domains that are important for regulating glycerol flux through the channel. Here we show that the transmembrane core of the protein plays an equally important role. The evidence is based on results from an intragenic suppressor mutation screen and domain swapping between the regulated variant of Fps1 from Saccharomyces cerevisiae and the hyperactive Fps1 ortholog from Ashbya gossypii. This suggests a novel mechanism for regulation of glycerol flux in yeast, where the termini alone are not sufficient to restrict Fps1 transport. We propose that glycerol flux through the channel is regulated by interplay between the transmembrane helices and the termini. This mechanism enables yeast cells to fine-tune intracellular glycerol levels at a wide range of extracellular osmolarities.	[Lindkvist-Petersson, Karin] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Klein, Dagmara Medrala] Thermo Fisher Sci, Clin Res & Dev Lab, Oxoid Microbiol, Basingstoke RG24 8PW, Hants, England; [Geijer, Cecilia; Ahmadpour, Doryaneh; Palmgren, Madelene; Filipsson, Caroline; Klein, Dagmara Medrala; Tamas, Markus J.; Hohmann, Stefan; Lindkvist-Petersson, Karin] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Lund University; Thermo Fisher Scientific; University of Gothenburg	Lindkvist-Petersson, K (corresponding author), Lund Univ, Dept Expt Med Sci, BMC C12, S-22184 Lund, Sweden.	Karin.Lindkvist@med.lu.se	Hohmann, Stefan/K-9895-2013; Tamas, Markus J/E-8183-2010	Hohmann, Stefan/0000-0002-0809-1985; Tamas, Markus J/0000-0002-0762-7848; Lindkvist, Karin/0000-0002-5209-3160; Geijer, Cecilia/0000-0002-4158-2938	Swedish Research Council; Swedish Foundation for Strategic Research; Cancer Foundation, Vinnova; European Community [RTN35995, NEST 012674, 201142]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Cancer Foundation, Vinnova; European Community(European Commission)	This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Cancer Foundation, Vinnova, and the European Community (AQUAGLYCEROPORIN (Grant RTN35995), SLEEPING BEAUTY (Grant NEST 012674), and FP7 UNICELLSYS (Contract 201142)).	Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Bansal A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-27; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Forster C, 1998, FEMS MICROBIOL LETT, V167, P209; Forster C, 1998, APPL MICROBIOL BIOT, V50, P219, DOI 10.1007/s002530051280; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hedfalk K, 2004, J BIOL CHEM, V279, P14954, DOI 10.1074/jbc.M313126200; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Jorde S, 2011, MICROBIOL RES, V166, P137, DOI 10.1016/j.micres.2010.09.003; Karlgren S, 2005, J BIOL CHEM, V280, P7186, DOI 10.1074/jbc.M413210200; Karlgren S, 2004, EUR J BIOCHEM, V271, P771, DOI 10.1111/j.1432-1033.2004.03980.x; Kato T, 2012, BIOTECHNOL LETT, V34, P611, DOI 10.1007/s10529-011-0833-z; Kondo H, 2002, EUR J BIOCHEM, V269, P1814, DOI 10.1046/j.1432-1033.2002.02821.x; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Sutherland FCW, 1997, J BACTERIOL, V179, P7790, DOI 10.1128/jb.179.24.7790-7795.1997; Tamas MJ, 2003, J BIOL CHEM, V278, P6337, DOI 10.1074/jbc.M209792200; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; von Bulow J, 2012, J BIOL CHEM, V287, P7487, DOI 10.1074/jbc.M111.329102; Walther A, 2008, NAT PROTOC, V3, P1414, DOI 10.1038/nprot.2008.137; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Wendland J, 2001, GENETICS, V157, P601; Wendland J, 2011, FEMS YEAST RES, V11, P418, DOI 10.1111/j.1567-1364.2011.00732.x; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x	34	11	11	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23562	23570		10.1074/jbc.M112.353482	http://dx.doi.org/10.1074/jbc.M112.353482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593571	Green Published, hybrid			2022-12-28	WOS:000306511300027
J	Shen, ZJ; Braun, RK; Hu, J; Xie, QF; Chu, HY; Love, RB; Stodola, LA; Rosenthal, LA; Szakaly, RJ; Sorkness, RL; Malter, JS				Shen, Zhong-Jian; Braun, Ruedi K.; Hu, Jie; Xie, Qifa; Chu, Haiyan; Love, Robert B.; Stodola, Levi A.; Rosenthal, Louis A.; Szakaly, Renee J.; Sorkness, Ronald L.; Malter, James S.			Pin1 Protein Regulates Smad Protein Signaling and Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LUNG FIBROBLASTS; EXPRESSION; EOSINOPHILS; DEGRADATION; SURVIVAL; CELLS; METALLOPROTEINASES; CONTRIBUTES; ANTAGONIST	Interstitial pulmonary fibrosis is caused by the excess production of extracellular matrix (ECM) by Fb in response to TGF-beta 1. Here, we show that the peptidyl-prolyl isomerase Pin1 modulates the production of many pro-and antifibrogenic cytokines and ECM. After acute, bleomycin injury, Pin1(-/-) mice showed reduced, pulmonary expression of collagens, tissue inhibitors of metalloproteinases, and fibrogenic cytokines but increased matrix metalloproteinases, compared with WT mice, despite similar levels of inflammation. In primary fibroblasts, Pin1 was required for TGF-beta-induced phosphorylation, nuclear translocation, and transcriptional activity of Smad3. In Pin1(-/-) cells, inhibitory Smad6 was found in the cytoplasm rather than nucleus. Smad6 knockdown in Pin1(-/-) fibroblasts restored TGF-beta-induced Smad3 activation, translocation, and target gene expression. Therefore, Pin1 is essential for normal Smad6 function and ECM production in response to injury or TGF-beta and thus may be an attractive therapeutic target to prevent excess scarring in diverse lung diseases.	[Shen, Zhong-Jian; Xie, Qifa; Chu, Haiyan; Stodola, Levi A.; Malter, James S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Rosenthal, Louis A.; Szakaly, Renee J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA; [Shen, Zhong-Jian; Xie, Qifa; Chu, Haiyan; Stodola, Levi A.; Malter, James S.] Univ Wisconsin, Waisman Ctr Dev Disabil, Madison, WI 53705 USA; [Braun, Ruedi K.; Love, Robert B.] Univ Wisconsin, Dept Pediat, Madison, WI 53792 USA; [Sorkness, Ronald L.] Univ Wisconsin, Dept Med & Pediat, Madison, WI 53706 USA; [Sorkness, Ronald L.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Hu, Jie; Malter, James S.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Southwestern Medical Center Dallas	Malter, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	James.Malter@UTSouthwestern.edu		Braun, Rudolf/0000-0002-1778-9613	National Institutes of Health [R01HL087950, P01HL088594, P30HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087950, P01HL088594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL087950, P01HL088594, and P30HD03352 (to J. S. M.).	Avcuoglu S, 2011, AM J RESP CELL MOL, V45, P768, DOI 10.1165/rcmb.2010-0195OC; Boussetta T, 2010, BLOOD, V116, P5795, DOI 10.1182/blood-2010-03-273094; Cataldo DD, 2003, CELL MOL BIOL, V49, P875; Chiappara G, 2001, CURR OPIN ALLERGY CL, V1, P85, DOI 10.1097/01.all.0000010990.97765.a1; Esnault S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000226; Fan G, 2009, CANCER RES, V69, P4589, DOI 10.1158/0008-5472.CAN-08-4117; Fang QH, 2006, AM J RESP CELL MOL, V35, P714, DOI 10.1165/rcmb.2005-0026OC; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Glesne D, 2006, ONCOGENE, V25, P4086, DOI 10.1038/sj.onc.1209436; Guo CX, 2009, BIOORG MED CHEM LETT, V19, P5613, DOI 10.1016/j.bmcl.2009.08.034; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Izquierdo JM, 2010, NUCLEIC ACIDS RES, V38, P8001, DOI 10.1093/nar/gkq698; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Le AV, 2007, J IMMUNOL, V178, P7310, DOI 10.4049/jimmunol.178.11.7310; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Ramos C, 2006, AM J PHYSIOL-LUNG C, V291, pL871, DOI 10.1152/ajplung.00019.2006; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Todorova L, 2009, RESP MED, V103, P1755, DOI 10.1016/j.rmed.2009.03.018; TOMPA A, 1979, IN VITRO CELL DEV B, V15, P569; Uhal BD, 2007, CURR PHARM DESIGN, V13, P1247, DOI 10.2174/138161207780618885; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Zheng L, 2004, J HEART LUNG TRANSPL, V23, P446, DOI 10.1016/S1053-2498(03)00199-2	39	31	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23294	23305		10.1074/jbc.M111.313684	http://dx.doi.org/10.1074/jbc.M111.313684			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613712	hybrid, Green Published			2022-12-28	WOS:000306511300004
J	Koo, BH; Kim, YH; Han, JH; Kim, DS				Koo, Bon-Hun; Kim, Yeon Hyang; Han, Jung Ho; Kim, Doo-Sik			Dimerization of Matrix Metalloproteinase-2 (MMP-2) FUNCTIONAL IMPLICATION IN MMP-2 ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN NEUTROPHIL GELATINASE; PROTEIN-KINASE-C; IV COLLAGENASE; REGULATORY MECHANISM; ENDOTHELIAL-CELLS; ALPHA-LACTALBUMIN; COMPLEX-FORMATION; STRUCTURAL BASIS; SNAKE-VENOM	Matrix metalloproteinase-2 (MMP-2) functions in diverse bio-logical processes through the degradation of extracellular and non-extracellular matrix molecules. Because of its potential for tissue damage, there are several ways to regulateMMP-2activity, including gene expression, compartmentalization, zymogen activation, and enzyme inactivation by extracellular inhibitors. Enzyme regulation through zymogen activation is important for the regulation ofMMP-2activity. In our previous studies, we showed that thrombin directly cleaved the propeptide of MMP-2 at specific sites for enzyme activation. We also demonstrated that heparan sulfate was required for thrombin-mediated activation of pro-MMP-2 by binding to thrombin, presumably through conformational changes at the active site of the enzyme. This suggests a regulatory mechanism for thrombin-mediated activation of pro-MMP-2. In this study, we found that MMP-2 formed a reduction-sensitive homodimerin a controlled manner and that Ca2+ ion was essential for homodimerization of MMP-2. Homodimerization was not associated with protein kinase C-mediated phosphorylation of MMP-2. MMP-2 formed a homodimer through an intermolecular disulfide bond between Cys(102) and the neighboring Cys(102). Homodimerization of MMP-2 enhanced thrombin-mediated activation of pro-MMP-2. Moreover, the MMP-2 homodimer could cleave a small peptide substrate without removal of the propeptide. Taken together, our experimental data suggest a novel regulatory mechanism for pro-MMP-2 activation that is modulated through Downloaded from www. jbc. org at ISI, Thomson Scientific, on July 17, 2012	[Koo, Bon-Hun; Kim, Yeon Hyang; Kim, Doo-Sik] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Han, Jung Ho] Seoul Natl Univ, Coll Med, Med Res Ctr, Seoul 110799, South Korea	Yonsei University; Seoul National University (SNU)	Koo, BH (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, 134 Sinchon Dong, Seoul 120749, South Korea.	k4119@yonsei.ac.kr; dskim@yonsei.ac.kr			Future-based Technology Development Program through National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2009-0081760]	Future-based Technology Development Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Future-based Technology Development Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science, and Technology Grant 2009-0081760.	Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Bescond A, 1999, BIOCHEM BIOPH RES CO, V263, P498, DOI 10.1006/bbrc.1999.1391; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chang JY, 2002, BIOCHEMISTRY-US, V41, P8405, DOI 10.1021/bi020169k; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Chen JM, 1998, BIOCHEM J, V335, P111, DOI 10.1042/bj3350111; Cominetti MR, 2003, ARCH BIOCHEM BIOPHYS, V416, P171, DOI 10.1016/S0003-9861(03)00298-4; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; Fernandez-Patron C, 2000, CIRC RES, V87, P670, DOI 10.1161/01.RES.87.8.670; Fujisaki S, 2003, BIOCHEM BIOPH RES CO, V300, P135, DOI 10.1016/S0006-291X(02)02791-2; Galis ZS, 1997, ARTERIOSCL THROM VAS, V17, P483, DOI 10.1161/01.ATV.17.3.483; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jackson MT, 2009, ARTHRITIS RHEUM-US, V60, P780, DOI 10.1002/art.24303; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Koo BH, 2010, J BIOL CHEM, V285, P41270, DOI 10.1074/jbc.M110.171595; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Mikhailova EO, 2009, BIOCHEMISTRY-MOSCOW+, V74, P308, DOI 10.1134/S0006297909030109; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakada M, 2001, CANCER RES, V61, P8896; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Nguyen M, 1999, LAB INVEST, V79, P467; Nie J, 2003, CANCER RES, V63, P6758; Nikai T, 2000, ARCH BIOCHEM BIOPHYS, V378, P6, DOI 10.1006/abbi.2000.1795; OISHI K, 1994, J CELL BIOCHEM, V55, P168, DOI 10.1002/jcb.240550203; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; RAO KR, 1989, BIOCHEM BIOPH RES CO, V163, P1390, DOI 10.1016/0006-291X(89)91133-9; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Wang ZB, 2009, NEUROSCI LETT, V451, P199, DOI 10.1016/j.neulet.2009.01.003; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Yazdanparast R, 2005, BIOTECHNOL APPL BIOC, V41, P157; Zhu DM, 1998, CLIN CANCER RES, V4, P2967	52	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22643	22653		10.1074/jbc.M111.337949	http://dx.doi.org/10.1074/jbc.M111.337949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577146	hybrid, Green Published			2022-12-28	WOS:000306495000021
J	Tung, HH; Lee, SL				Tung, Hsiu-Hui; Lee, Sheau-Ling			Neural Transmembrane Protease and Endothelial G(s) Protein Activation in Cell Contact-dependent Signaling between Neural Stem/Progenitor Cells and Brain Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; VASCULAR NICHE; SERINE-PROTEASE; FUSION PROTEIN; BLOOD-VESSELS; ADULT BRAIN; IN-VITRO; INTERLEUKIN-6; MIGRATION; DIFFERENTIATION	Vasculature is an important component of the neural stem cell niche in brain. It regulates neural stem/progenitor (NS/P) cell self-renewal, differentiation, and migration. In the neurogenic niches of adult brain, NS/P cells lie close to blood vessels, and proliferating NS/P cells frequently contact the vasculature. In the present study we showed that NS/P cells in co-culture with brain endothelial (bEND) cells activated endothelial G proteins and p38 mitogen-activated protein kinase ( p38 MAPK) and stimulated cytokine/ chemokine expression. These NS/P cell-induced endothelial responses took place during NS/P cell and bEND cell direct contact and were critically dependent on the expression of the type II transmembrane serine protease matriptase (MTP) by NS/P cells, because knocking down of MTP in NS/P cells impaired and re-expression of MTP restored their ability to induce endothelial cytokine/chemokine expression, p38 MAPK, or G protein activation. Cholera toxin blocked NS/P cell-induced endothelial responses, suggesting that the endothelial G protein activated by NS/P MTP is in the G(s) subfamily. The addition of p38 MAPK inhibitor impaired NS/P cell-induced endothelial cytokine/ chemokine expression. The known G protein-coupled receptor substrate of MTP, protease-activated receptor 2, was not involved in this system. These results revealed a novel signaling pathway in neural stem cell vascular niches that is mediated by neural MTP and endothelial Gs protein signaling at the cell-cell interface. This is the first report of direct cell-cell signaling between NS/P and bEND cells.	[Tung, Hsiu-Hui; Lee, Sheau-Ling] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.org.tw			National Health Research Institutes, Taiwan, Republic of China [00A1-CSPP13-014]	National Health Research Institutes, Taiwan, Republic of China(National Health Research Institutes - Taiwan)	This work was supported by National Health Research Institutes Grant 00A1-CSPP13-014 (to S.-L. L.) Taiwan, Republic of China.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Dong CY, 2008, EXP HEMATOL, V36, P938, DOI 10.1016/j.exphem.2008.03.009; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Fee D, 2000, CYTOKINE, V12, P655, DOI 10.1006/cyto.1999.0599; Gonzalez R, 2007, REGEN MED, V2, P771, DOI 10.2217/17460751.2.5.771; Gupta P, 2008, J CELL PHYSIOL, V215, P827, DOI 10.1002/jcp.21369; Hakkoum D, 2007, J NEUROCHEM, V100, P747, DOI 10.1111/j.1471-4159.2006.04257.x; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Honeth G, 2006, EXP CELL RES, V312, P1265, DOI 10.1016/j.yexcr.2005.12.018; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Jinquan T, 2001, J IMMUNOL, V167, P4405, DOI 10.4049/jimmunol.167.8.4405; Kaliberova LN, 2009, CANCER GENE THER, V16, P794, DOI 10.1038/cgt.2009.23; Kalwitz G, 2010, CONNECT TISSUE RES, V51, P113, DOI 10.3109/03008200903111906; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Poindexter NJ, 2010, EXP DERMATOL, V19, P714, DOI 10.1111/j.1600-0625.2010.01077.x; Rahmani M, 2010, MOL PHARMACOL, V78, P1096, DOI 10.1124/mol.110.068007; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Schafer KH, 1999, J INTERF CYTOK RES, V19, P527, DOI 10.1089/107999099313974; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zerlin M, 1997, J COMP NEUROL, V387, P537, DOI 10.1002/(SICI)1096-9861(19971103)387:4<537::AID-CNE5>3.0.CO;2-3	36	8	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22497	22508		10.1074/jbc.M111.330589	http://dx.doi.org/10.1074/jbc.M111.330589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577149	hybrid, Green Published			2022-12-28	WOS:000306495000008
J	Soule, J; Alme, M; Myrum, C; Schubert, M; Kanhema, T; Bramham, CR				Soule, Jonathan; Alme, Maria; Myrum, Craig; Schubert, Manja; Kanhema, Tambudzai; Bramham, Clive R.			Balancing Arc Synthesis, mRNA Decay, and Proteasomal Degradation MAXIMAL PROTEIN EXPRESSION TRIGGERED BY RAPID EYE MOVEMENT SLEEP-LIKE BURSTS OF MUSCARINIC CHOLINERGIC RECEPTOR STIMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; MUSCARINIC ACETYLCHOLINE-RECEPTORS; EARLY GENE ARC/ARG3.1; SH-SY5Y NEUROBLASTOMA-CELLS; PONTINE-WAVE GENERATOR; GYRUS IN-VIVO; SYNAPTIC PLASTICITY; ENDOPLASMIC-RETICULUM; RAT HIPPOCAMPUS; DORSAL HIPPOCAMPUS	Cholinergic signaling induces Arc/Arg3.1, an immediate early gene crucial for synaptic plasticity. However, the molecular mechanisms that dictate Arc mRNA and protein dynamics during and after cholinergic epochs are little understood. Using human SH-SY5Y neuroblastoma cells, we show that muscarinic cholinergic receptor (mAchR) stimulation triggers Arc synthesis, whereas translation-dependent RNA decay and proteasomal degradation strictly limit the amount and duration of Arc expression. Chronic application of the mAchR agonist, carbachol (Cch), induces Arc transcription via ERK signaling and release of calcium from IP3-sensitive stores. Arc translation requires ERK activation, but not changes in intracellular calcium. Proteasomal degradation of Arc (half-life similar to 37 min) was enhanced by thapsigargin, an inhibitor of the endoplasmic calcium-ATPase pump. Similar mechanisms of Arc protein regulation were observed in cultured rat hippocampal slices. Functionally, we studied the impact of cholinergic epoch duration and temporal pattern on Arc protein expression. Acute Cch treatment (as short as 2 min) induces transient, moderate Arc expression, whereas continuous treatment of more than 30 min induces maximal expression, followed by rapid decline. Cholinergic activity associated with rapid eye movement sleep may function to facilitate long term synaptic plasticity and memory. Employing a paradigm designed to mimic intermittent rapid eye movement sleep epochs, we show that application of Cch in a series of short bursts generates persistent and maximal Arc protein expression. The results demonstrate dynamic, multifaceted control of Arc synthesis during mAchR signaling, and implicate cholinergic epoch duration and repetition as critical determinants of Arc expression and function in synaptic plasticity and behavior.	[Soule, Jonathan; Alme, Maria; Myrum, Craig; Schubert, Manja; Kanhema, Tambudzai; Bramham, Clive R.] Univ Bergen, Dept Biomed, KG Jebsen Ctr Res Neuropsychiat Disorders, N-5009 Bergen, Norway	University of Bergen	Bramham, CR (corresponding author), Univ Bergen, Dept Biomed, KG Jebsen Ctr Res Neuropsychiat Disorders, Jonas Lies Vei 91, N-5009 Bergen, Norway.	clive.bramham@biomed.uib.no	Schubert, Manja/AAJ-9575-2021; Bramham, Clive/Q-1854-2018	Schubert, Manja/0000-0003-3592-2470; Bramham, Clive/0000-0001-5958-7115	Research Council of Norway [191912, 186115, 204861]; Western Norway Regional Health Authority; University of Bergen	Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority; University of Bergen	This work was supported by Research Council of Norway Grants 191912, 186115, and 204861, the Western Norway Regional Health Authority, and the University of Bergen.	Adams SV, 2004, HIPPOCAMPUS, V14, P413, DOI 10.1002/hipo.10197; AUERBACH JM, 1994, J NEUROPHYSIOL, V72, P2034, DOI 10.1152/jn.1994.72.4.2034; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Best J, 2007, J BIOL RHYTHM, V22, P220, DOI 10.1177/0748730407301239; BLOKLAND A, 1992, PSYCHOPHARMACOLOGY, V109, P373, DOI 10.1007/BF02245886; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; BRAMHAM CR, 1989, BRAIN RES, V493, P74, DOI 10.1016/0006-8993(89)91001-9; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Chotiner JK, 2010, LEARN MEMORY, V17, P117, DOI 10.1101/lm.1585910; Comte JC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056127; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Datta S, 2008, EUR J NEUROSCI, V27, P1876, DOI 10.1111/j.1460-9568.2008.06166.x; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ebihara T, 2006, J BIOCHEM, V139, P449, DOI 10.1093/jb/mvj064; FEIG S, 1993, J NEUROSCI, V13, P1010; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Fletcher BR, 2007, HIPPOCAMPUS, V17, P227, DOI 10.1002/hipo.20261; Garavito-Aguilar ZV, 2004, BRAIN RES, V1011, P177, DOI 10.1016/j.brainres.2004.03.020; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gil-Bea FJ, 2011, HIPPOCAMPUS, V21, P999, DOI 10.1002/hipo.20812; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guo X, 2011, J BIOL CHEM, V286, P18037, DOI 10.1074/jbc.M111.225615; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Hong M, 2004, J CELL BIOCHEM, V92, P723, DOI 10.1002/jcb.20118; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Ichikawa H, 2003, J PHARMACOL SCI, V91, P247; Ishikawa A, 2006, EUR J NEUROSCI, V24, P243, DOI 10.1111/j.1460-9568.2006.04874.x; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Kim JY, 1999, BIOCHEM J, V337, P275, DOI 10.1042/0264-6021:3370275; Leung LS, 2003, J NEUROSCI, V23, P9297; Lopez J, 2008, NEUROSCIENCE, V153, P44, DOI 10.1016/j.neuroscience.2008.01.072; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; MARROSU F, 1995, BRAIN RES, V671, P329, DOI 10.1016/0006-8993(94)01399-3; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MATESIC DF, 1991, FEBS LETT, V284, P184, DOI 10.1016/0014-5793(91)80680-2; MATHES C, 1994, J GEN PHYSIOL, V104, P107, DOI 10.1085/jgp.104.1.107; MATHES C, 1995, J GEN PHYSIOL, V106, P975, DOI 10.1085/jgp.106.5.975; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Natsume K, 1997, NEUROSCI RES, V27, P335, DOI 10.1016/S0168-0102(97)01167-X; Navakkode S, 2012, HIPPOCAMPUS, V22, P335, DOI 10.1002/hipo.20902; OFFERMANNS S, 1993, BIOCHEM J, V294, P545, DOI 10.1042/bj2940545; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Ravassard P, 2009, SLEEP, V32, P227, DOI 10.1093/sleep/32.2.227; Ribeiro S, 2012, PFLUG ARCH EUR J PHY, V463, P111, DOI 10.1007/s00424-011-1031-5; Rogers JL, 2003, NEUROBIOL LEARN MEM, V80, P332, DOI 10.1016/S1074-7427(03)00063-7; Romcy-Pereira R, 2004, EUR J NEUROSCI, V20, P3453, DOI 10.1111/j.1460-9568.2004.03808.x; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; SADEE W, 1987, CANCER RES, V47, P5207; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Teber I, 2004, MOL BRAIN RES, V121, P131, DOI 10.1016/j.molbrainres.2003.11.017; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toresson H, 2005, EUR J NEUROSCI, V22, P1793, DOI 10.1111/j.1460-9568.2005.04342.x; Ulloor J, 2005, J NEUROCHEM, V95, P418, DOI 10.1111/j.1471-4159.2005.03378.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; VIVALDI EA, 1994, J NEUROPHYSIOL, V72, P1745; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wylie PG, 1999, BIOCHEM J, V338, P619, DOI 10.1042/0264-6021:3380619; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	85	49	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					22354	22366		10.1074/jbc.M112.376491	http://dx.doi.org/10.1074/jbc.M112.376491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22584581	Green Published, hybrid			2022-12-28	WOS:000306418600072
J	Riad, A; Schwabedissen, HMZ; Weitmann, K; Herda, LR; Dorr, M; Empen, K; Kieback, A; Hummel, A; Reinthaler, M; Grube, M; Klingel, K; Nauck, M; Kandolf, R; Hoffmann, W; Kroemer, HK; Felix, SB				Riad, Alexander; Schwabedissen, Henriette Meyer Zu; Weitmann, Kerstin; Herda, Lars R.; Doerr, Marcus; Empen, Klaus; Kieback, Arne; Hummel, Astrid; Reinthaler, Marcus; Grube, Marcus; Klingel, Karin; Nauck, Matthias; Kandolf, Reinhard; Hoffmann, Wolfgang; Kroemer, Heyo K.; Felix, Stephan B.			Variants of Toll-like Receptor 4 Predict Cardiac Recovery in Patients with Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; TASK-FORCE; HEART-FAILURE; IMMUNOADSORPTION; MYOCARDITIS; TOLL-LIKE-RECEPTOR-4; ASSOCIATION; CARDIOLOGY; MICE; CLASSIFICATION	The clinical course of patients with dilated cardiomyopathy (DCM) varies from cardiac recovery to end stage heart failure. The etiology of this variability is largely unknown. In this study, we investigated the impact of coding polymorphisms of the innate immune protein Toll-like receptor 4 (TLR4) on left ventricular performance in patients with DCM. Two variants of TLR4 (rs4986790, TLR4 c.1187A -> G, p.299D -> G and rs4986791, TLR4c.1487C -> T, p.T399I) were investigated in 158 patients with DCM. Other reasons for heart failure were excluded by coronary angiography, myocardial biopsy, and echocardiography. Risk factors, age, gender, or treatment did not differ among the groups. At the follow-up evaluation (median 4.0-5.4 months), patients carrying the TLR4 wild type gene displayed cardiac recovery under intense medical heart failure therapy indexed by reduced left ventricular dilation, improved left ventricular ejection fraction, and reduced NT-probrain natriuretic peptide blood level when compared with the initial evaluation. In contrast, patients carrying both the rs4986790 and the rs4986791 variant showed significantly reduced improvement of left ventricular ejection fraction (p = 0.006) and left ventricular dilation (p = 0.015) at the follow-up evaluation when compared with carriers of the wild type gene under the same treatment conditions. In addition, NT-probrain natriuretic peptide level in carriers of both TLR4 variants did not change significantly at the follow up when compared with the first evaluation. Among patients with DCM, the presence of the TLR4 variants rs4986790 and rs4986791 predicts impaired cardiac recovery independently of medical treatment or cardiac risk factors.	[Riad, Alexander; Herda, Lars R.; Doerr, Marcus; Empen, Klaus; Kieback, Arne; Hummel, Astrid; Reinthaler, Marcus; Felix, Stephan B.] Univ Med Greifswald, Dept Cardiol & Pulmonol, D-17475 Greifswald, Germany; [Schwabedissen, Henriette Meyer Zu; Grube, Marcus; Kroemer, Heyo K.] Univ Med Greifswald, Dept Clin Pharmacol, D-17489 Greifswald, Germany; [Weitmann, Kerstin; Hoffmann, Wolfgang] Univ Med Greifswald, Dept Community Med, D-17487 Greifswald, Germany; [Nauck, Matthias] Univ Med Greifswald, Dept Lab Med, D-17487 Greifswald, Germany; [Klingel, Karin; Kandolf, Reinhard] Univ Tubingen, Inst Pathol & Neuropathol, Dept Mol Pathol, D-72076 Tubingen, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Riad, A (corresponding author), Univ Med Greifswald, Dept Cardiol & Pulmonol, D-17475 Greifswald, Germany.	alexander.riad@uni-greifswald.de	Dörr, Marcus/F-1919-2010	Dörr, Marcus/0000-0001-7471-475X; Meyer zu Schwabedissen, Henriette/0000-0003-0458-4579	Transregional Collaborative Research Centre of the German Research Foundation [SFB-TR-19]; Deutsche Herzstiftung [F/01/10]; German Centre of Cardiovascular Research from the German Ministry of Education and Science	Transregional Collaborative Research Centre of the German Research Foundation; Deutsche Herzstiftung; German Centre of Cardiovascular Research from the German Ministry of Education and Science	This work was supported by Transregional Collaborative Research Centre of the German Research Foundation Grant SFB-TR-19, Deutsche Herzstiftung Grant F/01/10, and the German Centre of Cardiovascular Research from the German Ministry of Education and Science.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Boekholdt SM, 2003, CIRCULATION, V107, P2416, DOI 10.1161/01.CIR.0000068311.40161.28; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; De Gennaro L, 2008, HEART VESSELS, V23, P445, DOI 10.1007/s00380-008-1075-4; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Garantziotis S, 2008, ANNU REV MED, V59, P343, DOI 10.1146/annurev.med.59.061206.112455; Herda LR, 2010, AM HEART J, V159, P809, DOI 10.1016/j.ahj.2010.01.012; Herda LR, 2009, ATHEROSCLEROSIS SUPP, V10, P126, DOI 10.1016/S1567-5688(09)71826-4; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kim Se-Chan, 2007, BMC Physiology, V7, P5, DOI 10.1186/1472-6793-7-5; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; McNamara DM, 2011, J AM COLL CARDIOL, V58, P1112, DOI 10.1016/j.jacc.2011.05.033; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Riad A, 2008, J IMMUNOL, V180, P6954, DOI 10.4049/jimmunol.180.10.6954; Riad A, 2008, EUR J HEART FAIL, V10, P233, DOI 10.1016/j.ejheart.2008.01.004; Riad A, 2011, J IMMUNOL, V186, P2561, DOI 10.4049/jimmunol.1002029; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Sheppard R, 2005, J AM COLL CARDIOL, V46, P1036, DOI 10.1016/j.jacc.2005.05.067; Shimamoto A, 2006, CIRCULATION, V114, pI270, DOI 10.1161/CIRCULATIONAHA.105.000901; Stapel H, 2006, EUR J HEART FAIL, V8, P665, DOI 10.1016/j.ejheart.2006.03.005; Staudt A, 2006, THER APHER DIAL, V10, P42, DOI 10.1111/j.1744-9987.2006.00343.x; Staudt A, 2001, CIRCULATION, V103, P2681; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167	34	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27236	27243		10.1074/jbc.M112.369728	http://dx.doi.org/10.1074/jbc.M112.369728			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22645142	hybrid, Green Published			2022-12-28	WOS:000307386000075
J	Muhle-Goll, C; Hoffmann, S; Afonin, S; Grage, SL; Polyansky, AA; Windisch, D; Zeitler, M; Burck, J; Ulrich, AS				Muhle-Goll, Claudia; Hoffmann, Silke; Afonin, Sergii; Grage, Stephan L.; Polyansky, Anton A.; Windisch, Dirk; Zeitler, Marcel; Buerck, Jochen; Ulrich, Anne S.			Hydrophobic Matching Controls the Tilt and Stability of the Dimeric Platelet-derived Growth Factor Receptor (PDGFR) beta Transmembrane Segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; TYROSINE KINASE; CIRCULAR-DICHROISM; EGF RECEPTOR; SPATIAL STRUCTURE; DOMAIN; MEMBRANE; HELIX; ACTIVATION; ORIENTATION	The platelet-derived growth factor receptor beta is a member of the cell surface receptor tyrosine kinase family and dimerizes upon activation. We determined the structure of the transmembrane segment in dodecylphosphocholine micelles by liquid-state NMR and found that it forms a stable left-handed helical dimer. Solid-state NMR and oriented circular dichroism were used to measure the tilt angle of the helical segments in macroscopically aligned model membranes with different acyl chain lengths. Both methods showed that decreasing bilayer thickness (DEPC-POPC-DMPC) led to an increase in the helix tilt angle from 10 to 30 with respect to the bilayer normal. At the same time, reconstitution of the comparatively long hydrophobic segment became less effective, eventually resulting in complete protein aggregation in the short-chain lipid DLPC. Unrestrained molecular dynamics simulations of the dimer were carried out in explicit lipid bilayers (DEPC, POPC, DMPC, sphingomyelin), confirming the observed dependence of the helix tilt angle on bilayer thickness. Notably, molecular dynamics revealed that the left-handed dimer gets tilted en bloc, whereas conformational transitions to alternative (e. g. right-handed dimeric) states were not supported. The experimental data along with the simulation results demonstrate a pronounced interplay between the platelet-directed growth factor receptor beta transmembrane segment and the bilayer thickness. The effect of hydrophobic mismatch might play a key role in the redistribution and activation of the receptor within different lipid microdomains of the plasma membrane in vivo.	[Muhle-Goll, Claudia; Hoffmann, Silke; Zeitler, Marcel; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Organ Chem, D-76131 Karlsruhe, Germany; [Muhle-Goll, Claudia; Hoffmann, Silke; Zeitler, Marcel; Ulrich, Anne S.] Karlsruhe Inst Technol, DFG Ctr Funct Nanostruct, D-76131 Karlsruhe, Germany; [Muhle-Goll, Claudia; Afonin, Sergii; Grage, Stephan L.; Windisch, Dirk; Buerck, Jochen; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76021 Karlsruhe, Germany; [Polyansky, Anton A.] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, AT-1030 Vienna, Austria; [Polyansky, Anton A.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Vienna; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Ulrich, AS (corresponding author), Karlsruhe Inst Technol, Inst Organ Chem, Fritz Haber Weg 6, D-76131 Karlsruhe, Germany.	anne.ulrich@kit.edu	Ulrich, Anne S/H-5519-2013; Afonin, Sergii/T-2737-2019; Muhle-Goll, Claudia/AAM-6070-2021; Polyansky, Anton A/J-2145-2018	Ulrich, Anne S/0000-0001-5571-9483; Afonin, Sergii/0000-0002-2356-4226; Polyansky, Anton A/0000-0002-1011-2706	European Union [026145]; Russian Ministry of Science and Education [MK-8439.2010.4]; Austrian Science Fund FWF START [Y 514-B11]	European Union(European Commission); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); Austrian Science Fund FWF START(Austrian Science Fund (FWF))	High-field NOESY spectra were recorded at the Frankfurt Facility for Biomolecular NMR, which is funded by the European Union Project "EU-NMR-European Network of Research Infrastructures for Providing Access and Technological Advancement in Bio-NMR" FP-2005-RII3 Contract 026145. The modeling part of the study was supported by Russian Ministry of Science and Education Grant MK-8439.2010.4 and Austrian Science Fund FWF START Grant Y 514-B11.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bocharov EV, 2008, J BIOL CHEM, V283, P29385, DOI 10.1074/jbc.M803089200; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; Clayton AHA, 2000, BBA-BIOMEMBRANES, V1467, P124, DOI 10.1016/S0005-2736(00)00208-X; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Fernandes F, 2003, BIOPHYS J, V85, P2430, DOI 10.1016/S0006-3495(03)74666-9; He LJ, 2011, BBA-BIOMEMBRANES, V1808, P253, DOI 10.1016/j.bbamem.2010.08.007; Isozaki K, 2006, CURR GENOMICS, V7, P469, DOI 10.2174/138920206779315755; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kim T, 2010, BIOPHYS J, V99, P175, DOI 10.1016/j.bpj.2010.04.015; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; LEWIS BA, 1983, J MOL BIOL, V166, P203, DOI 10.1016/S0022-2836(83)80006-0; Lindner R, 2009, EXP CELL RES, V315, P2871, DOI 10.1016/j.yexcr.2009.07.020; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Mathai JC, 2008, J GEN PHYSIOL, V131, P69, DOI 10.1085/jgp.200709848; Matveev SV, 2002, AM J PHYSIOL-CELL PH, V282, pC935, DOI 10.1152/ajpcell.00349.2001; Mineev KS, 2011, BBA-BIOMEMBRANES, V1808, P2081, DOI 10.1016/j.bbamem.2011.04.017; Mineev KS, 2010, J MOL BIOL, V400, P231, DOI 10.1016/j.jmb.2010.05.016; Monticelli L, 2010, BIOPHYS J, V99, P1455, DOI 10.1016/j.bpj.2010.05.039; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Park SH, 2005, J MOL BIOL, V350, P310, DOI 10.1016/j.jmb.2005.05.004; Petti LM, 1998, ONCOGENE, V16, P843, DOI 10.1038/sj.onc.1201590; Petti LM, 1997, J VIROL, V71, P7318, DOI 10.1128/JVI.71.10.7318-7327.1997; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; Polyansky AA, 2011, ADV PROTEIN CHEM STR, V83, P129, DOI 10.1016/B978-0-12-381262-9.00004-5; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Smeijers AF, 2006, J PHYS CHEM B, V110, P13614, DOI 10.1021/jp062012y; Strandberg E, 2009, BIOPHYS J, V96, P3223, DOI 10.1016/j.bpj.2009.02.040; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; VOGEL H, 1987, BIOCHEMISTRY-US, V26, P4562, DOI 10.1021/bi00388a060; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Windisch D, 2010, BIOPHYS J, V99, P1764, DOI 10.1016/j.bpj.2010.06.073; Xu Q, 2008, BIOPHYS J, V95, P2849, DOI 10.1529/biophysj.108.133629; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	47	52	53	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26178	26186		10.1074/jbc.M111.325555	http://dx.doi.org/10.1074/jbc.M111.325555			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22619173	Green Published, hybrid			2022-12-28	WOS:000306916300045
J	Kuhn-Nentwig, L; Fedorova, IM; Luscher, BP; Kopp, LS; Trachsel, C; Schaller, J; Vu, XL; Seebeck, T; Streitberger, K; Nentwig, W; Sigel, E; Magazanik, LG				Kuhn-Nentwig, Lucia; Fedorova, Irina M.; Luescher, Benjamin P.; Kopp, Lukas S.; Trachsel, Christian; Schaller, Johann; Vu, Xuan Lan; Seebeck, Thomas; Streitberger, Kathrin; Nentwig, Wolfgang; Sigel, Erwin; Magazanik, Lev G.			A Venom-derived Neurotoxin, CsTx-1, from the Spider Cupiennius salei Exhibits Cytolytic Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; AMINO-ACID-SEQUENCE; ANTIMICROBIAL PEPTIDES; SCORPION VENOMS; OUTER PORE; BETA-KTX; CHANNELS; CTENIDAE; TOXIN; PERMEABILITY	CsTx-1, the main neurotoxic acting peptide in the venom of the spider Cupiennius salei, is composed of 74 amino acid residues, exhibits an inhibitory cysteine knot motif, and is further characterized by its highly cationic charged C terminus. Venom gland cDNA library analysis predicted a prepropeptide structure for CsTx-1 precursor. In the presence of trifluoroethanol, CsTx-1 and the long C-terminal part alone (CT1-long; Gly-45-Lys-74) exhibit an alpha-helical structure, as determined by CD measurements. CsTx-1 and CT1-long are insecticidal toward Drosophila flies and destroys Escherichia coli SBS 363 cells. CsTx-1 causes a stable and irreversible depolarization of insect larvae muscle cells and frog neuromuscular preparations, which seem to be receptor-independent. Furthermore, this membranolytic activity could be measured for Xenopus oocytes, in which CsTx-1 and CT1-long increase ion permeability non-specifically. These results support our assumption that the membranolytic activities of CsTx-1 are caused by its C-terminal tail, CT1-long. Together, CsTx-1 exhibits two different functions; as a neurotoxin it inhibits L-type Ca2+ channels, and as a membranolytic peptide it destroys a variety of prokaryotic and eukaryotic cell membranes. Such a dualism is discussed as an important new mechanism for the evolution of spider venomous peptides.	[Kuhn-Nentwig, Lucia; Streitberger, Kathrin; Nentwig, Wolfgang] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Fedorova, Irina M.; Magazanik, Lev G.] Russian Acad Sci, IM Sechenov Inst Evolut Physiol & Biochem, St Petersburg 194223, Russia; [Luescher, Benjamin P.; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Kopp, Lukas S.; Trachsel, Christian; Schaller, Johann] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Vu, Xuan Lan; Seebeck, Thomas] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Magazanik, Lev G.] St Petersburg State Univ, Fac Med, St Petersburg 199034, Russia	University of Bern; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; University of Bern; University of Bern; University of Bern; Saint Petersburg State University	Kuhn-Nentwig, L (corresponding author), Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland.	lucia.kuhn@iee.unibe.ch	Sigel, Erwin/F-7736-2015; Nentwig, Wolfgang/A-6624-2011; Magazanik, Lev G/K-4380-2014	Magazanik, Lev G/0000-0002-5856-5798	Swiss National Science Foundation [310030-127500, 31003A-113681]; Russian Academy of Science "Molecular and Cell Biology"; Ministry of Education and Science of the Russian Federation [16.512.11.2197]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Russian Academy of Science "Molecular and Cell Biology"(Russian Academy of Sciences); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	We thank the Swiss National Science Foundation (Grants 310030-127500 and 31003A-113681) for funding. The work was further supported by a grant from the Russian Academy of Science "Molecular and Cell Biology" and a grant by the Ministry of Education and Science of the Russian Federation (state contract 16.512.11.2197).	Baur R, 2007, J NEUROCHEM, V103, P2556, DOI 10.1111/j.1471-4159.2007.04982.x; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Budnik BA, 2004, J MASS SPECTROM, V39, P193, DOI 10.1002/jms.577; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Diego-Garcia E, 2007, PEPTIDES, V28, P31, DOI 10.1016/j.peptides.2006.06.012; Dubovskii PV, 2011, FEBS J, V278, P4382, DOI 10.1111/j.1742-4658.2011.08361.x; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Fedorova IM, 2009, COMP BIOCHEM PHYS C, V149, P275, DOI 10.1016/j.cbpc.2008.07.010; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hurst AC, 2009, EUR BIOPHYS J BIOPHY, V38, P415, DOI 10.1007/s00249-008-0386-9; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kubista H, 2007, NEUROPHARMACOLOGY, V52, P1650, DOI 10.1016/j.neuropharm.2007.03.012; Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009; Kuhn-Nentwig L, 2002, J BIOL CHEM, V277, P11208, DOI 10.1074/jbc.M111099200; Kuhn-Nentwig L, 2000, ARCH INSECT BIOCHEM, V44, P101, DOI 10.1002/1520-6327(200007)44:3&lt;101::AID-ARCH1&gt;3.0.CO;2-S; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; Kuhn-Nentwig L, 2011, AMINO ACIDS, V40, P69, DOI 10.1007/s00726-009-0471-0; Kuhn-Nentwig Lucia, 2009, P447, DOI 10.1201/9781420061161-c19; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; MAGAZANIK LG, 1992, NEUROSCIENCE, V46, P181, DOI 10.1016/0306-4522(92)90017-V; Nishizawa M, 2007, BIOPHYS J, V92, P4233, DOI 10.1529/biophysj.106.101071; Platnick NI, 2011, WORLD SPIDER CATALOG; Selden PA, 2008, P NATL ACAD SCI USA, V105, P20781, DOI 10.1073/pnas.0809174106; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Trachsel C., 2010, THESIS U BERN SWITZE; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI [10.1042/BJ20071123, 10.1042/bj20071123]; Vassilevski AA, 2010, J BIOL CHEM, V285, P32293, DOI 10.1074/jbc.M110.104265; Villegas E, 2008, TOXICON, V52, P228, DOI 10.1016/j.toxicon.2008.05.019; Wang ZR, 2009, J GEN PHYSIOL, V133, P361, DOI 10.1085/jgp.200810139; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wullschleger B, 2005, J EXP BIOL, V208, P2115, DOI 10.1242/jeb.01594; Wullschleger B, 2004, P NATL ACAD SCI USA, V101, P11251, DOI 10.1073/pnas.0402226101; XU K, 1989, Acta Zoologica Sinica, V35, P300; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1; Zhu SY, 2010, BBA-PROTEINS PROTEOM, V1804, P872, DOI 10.1016/j.bbapap.2009.12.017	45	30	36	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25640	25649		10.1074/jbc.M112.339051	http://dx.doi.org/10.1074/jbc.M112.339051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22613721	hybrid, Green Published			2022-12-28	WOS:000306651700071
J	Duan, YJ; Chen, YL; Hu, WQ; Li, XJ; Yang, XX; Zhou, X; Yin, ZN; Kong, DL; Yao, Z; Hajjar, DP; Liu, L; Liu, Q; Han, JH				Duan, Yajun; Chen, Yuanli; Hu, Wenquan; Li, Xiaoju; Yang, Xiaoxiao; Zhou, Xin; Yin, Zhinan; Kong, Deling; Yao, Zhi; Hajjar, David P.; Liu, Lin; Liu, Qiang; Han, Jihong			Peroxisome Proliferator-activated Receptor gamma Activation by Ligands and Dephosphorylation Induces Proprotein Convertase Subtilisin Kexin Type 9 and Low Density Lipoprotein Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-REGENERATION; PLASMA-CHOLESTEROL; NONHUMAN-PRIMATES; DIABETIC-PATIENTS; LDL CHOLESTEROL; DEFICIENT MICE; MOUSE-LIVER; PPAR-GAMMA; PCSK9; ATHEROSCLEROSIS	Proprotein convertase subtilisin kexin type 9 (PCSK9) plays an important role in cholesterol homeostasis by enhancing the degradation of LDL receptor (LDLR) protein. Peroxisome proliferator-activated receptor gamma (PPAR gamma) has been shown to be atheroprotective. PPAR gamma can be activated by ligands and/or dephosphorylation with ERK1/2 inhibitors. The effect of PPAR gamma on PCSK9 and LDLR expression remains unknown. In this study, we investigated the effects of PPAR gamma on PCSK9 and LDLR expression. At the cellular levels, PPAR gamma ligands induced PCSK9 mRNA and protein expression in HepG2 cells. PCSK9 expression was induced by inhibition of ERK1/2 activity but inhibited by ERK1/2 activation. The mutagenic study and promoter activity assay suggested that the induction of PCSK9 expression by ERK1/2 inhibitors was tightly linked to PPAR gamma dephosphorylation. However, PPAR gamma activation by ligands or ERK1/2 inhibitors induced hepatic LDLR expression. The promoter assay indicated that the induction of LDLR expression by PPAR gamma was sterol regulatory element-dependent because PPAR gamma enhanced sterol regulatory element-binding protein 2 (SREBP2) processing. In vivo, administration of pioglitazone or U0126 alone increased PCSK9 expression in mouse liver but had little effect on PCSK9 secretion. However, the co-treatment of pioglitazone and U0126 enhanced both PCSK9 expression and secretion. Similar to in vitro, the increased PCSK9 expression by pioglitazone and/or U0126 did not result in decreased LDLR expression and function. In contrast, pioglitazone and/or U0126 increased LDLR protein expression and membrane translocation, SREBP2 processing, and CYP7A1 expression in the liver, which led to decreased total and LDL cholesterol levels in serum. Our results indicate that although PPAR gamma activation increased PCSK9 expression, PPAR gamma activation induced LDLR and CYP7A1 expression that enhanced LDL cholesterol metabolism.	[Duan, Yajun; Chen, Yuanli; Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Duan, Yajun; Chen, Yuanli; Hu, Wenquan; Li, Xiaoju; Yang, Xiaoxiao; Yin, Zhinan; Kong, Deling; Liu, Lin; Han, Jihong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zhou, Xin] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Cardiovasc Dis & Heart Ctr, Tianjin 300071, Peoples R China; [Yao, Zhi] Tianjin Med Univ, Tianjin 300071, Peoples R China; [Hajjar, David P.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Liu, Qiang] Univ Saskatchewan, Saskatoon, SK S7N 5A2, Canada	Nankai University; Nankai University; Tianjin Medical University; Cornell University; University of Saskatchewan	Han, JH (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	jihonghan2008@nankai.edu.cn	Zhou, Xin/AAH-7351-2019	Zhou, Xin/0000-0003-1395-7103	Ministry of Science and Technology of China [2010CB945003, 2009 DFB30560]; National Science Foundation of China [30971271, 81000128]; Tianjin Municipal Science and Technology Commission of China [08ZCKFSH04400, 2009ZCZDSF04200, 11JCYBJC10600]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission of China	This work was supported by Ministry of Science and Technology of China Grants 2010CB945003 and 2009 DFB30560 (to J. H.), National Science Foundation of China Grants 30971271 (to J. H.) and 81000128 (to Y. D.), and Tianjin Municipal Science and Technology Commission of China Grants 08ZCKFSH04400, 2009ZCZDSF04200, and 11JCYBJC10600 (to J. H.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Calkin AC, 2005, ARTERIOSCL THROM VAS, V25, P1903, DOI 10.1161/01.ATV.0000177813.99577.6b; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Chan DC, 2010, DIABETES OBES METAB, V12, P752, DOI 10.1111/j.1463-1326.2010.01229.x; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Costet P, 2010, ATHEROSCLEROSIS, V212, P246, DOI 10.1016/j.atherosclerosis.2010.05.027; Defesche Joep C, 2004, Semin Vasc Med, V4, P5; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Han JH, 2002, J BIOL CHEM, V277, P23582, DOI 10.1074/jbc.M200685200; Hsi LC, 2001, J BIOL CHEM, V276, P34545, DOI 10.1074/jbc.M100280200; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Konrad RJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-38; Kourimate S, 2008, J BIOL CHEM, V283, P9666, DOI 10.1074/jbc.M705831200; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Levi Z, 2003, DIABETES OBES METAB, V5, P45, DOI 10.1046/j.1463-1326.2003.00240.x; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Noguchi T, 2011, ATHEROSCLEROSIS, V217, P165, DOI 10.1016/j.atherosclerosis.2011.02.012; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Soutar AK, 2011, CURR OPIN LIPIDOL, V22, P192, DOI 10.1097/MOL.0b013e32834622b5; Troutt JS, 2010, J LIPID RES, V51, P345, DOI 10.1194/jlr.M000620; van Aalst-Cohen Emily S, 2004, Semin Vasc Med, V4, P31; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354	42	60	64	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23667	23677		10.1074/jbc.M112.350181	http://dx.doi.org/10.1074/jbc.M112.350181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593575	Green Published, hybrid			2022-12-28	WOS:000306511300037
J	Cabrera, PV; Pang, M; Marshall, JL; Kung, R; Nelson, SF; Stalnaker, SH; Wells, L; Crosbie-Watson, RH; Baum, LG				Cabrera, Paula V.; Pang, Mabel; Marshall, Jamie L.; Kung, Raymond; Nelson, Stanley F.; Stalnaker, Stephanie H.; Wells, Lance; Crosbie-Watson, Rachelle H.; Baum, Linda G.			High Throughput Screening for Compounds That Alter Muscle Cell Glycosylation Identifies New Role for N-Glycans in Regulating Sarcolemmal Protein Abundance and Laminin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS MUSCULAR-DYSTROPHY; CT GALNAC TRANSFERASE; ALPHA-DYSTROGLYCAN; SKELETAL-MUSCLE; GLYCOPROTEIN COMPLEX; O-GLYCAN; MDX MICE; OVEREXPRESSION; EXPRESSION; LOBELINE	Duchenne muscular dystrophy is an X-linked disorder characterized by loss of dystrophin, a cytoskeletal protein that connects the actin cytoskeleton in skeletal muscle cells to extracellular matrix. Dystrophin binds to the cytoplasmic domain of the transmembrane glycoprotein beta-dystroglycan (beta-DG), which associates with cell surface alpha-dystroglycan (alpha-DG) that binds laminin in the extracellular matrix. beta-DG can also associate with utrophin, and this differential association correlates with specific glycosylation changes on alpha-DG. Genetic modification of alpha-DG glycosylation can promote utrophin binding and rescue dystrophic phenotypes in mouse dystrophy models. We used high throughput screening with the plant lectin Wisteria floribunda agglutinin (WFA) to identify compounds that altered muscle cell surface glycosylation, with the goal of finding compounds that increase abundance of alpha-DG and associated sarcolemmal glycoproteins, increase utrophin usage, and increase laminin binding. We identified one compound, lobeline, from the Prestwick library of Food and Drug Administration-approved compounds that fulfilled these criteria, increasing WFA binding to C2C12 cells and to primary muscle cells from wild type and mdx mice. WFA binding and enhancement by lobeline required complex N-glycans but not O-mannose glycans that bind laminin. However, inhibiting complex N-glycan processing reduced laminin binding to muscle cell glycoproteins, although O-mannosylation was intact. Glycan analysis demonstrated a general increase in N-glycans on lobeline-treated cells rather than specific alterations in cell surface glycosylation, consistent with increased abundance of multiple sarcolemmal glycoproteins. This demonstrates the feasibility of high throughput screening with plant lectins to identify compounds that alter muscle cell glycosylation and identifies a novel role for N-glycans in regulating muscle cell function.	[Cabrera, Paula V.; Pang, Mabel; Kung, Raymond; Baum, Linda G.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Sch Med, Los Angeles, CA 90095 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, Dept Human Genet, Sch Med, Los Angeles, CA 90095 USA; [Marshall, Jamie L.; Crosbie-Watson, Rachelle H.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Crosbie-Watson, Rachelle H.; Baum, Linda G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Stalnaker, Stephanie H.; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Stalnaker, Stephanie H.; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Baum, LG (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Sch Med, 10833 LeConte Ave, Los Angeles, CA 90095 USA.	lbaum@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009; Wells, Lance/H-3118-2013	Nelson, Stanley F/0000-0002-2082-3114; Kung, Raymond/0000-0003-3476-9013; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [P30 AR057230, R01 AR048179, T32 GM07104]; Foundation to Eradicate Duchenne, Department of Defense [8528-01-03]; Muscular Dystrophy Association [RG 135449]; Edith Hyde Fellowship; Eureka Fellowship; UCLA Muscular Dystrophy Core Center (National Institutes of Health) [P30 AR057230]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230, R01AR048179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, T32GM007104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation to Eradicate Duchenne, Department of Defense(United States Department of Defense); Muscular Dystrophy Association(Muscular Dystrophy Association); Edith Hyde Fellowship; Eureka Fellowship; UCLA Muscular Dystrophy Core Center (National Institutes of Health); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 AR057230 (to L. G. B and R. C.-W.), R01 AR048179 (to R. C.-W.), and T32 GM07104 (to J. L. M.). This work was also supported by the Foundation to Eradicate Duchenne, Department of Defense Award 8528-01-03, and Muscular Dystrophy Association Grant RG 135449 (to L. G. B and R. C.-W.) and the Edith Hyde Fellowship and Eureka Fellowship (to J. L. M.). Support was also provided by the UCLA Muscular Dystrophy Core Center (National Institutes of Health Grant P30 AR057230), including the Bioinformatics and Genomics Core and the High Throughput Screening Core, using the UCLA Molecular Screening Shared Resource, in the Center for Duchenne Muscular Dystrophy at UCLA.	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Blake Derek J., 1994, Trends in Cell Biology, V4, P19, DOI 10.1016/0962-8924(94)90034-5; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; CAPALDI MJ, 1985, HISTOCHEM J, V17, P81, DOI 10.1007/BF01003405; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Dwoskin LP, 2002, BIOCHEM PHARMACOL, V63, P89, DOI 10.1016/S0006-2952(01)00899-1; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Esapa CT, 2003, FEBS LETT, V555, P209, DOI 10.1016/S0014-5793(03)01230-4; Gundry RL, 2009, MOL CELL PROTEOMICS, V8, P2555, DOI 10.1074/mcp.M900195-MCP200; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hu YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016866; Jayasinha V, 2003, BIOCHEM BIOPH RES CO, V302, P831, DOI 10.1016/S0006-291X(03)00271-7; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Kimura E, 2008, HUM MOL GENET, V17, P2507, DOI 10.1093/hmg/ddn151; Lee WC, 2010, J NEUROSCI, V30, P5489, DOI 10.1523/JNEUROSCI.6383-09.2010; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Nguyen HH, 2002, P NATL ACAD SCI USA, V99, P5616, DOI 10.1073/pnas.082613599; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Orlando R, 2009, J PROTEOME RES, V8, P3816, DOI 10.1021/pr8010028; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peter AK, 2009, HUM MOL GENET, V18, P318, DOI 10.1093/hmg/ddn358; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Santha E, 2000, J PHARMACOL EXP THER, V294, P302; Sgambato A, 2005, J CELL PHYSIOL, V205, P163, DOI 10.1002/jcp.20411; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Wilhelm CJ, 2008, BIOCHEM PHARMACOL, V75, P1411, DOI 10.1016/j.bcp.2007.11.019; Xia B, 2002, DEV BIOL, V242, P58, DOI 10.1006/dbio.2001.0530; Xu R, 2007, AM J PATHOL, V171, P181, DOI 10.2353/ajpath.2007.060927; Xu R, 2009, AM J PATHOL, V175, P235, DOI 10.2353/ajpath.2009.080967; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yoon JH, 2009, MOL CELL NEUROSCI, V41, P448, DOI 10.1016/j.mcn.2009.04.013; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang P, 2012, GLYCOBIOLOGY, V22, P235, DOI 10.1093/glycob/cwr131; Zhang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019080	39	12	12	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22759	22770		10.1074/jbc.M111.334581	http://dx.doi.org/10.1074/jbc.M111.334581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22570487	Green Published, hybrid			2022-12-28	WOS:000306495000033
J	Kim, YM; Saburi, W; Yu, S; Nakai, H; Maneesan, J; Kang, MS; Chiba, S; Kim, D; Okuyama, M; Mori, H; Kimura, A				Kim, Young-Min; Saburi, Wataru; Yu, Shukun; Nakai, Hiroyuki; Maneesan, Janjira; Kang, Min-Sun; Chiba, Seiya; Kim, Doman; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo			A Novel Metabolic Pathway for Glucose Production Mediated by alpha-Glucosidase-catalyzed Conversion of 1,5-Anhydrofructose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN DEGRADING ENZYME; SUBSTRATE-SPECIFICITY; ASPERGILLUS-NIGER; CRYSTAL-STRUCTURE; ALPHA-1,4-GLUCAN LYASE; DEXTRAN GLUCOSIDASE; SUBSITE AFFINITIES; AMINO-ACID; PURIFICATION; MECHANISM	alpha-Glucosidase is in the glycoside hydrolase family 13 (13AG) and 31 (31AG). Only 31AGs can hydrate the D-glucal double bond to form alpha-2-deoxyglucose. Because 1,5-anhydrofructose (AF), having a 2-OH group, mimics the oxocarbenium ion transition state, AF may be a substrate for alpha-glucosidases. alpha-Glucosidase-catalyzed hydration produced alpha-glucose from AF, which plateaued with time. Combined reaction with alpha-1,4-glucan lyase and 13AG eliminated the plateau. Aspergillus niger alpha-glucosidase (31AG), which is stable in organic solvent, produced ethyl alpha-glucoside from AF in 80% ethanol. The findings indicate that alpha-glucosidases catalyze trans-addition. This is the first report of alpha-glucosidase-associated glucose formation from AF, possibly contributing to the salvage pathway of unutilized AF.	[Kim, Young-Min; Saburi, Wataru; Nakai, Hiroyuki; Maneesan, Janjira; Kang, Min-Sun; Chiba, Seiya; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Yu, Shukun] Danisco AS, Danisco Innovat, DK-1001 Copenhagen, Denmark; [Kim, Doman] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea	Hokkaido University; Chonnam National University	Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.	kimura@abs.agr.hokudai.ac.jp	Saburi, Wataru/A-4271-2012; Okuyama, Masayuki/D-8739-2012; Mori, Haruhide/AAV-6374-2021; Mori, Haruhide/B-7777-2012	Saburi, Wataru/0000-0002-2015-7086; Okuyama, Masayuki/0000-0001-7013-6032; Mori, Haruhide/0000-0001-7346-9131; 	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	CHIBA S, 1965, AGR BIOL CHEM TOKYO, V29, P486, DOI 10.1080/00021369.1965.10858415; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; CHIBA S, 1988, BIOCHEMISTRY-US, V27, P1564, DOI 10.1021/bi00405a025; de Koker TH, 2004, APPL ENVIRON MICROB, V70, P5794, DOI 10.1128/AEM.70.10.5794-5800.2004; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Frandsen TP, 2000, PLANT PHYSIOL, V123, P275, DOI 10.1104/pp.123.1.275; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; HEHRE EJ, 1977, BIOCHEMISTRY-US, V16, P1780, DOI 10.1021/bi00628a003; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hirano K, 2000, GLYCOBIOLOGY, V10, P1283, DOI 10.1093/glycob/10.12.1283; Hondoh H, 2008, J MOL BIOL, V378, P913, DOI 10.1016/j.jmb.2008.03.016; KANAYA KI, 1976, AGR BIOL CHEM TOKYO, V40, P1929, DOI 10.1080/00021369.1976.10862342; Kim YM, 2005, TETRAHEDRON-ASYMMETR, V16, P403, DOI 10.1016/j.tetasy.2004.11.046; KIMURA A, 1992, BIOSCI BIOTECH BIOCH, V56, P1368, DOI 10.1271/bbb.56.1368; Kimura A, 1997, BIOSCI BIOTECH BIOCH, V61, P1091, DOI 10.1271/bbb.61.1091; KIMURA A, 1990, J BIOCHEM-TOKYO, V107, P762, DOI 10.1093/oxfordjournals.jbchem.a123122; KITA A, 1991, AGR BIOL CHEM TOKYO, V55, P2327, DOI 10.1080/00021369.1991.10870952; KURIKI T, 1995, ENZYME CHEM MOL BIOL, P87; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MATSUSAKA K, 1977, AGR BIOL CHEM TOKYO, V41, P1917, DOI 10.1080/00021369.1977.10862786; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Mori H, 2009, BIOSCI BIOTECH BIOCH, V73, P2466, DOI 10.1271/bbb.90447; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1703, DOI 10.1271/bbb.70125; Nishio T, 2002, CARBOHYD RES, V337, P629, DOI 10.1016/S0008-6215(02)00026-5; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; Saeki T., 1998, Journal of Applied Glycoscience, V45, P281; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; TAKEWAKI S, 1980, AGR BIOL CHEM TOKYO, V44, P731, DOI 10.1080/00021369.1980.10864027; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; YU S, 1993, BIOCHIM BIOPHYS ACTA, V1156, P313, DOI 10.1016/0304-4165(93)90049-E; Yu SK, 1999, BBA-PROTEIN STRUCT M, V1433, P1, DOI 10.1016/S0167-4838(99)00152-1; Yu SK, 2004, FOOD CHEM TOXICOL, V42, P1677, DOI 10.1016/j.fct.2004.06.004; YU SK, 1995, BBA-GEN SUBJECTS, V1244, P1, DOI 10.1016/0304-4165(94)00202-9	35	6	6	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22441	22444		10.1074/jbc.C112.360909	http://dx.doi.org/10.1074/jbc.C112.360909			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613728	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000306495000003
J	Li, XF; Kuang, JQ; Shen, Y; Majer, MM; Nelson, CC; Parsawar, K; Heichman, KA; Kuwada, SK				Li, Xiufen; Kuang, Jinqiu; Shen, Yi; Majer, Martin M.; Nelson, Chad C.; Parsawar, Krishna; Heichman, Karen A.; Kuwada, Scott K.			The Atypical Histone MacroH2A1.2 Interacts with HER-2 Protein in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL OVARIAN-CANCER; EPIDERMAL-GROWTH-FACTOR; HUMAN BREAST-CANCER; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; IONIZING-RADIATION; COLORECTAL-CANCER; TYROSINE KINASE; ERBB RECEPTORS; POOR SURVIVAL	Because HER-2 has been demonstrated in the nuclei of cancer cells, we hypothesized that it might interact with transcription factors that activate ERBB2 transcription. Macrohistone 2A1 ( H2AFY; mH2A1) was found to interact with HER-2 in cancer cells that overexpress HER-2. Of the two human mH2A1 isoforms, mH2A1.2, but not mH2A1.1, interacted with HER-2 in human cancer cell lines. Overexpression of mH2A1.2, but not mH2A1.1, in cancer cells significantly increased HER-2 expression and tumorigenicity. Inhibition of HER-2 kinase activity diminished mH2A1 expression and mH2A1.2-induced ERBB2 transcription in cancer cells. Chromatin immunoprecipitation of mH2A1.2 in cancer cells stably transfected with mH2A1.2 showed enrichment of mH2A1.2 at the HER-2 promoter, suggesting a role for mH2A1.2 in driving HER-2 overexpression. The evolutionarily conserved macro domain of mH2A1.2 was sufficient for the interaction between HER-2 and mH2A1.2 and for mH2A1.2-induced ERBB2 transcription. Within the macro domain of mH2A1.2, a trinucleotide insertion (-EIS-) sequence not found in mH2A1.1 was essential for the interaction between HER-2 and mH2A1.2 as well as mH2A1.2-induced HER-2 expression and cell proliferation.	[Li, Xiufen; Shen, Yi; Kuwada, Scott K.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA; [Kuang, Jinqiu; Majer, Martin M.] Corvallis Clin, Corvallis, OR 97330 USA; [Nelson, Chad C.; Parsawar, Krishna] Univ Utah, Dept Med Chem, Salt Lake City, UT 84132 USA; [Heichman, Karen A.] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA	University of Hawaii System; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kuwada, SK (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Med, 651 Ilalo St,BSB 211D, Honolulu, HI 96813 USA.	skkuwada@hawaii.edu			National Institutes of Health [5 G12 RR003061]; National Center for Research Resources; National Institute on Minority Health and Health Disparities [8 G12 MD007601]; NCI Cancer Center support grant; Veterans Affairs research grant; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs research grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 G12 RR003061, a Research Centers in Minority Institutions grant from the National Center for Research Resources, and 8 G12 MD007601 from the National Institute on Minority Health and Health Disparities and an NCI Cancer Center support grant (to the Huntsman Cancer Institute). This work was also supported by a Veterans Affairs research grant (to S. K. K.).	Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; BERCHUCK A, 1990, CANCER RES, V50, P4087; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Dittmann K, 2010, FEBS LETT, V584, P3878, DOI 10.1016/j.febslet.2010.08.005; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Farin K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006128; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Half E, 2004, INT J CANCER, V108, P540, DOI 10.1002/ijc.11599; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Kapitanovic S, 1997, GASTROENTEROLOGY, V112, P1103, DOI 10.1016/S0016-5085(97)70120-3; KAPITANOVIC S, 1994, CANCER DETECT PREV, V18, P97; Kapitanovic S, 2000, J CANCER RES CLIN, V126, P205, DOI 10.1007/s004320050034; Koka V, 2002, ANTICANCER RES, V22, P1593; Kono K, 2002, INT J CANCER, V98, P216, DOI 10.1002/ijc.10179; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Kuwada SK, 2004, INT J CANCER, V109, P291, DOI 10.1002/ijc.11686; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Marti U, 2001, THYROID, V11, P137, DOI 10.1089/105072501300042785; Nathanson DR, 2003, INT J CANCER, V105, P796, DOI 10.1002/ijc.11137; Novotny J, 2001, NEOPLASMA, V48, P188; Ogawa Y, 2005, BIOCHEM BIOPH RES CO, V336, P204, DOI 10.1016/j.bbrc.2005.08.046; Pegram MD, 1998, BREAST CANCER RES TR, V52, P65, DOI 10.1023/A:1006111117877; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Ross JS, 2001, CANCER INVEST, V19, P554, DOI 10.1081/CNV-100103852; SADASIVAN R, 1993, J UROLOGY, V150, P126, DOI 10.1016/S0022-5347(17)35413-7; Saxby AJ, 2005, AM J SURG PATHOL, V29, P1125, DOI 10.1097/01.pas.0000160979.85457.73; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; TIWARI RK, 1992, ANTICANCER RES, V12, P419; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294	43	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23171	23183		10.1074/jbc.M112.379412	http://dx.doi.org/10.1074/jbc.M112.379412			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22589551	Green Published, hybrid			2022-12-28	WOS:000306495000072
J	Rybin, VO; Guo, JF; Harleton, E; Zhang, F; Steinberg, SF				Rybin, Vitalyi O.; Guo, Jianfen; Harleton, Erin; Zhang, Fan; Steinberg, Susan F.			Regulatory Domain Determinants That Control PKD1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-D; C-MU; PROTEOLYTIC CLEAVAGE; D ACTIVATION; D1; IDENTIFICATION; CELLS	The canonical pathway for protein kinase D1 (PKD1) activation by growth factor receptors involves diacylglycerol binding to the C1 domain and protein kinase C-dependent phosphorylation at the activation loop. PKD1 then autophosphorylates at Ser(916), a modification frequently used as a surrogate marker of PKD1 activity. PKD1 also is cleaved by caspase-3 at a site in the C1-PH interdomain during apoptosis; the functional consequences of this cleavage event remain uncertain. This study shows that PKD1-Delta 1-321 (an N-terminal deletion mutant lacking the C1 domain and flanking sequence that models the catalytic fragment that accumulates during apoptosis) and PKD1-CD ( the isolated catalytic domain) display high basal Ser916 autocatalytic activity and robust activity toward CREBtide ( a peptide substrate) but little to no activation loop autophosphorylation and no associated activity toward protein substrates, such as cAMP-response element binding protein and cardiac troponin I. In contrast, PKD1-Delta PH (a PH domain deletion mutant) is recovered as a constitutively active enzyme, with high basal autocatalytic activity and high basal activity toward peptide and protein substrates. These results indicate that individual regions in the regulatory domain act in a distinct manner to control PKD1 activity. Finally, cell-based studies show that PKD1-Delta 1-321 does not substitute for WT-PKD1 as an in vivo activator of cAMP-response element binding protein and ERK phosphorylation. Proteolytic events that remove the C1 domain ( but not the autoinhibitory PH domain) limit maximal PKD1 activity toward physiologically relevant protein substrates and lead to a defect in PKD1-dependent cellular responses.	[Rybin, Vitalyi O.; Guo, Jianfen; Harleton, Erin; Zhang, Fan; Steinberg, Susan F.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University	Steinberg, SF (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pharmacol, 630 W 168 St, New York, NY 10032 USA.	sfs1@columbia.edu			National Institutes of Health (NIH), NHLBI [HL 77860]; National Center for Research Resources (NCRR) [TL1 RR024158]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077860, R01HL112388] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NHLBI, Grant HL 77860 and National Center for Research Resources (NCRR) (a component of the NIH and NIH Roadmap for Medical Research) Grant TL1 RR024158.	Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Gschwendt M, 1997, J BIOL CHEM, V272, P20742, DOI 10.1074/jbc.272.33.20742; Guo JF, 2011, J BIOL CHEM, V286, P6500, DOI 10.1074/jbc.M110.208058; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Haussermann S, 1999, FEBS LETT, V462, P442, DOI 10.1016/S0014-5793(99)01577-X; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Kim MS, 2009, DIABETES, V58, P2464, DOI 10.2337/db09-0681; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Vantus T, 2004, CELL SIGNAL, V16, P703, DOI 10.1016/j.cellsig.2003.11.009	15	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22609	22615		10.1074/jbc.M112.379719	http://dx.doi.org/10.1074/jbc.M112.379719			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22582392	hybrid, Green Published			2022-12-28	WOS:000306495000017
J	Banda, K; Gregg, CJ; Chow, R; Varki, NM; Varki, A				Banda, Kalyan; Gregg, Christopher J.; Chow, Renee; Varki, Nissi M.; Varki, Ajit			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups MECHANISMS UNDERLYING GASTROINTESTINAL INCORPORATION OF THE NON-HUMAN SIALIC ACID XENO-AUTOANTIGEN N-GLYCOLYLNEURAMINIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLNEURAMINIC ACID; GLYCOLOYLNEURAMINIC ACID; MOUSE-LIVER; HUMAN-MILK; HYDROXYLASE; EXPRESSION; CELLS; RAT; AUTOANTIBODIES; ANTIBODIES	Although N-acetyl groups are common in nature, N-glycolyl groups are rare. Mammals express two major sialic acids, N-acetylneuraminic acid and N-glycolylneuraminic acid (Neu5Gc). Although humans cannot produce Neu5Gc, it is detected in the epithelial lining of hollow organs, endothelial lining of the vasculature, fetal tissues, and carcinomas. This unexpected expression is hypothesized to result via metabolic incorporation of Neu5Gc from mammalian foods. This accumulation has relevance for diseases associated with such nutrients, via interaction with Neu5Gc-specific antibodies. Little is known about how ingested sialic acids in general and Neu5Gc in particular are metabolized in the gastrointestinal tract. We studied the gastrointestinal and systemic fate of Neu5Gc-containing glycoproteins (Neu5Gc-glycoproteins) or free Neu5Gc in the Neu5Gc-free Cmah(-/-) mouse model. Ingested free Neu5Gc showed rapid absorption into the circulation and urinary excretion. In contrast, ingestion of Neu5Gc-glycoproteins led to Neu5Gc incorporation into the small intestinal wall, appearance in circulation at a steady-state level for several hours, and metabolic incorporation into multiple peripheral tissue glycoproteins and glycolipids, thus conclusively proving that Neu5Gc can be metabolically incorporated from food. Feeding Neu5Gc-glycoproteins but not free Neu5Gc mimics the human condition, causing tissue incorporation into human-like sites in Cmah(-/-) fetal and adult tissues, as well as developing tumors. Thus, glycoproteins containing glycosidically linked Neu5Gc are the likely dietary source for human tissue accumulation, and not the free monosaccharide. This human-like model can be used to elucidate specific mechanisms of Neu5Gc delivery from the gut to tissues, as well as general mechanisms of metabolism of ingested sialic acids.	[Banda, Kalyan; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Gregg, Christopher J.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chow, Renee; Varki, Nissi M.] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu			National Institutes of Health [R01GM32373]; Institut Merieux; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Merieux; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM32373. This work was also supported by a research grant from the Institut Merieux. A. V. and N. M. V. are co-founders of and consultants for Sialix Inc., a biotech startup company interested in the practical implications of Neu5Gc uptake in humans.	Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bergfeld AK, 2012, J BIOL CHEM, V287, P28865, DOI 10.1074/jbc.M112.363549; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; DICKSON JJ, 1978, BIOCHEM J, V170, P407, DOI 10.1042/bj1700407; Eckhardt AE, 1997, J BIOL CHEM, V272, P33204, DOI 10.1074/jbc.272.52.33204; Gottschalk A, 1960, CHEM BIOL SIALIC ACI, P1; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P251; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Lofling JC, 2009, KIDNEY INT, V76, P140, DOI 10.1038/ki.2009.131; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; MORGAN BLG, 1979, P SOC EXP BIOL MED, V161, P534; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; NOHLE U, 1984, H-S Z PHYSIOL CHEM, V365, P1457, DOI 10.1515/bchm2.1984.365.2.1457; NOHLE U, 1981, H-S Z PHYSIOL CHEM, V362, P1495, DOI 10.1515/bchm2.1981.362.2.1495; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; NORGARD KE, 1993, P NATL ACAD SCI USA, V90, P1068, DOI 10.1073/pnas.90.3.1068; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Pearce OMT, 2010, CARBOHYD RES, V345, P1225, DOI 10.1016/j.carres.2010.04.003; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Schauer R, 1978, Methods Enzymol, V50, P64; Schauer R, 2009, CARBOHYD RES, V344, P1494, DOI 10.1016/j.carres.2009.05.020; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; SHAW L, 1994, EUR J BIOCHEM, V219, P1001, DOI 10.1111/j.1432-1033.1994.tb18583.x; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; TAKEMATSU H, 1994, J BIOCHEM-TOKYO, V115, P381, DOI 10.1093/oxfordjournals.jbchem.a124347; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; TSO P, 1986, AM J PHYSIOL, V250, pG715, DOI 10.1152/ajpgi.1986.250.6.G715; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Wang B, 2001, AM J CLIN NUTR, V74, P510; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615	50	69	73	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28852	28864		10.1074/jbc.M112.364182	http://dx.doi.org/10.1074/jbc.M112.364182			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692204	Green Published, hybrid			2022-12-28	WOS:000308074600057
J	Devel, L; Beau, F; Amoura, M; Vera, L; Cassar-Lajeunesse, E; Garcia, S; Czarny, B; Stura, EA; Dive, V				Devel, Laurent; Beau, Fabrice; Amoura, Mehdi; Vera, Laura; Cassar-Lajeunesse, Evelyne; Garcia, Sandra; Czarny, Bertrand; Stura, Enrico A.; Dive, Vincent			Simple Pseudo-dipeptides with a P-2(') Glutamate A NOVEL INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER METZINCINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC CHELATING INHIBITORS; CONFORMATIONAL VARIABILITY; SELECTIVE-INHIBITION; POTENTIAL TREATMENT; BINDING INHIBITORS; STRUCTURAL BASIS; DRUG TARGETS; LIGAND; CANCER; 3RD-GENERATION	A series of pseudo-peptides with general formula X-L-Glu-NH2 (with X corresponding to an acyl moiety with a long aryl-alkyl side chain) have been synthesized, evaluated as inhibitors of matrix metalloproteases (MMPs), and found to display remarkable nanomolar affinity. The loss in potency associated with a substitution of the P-2' L-glutamate by a L-glutamine corroborates the importance of a carboxylate at this position. The binding mode of some of these inhibitors was characterized in solution and by x-ray crystallography in complex with various MMPs. The x-ray crystal structures reveal an unusual binding mode with the glutamate side chain chelating the active site zinc ion. Competition experiments between these inhibitors and acetohydroxamic acid, a small zinc-binding molecule, are in accord with the crystallographic results. One of these pseudo-dipeptides displays potency and selectivity toward MMP-12 similar to the best MMP-12 inhibitors reported to date. This novel family of pseudo peptides opens new opportunities to develop potent and selective inhibitors for several metzincins.	[Devel, Laurent; Beau, Fabrice; Amoura, Mehdi; Vera, Laura; Cassar-Lajeunesse, Evelyne; Garcia, Sandra; Czarny, Bertrand; Stura, Enrico A.; Dive, Vincent] CE Saclay, CEA, iBiTec S, Serv Ingn Mol Prot SIMOPRO, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Devel, L (corresponding author), CE Saclay, CEA, iBiTec S, Serv Ingn Mol Prot SIMOPRO, Bat 152, F-91191 Gif Sur Yvette, France.	laurent.devel@cea.fr	Stura, Enrico A./A-2793-2010; CZARNY, bertrand/AAP-6603-2020; Czarny, Bertrand/F-2001-2018	Stura, Enrico A./0000-0001-6718-2118; CZARNY, bertrand/0000-0002-9586-0913; Czarny, Bertrand/0000-0002-9586-0913	Commissariat a l'Energie Atomique (CEA)	Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by the Commissariat a l'Energie Atomique (CEA).	Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bode W, 2003, BIOCHEM SOC SYMP, V70, P1; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Dabert-Gay AS, 2008, J BIOL CHEM, V283, P31058, DOI 10.1074/jbc.M805795200; De Savi C, 2012, BIOORG MED CHEM LETT, V22, P271, DOI 10.1016/j.bmcl.2011.11.034; De Savi C, 2011, BIOORG MED CHEM LETT, V21, P4215, DOI 10.1016/j.bmcl.2011.05.075; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Devel L., 2011, Patent No. [WO2011/023864, 2011023864]; Devel L, 2010, J BIOL CHEM, V285, P35900, DOI 10.1074/jbc.M110.139634; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Gao DA, 2010, BIOORG MED CHEM LETT, V20, P5039, DOI 10.1016/j.bmcl.2010.07.036; Gege C, 2012, J MED CHEM, V55, P709, DOI 10.1021/jm201152u; Heim-Riether A, 2009, BIOORG MED CHEM LETT, V19, P5321, DOI 10.1016/j.bmcl.2009.07.151; Holmes IP, 2009, BIOORG MED CHEM LETT, V19, P5760, DOI 10.1016/j.bmcl.2009.07.155; HOROVITZ A, 1987, P NATL ACAD SCI USA, V84, P6654, DOI 10.1073/pnas.84.19.6654; Jacobsen JA, 2010, BBA-MOL CELL RES, V1803, P72, DOI 10.1016/j.bbamcr.2009.08.006; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lagente V, 2010, J MOL CELL CARDIOL, V48, P440, DOI 10.1016/j.yjmcc.2009.09.017; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li JJ, 2008, J MED CHEM, V51, P835, DOI 10.1021/jm701274v; Li W, 2009, J MED CHEM, V52, P5408, DOI 10.1021/jm900809r; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Piecha D, 2010, INFLAMM RES, V59, P379, DOI 10.1007/s00011-009-0112-9; Pochetti G, 2009, J MED CHEM, V52, P1040, DOI 10.1021/jm801166j; Quillard T, 2011, ARTERIOSCL THROM VAS, V31, P2464, DOI 10.1161/ATVBAHA.111.231563; Roth J, 2011, BIOORG MED CHEM LETT, V21, P7180, DOI 10.1016/j.bmcl.2011.09.077; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Schnute ME, 2010, BIOORG MED CHEM LETT, V20, P576, DOI 10.1016/j.bmcl.2009.11.081; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tu GG, 2008, CURR MED CHEM, V15, P1388, DOI 10.2174/092986708784567680; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yiotakis A, 2008, MOL ASPECTS MED, V29, P329, DOI 10.1016/j.mam.2008.06.001; YONETANI T, 1982, METHOD ENZYMOL, V87, P500	58	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26647	26656		10.1074/jbc.M112.380782	http://dx.doi.org/10.1074/jbc.M112.380782			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22689580	Green Published, hybrid			2022-12-28	WOS:000307386000016
J	Li, L; Carrie, C; Nelson, C; Whelan, J; Millar, AH				Li, Lei; Carrie, Chris; Nelson, Clark; Whelan, James; Millar, A. Harvey			Accumulation of Newly Synthesized F-1 in Vivo in Arabidopsis Mitochondria Provides Evidence for Modular Assembly of the Plant F1Fo ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN COMPLEXES; NATIVE ELECTROPHORESIS; GEL-ELECTROPHORESIS; RESPIRATORY-CHAIN; F1F0-ATP SYNTHASE; FUNCTIONAL ASSAYS; SUBUNITS; IDENTIFICATION; SUPERCOMPLEXES; SUBCOMPLEXES	F-1 subcomplex in mitochondrial samples is often considered to be a breakage product of the F1FO ATP synthase during sample handling and electrophoresis. We have used a progressive N-15 incorporation strategy to investigate the plant F1FO ATP synthase assembly model and the apparently free F-1 in plant mitochondria which is found in both the inner membrane and matrix. We show that subunits within F-1 in the inner membrane and matrix had a relatively higher N-15 incorporation rate than corresponding subunits in intact membrane F1FO. This demonstrates that free F-1 was a newer pool with a faster turnover rate consistent with it being an assembly intermediate in vivo. Import of [S-35] Met-labeled F-1 subunit precursors into Arabidopsis mitochondria showed the rapid accumulation of F-1 assembly intermediates. The different N-15 incorporation rate in matrix F-1, inner membrane F-1 and intact F1FO demonstrates these three represent different protein populations and are likely step by step intermediates during the assembly process of plant mitochondrial ATP synthase. The potential biological implications of in vivo accumulation of enzymatically active F-1 in mitochondria are discussed.	[Li, Lei; Carrie, Chris; Nelson, Clark; Whelan, James; Millar, A. Harvey] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Li, Lei; Nelson, Clark; Millar, A. Harvey] Univ Western Australia, Ctr Comparat Anal Biomol Networks, Crawley, WA 6009, Australia	University of Western Australia; University of Western Australia	Millar, AH (corresponding author), Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, MCS Bldg M316, Crawley, WA 6009, Australia.	harvey.millar@uwa.edu.au	Li, Lei/A-1631-2012; Whelan, James/F-6402-2011; Millar, A. Harvey/A-5452-2008; Carrie, Chris/A-2638-2010	Li, Lei/0000-0003-1508-5484; Whelan, James/0000-0001-5754-025X; Millar, A. Harvey/0000-0001-9679-1473; Carrie, Chris/0000-0002-4240-4674; Nelson, Clark/0000-0002-8796-8326	ARC Centre of Excellence in Plant Energy Biology [CE0561495]; Scholarship International Research Fees (SIRF); University International Stipend (UIS); Top Up Scholarship	ARC Centre of Excellence in Plant Energy Biology(Australian Research Council); Scholarship International Research Fees (SIRF); University International Stipend (UIS); Top Up Scholarship	This work was funded by the ARC Centre of Excellence in Plant Energy Biology (CE0561495) (to A. H. M. and J. W.).; Funded by Scholarship International Research Fees (SIRF), University International Stipend (UIS), and a Top Up Scholarship for UIS.	ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Carrie C, 2010, J BIOL CHEM, V285, P36138, DOI 10.1074/jbc.M110.121202; Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729; Cortes-Hernandez P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Diaz F., 2009, CURR PROTOC HUM GENE, V19, P41; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; HAMASUR B, 1992, EUR J BIOCHEM, V205, P409, DOI 10.1111/j.1432-1033.1992.tb16794.x; Heazlewood JL, 2003, FEBS LETT, V540, P201, DOI 10.1016/S0014-5793(03)00264-3; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Lee CP, 2008, MOL CELL PROTEOMICS, V7, P1297, DOI 10.1074/mcp.M700535-MCP200; Li L., 2012, MOL CELL PROTEOMICS, DOI M111.010025; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; MYERS M, 1993, J CELL PHYSIOL, V156, P35, DOI 10.1002/jcp.1041560106; Nijtmans LGJ, 1995, BBA-MOL BASIS DIS, V1272, P190, DOI 10.1016/0925-4439(95)00087-9; Rak M, 2011, FEBS LETT, V585, P2582, DOI 10.1016/j.febslet.2011.07.011; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Sabar M, 2003, EMBO REP, V4, P381, DOI 10.1038/sj.embor.embor800; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Sperling E, 2008, ANAL CHEM, V80, P4906, DOI 10.1021/ac800080v; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Werhahn W, 2002, ELECTROPHORESIS, V23, P640, DOI 10.1002/1522-2683(200202)23:4&lt;640::AID-ELPS640&gt;3.0.CO;2-F; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006	40	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25749	25757		10.1074/jbc.M112.373506	http://dx.doi.org/10.1074/jbc.M112.373506			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22674576	hybrid, Green Published			2022-12-28	WOS:000306916300006
J	Hozumi, K; Ishikawa, M; Hayashi, T; Yamada, Y; Katagiri, F; Kikkawa, Y; Nomizu, M				Hozumi, Kentaro; Ishikawa, Masaya; Hayashi, Takemitsu; Yamada, Yuji; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi			Identification of Cell Adhesive Sequences in the N-terminal Region of the Laminin alpha 2 Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-DOMAIN; BINDING-SITES; SYNTHETIC PEPTIDES; GLOBULAR DOMAIN; HEPARIN-BINDING; MUSCULAR-DYSTROPHY; CHITOSAN MEMBRANES; NEURITE OUTGROWTH; SHORT ARM; INTEGRIN	The laminin alpha 2 chain is specifically expressed in the basement membrane surrounding muscle and nerve. We screened biologically active sequences in the mouse laminin N-terminal region of alpha 2 chain using 216 soluble peptides and three recombinant proteins (rec-a2LN, rec-a2LN+, and rec-a2N) by both the peptide-or protein-coated plate and the peptide-conjugated Sepharose bead assays. Ten peptides showed cell attachment activity in the plate assay, and 8 peptides were active in the bead assay. Seven peptides were active in the both assays. Five peptides promoted neurite outgrowth with PC12 cells. To clarify the cellular receptors, we examined the effects of heparin and EDTA on cell attachment to 11 active peptides. Heparin inhibited cell attachment to 10 peptides, and EDTA significantly affected only A2-8 peptide (YHYVTITLDLQQ, mouse laminin alpha 2 chain, 117-128)-mediated cell attachment. Cell attachment to A2-8 was also specifically inhibited by anti-integrin beta 1 and anti-integrin alpha 2 beta 1 antibodies. These results suggest that A2-8 promotes an integrin alpha 2 beta 1-mediated cell attachment. The rec-a2LN protein, containing the A2-8 sequence, bound to integrin alpha 2 beta 1 and cell attachment to rec-a2LN was inhibited by A2-8 peptide. Further, alanine substitution analysis of both the A2-8 peptide and the rec-a2LN+ protein revealed that the amino acids Ile-122, Leu-124, and Asp-125 were involved in integrin alpha 2 beta 1-mediated cell attachment, suggesting that the A2-8 site plays a functional role as an integrin alpha 2 beta 1 binding site in the LN module. These active peptides may provide new insights on the molecular mechanism of laminin-receptor interactions.	[Hozumi, Kentaro; Ishikawa, Masaya; Hayashi, Takemitsu; Yamada, Yuji; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences	Nomizu, M (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	nomizu@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010	Hozumi, Kentaro/0000-0002-6671-4386; Yamada, Yuji/0000-0003-2338-6906	Ministry of Education, Cultures, Sports, Science and Technology of Japan [MN 22390017]	Ministry of Education, Cultures, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research MN 22390017 from the Ministry of Education, Cultures, Sports, Science and Technology of Japan.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BERNIER SM, 1995, MATRIX BIOL, V14, P447, DOI 10.1016/0945-053X(95)90002-0; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Colognato H, 1997, J BIOL CHEM, V272, P29330, DOI 10.1074/jbc.272.46.29330; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; Helbling-Leclerc A, 2002, EUR J HUM GENET, V10, P157, DOI 10.1038/sj.ejhg.5200744; Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012; Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043; Hozumi K, 2009, BIOCHEMISTRY-US, V48, P5375, DOI 10.1021/bi900542u; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Kim WH, 1998, INT J CANCER, V77, P632, DOI 10.1002/(SICI)1097-0215(19980812)77:4<632::AID-IJC25>3.0.CO;2-6; Makino M, 2002, EXP CELL RES, V277, P95, DOI 10.1006/excr.2002.5540; MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047; Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563; Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje; Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221; NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Nomizu M, 2001, BIOCHEMISTRY-US, V40, P15310, DOI 10.1021/bi011552c; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Song SY, 1997, INT J CANCER, V71, P436, DOI 10.1002/(SICI)1097-0215(19970502)71:3<436::AID-IJC22>3.0.CO;2-C; Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Suzuki N, 2010, MATRIX BIOL, V29, P143, DOI 10.1016/j.matbio.2009.09.006; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006; Urushibata S, 2009, BIOCHEMISTRY-US, V48, P10522, DOI 10.1021/bi901421t; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8	45	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25111	25122		10.1074/jbc.M112.348151	http://dx.doi.org/10.1074/jbc.M112.348151			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654118	Green Published, hybrid			2022-12-28	WOS:000306651700023
J	Kim, TW; Yu, MJ; Zhou, H; Cui, W; Wang, JA; DiCorleto, P; Fox, P; Xiao, H; Li, XX				Kim, Tae Whan; Yu, Minjia; Zhou, Hao; Cui, Wei; Wang, Jianan; DiCorleto, Paul; Fox, Paul; Xiao, Hui; Li, Xiaoxia			Pellino 2 Is critical for Toll-like Receptor/Interleukin-1 Receptor (TLR/IL-1R)-mediated Post-transcriptional Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE PELLINO; KAPPA-B ACTIVATION; INTERLEUKIN-1 RECEPTOR; CYTOKINE PRODUCTION; INNATE IMMUNITY; KINASE; IL-1; IRAK; PROTEINS; FAMILY	Interleukin 1 receptor-associated kinase 1(IRAK1), a key molecule in TLR/IL-1R-mediated signaling, is phosphorylated, ubiquitinated, and degraded upon ligand stimulation. We and others have recently identified Pellino proteins as novel RING E3 ubiquitin ligases involved in IRAK1 polyubiquitination and degradation. However, it remains unclear how each Pellino member distinctly regulates TLR/IL-1R signaling by modulating IRAK1 ubiquitination. In this study we examined the role of Pellino 2 in IL-1- and LPS-mediated signaling and gene expression by knocking down Pellino 2 in human 293-IL-1R cells and primary bone marrow macrophages. Pellino 2 (but not Pellino 1) knockdown abolished IL-1- and LPS-induced Lys-63-linked IRAK1 ubiquitination with reduced Lys-48-linked IRAK1 ubiquitination. Furthermore, Pellino 2 is required for TAK1-dependent NF kappa B activation. However, because of the retained TAK1-independent NF kappa B activation, the levels of IL-1- and LPS-induced NF kappa B activation were not substantially affected in Pellino 2 knockdown 293-IL-1R cells and primary macrophages, respectively. On the other hand, Pellino 2 knockdown reduced the IL-1- and LPS-induced inflammatory gene expression at late time points, which was accompanied by increased decay rates of the mRNAs of the inflammatory genes. Importantly, IL-1- and LPS-mediated JNK and ERK activation were substantially attenuated in Pellino 2 knock-down cells, implicating MAPK activation in TLR/IL-1R-induced mRNA stabilization. Taken together, this study demonstrated that Pellino 2 plays a critical role for TLR/IL-1R-mediated post-transcriptional control.	[Kim, Tae Whan; Yu, Minjia; Zhou, Hao; Cui, Wei; Xiao, Hui; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; [Yu, Minjia; Wang, Jianan] Zhejiang Univ, Dept Cardiol, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China; [DiCorleto, Paul; Fox, Paul] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Zhejiang University; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org			National Institutes of Health [2PO1 HL 029582-26A1, 2PO1CA062220-16A1]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2PO1 HL 029582-26A1 and 2PO1CA062220-16A1.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Rich T, 2000, IMMUNOGENETICS, V52, P145, DOI 10.1007/s002510000249; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	28	25	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25686	25695		10.1074/jbc.M112.352625	http://dx.doi.org/10.1074/jbc.M112.352625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669975	Green Published, hybrid			2022-12-28	WOS:000306651700076
J	Liu, FY; Bardhan, K; Yang, DF; Thangaraju, M; Ganapathy, V; Waller, JL; Liles, GB; Lee, JR; Liu, KB				Liu, Feiyan; Bardhan, Kankana; Yang, Dafeng; Thangaraju, Muthusamy; Ganapathy, Vadivel; Waller, Jennifer L.; Liles, Georgia B.; Lee, Jeffrey R.; Liu, Kebin			NF-kappa B Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPHA-DEPENDENT APOPTOSIS; CELL-DEATH; CANCER DEVELOPMENT; MOUSE MODEL; IFN-GAMMA; IKK-BETA; IN-VIVO; RECEPTOR; CD95	Fas is a member of the death receptor family. Stimulation of Fas leads to induction of apoptotic signals, such as caspase 8 activation, as well as "non-apoptotic" cellular responses, notably NF-kappa B activation. Convincing experimental data have identified NF-kappa B as a critical promoter of cancer development, creating a solid rationale for the development of antitumor therapy that suppresses NF-kappa B activity. On the other hand, compelling data have also shown that NF-kappa B activity enhances tumor cell sensitivity to apoptosis and senescence. Furthermore, although stimulation of Fas activates NF-kappa B, the function of NF-kappa B in the Fas-mediated apoptosis pathway remains largely undefined. In this study, we observed that deficiency of either Fas or FasL resulted in significantly increased incidence of 3-methylcholanthrene-induced spontaneous sarcoma development in mice. Furthermore, Fas-deficient mice also exhibited significantly greater incidence of azoxymethane and dextran sodium sulfate-induced colon carcinoma. In addition, human colorectal cancer patients with high Fas protein in their tumor cells had a longer time before recurrence occurred. Engagement of Fas with FasL triggered NF-kappa B activation. Interestingly, canonical NF-kappa B was found to directly bind to the FAS promoter. Blocking canonical NF-kappa B activation diminished Fas expression, whereas blocking alternate NF-kappa B increased Fas expression in human carcinoma cells. Moreover, although canonical NF-kappa B protected mouse embryo fibroblast (MEF) cells from TNF alpha-induced apoptosis, knocking out p65 diminished Fas expression in MEF cells, resulting in inhibition of FasL-induced caspase 8 activation and apoptosis. In contrast, knocking out p52 increased Fas expression in MEF cells. Our observations suggest that canonical NF-kappa B is a Fas transcription activator and alternate NF-kappa B is a Fas transcription repressor, and Fas functions as a suppressor of spontaneous sarcoma and colon carcinoma.	[Liu, Feiyan; Bardhan, Kankana; Yang, Dafeng; Thangaraju, Muthusamy; Ganapathy, Vadivel; Liu, Kebin] Georgia Hlth Sci Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Waller, Jennifer L.] Georgia Hlth Sci Univ, Dept Biostat, Augusta, GA 30912 USA; [Liles, Georgia B.; Lee, Jeffrey R.] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA 30912 USA; [Liu, Feiyan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Liles, Georgia B.; Lee, Jeffrey R.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30904 USA; [Liu, Kebin] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Zhejiang University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University	Liu, KB (corresponding author), Georgia Hlth Sci Univ, Dept Biochem & Mol Biol, 1410 Laney Walker Blvd, Augusta, GA 30912 USA.	Kliu@georgiahealth.edu		Liu, Kebin/0000-0003-1965-7240	National Institutes of Health Grant [CA133085]; American Cancer Society Grant [RSG-09-209-01-TBG]; Siyuan Foundation; NATIONAL CANCER INSTITUTE [R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Grant(American Cancer Society); Siyuan Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133085 (to K. L.). This work was also supported by American Cancer Society Grant RSG-09-209-01-TBG (to K. L.) and the Siyuan Foundation (to F. L.).	Ahn EY, 2002, INT J CANCER, V100, P445, DOI 10.1002/ijc.10516; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bista P, 2010, J BIOL CHEM, V285, P12971, DOI 10.1074/jbc.M109.076091; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Caldwell SA, 2003, J IMMUNOL, V171, P2402, DOI 10.4049/jimmunol.171.5.2402; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dowdell KC, 2010, BLOOD, V115, P5164, DOI 10.1182/blood-2010-01-263145; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guillen-Ahlers H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009070; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Jennewein C, 2012, ONCOGENE, V31, P1468, DOI 10.1038/onc.2011.333; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kew RR, 2012, J IMMUNOL, V188, P2380, DOI 10.4049/jimmunol.1102454; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Klein U, 2011, CANCER CELL, V20, P556, DOI 10.1016/j.ccr.2011.10.026; Kober AMM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.93; Krammer P H, 1999, Adv Immunol, V71, P163; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lei DP, 2010, CANCER EPIDEM BIOMAR, V19, P1484, DOI 10.1158/1055-9965.EPI-10-0030; Lenardo Michael J, 2010, Immunity, V32, P291, DOI 10.1016/j.immuni.2010.03.013; Liu FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016241; Neven B, 2011, BLOOD, V118, P4798, DOI 10.1182/blood-2011-04-347641; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Owen-Schaub LB, 1998, J EXP MED, V188, P1717, DOI 10.1084/jem.188.9.1717; Park WS, 2001, J PATHOL, V193, P162; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Qiu LX, 2009, HUM GENET, V125, P431, DOI 10.1007/s00439-009-0639-4; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Ruiz-Ruiz C, 2003, J BIOL CHEM, V278, P31667, DOI 10.1074/jbc.M304397200; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Schillaci R, 2006, J IMMUNOL, V176, P3426, DOI 10.4049/jimmunol.176.6.3426; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shanker A, 2009, CANCER RES, V69, P6615, DOI 10.1158/0008-5472.CAN-09-0685; Sibley K, 2003, CANCER RES, V63, P4327; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Strater J, 2005, GUT, V54, P661, DOI 10.1136/gut.2004.052696; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Sunter NJ, 2012, BLOOD, V119, P196, DOI 10.1182/blood-2011-04-349803; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wingender G, 2010, J IMMUNOL, V185, P2721, DOI 10.4049/jimmunol.1001018; Yang DF, 2009, CANCER RES, V69, P1080, DOI 10.1158/0008-5472.CAN-08-2520; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949; Zimmerman M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014076	60	99	102	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25530	25540		10.1074/jbc.M112.356279	http://dx.doi.org/10.1074/jbc.M112.356279			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22669972	Green Published, hybrid			2022-12-28	WOS:000306651700059
J	Mukherjee, A; Wu, JH; Barbour, S; Fang, XJ				Mukherjee, Abir; Wu, Jinhua; Barbour, Suzanne; Fang, Xianjun			Lysophosphatidic Acid Activates Lipogenic Pathways and de Novo Lipid Synthesis in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY ELEMENT; PROTEIN-COUPLED RECEPTOR; BREAST-CANCER; GROWTH-FACTOR; SYNTHASE INHIBITION; OVER-EXPRESSION; LPA RECEPTORS; SREBP PATHWAY; KINASE; IDENTIFICATION	One of the most common molecular changes in cancer is the increased endogenous lipid synthesis, mediated primarily by overexpression and/or hyperactivity of fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC). The changes in these key lipogenic enzymes are critical for the development and maintenance of the malignant phenotype. Previous efforts to control oncogenic lipogenesis have been focused on pharmacological inhibitors of FAS and ACC. Although they show anti-tumor effects in culture and in mouse models, these inhibitors are nonselective blockers of lipid synthesis in both normal and cancer cells. To target lipid anabolism in tumor cells specifically, it is important to identify the mechanism governing hyperactive lipogenesis in malignant cells. In this study, we demonstrate that lysophosphatidic acid (LPA), a growth factor-like mediator present at high levels in ascites of ovarian cancer patients, regulates the sterol regulatory element binding protein-FAS and AMP-activated protein kinase-ACC pathways in ovarian cancer cells but not in normal or immortalized ovarian epithelial cells. Activation of these lipogenic pathways is linked to increased de novo lipid synthesis. The pro-lipogenic action of LPA is mediated through LPA(2), an LPA receptor subtype overexpressed in ovarian cancer and other malignancies. Downstream of LPA(2), the G(12/13) and G(q) signaling cascades mediate LPA-dependent sterol regulatory element-binding protein activation and AMP-activated protein kinase inhibition, respectively. Moreover, inhibition of de novo lipid synthesis dramatically attenuated LPA-induced cell proliferation. These results demonstrate that LPA signaling is causally linked to the hyperactive lipogenesis in ovarian cancer cells, which can be exploited for development of new anti-cancer therapies.	[Mukherjee, Abir; Wu, Jinhua; Barbour, Suzanne; Fang, Xianjun] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Fang, XJ (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	xfang@vcu.edu			National Institutes of Health from NCI [2R01CA102196, R21CA161478]; Department of Defense [W81XWH-11-1-0541]; Jeffress Memorial Fund award; National Institutes of Health [P30 CA16059]; NATIONAL CANCER INSTITUTE [R21CA161478, R01CA102196, P30CA016059] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Jeffress Memorial Fund award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01CA102196 and R21CA161478 from NCI (to X. F.). This work was also supported by Department of Defense Ovarian Cancer Research Program Grant W81XWH-11-1-0541 (to X. F.) and The Jeffress Memorial Fund award (to X. F.).; Massey Cancer Center of Virginia Commonwealth University School of Medicine was recipient of National Institutes of Health Grant P30 CA16059.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Baker DL, 2002, JAMA-J AM MED ASSOC, V287, P3081, DOI 10.1001/jama.287.23.3081; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942; Dent P, 2005, BIOCHEM PHARMACOL, V70, P1685, DOI 10.1016/j.bcp.2005.08.020; Fang XJ, 2004, J BIOL CHEM, V279, P9653, DOI 10.1074/jbc.M306662200; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Fang XJ, 1998, ONCOGENE, V16, P1, DOI 10.1038/sj.onc.1201525; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Goetzl EJ, 1999, CANCER RES, V59, P5370; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Goldsmith Zachariah G, 2011, Genes Cancer, V2, P563, DOI 10.1177/1947601911419362; HA J, 1994, J BIOL CHEM, V269, P22162; HALVORSON DL, 1984, LIPIDS, V19, P851, DOI 10.1007/BF02534514; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Heemers H, 2001, MOL ENDOCRINOL, V15, P1817, DOI 10.1210/me.15.10.1817; Huang MC, 2004, ONCOGENE, V23, P122, DOI 10.1038/sj.onc.1206986; Jeong KJ, 2008, EXP MOL MED, V40, P607, DOI 10.3858/emm.2008.40.6.607; Kamrava M, 2005, ONCOGENE, V24, P7084, DOI 10.1038/sj.onc.1208857; Kim EK, 2011, J BIOL CHEM, V286, P24036, DOI 10.1074/jbc.M110.209908; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Kitayama J, 2004, BREAST CANCER RES, V6, pR640, DOI 10.1186/bcr935; KUHAJDA FP, 1989, NEW ENGL J MED, V321, P636, DOI 10.1056/NEJM198909073211003; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Li JN, 2001, CANCER RES, V61, P1493; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Menendez JA, 2005, INT J ONCOL, V26, P1507; Menendez JA, 2004, ONCOL REP, V12, P411; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; OOKHTENS M, 1984, AM J PHYSIOL, V247, pR146, DOI 10.1152/ajpregu.1984.247.1.R146; Oyesanya RA, 2008, FASEB J, V22, P2639, DOI 10.1096/fj.07-101428; Pizer ES, 2000, CANCER RES, V60, P213; Pua TL, 2009, FUTURE ONCOL, V5, P1659, DOI 10.2217/FON.09.120; Rashid A, 1997, AM J PATHOL, V150, P201; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schulte KM, 2001, INT J CANCER, V92, P249, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1166>3.0.CO;2-D; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shida D, 2004, LAB INVEST, V84, P1352, DOI 10.1038/labinvest.3700146; Soede RDM, 2000, BLOOD, V96, P691; Song YD, 2009, CLIN CANCER RES, V15, P492, DOI 10.1158/1078-0432.CCR-08-1945; Stanners J, 1995, J BIOL CHEM, V270, P30635, DOI 10.1074/jbc.270.51.30635; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2000, ONCOGENE, V19, P5173, DOI 10.1038/sj.onc.1203889; Swinnen JV, 1997, CANCER RES, V57, P1086; Van de Sande T, 2002, CANCER RES, V62, P642; Wang Chun, 2010, Front Biosci (Schol Ed), V2, P515; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhao YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-114; Zhou WB, 2003, CANCER RES, V63, P7330	71	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24990	25000		10.1074/jbc.M112.340083	http://dx.doi.org/10.1074/jbc.M112.340083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22665482	Green Published, hybrid			2022-12-28	WOS:000306651700012
J	Trattnig, SM; Harpsoe, K; Thygesen, SB; Rahr, LM; Ahring, PK; Balle, T; Jensen, AA				Trattnig, Sarah M.; Harpsoe, Kasper; Thygesen, Sarah B.; Rahr, Louise M.; Ahring, Philip K.; Balle, Thomas; Jensen, Anders A.			Discovery of a Novel Allosteric Modulator of 5-HT3 Receptors INHIBITION AND POTENTIATION OF CYS-LOOP RECEPTOR SIGNALING THROUGH A CONSERVED TRANSMEMBRANE INTERSUBUNIT SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; X-RAY-STRUCTURE; GLYCINE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; GENERAL-ANESTHETICS; GABA(A) RECEPTORS; LIGAND-BINDING; ACTIVATION; IVERMECTIN; PHARMACOLOGY	The ligand-gated ion channels in the Cys-loop receptor superfamily mediate the effects of neurotransmitters acetylcholine, serotonin, GABA, and glycine. Cys-loop receptor signaling is susceptible to modulation by ligands acting through numerous allosteric sites. Here we report the discovery of a novel class of negative allosteric modulators of the 5-HT3 receptors (5-HT(3)Rs). PU02 (6-[(1-naphthylmethyl)thio]-9H-purine) is a potent and selective antagonist displaying IC50 values of similar to 1 mu M at 5-HT(3)Rs and substantially lower activities at other Cys-loop receptors. In an elaborate mutagenesis study of the 5-HT(3)A receptor guided by a homology model, PU02 is demonstrated to act through a transmembrane intersubunit site situated in the upper three helical turns of TM2 and TM3 in the (+)-subunit and TM1 and TM2 in the (+)-subunit. The Ser(248), Leu(288), Ile(290), Thr(294), and Gly(306) residues are identified as important molecular determinants of PU02 activity with minor contributions from Ser(292) and Val(310), and we propose that the naphthalene group of PU02 docks into the hydrophobic cavity formed by these. Interestingly, specific mutations of Ser(248), Thr(294), and Gly(306) convert PU02 into a complex modulator, potentiating and inhibiting 5-HT-evoked signaling through these mutants at low and high concentrations, respectively. The PU02 binding site in the 5-HT3R corresponds to allosteric sites in anionic Cysloop receptors, which emphasizes the uniform nature of the molecular events underlying signaling through the receptors. Moreover, the dramatic changes in the functional properties of PU02 induced by subtle changes in its binding site bear witness to the delicate structural discrimination between allosteric inhibition and potentiation of Cys-loop receptors.	[Trattnig, Sarah M.; Harpsoe, Kasper; Thygesen, Sarah B.; Rahr, Louise M.; Balle, Thomas; Jensen, Anders A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Ahring, Philip K.] NeuroSearch AS, DK-2750 Ballerup, Denmark	University of Copenhagen	Jensen, AA (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Univ Pk 2, DK-2100 Copenhagen, Denmark.	aaj@farma.ku.dk	Harpsøe, Kasper/V-6870-2018; Jensen, Anders/AAJ-3335-2020	Harpsøe, Kasper/0000-0002-9326-9644; Jensen, Anders/0000-0002-7927-5052; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	Lundbeck Foundation; Carlsberg Foundation; Drug Research Academy; FARMA; University of Copenhagen; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation [R31-2008-2516] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Drug Research Academy; FARMA; University of Copenhagen; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Lundbeck Foundation (to S. M. T., T. B., and A. A. J.), the Carlsberg Foundation (to K. H. and A. A. J.), the Drug Research Academy, FARMA, University of Copenhagen (to K. H. and T. B.), the Danish Medical Research Council (to A. A. J.), and the Novo Nordisk Foundation (to A. A. J.). Part of this work was presented in the form of a poster by S. M. T. at the Society of Neuroscience conference in San Diego, November 13-17, 2010.	ADODRA S, 1995, BRIT J PHARMACOL, V115, P953, DOI 10.1111/j.1476-5381.1995.tb15903.x; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Barann M, 2000, N-S ARCH PHARMACOL, V362, P255, DOI 10.1007/s002100000288; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2010, BBA-BIOMEMBRANES, V1798, P1608, DOI 10.1016/j.bbamem.2010.04.014; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Christensen JK, 2004, J PHARMACOL EXP THER, V309, P1003, DOI 10.1124/jpet.103.062794; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Davies PA, 2011, CURR OPIN PHARMACOL, V11, P75, DOI 10.1016/j.coph.2011.01.010; DeLano W.L, PYMOL MOL GRAPHICS S; Feuerbach D, 2005, NEUROPHARMACOLOGY, V48, P215, DOI 10.1016/j.neuropharm.2004.10.003; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Hsiao B, 2006, MOL PHARMACOL, V69, P27, DOI 10.1124/mol.105.015164; Hsiao B, 2001, J NEUROSCI, V21, P1848, DOI 10.1523/JNEUROSCI.21-06-01848.2001; Jensen AA, 2004, BIOCHEM PHARMACOL, V67, P1789, DOI 10.1016/j.bcp.2003.12.037; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jensen AA, 2008, TRENDS PHARMACOL SCI, V29, P437, DOI 10.1016/j.tips.2008.06.001; Jensen AA, 2007, J MED CHEM, V50, P4616, DOI 10.1021/jm070574f; Jorgensen CG, 2011, CHEMMEDCHEM, V6, P725, DOI 10.1002/cmdc.201000444; Karadsheh MS, 2004, J NEUROCHEM, V91, P1138, DOI 10.1111/j.1471-4159.2004.02801.x; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; Krzywkowski K, 2007, PHARMACOGENET GENOM, V17, P255, DOI 10.1097/FPC.0b013e3280117269; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lochner M, 2010, BIOPHYS J, V98, P1494, DOI 10.1016/j.bpj.2009.12.4313; Madsen C, 2007, J MED CHEM, V50, P4147, DOI 10.1021/jm070447j; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pistis M, 1997, BRIT J PHARMACOL, V122, P1707, DOI 10.1038/sj.bjp.0701563; Rojas C, 2008, ANESTH ANALG, V107, P469, DOI 10.1213/ane.0b013e318172fa74; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thompson AJ, 2011, J PHYSIOL-LONDON, V589, P4243, DOI 10.1113/jphysiol.2011.208439; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	58	26	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25241	25254		10.1074/jbc.M112.360370	http://dx.doi.org/10.1074/jbc.M112.360370			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22589534	Green Published, hybrid			2022-12-28	WOS:000306651700033
J	Zhao, P; Nairn, AV; Hester, S; Moremen, KW; O'Regan, RM; Oprea, G; Wells, L; Pierce, M; Abbott, KL				Zhao, Peng; Nairn, Alison V.; Hester, Shanterian; Moremen, Kelley W.; O'Regan, Ruth M.; Oprea, Gabriella; Wells, Lance; Pierce, Michael; Abbott, Karen L.			Proteomic Identification of Glycosylphosphatidylinositol Anchor-dependent Membrane Proteins Elevated in Breast Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; SEPTICUM ALPHA-TOXIN; GPI TRANSAMIDASE; PROSTATE-CANCER; DIFFERENTIATION; ATTACHMENT; EXPRESSION; SEQUENCES; CLEAVAGE; INVASION	The glycosylphosphatidylinositol (GPI) anchor is a lipid and glycan modification added to the C terminus of certain proteins in the endoplasmic reticulum by the activity of a multiple subunit enzyme complex known as the GPI transamidase (GPIT). Several subunits of GPIT have increased expression levels in breast carcinoma. In an effort to identify GPI-anchored proteins and understand the possible role of these proteins in breast cancer progression, we employed a combination of strategies. First, alpha toxin from Clostridium septicum was used to capture GPI-anchored proteins from human breast cancer tissues, cells, and serum for proteomic analysis. We also expressed short interfering RNAs targeting the expression of the GPAA1 and PIGT subunits of GPIT in breast cancer cell lines to identify proteins in which membrane localization is dependent on GPI anchor addition. Comparative membrane proteomics using nano-ESI-RPLC-MS/MS led to the discovery of several new potential diagnostic and therapeutic targets for breast cancer. Furthermore, we provide evidence that increased levels of GPI anchor addition in malignant breast epithelial cells promotes the dedifferentiation of malignant breast epithelial cells in part by increasing the levels of cell surface markers associated with mesenchymal stem cells.	[Zhao, Peng; Wells, Lance] Univ Georgia, Dept Chem, Athens, GA 30605 USA; [Nairn, Alison V.; Hester, Shanterian; Moremen, Kelley W.; Pierce, Michael; Abbott, Karen L.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30605 USA; [O'Regan, Ruth M.; Oprea, Gabriella] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University	Abbott, KL (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	kabbott@uga.edu	Wells, Lance/H-3118-2013; Moremen, Kelley/AAD-4661-2019	Nairn, Alison/0000-0002-4453-7593; Wells, Lance/0000-0003-4956-5363; Zhao, Peng/0000-0002-9296-5293	National Institutes of Health Grants [UO1CA128454, P41RR018502]; Department of Defense Breast Cancer Concept Award [BC075534]; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Concept Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants UO1CA128454 and P41RR018502. This work was also supported by Department of Defense Breast Cancer Concept Award BC075534 (to K.L.A.).	Al-Nbaheen M, 2012, STEM CELL R IN PRESS; Argani P, 2001, CLIN CANCER RES, V7, P3862; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Doering T. L., 2001, CURR PROTOC PROTEIN; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Eisenhaber B, 2001, PROTEIN ENG, V14, P17, DOI 10.1093/protein/14.1.17; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Han KR, 2004, J UROLOGY, V171, P1117, DOI 10.1097/01.ju.0000109982.60619.93; IKEZAWA H, 1991, CELL BIOL INT REP, V15, P1115; Jeong JA, 2007, PROTEOMICS, V7, P4181, DOI 10.1002/pmic.200700502; KOOYMAN DL, 1995, SCIENCE, V269, P89, DOI 10.1126/science.7541557; Lidell ME, 2011, DIABETES, V60, P427, DOI 10.2337/db10-0409; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; McCabe NP, 2000, ONCOL REP, V7, P879; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P7939, DOI 10.1073/pnas.87.20.7939; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Ohishi K, 2000, MOL BIOL CELL, V11, P1523, DOI 10.1091/mbc.11.5.1523; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Sano H, 2010, BIOCHEM BIOPH RES CO, V392, P201, DOI 10.1016/j.bbrc.2010.01.015; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Shin DJ, 2005, J MICROBIOL, V43, P266; Steinert AF, 2011, TISSUE ENG PT A, V17, P1375, DOI [10.1089/ten.tea.2010.0413, 10.1089/ten.TEA.2010.0413]; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; TREUMANN A, 1995, J BIOL CHEM, V270, P6088, DOI 10.1074/jbc.270.11.6088; Weise F, 2000, J CELL SCI, V113, P4587; Wu GJ, 2006, CANCER RES, V66, P9829, DOI 10.1158/0008-5472.CAN-06-0506; Yamamoto Y, 2005, BIOCHEM BIOPH RES CO, V333, P223, DOI 10.1016/j.bbrc.2005.05.084	36	37	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25230	25240		10.1074/jbc.M112.339465	http://dx.doi.org/10.1074/jbc.M112.339465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22654114	hybrid, Green Published			2022-12-28	WOS:000306651700032
J	Alam, A; Haldar, S; Thulasiram, HV; Kumar, R; Goyal, M; Iqbal, MS; Pal, C; Dey, S; Bindu, S; Sarkar, S; Pal, U; Maiti, NC; Bandyopadhyay, U				Alam, Athar; Haldar, Saikat; Thulasiram, Hirekodathakallu V.; Kumar, Rahul; Goyal, Manish; Iqbal, Mohd Shameel; Pal, Chinmay; Dey, Sumanta; Bindu, Samik; Sarkar, Souvik; Pal, Uttam; Maiti, Nakul C.; Bandyopadhyay, Uday			Novel Anti-inflammatory Activity of Epoxyazadiradione against Macrophage Migration Inhibitory Factor INHIBITION OF TAUTOMERASE AND PROINFLAMMATORY ACTIVITIES OF MACROPHAGE MIGRATION INHIBITORY FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDICA BARK EXTRACT; TOLL-LIKE RECEPTOR-4; KAPPA-B ACTIVATION; FACTOR MIF; FUNCTIONAL-CHARACTERIZATION; PLASMODIUM-FALCIPARUM; THERAPEUTIC TARGET; OXIDATIVE STRESS; NITRIC-OXIDE; EXPRESSION	Macrophage migration inhibitory factor (MIF) is responsible for proinflammatory reactions in various infectious and noninfectious diseases. We have investigated the mechanism of anti-inflammatory activity of epoxyazadiradione, a limonoid purified from neem (Azadirachta indica) fruits, against MIF. Epoxyazadiradione inhibited the tautomerase activity of MIF of both human (huMIF) and malaria parasites (Plasmodium falciparum (PfMIF) and Plasmodium yoelii (PyMIF)) non-competitively in a reversible fashion (K-i, 2.11-5.23 mu M). Epoxyazadiradione also significantly inhibited MIF (huMIF, PyMIF, and PfMIF)-mediated proinflammatory activities in RAW 264.7 cells. It prevented MIF-induced macrophage chemotactic migration, NF-kappa B translocation to the nucleus, up-regulation of inducible nitric-oxide synthase, and nitric oxide production in RAW 264.7 cells. Epoxyazadiradione not only exhibited anti-inflammatory activity in vitro but also in vivo. We tested the anti-inflammatory activity of epoxyazadiradione in vivo after co-administering LPS and MIF in mice to mimic the disease state of sepsis or bacterial infection. Epoxyazadiradione prevented the release of proinflammatory cytokines such as IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha when LPS and PyMIF were co-administered to BALB/c mice. The molecular basis of interaction of epoxyazadiradione with MIFs was explored with the help of computational chemistry tools and a biological knowledge base. Docking simulation indicated that the binding was highly specific and allosteric in nature. The well known MIF inhibitor (S, R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1) inhibited huMIF but not MIF of parasitic origin. In contrast, epoxyazadiradione inhibited both huMIF and plasmodial MIF, thus bearing an immense therapeutic potential against proinflammatory reactions induced by MIF of both malaria parasites and human.	[Alam, Athar; Kumar, Rahul; Goyal, Manish; Iqbal, Mohd Shameel; Pal, Chinmay; Dey, Sumanta; Bindu, Samik; Sarkar, Souvik; Bandyopadhyay, Uday] Indian Inst Chem Biol, CSIR, Div Infect Dis & Immunol, Kolkata 700032, W Bengal, India; [Pal, Uttam; Maiti, Nakul C.] Indian Inst Chem Biol, CSIR, Dept Biol Struct, Kolkata 700032, W Bengal, India; [Pal, Uttam; Maiti, Nakul C.] Indian Inst Chem Biol, CSIR, Bioinformat Div, Kolkata 700032, W Bengal, India; [Haldar, Saikat; Thulasiram, Hirekodathakallu V.] CSIR Natl Chem Lab, Div Organ Chem, Chem Biol Unit, Pune 411008, Maharashtra, India; [Thulasiram, Hirekodathakallu V.] CSIR Inst Genom & Integrat Biol, New Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, CSIR, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Pal, Uttam/A-8544-2013; Alam, Athar/B-3642-2010; Maiti, Nakul/GLR-3207-2022; Iqbal, Mohd Shameel/AAD-9641-2021; Goyal, Manish/O-2183-2015	Pal, Uttam/0000-0003-2110-4610; Maiti, Nakul/0000-0002-8498-6502; Iqbal, Mohd Shameel/0000-0002-0353-3561; Goyal, Manish/0000-0003-2383-5409; /0000-0002-5945-976X; Bindu, Samik/0000-0003-1416-2003	Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi and the University Grants Commission, New Delhi.	Akihisa T, 2009, J OLEO SCI, V58, P581, DOI 10.5650/jos.58.581; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Alam A, 2011, BIOORGAN MED CHEM, V19, P7365, DOI 10.1016/j.bmc.2011.10.056; Alam A, 2011, FREE RADICAL BIO MED, V50, P1659, DOI 10.1016/j.freeradbiomed.2011.03.012; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; AROCA P, 1991, BIOCHEM J, V277, P393, DOI 10.1042/bj2770393; Augustijn KD, 2007, INFECT IMMUN, V75, P1116, DOI 10.1128/IAI.00902-06; Bandyopadhyay U, 2004, LIFE SCI, V75, P2867, DOI 10.1016/j.lfs.2004.04.050; Bandyopadhyay U, 2002, LIFE SCI, V71, P2845, DOI 10.1016/S0024-3205(02)02143-4; Bandyopadhyay U., 2010, PHYTOCHEMICALS HUMAN, P187; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Beswick EJ, 2006, INFECT IMMUN, V74, P1148, DOI 10.1128/IAI.74.2.1148-1155.2006; Biswas K., 2002, CURR SCI, V82, P10; Bozza Marcelo T, 2012, J Parasitol Res, V2012, P413052, DOI 10.1155/2012/413052; Bucala R, 2005, DRUG NEWS PERSPECT, V18, P417, DOI 10.1358/dnp.2005.18.7.939345; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Chattopadhyay Ishita, 2004, Inflammopharmacology, V12, P153, DOI 10.1163/1568560041352257; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013; Dagia NM, 2009, EUR J PHARMACOL, V607, P201, DOI 10.1016/j.ejphar.2009.02.031; Denkinger CM, 2004, ARCH IMMUNOL THER EX, V52, P389; Dey S, 2009, FREE RADICAL BIO MED, V46, P271, DOI 10.1016/j.freeradbiomed.2008.10.032; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Doernberg S, 2011, CYTOKINE, V53, P292, DOI 10.1016/j.cyto.2010.12.010; Enomoto A, 2011, AM J PATHOL, V178, P679, DOI 10.1016/j.ajpath.2010.10.021; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; FUJIWARA T, 1982, CHEM PHARM BULL, V30, P4025; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Goyal M, 2012, NUCLEIC ACIDS RES, V40, P1174, DOI 10.1093/nar/gkr821; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Guo Yong-Shun, 2011, Zhonghua Zhong Liu Za Zhi, V33, P28; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hawkins O, 2011, J IMMUNOL, V186, P6607, DOI 10.4049/jimmunol.1003995; Huang XR, 2001, GASTROENTEROLOGY, V121, P619, DOI 10.1053/gast.2001.27205; Jain Vidhan, 2009, BMC Res Notes, V2, P36, DOI 10.1186/1756-0500-2-36; Johnson S, 1997, J CHROMATOGR A, V761, P53, DOI 10.1016/S0021-9673(96)00796-0; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; JONES IW, 1994, FEMS MICROBIOL LETT, V120, P267, DOI 10.1111/j.1574-6968.1994.tb07044.x; Juni P, 2005, BMJ-BRIT MED J, V330, P1342, DOI 10.1136/bmj.330.7504.1342; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kim HR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3279; KLENK A, 1986, J CHEM SOC CHEM COMM, P523, DOI 10.1039/c39860000523; Kumar S, 2008, ANTIMICROB AGENTS CH, V52, P705, DOI 10.1128/AAC.00898-07; LANGMAN M J S, 1988, American Journal of Medicine, V84, P15, DOI 10.1016/0002-9343(88)90249-5; LAVIE D, 1971, TETRAHEDRON, V27, P3927, DOI 10.1016/S0040-4020(01)98254-7; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Li C, 2011, NUTR RES PRACT, V5, P101, DOI 10.4162/nrp.2011.5.2.101; Lin JH, 1997, PHARMACOL REV, V49, P403; Liu SF, 1997, J IMMUNOL, V159, P3976; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Maity P, 2009, PHYTOTHER RES, V23, P747, DOI 10.1002/ptr.2721; Martiney JA, 2000, INFECT IMMUN, V68, P2259, DOI 10.1128/IAI.68.4.2259-2267.2000; McCafferty DM, 2000, GUT, V46, P436, DOI 10.1136/gut.46.3.436; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Molnar V, 2005, INT IMMUNOPHARMACOL, V5, P849, DOI 10.1016/j.intimp.2004.12.017; Morand EF, 2005, INTERN MED J, V35, P419, DOI 10.1111/j.1445-5994.2005.00853.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nicoletti A, 2011, CYTOKINE, V55, P165, DOI 10.1016/j.cyto.2011.03.027; Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190; PILLAI NR, 1981, PLANTA MED, V43, P59, DOI 10.1055/s-2007-971474; PILLAI NR, 1984, PLANTA MED, V50, P143, DOI 10.1055/s-2007-969654; Reyes JL, 2006, INFECT IMMUN, V74, P3170, DOI 10.1128/IAI.01648-05; Rodriguez-Sosa M, 2003, INFECT IMMUN, V71, P1247, DOI 10.1128/IAI.71.3.1247-1254.2003; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCHROEDER DR, 1987, J NAT PROD, V50, P241, DOI 10.1021/np50050a023; Shao DD, 2010, MOL IMMUNOL, V47, P726, DOI 10.1016/j.molimm.2009.10.037; Sharma V, 2003, J AGR FOOD CHEM, V51, P3966, DOI 10.1021/jf0342167; SIDDIQUI S, 1988, J NAT PROD, V51, P30, DOI 10.1021/np50055a003; Sienel G., 2000, ULLMANNS ENCY IND CH, V13, P140; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Suganuma H, 2011, BIOCHEM BIOPH RES CO, V405, P146, DOI 10.1016/j.bbrc.2011.01.025; Thoh M, 2011, J BIOL CHEM, V286, P4690, DOI 10.1074/jbc.M110.169334; Thorat S, 2010, INFECT IMMUN, V78, P5151, DOI 10.1128/IAI.00277-10; VANDERNAT JM, 1991, PLANTA MED, V57, P65, DOI 10.1055/s-2006-960021; Waheed Akbar, 2006, Pak J Pharm Sci, V19, P322; Wu Z, 2003, J PARASITOL, V89, P507, DOI 10.1645/0022-3395(2003)089[0507:MEACOA]2.0.CO;2; Zhang Y, 2011, INT IMMUNOPHARMACOL, V11, P1333, DOI 10.1016/j.intimp.2011.04.017; Zhao YM, 2011, INT J CANCER, V129, P2463, DOI 10.1002/ijc.25918	94	66	70	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24844	24861		10.1074/jbc.M112.341321	http://dx.doi.org/10.1074/jbc.M112.341321			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645149	Green Published, hybrid			2022-12-28	WOS:000306651100077
J	Greene, D; Kang, S; Kosenko, A; Hoshi, N				Greene, Derek; Kang, Seungwoo; Kosenko, Anastasia; Hoshi, Naoto			Adrenergic Regulation of HCN4 Channel Requires Protein Association with beta(2)-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING COMPLEX; CA2+ CHANNELS; FUNNY CURRENT; HEART-RATE; KINASE-A; CAMP; LOCALIZATION; MODULATION; MYOCYTES	beta(1)- and beta(2)-adrenergic receptors utilize different signaling mechanisms to control cardiac function. Recent studies demonstrated that beta(2)-adrenergic receptors (beta(2)ARs) colocalize with some ion channels that are critical for proper cardiac function. Here, we demonstrate that beta(2)ARs form protein complexes with the pacemaker HCN4 channel, as well as with other subtypes of HCN channels. The adrenergic receptor-binding site was identified at a proximal region of the N-terminal tail of the HCN4 channel. A synthetic peptide derived from the beta(2)AR-binding domain of the HCN4 channel disrupted interaction between HCN4 and beta(2)AR. In addition, treatment with this peptide prevented adrenergic augmentation of pacemaker currents and spontaneous contraction rates but did not affect adrenergic regulation of voltage-gated calcium currents. These results suggest that the ion channel-receptor complex is a critical mechanism in ion channel regulation.	[Greene, Derek; Kang, Seungwoo; Kosenko, Anastasia; Hoshi, Naoto] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hoshi, N (corresponding author), Univ Calif Irvine, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.	nhoshi@uci.edu	Kang, Seungwoo/L-4841-2019; Kang, Seungwoo/K-5130-2015	Kang, Seungwoo/0000-0003-1301-8480; Kang, Seungwoo/0000-0003-1301-8480	National Institutes of Health [NS067288]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS067288 (to N. H.).	Alig J, 2009, P NATL ACAD SCI USA, V106, P12189, DOI 10.1073/pnas.0810332106; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Barbuti A, 2004, CIRC RES, V94, P1325, DOI 10.1161/01.RES.0000127621.54132.AE; Barbuti A, 2007, J MOL CELL CARDIOL, V42, P71, DOI 10.1016/j.yjmcc.2006.09.018; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DiFrancesco D, 2007, DRUGS, V67, P15, DOI 10.2165/00003495-200767002-00003; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Harzheim D, 2008, EMBO J, V27, P692, DOI 10.1038/emboj.2008.3; Herrmann S, 2012, BRIT J PHARMACOL, V166, P501, DOI 10.1111/j.1476-5381.2011.01798.x; Herrmann S, 2011, J MOL CELL CARDIOL, V51, P997, DOI 10.1016/j.yjmcc.2011.09.005; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Katzung B.G., 2010, BASIC CLIN PHARM; Mika D, 2012, J MOL CELL CARDIOL, V52, P323, DOI 10.1016/j.yjmcc.2011.08.016; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Smith IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026338; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Ye B, 2008, BIOCHEMISTRY-US, V47, P12312, DOI 10.1021/bi8009295; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	26	14	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23690	23697		10.1074/jbc.M112.366955	http://dx.doi.org/10.1074/jbc.M112.366955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613709	Green Published, hybrid			2022-12-28	WOS:000306511300039
J	Milbradt, J; Auerochs, S; Sevvana, M; Muller, YA; Sticht, H; Marschall, M				Milbradt, Jens; Auerochs, Sabrina; Sevvana, Madhumati; Muller, Yves A.; Sticht, Heinrich; Marschall, Manfred			Specific Residues of a Conserved Domain in the N Terminus of the Human Cytomegalovirus pUL50 Protein Determine Its Intranuclear Interaction with pUL53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; SIMPLEX-VIRUS 1; NUCLEAR EGRESS COMPLEX; MEMBRANE CURVATURE; U(L)34 PROTEIN; VIRAL-PROTEINS; LAMINA; REPLICATION; ENVELOPMENT; UL34	Herpesviral capsids are assembled in the host cell nucleus and are subsequently translocated to the cytoplasm. During this process it has been demonstrated that the human cytomegalovirus proteins pUL50 and pUL53 interact and form, together with other viral and cellular proteins, the nuclear egress complex at the nuclear envelope. In this study we provide evidence that specific residues of a conserved N-terminal region of pUL50 determine its intranuclear interaction with pUL53. In silico evaluation and biophysical analyses suggested that the conserved region forms a regular secondary structure adopting a globular fold. Importantly, site-directed replacement of individual amino acids by alanine indicated a strong functional influence of specific residues inside this globular domain. In particular, mutation of the widely conserved residues Glu-56 or Tyr-57 led to a loss of interaction with pUL53. Consistent with the loss of binding properties, mutants E56A and Y57A showed a defective function in the recruitment of pUL53 to the nuclear envelope in expression plasmid-transfected and human cyto-megalovirus-infected cells. In addition, in silico analysis suggested that residues 3-20 form an amphipathic alpha-helix that appears to be conserved among Herpesviridae. Point mutants revealed a structural role of this N-terminal alpha-helix for pUL50 stability rather than a direct role in the binding of pUL53. In contrast, the central part of the globular domain including Glu-56 and Tyr-57 is directly responsible for the functional interaction with pUL53 and thus determines formation of the basic nuclear egress complex.	[Milbradt, Jens; Auerochs, Sabrina; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Div Biotechnol, D-91054 Erlangen, Germany; [Sevvana, Madhumati; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Div Bioinformat, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Milbradt, J (corresponding author), Schlossgarten 4, D-91054 Erlangen, Germany.	jens.milbradt@viro.med.uni-erlangen.de	Muller, Yves A/R-5397-2016; Sevvana, Madhumati/S-3297-2019	Muller, Yves A/0000-0003-0519-8928; Sevvana, Madhumati/0000-0003-4992-6296; Milbradt, Jens/0000-0003-2172-7471; Sticht, Heinrich/0000-0001-5644-045X	Deutsche Forschungsgemeinschaft [MA 1289/6-1, 7-1];  [SFB796]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by SFB796 Subprojects A2, A3, B3, C3, and Z as well as Deutsche Forschungsgemeinschaft MA 1289/6-1 and 7-1.	Bjerke SL, 2003, J VIROL, V77, P7601, DOI 10.1128/JVI.77.13.7601-7610.2003; Bubeck A, 2004, J VIROL, V78, P8026, DOI 10.1128/JVI.78.15.8026-8035.2004; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Buser C, 2007, J VIROL, V81, P3042, DOI 10.1128/JVI.01564-06; Camozzi D, 2008, J GEN VIROL, V89, P731, DOI 10.1099/vir.0.83377-0; Chen DH, 1999, VIROLOGY, V260, P10, DOI 10.1006/viro.1999.9791; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fuchs W, 2002, J VIROL, V76, P364, DOI 10.1128/JVI.76.1.364-378.2002; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Haugo AC, 2011, J VIROL, V85, P7203, DOI 10.1128/JVI.00262-11; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104; Lake CM, 2004, VIROLOGY, V320, P99, DOI 10.1016/j.virol.2003.11.018; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Liang L, 2005, J VIROL, V79, P3797, DOI 10.1128/JVI.79.6.3797-3806.2005; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lotzerich M, 2006, J VIROL, V80, P73, DOI 10.1128/JVI.80.1.73-84.2006; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Mettenleiter TC, 2006, VET MICROBIOL, V113, P163, DOI 10.1016/j.vetmic.2005.11.040; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Mou F, 2009, J VIROL, V83, P5181, DOI 10.1128/JVI.00090-09; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Roller RJ, 2011, J VIROL, V85, P11615, DOI 10.1128/JVI.05730-11; Roller RJ, 2010, J VIROL, V84, P3921, DOI 10.1128/JVI.01638-09; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sam MD, 2009, J VIROL, V83, P2996, DOI 10.1128/JVI.02441-08; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sanchez V, 2002, SCIENCE, V297, P778, DOI 10.1126/science.1075102; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	44	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					24004	24016		10.1074/jbc.M111.331207	http://dx.doi.org/10.1074/jbc.M111.331207			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22589554	hybrid, Green Published			2022-12-28	WOS:000306511300069
J	Iyoda, T; Zhang, FQ; Sun, LS; Hao, F; Schmitz-Peiffer, C; Xu, XM; Cui, MZ				Iyoda, Takuya; Zhang, Fuqiang; Sun, Longsheng; Hao, Feng; Schmitz-Peiffer, Carsten; Xu, Xuemin; Cui, Mei-Zhen			Lysophosphatidic Acid Induces Early Growth Response-1 (Egr-1) Protein Expression via Protein Kinase C delta-regulated Extracellular Signal-regulated Kinase (ERK) and c-Jun N-terminal Kinase (JNK) Activation in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR EXPRESSION; BRONCHIAL EPITHELIAL-CELLS; LOW-DENSITY-LIPOPROTEIN; INTERLEUKIN-8 SECRETION; ENDOTHELIAL-CELLS; FACTOR GENE; PATHWAY; PHOSPHORYLATION; INDUCTION; CREB	Lysophosphatidic acid (LPA) modulates vascular cell function in vitro and in vivo via regulating the expression of specific genes. Previously, we reported that a transcriptional mechanism controls LPA-induced expression of Egr-1 in vascular smooth muscle cells. Egr-1 is a master transcription factor mediating the expression of various genes that have been implied to modulate a broad spectrum of vascular pathologies. In this study, we determined the essential intracellular signaling pathway leading to LPA-induced Egr-1 expression. Our data demonstrate that activation of ERK1/2 and JNK, but not p38 MAPK, is required for LPA-induced Egr-1 expression in smooth muscle cells. We provide the first evidence that MEK-mediated JNK activation leads to LPA-induced gene expression. JNK2 is required for Egr-1 induction. Examining the upstream kinases that mediate ERK and JNK activation, leading to Egr-1 expression, we found that LPA-induced activation of MAPKs and expression of Egr-1 are dependent on PKC activation. We observed that LPA rapidly activates PKC delta and PKC0. Overexpression of dominant-negative PKC delta, but not dominant-negative PKC delta, diminished activation of ERK and JNK and blocked LPA-induced expression of Egr-1 mRNA and protein. We also evaluated LPA receptor involvement. Our data reveal an intracellular regulatory mechanism: LPA induction of Egr-1 expression is via LPA cognate receptor (LPA receptor 1)-dependent and PKC delta-mediated ERK and JNK activation. This study provides the first evidence that PKC delta mediates ERK and JNK activation in the LPA signaling pathway and that this pathway is required for LPA-induced gene regulation as evidenced by Egr-1 expression.	[Iyoda, Takuya; Zhang, Fuqiang; Sun, Longsheng; Hao, Feng; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA; [Schmitz-Peiffer, Carsten] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW 2010, Australia; [Zhang, Fuqiang] Jilin Univ, Coll Pharm, Dept Med Bioengn, Changchun 130021, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Garvan Institute of Medical Research; Jilin University	Cui, MZ (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu	Schmitz-Peiffer, Carsten/J-6918-2012	Schmitz-Peiffer, Carsten/0000-0001-7330-7255; Cui, Mei-Zhen/0000-0003-4745-6999	National Institutes of Health [HL074341, HL107466, AG026640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074341, R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026640, R21AG039596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL074341 and HL107466 (to M.-Z. C.) and AG026640 (to X. X.).	Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bea F, 2003, CIRC RES, V92, P394, DOI 10.1161/01.RES.0000059982.43865.75; Blaschke F, 2004, REV ENDOCR METAB DIS, V5, P249, DOI 10.1023/B:REMD.0000032413.88756.ee; BROCK TA, 1985, HYPERTENSION, V7, pI105, DOI 10.1161/01.HYP.7.3_Pt_2.I105; Budnik LT, 2002, BIOL REPROD, V67, P935, DOI 10.1095/biolreprod.101.003087; Cazzolli R, 2002, AM J PHYSIOL-ENDOC M, V282, pE1204, DOI 10.1152/ajpendo.00487.2001; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Chung WC, 2009, J IMMUNOL, V182, P2349, DOI 10.4049/jimmunol.0713637; Cui MZ, 2011, CLIN LIPIDOL, V6, P413, DOI 10.2217/CLP.11.38; Cui MZ, 2006, ARTERIOSCL THROM VAS, V26, P1029, DOI 10.1161/01.ATV.0000214980.90567.b5; Cui MZ, 1999, J BIOL CHEM, V274, P32795, DOI 10.1074/jbc.274.46.32795; Cui MZ, 2003, ARTERIOSCL THROM VAS, V23, P224, DOI 10.1161/01.ATV.0000054660.61191.7D; Cui MZ, 1996, J BIOL CHEM, V271, P2731, DOI 10.1074/jbc.271.5.2731; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Gelain DP, 2006, CELL SIGNAL, V18, P1685, DOI 10.1016/j.cellsig.2006.01.008; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hao F, 2010, AM J PHYSIOL-HEART C, V298, pH974, DOI 10.1152/ajpheart.00895.2009; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; HOWE LR, 1993, J BIOL CHEM, V268, P20717; Kaneyuki U, 2007, VASC PHARMACOL, V46, P286, DOI 10.1016/j.vph.2006.11.002; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Ohtani K, 2004, GENE THER, V11, P126, DOI 10.1038/sj.gt.3302153; Prince JM, 2007, SHOCK, V27, P157, DOI 10.1097/01.shk.0000245025.01365.8e; Reiser COA, 1998, BIOCHEM J, V330, P1107; Rupp J, 2005, P NATL ACAD SCI USA, V102, P3447, DOI 10.1073/pnas.0407759102; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	33	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22635	22642		10.1074/jbc.M111.335695	http://dx.doi.org/10.1074/jbc.M111.335695			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22577133	hybrid, Green Published			2022-12-28	WOS:000306495000020
J	Stieglitz, B; Haire, LF; Dikic, I; Rittinger, K				Stieglitz, Benjamin; Haire, Lesley F.; Dikic, Ivan; Rittinger, Katrin			Structural Analysis of SHARPIN, a Subunit of a Large Multi-protein E3 Ubiquitin Ligase, Reveals a Novel Dimerization Function for the Pleckstrin Homology Superfold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR UBIQUITINATION; INFLAMMATION; DIVERSITY; DOMAINS; DYNAMIN; SYSTEM	SHARPIN (SHANK-associated RH domain interacting protein) is part of a large multi-protein E3 ubiquitin ligase complex called LUBAC(linear ubiquitin chain assembly complex), which catalyzes the formation of linear ubiquitin chains and regulates immune and apoptopic signaling pathways. The C-terminal half of SHARPIN contains ubiquitin-like domain and Npl4-zinc finger domains that mediate the interaction with the LUBAC subunit HOIP and ubiquitin, respectively. In contrast, the N-terminal region does not show any homology with known protein interaction domains but has been suggested to be responsible for self-association of SHARPIN, presumably via a coiled-coil region. We have determined the crystal structure of the N-terminal portion of SHARPIN, which adopts the highly conserved pleckstrin homology superfold that is often used as a scaffold to create protein interaction modules. We show that in SHARPIN, this domain does not appear to be used as a ligand recognition domain because it lacks many of the surface properties that are present in other pleckstrin homology fold-based interaction modules. Instead, it acts as a dimerization module extending the functional applications of this superfold.	[Stieglitz, Benjamin; Haire, Lesley F.; Rittinger, Katrin] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Buchmann Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany	MRC National Institute for Medical Research; Goethe University Frankfurt; Goethe University Frankfurt	Rittinger, K (corresponding author), Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England.	katrin.rittinger@nimr.mrc.ac.uk	Stieglitz, Benjamin/AAY-4140-2020; Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014; Dikic, Ivan/O-4650-2015	Stieglitz, Benjamin/0000-0003-3634-6997; Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Dikic, Ivan/0000-0001-8156-9511	Medical Research Council UK [U117565398]; MRC [MC_U117565398] Funding Source: UKRI; Medical Research Council [MC_U117565398] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council UK Grant U117565398.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ball LJ, 2002, FEBS LETT, V513, P45, DOI 10.1016/S0014-5793(01)03291-4; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Emmerich CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002187; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUSHMAN D, 1995, P NATL ACAD SCI USA, V92, P816, DOI 10.1073/pnas.92.3.816; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Landgraf K, 2010, MOL CELL BIOL, V30, P5764, DOI 10.1128/MCB.01645-09; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Masters TA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000738; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson FC, 2009, FRONT BIOSCI-LANDMRK, V14, P833, DOI 10.2741/3281; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821	33	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2012	287	25					20823	20829		10.1074/jbc.M112.359547	http://dx.doi.org/10.1074/jbc.M112.359547			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FQ	22549881	Green Published, hybrid			2022-12-28	WOS:000306416800004
J	Bai, M; Pang, XY; Lou, JZ; Zhou, QJ; Zhang, K; Ma, J; Li, J; Sun, F; Hsu, VW				Bai, Ming; Pang, Xiaoyun; Lou, Jizhong; Zhou, Qiangjun; Zhang, Kai; Ma, Jun; Li, Jian; Sun, Fei; Hsu, Victor W.			Mechanistic Insights into Regulated Cargo Binding by ACAP1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; ALPHA-5-BETA-1 INTEGRIN; 3D MICROENVIRONMENTS; VESICLE FORMATION; ARFGAP1 PROMOTES; COAT; TRAFFICKING; REFINEMENT; TRANSPORT; DYNAMICS	Coat complexes sort protein cargoes into vesicular transport pathways. An emerging class of coat components has been the GTPase-activating proteins (GAPs) that act on the ADP-ribosylation factor (ARF) family of small GTPases. ACAP1 (ArfGAP with coiled-coil, ankyrin repeat, and PH domains protein 1) is an ARF6 GAP that also acts as a key component of a recently defined clathrin complex for endocytic recycling. Phosphorylation by Akt has been shown to enhance cargo binding by ACAP1 in explaining how integrin recycling is an example of regulated transport. We now shed further mechanistic insights into how this regulation is achieved at the level of cargo binding by ACAP1. We initially defined a critical sequence in the cytoplasmic domain of integrin beta 1 recognized by ACAP1 and showed that this sequence acts as a recycling sorting signal. We then pursued a combination of structural, modeling, and functional studies, which suggest that phosphorylation of ACAP1 relieves a localized mechanism of autoinhibition in regulating cargo binding. Thus, we have elucidated a key regulatory juncture that controls integrin recycling and also advanced the understanding of how regulated cargo binding can lead to regulated transport.	[Bai, Ming; Li, Jian; Hsu, Victor W.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Bai, Ming; Li, Jian; Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Pang, Xiaoyun; Lou, Jizhong; Zhou, Qiangjun; Zhang, Kai; Ma, Jun; Sun, Fei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Institute of Biophysics, CAS	Li, J (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	jli@rics.bwh.harvard.edu; feisun@sun5.ibp.ac.cn; vhsu@rics.bwh.harvard.edu	Sun, Fei/C-4190-2015; Sun, Fei/AAR-3186-2020	Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144; Zhou, Qiangjun/0000-0003-1789-9588; Zhou, Qiangjun/0000-0002-7768-0249; Zhang, Kai/0000-0001-8617-2855	National Institutes of Health [GM073016]; National Science Foundation of China [31000635, 31021062, 31070827]; Chinese Ministry of Science and Technology [2011CB910301, 2011CB910900]; Chinese Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073016. This work was also supported by National Science Foundation of China Grants 31000635 and 31021062 and Chinese Ministry of Science and Technology 973 Project Grants 2011CB910301 and 2011CB910900.; Supported by National Science Foundation of China Grant 31070827 and the Knowledge Innovation Program of the Chinese Academy of Sciences.	Bai M, 2011, NAT CELL BIOL, V13, P559, DOI 10.1038/ncb2221; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hao Q, 2000, J APPL CRYSTALLOGR, V33, P980, DOI 10.1107/S0021889800001424; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Oh SJ, 2010, J BIOL CHEM, V285, P14610, DOI 10.1074/jbc.M109.043935; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015	43	20	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28675	28685		10.1074/jbc.M112.378810	http://dx.doi.org/10.1074/jbc.M112.378810			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22645133	Green Published, hybrid			2022-12-28	WOS:000308074600041
J	Bergfeld, AK; Pearce, OMT; Diaz, SL; Lawrence, R; Vocadlo, DJ; Choudhury, B; Esko, JD; Varki, A				Bergfeld, Anne K.; Pearce, Oliver M. T.; Diaz, Sandra L.; Lawrence, Roger; Vocadlo, David J.; Choudhury, Biswa; Esko, Jeffrey D.; Varki, Ajit			Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups INCORPORATION OF N-GLYCOLYLHEXOSAMINES INTO MAMMALIAN GLYCANS BY FEEDING N-GLYCOLYLGALACTOSAMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLNEURAMINIC ACID HYDROXYLASE; NONHUMAN SIALIC-ACID; HANGANUTZIU-DEICHER ANTIGEN; GLYCOLYLNEURAMINIC ACID; MOUSE-LIVER; LINKED GLYCOSYLATION; CELL LINE; RAT-LIVER; BIOSYNTHESIS; GALNAC	The outermost positions of mammalian cell-surface glycans are predominantly occupied by the sialic acids N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc). To date, hydroxylation of CMP-Neu5Ac resulting in the conversion into CMP-Neu5Gc is the only known enzymatic reaction in mammals to synthesize a monosaccharide carrying an N-glycolyl group. In our accompanying paper (Bergfeld, A. K., Pearce, O. M., Diaz, S. L., Pham, T., and Varki, A. (2012) J. Biol. Chem. 287, jbc.M112.363549), we report a metabolic pathway for degradation of Neu5Gc, demonstrating that N-acetylhexosamine pathways are tolerant toward the N-glycolyl substituent of Neu5Gc breakdown products. In this study, we show that exogenously added N-glycolylgalactosamine (GalNGc) serves as a precursor for Neu5Gc de novo biosynthesis, potentially involving seven distinct mammalian enzymes. Following the GalNAc salvage pathway, UDP-GalNGc is epimerized to UDP-GlcNGc, which might compete with the endogenous UDP-GlcNAc for the sialic acid biosynthetic pathway. Using UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase-deficient cells, we confirm that conversion of GalNGc into Neu5Gc depends on this key enzyme of sialic acid biosynthesis. Furthermore, we demonstrate by mass spectrometry that the metabolic intermediates UDP-GalNGc and UDP-GlcNGc serve as substrates for assembly of most major classes of cellular glycans. We show for the first time incorporation of GalNGc and GlcNGc into chondroitin/dermatan sulfates and heparan sulfates, respectively. As demonstrated by structural analysis, N-glycolylated hexosamines were found in cellular gangliosides and incorporated into Chinese hamster ovary cell O-glycans. Remarkably, GalNAc derivatives altered the overall O-glycosylation pattern as indicated by the occurrence of novel O-glycan structures. This study demonstrates that mammalian N-acetylhexosamine pathways and glycan assembly are surprisingly tolerant toward the N-glycolyl substituent.	[Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Bergfeld, Anne K.; Pearce, Oliver M. T.; Diaz, Sandra L.; Lawrence, Roger; Choudhury, Biswa; Esko, Jeffrey D.; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; Simon Fraser University	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Pearce, Oliver/0000-0003-3953-1629	National Institutes of Health [R01GM32373, R01CA38701]; Deutsche Forschungsgemeinschaft [BE 4643/1-1]; Cancer Research Institute/Samuel and Ruth Engelberg Fellowship; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Institute/Samuel and Ruth Engelberg Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM32373 and R01CA38701 (to A. V.). This work was also supported by Deutsche Forschungsgemeinschaft Research Fellowship BE 4643/1-1 (to A. K. B.) and a Cancer Research Institute/Samuel and Ruth Engelberg Fellowship (to O. M. T. P.).	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bergfeld A. K., 2012, J BIOL CHEM, V287; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Brockhausen I, 2009, ESSENTIALS GLYCOBIOL, P115; Bulai T, 2002, BIOCHIMIE, V84, P655, DOI 10.1016/S0300-9084(02)01436-0; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; DEVINE PL, 1991, CANCER RES, V51, P5826; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Esko J.D., 2001, CURR PROTOC MOL BIOL, DOI 10.1002/0471142727.mb1702s22; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; GLOWACKA D, 1978, BIOCHEM MED METAB B, V19, P202, DOI 10.1016/0006-2944(78)90021-2; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; HAYES BK, 1993, J BIOL CHEM, V268, P16139; HIGASHI H, 1985, CANCER RES, V45, P3796; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P614; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; JOURDIAN GW, 1962, J BIOL CHEM, V237, P2442; KAWACHI S, 1988, INT ARCH ALLER A IMM, V85, P381, DOI 10.1159/000234536; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KAWANO T, 1993, GLYCOCONJUGATE J, V10, P109, DOI 10.1007/BF00731194; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KOZUTSUMI Y, 1990, J BIOCHEM, V108, P704, DOI 10.1093/oxfordjournals.jbchem.a123268; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; MENEZES J, 1975, BIOMEDICINE, V22, P276; MIYOSHI I, 1986, MOL IMMUNOL, V23, P631, DOI 10.1016/0161-5890(86)90100-8; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Pastuszak I, 1996, J BIOL CHEM, V271, P20776, DOI 10.1074/jbc.271.34.20776; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; Pouilly S, 2012, ACS CHEM BIOL, V7, P753, DOI 10.1021/cb200511t; Pouilly S, 2012, FEBS J, V279, P586, DOI 10.1111/j.1742-4658.2011.08448.x; ROSEMAN S, 1961, P NATL ACAD SCI USA, V47, P958, DOI 10.1073/pnas.47.7.958; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Schauer R, 1999, BIOSCIENCE REP, V19, P373, DOI 10.1023/A:1020256004616; Schlenzka W, 1996, FEBS LETT, V385, P197, DOI 10.1016/0014-5793(96)00384-5; Schnaar RL, 2009, ESSENTIALS GLYCOBIOL, P129; SHAW L, 1992, EUR J BIOCHEM, V206, P269, DOI 10.1111/j.1432-1033.1992.tb16925.x; SHAW L, 1994, EUR J BIOCHEM, V219, P1001, DOI 10.1111/j.1432-1033.1994.tb18583.x; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; Stanley P., 2009, ESSENTIALS GLYCOBIOL; TAKEMATSU H, 1994, J BIOCHEM-TOKYO, V115, P381, DOI 10.1093/oxfordjournals.jbchem.a124347; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Varki A, 2001, BIOCHIMIE, V83, P615, DOI 10.1016/S0300-9084(01)01309-8; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Wang-Gillam A, 2000, J BIOL CHEM, V275, P1433, DOI 10.1074/jbc.275.2.1433	69	21	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28898	28916		10.1074/jbc.M112.363499	http://dx.doi.org/10.1074/jbc.M112.363499			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22692203	Green Published, hybrid			2022-12-28	WOS:000308074600060
J	Li, J; Motlagh, HN; Chakuroff, C; Thompson, EB; Hilser, VJ				Li, Jing; Motlagh, Hesam N.; Chakuroff, Carolyn; Thompson, E. Brad; Hilser, Vincent J.			Thermodynamic Dissection of the Intrinsically Disordered N-terminal Domain of Human Glucocorticoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSTRUCTURED PROTEINS; UNFOLDED PROTEINS; BINDING; COOPERATIVITY; OSMOLYTES; TRANSACTIVATION; INDUCTION; MECHANISM; ALLOSTERY; FRAGMENT	Intrinsically disordered (ID) sequence segments are abundant in cell signaling proteins and transcription factors. Because ID regions commonly fold as part of their intracellular function, it is crucial to understand the folded states as well as the transitions between the unfolded and folded states. Specifically, it is important to determine 1) whether large ID segments contain different thermodynamically and/or functionally distinct regions, 2) whether any ID regions fold upon activation, 3) the degree of coupling between the different ID regions, and 4) whether the stability of ID domains is a determinant of function. In this study, we thermodynamically characterized the full-length ID N-terminal domain (NTD) of human glucocorticoid receptor (GR) and two of its naturally occurring translational isoforms. The protective osmolyte trimethylamine N-oxide (TMAO) was used to induce folding transitions. Each of the three NTD isoforms was found to undergo a cooperative folding transition that is thermodynamically indistinguishable (based on m-values) from that of a globular protein of similar size. The extrapolated stabilities for the NTD isoforms showed clear correlation with the known activities of their corresponding GR translational isoforms. The data reveal that the full-length NTD can be viewed as having at least two thermodynamically coupled regions, a functional region, which is indispensable for GR transcriptional activity, and a regulatory region, the length of which serves to regulate the stability of NTD and thus the activity of GR. These results suggest a new functional paradigm whereby steroid hormone receptors in particular and ID proteins in general can have multiple functionally distinct ID regions that interact and modulate the stability of important functional sites.	[Li, Jing; Chakuroff, Carolyn; Hilser, Vincent J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Li, Jing; Motlagh, Hesam N.; Hilser, Vincent J.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Thompson, E. Brad] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX 77204 USA; [Thompson, E. Brad] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Johns Hopkins University; Johns Hopkins University; University of Houston System; University of Houston; University of Texas System; University of Texas Medical Branch Galveston	Hilser, VJ (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	hilser@jhu.edu		Motlagh, Hesam/0000-0003-3834-926X	National Science Foundation [MCB-0446050, DBI-1005027]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants MCB-0446050 (to V. J. H.) and DBI-1005027 (to C. C.).	Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Auton M, 2007, METHOD ENZYMOL, V428, P397, DOI 10.1016/S0076-6879(07)28023-1; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Bray PJ, 2003, HUM MUTAT, V21, P557, DOI 10.1002/humu.10213; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Freiburger LA, 2011, NAT STRUCT MOL BIOL, V18, P288, DOI 10.1038/nsmb.1978; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Ghosh K, 2009, P NATL ACAD SCI USA, V106, P10649, DOI 10.1073/pnas.0903995106; Griekspoor A., 2007, NUCL RECEPT SIGNAL, V9, pE003, DOI DOI 10.1621/NRS.05003; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henkels CH, 2001, BIOCHEMISTRY-US, V40, P2777, DOI 10.1021/bi002078y; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kumar R, 2007, ARCH BIOCHEM BIOPHYS, V465, P452, DOI 10.1016/j.abb.2007.06.019; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Midic U., 2009, P KDD 09 WORKSH STAT, P27; Midic U, 2009, PROTEIN PEPTIDE LETT, V16, P1533, DOI 10.2174/092986609789839377; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Pradeep L, 2004, J BIOL CHEM, V279, P40303, DOI 10.1074/jbc.M406323200; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SHORTLE D, 1995, ADV PROTEIN CHEM, V46, P217, DOI 10.1016/S0065-3233(08)60336-8; TANFORD C, 1964, J AM CHEM SOC, V86, P2050, DOI 10.1021/ja01064a028; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Whitmore L, 2011, NUCLEIC ACIDS RES, V39, pD480, DOI 10.1093/nar/gkq1026; Whitten ST, 2001, J MOL BIOL, V309, P1165, DOI 10.1006/jmbi.2001.4726; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu P, 2006, PROTEINS, V63, P290, DOI 10.1002/prot.20868	55	37	37	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26777	26787		10.1074/jbc.M112.355651	http://dx.doi.org/10.1074/jbc.M112.355651			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22669939	Green Published, hybrid			2022-12-28	WOS:000307386000027
J	Juarez, O; Neehaul, Y; Turk, E; Chahboun, N; Demicco, JM; Hellwig, P; Barquera, B				Juarez, Oscar; Neehaul, Yashvin; Turk, Erin; Chahboun, Najat; Demicco, Jessica M.; Hellwig, Petra; Barquera, Blanca			The Role of Glycine Residues 140 and 141 of Subunit B in the Functional Ubiquinone Binding Site of the Na+-pumping NADH: quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; NADHQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; CYTOCHROME-C; INFRARED-SPECTROSCOPY; MEMBRANE-PROTEINS; NQRC SUBUNITS; ALGINOLYTICUS; REDUCTASE; KORORMICIN	The Na+-pumping NADH: quinone oxidoreductase (Na+-NQR) is the main entrance for electrons into the respiratory chain of many marine and pathogenic bacteria. The enzyme accepts electrons from NADH and donates them to ubiquinone, and the free energy released by this redox reaction is used to create an electrochemical gradient of sodium across the cell membrane. Here we report the role of glycine 140 and glycine 141 of the NqrB subunit in the functional binding of ubiquinone. Mutations at these residues altered the affinity of the enzyme for ubiquinol. Moreover, mutations in residue NqrB-G140 almost completely abolished the electron transfer to ubiquinone. Thus, NqrB-G140 and -G141 are critical for the binding and reaction of Na+-NQR with its electron acceptor, ubiquinone.	[Juarez, Oscar; Demicco, Jessica M.; Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Troy, NY 12180 USA; [Neehaul, Yashvin; Chahboun, Najat; Hellwig, Petra] Univ Strasbourg, CNRS, Inst Chim, Lab Spectroscopie Vibrat & Electrochim Biomol, F-67060 Strasbourg, France; [Turk, Erin] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Rensselaer Polytechnic Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Stanford University	Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Rm 2239,110 8th St, Troy, NY 12180 USA.			Juarez, Oscar/0000-0002-2915-8413; hellwig, petra/0000-0001-6294-5163; Piazza, Erin/0000-0002-3263-5946	National Science Foundation Division of Molecular and Cellular Biosciences Grant [1052234]	National Science Foundation Division of Molecular and Cellular Biosciences Grant	This work was supported in part by National Science Foundation Division of Molecular and Cellular Biosciences Grant 1052234.	Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Behr J, 1998, BIOCHEMISTRY-US, V37, P7400, DOI 10.1021/bi9731697; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; HAYASHI M, 1992, BIOCHIM BIOPHYS ACTA, V1099, P145, DOI 10.1016/0005-2728(92)90211-J; Hellwig P, 2000, BIOCHEMISTRY-US, V39, P10884, DOI 10.1021/bi000842a; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; MOSS D, 1990, EUR J BIOCHEM, V187, P565, DOI 10.1111/j.1432-1033.1990.tb15338.x; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Yoshikawa K, 1997, J ANTIBIOT, V50, P949, DOI 10.7164/antibiotics.50.949; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182	37	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25678	25685		10.1074/jbc.M112.366088	http://dx.doi.org/10.1074/jbc.M112.366088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22645140	hybrid, Green Published			2022-12-28	WOS:000306651700075
J	Nakamura, K; Man, ZQ; Xie, Y; Hanai, A; Makyio, H; Kawasaki, M; Kato, R; Shin, HW; Nakayama, K; Wakatsuki, S				Nakamura, Kensuke; Man, Zhiqiu; Xie, Yong; Hanai, Ayako; Makyio, Hisayoshi; Kawasaki, Masato; Kato, Ryuichi; Shin, Hye-Won; Nakayama, Kazuhisa; Wakatsuki, Soichi			Structural Basis for Membrane Binding Specificity of the Bin/Amphiphysin/Rvs (BAR) Domain of Arfaptin-2 Determined by Arl1 GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; RAC1-INTERACTING PROTEIN; TRAFFICKING; RECRUITMENT; COMPARTMENT; CURVATURE; ARFRP1; RAB5; PX	Membrane-sculpting BAR (Bin/Amphiphysin/Rvs) domains form a crescent-shaped homodimer that can sense and induce membrane curvature through its positively charged concave face. We have recently shown that Arfaptin-2, which was originally identified as a binding partner for the Arf and Rac1 GTPases, binds to Arl1 through its BAR domain and is recruited onto Golgi membranes. There, Arfaptin-2 induces membrane tubules. Here, we report the crystal structure of the Arfaptin-2 BAR homodimer in complex with two Arl1 molecules bound symmetrically to each side, leaving the concave face open for membrane association. The overall structure of the Arl1.Arfaptin-2 BAR complex closely resembles that of the PX-BAR domain of sorting nexin 9, suggesting similar mechanisms underlying BAR domain targeting to specific organellar membranes. The Arl1.Arfaptin-2 BAR structure suggests that one of the two Arl1 molecules competes with Rac1, which binds to the concave face of the Arfaptin-2 BAR homodimer and may hinder its membrane association.	[Man, Zhiqiu; Hanai, Ayako; Shin, Hye-Won; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Nakamura, Kensuke; Xie, Yong; Makyio, Hisayoshi; Kawasaki, Masato; Kato, Ryuichi; Wakatsuki, Soichi] High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Kawasaki, Masato; Kato, Ryuichi; Wakatsuki, Soichi] Grad Univ Adv Studies, Sch High Energy Accelerator Sci, Tsukuba, Ibaraki 3050801, Japan; [Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Kyoto University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp; soichi.wakatsuki@kek.jp	Makyio, Hisayoshi/E-1166-2014; Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020	Makyio, Hisayoshi/0000-0002-0611-6544; Shin, Hye-Won/0000-0002-9138-9554; Kato, Ryuichi/0000-0003-2087-2896; Nakayama, Kazuhisa/0000-0001-7701-7183; Kawasaki, Masato/0000-0002-8319-2102; Wakatsuki, Soichi/0000-0001-5896-7968	Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science; Grants-in-Aid for Scientific Research [10J03618] Funding Source: KAKEN	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Targeted Proteins Research Program, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for Promotion of Science.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Hiraki M, 2006, ACTA CRYSTALLOGR D, V62, P1058, DOI 10.1107/S0907444906023821; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Rao YJ, 2011, CELL MOL LIFE SCI, V68, P3983, DOI 10.1007/s00018-011-0768-5; Sahin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001620; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2012, MEMBRANES-BASEL, V2, DOI 10.3390/membranes2010118; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	36	29	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25478	25489		10.1074/jbc.M112.365783	http://dx.doi.org/10.1074/jbc.M112.365783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22679020	Green Published, hybrid			2022-12-28	WOS:000306651700054
J	Nakayama, Y; Matsui, Y; Takeda, Y; Okamoto, M; Abe, K; Fukumoto, Y; Yamaguchi, N				Nakayama, Yuji; Matsui, Yuki; Takeda, Yumi; Okamoto, Mai; Abe, Kohei; Fukumoto, Yasunori; Yamaguchi, Naoto			c-Src but Not Fyn Promotes Proper Spindle Orientation in Early Prometaphase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; AURORA-A KINASE; MITOTIC SPINDLE; FAMILY KINASES; CENTROSOME MATURATION; NUCLEAR-LOCALIZATION; PROTEIN-KINASES; CELL-CYCLE; ACTIVATION; PHOSPHORYLATION	Src family tyrosine kinases (SFKs) participate in mitotic signal transduction events, including mitotic entry, cleavage furrow ingression, and cytokinesis abscission. Although SFKs have been shown to associate with the mitotic spindle, the role of SFKs in mitotic spindle formation remains unclear. Here, we show that c-Src promotes proper spindle orientation in early prometaphase. Src localizes close to spindle poles in a manner independent of Src kinase activity. Three-dimensional analyses showed that Src inhibition induced spindle misorientation, exhibiting a tilting spindle in early prometaphase. Spindle misorientation is frequently seen in SYF cells, which harbor triple knock-out mutations of c-Src, c-Yes, and Fyn, and reintroduction of c-Src but not Fyn into SYF cells rescued spindle misorientation. Spindle misorientation was also observed upon Src inhibition under conditions in which Aurora B was inhibited. Inducible expression of c-Src promoted a properly oriented bipolar spindle, which was suppressed by Src inhibition. Aster formation was severely inhibited in SYF cells upon Aurora B inhibition, which was rescued by reintroduction of c-Src into SYF cells. Furthermore, reintroduction of c-Src facilitated microtubule regrowth from cold-induced depolymerization and accelerated M phase progression. These results suggest that c-Src is involved in spindle orientation through centrosome-mediated aster formation.	[Nakayama, Yuji] Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Chiba University	Nakayama, Y (corresponding author), Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nakayama@p.chiba-u.ac.jp; nyama@faculty.chiba-u.jp		Nakayama, Yuji/0000-0001-7882-0066	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Chiba University; Futaba Electronics Memorial Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Chiba University; Futaba Electronics Memorial Foundation	This work was supported in part by grants-in-aid for scientific research and special funds for education and research (Development of SPECT Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; a research grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research; and a research grant from the Nanohana Competition 2011 Award of Chiba University and the Futaba Electronics Memorial Foundation (to Y. F.).	Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Borysova MK, 2008, CELL CYCLE, V7, P2894, DOI 10.4161/cc.7.18.6678; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BUSS JE, 1985, J VIROL, V53, P7, DOI 10.1128/JVI.53.1.7-12.1985; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; DAVIDPFEUTY T, 1993, J CELL SCI, V105, P613; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HEIDER H, 1994, EUR J BIOCHEM, V219, P513, DOI 10.1111/j.1432-1033.1994.tb19966.x; Horne MM, 2003, J CELL BIOL, V161, P1021, DOI 10.1083/jcb.200304144; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kesavan KP, 2002, J BIOL CHEM, V277, P14666, DOI 10.1074/jbc.M111911200; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kikuchi I, 2010, CELL BIOL INT, V34, P645, DOI 10.1042/CBI20090398; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kuga T, 2008, EXP CELL RES, V314, P2040, DOI 10.1016/j.yexcr.2008.03.018; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; McGinnis LK, 2007, DEV BIOL, V306, P241, DOI 10.1016/j.ydbio.2007.03.024; Moasser MM, 1999, CANCER RES, V59, P6145; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Perez Y, 2009, J MOL BIOL, V391, P136, DOI 10.1016/j.jmb.2009.06.018; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Talmor-Cohen A, 2004, REPRODUCTION, V128, P387, DOI 10.1530/rep.1.00266; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Wang LH, 2008, CELL CYCLE, V7, P1104, DOI 10.4161/cc.7.8.5738; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Yamaguchi N, 2001, J CELL SCI, V114, P1631; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	65	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24905	24915		10.1074/jbc.M112.341578	http://dx.doi.org/10.1074/jbc.M112.341578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22689581	Green Published, hybrid			2022-12-28	WOS:000306651700005
J	Gan, SW; Tan, E; Lin, X; Yu, DJ; Wang, JJ; Tan, GMY; Vararattanavech, A; Yeo, CY; Soon, CH; Soong, TW; Pervushin, K; Torres, J				Gan, Siok-Wan; Tan, Edward; Lin, Xin; Yu, Dejie; Wang, Juejin; Tan, Gregory Ming-Yeong; Vararattanavech, Ardcharaporn; Yeo, Chiew Ying; Soon, Cin Huang; Soong, Tuck Wah; Pervushin, Konstantin; Torres, Jaume			The Small Hydrophobic Protein of the Human Respiratory Syncytial Virus Forms Pentameric Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; INTEGRAL MEMBRANE-PROTEIN; INFLUENZA-A VIRUS; TRANSMEMBRANE DOMAIN; SH GENE; HISTIDINE RESIDUE; STRUCTURAL BASIS; PROTON CHANNEL; P7 PROTEIN; SUBGROUP-B	The small hydrophobic (SH) protein is encoded by the human respiratory syncytial virus. Its absence leads to viral attenuation in the context of whole organisms, and it prevents apoptosis in infected cells. Herein, we have examined the structure of SH protein in detergent micelles and in lipid bilayers, by solution NMR and attenuated total reflection-Fourier transform infrared spectroscopy, respectively. We found that SH protein has a single alpha-helical transmembrane domain and forms homopentamers in several detergents. In detergent micelles, the transmembrane domain is flanked N-terminally by an alpha-helix that forms a ring around the lumen of the pore and C-terminally by an extended beta-turn. SH protein was found in the plasma membrane of transiently expressing HEK 293 cells, which showed pH-dependent (acid-activated) channel activity. Channel activity was abolished in mutants lacking both native His residues, His(22) and His(51), but not when either His was present. Herein, we propose that the pentameric model of SH protein presented is a physiologically relevant conformation, albeit probably not the only one, in which SH contributes to RSV infection and replication. Viroporins are short (similar to 100 amino acids) viral membrane proteins that form oligomers of a defined size, act as proton or ion channels, and in general enhance membrane permeability in the host. However, with some exceptions, their precise biological role of their channel activity is not understood. In general, viroporins resemble poorly specialized proteins but are nevertheless critical for viral fitness. In vivo, viruses lacking viroporins usually exhibit an attenuated or weakened phenotype, altered tropism, and diminished pathological effects. We have chosen to study the SH protein, 64 amino acids long, found in the human respiratory syncytial virus because of the effect of RSV on human health and the lack of adequate antivirals. We show that SH protein forms oligomers that behave as ion channels when activated at low pH. This study adds SH protein to a growing group of viroporins that have been structurally characterized. Although the precise biological role of this pentameric channel is still unknown, this report is nevertheless essential to fill some of the many gaps that exist in the understanding of SH protein function.	[Gan, Siok-Wan; Tan, Edward; Lin, Xin; Vararattanavech, Ardcharaporn; Yeo, Chiew Ying; Soon, Cin Huang; Pervushin, Konstantin; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Yu, Dejie; Wang, Juejin; Tan, Gregory Ming-Yeong; Soong, Tuck Wah] Natl Univ Singapore, Ctr Life Sci, Dept Physiol, Singapore 117456, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Pervushin, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	kpervushin@ntu.edu.sg; jtorres@ntu.edu.sg	Juejin, Wang/ABA-7017-2020; Tan, Edward/W-8611-2019; Pervushin, Konstantin/AAJ-6580-2020; Wang, Jue/GVU-0480-2022; Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020	Pervushin, Konstantin/0000-0002-6393-4340; Torres, Jaume/0000-0002-1282-9727; , Juejin/0000-0003-4921-5451	National Research Foundation [NRF-CRP4-2008-02]	National Research Foundation	This work was supported by National Research Foundation Grant NRF-CRP4-2008-02 (to J. T.).	ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Arkin IT, 1997, J AM CHEM SOC, V119, P8973, DOI 10.1021/ja964253x; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Briggs JAG, 2001, PROTEINS, V44, P370, DOI 10.1002/prot.1102; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bukreyev A, 1997, J VIROL, V71, P8973, DOI 10.1128/JVI.71.12.8973-8982.1997; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Campanella M, 2004, J BIOL CHEM, V279, P18440, DOI 10.1074/jbc.M309494200; Carter SD, 2010, FEBS LETT, V584, P2786, DOI 10.1016/j.febslet.2010.05.006; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Chen MD, 2000, J INFECT DIS, V182, P1228, DOI 10.1086/315829; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; COLLINS PL, 1990, J GEN VIROL, V71, P1571, DOI 10.1099/0022-1317-71-7-1571; COLLINS PL, 1993, J GEN VIROL, V74, P1445, DOI 10.1099/0022-1317-74-7-1445; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; Gan SW, 2008, PROTEIN SCI, V17, P813, DOI 10.1110/ps.073366208; Gan SW, 2011, ANAL BIOCHEM, V416, P100, DOI 10.1016/j.ab.2011.05.007; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He B, 2001, J VIROL, V75, P4068, DOI 10.1128/JVI.75.9.4068-4079.2001; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Howard KP, 2002, P NATL ACAD SCI USA, V99, P8568, DOI 10.1073/pnas.132266099; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Lin YA, 2003, J VIROL, V77, P3371, DOI 10.1128/JVI.77.6.3371-3383.2003; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; Madan V, 2008, CELL MICROBIOL, V10, P437, DOI 10.1111/j.1462-5822.2007.01057.x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x; MORRIS JA, 1956, P SOC EXP BIOL MED, V92, P544, DOI 10.3181/00379727-92-22538; Neznanov N, 2001, J VIROL, V75, P10409, DOI 10.1128/JVI.75.21.10409-10420.2001; OLMSTED RA, 1989, J VIROL, V63, P2019, DOI 10.1128/JVI.63.5.2019-2029.1989; Parthasarathy K, 2008, BIOPHYS J, V95, pL39, DOI 10.1529/biophysj.108.133041; Perez M, 1997, VIROLOGY, V235, P342, DOI 10.1006/viro.1997.8696; Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; Rixon HWM, 2005, J GEN VIROL, V86, P375, DOI 10.1099/vir.0.80563-0; Rixon HWML, 2004, J GEN VIROL, V85, P1153, DOI 10.1099/vir.0.19769-0; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takeuchi K, 2007, J BIOL CHEM, V282, P15179, DOI 10.1074/jbc.M608264200; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Tolley KP, 1996, VACCINE, V14, P1637, DOI 10.1016/S0264-410X(96)00136-3; Torres J, 2001, BIOPOLYMERS, V59, P396, DOI 10.1002/1097-0282(200111)59:6<396::AID-BIP1044>3.3.CO;2-P; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; Wilson L, 2004, VIROLOGY, V330, P322, DOI 10.1016/j.virol.2004.09.033; Wilson RL, 2006, J VIROL, V80, P1700, DOI 10.1128/JVI.80.4.1700-1709.2006; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7	73	85	87	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24671	24689		10.1074/jbc.M111.332791	http://dx.doi.org/10.1074/jbc.M111.332791			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22621926	Green Published, hybrid			2022-12-28	WOS:000306651100061
J	Ji, YW; Sun, SY; Xia, S; Yang, L; Li, XQ; Qi, L				Ji, Yewei; Sun, Shengyi; Xia, Sheng; Yang, Liu; Li, Xiaoqing; Qi, Ling			Short Term High Fat Diet Challenge Promotes Alternative Macrophage Polarization in Adipose Tissue via Natural Killer T Cells and Interleukin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; INVARIANT NKT CELLS; IN-VIVO; LIVER-DISEASE; ACTIVATION; INFLAMMATION; OBESITY; MECHANISM; SENSITIVITY; PRECURSOR	Inflammation in adipose tissue plays an important role in the pathogenesis of obesity-associated complications. However, the detailed cellular events underlying the inflammatory changes at the onset of obesity have not been characterized. Here we show that an acute HFD challenge is unexpectedly associated with elevated alternative (M2) macrophage polarization in adipose tissue mediated by Natural Killer T (NKT) cells. Upon 4d HFD feeding, NKT cells are activated, promote M2 macrophage polarization and induce arginase 1 expression via interleukin (IL)-4 in adipose tissue, not in the liver. In NKT-deficient CD1d(-/-) mice, M2 macrophage polarization in adipose tissue is reduced while systemic glucose homeostasis and insulin tolerance are impaired upon 4d HFD challenge. Thus, our study demonstrate, for the first time to our knowledge, that acute HFD feeding is associated with remarkably pronounced and dynamic immune responses in adipose tissue, and adipose-resident NKT cells may link acute HFD feeding with inflammation.	[Ji, Yewei; Xia, Sheng; Li, Xiaoqing; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Sun, Shengyi; Qi, Ling] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Qi, L (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	lq35@cornell.edu	Ji, Yewei/F-5040-2014	Ji, Yewei/0000-0002-4249-6812; Qi, Ling/0000-0001-8229-0184; Sun, Shengyi/0000-0002-1734-3902	National Institutes of Health NIDDK [R01DK082582, R01DK082582-S1]; American Diabetes Association (ADA) [7-08-JF-47, 1-12-CD-04]; Howard Hughes Medical Institute; American Heart Association; ADA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association (ADA)(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); ADA(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded, in whole or in part, by National Institutes of Health NIDDK R01DK082582 and R01DK082582-S1 (to L. Q.) and American Diabetes Association (ADA) Grants 7-08-JF-47 and 1-12-CD-04.; Supported by the International Student Research Fellowship from Howard Hughes Medical Institute.; Supported by the Predoctoral Fellowship from American Heart Association.; Recipient of the Junior Faculty and Career Development Awards from ADA. To whom correspondence should be addressed. Tel.: 607-254-8857; Fax: 607-255-6269; E-mail:lq35@cornell.edu.	Bai L, 2012, J IMMUNOL, V188, P3053, DOI 10.4049/jimmunol.1102414; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; MACDONALD HR, 1993, IMMUNOL REV, V133, P105, DOI 10.1111/j.1600-065X.1993.tb01512.x; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sun S., 2012, ANN REV NUT IN PRESS; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zhang GQ, 2011, AM J PHYSIOL-LUNG C, V301, pL975, DOI 10.1152/ajplung.00114.2011	49	109	113	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24378	24386		10.1074/jbc.M112.371807	http://dx.doi.org/10.1074/jbc.M112.371807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22645141	Green Published, hybrid			2022-12-28	WOS:000306651100032
J	Orlichenko, L; Stolz, DB; Noel, P; Behari, J; Liu, SG; Singh, VP				Orlichenko, Lidiya; Stolz, Donna B.; Noel, Pawan; Behari, Jaideep; Liu, Shiguang; Singh, Vijay P.			ADP-ribosylation Factor 1 Protein Regulates Trypsinogen Activation via Organellar Trafficking of Procathepsin B Protein and Autophagic Maturation in Acute Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINAR-CELLS; CATHEPSIN-B; CERULEIN-PANCREATITIS; DUCT OBSTRUCTION; PLASMA-MEMBRANE; EARLY EVENTS; IN-VITRO; GOLGI; MICE; INHIBITION	Several studies have suggested that autophagy might play a deleterious role in acute pancreatitis via intra-acinar activation of digestive enzymes. The prototype for this phenomenon is cathepsin B-mediated trypsin generation. To determine the organellar basis of this process, we investigated the subcellular distribution of the cathepsin B precursor, procathepsin B. We found that procathepsin B is enriched in Golgi-containing microsomes, suggesting a role for the ADP-ribosylation (ARF)-dependent trafficking of cathepsin B. Indeed, caerulein treatment increased processing of procathepsin B, whereas a known ARF inhibitor brefeldin A (BFA) prevented this. Similar treatment did not affect processing of procathepsin L. BFA-mediated ARF1 inhibition resulted in reduced cathepsin B activity and consequently reduced trypsinogen activation. However, formation of light chain 3 (LC3-II) was not affected, suggesting that BFA did not prevent autophagy induction. Instead, sucrose density gradient centrifugation and electron microscopy showed that BFA arrested caerulein-induced autophagosomal maturation. Therefore, ARF1-dependent trafficking of procathepsin B and the maturation of autophagosomes results in cathepsin B-mediated trypsinogen activation induced by caerulein.	[Orlichenko, Lidiya; Noel, Pawan; Behari, Jaideep; Liu, Shiguang; Singh, Vijay P.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, VP (corresponding author), Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, 566,Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	singhv2@upmc.edu		Singh, Vijay/0000-0001-6611-1908	University of Pittsburgh Department of Medicine	University of Pittsburgh Department of Medicine(University of Pittsburgh)	This work was supported by a startup package from the University of Pittsburgh Department of Medicine (to V. P. S.).	Bhagat L, 2002, GASTROENTEROLOGY, V122, P156, DOI 10.1053/gast.2002.30314; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; Chagas JR, 1996, FEBS LETT, V392, P233, DOI 10.1016/0014-5793(96)00822-8; Chiari H, 1906, ZEUTRALBL PATHOL, V17, P798; Crozier SJ, 2008, AM J PHYSIOL-GASTR L, V294, pG1148, DOI 10.1152/ajpgi.00426.2007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; FIGARELLA C, 1988, BIOL CHEM H-S, V369, P293; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; Gaiser S, 2011, GUT, V60, P1379, DOI 10.1136/gut.2010.226175; Geng JF, 2010, AUTOPHAGY, V6, P950, DOI 10.4161/auto.6.7.13009; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; HENDRICKS LC, 1992, EUR J CELL BIOL, V58, P202; HENDRICKS LC, 1992, P NATL ACAD SCI USA, V89, P7242, DOI 10.1073/pnas.89.15.7242; HIRANO T, 1991, J CLIN INVEST, V87, P865, DOI 10.1172/JCI115091; HIRAOKA T, 1984, WORLD J SURG, V8, P766, DOI 10.1007/BF01655776; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; KLOPPEL G, 1986, VIRCHOWS ARCH A, V409, P791, DOI 10.1007/BF00710764; Lippincott-Schwartz J, 1998, HISTOCHEM CELL BIOL, V109, P449, DOI 10.1007/s004180050247; MACH L, 1994, J BIOL CHEM, V269, P13030; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; NEVALAINEN TJ, 1974, VIRCHOWS ARCH B, V15, P107; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Ohmuraya M, 2006, PANCREAS, V33, P104, DOI 10.1097/01.mpa.0000226889.86322.9b; Orlichenko LS, 2010, AM J PHYSIOL-GASTR L, V299, pG867, DOI 10.1152/ajpgi.00177.2010; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; SAITO I, 1987, AM J PHYSIOL, V253, pG517, DOI 10.1152/ajpgi.1987.253.4.G517; SALUJA A, 1989, J CLIN INVEST, V84, P1260, DOI 10.1172/JCI114293; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Sausville E A, 1996, Cancer J Sci Am, V2, P52; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Singh VP, 2008, MOL BIOL CELL, V19, P2339, DOI 10.1091/mbc.E07-11-1130; Singh VP, 2009, AM J PHYSIOL-GASTR L, V296, pG1040, DOI 10.1152/ajpgi.90642.2008; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; STEER ML, 1984, DIGEST DIS SCI, V29, P934, DOI 10.1007/BF01312483; Stolz DB, 1999, AM J PATHOL, V155, P1487, DOI 10.1016/S0002-9440(10)65464-8; Sutton R, 2003, PANCREATOLOGY, V3, P497, DOI 10.1159/000075581; Suzuki T, 2006, MOL CELL BIOL, V26, P6149, DOI 10.1128/MCB.00298-06; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Torgerson RR, 1998, J CELL SCI, V111, P2911; Van Acker GJD, 2007, AM J PHYSIOL-GASTR L, V292, pG1738, DOI 10.1152/ajpgi.00543.2006; Van Acker GJD, 2002, AM J PHYSIOL-GASTR L, V283, pG794, DOI 10.1152/ajpgi.00363.2001; Waldthaler A, 2010, DIGEST DIS, V28, P364, DOI 10.1159/000319416; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; WATANABE O, 1984, AM J PHYSIOL, V246, pG457, DOI 10.1152/ajpgi.1984.246.4.G457; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; WILLEMER S, 1990, HISTOCHEMISTRY, V94, P161, DOI 10.1007/BF02440183; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	59	9	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24284	24293		10.1074/jbc.M111.328815	http://dx.doi.org/10.1074/jbc.M111.328815			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22570480	hybrid, Green Published			2022-12-28	WOS:000306651100022
J	Peters, SJ; Smales, CM; Henry, AJ; Stephens, PE; West, S; Humphreys, DP				Peters, Shirley J.; Smales, C. Mark; Henry, Alistair J.; Stephens, Paul E.; West, Shauna; Humphreys, David P.			Engineering an Improved IgG4 Molecule with Reduced Disulfide Bond Heterogeneity and Increased Fab Domain Thermal Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED AGGREGATION; IMMUNOGLOBULIN G4; MONOCLONAL IGG1; ARM EXCHANGE; ANTIBODIES; ISOTYPES; BINDING; REGION	The integrity of antibody structure, stability, and biophysical characterization are becoming increasingly important as antibodies receive increasing scrutiny from regulatory authorities. We altered the disulfide bond arrangement of an IgG4 molecule by mutation of the Cys at the N terminus of the heavy chain constant domain 1 (C(H)1) (Kabat position 127) to a Ser and introduction of a Cys at a variety of positions (positions 227-230) at the C terminus of C(H)1. An inter-LC-C(H)1 disulfide bond is thus formed, which mimics the disulfide bond arrangement found in an IgG1 molecule. The antibody species present in the supernatant following transient expression in Chinese hamster ovary cells were analyzed by immunoblot to investigate product homogeneity, and purified product was analyzed by a thermofluor assay to determine thermal stability. We show that the light chain can form an inter-LC-C(H)1 disulfide bond with a Cys when present at several positions on the upper hinge (positions 227-230) and that such engineered disulfide bonds can consequently increase the Fab domain thermal stability between 3 and 6.8 degrees C. The IgG4 disulfide mutants displaying the greatest increase in Fab thermal stability were also the most homogeneous in terms of disulfide bond arrangement and antibody species present. Importantly, mutations did not affect the affinity for antigen of the resultant molecules. In combination with the previously described S241P mutation, we present an IgG4 molecule with increased Fab thermal stability and reduced product heterogeneity that potentially offers advantages for the production of IgG4 molecules.	[Peters, Shirley J.; Henry, Alistair J.; Stephens, Paul E.; West, Shauna; Humphreys, David P.] UCB Pharma Slough, Slough SL1 3WE, Berks, England; [Peters, Shirley J.; Smales, C. Mark] Univ Kent, Ctr Mol Proc, Canterbury CT2 7NJ, Kent, England; [Peters, Shirley J.; Smales, C. Mark] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	UCB Pharma SA; University of Kent; University of Kent	Peters, SJ (corresponding author), UCB Pharma Slough, 208 Bath Rd, Slough SL1 3WE, Berks, England.	shirley.peters@ucb.com		Smales, Christopher Mark/0000-0002-2762-4724	UCB Pharma	UCB Pharma(UCB Pharma SA)	Recipient of Ph.D. support from UCB Pharma. To whom correspondence should be addressed: UCB Pharma Slough, 208 Bath Rd., Slough SL1 3WE, United Kingdom. Tel.: 44-1753-447460; E-mail: shirley.peters@ucb.com.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; BINDON CI, 1988, J EXP MED, V168, P127, DOI 10.1084/jem.168.1.127; Bloom JW, 1997, PROTEIN SCI, V6, P407; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Correia IR, 2010, MABS-AUSTIN, V2, P221, DOI 10.4161/mabs.2.3.11788; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; FRANGIONE B, 1969, NATURE, V221, P145, DOI 10.1038/221145a0; FRIES LF, 1982, J IMMUNOL, V129, P1041; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Ishikawa T, 2010, BIOL PHARM BULL, V33, P1413, DOI 10.1248/bpb.33.1413; Kabat EA, 1991, SEQUENCES PROTEINS I; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; KURLANDER RJ, 1982, J CLIN INVEST, V69, P1, DOI 10.1172/JCI110419; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Liu HC, 2007, BIOTECHNOL LETT, V29, P1611, DOI 10.1007/s10529-007-9449-8; Lu YL, 2008, J PHARM SCI-US, V97, P960, DOI 10.1002/jps.21016; Martinez T, 2008, BIOCHEMISTRY-US, V47, P7496, DOI 10.1021/bi800576c; Nobuaki T., 2007, EPO Patent EP, Patent No. 1810979; Rose RJ, 2011, STRUCTURE, V19, P1274, DOI 10.1016/j.str.2011.06.016; Roux KH, 1997, J IMMUNOL, V159, P3372; Sahin E, 2010, J PHARM SCI-US, V99, P4830, DOI 10.1002/jps.22198; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schur P H, 1972, Prog Clin Immunol, V1, P71; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; WOOF JM, 1986, MOL IMMUNOL, V23, P319, DOI 10.1016/0161-5890(86)90059-3; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200	35	26	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24525	24533		10.1074/jbc.M112.369744	http://dx.doi.org/10.1074/jbc.M112.369744			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22610095	hybrid, Green Published			2022-12-28	WOS:000306651100045
J	Chen, ZJ; Vigueira, PA; Chambers, KT; Hall, AM; Mitra, MS; Qi, N; McDonald, WG; Colca, JR; Kletzien, RF; Finck, BN				Chen, Zhouji; Vigueira, Patrick A.; Chambers, Kari T.; Hall, Angela M.; Mitra, Mayurranjan S.; Qi, Nathan; McDonald, William G.; Colca, Jerry R.; Kletzien, Rolf F.; Finck, Brian N.			Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor gamma-sparing Thiazolidinedione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; MITOCHONDRIAL-MEMBRANE PROTEIN; PERFUSED-RAT-LIVER; PPAR-GAMMA; FATTY LIVERS; ROSIGLITAZONE; PIOGLITAZONE; ADIPONECTIN; MITONEET; DELETION	Currently approved thiazolidinediones (TZDs) are effective insulin-sensitizing drugs that may have efficacy for treatment of a variety of metabolic and inflammatory diseases, but their use is limited by side effects that are mediated through ectopic activation of the peroxisome proliferator-activated receptor gamma (PPAR gamma). Emerging evidence suggests that the potent anti-diabetic efficacy of TZDs can be separated from the ability to serve as ligands for PPAR gamma. A novel TZD analog (MSDC-0602) with very low affinity for binding and activation of PPAR gamma was evaluated for its effects on insulin resistance in obese mice. MSDC-0602 treatment markedly improved several measures of multiorgan insulin sensitivity, adipose tissue inflammation, and hepatic metabolic derangements, including suppressing hepatic lipogenesis and gluconeogenesis. These beneficial effects were mediated at least in part via direct actions on hepatocytes and were preserved in hepatocytes from liver-specific PPAR gamma(-/-) mice, indicating that PPAR gamma was not required to suppress these pathways. In conclusion, the beneficial pharmacology exhibited by MSDC-0602 on insulin sensitivity suggests that PPAR gamma-sparing TZDs are effective for treatment of type 2 diabetes with reduced risk of PPAR gamma-mediated side effects.	[Chen, Zhouji; Vigueira, Patrick A.; Chambers, Kari T.; Hall, Angela M.; Mitra, Mayurranjan S.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [McDonald, William G.; Colca, Jerry R.; Kletzien, Rolf F.] Metab Solut Dev Co, Kalamazoo, MI 49007 USA; [Qi, Nathan] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Washington University (WUSTL); University of Michigan System; University of Michigan	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Box 8031, St Louis, MO 63110 USA.	bfinck@wustl.edu		Hall, Angela Marie/0000-0003-0006-7910; Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R41 DK084596, R42 AA021228, T32 DK007296]; core services of the Digestive Diseases Research Core Center [P30 DK52574]; Nutrition Obesity Research Center at Washington University School of Medicine [P30 DK56341]; Barnes Jewish Hospital Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK052574, P30DK020572, P30DK020579, T32DK007296, R41DK084596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R42AA021228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); core services of the Digestive Diseases Research Core Center; Nutrition Obesity Research Center at Washington University School of Medicine; Barnes Jewish Hospital Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R41 DK084596 and R42 AA021228 and the core services of the Digestive Diseases Research Core Center (Grant P30 DK52574) and the Nutrition Obesity Research Center (Grant P30 DK56341) at Washington University School of Medicine. This work was also supported by a grant from the Barnes Jewish Hospital Foundation. We wish to disclose that Drs. McDonald, Colca, and Kletzien are employees and significant stockholders of Metabolic Solutions Development Co. The drugs provided in this study were provided by Metabolic Solutions Development Co.; Diabetes Research Postdoctoral Training Program Fellow (National Institutes of Health Grant T32 DK007296).	Adams MD, 1998, BIOCHEM PHARMACOL, V55, P1915, DOI 10.1016/S0006-2952(98)00052-5; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Balkrishnan R, 2007, CLIN THER, V29, P1306, DOI 10.1016/j.clinthera.2007.06.019; Beysen C, 2008, J LIPID RES, V49, P2657, DOI 10.1194/jlr.M800165-JLR200; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Cho MC, 2011, MOL CELL BIOCHEM, V358, P75, DOI 10.1007/s11010-011-0923-1; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Colca J. R., 2009, 20 WORLD DIAB C OCT; Colca JR, 2006, EXPERT OPIN INV DRUG, V15, P205, DOI 10.1517/13543784.15.3.205; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; de Vries CS, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3076; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Irons BK, 2006, PHARMACOTHERAPY, V26, P168, DOI 10.1592/phco.26.2.168; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Malinowski JM, 2000, CLIN THER, V22, P1151, DOI 10.1016/S0149-2918(00)83060-X; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nishimura Y, 1997, ACTA DIABETOL, V34, P206, DOI 10.1007/s005920050075; Pereira RI, 2008, LIFE SCI, V83, P638, DOI 10.1016/j.lfs.2008.09.002; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Singh S, 2008, EXPERT OPIN DRUG SAF, V7, P579, DOI [10.1517/14740338.7.5.579, 10.1517/14740338.7.5.579 ]; Starner CI, 2008, J MANAGE CARE PHARM, V14, P523, DOI 10.18553/jmcp.2008.14.6.523; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	46	86	97	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23537	23548		10.1074/jbc.M112.363960	http://dx.doi.org/10.1074/jbc.M112.363960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22621923	Green Published, hybrid			2022-12-28	WOS:000306511300025
J	Kannan, Y; Sundaram, K; Narasimhulu, CA; Parthasarathy, S; Wewers, MD				Kannan, Yashaswini; Sundaram, Kruthika; Narasimhulu, Chandrakala Aluganti; Parthasarathy, Sampath; Wewers, Mark D.			Oxidatively Modified Low Density Lipoprotein (LDL) Inhibits TLR2 and TLR4 Cytokine Responses in Human Monocytes but Not in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AORTIC ENDOTHELIAL-CELLS; RECEPTOR CROSS-LINKING; NECROSIS-FACTOR-ALPHA; KAPPA-B-ZETA; OXIDIZED LDL; PATHOGEN RECOGNITION; GENE-EXPRESSION; INNATE IMMUNITY; MESSENGER-RNA; ATHEROSCLEROSIS	Inflammation characterized by the expression and release of cytokines and chemokines is implicated in the development and progression of atherosclerosis. Oxidatively modified low density lipoproteins, central to the formation of atherosclerotic plaques, have been reported to signal through Toll-like receptors (TLRs), TLR4 and TLR2, in concert with scavenger receptors to regulate the inflammatory microenvironment in atherosclerosis. This study evaluates the role of low density lipoproteins (LDL) and oxidatively modified LDL (oxmLDL) in the expression and release of proinflammatory mediators I kappa B zeta, IL-6, IL-1 beta, TNF alpha, and IL-8 in human monocytes and macrophages. Although standard LDL preparations induced I kappa B zeta along with IL-6 and IL-8 production, this inflammatory effect was eliminated when LDL was isolated under endotoxin-restricted conditions. However, when added with TLR4 and TLR2 ligands, this low endotoxin preparation of oxmLDL suppressed the expression and release of IL-1 beta, IL-6, and TNF alpha but surprisingly spared IL-8 production. The suppressive effect of oxmLDL was specific to monocytes as it did not inhibit LPS-induced pro-inflammatory cytokines in human macrophages. Thus, TLR ligand contamination of LDL/oxmLDL preparations can complicate interpretations of inflammatory responses to these modified lipoproteins. In contrast to providing a proinflammatory function, oxmLDL suppresses the expression and release of selected proinflammatory mediators.	[Wewers, Mark D.] Ohio State Univ, Davis Heart & Lung Res Inst 201, Div Pulm Allergy Crit Care & Sleep Med, Med Ctr, Columbus, OH 43210 USA; [Kannan, Yashaswini; Sundaram, Kruthika; Wewers, Mark D.] Ohio State Univ, Davis Heart & Lung Res Inst, Med Ctr, Columbus, OH 43210 USA; [Kannan, Yashaswini; Sundaram, Kruthika; Wewers, Mark D.] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Narasimhulu, Chandrakala Aluganti; Parthasarathy, Sampath] Ohio State Univ, Med Ctr, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 201, Div Pulm Allergy Crit Care & Sleep Med, Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	wewers.2@osu.edu	Sundaram, Kruthika/J-4010-2019; Aluganti Narasimhulu, Chandrakala/ADB-6684-2022; Parthasarathy, Sampath/AAP-3361-2020; Wewers, Mark/AAB-6202-2021	Sundaram, Kruthika/0000-0003-0510-424X; 	National Institutes of Health [R01 HL089440]; American Heart Association Great Rivers Affiliate predoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Great Rivers Affiliate predoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089440 (to M. D. W). This work was also supported by an American Heart Association Great Rivers Affiliate predoctoral fellowship (to Y. K.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; AQEL NM, 1984, ATHEROSCLEROSIS, V53, P265, DOI 10.1016/0021-9150(84)90127-8; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Biwa T, 2000, J Atheroscler Thromb, V7, P14; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Byrne GI, 1999, AM HEART J, V138, pS488, DOI 10.1016/S0002-8703(99)70282-6; Carter Angela M, 2005, Diab Vasc Dis Res, V2, P113, DOI 10.3132/dvdr.2005.018; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; HAMILTON TA, 1990, J IMMUNOL, V144, P2343; HAMILTON TA, 1995, J CLIN INVEST, V95, P2020, DOI 10.1172/JCI117887; Hamilton TA, 1996, J LEUKOCYTE BIOL, V59, P940, DOI 10.1002/jlb.59.6.940; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; HERZYK DJ, 1992, J IMMUNOL, V149, P3052; Hirose K, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-1; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Huh HY, 1996, BLOOD, V87, P2020; Jimenez-Dalmaroni MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007411; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; Leitinger N, 2005, MOL NUTR FOOD RES, V49, P1063, DOI 10.1002/mnfr.200500086; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lopes-Virella MF, 2010, CLIN IMMUNOL, V134, P55, DOI 10.1016/j.clim.2009.04.001; MARSH CB, 1995, J IMMUNOL, V155, P3161; Marsh CB, 1998, J IMMUNOL, V160, P3942; Mattaliano MD, 2009, AM J PHYSIOL-CELL PH, V296, pC1329, DOI 10.1152/ajpcell.00513.2008; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Parthasarathy S, 2010, METHODS MOL BIOL, V610, P403, DOI 10.1007/978-1-60327-029-8_24; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Raices RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006776; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SANTANAM N, 1995, J CLIN INVEST, V95, P2594, DOI 10.1172/JCI117961; SATO T, 1987, ATHEROSCLEROSIS, V68, P191, DOI 10.1016/0021-9150(87)90198-5; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SCHWARTZ CJ, 1985, ANN NY ACAD SCI, V454, P115, DOI 10.1111/j.1749-6632.1985.tb11849.x; Seshadri S, 2009, J IMMUNOL, V183, P5358, DOI 10.4049/jimmunol.0802736; Seshiah PN, 2002, CIRCULATION, V105, P174, DOI 10.1161/hc0202.102248; Silverstein R. L., 2009, CLEVE CLIN J MED S2, V76, pS27; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Yumoto H, 2005, INFECT IMMUN, V73, P8050, DOI 10.1128/IAI.73.12.8050-8059.2005	55	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23479	23488		10.1074/jbc.M111.320960	http://dx.doi.org/10.1074/jbc.M111.320960			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613713	Green Published, hybrid			2022-12-28	WOS:000306511300020
J	Miropolskaya, N; Ignatov, A; Bass, I; Zhilina, E; Pupov, D; Kulbachinskiy, A				Miropolskaya, Nataliya; Ignatov, Artem; Bass, Irina; Zhilina, Ekaterina; Pupov, Danil; Kulbachinskiy, Andrey			Distinct Functions of Regions 1.1 and 1.2 of RNA Polymerase sigma Subunits from Escherichia coli and Thermus aquaticus in Transcription Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; OPEN COMPLEX-FORMATION; PROMOTER DNA; ALLOSTERIC CONTROL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MELTING REGION; BETA' SUBUNIT; BINDING; RECOGNITION	RNA polymerase (RNAP) from thermophilic Thermus aquaticus is characterized by higher temperature of promoter opening, lower promoter complex stability, and higher promoter escape efficiency than RNAP from mesophilic Escherichia coli. We demonstrate that these differences are in part explained by differences in the structures of the N-terminal regions 1.1 and 1.2 of the E. coli sigma(70) and T. aquaticus sigma(A) subunits. In particular, region 1.1 and, to a lesser extent, region 1.2 of the E. coli sigma(70) subunit determine higher promoter complex stability of E. coli RNAP. On the other hand, nonconserved amino acid substitutions in region 1.2, but not region 1.1, contribute to the differences in promoter opening between E. coli and T. aquaticus RNAPs, likely through affecting the sigma subunit contacts with DNA nucleotides downstream of the -10 element. At the same time, substitutions in sigma regions 1.1 and 1.2 do not affect promoter escape by E. coli and T. aquaticus RNAPs. Thus, evolutionary substitutions in various regions of the sigma subunit modulate different steps of the open promoter complex formation pathway, with regions 1.1 and 1.2 affecting promoter complex stability and region 1.2 involved in DNA melting during initiation.	[Miropolskaya, Nataliya; Ignatov, Artem; Bass, Irina; Zhilina, Ekaterina; Pupov, Danil; Kulbachinskiy, Andrey] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Ignatov, Artem] Moscow MV Lomonosov State Univ, Fac Biol, Dept Mol Biol, Moscow 119991, Russia	Russian Academy of Sciences; Lomonosov Moscow State University	Kulbachinskiy, A (corresponding author), Russian Acad Sci, Inst Mol Genet, 2 Kurchatov Sq, Moscow 123182, Russia.	akulb@img.ras.ru	Kulbachinskiy, Andrey/P-5401-2016; Pupov, Danil/CAF-6818-2022	Kulbachinskiy, Andrey/0000-0002-2292-6424; Pupov, Danil/0000-0003-4961-6888	Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology; Russian Foundation for Basic Research [10-04-00925]; Federal Targeted Program "Scientific and scientific-pedagogical personnel of innovative Russia" [02.740.11.0771]; President of the Russian Federation [MD-618.2011.4, MK-7156.2012.4]	Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Targeted Program "Scientific and scientific-pedagogical personnel of innovative Russia"; President of the Russian Federation	This work was supported in part by funds from the Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology (to A. K.), Russian Foundation for Basic Research Grant 10-04-00925, Federal Targeted Program "Scientific and scientific-pedagogical personnel of innovative Russia 2009-2013" State Contract 02.740.11.0771, and President of the Russian Federation Grants MD-618.2011.4 and MK-7156.2012.4.	Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Baldwin NE, 2001, MOL MICROBIOL, V42, P427, DOI 10.1046/j.1365-2958.2001.02642.x; Barinova N, 2008, J BACTERIOL, V190, P3088, DOI 10.1128/JB.00008-08; Barinova N, 2008, J BIOL CHEM, V283, P22482, DOI 10.1074/jbc.M802445200; Bowers CW, 2000, J BACTERIOL, V182, P221, DOI 10.1128/JB.182.1.221-224.2000; Bowers CW, 1999, EMBO J, V18, P709, DOI 10.1093/emboj/18.3.709; Brodolin K, 2000, J BIOL CHEM, V275, P3661, DOI 10.1074/jbc.275.5.3661; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Gries TJ, 2010, P NATL ACAD SCI USA, V107, P10418, DOI 10.1073/pnas.1000967107; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Iyer LM, 2004, GENE, V335, P73, DOI 10.1016/j.gene.2004.03.017; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; Kontur WS, 2008, J MOL BIOL, V376, P1034, DOI 10.1016/j.jmb.2007.11.064; Kontur WS, 2010, BIOCHEMISTRY-US, V49, P4361, DOI 10.1021/bi100092a; Kulbachinskiy A, 1999, FEBS LETT, V454, P71, DOI 10.1016/S0014-5793(99)00778-4; Kulbachinskiy A, 2004, EUR J BIOCHEM, V271, P4921, DOI 10.1111/j.1432-1033.2004.04461.x; Kulbachinskiy A, 2004, J BACTERIOL, V186, P7818, DOI 10.1128/JB.186.22.7818-7820.2004; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Kulbachinskiy AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1227, DOI 10.1007/s10541-005-0251-8; Kuznedelov K, 2003, METHOD ENZYMOL, V370, P94; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Minakhin L, 2001, J BACTERIOL, V183, P71, DOI 10.1128/JB.183.1.71-76.2001; Miropolskaya N, 2009, P NATL ACAD SCI USA, V106, P18942, DOI 10.1073/pnas.0905402106; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nickels BE, 2005, P NATL ACAD SCI USA, V102, P4488, DOI 10.1073/pnas.0409850102; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Panaghie G, 2000, J MOL BIOL, V299, P1217, DOI 10.1006/jmbi.2000.3808; Pupov D, 2010, NUCLEIC ACIDS RES, V38, P5784, DOI 10.1093/nar/gkq355; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; SAVINKOVA L K, 1988, Molekulyarnaya Biologiya (Moscow), V22, P807; Schroeder LA, 2005, J BIOL CHEM, V280, P17422, DOI 10.1074/jbc.M501281200; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Schroeder LA, 2009, J MOL BIOL, V385, P339, DOI 10.1016/j.jmb.2008.10.023; Schwartz EC, 2008, CHEM BIOL, V15, P1091, DOI 10.1016/j.chembiol.2008.09.008; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vuthoori S, 2001, J MOL BIOL, V309, P561, DOI 10.1006/jmbi.2001.4690; Wilson C, 1997, J MOL BIOL, V267, P60, DOI 10.1006/jmbi.1997.0875; Yuzenkova Y, 2011, EMBO J, V30, P3766, DOI 10.1038/emboj.2011.252; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555	59	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23779	23789		10.1074/jbc.M112.363242	http://dx.doi.org/10.1074/jbc.M112.363242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605342	hybrid, Green Published			2022-12-28	WOS:000306511300048
J	Patzer, SI; Albrecht, R; Braun, V; Zeth, K				Patzer, Silke I.; Albrecht, Reinhard; Braun, Volkmar; Zeth, Kornelius			Structural and Mechanistic Studies of Pesticin, a Bacterial Homolog of Phage Lysozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; RECEPTOR-BINDING; COLICIN-M; R-DOMAIN; CRYSTAL-STRUCTURE; PROTEIN; IMPORT; BTUB; TRANSLOCATION; COMPLEX	Yersinia pestis produces and secretes a toxin named pesticin that kills related bacteria of the same niche. Uptake of the bacteriocin is required for activity in the periplasm leading to hydrolysis of peptidoglycan. To understand the uptake mechanism and to investigate the function of pesticin, we combined crystal structures of the wild type enzyme, active site mutants, and a chimera protein with in vivo and in vitro activity assays. Wild type pesticin comprises an elongated N-terminal translocation domain, the intermediate receptor binding domain, and a C-terminal activity domain with structural analogy to lysozyme homologs. The full-length protein is toxic to bacteria when taken up to the target site via the outer or the inner membrane. Uptake studies of deletion mutants in the translocation domain demonstrate their critical size for import. To further test the plasticity of pesticin during uptake into bacterial cells, the activity domain was replaced by T4 lysozyme. Surprisingly, this replacement resulted in an active chimera protein that is not inhibited by the immunity protein Pim. Activity of pesticin and the chimera protein was blocked through introduction of disulfide bonds, which suggests unfolding as the prerequisite to gain access to the periplasm. Pesticin, a muramidase, was characterized by active site mutations demonstrating a similar but not identical residue pattern in comparison with T4 lysozyme.	[Patzer, Silke I.; Albrecht, Reinhard; Braun, Volkmar; Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society	Patzer, SI (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	silke.patzer@tuebingen.mpg.de; kornelius.zeth@googlemail.com			Max Planck Society; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Max Planck Society and the Fonds der Chemischen Industrie (to V. B.).	ANDERSON WF, 1981, J MOL BIOL, V147, P523, DOI 10.1016/0022-2836(81)90398-3; Arnold T, 2009, J BIOL CHEM, V284, P6403, DOI 10.1074/jbc.M808504200; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DUCHE D, 1994, J BIOL CHEM, V269, P24820; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERBER DM, 1979, J BACTERIOL, V139, P495, DOI 10.1128/JB.139.2.495-501.1979; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HALL PJ, 1978, J BACTERIOL, V136, P786, DOI 10.1128/JB.136.2.786-789.1978; Hanoulle X, 2004, J MOL BIOL, V342, P195, DOI 10.1016/j.jmb.2004.07.004; HARKNESS RE, 1990, MOL GEN GENET, V222, P37, DOI 10.1007/BF00283020; Helbig S, 2011, J BIOL CHEM, V286, P6280, DOI 10.1074/jbc.M110.165274; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jakes KS, 2010, MOL MICROBIOL, V75, P567, DOI 10.1111/j.1365-2958.2009.06966.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kanamaru S, 2005, J MOL BIOL, V346, P1013, DOI 10.1016/j.jmb.2004.12.042; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; MENDE J, 1990, MOL MICROBIOL, V4, P1523, DOI 10.1111/j.1365-2958.1990.tb02063.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mora L, 2005, J BACTERIOL, V187, P2693, DOI 10.1128/JB.187.8.2693-2697.2005; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Penfold CN, 2004, J BACTERIOL, V186, P4520, DOI 10.1128/JB.186.14.4520-4527.2004; Pilsl H, 1996, J BACTERIOL, V178, P2431, DOI 10.1128/jb.178.8.2431-2435.1996; Rakin A, 1996, MICROBIOL-UK, V142, P3415, DOI 10.1099/13500872-142-12-3415; RAKIN A, 1994, MOL MICROBIOL, V13, P253, DOI 10.1111/j.1365-2958.1994.tb00420.x; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; Saeidi N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.55; Sambrook J., 2001, MOL CLONING LAB MANU; SCHALLER K, 1982, J BACTERIOL, V152, P994; Sharma O, 2007, J BIOL CHEM, V282, P23163, DOI 10.1074/jbc.M703004200; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tsugita A., 1971, ENZYMES, P343; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Zakharov SD, 2008, BIOCHEMISTRY-US, V47, P12802, DOI 10.1021/bi800865h; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200; Zhang Y, 2008, J BACTERIOL, V190, P4342, DOI 10.1128/JB.00047-08; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	53	35	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23381	23396		10.1074/jbc.M112.362913	http://dx.doi.org/10.1074/jbc.M112.362913			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593569	Green Published, hybrid			2022-12-28	WOS:000306511300011
J	Sommer, A; Fries, A; Cornelsen, I; Speck, N; Koch-Nolte, F; Gimpl, G; Andra, J; Bhakdi, S; Reiss, K				Sommer, Anselm; Fries, Anja; Cornelsen, Isabell; Speck, Nancy; Koch-Nolte, Friedrich; Gimpl, Gerald; Andrae, Joerg; Bhakdi, Sucharit; Reiss, Karina			Melittin Modulates Keratinocyte Function through P2 Receptor-dependent ADAM Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; CELL-CELL ADHESION; P2X(7) RECEPTOR; L-SELECTIN; BEE VENOM; MEDIATOR GENERATION; EXTRACELLULAR ATP; FATTY-ACIDS	Melittin, the major component of the bee venom, is an amphipathic, cationic peptide with a wide spectrum of biological properties that is being considered as an anti-inflammatory and anti-cancer agent. It modulates multiple cellular functions but the underlying mechanisms are not clearly understood. Here, we report that melittin activates disintegrin-like metalloproteases (ADAMs) and that downstream events likely contribute to the biological effects evoked by the peptide. Melittin stimulated the proteolysis of ADAM10 and ADAM17 substrates in human neutrophil granulocytes, endothelial cells and murine fibroblasts. In human HaCaT keratinocytes, melittin induced shedding of the adhesion molecule E-cadherin and release of TGF-alpha, which was accompanied by transactivation of the EGF receptor and ERK1/2 phosphorylation. This was followed by functional consequences such as increased keratinocyte proliferation and enhanced cell migration. Evidence is provided that ATP release and activation of purinergic P2 receptors are involved in melittin-induced ADAM activation. E-cadherin shedding and EGFR phosphorylation were dose-dependently reduced in the presence of ATPases or P2 receptor antagonists. The involvement of P2 receptors was underscored in experiments with HEK cells, which lack the P2X7 receptor and showed strikingly increased response to melittin stimulation after transfection with this receptor. Our study provides new insight into the mechanism of melittin function which should be of interest particularly in the context of its potential use as an anti-inflammatory or anti-cancer agent.	[Fries, Anja; Cornelsen, Isabell; Bhakdi, Sucharit] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Sommer, Anselm; Speck, Nancy; Reiss, Karina] Univ Kiel, Dept Dermatol, D-24098 Kiel, Germany; [Koch-Nolte, Friedrich] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, D-20246 Hamburg, Germany; [Gimpl, Gerald] Johannes Gutenberg Univ Mainz, Dept Biochem, D-55128 Mainz, Germany; [Andrae, Joerg] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, D-23845 Borstel, Germany	Johannes Gutenberg University of Mainz; University of Kiel; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Forschungszentrum Borstel	Bhakdi, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Hochhaus Augustuspl, D-55131 Mainz, Germany.	sbhakdi@uni-mainz.de; kreiss@dermatology.uni-kiel.de	Reiss, Karina/B-3175-2010; Gimpl, Gerald/R-3722-2019	Koch-Nolte, Friedrich/0000-0003-1730-6674; Gimpl, Gerald/0000-0002-5703-1989; Sommer, Anselm/0000-0002-6485-4860	Deutsche Forschungsgemeinschaft [CRC 490, DFG AN301/5-1, CRC 877]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by the Deutsche Forschungsgemeinschaft, CRC 490 (to S. B.), DFG AN301/5-1 (to J. A.), CRC 877 (to K. R.), and the Cluster of Excellence "Inflammation at Interfaces" (to K. R.).	Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Cho HJ, 2010, J ETHNOPHARMACOL, V127, P662, DOI 10.1016/j.jep.2009.12.007; DAWSON CR, 1978, BIOCHIM BIOPHYS ACTA, V510, P75, DOI 10.1016/0005-2736(78)90131-1; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; Drechsler S., 2011, J BIOENERG BIOMEMBR; Duclohier H, 2010, CURR PHARM DESIGN, V16, P3212, DOI 10.2174/138161210793292500; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Firth JD, 2004, J INVEST DERMATOL, V122, P222, DOI 10.1046/j.0022-202X.2003.22124.x; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; Greig AVH, 2003, J INVEST DERMATOL, V120, P1007, DOI 10.1046/j.1523-1747.2003.12261.x; Gu B, 1998, BLOOD, V92, P946; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Jamieson GP, 1996, J CELL PHYSIOL, V166, P637, DOI 10.1002/(SICI)1097-4652(199603)166:3<637::AID-JCP19>3.0.CO;2-3; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Keith DJ, 2011, EUR J PHARMACOL, V650, P501, DOI 10.1016/j.ejphar.2010.10.023; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Lambrecht G, 2000, N-S ARCH PHARMACOL, V362, P340, DOI 10.1007/s002100000312; LAVIALLE F, 1980, BIOCHIM BIOPHYS ACTA, V600, P62, DOI 10.1016/0005-2736(80)90411-3; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lee SY, 2001, ARCH BIOCHEM BIOPHYS, V389, P57, DOI 10.1006/abbi.2001.2314; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Liu SJ, 2008, HEPATOLOGY, V47, P1964, DOI 10.1002/hep.22240; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maher S, 2008, BIOCHEM PHARMACOL, V75, P1104, DOI 10.1016/j.bcp.2007.10.029; Maher S, 2007, PHARM RES-DORDR, V24, P1336, DOI 10.1007/s11095-007-9288-2; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; Moon DO, 2006, INT IMMUNOPHARMACOL, V6, P1796, DOI 10.1016/j.intimp.2006.07.027; Moon H, 2006, IMMUNOL LETT, V102, P98, DOI 10.1016/j.imlet.2005.08.004; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nah SS, 2008, J PHARMACOL SCI, V106, P162, DOI 10.1254/jphs.SC0070215; NEEDHAM L, 1987, BIOCHIM BIOPHYS ACTA, V899, P44, DOI 10.1016/0005-2736(87)90237-9; Orsolic N, 2012, CANCER METAST REV, V31, P173, DOI 10.1007/s10555-011-9339-3; Park HJ, 2004, ARTHRITIS RHEUM-US, V50, P3504, DOI 10.1002/art.20626; Park HJ, 2007, BIOCHEM PHARMACOL, V73, P237, DOI 10.1016/j.bcp.2006.09.023; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2011, J BIOL CHEM, V286, P26931, DOI 10.1074/jbc.M111.243485; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Russell PJ, 2004, CANCER IMMUNOL IMMUN, V53, P411, DOI 10.1007/s00262-003-0457-9; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; SCHOCH P, 1980, BIOCHIM BIOPHYS ACTA, V602, P234, DOI 10.1016/0005-2736(80)90307-7; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sengstake S, 2006, INT IMMUNOL, V18, P1171, DOI 10.1093/intimm/dxl051; SESSA G, 1969, J BIOL CHEM, V244, P3575; Sluyter R, 2002, INT IMMUNOL, V14, P1415, DOI 10.1093/intimm/dxf111; Soman NR, 2009, J CLIN INVEST, V119, P2830, DOI 10.1172/JCI38842; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; Stuhlmeier KM, 2007, J IMMUNOL, V179, P655, DOI 10.4049/jimmunol.179.1.655; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; VERNON LP, 1992, PHARMACOL THERAPEUT, V54, P269, DOI 10.1016/0163-7258(92)90003-I; Wewers MD, 2009, PURINERG SIGNAL, V5, P189, DOI 10.1007/s11302-009-9131-9; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008	70	34	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23678	23689		10.1074/jbc.M112.362756	http://dx.doi.org/10.1074/jbc.M112.362756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613720	hybrid, Green Published			2022-12-28	WOS:000306511300038
J	Fang, R; Xiao, T; Fang, ZY; Sun, YH; Li, F; Gao, YJ; Feng, Y; Li, L; Wang, Y; Liu, XL; Chen, HQ; Liu, XY; Ji, HB				Fang, Rong; Xiao, Tian; Fang, Zhaoyuan; Sun, Yihua; Li, Fei; Gao, Yijun; Feng, Yan; Li, Li; Wang, Ye; Liu, Xiaolong; Chen, Haiquan; Liu, Xin-Yuan; Ji, Hongbin			MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROBE LEVEL DATA; PROTEIN-SYNTHESIS; LUNG-CANCER; THERAPY; WARBURG; CELLS; NORMALIZATION; MITOCHONDRIA; METABOLISM; EXPRESSION	High glycolysis, well known as "Warburg effect," is frequently observed in a variety of cancers. Whether the deregulation of miRNAs contributes to the Warburg effect remains largely unknown. Because miRNA regulates gene expression at both mRNA and protein levels, we constructed a gene functional association network, which allows us to detect the gene activity instead of gene expression, to integratively analyze the microarray data for gene expression and miRNA expression profiling and identify glycolysis-related gene-miRNA pairs deregulated in cancer. Hexokinase 2 (HK2), coding for the first rate-limiting enzyme of glycolysis, is among the top list of genes predicted and potentially regulated by multiple miRNAs including miR-143. Interestingly, miR-143 expression was inversely associated with HK2 protein level but not mRNA level in human lung cancer samples. miR-143, down-regulated by mammalian target of rapamycin activation, reduces glucose metabolism and inhibits cancer cell proliferation and tumor formation through targeting HK2. Collectively, we have not only established a novel methodology for gene-miRNA pair prediction but also identified miR-143 as an essential regulator of cancer glycolysis via targeting HK2.	[Fang, Rong; Xiao, Tian; Fang, Zhaoyuan; Li, Fei; Gao, Yijun; Feng, Yan; Li, Li; Wang, Ye; Liu, Xiaolong; Liu, Xin-Yuan; Ji, Hongbin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Sun, Yihua; Chen, Haiquan] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, Shanghai 200032, Peoples R China; [Sun, Yihua; Chen, Haiquan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University	Xiao, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	txiao@sibs.ac.cn; xyliu@sibs.ac.cn; hbji@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022; Fang, Zhaoyuan/ABD-1543-2020	Gao, Yijun/0000-0003-4978-3205	National Basic Research Program of China [2010CB912102, 2012CB910800]; National Natural Science Foundation of China [30971461, 81101583]; Science and Technology Commission of Shanghai Municipality [09JC1416300]; Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2011KIP504]; China Postdoctoral Science Foundation [20100480639]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program	This work was supported by the National Basic Research Program of China (Grants 2010CB912102 and 2012CB910800), the National Natural Science Foundation of China (Grants 30971461 and 81101583), the Science and Technology Commission of Shanghai Municipality (Grant 09JC1416300), the Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Grant 2011KIP504), the China Postdoctoral Science Foundation funded project (Grant 20100480639), and the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program.	Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Fang ZY, 2012, CELL RES, V22, P565, DOI 10.1038/cr.2011.149; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; Peschiaroli A, 2013, ONCOGENE, V32, P797, DOI 10.1038/onc.2012.100; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	35	191	202	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23227	23235		10.1074/jbc.M112.373084	http://dx.doi.org/10.1074/jbc.M112.373084			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593586	Green Published, hybrid			2022-12-28	WOS:000306495000077
J	Stack, J; Bowie, AG				Stack, Julianne; Bowie, Andrew G.			Poxviral Protein A46 Antagonizes Toll-like Receptor 4 Signaling by Targeting BB Loop Motifs in Toll-IL-1 Receptor Adaptor Proteins to Disrupt Receptor: Adaptor Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; TIR-DOMAIN; VACCINIA-VIRUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INNATE IMMUNITY; I INTERFERON; MYD88; TLR4	Toll-like receptors (TLRs) have an anti-viral role in that they detect viruses, leading to cytokine and IFN induction, and as such are targeted by viruses for immune evasion. TLR4, although best known for its role in recognizing bacterial LPS, is also strongly implicated in the immune response to viruses. We previously showed that the poxviral protein A46 inhibits TLR4 signaling and interacts with Toll-IL-1 receptor (TIR) domaincontaining proteins of the receptor complex. However the exact molecular mechanism whereby A46 disrupts TLR4 signaling remains to be established, and may yield insight into how the TLR4 complex functions, since viruses often optimally target key residues and motifs on host proteins for maximal efficiency. Here we show that A46 targets the BB loop motif of TIR proteins and thereby disrupts receptor: adaptor (TLR4: Mal and TLR4: TRAM), but not receptor: receptor (TLR4: TLR4) nor adaptor: adaptor (Mal: MyD88, TRAM: TRIF, and Mal: Mal) TIR interactions. The requirement for an intact BB loop for TIR adaptor interactions correlated with the protein: protein interfaces antagonized by A46. We previously discovered a peptide fragment derived from A46 termed VIPER (Viral Inhibitory Peptide of TLR4), which specifically inhibits TLR4 responses. Here we demonstrate that the region of A46 from which VIPER is derived represents the TLR4-specific inhibitory motif of the intact protein, and is essential for A46: TRAM interactions. This study provides the molecular basis for pathogen subversion of TLR4 signaling and clarifies the importance of TIR motif BB loops, which have been selected for viral antagonism, in the formation of the TLR4 complex.	[Stack, Julianne; Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immunol Res Ctr, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immunol Res Ctr, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland; Immunology Research Centre; SFI Strategic Research Cluster [07/SRC/B1144]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Immunology Research Centre(Science Foundation Ireland); SFI Strategic Research Cluster(Science Foundation Ireland)	This work was supported by Science Foundation Ireland as part of the Immunology Research Centre, an SFI Strategic Research Cluster (07/SRC/B1144).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bovijn C, 2012, J BIOL CHEM, V287, P4088, DOI 10.1074/jbc.M111.282350; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Gangloff M, 2012, TRENDS BIOCHEM SCI, V37, P92, DOI 10.1016/j.tibs.2011.11.003; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hutchens MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000153; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oda SI, 2011, MOL IMMUNOL, V48, P2144, DOI 10.1016/j.molimm.2011.07.014; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	53	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22672	22682		10.1074/jbc.M112.349225	http://dx.doi.org/10.1074/jbc.M112.349225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593572	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000306495000024
J	Maller, JL				Maller, James L.			Pioneering the Xenopus Oocyte and Egg Extract System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION-PROMOTING FACTOR; RIBOSOMAL-PROTEIN S6; RABBIT SKELETAL MUSCLE; MEIOTIC MATURATION; CELL-CYCLE; CENTROSOME DUPLICATION; ADENYLATE-CYCLASE; LAEVIS OOCYTES; RANA-PIPIENS; MOUSE OOCYTE		Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Maller, JL (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	jim.maller@ucdenver.edu						ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Ben-Yehoshua LJ, 2007, MOL ENDOCRINOL, V21, P664, DOI 10.1210/me.2006-0256; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eckerdt F, 2011, CURR BIOL, V21, P428, DOI 10.1016/j.cub.2011.01.072; ERIKSON E, 1985, P NATL ACAD SCI USA, V82, P742, DOI 10.1073/pnas.82.3.742; Erikson E, 2004, J BIOL CHEM, V279, P32219, DOI 10.1074/jbc.M403840200; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Eyers PA, 2005, J BIOL CHEM, V280, P24339, DOI 10.1074/jbc.M412442200; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; FINIDORILEPICARD J, 1981, NATURE, V292, P255, DOI 10.1038/292255a0; Gall J. G., 2001, LANDMARK PAPERS CELL; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; GURDON JB, 1968, J EMBRYOL EXP MORPH, V20, P401; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; KREBS EG, 1964, BIOCHEMISTRY-US, V3, P1022, DOI 10.1021/bi00896a003; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; LOHKA MJ, 1987, MOL CELL BIOL, V7, P760, DOI 10.1128/MCB.7.2.760; MALLER J, 1977, DEV BIOL, V58, P295, DOI 10.1016/0012-1606(77)90093-8; MALLER JL, 1977, J BIOL CHEM, V252, P1712; MALLER JL, 1979, J BIOL CHEM, V254, P579; MALLER JL, 1978, P NATL ACAD SCI USA, V75, P248, DOI 10.1073/pnas.75.1.248; Martin ES, 2003, P NATL ACAD SCI USA, V100, P11517, DOI 10.1073/pnas.1934602100; MASARACCHIA RA, 1979, ARCH BIOCHEM BIOPHYS, V194, P1, DOI 10.1016/0003-9861(79)90589-7; MASUI Y, 1967, J EXP ZOOL, V166, P365, DOI 10.1002/jez.1401660309; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; MEIJER L, 1987, DEV BIOL, V121, P306, DOI 10.1016/0012-1606(87)90166-7; MORRILL GA, 1972, NATURE, V238, P282, DOI 10.1038/238282a0; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NIELSEN PJ, 1982, P NATL ACAD SCI-BIOL, V79, P2937, DOI 10.1073/pnas.79.9.2937; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; Qian YW, 1998, SCIENCE, V282, P1701, DOI 10.1126/science.282.5394.1701; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; SADLER SE, 1987, J BIOL CHEM, V262, P10644; SADLER SE, 1985, ADV CYCLIC NUCL PROT, V19, P179; Schmitt A, 2002, P NATL ACAD SCI USA, V99, P4361, DOI 10.1073/pnas.022056399; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; Shah Kavita, 2003, Methods Mol Biol, V233, P253; Slack J. M. W., 1999, EGG EGO ALMOST TRUE; SMITH LD, 1971, DEV BIOL, V25, P232, DOI 10.1016/0012-1606(71)90029-7; SPIVACK JG, 1984, MOL CELL BIOL, V4, P1631, DOI 10.1128/MCB.4.8.1631; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Tian JD, 2000, P NATL ACAD SCI USA, V97, P14358, DOI 10.1073/pnas.250492197; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WALSH DA, 1968, J BIOL CHEM, V243, P3763; WANG JH, 1976, J BIOL CHEM, V251, P4521; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; WU M, 1980, DEV BIOL, V79, P465, DOI 10.1016/0012-1606(80)90131-1; Zhu Y, 2008, COMP BIOCHEM PHYS C, V148, P381, DOI 10.1016/j.cbpc.2008.05.019	64	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21640	21653		10.1074/jbc.X112.371161	http://dx.doi.org/10.1074/jbc.X112.371161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22570479	hybrid, Green Published			2022-12-28	WOS:000306418600007
J	Ryder, C; McColl, K; Zhong, F; Distelhorst, CW				Ryder, Christopher; McColl, Karen; Zhong, Fei; Distelhorst, Clark W.			Acidosis Promotes Bcl-2 Family-mediated Evasion of Apoptosis INVOLVEMENT OF ACID-SENSING G PROTEIN-COUPLED RECEPTOR GPR65 SIGNALING TO MEK/ERK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BONE-MARROW MICROENVIRONMENT; ACUTE MYELOID-LEUKEMIA; CELL-DEATH; MESSENGER-RNA; CHEMOTHERAPEUTIC DRUGS; KINASE PATHWAYS; CANCER-THERAPY; AMINO-ACID; B-CELLS	Acidosis arises in solid and lymphoid malignancies secondary to altered nutrient supply and utilization. Tumor acidosis correlates with therapeutic resistance, although the mechanism behind this effect is not fully understood. Here we show that incubation of lymphoma cell lines in acidic conditions (pH 6.5) blocks apoptosis induced by multiple cytotoxic metabolic stresses, including deprivation of glucose or glutamine and treatment with dexamethasone. We sought to examine the role of the Bcl-2 family of apoptosis regulators in this process. Interestingly, we found that acidic culture causes elevation of both Bcl-2 and Bcl-xL, while also attenuating glutamine starvation-induced elevation of p53-up-regulated modulator of apoptosis (PUMA) and Bim. We confirmed with knockdown studies that these shifts direct survival decisions during starvation and acidosis. Importantly, the promotion of a high anti- to pro-apoptotic Bcl-2 family member ratio by acidosis renders cells exquisitely sensitive to the Bcl-2/Bcl-xL antagonist ABT-737, suggesting that acidosis causes Bcl-2 family dependence. This dependence appears to be mediated, in part, by the acid-sensing G protein-coupled receptor, GPR65, via a MEK/ERK pathway.	[Ryder, Christopher; Distelhorst, Clark W.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Pharmacol, Cleveland, OH 44106 USA; [Ryder, Christopher; McColl, Karen; Zhong, Fei; Distelhorst, Clark W.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Med, Cleveland, OH 44106 USA; [Ryder, Christopher; McColl, Karen; Zhong, Fei; Distelhorst, Clark W.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Distelhorst, CW (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	cwd@case.edu			National Institutes of Health [R01 CA42755, R01 CA085804, T32 GM08803]; Leukemia and Lymphoma Society Translational Research Program; Flow Cytometry Core Facility of the Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA085804, R01CA042755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803, T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Flow Cytometry Core Facility of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA42755, R01 CA085804, and T32 GM08803. This work was also supported by a Leukemia and Lymphoma Society Translational Research Program grant and by the Flow Cytometry Core Facility of the Case Comprehensive Cancer Center Grant P30 CA43703.	Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Coloff JL, 2011, J BIOL CHEM, V286, P5921, DOI 10.1074/jbc.M110.179101; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; DOWD DR, 1992, MOL CELL BIOL, V12, P3600, DOI 10.1128/MCB.12.8.3600; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Evelhoch J L, 2001, Novartis Found Symp, V240, P68; Evelhoch J. L., 2001, NOVART FDN SYMP, V240, P80; Evelhoch J. L., 2001, NOVART FDN SYMP, V240, P152; Flacke JP, 2009, APOPTOSIS, V14, P90, DOI 10.1007/s10495-008-0287-5; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hockenbery DM, 2010, ENVIRON MOL MUTAGEN, V51, P476, DOI 10.1002/em.20552; Holcik M, 2000, ONCOGENE, V19, P4174, DOI 10.1038/sj.onc.1203765; Ihara Y, 2010, P NATL ACAD SCI USA, V107, P17309, DOI 10.1073/pnas.1001165107; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Jeong DW, 2001, BIOCHEM BIOPH RES CO, V289, P1141, DOI 10.1006/bbrc.2001.6091; Klymenko T, 2011, MOL CANCER THER, V10, P2373, DOI 10.1158/1535-7163.MCT-11-0326; Kottyan LC, 2009, BLOOD, V114, P2774, DOI 10.1182/blood-2009-05-220681; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Lapucci A, 2010, FASEB J, V24, P1852, DOI 10.1096/fj.09-140459; Laroche-Joubert N, 2002, J BIOL CHEM, V277, P18598, DOI 10.1074/jbc.M201868200; Letai A, 2005, J CLIN INVEST, V115, P2648, DOI 10.1172/JCI26250; Li SY, 2005, INT J ONCOL, V27, P1329; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Malone MH, 2004, J BIOL CHEM, V279, P52850, DOI 10.1074/jbc.M408040200; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; McCarty MF, 2010, ALTERN MED REV, V15, P264; McGuire J, 2009, BIOCHEM BIOPH RES CO, V386, P420, DOI 10.1016/j.bbrc.2009.05.133; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Mortensen BT, 1998, BRIT J HAEMATOL, V102, P458; MOYER GH, 1974, CANCER RES, V34, P2647; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Radu CG, 2006, MOL CELL BIOL, V26, P668, DOI 10.1128/MCB.26.2.668-677.2006; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; REED JC, 1989, ONCOGENE RES, V4, P271; Reichert M, 2002, CANCER, V95, P1113, DOI 10.1002/cncr.10767; ROSEN J M, 1970, Biochimica et Biophysica Acta, V219, P447, DOI 10.1016/0005-2736(70)90222-1; SAUER LA, 1982, CANCER RES, V42, P4090; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sin WC, 2004, ONCOGENE, V23, P6299, DOI 10.1038/sj.onc.1207838; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Thews O, 2007, ADV EXP MED BIOL, V599, P155; Thews O, 2006, NEOPLASIA, V8, P143, DOI 10.1593/neo.05697; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; VAUPEL P, 1989, CANCER RES, V49, P6449; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665; Wensveen FM, 2011, APOPTOSIS, V16, P708, DOI 10.1007/s10495-011-0599-8; Willimott S, 2010, BIOCHEM SOC T, V38, P1571, DOI 10.1042/BST0381571; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang WG, 2010, CANCER RES, V70, P2424, DOI 10.1158/0008-5472.CAN-09-0878	77	45	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27863	27875		10.1074/jbc.M112.384685	http://dx.doi.org/10.1074/jbc.M112.384685			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22685289	hybrid, Green Published			2022-12-28	WOS:000307840700060
J	Ghosh, A; Pahan, K				Ghosh, Arunava; Pahan, Kalipada			Gemfibrozil, a Lipid-lowering Drug, Induces Suppressor of Cytokine Signaling 3 in Glial Cells IMPLICATIONS FOR NEURODEGENERATIVE DISORDERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENSITY-LIPOPROTEIN-CHOLESTEROL; ALZHEIMERS-DISEASE; GENE-EXPRESSION; KAPPA-B; RAW264.7 MACROPHAGES; HUMAN ASTROCYTES; SOCS PROTEINS; UP-REGULATION; MICROGLIA	Glial inflammation is an important feature of several neurodegenerative disorders. Suppressor of cytokine signaling (SOCS) proteins play a crucial role in inhibiting cytokine signaling and inflammatory gene expression in various cell types, including glial cells. However, mechanisms by which SOCS genes could be up-regulated are poorly understood. This study underlines the importance of gemfibrozil, a Food and Drug Administration-approved lipid-lowering drug, in up-regulating the expression of SOCS3 in glial cells. Gemfibrozil increased the expression of Socs3 mRNA and protein in mouse astroglia and microglia in both a time- and dose-dependent manner. Interestingly, gemfibrozil induced the activation of type IA phosphatidylinositol (PI) 3-kinase and AKT. Accordingly, inhibition of PI 3-kinase and AKT by chemical inhibitors abrogated gemfibrozil-mediated up-regulation of SOCS3. Furthermore, we demonstrated that gemfibrozil induced the activation of Kruppel-like factor 4 (KLF4) via the PI 3-kinase-AKT pathway and that siRNA knockdown of KLF4 abrogated gemfibrozil-mediated up-regulation of SOCS3. Gemfibrozil also induced the recruitment of KLF4 to the distal, but not proximal, KLF4-binding site of the Socs3 promoter. This study delineates a novel property of gemfibrozil in up-regulating SOCS3 in glial cells via PI 3-kinase-AKT-mediated activation of KLF4 and suggests that gemfibrozil may find therapeutic application in neuroinflammatory and neurodegenerative disorders.	[Ghosh, Arunava; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Suite Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu		GHOSH, ARUNAVA/0000-0002-8471-8161	National Institutes of Health Grants [AT6681, NS64564, NS71479]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071479, R21NS064564] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681, NS64564, and NS71479.	Ai WD, 2004, J BIOL CHEM, V279, P8684, DOI 10.1074/jbc.M308278200; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; ANDREWS S, 2007, SCI STKE, pCM2; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Barclay JL, 2007, MOL ENDOCRINOL, V21, P2516, DOI 10.1210/me.2007-0030; Bluyssen HAR, 2010, AM J PHYSIOL-CELL PH, V299, pC354, DOI 10.1152/ajpcell.00513.2009; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Cummings JL, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.1_Suppl_1.S2; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Fukushima A, 2010, J ENDODONT, V36, P1004, DOI 10.1016/j.joen.2010.02.027; Gatto L, 2004, J BIOL CHEM, V279, P13746, DOI 10.1074/jbc.M308999200; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hagos EG, 2011, AM J CANCER RES, V1, P85; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hannan KM, 2003, BIOCHEM J, V370, P469, DOI 10.1042/BJ20021709; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2008, J IMMUNOL, V181, P7254, DOI 10.4049/jimmunol.181.10.7254; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Liu JW, 2008, SHOCK, V30, P260, DOI 10.1097/shk.0b013e318162bef7; Liu JW, 2007, BIOCHEM BIOPH RES CO, V362, P575, DOI 10.1016/j.bbrc.2007.07.157; Liu Y, 2010, CELL STRESS CHAPERON, V15, P211, DOI 10.1007/s12192-009-0135-8; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Pahan K, 2006, CELL MOL LIFE SCI, V63, P1165, DOI 10.1007/s00018-005-5406-7; Pahan K, 2002, J BIOL CHEM, V277, P45984, DOI 10.1074/jbc.M200250200; Peraldi P, 2001, J BIOL CHEM, V276, P24614, DOI 10.1074/jbc.M102209200; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; Ramgolam V. S., 2011, J SIGNAL TRANSDUCT; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; RUBINS HB, 1992, J INTERN MED, V231, P421, DOI 10.1111/j.1365-2796.1992.tb00954.x; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Stark JL, 2006, INT IMMUNOL, V18, P347, DOI 10.1093/intimm/dxh373; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Yan FF, 2008, MED HYPOTHESES, V70, P845, DOI 10.1016/j.mehy.2007.07.031; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303	53	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27189	27203		10.1074/jbc.M112.346932	http://dx.doi.org/10.1074/jbc.M112.346932			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685291	hybrid, Green Published			2022-12-28	WOS:000307386000071
J	van Eijk, M; Rynkiewicz, MJ; White, MR; Hartshorn, KL; Zou, XQ; Schulten, K; Luo, D; Crouch, EC; Cafarella, TR; Head, JF; Haagsman, HP; Seaton, BA				van Eijk, Martin; Rynkiewicz, Michael J.; White, Mitchell R.; Hartshorn, Kevan L.; Zou, Xueqing; Schulten, Klaus; Luo, Dong; Crouch, Erika C.; Cafarella, Tanya R.; Head, James F.; Haagsman, Henk P.; Seaton, Barbara A.			A Unique Sugar-binding Site Mediates the Distinct Anti-influenza Activity of Pig Surfactant Protein D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUSES; INNATE IMMUNE PROTEINS; CARBOHYDRATE-RECOGNITION; MOLECULAR-DYNAMICS; ANTIVIRAL ACTIVITY; COLLECTINS; DOMAIN; MODEL; HEMAGGLUTININ; TRANSMISSION	Pigs can act as intermediate hosts by which reassorted influenza A virus (IAV) strains can be transmitted to humans and cause pandemic influenza outbreaks. The innate host defense component surfactant protein D (SP-D) interacts with glycans on the hemagglutinin of IAV and contributes to protection against IAV infection in mammals. This study shows that a recombinant trimeric neck lectin fragment derived from porcine SP-D (pSP-D) exhibits profound inhibitory activity against IAV, in contrast to comparable fragments derived from human SP-D. Crystallographic analysis of the pSP-D fragment complexed with a viral sugar component shows that a unique tripeptide loop alters the lectin site conformation of pSP-D. Molecular dynamics simulations highlight the role of this flexible loop, which adopts a more stable conformation upon sugar binding and may facilitate binding to viral glycans through contact with distal portions of the branched mannoside. The combined data demonstrate that porcine-specific structural features of SP-D contribute significantly to its distinct anti-IAV activity. These findings could help explain why pigs serve as important reservoirs for newly emerging pathogenic IAV strains.	[Rynkiewicz, Michael J.; Luo, Dong; Cafarella, Tanya R.; Head, James F.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [White, Mitchell R.; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [van Eijk, Martin; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Zou, Xueqing; Schulten, Klaus] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Crouch, Erika C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Boston University; Boston University; Utrecht University; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL)	Seaton, BA (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, 715 Albany St, Boston, MA 02118 USA.	seatonba@bu.edu	Haagsman, Henk P/F-8919-2010	Hartshorn, Kevan/0000-0002-7196-7433; Zou, Xueqing/0000-0003-1143-1028; Rynkiewicz, Michael/0000-0002-4717-5700; Head, James/0000-0002-6226-4146; Seaton, Barbara/0000-0003-4654-7709	Texas Advanced Computing Center via TeraGrid Resource Allocation Committee [MCA93S028]; National Institutes of Health [AI083222, HL069031, P41-RR005969]; European Union FP6 Grant Specific Targeted Research Project [LSHM-CT-2004-512093]; Human Frontier Science Program [RGP0016/2009-C]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER	Texas Advanced Computing Center via TeraGrid Resource Allocation Committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union FP6 Grant Specific Targeted Research Project; Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M. V. E. and H. P. H. thank Sanne Raadsveld for technical support. Supercomputer time was provided by Texas Advanced Computing Center via TeraGrid Resource Allocation Committee Grant MCA93S028.; This work was supported, in whole or in part, by National Institutes of Health Grants AI083222 (to B. A. S.) and HL069031 (to K. L. H.). This work was also supported by European Union FP6 Grant Specific Targeted Research Project Contract LSHM-CT-2004-512093 (to H. P. H.) and Human Frontier Science Program Grant RGP0016/2009-C (to H. P. H.); Recipient of National Institutes of Health Grant P41-RR005969.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cason C., 2005, PERSISTENCE VISION; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Crouch E, 2011, J BIOL CHEM, V286, P40681, DOI 10.1074/jbc.M111.300673; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez L, 2000, ARCH BIOCHEM BIOPHYS, V383, P17, DOI 10.1006/abbi.2000.2031; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn KL, 2010, SCAND J IMMUNOL, V72, P22, DOI 10.1111/j.1365-3083.2010.02409.x; Hartshorn KL, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-9; Hartshorn KL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-65; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; Hartshorn KL, 1996, BLOOD, V87, P3450, DOI 10.1182/blood.V87.8.3450.bloodjournal8783450; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Liu W, 2011, VET J, V187, P200, DOI 10.1016/j.tvjl.2009.10.026; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Morlot C, 2007, ACTA CRYSTALLOGR D, V63, P961, DOI 10.1107/S0907444907035470; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reading PC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-117; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Tecle T, 2008, BIOCHEM J, V412, P323, DOI 10.1042/BJ20071663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2002, AM J RESP CELL MOL, V26, P739, DOI 10.1165/ajrcmb.26.6.4520; van Eijk M, 2000, J IMMUNOL, V164, P1442, DOI 10.4049/jimmunol.164.3.1442; van Eijk M, 2011, J BIOL CHEM, V286, P20137, DOI 10.1074/jbc.M111.224469; Van Reeth K, 2007, VET RES, V38, P243, DOI 10.1051/vetres:2006062; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Webster RG, 1997, ARCH VIROL, P105; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; White M, 2008, J IMMUNOL, V181, P7936, DOI 10.4049/jimmunol.181.11.7936; White MR, 2008, EXPERT REV CLIN IMMU, V4, P497, DOI 10.1586/1744666X.4.4.497; White MR, 2005, AM J PHYSIOL-LUNG C, V289, pL606, DOI 10.1152/ajplung.00130.2005	65	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26666	26677		10.1074/jbc.M112.368571	http://dx.doi.org/10.1074/jbc.M112.368571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22685299	Green Published, hybrid			2022-12-28	WOS:000307386000018
J	Singh, A; Ram, H; Abbas, N; Chattopadhyay, S				Singh, Aparna; Ram, Hathi; Abbas, Nazia; Chattopadhyay, Sudip			Molecular Interactions of GBF1 with HY5 and HYH Proteins during Light-mediated Seedling Development in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX BINDING-FACTORS; TRANSCRIPTION-FACTOR; GENE-EXPRESSION; BLUE-LIGHT; PHYTOCHROME-A; PHOTOMORPHOGENIC GROWTH; BZIP PROTEINS; COP1; PROMOTERS; HYPOCOTYL	Arabidopsis bZIP transcription factor, GBF1, acts as a differential regulator of cryptochrome-mediated blue light signaling. Whereas the bZIP proteins, HY5 (elongated hypocotyl 5) and HYH (HY5 homologue), are degraded by COP1-mediated proteasomal pathways, GBF1 is degraded by a proteasomal pathway independent of COP1. In this study, we have investigated the functional interrelations of GBF1 with HY5 and HYH in Arabidopsis seedling development. The genetic studies using double and triple mutants reveal that GBF1 largely acts antagonistically with HY5 and HYH in Arabidopsis seedling development. Further, GBF1 and HY5 play more important roles than HYH in blue light-mediated photomorphogenic growth. This study reveals that GBF1 is able to form a G-box-binding heterodimer with HY5 but not with HYH. The in vitro and in vivo studies demonstrate that GBF1 co-localizes with HY5 or HYH in the nucleus and physically interacts with both of the proteins. The protein-protein interaction studies further reveal that the bZIP domain of GBF1 is essential and sufficient for the interaction with HY5 or HYH. Taken together, these data demonstrate the functional interrelations of GBF1 with HY5 and HYH in Arabidopsis seedling development.	[Chattopadhyay, Sudip] Natl Inst Technol, Dept Biotechnol, Durgapur 713209, W Bengal, India; [Singh, Aparna; Ram, Hathi; Abbas, Nazia] Natl Inst Plant Genome Res, New Delhi 10067, India	National Institute of Technology (NIT System); National Institute of Technology Durgapur; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, S (corresponding author), Natl Inst Technol, Dept Biotechnol, Mahatma Gandhi Ave, Durgapur 713209, W Bengal, India.	sudipchatto@gmail.com	Chattopadhyay, Sudip/P-8491-2014	Ram, Dr Hasthi/0000-0003-0893-3895	J.C. Bose National Fellowship Award Grant; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	J.C. Bose National Fellowship Award Grant; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work is supported by a J.C. Bose National Fellowship Award Grant and in part by a research grant from the Department of Science and Technology, Government of India (to S. C.).; Both authors contributed equally to this work and are recipients of fellowships from the Council of Scientific and Industrial Research, Government of India.; Recipient of a fellowship from the Department of Biotechnology, Government of India.	ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bhatia S, 2008, PLANT PHYSIOL, V147, P169, DOI 10.1104/pp.108.118174; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chattopadhyay S, 1998, PLANT J, V15, P69, DOI 10.1046/j.1365-313X.1998.00180.x; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Datta S, 2008, PLANT CELL, V20, P2324, DOI 10.1105/tpc.108.061747; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; HARTER K, 1994, PLANT CELL, V6, P545, DOI 10.1105/tpc.6.4.545; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kirby J, 2002, PLANT J, V32, P391, DOI 10.1046/j.1365-313X.2002.01422.x; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kushwaha R, 2008, PLANT CELL, V20, P1747, DOI 10.1105/tpc.107.057612; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lin C, 2002, SCI STKE, V2002, ppe5; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mallappa C, 2008, J BIOL CHEM, V283, P35772, DOI 10.1074/jbc.M803437200; Mallappa C, 2006, J BIOL CHEM, V281, P22190, DOI 10.1074/jbc.M601172200; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; Neff MM, 2000, GENE DEV, V14, P257; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Osterlund MT, 1998, PLANT J, V16, P201, DOI 10.1046/j.1365-313x.1998.00290.x; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Pepper AE, 1997, GENETICS, V145, P1125; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Saijo Y, 2003, GENE DEV, V17, P2642, DOI 10.1101/gad.1122903; Schepens I, 2004, CURR OPIN PLANT BIOL, V7, P564, DOI 10.1016/j.pbi.2004.07.004; SCHINDLER U, 1992, EMBO J, V11, P1275, DOI 10.1002/j.1460-2075.1992.tb05171.x; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yadav V, 2002, PLANT J, V31, P741, DOI 10.1046/j.1365-313X.2002.01395.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang HY, 2011, PLANT J, V65, P346, DOI 10.1111/j.1365-313X.2010.04426.x	45	63	73	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25995	26009		10.1074/jbc.M111.333906	http://dx.doi.org/10.1074/jbc.M111.333906			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22692212	hybrid, Green Published			2022-12-28	WOS:000306916300027
J	Vaiyapuri, S; Hutchinson, EG; Ali, MS; Dannoura, A; Stanley, RG; Harrison, RA; Bicknell, AB; Gibbins, JM				Vaiyapuri, Sakthivel; Hutchinson, E. Gail; Ali, Marfoua S.; Dannoura, Abeer; Stanley, Ronald G.; Harrison, Robert A.; Bicknell, Andrew B.; Gibbins, Jonathan M.			Rhinocetin, a Venom-derived Integrin-specific Antagonist Inhibits Collagen-induced Platelet and Endothelial Cell Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; CROTALUS-DURISSUS-TERRIFICUS; BITIS-GABONICA-RHINOCEROS; ALPHA-2-BETA-1 INTEGRIN; VONWILLEBRAND-FACTOR; CRYSTAL-STRUCTURE; SNAKE-VENOMS; BINDING; PROTEIN; VIPER	Snaclecs are small non-enzymatic proteins present in viper venoms reported to modulate hemostasis of victims through effects on platelets, vascular endothelial, and smooth muscle cells. In this study, we have isolated and functionally characterized a snaclec that we named "rhinocetin" from the venom of West African gaboon viper, Bitis gabonica rhinoceros. Rhinocetin was shown to comprise alpha and beta chains with the molecular masses of 13.5 and 13 kDa, respectively. Sequence and immunoblot analysis of rhinocetin confirmed this to be a novel snaclec. Rhinocetin inhibited collagen-stimulated activation of human platelets in a dose-dependent manner but displayed no inhibitory effects on glycoprotein VI (collagen receptor) selective agonist, CRP-XL-, ADP-, or thrombin-induced platelet activation. Rhinocetin antagonized the binding of monoclonal antibodies against the alpha 2 subunit of integrin alpha 2 beta 1 to platelets and coimmunoprecipitation analysis confirmed integrin alpha 2 beta 1 as a target for this venom protein. Rhinocetin inhibited a range of collagen-induced platelet functions such as fibrinogen binding, calcium mobilization, granule secretion, aggregation, and thrombus formation. It also inhibited integrin alpha 2 beta 1-dependent functions of human endothelial cells. Together, our data suggest rhinocetin to be a modulator of integrin alpha 2 beta 1 function and thus may provide valuable insights into the role of this integrin in physiological and pathophysiological scenarios, including hemostasis, thrombosis, and envenomation.	[Vaiyapuri, Sakthivel; Hutchinson, E. Gail; Ali, Marfoua S.; Stanley, Ronald G.; Bicknell, Andrew B.; Gibbins, Jonathan M.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading RG6 6UB, Berks, England; [Dannoura, Abeer] Univ Reading, Sch Pharm Food Biosci & Chem, Reading RG6 6UB, Berks, England; [Harrison, Robert A.] Univ Liverpool, Liverpool Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool L3 5QA, Merseyside, England	University of Reading; University of Reading; Liverpool School of Tropical Medicine; University of Liverpool	Gibbins, JM (corresponding author), Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading RG6 6UB, Berks, England.	j.m.gibbins@reading.ac.uk	Vaiyapuri, Sakthivel/M-4198-2013; ali, marfoua saleh/H-9824-2019	Vaiyapuri, Sakthivel/0000-0002-6006-6517; Gibbins, Jonathan/0000-0002-0372-5352	British Heart Foundation [PG/08/100/26125, PG/11/125/29320]; Medical Research Council UK [G0701399]; Biotechnology and Biological Sciences Research Council [BB/F012675/1]; Medical Research Council [G0701399] Funding Source: researchfish; BBSRC [BB/F012675/1] Funding Source: UKRI; MRC [G0701399] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Grants PG/08/100/26125 and PG/11/125/29320, Medical Research Council UK Grant G0701399, and Biotechnology and Biological Sciences Research Council Grant BB/F012675/1.	Aird SD, 2002, TOXICON, V40, P335, DOI 10.1016/S0041-0101(01)00232-X; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Clemetson K. J., 2002, PLATELET RECEPTORS P, P117; Clemetson KJ, 2010, TOXICON, V56, P1236, DOI 10.1016/j.toxicon.2010.03.011; COLLER BS, 1989, BLOOD, V74, P182; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Du XY, 2002, J BIOL CHEM, V277, P35124, DOI 10.1074/jbc.M204372200; Eble JA, 2009, FASEB J, V23, P2917, DOI 10.1096/fj.08-126763; Fox JW, 2007, CURR PHARM DESIGN, V13, P2927, DOI 10.2174/138161207782023739; Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Gotwals PJ, 1996, J CLIN INVEST, V97, P2469, DOI 10.1172/JCI118693; Harrison RA, 2003, GENE, V315, P95, DOI 10.1016/S0378-1119(03)00716-9; HATHAWAY DR, 1979, P NATL ACAD SCI USA, V76, P1653, DOI 10.1073/pnas.76.4.1653; Horii K, 2004, J MOL BIOL, V341, P519, DOI 10.1016/j.jmb.2004.06.036; Kaiser WJ, 2009, J PROTEOME RES, V8, P2903, DOI 10.1021/pr900027j; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latallo Z. S., 1971, SCAND J HAEMAT     S, V13, P261; Marcinkiewicz C, 2005, CURR PHARM DESIGN, V11, P815, DOI 10.2174/1381612053381765; Marcinkiewicz C, 2000, BIOCHEMISTRY-US, V39, P9859, DOI 10.1021/bi000428a; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016; MARSH NA, 1974, BRIT J HAEMATOL, V26, P295, DOI 10.1111/j.1365-2141.1974.tb00474.x; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; Murakami MT, 2003, BIOCHEM BIOPH RES CO, V310, P478, DOI 10.1016/j.bbrc.2003.09.032; PENG ML, 1993, BLOOD, V81, P2321; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; READ MS, 1983, J LAB CLIN MED, V101, P74; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sajevic T, 2011, TOXICON, V57, P627, DOI 10.1016/j.toxicon.2011.01.006; Sarray S, 2003, BBA-PROTEINS PROTEOM, V1651, P30, DOI 10.1016/S1570-9639(03)00232-2; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Smith RA, 1997, J BIOL CHEM, V272, P22080, DOI 10.1074/jbc.272.35.22080; Spyridon M, 2011, BLOOD, V117, P5751, DOI 10.1182/blood-2010-09-306142; Staniszewska I, 2009, CANCER BIOL THER, V8, P1507, DOI 10.4161/cbt.8.15.8999; TOKUNAGA F, 1988, J BIOL CHEM, V263, P17471; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Vaiyapuri S, 2012, CIRCULATION, V125, P2479, DOI 10.1161/CIRCULATIONAHA.112.101246; Vaiyapuri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021532; Vaiyapuri S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000796; Vaiyapuri S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009687; Wang RH, 1999, BIOCHEMISTRY-US, V38, P7584, DOI 10.1021/bi982132z; White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhong SR, 2006, TOXICON, V47, P104, DOI 10.1016/j.toxicon.2005.10.002	53	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26235	26244		10.1074/jbc.M112.381483	http://dx.doi.org/10.1074/jbc.M112.381483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22689571	Green Published, hybrid			2022-12-28	WOS:000306916300050
J	Bena, S; Brancaleone, V; Wang, JM; Perretti, M; Flower, RJ				Bena, Stefania; Brancaleone, Vincenzo; Wang, Ji Ming; Perretti, Mauro; Flower, Roderick J.			Annexin A1 Interaction with the FPR2/ALX Receptor IDENTIFICATION OF DISTINCT DOMAINS AND DOWNSTREAM ASSOCIATED SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYL-PEPTIDE RECEPTOR; FUNCTIONAL DOMAINS; HUMAN NEUTROPHILS; INFLAMMATION; RESPONSES; AGONIST; LIGAND; FPR; ACTIVATION; PATHWAYS	Understanding how proresolving agonists selectively activate FPR2/ALX is a crucial step in the clarification of proresolution molecular networks that can be harnessed for the design of novel therapeutics for inflammatory disease. FPR2/ALX, a G protein-coupled receptor belonging to the formyl peptide receptor (FPR) family, conveys the biological functions of a variety of ligands, including the proresolution mediators annexin A1 (AnxA1) and lipoxin A(4), as well as the activating and proinflammatory protein serum amyloid A. FPR2/ALX is the focus of intense screening for novel anti-inflammatory therapeutics, and the small molecule compound 43 was identified as a receptor ligand. Here, we used chimeric FPR1 and FPR2/ALX clones (stably transfected in HEK293 cells) to identify the N-terminal region and extracellular loop II as the FPR2/ALX domain required for AnxA1-mediated signaling. Genomic responses were also assessed with domain-specific effects emerging, so the N-terminal region is required for AnxA1 induction of JAG1 and JAM3, whereas it is dispensable for modulation of SGPP2. By comparison, serum amyloid A non-genomic responses were reliant on extracellular loops I and II, whereas the small molecule compound 43 activated extracellular loop I with downstream signaling dependent on transmembrane region II. In desensitization experiments, the N-terminal region was dispensable for AnxA1-induced FPR2/ALX down-regulation in both the homologous and heterologous desensitization modes.	[Bena, Stefania; Brancaleone, Vincenzo; Perretti, Mauro; Flower, Roderick J.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England; [Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Ctr Canc Res, Frederick, MD 21702 USA	University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Perretti, M (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England.	m.perretti@qmul.ac.uk; r.j.flower@qmul.ac.uk		brancaleone, vincenzo/0000-0002-0063-659X	Wellcome Trust [086867/Z/08]; National Institute for Health Research; Medical Research Council [1094730] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010015] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Wellcome Trust Programme 086867/Z/08. This work forms part of the research themes contributing to the translational research portfolio of Barts and The London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute for Health Research.	Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Brancaleone V, 2011, J IMMUNOL, V186, P4905, DOI 10.4049/jimmunol.1003145; Burli RW, 2006, BIOORG MED CHEM LETT, V16, P3713, DOI 10.1016/j.bmcl.2006.04.068; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Dalli J, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00028; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Kirpotina LN, 2010, MOL PHARMACOL, V77, P159, DOI 10.1124/mol.109.060673; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lala A, 1999, EUR J BIOCHEM, V264, P495, DOI 10.1046/j.1432-1327.1999.00647.x; Le YY, 2005, FEBS J, V272, P769, DOI 10.1111/j.1742-4658.2004.04514.x; Le YY, 2001, CLIN IMMUNOL, V99, P365, DOI 10.1006/clim.2001.5021; Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Rabiet MJ, 2011, J BIOL CHEM, V286, P26718, DOI 10.1074/jbc.M111.244590; Renshaw D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012771; Rosengarth A, 2003, J MOL BIOL, V326, P1317, DOI 10.1016/S0022-2836(03)00027-5; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sogawa Y, 2011, J PHARMACOL SCI, V115, P63, DOI 10.1254/jphs.10194FP; Sogawa Y, 2009, J PHARMACOL SCI, V111, P317, DOI 10.1254/jphs.09196SC; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wenzel-Seifert K, 1998, J BIOL CHEM, V273, P24181, DOI 10.1074/jbc.273.37.24181; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	33	89	95	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24690	24697		10.1074/jbc.M112.377101	http://dx.doi.org/10.1074/jbc.M112.377101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22610094	Green Published, hybrid			2022-12-28	WOS:000306651100062
J	Bu, LT; Nimlos, MR; Shirts, MR; Stahlberg, J; Himmel, ME; Crowley, MF; Beckham, GT				Bu, Lintao; Nimlos, Mark R.; Shirts, Michael R.; Stahlberg, Jerry; Himmel, Michael E.; Crowley, Michael F.; Beckham, Gregg T.			Product Binding Varies Dramatically between Processive and Nonprocessive Cellulase Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TRICHODERMA-REESEI; HUMICOLA-INSOLENS; ENZYMATIC-HYDROLYSIS; FORCE-FIELDS; SIMULTANEOUS SACCHARIFICATION; CELLOBIOHYDROLASE CEL6A; BIOMASS RECALCITRANCE; FUNGAL CELLULASE; PROTEIN	Cellulases hydrolyze beta-1,4 glycosidic linkages in cellulose, which are among the most prevalent and stable bonds in Nature. Cellulases comprise many glycoside hydrolase families and exist as processive or nonprocessive enzymes. Product inhibition negatively impacts cellulase action, but experimental measurements of product-binding constants vary significantly, and there is little consensus on the importance of this phenomenon. To provide molecular level insights into cellulase product inhibition, we examine the impact of product binding on processive and nonprocessive cellulases by calculating the binding free energy of cellobiose to the product sites of catalytic domains of processive and nonprocessive enzymes from glycoside hydrolase families 6 and 7. The results suggest that cellobiose binds to processive cellulases much more strongly than nonprocessive cellulases. We also predict that the presence of a cellodextrin bound in the reactant site of the catalytic domain, which is present during enzymatic catalysis, has no effect on product binding in nonprocessive cellulases, whereas it significantly increases product binding to processive cellulases. This difference in product binding correlates with hydrogen bonding between the substrate-side ligand and the cellobiose product in processive cellulase tunnels and the additional stabilization from the longer tunnel-forming loops. The hydrogen bonds between the substrate-and product-side ligands are disrupted by water in nonprocessive cellulase clefts, and the lack of long tunnel-forming loops results in lower affinity of the product ligand. These findings provide new insights into the large discrepancies reported for binding constants for cellulases and suggest that product inhibition will vary significantly based on the amount of productive binding for processive cellulases on cellulose.	[Bu, Lintao; Nimlos, Mark R.; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA; [Shirts, Michael R.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA; [Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Biol, S-75651 Uppsala, Sweden	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; University of Virginia; Swedish University of Agricultural Sciences	Bu, LT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.	lintao.bu@nrel.gov; gregg.beckham@nrel.gov	crowley, michael F/A-4852-2013; Stahlberg, Jerry/D-4163-2013	crowley, michael F/0000-0001-5163-9398; Stahlberg, Jerry/0000-0003-4059-8580	Department of Energy Office of the Biomass Program; National Science Foundation through TeraGrid resources [TG-MCB090159]; Department of Energy EERE [DE-AC36-08GO28308]	Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); National Science Foundation through TeraGrid resources(National Science Foundation (NSF)); Department of Energy EERE(United States Department of Energy (DOE))	This work was supported by the Department of Energy Office of the Biomass Program. Computational time for this research was supported in part by the National Science Foundation through TeraGrid resources under Grant TG-MCB090159 and by the NREL Computational Sciences Center supported by the Department of Energy EERE under Contract DE-AC36-08GO28308.	Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Bezerra RMF, 2005, APPL BIOCHEM BIOTECH, V126, P49, DOI 10.1007/s12010-005-0005-5; Bezerra RMF, 2004, APPL BIOCHEM BIOTECH, V112, P173, DOI 10.1385/ABAB:112:3:173; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Bommarius AS, 2008, METAB ENG, V10, P370, DOI 10.1016/j.ymben.2008.06.008; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHANZY H, 1983, FEBS LETT, V153, P113, DOI 10.1016/0014-5793(83)80129-X; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; CLAEYSSENS M, 1989, BIOCHEM J, V261, P819, DOI 10.1042/bj2610819; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Du F., APPL BIOCH BIOTECHNO, V161, P313; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Gan Q, 2003, PROCESS BIOCHEM, V38, P1003, DOI 10.1016/S0032-9592(02)00220-0; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; GUSAKOV AV, 1987, BIOTECHNOL BIOENG, V29, P906, DOI 10.1002/bit.260290715; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Oh KK, 2000, APPL BIOCHEM BIOTECH, V89, P15, DOI 10.1385/ABAB:89:1:15; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; PHILIPPIDIS GP, 1993, BIOTECHNOL BIOENG, V41, P846, DOI 10.1002/bit.260410903; Rosgaard L, 2007, BIOTECHNOL PROGR, V23, P1270, DOI 10.1021/bp070329p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; Taylor CB, 2012, J BIOL CHEM, V287, P3147, DOI 10.1074/jbc.M111.270389; Ubhayasekera W, 2005, FEBS J, V272, P1952, DOI 10.1111/j.1742-4658.2005.04625.x; VANTILBEURGH H, 1989, EUR J BIOCHEM, V184, P553; Varrot A, 1999, BIOCHEMISTRY-US, V38, P8884, DOI 10.1021/bi9903998; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; WALD S, 1984, BIOTECHNOL BIOENG, V26, P221, DOI 10.1002/bit.260260305	56	50	50	2	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24807	24813		10.1074/jbc.M112.365510	http://dx.doi.org/10.1074/jbc.M112.365510			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22648408	Green Published, hybrid			2022-12-28	WOS:000306651100073
J	Yu, ZX; Visse, R; Inouye, M; Nagase, H; Brodsky, B				Yu, Zhuoxin; Visse, Robert; Inouye, Masayori; Nagase, Hideaki; Brodsky, Barbara			Defining Requirements for Collagenase Cleavage in Collagen Type III Using a Bacterial Collagen System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; HUMAN-FIBROBLAST-COLLAGENASE; C-TERMINAL DOMAIN; MOLECULAR-STRUCTURE; SUBSTRATE-SPECIFICITY; THERMAL-STABILITY; METALLOPROTEINASE; PEPTIDE; IDENTIFICATION; CATABOLISM	Degradation of fibrillar collagens is important in many physiological and pathological events. These collagens are resistant to most proteases due to the tightly packed triple-helical structure, but are readily cleaved at a specific site by collagenases, selected members of the matrix metalloproteinases (MMPs). To investigate the structural requirements for collagenolysis, varying numbers of GXY triplets from human type III collagen around the collagenase cleavage site were inserted between two triple helix domains of the Scl2 bacterial collagen protein. The original bacterial CL domain was not cleaved by MMP-1 (collagenase 1) or MMP-13 (collagenase 3). The minimum type III sequence necessary for cleavage by the two collagenases was 5 GXY triplets, including 4 residues before and 11 residues after the cleavage site (P4-P11'). Cleavage of these chimeric substrates was not achieved by the catalytic domain of MMP-1 or MMP-13, nor by full-length MMP-3. Kinetic analysis of the chimeras indicated that the rate of cleavage by MMP-1 of the chimera containing six triplets (P7-P11') of collagen III was similar to that of native collagen III. The collagenase-susceptible chimeras were cleaved very slowly by trypsin, a property also seen for native collagen III, supporting a local structural relaxation of the triple helix near the collagenase cleavage site. The recombinant bacterial-human collagen system characterized here is a good model to investigate the specificity and mechanism of action of collagenases.	[Visse, Robert; Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London W6 8LH, England; [Yu, Zhuoxin; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Yu, Zhuoxin; Inouye, Masayori] Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts University	Nagase, H (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, 65 Aspenlea Rd, London W6 8LH, England.	h.nagase@imperial.ac.uk; barbara.brodsky@tufts.edu	Yu, Zhuoxin/L-1512-2013		National Institutes of Health [GM60048, EB011620]; Arthritis Research United Kingdom; Wellcome Trust [075473]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research United Kingdom(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60048 and EB011620 (to B. B.). This work was also supported by Arthritis Research United Kingdom and Wellcome Trust Grant 075473 (to H. N.).	BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; BROWN FR, 1969, J MOL BIOL, V39, P307, DOI 10.1016/0022-2836(69)90319-2; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Cheng HM, 2011, J BIOL CHEM, V286, P2041, DOI 10.1074/jbc.M110.153965; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; DANIELSEN CC, 1987, BIOCHEM J, V247, P725, DOI 10.1042/bj2470725; DAVIS JM, 1993, J BIOL CHEM, V268, P25965; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a; Gross J., 1980, COLLAGENASE NORMAL P, P11; GUNJASMITH Z, 1989, BIOCHEM J, V258, P115, DOI 10.1042/bj2580115; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; HASTY KA, 1987, J BIOL CHEM, V262, P10048; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; MILLER EJ, 1976, BIOCHEMISTRY-US, V15, P787, DOI 10.1021/bi00649a009; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; MURPHY G, 1992, J BIOL CHEM, V267, P9612; NAGAI Y, 1966, BIOCHEMISTRY-US, V5, P3123, DOI 10.1021/bi00874a007; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Salsas-Escat R, 2010, BIOCHEMISTRY-US, V49, P4147, DOI 10.1021/bi9021473; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; WELGUS HG, 1985, J BIOL CHEM, V260, P1052; WELGUS HG, 1982, J BIOL CHEM, V257, P1534; Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009; Woessner JF, 1998, BIOL EXTRAC, P1; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xu YJ, 2009, METHOD ENZYMOL, V466, P211, DOI 10.1016/S0076-6879(09)66009-2; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134	56	56	57	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22988	22997		10.1074/jbc.M112.348979	http://dx.doi.org/10.1074/jbc.M112.348979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22573319	hybrid, Green Published			2022-12-28	WOS:000306495000055
J	Culver, BP; Savas, JN; Park, SK; Choi, JH; Zheng, SQ; Zeitlin, SO; Yates, JR; Tanese, N				Culver, Brady P.; Savas, Jeffrey N.; Park, Sung K.; Choi, Jeong H.; Zheng, Shuqiu; Zeitlin, Scott O.; Yates, John R., III; Tanese, Naoko			Proteomic Analysis of Wild-type and Mutant Huntingtin-associated Proteins in Mouse Brains Identifies Unique Interactions and Involvement in Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE PROTEIN; SHOTGUN PROTEOMICS; RAT-BRAIN; STRESS GRANULES; MESSENGER-RNAS; YEAST PROTEOME; EARLY MOTOR; COMPLEX; DOMAIN; LOCALIZATION	Huntington disease is a neurodegenerative disorder caused by a CAG repeat amplification in the gene huntingtin (HTT) that is reflected by a polyglutamine expansion in the Htt protein. Nearly 20 years of research have uncovered roles for Htt in a wide range of cellular processes, and many of these discoveries stemmed from the identification of Htt-interacting proteins. However, no study has employed an impartial and comprehensive strategy to identify proteins that differentially associate with full-length wild-type and mutant Htt in brain tissue, the most relevant sample source to the disease condition. We analyzed Htt affinity-purified complexes from wild-type and HTT mutant juvenile mouse brain from two different biochemical fractions by tandem mass spectrometry. We compared variations in protein spectral counts relative to Htt to identify those proteins that are the most significantly contrasted between wild-type and mutant Htt purifications. Previously unreported Htt interactions with Myo5a, Prkra (PACT), Gnb2l1 (RACK1), Rps6, and Syt2 were confirmed by Western blot analysis. Gene Ontology analysis of these and other Htt-associated proteins revealed a statistically significant enrichment for proteins involved in translation among other categories. Furthermore, Htt co-sedimentation with polysomes in cytoplasmic mouse brain extracts is dependent upon the presence of intact ribosomes. Finally, wild-type or mutant Htt overexpression inhibits cap-dependent translation of a reporter mRNA in an in vitro system. Cumulatively, these data support a new role for Htt in translation and provide impetus for further study into the link between protein synthesis and Huntington disease pathogenesis.	[Culver, Brady P.; Savas, Jeffrey N.; Tanese, Naoko] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Savas, Jeffrey N.; Park, Sung K.; Choi, Jeong H.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Zheng, Shuqiu; Zeitlin, Scott O.] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	New York University; Scripps Research Institute; University of Virginia	Tanese, N (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.	tanesn01@med.nyu.edu	Zeitlin, Scott/P-5787-2019	Tanese, Naoko/0000-0002-1946-3211	National Institutes of Health [R01 NS061917, R01 MH067880-09, P01 AG031097-03, P41 RR011823-14]; Shared Instrumentation Grant [S10 RR017970]; CHDI Foundation, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017970, P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043466, R01NS061917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031097, F32AG039127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Instrumentation Grant; CHDI Foundation, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS061917 (to N. T.) and R01 MH067880-09, P01 AG031097-03, and P41 RR011823-14 (to J. R. Y.), and Shared Instrumentation Grant S10 RR017970. This work was also supported by the CHDI Foundation, Inc. (to N. T.).	Angenstein F, 2002, J NEUROSCI, V22, P8827; Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bai Fengju, 2007, V43, P77, DOI 10.1007/978-1-4020-5943-8_6; Bano D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.112; Bern M, 2004, BIOINFORMATICS, V20, P49, DOI 10.1093/bioinformatics/bth947; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Ma B, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-22; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mitsui K, 2002, J NEUROSCI, V22, P9267; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peel AL, 2001, HUM MOL GENET, V10, P1531, DOI 10.1093/hmg/10.15.1531; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rakotondrafara AM, 2011, NAT PROTOC, V6, P563, DOI 10.1038/nprot.2011.314; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Savas JN, 2010, J BIOL CHEM, V285, P13142, DOI 10.1074/jbc.M110.114561; SILMAN N, 1965, BIOCHIM BIOPHYS ACTA, V103, P231, DOI 10.1016/0005-2787(65)90164-4; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tauber E, 2011, J BIOL CHEM, V286, P410, DOI 10.1074/jbc.M110.101527; Teuling E, 2011, PLOS CURR, V3; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Washburn MP, 2011, TRENDS BIOCHEM SCI, V36, P170, DOI 10.1016/j.tibs.2010.09.001; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	70	87	89	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21599	21614		10.1074/jbc.M112.359307	http://dx.doi.org/10.1074/jbc.M112.359307			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556411	Green Published, hybrid			2022-12-28	WOS:000306418600004
J	Hoang, B; Benavides, A; Shi, YJ; Yang, YH; Frost, P; Gera, J; Lichtenstein, A				Hoang, Bao; Benavides, Angelica; Shi, Yijiang; Yang, Yonghui; Frost, Patrick; Gera, Joseph; Lichtenstein, Alan			The PP242 Mammalian Target of Rapamycin (mTOR) Inhibitor Activates Extracellular Signal-regulated Kinase (ERK) in Multiple Myeloma Cells via a Target of Rapamycin Complex 1 (TORC1)/Eukaryotic Translation Initiation Factor 4E (eIF-4E)/RAF Pathway and Activation Is a Mechanism of Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASCADE INHIBITORS; TUMOR PROGRESSION; EIF4E; BRAF; PHOSPHORYLATION; SENSITIVITY; RAF-1; AKT	Activation of PI3-K-AKT and ERK pathways is a complication of mTOR inhibitor therapy. Newer mTOR inhibitors (like pp242) can overcome feedback activation of AKT in multiple myeloma (MM) cells. We, thus, studied if feedback activation of ERK is still a complication of therapy with such drugs in this tumor model. PP242 induced ERK activation in MM cell lines as well as primary cells. Surprisingly, equimolar concentrations of rapamycin were relatively ineffective at ERK activation. Activation was not correlated with P70S6kinase inhibition nor was it prevented by PI3-kinase inhibition. ERK activation was prevented by MEK inhibitors and was associated with concurrent stimulation of RAF kinase activity but not RAS activation. RAF activation correlated with decreased phosphorylation of RAF at Ser-289, Ser-296, and Ser-301 inhibitory residues. Knockdown studies confirmed TORC1 inhibition was the key proximal event that resulted in ERK activation. Furthermore, ectopic expression of eIF-4E blunted pp242-induced ERK phosphorylation. Since pp242 was more potent than rapamycin in causing sequestering of eIF-4E, a TORC1/4E-BP1/eIF-4E-mediated mechanism of ERK activation could explain the greater effectiveness of pp242. Use of MEK inhibitors confirmed ERK activation served as a mechanism of resistance to the lethal effects of pp242. Thus, although active site mTOR inhibitors overcome AKT activation often seen with rapalog therapy, feedback ERK activation is still a problem of resistance, is more severe than that seen with use of first generation rapalogs and is mediated by a TORC1-and eIF-4E-dependent mechanism ultimately signaling to RAF.	UCLA GLA VA Healthcare Syst, Div Hematol Oncol, Los Angeles, CA 90073 USA; Jonsson Comprehens Canc Ctr, Los Angeles, CA 90073 USA	UCLA Jonsson Comprehensive Cancer Center	Lichtenstein, A (corresponding author), VA W Hosp, W111H,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	Alan.lichtenstein@med.va.gov		Frost, Patrick/0000-0003-3348-5983; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [R01 CA109312, R01 CA111448]; Veteran's Administration; Dept. of Defense; Multiple Myeloma Research Foundation;  [JCCC/P30 CA016042];  [CURE/P30 DK041301]; NATIONAL CANCER INSTITUTE [P30CA016042, R01CA111448, R01CA168700, R01CA109312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); Dept. of Defense(United States Department of Defense); Multiple Myeloma Research Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA109312 and R01 CA111448, research funds of the Veteran's Administration and Dept. of Defense and the Multiple Myeloma Research Foundation. The UCLA Vector Core is supported by JCCC/P30 CA016042 and CURE/P30 DK041301.	Annunziata CM, 2011, BLOOD, V117, P2396, DOI 10.1182/blood-2010-04-278788; Bondzi C, 2000, ONCOGENE, V19, P5030, DOI 10.1038/sj.onc.1203862; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chang FM, 2003, INT J ONCOL, V22, P469; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Depoil D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pt1; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Hay N, 2010, P NATL ACAD SCI USA, V107, P13975, DOI 10.1073/pnas.1008908107; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Shelton JG, 2003, LEUKEMIA, V17, P1765, DOI 10.1038/sj.leu.2403052; Shi Y, 2005, INT J INF TECH DECIS, V4, P1; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Shi YJ, 2002, CANCER RES, V62, P5027; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	31	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2012	287	26					21796	21805		10.1074/jbc.M111.304626	http://dx.doi.org/10.1074/jbc.M111.304626			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974GH	22556409	Green Published, hybrid			2022-12-28	WOS:000306418600021
